,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
7354,GO:0031424,7.80206635114352e-18,1,24,84,keratinization,BP,RPTN;SPRR2G;SPRR2A;TCHH;LCE1B;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;FLG;LCE3D;LCE3E;KRT78;SPRR2E;SPRR2D;KRT4;HRNR;KRT13;CDSN;KRT23;LCE1C;KRT34
482,GO:0001533,2.24021129499704e-16,1,18,46,cornified envelope,CC,RPTN;SPRR2G;SPRR2A;FLG2;TCHH;LCE1B;KRT1;KRT2;SPRR3;FLG;LCE3D;LCE3E;SPRR2E;SPRR2D;HRNR;CDSN;ANXA1;LCE1C
14626,GO:0070268,5.12551667477635e-15,1,20,70,cornification,BP,RPTN;SPRR2G;SPRR2A;TCHH;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;FLG;LCE3D;KRT78;SPRR2E;SPRR2D;KRT4;KRT13;CDSN;KRT23;KRT34
12319,GO:0048731,6.60295766124013e-15,1,156,2928,system development,BP,NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;CXCL1;TENM3;LGALS1;DSCAM;OSR2;KRT24;ASPRV1;KRT2;LCP1;KRT18;SPRR3;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;DPYSL3;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;GREB1L;SPRR2D;CCBE1;JUN;KRT4;CLDN11;MCAM;RIPK2;NFKB2;SPNS2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;TRIB1;KRT23;CD83;ITGAV;LYN;COL8A1;ANXA1;COL4A4;G6PD;NBN;SLC8A1;NEDD4L;LCE1C;VEGFC;RHOB;XBP1;MOBP;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;KLK6;PAPSS2;FRAS1;RIMS2;NRP1;IL7R;EGLN1;SETX;CXCR5;KLF10;NRG1;IFRD1;SERPINH1;HSP90AB1;KRT34;ADAM8;L1CAM;NR2F2;CALR;CTR9;AMOTL2;SERP1;EIF2B1;MAFF;HMGCS1;UBP1;CORO1C;IL23A;MME;DLG1;GDA;EHD1;CITED2;LOX;ETS1;HAS2;ADGRL3;BAMBI;TFRC;ZFP42;NEDD4;CDK6;TUBB3;NTNG1;PML;OXCT1;EPHA2;MYH9;HES4;SOX11;ENPP1;SORBS2;TNFAIP2;HSPD1;MAGED1;CYP1A1;PARVA
4365,GO:0010033,1.33679968479384e-14,1,125,2152,response to organic substance,BP,IL32;NFKBIA;MMP9;IL1A;TRIM16;NEFL;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;LCP1;TNIP1;KRT18;NFKB1;RELB;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;UBQLN2;CHAC1;CDKN2B;CLDN7;DNAJB1;PEG10;CCBE1;JUN;RIPK2;IL16;NFKB2;HERPUD1;PARP1;OPTN;SDK1;HSPA5;IL1B;KRT13;JUNB;TJP2;IL6ST;CRYAB;ATF3;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;HSPA6;NOCT;IKBKE;CYLD;FBN2;DUSP1;TRIB1;CD83;LYN;ANXA1;DERL3;G6PD;SLC8A1;BIRC3;VEGFC;XBP1;ARG1;UGGT1;TRAF3;HMOX1;MMP19;IL24;HSP90AA1;CANX;NRP1;IL7R;TRAF1;SETX;TNFSF15;CXCR5;SOD2;KLF10;SERPINH1;HSP90AB1;NR2F2;CALR;PDIA6;IFNAR1;CTR9;SEL1L;SERP1;EIF2B1;HMGCS1;IL23A;MME;EHD1;CITED2;LOX;ETS1;HAS2;ADGRL3;MGST3;BAMBI;DNAJC3;ZC3H7B;IFNGR1;HSP90B1;TFRC;HTR1B;SVIP;NEDD4;PML;OXCT1;EPHA2;SOX11;ENPP1;HSPD1;IRAK2;SDF2L1;CYP1A1
3446,GO:0007275,1.52278435823498e-14,1,168,3292,multicellular organism development,BP,NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;CXCL1;TENM3;LGALS1;DSCAM;OSR2;KRT24;ASPRV1;KRT2;LCP1;KRT18;SPRR3;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;GREB1L;SPRR2D;CCBE1;JUN;KRT4;CLDN11;MCAM;RIPK2;NFKB2;SPNS2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;EHF;GADD45B;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;DUSP1;TRIB1;KRT23;CD83;ITGAV;LYN;COL8A1;ANXA1;COL4A4;G6PD;NBN;SLC8A1;NEDD4L;LCE1C;VEGFC;RHOB;XBP1;MOBP;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;KLK6;PAPSS2;FRAS1;RIMS2;NRP1;IL7R;EGLN1;SETX;CXCR5;KLF10;NRG1;ACO1;IFRD1;SERPINH1;HSP90AB1;KRT34;ADAM8;C2ORF49;L1CAM;NR2F2;CALR;CTR9;AMOTL2;EYA3;SERP1;EIF2B1;MAFF;HMGCS1;ARHGDIB;UBP1;CORO1C;IL23A;MME;DLG1;GDA;EHD1;ZMYM4;CITED2;LOX;TXNRD1;ETS1;HAS2;ADGRL3;SEC24D;BAMBI;TFRC;ZFP42;NEDD4;CDK6;TUBB3;NTNG1;PML;OXCT1;EPHA2;MYH9;HES4;SOX11;ENPP1;SORBS2;TNFAIP2;HSPD1;MAGED1;CYP1A1;PARVA
6717,GO:0030154,2.49892037627803e-14,1,139,2511,cell differentiation,BP,NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;TENM3;LGALS1;DSCAM;OSR2;KRT24;KRT2;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;SPRR2D;PEG10;JUN;KRT4;RIPK2;NFKB2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;TJP2;IL6ST;ATF3;DNAJB9;AXL;ACTG1;EHF;GADD45B;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;TRIB1;FADS1;KRT23;CD83;ITGAV;LYN;COL8A1;ANXA1;G6PD;SLC8A1;NEDD4L;LCE1C;VEGFC;NOC3L;RHOB;XBP1;SEMA3D;MMP19;KLK6;RIMS2;NRP1;IL7R;SETX;KLF10;NRG1;IFRD1;SERPINH1;HSP90AB1;KRT34;ADAM8;L1CAM;NR2F2;STEAP4;CALR;CTR9;IGFBP3;EYA3;EIF2B1;MAFF;RRAS2;CORO1C;IL23A;EHD1;CITED2;ETS1;HAS2;ADGRL3;BAMBI;TFRC;NEDD4;CDK6;TUBB3;NTNG1;PML;EPHA2;MYH9;HES4;SOX11;ENPP1;SORBS2;TNFAIP2;TPM4;SND1;CYP1A1;TJP1;PARVA
6761,GO:0030216,3.1875091096568e-14,1,27,149,keratinocyte differentiation,BP,RPTN;SPRR2G;SPRR2A;TRIM16;TCHH;LCE1B;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;FLG;LCE3D;LCE3E;KRT78;SPRR2E;SPRR2D;KRT4;HRNR;KRT13;CDSN;KRT23;ANXA1;LCE1C;KRT34;EPHA2
4319,GO:0009888,3.82927258843416e-14,1,86,1219,tissue development,BP,RPTN;MMP9;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;KRT8;OSR2;KRT24;KRT2;KRT18;SPRR3;B4GALT1;EDN1;PSMB9;FLG;LCE3D;LCE3E;SLIT2;CLDN1;COL12A1;KRT78;EPCAM;PGK1;SPRR2E;SPRR2D;JUN;KRT4;HRNR;IL1B;KRT13;JUNB;TJP2;PHLDA2;ATF3;EHF;SEMA7A;CDSN;FBN2;DUSP1;KRT23;ITGAV;COL8A1;ANXA1;G6PD;SLC8A1;LCE1C;VEGFC;RHOB;XBP1;SEMA3D;KLK6;FRAS1;NRP1;EGLN1;KLF10;NRG1;IFRD1;SERPINH1;KRT34;NR2F2;CALR;CTR9;AJUBA;MAFF;CORO1C;DLG1;CITED2;TXNRD1;HAS2;BAMBI;NEDD4;CDK6;PML;OXCT1;EPHA2;SOX11;UGCG;ENPP1;SORBS2;MAGED1;CYP1A1;TJP1
7904,GO:0032501,8.68802930647291e-14,1,195,4160,multicellular organismal process,BP,NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;ASPRV1;KRT2;LCP1;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;GREB1L;SPRR2D;CCBE1;JUN;KRT4;CLDN11;MCAM;RIPK2;NFKB2;SPNS2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;DUSP1;STAC;ANXA8;TRIB1;KRT23;CD83;ITGAV;LYN;NCEH1;COL8A1;ANXA1;COL4A4;G6PD;NBN;SLC8A1;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;RHOB;XBP1;MOBP;ARG1;SEMA3D;SUDS3;TRAF3;CSRP1;HMOX1;MMP19;SYT11;KLK6;PAPSS2;FRAS1;RIMS2;NRP1;IL7R;EGLN1;BRD2;SETX;CXCR5;SOD2;KLF10;NRG1;ACO1;IFRD1;SERPINH1;HSP90AB1;KRT34;GGCX;ADAM8;C2ORF49;L1CAM;NR2F2;CALR;CTR9;IGFBP3;AMOTL2;EYA3;SERP1;EIF2B1;MAFF;MAGT1;RRAS2;HMGCS1;ARHGDIB;UBP1;CORO1C;IL23A;MME;DLG1;GDA;EHD1;ZMYM4;CITED2;LOX;TXNRD1;ETS1;HAS2;ADGRL3;SEC24D;BAMBI;TFRC;ZFP42;NLRP10;HTR1B;NEDD4;CDK6;TUBB3;NTNG1;PML;OXCT1;EPHA2;MYH9;HES4;SOX11;ENPP1;SORBS2;TNFAIP2;TPM4;HSPD1;SND1;MAGED1;CYP1A1;PARVA
12384,GO:0048869,1.14115946733774e-13,1,143,2667,cellular developmental process,BP,CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;TENM3;LGALS1;DSCAM;OSR2;KRT24;KRT2;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;SPRR2D;PEG10;JUN;KRT4;RIPK2;NFKB2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;TJP2;IL6ST;ATF3;DNAJB9;AXL;ACTG1;EHF;GADD45B;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;TRIB1;FADS1;KRT23;CD83;ITGAV;LYN;COL8A1;ANXA1;G6PD;SLC8A1;NEDD4L;LCE1C;VEGFC;NOC3L;RHOB;XBP1;SEMA3D;MMP19;KLK6;RIMS2;NRP1;IL7R;SETX;KLF10;NRG1;IFRD1;SERPINH1;HSP90AB1;KRT34;ADAM8;L1CAM;NR2F2;STEAP4;CALR;CTR9;IGFBP3;EYA3;EIF2B1;MAFF;RRAS2;CORO1C;IL23A;MME;DLG1;EHD1;ZMYM4;CITED2;ETS1;HAS2;ADGRL3;BAMBI;TFRC;NEDD4;CDK6;TUBB3;NTNG1;PML;EPHA2;MYH9;HES4;SOX11;ENPP1;SORBS2;TNFAIP2;TPM4;SND1;CYP1A1;TJP1;PARVA
9872,GO:0042221,1.55358595808371e-13,1,145,2764,response to chemical,BP,IL32;NFKBIA;MMP9;IL1A;TRIM16;NEFL;KRT8;SERPINB2;CXCL1;LGALS1;DSCAM;SAA1;LCP1;TNIP1;KRT18;NFKB1;RELB;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;UBQLN2;CHAC1;CDKN2B;PGK1;CLDN7;DNAJB1;PEG10;CCBE1;JUN;RIPK2;IL16;NFKB2;HERPUD1;PARP1;OPTN;SDK1;HSPA5;IL1B;KRT13;JUNB;TJP2;IL6ST;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;HSPA6;NOCT;IKBKE;CYLD;SEMA7A;FBN2;NFKBIE;DUSP1;TRIB1;CD83;ITGAV;LYN;NCEH1;ANXA1;DERL3;G6PD;SLC8A1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEMA3D;TRAF3;HMOX1;MMP19;IL24;HSP90AA1;CANX;NRP1;IL7R;TRAF1;EGLN1;SETX;TNFSF15;CXCR5;SOD2;KLF10;NRG1;ACO1;SERPINH1;HSP90AB1;ADAM8;L1CAM;NR2F2;CALR;PDIA6;IFNAR1;CTR9;AJUBA;SEL1L;SERP1;EIF2B1;PRR5L;HMGCS1;IL23A;MME;EHD1;CITED2;LOX;TXNRD1;ETS1;HAS2;ADGRL3;MGST3;BAMBI;DNAJC3;ZC3H7B;IFNGR1;HSP90B1;TFRC;HTR1B;SVIP;NEDD4;TUBB3;PML;OXCT1;EPHA2;SOX11;ENPP1;HSPD1;IRAK2;SDF2L1;CYP1A1;PARVA
7905,GO:0032502,1.82967571206408e-13,1,185,3884,developmental process,BP,CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;CXCL1;TENM3;LGALS1;DSCAM;OSR2;KRT24;ASPRV1;KRT2;LCP1;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;GREB1L;SPRR2D;PEG10;CCBE1;JUN;KRT4;CLDN11;MCAM;RIPK2;NFKB2;SPNS2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;EHF;GADD45B;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;DUSP1;TRIB1;FADS1;KRT23;CD83;ITGAV;LYN;COL8A1;ANXA1;COL4A4;G6PD;NBN;SLC8A1;WWC1;NEDD4L;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;KLK6;PAPSS2;FRAS1;RIMS2;CANX;NRP1;IL7R;EGLN1;SETX;CXCR5;SOD2;KLF10;NRG1;ACO1;IFRD1;SERPINH1;HSP90AB1;KRT34;ADAM8;C2ORF49;L1CAM;NR2F2;STEAP4;CALR;CTR9;AJUBA;IGFBP3;AMOTL2;EYA3;SERP1;EIF2B1;MAFF;RRAS2;HMGCS1;ARHGDIB;UBP1;CORO1C;IL23A;MME;DLG1;GDA;EHD1;ZMYM4;CITED2;LOX;TXNRD1;ETS1;HAS2;ADGRL3;SEC24D;BAMBI;TFRC;ZFP42;NEDD4;CDK6;TUBB3;NTNG1;PML;OXCT1;EPHA2;MYH9;HES4;SOX11;UGCG;ENPP1;SORBS2;TNFAIP2;TPM4;HSPD1;SND1;MAGED1;CYP1A1;TJP1;PARVA
4331,GO:0009913,5.87778409639115e-13,1,28,180,epidermal cell differentiation,BP,RPTN;SPRR2G;SPRR2A;TRIM16;TCHH;LCE1B;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;FLG;LCE3D;LCE3E;KRT78;SPRR2E;SPRR2D;KRT4;HRNR;KRT13;CDSN;KRT23;ANXA1;LCE1C;KRT34;MAFF;EPHA2
12204,GO:0048513,6.61651482471691e-13,1,120,2121,animal organ development,BP,NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;TENM3;LGALS1;DSCAM;OSR2;KRT24;ASPRV1;KRT2;LCP1;KRT18;SPRR3;MAFB;RELB;B4GALT1;FEZ1;EDN1;PSMB9;FLG;LCE3D;LCE3E;SLIT2;CLDN1;KRT78;EPCAM;CDKN2B;SPRR2E;GREB1L;SPRR2D;CCBE1;JUN;KRT4;RIPK2;NFKB2;SPNS2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;JUNB;TJP2;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;CYLD;SEMA7A;CDSN;FBN2;TRIB1;KRT23;CD83;LYN;COL8A1;ANXA1;COL4A4;G6PD;SLC8A1;LCE1C;VEGFC;XBP1;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;PAPSS2;FRAS1;NRP1;IL7R;EGLN1;CXCR5;KLF10;NRG1;SERPINH1;HSP90AB1;KRT34;ADAM8;NR2F2;CALR;CTR9;SERP1;MAFF;HMGCS1;CORO1C;IL23A;MME;DLG1;CITED2;LOX;ETS1;HAS2;BAMBI;TFRC;ZFP42;NEDD4;CDK6;PML;OXCT1;EPHA2;MYH9;SOX11;ENPP1;SORBS2;MAGED1;CYP1A1;PARVA
3257,GO:0006950,9.73578221465669e-13,1,138,2640,response to stress,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;KRT1;NEFL;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;TNIP1;SPRR3;NFKB1;RELB;B4GALT1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CLDN1;RNASE7;UBQLN2;CHAC1;NABP1;PGK1;DNAJB1;JUN;MCAM;RIPK2;NFKB2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;MSRB3;JUNB;C1QTNF1;IL6ST;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;HSPA6;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;CD83;LYN;C1R;ANXA1;DERL3;G6PD;NBN;SLC8A1;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;TRAF3;CSRP1;HMOX1;SYT11;KLK6;PAPSS2;IL24;HSP90AA1;NRP1;EGLN1;SETX;SOD2;KLF10;NRG1;IFRD1;SERPINH1;HSP90AB1;GGCX;ADAM8;CALR;PDIA6;IFNAR1;AJUBA;SEL1L;EYA3;SERP1;EIF2B1;MAFF;PRR5L;IL23A;DLG1;PDIA4;RBMS3;EHD1;PITHD1;CITED2;LOX;TXNRD1;PTTG1IP;ETS1;HAS2;CHORDC1;DNAJC3;IFNGR1;HSP90B1;NLRP10;SVIP;NEDD4;CDK6;PML;OXCT1;EPHA2;PVR;MYH9;EID3;HSPD1;IRAK2;SDF2L1;CYP1A1
12374,GO:0048856,1.21016141796432e-12,1,173,3599,anatomical structure development,BP,NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;CXCL1;TENM3;LGALS1;DSCAM;OSR2;KRT24;ASPRV1;KRT2;LCP1;KRT18;SPRR3;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CLDN1;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;PGK1;SPRR2E;GREB1L;SPRR2D;CCBE1;JUN;KRT4;CLDN11;MCAM;RIPK2;NFKB2;SPNS2;PARP1;SDK1;HRNR;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;EHF;GADD45B;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;DUSP1;TRIB1;KRT23;CD83;ITGAV;LYN;COL8A1;ANXA1;COL4A4;G6PD;NBN;SLC8A1;NEDD4L;LCE1C;VEGFC;RHOB;XBP1;MOBP;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;KLK6;PAPSS2;FRAS1;RIMS2;NRP1;IL7R;EGLN1;SETX;CXCR5;KLF10;NRG1;ACO1;IFRD1;SERPINH1;HSP90AB1;KRT34;ADAM8;C2ORF49;L1CAM;NR2F2;CALR;CTR9;AJUBA;IGFBP3;AMOTL2;EYA3;SERP1;EIF2B1;MAFF;HMGCS1;ARHGDIB;UBP1;CORO1C;IL23A;MME;DLG1;GDA;EHD1;ZMYM4;CITED2;LOX;TXNRD1;ETS1;HAS2;ADGRL3;SEC24D;BAMBI;TFRC;ZFP42;NEDD4;CDK6;TUBB3;NTNG1;PML;OXCT1;EPHA2;MYH9;HES4;SOX11;UGCG;ENPP1;SORBS2;TNFAIP2;HSPD1;MAGED1;CYP1A1;TJP1;PARVA
6574,GO:0022610,1.66341485475402e-12,1,63,792,biological adhesion,BP,IL32;CDKN2A;TENM3;LGALS1;DSCAM;SAA1;TNIP1;KRT18;B4GALT1;FEZ1;CD274;CLDN1;COL12A1;EPCAM;CLDN7;CLDN11;MCAM;RIPK2;SDK1;IL1B;CNTNAP1;C1QTNF1;IL6ST;AXL;ACTG1;CYLD;CDSN;CD83;ITGAV;LYN;COL8A1;ANXA1;PLEKHA2;VEGFC;RHOB;XBP1;ARG1;CSRP1;NRP1;IL7R;HSP90AB1;ADAM8;L1CAM;CALR;AJUBA;ARHGDIB;CORO1C;NID2;IL23A;DLG1;CITED2;ETS1;HAS2;ADGRL3;CBLL1;TFRC;CDK6;PML;EPHA2;PVR;MYH9;HSPD1;PARVA
7048,GO:0030855,2.93909595301218e-12,1,43,427,epithelial cell differentiation,BP,RPTN;SPRR2G;SPRR2A;TRIM16;TCHH;LCE1B;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;B4GALT1;FLG;LCE3D;LCE3E;CLDN1;KRT78;PGK1;SPRR2E;SPRR2D;JUN;KRT4;HRNR;IL1B;KRT13;TJP2;EHF;CDSN;KRT23;ANXA1;LCE1C;XBP1;NRP1;NRG1;KRT34;NR2F2;MAFF;CDK6;EPHA2;SOX11;CYP1A1;TJP1
10576,GO:0043588,4.33820068480508e-12,1,31,236,skin development,BP,RPTN;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;KRT8;KRT24;ASPRV1;KRT2;KRT18;SPRR3;FLG;LCE3D;LCE3E;CLDN1;KRT78;SPRR2E;SPRR2D;KRT4;HRNR;KRT13;CDSN;KRT23;ANXA1;LCE1C;FRAS1;KRT34;EPHA2
3362,GO:0007155,4.35551932416358e-12,1,62,789,cell adhesion,BP,IL32;CDKN2A;TENM3;LGALS1;DSCAM;SAA1;TNIP1;KRT18;B4GALT1;FEZ1;CD274;CLDN1;COL12A1;EPCAM;CLDN7;CLDN11;MCAM;RIPK2;SDK1;IL1B;CNTNAP1;C1QTNF1;IL6ST;AXL;ACTG1;CYLD;CDSN;CD83;ITGAV;LYN;COL8A1;ANXA1;PLEKHA2;VEGFC;RHOB;XBP1;ARG1;CSRP1;NRP1;IL7R;ADAM8;L1CAM;CALR;AJUBA;ARHGDIB;CORO1C;NID2;IL23A;DLG1;CITED2;ETS1;HAS2;ADGRL3;CBLL1;TFRC;CDK6;PML;EPHA2;PVR;MYH9;HSPD1;PARVA
10849,GO:0044421,5.2981154571652e-12,1,129,2496,extracellular region part,CC,IL32;RPTN;MMP9;IL1A;FLG2;KRT1;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;B4GALT1;EDN1;DPYSL3;CXCL16;PSMB9;CD274;FGF5;NAGK;SLIT2;RNASE7;KPRP;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CCBE1;CLDN11;MCAM;IL16;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;C1QTNF1;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;ERAP1;SEMA7A;CDSN;FBN2;PLBD1;ITGAV;LYN;COBLL1;COL8A1;C1R;ANXA1;COL4A4;G6PD;NEDD4L;VEGFC;RHOB;ARG1;UGGT1;SEMA3D;CSRP1;GSTCD;HMOX1;MMP19;KLK6;FRAS1;KCTD12;IL24;RIMS2;HSP90AA1;CANX;FTH1;NRP1;SETX;TNFSF15;SOD2;NRG1;ACO1;SERPINH1;HSP90AB1;KRT34;L1CAM;STEAP4;CALR;PDIA6;IGFBP3;MGAT5;RRAS2;ARHGDIB;CS;NID2;IL23A;MME;DLG1;PDIA4;GDA;EHD1;LOX;TXNRD1;PTTG1IP;TGFA;MGST3;DNAJC3;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;PVR;EPB41L2;MYH9;GBE1;CPPED1;ENPP1;RPL26L1;TNFAIP2;TPM4;HSPD1;SND1
8567,GO:0034097,5.70208010538728e-12,1,61,798,response to cytokine,BP,IL32;NFKBIA;MMP9;IL1A;KRT8;SERPINB2;CXCL1;SAA1;LCP1;KRT18;NFKB1;RELB;EDN1;TP53;DPYSL3;CXCL16;PSMB9;CD274;SLIT2;CLDN1;JUN;RIPK2;IL16;NFKB2;HSPA5;IL1B;JUNB;TJP2;IL6ST;AXL;ACTG1;IFITM2;IKBKE;CYLD;ANXA1;BIRC3;VEGFC;XBP1;ARG1;TRAF3;HMOX1;IL24;HSP90AA1;CANX;IL7R;TRAF1;TNFSF15;CXCR5;SOD2;HSP90AB1;IFNAR1;CTR9;IL23A;MME;ETS1;HAS2;IFNGR1;HSP90B1;TFRC;PML;IRAK2
12880,GO:0051270,9.01384692951626e-12,1,52,603,regulation of cellular component movement,BP,MMP9;IL1A;CXCL1;DSCAM;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;CLDN7;CCBE1;JUN;MCAM;HSPA5;IL1B;PHLDA2;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;SOD2;NRG1;ADAM8;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;DLG1;CITED2;ETS1;HAS2;CBLL1;CDK6;EPHA2
3695,GO:0008219,1.09181980133546e-11,1,94,1564,cell death,BP,CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;TCHH;KRT1;NEFL;KRT8;SERPINB2;LGALS1;KRT24;KRT2;KRT18;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;CD274;FLG;LCE3D;SLIT2;CHAC1;KRT78;CLDN7;SPRR2E;SPRR2D;PEG10;JUN;KRT4;RIPK2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;KRT13;JUNB;IL6ST;PHLDA2;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;CDSN;DUSP1;KRT23;ITGAV;LYN;ANXA1;G6PD;NBN;BIRC3;RHOB;XBP1;SUDS3;TRAF3;HMOX1;KLK6;IL24;NRP1;TRAF1;EGLN1;SETX;DCUN1D3;TNFSF15;SOD2;HSP90AB1;KRT34;ADAM8;EIF4G2;CALR;PPID;IGFBP3;EYA3;RRAS2;CITED2;PTTG1IP;DNAJC3;HSP90B1;PML;EPHA2;BTBD10;SOX11;HSPD1;MAGED1;SDF2L1
5891,GO:0018149,1.14384955426746e-11,1,12,30,peptide cross-linking,BP,SPRR2A;LCE1B;KRT1;KRT2;SPRR3;FLG;LCE3D;LCE3E;SPRR2E;SPRR2D;ANXA1;LCE1C
2392,GO:0005576,2.09823670796798e-11,1,137,2770,extracellular region,CC,IL32;RPTN;MMP9;IL1A;FLG2;KRT1;NETO1;KRT8;SERPINB2;CXCL1;LGALS1;DSCAM;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;NFKB1;B4GALT1;EDN1;DPYSL3;CXCL16;PSMB9;CD274;FGF5;NAGK;SLIT2;RNASE7;KPRP;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CCBE1;CLDN11;MCAM;IL16;APOL6;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;C1QTNF1;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;ERAP1;SEMA7A;CDSN;FBN2;PLBD1;ITGAV;LYN;COBLL1;COL8A1;C1R;ANXA1;COL4A4;G6PD;NEDD4L;VEGFC;RHOB;ARG1;UGGT1;SEMA3D;CSRP1;GSTCD;HMOX1;MMP19;KLK6;FRAS1;KCTD12;IL24;RIMS2;HSP90AA1;CANX;FTH1;NRP1;IL7R;SETX;TNFSF15;SOD2;NRG1;ACO1;SERPINH1;HSP90AB1;KRT34;L1CAM;STEAP4;CALR;PDIA6;IGFBP3;MGAT5;RRAS2;ARHGDIB;CS;NID2;IL23A;MME;DLG1;PDIA4;GDA;EHD1;LOX;TXNRD1;PTTG1IP;CALU;TGFA;MGST3;DNAJC3;RSPRY1;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;NTNG1;PVR;EPB41L2;MYH9;GBE1;CPPED1;ENPP1;RPL26L1;TNFAIP2;TPM4;HSPD1;SND1
2418,GO:0005615,2.25452811385679e-11,1,123,2385,extracellular space,CC,IL32;MMP9;IL1A;FLG2;KRT1;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;B4GALT1;EDN1;DPYSL3;CXCL16;PSMB9;CD274;FGF5;NAGK;SLIT2;RNASE7;KPRP;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CCBE1;CLDN11;MCAM;IL16;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;C1QTNF1;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;ERAP1;SEMA7A;CDSN;PLBD1;ITGAV;LYN;COBLL1;COL8A1;C1R;ANXA1;G6PD;NEDD4L;VEGFC;RHOB;ARG1;UGGT1;SEMA3D;CSRP1;GSTCD;HMOX1;MMP19;KLK6;KCTD12;IL24;RIMS2;HSP90AA1;CANX;FTH1;NRP1;TNFSF15;SOD2;NRG1;ACO1;SERPINH1;HSP90AB1;KRT34;STEAP4;CALR;PDIA6;IGFBP3;MGAT5;RRAS2;ARHGDIB;CS;NID2;IL23A;MME;DLG1;PDIA4;GDA;EHD1;LOX;TXNRD1;PTTG1IP;TGFA;MGST3;DNAJC3;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;PVR;EPB41L2;MYH9;GBE1;CPPED1;ENPP1;RPL26L1;TNFAIP2;TPM4;HSPD1;SND1
9762,GO:0040012,4.18364881122665e-11,1,51,609,regulation of locomotion,BP,MMP9;IL1A;CXCL1;DSCAM;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;CLDN7;CCBE1;JUN;MCAM;IL16;HSPA5;IL1B;PHLDA2;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;SOD2;NRG1;ADAM8;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;CBLL1;CDK6;PML;EPHA2
2254,GO:0005198,5.57179910270621e-11,1,44,504,structural molecule activity,MF,RPTN;SPRR2A;FLG2;LCE1B;KRT1;NEFL;KRT8;KRT24;KRT2;KRT18;SPRR3;NEFM;FLG;LCE3D;LCE3E;CLDN1;COL12A1;KRT78;CLDN7;SPRR2E;SPRR2D;KRT4;CLDN11;MAP7D2;HRNR;KRT13;CRYAB;ACTG1;FBN2;KRT23;ANXA1;COL4A4;WWC1;LCE1C;MOBP;KRT34;DLG1;PDE4DIP;TUBB3;EPB41L2;MRPS24;SORBS2;RPL26L1;TPM4
6054,GO:0019221,5.75883404185588e-11,1,45,519,cytokine-mediated signaling pathway,BP,IL32;NFKBIA;MMP9;IL1A;KRT8;SERPINB2;CXCL1;SAA1;LCP1;KRT18;NFKB1;EDN1;TP53;PSMB9;SLIT2;RIPK2;IL16;IL1B;JUNB;TJP2;IL6ST;AXL;IFITM2;CYLD;ANXA1;BIRC3;ARG1;TRAF3;HMOX1;IL24;HSP90AA1;CANX;IL7R;TRAF1;TNFSF15;CXCR5;SOD2;HSP90AB1;IFNAR1;CTR9;IL23A;IFNGR1;HSP90B1;PML;IRAK2
14937,GO:0070887,6.67928455615301e-11,1,113,2103,cellular response to chemical stimulus,BP,IL32;NFKBIA;MMP9;IL1A;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;LCP1;TNIP1;KRT18;NFKB1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;CDKN2B;PGK1;PEG10;CCBE1;JUN;RIPK2;IL16;HERPUD1;PARP1;OPTN;HSPA5;IL1B;KRT13;JUNB;TJP2;IL6ST;ATF3;GPX8;DNAJB9;AXL;ACTG1;IFITM2;HSPA6;CYLD;FBN2;DUSP1;TRIB1;LYN;NCEH1;ANXA1;DERL3;G6PD;SLC8A1;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;TRAF3;HMOX1;IL24;HSP90AA1;CANX;NRP1;IL7R;TRAF1;EGLN1;SETX;TNFSF15;CXCR5;SOD2;KLF10;HSP90AB1;ADAM8;NR2F2;CALR;PDIA6;IFNAR1;CTR9;AJUBA;SERP1;PRR5L;HMGCS1;IL23A;MME;EHD1;CITED2;TXNRD1;ETS1;HAS2;MGST3;BAMBI;DNAJC3;ZC3H7B;IFNGR1;HSP90B1;TFRC;HTR1B;NEDD4;PML;OXCT1;EPHA2;SOX11;ENPP1;IRAK2;SDF2L1;CYP1A1;PARVA
19715,GO:2000145,8.38802452604203e-11,1,48,562,regulation of cell motility,BP,MMP9;IL1A;CXCL1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;CLDN7;CCBE1;JUN;MCAM;HSPA5;IL1B;PHLDA2;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;SOD2;NRG1;ADAM8;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;CBLL1;CDK6;EPHA2
3261,GO:0006955,1.25030206447022e-10,1,76,1201,immune response,BP,IL32;NFKBIA;MMP9;IL1A;FLG2;KRT1;CXCL1;LGALS1;SAA1;LCP1;TNIP1;NFKB1;RELB;B4GALT1;EDN1;CXCL16;PSMB9;CD274;CLDN1;RNASE7;JUN;RIPK2;IL16;NFKB2;SPNS2;OPTN;HRNR;IL1B;ANPEP;IL6ST;AXL;ACTG1;IFITM2;HSPA6;IKBKE;ERAP1;CYLD;SEMA7A;CD83;ITGAV;LYN;C1R;ANXA1;NBN;BIRC3;XBP1;ARG1;TRAF3;HMOX1;HSP90AA1;FTH1;IL7R;TNFSF15;CXCR5;HSP90AB1;ADAM8;IFNAR1;EIF2B1;MAGT1;IL23A;MME;DLG1;ETS1;DNAJC3;IFNGR1;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;PML;PVR;CPPED1;ENPP1;HSPD1;IRAK2
6844,GO:0030334,1.31129196735976e-10,1,46,530,regulation of cell migration,BP,MMP9;IL1A;CXCL1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;CCBE1;JUN;MCAM;HSPA5;IL1B;PHLDA2;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;SOD2;NRG1;ADAM8;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;CBLL1;EPHA2
12760,GO:0051094,1.46479226758651e-10,1,60,819,positive regulation of developmental process,BP,CDKN2A;IL1A;TRIM16;NEFL;TENM3;DSCAM;OSR2;NFKB1;B4GALT1;FEZ1;EDN1;DPYSL3;SLIT2;CCBE1;JUN;RIPK2;PARP1;HSPA5;IL1B;JUNB;IL6ST;AXL;NOCT;ERAP1;CYLD;SEMA7A;FBN2;TRIB1;CD83;LYN;ANXA1;SLC8A1;NEDD4L;VEGFC;RHOB;XBP1;HMOX1;RIMS2;NRP1;IL7R;SETX;KLF10;NRG1;HSP90AB1;ADAM8;L1CAM;CALR;IGFBP3;SERP1;CORO1C;IL23A;EHD1;CITED2;ETS1;HAS2;ADGRL3;BAMBI;TFRC;SOX11;MAGED1
9767,GO:0040017,1.82446156035813e-10,1,35,336,positive regulation of locomotion,BP,MMP9;IL1A;CXCL1;DSCAM;EDN1;TP53;CXCL16;CD274;SLIT2;CLDN7;CCBE1;JUN;MCAM;IL16;HSPA5;IL1B;SEMA7A;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;NRP1;SOD2;ADAM8;CALR;RRAS2;IL23A;ETS1;HAS2;CBLL1
12882,GO:0051272,1.98716827318949e-10,1,34,320,positive regulation of cellular component movement,BP,MMP9;IL1A;CXCL1;DSCAM;FEZ1;EDN1;TP53;CXCL16;CD274;CLDN7;CCBE1;JUN;MCAM;HSPA5;IL1B;SEMA7A;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;NRP1;SOD2;ADAM8;CALR;RRAS2;IL23A;ETS1;HAS2;CBLL1
12240,GO:0048584,2.09804228681151e-10,1,85,1419,positive regulation of response to stimulus,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;KRT1;NETO1;CXCL1;LGALS1;DSCAM;SAA1;TNIP1;NFKB1;RELB;EDN1;TP53;PMAIP1;PSMB9;FGF5;SLIT2;UBQLN2;CDKN2B;CCBE1;JUN;RIPK2;IL16;HERPUD1;PARP1;OPTN;IL1B;CNTNAP1;C1QTNF1;IL6ST;ATF3;AXL;ACTG1;GADD45B;IKBKE;CYLD;SEMA7A;ITGAV;LYN;C1R;ANXA1;WWC1;BIRC3;VEGFC;XBP1;ARG1;TRAF3;HMOX1;KLK6;IL24;RIMS2;HSP90AA1;NRP1;IL7R;TNFSF15;NRG1;HSP90AB1;ADAM8;CALR;AJUBA;IGFBP3;EYA3;EIF2B1;PRR5L;IL23A;CITED2;ETS1;TGFA;BAMBI;HSP90B1;TFRC;NLRP10;NEDD4;PML;OXCT1;EPHA2;PVR;EID3;SOX11;HSPD1;MAGED1;IRAK2
5496,GO:0016477,2.34732709227078e-10,1,62,869,cell migration,BP,MMP9;IL1A;CXCL1;SAA1;KRT2;LCP1;B4GALT1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;EPCAM;CCBE1;JUN;MCAM;IL16;SPNS2;HSPA5;IL1B;PHLDA2;AXL;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;WWC1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;CXCR5;SOD2;NRG1;ADAM8;L1CAM;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;ADGRL3;BAMBI;CBLL1;PML;EPHA2;MYH9;PARVA
4248,GO:0009611,2.35926127339991e-10,1,39,415,response to wounding,BP,IL1A;KRT1;NEFL;SERPINB2;LGALS1;SAA1;SPRR3;B4GALT1;EDN1;TP53;DPYSL3;JUN;MCAM;C1QTNF1;AXL;ACTG1;ANXA8;LYN;ANXA1;RHOB;XBP1;ARG1;CSRP1;HMOX1;SYT11;KLK6;PAPSS2;IL24;NRP1;NRG1;IFRD1;GGCX;AJUBA;MAFF;EHD1;LOX;ETS1;MYH9;CYP1A1
4245,GO:0009607,2.4018083826108e-10,1,45,537,response to biotic stimulus,BP,NFKBIA;KRT8;CXCL1;TNIP1;NFKB1;EDN1;TP53;PMAIP1;CD274;CLDN1;RNASE7;JUN;RIPK2;NFKB2;OPTN;HSPA5;IL1B;JUNB;TMEM265;AXL;IFITM2;NOCT;IKBKE;ERAP1;TRIB1;LYN;BIRC3;XBP1;ARG1;TRAF3;SYT11;IL24;IFNAR1;CTR9;IL23A;RBMS3;DNAJC3;IFNGR1;NLRP10;CDK6;PML;PVR;HSPD1;IRAK2;CYP1A1
3887,GO:0008544,3.0549842349801e-10,1,30,264,epidermis development,BP,RPTN;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;FLG;LCE3D;LCE3E;KRT78;SPRR2E;SPRR2D;KRT4;HRNR;KRT13;CDSN;KRT23;ANXA1;LCE1C;KRT34;MAFF;EPHA2;UGCG
15158,GO:0071345,3.65713960811606e-10,1,54,732,cellular response to cytokine stimulus,BP,IL32;NFKBIA;MMP9;IL1A;KRT8;SERPINB2;CXCL1;SAA1;LCP1;KRT18;NFKB1;EDN1;TP53;DPYSL3;PSMB9;SLIT2;CLDN1;RIPK2;IL16;HSPA5;IL1B;JUNB;TJP2;IL6ST;AXL;ACTG1;IFITM2;CYLD;ANXA1;BIRC3;VEGFC;XBP1;ARG1;TRAF3;HMOX1;IL24;HSP90AA1;CANX;IL7R;TRAF1;TNFSF15;CXCR5;SOD2;HSP90AB1;IFNAR1;CTR9;IL23A;MME;HAS2;IFNGR1;HSP90B1;TFRC;PML;IRAK2
949,GO:0002376,4.07630509025169e-10,1,100,1830,immune system process,BP,IL32;NFKBIA;MMP9;IL1A;FLG2;KRT1;CXCL1;LGALS1;SAA1;LCP1;TNIP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;CD274;SLIT2;CLDN1;RNASE7;EPCAM;CDKN2B;JUN;RIPK2;IL16;NFKB2;SPNS2;PARP1;OPTN;HRNR;IL1B;ANPEP;JUNB;TJP2;IL6ST;DNAJB9;AXL;ACTG1;IFITM2;HSPA6;IKBKE;ERAP1;CYLD;SEMA7A;TRIB1;CD83;ITGAV;LYN;C1R;ANXA1;G6PD;NBN;BIRC3;VEGFC;XBP1;ARG1;TRAF3;HMOX1;HSP90AA1;CANX;FTH1;IL7R;TNFSF15;CXCR5;KLF10;HSP90AB1;ADAM8;L1CAM;CALR;IFNAR1;CTR9;EIF2B1;MAGT1;IL23A;MME;DLG1;CITED2;ETS1;SEC24D;DNAJC3;IFNGR1;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;CDK6;PML;EPHA2;PVR;MYH9;SOX11;CPPED1;ENPP1;HSPD1;IRAK2
6718,GO:0030155,4.11680807492308e-10,1,39,417,regulation of cell adhesion,BP,CDKN2A;LGALS1;DSCAM;SAA1;CD274;EPCAM;CLDN7;RIPK2;IL1B;C1QTNF1;IL6ST;CYLD;CDSN;CD83;ITGAV;LYN;COL8A1;ANXA1;PLEKHA2;VEGFC;XBP1;ARG1;NRP1;IL7R;ADAM8;CALR;ARHGDIB;CORO1C;IL23A;DLG1;CITED2;ETS1;HAS2;CBLL1;TFRC;CDK6;PML;EPHA2;HSPD1
16744,GO:0098609,4.27910264166277e-10,1,40,437,cell-cell adhesion,BP,TENM3;LGALS1;DSCAM;TNIP1;KRT18;CD274;CLDN1;EPCAM;CLDN7;CLDN11;RIPK2;SDK1;IL1B;C1QTNF1;IL6ST;ACTG1;CYLD;CDSN;CD83;ITGAV;LYN;ANXA1;XBP1;ARG1;CSRP1;IL7R;ADAM8;AJUBA;IL23A;DLG1;CITED2;ETS1;HAS2;ADGRL3;CBLL1;TFRC;PVR;MYH9;HSPD1;PARVA
4788,GO:0012501,5.10900439701138e-10,1,86,1478,programmed cell death,BP,CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;TCHH;KRT1;NEFL;KRT8;SERPINB2;LGALS1;KRT24;KRT2;KRT18;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;CD274;FLG;LCE3D;SLIT2;CHAC1;KRT78;CLDN7;SPRR2E;SPRR2D;PEG10;JUN;KRT4;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;KRT13;IL6ST;PHLDA2;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;CDSN;DUSP1;KRT23;ITGAV;LYN;ANXA1;G6PD;NBN;BIRC3;RHOB;XBP1;SUDS3;TRAF3;HMOX1;IL24;NRP1;TRAF1;SETX;DCUN1D3;TNFSF15;SOD2;HSP90AB1;KRT34;ADAM8;CALR;PPID;IGFBP3;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;PML;EPHA2;HSPD1;MAGED1;SDF2L1
15936,GO:0080134,6.79230235023987e-10,1,65,978,regulation of response to stress,BP,CDKN2A;NFKBIA;IL1A;KRT1;SERPINB2;SAA1;TNIP1;NFKB1;RELB;EDN1;TP53;PMAIP1;PSMB9;UBQLN2;DNAJB1;RIPK2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;C1QTNF1;IL6ST;HSPB8;CRYAB;DNAJB9;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FIGN;LYN;C1R;ANXA1;DERL3;BIRC3;XBP1;ARG1;TRAF3;SYT11;HSP90AA1;SOD2;HSP90AB1;ADAM8;IFNAR1;AJUBA;EYA3;IL23A;DLG1;PTTG1IP;ETS1;CHORDC1;DNAJC3;IFNGR1;HSP90B1;NLRP10;SVIP;CDK6;PML;PVR;EID3;HSPD1;IRAK2
12385,GO:0048870,7.62753524471179e-10,1,64,941,cell motility,BP,MMP9;IL1A;CXCL1;SAA1;KRT2;LCP1;B4GALT1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;EPCAM;CLDN7;CCBE1;JUN;MCAM;IL16;SPNS2;HSPA5;IL1B;PHLDA2;AXL;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;WWC1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;CXCR5;SOD2;NRG1;ADAM8;L1CAM;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;ADGRL3;BAMBI;CBLL1;CDK6;PML;EPHA2;MYH9;PARVA
13088,GO:0051674,7.62753524471179e-10,1,64,941,localization of cell,BP,MMP9;IL1A;CXCL1;SAA1;KRT2;LCP1;B4GALT1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;EPCAM;CLDN7;CCBE1;JUN;MCAM;IL16;SPNS2;HSPA5;IL1B;PHLDA2;AXL;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;WWC1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;CXCR5;SOD2;NRG1;ADAM8;L1CAM;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;ADGRL3;BAMBI;CBLL1;CDK6;PML;EPHA2;MYH9;PARVA
8129,GO:0032879,9.34407169779643e-10,1,94,1675,regulation of localization,BP,NFKBIA;MMP9;IL1A;TRIM16;NETO1;CXCL1;DSCAM;SAA1;LCP1;NFKB1;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;CD274;SLIT2;UBQLN2;CLDN7;CCBE1;JUN;MCAM;RIPK2;IL16;PARP1;HSPA5;IL1B;C1QTNF1;PHLDA2;CRYAB;AXL;IKBKE;CYLD;SEMA7A;STAC;TRIB1;ITGAV;LYN;ANXA1;DERL3;G6PD;SLC8A1;WWC1;NEDD4L;VEGFC;RHOB;XBP1;ARG1;SEMA3D;HMOX1;SYT11;IL24;RIMS2;NRP1;KCNQ5;SOD2;NRG1;HSP90AB1;ADAM8;STXBP5;NR2F2;CALR;PPID;AJUBA;IGFBP3;AMOTL2;SERP1;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;DLG1;EHD1;CITED2;ETS1;HAS2;REEP1;CBLL1;NLRP10;HTR1B;SVIP;NEDD4;CDK6;PML;OXCT1;EPHA2;EPB41L2;SOX11;UGCG;ENPP1;MIDN
4244,GO:0009605,9.50027837790935e-10,1,79,1315,response to external stimulus,BP,NFKBIA;KRT1;KRT8;SERPINB2;CXCL1;DSCAM;SAA1;TNIP1;NFKB1;FEZ1;EDN1;TP53;CXCL16;PMAIP1;CD274;SLIT2;CLDN1;RNASE7;CDKN2B;JUN;RIPK2;IL16;NFKB2;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;ATF3;AXL;IFITM2;NOCT;IKBKE;MGLL;ERAP1;SEMA7A;TRIB1;FADS1;ITGAV;LYN;C1R;ANXA1;G6PD;SLC8A1;BIRC3;VEGFC;XBP1;ARG1;SEMA3D;TRAF3;ARNTL2;HMOX1;SYT11;IL24;NRP1;CXCR5;KLF10;NRG1;ADAM8;L1CAM;CALR;IFNAR1;CTR9;HMGCS1;IL23A;ETS1;DNAJC3;IFNGR1;HSP90B1;NLRP10;CDK6;TUBB3;PML;OXCT1;EPHA2;IRAK2;CYP1A1;PARVA
12205,GO:0048514,1.01331553051202e-09,1,36,372,blood vessel morphogenesis,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;NR2F2;AMOTL2;UBP1;LOX;ETS1;HAS2;NEDD4;PML;EPHA2;MYH9;TNFAIP2;PARVA
9761,GO:0040011,1.03424996759579e-09,1,70,1085,locomotion,BP,MMP9;IL1A;NEFL;CXCL1;DSCAM;SAA1;KRT2;LCP1;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;EPCAM;CLDN7;CCBE1;JUN;MCAM;IL16;SPNS2;HSPA5;IL1B;PHLDA2;AXL;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;SLC8A1;WWC1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;IL24;NRP1;CXCR5;SOD2;NRG1;ADAM8;L1CAM;NR2F2;CALR;PPID;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;CITED2;ETS1;HAS2;ADGRL3;BAMBI;CBLL1;NEDD4;CDK6;TUBB3;PML;EPHA2;MYH9;PARVA
1088,GO:0002684,1.19573520292979e-09,1,47,601,positive regulation of immune system process,BP,NFKBIA;IL1A;KRT1;CXCL1;LGALS1;TNIP1;NFKB1;RELB;EDN1;TP53;PSMB9;CD274;JUN;RIPK2;IL1B;IL6ST;AXL;ACTG1;IKBKE;CYLD;SEMA7A;TRIB1;CD83;LYN;C1R;ANXA1;BIRC3;VEGFC;XBP1;ARG1;TRAF3;HMOX1;HSP90AA1;IL7R;KLF10;HSP90AB1;ADAM8;CALR;EIF2B1;IL23A;ETS1;HSP90B1;TFRC;NLRP10;PVR;HSPD1;IRAK2
15500,GO:0071944,1.19609061933365e-09,1,139,2890,cell periphery,CC,NFKBIA;RPTN;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NETO1;KRT8;SERPINB2;TENM3;DSCAM;KRT2;LCP1;KRT18;SPRR3;B4GALT1;FEZ1;CXCL16;CD274;FLG;LCE3D;LCE3E;SLIT2;CLDN1;UBQLN2;EPCAM;SLC16A9;CLDN7;SPRR2E;MYO1B;SPRR2D;CLDN11;MCAM;IL16;SDK1;HRNR;HSPA5;CDV3;CNTNAP1;ANPEP;C1QTNF1;TJP2;IL6ST;CRYAB;AXL;ACTG1;IFITM2;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;STAC;ANXA8;CD83;ITGAV;LYN;ANXA1;GPR176;G6PD;SLC8A1;PLEKHA2;WWC1;NEDD4L;LCE1C;RHOB;MOBP;TRAF3;HMOX1;FAM126B;SYT11;FRAS1;KCTD12;RIMS2;HSP90AA1;FAM84B;DAPP1;NRP1;IL7R;DCUN1D3;KCNQ5;TNFSF15;CXCR5;NRG1;HSP90AB1;SDR16C5;SLC7A5P2;ADAM8;L1CAM;STXBP5;STEAP4;CALR;PDIA6;IFNAR1;AJUBA;ANO4;SLC39A14;AMOTL2;EIF2B1;MAGT1;RRAS2;CORO1C;NID2;MME;DLG1;EHD1;HAS2;ADGRL3;MSMO1;TGFA;BAMBI;IFNGR1;ANKRD13A;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;TUBB3;NTNG1;EPHA2;PVR;EPB41L2;MYH9;CPPED1;ENPP1;SORBS2;TNFAIP2;TPM4;HSPD1;MAGED1;IRAK2;TJP1;PARVA
19717,GO:2000147,1.65723235273929e-09,1,32,312,positive regulation of cell motility,BP,MMP9;IL1A;CXCL1;EDN1;TP53;CXCL16;CD274;CLDN7;CCBE1;JUN;MCAM;HSPA5;IL1B;SEMA7A;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;NRP1;SOD2;ADAM8;CALR;RRAS2;IL23A;ETS1;HAS2;CBLL1
15135,GO:0071310,1.83209650058126e-09,1,97,1790,cellular response to organic substance,BP,IL32;NFKBIA;MMP9;IL1A;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;LCP1;TNIP1;KRT18;NFKB1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;CD274;FGF5;SLIT2;CLDN1;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;HERPUD1;PARP1;OPTN;HSPA5;IL1B;KRT13;JUNB;TJP2;IL6ST;ATF3;DNAJB9;AXL;ACTG1;IFITM2;HSPA6;CYLD;FBN2;DUSP1;TRIB1;LYN;ANXA1;DERL3;SLC8A1;BIRC3;VEGFC;XBP1;ARG1;UGGT1;TRAF3;HMOX1;IL24;HSP90AA1;CANX;NRP1;IL7R;TRAF1;SETX;TNFSF15;CXCR5;SOD2;KLF10;HSP90AB1;NR2F2;CALR;PDIA6;IFNAR1;CTR9;SERP1;HMGCS1;IL23A;MME;EHD1;CITED2;HAS2;BAMBI;DNAJC3;ZC3H7B;IFNGR1;HSP90B1;TFRC;HTR1B;NEDD4;PML;OXCT1;SOX11;ENPP1;IRAK2;SDF2L1;CYP1A1
6845,GO:0030335,5.22527586742116e-09,0.999999998932099,31,306,positive regulation of cell migration,BP,MMP9;IL1A;CXCL1;EDN1;TP53;CXCL16;CD274;CCBE1;JUN;MCAM;HSPA5;IL1B;SEMA7A;ITGAV;LYN;ANXA1;SLC8A1;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;NRP1;SOD2;ADAM8;CALR;RRAS2;IL23A;ETS1;HAS2;CBLL1
12857,GO:0051239,5.86576413938351e-09,1,97,1818,regulation of multicellular organismal process,BP,NFKBIA;MMP9;IL1A;TRIM16;KRT1;NEFL;SERPINB2;TENM3;LGALS1;DSCAM;SAA1;OSR2;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;DPYSL3;PSMB9;CD274;SLIT2;PGK1;CCBE1;JUN;RIPK2;NFKB2;PARP1;SDK1;HSPA5;IL1B;C1QTNF1;TJP2;IL6ST;PHLDA2;AXL;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;TRIB1;CD83;LYN;ANXA1;G6PD;SLC8A1;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;SEMA3D;TRAF3;HMOX1;SYT11;KLK6;RIMS2;NRP1;IL7R;EGLN1;SETX;KLF10;NRG1;IFRD1;HSP90AB1;ADAM8;L1CAM;NR2F2;CALR;CTR9;SERP1;MAFF;ARHGDIB;CORO1C;IL23A;DLG1;CITED2;ETS1;HAS2;ADGRL3;BAMBI;TFRC;NLRP10;NEDD4;CDK6;PML;EPHA2;SOX11;ENPP1;HSPD1;MAGED1
6802,GO:0030280,5.91039365722255e-09,0.999999999913011,7,11,structural constituent of epidermis,MF,RPTN;FLG2;KRT1;KRT2;FLG;SPRR2E;HRNR
2578,GO:0005886,5.99825845412941e-09,1,134,2818,plasma membrane,CC,NFKBIA;RPTN;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NETO1;KRT8;SERPINB2;TENM3;DSCAM;KRT2;LCP1;SPRR3;B4GALT1;FEZ1;CXCL16;CD274;FLG;LCE3D;LCE3E;SLIT2;CLDN1;UBQLN2;EPCAM;SLC16A9;CLDN7;SPRR2E;MYO1B;SPRR2D;CLDN11;MCAM;IL16;SDK1;HRNR;HSPA5;CDV3;CNTNAP1;ANPEP;C1QTNF1;TJP2;IL6ST;CRYAB;AXL;ACTG1;IFITM2;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;STAC;ANXA8;CD83;ITGAV;LYN;ANXA1;GPR176;G6PD;SLC8A1;PLEKHA2;WWC1;NEDD4L;LCE1C;RHOB;TRAF3;HMOX1;FAM126B;SYT11;FRAS1;KCTD12;RIMS2;HSP90AA1;FAM84B;DAPP1;NRP1;IL7R;DCUN1D3;KCNQ5;TNFSF15;CXCR5;NRG1;HSP90AB1;SDR16C5;SLC7A5P2;ADAM8;L1CAM;STXBP5;STEAP4;CALR;PDIA6;IFNAR1;AJUBA;ANO4;SLC39A14;AMOTL2;EIF2B1;MAGT1;RRAS2;CORO1C;NID2;MME;DLG1;EHD1;HAS2;ADGRL3;MSMO1;TGFA;BAMBI;IFNGR1;ANKRD13A;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;NTNG1;EPHA2;PVR;EPB41L2;MYH9;CPPED1;ENPP1;SORBS2;HSPD1;MAGED1;IRAK2;TJP1;PARVA
3244,GO:0006928,6.59662815668697e-09,1,75,1252,movement of cell or subcellular component,BP,MMP9;IL1A;NEFL;CXCL1;DSCAM;SAA1;KRT2;LCP1;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;CD274;SLIT2;EPCAM;CLDN7;MYO1B;CCBE1;JUN;MCAM;IL16;SPNS2;HSPA5;IL1B;IFT46;PHLDA2;AXL;SEMA7A;TRIB1;ITGAV;LYN;AP3M1;ANXA1;SLC8A1;WWC1;NEDD4L;VEGFC;RHOB;XBP1;MOBP;SEMA3D;HMOX1;IL24;NRP1;CXCR5;SOD2;NRG1;ADAM8;L1CAM;NR2F2;CALR;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;ARHGDIB;CORO1C;IL23A;DLG1;CITED2;ETS1;HAS2;ADGRL3;BAMBI;CBLL1;CDK6;TUBB3;PML;EPHA2;MYH9;TPM4;PARVA
13790,GO:0060429,7.00050853514491e-09,1,55,803,epithelium development,BP,RPTN;SPRR2G;SPRR2A;TRIM16;TCHH;LCE1B;KRT1;KRT8;KRT24;KRT2;KRT18;SPRR3;B4GALT1;EDN1;PSMB9;FLG;LCE3D;LCE3E;SLIT2;CLDN1;KRT78;EPCAM;PGK1;SPRR2E;SPRR2D;JUN;KRT4;HRNR;IL1B;KRT13;TJP2;EHF;CDSN;KRT23;ANXA1;LCE1C;VEGFC;RHOB;XBP1;FRAS1;NRP1;NRG1;KRT34;NR2F2;AJUBA;MAFF;DLG1;CITED2;CDK6;PML;EPHA2;SOX11;MAGED1;CYP1A1;TJP1
4251,GO:0009617,7.6637933107348e-09,0.999999998477446,29,286,response to bacterium,BP,NFKBIA;CXCL1;TNIP1;NFKB1;EDN1;CD274;CLDN1;RNASE7;JUN;RIPK2;NFKB2;OPTN;IL1B;JUNB;AXL;NOCT;ERAP1;TRIB1;LYN;XBP1;ARG1;SYT11;IL24;IFNAR1;CTR9;IL23A;NLRP10;IRAK2;CYP1A1
12572,GO:0050793,8.39124282361283e-09,1,90,1645,regulation of developmental process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;KRT1;NEFL;TENM3;LGALS1;DSCAM;OSR2;NFKB1;MAFB;B4GALT1;FEZ1;EDN1;DPYSL3;PSMB9;SLIT2;PGK1;CCBE1;JUN;RIPK2;PARP1;SDK1;HSPA5;IL1B;JUNB;TJP2;IL6ST;PHLDA2;AXL;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;TRIB1;FADS1;CD83;ITGAV;LYN;ANXA1;G6PD;SLC8A1;WWC1;NEDD4L;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;KLK6;RIMS2;NRP1;IL7R;EGLN1;SETX;KLF10;NRG1;IFRD1;HSP90AB1;ADAM8;L1CAM;CALR;CTR9;IGFBP3;SERP1;MAFF;ARHGDIB;CORO1C;IL23A;DLG1;EHD1;ZMYM4;CITED2;ETS1;HAS2;ADGRL3;BAMBI;TFRC;NEDD4;CDK6;PML;EPHA2;MYH9;SOX11;ENPP1;MAGED1;PARVA
2574,GO:0005882,9.25470343489132e-09,0.999999999034231,14,67,intermediate filament,CC,KRT1;NEFL;KRT8;KRT24;KRT2;KRT18;NEFM;FLG;KRT78;KRT4;KRT13;KRT23;NRP1;KRT34
11250,GO:0045597,1.33780183866465e-08,1,45,594,positive regulation of cell differentiation,BP,TRIM16;NEFL;TENM3;DSCAM;NFKB1;FEZ1;EDN1;DPYSL3;SLIT2;JUN;RIPK2;PARP1;HSPA5;IL1B;JUNB;IL6ST;AXL;NOCT;CYLD;SEMA7A;FBN2;TRIB1;CD83;LYN;ANXA1;NEDD4L;VEGFC;XBP1;RIMS2;NRP1;IL7R;SETX;KLF10;NRG1;HSP90AB1;ADAM8;L1CAM;CALR;IGFBP3;IL23A;EHD1;ETS1;HAS2;BAMBI;SOX11
479,GO:0001525,1.50738453144761e-08,0.999999996179188,31,317,angiogenesis,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;AMOTL2;UBP1;ETS1;PML;EPHA2;MYH9;TNFAIP2;PARVA
19659,GO:2000026,1.50933056655518e-08,1,74,1264,regulation of multicellular organismal development,BP,NFKBIA;IL1A;TRIM16;KRT1;NEFL;TENM3;LGALS1;DSCAM;OSR2;MAFB;B4GALT1;FEZ1;EDN1;DPYSL3;PSMB9;SLIT2;PGK1;CCBE1;JUN;RIPK2;SDK1;HSPA5;IL1B;TJP2;IL6ST;PHLDA2;AXL;NOCT;ERAP1;CYLD;SEMA7A;CDSN;FBN2;TRIB1;CD83;LYN;ANXA1;G6PD;SLC8A1;NEDD4L;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;KLK6;RIMS2;NRP1;IL7R;EGLN1;SETX;KLF10;NRG1;IFRD1;ADAM8;L1CAM;CALR;CTR9;MAFF;ARHGDIB;IL23A;DLG1;CITED2;ETS1;ADGRL3;BAMBI;TFRC;NEDD4;CDK6;PML;EPHA2;SOX11;ENPP1;MAGED1
9804,GO:0042060,1.52081416135514e-08,0.999999996698339,32,342,wound healing,BP,IL1A;KRT1;SERPINB2;SAA1;SPRR3;B4GALT1;EDN1;TP53;MCAM;C1QTNF1;AXL;ACTG1;ANXA8;LYN;ANXA1;RHOB;XBP1;CSRP1;HMOX1;SYT11;KLK6;PAPSS2;IL24;NRG1;IFRD1;GGCX;AJUBA;MAFF;EHD1;LOX;ETS1;MYH9
11362,GO:0045785,1.53936296495151e-08,0.999999996587689,26,236,positive regulation of cell adhesion,BP,LGALS1;SAA1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;ITGAV;LYN;COL8A1;ANXA1;PLEKHA2;VEGFC;XBP1;NRP1;IL7R;ADAM8;CALR;IL23A;CITED2;ETS1;HAS2;TFRC;CDK6;HSPD1
7899,GO:0032496,1.88903715323603e-08,0.999999996084642,23,194,response to lipopolysaccharide,BP,NFKBIA;CXCL1;TNIP1;NFKB1;EDN1;CD274;CLDN1;JUN;RIPK2;NFKB2;IL1B;JUNB;AXL;NOCT;TRIB1;LYN;XBP1;ARG1;IL24;IFNAR1;CTR9;IRAK2;CYP1A1
1086,GO:0002682,2.11474933695231e-08,1,58,910,regulation of immune system process,BP,NFKBIA;IL1A;KRT1;CXCL1;LGALS1;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;CD274;SLIT2;JUN;RIPK2;SPNS2;IL1B;TJP2;IL6ST;AXL;ACTG1;IKBKE;ERAP1;CYLD;SEMA7A;TRIB1;CD83;LYN;C1R;ANXA1;BIRC3;VEGFC;XBP1;ARG1;TRAF3;HMOX1;HSP90AA1;IL7R;KLF10;HSP90AB1;ADAM8;CALR;IFNAR1;CTR9;EIF2B1;IL23A;DLG1;ETS1;IFNGR1;HSP90B1;TFRC;NLRP10;CDK6;PVR;SOX11;HSPD1;IRAK2
12643,GO:0050896,2.56585387090598e-08,1,218,5509,response to stimulus,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;FLG2;TRIM16;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;RNASE7;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;CLDN7;DNAJB1;PEG10;CCBE1;JUN;MCAM;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;TMEM265;ATF3;GPX8;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;CD83;ITGAV;LYN;NCEH1;C1R;ANXA1;PDE1C;GPR176;DERL3;G6PD;NBN;SLC8A1;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEMA3D;TRAF3;CSRP1;ARNTL2;HMOX1;MMP19;SYT11;KLK6;PAPSS2;IL24;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;IL7R;TRAF1;EGLN1;SETX;DCUN1D3;TNFSF15;CXCR5;SOD2;KLF10;NRG1;ACO1;IFRD1;SERPINH1;HSP90AB1;GGCX;ADAM8;L1CAM;NR2F2;CALR;PDIA6;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;MAFF;MAGT1;RRAS2;PRR5L;RAB30;HMGCS1;ARHGDIB;GIT2;CORO1C;IL23A;MME;DLG1;PDIA4;RBMS3;EHD1;PITHD1;CITED2;LOX;TXNRD1;PTTG1IP;ETS1;HAS2;ADGRL3;CHORDC1;TGFA;MGST3;BAMBI;DNAJC3;ZC3H7B;IFNGR1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;CDK6;TUBB3;PML;OXCT1;EPHA2;PVR;MYH9;EID3;SOX11;CPPED1;ENPP1;AFAP1;HSPD1;MAGED1;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
12858,GO:0051240,2.71009618453369e-08,1,61,967,positive regulation of multicellular organismal process,BP,MMP9;IL1A;TRIM16;NEFL;TENM3;DSCAM;SAA1;OSR2;NFKB1;B4GALT1;FEZ1;EDN1;DPYSL3;CD274;SLIT2;CCBE1;JUN;RIPK2;NFKB2;PARP1;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;ERAP1;CYLD;SEMA7A;FBN2;TRIB1;CD83;LYN;ANXA1;SLC8A1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;HMOX1;RIMS2;NRP1;IL7R;SETX;KLF10;NRG1;ADAM8;L1CAM;CALR;SERP1;IL23A;CITED2;ETS1;HAS2;ADGRL3;BAMBI;TFRC;NLRP10;SOX11;HSPD1;MAGED1
4367,GO:0010035,3.54820877897637e-08,0.999999990653195,31,339,response to inorganic substance,BP,MMP9;IL1A;NEFL;KRT8;EDN1;TP53;CLDN1;JUN;PARP1;HSPA5;JUNB;CRYAB;AXL;DUSP1;ANXA1;G6PD;SLC8A1;NEDD4L;RHOB;ARG1;HMOX1;EGLN1;SETX;SOD2;ACO1;CALR;HMGCS1;TXNRD1;ETS1;NEDD4;CYP1A1
606,GO:0001775,3.56848758903012e-08,1,55,851,cell activation,BP,MMP9;FLG2;KRT1;CXCL1;LGALS1;SAA1;KRT2;LCP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;CD274;JUN;RIPK2;NFKB2;HRNR;IL1B;ANPEP;C1QTNF1;IL6ST;DNAJB9;AXL;ACTG1;HSPA6;CYLD;CD83;ITGAV;LYN;ANXA1;NBN;RHOB;XBP1;ARG1;CSRP1;HMOX1;HSP90AA1;FTH1;IL7R;CXCR5;HSP90AB1;ADAM8;MAGT1;IL23A;MME;DLG1;DNAJC3;TFRC;SVIP;NEDD4;MYH9;SOX11;CPPED1;HSPD1
12645,GO:0050900,4.07734823880556e-08,0.999999990851866,24,216,leukocyte migration,BP,MMP9;IL1A;CXCL1;SAA1;B4GALT1;EDN1;TP53;CXCL16;SLIT2;EPCAM;IL16;SPNS2;IL1B;ITGAV;LYN;ANXA1;VEGFC;HMOX1;CXCR5;ADAM8;L1CAM;CALR;IL23A;MYH9
12239,GO:0048583,4.24124515551862e-08,1,126,2698,regulation of response to stimulus,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;KRT1;NETO1;SERPINB2;CXCL1;LGALS1;DSCAM;SAA1;TNIP1;DUSP8;NFKB1;RELB;EDN1;TP53;CXCL16;PMAIP1;PSMB9;FGF5;SLIT2;UBQLN2;CHAC1;CDKN2B;DNAJB1;PEG10;CCBE1;JUN;RIPK2;IL16;SPNS2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;C1QTNF1;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FBN2;DUSP1;TRIB1;FIGN;ITGAV;LYN;C1R;ANXA1;DERL3;G6PD;NBN;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;SEMA3D;TRAF3;HMOX1;SYT11;KLK6;IL24;RIMS2;HSP90AA1;NRP1;IL7R;TRAF1;TNFSF15;SOD2;NRG1;HSP90AB1;ADAM8;CALR;IFNAR1;AJUBA;IGFBP3;EYA3;EIF2B1;PRR5L;ARHGDIB;GIT2;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;ETS1;CHORDC1;TGFA;BAMBI;DNAJC3;IFNGR1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;CDK6;PML;OXCT1;EPHA2;PVR;EID3;SOX11;ENPP1;AFAP1;HSPD1;MAGED1;IRAK2
872,GO:0002237,4.52779138207758e-08,0.999999990162808,23,203,response to molecule of bacterial origin,BP,NFKBIA;CXCL1;TNIP1;NFKB1;EDN1;CD274;CLDN1;JUN;RIPK2;NFKB2;IL1B;JUNB;AXL;NOCT;TRIB1;LYN;XBP1;ARG1;IL24;IFNAR1;CTR9;IRAK2;CYP1A1
3278,GO:0006986,5.42185420517301e-08,0.999999989579669,20,157,response to unfolded protein,BP,CHAC1;DNAJB1;HERPUD1;OPTN;HSPA5;ATF3;DNAJB9;HSPA6;DERL3;XBP1;UGGT1;HSP90AA1;SERPINH1;HSP90AB1;CALR;PDIA6;SERP1;DNAJC3;HSP90B1;HSPD1
10351,GO:0043207,5.93339353914656e-08,0.999999985013492,39,510,response to external biotic stimulus,BP,NFKBIA;KRT8;CXCL1;TNIP1;NFKB1;EDN1;PMAIP1;CD274;CLDN1;RNASE7;JUN;RIPK2;NFKB2;OPTN;IL1B;JUNB;AXL;IFITM2;NOCT;IKBKE;ERAP1;TRIB1;LYN;BIRC3;XBP1;ARG1;TRAF3;SYT11;IL24;IFNAR1;CTR9;IL23A;DNAJC3;IFNGR1;NLRP10;CDK6;PML;IRAK2;CYP1A1
13101,GO:0051707,5.93339353914656e-08,0.999999985013492,39,510,response to other organism,BP,NFKBIA;KRT8;CXCL1;TNIP1;NFKB1;EDN1;PMAIP1;CD274;CLDN1;RNASE7;JUN;RIPK2;NFKB2;OPTN;IL1B;JUNB;AXL;IFITM2;NOCT;IKBKE;ERAP1;TRIB1;LYN;BIRC3;XBP1;ARG1;TRAF3;SYT11;IL24;IFNAR1;CTR9;IL23A;DNAJC3;IFNGR1;NLRP10;CDK6;PML;IRAK2;CYP1A1
12271,GO:0048646,5.99943758787178e-08,1,48,686,anatomical structure formation involved in morphogenesis,BP,MMP9;IL1A;KRT1;KRT8;DSCAM;MAFB;B4GALT1;EDN1;SLIT2;COL12A1;PGK1;CCBE1;JUN;MCAM;NFKB2;SDK1;IL1B;CNTNAP1;ANPEP;JUNB;ACTG1;ERAP1;FBN2;DUSP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;CTR9;AMOTL2;UBP1;EHD1;CITED2;TXNRD1;ETS1;PML;EPHA2;MYH9;SOX11;TNFAIP2;PARVA
2518,GO:0005788,6.26975906366755e-08,0.999999986629064,22,186,endoplasmic reticulum lumen,CC,LGALS1;EDN1;COL12A1;HSPA5;GPX8;DNAJB9;DNAJC10;ERAP1;COL8A1;COL4A4;UGGT1;CANX;SERPINH1;CALR;PDIA6;IGFBP3;IL23A;PDIA4;CALU;DNAJC3;HSP90B1;SDF2L1
9377,GO:0035966,6.60139697547437e-08,0.999999986490483,21,174,response to topologically incorrect protein,BP,CHAC1;DNAJB1;HERPUD1;OPTN;HSPA5;ATF3;DNAJB9;HSPA6;DERL3;XBP1;UGGT1;HSP90AA1;SERPINH1;HSP90AB1;CALR;PDIA6;SERP1;DNAJC3;HSP90B1;HSPD1;SDF2L1
505,GO:0001568,7.07184758346738e-08,0.999999978984343,36,432,blood vessel development,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;NR2F2;AMOTL2;UBP1;LOX;ETS1;HAS2;NEDD4;PML;EPHA2;MYH9;TNFAIP2;PARVA
18194,GO:1903039,1.01031784479354e-07,0.999999983038161,17,119,positive regulation of leukocyte cell-cell adhesion,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;IL7R;ADAM8;IL23A;ETS1;HAS2;TFRC;HSPD1
7652,GO:0032103,1.41782738123875e-07,0.999999972374286,19,152,positive regulation of response to external stimulus,BP,NFKBIA;CXCL1;DSCAM;TNIP1;EDN1;SLIT2;RIPK2;IL16;OPTN;IL1B;IL6ST;VEGFC;ARG1;NRP1;ADAM8;CALR;IL23A;ETS1;NLRP10
6562,GO:0022409,2.10218287585239e-07,0.999999960219031,18,139,positive regulation of cell-cell adhesion,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;IL7R;ADAM8;IL23A;CITED2;ETS1;HAS2;TFRC;HSPD1
714,GO:0001944,2.14672219122339e-07,0.999999929896883,36,452,vasculature development,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;NR2F2;AMOTL2;UBP1;LOX;ETS1;HAS2;NEDD4;PML;EPHA2;MYH9;TNFAIP2;PARVA
7650,GO:0032101,2.63094151449141e-07,0.999999916133544,34,426,regulation of response to external stimulus,BP,NFKBIA;KRT1;SERPINB2;CXCL1;DSCAM;SAA1;TNIP1;NFKB1;EDN1;SLIT2;RIPK2;IL16;OPTN;IL1B;C1QTNF1;IL6ST;MGLL;SEMA7A;TRIB1;LYN;C1R;ANXA1;BIRC3;VEGFC;ARG1;SEMA3D;TRAF3;SYT11;NRP1;ADAM8;CALR;IL23A;ETS1;NLRP10
15722,GO:0072358,2.94645362621763e-07,0.999999902472588,36,458,cardiovascular system development,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;NR2F2;AMOTL2;UBP1;LOX;ETS1;HAS2;NEDD4;PML;EPHA2;MYH9;TNFAIP2;PARVA
4268,GO:0009653,3.45628971336697e-07,1,87,1693,anatomical structure morphogenesis,BP,MMP9;IL1A;KRT1;NEFL;KRT8;TENM3;DSCAM;OSR2;KRT18;MAFB;B4GALT1;FEZ1;EDN1;PSMB9;SLIT2;COL12A1;PGK1;CCBE1;JUN;MCAM;NFKB2;SDK1;HSPA5;IL1B;KRT13;CNTNAP1;ANPEP;JUNB;PHLDA2;CRYAB;AXL;ACTG1;ERAP1;SEMA7A;CDSN;FBN2;DUSP1;ITGAV;COL8A1;ANXA1;NEDD4L;VEGFC;RHOB;XBP1;ARG1;SEMA3D;HMOX1;MMP19;FRAS1;RIMS2;NRP1;IL7R;EGLN1;NRG1;IFRD1;SERPINH1;ADAM8;C2ORF49;L1CAM;NR2F2;CALR;CTR9;AJUBA;AMOTL2;EYA3;SERP1;UBP1;CORO1C;DLG1;EHD1;ZMYM4;CITED2;LOX;TXNRD1;ETS1;HAS2;BAMBI;NEDD4;TUBB3;NTNG1;PML;EPHA2;MYH9;SOX11;TNFAIP2;MAGED1;PARVA
4744,GO:0010941,3.48612575796024e-07,1,66,1183,regulation of cell death,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;SERPINB2;LGALS1;KRT18;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;CD274;SLIT2;CLDN7;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;JUNB;IL6ST;CRYAB;ATF3;AXL;GADD45B;CYLD;CDSN;DUSP1;ITGAV;LYN;ANXA1;G6PD;BIRC3;RHOB;XBP1;SUDS3;TRAF3;HMOX1;NRP1;TRAF1;EGLN1;SETX;DCUN1D3;TNFSF15;SOD2;HSP90AB1;ADAM8;CALR;PPID;IGFBP3;EYA3;RRAS2;CITED2;PTTG1IP;DNAJC3;HSP90B1;PML;EPHA2;BTBD10;SOX11;HSPD1;MAGED1;SDF2L1
6560,GO:0022407,4.33056734459052e-07,0.999999891579827,23,227,regulation of cell-cell adhesion,BP,LGALS1;CD274;EPCAM;RIPK2;IL1B;C1QTNF1;IL6ST;CYLD;CDSN;CD83;LYN;ANXA1;XBP1;ARG1;IL7R;ADAM8;IL23A;DLG1;CITED2;ETS1;HAS2;TFRC;HSPD1
8411,GO:0033554,5.06948012541895e-07,1,82,1613,cellular response to stress,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;NFKB1;RELB;EDN1;TP53;PMAIP1;PSMB9;UBQLN2;CHAC1;NABP1;PGK1;DNAJB1;JUN;RIPK2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;AXL;DNAJC10;HSPA6;GADD45B;IKBKE;STAC;TRIB1;FADS1;FIGN;LYN;ANXA1;DERL3;G6PD;NBN;SLC8A1;RHOB;XBP1;ARG1;UGGT1;HMOX1;HSP90AA1;EGLN1;SETX;SOD2;KLF10;HSP90AB1;ADAM8;CALR;PDIA6;AJUBA;SEL1L;EYA3;SERP1;PRR5L;DLG1;PDIA4;PITHD1;CITED2;TXNRD1;PTTG1IP;ETS1;HAS2;CHORDC1;DNAJC3;HSP90B1;SVIP;NEDD4;CDK6;PML;EPHA2;EID3;IRAK2;SDF2L1
13711,GO:0060326,5.52957558155258e-07,0.999999893859965,17,135,cell chemotaxis,BP,CXCL1;SAA1;EDN1;CXCL16;SLIT2;IL16;IL1B;LYN;ANXA1;VEGFC;NRP1;CXCR5;ADAM8;CALR;IL23A;EPHA2;PARVA
11763,GO:0046677,5.74194862682929e-07,0.999999858955129,22,216,response to antibiotic,BP,NEFL;EDN1;TP53;CLDN1;CLDN7;JUN;HSPA5;CRYAB;AXL;DUSP1;ANXA1;G6PD;SLC8A1;RHOB;ARG1;HMOX1;HSP90AA1;SETX;ETS1;HTR1B;OXCT1;CYP1A1
17711,GO:1901700,6.14289635156413e-07,0.999999807891027,59,1010,response to oxygen-containing compound,BP,NFKBIA;MMP9;TRIM16;NEFL;KRT8;CXCL1;LGALS1;TNIP1;NFKB1;EDN1;TP53;CD274;SLIT2;CLDN1;CLDN7;JUN;RIPK2;NFKB2;PARP1;SDK1;HSPA5;IL1B;KRT13;JUNB;CRYAB;AXL;NOCT;DUSP1;TRIB1;LYN;ANXA1;G6PD;SLC8A1;RHOB;XBP1;ARG1;HMOX1;MMP19;IL24;EGLN1;SETX;SOD2;KLF10;HSP90AB1;NR2F2;CALR;IFNAR1;CTR9;EIF2B1;HMGCS1;TXNRD1;ETS1;ADGRL3;HSP90B1;HTR1B;OXCT1;ENPP1;IRAK2;CYP1A1
8998,GO:0035239,6.21645292712538e-07,0.999999778420691,39,533,tube morphogenesis,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;NR2F2;AMOTL2;UBP1;DLG1;LOX;ETS1;HAS2;NEDD4;PML;EPHA2;MYH9;SOX11;TNFAIP2;MAGED1;PARVA
12859,GO:0051241,6.3725060127676e-07,0.999999771318062,45,679,negative regulation of multicellular organismal process,BP,NFKBIA;KRT1;SERPINB2;LGALS1;NFKB1;MAFB;RELB;EDN1;DPYSL3;CD274;SLIT2;PGK1;IL1B;C1QTNF1;TJP2;AXL;NOCT;IKBKE;CYLD;SEMA7A;CDSN;TRIB1;CD83;LYN;ANXA1;G6PD;WWC1;ARG1;SEMA3D;TRAF3;HMOX1;SYT11;NRP1;NRG1;IFRD1;HSP90AB1;NR2F2;CALR;CTR9;ARHGDIB;CORO1C;IL23A;CDK6;PML;SOX11
7317,GO:0031347,6.53265856749967e-07,0.999999779766902,34,447,regulation of defense response,BP,NFKBIA;KRT1;SAA1;TNIP1;NFKB1;RELB;PSMB9;RIPK2;OPTN;IL1B;IL6ST;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;LYN;C1R;ANXA1;BIRC3;ARG1;TRAF3;SYT11;HSP90AB1;ADAM8;IFNAR1;IL23A;ETS1;IFNGR1;HSP90B1;NLRP10;PVR;HSPD1;IRAK2
11163,GO:0045321,6.76019897373863e-07,0.999999800810792,48,758,leukocyte activation,BP,MMP9;FLG2;KRT1;CXCL1;LGALS1;LCP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;CD274;JUN;RIPK2;HRNR;IL1B;ANPEP;IL6ST;DNAJB9;AXL;HSPA6;CYLD;CD83;ITGAV;LYN;ANXA1;NBN;XBP1;ARG1;HMOX1;HSP90AA1;FTH1;IL7R;CXCR5;HSP90AB1;ADAM8;MAGT1;IL23A;MME;DLG1;DNAJC3;TFRC;SVIP;NEDD4;MYH9;SOX11;CPPED1;HSPD1
18192,GO:1903037,6.97231876608691e-07,0.999999847757821,19,167,regulation of leukocyte cell-cell adhesion,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;IL7R;ADAM8;IL23A;DLG1;ETS1;HAS2;TFRC;HSPD1
3366,GO:0007159,8.20249624781307e-07,0.999999809979614,20,185,leukocyte cell-cell adhesion,BP,LGALS1;TNIP1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;IL7R;ADAM8;IL23A;DLG1;ETS1;HAS2;TFRC;HSPD1
6938,GO:0030595,8.31619093306655e-07,0.99999986743672,14,96,leukocyte chemotaxis,BP,CXCL1;SAA1;EDN1;CXCL16;SLIT2;IL16;IL1B;LYN;ANXA1;VEGFC;CXCR5;ADAM8;CALR;IL23A
547,GO:0001667,8.98737198991376e-07,0.999999748519089,25,268,ameboidal-type cell migration,BP,MMP9;KRT2;EDN1;SLIT2;CCBE1;JUN;SEMA7A;ANXA1;SLC8A1;VEGFC;RHOB;SEMA3D;HMOX1;NRP1;NR2F2;CALR;AMOTL2;PRR5L;ARHGDIB;CORO1C;ETS1;HAS2;PML;EPHA2;MYH9
12492,GO:0050673,9.443898001985e-07,0.999999742994256,24,253,epithelial cell proliferation,BP,OSR2;KRT2;B4GALT1;CDKN2B;JUN;KRT4;EHF;COL8A1;VEGFC;XBP1;ARG1;HMOX1;NRP1;SDR16C5;NR2F2;IGFBP3;DLG1;HAS2;TGFA;CDK6;EPHA2;BTBD10;SOX11;MAGED1
15085,GO:0071216,9.47736403342982e-07,0.999999822080954,16,123,cellular response to biotic stimulus,BP,NFKBIA;TNIP1;NFKB1;TP53;CD274;RIPK2;HSPA5;IL1B;AXL;TRIB1;LYN;XBP1;ARG1;IL24;CTR9;IRAK2
8534,GO:0033993,1.00876677063693e-06,0.999999628493188,40,579,response to lipid,BP,NFKBIA;TRIM16;NEFL;CXCL1;TNIP1;NFKB1;EDN1;TP53;CD274;SLIT2;CLDN1;JUN;RIPK2;NFKB2;PARP1;IL1B;KRT13;JUNB;CRYAB;AXL;NOCT;DUSP1;TRIB1;LYN;ANXA1;XBP1;ARG1;IL24;SETX;NR2F2;CALR;IFNAR1;CTR9;HMGCS1;LOX;ETS1;HTR1B;NEDD4;IRAK2;CYP1A1
4254,GO:0009628,1.15464401158405e-06,0.999999554040295,52,861,response to abiotic stimulus,BP,NFKBIA;IL1A;NETO1;KRT8;NFKB1;RELB;EDN1;TP53;PMAIP1;PSMB9;CLDN1;NABP1;PGK1;DNAJB1;JUN;PARP1;HSPA5;IL1B;KRT13;JUNB;HSPB8;CRYAB;HSPA6;DUSP1;STAC;LYN;ANXA1;SLC8A1;VEGFC;RHOB;HMOX1;HSP90AA1;EGLN1;DCUN1D3;HSP90AB1;ADAM8;PPID;AJUBA;EYA3;EIF2B1;HMGCS1;MME;CITED2;ETS1;CHORDC1;DNAJC3;HSP90B1;HTR1B;NEDD4;PML;HSPD1;CYP1A1
9569,GO:0036457,1.15784191393881e-06,1,4,4,keratohyalin granule,CC,RPTN;FLG2;FLG;HRNR
8913,GO:0034976,1.18528145628657e-06,0.999999683416147,23,241,response to endoplasmic reticulum stress,BP,TP53;PMAIP1;UBQLN2;CHAC1;JUN;HERPUD1;HSPA5;ATF3;DNAJB9;DNAJC10;DERL3;XBP1;UGGT1;CALR;PDIA6;SEL1L;SERP1;PDIA4;DNAJC3;HSP90B1;SVIP;PML;SDF2L1
4351,GO:0009986,1.22332595928272e-06,0.999999604732156,30,369,cell surface,CC,LGALS1;B4GALT1;CD274;EPCAM;KRT4;MCAM;HSPA5;ANPEP;IL6ST;CRYAB;AXL;SEMA7A;CD83;ITGAV;ANXA1;NRP1;IL7R;CXCR5;NRG1;HSP90AB1;ADAM8;L1CAM;CALR;PDIA4;TGFA;TFRC;EPHA2;PVR;ENPP1;HSPD1
11248,GO:0045595,1.27343538068283e-06,0.99999958613378,64,1150,regulation of cell differentiation,BP,NFKBIA;TRIM16;NEFL;TENM3;LGALS1;DSCAM;NFKB1;MAFB;FEZ1;EDN1;DPYSL3;PSMB9;SLIT2;JUN;RIPK2;PARP1;SDK1;HSPA5;IL1B;JUNB;TJP2;IL6ST;AXL;NOCT;CYLD;SEMA7A;CDSN;FBN2;TRIB1;FADS1;CD83;ITGAV;LYN;ANXA1;G6PD;NEDD4L;VEGFC;XBP1;SEMA3D;KLK6;RIMS2;NRP1;IL7R;SETX;KLF10;NRG1;IFRD1;HSP90AB1;ADAM8;L1CAM;CALR;CTR9;IGFBP3;MAFF;CORO1C;IL23A;EHD1;ETS1;HAS2;BAMBI;NEDD4;CDK6;SOX11;ENPP1
12207,GO:0048518,1.50911416821972e-06,0.999999433988846,160,3873,positive regulation of biological process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;KRT1;NEFL;NETO1;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;LCP1;TNIP1;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;UBQLN2;EPCAM;CDKN2B;CLDN7;CCBE1;JUN;MCAM;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;JUNB;C1QTNF1;IL6ST;ATF3;AXL;ACTG1;CREB5;EHF;GADD45B;NOCT;IKBKE;ERAP1;CYLD;SEMA7A;FBN2;DUSP1;STAC;TRIB1;CD83;ITGAV;LYN;COL8A1;C1R;ANXA1;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;SEMA3D;SUDS3;TRAF3;ARNTL2;HMOX1;SYT11;KLK6;IL24;RIMS2;HSP90AA1;NRP1;IL7R;TRAF1;EGLN1;SETX;DCUN1D3;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;SDR16C5;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;EIF2B1;MAFF;RRAS2;PRR5L;CORO1C;IL23A;DLG1;RBMS3;EHD1;CITED2;PTTG1IP;ETS1;HAS2;ADGRL3;TGFA;BAMBI;DNAJC3;CBLL1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;CDK6;PML;OXCT1;EPHA2;PVR;EPB41L2;MYH9;EID3;BTBD10;SOX11;UGCG;HSPD1;MAGED1;SUPT3H;IRAK2;CYP1A1
12626,GO:0050870,1.61006650469471e-06,0.999999705016285,15,114,positive regulation of T cell activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;IL7R;ADAM8;IL23A;TFRC;HSPD1
11065,GO:0045111,1.67810311213364e-06,0.999999714912136,14,99,intermediate filament cytoskeleton,CC,KRT1;NEFL;KRT8;KRT24;KRT2;KRT18;NEFM;FLG;KRT78;KRT4;KRT13;KRT23;NRP1;KRT34
15090,GO:0071222,1.73830267231794e-06,0.999999703532326,14,100,cellular response to lipopolysaccharide,BP,NFKBIA;TNIP1;NFKB1;CD274;RIPK2;IL1B;AXL;TRIB1;LYN;XBP1;ARG1;IL24;CTR9;IRAK2
14474,GO:0065008,2.04615656199398e-06,0.999999041309112,109,2379,regulation of biological quality,BP,NFKBIA;RPTN;IL1A;FLG2;KRT1;NEFL;NETO1;SERPINB2;LGALS1;DSCAM;SAA1;NFKB1;MAFB;EDN1;TP53;PMAIP1;PSMB9;FLG;SLIT2;CLDN1;JUN;SPNS2;HERPUD1;PARP1;HRNR;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;C1QTNF1;TJP2;CRYAB;AXL;ACTG1;DNAJC10;NOCT;IKBKE;ERAP1;CYLD;SEMA7A;FBN2;NFKBIE;ANXA8;ITGAV;LYN;ANXA1;G6PD;NBN;SLC8A1;NEDD4L;VEGFC;RHOB;XBP1;SEMA3D;CSRP1;HMOX1;SYT11;KLK6;PAPSS2;RIMS2;HSP90AA1;FTH1;NRP1;IL7R;EGLN1;SOD2;NRG1;ACO1;IFRD1;HSP90AB1;SDR16C5;GGCX;ADAM8;L1CAM;NR2F2;STEAP4;CALR;PDIA6;ANO4;SEL1L;SLC39A14;SERP1;ORMDL1;MAFF;MME;DLG1;PDIA4;EHD1;TXNRD1;ETS1;HAS2;ADGRL3;BAMBI;SUGT1;HSP90B1;TFRC;HTR1B;NEDD4;CDK6;PML;OXCT1;MYH9;SOX11;ENPP1;HSPD1;MIDN;CYP1A1;PARVA
14560,GO:0070161,2.08111719360746e-06,0.999999255371426,34,463,anchoring junction,CC,LCP1;KRT18;B4GALT1;MCAM;HSPA5;TJP2;ACTG1;CDSN;ITGAV;LYN;ANXA1;RHOB;CSRP1;NRP1;L1CAM;EIF4G2;CALR;AJUBA;RRAS2;GIT2;CORO1C;MME;DLG1;FOCAD;HSP90B1;EPHA2;PVR;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;TJP1;PARVA
9035,GO:0035295,2.08321094086938e-06,0.999999184404133,43,648,tube development,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;EPCAM;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;VEGFC;RHOB;XBP1;ARG1;HMOX1;MMP19;NRP1;EGLN1;ADAM8;NR2F2;AMOTL2;UBP1;DLG1;CITED2;LOX;ETS1;HAS2;NEDD4;PML;EPHA2;MYH9;SOX11;TNFAIP2;MAGED1;CYP1A1;PARVA
15723,GO:0072359,2.19345005834976e-06,0.999999131018706,44,673,circulatory system development,BP,IL1A;KRT1;B4GALT1;EDN1;SLIT2;PGK1;CCBE1;JUN;MCAM;IL1B;ANPEP;JUNB;ERAP1;ITGAV;COL8A1;ANXA1;G6PD;SLC8A1;VEGFC;RHOB;XBP1;HMOX1;MMP19;NRP1;EGLN1;NRG1;ADAM8;NR2F2;CALR;AMOTL2;UBP1;CITED2;LOX;ETS1;HAS2;NEDD4;PML;OXCT1;EPHA2;MYH9;SOX11;SORBS2;TNFAIP2;PARVA
14506,GO:0070062,2.44903218550455e-06,0.999998876594734,94,2029,extracellular exosome,CC,MMP9;FLG2;KRT1;KRT8;LGALS1;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;B4GALT1;PSMB9;CD274;NAGK;SLIT2;RNASE7;KPRP;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CLDN11;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;ERAP1;CDSN;ITGAV;LYN;COBLL1;COL8A1;C1R;ANXA1;G6PD;NEDD4L;RHOB;ARG1;UGGT1;CSRP1;GSTCD;KCTD12;RIMS2;HSP90AA1;CANX;FTH1;SOD2;ACO1;SERPINH1;HSP90AB1;KRT34;STEAP4;CALR;PDIA6;IGFBP3;MGAT5;RRAS2;ARHGDIB;CS;NID2;MME;DLG1;GDA;EHD1;TXNRD1;PTTG1IP;MGST3;DNAJC3;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;PVR;EPB41L2;MYH9;GBE1;CPPED1;RPL26L1;TPM4;HSPD1;SND1
10270,GO:0043067,2.45957781100799e-06,0.999998979047713,61,1106,regulation of programmed cell death,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;SERPINB2;LGALS1;KRT18;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;CD274;SLIT2;CLDN7;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;IL6ST;CRYAB;ATF3;AXL;GADD45B;CYLD;CDSN;DUSP1;ITGAV;LYN;ANXA1;G6PD;BIRC3;RHOB;XBP1;SUDS3;TRAF3;HMOX1;NRP1;TRAF1;SETX;DCUN1D3;TNFSF15;SOD2;HSP90AB1;ADAM8;CALR;PPID;IGFBP3;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;PML;EPHA2;HSPD1;MAGED1;SDF2L1
8837,GO:0034663,2.62955704285479e-06,0.999999947188574,5,9,endoplasmic reticulum chaperone complex,CC,HSPA5;DNAJC10;PDIA6;HSP90B1;SDF2L1
10010,GO:0042493,2.73857298122579e-06,0.999998927260145,40,605,response to drug,BP,NFKBIA;NEFL;LGALS1;NFKB1;EDN1;TP53;SLIT2;CLDN1;CLDN7;JUN;RIPK2;SDK1;HSPA5;IL1B;JUNB;CRYAB;AXL;NFKBIE;DUSP1;LYN;ANXA1;G6PD;SLC8A1;VEGFC;RHOB;ARG1;HMOX1;EGLN1;SETX;HSP90AB1;CALR;HMGCS1;LOX;ETS1;ADGRL3;HSP90B1;TFRC;HTR1B;OXCT1;CYP1A1
12033,GO:0048018,2.8259314794639e-06,0.999999381539993,17,154,receptor ligand activity,MF,IL32;IL1A;CXCL1;SAA1;EDN1;CXCL16;FGF5;IL16;IL1B;SEMA7A;VEGFC;SEMA3D;IL24;TNFSF15;NRG1;IL23A;TGFA
11053,GO:0045087,2.95132521709959e-06,0.999998875912256,37,546,innate immune response,BP,NFKBIA;KRT1;SAA1;TNIP1;NFKB1;RELB;EDN1;CXCL16;PSMB9;CLDN1;RNASE7;RIPK2;NFKB2;OPTN;AXL;ACTG1;IFITM2;IKBKE;ERAP1;CYLD;LYN;C1R;ANXA1;BIRC3;ARG1;TRAF3;HSP90AB1;ADAM8;IFNAR1;IL23A;IFNGR1;HSP90B1;NLRP10;PML;PVR;HSPD1;IRAK2
10365,GO:0043230,2.98959673310845e-06,0.999998622779218,94,2038,extracellular organelle,CC,MMP9;FLG2;KRT1;KRT8;LGALS1;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;B4GALT1;PSMB9;CD274;NAGK;SLIT2;RNASE7;KPRP;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CLDN11;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;ERAP1;CDSN;ITGAV;LYN;COBLL1;COL8A1;C1R;ANXA1;G6PD;NEDD4L;RHOB;ARG1;UGGT1;CSRP1;GSTCD;KCTD12;RIMS2;HSP90AA1;CANX;FTH1;SOD2;ACO1;SERPINH1;HSP90AB1;KRT34;STEAP4;CALR;PDIA6;IGFBP3;MGAT5;RRAS2;ARHGDIB;CS;NID2;MME;DLG1;GDA;EHD1;TXNRD1;PTTG1IP;MGST3;DNAJC3;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;PVR;EPB41L2;MYH9;GBE1;CPPED1;RPL26L1;TPM4;HSPD1;SND1
18424,GO:1903561,2.98959673310845e-06,0.999998622779218,94,2038,extracellular vesicle,CC,MMP9;FLG2;KRT1;KRT8;LGALS1;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;B4GALT1;PSMB9;CD274;NAGK;SLIT2;RNASE7;KPRP;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CLDN11;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;ERAP1;CDSN;ITGAV;LYN;COBLL1;COL8A1;C1R;ANXA1;G6PD;NEDD4L;RHOB;ARG1;UGGT1;CSRP1;GSTCD;KCTD12;RIMS2;HSP90AA1;CANX;FTH1;SOD2;ACO1;SERPINH1;HSP90AB1;KRT34;STEAP4;CALR;PDIA6;IGFBP3;MGAT5;RRAS2;ARHGDIB;CS;NID2;MME;DLG1;GDA;EHD1;TXNRD1;PTTG1IP;MGST3;DNAJC3;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;PVR;EPB41L2;MYH9;GBE1;CPPED1;RPL26L1;TPM4;HSPD1;SND1
11058,GO:0045095,3.00875836505953e-06,0.999999822087292,7,23,keratin filament,CC,KRT1;KRT8;KRT2;KRT18;KRT78;KRT4;KRT13
3258,GO:0006952,3.1536175001454e-06,0.999998648775724,52,896,defense response,BP,IL32;NFKBIA;IL1A;KRT1;CXCL1;SAA1;TNIP1;NFKB1;RELB;B4GALT1;EDN1;CXCL16;PMAIP1;PSMB9;CLDN1;RNASE7;RIPK2;NFKB2;OPTN;IL1B;IL6ST;AXL;ACTG1;IFITM2;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CD83;LYN;C1R;ANXA1;BIRC3;ARG1;TRAF3;HMOX1;SYT11;HSP90AB1;ADAM8;IFNAR1;IL23A;RBMS3;ETS1;DNAJC3;IFNGR1;HSP90B1;NLRP10;PML;PVR;HSPD1;IRAK2
15087,GO:0071219,3.1900082876986e-06,0.999999423901682,14,105,cellular response to molecule of bacterial origin,BP,NFKBIA;TNIP1;NFKB1;CD274;RIPK2;IL1B;AXL;TRIB1;LYN;XBP1;ARG1;IL24;CTR9;IRAK2
4328,GO:0009897,3.33075372696351e-06,0.999999396578083,14,104,external side of plasma membrane,CC,B4GALT1;CD274;MCAM;ANPEP;IL6ST;SEMA7A;CD83;ITGAV;ANXA1;IL7R;CXCR5;NRG1;CALR;TFRC
12560,GO:0050776,3.4177401465575e-06,0.999998671848774,38,568,regulation of immune response,BP,NFKBIA;KRT1;TNIP1;NFKB1;RELB;PSMB9;JUN;RIPK2;SPNS2;IL1B;IL6ST;ACTG1;IKBKE;ERAP1;CYLD;SEMA7A;LYN;C1R;ANXA1;BIRC3;XBP1;ARG1;TRAF3;HMOX1;HSP90AA1;IL7R;HSP90AB1;ADAM8;IFNAR1;EIF2B1;IL23A;IFNGR1;HSP90B1;TFRC;NLRP10;PVR;HSPD1;IRAK2
12601,GO:0050839,3.42810626233241e-06,0.99999882852998,30,391,cell adhesion molecule binding,MF,TENM3;LCP1;KRT18;EPCAM;CLDN7;MYO1B;DNAJB1;HSPA5;IL1B;EFHD2;TJP2;SEMA7A;ITGAV;LYN;COBLL1;ANXA1;NRG1;HSP90AB1;ADAM8;EIF4G2;CALR;DLG1;EHD1;EPHA2;PVR;MYH9;CLINT1;SND1;TJP1;PARVA
10215,GO:0042981,3.59403793860286e-06,0.999998499096335,60,1094,regulation of apoptotic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;SERPINB2;LGALS1;KRT18;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;CD274;SLIT2;CLDN7;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;IL6ST;CRYAB;ATF3;AXL;GADD45B;CYLD;DUSP1;ITGAV;LYN;ANXA1;G6PD;BIRC3;RHOB;XBP1;SUDS3;TRAF3;HMOX1;NRP1;TRAF1;SETX;DCUN1D3;TNFSF15;SOD2;HSP90AB1;ADAM8;CALR;PPID;IGFBP3;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;PML;EPHA2;HSPD1;MAGED1;SDF2L1
2211,GO:0005125,3.63023809697431e-06,0.99999950590546,11,68,cytokine activity,MF,IL32;IL1A;CXCL1;EDN1;CXCL16;IL16;IL1B;IL24;TNFSF15;NRG1;IL23A
1040,GO:0002573,3.70068933508456e-06,0.999999270796445,15,119,myeloid leukocyte differentiation,BP,MMP9;MAFB;RELB;JUN;PARP1;JUNB;TJP2;TRIB1;LYN;KLF10;IL23A;TFRC;CDK6;EPHA2;MYH9
18023,GO:1902622,3.79116953529167e-06,0.999999840589078,6,16,regulation of neutrophil migration,BP,IL1A;CXCL1;EDN1;SLIT2;ADAM8;IL23A
4258,GO:0009636,4.07654688275559e-06,0.999998714668397,26,321,response to toxic substance,BP,NEFL;NFKB1;EDN1;TP53;CLDN1;CLDN7;JUN;CRYAB;GPX8;AXL;DUSP1;LYN;ANXA1;G6PD;SLC8A1;RHOB;ARG1;HMOX1;SETX;SOD2;TXNRD1;ETS1;MGST3;HTR1B;OXCT1;CYP1A1
7580,GO:0031982,4.42452988606329e-06,0.999997637060574,129,3044,vesicle,CC,MMP9;FLG2;KRT1;KRT8;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;KRT18;SPRR3;NFKB1;B4GALT1;EDN1;DPYSL3;PSMB9;CD274;DBNDD2;NAGK;SLIT2;RNASE7;KPRP;UBQLN2;COL12A1;KRT78;EPCAM;PGK1;MYO1B;DNAJB1;CLDN11;RIPK2;SPNS2;OPTN;SDK1;HRNR;HSPA5;IL1B;KRT13;ANPEP;IL6ST;CRYAB;DNAJB9;AXL;ACTG1;CREB5;HSPA6;IKBKE;ERAP1;STOML1;CDSN;ANXA8;ITGAV;LYN;COBLL1;AP3M1;COL8A1;C1R;ANXA1;G6PD;NEDD4L;VEGFC;RHOB;ARG1;UGGT1;TRAF3;CSRP1;GSTCD;SYT11;KLK6;KCTD12;RIMS2;HSP90AA1;CANX;FTH1;NRP1;IL7R;SOD2;ACO1;SERPINH1;HSP90AB1;KRT34;ADAM8;STXBP5;STEAP4;UQCC1;CALR;PDIA6;IFNAR1;IGFBP3;AMOTL2;MGAT5;MAGT1;RRAS2;ARHGDIB;CS;CORO1C;NID2;MME;DLG1;PDIA4;GDA;EHD1;TXNRD1;PTTG1IP;SEC24D;CALU;TGFA;MGST3;DNAJC3;ANKRD13A;HSP90B1;TFRC;SVIP;NEDD4;TUBB3;PML;PVR;MON1A;EPB41L2;MYH9;GBE1;CPPED1;RPL26L1;CLINT1;TPM4;HSPD1;SND1;IRAK2
1014,GO:0002521,4.50674552641293e-06,0.999998608967213,25,295,leukocyte differentiation,BP,MMP9;LGALS1;MAFB;RELB;JUN;RIPK2;PARP1;JUNB;TJP2;DNAJB9;AXL;CYLD;TRIB1;CD83;LYN;ANXA1;XBP1;IL7R;KLF10;ADAM8;IL23A;TFRC;CDK6;EPHA2;MYH9
878,GO:0002250,4.96745384392469e-06,0.999998746733992,19,189,adaptive immune response,BP,RELB;RIPK2;NFKB2;IL1B;IL6ST;ERAP1;LYN;C1R;ANXA1;NBN;ARG1;IL7R;IL23A;DLG1;TFRC;NLRP10;NEDD4;PVR;HSPD1
3730,GO:0008284,5.70573137516677e-06,0.999997785062224,36,533,positive regulation of cell proliferation,BP,MMP9;OSR2;B4GALT1;EDN1;CD274;FGF5;EPCAM;CLDN7;JUN;RIPK2;IL1B;IL6ST;ATF3;ITGAV;LYN;ANXA1;VEGFC;XBP1;ARG1;HMOX1;IL24;NRP1;IL7R;NRG1;CALR;IL23A;DLG1;ETS1;HAS2;TGFA;BAMBI;TFRC;HTR1B;CDK6;PML;SOX11
623,GO:0001816,6.30308798924827e-06,0.999997690237854,32,448,cytokine production,BP,IL1A;TRIM16;SAA1;NFKB1;RELB;CD274;CCBE1;RIPK2;NFKB2;IL1B;IL6ST;AXL;IKBKE;CYLD;SEMA7A;CD83;ITGAV;LYN;ANXA1;BIRC3;XBP1;ARG1;TRAF3;HMOX1;SYT11;HSP90AB1;ADAM8;IL23A;DLG1;NLRP10;PML;HSPD1
2594,GO:0005912,6.53615436710544e-06,0.999997600647608,32,446,adherens junction,CC,LCP1;KRT18;MCAM;HSPA5;TJP2;ACTG1;ITGAV;LYN;ANXA1;RHOB;CSRP1;NRP1;L1CAM;EIF4G2;CALR;AJUBA;RRAS2;GIT2;CORO1C;MME;DLG1;FOCAD;HSP90B1;EPHA2;PVR;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;TJP1;PARVA
147,GO:0000302,7.25373481435925e-06,0.999998286937484,17,163,response to reactive oxygen species,BP,MMP9;EDN1;TP53;JUN;CRYAB;AXL;DUSP1;ANXA1;SLC8A1;RHOB;ARG1;HMOX1;EGLN1;SETX;SOD2;TXNRD1;ETS1
1160,GO:0002790,7.28512532669695e-06,0.999997564729799,27,345,peptide secretion,BP,IL1A;TRIM16;SAA1;EDN1;CD274;RIPK2;IL1B;ITGAV;LYN;ANXA1;VEGFC;XBP1;SYT11;RIMS2;CANX;GNPTAB;ADAM8;STXBP5;PPID;SEL1L;SERP1;PDIA4;NLRP10;PML;OXCT1;MON1A;MIDN
4172,GO:0009266,7.28587631296455e-06,0.999998191773094,18,177,response to temperature stimulus,BP,NFKBIA;IL1A;TP53;DNAJB1;HSPA5;HSPB8;CRYAB;HSPA6;STAC;LYN;HMOX1;HSP90AA1;HSP90AB1;EIF2B1;CHORDC1;DNAJC3;HTR1B;HSPD1
624,GO:0001817,7.32241951167621e-06,0.999997390819997,30,409,regulation of cytokine production,BP,IL1A;TRIM16;SAA1;NFKB1;RELB;CD274;CCBE1;RIPK2;NFKB2;IL1B;IL6ST;AXL;IKBKE;CYLD;SEMA7A;CD83;LYN;ANXA1;BIRC3;XBP1;ARG1;TRAF3;HMOX1;SYT11;HSP90AB1;ADAM8;IL23A;NLRP10;PML;HSPD1
13108,GO:0051716,7.95005227671444e-06,0.999995583507455,182,4649,cellular response to stimulus,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;SAA1;LCP1;TNIP1;DUSP8;KRT18;NFKB1;RELB;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;PEG10;CCBE1;JUN;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;IFT46;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;HSPA6;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FBN2;DUSP1;STAC;TRIB1;FADS1;FIGN;CD83;ITGAV;LYN;NCEH1;ANXA1;PDE1C;GPR176;DERL3;G6PD;NBN;SLC8A1;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEMA3D;TRAF3;HMOX1;KLK6;IL24;RIMS2;HSP90AA1;CANX;DAPP1;NRP1;IL7R;TRAF1;EGLN1;SETX;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;ADAM8;NR2F2;CALR;PDIA6;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;RRAS2;PRR5L;RAB30;HMGCS1;ARHGDIB;GIT2;CORO1C;IL23A;MME;DLG1;PDIA4;RBMS3;EHD1;PITHD1;CITED2;TXNRD1;PTTG1IP;ETS1;HAS2;ADGRL3;CHORDC1;TGFA;MGST3;BAMBI;DNAJC3;ZC3H7B;IFNGR1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;CDK6;PML;OXCT1;EPHA2;MYH9;EID3;SOX11;ENPP1;AFAP1;HSPD1;MAGED1;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
12211,GO:0048522,8.03716369249942e-06,0.999995603382071,144,3464,positive regulation of cellular process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;NEFL;NETO1;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;LCP1;TNIP1;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CLDN1;UBQLN2;EPCAM;CDKN2B;CLDN7;CCBE1;JUN;MCAM;RIPK2;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;JUNB;C1QTNF1;IL6ST;ATF3;AXL;CREB5;EHF;GADD45B;NOCT;IKBKE;CYLD;SEMA7A;FBN2;DUSP1;TRIB1;CD83;ITGAV;LYN;ANXA1;NBN;SLC8A1;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;SEMA3D;SUDS3;ARNTL2;HMOX1;KLK6;IL24;RIMS2;HSP90AA1;NRP1;IL7R;EGLN1;SETX;DCUN1D3;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;SDR16C5;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;MAFF;RRAS2;PRR5L;CORO1C;IL23A;DLG1;RBMS3;EHD1;CITED2;PTTG1IP;ETS1;HAS2;ADGRL3;TGFA;BAMBI;DNAJC3;CBLL1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;CDK6;PML;OXCT1;EPHA2;MYH9;EID3;BTBD10;SOX11;UGCG;HSPD1;MAGED1;SUPT3H;IRAK2;CYP1A1
989,GO:0002460,8.1679495352095e-06,0.999998269407856,15,129,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RELB;RIPK2;NFKB2;IL1B;C1R;ANXA1;NBN;ARG1;IL7R;IL23A;DLG1;TFRC;NLRP10;PVR;HSPD1
17832,GO:1902107,8.20524866063873e-06,0.999998636128599,12,84,positive regulation of leukocyte differentiation,BP,JUN;RIPK2;AXL;CYLD;TRIB1;CD83;ANXA1;XBP1;IL7R;KLF10;ADAM8;IL23A
3373,GO:0007166,8.36391932416339e-06,0.999995577421284,88,1851,cell surface receptor signaling pathway,BP,IL32;NFKBIA;MMP9;IL1A;NETO1;KRT8;SERPINB2;CXCL1;SAA1;LCP1;KRT18;NFKB1;RELB;EDN1;TP53;PMAIP1;PSMB9;CD274;FGF5;SLIT2;CHAC1;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;PARP1;HSPA5;IL1B;IFT46;JUNB;TJP2;IL6ST;ATF3;AXL;ACTG1;IFITM2;CYLD;SEMA7A;FBN2;TRIB1;ITGAV;LYN;ANXA1;WWC1;BIRC3;VEGFC;ARG1;SEMA3D;TRAF3;HMOX1;IL24;RIMS2;HSP90AA1;CANX;NRP1;IL7R;TRAF1;SETX;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;IFNAR1;CTR9;IGFBP3;SEL1L;AMOTL2;EYA3;EIF2B1;IL23A;RBMS3;CITED2;ADGRL3;TGFA;BAMBI;IFNGR1;HSP90B1;NEDD4;PML;EPHA2;MYH9;SOX11;ENPP1;IRAK2
941,GO:0002366,9.56420516072552e-06,0.999996414284162,32,463,leukocyte activation involved in immune response,BP,MMP9;FLG2;KRT1;CXCL1;LGALS1;LCP1;NFKB1;RELB;B4GALT1;RIPK2;HRNR;ANPEP;HSPA6;ITGAV;LYN;ANXA1;NBN;XBP1;ARG1;HMOX1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;IL23A;MME;DNAJC3;TFRC;SVIP;CPPED1;HSPD1
4182,GO:0009306,1.00753612593188e-05,0.999996646354174,26,331,protein secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;ITGAV;LYN;ANXA1;VEGFC;XBP1;SYT11;RIMS2;CANX;GNPTAB;ADAM8;STXBP5;PPID;SEL1L;SERP1;PDIA4;NLRP10;PML;OXCT1;MON1A;MIDN
19453,GO:1990266,1.01148012294053e-05,0.999999036186825,8,37,neutrophil migration,BP,IL1A;CXCL1;SAA1;EDN1;SLIT2;IL1B;ADAM8;IL23A
8172,GO:0032940,1.03207016487815e-05,0.99999525600047,52,927,secretion by cell,BP,MMP9;IL1A;FLG2;TRIM16;KRT1;CXCL1;SAA1;NFKB1;B4GALT1;EDN1;CD274;RIPK2;HRNR;IL1B;ANPEP;C1QTNF1;AXL;HSPA6;ITGAV;LYN;ANXA1;VEGFC;XBP1;ARG1;HMOX1;SYT11;RIMS2;HSP90AA1;CANX;FTH1;GNPTAB;HSP90AB1;ADAM8;STXBP5;PPID;SEL1L;SERP1;MAGT1;SEC22A;MME;PDIA4;DNAJC3;NLRP10;HTR1B;SVIP;PML;OXCT1;MON1A;SOX11;CPPED1;TNFAIP2;MIDN
1167,GO:0002821,1.05326101940385e-05,0.999998776700133,9,48,positive regulation of adaptive immune response,BP,RIPK2;IL1B;IL6ST;ANXA1;IL23A;TFRC;NLRP10;PVR;HSPD1
6917,GO:0030545,1.0872841243674e-05,0.999997343606132,17,170,receptor regulator activity,MF,IL32;IL1A;CXCL1;SAA1;EDN1;CXCL16;FGF5;IL16;IL1B;SEMA7A;VEGFC;SEMA3D;IL24;TNFSF15;NRG1;IL23A;TGFA
885,GO:0002263,1.10390731755923e-05,0.999995829740945,32,466,cell activation involved in immune response,BP,MMP9;FLG2;KRT1;CXCL1;LGALS1;LCP1;NFKB1;RELB;B4GALT1;RIPK2;HRNR;ANPEP;HSPA6;ITGAV;LYN;ANXA1;NBN;XBP1;ARG1;HMOX1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;IL23A;MME;DNAJC3;TFRC;SVIP;CPPED1;HSPD1
12241,GO:0048585,1.11014501360245e-05,0.999994667352381,59,1100,negative regulation of response to stimulus,BP,NFKBIA;MMP9;IL1A;KRT1;SERPINB2;SAA1;TNIP1;DUSP8;NFKB1;EDN1;PSMB9;SLIT2;UBQLN2;CHAC1;PEG10;HERPUD1;OPTN;HSPA5;IL1B;C1QTNF1;ATF3;DNAJB9;AXL;CYLD;SEMA7A;FBN2;DUSP1;TRIB1;ITGAV;LYN;ANXA1;DERL3;WWC1;XBP1;ARG1;SEMA3D;HMOX1;NRP1;IL7R;SOD2;NRG1;CALR;AJUBA;IGFBP3;EYA3;PRR5L;DLG1;RBMS3;PTTG1IP;ETS1;BAMBI;DNAJC3;NLRP10;HTR1B;SVIP;NEDD4;CDK6;EPHA2;ENPP1
880,GO:0002252,1.15835834354963e-05,0.999994922918747,44,740,immune effector process,BP,MMP9;FLG2;KRT1;CXCL1;LGALS1;LCP1;NFKB1;RELB;B4GALT1;PMAIP1;RIPK2;HRNR;IL1B;ANPEP;ACTG1;IFITM2;HSPA6;SEMA7A;ITGAV;LYN;C1R;ANXA1;NBN;BIRC3;XBP1;ARG1;TRAF3;HMOX1;HSP90AA1;FTH1;IL7R;HSP90AB1;ADAM8;MAGT1;IL23A;MME;DLG1;DNAJC3;TFRC;SVIP;PML;PVR;CPPED1;HSPD1
6667,GO:0030054,1.28570859900829e-05,0.999994054241976,50,869,cell junction,CC,NETO1;KRT8;DSCAM;LCP1;KRT18;B4GALT1;CLDN1;EPCAM;CLDN7;CLDN11;MCAM;SDK1;HSPA5;CNTNAP1;TJP2;ACTG1;CDSN;ITGAV;LYN;ANXA1;SLC8A1;RHOB;CSRP1;SYT11;KCTD12;RIMS2;NRP1;L1CAM;STXBP5;EIF4G2;CALR;AJUBA;AMOTL2;RRAS2;GIT2;CORO1C;MME;DLG1;ADGRL3;FOCAD;HSP90B1;EPHA2;PVR;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;TJP1;PARVA
4346,GO:0009967,1.29685166468393e-05,0.999993804164868,57,1055,positive regulation of signal transduction,BP,MMP9;IL1A;TRIM16;NETO1;LGALS1;SAA1;NFKB1;EDN1;TP53;PMAIP1;PSMB9;FGF5;UBQLN2;CDKN2B;CCBE1;JUN;RIPK2;PARP1;IL1B;CNTNAP1;C1QTNF1;IL6ST;ATF3;AXL;GADD45B;IKBKE;CYLD;SEMA7A;ITGAV;LYN;WWC1;BIRC3;XBP1;HMOX1;KLK6;IL24;RIMS2;NRP1;IL7R;TNFSF15;NRG1;HSP90AB1;ADAM8;CALR;AJUBA;IGFBP3;PRR5L;IL23A;CITED2;TGFA;BAMBI;NEDD4;PML;EPHA2;SOX11;MAGED1;IRAK2
16613,GO:0097530,1.43056514504973e-05,0.999998263655438,9,50,granulocyte migration,BP,IL1A;CXCL1;SAA1;EDN1;SLIT2;IL1B;ANXA1;ADAM8;IL23A
3372,GO:0007165,1.53781188144316e-05,0.999991055764685,149,3654,signal transduction,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;SAA1;LCP1;TNIP1;DUSP8;KRT18;NFKB1;RELB;EDN1;TP53;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FBN2;DUSP1;STAC;TRIB1;CD83;ITGAV;LYN;ANXA1;PDE1C;GPR176;DERL3;NBN;SLC8A1;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEMA3D;TRAF3;HMOX1;KLK6;IL24;RIMS2;HSP90AA1;CANX;DAPP1;NRP1;IL7R;TRAF1;SETX;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;ADAM8;NR2F2;CALR;PDIA6;IFNAR1;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;RRAS2;PRR5L;RAB30;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;RBMS3;CITED2;TXNRD1;PTTG1IP;ADGRL3;TGFA;BAMBI;DNAJC3;IFNGR1;HSP90B1;NLRP10;HTR1B;NEDD4;CDK6;PML;EPHA2;MYH9;SOX11;ENPP1;AFAP1;HSPD1;MAGED1;IRAK2;TJP1
12734,GO:0051049,1.59981421907938e-05,0.999992218796122,59,1107,regulation of transport,BP,NFKBIA;MMP9;IL1A;TRIM16;NETO1;SAA1;LCP1;NFKB1;FEZ1;EDN1;TP53;PMAIP1;CD274;UBQLN2;RIPK2;IL16;IL1B;C1QTNF1;CRYAB;AXL;STAC;ITGAV;LYN;ANXA1;DERL3;G6PD;SLC8A1;WWC1;NEDD4L;VEGFC;XBP1;ARG1;HMOX1;SYT11;RIMS2;NRP1;KCNQ5;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;SERP1;PRR5L;DLG1;EHD1;REEP1;CBLL1;NLRP10;HTR1B;SVIP;NEDD4;PML;OXCT1;SOX11;UGCG;ENPP1;MIDN
19696,GO:2000108,1.67263855800038e-05,0.999999016113674,6,20,positive regulation of leukocyte apoptotic process,BP,CDKN2A;TP53;CD274;LYN;ANXA1;ADAM8
1089,GO:0002685,1.7089293054195e-05,0.999996916831473,12,92,regulation of leukocyte migration,BP,IL1A;CXCL1;EDN1;TP53;SLIT2;LYN;ANXA1;VEGFC;HMOX1;ADAM8;CALR;IL23A
12533,GO:0050727,1.85120329335999e-05,0.999995277132024,17,173,regulation of inflammatory response,BP,NFKBIA;KRT1;SAA1;TNIP1;NFKB1;IL1B;IL6ST;MGLL;SEMA7A;LYN;C1R;ANXA1;BIRC3;ADAM8;IL23A;ETS1;NLRP10
16612,GO:0097529,1.91163726480842e-05,0.999996845427615,11,78,myeloid leukocyte migration,BP,IL1A;CXCL1;SAA1;EDN1;SLIT2;IL1B;LYN;ANXA1;VEGFC;ADAM8;IL23A
12865,GO:0051251,1.93207205002314e-05,0.999995303971297,16,156,positive regulation of lymphocyte activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;AXL;CYLD;CD83;LYN;ANXA1;XBP1;IL7R;ADAM8;IL23A;TFRC;HSPD1
12208,GO:0048519,1.9717153608059e-05,0.999988207969633,147,3628,negative regulation of biological process,BP,CDKN2A;NFKBIA;MMP9;IL1A;KRT1;NEFL;SERPINB2;CXCL1;LGALS1;DSCAM;SAA1;OSR2;TNIP1;DUSP8;KRT18;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;CD274;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;CLDN7;DNAJB1;PEG10;JUN;KRT4;RIPK2;NFKB2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;DNAJB9;AXL;DNAJC10;IFITM2;GADD45B;NOCT;IKBKE;CYLD;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;ANXA8;TRIB1;CD83;ITGAV;LYN;ANXA1;GPR176;DERL3;G6PD;NBN;SLC8A1;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;SEMA3D;SUDS3;TRAF3;HMOX1;SYT11;IL24;FTH1;NRP1;IL7R;EGLN1;SETX;DCUN1D3;SOD2;KLF10;NRG1;IFRD1;SERPINH1;HSP90AB1;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;CALR;PPID;CTR9;AJUBA;IGFBP3;EYA3;ORMDL1;MGA;PRR5L;ARHGDIB;UBP1;CORO1C;IL23A;DLG1;RBMS3;CITED2;ZNF814;PTTG1IP;ETS1;CHORDC1;BAMBI;DNAJC3;CBLL1;ZC3H7B;HSP90B1;NLRP10;HTR1B;SVIP;NEDD4;CDK6;PML;EPHA2;MYH9;BTBD10;ZBTB21;SOX11;ENPP1;HSPD1;SND1;MAGED1;MIDN;IRAK2
18025,GO:1902624,2.07295013512279e-05,0.999999197362058,5,13,positive regulation of neutrophil migration,BP,IL1A;CXCL1;EDN1;ADAM8;IL23A
12483,GO:0050663,2.11662583196407e-05,0.999995745731998,13,107,cytokine secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;ITGAV;LYN;ANXA1;XBP1;SYT11;NLRP10;PML
11267,GO:0045621,2.17675891903617e-05,0.999997198734564,9,52,positive regulation of lymphocyte differentiation,BP,RIPK2;AXL;CYLD;CD83;ANXA1;XBP1;IL7R;ADAM8;IL23A
1165,GO:0002819,2.26451651890767e-05,0.999996188523961,11,79,regulation of adaptive immune response,BP,RIPK2;IL1B;IL6ST;ANXA1;ARG1;IL7R;IL23A;TFRC;NLRP10;PVR;HSPD1
2365,GO:0005509,2.27201245067284e-05,0.99999187185827,27,362,calcium ion binding,MF,RPTN;FLG2;TCHH;LCP1;FLG;SLIT2;CCBE1;HRNR;HSPA5;EFHD2;FBN2;ANXA8;C1R;ANXA1;SLC8A1;SYT11;CANX;GNPTAB;ADAM8;CALR;NID2;EHD1;ADGRL3;CALU;HSP90B1;ENPP1;TPM4
1173,GO:0002827,2.29239363410774e-05,0.999999595938889,4,7,positive regulation of T-helper 1 type immune response,BP,RIPK2;ANXA1;IL23A;NLRP10
3260,GO:0006954,2.35222768367692e-05,0.999991746463525,26,351,inflammatory response,BP,NFKBIA;IL1A;KRT1;CXCL1;SAA1;TNIP1;NFKB1;RELB;B4GALT1;RIPK2;NFKB2;IL1B;IL6ST;AXL;MGLL;SEMA7A;LYN;C1R;ANXA1;BIRC3;HMOX1;ADAM8;IL23A;ETS1;NLRP10;IRAK2
9830,GO:0042110,2.41870245360074e-05,0.999992354148292,22,268,T cell activation,BP,LGALS1;LCP1;MAFB;RELB;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;IL7R;ADAM8;IL23A;DLG1;TFRC;NEDD4;MYH9;HSPD1
17830,GO:1902105,2.47472911906688e-05,0.999993856274074,16,157,regulation of leukocyte differentiation,BP,MAFB;JUN;RIPK2;TJP2;AXL;CYLD;TRIB1;CD83;LYN;ANXA1;XBP1;IL7R;KLF10;ADAM8;IL23A;CDK6
8340,GO:0033256,2.48081878694248e-05,0.999999553646674,4,7,I-kappaB/NF-kappaB complex,CC,NFKBIA;NFKB1;RELB;NFKB2
12518,GO:0050707,2.58734027493853e-05,0.999995119518477,12,94,regulation of cytokine secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;LYN;ANXA1;XBP1;SYT11;NLRP10;PML
4533,GO:0010632,2.61619469550729e-05,0.999993476378187,16,156,regulation of epithelial cell migration,BP,MMP9;EDN1;SLIT2;CCBE1;JUN;ANXA1;VEGFC;RHOB;HMOX1;NRP1;NR2F2;CALR;CORO1C;ETS1;HAS2;EPHA2
12562,GO:0050778,2.6936524737279e-05,0.999989672441552,30,440,positive regulation of immune response,BP,NFKBIA;KRT1;TNIP1;NFKB1;RELB;PSMB9;RIPK2;IL1B;IL6ST;ACTG1;IKBKE;CYLD;SEMA7A;LYN;C1R;ANXA1;BIRC3;XBP1;TRAF3;HSP90AA1;HSP90AB1;ADAM8;EIF2B1;IL23A;HSP90B1;TFRC;NLRP10;PVR;HSPD1;IRAK2
2602,GO:0005925,2.70967164787226e-05,0.999990408281888,26,353,focal adhesion,CC,LCP1;MCAM;HSPA5;ACTG1;ITGAV;ANXA1;RHOB;CSRP1;NRP1;L1CAM;CALR;AJUBA;RRAS2;GIT2;CORO1C;MME;FOCAD;HSP90B1;EPHA2;PVR;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;PARVA
7319,GO:0031349,2.73285415946306e-05,0.999991024480239,23,294,positive regulation of defense response,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;RIPK2;OPTN;IL1B;IL6ST;IKBKE;CYLD;LYN;BIRC3;ARG1;TRAF3;ADAM8;IL23A;ETS1;HSP90B1;NLRP10;PVR;HSPD1;IRAK2
2601,GO:0005924,2.8298366060749e-05,0.999989955497038,26,354,cell-substrate adherens junction,CC,LCP1;MCAM;HSPA5;ACTG1;ITGAV;ANXA1;RHOB;CSRP1;NRP1;L1CAM;CALR;AJUBA;RRAS2;GIT2;CORO1C;MME;FOCAD;HSP90B1;EPHA2;PVR;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;PARVA
18485,GO:1903708,2.91863347802731e-05,0.999993935475368,13,110,positive regulation of hemopoiesis,BP,JUN;RIPK2;AXL;CYLD;TRIB1;CD83;ANXA1;XBP1;IL7R;KLF10;ADAM8;IL23A;ETS1
9396,GO:0035994,2.9645285191183e-05,0.999998761399412,5,13,response to muscle stretch,BP,NFKBIA;NFKB1;EDN1;JUN;SLC8A1
14261,GO:0061436,3.00228945437392e-05,0.999998012572012,6,21,establishment of skin barrier,BP,RPTN;FLG2;KRT1;FLG;CLDN1;HRNR
11240,GO:0045582,3.01945516578304e-05,0.999996580758136,8,42,positive regulation of T cell differentiation,BP,RIPK2;CYLD;CD83;ANXA1;XBP1;IL7R;ADAM8;IL23A
4548,GO:0010647,3.23781329945838e-05,0.999983497713378,59,1139,positive regulation of cell communication,BP,MMP9;IL1A;TRIM16;NETO1;LGALS1;SAA1;NFKB1;EDN1;TP53;PMAIP1;PSMB9;FGF5;UBQLN2;CDKN2B;CCBE1;JUN;RIPK2;PARP1;IL1B;CNTNAP1;C1QTNF1;IL6ST;ATF3;AXL;GADD45B;IKBKE;CYLD;SEMA7A;ITGAV;LYN;WWC1;BIRC3;XBP1;HMOX1;KLK6;IL24;RIMS2;NRP1;IL7R;TNFSF15;NRG1;HSP90AB1;ADAM8;CALR;AJUBA;IGFBP3;SERP1;PRR5L;IL23A;CITED2;TGFA;BAMBI;NEDD4;PML;OXCT1;EPHA2;SOX11;MAGED1;IRAK2
11852,GO:0046903,3.26510746675173e-05,0.999983916852674,53,990,secretion,BP,MMP9;IL1A;FLG2;TRIM16;KRT1;CXCL1;SAA1;NFKB1;B4GALT1;EDN1;CD274;RIPK2;HRNR;IL1B;ANPEP;C1QTNF1;AXL;HSPA6;ITGAV;LYN;ANXA1;VEGFC;XBP1;ARG1;HMOX1;SYT11;RIMS2;HSP90AA1;CANX;FTH1;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;PPID;SEL1L;SERP1;MAGT1;SEC22A;MME;PDIA4;DNAJC3;NLRP10;HTR1B;SVIP;PML;OXCT1;MON1A;SOX11;CPPED1;TNFAIP2;MIDN
1177,GO:0002831,3.26993581318922e-05,0.999993670201017,12,96,regulation of response to biotic stimulus,BP,RIPK2;OPTN;IL1B;TRIB1;BIRC3;ARG1;TRAF3;SYT11;IL23A;NLRP10;PVR;HSPD1
12861,GO:0051247,3.30248270719951e-05,0.999983155788794,59,1139,positive regulation of protein metabolic process,BP,NFKBIA;MMP9;IL1A;SAA1;TNIP1;EDN1;TP53;PMAIP1;UBQLN2;CCBE1;JUN;RIPK2;HERPUD1;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;TRIB1;ITGAV;LYN;NBN;WWC1;NEDD4L;BIRC3;VEGFC;XBP1;HMOX1;IL24;HSP90AA1;NRP1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;ADAM8;UQCC1;CTR9;AJUBA;IGFBP3;SERP1;PRR5L;IL23A;DLG1;RBMS3;PTTG1IP;TGFA;DNAJC3;SVIP;NEDD4;PML;EPHA2;MYH9;HSPD1;MAGED1;IRAK2
1103,GO:0002699,3.31203611585962e-05,0.999993575789051,12,97,positive regulation of immune effector process,BP,RIPK2;IL1B;SEMA7A;LYN;ANXA1;XBP1;ARG1;HMOX1;IL23A;TFRC;PVR;HSPD1
703,GO:0001932,3.42539741908216e-05,0.999983316581316,51,933,regulation of protein phosphorylation,BP,CDKN2A;MMP9;IL1A;SAA1;TNIP1;DUSP8;EDN1;TP53;DBNDD2;SLIT2;CDKN2B;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;NRP1;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;PML;EPHA2;ENPP1;MAGED1;IRAK2
6668,GO:0030055,3.48905000744513e-05,0.999987451317181,26,358,cell-substrate junction,CC,LCP1;MCAM;HSPA5;ACTG1;ITGAV;ANXA1;RHOB;CSRP1;NRP1;L1CAM;CALR;AJUBA;RRAS2;GIT2;CORO1C;MME;FOCAD;HSP90B1;EPHA2;PVR;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;PARVA
3274,GO:0006979,3.65631494455372e-05,0.999987419905102,24,321,response to oxidative stress,BP,MMP9;KRT1;EDN1;TP53;JUN;PARP1;MSRB3;CRYAB;GPX8;AXL;DUSP1;ANXA1;G6PD;SLC8A1;RHOB;ARG1;HMOX1;EGLN1;SETX;SOD2;PRR5L;TXNRD1;ETS1;PML
12619,GO:0050863,3.75973758717657e-05,0.999989817700862,17,182,regulation of T cell activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;IL7R;ADAM8;IL23A;DLG1;TFRC;HSPD1
6629,GO:0023056,3.77786045292241e-05,0.999980633537067,59,1145,positive regulation of signaling,BP,MMP9;IL1A;TRIM16;NETO1;LGALS1;SAA1;NFKB1;EDN1;TP53;PMAIP1;PSMB9;FGF5;UBQLN2;CDKN2B;CCBE1;JUN;RIPK2;PARP1;IL1B;CNTNAP1;C1QTNF1;IL6ST;ATF3;AXL;GADD45B;IKBKE;CYLD;SEMA7A;ITGAV;LYN;WWC1;BIRC3;XBP1;HMOX1;KLK6;IL24;RIMS2;NRP1;IL7R;TNFSF15;NRG1;HSP90AB1;ADAM8;CALR;AJUBA;IGFBP3;SERP1;PRR5L;IL23A;CITED2;TGFA;BAMBI;NEDD4;PML;OXCT1;EPHA2;SOX11;MAGED1;IRAK2
9378,GO:0035967,3.82846762152359e-05,0.999990648987969,15,146,cellular response to topologically incorrect protein,BP,HERPUD1;OPTN;HSPA5;ATF3;DNAJB9;HSPA6;DERL3;XBP1;UGGT1;CALR;PDIA6;SERP1;DNAJC3;HSP90B1;SDF2L1
3239,GO:0006915,3.91571596432621e-05,0.999979065789464,68,1391,apoptotic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;KRT8;SERPINB2;LGALS1;KRT18;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;CD274;SLIT2;CHAC1;CLDN7;PEG10;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;IL6ST;PHLDA2;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;DUSP1;ITGAV;LYN;ANXA1;G6PD;NBN;BIRC3;RHOB;XBP1;SUDS3;TRAF3;HMOX1;IL24;NRP1;TRAF1;SETX;DCUN1D3;TNFSF15;SOD2;HSP90AB1;ADAM8;CALR;PPID;IGFBP3;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;PML;EPHA2;HSPD1;MAGED1;SDF2L1
12748,GO:0051082,4.08098089442359e-05,0.99999188806617,12,101,unfolded protein binding,MF,DNAJB1;HSPA5;CRYAB;HSPA6;UGGT1;HSP90AA1;CANX;SERPINH1;HSP90AB1;CALR;HSP90B1;HSPD1
1170,GO:0002824,4.09258495524823e-05,0.999995131283429,8,44,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RIPK2;IL1B;ANXA1;IL23A;TFRC;NLRP10;PVR;HSPD1
4407,GO:0010243,4.09447829433755e-05,0.999981828835107,39,648,response to organonitrogen compound,BP,NFKBIA;TRIM16;NEFL;NFKB1;EDN1;TP53;SLIT2;UBQLN2;JUN;RIPK2;HERPUD1;PARP1;SDK1;HSPA5;IL1B;JUNB;DNAJB9;DNAJC10;DUSP1;LYN;ANXA1;DERL3;SLC8A1;XBP1;ARG1;UGGT1;MMP19;KLF10;HSP90AB1;SEL1L;EIF2B1;HMGCS1;ADGRL3;MGST3;HSP90B1;HTR1B;SVIP;ENPP1;SDF2L1
7732,GO:0032270,4.15862753153295e-05,0.999978946482903,56,1071,positive regulation of cellular protein metabolic process,BP,NFKBIA;MMP9;IL1A;SAA1;TNIP1;EDN1;TP53;PMAIP1;UBQLN2;CCBE1;JUN;RIPK2;HERPUD1;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;TRIB1;ITGAV;LYN;NBN;WWC1;BIRC3;VEGFC;XBP1;IL24;HSP90AA1;NRP1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;ADAM8;UQCC1;CTR9;AJUBA;IGFBP3;SERP1;PRR5L;IL23A;DLG1;RBMS3;PTTG1IP;TGFA;DNAJC3;SVIP;PML;EPHA2;MYH9;HSPD1;MAGED1;IRAK2
8912,GO:0034975,4.4106528129468e-05,0.999997936664812,5,14,protein folding in endoplasmic reticulum,BP,HSPA5;DNAJC10;CANX;CALR;HSP90B1
8808,GO:0034620,4.43294034409436e-05,0.999989677522236,14,131,cellular response to unfolded protein,BP,HERPUD1;OPTN;HSPA5;ATF3;DNAJB9;HSPA6;DERL3;XBP1;UGGT1;CALR;PDIA6;SERP1;DNAJC3;HSP90B1
8801,GO:0034605,4.54422789801506e-05,0.99999011334489,13,114,cellular response to heat,BP,IL1A;TP53;DNAJB1;HSPA5;HSPB8;CRYAB;HSPA6;STAC;LYN;HMOX1;HSP90AA1;HSP90AB1;CHORDC1
4532,GO:0010631,4.57780826731513e-05,0.999986838228801,18,199,epithelial cell migration,BP,MMP9;KRT2;EDN1;SLIT2;CCBE1;JUN;ANXA1;VEGFC;RHOB;HMOX1;NRP1;NR2F2;CALR;CORO1C;ETS1;HAS2;EPHA2;MYH9
1168,GO:0002822,4.78744439734264e-05,0.999992112321936,10,71,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,RIPK2;IL1B;ANXA1;ARG1;IL7R;IL23A;TFRC;NLRP10;PVR;HSPD1
2920,GO:0006457,4.85456313123129e-05,0.999985951630652,18,209,protein folding,BP,DNAJB1;HSPA5;CRYAB;DNAJC10;HSPA6;UGGT1;HSP90AA1;CANX;HSP90AB1;CALR;PDIA6;PPID;PDIA4;NGLY1;CHORDC1;SUGT1;HSP90B1;HSPD1
16090,GO:0090132,4.91240977320967e-05,0.9999857940604,18,200,epithelium migration,BP,MMP9;KRT2;EDN1;SLIT2;CCBE1;JUN;ANXA1;VEGFC;RHOB;HMOX1;NRP1;NR2F2;CALR;CORO1C;ETS1;HAS2;EPHA2;MYH9
15377,GO:0071682,4.93683300762623e-05,0.999998811028377,4,8,endocytic vesicle lumen,CC,SAA1;HSP90AA1;CALR;HSP90B1
12212,GO:0048523,5.00191437181475e-05,0.999969090945418,134,3280,negative regulation of cellular process,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;SERPINB2;CXCL1;LGALS1;DSCAM;OSR2;TNIP1;DUSP8;KRT18;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PSMB9;CD274;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;CLDN7;DNAJB1;PEG10;JUN;KRT4;RIPK2;NFKB2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;DNAJB9;AXL;DNAJC10;GADD45B;NOCT;CYLD;SEMA7A;CDSN;FBN2;DUSP1;ANXA8;TRIB1;ITGAV;LYN;ANXA1;GPR176;DERL3;G6PD;NBN;SLC8A1;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;ARG1;SEMA3D;SUDS3;HMOX1;SYT11;IL24;FTH1;NRP1;EGLN1;SETX;DCUN1D3;SOD2;KLF10;NRG1;IFRD1;SERPINH1;HSP90AB1;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;CALR;PPID;CTR9;AJUBA;IGFBP3;EYA3;ORMDL1;MGA;PRR5L;ARHGDIB;UBP1;CORO1C;DLG1;RBMS3;CITED2;ZNF814;PTTG1IP;ETS1;CHORDC1;BAMBI;DNAJC3;CBLL1;ZC3H7B;HSP90B1;HTR1B;SVIP;NEDD4;CDK6;PML;EPHA2;MYH9;BTBD10;ZBTB21;SOX11;ENPP1;HSPD1;MAGED1;MIDN
16088,GO:0090130,5.20421178903549e-05,0.999984878022485,18,201,tissue migration,BP,MMP9;KRT2;EDN1;SLIT2;CCBE1;JUN;ANXA1;VEGFC;RHOB;HMOX1;NRP1;NR2F2;CALR;CORO1C;ETS1;HAS2;EPHA2;MYH9
8417,GO:0033561,5.32608493204357e-05,0.999996005072721,6,23,regulation of water loss via skin,BP,RPTN;FLG2;KRT1;FLG;CLDN1;HRNR
10858,GO:0044432,5.36383551286371e-05,0.999973384040535,51,959,endoplasmic reticulum part,CC,LGALS1;EDN1;COL12A1;HERPUD1;HSPA5;GPX8;DNAJB9;DNAJC10;MGLL;ERAP1;FADS1;STT3A;NCEH1;COL8A1;FADS3;COL4A4;DERL3;XBP1;UGGT1;SEC11C;HMOX1;CANX;SERPINH1;SDR16C5;GGCX;CALR;PDIA6;IGFBP3;SEL1L;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;IL23A;DLG1;PDIA4;DHDDS;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;DNAJC3;HSP90B1;SVIP;ZDHHC6;PML;SDF2L1;CYP1A1
3729,GO:0008283,5.3755903488358e-05,0.999971179000107,65,1318,cell proliferation,BP,CDKN2A;NFKBIA;MMP9;IL1A;CXCL1;OSR2;KRT2;B4GALT1;EDN1;TP53;CD274;FGF5;EPCAM;CDKN2B;CLDN7;JUN;KRT4;RIPK2;IL1B;CDV3;JUNB;IL6ST;PHLDA2;ATF3;EHF;TRIB1;ITGAV;LYN;COL8A1;ANXA1;NBN;VEGFC;XBP1;ARG1;HMOX1;IL24;FTH1;NRP1;IL7R;SOD2;KLF10;NRG1;SDR16C5;NR2F2;CALR;IGFBP3;IL23A;DLG1;CITED2;TXNRD1;ETS1;HAS2;TGFA;BAMBI;BCAT1;TFRC;HTR1B;CDK6;PML;EPHA2;BTBD10;SOX11;HSPD1;MAGED1;CYP1A1
9605,GO:0036503,5.55757104034062e-05,0.999989591018066,11,86,ERAD pathway,BP,UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;DERL3;UGGT1;SEL1L;HSP90B1;SVIP;SDF2L1
11857,GO:0046914,5.76622422741971e-05,0.999973186906368,42,730,transition metal ion binding,MF,RPTN;MMP9;IL1A;FLG2;TRIM16;TCHH;B4GALT1;TP53;FLG;PEG10;PARP1;HRNR;MSRB3;ANPEP;ERAP1;CYLD;ARG1;TRAF3;CSRP1;MMP19;ZNF638;HEPHL1;FTH1;TRAF1;EGLN1;SOD2;SNAI3;ADAM8;NR2F2;CALR;ZCCHC8;MME;GDA;ZMYM4;LOX;SEC24D;MSMO1;CHORDC1;PML;TRIM47;ENPP1;CYP1A1
11750,GO:0046649,5.92046027261738e-05,0.999977516014219,27,389,lymphocyte activation,BP,LGALS1;LCP1;MAFB;RELB;CD274;RIPK2;IL1B;IL6ST;DNAJB9;AXL;CYLD;CD83;LYN;ANXA1;NBN;XBP1;ARG1;IL7R;CXCR5;ADAM8;IL23A;DLG1;TFRC;NEDD4;MYH9;SOX11;HSPD1
10028,GO:0042542,6.0600183142613e-05,0.99998741682712,12,104,response to hydrogen peroxide,BP,TP53;JUN;CRYAB;AXL;DUSP1;ANXA1;SLC8A1;RHOB;ARG1;HMOX1;SETX;ETS1
17709,GO:1901698,6.27623105472475e-05,0.999970697528703,42,733,response to nitrogen compound,BP,NFKBIA;TRIM16;NEFL;NFKB1;EDN1;TP53;PMAIP1;SLIT2;UBQLN2;JUN;RIPK2;HERPUD1;PARP1;SDK1;HSPA5;IL1B;JUNB;DNAJB9;DNAJC10;DUSP1;LYN;ANXA1;DERL3;SLC8A1;XBP1;ARG1;UGGT1;MMP19;EGLN1;KLF10;HSP90AB1;SEL1L;EIF2B1;HMGCS1;ADGRL3;MGST3;ZC3H7B;HSP90B1;HTR1B;SVIP;ENPP1;SDF2L1
4535,GO:0010634,6.36693589199416e-05,0.999986732732513,12,101,positive regulation of epithelial cell migration,BP,MMP9;EDN1;CCBE1;JUN;ANXA1;VEGFC;RHOB;HMOX1;NRP1;CALR;ETS1;HAS2
1100,GO:0002696,6.46061679899793e-05,0.999982515277985,16,172,positive regulation of leukocyte activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;AXL;CYLD;CD83;LYN;ANXA1;XBP1;IL7R;ADAM8;IL23A;TFRC;HSPD1
13142,GO:0051787,6.51546058748008e-05,0.999994885147105,6,24,misfolded protein binding,MF,HSPA5;DNAJB9;DNAJC10;HSPA6;DNAJC3;SDF2L1
12202,GO:0048511,6.7348144186952e-05,0.999980837693989,17,187,rhythmic process,BP,RELB;TP53;SLIT2;JUN;NFKB2;AXL;NOCT;ANXA1;GPR176;ARNTL2;MMP19;SETX;KLF10;ETS1;HAS2;PML;MAGED1
12631,GO:0050878,6.85876822549925e-05,0.999976001539411,23,308,regulation of body fluid levels,BP,RPTN;FLG2;KRT1;SERPINB2;SAA1;EDN1;FLG;CLDN1;HRNR;C1QTNF1;AXL;ACTG1;ANXA8;LYN;RHOB;XBP1;CSRP1;PAPSS2;GGCX;MAFF;EHD1;HAS2;MYH9
9925,GO:0042325,6.97575587862742e-05,0.999964363126068,54,1034,regulation of phosphorylation,BP,CDKN2A;MMP9;IL1A;DSCAM;SAA1;TNIP1;DUSP8;EDN1;TP53;DBNDD2;SLIT2;CDKN2B;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;NRP1;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;PML;EPHA2;BTBD10;ENPP1;MAGED1;MIDN;IRAK2
10272,GO:0043069,7.14303392658272e-05,0.999968093745759,37,625,negative regulation of programmed cell death,BP,NFKBIA;MMP9;IL1A;NEFL;SERPINB2;KRT18;NFKB1;EDN1;TP53;CLDN7;JUN;RIPK2;HERPUD1;HSPA5;IL1B;IL6ST;CRYAB;AXL;CDSN;DUSP1;ITGAV;ANXA1;BIRC3;XBP1;HMOX1;NRP1;SETX;SOD2;HSP90AB1;ADAM8;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;EPHA2;HSPD1
3249,GO:0006935,7.16303383060599e-05,0.999973615525063,25,347,chemotaxis,BP,CXCL1;DSCAM;SAA1;FEZ1;EDN1;CXCL16;SLIT2;IL16;IL1B;SEMA7A;ITGAV;LYN;ANXA1;VEGFC;SEMA3D;NRP1;CXCR5;NRG1;ADAM8;L1CAM;CALR;IL23A;TUBB3;EPHA2;PARVA
9929,GO:0042330,7.16303383060599e-05,0.999973615525063,25,347,taxis,BP,CXCL1;DSCAM;SAA1;FEZ1;EDN1;CXCL16;SLIT2;IL16;IL1B;SEMA7A;ITGAV;LYN;ANXA1;VEGFC;SEMA3D;NRP1;CXCR5;NRG1;ADAM8;L1CAM;CALR;IL23A;TUBB3;EPHA2;PARVA
6570,GO:0022603,7.20675061789015e-05,0.999966450616606,41,707,regulation of anatomical structure morphogenesis,BP,IL1A;KRT1;NEFL;DSCAM;B4GALT1;EDN1;PSMB9;SLIT2;PGK1;CCBE1;IL1B;ERAP1;SEMA7A;ANXA1;NEDD4L;VEGFC;RHOB;XBP1;SEMA3D;HMOX1;RIMS2;NRP1;EGLN1;NRG1;IFRD1;L1CAM;CALR;CORO1C;DLG1;EHD1;ZMYM4;CITED2;ETS1;HAS2;BAMBI;NEDD4;PML;EPHA2;MYH9;MAGED1;PARVA
10879,GO:0044459,7.41135427751286e-05,0.999959006414615,70,1444,plasma membrane part,CC,NETO1;KRT8;TENM3;DSCAM;LCP1;B4GALT1;CD274;CLDN1;EPCAM;SLC16A9;CLDN7;MCAM;CNTNAP1;ANPEP;C1QTNF1;IL6ST;CRYAB;AXL;CYLD;SEMA7A;STAC;CD83;ITGAV;LYN;ANXA1;GPR176;G6PD;SLC8A1;WWC1;RHOB;TRAF3;HMOX1;SYT11;KCTD12;RIMS2;HSP90AA1;IL7R;KCNQ5;TNFSF15;CXCR5;NRG1;HSP90AB1;SLC7A5P2;ADAM8;STXBP5;STEAP4;CALR;IFNAR1;SLC39A14;AMOTL2;MAGT1;CORO1C;MME;DLG1;EHD1;HAS2;ADGRL3;TGFA;IFNGR1;TFRC;NLRP10;HTR1B;NEDD4;NTNG1;EPHA2;PVR;MYH9;ENPP1;SORBS2;TJP1
980,GO:0002443,7.42516446364511e-05,0.999969309099244,31,492,leukocyte mediated immunity,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;IL1B;ANPEP;HSPA6;ITGAV;LYN;C1R;NBN;ARG1;HMOX1;HSP90AA1;FTH1;IL7R;HSP90AB1;ADAM8;MAGT1;IL23A;MME;DLG1;DNAJC3;TFRC;SVIP;PVR;CPPED1;HSPD1
626,GO:0001819,7.64011922506007e-05,0.999975333136375,20,250,positive regulation of cytokine production,BP,IL1A;TRIM16;SAA1;NFKB1;CD274;CCBE1;RIPK2;NFKB2;IL1B;IL6ST;SEMA7A;CD83;ANXA1;BIRC3;XBP1;HMOX1;ADAM8;IL23A;NLRP10;HSPD1
1013,GO:0002520,7.77223399332164e-05,0.999964740786085,38,651,immune system development,BP,NFKBIA;MMP9;LGALS1;MAFB;RELB;PSMB9;CDKN2B;JUN;RIPK2;NFKB2;SPNS2;PARP1;JUNB;TJP2;DNAJB9;AXL;CYLD;TRIB1;CD83;LYN;ANXA1;G6PD;NBN;XBP1;IL7R;CXCR5;KLF10;ADAM8;CTR9;IL23A;CITED2;ETS1;TFRC;CDK6;PML;EPHA2;MYH9;HSPD1
11353,GO:0045765,8.08591303230033e-05,0.99997768901129,16,171,regulation of angiogenesis,BP,IL1A;KRT1;PGK1;CCBE1;IL1B;ERAP1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;NRP1;EGLN1;ETS1;PML;EPHA2
9926,GO:0042326,8.26728935668797e-05,0.99996924694871,25,354,negative regulation of phosphorylation,BP,CDKN2A;TNIP1;DUSP8;DBNDD2;SLIT2;CDKN2B;JUN;IL1B;ATF3;DNAJC10;GADD45B;DUSP1;TRIB1;LYN;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;CDK6;ENPP1;MIDN
4368,GO:0010038,8.43021757325536e-05,0.999974478604283,18,214,response to metal ion,BP,MMP9;IL1A;EDN1;TP53;CLDN1;JUN;PARP1;HSPA5;JUNB;DUSP1;G6PD;NEDD4L;ARG1;HMOX1;ACO1;CALR;NEDD4;CYP1A1
18433,GO:1903573,8.44808919238984e-05,0.99999078772605,7,36,negative regulation of response to endoplasmic reticulum stress,BP,HERPUD1;HSPA5;DNAJB9;DERL3;XBP1;DNAJC3;SVIP
4345,GO:0009966,8.53416229373173e-05,0.999949363664254,94,2132,regulation of signal transduction,BP,IL32;NFKBIA;MMP9;IL1A;TRIM16;NETO1;CXCL1;LGALS1;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;FGF5;SLIT2;UBQLN2;CHAC1;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;C1QTNF1;IL6ST;PHLDA2;ATF3;DNAJB9;AXL;GADD45B;IKBKE;MGLL;CYLD;SEMA7A;FBN2;DUSP1;TRIB1;ITGAV;LYN;NBN;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;HMOX1;KLK6;IL24;RIMS2;NRP1;IL7R;TRAF1;TNFSF15;SOD2;NRG1;HSP90AB1;ADAM8;CALR;IFNAR1;AJUBA;IGFBP3;EYA3;PRR5L;ARHGDIB;GIT2;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;TGFA;BAMBI;IFNGR1;NLRP10;HTR1B;NEDD4;PML;EPHA2;SOX11;ENPP1;AFAP1;MAGED1;IRAK2
4547,GO:0010646,8.88911371384281e-05,0.999946396822657,100,2303,regulation of cell communication,BP,IL32;NFKBIA;MMP9;IL1A;TRIM16;NETO1;CXCL1;LGALS1;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;FGF5;SLIT2;UBQLN2;CHAC1;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;C1QTNF1;IL6ST;PHLDA2;ATF3;DNAJB9;AXL;GADD45B;IKBKE;MGLL;CYLD;SEMA7A;FBN2;DUSP1;TRIB1;ITGAV;LYN;ANXA1;NBN;SLC8A1;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;HMOX1;SYT11;KLK6;IL24;RIMS2;NRP1;IL7R;TRAF1;TNFSF15;SOD2;NRG1;HSP90AB1;ADAM8;CALR;IFNAR1;AJUBA;IGFBP3;EYA3;SERP1;PRR5L;ARHGDIB;GIT2;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;TGFA;BAMBI;IFNGR1;NLRP10;HTR1B;NEDD4;PML;OXCT1;EPHA2;SOX11;ENPP1;AFAP1;MAGED1;MIDN;IRAK2
12860,GO:0051246,8.95359129212208e-05,0.999947357962769,89,2007,regulation of protein metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;SERPINB2;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;PMAIP1;PSMB9;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;CCBE1;JUN;RIPK2;HERPUD1;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;ANXA8;TRIB1;ITGAV;LYN;C1R;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;VEGFC;XBP1;TRAF3;HMOX1;IL24;HSP90AA1;NRP1;DCUN1D3;TNFSF15;NRG1;ACO1;SERPINH1;HSP90AB1;SDR16C5;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;CTR9;AJUBA;IGFBP3;SERP1;PRR5L;CORO1C;IL23A;DLG1;RBMS3;PTTG1IP;CHORDC1;TGFA;DNAJC3;ZC3H7B;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;PML;EPHA2;MYH9;ENPP1;HSPD1;MAGED1;IRAK2
625,GO:0001818,9.0956401767864e-05,0.999975876719638,15,159,negative regulation of cytokine production,BP,NFKB1;RELB;CD274;AXL;IKBKE;CYLD;CD83;ANXA1;ARG1;TRAF3;HMOX1;SYT11;HSP90AB1;IL23A;PML
13863,GO:0060548,9.2539526809431e-05,0.999957193850195,39,681,negative regulation of cell death,BP,NFKBIA;MMP9;IL1A;NEFL;SERPINB2;KRT18;NFKB1;EDN1;TP53;CLDN7;JUN;RIPK2;HERPUD1;HSPA5;IL1B;IL6ST;CRYAB;AXL;CDSN;DUSP1;ITGAV;ANXA1;BIRC3;XBP1;HMOX1;NRP1;SETX;SOD2;HSP90AB1;ADAM8;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;EPHA2;BTBD10;SOX11;HSPD1
7337,GO:0031399,9.3166271831332e-05,0.999949582143429,62,1255,regulation of protein modification process,BP,CDKN2A;MMP9;IL1A;SAA1;TNIP1;DUSP8;EDN1;TP53;DBNDD2;SLIT2;CDKN2B;JUN;RIPK2;HERPUD1;HSPA5;IL1B;C1QTNF1;IL6ST;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;G6PD;NBN;WWC1;BIRC3;VEGFC;IL24;HSP90AA1;NRP1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;ADAM8;NR2F2;CTR9;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;PTTG1IP;CHORDC1;TGFA;DNAJC3;HSP90B1;SVIP;UBXN2B;CDK6;PML;EPHA2;ENPP1;MAGED1;IRAK2
12735,GO:0051050,9.36812234552611e-05,0.999958053034526,36,603,positive regulation of transport,BP,NFKBIA;IL1A;TRIM16;SAA1;FEZ1;EDN1;TP53;PMAIP1;CD274;RIPK2;IL1B;C1QTNF1;AXL;STAC;ITGAV;ANXA1;G6PD;NEDD4L;VEGFC;XBP1;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;SERP1;PRR5L;DLG1;EHD1;CBLL1;NLRP10;NEDD4;OXCT1;SOX11;UGCG
4213,GO:0009408,9.52391689474801e-05,0.999976064323566,14,140,response to heat,BP,IL1A;TP53;DNAJB1;HSPA5;HSPB8;CRYAB;HSPA6;STAC;LYN;HMOX1;HSP90AA1;HSP90AB1;EIF2B1;CHORDC1
15166,GO:0071353,9.68377272849845e-05,0.999991700384864,6,26,cellular response to interleukin-4,BP,HSPA5;XBP1;ARG1;IL24;HSP90AB1;PML
4840,GO:0014070,9.86258106263201e-05,0.999955206223051,37,629,response to organic cyclic compound,BP,NFKBIA;NEFL;LGALS1;NFKB1;EDN1;TP53;PMAIP1;SLIT2;CLDN1;JUN;RIPK2;PARP1;SDK1;HSPA5;IL1B;JUNB;CRYAB;DUSP1;CD83;LYN;ANXA1;G6PD;SLC8A1;ARG1;MMP19;HSP90AB1;NR2F2;CALR;HMGCS1;LOX;ETS1;ADGRL3;ZC3H7B;HSP90B1;HTR1B;NEDD4;CYP1A1
15937,GO:0080135,9.88507245928324e-05,0.99995725636364,33,536,regulation of cellular response to stress,BP,CDKN2A;IL1A;EDN1;TP53;PMAIP1;UBQLN2;DNAJB1;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;HSPB8;CRYAB;DNAJB9;GADD45B;FIGN;LYN;DERL3;XBP1;HSP90AA1;SOD2;HSP90AB1;AJUBA;EYA3;DLG1;PTTG1IP;CHORDC1;DNAJC3;SVIP;CDK6;PML;EID3
6685,GO:0030104,0.000102421501407089,0.999985942882528,8,48,water homeostasis,BP,RPTN;FLG2;KRT1;FLG;CLDN1;HRNR;NEDD4L;HAS2
10269,GO:0043066,0.000102463527908725,0.999953892549559,36,612,negative regulation of apoptotic process,BP,NFKBIA;MMP9;IL1A;NEFL;SERPINB2;KRT18;NFKB1;EDN1;TP53;CLDN7;JUN;RIPK2;HERPUD1;HSPA5;IL1B;IL6ST;CRYAB;AXL;DUSP1;ITGAV;ANXA1;BIRC3;XBP1;HMOX1;NRP1;SETX;SOD2;HSP90AB1;ADAM8;EYA3;CITED2;PTTG1IP;DNAJC3;HSP90B1;EPHA2;HSPD1
1179,GO:0002833,0.000103416067370707,0.999991027986272,6,26,positive regulation of response to biotic stimulus,BP,RIPK2;OPTN;ARG1;NLRP10;PVR;HSPD1
17989,GO:1902533,0.000103486925339545,0.999952362321559,38,655,positive regulation of intracellular signal transduction,BP,IL1A;LGALS1;SAA1;EDN1;TP53;PMAIP1;FGF5;JUN;RIPK2;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;IKBKE;SEMA7A;ITGAV;LYN;WWC1;BIRC3;HMOX1;IL24;NRP1;IL7R;TNFSF15;NRG1;ADAM8;CALR;AJUBA;IGFBP3;PRR5L;IL23A;TGFA;NEDD4;EPHA2;SOX11;MAGED1;IRAK2
12623,GO:0050867,0.000104286037840018,0.999970520136402,16,179,positive regulation of cell activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;AXL;CYLD;CD83;LYN;ANXA1;XBP1;IL7R;ADAM8;IL23A;TFRC;HSPD1
12217,GO:0048534,0.000108072625416792,0.999951229225535,36,614,hematopoietic or lymphoid organ development,BP,NFKBIA;MMP9;LGALS1;MAFB;RELB;PSMB9;CDKN2B;JUN;RIPK2;NFKB2;SPNS2;PARP1;JUNB;TJP2;DNAJB9;AXL;CYLD;TRIB1;CD83;LYN;ANXA1;G6PD;XBP1;IL7R;CXCR5;KLF10;ADAM8;CTR9;IL23A;CITED2;ETS1;TFRC;CDK6;PML;EPHA2;MYH9
4456,GO:0010469,0.000119561874930255,0.999964180338332,17,204,regulation of signaling receptor activity,BP,IL32;IL1A;NETO1;CXCL1;EDN1;CXCL16;FGF5;IL16;IL1B;PHLDA2;VEGFC;IL24;NRP1;TNFSF15;NRG1;IL23A;TGFA
4511,GO:0010594,0.000119963930732883,0.999973134263253,12,108,regulation of endothelial cell migration,BP,EDN1;SLIT2;CCBE1;ANXA1;VEGFC;RHOB;HMOX1;NRP1;NR2F2;CALR;ETS1;EPHA2
14843,GO:0070670,0.000123929812681445,0.999988810329112,6,27,response to interleukin-4,BP,HSPA5;XBP1;ARG1;IL24;HSP90AB1;PML
3361,GO:0007154,0.000123976071798035,0.999919862217521,154,3940,cell communication,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;SAA1;LCP1;TNIP1;DUSP8;KRT18;NFKB1;RELB;EDN1;TP53;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FBN2;DUSP1;STAC;TRIB1;FADS1;CD83;ITGAV;LYN;ANXA1;PDE1C;GPR176;DERL3;NBN;SLC8A1;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEMA3D;TRAF3;HMOX1;SYT11;KLK6;FRAS1;IL24;RIMS2;HSP90AA1;CANX;DAPP1;NRP1;IL7R;TRAF1;SETX;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;ADAM8;NR2F2;CALR;PDIA6;IFNAR1;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;RRAS2;PRR5L;RAB30;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;RBMS3;CITED2;TXNRD1;PTTG1IP;ADGRL3;TGFA;BAMBI;DNAJC3;IFNGR1;HSP90B1;NLRP10;HTR1B;NEDD4;CDK6;PML;OXCT1;EPHA2;MYH9;SOX11;ENPP1;AFAP1;HSPD1;MAGED1;MIDN;IRAK2;TJP1
10446,GO:0043372,0.000125501546708396,0.999995614061089,4,10,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,RIPK2;CD83;ANXA1;IL23A
10060,GO:0042592,0.000126194139688667,0.999933233462728,55,1094,homeostatic process,BP,RPTN;IL1A;FLG2;KRT1;LGALS1;SAA1;MAFB;EDN1;TP53;PMAIP1;FLG;CLDN1;SPNS2;HERPUD1;PARP1;HRNR;IL1B;C1QTNF1;AXL;ACTG1;DNAJC10;CYLD;ITGAV;LYN;ANXA1;G6PD;NBN;SLC8A1;NEDD4L;XBP1;HMOX1;HSP90AA1;FTH1;IL7R;EGLN1;SOD2;ACO1;HSP90AB1;ADAM8;STEAP4;CALR;PDIA6;SLC39A14;ORMDL1;PDIA4;EHD1;TXNRD1;ETS1;HAS2;HSP90B1;TFRC;CDK6;PML;OXCT1;ENPP1
6053,GO:0019220,0.000126550347175787,0.999931650506993,59,1187,regulation of phosphate metabolic process,BP,CDKN2A;MMP9;IL1A;DSCAM;SAA1;TNIP1;DUSP8;EDN1;TP53;DBNDD2;SLIT2;CDKN2B;JUN;RIPK2;PARP1;HSPA5;IL1B;C1QTNF1;IL6ST;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;GPR176;NBN;WWC1;VEGFC;IL24;NRP1;EGLN1;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;HSP90B1;UBXN2B;CDK6;PML;EPHA2;BTBD10;ENPP1;MAGED1;MIDN;IRAK2
9239,GO:0035690,0.000129373937909585,0.999957901269912,19,239,cellular response to drug,BP,NFKB1;EDN1;TP53;SLIT2;RIPK2;HSPA5;IL1B;AXL;ANXA1;SLC8A1;RHOB;ARG1;HMOX1;SETX;HSP90AB1;ETS1;HSP90B1;TFRC;HTR1B
6628,GO:0023052,0.000134526311933435,0.999912902839848,153,3913,signaling,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;SAA1;LCP1;TNIP1;DUSP8;KRT18;NFKB1;RELB;EDN1;TP53;CXCL16;PMAIP1;PSMB9;CD274;FGF5;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;GADD45B;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;FBN2;DUSP1;STAC;TRIB1;FADS1;CD83;ITGAV;LYN;ANXA1;PDE1C;GPR176;DERL3;NBN;SLC8A1;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEMA3D;TRAF3;HMOX1;SYT11;KLK6;IL24;RIMS2;HSP90AA1;CANX;DAPP1;NRP1;IL7R;TRAF1;SETX;TNFSF15;CXCR5;SOD2;KLF10;NRG1;HSP90AB1;ADAM8;NR2F2;CALR;PDIA6;IFNAR1;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;RRAS2;PRR5L;RAB30;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;RBMS3;CITED2;TXNRD1;PTTG1IP;ADGRL3;TGFA;BAMBI;DNAJC3;IFNGR1;HSP90B1;NLRP10;HTR1B;NEDD4;CDK6;PML;OXCT1;EPHA2;MYH9;SOX11;ENPP1;AFAP1;HSPD1;MAGED1;MIDN;IRAK2;TJP1
16719,GO:0098552,0.000135868768064438,0.999954127712755,20,258,side of membrane,CC,B4GALT1;CD274;MCAM;ANPEP;IL6ST;CYLD;SEMA7A;CD83;ITGAV;LYN;ANXA1;G6PD;TRAF3;CANX;IL7R;CXCR5;NRG1;CALR;DLG1;TFRC
1171,GO:0002825,0.000136089727942803,0.99999514120977,4,10,regulation of T-helper 1 type immune response,BP,RIPK2;ANXA1;IL23A;NLRP10
13099,GO:0051704,0.000145622597604922,0.99991656398948,72,1570,multi-organism process,BP,NFKBIA;MMP9;KRT8;CXCL1;LGALS1;TNIP1;KRT18;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;CD274;CLDN1;RNASE7;JUN;CLDN11;RIPK2;IL16;NFKB2;OPTN;IL1B;ANPEP;JUNB;IL6ST;AXL;IFITM2;NOCT;IKBKE;ERAP1;TRIB1;ITGAV;LYN;NEDD4L;BIRC3;XBP1;ARG1;TRAF3;MMP19;SYT11;IL24;BRD2;SETX;HSP90AB1;NR2F2;CALR;IFNAR1;PPID;CTR9;MAFF;ARHGDIB;UBP1;IL23A;DLG1;ETS1;SUGT1;DNAJC3;CBLL1;ZC3H7B;IFNGR1;TFRC;NLRP10;NEDD4;CDK6;PML;EPHA2;PVR;HSPD1;SND1;IRAK2;CYP1A1
15298,GO:0071560,0.000147560469653591,0.999959037555118,15,162,cellular response to transforming growth factor beta stimulus,BP,EDN1;CLDN1;CDKN2B;PEG10;JUN;PARP1;HSPA5;FBN2;ARG1;KLF10;HSP90AB1;CITED2;BAMBI;PML;SOX11
9602,GO:0036500,0.000148587692706569,0.999994570314158,4,10,ATF6-mediated unfolded protein response,BP,HSPA5;XBP1;CALR;HSP90B1
6627,GO:0023051,0.000149998021262709,0.9999078935484,100,2334,regulation of signaling,BP,IL32;NFKBIA;MMP9;IL1A;TRIM16;NETO1;CXCL1;LGALS1;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;FGF5;SLIT2;UBQLN2;CHAC1;CDKN2B;PEG10;CCBE1;JUN;RIPK2;IL16;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;C1QTNF1;IL6ST;PHLDA2;ATF3;DNAJB9;AXL;GADD45B;IKBKE;MGLL;CYLD;SEMA7A;FBN2;DUSP1;TRIB1;ITGAV;LYN;ANXA1;NBN;SLC8A1;WWC1;BIRC3;VEGFC;RHOB;XBP1;ARG1;HMOX1;SYT11;KLK6;IL24;RIMS2;NRP1;IL7R;TRAF1;TNFSF15;SOD2;NRG1;HSP90AB1;ADAM8;CALR;IFNAR1;AJUBA;IGFBP3;EYA3;SERP1;PRR5L;ARHGDIB;GIT2;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;TGFA;BAMBI;IFNGR1;NLRP10;HTR1B;NEDD4;PML;OXCT1;EPHA2;SOX11;ENPP1;AFAP1;MAGED1;MIDN;IRAK2
9837,GO:0042127,0.000153921916002492,0.999919266552376,52,1023,regulation of cell proliferation,BP,CDKN2A;NFKBIA;MMP9;IL1A;CXCL1;OSR2;B4GALT1;EDN1;TP53;CD274;FGF5;EPCAM;CDKN2B;CLDN7;JUN;KRT4;RIPK2;IL1B;JUNB;IL6ST;PHLDA2;ATF3;TRIB1;ITGAV;LYN;ANXA1;VEGFC;XBP1;ARG1;HMOX1;IL24;FTH1;NRP1;IL7R;SOD2;KLF10;NRG1;NR2F2;CALR;IGFBP3;IL23A;DLG1;ETS1;HAS2;TGFA;BAMBI;TFRC;HTR1B;CDK6;PML;SOX11;MAGED1
14138,GO:0061077,0.000155144905479444,0.9999735107,9,67,chaperone-mediated protein folding,BP,DNAJB1;HSPA5;HSPA6;CANX;CALR;PPID;PDIA4;CHORDC1;HSPD1
3277,GO:0006984,0.000156477913138333,0.99998093669563,7,39,ER-nucleus signaling pathway,BP,TP53;HERPUD1;HSPA5;ATF3;XBP1;CALR;HSP90B1
11054,GO:0045088,0.000156921775017736,0.999944756248362,21,286,regulation of innate immune response,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;RIPK2;IKBKE;ERAP1;CYLD;LYN;BIRC3;ARG1;TRAF3;HSP90AB1;ADAM8;IFNAR1;IFNGR1;HSP90B1;PVR;HSPD1;IRAK2
12863,GO:0051249,0.000167418952679364,0.999944348770835,19,245,regulation of lymphocyte activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;AXL;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;IL7R;ADAM8;IL23A;DLG1;TFRC;SOX11;HSPD1
10702,GO:0044092,0.000169911836905375,0.999917380629268,41,751,negative regulation of molecular function,BP,CDKN2A;NFKBIA;MMP9;SERPINB2;DUSP8;NFKB1;TP53;DBNDD2;SLIT2;CDKN2B;JUN;HERPUD1;HSPA5;IL1B;CRYAB;GADD45B;CYLD;NFKBIE;DUSP1;ANXA8;TRIB1;LYN;ANXA1;NEDD4L;BIRC3;TRAF3;HMOX1;EGLN1;SERPINH1;NR2F2;AJUBA;CORO1C;CHORDC1;SUGT1;DNAJC3;NLRP10;NEDD4;CDK6;SOX11;MIDN;IRAK2
6681,GO:0030099,0.00017067726486746,0.999939528268487,21,287,myeloid cell differentiation,BP,NFKBIA;MMP9;MAFB;RELB;CDKN2B;JUN;PARP1;JUNB;TJP2;TRIB1;LYN;G6PD;KLF10;CTR9;IL23A;ETS1;TFRC;CDK6;PML;EPHA2;MYH9
12816,GO:0051174,0.000170973422704399,0.999906522623314,59,1200,regulation of phosphorus metabolic process,BP,CDKN2A;MMP9;IL1A;DSCAM;SAA1;TNIP1;DUSP8;EDN1;TP53;DBNDD2;SLIT2;CDKN2B;JUN;RIPK2;PARP1;HSPA5;IL1B;C1QTNF1;IL6ST;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;GPR176;NBN;WWC1;VEGFC;IL24;NRP1;EGLN1;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;HSP90B1;UBXN2B;CDK6;PML;EPHA2;BTBD10;ENPP1;MAGED1;MIDN;IRAK2
19352,GO:1905897,0.000174099547101445,0.999969806023595,9,67,regulation of response to endoplasmic reticulum stress,BP,PMAIP1;UBQLN2;HERPUD1;HSPA5;DNAJB9;DERL3;XBP1;DNAJC3;SVIP
11354,GO:0045766,0.000174333394660281,0.999962495848769,11,96,positive regulation of angiogenesis,BP,IL1A;CCBE1;IL1B;ERAP1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;NRP1;ETS1
12662,GO:0050920,0.000177967556741392,0.999958269859121,12,114,regulation of chemotaxis,BP,CXCL1;DSCAM;EDN1;SLIT2;IL16;SEMA7A;LYN;VEGFC;SEMA3D;NRP1;CALR;IL23A
15297,GO:0071559,0.00018140961391144,0.999948618555489,15,165,response to transforming growth factor beta,BP,EDN1;CLDN1;CDKN2B;PEG10;JUN;PARP1;HSPA5;FBN2;ARG1;KLF10;HSP90AB1;CITED2;BAMBI;PML;SOX11
16955,GO:0099081,0.000188685065978041,0.999913243631717,35,597,supramolecular polymer,CC,KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;FEZ1;DPYSL3;FLG;KRT78;MYO1B;KRT4;KRT13;CRYAB;ACTG1;CYLD;FBN2;FIGN;KRT23;COL8A1;ANXA1;COL4A4;SLC8A1;NRP1;KRT34;SERP1;DLG1;PDE4DIP;TUBB3;SORBS2;TPM4;PARVA
704,GO:0001933,0.000190839202517865,0.999928159605059,23,330,negative regulation of protein phosphorylation,BP,CDKN2A;TNIP1;DUSP8;DBNDD2;SLIT2;CDKN2B;JUN;IL1B;ATF3;DNAJC10;GADD45B;DUSP1;TRIB1;LYN;NR2F2;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;CDK6;ENPP1
501,GO:0001558,0.000191780713839358,0.999931459399258,21,286,regulation of cell growth,BP,CDKN2A;DSCAM;EDN1;TP53;CXCL16;SLIT2;CRYAB;SEMA7A;G6PD;NEDD4L;SEMA3D;RIMS2;NRP1;DCUN1D3;NRG1;IFRD1;L1CAM;EIF4G2;IGFBP3;PML;ENPP1
16954,GO:0099080,0.000195317766416823,0.999910020630943,35,598,supramolecular complex,CC,KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;FEZ1;DPYSL3;FLG;KRT78;MYO1B;KRT4;KRT13;CRYAB;ACTG1;CYLD;FBN2;FIGN;KRT23;COL8A1;ANXA1;COL4A4;SLC8A1;NRP1;KRT34;SERP1;DLG1;PDE4DIP;TUBB3;SORBS2;TPM4;PARVA
6936,GO:0030593,0.00020088131954703,0.999979830844786,6,30,neutrophil chemotaxis,BP,CXCL1;SAA1;EDN1;SLIT2;IL1B;IL23A
6879,GO:0030433,0.000202127792061849,0.999964186183433,9,68,ubiquitin-dependent ERAD pathway,BP,UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;DERL3;SEL1L;HSP90B1;SVIP
3369,GO:0007162,0.000205122976983483,0.999941197287342,15,167,negative regulation of cell adhesion,BP,CDKN2A;LGALS1;DSCAM;CD274;EPCAM;CLDN7;C1QTNF1;CYLD;CDSN;ANXA1;ARG1;ARHGDIB;CORO1C;DLG1;CBLL1
15336,GO:0071621,0.000205674780657863,0.999973568257662,7,42,granulocyte chemotaxis,BP,CXCL1;SAA1;EDN1;SLIT2;IL1B;ANXA1;IL23A
7116,GO:0030968,0.000207935607568817,0.999950355917864,12,116,endoplasmic reticulum unfolded protein response,BP,HERPUD1;HSPA5;ATF3;DNAJB9;DERL3;XBP1;UGGT1;CALR;PDIA6;SERP1;DNAJC3;HSP90B1
8048,GO:0032743,0.000214266174755753,0.999984636901903,5,19,positive regulation of interleukin-2 production,BP,IL1A;RIPK2;IL1B;CD83;ANXA1
11443,GO:0045936,0.000218781466553179,0.999908026547528,28,443,negative regulation of phosphate metabolic process,BP,CDKN2A;TNIP1;DUSP8;DBNDD2;SLIT2;CDKN2B;JUN;PARP1;IL1B;ATF3;DNAJC10;GADD45B;DUSP1;TRIB1;LYN;GPR176;EGLN1;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;CDK6;ENPP1;MIDN
4495,GO:0010563,0.000226588797554372,0.999904528386569,28,444,negative regulation of phosphorus metabolic process,BP,CDKN2A;TNIP1;DUSP8;DBNDD2;SLIT2;CDKN2B;JUN;PARP1;IL1B;ATF3;DNAJC10;GADD45B;DUSP1;TRIB1;LYN;GPR176;EGLN1;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;CDK6;ENPP1;MIDN
17591,GO:1901342,0.00022885253736611,0.999930477567474,16,187,regulation of vasculature development,BP,IL1A;KRT1;PGK1;CCBE1;IL1B;ERAP1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;NRP1;EGLN1;ETS1;PML;EPHA2
12663,GO:0050921,0.000233679910599928,0.999957678538818,9,70,positive regulation of chemotaxis,BP,CXCL1;DSCAM;EDN1;SLIT2;IL16;VEGFC;NRP1;CALR;IL23A
10166,GO:0042802,0.000243657760947339,0.999866610896164,56,1157,identical protein binding,MF,NFKBIA;MMP9;NEFL;TENM3;LGALS1;LCP1;TNIP1;NFKB1;MAFB;RELB;TP53;SLIT2;CLDN1;CLDN7;JUN;CLDN11;RIPK2;PARP1;OPTN;SDK1;IL6ST;HSPB8;CRYAB;ATF3;ACTG1;MGLL;CDSN;ANXA1;G6PD;XBP1;HMOX1;SYT11;KCTD12;HSP90AA1;TPP2;TRAF1;SETX;SOD2;HSP90AB1;NR2F2;AMOTL2;EIF2B1;HMGCS1;EHD1;ETS1;CBLL1;BCAT1;TFRC;PML;OXCT1;PVR;MYH9;ENPP1;TPM4;MAGED1;IRAK2
7730,GO:0032268,0.000246130122116497,0.999851697825809,83,1893,regulation of cellular protein metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;SERPINB2;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;PMAIP1;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;CCBE1;JUN;RIPK2;HERPUD1;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;SEMA7A;DUSP1;ANXA8;TRIB1;ITGAV;LYN;DERL3;G6PD;NBN;WWC1;BIRC3;VEGFC;XBP1;IL24;HSP90AA1;NRP1;DCUN1D3;TNFSF15;NRG1;ACO1;SERPINH1;HSP90AB1;SDR16C5;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;CTR9;AJUBA;IGFBP3;SERP1;PRR5L;CORO1C;IL23A;DLG1;RBMS3;PTTG1IP;CHORDC1;TGFA;DNAJC3;ZC3H7B;HSP90B1;SVIP;UBXN2B;CDK6;PML;EPHA2;MYH9;ENPP1;HSPD1;MAGED1;IRAK2
8797,GO:0034599,0.000262258017804029,0.999915769346604,17,215,cellular response to oxidative stress,BP,MMP9;TP53;JUN;PARP1;GPX8;AXL;ANXA1;G6PD;RHOB;ARG1;HMOX1;SETX;SOD2;PRR5L;TXNRD1;ETS1;PML
19375,GO:1905954,0.000267962391384422,0.999963926525045,7,43,positive regulation of lipid localization,BP,NFKBIA;NFKB1;EDN1;IL1B;C1QTNF1;IKBKE;EHD1
4512,GO:0010595,0.000273061225377344,0.99994947744534,9,70,positive regulation of endothelial cell migration,BP,EDN1;CCBE1;ANXA1;VEGFC;RHOB;HMOX1;NRP1;CALR;ETS1
5293,GO:0016020,0.000274337431169977,0.99981687645898,207,5727,membrane,CC,IL32;NFKBIA;RPTN;SPRR2G;SPRR2A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NETO1;KRT8;SERPINB2;TENM3;DSCAM;ASPRV1;KRT2;LCP1;SPRR3;B4GALT1;FEZ1;CXCL16;PMAIP1;CD274;FLG;LCE3D;LCE3E;DBNDD2;SLIT2;CLDN1;UBQLN2;EPCAM;SLC16A9;PGK1;CLDN7;HS3ST1;SPRR2E;MYO1B;GREB1L;SPRR2D;CLDN11;MCAM;FAM173B;IL16;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;CDV3;CNTNAP1;ANPEP;EFHD2;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;TMEM265;GPX8;DNAJB9;AXL;ACTG1;DNAJC10;IFITM2;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;STAC;ANXA8;FADS1;CD83;STT3A;ITGAV;LYN;NCEH1;AP3M1;ANXA1;FADS3;GPR176;DERL3;G6PD;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;RHOB;XBP1;ARG1;SEC11C;TRAF3;HMOX1;FAM126B;SYT11;FRAS1;KCTD12;HEPHL1;RIMS2;HSP90AA1;FAM84B;CANX;DAPP1;NRP1;IL7R;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;SOD2;NRG1;SERPINH1;PREP;HSP90AB1;SDR16C5;SLC7A5P2;GGCX;ADAM8;L1CAM;CLCC1;STXBP5;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;IFNAR1;AJUBA;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;SLC35B1;SERP1;EIF2B1;ORMDL1;MAGT1;RRAS2;RAB30;SEC22A;ARHGDIB;GIT2;CORO1C;NID2;MME;DLG1;EHD1;PTTG1IP;DHDDS;HAS2;ADGRL3;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;BAMBI;FOCAD;PRPF38A;DNAJC3;IFNGR1;ANKRD13A;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;NTNG1;ZDHHC6;PML;EPHA2;CCDC167;PVR;EPB41L2;MRPS24;MYH9;GALNT14;TOR1AIP1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;CLINT1;TPM4;HSPD1;SND1;MAGED1;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA;TMPPE
10636,GO:0043900,0.000281953794406507,0.999899025429134,20,278,regulation of multi-organism process,BP,LGALS1;TNIP1;B4GALT1;JUN;RIPK2;OPTN;IL1B;IFITM2;TRIB1;ITGAV;BIRC3;ARG1;TRAF3;SYT11;CALR;PPID;ARHGDIB;IL23A;NLRP10;PML
9763,GO:0040013,0.000282736489149762,0.999908659726111,17,210,negative regulation of locomotion,BP,DPYSL3;SLIT2;SEMA7A;TRIB1;RHOB;SEMA3D;HMOX1;IL24;NRP1;NRG1;NR2F2;CALR;IGFBP3;ARHGDIB;CORO1C;CITED2;PML
1113,GO:0002709,0.000298494304072721,0.999967427648152,6,32,regulation of T cell mediated immunity,BP,IL1B;ARG1;IL7R;IL23A;PVR;HSPD1
13096,GO:0051701,0.000301707347827422,0.999914661328304,14,156,interaction with host,BP,LGALS1;TNIP1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;PPID;CBLL1;TFRC;NEDD4;PML;EPHA2;PVR
10545,GO:0043542,0.000312629702755723,0.999916332759436,13,137,endothelial cell migration,BP,EDN1;SLIT2;CCBE1;ANXA1;VEGFC;RHOB;HMOX1;NRP1;NR2F2;CALR;ETS1;EPHA2;MYH9
523,GO:0001618,0.000314739798380139,0.999956473591697,7,43,virus receptor activity,MF,CLDN1;ANPEP;AXL;ITGAV;TFRC;EPHA2;PVR
17145,GO:0104005,0.000314739798380139,0.999956473591697,7,43,hijacked molecular function,MF,CLDN1;ANPEP;AXL;ITGAV;TFRC;EPHA2;PVR
1101,GO:0002697,0.000323400696033359,0.999898417892602,16,197,regulation of immune effector process,BP,RIPK2;IL1B;SEMA7A;LYN;C1R;ANXA1;BIRC3;XBP1;ARG1;TRAF3;HMOX1;IL7R;IL23A;TFRC;PVR;HSPD1
6282,GO:0019915,0.000329764080429131,0.999953932096159,7,44,lipid storage,BP,NFKBIA;NFKB1;IL1B;IKBKE;ITGAV;EHD1;ENPP1
2212,GO:0005126,0.000333619526929791,0.999915777423538,12,124,cytokine receptor binding,MF,IL1A;CXCL1;CXCL16;IL1B;IL6ST;ERAP1;VEGFC;TRAF3;TRAF1;TNFSF15;IL23A;BAMBI
12493,GO:0050678,0.000338101731877486,0.999888952982211,17,215,regulation of epithelial cell proliferation,BP,OSR2;B4GALT1;CDKN2B;JUN;KRT4;VEGFC;XBP1;ARG1;HMOX1;NRP1;NR2F2;DLG1;HAS2;TGFA;CDK6;SOX11;MAGED1
6823,GO:0030308,0.00034183053452003,0.999913532412992,12,122,negative regulation of cell growth,BP,CDKN2A;TP53;SLIT2;CRYAB;SEMA7A;G6PD;SEMA3D;NRP1;DCUN1D3;IFRD1;PML;ENPP1
81,GO:0000165,0.000353681334203426,0.999833361265209,34,598,MAPK cascade,BP,IL1A;NEFL;SAA1;TNIP1;DUSP8;NFKB1;EDN1;PSMB9;FGF5;JUN;RIPK2;IL1B;C1QTNF1;CRYAB;ATF3;AXL;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;WWC1;NRP1;SETX;NRG1;ADAM8;AJUBA;IGFBP3;DLG1;TGFA;EPHA2;MAGED1;IRAK2
18406,GO:1903532,0.000358426181558418,0.999881632684328,17,217,positive regulation of secretion by cell,BP,IL1A;TRIM16;SAA1;EDN1;CD274;RIPK2;IL1B;C1QTNF1;VEGFC;XBP1;ADAM8;STXBP5;PPID;SERP1;NLRP10;OXCT1;SOX11
1098,GO:0002694,0.000366718340494024,0.999865860129661,20,281,regulation of leukocyte activation,BP,LGALS1;CD274;RIPK2;IL1B;IL6ST;AXL;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;HMOX1;IL7R;ADAM8;IL23A;DLG1;TFRC;SOX11;HSPD1
12519,GO:0050708,0.000380127418804351,0.999864711486117,19,259,regulation of protein secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;LYN;ANXA1;VEGFC;XBP1;SYT11;ADAM8;STXBP5;PPID;SERP1;NLRP10;PML;OXCT1;MIDN
16023,GO:0090022,0.000390571566607624,0.999979699362311,4,13,regulation of neutrophil chemotaxis,BP,CXCL1;EDN1;SLIT2;IL23A
9927,GO:0042327,0.000405244135406132,0.999803282387922,36,646,positive regulation of phosphorylation,BP,MMP9;IL1A;DSCAM;SAA1;EDN1;TP53;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;NRP1;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IGFBP3;PRR5L;IL23A;DLG1;TGFA;EPHA2;BTBD10;MAGED1;IRAK2
12736,GO:0051051,0.000410550991771891,0.999852902560194,19,262,negative regulation of transport,BP,MMP9;NFKB1;EDN1;UBQLN2;IL1B;CRYAB;ITGAV;ANXA1;DERL3;NEDD4L;HMOX1;SYT11;NRG1;HTR1B;SVIP;NEDD4;PML;ENPP1;MIDN
9824,GO:0042102,0.000411664940888762,0.999939931571382,7,47,positive regulation of T cell proliferation,BP,CD274;RIPK2;IL1B;IL6ST;ANXA1;IL23A;TFRC
2520,GO:0005790,0.000419323594614923,0.999964137066972,5,22,smooth endoplasmic reticulum,CC,HSPA5;CANX;CALR;DNAJC3;SVIP
12819,GO:0051179,0.000426018639843845,0.999713058224992,162,4294,localization,BP,NFKBIA;MMP9;IL1A;FLG2;TRIM16;KRT1;NEFL;NETO1;CXCL1;DSCAM;SAA1;KRT2;LCP1;KRT18;NFKB1;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;SLIT2;CLDN1;UBQLN2;EPCAM;SLC16A9;CLDN7;MYO1B;CCBE1;JUN;MCAM;RIPK2;IL16;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HRNR;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;C1QTNF1;TJP2;PHLDA2;CRYAB;AXL;ACTG1;HSPA6;IKBKE;CYLD;STOML1;SEMA7A;FBN2;NFKBIE;STAC;ANXA8;TRIB1;ITGAV;LYN;AP3M1;ANXA1;DERL3;G6PD;SLC8A1;WWC1;NEDD4L;VEGFC;RHOB;XBP1;MOBP;ARG1;SEMA3D;HMOX1;SYT11;FRAS1;HEPHL1;IL24;RIMS2;HSP90AA1;CANX;FTH1;NRP1;KCNQ5;GNPTAB;CXCR5;SOD2;NRG1;ACO1;HSP90AB1;SLC7A5P2;ADAM8;L1CAM;CLCC1;STXBP5;NR2F2;STEAP4;CALR;PDIA6;PPID;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;SLC35B1;SERP1;MAGT1;RRAS2;PRR5L;RAB30;SEC22A;ARHGDIB;GIT2;CORO1C;IL23A;MME;DLG1;PDIA4;EHD1;CITED2;PTTG1IP;ETS1;HAS2;ADGRL3;SEC24D;REEP1;TGFA;BAMBI;DNAJC3;CBLL1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;CDK6;ZDHHC6;PML;OXCT1;EPHA2;MON1A;EPB41L2;MYH9;TOR1AIP1;SOX11;UGCG;CPPED1;ENPP1;CLINT1;TNFAIP2;CEP83;HSPD1;MIDN;PARVA
12881,GO:0051271,0.000426446079707811,0.999862554909652,16,198,negative regulation of cellular component movement,BP,DPYSL3;SLIT2;SEMA7A;TRIB1;RHOB;SEMA3D;HMOX1;IL24;NRP1;NRG1;NR2F2;CALR;IGFBP3;ARHGDIB;CORO1C;CITED2
12621,GO:0050865,0.000431135825399835,0.999835760042705,21,306,regulation of cell activation,BP,LGALS1;CD274;RIPK2;IL1B;C1QTNF1;IL6ST;AXL;CYLD;CD83;LYN;ANXA1;XBP1;ARG1;HMOX1;IL7R;ADAM8;IL23A;DLG1;TFRC;SOX11;HSPD1
12640,GO:0050891,0.000433426021797697,0.999936460069792,7,45,multicellular organismal water homeostasis,BP,RPTN;FLG2;KRT1;FLG;CLDN1;HRNR;HAS2
19919,GO:2000516,0.00043391081867312,0.999976801471035,4,13,positive regulation of CD4-positive, alpha-beta T cell activation,BP,RIPK2;CD83;ANXA1;IL23A
726,GO:0001959,0.000435234674557752,0.999886697747562,12,126,regulation of cytokine-mediated signaling pathway,BP,EDN1;SLIT2;RIPK2;AXL;CYLD;BIRC3;ARG1;TRAF1;HSP90AB1;IFNAR1;IFNGR1;IRAK2
867,GO:0002224,0.000436220937132501,0.999903688545968,10,91,toll-like receptor signaling pathway,BP,NFKBIA;TNIP1;RIPK2;IKBKE;LYN;BIRC3;TRAF3;HSP90B1;HSPD1;IRAK2
12535,GO:0050729,0.000445592943965735,0.999922185812842,8,61,positive regulation of inflammatory response,BP,NFKBIA;TNIP1;IL1B;IL6ST;ADAM8;IL23A;ETS1;NLRP10
12815,GO:0051173,0.000445993135186998,0.999721412104961,89,2083,positive regulation of nitrogen compound metabolic process,BP,NFKBIA;MMP9;IL1A;TRIM16;SAA1;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;UBQLN2;EPCAM;CDKN2B;CCBE1;JUN;RIPK2;NFKB2;ARID3B;HERPUD1;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;ATF3;AXL;CREB5;EHF;GADD45B;SEMA7A;TRIB1;ITGAV;LYN;NBN;WWC1;NEDD4L;BIRC3;VEGFC;XBP1;ARNTL2;HMOX1;IL24;HSP90AA1;NRP1;EGLN1;SETX;DCUN1D3;TNFSF15;KLF10;NRG1;HSP90AB1;SDR16C5;ADAM8;NR2F2;UQCC1;CALR;EDRF1;CTR9;AJUBA;IGFBP3;EYA3;SERP1;MAFF;PRR5L;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;ETS1;HAS2;TGFA;BAMBI;DNAJC3;TFRC;SVIP;NEDD4;PML;EPHA2;MYH9;SOX11;HSPD1;MAGED1;SUPT3H;IRAK2
11751,GO:0046651,0.000457346649714556,0.999872166170385,13,147,lymphocyte proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;ARG1;IL7R;IL23A;DLG1;TFRC;SOX11;HSPD1
9995,GO:0042470,0.000458152092671958,0.999898082155934,10,93,melanosome,CC,HSPA5;HSP90AA1;CANX;HSP90AB1;PDIA6;PDIA4;CALU;HSP90B1;TFRC;SND1
12342,GO:0048770,0.000458152092671958,0.999898082155934,10,93,pigment granule,CC,HSPA5;HSP90AA1;CANX;HSP90AB1;PDIA6;PDIA4;CALU;HSP90B1;TFRC;SND1
6789,GO:0030260,0.000466744566914095,0.999896043812391,10,91,entry into host cell,BP,LGALS1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;CBLL1;TFRC;EPHA2;PVR
10841,GO:0044409,0.000466744566914095,0.999896043812391,10,91,entry into host,BP,LGALS1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;CBLL1;TFRC;EPHA2;PVR
13156,GO:0051806,0.000466744566914095,0.999896043812391,10,91,entry into cell of other organism involved in symbiotic interaction,BP,LGALS1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;CBLL1;TFRC;EPHA2;PVR
13163,GO:0051828,0.000466744566914095,0.999896043812391,10,91,entry into other organism involved in symbiotic interaction,BP,LGALS1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;CBLL1;TFRC;EPHA2;PVR
13054,GO:0051604,0.000477448731421799,0.999844267476587,16,207,protein maturation,BP,ASPRV1;CHAC1;PGK1;CCBE1;RIPK2;PARP1;C1R;BIRC3;SEC11C;KLK6;SERPINH1;ADAM8;CALR;MME;MYH9;HSPD1
8174,GO:0032943,0.000487760229586335,0.999862681781014,13,148,mononuclear cell proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;ARG1;IL7R;IL23A;DLG1;TFRC;SOX11;HSPD1
18632,GO:1904018,0.000489222205449665,0.99988025403041,11,108,positive regulation of vasculature development,BP,IL1A;CCBE1;IL1B;ERAP1;ANXA1;VEGFC;RHOB;XBP1;HMOX1;NRP1;ETS1
12525,GO:0050714,0.000496544788526074,0.99986005138984,13,145,positive regulation of protein secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;VEGFC;XBP1;ADAM8;PPID;SERP1;NLRP10;OXCT1
9812,GO:0042088,0.000498405816081459,0.999955374286018,5,23,T-helper 1 type immune response,BP,RELB;RIPK2;ANXA1;IL23A;NLRP10
11787,GO:0046718,0.000503514822677583,0.999898019510731,9,76,viral entry into host cell,BP,LGALS1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;TFRC;EPHA2;PVR
7133,GO:0031012,0.000509555396458523,0.999819996598338,18,241,extracellular matrix,CC,RPTN;MMP9;KRT1;LGALS1;SLIT2;COL12A1;CCBE1;FBN2;COL8A1;COL4A4;MMP19;FRAS1;L1CAM;CALR;NID2;DLG1;LOX;HSP90B1
13547,GO:0060055,0.000512546563937124,0.99997134274309,4,13,angiogenesis involved in wound healing,BP,B4GALT1;MCAM;XBP1;ETS1
7339,GO:0031401,0.00051666415566728,0.99973375165465,41,781,positive regulation of protein modification process,BP,MMP9;IL1A;SAA1;TNIP1;EDN1;TP53;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;ITGAV;LYN;NBN;WWC1;BIRC3;VEGFC;IL24;NRP1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;ADAM8;CTR9;AJUBA;IGFBP3;PRR5L;IL23A;DLG1;PTTG1IP;TGFA;SVIP;EPHA2;MAGED1;IRAK2
18404,GO:1903530,0.000522208790534236,0.999779311905339,25,398,regulation of secretion by cell,BP,IL1A;TRIM16;SAA1;EDN1;CD274;RIPK2;IL1B;C1QTNF1;LYN;ANXA1;VEGFC;XBP1;HMOX1;SYT11;RIMS2;ADAM8;STXBP5;PPID;SERP1;NLRP10;HTR1B;PML;OXCT1;SOX11;MIDN
1091,GO:0002687,0.000532579420937913,0.999904200537751,8,63,positive regulation of leukocyte migration,BP,IL1A;CXCL1;EDN1;TP53;VEGFC;ADAM8;CALR;IL23A
11249,GO:0045596,0.000533016471490498,0.999770246927929,26,419,negative regulation of cell differentiation,BP,NFKBIA;LGALS1;MAFB;DPYSL3;SLIT2;TJP2;NOCT;CYLD;SEMA7A;CDSN;TRIB1;ITGAV;LYN;ANXA1;G6PD;XBP1;SEMA3D;NRP1;NRG1;IFRD1;CALR;CTR9;CORO1C;CDK6;SOX11;ENPP1
12753,GO:0051087,0.000536811659029931,0.999890034951728,9,79,chaperone binding,MF,TP53;DNAJB1;HSPA5;DNAJB9;DNAJC10;CALR;DNAJC3;HSPD1;SDF2L1
12242,GO:0048588,0.000543885350674776,0.999845322242987,13,142,developmental cell growth,BP,DSCAM;EDN1;SLIT2;SEMA7A;G6PD;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;SORBS2
3425,GO:0007249,0.000546348418088617,0.999819554588299,16,206,I-kappaB kinase/NF-kappaB signaling,BP,NFKBIA;IL1A;LGALS1;TNIP1;NFKB1;RELB;RIPK2;NFKB2;OPTN;IL1B;IKBKE;BIRC3;HMOX1;AJUBA;NLRP10;IRAK2
2593,GO:0005911,0.000557381855470485,0.999783413446938,21,302,cell-cell junction,CC,KRT8;KRT18;B4GALT1;CLDN1;EPCAM;CLDN7;CLDN11;CNTNAP1;TJP2;CDSN;LYN;ANXA1;SLC8A1;EIF4G2;AJUBA;AMOTL2;DLG1;ADGRL3;PVR;MYH9;TJP1
12731,GO:0051046,0.000560610792443853,0.999757463842308,26,423,regulation of secretion,BP,IL1A;TRIM16;SAA1;EDN1;CD274;RIPK2;IL1B;C1QTNF1;LYN;ANXA1;VEGFC;XBP1;HMOX1;SYT11;RIMS2;NRG1;ADAM8;STXBP5;PPID;SERP1;NLRP10;HTR1B;PML;OXCT1;SOX11;MIDN
16995,GO:0099513,0.000563928319993369,0.999747714139711,28,466,polymeric cytoskeletal fiber,CC,KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;FEZ1;DPYSL3;FLG;KRT78;MYO1B;KRT4;KRT13;ACTG1;CYLD;FIGN;KRT23;ANXA1;SLC8A1;NRP1;KRT34;SERP1;DLG1;TUBB3;TPM4
4842,GO:0014074,0.000565623312343172,0.999870683160737,10,93,response to purine-containing compound,BP,TP53;JUN;HSPA5;IL1B;JUNB;DUSP1;SLC8A1;MMP19;HMGCS1;HSP90B1
8042,GO:0032733,0.000566849536697626,0.999966773003992,4,14,positive regulation of interleukin-10 production,BP,CD274;CD83;IL23A;HSPD1
6615,GO:0023014,0.000599287018234412,0.999708679361876,34,615,signal transduction by protein phosphorylation,BP,IL1A;NEFL;SAA1;TNIP1;DUSP8;NFKB1;EDN1;PSMB9;FGF5;JUN;RIPK2;IL1B;C1QTNF1;CRYAB;ATF3;AXL;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;WWC1;NRP1;SETX;NRG1;ADAM8;AJUBA;IGFBP3;DLG1;TGFA;EPHA2;MAGED1;IRAK2
12489,GO:0050670,0.000601473025574595,0.999848650426434,11,114,regulation of lymphocyte proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;ARG1;IL23A;DLG1;TFRC;SOX11
705,GO:0001934,0.000606263080002133,0.999705108267166,34,612,positive regulation of protein phosphorylation,BP,MMP9;IL1A;SAA1;EDN1;TP53;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;NRP1;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IGFBP3;PRR5L;IL23A;DLG1;TGFA;EPHA2;MAGED1;IRAK2
3384,GO:0007179,0.00060957409154964,0.999834980502064,12,128,transforming growth factor beta receptor signaling pathway,BP,CDKN2B;PEG10;JUN;PARP1;HSPA5;FBN2;KLF10;HSP90AB1;CITED2;BAMBI;PML;SOX11
2954,GO:0006508,0.000630368339325825,0.999636677508397,58,1253,proteolysis,BP,NFKBIA;MMP9;SERPINB2;TENM3;ASPRV1;TNIP1;NFKB1;TP53;PMAIP1;PSMB9;UBQLN2;CHAC1;PGK1;CCBE1;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;ANPEP;CRYAB;DNAJB9;DNAJC10;ERAP1;CYLD;ANXA8;TRIB1;LYN;C1R;DERL3;NEDD4L;BIRC3;XBP1;UGGT1;SEC11C;SUDS3;TRAF3;MMP19;KLK6;TPP2;TNFSF15;SERPINH1;PREP;HSP90AB1;ADAM8;SEL1L;MME;NGLY1;DNAJC3;HSP90B1;SVIP;UBXN2B;NEDD4;PML;MYH9;HSPD1;SUPT3H;SDF2L1
15105,GO:0071248,0.000634194113186394,0.999852577490552,10,96,cellular response to metal ion,BP,MMP9;EDN1;CLDN1;JUN;PARP1;HSPA5;JUNB;HMOX1;CALR;CYP1A1
1161,GO:0002791,0.000634392928405971,0.999764073686051,19,270,regulation of peptide secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;LYN;ANXA1;VEGFC;XBP1;SYT11;ADAM8;STXBP5;PPID;SERP1;NLRP10;PML;OXCT1;MIDN
10472,GO:0043408,0.000636824390643592,0.999712750841854,28,470,regulation of MAPK cascade,BP,IL1A;SAA1;TNIP1;DUSP8;EDN1;JUN;RIPK2;IL1B;C1QTNF1;ATF3;AXL;GADD45B;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;WWC1;NRP1;NRG1;ADAM8;AJUBA;IGFBP3;DLG1;TGFA;EPHA2;MAGED1;IRAK2
14915,GO:0070848,0.000641235493539401,0.99971063929959,28,469,response to growth factor,BP,FEZ1;EDN1;FGF5;SLIT2;CLDN1;CDKN2B;PEG10;CCBE1;JUN;PARP1;HSPA5;IL1B;FBN2;ANXA1;VEGFC;ARG1;NRP1;SETX;KLF10;HSP90AB1;EHD1;CITED2;HAS2;BAMBI;NEDD4;PML;EPHA2;SOX11
8175,GO:0032944,0.000647054333705668,0.999835656212746,11,115,regulation of mononuclear cell proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;ARG1;IL23A;DLG1;TFRC;SOX11
2579,GO:0005887,0.000650888411054757,0.999666074011192,39,734,integral component of plasma membrane,CC,TENM3;DSCAM;CLDN1;EPCAM;SLC16A9;CNTNAP1;C1QTNF1;IL6ST;AXL;CD83;ITGAV;LYN;GPR176;SLC8A1;TRAF3;SYT11;KCNQ5;TNFSF15;CXCR5;NRG1;SLC7A5P2;ADAM8;STXBP5;STEAP4;IFNAR1;SLC39A14;MAGT1;MME;DLG1;HAS2;ADGRL3;TGFA;IFNGR1;TFRC;HTR1B;EPHA2;PVR;MYH9;ENPP1
12732,GO:0051047,0.000654891897368361,0.999771321720004,17,229,positive regulation of secretion,BP,IL1A;TRIM16;SAA1;EDN1;CD274;RIPK2;IL1B;C1QTNF1;VEGFC;XBP1;ADAM8;STXBP5;PPID;SERP1;NLRP10;OXCT1;SOX11
5500,GO:0016485,0.000654993228245507,0.999809471959906,13,151,protein processing,BP,ASPRV1;CHAC1;PGK1;CCBE1;RIPK2;PARP1;C1R;BIRC3;SEC11C;KLK6;ADAM8;MME;MYH9
7472,GO:0031663,0.000665925775373082,0.999914109110232,6,36,lipopolysaccharide-mediated signaling pathway,BP,NFKBIA;RIPK2;IL1B;TRIB1;LYN;IRAK2
3234,GO:0006909,0.000672338839718018,0.999803966108529,13,149,phagocytosis,BP,IL1B;AXL;ACTG1;ITGAV;LYN;ANXA1;SYT11;HSP90AA1;HSP90AB1;CALR;PDIA6;CORO1C;MYH9
16994,GO:0099512,0.000676189822842478,0.999672650463258,33,591,supramolecular fiber,CC,KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;FEZ1;DPYSL3;FLG;KRT78;MYO1B;KRT4;KRT13;CRYAB;ACTG1;CYLD;FBN2;FIGN;KRT23;ANXA1;SLC8A1;NRP1;KRT34;SERP1;DLG1;PDE4DIP;TUBB3;SORBS2;TPM4;PARVA
7296,GO:0031325,0.000676284762216308,0.99956937484816,91,2166,positive regulation of cellular metabolic process,BP,NFKBIA;MMP9;IL1A;TRIM16;DSCAM;SAA1;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;UBQLN2;EPCAM;CDKN2B;CCBE1;JUN;RIPK2;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;ATF3;AXL;CREB5;EHF;GADD45B;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;NBN;WWC1;BIRC3;VEGFC;XBP1;ARNTL2;HMOX1;IL24;HSP90AA1;NRP1;EGLN1;SETX;DCUN1D3;TNFSF15;KLF10;NRG1;HSP90AB1;SDR16C5;ADAM8;NR2F2;UQCC1;CALR;EDRF1;CTR9;AJUBA;IGFBP3;EYA3;SERP1;MAFF;PRR5L;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;ETS1;HAS2;TGFA;BAMBI;DNAJC3;TFRC;SVIP;PML;EPHA2;MYH9;BTBD10;SOX11;HSPD1;MAGED1;SUPT3H;IRAK2
12526,GO:0050715,0.000685473067743375,0.999871669740656,8,64,positive regulation of cytokine secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;XBP1;NLRP10
10588,GO:0043618,0.000691775199213332,0.999836939326388,10,101,regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;PSMB9;DNAJB1;JUN;HSPA5;ATF3;HMOX1;EGLN1;CITED2;NEDD4
15198,GO:0071396,0.000702325757139855,0.999702551278443,24,381,cellular response to lipid,BP,NFKBIA;TNIP1;NFKB1;EDN1;CD274;CLDN1;RIPK2;PARP1;IL1B;KRT13;AXL;TRIB1;LYN;ANXA1;XBP1;ARG1;IL24;SETX;NR2F2;CALR;CTR9;HMGCS1;NEDD4;IRAK2
14834,GO:0070661,0.000711552958042893,0.999790988455608,13,154,leukocyte proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;ARG1;IL7R;IL23A;DLG1;TFRC;SOX11;HSPD1
3530,GO:0007568,0.000711757807533268,0.999758795023748,16,211,aging,BP,CDKN2A;EDN1;TP53;CLDN1;JUN;NFKB2;CRYAB;ARG1;CANX;SOD2;CALR;SERP1;MME;CDK6;PML;CYP1A1
4769,GO:0010976,0.000717213386180103,0.99976704767724,15,185,positive regulation of neuron projection development,BP,NEFL;TENM3;DSCAM;FEZ1;DPYSL3;SLIT2;HSPA5;SEMA7A;LYN;NEDD4L;RIMS2;NRP1;SETX;NRG1;L1CAM
3540,GO:0007596,0.000725621835232568,0.999753610411086,16,212,blood coagulation,BP,KRT1;SERPINB2;SAA1;EDN1;C1QTNF1;AXL;ACTG1;ANXA8;LYN;RHOB;CSRP1;PAPSS2;GGCX;MAFF;EHD1;MYH9
4515,GO:0010604,0.00072973587755155,0.999533184767555,92,2205,positive regulation of macromolecule metabolic process,BP,NFKBIA;MMP9;IL1A;TRIM16;SAA1;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;UBQLN2;EPCAM;CDKN2B;CCBE1;JUN;RIPK2;NFKB2;ARID3B;HERPUD1;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;ATF3;AXL;CREB5;EHF;GADD45B;NOCT;SEMA7A;TRIB1;ITGAV;LYN;NBN;WWC1;NEDD4L;BIRC3;VEGFC;XBP1;ARNTL2;HMOX1;IL24;RIMS2;HSP90AA1;NRP1;IL7R;EGLN1;SETX;DCUN1D3;TNFSF15;KLF10;NRG1;HSP90AB1;SDR16C5;ADAM8;NR2F2;UQCC1;CALR;EDRF1;CTR9;AJUBA;IGFBP3;EYA3;SERP1;MAFF;PRR5L;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;ETS1;HAS2;TGFA;BAMBI;DNAJC3;TFRC;SVIP;NEDD4;PML;EPHA2;MYH9;SOX11;HSPD1;MAGED1;SUPT3H;IRAK2
12343,GO:0048771,0.000736621313210046,0.999825368542676,10,96,tissue remodeling,BP,IL1A;B4GALT1;AXL;ANXA1;ARG1;ADAM8;IL23A;TFRC;HTR1B;EPHA2
16451,GO:0097190,0.000747240578162611,0.999664392256009,27,464,apoptotic signaling pathway,BP,MMP9;IL1A;KRT8;KRT18;TP53;PMAIP1;CHAC1;JUN;HERPUD1;PARP1;IL1B;ATF3;DNAJC10;IKBKE;CYLD;ITGAV;NBN;XBP1;HMOX1;NRP1;TRAF1;SOD2;EYA3;PTTG1IP;PML;EPHA2;MAGED1
897,GO:0002285,0.000748656372418435,0.999822042821504,10,97,lymphocyte activation involved in immune response,BP,LGALS1;LCP1;RELB;RIPK2;ANXA1;NBN;XBP1;IL23A;TFRC;HSPD1
13989,GO:0060759,0.000758625000358772,0.999788983363269,12,134,regulation of response to cytokine stimulus,BP,EDN1;SLIT2;RIPK2;AXL;CYLD;BIRC3;ARG1;TRAF1;HSP90AB1;IFNAR1;IFNGR1;IRAK2
2396,GO:0005581,0.000762762859732858,0.999899311445358,6,35,collagen trimer,CC,COL12A1;CCBE1;C1QTNF1;COL8A1;COL4A4;LOX
12590,GO:0050817,0.000766982958617319,0.999738149876301,16,213,coagulation,BP,KRT1;SERPINB2;SAA1;EDN1;C1QTNF1;AXL;ACTG1;ANXA8;LYN;RHOB;CSRP1;PAPSS2;GGCX;MAFF;EHD1;MYH9
12515,GO:0050704,0.00077219198944135,0.999922771845262,5,25,regulation of interleukin-1 secretion,BP,TRIM16;SAA1;RIPK2;NLRP10;PML
2394,GO:0005578,0.000796732278586465,0.999738403945492,15,187,proteinaceous extracellular matrix,CC,RPTN;MMP9;LGALS1;SLIT2;COL12A1;CCBE1;FBN2;COL8A1;COL4A4;MMP19;FRAS1;CALR;NID2;DLG1;LOX
7118,GO:0030970,0.000797335818185038,0.999919680911841,5,25,retrograde protein transport, ER to cytosol,BP,HERPUD1;DERL3;SEL1L;HSP90B1;SVIP
18390,GO:1903513,0.000797335818185038,0.999919680911841,5,25,endoplasmic reticulum to cytosol transport,BP,HERPUD1;DERL3;SEL1L;HSP90B1;SVIP
15175,GO:0071363,0.000799565596038155,0.999639386778475,27,452,cellular response to growth factor stimulus,BP,FEZ1;EDN1;FGF5;SLIT2;CLDN1;CDKN2B;PEG10;CCBE1;JUN;PARP1;HSPA5;IL1B;FBN2;ANXA1;VEGFC;ARG1;NRP1;SETX;KLF10;HSP90AB1;EHD1;CITED2;HAS2;BAMBI;NEDD4;PML;SOX11
12537,GO:0050731,0.000803162552093006,0.999807209798945,10,98,positive regulation of peptidyl-tyrosine phosphorylation,BP,TP53;RIPK2;IL6ST;LYN;VEGFC;IL24;NRP1;NRG1;IL23A;TGFA
7470,GO:0031658,0.000804999895974639,0.999976131462513,3,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2A;CDKN2B;CDK6
20228,GO:2001236,0.00080861415828324,0.999788757278397,11,117,regulation of extrinsic apoptotic signaling pathway,BP,IL1A;PMAIP1;IL1B;ATF3;CYLD;ITGAV;HMOX1;NRP1;TRAF1;EYA3;PML
1163,GO:0002793,0.000814080114478743,0.999757372969352,13,153,positive regulation of peptide secretion,BP,IL1A;TRIM16;SAA1;CD274;RIPK2;IL1B;VEGFC;XBP1;ADAM8;PPID;SERP1;NLRP10;OXCT1
16768,GO:0098657,0.000814198177797103,0.999621071322744,29,499,import into cell,BP,SAA1;CXCL16;UBQLN2;IL1B;AXL;ACTG1;ITGAV;LYN;ANXA1;SLC8A1;NEDD4L;SYT11;HSP90AA1;CANX;HSP90AB1;STEAP4;CALR;PDIA6;SLC39A14;CORO1C;EHD1;CBLL1;HSP90B1;TFRC;HTR1B;NEDD4;MYH9;ENPP1;CLINT1
12862,GO:0051248,0.000817961933824557,0.999558065841129,44,890,negative regulation of protein metabolic process,BP,CDKN2A;MMP9;SERPINB2;TNIP1;DUSP8;NFKB1;EDN1;DBNDD2;SLIT2;CHAC1;CDKN2B;JUN;HERPUD1;IL1B;CRYAB;ATF3;DNAJC10;GADD45B;DUSP1;ANXA8;TRIB1;ITGAV;LYN;DERL3;G6PD;BIRC3;NRG1;SERPINH1;HSP90AB1;SDR16C5;NR2F2;CALR;AJUBA;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;ZC3H7B;SVIP;CDK6;PML;ENPP1
10924,GO:0044706,0.000823218186056417,0.999768833939018,12,134,multi-multicellular organism process,BP,MMP9;B4GALT1;EDN1;IL1B;JUNB;ARG1;NR2F2;CALR;MAFF;ARHGDIB;ETS1;CYP1A1
12494,GO:0050679,0.000825125565049895,0.999783986031305,11,116,positive regulation of epithelial cell proliferation,BP,OSR2;B4GALT1;JUN;VEGFC;XBP1;ARG1;HMOX1;NRP1;HAS2;TGFA;SOX11
3543,GO:0007599,0.000838099970662325,0.999711355104588,16,215,hemostasis,BP,KRT1;SERPINB2;SAA1;EDN1;C1QTNF1;AXL;ACTG1;ANXA8;LYN;RHOB;CSRP1;PAPSS2;GGCX;MAFF;EHD1;MYH9
4549,GO:0010648,0.000844689690694041,0.999536748976341,46,936,negative regulation of cell communication,BP,NFKBIA;MMP9;IL1A;TNIP1;DUSP8;EDN1;PSMB9;SLIT2;UBQLN2;CHAC1;PEG10;HERPUD1;OPTN;HSPA5;IL1B;ATF3;DNAJB9;AXL;CYLD;FBN2;DUSP1;TRIB1;ITGAV;LYN;WWC1;XBP1;ARG1;HMOX1;SYT11;NRP1;SOD2;NRG1;CALR;AJUBA;IGFBP3;EYA3;PRR5L;DLG1;RBMS3;PTTG1IP;BAMBI;HTR1B;NEDD4;EPHA2;ENPP1;MIDN
16482,GO:0097237,0.000848848490643707,0.999745551626903,13,158,cellular response to toxic substance,BP,NFKB1;TP53;GPX8;AXL;ANXA1;RHOB;ARG1;HMOX1;SETX;SOD2;TXNRD1;ETS1;MGST3
13678,GO:0060284,0.000857336701823841,0.999583763977585,32,568,regulation of cell development,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;EDN1;DPYSL3;SLIT2;SDK1;HSPA5;IL1B;TJP2;IL6ST;SEMA7A;TRIB1;LYN;G6PD;NEDD4L;VEGFC;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CALR;CORO1C;HAS2;NEDD4;SOX11
14836,GO:0070663,0.000858681200652305,0.999773840990442,11,119,regulation of leukocyte proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;ARG1;IL23A;DLG1;TFRC;SOX11
6679,GO:0030097,0.000859469231050508,0.999582474518614,32,585,hemopoiesis,BP,NFKBIA;MMP9;LGALS1;MAFB;RELB;PSMB9;CDKN2B;JUN;RIPK2;PARP1;JUNB;TJP2;DNAJB9;AXL;CYLD;TRIB1;CD83;LYN;ANXA1;G6PD;XBP1;IL7R;KLF10;ADAM8;CTR9;IL23A;ETS1;TFRC;CDK6;PML;EPHA2;MYH9
8221,GO:0033018,0.000890439401145154,1,2,2,sarcoplasmic reticulum lumen,CC,CALR;CALU
4587,GO:0010720,0.000896775274998349,0.999629069435776,22,338,positive regulation of cell development,BP,NEFL;TENM3;DSCAM;FEZ1;EDN1;DPYSL3;SLIT2;HSPA5;IL6ST;SEMA7A;TRIB1;LYN;NEDD4L;VEGFC;RIMS2;NRP1;SETX;NRG1;L1CAM;CALR;HAS2;SOX11
7239,GO:0031226,0.000897003780035821,0.999527499213628,40,772,intrinsic component of plasma membrane,CC,TENM3;DSCAM;CLDN1;EPCAM;SLC16A9;CNTNAP1;C1QTNF1;IL6ST;AXL;CD83;ITGAV;LYN;GPR176;SLC8A1;TRAF3;SYT11;KCNQ5;TNFSF15;CXCR5;NRG1;SLC7A5P2;ADAM8;STXBP5;STEAP4;IFNAR1;SLC39A14;MAGT1;MME;DLG1;HAS2;ADGRL3;TGFA;IFNGR1;TFRC;HTR1B;NTNG1;EPHA2;PVR;MYH9;ENPP1
6571,GO:0022604,0.000900388743423967,0.999627505164965,22,336,regulation of cell morphogenesis,BP,NEFL;DSCAM;SLIT2;SEMA7A;ANXA1;NEDD4L;RHOB;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;CALR;CORO1C;DLG1;ZMYM4;HAS2;BAMBI;NEDD4;MYH9;PARVA
17831,GO:1902106,0.000903828105970238,0.999848124293956,7,51,negative regulation of leukocyte differentiation,BP,MAFB;TJP2;CYLD;TRIB1;LYN;ANXA1;CDK6
6630,GO:0023057,0.000904374445053744,0.999502269671162,46,939,negative regulation of signaling,BP,NFKBIA;MMP9;IL1A;TNIP1;DUSP8;EDN1;PSMB9;SLIT2;UBQLN2;CHAC1;PEG10;HERPUD1;OPTN;HSPA5;IL1B;ATF3;DNAJB9;AXL;CYLD;FBN2;DUSP1;TRIB1;ITGAV;LYN;WWC1;XBP1;ARG1;HMOX1;SYT11;NRP1;SOD2;NRG1;CALR;AJUBA;IGFBP3;EYA3;PRR5L;DLG1;RBMS3;PTTG1IP;BAMBI;HTR1B;NEDD4;EPHA2;ENPP1;MIDN
4789,GO:0012505,0.000914257191346133,0.999385255963951,123,3156,endomembrane system,CC,MMP9;FLG2;KRT1;CXCL1;LGALS1;SPRR3;NFKB1;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CD274;DBNDD2;CHAC1;COL12A1;HS3ST1;MYO1B;HERPUD1;PARP1;OPTN;HRNR;HSPA5;IL1B;MSRB3;ANPEP;CRYAB;GPX8;DNAJB9;DNAJC10;EHF;HSPA6;IKBKE;MGLL;ERAP1;STOML1;NFKBIE;ANXA8;FADS1;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;FADS3;COL4A4;DERL3;NEDD4L;VEGFC;RHOB;XBP1;ARG1;UGGT1;SEC11C;TRAF3;HMOX1;SYT11;KLK6;HSP90AA1;CANX;FTH1;NRP1;GNPTAB;ACO1;SERPINH1;HSP90AB1;SDR16C5;GGCX;ADAM8;CLCC1;STXBP5;STEAP4;CALR;PDIA6;IFNAR1;AJUBA;IGFBP3;SEL1L;AMOTL2;MGAT5;SLC35B1;SERP1;ORMDL1;MAGT1;RRAS2;RAB30;SEC22A;IL23A;MME;DLG1;PDIA4;EHD1;DHDDS;SEC24D;REEP1;CALU;MSMO1;PDE4DIP;TGFA;MGST3;PRPF38A;DNAJC3;ANKRD13A;HSP90B1;TFRC;SVIP;UBXN2B;NEDD4;ZDHHC6;PML;MON1A;GALNT14;TOR1AIP1;UGCG;CPPED1;CLINT1;CEP83;HSPD1;IRAK2;SDF2L1;CYP1A1
889,GO:0002274,0.000919691201992964,0.999594806016624,25,422,myeloid leukocyte activation,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;RELB;B4GALT1;JUN;HRNR;ANPEP;HSPA6;ITGAV;LYN;ARG1;HMOX1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1;HSPD1
15261,GO:0071492,0.000924849670921588,1,2,2,cellular response to UV-A,BP,PPID;MME
8471,GO:0033673,0.000932443839921682,0.999675468450989,16,217,negative regulation of kinase activity,BP,CDKN2A;DUSP8;DBNDD2;CDKN2B;IL1B;GADD45B;DUSP1;TRIB1;LYN;NR2F2;AJUBA;CORO1C;CHORDC1;DNAJC3;CDK6;MIDN
9839,GO:0042129,0.000934231959243041,0.999792116103154,9,85,regulation of T cell proliferation,BP,CD274;RIPK2;IL1B;IL6ST;ANXA1;ARG1;IL23A;DLG1;TFRC
987,GO:0002456,0.000938160963009404,0.999840859950478,7,53,T cell mediated immunity,BP,IL1B;ARG1;IL7R;IL23A;DLG1;PVR;HSPD1
17620,GO:1901492,0.000946413277253617,1,2,2,positive regulation of lymphangiogenesis,BP,CCBE1;VEGFC
12926,GO:0051348,0.000969632299949105,0.999648533231377,17,240,negative regulation of transferase activity,BP,CDKN2A;DUSP8;TP53;DBNDD2;CDKN2B;IL1B;GADD45B;DUSP1;TRIB1;LYN;NR2F2;AJUBA;CORO1C;CHORDC1;DNAJC3;CDK6;MIDN
2575,GO:0005883,0.00098240972590036,0.999968766300208,3,7,neurofilament,CC,NEFL;NEFM;NRP1
9050,GO:0035329,0.00101897662940197,0.999856836395282,6,37,hippo signaling,BP,TJP2;WWC1;AJUBA;AMOTL2;SOX11;TJP1
1087,GO:0002683,0.00101972208515194,0.999616170175712,18,263,negative regulation of immune system process,BP,NFKBIA;MAFB;CD274;SLIT2;TJP2;AXL;CYLD;TRIB1;LYN;ANXA1;ARG1;HMOX1;IL7R;CTR9;DLG1;NLRP10;CDK6;SOX11
10590,GO:0043620,0.00103900502857039,0.999740972879991,10,106,regulation of DNA-templated transcription in response to stress,BP,TP53;PSMB9;DNAJB1;JUN;HSPA5;ATF3;HMOX1;EGLN1;CITED2;NEDD4
5305,GO:0016049,0.00104213288253019,0.999563596714557,22,346,cell growth,BP,CDKN2A;DSCAM;EDN1;TP53;CXCL16;SLIT2;CRYAB;SEMA7A;G6PD;NEDD4L;SEMA3D;RIMS2;NRP1;DCUN1D3;NRG1;IFRD1;L1CAM;EIF4G2;IGFBP3;PML;ENPP1;SORBS2
6744,GO:0030198,0.00104771028553407,0.999631517655144,16,211,extracellular matrix organization,BP,MMP9;LCP1;B4GALT1;COL12A1;NFKB2;FBN2;ITGAV;COL8A1;COL4A4;MMP19;SERPINH1;ADAM8;NID2;LOX;ETS1;HAS2
4768,GO:0010975,0.00104897947984435,0.999570675178279,21,318,regulation of neuron projection development,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;DPYSL3;SLIT2;SDK1;HSPA5;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;NEDD4
12622,GO:0050866,0.00105347976116164,0.999737342368966,10,102,negative regulation of cell activation,BP,CD274;C1QTNF1;AXL;CYLD;LYN;ANXA1;ARG1;HMOX1;DLG1;SOX11
12854,GO:0051235,0.00107508741147113,0.999620638204639,16,217,maintenance of location,BP,NFKBIA;NFKB1;HSPA5;IL1B;IKBKE;FBN2;NFKBIE;ITGAV;LYN;SLC8A1;FTH1;CALR;EHD1;HSP90B1;PML;ENPP1
4324,GO:0009893,0.00107856696561714,0.999295148047556,96,2349,positive regulation of metabolic process,BP,NFKBIA;MMP9;IL1A;TRIM16;DSCAM;SAA1;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;UBQLN2;EPCAM;CDKN2B;CCBE1;JUN;RIPK2;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;ATF3;AXL;CREB5;EHF;GADD45B;NOCT;SEMA7A;TRIB1;ITGAV;LYN;ANXA1;NBN;WWC1;NEDD4L;BIRC3;VEGFC;XBP1;ARNTL2;HMOX1;IL24;RIMS2;HSP90AA1;NRP1;IL7R;EGLN1;SETX;DCUN1D3;TNFSF15;KLF10;NRG1;HSP90AB1;SDR16C5;ADAM8;NR2F2;UQCC1;CALR;EDRF1;CTR9;AJUBA;IGFBP3;EYA3;SERP1;MAFF;PRR5L;IL23A;DLG1;RBMS3;CITED2;PTTG1IP;ETS1;HAS2;TGFA;BAMBI;DNAJC3;TFRC;SVIP;NEDD4;PML;EPHA2;MYH9;BTBD10;SOX11;HSPD1;MAGED1;SUPT3H;IRAK2
19694,GO:2000106,0.00109072297329373,0.999809818595265,7,54,regulation of leukocyte apoptotic process,BP,CDKN2A;TP53;CD274;AXL;LYN;ANXA1;ADAM8
1092,GO:0002688,0.00109312203660881,0.999809071278287,7,55,regulation of leukocyte chemotaxis,BP,CXCL1;EDN1;SLIT2;LYN;VEGFC;CALR;IL23A
7972,GO:0032612,0.00109612010557397,0.999808713514416,7,54,interleukin-1 production,BP,TRIM16;SAA1;RIPK2;IL1B;ANXA1;NLRP10;PML
16290,GO:0090557,0.00111034330511385,0.999963147594692,3,7,establishment of endothelial intestinal barrier,BP,CLDN1;TJP2;TJP1
9871,GO:0042220,0.00111527216809343,0.999878143102391,5,26,response to cocaine,BP,SDK1;HSPA5;HSP90AB1;ADGRL3;HTR1B
7731,GO:0032269,0.00114664379615601,0.999378053737739,42,852,negative regulation of cellular protein metabolic process,BP,CDKN2A;MMP9;SERPINB2;TNIP1;DUSP8;NFKB1;EDN1;DBNDD2;SLIT2;CHAC1;CDKN2B;JUN;HERPUD1;IL1B;CRYAB;ATF3;DNAJC10;GADD45B;DUSP1;ANXA8;TRIB1;LYN;DERL3;G6PD;BIRC3;SERPINH1;HSP90AB1;SDR16C5;NR2F2;CALR;AJUBA;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;ZC3H7B;SVIP;CDK6;PML;ENPP1
1017,GO:0002526,0.00115160807361258,0.99979702436417,7,55,acute inflammatory response,BP,IL1A;SAA1;B4GALT1;IL1B;IL6ST;C1R;ADAM8
2476,GO:0005737,0.00115550950714494,0.999234261978962,279,8347,cytoplasm,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;LCE3D;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;JUN;KRT4;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;ANPEP;TJP2;HSPB8;PHLDA2;CRYAB;GPX8;DNAJB9;AXL;ACTG1;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;GSTCD;HMOX1;FAM126B;SYT11;KLK6;ZNF638;PAPSS2;UBTD2;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;SOD2;NRG1;ACO1;IFRD1;SERPINH1;PREP;HSP90AB1;KRT34;SDR16C5;GGCX;ADAM8;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;IFNAR1;PPID;AJUBA;IGFBP3;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;IL23A;MME;DLG1;PDIA4;TRMT44;RBMS3;NGLY1;GDA;EHD1;ZMYM4;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;IQCJ-SCHIP1;BAMBI;SUGT1;DNAJC3;CBLL1;BCAT1;ANKRD13A;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;ZBTB21;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
11765,GO:0046683,0.00116897967579499,0.999731349972915,9,85,response to organophosphorus,BP,TRIM16;JUN;HSPA5;IL1B;JUNB;DUSP1;SLC8A1;MMP19;HSP90B1
675,GO:0001889,0.00119880944737647,0.999695755051957,10,103,liver development,BP,NFKBIA;CLDN1;JUN;ANXA1;XBP1;ARG1;HMOX1;HMGCS1;CITED2;CYP1A1
530,GO:0001649,0.00120485038569631,0.999645812180316,12,138,osteoblast differentiation,BP,JUNB;IL6ST;NOCT;SEMA7A;FBN2;IGFBP3;RRAS2;CDK6;EPHA2;SOX11;TPM4;SND1
3731,GO:0008285,0.00120642227080894,0.999439704237723,27,470,negative regulation of cell proliferation,BP,CDKN2A;IL1A;CXCL1;B4GALT1;TP53;CD274;CDKN2B;JUN;KRT4;IL1B;TRIB1;LYN;VEGFC;ARG1;HMOX1;IL24;FTH1;SOD2;KLF10;NR2F2;IGFBP3;DLG1;ETS1;CDK6;PML;SOX11;MAGED1
10105,GO:0042698,0.00120794943126857,0.999823610390578,6,39,ovulation cycle,BP,SLIT2;AXL;ANXA1;MMP19;ETS1;HAS2
5440,GO:0016338,0.00122588835976952,0.999955068654854,3,8,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN1;CLDN7;CLDN11
14838,GO:0070665,0.00124760235839846,0.999741594053052,8,72,positive regulation of leukocyte proliferation,BP,CD274;RIPK2;IL1B;IL6ST;LYN;ANXA1;IL23A;TFRC
1146,GO:0002761,0.00124956674595028,0.99974178239048,8,69,regulation of myeloid leukocyte differentiation,BP,MAFB;JUN;TJP2;TRIB1;LYN;KLF10;IL23A;CDK6
14680,GO:0070371,0.00125316228876029,0.99958728825859,14,179,ERK1 and ERK2 cascade,BP,IL1A;TNIP1;JUN;RIPK2;IL1B;ATF3;AXL;SEMA7A;DUSP1;ITGAV;LYN;NRP1;DLG1;EPHA2
12391,GO:0048878,0.00126539149150418,0.99935603487121,34,644,chemical homeostasis,BP,RPTN;FLG2;KRT1;LGALS1;SAA1;EDN1;TP53;FLG;CLDN1;HERPUD1;PARP1;HRNR;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;XBP1;HMOX1;FTH1;EGLN1;SOD2;ACO1;STEAP4;CALR;SLC39A14;ORMDL1;EHD1;HAS2;HSP90B1;TFRC;PML;OXCT1;ENPP1
1099,GO:0002695,0.00127647640565472,0.999702522367581,9,87,negative regulation of leukocyte activation,BP,CD274;AXL;CYLD;LYN;ANXA1;ARG1;HMOX1;DLG1;SOX11
464,GO:0001503,0.00129634433250699,0.999517236191434,17,239,ossification,BP,MMP9;OSR2;JUNB;IL6ST;NOCT;SEMA7A;FBN2;SLC8A1;KLF10;IGFBP3;RRAS2;CDK6;EPHA2;SOX11;ENPP1;TPM4;SND1
4873,GO:0014812,0.00129736627331654,0.999766841383251,7,54,muscle cell migration,BP,SLIT2;TRIB1;ANXA1;NRP1;IGFBP3;HAS2;PARVA
865,GO:0002221,0.00129962074712349,0.999639158043392,11,122,pattern recognition receptor signaling pathway,BP,NFKBIA;TNIP1;RIPK2;IKBKE;CYLD;LYN;BIRC3;TRAF3;HSP90B1;HSPD1;IRAK2
4215,GO:0009410,0.00130517701271489,0.999589067572576,13,164,response to xenobiotic stimulus,BP,EDN1;TP53;CLDN1;SDK1;HSPA5;NCEH1;SLC8A1;ARG1;HSP90AB1;ADGRL3;MGST3;HTR1B;CYP1A1
3665,GO:0008180,0.0013102119921094,0.999850077021191,5,28,COP9 signalosome,CC,HSPA5;HSPA6;HSP90AB1;EPB41L2;MYH9
12783,GO:0051128,0.00131623239648286,0.999165957830207,77,1799,regulation of cellular component organization,BP,CDKN2A;MMP9;IL1A;NEFL;TENM3;LGALS1;DSCAM;LCP1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;SLIT2;CLDN1;UBQLN2;CLDN7;DNAJB1;JUN;PARP1;OPTN;SDK1;HSPA5;IL1B;CRYAB;AXL;CYLD;SEMA7A;DUSP1;ITGAV;LYN;ANXA1;G6PD;NBN;NEDD4L;RHOB;SEMA3D;SYT11;KLK6;RIMS2;HSP90AA1;NRP1;SETX;DCUN1D3;NRG1;IFRD1;SDR16C5;L1CAM;EIF4G2;CALR;CTR9;AJUBA;IGFBP3;ARHGDIB;CORO1C;DLG1;EHD1;ZMYM4;ETS1;HAS2;ADGRL3;PDE4DIP;CHORDC1;TGFA;BAMBI;CBLL1;SVIP;NEDD4;PML;EPHA2;MYH9;UGCG;ENPP1;AFAP1;TJP1;PARVA
4810,GO:0014032,0.00132598355789397,0.999760786963072,7,54,neural crest cell development,BP,EDN1;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;SOX11
4494,GO:0010562,0.00135274480922532,0.999295126566956,36,691,positive regulation of phosphorus metabolic process,BP,MMP9;IL1A;DSCAM;SAA1;EDN1;TP53;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;NRP1;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IGFBP3;PRR5L;IL23A;DLG1;TGFA;EPHA2;BTBD10;MAGED1;IRAK2
11444,GO:0045937,0.00135274480922532,0.999295126566956,36,691,positive regulation of phosphate metabolic process,BP,MMP9;IL1A;DSCAM;SAA1;EDN1;TP53;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;AXL;GADD45B;SEMA7A;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;NRP1;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IGFBP3;PRR5L;IL23A;DLG1;TGFA;EPHA2;BTBD10;MAGED1;IRAK2
12845,GO:0051223,0.00136422777305239,0.999360776445768,27,475,regulation of protein transport,BP,IL1A;TRIM16;SAA1;LCP1;TP53;CD274;RIPK2;IL1B;LYN;ANXA1;DERL3;VEGFC;XBP1;SYT11;NRG1;HSP90AB1;ADAM8;STXBP5;PPID;SERP1;PRR5L;NLRP10;SVIP;PML;OXCT1;UGCG;MIDN
2226,GO:0005149,0.00136476515675983,0.999948052741298,3,8,interleukin-1 receptor binding,MF,IL1A;IL1B;ERAP1
19373,GO:1905952,0.00136977820374645,0.999712300107318,8,71,regulation of lipid localization,BP,NFKBIA;NFKB1;EDN1;IL1B;C1QTNF1;IKBKE;ITGAV;EHD1
14099,GO:0061008,0.00139380615688045,0.999638700128897,10,105,hepaticobiliary system development,BP,NFKBIA;CLDN1;JUN;ANXA1;XBP1;ARG1;HMOX1;HMGCS1;CITED2;CYP1A1
10474,GO:0043410,0.00140566654174098,0.999410229583117,21,330,positive regulation of MAPK cascade,BP,IL1A;SAA1;EDN1;JUN;RIPK2;IL1B;C1QTNF1;AXL;GADD45B;SEMA7A;ITGAV;WWC1;NRP1;NRG1;ADAM8;AJUBA;IGFBP3;TGFA;EPHA2;MAGED1;IRAK2
4703,GO:0010883,0.0014160526303397,0.999835071447793,5,28,regulation of lipid storage,BP,NFKBIA;NFKB1;IKBKE;ITGAV;EHD1
14528,GO:0070098,0.00142364092516816,0.999888098592879,4,17,chemokine-mediated signaling pathway,BP,CXCL1;EDN1;SLIT2;CXCR5
6928,GO:0030574,0.00144550474076921,0.999780797584968,6,40,collagen catabolic process,BP,MMP9;COL12A1;COL8A1;COL4A4;MMP19;KLK6
12527,GO:0050716,0.00146897843609576,0.999883536666906,4,17,positive regulation of interleukin-1 secretion,BP,TRIM16;SAA1;RIPK2;NLRP10
546,GO:0001666,0.00147131045680011,0.999444800069042,17,251,response to hypoxia,BP,EDN1;TP53;PMAIP1;PSMB9;PGK1;CRYAB;SLC8A1;VEGFC;HMOX1;EGLN1;ADAM8;AJUBA;CITED2;ETS1;HSP90B1;PML;CYP1A1
8802,GO:0034612,0.00147815923454934,0.999481470754395,15,211,response to tumor necrosis factor,BP,NFKBIA;KRT8;KRT18;NFKB1;EDN1;CXCL16;PSMB9;CLDN1;TJP2;CYLD;BIRC3;TRAF3;TRAF1;TNFSF15;HAS2
17987,GO:1902531,0.00150326535527621,0.999094406620171,59,1306,regulation of intracellular signal transduction,BP,MMP9;IL1A;LGALS1;SAA1;TNIP1;DUSP8;EDN1;TP53;PMAIP1;FGF5;SLIT2;JUN;RIPK2;HERPUD1;PARP1;OPTN;IL1B;C1QTNF1;IL6ST;ATF3;AXL;GADD45B;IKBKE;CYLD;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;NBN;WWC1;BIRC3;RHOB;XBP1;HMOX1;IL24;NRP1;IL7R;TNFSF15;SOD2;NRG1;ADAM8;CALR;AJUBA;IGFBP3;PRR5L;ARHGDIB;GIT2;IL23A;DLG1;PTTG1IP;TGFA;NLRP10;NEDD4;PML;EPHA2;SOX11;MAGED1;IRAK2
4354,GO:0009991,0.001552564472493,0.999342878714093,21,338,response to extracellular stimulus,BP,TP53;PMAIP1;CDKN2B;JUN;HSPA5;IL1B;ATF3;AXL;NOCT;FADS1;LYN;G6PD;SLC8A1;XBP1;ARG1;HMOX1;KLF10;HMGCS1;HSP90B1;OXCT1;CYP1A1
2925,GO:0006468,0.00156597547601871,0.999054814329329,59,1310,protein phosphorylation,BP,CDKN2A;MMP9;IL1A;NEFL;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;PSMB9;FGF5;DBNDD2;SLIT2;CDKN2B;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;NBN;WWC1;VEGFC;IL24;HSP90AA1;NRP1;SETX;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;PML;EPHA2;ENPP1;MAGED1;IRAK2
564,GO:0001706,0.0015909115855724,0.99975357374379,6,41,endoderm formation,BP,MMP9;COL12A1;DUSP1;ITGAV;COL8A1;CTR9
4347,GO:0009968,0.00161541562211243,0.999100755291887,43,887,negative regulation of signal transduction,BP,NFKBIA;MMP9;IL1A;TNIP1;DUSP8;PSMB9;SLIT2;UBQLN2;CHAC1;PEG10;HERPUD1;OPTN;HSPA5;IL1B;ATF3;DNAJB9;AXL;CYLD;FBN2;DUSP1;TRIB1;ITGAV;LYN;WWC1;XBP1;ARG1;HMOX1;NRP1;SOD2;NRG1;CALR;AJUBA;IGFBP3;EYA3;PRR5L;DLG1;RBMS3;PTTG1IP;BAMBI;HTR1B;NEDD4;EPHA2;ENPP1
2200,GO:0005102,0.00162131847329497,0.999103460127639,42,864,signaling receptor binding,MF,IL32;IL1A;NETO1;CXCL1;SAA1;LCP1;EDN1;TP53;CXCL16;FGF5;SLIT2;CHAC1;RIPK2;IL16;PARP1;IL1B;IL6ST;ERAP1;SEMA7A;ITGAV;LYN;ANXA1;VEGFC;SEMA3D;TRAF3;IL24;CANX;TRAF1;TNFSF15;NRG1;HSP90AB1;CALR;PPID;IL23A;DLG1;REEP1;TGFA;BAMBI;HSP90B1;NEDD4;PVR;ENPP1
16452,GO:0097191,0.00165062832440887,0.999466018489035,13,167,extrinsic apoptotic signaling pathway,BP,IL1A;KRT8;KRT18;PMAIP1;IL1B;ATF3;CYLD;ITGAV;HMOX1;NRP1;TRAF1;EYA3;PML
4809,GO:0014031,0.00166553904537861,0.999686429467761,7,56,mesenchymal cell development,BP,EDN1;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;SOX11
14608,GO:0070234,0.00168700439817824,0.999927580469722,3,9,positive regulation of T cell apoptotic process,BP,TP53;CD274;ADAM8
18483,GO:1903706,0.00169052047245008,0.99929583222579,20,325,regulation of hemopoiesis,BP,NFKBIA;MAFB;PSMB9;JUN;RIPK2;TJP2;AXL;CYLD;TRIB1;CD83;LYN;ANXA1;XBP1;IL7R;KLF10;ADAM8;CTR9;IL23A;ETS1;CDK6
2519,GO:0005789,0.00169666841574265,0.999080170217708,39,791,endoplasmic reticulum membrane,CC,HERPUD1;HSPA5;DNAJB9;MGLL;ERAP1;FADS1;STT3A;NCEH1;FADS3;DERL3;XBP1;SEC11C;HMOX1;CANX;SDR16C5;GGCX;CALR;PDIA6;SEL1L;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;DLG1;DHDDS;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;DNAJC3;HSP90B1;SVIP;ZDHHC6;PML;SDF2L1;CYP1A1
3226,GO:0006897,0.00170000271438946,0.999203113725463,26,452,endocytosis,BP,SAA1;CXCL16;UBQLN2;IL1B;AXL;ACTG1;ITGAV;LYN;ANXA1;NEDD4L;SYT11;HSP90AA1;CANX;HSP90AB1;CALR;PDIA6;CORO1C;EHD1;CBLL1;HSP90B1;TFRC;HTR1B;NEDD4;MYH9;ENPP1;CLINT1
11435,GO:0045926,0.00172996518534611,0.999437463675964,13,166,negative regulation of growth,BP,CDKN2A;TP53;SLIT2;CRYAB;SEMA7A;G6PD;WWC1;SEMA3D;NRP1;DCUN1D3;IFRD1;PML;ENPP1
11270,GO:0045624,0.00175221011128332,0.999923766358539,3,9,positive regulation of T-helper cell differentiation,BP,RIPK2;ANXA1;IL23A
6724,GO:0030162,0.00175955152855273,0.999147856704892,28,516,regulation of proteolysis,BP,MMP9;SERPINB2;TNIP1;PMAIP1;PSMB9;UBQLN2;CHAC1;CCBE1;RIPK2;HERPUD1;IL1B;CRYAB;ANXA8;TRIB1;LYN;C1R;DERL3;BIRC3;XBP1;TRAF3;TNFSF15;SERPINH1;HSP90AB1;ADAM8;SVIP;PML;MYH9;HSPD1
20225,GO:2001233,0.00178519259360915,0.999271800970644,19,302,regulation of apoptotic signaling pathway,BP,MMP9;IL1A;TP53;PMAIP1;HERPUD1;PARP1;IL1B;ATF3;CYLD;ITGAV;XBP1;HMOX1;NRP1;TRAF1;SOD2;EYA3;PTTG1IP;PML;MAGED1
12380,GO:0048864,0.00180111734326202,0.999655761502035,7,57,stem cell development,BP,EDN1;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;SOX11
6155,GO:0019538,0.00180274831422674,0.99873447398229,154,4200,protein metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;SAA1;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;PGK1;SPRR2E;SPRR2D;CCBE1;JUN;RIPK2;HERPUD1;PARP1;APOL6;HSPA5;IL1B;MSRB3;ANPEP;C1QTNF1;IL6ST;CRYAB;ATF3;DNAJB9;AXL;DNAJC10;GADD45B;IKBKE;ERAP1;CYLD;SEMA7A;DUSP1;ANXA8;TRIB1;STT3A;ITGAV;LYN;C1R;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;XBP1;UGGT1;SEC11C;SUDS3;TRAF3;HMOX1;MMP19;KLK6;IL24;HSP90AA1;DAPP1;NRP1;TPP2;EGLN1;SETX;DCUN1D3;GNPTAB;TNFSF15;NRG1;ACO1;SERPINH1;PREP;HSP90AB1;SDR16C5;GGCX;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;EIF2B1;MAGT1;MOCS2;PRR5L;CORO1C;IL23A;MME;DLG1;MED18;RBMS3;NGLY1;LOX;PTTG1IP;DHDDS;CALU;CHORDC1;TGFA;DNAJC3;CBLL1;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;GALNT14;SOX11;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;MAGED1;SUPT3H;IRAK2;SDF2L1
10444,GO:0043370,0.0018030317524243,0.99984716618222,4,18,regulation of CD4-positive, alpha-beta T cell differentiation,BP,RIPK2;CD83;ANXA1;IL23A
12661,GO:0050919,0.00181469517375135,0.999776282407964,5,28,negative chemotaxis,BP,SLIT2;SEMA7A;ITGAV;SEMA3D;NRG1
12025,GO:0048010,0.00181867120024397,0.999599712115257,8,73,vascular endothelial growth factor receptor signaling pathway,BP,IL1B;AXL;ACTG1;ITGAV;VEGFC;HSP90AA1;NRP1;NEDD4
14681,GO:0070372,0.00181930022685906,0.999405007257045,13,166,regulation of ERK1 and ERK2 cascade,BP,IL1A;TNIP1;JUN;RIPK2;IL1B;ATF3;AXL;SEMA7A;DUSP1;LYN;NRP1;DLG1;EPHA2
1147,GO:0002762,0.0018240138638506,0.99977392554658,5,29,negative regulation of myeloid leukocyte differentiation,BP,MAFB;TJP2;TRIB1;LYN;CDK6
18036,GO:1902667,0.00182746910889576,0.99977434377041,5,28,regulation of axon guidance,BP,DSCAM;SLIT2;SEMA7A;SEMA3D;NRP1
7433,GO:0031589,0.00183673185977195,0.999316241217777,16,224,cell-substrate adhesion,BP,CDKN2A;LGALS1;AXL;ITGAV;COL8A1;PLEKHA2;VEGFC;NRP1;L1CAM;CALR;AJUBA;CORO1C;NID2;HAS2;CDK6;PARVA
8053,GO:0032755,0.00183837053295655,0.999705732231743,6,43,positive regulation of interleukin-6 production,BP,IL1A;RIPK2;IL1B;XBP1;NLRP10;HSPD1
977,GO:0002440,0.00184830627252451,0.999501146479023,10,110,production of molecular mediator of immune response,BP,DNAJB9;SEMA7A;NBN;XBP1;ARG1;HMOX1;IL7R;DLG1;TFRC;HSPD1
5847,GO:0017171,0.00184849761574939,0.999543761943916,9,93,serine hydrolase activity,MF,MMP9;NCEH1;C1R;SEC11C;MMP19;KLK6;TPP2;PREP;ADAM8
19495,GO:1990440,0.00185024001739756,0.999917936048086,3,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,TP53;HSPA5;ATF3
12368,GO:0048846,0.00185027827046645,0.999770874175463,5,28,axon extension involved in axon guidance,BP,DSCAM;SLIT2;SEMA7A;SEMA3D;NRP1
17903,GO:1902284,0.00185027827046645,0.999770874175463,5,28,neuron projection extension involved in neuron projection guidance,BP,DSCAM;SLIT2;SEMA7A;SEMA3D;NRP1
16843,GO:0098827,0.0018592011511162,0.998986604605643,39,795,endoplasmic reticulum subcompartment,CC,HERPUD1;HSPA5;DNAJB9;MGLL;ERAP1;FADS1;STT3A;NCEH1;FADS3;DERL3;XBP1;SEC11C;HMOX1;CANX;SDR16C5;GGCX;CALR;PDIA6;SEL1L;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;DLG1;DHDDS;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;DNAJC3;HSP90B1;SVIP;ZDHHC6;PML;SDF2L1;CYP1A1
4811,GO:0014033,0.00186440418246582,0.999641479537574,7,57,neural crest cell differentiation,BP,EDN1;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;SOX11
10409,GO:0043299,0.00186961507151818,0.999178221913905,22,373,leukocyte degranulation,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;LYN;ARG1;HMOX1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
12512,GO:0050701,0.00187131435793291,0.999765790210996,5,30,interleukin-1 secretion,BP,TRIM16;SAA1;RIPK2;NLRP10;PML
18484,GO:1903707,0.00187504733012981,0.999536004394477,9,94,negative regulation of hemopoiesis,BP,NFKBIA;MAFB;TJP2;CYLD;TRIB1;LYN;ANXA1;CTR9;CDK6
6846,GO:0030336,0.00189329387524225,0.999377979505693,13,166,negative regulation of cell migration,BP,DPYSL3;SLIT2;TRIB1;RHOB;HMOX1;IL24;NRG1;NR2F2;CALR;IGFBP3;ARHGDIB;CORO1C;CITED2
1080,GO:0002675,0.00189735710728956,0.999915093629627,3,9,positive regulation of acute inflammatory response,BP,IL1B;IL6ST;ADAM8
8186,GO:0032963,0.00193041020069754,0.99957070305969,8,74,collagen metabolic process,BP,MMP9;COL12A1;COL8A1;COL4A4;ARG1;MMP19;KLK6;SERPINH1
11159,GO:0045296,0.00194388120781876,0.999201237976388,19,298,cadherin binding,MF,KRT18;EPCAM;MYO1B;DNAJB1;HSPA5;EFHD2;TJP2;COBLL1;ANXA1;HSP90AB1;EIF4G2;DLG1;EHD1;EPHA2;MYH9;CLINT1;SND1;TJP1;PARVA
18207,GO:1903069,0.00194805003338109,0.999912007012042,3,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,UBQLN2;HERPUD1;SVIP
10982,GO:0044849,0.00196986942172208,0.999910669488717,3,9,estrous cycle,BP,ANXA1;ETS1;HAS2
9155,GO:0035556,0.001987649096233,0.998704360367501,82,1976,intracellular signal transduction,BP,CDKN2A;NFKBIA;MMP9;IL1A;NEFL;CXCL1;LGALS1;SAA1;LCP1;TNIP1;DUSP8;NFKB1;RELB;EDN1;TP53;PMAIP1;PSMB9;FGF5;SLIT2;CHAC1;JUN;RIPK2;NFKB2;HERPUD1;PARP1;OPTN;IL1B;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;SEMA7A;DUSP1;STAC;TRIB1;ITGAV;LYN;NBN;SLC8A1;WWC1;BIRC3;RHOB;XBP1;HMOX1;IL24;RIMS2;NRP1;IL7R;SETX;TNFSF15;SOD2;NRG1;ADAM8;CALR;IFNAR1;CTR9;AJUBA;IGFBP3;AMOTL2;RRAS2;PRR5L;RAB30;ARHGDIB;GIT2;IL23A;DLG1;PTTG1IP;TGFA;NLRP10;NEDD4;PML;EPHA2;SOX11;MAGED1;IRAK2;TJP1
16064,GO:0090087,0.00200462626510448,0.999034009024918,27,488,regulation of peptide transport,BP,IL1A;TRIM16;SAA1;LCP1;TP53;CD274;RIPK2;IL1B;LYN;ANXA1;DERL3;VEGFC;XBP1;SYT11;NRG1;HSP90AB1;ADAM8;STXBP5;PPID;SERP1;PRR5L;NLRP10;SVIP;PML;OXCT1;UGCG;MIDN
5432,GO:0016323,0.00201358866707336,0.99940813534297,11,126,basolateral plasma membrane,CC,B4GALT1;CLDN1;EPCAM;CLDN7;ANXA1;HSP90AB1;DLG1;TGFA;TFRC;ENPP1;TJP1
10268,GO:0043065,0.00202465951344172,0.999038087017358,26,467,positive regulation of apoptotic process,BP,CDKN2A;MMP9;B4GALT1;TP53;PMAIP1;CD274;SLIT2;JUN;RIPK2;ATF3;GADD45B;CYLD;DUSP1;LYN;ANXA1;RHOB;SUDS3;HMOX1;DCUN1D3;TNFSF15;ADAM8;PPID;IGFBP3;PML;HSPD1;MAGED1
6828,GO:0030316,0.0020260056723955,0.999604149584444,7,58,osteoclast differentiation,BP,MAFB;JUNB;TJP2;KLF10;IL23A;TFRC;EPHA2
3529,GO:0007567,0.00205240212442361,0.999905562188612,3,9,parturition,BP,EDN1;MAFF;CYP1A1
15169,GO:0071356,0.00206243063237727,0.999281184575223,14,197,cellular response to tumor necrosis factor,BP,NFKBIA;KRT8;KRT18;NFKB1;EDN1;PSMB9;CLDN1;TJP2;CYLD;BIRC3;TRAF3;TRAF1;TNFSF15;HAS2
6617,GO:0023019,0.00206498354163757,0.999904777024008,3,9,signal transduction involved in regulation of gene expression,BP,FGF5;EPCAM;PARP1
14591,GO:0070201,0.00207984009513866,0.998980808881085,28,514,regulation of establishment of protein localization,BP,IL1A;TRIM16;SAA1;LCP1;TP53;PMAIP1;CD274;RIPK2;IL1B;LYN;ANXA1;DERL3;VEGFC;XBP1;SYT11;NRG1;HSP90AB1;ADAM8;STXBP5;PPID;SERP1;PRR5L;NLRP10;SVIP;PML;OXCT1;UGCG;MIDN
17528,GO:1901164,0.00208904625036639,0.999981202058419,2,3,negative regulation of trophoblast cell migration,BP,CALR;ARHGDIB
9510,GO:0036293,0.00209159798926045,0.999183123315128,17,259,response to decreased oxygen levels,BP,EDN1;TP53;PMAIP1;PSMB9;PGK1;CRYAB;SLC8A1;VEGFC;HMOX1;EGLN1;ADAM8;AJUBA;CITED2;ETS1;HSP90B1;PML;CYP1A1
916,GO:0002317,0.00210810374754529,0.999980941861584,2,3,plasma cell differentiation,BP,LGALS1;XBP1
1299,GO:0003158,0.00212176754865558,0.999520907897265,8,74,endothelium development,BP,CLDN1;IL1B;TJP2;RHOB;NRP1;NRG1;NR2F2;TJP1
15009,GO:0070997,0.00212232732322757,0.999197598519482,16,233,neuron death,BP,NEFL;TP53;JUN;PARP1;HSPA5;AXL;G6PD;HMOX1;KLK6;NRP1;EGLN1;SOD2;HSP90AB1;ADAM8;RRAS2;BTBD10
12756,GO:0051090,0.00213034984324981,0.999117253192577,19,300,regulation of DNA binding transcription factor activity,BP,CDKN2A;NFKBIA;NFKB1;EDN1;JUN;RIPK2;NFKB2;IL1B;CYLD;NFKBIE;TRIB1;TRAF3;HMOX1;TRAF1;EGLN1;IFRD1;ADAM8;NLRP10;IRAK2
890,GO:0002275,0.0021479618384361,0.999044883702513,22,377,myeloid cell activation involved in immune response,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;LYN;ARG1;HMOX1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
8130,GO:0032880,0.00217790026248689,0.9988417907045,35,690,regulation of protein localization,BP,IL1A;TRIM16;SAA1;LCP1;TP53;PMAIP1;CD274;RIPK2;PARP1;IL1B;CYLD;STAC;LYN;ANXA1;DERL3;NEDD4L;VEGFC;XBP1;SYT11;NRG1;HSP90AB1;ADAM8;STXBP5;PPID;SERP1;PRR5L;DLG1;NLRP10;SVIP;PML;OXCT1;EPHA2;EPB41L2;UGCG;MIDN
14475,GO:0065009,0.00218831335144552,0.998545723862918,90,2228,regulation of molecular function,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;NEFL;NETO1;SERPINB2;CXCL1;SAA1;DUSP8;NFKB1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;FGF5;DBNDD2;SLIT2;CDKN2B;DNAJB1;JUN;RIPK2;IL16;NFKB2;HERPUD1;PARP1;HSPA5;IL1B;PHLDA2;CRYAB;AXL;DNAJC10;GADD45B;CYLD;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;LYN;ANXA1;NBN;NEDD4L;BIRC3;VEGFC;TRAF3;HMOX1;IL24;HSP90AA1;NRP1;TRAF1;EGLN1;DCUN1D3;TNFSF15;NRG1;IFRD1;SERPINH1;HSP90AB1;ADAM8;STXBP5;NR2F2;AJUBA;IGFBP3;EIF2B1;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;CHORDC1;TGFA;BAMBI;SUGT1;DNAJC3;HSP90B1;NLRP10;UBXN2B;NEDD4;CDK6;PML;EPHA2;MON1A;TOR1AIP1;SOX11;HSPD1;MAGED1;MIDN;IRAK2
1143,GO:0002758,0.00218942932231331,0.999232237252059,14,194,innate immune response-activating signal transduction,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;RIPK2;IKBKE;CYLD;LYN;BIRC3;TRAF3;HSP90B1;HSPD1;IRAK2
10852,GO:0044425,0.00219891711931977,0.998459167948346,138,3688,membrane part,CC,NETO1;KRT8;TENM3;DSCAM;ASPRV1;LCP1;B4GALT1;CXCL16;CD274;CLDN1;EPCAM;SLC16A9;PGK1;CLDN7;HS3ST1;GREB1L;CLDN11;MCAM;FAM173B;SPNS2;HERPUD1;SDK1;HSPA5;CNTNAP1;ANPEP;EFHD2;C1QTNF1;IL6ST;CRYAB;TMEM265;GPX8;DNAJB9;AXL;IFITM2;MGLL;ERAP1;CYLD;STOML1;SEMA7A;STAC;FADS1;CD83;STT3A;ITGAV;LYN;NCEH1;AP3M1;ANXA1;FADS3;GPR176;DERL3;G6PD;SLC8A1;WWC1;BIRC3;RHOB;XBP1;SEC11C;TRAF3;HMOX1;SYT11;FRAS1;KCTD12;HEPHL1;RIMS2;HSP90AA1;CANX;NRP1;IL7R;KCNQ5;GNPTAB;TNFSF15;CXCR5;NRG1;SERPINH1;HSP90AB1;SDR16C5;SLC7A5P2;GGCX;ADAM8;L1CAM;CLCC1;STXBP5;STEAP4;CALR;PDIA6;IFNAR1;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;CORO1C;MME;DLG1;EHD1;PTTG1IP;DHDDS;HAS2;ADGRL3;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;BAMBI;FOCAD;DNAJC3;IFNGR1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;NTNG1;ZDHHC6;PML;EPHA2;CCDC167;PVR;MYH9;GALNT14;TOR1AIP1;UGCG;ENPP1;SORBS2;HSPD1;SDF2L1;CYP1A1;TJP1;TMPPE
10271,GO:0043068,0.00221947872865837,0.99893818616016,26,470,positive regulation of programmed cell death,BP,CDKN2A;MMP9;B4GALT1;TP53;PMAIP1;CD274;SLIT2;JUN;RIPK2;ATF3;GADD45B;CYLD;DUSP1;LYN;ANXA1;RHOB;SUDS3;HMOX1;DCUN1D3;TNFSF15;ADAM8;PPID;IGFBP3;PML;HSPD1;MAGED1
16024,GO:0090023,0.00225847571004659,0.999888795437268,3,10,positive regulation of neutrophil chemotaxis,BP,CXCL1;EDN1;IL23A
8572,GO:0034105,0.00227016308509724,0.999793019298309,4,19,positive regulation of tissue remodeling,BP,B4GALT1;ADAM8;IL23A;TFRC
12864,GO:0051250,0.00227290911875608,0.999479923676735,8,77,negative regulation of lymphocyte activation,BP,CD274;AXL;CYLD;LYN;ANXA1;ARG1;DLG1;SOX11
15836,GO:0072604,0.0022799286308292,0.999791881036958,4,19,interleukin-6 secretion,BP,IL1B;XBP1;SYT11;NLRP10
981,GO:0002444,0.00229253097715132,0.99897500866576,22,379,myeloid leukocyte mediated immunity,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;LYN;ARG1;HMOX1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
11238,GO:0045580,0.00229280481650543,0.999474630542299,8,77,regulation of T cell differentiation,BP,RIPK2;CYLD;CD83;ANXA1;XBP1;IL7R;ADAM8;IL23A
8004,GO:0032663,0.00231288139546969,0.999694931345423,5,31,regulation of interleukin-2 production,BP,IL1A;RIPK2;IL1B;CD83;ANXA1
4745,GO:0010942,0.00231648039314911,0.998871627122723,27,496,positive regulation of cell death,BP,CDKN2A;MMP9;B4GALT1;TP53;PMAIP1;CD274;SLIT2;JUN;RIPK2;PARP1;ATF3;GADD45B;CYLD;DUSP1;LYN;ANXA1;RHOB;SUDS3;HMOX1;DCUN1D3;TNFSF15;ADAM8;PPID;IGFBP3;PML;HSPD1;MAGED1
2513,GO:0005783,0.00232566166063082,0.998574924551272,58,1323,endoplasmic reticulum,CC,LGALS1;EDN1;TP53;COL12A1;HERPUD1;HSPA5;MSRB3;GPX8;DNAJB9;DNAJC10;MGLL;ERAP1;FADS1;STT3A;NCEH1;COL8A1;FADS3;COL4A4;DERL3;XBP1;UGGT1;SEC11C;HMOX1;KLK6;CANX;ACO1;SERPINH1;SDR16C5;GGCX;CLCC1;CALR;PDIA6;IGFBP3;SEL1L;SLC35B1;SERP1;ORMDL1;MAGT1;RRAS2;SEC22A;IL23A;DLG1;PDIA4;DHDDS;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;DNAJC3;HSP90B1;SVIP;UBXN2B;ZDHHC6;PML;SDF2L1;CYP1A1
14708,GO:0070423,0.00235636687303694,0.999687851501123,5,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,NFKBIA;RIPK2;CYLD;BIRC3;IRAK2
12597,GO:0050829,0.00238262718461099,0.99977645986949,4,21,defense response to Gram-negative bacterium,BP,RNASE7;OPTN;IL23A;NLRP10
9862,GO:0042175,0.00240372613652926,0.998669555109655,39,806,nuclear outer membrane-endoplasmic reticulum membrane network,CC,HERPUD1;HSPA5;DNAJB9;MGLL;ERAP1;FADS1;STT3A;NCEH1;FADS3;DERL3;XBP1;SEC11C;HMOX1;CANX;SDR16C5;GGCX;CALR;PDIA6;SEL1L;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;DLG1;DHDDS;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;DNAJC3;HSP90B1;SVIP;ZDHHC6;PML;SDF2L1;CYP1A1
12759,GO:0051093,0.00243783909018089,0.998760830446845,30,563,negative regulation of developmental process,BP,NFKBIA;LGALS1;MAFB;DPYSL3;SLIT2;PGK1;TJP2;NOCT;CYLD;SEMA7A;CDSN;TRIB1;ITGAV;LYN;ANXA1;G6PD;WWC1;XBP1;SEMA3D;NRP1;NRG1;IFRD1;CALR;CTR9;ARHGDIB;CORO1C;CDK6;PML;SOX11;ENPP1
12182,GO:0048468,0.00248188054183754,0.998474719477161,58,1292,cell development,BP,IL1A;NEFL;KRT8;TENM3;LGALS1;DSCAM;KRT2;NEFM;B4GALT1;FEZ1;EDN1;DPYSL3;DBNDD2;SLIT2;CLDN1;JUN;SDK1;HSPA5;IL1B;CNTNAP1;TJP2;IL6ST;AXL;ACTG1;SEMA7A;CDSN;TRIB1;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;VEGFC;XBP1;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;SERPINH1;L1CAM;CALR;EIF2B1;CORO1C;EHD1;HAS2;NEDD4;CDK6;TUBB3;NTNG1;EPHA2;MYH9;SOX11;SORBS2;TJP1;PARVA
11306,GO:0045666,0.00249744853488384,0.999040340192313,16,231,positive regulation of neuron differentiation,BP,NEFL;TENM3;DSCAM;FEZ1;DPYSL3;SLIT2;HSPA5;SEMA7A;LYN;NEDD4L;RIMS2;NRP1;SETX;NRG1;L1CAM;SOX11
4504,GO:0010575,0.00251181733778586,0.99976445369145,4,19,positive regulation of vascular endothelial growth factor production,BP,IL1A;CCBE1;IL1B;IL6ST
1115,GO:0002711,0.00251930223205582,0.999761652474761,4,20,positive regulation of T cell mediated immunity,BP,IL1B;IL23A;PVR;HSPD1
17362,GO:1900138,0.00253239641365449,0.999974841023424,2,3,negative regulation of phospholipase A2 activity,BP,ANXA8;ANXA1
14780,GO:0070555,0.00253379622311376,0.999230240392329,11,138,response to interleukin-1,BP,NFKBIA;IL1A;NFKB1;EDN1;PSMB9;RIPK2;IL1B;ANXA1;ETS1;HAS2;IRAK2
7994,GO:0032649,0.00255097468599806,0.999560893243909,6,47,regulation of interferon-gamma production,BP,CD274;RIPK2;IL1B;AXL;IL23A;HSPD1
1296,GO:0003151,0.00255594188397096,0.999561327749397,6,45,outflow tract morphogenesis,BP,JUN;NRP1;CITED2;NEDD4;SOX11;PARVA
4943,GO:0015036,0.0025573111462414,0.999651528755902,5,34,disulfide oxidoreductase activity,MF,PGK1;DNAJC10;PDIA6;PDIA4;TXNRD1
5435,GO:0016328,0.00256085091620259,0.999560315161004,6,45,lateral plasma membrane,CC,CLDN1;EPCAM;CLDN7;ANXA1;CORO1C;DLG1
12785,GO:0051130,0.00258875845328568,0.998520196018058,43,901,positive regulation of cellular component organization,BP,MMP9;IL1A;NEFL;TENM3;DSCAM;LCP1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;SLIT2;CLDN1;JUN;PARP1;OPTN;HSPA5;IL1B;AXL;SEMA7A;ITGAV;LYN;ANXA1;NBN;NEDD4L;RIMS2;NRP1;SETX;NRG1;SDR16C5;L1CAM;CALR;CTR9;AJUBA;CORO1C;DLG1;EHD1;HAS2;ADGRL3;TGFA;CBLL1;PML;UGCG
4352,GO:0009987,0.00259685248456904,0.998534861937951,335,10474,cellular process,BP,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;CCBE1;JUN;KRT4;CLDN11;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;CD83;STT3A;ITGAV;LYN;NCEH1;COBLL1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SEMA3D;SUDS3;TRAF3;CSRP1;ARNTL2;HMOX1;MMP19;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;KCTD12;IL24;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;KRT34;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;L1CAM;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;METTL2A;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;ADGRL3;TYW1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;CHORDC1;TGFA;MGST3;BAMBI;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
11273,GO:0045627,0.00261158807295238,0.999973639292932,2,3,positive regulation of T-helper 1 cell differentiation,BP,RIPK2;ANXA1
12942,GO:0051385,0.00262701761000184,0.999748546882502,4,20,response to mineralocorticoid,BP,NEFL;EDN1;PARP1;HTR1B
10531,GO:0043523,0.00262963970277335,0.999198075518142,11,134,regulation of neuron apoptotic process,BP,NEFL;TP53;JUN;PARP1;AXL;G6PD;HMOX1;NRP1;SOD2;HSP90AB1;ADAM8
14712,GO:0070427,0.00263219573032829,0.999973323425343,2,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,NFKBIA;RIPK2
11055,GO:0045089,0.00264111904171604,0.998978295544756,16,241,positive regulation of innate immune response,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;RIPK2;IKBKE;CYLD;LYN;BIRC3;TRAF3;ADAM8;HSP90B1;PVR;HSPD1;IRAK2
16454,GO:0097193,0.0026633690526101,0.99896860667478,16,243,intrinsic apoptotic signaling pathway,BP,MMP9;TP53;PMAIP1;CHAC1;HERPUD1;PARP1;DNAJC10;IKBKE;CYLD;NBN;XBP1;HMOX1;SOD2;PTTG1IP;PML;EPHA2
16195,GO:0090287,0.00268309636463551,0.999081273102967,13,172,regulation of cellular response to growth factor stimulus,BP,SLIT2;CDKN2B;PEG10;CCBE1;HSPA5;IL1B;FBN2;VEGFC;HSP90AB1;CITED2;BAMBI;NEDD4;SOX11
9330,GO:0035872,0.00269479661118795,0.999630500329141,5,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,NFKBIA;RIPK2;CYLD;BIRC3;IRAK2
7997,GO:0032652,0.00270138648495133,0.999529598176859,6,47,regulation of interleukin-1 production,BP,TRIM16;SAA1;RIPK2;ANXA1;NLRP10;PML
11265,GO:0045619,0.00272083620677722,0.999287382914619,9,97,regulation of lymphocyte differentiation,BP,RIPK2;AXL;CYLD;CD83;ANXA1;XBP1;IL7R;ADAM8;IL23A
15100,GO:0071241,0.00272320071849028,0.999222973419153,10,116,cellular response to inorganic substance,BP,MMP9;EDN1;CLDN1;JUN;PARP1;HSPA5;JUNB;HMOX1;CALR;CYP1A1
16523,GO:0097350,0.00272635795647599,0.999971863785023,2,3,neutrophil clearance,BP,AXL;ANXA1
10167,GO:0042803,0.00274646026302678,0.99862642808649,28,529,protein homodimerization activity,MF,TENM3;LGALS1;NFKB1;MAFB;SLIT2;JUN;RIPK2;IL6ST;CRYAB;ATF3;MGLL;CDSN;ANXA1;G6PD;HMOX1;SYT11;HSP90AA1;HSP90AB1;NR2F2;HMGCS1;TFRC;PML;OXCT1;PVR;MYH9;ENPP1;TPM4;IRAK2
17388,GO:1900186,0.00274670388413175,0.999971544897863,2,3,negative regulation of clathrin-dependent endocytosis,BP,UBQLN2;SYT11
18037,GO:1902668,0.0027691811342939,0.999733157412767,4,19,negative regulation of axon guidance,BP,SLIT2;SEMA7A;SEMA3D;NRP1
1182,GO:0002836,0.00277810986592805,0.99997105024304,2,3,positive regulation of response to tumor cell,BP,PVR;HSPD1
1185,GO:0002839,0.00277810986592805,0.99997105024304,2,3,positive regulation of immune response to tumor cell,BP,PVR;HSPD1
1717,GO:0004322,0.00279326348344246,0.999970810521596,2,3,ferroxidase activity,MF,HEPHL1;FTH1
5620,GO:0016724,0.00279326348344246,0.999970810521596,2,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,HEPHL1;FTH1
15337,GO:0071622,0.0028161398435506,0.999723202303316,4,21,regulation of granulocyte chemotaxis,BP,CXCL1;EDN1;SLIT2;IL23A
932,GO:0002347,0.00284691266331367,0.999847777813517,3,10,response to tumor cell,BP,RBMS3;PVR;HSPD1
4926,GO:0014909,0.00284896903978774,0.999499346062236,6,46,smooth muscle cell migration,BP,SLIT2;TRIB1;NRP1;IGFBP3;HAS2;PARVA
14917,GO:0070851,0.00285805146011439,0.999320302641104,8,79,growth factor receptor binding,MF,IL1A;FGF5;IL1B;IL6ST;ERAP1;LYN;VEGFC;TGFA
7311,GO:0031341,0.00290400837894329,0.999592405996499,5,34,regulation of cell killing,BP,ARG1;IL7R;HSP90AB1;IL23A;PVR
16175,GO:0090259,0.00291591384679313,0.999968845414903,2,3,regulation of retinal ganglion cell axon guidance,BP,SLIT2;NRP1
17356,GO:1900127,0.00292807910298567,0.999968648110877,2,3,positive regulation of hyaluronan biosynthetic process,BP,NFKB1;HAS2
8804,GO:0034614,0.00292880319897226,0.999154955324811,10,119,cellular response to reactive oxygen species,BP,MMP9;TP53;JUN;AXL;ANXA1;RHOB;ARG1;SETX;SOD2;ETS1
10353,GO:0043209,0.00292901897574814,0.999093188551996,11,138,myelin sheath,CC,NEFL;CLDN11;HSPA5;CNTNAP1;CRYAB;ACTG1;MOBP;HSP90AA1;CANX;DLG1;HSPD1
8489,GO:0033693,0.00293573534871278,0.999968523717225,2,3,neurofilament bundle assembly,BP,NEFL;NEFM
19858,GO:2000389,0.00294654514110636,0.999968347798315,2,3,regulation of neutrophil extravasation,BP,IL1A;ADAM8
19859,GO:2000391,0.00294654514110636,0.999968347798315,2,3,positive regulation of neutrophil extravasation,BP,IL1A;ADAM8
19419,GO:1990138,0.00296090295971513,0.999146397631664,10,112,neuron projection extension,BP,DSCAM;SLIT2;SEMA7A;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM
11856,GO:0046912,0.00297626031599673,0.999967862476468,2,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,HMGCS1;CS
15339,GO:0071624,0.00298373082543754,0.999833479223822,3,11,positive regulation of granulocyte chemotaxis,BP,CXCL1;EDN1;IL23A
8009,GO:0032675,0.00303728229944129,0.999358567874071,7,63,regulation of interleukin-6 production,BP,IL1A;RIPK2;IL1B;XBP1;SYT11;NLRP10;HSPD1
5596,GO:0016667,0.00308100935867784,0.999446579208786,6,50,oxidoreductase activity, acting on a sulfur group of donors,MF,PGK1;MSRB3;DNAJC10;PDIA6;PDIA4;TXNRD1
10798,GO:0044325,0.00308214490275237,0.99925742014567,8,80,ion channel binding,MF,HERPUD1;STAC;LYN;SLC8A1;NEDD4L;RIMS2;HSP90AB1;DLG1
12951,GO:0051402,0.00310606062113648,0.998971546849608,12,157,neuron apoptotic process,BP,NEFL;TP53;JUN;PARP1;HSPA5;AXL;G6PD;HMOX1;NRP1;SOD2;HSP90AB1;ADAM8
19716,GO:2000146,0.00311377704989369,0.998914327543624,13,176,negative regulation of cell motility,BP,DPYSL3;SLIT2;TRIB1;RHOB;HMOX1;IL24;NRG1;NR2F2;CALR;IGFBP3;ARHGDIB;CORO1C;CITED2
6822,GO:0030307,0.0031171995982148,0.999093291799462,10,117,positive regulation of cell growth,BP,DSCAM;EDN1;CXCL16;SEMA7A;NEDD4L;RIMS2;NRP1;NRG1;L1CAM;EIF4G2
11743,GO:0046638,0.00313914992317654,0.999681943566864,4,21,positive regulation of alpha-beta T cell differentiation,BP,RIPK2;CD83;ANXA1;IL23A
1107,GO:0002703,0.00314931251137788,0.999155701477154,9,100,regulation of leukocyte mediated immunity,BP,IL1B;LYN;ARG1;HMOX1;IL7R;IL23A;TFRC;PVR;HSPD1
10538,GO:0043534,0.00318545799277757,0.999228362116314,8,80,blood vessel endothelial cell migration,BP,SLIT2;ANXA1;VEGFC;HMOX1;NRP1;ETS1;EPHA2;MYH9
5767,GO:0017015,0.0032214813121487,0.999218191855441,8,80,regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B;PEG10;HSPA5;FBN2;HSP90AB1;CITED2;BAMBI;SOX11
14503,GO:0070059,0.00323739935322522,0.999413434851734,6,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,PMAIP1;CHAC1;HERPUD1;DNAJC10;XBP1;PML
17712,GO:1901701,0.00326060960398646,0.998220363320392,35,706,cellular response to oxygen-containing compound,BP,NFKBIA;MMP9;LGALS1;TNIP1;NFKB1;EDN1;TP53;CD274;SLIT2;CLDN1;JUN;RIPK2;PARP1;HSPA5;IL1B;KRT13;AXL;TRIB1;LYN;ANXA1;SLC8A1;RHOB;XBP1;ARG1;IL24;SETX;SOD2;KLF10;CTR9;HMGCS1;ETS1;HSP90B1;OXCT1;ENPP1;IRAK2
10400,GO:0043279,0.00326713854545506,0.999300206618221,7,64,response to alkaloid,BP,TP53;SDK1;HSPA5;SLC8A1;HSP90AB1;ADGRL3;HTR1B
7188,GO:0031099,0.00331825775613757,0.99902567481286,10,119,regeneration,BP,NFKBIA;NEFL;LCP1;CLDN1;JUN;AXL;ANXA1;HMOX1;KLK6;IFRD1
7570,GO:0031960,0.00335374634110796,0.999091923774317,9,101,response to corticosteroid,BP,NEFL;EDN1;SLIT2;CLDN1;PARP1;DUSP1;ANXA1;ARG1;HTR1B
10485,GO:0043433,0.00340129750190863,0.998997810166789,10,119,negative regulation of DNA binding transcription factor activity,BP,CDKN2A;NFKBIA;CYLD;NFKBIE;TRIB1;TRAF3;HMOX1;EGLN1;NLRP10;IRAK2
11356,GO:0045773,0.00346046151074396,0.999495404144657,5,33,positive regulation of axon extension,BP,DSCAM;SEMA7A;NRP1;NRG1;L1CAM
12289,GO:0048678,0.00346896236565552,0.999362573865124,6,49,response to axon injury,BP,NEFL;LGALS1;DPYSL3;JUN;LYN;ARG1
14812,GO:0070613,0.00347682404712068,0.999360834216005,6,49,regulation of protein processing,BP,CHAC1;CCBE1;C1R;BIRC3;ADAM8;MYH9
7917,GO:0032527,0.0034818634958555,0.999490099297575,5,34,protein exit from endoplasmic reticulum,BP,HERPUD1;DERL3;SEL1L;HSP90B1;SVIP
3693,GO:0008217,0.00351893335113557,0.999132439168638,8,82,regulation of blood pressure,BP,EDN1;ANPEP;ERAP1;VEGFC;HMOX1;SOD2;NR2F2;MME
7998,GO:0032653,0.00356848178571357,0.999622816607587,4,22,regulation of interleukin-10 production,BP,CD274;CD83;IL23A;HSPD1
2923,GO:0006464,0.00359181087829225,0.997480904143086,117,3073,cellular protein modification process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;LGALS1;SAA1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CDKN2B;SPRR2E;SPRR2D;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;SEMA7A;DUSP1;TRIB1;STT3A;ITGAV;LYN;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;UGGT1;SUDS3;TRAF3;IL24;HSP90AA1;DAPP1;NRP1;TPP2;EGLN1;SETX;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;GGCX;ADAM8;NR2F2;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;MAGT1;PRR5L;CORO1C;IL23A;DLG1;MED18;NGLY1;LOX;PTTG1IP;DHDDS;CALU;CHORDC1;TGFA;DNAJC3;CBLL1;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;GALNT14;CPPED1;ENPP1;MAGED1;SUPT3H;IRAK2;SDF2L1
9486,GO:0036211,0.00359181087829225,0.997480904143086,117,3073,protein modification process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;LGALS1;SAA1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CDKN2B;SPRR2E;SPRR2D;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;SEMA7A;DUSP1;TRIB1;STT3A;ITGAV;LYN;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;UGGT1;SUDS3;TRAF3;IL24;HSP90AA1;DAPP1;NRP1;TPP2;EGLN1;SETX;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;GGCX;ADAM8;NR2F2;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;MAGT1;PRR5L;CORO1C;IL23A;DLG1;MED18;NGLY1;LOX;PTTG1IP;DHDDS;CALU;CHORDC1;TGFA;DNAJC3;CBLL1;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;GALNT14;CPPED1;ENPP1;MAGED1;SUPT3H;IRAK2;SDF2L1
10277,GO:0043086,0.00363188286164112,0.998145619446304,28,539,negative regulation of catalytic activity,BP,CDKN2A;MMP9;SERPINB2;DUSP8;NFKB1;TP53;DBNDD2;SLIT2;CDKN2B;HERPUD1;IL1B;CRYAB;GADD45B;DUSP1;ANXA8;TRIB1;LYN;ANXA1;BIRC3;EGLN1;SERPINH1;NR2F2;AJUBA;CORO1C;CHORDC1;DNAJC3;CDK6;MIDN
12263,GO:0048638,0.00364287904658435,0.998647487446609,14,197,regulation of developmental growth,BP,DSCAM;EDN1;PHLDA2;SEMA7A;G6PD;WWC1;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;SERP1
3245,GO:0006929,0.00364694813623289,0.999614607001283,4,21,substrate-dependent cell migration,BP,SLIT2;VEGFC;NRP1;ADAM8
16737,GO:0098590,0.00366350288264204,0.998041891817143,32,621,plasma membrane region,CC,NETO1;KRT8;LCP1;B4GALT1;CLDN1;EPCAM;CLDN7;CRYAB;ITGAV;ANXA1;SLC8A1;WWC1;RHOB;HMOX1;SYT11;KCTD12;RIMS2;HSP90AA1;NRG1;HSP90AB1;AMOTL2;CORO1C;DLG1;EHD1;TGFA;TFRC;NEDD4;EPHA2;MYH9;ENPP1;SORBS2;TJP1
10267,GO:0043062,0.0037138644644807,0.998512239353984,16,240,extracellular structure organization,BP,MMP9;LCP1;B4GALT1;COL12A1;NFKB2;FBN2;ITGAV;COL8A1;COL4A4;MMP19;SERPINH1;ADAM8;NID2;LOX;ETS1;HAS2
18548,GO:1903844,0.00371446295067221,0.999076008426234,8,82,regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B;PEG10;HSPA5;FBN2;HSP90AB1;CITED2;BAMBI;SOX11
4629,GO:0010769,0.00372311926767083,0.998614286261659,14,197,regulation of cell morphogenesis involved in differentiation,BP,NEFL;DSCAM;SLIT2;SEMA7A;NEDD4L;SEMA3D;NRP1;NRG1;IFRD1;L1CAM;CALR;CORO1C;HAS2;NEDD4
11282,GO:0045638,0.00378686460036276,0.999163988337252,7,68,negative regulation of myeloid cell differentiation,BP,NFKBIA;MAFB;TJP2;TRIB1;LYN;CTR9;CDK6
10421,GO:0043312,0.00379295618990305,0.998301238270679,20,347,neutrophil degranulation,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;ARG1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
17543,GO:1901214,0.00379457675143517,0.998583536605896,14,203,regulation of neuron death,BP,NEFL;TP53;JUN;PARP1;AXL;G6PD;HMOX1;NRP1;EGLN1;SOD2;HSP90AB1;ADAM8;RRAS2;BTBD10
7338,GO:0031400,0.00380249540005327,0.998131940653981,25,461,negative regulation of protein modification process,BP,CDKN2A;TNIP1;DUSP8;DBNDD2;SLIT2;CDKN2B;JUN;IL1B;ATF3;DNAJC10;GADD45B;DUSP1;TRIB1;LYN;G6PD;SDR16C5;NR2F2;IGFBP3;PRR5L;CORO1C;DLG1;CHORDC1;DNAJC3;CDK6;ENPP1
2926,GO:0006469,0.00382840957129659,0.998569111156081,14,205,negative regulation of protein kinase activity,BP,CDKN2A;DUSP8;DBNDD2;CDKN2B;IL1B;GADD45B;DUSP1;TRIB1;LYN;NR2F2;CORO1C;CHORDC1;DNAJC3;CDK6
12490,GO:0050671,0.00384000804598121,0.999150097217743,7,68,positive regulation of lymphocyte proliferation,BP,CD274;RIPK2;IL1B;IL6ST;ANXA1;IL23A;TFRC
9012,GO:0035255,0.00386762654535735,0.999584464989007,4,21,ionotropic glutamate receptor binding,MF,NETO1;CANX;DLG1;NEDD4
4751,GO:0010954,0.00386898501492356,0.999763019324059,3,11,positive regulation of protein processing,BP,CCBE1;ADAM8;MYH9
18306,GO:1903317,0.00388568517629172,0.999268226750312,6,50,regulation of protein maturation,BP,CHAC1;CCBE1;C1R;BIRC3;ADAM8;MYH9
896,GO:0002283,0.00392268772743449,0.998237686289423,20,348,neutrophil activation involved in immune response,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;ARG1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
6758,GO:0030213,0.00392618890886505,0.999758243618282,3,11,hyaluronan biosynthetic process,BP,NFKB1;IL1B;HAS2
16254,GO:0090399,0.0039408971483286,0.99975701154689,3,11,replicative senescence,BP,CDKN2A;TP53;MME
9390,GO:0035987,0.00397341291566517,0.999399736792783,5,34,endodermal cell differentiation,BP,MMP9;COL12A1;ITGAV;COL8A1;CTR9
6782,GO:0030246,0.00398038980932943,0.998800063892717,10,121,carbohydrate binding,MF,KRT1;LGALS1;G6PD;CANX;EGLN1;CALR;ADGRL3;GALNT14;GBE1;ENPP1
4424,GO:0010332,0.00402194511822555,0.999237192492538,6,50,response to gamma radiation,BP,TP53;PARP1;HSPA5;CRYAB;DCUN1D3;PML
14108,GO:0061029,0.00403893689435967,0.99974875607189,3,11,eyelid development in camera-type eye,BP,OSR2;JUN;SOX11
12556,GO:0050772,0.00405471518944247,0.999095850996651,7,65,positive regulation of axonogenesis,BP,NEFL;DSCAM;SLIT2;SEMA7A;NRP1;NRG1;L1CAM
7166,GO:0031072,0.00409781780951161,0.998855164166949,9,103,heat shock protein binding,MF,NFKBIA;DNAJB1;HSPA5;DNAJB9;DNAJC10;HSPA6;HSP90AB1;PPID;CHORDC1
17212,GO:0120035,0.00410590850962618,0.998002809243606,24,429,regulation of plasma membrane bounded cell projection organization,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;DPYSL3;SLIT2;SDK1;HSPA5;CYLD;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CORO1C;NEDD4;EPHA2
9821,GO:0042098,0.00413658663457914,0.9988417825298,9,105,T cell proliferation,BP,CD274;RIPK2;IL1B;IL6ST;ANXA1;ARG1;IL23A;DLG1;TFRC
11212,GO:0045446,0.00413665251372174,0.99907419195852,7,65,endothelial cell differentiation,BP,CLDN1;IL1B;TJP2;NRP1;NRG1;NR2F2;TJP1
4503,GO:0010574,0.00414041780799248,0.999543641640105,4,22,regulation of vascular endothelial growth factor production,BP,IL1A;CCBE1;IL1B;IL6ST
14604,GO:0070230,0.00416609032456373,0.999732460088038,3,12,positive regulation of lymphocyte apoptotic process,BP,TP53;CD274;ADAM8
8177,GO:0032946,0.00416688546909651,0.999063139577829,7,69,positive regulation of mononuclear cell proliferation,BP,CD274;RIPK2;IL1B;IL6ST;ANXA1;IL23A;TFRC
7477,GO:0031668,0.00418447969536533,0.99848711547223,13,184,cellular response to extracellular stimulus,BP,TP53;PMAIP1;CDKN2B;JUN;HSPA5;ATF3;AXL;FADS1;LYN;XBP1;HMOX1;KLF10;HSP90B1
15469,GO:0071887,0.00419761486390031,0.999055689498729,7,68,leukocyte apoptotic process,BP,CDKN2A;TP53;CD274;AXL;LYN;ANXA1;ADAM8
12273,GO:0048660,0.00422776937544011,0.998924244545389,8,84,regulation of smooth muscle cell proliferation,BP,MMP9;EDN1;TP53;JUN;TRIB1;HMOX1;IGFBP3;HTR1B
7985,GO:0032635,0.00424339111686377,0.999044253701784,7,67,interleukin-6 production,BP,IL1A;RIPK2;IL1B;XBP1;SYT11;NLRP10;HSPD1
4867,GO:0014805,0.00427229454606359,0.999921676620418,2,4,smooth muscle adaptation,BP,IL1B;HMOX1
15479,GO:0071900,0.00427856791705229,0.997982702308796,22,390,regulation of protein serine/threonine kinase activity,BP,CDKN2A;SAA1;DUSP8;EDN1;CDKN2B;RIPK2;IL1B;GADD45B;DUSP1;TRIB1;LYN;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;CHORDC1;TGFA;CDK6;MAGED1;IRAK2
11209,GO:0045429,0.00431634889889804,0.999518619934673,4,22,positive regulation of nitric oxide biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
18786,GO:1904407,0.00431634889889804,0.999518619934673,4,22,positive regulation of nitric oxide metabolic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
13827,GO:0060485,0.00432305953366588,0.998507011477464,12,161,mesenchyme development,BP,EDN1;IL1B;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;CITED2;HAS2;BAMBI;NEDD4;SOX11
863,GO:0002218,0.00434299371726043,0.99835253809225,14,209,activation of innate immune response,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;RIPK2;IKBKE;CYLD;LYN;BIRC3;TRAF3;HSP90B1;HSPD1;IRAK2
5359,GO:0016192,0.00440010523901819,0.997188138931297,61,1433,vesicle-mediated transport,BP,MMP9;FLG2;KRT1;CXCL1;SAA1;KRT18;NFKB1;B4GALT1;CXCL16;UBQLN2;MYO1B;OPTN;HRNR;IL1B;ANPEP;AXL;ACTG1;HSPA6;ANXA8;ITGAV;LYN;AP3M1;ANXA1;NEDD4L;VEGFC;RHOB;ARG1;HMOX1;SYT11;RIMS2;HSP90AA1;CANX;FTH1;NRP1;HSP90AB1;ADAM8;STXBP5;CALR;PDIA6;MAGT1;SEC22A;GIT2;CORO1C;MME;EHD1;SEC24D;TGFA;DNAJC3;CBLL1;HSP90B1;TFRC;HTR1B;SVIP;NEDD4;MON1A;MYH9;CPPED1;ENPP1;CLINT1;TNFAIP2;CEP83
3534,GO:0007584,0.0044098437452844,0.998556705040269,11,144,response to nutrient,BP,TP53;CDKN2B;IL1B;SLC8A1;XBP1;ARG1;HMOX1;HMGCS1;HSP90B1;OXCT1;CYP1A1
14739,GO:0070482,0.00447293950629248,0.998113875896279,17,279,response to oxygen levels,BP,EDN1;TP53;PMAIP1;PSMB9;PGK1;CRYAB;SLC8A1;VEGFC;HMOX1;EGLN1;ADAM8;AJUBA;CITED2;ETS1;HSP90B1;PML;CYP1A1
14644,GO:0070301,0.00448313768501661,0.998978406439427,7,69,cellular response to hydrogen peroxide,BP,TP53;AXL;ANXA1;RHOB;ARG1;SETX;ETS1
706,GO:0001935,0.0044979687717706,0.998842969256462,8,85,endothelial cell proliferation,BP,JUN;VEGFC;XBP1;ARG1;HMOX1;NRP1;NR2F2;DLG1
9051,GO:0035330,0.0045075104601264,0.999708296869473,3,11,regulation of hippo signaling,BP,WWC1;AJUBA;SOX11
12844,GO:0051222,0.00451320268146527,0.998042663682853,18,298,positive regulation of protein transport,BP,IL1A;TRIM16;SAA1;TP53;CD274;RIPK2;IL1B;VEGFC;XBP1;NRG1;HSP90AB1;ADAM8;PPID;SERP1;PRR5L;NLRP10;OXCT1;UGCG
4257,GO:0009635,0.00453604028367427,0.99969964111332,3,12,response to herbicide,BP,NEFL;ARG1;CYP1A1
12272,GO:0048659,0.00453929416659786,0.998830552200624,8,85,smooth muscle cell proliferation,BP,MMP9;EDN1;TP53;JUN;TRIB1;HMOX1;IGFBP3;HTR1B
9835,GO:0042119,0.00458552856884029,0.997909854315803,20,353,neutrophil activation,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;ARG1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
17820,GO:1902074,0.00460123358127598,0.999693752570223,3,12,response to salt,BP,NEFL;EDN1;HSPA5
15235,GO:0071456,0.00462538154488104,0.998475143973034,11,148,cellular response to hypoxia,BP,EDN1;TP53;PMAIP1;PSMB9;PGK1;SLC8A1;HMOX1;EGLN1;ADAM8;AJUBA;CITED2
19807,GO:2000318,0.00467419799617036,0.999910223177487,2,4,positive regulation of T-helper 17 type immune response,BP,IL23A;NLRP10
16300,GO:0090596,0.00467915759093866,0.998457366389416,11,141,sensory organ morphogenesis,BP,TENM3;DSCAM;OSR2;MAFB;EDN1;SDK1;KRT13;FBN2;COL8A1;EPHA2;SOX11
12218,GO:0048535,0.00469302836554642,0.999685409097112,3,12,lymph node development,BP,SPNS2;IL7R;CXCR5
10441,GO:0043367,0.00470968906582788,0.999255474217433,5,36,CD4-positive, alpha-beta T cell differentiation,BP,RELB;RIPK2;CD83;ANXA1;IL23A
16992,GO:0099503,0.00473005518902464,0.997478008352135,30,605,secretory vesicle,CC,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;EDN1;DPYSL3;DBNDD2;HRNR;IL1B;ANPEP;HSPA6;ITGAV;VEGFC;ARG1;SYT11;KLK6;HSP90AA1;FTH1;HSP90AB1;ADAM8;STXBP5;CALR;MAGT1;MME;DNAJC3;SVIP;CPPED1;HSPD1
10552,GO:0043549,0.00475424212847871,0.997411584273194,32,643,regulation of kinase activity,BP,CDKN2A;SAA1;DUSP8;EDN1;DBNDD2;CDKN2B;RIPK2;HSPA5;IL1B;AXL;GADD45B;DUSP1;TRIB1;LYN;NBN;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;EPHA2;MAGED1;MIDN;IRAK2
3227,GO:0006898,0.0047719242421745,0.998330343177152,12,164,receptor-mediated endocytosis,BP,SAA1;CXCL16;UBQLN2;SYT11;HSP90AA1;CANX;CALR;HSP90B1;TFRC;HTR1B;NEDD4;ENPP1
4318,GO:0009887,0.00479686892560066,0.997386897432459,32,640,animal organ morphogenesis,BP,TENM3;DSCAM;OSR2;MAFB;B4GALT1;EDN1;PSMB9;JUN;SDK1;KRT13;PHLDA2;CDSN;FBN2;COL8A1;VEGFC;XBP1;ARG1;FRAS1;NRP1;EGLN1;NRG1;SERPINH1;SERP1;DLG1;CITED2;HAS2;NEDD4;PML;EPHA2;SOX11;MAGED1;PARVA
7969,GO:0032609,0.00480690298111961,0.999050593308116,6,53,interferon-gamma production,BP,CD274;RIPK2;IL1B;AXL;IL23A;HSPD1
16462,GO:0097201,0.00481403930638097,0.999674317961175,3,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,DNAJB1;JUN;CITED2
4877,GO:0014821,0.00482294776100147,0.999905848849484,2,4,phasic smooth muscle contraction,BP,EDN1;DLG1
2364,GO:0005507,0.00483031657937398,0.999228327972085,5,38,copper ion binding,MF,IL1A;TP53;HEPHL1;SNAI3;LOX
4502,GO:0010573,0.00489218870803505,0.999431466994881,4,23,vascular endothelial growth factor production,BP,IL1A;CCBE1;IL1B;IL6ST
11304,GO:0045664,0.00490261293121085,0.997619532479038,23,410,regulation of neuron differentiation,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;DPYSL3;SLIT2;SDK1;HSPA5;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CALR;NEDD4;SOX11
982,GO:0002446,0.00490431183256698,0.99775049197068,20,355,neutrophil mediated immunity,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;ARG1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
7651,GO:0032102,0.00491342398637654,0.998187929852638,13,188,negative regulation of response to external stimulus,BP,KRT1;SERPINB2;SAA1;NFKB1;EDN1;SLIT2;C1QTNF1;SEMA7A;TRIB1;SEMA3D;NRP1;ETS1;NLRP10
7979,GO:0032623,0.00495417738745987,0.999205499457837,5,37,interleukin-2 production,BP,IL1A;RIPK2;IL1B;CD83;ANXA1
7469,GO:0031657,0.00498543723947085,0.999658432187879,3,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,CDKN2A;CDKN2B;CDK6
8742,GO:0034446,0.00499886678690775,0.998838667778584,7,68,substrate adhesion-dependent cell spreading,BP,AXL;ITGAV;NRP1;CALR;CORO1C;HAS2;PARVA
7973,GO:0032613,0.00500371729411696,0.999411763848024,4,24,interleukin-10 production,BP,CD274;CD83;IL23A;HSPD1
7314,GO:0031344,0.00501407552256897,0.997520087729912,24,436,regulation of cell projection organization,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;DPYSL3;SLIT2;SDK1;HSPA5;CYLD;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CORO1C;NEDD4;EPHA2
15807,GO:0072562,0.00505802800509127,0.999183045848057,5,38,blood microparticle,CC,KRT1;ACTG1;HSPA6;C1R;TFRC
4704,GO:0010884,0.00506563254473918,0.999650929420655,3,12,positive regulation of lipid storage,BP,NFKB1;IKBKE;EHD1
6904,GO:0030516,0.00506857495383286,0.99882038516455,7,67,regulation of axon extension,BP,DSCAM;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;L1CAM
18308,GO:1903319,0.00514106438536658,0.999643832112153,3,12,positive regulation of protein maturation,BP,CCBE1;ADAM8;MYH9
9494,GO:0036230,0.0051749041826812,0.997614364898483,20,357,granulocyte activation,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;ARG1;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
3171,GO:0006810,0.00518403777886857,0.996292104738144,124,3339,transport,BP,NFKBIA;MMP9;IL1A;FLG2;TRIM16;KRT1;NEFL;NETO1;CXCL1;SAA1;LCP1;KRT18;NFKB1;B4GALT1;FEZ1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;CD274;CLDN1;UBQLN2;SLC16A9;MYO1B;RIPK2;IL16;SPNS2;HERPUD1;APOL6;OPTN;HRNR;HSPA5;IL1B;IFT46;ANPEP;C1QTNF1;TJP2;CRYAB;AXL;ACTG1;HSPA6;STOML1;NFKBIE;STAC;ANXA8;ITGAV;LYN;AP3M1;ANXA1;DERL3;G6PD;SLC8A1;WWC1;NEDD4L;VEGFC;RHOB;XBP1;MOBP;ARG1;HMOX1;SYT11;FRAS1;HEPHL1;RIMS2;HSP90AA1;CANX;FTH1;NRP1;KCNQ5;GNPTAB;NRG1;ACO1;HSP90AB1;SLC7A5P2;ADAM8;CLCC1;STXBP5;STEAP4;CALR;PDIA6;PPID;ANO4;SEL1L;SLC39A14;SLC35B1;SERP1;MAGT1;PRR5L;RAB30;SEC22A;GIT2;CORO1C;MME;DLG1;PDIA4;EHD1;PTTG1IP;HAS2;SEC24D;REEP1;TGFA;DNAJC3;CBLL1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;SOX11;UGCG;CPPED1;ENPP1;CLINT1;TNFAIP2;CEP83;HSPD1;MIDN
12264,GO:0048639,0.00521101330342849,0.998488661680349,9,104,positive regulation of developmental growth,BP,DSCAM;EDN1;SEMA7A;NEDD4L;RIMS2;NRP1;NRG1;L1CAM;SERP1
1110,GO:0002706,0.00521120520807788,0.998777255123045,7,71,regulation of lymphocyte mediated immunity,BP,IL1B;ARG1;IL7R;IL23A;TFRC;PVR;HSPD1
12553,GO:0050769,0.00522484115043498,0.997701694414439,18,295,positive regulation of neurogenesis,BP,NEFL;TENM3;DSCAM;FEZ1;DPYSL3;SLIT2;HSPA5;IL6ST;SEMA7A;LYN;NEDD4L;VEGFC;RIMS2;NRP1;SETX;NRG1;L1CAM;SOX11
3209,GO:0006875,0.00524826401916486,0.997750691206746,17,279,cellular metal ion homeostasis,BP,SAA1;EDN1;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;HMOX1;FTH1;EGLN1;ACO1;CALR;SLC39A14;HSP90B1;TFRC;PML
985,GO:0002449,0.00526959071873761,0.998343057923542,10,128,lymphocyte mediated immunity,BP,IL1B;C1R;NBN;ARG1;IL7R;IL23A;DLG1;TFRC;PVR;HSPD1
9759,GO:0040008,0.0052739020030797,0.997379825656419,24,445,regulation of growth,BP,CDKN2A;DSCAM;EDN1;TP53;CXCL16;SLIT2;PHLDA2;CRYAB;SEMA7A;G6PD;WWC1;NEDD4L;SEMA3D;RIMS2;NRP1;DCUN1D3;NRG1;IFRD1;L1CAM;EIF4G2;IGFBP3;SERP1;PML;ENPP1
1377,GO:0003298,0.00527745407531495,0.99963090153076,3,12,physiological muscle hypertrophy,BP,EDN1;G6PD;SORBS2
1380,GO:0003301,0.00527745407531495,0.99963090153076,3,12,physiological cardiac muscle hypertrophy,BP,EDN1;G6PD;SORBS2
14125,GO:0061049,0.00527745407531495,0.99963090153076,3,12,cell growth involved in cardiac muscle cell development,BP,EDN1;G6PD;SORBS2
11031,GO:0045063,0.00535022826159704,0.999623951109112,3,12,T-helper 1 cell differentiation,BP,RELB;RIPK2;ANXA1
13866,GO:0060558,0.00536061460433256,0.999889448521591,2,4,regulation of calcidiol 1-monooxygenase activity,BP,NFKB1;IL1B
881,GO:0002253,0.00539074556159752,0.997505932676109,20,353,activation of immune response,BP,NFKBIA;KRT1;TNIP1;NFKB1;RELB;PSMB9;RIPK2;ACTG1;IKBKE;CYLD;LYN;C1R;BIRC3;TRAF3;HSP90AA1;HSP90AB1;EIF2B1;HSP90B1;HSPD1;IRAK2
3701,GO:0008236,0.00542505923353217,0.998556257087477,8,90,serine-type peptidase activity,MF,MMP9;C1R;SEC11C;MMP19;KLK6;TPP2;PREP;ADAM8
19917,GO:2000514,0.00544139398891317,0.999344861081306,4,24,regulation of CD4-positive, alpha-beta T cell activation,BP,RIPK2;CD83;ANXA1;IL23A
15265,GO:0071496,0.00545473003944612,0.997795222337298,15,234,cellular response to external stimulus,BP,NFKB1;TP53;PMAIP1;CDKN2B;JUN;HSPA5;IL1B;ATF3;AXL;FADS1;LYN;XBP1;HMOX1;KLF10;HSP90B1
16796,GO:0098742,0.00546721277005627,0.998402489652048,9,104,cell-cell adhesion via plasma-membrane adhesion molecules,BP,TENM3;DSCAM;CLDN1;CLDN7;CLDN11;SDK1;AJUBA;ADGRL3;PVR
690,GO:0001914,0.00550120392069036,0.999602799774086,3,13,regulation of T cell mediated cytotoxicity,BP,IL7R;IL23A;PVR
18571,GO:1903895,0.00551862961032981,0.999884457478698,2,4,negative regulation of IRE1-mediated unfolded protein response,BP,HSPA5;DNAJB9
6931,GO:0030578,0.0055222179727845,0.999884343251891,2,4,PML body organization,BP,ETS1;PML
14742,GO:0070487,0.00552325395323465,0.999884310266687,2,4,monocyte aggregation,BP,IL1B;HAS2
4369,GO:0010039,0.00557234513404972,0.99932452920122,4,24,response to iron ion,BP,G6PD;HMOX1;ACO1;CYP1A1
1696,GO:0004252,0.0056256392309606,0.998660195438269,7,72,serine-type endopeptidase activity,MF,MMP9;C1R;MMP19;KLK6;TPP2;PREP;ADAM8
3776,GO:0008361,0.00562820034208768,0.998215286299243,10,124,regulation of cell size,BP,DSCAM;EDN1;SEMA7A;SEMA3D;NRP1;IL7R;NRG1;IFRD1;HSP90AB1;L1CAM
11638,GO:0046456,0.00566876225695521,0.99930625585609,4,25,icosanoid biosynthetic process,BP,EDN1;FADS1;ANXA1;MGST3
12874,GO:0051260,0.00568973595451954,0.997771974314935,14,215,protein homooligomerization,BP,B4GALT1;TP53;DPYSL3;CLDN1;CLDN7;C1QTNF1;CRYAB;IKBKE;ARG1;HMOX1;SYT11;KCTD12;SOD2;EHD1
9940,GO:0042359,0.00571824103324266,0.999581298968436,3,13,vitamin D metabolic process,BP,NFKB1;IL1B;CYP1A1
7346,GO:0031410,0.00574143899481635,0.996225529348636,66,1601,cytoplasmic vesicle,CC,MMP9;FLG2;KRT1;CXCL1;SAA1;NFKB1;B4GALT1;EDN1;DPYSL3;DBNDD2;UBQLN2;MYO1B;OPTN;HRNR;HSPA5;IL1B;ANPEP;ACTG1;HSPA6;IKBKE;STOML1;ANXA8;ITGAV;AP3M1;ANXA1;NEDD4L;VEGFC;RHOB;ARG1;TRAF3;SYT11;KLK6;HSP90AA1;CANX;FTH1;NRP1;IL7R;HSP90AB1;ADAM8;STXBP5;STEAP4;UQCC1;CALR;PDIA6;IFNAR1;AMOTL2;MAGT1;ARHGDIB;MME;PDIA4;EHD1;SEC24D;CALU;TGFA;DNAJC3;ANKRD13A;HSP90B1;TFRC;SVIP;PML;MON1A;CPPED1;CLINT1;HSPD1;SND1;IRAK2
17618,GO:1901490,0.00574257316475234,0.999877254216306,2,4,regulation of lymphangiogenesis,BP,CCBE1;VEGFC
12916,GO:0051338,0.00575609383075928,0.996736993185188,35,733,regulation of transferase activity,BP,CDKN2A;SAA1;DUSP8;EDN1;TP53;DBNDD2;CDKN2B;RIPK2;HSPA5;IL1B;AXL;GADD45B;DUSP1;TRIB1;LYN;NBN;HSP90AA1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;EPHA2;MAGED1;MIDN;IRAK2
16371,GO:0097048,0.00577903529934496,0.999876067142234,2,4,dendritic cell apoptotic process,BP,AXL;LYN
20006,GO:2000668,0.00577903529934496,0.999876067142234,2,4,regulation of dendritic cell apoptotic process,BP,AXL;LYN
10369,GO:0043235,0.00578704909788224,0.997824151683779,13,184,receptor complex,CC,IL6ST;AXL;ITGAV;LYN;TRAF3;NRP1;HSP90AB1;STXBP5;DLG1;TFRC;EPHA2;MYH9;HSPD1
7793,GO:0032368,0.00581524508367026,0.998803706411952,6,54,regulation of lipid transport,BP,NFKBIA;NFKB1;EDN1;IL1B;C1QTNF1;ITGAV
12387,GO:0048872,0.00582533021472255,0.997907366596144,12,169,homeostasis of number of cells,BP,MAFB;PMAIP1;SPNS2;AXL;CYLD;LYN;ANXA1;G6PD;HMOX1;IL7R;ETS1;CDK6
8573,GO:0034109,0.00582995407128514,0.998800048100318,6,54,homotypic cell-cell adhesion,BP,LGALS1;C1QTNF1;ACTG1;LYN;CSRP1;MYH9
19030,GO:1904951,0.00584326951106296,0.997335605563957,19,330,positive regulation of establishment of protein localization,BP,IL1A;TRIM16;SAA1;TP53;PMAIP1;CD274;RIPK2;IL1B;VEGFC;XBP1;NRG1;HSP90AB1;ADAM8;PPID;SERP1;PRR5L;NLRP10;OXCT1;UGCG
15859,GO:0072672,0.00589441963719041,0.999872284607666,2,4,neutrophil extravasation,BP,IL1A;ADAM8
12733,GO:0051048,0.00589871922271009,0.998252764836278,9,109,negative regulation of secretion,BP,EDN1;IL1B;ANXA1;HMOX1;SYT11;NRG1;HTR1B;PML;MIDN
7295,GO:0031324,0.005905552538985,0.99601626219343,76,1892,negative regulation of cellular metabolic process,BP,CDKN2A;MMP9;SERPINB2;OSR2;TNIP1;DUSP8;NFKB1;RELB;FEZ1;EDN1;TP53;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;DNAJB1;JUN;NFKB2;HERPUD1;PARP1;OPTN;IL1B;JUNB;CRYAB;ATF3;DNAJC10;GADD45B;NOCT;DUSP1;ANXA8;TRIB1;ITGAV;LYN;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;SUDS3;HMOX1;EGLN1;KLF10;NRG1;SERPINH1;HSP90AB1;SDR16C5;SNAI3;NR2F2;EIF4G2;CALR;PPID;CTR9;AJUBA;IGFBP3;ORMDL1;PRR5L;UBP1;CORO1C;DLG1;CITED2;ZNF814;CHORDC1;DNAJC3;ZC3H7B;SVIP;NEDD4;CDK6;PML;ZBTB21;SOX11;ENPP1;MAGED1;MIDN
16674,GO:0097708,0.00591965731247122,0.996102549875625,66,1603,intracellular vesicle,CC,MMP9;FLG2;KRT1;CXCL1;SAA1;NFKB1;B4GALT1;EDN1;DPYSL3;DBNDD2;UBQLN2;MYO1B;OPTN;HRNR;HSPA5;IL1B;ANPEP;ACTG1;HSPA6;IKBKE;STOML1;ANXA8;ITGAV;AP3M1;ANXA1;NEDD4L;VEGFC;RHOB;ARG1;TRAF3;SYT11;KLK6;HSP90AA1;CANX;FTH1;NRP1;IL7R;HSP90AB1;ADAM8;STXBP5;STEAP4;UQCC1;CALR;PDIA6;IFNAR1;AMOTL2;MAGT1;ARHGDIB;MME;PDIA4;EHD1;SEC24D;CALU;TGFA;DNAJC3;ANKRD13A;HSP90B1;TFRC;SVIP;PML;MON1A;CPPED1;CLINT1;HSPD1;SND1;IRAK2
6463,GO:0021825,0.00596086476729998,0.999870088541952,2,4,substrate-dependent cerebral cortex tangential migration,BP,SLIT2;NRP1
13136,GO:0051781,0.00599021731232737,0.998760059307519,6,54,positive regulation of cell division,BP,IL1A;FGF5;IL1B;VEGFC;CXCR5;TGFA
11740,GO:0046635,0.00610058307718319,0.999237581569982,4,25,positive regulation of alpha-beta T cell activation,BP,RIPK2;CD83;ANXA1;IL23A
6664,GO:0030048,0.00614421701561322,0.998515616364228,7,69,actin filament-based movement,BP,MYO1B;NEDD4L;MOBP;DLG1;MYH9;TPM4;PARVA
13471,GO:0055082,0.00617726467938188,0.996938706228133,23,429,cellular chemical homeostasis,BP,LGALS1;SAA1;EDN1;TP53;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;XBP1;HMOX1;FTH1;EGLN1;ACO1;CALR;SLC39A14;ORMDL1;HSP90B1;TFRC;PML;OXCT1;ENPP1
9789,GO:0042026,0.00623098744046931,0.99921655461592,4,25,protein refolding,BP,HSPA5;HSPA6;HSP90AA1;HSPD1
12599,GO:0050832,0.00624002946479711,0.999521745596814,3,14,defense response to fungus,BP,RNASE7;ARG1;NLRP10
12796,GO:0051146,0.00624291681090855,0.997856515730094,11,148,striated muscle cell differentiation,BP,KRT8;EDN1;ACTG1;G6PD;SLC8A1;XBP1;NRG1;CALR;EHD1;MYH9;SORBS2
19007,GO:1904894,0.00625635006265715,0.998932525699204,5,40,positive regulation of STAT cascade,BP,IL6ST;LYN;IL24;IL7R;IL23A
12287,GO:0048675,0.00635446634737784,0.998265494414996,8,87,axon extension,BP,DSCAM;SLIT2;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;L1CAM
5434,GO:0016327,0.00637356904713504,0.999514555639731,3,13,apicolateral plasma membrane,CC,KRT8;CLDN7;NEDD4
10761,GO:0044267,0.00640475365583764,0.995332777868414,141,3911,cellular protein metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;LGALS1;SAA1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;SPRR2E;SPRR2D;CCBE1;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;MSRB3;C1QTNF1;IL6ST;CRYAB;ATF3;DNAJB9;AXL;DNAJC10;GADD45B;IKBKE;CYLD;SEMA7A;DUSP1;ANXA8;TRIB1;STT3A;ITGAV;LYN;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;XBP1;UGGT1;SEC11C;SUDS3;TRAF3;IL24;HSP90AA1;DAPP1;NRP1;TPP2;EGLN1;SETX;DCUN1D3;TNFSF15;NRG1;ACO1;SERPINH1;HSP90AB1;SDR16C5;GGCX;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;EIF2B1;MAGT1;MOCS2;PRR5L;CORO1C;IL23A;DLG1;MED18;RBMS3;NGLY1;LOX;PTTG1IP;DHDDS;CALU;CHORDC1;TGFA;DNAJC3;CBLL1;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;GALNT14;SOX11;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;MAGED1;SUPT3H;IRAK2;SDF2L1
13234,GO:0051962,0.00665848973878667,0.996926172018657,19,325,positive regulation of nervous system development,BP,NEFL;TENM3;DSCAM;FEZ1;DPYSL3;SLIT2;HSPA5;IL6ST;SEMA7A;LYN;NEDD4L;VEGFC;RIMS2;NRP1;SETX;NRG1;L1CAM;ADGRL3;SOX11
15714,GO:0072347,0.00666423197473156,0.99884774117739,5,39,response to anesthetic,BP,SDK1;HSPA5;HSP90AB1;ADGRL3;HTR1B
9511,GO:0036294,0.00667718098666088,0.997683061428321,11,155,cellular response to decreased oxygen levels,BP,EDN1;TP53;PMAIP1;PSMB9;PGK1;SLC8A1;HMOX1;EGLN1;ADAM8;AJUBA;CITED2
10532,GO:0043524,0.00668364053840955,0.998156354464916,8,91,negative regulation of neuron apoptotic process,BP,NEFL;JUN;AXL;HMOX1;NRP1;SOD2;HSP90AB1;ADAM8
16830,GO:0098802,0.00669172753652276,0.998155454700618,8,89,plasma membrane receptor complex,CC,IL6ST;ITGAV;LYN;TRAF3;STXBP5;DLG1;TFRC;MYH9
7316,GO:0031346,0.00669407928420567,0.997141723247651,16,256,positive regulation of cell projection organization,BP,NEFL;TENM3;DSCAM;FEZ1;DPYSL3;SLIT2;HSPA5;SEMA7A;LYN;NEDD4L;RIMS2;NRP1;SETX;NRG1;L1CAM;CORO1C
3097,GO:0006690,0.00670239132906943,0.998575068975428,6,57,icosanoid metabolic process,BP,EDN1;MGLL;FADS1;ANXA1;MGST3;CYP1A1
8325,GO:0033209,0.00670674082589228,0.997810721914492,10,138,tumor necrosis factor-mediated signaling pathway,BP,NFKBIA;KRT8;KRT18;PSMB9;TJP2;CYLD;BIRC3;TRAF3;TRAF1;TNFSF15
2367,GO:0005515,0.00670811532731842,0.995229099116068,273,8286,protein binding,MF,IL32;CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;NETO1;KRT8;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT2;LCP1;TNIP1;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;KPRP;UBQLN2;CHAC1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;SPRR2E;MYO1B;DNAJB1;PEG10;CCBE1;JUN;KRT4;CLDN11;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;SDK1;HSPA5;IL1B;MSRB3;IFT46;KRT13;CNTNAP1;JUNB;EFHD2;C1QTNF1;TJP2;IL6ST;HSPB8;CRYAB;ATF3;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;CRCT1;HSPA6;GADD45B;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FIGN;CD83;STT3A;ITGAV;LYN;COBLL1;AP3M1;COL8A1;C1R;ANXA1;PDE1C;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;RHOB;XBP1;MOBP;UGGT1;SEMA3D;SUDS3;TRAF3;ARNTL2;GSTCD;HMOX1;FAM126B;SYT11;KLK6;UBTD2;KCTD12;IL24;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;SOD2;POP4;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;HSP90AB1;GPATCH11;SDR16C5;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;AMOTL2;EYA3;ZCCHC8;SERP1;EIF2B1;MAFF;MAGT1;RRAS2;MGA;PRR5L;SEC22A;HMGCS1;ARHGDIB;GIT2;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;MED18;NGLY1;GDA;EHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;DHDDS;ETS1;ADGRL3;SEC24D;REEP1;CALU;PDE4DIP;CHORDC1;TGFA;MGST3;BAMBI;SUGT1;FOCAD;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MYH9;EID3;TOR1AIP1;ZBTB21;HES4;GBE1;MRPL53;ENPP1;SORBS2;AFAP1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
1078,GO:0002673,0.00673769601828182,0.999129967191239,4,26,regulation of acute inflammatory response,BP,IL1B;IL6ST;C1R;ADAM8
13015,GO:0051546,0.00674581005621975,0.999475471994579,3,13,keratinocyte migration,BP,MMP9;KRT2;HAS2
12363,GO:0048841,0.00682490204620402,0.999123218467983,4,24,regulation of axon extension involved in axon guidance,BP,DSCAM;SEMA7A;SEMA3D;NRP1
14761,GO:0070527,0.00682854290252515,0.998810088215202,5,40,platelet aggregation,BP,C1QTNF1;ACTG1;LYN;CSRP1;MYH9
13468,GO:0055078,0.00692448164069645,0.999456421571597,3,13,sodium ion homeostasis,BP,EDN1;SLC8A1;NEDD4L
17645,GO:1901564,0.00697846024989633,0.994846658952624,171,4897,organonitrogen compound metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;SAA1;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;UBQLN2;CHAC1;SLC16A9;CDKN2B;PGK1;HS3ST1;SPRR2E;SPRR2D;CCBE1;JUN;RIPK2;SPNS2;HERPUD1;PARP1;APOL6;HSPA5;IL1B;MSRB3;ANPEP;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;DNAJB9;AXL;DNAJC10;GADD45B;IKBKE;ERAP1;CYLD;SEMA7A;DUSP1;ANXA8;TRIB1;PLBD1;STT3A;ITGAV;LYN;C1R;ANXA1;GPR176;DERL3;G6PD;NBN;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;HMOX1;MMP19;KLK6;PAPSS2;IL24;HSP90AA1;DAPP1;NRP1;TPP2;EGLN1;SETX;DCUN1D3;GNPTAB;TNFSF15;NRG1;ACO1;SERPINH1;PREP;HSP90AB1;SDR16C5;GGCX;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;EIF2B1;ORMDL1;MAGT1;MOCS2;PRR5L;CORO1C;IL23A;MME;DLG1;MED18;RBMS3;NGLY1;GDA;LOX;PTTG1IP;DHDDS;HAS2;CALU;IVD;CHORDC1;TGFA;MGST3;DNAJC3;CBLL1;BCAT1;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;GALNT14;SOX11;UGCG;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;MAGED1;SUPT3H;IRAK2;SDF2L1;CYP1A1
10475,GO:0043412,0.00702774234994205,0.994931043679736,120,3232,macromolecule modification,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;LGALS1;SAA1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;B4GALT1;EDN1;TP53;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;CDKN2B;SPRR2E;SPRR2D;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;CYLD;SEMA7A;DUSP1;TRIB1;STT3A;ITGAV;LYN;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;UGGT1;SUDS3;TRAF3;IL24;HSP90AA1;DAPP1;NRP1;TPP2;EGLN1;SETX;DCUN1D3;TNFSF15;NRG1;HSP90AB1;SDR16C5;GGCX;ADAM8;NR2F2;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;MAGT1;PRR5L;METTL2A;CORO1C;IL23A;DLG1;TRMT44;MED18;NGLY1;LOX;PTTG1IP;DHDDS;CALU;CHORDC1;TGFA;DNAJC3;CBLL1;HSP90B1;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;GALNT14;CPPED1;ENPP1;MAGED1;SUPT3H;IRAK2;SDF2L1
1109,GO:0002705,0.00704289734282812,0.998486990445807,6,57,positive regulation of leukocyte mediated immunity,BP,IL1B;ARG1;IL23A;TFRC;PVR;HSPD1
10238,GO:0043010,0.00709319348825028,0.997262900802373,13,191,camera-type eye development,BP,TENM3;DSCAM;OSR2;JUN;SDK1;CRYAB;FBN2;COL8A1;NRP1;DLG1;EPHA2;SOX11;CYP1A1
2600,GO:0005923,0.00717523513771645,0.997998418898284,8,89,bicellular tight junction,CC,CLDN1;EPCAM;CLDN7;CLDN11;TJP2;AMOTL2;DLG1;TJP1
4794,GO:0014003,0.00719032692366548,0.999053995757939,4,26,oligodendrocyte development,BP,CNTNAP1;LYN;EIF2B1;SOX11
8415,GO:0033559,0.00720866986446695,0.998442245996425,6,58,unsaturated fatty acid metabolic process,BP,EDN1;MGLL;FADS1;ANXA1;FADS3;CYP1A1
10540,GO:0043536,0.00735510054982358,0.99869511498414,5,40,positive regulation of blood vessel endothelial cell migration,BP,ANXA1;VEGFC;HMOX1;NRP1;ETS1
7760,GO:0032306,0.00740273798001619,0.999790769135482,2,5,regulation of prostaglandin secretion,BP,EDN1;IL1B
7761,GO:0032308,0.00740273798001619,0.999790769135482,2,5,positive regulation of prostaglandin secretion,BP,EDN1;IL1B
11334,GO:0045736,0.00742918995371955,0.999013321275235,4,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2A;CDKN2B;NR2F2;CDK6
14133,GO:0061061,0.00744457299640599,0.996379033245988,21,380,muscle structure development,BP,KRT8;LGALS1;EDN1;CRYAB;ATF3;ACTG1;G6PD;SLC8A1;XBP1;EGLN1;NRG1;IFRD1;NR2F2;CALR;IGFBP3;SERP1;MAFF;EHD1;MYH9;SOX11;SORBS2
3218,GO:0006887,0.00745340452099199,0.995932886757005,29,595,exocytosis,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;LYN;ANXA1;VEGFC;ARG1;HMOX1;SYT11;RIMS2;HSP90AA1;FTH1;HSP90AB1;ADAM8;STXBP5;MAGT1;SEC22A;MME;DNAJC3;SVIP;CPPED1;TNFAIP2
6580,GO:0022617,0.00746093825466564,0.998379214827034,6,56,extracellular matrix disassembly,BP,MMP9;LCP1;FBN2;MMP19;ADAM8;ETS1
2250,GO:0005178,0.00748701175951921,0.998117488359416,7,73,integrin binding,MF,LCP1;IL1B;SEMA7A;ITGAV;LYN;NRG1;CALR
1094,GO:0002690,0.00749709756014514,0.998659018728266,5,42,positive regulation of leukocyte chemotaxis,BP,CXCL1;EDN1;VEGFC;CALR;IL23A
4630,GO:0010770,0.00751740291927752,0.997685947846157,9,110,positive regulation of cell morphogenesis involved in differentiation,BP,NEFL;DSCAM;SLIT2;SEMA7A;NRP1;NRG1;L1CAM;CALR;HAS2
9382,GO:0035976,0.00755146474553067,0.999784337854208,2,5,transcription factor AP-1 complex,CC,JUN;JUNB
18739,GO:1904292,0.00758828492272146,0.998986012250593,4,26,regulation of ERAD pathway,BP,UBQLN2;HERPUD1;DERL3;SVIP
652,GO:0001846,0.00762003712984585,0.999781349869109,2,5,opsonin binding,MF,ITGAV;CALR
4189,GO:0009314,0.00763402297590921,0.996426226087961,19,337,response to radiation,BP,NETO1;TP53;NABP1;JUN;PARP1;HSPA5;KRT13;JUNB;CRYAB;DUSP1;ANXA1;RHOB;DCUN1D3;PPID;EYA3;HMGCS1;MME;NEDD4;PML
10795,GO:0044322,0.00776019319725679,0.998956311284808,4,26,endoplasmic reticulum quality control compartment,CC,UGGT1;CANX;CALR;SEL1L
3054,GO:0006636,0.00778040013614676,0.998948768740472,4,27,unsaturated fatty acid biosynthetic process,BP,EDN1;FADS1;ANXA1;FADS3
3563,GO:0007623,0.00792983036743979,0.99734985344557,10,133,circadian rhythm,BP,RELB;TP53;JUN;NOCT;GPR176;ARNTL2;SETX;KLF10;PML;MAGED1
13724,GO:0060341,0.00799129205354829,0.995570143337749,30,615,regulation of cellular localization,BP,LCP1;FEZ1;TP53;PMAIP1;PARP1;IL1B;CRYAB;CYLD;STAC;LYN;DERL3;SLC8A1;WWC1;NEDD4L;HMOX1;SYT11;RIMS2;NRG1;HSP90AB1;PRR5L;DLG1;EHD1;REEP1;SVIP;NEDD4;PML;OXCT1;EPHA2;EPB41L2;UGCG
4401,GO:0010212,0.00804043022081904,0.997306748069439,10,134,response to ionizing radiation,BP,TP53;NABP1;PARP1;HSPA5;CRYAB;ANXA1;RHOB;DCUN1D3;EYA3;PML
15349,GO:0071639,0.00809420122903696,0.999760300621162,2,5,positive regulation of monocyte chemotactic protein-1 production,BP,IL1A;IL1B
4371,GO:0010041,0.00810189496925352,0.999759953546607,2,5,response to iron(III) ion,BP,G6PD;CYP1A1
14559,GO:0070160,0.008155646208322,0.997672061354198,8,91,occluding junction,CC,CLDN1;EPCAM;CLDN7;CLDN11;TJP2;AMOTL2;DLG1;TJP1
7476,GO:0031667,0.00816157551661677,0.996240966612772,18,316,response to nutrient levels,BP,TP53;PMAIP1;CDKN2B;JUN;HSPA5;IL1B;ATF3;FADS1;G6PD;SLC8A1;XBP1;ARG1;HMOX1;KLF10;HMGCS1;HSP90B1;OXCT1;CYP1A1
2103,GO:0004904,0.00821661395968056,0.999754757698555,2,5,interferon receptor activity,MF,IFNAR1;IFNGR1
6292,GO:0019955,0.00824483676127128,0.998166986242635,6,58,cytokine binding,MF,TRIM16;IL6ST;ITGAV;NRP1;IFNAR1;IFNGR1
7447,GO:0031625,0.00824666959005599,0.996394118282095,16,270,ubiquitin protein ligase binding,MF,NFKBIA;TP53;JUN;HSPA5;ACTG1;HSPA6;IKBKE;TRIB1;LYN;TRAF3;SYT11;TRAF1;CALR;PRR5L;PML;HSPD1
3207,GO:0006873,0.00829023243867383,0.996086639438149,19,341,cellular ion homeostasis,BP,SAA1;EDN1;TP53;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;HMOX1;FTH1;EGLN1;ACO1;CALR;SLC39A14;HSP90B1;TFRC;PML;ENPP1
15480,GO:0071901,0.00830167576821459,0.997399102754478,9,116,negative regulation of protein serine/threonine kinase activity,BP,CDKN2A;DUSP8;CDKN2B;IL1B;DUSP1;LYN;NR2F2;CHORDC1;CDK6
5618,GO:0016722,0.00832239081618524,0.999291456889932,3,14,oxidoreductase activity, oxidizing metal ions,MF,HEPHL1;FTH1;STEAP4
6192,GO:0019725,0.00832891184534201,0.995519700141207,27,545,cellular homeostasis,BP,LGALS1;SAA1;EDN1;TP53;HERPUD1;C1QTNF1;DNAJC10;ITGAV;LYN;SLC8A1;NEDD4L;XBP1;HMOX1;FTH1;EGLN1;ACO1;CALR;PDIA6;SLC39A14;ORMDL1;PDIA4;TXNRD1;HSP90B1;TFRC;PML;OXCT1;ENPP1
15365,GO:0071670,0.00837634206501695,0.999747458923421,2,5,smooth muscle cell chemotaxis,BP,SLIT2;PARVA
14614,GO:0070245,0.0083791484119361,0.999747330020832,2,5,positive regulation of thymocyte apoptotic process,BP,TP53;ADAM8
2940,GO:0006487,0.0084512721541589,0.99781906829827,7,78,protein N-linked glycosylation,BP,B4GALT1;STT3A;DERL3;UGGT1;MGAT5;MAGT1;DHDDS
14251,GO:0061387,0.00846108266420011,0.997821260451169,7,74,regulation of extent of cell growth,BP,DSCAM;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;L1CAM
8176,GO:0032945,0.00848250471160387,0.998436556293675,5,42,negative regulation of mononuclear cell proliferation,BP,CD274;LYN;ARG1;DLG1;SOX11
12491,GO:0050672,0.00848250471160387,0.998436556293675,5,42,negative regulation of lymphocyte proliferation,BP,CD274;LYN;ARG1;DLG1;SOX11
13864,GO:0060556,0.00852932071578603,0.999740398837526,2,5,regulation of vitamin D biosynthetic process,BP,NFKB1;IL1B
16561,GO:0097433,0.00853323674183679,0.999740217219166,2,5,dense body,CC,ACTG1;SND1
2100,GO:0004896,0.00856607707878098,0.998417375206681,5,42,cytokine receptor activity,MF,IL6ST;IL7R;CXCR5;IFNAR1;IFNGR1
2595,GO:0005913,0.00857034683033858,0.997786352664465,7,75,cell-cell adherens junction,CC,KRT18;LYN;ANXA1;EIF4G2;PVR;MYH9;TJP1
8131,GO:0032881,0.00857536480744202,0.998812834308323,4,26,regulation of polysaccharide metabolic process,BP,NFKB1;PHLDA2;HAS2;ENPP1
821,GO:0002102,0.00858605026542773,0.998810925402299,4,26,podosome,CC,LCP1;ADAM8;TPM4;TJP1
4927,GO:0014910,0.00860387277015383,0.998411400812983,5,41,regulation of smooth muscle cell migration,BP,SLIT2;TRIB1;NRP1;IGFBP3;HAS2
3504,GO:0007492,0.00861944860945181,0.998067383973045,6,57,endoderm development,BP,MMP9;COL12A1;DUSP1;ITGAV;COL8A1;CTR9
8041,GO:0032732,0.00863372234824366,0.998797800970875,4,27,positive regulation of interleukin-1 production,BP,TRIM16;SAA1;RIPK2;NLRP10
11271,GO:0045625,0.00867347112480644,0.999733684240388,2,5,regulation of T-helper 1 cell differentiation,BP,RIPK2;ANXA1
8260,GO:0033089,0.00869475399529313,0.999732687809349,2,5,positive regulation of T cell differentiation in thymus,BP,IL7R;ADAM8
7789,GO:0032364,0.0087344396955744,0.999730826317943,2,5,oxygen homeostasis,BP,EGLN1;SOD2
6872,GO:0030424,0.008830117988401,0.995718516356891,20,360,axon,CC,NEFL;TENM3;DSCAM;NEFM;FEZ1;DPYSL3;CNTNAP1;CRYAB;AP3M1;SYT11;CANX;NRP1;SETX;NRG1;L1CAM;MME;DLG1;ADGRL3;IQCJ-SCHIP1;TUBB3
9300,GO:0035810,0.00883293287602588,0.999726186954419,2,5,positive regulation of urine volume,BP,EDN1;HAS2
18904,GO:1904705,0.00886247987174458,0.998756544017992,4,27,regulation of vascular smooth muscle cell proliferation,BP,MMP9;JUN;HMOX1;HTR1B
19610,GO:1990874,0.00886247987174458,0.998756544017992,4,27,vascular smooth muscle cell proliferation,BP,MMP9;JUN;HMOX1;HTR1B
2646,GO:0006006,0.00886530506142238,0.996985663023733,10,136,glucose metabolic process,BP,PMAIP1;PGK1;C1QTNF1;PHLDA2;ATF3;G6PD;IGFBP3;SERP1;ENPP1;MIDN
14553,GO:0070141,0.0089171227598175,0.999722199416612,2,5,response to UV-A,BP,PPID;MME
2221,GO:0005138,0.00898762909723649,0.999718844508588,2,5,interleukin-6 receptor binding,MF,IL6ST;ERAP1
7811,GO:0032386,0.00899780766565574,0.99581382199825,18,318,regulation of intracellular transport,BP,LCP1;FEZ1;TP53;IL1B;CRYAB;LYN;DERL3;WWC1;HMOX1;RIMS2;NRG1;HSP90AB1;PRR5L;EHD1;REEP1;SVIP;NEDD4;UGCG
20226,GO:2001234,0.00902114264125088,0.996732925621356,11,161,negative regulation of apoptotic signaling pathway,BP,MMP9;IL1A;HERPUD1;IL1B;ITGAV;XBP1;HMOX1;NRP1;SOD2;EYA3;PTTG1IP
6561,GO:0022408,0.00920908872628972,0.997308688778719,8,97,negative regulation of cell-cell adhesion,BP,CD274;EPCAM;C1QTNF1;CYLD;CDSN;ANXA1;ARG1;DLG1
12275,GO:0048662,0.00921012775420015,0.998688622637682,4,28,negative regulation of smooth muscle cell proliferation,BP,TP53;TRIB1;HMOX1;IGFBP3
6680,GO:0030098,0.00929530044948041,0.996285446340135,13,201,lymphocyte differentiation,BP,LGALS1;MAFB;RELB;RIPK2;DNAJB9;AXL;CYLD;CD83;ANXA1;XBP1;IL7R;ADAM8;IL23A
10515,GO:0043500,0.00931284007136081,0.997873131268863,6,59,muscle adaptation,BP,EDN1;PARP1;IL1B;IL6ST;G6PD;HMOX1
6762,GO:0030217,0.00941672825600294,0.996769170550927,10,136,T cell differentiation,BP,MAFB;RELB;RIPK2;CYLD;CD83;ANXA1;XBP1;IL7R;ADAM8;IL23A
2369,GO:0005518,0.0094207124231658,0.998218547169054,5,42,collagen binding,MF,MMP9;CCBE1;C1QTNF1;SERPINH1;NID2
11268,GO:0045622,0.00944196751543594,0.999148077658967,3,15,regulation of T-helper cell differentiation,BP,RIPK2;ANXA1;IL23A
6258,GO:0019871,0.00945311367980803,0.999696344876151,2,5,sodium channel inhibitor activity,MF,NEDD4L;NEDD4
13518,GO:0060022,0.00947039587978474,0.999695497906894,2,5,hard palate development,BP,DLG1;SOX11
2256,GO:0005200,0.00950491990791152,0.997491559470594,7,78,structural constituent of cytoskeleton,MF,NEFL;KRT2;NEFM;ACTG1;TUBB3;EPB41L2;SORBS2
18643,GO:1904030,0.00954389420179968,0.998626946450926,4,28,negative regulation of cyclin-dependent protein kinase activity,BP,CDKN2A;CDKN2B;NR2F2;CDK6
10847,GO:0044419,0.00954394496271021,0.994484845875629,33,723,interspecies interaction between organisms,BP,NFKBIA;KRT8;LGALS1;TNIP1;KRT18;TP53;PSMB9;CLDN1;RNASE7;JUN;IL16;ANPEP;IL6ST;AXL;IFITM2;ITGAV;LYN;NEDD4L;ARG1;HSP90AB1;PPID;UBP1;DLG1;SUGT1;CBLL1;ZC3H7B;TFRC;NEDD4;PML;EPHA2;PVR;HSPD1;SND1
4696,GO:0010876,0.00956563327912894,0.996013577997603,14,223,lipid localization,BP,NFKBIA;NFKB1;EDN1;SPNS2;APOL6;IL1B;C1QTNF1;IKBKE;STOML1;ITGAV;ANXA1;ANO4;EHD1;ENPP1
15160,GO:0071347,0.00967280451219507,0.996889328216334,9,122,cellular response to interleukin-1,BP,NFKBIA;IL1A;NFKB1;EDN1;PSMB9;RIPK2;IL1B;HAS2;IRAK2
5424,GO:0016310,0.00967442839199471,0.993471884863719,66,1636,phosphorylation,BP,CDKN2A;MMP9;IL1A;NEFL;DSCAM;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;PSMB9;FGF5;DBNDD2;NAGK;SLIT2;CDKN2B;PGK1;JUN;RIPK2;HSPA5;IL1B;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;SEMA7A;DUSP1;TRIB1;ITGAV;LYN;NBN;WWC1;VEGFC;PAPSS2;IL24;HSP90AA1;NRP1;SETX;GNPTAB;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;PRR5L;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;PML;EPHA2;BTBD10;ENPP1;MAGED1;MIDN;IRAK2
8598,GO:0034142,0.00970664461866216,0.999115232559093,3,15,toll-like receptor 4 signaling pathway,BP,NFKBIA;RIPK2;LYN
6905,GO:0030517,0.0097105577836147,0.998600826518335,4,27,negative regulation of axon extension,BP,SEMA7A;SEMA3D;NRP1;IFRD1
4588,GO:0010721,0.00972821929720871,0.996090490430397,13,200,negative regulation of cell development,BP,LGALS1;DPYSL3;SLIT2;TJP2;SEMA7A;G6PD;SEMA3D;NRP1;NRG1;IFRD1;CALR;CORO1C;SOX11
4605,GO:0010743,0.00973073962257324,0.99911222547734,3,15,regulation of macrophage derived foam cell differentiation,BP,NFKBIA;NFKB1;ITGAV
18405,GO:1903531,0.009747841001098,0.997121767360837,8,98,negative regulation of secretion by cell,BP,EDN1;IL1B;ANXA1;HMOX1;SYT11;HTR1B;PML;MIDN
12336,GO:0048762,0.00981211809457383,0.99661268681655,10,136,mesenchymal cell differentiation,BP,EDN1;IL1B;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;HAS2;BAMBI;SOX11
6452,GO:0021800,0.00982575038078511,0.999677900580367,2,5,cerebral cortex tangential migration,BP,SLIT2;NRP1
686,GO:0001910,0.00983930520177615,0.998567171676455,4,29,regulation of leukocyte mediated cytotoxicity,BP,ARG1;IL7R;IL23A;PVR
9248,GO:0035710,0.00984933250385112,0.99811401985667,5,43,CD4-positive, alpha-beta T cell activation,BP,RELB;RIPK2;CD83;ANXA1;IL23A
1112,GO:0002708,0.00987855702141386,0.998104146481744,5,44,positive regulation of lymphocyte mediated immunity,BP,IL1B;IL23A;TFRC;PVR;HSPD1
8676,GO:0034341,0.00992981114150326,0.996793994749688,9,121,response to interferon-gamma,BP,EDN1;CXCL16;CLDN1;ACTG1;IFITM2;ARG1;HSP90AB1;IFNGR1;PML
5883,GO:0018108,0.00993623442465055,0.99583929447517,14,225,peptidyl-tyrosine phosphorylation,BP,TP53;FGF5;RIPK2;IL6ST;AXL;LYN;VEGFC;IL24;HSP90AA1;NRP1;NRG1;IL23A;TGFA;EPHA2
498,GO:0001554,0.0099693840820926,0.999670689988219,2,5,luteolysis,BP,SLIT2;MMP19
11767,GO:0046685,0.00997040691518288,0.998542464093919,4,29,response to arsenic-containing substance,BP,NEFL;ATF3;HMOX1;CYP1A1
16042,GO:0090050,0.00997490539176502,0.999081594848969,3,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,ANXA1;HMOX1;NRP1
1149,GO:0002764,0.00998156842324394,0.995198667275383,19,349,immune response-regulating signaling pathway,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;JUN;RIPK2;ACTG1;IKBKE;CYLD;LYN;BIRC3;TRAF3;HSP90AA1;HSP90AB1;EIF2B1;HSP90B1;HSPD1;IRAK2
677,GO:0001891,0.00998393977726301,0.999080455978863,3,15,phagocytic cup,CC,LCP1;ANXA1;SYT11
13459,GO:0055065,0.0100017857303515,0.995294715365467,18,322,metal ion homeostasis,BP,SAA1;EDN1;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;HMOX1;FTH1;EGLN1;ACO1;STEAP4;CALR;SLC39A14;HSP90B1;TFRC;PML
18359,GO:1903428,0.0100206253397735,0.998537720587875,4,28,positive regulation of reactive oxygen species biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
12320,GO:0048732,0.010024871895798,0.995397974966905,17,294,gland development,BP,NFKBIA;MAFB;B4GALT1;CLDN1;JUN;ANXA1;XBP1;ARG1;HMOX1;NRP1;NRG1;HMGCS1;CITED2;ETS1;PML;EPHA2;CYP1A1
1142,GO:0002757,0.010060183443311,0.995263648391034,18,325,immune response-activating signal transduction,BP,NFKBIA;TNIP1;NFKB1;RELB;PSMB9;RIPK2;ACTG1;IKBKE;CYLD;LYN;BIRC3;TRAF3;HSP90AA1;HSP90AB1;EIF2B1;HSP90B1;HSPD1;IRAK2
8203,GO:0032989,0.0102424551840628,0.993957289050407,35,744,cellular component morphogenesis,BP,NEFL;KRT8;TENM3;DSCAM;FEZ1;EDN1;SLIT2;CNTNAP1;AXL;ACTG1;SEMA7A;ITGAV;ANXA1;NEDD4L;RHOB;SEMA3D;RIMS2;NRP1;IL7R;NRG1;IFRD1;ADAM8;L1CAM;CALR;CORO1C;DLG1;ZMYM4;HAS2;BAMBI;NEDD4;TUBB3;NTNG1;EPHA2;MYH9;PARVA
14837,GO:0070664,0.0102457878603767,0.998015953956358,5,44,negative regulation of leukocyte proliferation,BP,CD274;LYN;ARG1;DLG1;SOX11
17351,GO:1900120,0.0103818408538745,0.999020193352289,3,16,regulation of receptor binding,BP,MMP9;PHLDA2;NRP1
12577,GO:0050801,0.0104553801256243,0.994655802097146,22,423,ion homeostasis,BP,SAA1;EDN1;TP53;HERPUD1;PARP1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;XBP1;HMOX1;FTH1;EGLN1;ACO1;STEAP4;CALR;SLC39A14;HSP90B1;TFRC;PML;ENPP1
8038,GO:0032729,0.0104768605538265,0.99844609985626,4,29,positive regulation of interferon-gamma production,BP,RIPK2;IL1B;IL23A;HSPD1
11024,GO:0045055,0.0106478489949768,0.994299291674577,25,507,regulated exocytosis,BP,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;HRNR;ANPEP;HSPA6;ITGAV;LYN;VEGFC;ARG1;HMOX1;SYT11;RIMS2;HSP90AA1;FTH1;HSP90AB1;ADAM8;MAGT1;MME;DNAJC3;SVIP;CPPED1
6710,GO:0030141,0.0106781225578987,0.99420719439016,26,536,secretory granule,CC,MMP9;FLG2;KRT1;CXCL1;NFKB1;B4GALT1;EDN1;HRNR;IL1B;ANPEP;HSPA6;ITGAV;VEGFC;ARG1;KLK6;HSP90AA1;FTH1;HSP90AB1;ADAM8;CALR;MAGT1;MME;DNAJC3;SVIP;CPPED1;HSPD1
4645,GO:0010811,0.0107472045155367,0.99709594391974,7,78,positive regulation of cell-substrate adhesion,BP,COL8A1;PLEKHA2;VEGFC;NRP1;CALR;HAS2;CDK6
16363,GO:0097028,0.011018813183343,0.998936937934865,3,16,dendritic cell differentiation,BP,RELB;AXL;LYN
5915,GO:0018212,0.0110418117734651,0.995315467644887,14,228,peptidyl-tyrosine modification,BP,TP53;FGF5;RIPK2;IL6ST;AXL;LYN;VEGFC;IL24;HSP90AA1;NRP1;NRG1;IL23A;TGFA;EPHA2
14118,GO:0061041,0.0110997854408237,0.996978651175995,7,80,regulation of wound healing,BP,KRT1;SERPINB2;EDN1;C1QTNF1;LYN;ANXA1;XBP1
5992,GO:0019058,0.0113037659222261,0.995027727201036,15,254,viral life cycle,BP,LGALS1;TNIP1;CLDN1;ANPEP;AXL;IFITM2;ITGAV;NEDD4L;HSP90AB1;PPID;UBP1;TFRC;PML;EPHA2;PVR
17353,GO:1900122,0.0114688080154459,0.999557115556381,2,6,positive regulation of receptor binding,BP,MMP9;NRP1
7763,GO:0032310,0.0115140771794294,0.99955444448472,2,6,prostaglandin secretion,BP,EDN1;IL1B
20067,GO:2000778,0.0115616879979228,0.998864516296727,3,16,positive regulation of interleukin-6 secretion,BP,IL1B;XBP1;NLRP10
3211,GO:0006879,0.0116106274018145,0.997674629325594,5,46,cellular iron ion homeostasis,BP,HMOX1;FTH1;EGLN1;ACO1;TFRC
7869,GO:0032459,0.0116624562605913,0.998209686422268,4,30,regulation of protein oligomerization,BP,TP53;PMAIP1;CLDN7;CRYAB
4929,GO:0014912,0.0116922502518005,0.998846902068558,3,16,negative regulation of smooth muscle cell migration,BP,SLIT2;TRIB1;IGFBP3
6743,GO:0030195,0.0117030639551461,0.998201616650422,4,30,negative regulation of blood coagulation,BP,KRT1;SERPINB2;EDN1;C1QTNF1
17316,GO:1900047,0.0117030639551461,0.998201616650422,4,30,negative regulation of hemostasis,BP,KRT1;SERPINB2;EDN1;C1QTNF1
898,GO:0002286,0.0117344906508836,0.99764688052662,5,45,T cell activation involved in immune response,BP,LCP1;RELB;RIPK2;ANXA1;IL23A
629,GO:0001822,0.0118089040879262,0.995335183104089,12,182,kidney development,BP,OSR2;SLIT2;EPCAM;GREB1L;COL4A4;FRAS1;NRP1;MME;DLG1;HAS2;SOX11;MAGED1
2921,GO:0006458,0.0118193668151687,0.997622354509693,5,46,'de novo' protein folding,BP,DNAJB1;HSPA5;HSPA6;UGGT1;HSPD1
2391,GO:0005575,0.0119390038837224,0.996396754393765,361,11676,cellular_component,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;ASPRV1;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;HS3ST1;SPRR2E;MYO1B;DNAJB1;GREB1L;SPRR2D;PEG10;CCBE1;JUN;KRT4;CLDN11;MCAM;FAM173B;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;CNTNAP1;ANPEP;JUNB;EFHD2;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;TMEM265;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;CD83;STT3A;ITGAV;LYN;NCEH1;COBLL1;AP3M1;COL8A1;C1R;ANXA1;PDE1C;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SEMA3D;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;MMP19;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;UBTD2;KCTD12;HEPHL1;IL24;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SLC7A5P2;SNAI3;GGCX;ADAM8;C2ORF49;L1CAM;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;MOB3A;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;ADGRL3;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;CHORDC1;TGFA;MGST3;IQCJ-SCHIP1;BAMBI;SUGT1;FOCAD;PRPF38A;DNAJC3;CBLL1;RSPRY1;BCAT1;ZC3H7B;IFNGR1;ANKRD13A;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;CCDC167;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA;TMPPE
12853,GO:0051234,0.0119894394385474,0.991141107571025,124,3423,establishment of localization,BP,NFKBIA;MMP9;IL1A;FLG2;TRIM16;KRT1;NEFL;NETO1;CXCL1;SAA1;LCP1;KRT18;NFKB1;B4GALT1;FEZ1;EDN1;TP53;CXCL16;PMAIP1;PSMB9;CD274;CLDN1;UBQLN2;SLC16A9;MYO1B;RIPK2;IL16;SPNS2;HERPUD1;APOL6;OPTN;HRNR;HSPA5;IL1B;IFT46;ANPEP;C1QTNF1;TJP2;CRYAB;AXL;ACTG1;HSPA6;STOML1;NFKBIE;STAC;ANXA8;ITGAV;LYN;AP3M1;ANXA1;DERL3;G6PD;SLC8A1;WWC1;NEDD4L;VEGFC;RHOB;XBP1;MOBP;ARG1;HMOX1;SYT11;FRAS1;HEPHL1;RIMS2;HSP90AA1;CANX;FTH1;NRP1;KCNQ5;GNPTAB;NRG1;ACO1;HSP90AB1;SLC7A5P2;ADAM8;CLCC1;STXBP5;STEAP4;CALR;PDIA6;PPID;ANO4;SEL1L;SLC39A14;SLC35B1;SERP1;MAGT1;PRR5L;RAB30;SEC22A;GIT2;CORO1C;MME;DLG1;PDIA4;EHD1;PTTG1IP;HAS2;SEC24D;REEP1;TGFA;DNAJC3;CBLL1;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;SOX11;UGCG;CPPED1;ENPP1;CLINT1;TNFAIP2;CEP83;HSPD1;MIDN
6741,GO:0030193,0.0120154814480931,0.997573022887991,5,46,regulation of blood coagulation,BP,KRT1;SERPINB2;EDN1;C1QTNF1;LYN
17315,GO:1900046,0.0120154814480931,0.997573022887991,5,46,regulation of hemostasis,BP,KRT1;SERPINB2;EDN1;C1QTNF1;LYN
6961,GO:0030656,0.0120253108033379,0.999523890776304,2,6,regulation of vitamin metabolic process,BP,NFKB1;IL1B
562,GO:0001704,0.0120670222339822,0.996663512688452,7,79,formation of primary germ layer,BP,MMP9;COL12A1;DUSP1;ITGAV;COL8A1;CTR9;TXNRD1
7478,GO:0031669,0.0121114340421014,0.995424726379434,11,164,cellular response to nutrient levels,BP,TP53;PMAIP1;CDKN2B;JUN;HSPA5;ATF3;FADS1;XBP1;HMOX1;KLF10;HSP90B1
12555,GO:0050771,0.0121138383786813,0.997555097324168,5,44,negative regulation of axonogenesis,BP,SLIT2;SEMA7A;SEMA3D;NRP1;IFRD1
950,GO:0002377,0.0121339749532795,0.997056433116772,6,63,immunoglobulin production,BP,DNAJB9;NBN;XBP1;IL7R;TFRC;HSPD1
790,GO:0002064,0.0121434639792565,0.995666787728637,10,140,epithelial cell development,BP,KRT2;B4GALT1;CLDN1;IL1B;TJP2;CDSN;XBP1;CDK6;EPHA2;TJP1
9947,GO:0042368,0.0121511461302184,0.999516261622022,2,6,vitamin D biosynthetic process,BP,NFKB1;IL1B
13232,GO:0051960,0.0121515828815643,0.993258786851445,27,545,regulation of nervous system development,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;DPYSL3;SLIT2;SDK1;HSPA5;IL6ST;SEMA7A;LYN;NEDD4L;VEGFC;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CALR;DLG1;ADGRL3;NEDD4;SOX11
875,GO:0002246,0.0121761635179789,0.999514739791131,2,6,wound healing involved in inflammatory response,BP,IL1A;HMOX1
11063,GO:0045109,0.012208640640005,0.998776502433672,3,16,intermediate filament organization,BP,NEFL;KRT2;NEFM
7637,GO:0032088,0.0123300925458381,0.996996128300739,6,64,negative regulation of NF-kappaB transcription factor activity,BP,CDKN2A;NFKBIA;CYLD;TRAF3;NLRP10;IRAK2
13043,GO:0051591,0.0123394042176668,0.996998047841814,6,62,response to cAMP,BP,JUN;HSPA5;JUNB;DUSP1;SLC8A1;MMP19
11046,GO:0045080,0.012381703115,0.999502173168406,2,6,positive regulation of chemokine biosynthetic process,BP,IL1B;HMOX1
4476,GO:0010519,0.0123833234296676,0.999502073654617,2,6,negative regulation of phospholipase activity,BP,ANXA8;ANXA1
15232,GO:0071453,0.0124394484313953,0.995279239422888,11,169,cellular response to oxygen levels,BP,EDN1;TP53;PMAIP1;PSMB9;PGK1;SLC8A1;HMOX1;EGLN1;ADAM8;AJUBA;CITED2
10833,GO:0044389,0.0124854198786004,0.994277668377697,16,283,ubiquitin-like protein ligase binding,MF,NFKBIA;TP53;JUN;HSPA5;ACTG1;HSPA6;IKBKE;TRIB1;LYN;TRAF3;SYT11;TRAF1;CALR;PRR5L;PML;HSPD1
8232,GO:0033034,0.0124995655224108,0.999494916261379,2,6,positive regulation of myeloid cell apoptotic process,BP,CDKN2A;ANXA1
4489,GO:0010557,0.0125308794704228,0.991792090594029,52,1242,positive regulation of macromolecule biosynthetic process,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;WWC1;XBP1;ARNTL2;HMOX1;HSP90AA1;EGLN1;SETX;KLF10;NRG1;HSP90AB1;NR2F2;UQCC1;CALR;EDRF1;CTR9;SERP1;MAFF;IL23A;RBMS3;CITED2;ETS1;HAS2;BAMBI;DNAJC3;SVIP;PML;SOX11;MAGED1;SUPT3H
11742,GO:0046637,0.0125321864731823,0.998035005274302,4,30,regulation of alpha-beta T cell differentiation,BP,RIPK2;CD83;ANXA1;IL23A
12814,GO:0051172,0.012553293535379,0.99133202210089,70,1777,negative regulation of nitrogen compound metabolic process,BP,CDKN2A;MMP9;SERPINB2;OSR2;TNIP1;DUSP8;NFKB1;RELB;EDN1;TP53;DBNDD2;SLIT2;CHAC1;CDKN2B;DNAJB1;JUN;NFKB2;HERPUD1;PARP1;IL1B;JUNB;CRYAB;ATF3;DNAJC10;GADD45B;NOCT;DUSP1;ANXA8;TRIB1;ITGAV;LYN;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;SUDS3;EGLN1;KLF10;NRG1;SERPINH1;HSP90AB1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;IGFBP3;ORMDL1;PRR5L;UBP1;CORO1C;DLG1;CITED2;ZNF814;CHORDC1;DNAJC3;ZC3H7B;SVIP;NEDD4;CDK6;PML;ZBTB21;SOX11;ENPP1;MAGED1
7299,GO:0031328,0.0125668633961211,0.991706486854371,54,1300,positive regulation of cellular biosynthetic process,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;ANXA1;WWC1;XBP1;ARNTL2;HMOX1;HSP90AA1;EGLN1;SETX;KLF10;NRG1;HSP90AB1;NR2F2;UQCC1;CALR;EDRF1;CTR9;AJUBA;SERP1;MAFF;IL23A;RBMS3;CITED2;ETS1;HAS2;BAMBI;DNAJC3;SVIP;PML;SOX11;MAGED1;SUPT3H
13597,GO:0060137,0.0125770003056854,0.999490128445744,2,6,maternal process involved in parturition,BP,EDN1;CYP1A1
642,GO:0001836,0.0126553908741382,0.997400881630641,5,49,release of cytochrome c from mitochondria,BP,MMP9;TP53;PMAIP1;JUN;SOD2
11397,GO:0045859,0.0126830798985284,0.992858222763473,28,585,regulation of protein kinase activity,BP,CDKN2A;SAA1;DUSP8;EDN1;DBNDD2;CDKN2B;RIPK2;HSPA5;IL1B;GADD45B;DUSP1;TRIB1;LYN;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;CORO1C;IL23A;DLG1;CHORDC1;TGFA;DNAJC3;CDK6;MAGED1;IRAK2
20234,GO:2001242,0.0126908770630175,0.995729500033494,9,127,regulation of intrinsic apoptotic signaling pathway,BP,MMP9;TP53;PMAIP1;HERPUD1;PARP1;CYLD;XBP1;SOD2;PTTG1IP
4644,GO:0010810,0.0126941557809986,0.995439499490397,10,140,regulation of cell-substrate adhesion,BP,CDKN2A;LGALS1;COL8A1;PLEKHA2;VEGFC;NRP1;CALR;CORO1C;HAS2;CDK6
541,GO:0001660,0.012714981072519,0.99948155773921,2,6,fever generation,BP,IL1A;IL1B
2330,GO:0005381,0.012718388842103,0.999481345429088,2,6,iron ion transmembrane transporter activity,MF,SLC39A14;TFRC
1030,GO:0002548,0.012719038887308,0.99869463980231,3,17,monocyte chemotaxis,BP,SLIT2;LYN;ANXA1
8996,GO:0035234,0.0127264698071116,0.999480841848261,2,6,ectopic germ cell programmed cell death,BP,IL1A;IL1B
12551,GO:0050767,0.012778852182387,0.993051478468037,25,497,regulation of neurogenesis,BP,NEFL;TENM3;LGALS1;DSCAM;FEZ1;DPYSL3;SLIT2;SDK1;HSPA5;IL6ST;SEMA7A;LYN;NEDD4L;VEGFC;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CALR;NEDD4;SOX11
9831,GO:0042113,0.012893750629745,0.995353957699433,10,143,B cell activation,BP,LGALS1;DNAJB9;CYLD;LYN;NBN;XBP1;IL7R;CXCR5;TFRC;HSPD1
11052,GO:0045086,0.0129009799980696,0.99946992502371,2,6,positive regulation of interleukin-2 biosynthetic process,BP,IL1A;IL1B
14119,GO:0061042,0.0129085561415863,0.999469449273637,2,6,vascular wound healing,BP,MCAM;XBP1
19172,GO:1905323,0.0129588968594616,0.99946628427246,2,6,telomerase holoenzyme complex assembly,BP,HSP90AA1;HSP90AB1
688,GO:0001912,0.0129687457527617,0.998659349786322,3,17,positive regulation of leukocyte mediated cytotoxicity,BP,ARG1;IL23A;PVR
14020,GO:0060839,0.0129852273077238,0.999464626196071,2,6,endothelial cell fate commitment,BP,NRP1;NR2F2
12786,GO:0051131,0.0130521987032162,0.998647497259758,3,17,chaperone-mediated protein complex assembly,BP,HSP90AA1;HSP90AB1;HSPD1
7999,GO:0032655,0.0130620849202584,0.997920999862091,4,31,regulation of interleukin-12 production,BP,NFKB1;RIPK2;IL23A;HSPD1
18790,GO:1904415,0.0130959606203129,0.999457633316092,2,6,regulation of xenophagy,BP,RIPK2;OPTN
18791,GO:1904417,0.0130959606203129,0.999457633316092,2,6,positive regulation of xenophagy,BP,RIPK2;OPTN
1180,GO:0002834,0.0131254717042799,0.999455764282256,2,6,regulation of response to tumor cell,BP,PVR;HSPD1
1183,GO:0002837,0.0131254717042799,0.999455764282256,2,6,regulation of immune response to tumor cell,BP,PVR;HSPD1
6729,GO:0030168,0.0131267755043308,0.995909380251964,8,102,platelet activation,BP,SAA1;C1QTNF1;AXL;ACTG1;LYN;RHOB;CSRP1;MYH9
11900,GO:0046983,0.0131440042642434,0.991989389654726,37,850,protein dimerization activity,MF,NEFL;TENM3;LGALS1;NFKB1;MAFB;TP53;SLIT2;JUN;RIPK2;IL6ST;CRYAB;ATF3;AXL;MGLL;CDSN;ANXA1;G6PD;XBP1;ARNTL2;HMOX1;SYT11;HSP90AA1;HSP90AB1;NR2F2;ANO4;MGA;HMGCS1;TFRC;PML;OXCT1;PVR;MYH9;HES4;ENPP1;TPM4;SUPT3H;IRAK2
12536,GO:0050730,0.0131919331291499,0.995228011712802,10,145,regulation of peptidyl-tyrosine phosphorylation,BP,TP53;RIPK2;IL6ST;LYN;VEGFC;IL24;NRP1;NRG1;IL23A;TGFA
13463,GO:0055072,0.0132131113123793,0.996729775607593,6,65,iron ion homeostasis,BP,HMOX1;FTH1;EGLN1;ACO1;STEAP4;TFRC
10839,GO:0044403,0.0132480370573505,0.992220350184129,32,712,symbiont process,BP,NFKBIA;KRT8;LGALS1;TNIP1;KRT18;TP53;PSMB9;CLDN1;JUN;IL16;ANPEP;IL6ST;AXL;IFITM2;ITGAV;LYN;NEDD4L;ARG1;HSP90AB1;PPID;UBP1;DLG1;SUGT1;CBLL1;ZC3H7B;TFRC;NEDD4;PML;EPHA2;PVR;HSPD1;SND1
9601,GO:0036499,0.0132964889309833,0.998612634592172,3,17,PERK-mediated unfolded protein response,BP,HERPUD1;HSPA5;ATF3
14529,GO:0070099,0.013331854251848,0.999442630231404,2,6,regulation of chemokine-mediated signaling pathway,BP,EDN1;SLIT2
6635,GO:0030003,0.0133622296084278,0.993516624843992,18,333,cellular cation homeostasis,BP,SAA1;EDN1;TP53;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;HMOX1;FTH1;EGLN1;ACO1;CALR;SLC39A14;HSP90B1;TFRC;PML
3259,GO:0006953,0.0133729380059816,0.998601673691779,3,17,acute-phase response,BP,IL1A;SAA1;IL1B
10539,GO:0043535,0.0135022919200513,0.996644851016887,6,64,regulation of blood vessel endothelial cell migration,BP,ANXA1;VEGFC;HMOX1;NRP1;ETS1;EPHA2
12554,GO:0050770,0.0135250335052298,0.995408840284374,9,120,regulation of axonogenesis,BP,NEFL;DSCAM;SLIT2;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;L1CAM
11064,GO:0045110,0.0135313892002679,0.999429827351879,2,6,intermediate filament bundle assembly,BP,NEFL;NEFM
12750,GO:0051084,0.0135836209731721,0.997812814584529,4,31,'de novo' posttranslational protein folding,BP,DNAJB1;HSPA5;HSPA6;UGGT1
13018,GO:0051549,0.0136119432965894,0.999424629720171,2,6,positive regulation of keratinocyte migration,BP,MMP9;HAS2
17354,GO:1900125,0.0136125606072801,0.99942458982493,2,6,regulation of hyaluronan biosynthetic process,BP,NFKB1;HAS2
4214,GO:0009409,0.0137541682539941,0.997777156175642,4,31,response to cold,BP,NFKBIA;HSP90AA1;DNAJC3;HSPD1
10859,GO:0044433,0.0137848379190285,0.991226100601359,44,1036,cytoplasmic vesicle part,CC,MMP9;FLG2;KRT1;CXCL1;SAA1;NFKB1;B4GALT1;DBNDD2;MYO1B;OPTN;HRNR;ANPEP;HSPA6;IKBKE;STOML1;ANXA8;ITGAV;AP3M1;ANXA1;VEGFC;RHOB;ARG1;SYT11;HSP90AA1;FTH1;IL7R;HSP90AB1;ADAM8;STXBP5;STEAP4;CALR;MAGT1;MME;EHD1;SEC24D;TGFA;DNAJC3;HSP90B1;TFRC;SVIP;PML;MON1A;CPPED1;IRAK2
9011,GO:0035254,0.0138653822465524,0.997759997299729,4,30,glutamate receptor binding,MF,NETO1;CANX;DLG1;NEDD4
7762,GO:0032309,0.0140429626840682,0.998504585710884,3,17,icosanoid secretion,BP,EDN1;IL1B;ANXA1
10018,GO:0042531,0.014099900967065,0.99769856834886,4,32,positive regulation of tyrosine phosphorylation of STAT protein,BP,IL6ST;LYN;IL24;IL23A
11208,GO:0045428,0.0141499392923601,0.997693883084129,4,31,regulation of nitric oxide biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
430,GO:0001158,0.0142234703719826,0.996422558335237,6,65,enhancer sequence-specific DNA binding,MF,NFKB1;JUN;ARID3B;XBP1;ZFP42;SOX11
12570,GO:0050790,0.0142445419640573,0.990241204068846,64,1607,regulation of catalytic activity,BP,CDKN2A;MMP9;SERPINB2;CXCL1;SAA1;DUSP8;NFKB1;EDN1;TP53;PMAIP1;PSMB9;DBNDD2;SLIT2;CDKN2B;DNAJB1;JUN;RIPK2;HERPUD1;PARP1;HSPA5;IL1B;CRYAB;AXL;DNAJC10;GADD45B;DUSP1;ANXA8;TRIB1;LYN;ANXA1;NBN;BIRC3;HSP90AA1;NRP1;EGLN1;DCUN1D3;TNFSF15;NRG1;SERPINH1;HSP90AB1;ADAM8;STXBP5;NR2F2;AJUBA;IGFBP3;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;CHORDC1;TGFA;SUGT1;DNAJC3;HSP90B1;UBXN2B;CDK6;PML;EPHA2;TOR1AIP1;HSPD1;MAGED1;MIDN;IRAK2
10469,GO:0043405,0.0143393153829466,0.99351047522353,15,259,regulation of MAP kinase activity,BP,SAA1;DUSP8;EDN1;RIPK2;IL1B;GADD45B;DUSP1;TRIB1;LYN;NRG1;ADAM8;AJUBA;TGFA;MAGED1;IRAK2
12592,GO:0050819,0.0143566807578315,0.997644077830028,4,32,negative regulation of coagulation,BP,KRT1;SERPINB2;EDN1;C1QTNF1
12364,GO:0048842,0.0144257346057097,0.999371196224718,2,6,positive regulation of axon extension involved in axon guidance,BP,DSCAM;NRP1
18038,GO:1902669,0.0144257346057097,0.999371196224718,2,6,positive regulation of axon guidance,BP,DSCAM;NRP1
1148,GO:0002763,0.0144292504123592,0.997634678354529,4,31,positive regulation of myeloid leukocyte differentiation,BP,JUN;TRIB1;KLF10;IL23A
884,GO:0002262,0.0144624372807256,0.995411387555873,8,104,myeloid cell homeostasis,BP,MAFB;AXL;LYN;ANXA1;G6PD;HMOX1;ETS1;CDK6
10432,GO:0043325,0.014518936768325,0.998434518547243,3,17,phosphatidylinositol-3,4-bisphosphate binding,MF,ANXA8;PLEKHA2;DAPP1
1243,GO:0003008,0.0145204457886864,0.991149955500477,36,802,system process,BP,NEFL;NETO1;EDN1;SLIT2;CCBE1;JUN;MCAM;PARP1;IL1B;CNTNAP1;ANPEP;C1QTNF1;TJP2;IL6ST;CRYAB;MGLL;ERAP1;STAC;G6PD;NBN;SLC8A1;NEDD4L;VEGFC;HMOX1;SOD2;NRG1;ACO1;NR2F2;EYA3;MAGT1;MME;DLG1;HAS2;HTR1B;SORBS2;TPM4
7795,GO:0032370,0.0145894783383519,0.997594415409489,4,32,positive regulation of lipid transport,BP,NFKBIA;EDN1;IL1B;C1QTNF1
8483,GO:0033687,0.0146094556509117,0.998421091940689,3,17,osteoblast proliferation,BP,OSR2;JUNB;ITGAV
16757,GO:0098642,0.0146118368048421,0.999358742832647,2,6,network-forming collagen trimer,CC,COL8A1;COL4A4
16760,GO:0098645,0.0146118368048421,0.999358742832647,2,6,collagen network,CC,COL8A1;COL4A4
16764,GO:0098651,0.0146118368048421,0.999358742832647,2,6,basement membrane collagen trimer,CC,COL8A1;COL4A4
7974,GO:0032615,0.0146145280466374,0.997589056898555,4,32,interleukin-12 production,BP,NFKB1;RIPK2;IL23A;HSPD1
15099,GO:0071236,0.0147119081699163,0.995316390421734,8,105,cellular response to antibiotic,BP,TP53;HSPA5;AXL;ANXA1;RHOB;ARG1;SETX;ETS1
16811,GO:0098771,0.0147368309510005,0.992477785870878,20,386,inorganic ion homeostasis,BP,SAA1;EDN1;TP53;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;HMOX1;FTH1;EGLN1;ACO1;STEAP4;CALR;SLC39A14;HSP90B1;TFRC;PML;ENPP1
10758,GO:0044262,0.0148075855615935,0.993961394927347,12,190,cellular carbohydrate metabolic process,BP,B4GALT1;PMAIP1;NAGK;C1QTNF1;IL6ST;PHLDA2;GNPTAB;IGFBP3;HAS2;GBE1;ENPP1;MIDN
8043,GO:0032735,0.0148661548215708,0.998370728130133,3,18,positive regulation of interleukin-12 production,BP,RIPK2;IL23A;HSPD1
4631,GO:0010771,0.0148774734377723,0.996223736053635,6,64,negative regulation of cell morphogenesis involved in differentiation,BP,SLIT2;SEMA7A;SEMA3D;NRP1;IFRD1;CORO1C
17485,GO:1901016,0.0148875097768532,0.997536774327874,4,31,regulation of potassium ion transmembrane transporter activity,BP,NETO1;NEDD4L;DLG1;NEDD4
9653,GO:0038061,0.0151346086648718,0.995149932756177,8,110,NIK/NF-kappaB signaling,BP,NFKB1;RELB;PSMB9;NFKB2;IKBKE;BIRC3;TNFSF15;CALR
4322,GO:0009891,0.0151760330579006,0.989873403312738,54,1314,positive regulation of biosynthetic process,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;ANXA1;WWC1;XBP1;ARNTL2;HMOX1;HSP90AA1;EGLN1;SETX;KLF10;NRG1;HSP90AB1;NR2F2;UQCC1;CALR;EDRF1;CTR9;AJUBA;SERP1;MAFF;IL23A;RBMS3;CITED2;ETS1;HAS2;BAMBI;DNAJC3;SVIP;PML;SOX11;MAGED1;SUPT3H
8034,GO:0032722,0.0151839638377953,0.997466485119781,4,32,positive regulation of chemokine production,BP,IL1A;RIPK2;IL1B;HMOX1
4463,GO:0010498,0.0151843279139788,0.992087130231986,21,416,proteasomal protein catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;TRIB1;DERL3;NEDD4L;XBP1;UGGT1;HSP90AB1;SEL1L;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SDF2L1
18906,GO:1904707,0.0151999050629115,0.998332726639412,3,17,positive regulation of vascular smooth muscle cell proliferation,BP,MMP9;JUN;HTR1B
12591,GO:0050818,0.0154058838621614,0.99667655553798,5,49,regulation of coagulation,BP,KRT1;SERPINB2;EDN1;C1QTNF1;LYN
13776,GO:0060411,0.015445775902205,0.996673825384582,5,47,cardiac septum morphogenesis,BP,NRP1;EGLN1;CITED2;SOX11;PARVA
13431,GO:0055007,0.0156279017560116,0.995987123302495,6,65,cardiac muscle cell differentiation,BP,EDN1;G6PD;SLC8A1;NRG1;CALR;SORBS2
628,GO:0001821,0.0156454998276043,0.999249373691921,2,7,histamine secretion,BP,EDN1;LYN
11436,GO:0045927,0.0156684079088268,0.993851953946909,11,169,positive regulation of growth,BP,DSCAM;EDN1;CXCL16;SEMA7A;NEDD4L;RIMS2;NRP1;NRG1;L1CAM;EIF4G2;SERP1
12672,GO:0050930,0.0157513533316528,0.999241588658369,2,7,induction of positive chemotaxis,BP,IL16;VEGFC
14107,GO:0061028,0.015761590902814,0.997347444891568,4,31,establishment of endothelial barrier,BP,CLDN1;IL1B;TJP2;TJP1
12265,GO:0048640,0.0158185619210462,0.995927287658195,6,65,negative regulation of developmental growth,BP,SEMA7A;G6PD;WWC1;SEMA3D;NRP1;IFRD1
8321,GO:0033198,0.0158357075353589,0.998222897166761,3,18,response to ATP,BP,IL1B;SLC8A1;HSP90B1
9600,GO:0036498,0.0158707295103697,0.995905208271602,6,67,IRE1-mediated unfolded protein response,BP,HSPA5;DNAJB9;XBP1;PDIA6;SERP1;DNAJC3
4275,GO:0009719,0.01600989118084,0.989661644887076,45,1060,response to endogenous stimulus,BP,TRIM16;NEFL;NFKB1;EDN1;TP53;FGF5;SLIT2;CLDN1;CDKN2B;PEG10;JUN;RIPK2;PARP1;HSPA5;IL1B;JUNB;CRYAB;FBN2;DUSP1;LYN;ANXA1;SLC8A1;XBP1;ARG1;MMP19;SETX;KLF10;HSP90AB1;NR2F2;CALR;EIF2B1;HMGCS1;EHD1;CITED2;LOX;ETS1;HAS2;BAMBI;HSP90B1;HTR1B;NEDD4;PML;OXCT1;SOX11;ENPP1
322,GO:0000902,0.016043525135715,0.990442661429478,32,687,cell morphogenesis,BP,NEFL;TENM3;DSCAM;FEZ1;SLIT2;CNTNAP1;AXL;SEMA7A;ITGAV;ANXA1;NEDD4L;RHOB;SEMA3D;RIMS2;NRP1;IL7R;NRG1;IFRD1;ADAM8;L1CAM;CALR;CORO1C;DLG1;ZMYM4;HAS2;BAMBI;NEDD4;TUBB3;NTNG1;EPHA2;MYH9;PARVA
7884,GO:0032479,0.0160530884343267,0.994805278595253,8,107,regulation of type I interferon production,BP,NFKB1;RELB;RIPK2;NFKB2;IKBKE;CYLD;TRAF3;HSPD1
11061,GO:0045104,0.0160556046014094,0.997276096056248,4,32,intermediate filament cytoskeleton organization,BP,NEFL;KRT2;KRT18;NEFM
10134,GO:0042752,0.0160983468928548,0.995836245718705,6,66,regulation of circadian rhythm,BP,TP53;NOCT;ARNTL2;KLF10;PML;MAGED1
10723,GO:0044183,0.0161031465773084,0.997259116766138,4,33,protein binding involved in protein folding,MF,HSPA5;HSPA6;CALR;HSPD1
899,GO:0002287,0.0162279430269779,0.997238064906929,4,32,alpha-beta T cell activation involved in immune response,BP,RELB;RIPK2;ANXA1;IL23A
902,GO:0002293,0.0162279430269779,0.997238064906929,4,32,alpha-beta T cell differentiation involved in immune response,BP,RELB;RIPK2;ANXA1;IL23A
903,GO:0002294,0.0162279430269779,0.997238064906929,4,32,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,RELB;RIPK2;ANXA1;IL23A
9817,GO:0042093,0.0162279430269779,0.997238064906929,4,32,T-helper cell differentiation,BP,RELB;RIPK2;ANXA1;IL23A
11222,GO:0045499,0.0162410529422926,0.998173665884993,3,17,chemorepellent activity,MF,SEMA7A;SEMA3D;NRG1
15326,GO:0071605,0.0163465513755799,0.999197288769231,2,7,monocyte chemotactic protein-1 production,BP,IL1A;IL1B
15347,GO:0071637,0.0163465513755799,0.999197288769231,2,7,regulation of monocyte chemotactic protein-1 production,BP,IL1A;IL1B
13636,GO:0060205,0.0164478961232553,0.992908166525069,13,226,cytoplasmic vesicle lumen,CC,CXCL1;SAA1;NFKB1;HRNR;HSPA6;VEGFC;ARG1;HSP90AA1;HSP90AB1;CALR;DNAJC3;HSP90B1;CPPED1
11746,GO:0046641,0.0164568135194727,0.999188984745998,2,7,positive regulation of alpha-beta T cell proliferation,BP,RIPK2;IL23A
14682,GO:0070373,0.0165100174050635,0.996375690699082,5,49,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;ATF3;DUSP1;LYN;DLG1
16756,GO:0098641,0.0165459934710651,0.998099919425347,3,19,cadherin binding involved in cell-cell adhesion,MF,KRT18;EPCAM;ANXA1
11039,GO:0045073,0.0165955992343779,0.999178489620684,2,7,regulation of chemokine biosynthetic process,BP,IL1B;HMOX1
12333,GO:0048754,0.0165959267352457,0.994602257960625,8,104,branching morphogenesis of an epithelial tube,BP,B4GALT1;EDN1;SLIT2;NRP1;DLG1;PML;EPHA2;MAGED1
3744,GO:0008305,0.0166095801244387,0.99811639509206,3,17,integrin complex,CC,ITGAV;LYN;MYH9
16754,GO:0098636,0.0166095801244387,0.99811639509206,3,17,protein complex involved in cell adhesion,CC,ITGAV;LYN;MYH9
10407,GO:0043296,0.0167179599314515,0.994557105305056,8,103,apical junction complex,CC,CLDN1;EPCAM;CLDN7;CLDN11;TJP2;AMOTL2;DLG1;TJP1
942,GO:0002367,0.0167833150220961,0.996296217656426,5,50,cytokine production involved in immune response,BP,SEMA7A;ARG1;HMOX1;DLG1;HSPD1
7966,GO:0032606,0.0167973228164672,0.994518053171825,8,108,type I interferon production,BP,NFKB1;RELB;RIPK2;NFKB2;IKBKE;CYLD;TRAF3;HSPD1
8035,GO:0032725,0.0168143724199179,0.999161848943407,2,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
19805,GO:2000316,0.0168168112882745,0.999161662768558,2,7,regulation of T-helper 17 type immune response,BP,IL23A;NLRP10
5639,GO:0016758,0.0168293172969018,0.993671671329231,10,151,transferase activity, transferring hexosyl groups,MF,B4GALT1;STT3A;UGGT1;MGAT5;MAGT1;HAS2;GALNT14;GBE1;UGCG;SDF2L1
16299,GO:0090594,0.0169024038072874,0.999155119654843,2,7,inflammatory response to wounding,BP,IL1A;HMOX1
1379,GO:0003300,0.0169624519536761,0.996255234904153,5,48,cardiac muscle hypertrophy,BP,EDN1;PARP1;IL6ST;G6PD;SORBS2
2990,GO:0006551,0.0169658359882956,0.999150258965663,2,7,leucine metabolic process,BP,IVD;BCAT1
7581,GO:0031983,0.0170077766413703,0.992633676544225,13,227,vesicle lumen,CC,CXCL1;SAA1;NFKB1;HRNR;HSPA6;VEGFC;ARG1;HSP90AA1;HSP90AB1;CALR;DNAJC3;HSP90B1;CPPED1
18209,GO:1903071,0.0170331331740259,0.999145091312068,2,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,UBQLN2;HERPUD1
9008,GO:0035251,0.0170563575680209,0.999143305367746,2,7,UDP-glucosyltransferase activity,MF,UGGT1;UGCG
8569,GO:0034101,0.0170779377126236,0.994924933730838,7,87,erythrocyte homeostasis,BP,MAFB;AXL;LYN;G6PD;HMOX1;ETS1;CDK6
7846,GO:0032429,0.0170928843782625,0.999140493801988,2,7,regulation of phospholipase A2 activity,BP,ANXA8;ANXA1
4250,GO:0009615,0.0171683292185545,0.992558133781571,13,222,response to virus,BP,PMAIP1;IL1B;IFITM2;IKBKE;BIRC3;TRAF3;IFNAR1;IL23A;DNAJC3;IFNGR1;CDK6;PML;CYP1A1
12108,GO:0048247,0.0171716779817612,0.998000353349885,3,19,lymphocyte chemotaxis,BP,SAA1;CXCL16;ADAM8
6080,GO:0019318,0.0172047158161725,0.993152128839515,11,173,hexose metabolic process,BP,B4GALT1;PMAIP1;PGK1;C1QTNF1;PHLDA2;ATF3;G6PD;IGFBP3;SERP1;ENPP1;MIDN
11042,GO:0045076,0.0172200012964312,0.999130683843188,2,7,regulation of interleukin-2 biosynthetic process,BP,IL1A;IL1B
6650,GO:0030029,0.0173190092465286,0.990323157966182,25,511,actin filament-based process,BP,KRT8;CXCL1;LCP1;EDN1;DPYSL3;SLIT2;MYO1B;ACTG1;COBLL1;ANXA1;NEDD4L;RHOB;MOBP;NRP1;CALR;AMOTL2;ARHGDIB;CORO1C;DLG1;HSP90B1;EPB41L2;MYH9;SORBS2;TPM4;PARVA
17544,GO:1901215,0.0174199905765456,0.993819099777206,9,129,negative regulation of neuron death,BP,NEFL;JUN;AXL;HMOX1;NRP1;SOD2;HSP90AB1;ADAM8;BTBD10
13548,GO:0060056,0.0174216530724104,0.999115041010969,2,7,mammary gland involution,BP,B4GALT1;ARG1
733,GO:0001968,0.0175336261838242,0.997955521375225,3,18,fibronectin binding,MF,ITGAV;PLEKHA2;IGFBP3
10848,GO:0044420,0.0175851270994689,0.99475063020304,7,84,extracellular matrix component,CC,COL12A1;FBN2;COL8A1;COL4A4;FRAS1;NID2;DLG1
15515,GO:0072001,0.0176557794302779,0.992620588440398,12,192,renal system development,BP,OSR2;SLIT2;EPCAM;GREB1L;COL4A4;FRAS1;NRP1;MME;DLG1;HAS2;SOX11;MAGED1
536,GO:0001655,0.0176919464455171,0.992305530772289,13,215,urogenital system development,BP,OSR2;SLIT2;EPCAM;GREB1L;ANXA1;COL4A4;FRAS1;NRP1;MME;DLG1;HAS2;SOX11;MAGED1
6775,GO:0030235,0.0177088316555724,0.999092593271791,2,7,nitric-oxide synthase regulator activity,MF,HSP90AA1;HSP90AB1
4721,GO:0010906,0.0177363176444884,0.995309840782485,6,67,regulation of glucose metabolic process,BP,PMAIP1;C1QTNF1;PHLDA2;IGFBP3;ENPP1;MIDN
4527,GO:0010623,0.0177744634060678,0.999087435100768,2,7,programmed cell death involved in cell development,BP,IL1A;IL1B
12941,GO:0051384,0.0177858933564695,0.994667184933848,7,89,response to glucocorticoid,BP,NEFL;EDN1;SLIT2;CLDN1;DUSP1;ANXA1;ARG1
911,GO:0002312,0.0178811950599858,0.995990094267506,5,50,B cell activation involved in immune response,BP,LGALS1;NBN;XBP1;TFRC;HSPD1
11060,GO:0045103,0.0179003730660152,0.996855151669953,4,33,intermediate filament-based process,BP,NEFL;KRT2;KRT18;NEFM
11448,GO:0045944,0.0181010760421094,0.988863796868929,35,787,positive regulation of transcription by RNA polymerase II,BP,NFKBIA;IL1A;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;EHF;WWC1;XBP1;ARNTL2;EGLN1;SETX;KLF10;NRG1;CTR9;MAFF;IL23A;CITED2;ETS1;PML;SOX11
9103,GO:0035455,0.0182266039398053,0.997829275041664,3,19,response to interferon-alpha,BP,AXL;IFITM2;IFNAR1
12664,GO:0050922,0.0183318758332796,0.996756205469182,4,33,negative regulation of chemotaxis,BP,SLIT2;SEMA7A;SEMA3D;NRP1
1097,GO:0002693,0.0183336191858035,0.999043070566409,2,7,positive regulation of cellular extravasation,BP,IL1A;ADAM8
14750,GO:0070498,0.0183827287362955,0.99444321683829,7,93,interleukin-1-mediated signaling pathway,BP,NFKBIA;IL1A;NFKB1;PSMB9;RIPK2;IL1B;IRAK2
3528,GO:0007566,0.018384013402298,0.996737006868524,4,34,embryo implantation,BP,MMP9;IL1B;CALR;ARHGDIB
12245,GO:0048593,0.0184697110371631,0.995071645480662,6,67,camera-type eye morphogenesis,BP,TENM3;DSCAM;SDK1;COL8A1;EPHA2;SOX11
13195,GO:0051899,0.0184763010695177,0.995822031546795,5,50,membrane depolarization,BP,EDN1;JUN;PARP1;SLC8A1;NEDD4L
4919,GO:0014897,0.0184951250633212,0.995821362432063,5,49,striated muscle hypertrophy,BP,EDN1;PARP1;IL6ST;G6PD;SORBS2
19353,GO:1905898,0.0185215653179761,0.996705215123008,4,34,positive regulation of response to endoplasmic reticulum stress,BP,PMAIP1;UBQLN2;HERPUD1;XBP1
3573,GO:0008009,0.0185514407843361,0.99898901326986,2,8,chemokine activity,MF,CXCL1;CXCL16
12660,GO:0050918,0.0185770882935175,0.996692361279534,4,34,positive chemotaxis,BP,SAA1;IL16;VEGFC;NRP1
3367,GO:0007160,0.0186190233205279,0.992890447082065,10,148,cell-matrix adhesion,BP,CDKN2A;ITGAV;PLEKHA2;VEGFC;NRP1;L1CAM;AJUBA;CORO1C;NID2;CDK6
590,GO:0001755,0.0186433175174512,0.996684332844858,4,33,neural crest cell migration,BP,SEMA7A;SEMA3D;NRP1;CORO1C
1139,GO:0002753,0.0186567825284472,0.99577077304299,5,50,cytoplasmic pattern recognition receptor signaling pathway,BP,NFKBIA;RIPK2;CYLD;BIRC3;IRAK2
12365,GO:0048843,0.018670337803432,0.997770728506625,3,18,negative regulation of axon extension involved in axon guidance,BP,SEMA7A;SEMA3D;NRP1
11216,GO:0045471,0.018674246846607,0.994995305244756,6,70,response to ethanol,BP,TP53;CLDN1;CLDN7;G6PD;HTR1B;OXCT1
18919,GO:1904724,0.0186809728486662,0.996654884379448,4,36,tertiary granule lumen,CC,MMP9;FLG2;CXCL1;FTH1
14705,GO:0070417,0.0187425156997112,0.999010156809069,2,7,cellular response to cold,BP,NFKBIA;DNAJC3
16852,GO:0098839,0.0187490940673386,0.999009624059882,2,7,postsynaptic density membrane,CC,NETO1;DLG1
17055,GO:0099634,0.0187490940673386,0.999009624059882,2,7,postsynaptic specialization membrane,CC,NETO1;DLG1
11281,GO:0045637,0.0187520932307922,0.992434844600932,11,179,regulation of myeloid cell differentiation,BP,NFKBIA;MAFB;JUN;TJP2;TRIB1;LYN;KLF10;CTR9;IL23A;ETS1;CDK6
16253,GO:0090398,0.0188778077100668,0.995703228865922,5,51,cellular senescence,BP,CDKN2A;TP53;CALR;CDK6;PML
4252,GO:0009620,0.0188979249871567,0.997705099359705,3,20,response to fungus,BP,RNASE7;ARG1;NLRP10
442,GO:0001191,0.0189493840562448,0.996605861817157,4,34,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,DNAJB1;SDR16C5;CITED2;ZFP42
7563,GO:0031952,0.0190775901329977,0.996583482440211,4,33,regulation of protein autophosphorylation,BP,JUN;NBN;VEGFC;ENPP1
18421,GO:1903555,0.0190909303531624,0.994858373579374,6,70,regulation of tumor necrosis factor superfamily cytokine production,BP,CD274;RIPK2;AXL;SYT11;ADAM8;IL23A
16562,GO:0097435,0.019095580477376,0.98951068233498,23,466,supramolecular fiber organization,BP,NEFL;KRT8;KRT2;LCP1;NEFM;EDN1;DPYSL3;SLIT2;COL12A1;MYO1B;CRYAB;ACTG1;FIGN;COBLL1;RHOB;NRP1;SERPINH1;HSP90AB1;DLG1;LOX;HSP90B1;SORBS2;TPM4
12386,GO:0048871,0.0191030674257005,0.991921792996285,12,198,multicellular organismal homeostasis,BP,RPTN;IL1A;FLG2;KRT1;FLG;CLDN1;HRNR;IL1B;ACTG1;ADAM8;HAS2;TFRC
4621,GO:0010761,0.0191585978547995,0.996564589466036,4,33,fibroblast migration,BP,SLC8A1;PRR5L;CORO1C;PML
689,GO:0001913,0.0191881606425164,0.997656391698892,3,20,T cell mediated cytotoxicity,BP,IL7R;IL23A;PVR
4604,GO:0010742,0.0192780580836096,0.997654864800643,3,19,macrophage derived foam cell differentiation,BP,NFKBIA;NFKB1;ITGAV
16055,GO:0090077,0.0192780580836096,0.997654864800643,3,19,foam cell differentiation,BP,NFKBIA;NFKB1;ITGAV
7237,GO:0031224,0.0193807828152927,0.985664433874169,101,2755,intrinsic component of membrane,CC,NETO1;TENM3;DSCAM;ASPRV1;B4GALT1;CXCL16;CD274;CLDN1;EPCAM;SLC16A9;CLDN7;HS3ST1;GREB1L;CLDN11;MCAM;FAM173B;SPNS2;HERPUD1;SDK1;HSPA5;CNTNAP1;ANPEP;C1QTNF1;IL6ST;TMEM265;GPX8;AXL;IFITM2;ERAP1;STOML1;SEMA7A;FADS1;CD83;STT3A;ITGAV;LYN;NCEH1;FADS3;GPR176;DERL3;SLC8A1;XBP1;SEC11C;TRAF3;SYT11;FRAS1;HEPHL1;CANX;NRP1;IL7R;KCNQ5;GNPTAB;TNFSF15;CXCR5;NRG1;SDR16C5;SLC7A5P2;GGCX;ADAM8;L1CAM;CLCC1;STXBP5;STEAP4;CALR;IFNAR1;ANO4;SEL1L;SLC39A14;MGAT5;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;MME;DLG1;PTTG1IP;HAS2;ADGRL3;REEP1;MSMO1;TGFA;MGST3;BAMBI;FOCAD;IFNGR1;TFRC;HTR1B;SVIP;NTNG1;ZDHHC6;EPHA2;CCDC167;PVR;MYH9;GALNT14;TOR1AIP1;UGCG;ENPP1;HSPD1;TMPPE
2237,GO:0005164,0.0194897972576343,0.997605464068674,3,20,tumor necrosis factor receptor binding,MF,TRAF3;TRAF1;TNFSF15
15398,GO:0071715,0.0195142169446605,0.997615169282507,3,19,icosanoid transport,BP,EDN1;IL1B;ANXA1
17652,GO:1901571,0.0195142169446605,0.997615169282507,3,19,fatty acid derivative transport,BP,EDN1;IL1B;ANXA1
12244,GO:0048592,0.0195938367328106,0.994015076801208,7,87,eye morphogenesis,BP,TENM3;DSCAM;SDK1;FBN2;COL8A1;EPHA2;SOX11
10392,GO:0043269,0.019618300492382,0.99052027377078,16,295,regulation of ion transport,BP,MMP9;NETO1;EDN1;IL16;IL1B;STAC;LYN;G6PD;SLC8A1;NEDD4L;ARG1;KCNQ5;DLG1;HTR1B;NEDD4;PML
16670,GO:0097696,0.01968949844728,0.993970272738203,7,91,STAT cascade,BP,IL6ST;LYN;IL24;IL7R;IFNAR1;CTR9;IL23A
4918,GO:0014896,0.0197353096840964,0.99546171584002,5,50,muscle hypertrophy,BP,EDN1;PARP1;IL6ST;G6PD;SORBS2
7916,GO:0032526,0.020040471382468,0.994540465443206,6,71,response to retinoic acid,BP,TRIM16;TP53;KRT13;DUSP1;LYN;SETX
1247,GO:0003012,0.0201058318126968,0.991099524415128,13,222,muscle system process,BP,EDN1;PARP1;IL1B;IL6ST;CRYAB;STAC;G6PD;SLC8A1;NEDD4L;HMOX1;DLG1;SORBS2;TPM4
901,GO:0002292,0.0201319146850248,0.996327580893249,4,34,T cell differentiation involved in immune response,BP,RELB;RIPK2;ANXA1;IL23A
6656,GO:0030036,0.0201918790414263,0.988849112650213,23,467,actin cytoskeleton organization,BP,KRT8;CXCL1;LCP1;EDN1;DPYSL3;SLIT2;MYO1B;ACTG1;COBLL1;ANXA1;RHOB;NRP1;CALR;AMOTL2;ARHGDIB;CORO1C;DLG1;HSP90B1;EPB41L2;MYH9;SORBS2;TPM4;PARVA
17516,GO:1901099,0.0202767843318261,0.997471138174293,3,20,negative regulation of signal transduction in absence of ligand,BP,IL1A;IL1B;EYA3
20232,GO:2001240,0.0202767843318261,0.997471138174293,3,20,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1A;IL1B;EYA3
3537,GO:0007588,0.0202963272700678,0.99746777605304,3,20,excretion,BP,EDN1;NEDD4L;HMOX1
1980,GO:0004713,0.0203053516403352,0.993139658629648,8,108,protein tyrosine kinase activity,MF,FGF5;RIPK2;AXL;LYN;HSP90AA1;NRP1;NRG1;EPHA2
12758,GO:0051092,0.0203057372404498,0.99313181104765,8,112,positive regulation of NF-kappaB transcription factor activity,BP,NFKBIA;NFKB1;RIPK2;NFKB2;IL1B;TRAF1;ADAM8;IRAK2
535,GO:0001654,0.0203060023096321,0.991001348679727,13,219,eye development,BP,TENM3;DSCAM;OSR2;JUN;SDK1;CRYAB;FBN2;COL8A1;NRP1;DLG1;EPHA2;SOX11;CYP1A1
14271,GO:0061450,0.0203178406743671,0.998837745689349,2,8,trophoblast cell migration,BP,CALR;ARHGDIB
17527,GO:1901163,0.0203178406743671,0.998837745689349,2,8,regulation of trophoblast cell migration,BP,CALR;ARHGDIB
7104,GO:0030947,0.0203230618947403,0.997477787571602,3,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,IL1B;VEGFC;NEDD4
13713,GO:0060330,0.0203452318900419,0.997459357040721,3,20,regulation of response to interferon-gamma,BP,ARG1;HSP90AB1;IFNGR1
13717,GO:0060334,0.0203452318900419,0.997459357040721,3,20,regulation of interferon-gamma-mediated signaling pathway,BP,ARG1;HSP90AB1;IFNGR1
715,GO:0001945,0.020353778843692,0.997472527283931,3,19,lymph vessel development,BP,CCBE1;VEGFC;NR2F2
4522,GO:0010613,0.0205083536559176,0.997446008921788,3,19,positive regulation of cardiac muscle hypertrophy,BP,EDN1;PARP1;IL6ST
4862,GO:0014742,0.0205083536559176,0.997446008921788,3,19,positive regulation of muscle hypertrophy,BP,EDN1;PARP1;IL6ST
12602,GO:0050840,0.0205245814631756,0.996234011854433,4,34,extracellular matrix binding,MF,LGALS1;SLIT2;ITGAV;PLEKHA2
692,GO:0001916,0.0205536571462083,0.998816988514252,2,8,positive regulation of T cell mediated cytotoxicity,BP,IL23A;PVR
1114,GO:0002710,0.0209384601997946,0.998782837058952,2,8,negative regulation of T cell mediated immunity,BP,ARG1;IL7R
9791,GO:0042033,0.0211119594956267,0.998767325890086,2,8,chemokine biosynthetic process,BP,IL1B;HMOX1
12544,GO:0050755,0.0211119594956267,0.998767325890086,2,8,chemokine metabolic process,BP,IL1B;HMOX1
13057,GO:0051608,0.0212255878018225,0.998757129397982,2,8,histamine transport,BP,EDN1;LYN
20229,GO:2001237,0.0216414994960209,0.993998149735624,6,72,negative regulation of extrinsic apoptotic signaling pathway,BP,IL1A;IL1B;ITGAV;HMOX1;NRP1;EYA3
6916,GO:0030544,0.0217002021123643,0.995934354724719,4,36,Hsp70 protein binding,MF,DNAJB1;DNAJB9;DNAJC10;PPID
11400,GO:0045862,0.0217100351291681,0.989653981210505,15,279,positive regulation of proteolysis,BP,TNIP1;PMAIP1;UBQLN2;CCBE1;RIPK2;HERPUD1;IL1B;TRIB1;LYN;XBP1;TNFSF15;ADAM8;PML;MYH9;HSPD1
10296,GO:0043122,0.0217253578286764,0.991039762511262,11,180,regulation of I-kappaB kinase/NF-kappaB signaling,BP,IL1A;LGALS1;TNIP1;RIPK2;OPTN;IL1B;IKBKE;BIRC3;HMOX1;AJUBA;NLRP10
7759,GO:0032305,0.0217964883237505,0.99870544778699,2,8,positive regulation of icosanoid secretion,BP,EDN1;IL1B
19736,GO:2000193,0.0217964883237505,0.99870544778699,2,8,positive regulation of fatty acid transport,BP,EDN1;IL1B
12517,GO:0050706,0.0217987826796729,0.997205535533015,3,20,regulation of interleukin-1 beta secretion,BP,TRIM16;RIPK2;PML
9943,GO:0042362,0.0218397235542778,0.99870150331161,2,8,fat-soluble vitamin biosynthetic process,BP,NFKB1;IL1B
2955,GO:0006509,0.0219381866421115,0.995884070673071,4,35,membrane protein ectodomain proteolysis,BP,IL1B;ERAP1;ADAM8;MYH9
5158,GO:0015732,0.0220485844042261,0.998682388072087,2,8,prostaglandin transport,BP,EDN1;IL1B
15830,GO:0072593,0.0222068481015019,0.991263223976789,10,160,reactive oxygen species metabolic process,BP,EDN1;TP53;PMAIP1;IL1B;CRYAB;G6PD;HSP90AA1;SOD2;HSP90AB1;CYP1A1
7965,GO:0032604,0.0222852541657311,0.998660607404564,2,8,granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
7991,GO:0032645,0.0222852541657311,0.998660607404564,2,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,IL1B;IL23A
9299,GO:0035809,0.0223099658850008,0.998658325840928,2,8,regulation of urine volume,BP,EDN1;HAS2
12773,GO:0051117,0.022355169328812,0.994671055480989,5,54,ATPase binding,MF,DNAJB1;DNAJC10;SVIP;TOR1AIP1;SDF2L1
5333,GO:0016114,0.0223630161689569,0.998653423172189,2,8,terpenoid biosynthetic process,BP,HMGCS1;CYP1A1
777,GO:0002040,0.0223652333307214,0.993758465358668,6,70,sprouting angiogenesis,BP,SLIT2;CCBE1;ANXA1;HMOX1;NRP1;PARVA
11476,GO:0046007,0.0224117597546211,0.9986489128784,2,8,negative regulation of activated T cell proliferation,BP,CD274;ARG1
8392,GO:0033483,0.0225532284912308,0.998635792138783,2,8,gas homeostasis,BP,EGLN1;SOD2
7313,GO:0031343,0.0225702803673225,0.997052926486122,3,21,positive regulation of cell killing,BP,ARG1;IL23A;PVR
4520,GO:0010611,0.0225908669475364,0.995723667778854,4,35,regulation of cardiac muscle hypertrophy,BP,EDN1;PARP1;IL6ST;G6PD
14677,GO:0070365,0.0226363455877036,0.998628062194699,2,8,hepatocyte differentiation,BP,ANXA1;CYP1A1
13469,GO:0055080,0.0226514484034897,0.988122898757813,19,378,cation homeostasis,BP,SAA1;EDN1;TP53;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;NEDD4L;HMOX1;FTH1;EGLN1;ACO1;STEAP4;CALR;SLC39A14;HSP90B1;TFRC;PML
964,GO:0002418,0.0227502222399289,0.998617446262975,2,8,immune response to tumor cell,BP,PVR;HSPD1
1175,GO:0002829,0.0227542264723575,0.998617072443787,2,8,negative regulation of type 2 immune response,BP,ANXA1;ARG1
14715,GO:0070431,0.0227547095216952,0.998617027345783,2,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,NFKBIA;RIPK2
17305,GO:1900034,0.0228105235281548,0.993598349686478,6,72,regulation of cellular response to heat,BP,DNAJB1;HSPB8;CRYAB;HSP90AA1;HSP90AB1;CHORDC1
12540,GO:0050746,0.0229161646006503,0.998601924289125,2,8,regulation of lipoprotein metabolic process,BP,ITGAV;SVIP
11124,GO:0045214,0.0229217822868489,0.997004782198099,3,20,sarcomere organization,BP,KRT8;EDN1;ACTG1
12764,GO:0051098,0.0232084834448857,0.988846623785669,15,281,regulation of binding,BP,NFKBIA;MMP9;JUN;RIPK2;HERPUD1;PARP1;HSPA5;PHLDA2;CYLD;HMOX1;NRP1;NRG1;HSP90AB1;BAMBI;SOX11
16716,GO:0098542,0.0233095470440727,0.989111202512157,14,259,defense response to other organism,BP,PMAIP1;RNASE7;RIPK2;OPTN;IL1B;IFITM2;BIRC3;ARG1;TRAF3;SYT11;IL23A;DNAJC3;NLRP10;PML
9851,GO:0042149,0.0233769058059892,0.995519932702792,4,36,cellular response to glucose starvation,BP,TP53;PMAIP1;HSPA5;XBP1
19849,GO:2000379,0.0233894020493947,0.994359128389143,5,54,positive regulation of reactive oxygen species metabolic process,BP,EDN1;TP53;IL1B;HSP90AA1;HSP90AB1
1256,GO:0003044,0.0234074184150679,0.996900868624118,3,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,EDN1;SOD2;MME
7641,GO:0032092,0.0234304610681465,0.993380659205378,6,73,positive regulation of protein binding,BP,MMP9;RIPK2;HERPUD1;NRP1;HSP90AB1;BAMBI
13802,GO:0060443,0.023483647609159,0.995501856017724,4,35,mammary gland morphogenesis,BP,B4GALT1;ARG1;PML;EPHA2
12243,GO:0048589,0.0237216252830795,0.987281204739109,20,394,developmental growth,BP,DSCAM;EDN1;SLIT2;PHLDA2;SEMA7A;ANXA1;G6PD;NBN;WWC1;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;NRG1;IFRD1;L1CAM;CTR9;SERP1;SORBS2
17649,GO:1901568,0.0237258345132901,0.992443785318194,7,95,fatty acid derivative metabolic process,BP,EDN1;MGLL;FADS1;ANXA1;MGST3;OXCT1;CYP1A1
14872,GO:0070741,0.023889158728779,0.996828688181566,3,20,response to interleukin-6,BP,NFKB1;IL6ST;CTR9
15167,GO:0071354,0.023889158728779,0.996828688181566,3,20,cellular response to interleukin-6,BP,NFKB1;IL6ST;CTR9
4173,GO:0009267,0.0239316309289232,0.991651021126335,8,114,cellular response to starvation,BP,TP53;PMAIP1;JUN;HSPA5;ATF3;FADS1;XBP1;KLF10
10102,GO:0042692,0.0239454055575953,0.989538911840381,12,203,muscle cell differentiation,BP,KRT8;EDN1;ACTG1;G6PD;SLC8A1;XBP1;NRG1;IFRD1;CALR;EHD1;MYH9;SORBS2
11286,GO:0045646,0.023965533512581,0.995372140937673,4,36,regulation of erythrocyte differentiation,BP,MAFB;LYN;ETS1;CDK6
3374,GO:0007167,0.0239945909115761,0.985353740128506,31,691,enzyme linked receptor protein signaling pathway,BP,MMP9;FGF5;CDKN2B;PEG10;CCBE1;JUN;PARP1;HSPA5;IL1B;IL6ST;AXL;ACTG1;FBN2;ITGAV;LYN;VEGFC;HSP90AA1;NRP1;SETX;KLF10;NRG1;HSP90AB1;IGFBP3;CITED2;TGFA;BAMBI;NEDD4;PML;EPHA2;SOX11;ENPP1
12169,GO:0048384,0.0242900847246695,0.996738188706017,3,21,retinoic acid receptor signaling pathway,BP,TRIM16;CALR;PML
15392,GO:0071706,0.024440694211649,0.993025037951699,6,74,tumor necrosis factor superfamily cytokine production,BP,CD274;RIPK2;AXL;SYT11;ADAM8;IL23A
14464,GO:0062009,0.0244697888511338,0.998453622153124,2,8,secondary palate development,BP,DLG1;SOX11
10637,GO:0043901,0.0244747047648466,0.991419340523427,8,117,negative regulation of multi-organism process,BP,TNIP1;JUN;IFITM2;TRIB1;ITGAV;CALR;ARHGDIB;PML
3214,GO:0006883,0.0244829615319621,0.998452341957235,2,8,cellular sodium ion homeostasis,BP,SLC8A1;NEDD4L
11399,GO:0045861,0.0245721031984936,0.989217091117396,12,211,negative regulation of proteolysis,BP,MMP9;SERPINB2;CHAC1;HERPUD1;CRYAB;ANXA8;DERL3;BIRC3;SERPINH1;HSP90AB1;SVIP;PML
7092,GO:0030911,0.0246916371992262,0.998432011047047,2,8,TPR domain binding,MF,HSP90AA1;HSP90AB1
2576,GO:0005884,0.0247684561507639,0.992913829862675,6,73,actin filament,CC,LCP1;DPYSL3;MYO1B;ACTG1;ANXA1;TPM4
16046,GO:0090066,0.0248568993403735,0.987351599053873,17,327,regulation of anatomical structure size,BP,NEFL;DSCAM;EDN1;SLIT2;SEMA7A;SLC8A1;SEMA3D;HMOX1;NRP1;IL7R;SOD2;NRG1;IFRD1;HSP90AB1;L1CAM;DLG1;HTR1B
4651,GO:0010817,0.0249130925056877,0.987921664996931,15,280,regulation of hormone levels,BP,NFKB1;EDN1;IL1B;C1QTNF1;LYN;ANXA1;KLK6;RIMS2;SDR16C5;SERP1;MME;OXCT1;SOX11;MIDN;CYP1A1
4530,GO:0010628,0.0249494063225878,0.982842092004536,54,1356,positive regulation of gene expression,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;CCBE1;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;ATF3;CREB5;EHF;NOCT;WWC1;XBP1;ARNTL2;RIMS2;IL7R;EGLN1;SETX;KLF10;NRG1;ADAM8;NR2F2;UQCC1;CALR;EDRF1;CTR9;SERP1;MAFF;IL23A;RBMS3;CITED2;ETS1;BAMBI;DNAJC3;PML;MYH9;SOX11;MAGED1;SUPT3H
4863,GO:0014743,0.0249534836718167,0.995121470153024,4,36,regulation of muscle hypertrophy,BP,EDN1;PARP1;IL6ST;G6PD
13016,GO:0051547,0.0249880732309746,0.998402966508537,2,8,regulation of keratinocyte migration,BP,MMP9;HAS2
8574,GO:0034110,0.0250666653987987,0.996593100944524,3,21,regulation of homotypic cell-cell adhesion,BP,LGALS1;C1QTNF1;LYN
6866,GO:0030395,0.0250793951804923,1,1,1,lactose binding,MF,LGALS1
8581,GO:0034117,0.0250793951804923,1,1,1,erythrocyte aggregation,BP,LGALS1
8582,GO:0034118,0.0250793951804923,1,1,1,regulation of erythrocyte aggregation,BP,LGALS1
8583,GO:0034120,0.0250793951804923,1,1,1,positive regulation of erythrocyte aggregation,BP,LGALS1
12044,GO:0048030,0.0250793951804923,1,1,1,disaccharide binding,MF,LGALS1
8450,GO:0033619,0.0250938016469687,0.993836859132026,5,54,membrane protein proteolysis,BP,NFKB1;IL1B;ERAP1;ADAM8;MYH9
13065,GO:0051639,0.0251293417170492,0.998389057946918,2,8,actin filament network formation,BP,LCP1;COBLL1
8959,GO:0035094,0.0251887371182227,0.996570129682992,3,21,response to nicotine,BP,NFKB1;EDN1;HMOX1
13854,GO:0060537,0.0252103247115948,0.988488293408911,13,226,muscle tissue development,BP,EDN1;ATF3;G6PD;SLC8A1;EGLN1;NRG1;IFRD1;NR2F2;CALR;MAFF;DLG1;SOX11;SORBS2
5294,GO:0016021,0.0252106467092407,0.981180191375331,98,2690,integral component of membrane,CC,NETO1;TENM3;DSCAM;ASPRV1;B4GALT1;CXCL16;CD274;CLDN1;EPCAM;SLC16A9;CLDN7;HS3ST1;GREB1L;CLDN11;MCAM;FAM173B;SPNS2;HERPUD1;SDK1;HSPA5;CNTNAP1;ANPEP;C1QTNF1;IL6ST;TMEM265;GPX8;AXL;IFITM2;ERAP1;STOML1;FADS1;CD83;STT3A;ITGAV;LYN;NCEH1;FADS3;GPR176;DERL3;SLC8A1;XBP1;SEC11C;TRAF3;SYT11;FRAS1;HEPHL1;CANX;NRP1;IL7R;KCNQ5;GNPTAB;TNFSF15;CXCR5;NRG1;SDR16C5;SLC7A5P2;GGCX;ADAM8;L1CAM;CLCC1;STXBP5;STEAP4;CALR;IFNAR1;ANO4;SEL1L;SLC39A14;MGAT5;SLC35B1;SERP1;ORMDL1;MAGT1;SEC22A;MME;DLG1;PTTG1IP;HAS2;ADGRL3;REEP1;MSMO1;TGFA;MGST3;BAMBI;FOCAD;IFNGR1;TFRC;HTR1B;ZDHHC6;EPHA2;CCDC167;PVR;MYH9;GALNT14;TOR1AIP1;UGCG;ENPP1;HSPD1;TMPPE
5927,GO:0018279,0.0252688416026404,0.995023417244227,4,38,protein N-linked glycosylation via asparagine,BP,STT3A;DERL3;UGGT1;MAGT1
16605,GO:0097512,0.0253029698783714,1,1,1,cardiac myofibril,CC,CRYAB
11359,GO:0045778,0.0253106591952971,0.993769694040589,5,54,positive regulation of ossification,BP,OSR2;IL6ST;FBN2;SLC8A1;SOX11
6899,GO:0030511,0.0253766919641423,0.996534673807071,3,21,positive regulation of transforming growth factor beta receptor signaling pathway,BP,CDKN2B;HSP90AB1;CITED2
18550,GO:1903846,0.0253766919641423,0.996534673807071,3,21,positive regulation of cellular response to transforming growth factor beta stimulus,BP,CDKN2B;HSP90AB1;CITED2
19990,GO:2000650,0.0253826048294164,0.998364014774194,2,8,negative regulation of sodium ion transmembrane transporter activity,BP,NEDD4L;NEDD4
9052,GO:0035331,0.0253926085720318,0.998363022737791,2,8,negative regulation of hippo signaling,BP,WWC1;AJUBA
11737,GO:0046632,0.0254047311811146,0.993740508757758,5,54,alpha-beta T cell differentiation,BP,RELB;RIPK2;CD83;ANXA1;IL23A
7082,GO:0030898,0.0254056415250968,0.998361729981135,2,8,actin-dependent ATPase activity,MF,MYO1B;MYH9
12274,GO:0048661,0.0254200152883255,0.993735764142347,5,54,positive regulation of smooth muscle cell proliferation,BP,MMP9;EDN1;JUN;HMOX1;HTR1B
12548,GO:0050764,0.0254465207417787,0.994986163507607,4,37,regulation of phagocytosis,BP,IL1B;ITGAV;SYT11;CALR
549,GO:0001671,0.0254885023150535,0.996497450384419,3,22,ATPase activator activity,MF,DNAJB1;DNAJC10;TOR1AIP1
16069,GO:0090092,0.0256844909336091,0.990246733116929,9,137,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CDKN2B;PEG10;PARP1;HSPA5;FBN2;HSP90AB1;CITED2;BAMBI;SOX11
19759,GO:2000241,0.0257317937074415,0.992566100839575,6,75,regulation of reproductive process,BP,B4GALT1;PHLDA2;DUSP1;CALR;ARHGDIB;CITED2
14875,GO:0070757,0.0258622089383355,0.998316211638111,2,8,interleukin-35-mediated signaling pathway,BP,IL6ST;CANX
14535,GO:0070106,0.0258945278657827,0.998312972577787,2,8,interleukin-27-mediated signaling pathway,BP,IL6ST;CANX
457,GO:0001306,0.0259035164916026,1,1,1,age-dependent response to oxidative stress,BP,SOD2
458,GO:0001315,0.0259035164916026,1,1,1,age-dependent response to reactive oxygen species,BP,SOD2
1263,GO:0003068,0.0259035164916026,1,1,1,regulation of systemic arterial blood pressure by acetylcholine,BP,SOD2
1264,GO:0003069,0.0259035164916026,1,1,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,SOD2
1265,GO:0003070,0.0259035164916026,1,1,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,SOD2
3532,GO:0007571,0.0259035164916026,1,1,1,age-dependent general metabolic decline,BP,SOD2
11227,GO:0045519,0.0259360867710311,1,1,1,interleukin-23 receptor binding,MF,IL23A
14874,GO:0070743,0.0259360867710311,1,1,1,interleukin-23 complex,CC,IL23A
1884,GO:0004579,0.0259494217237707,0.998261135122484,2,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,STT3A;MAGT1
607,GO:0001776,0.0259512895211309,0.993564644680335,5,55,leukocyte homeostasis,BP,PMAIP1;SPNS2;AXL;LYN;ANXA1
8209,GO:0033002,0.0260741374267244,0.990754147499276,8,115,muscle cell proliferation,BP,MMP9;EDN1;TP53;JUN;TRIB1;HMOX1;IGFBP3;HTR1B
18557,GO:1903861,0.0261606527901925,0.998286216114739,2,8,positive regulation of dendrite extension,BP,NEDD4L;RIMS2
4833,GO:0014063,0.0261906578687851,1,1,1,negative regulation of serotonin secretion,BP,HTR1B
6622,GO:0023026,0.0261987914336647,0.998235365056358,2,9,MHC class II protein complex binding,MF,HSP90AA1;HSP90AB1
10370,GO:0043236,0.0262147841282983,0.996375304461832,3,21,laminin binding,MF,LGALS1;SLIT2;PLEKHA2
13868,GO:0060560,0.0262743636214309,0.989385332480818,10,156,developmental growth involved in morphogenesis,BP,DSCAM;SLIT2;SEMA7A;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM
3044,GO:0006622,0.026275074548992,0.996363760312706,3,21,protein targeting to lysosome,BP,AP3M1;GNPTAB;NEDD4
4412,GO:0010259,0.0263464625496231,0.996350077541914,3,21,multicellular organism aging,BP,EDN1;TP53;SERP1
3741,GO:0008299,0.0263861493856763,0.996325623170696,3,22,isoprenoid biosynthetic process,BP,HMGCS1;DHDDS;CYP1A1
13322,GO:0052548,0.0264418493741278,0.987438029858348,14,265,regulation of endopeptidase activity,BP,MMP9;SERPINB2;PMAIP1;PSMB9;RIPK2;HERPUD1;CRYAB;ANXA8;LYN;BIRC3;TNFSF15;SERPINH1;PML;HSPD1
6803,GO:0030282,0.0265759705912612,0.993374669872215,5,54,bone mineralization,BP,OSR2;FBN2;SLC8A1;KLF10;ENPP1
18701,GO:1904210,0.0266517693817064,1,1,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,SVIP
18718,GO:1904239,0.0266517693817064,1,1,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,SVIP
18719,GO:1904240,0.0266517693817064,1,1,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,SVIP
8473,GO:0033676,0.0266988035457411,1,1,1,double-stranded DNA-dependent ATPase activity,MF,ANXA1
11310,GO:0045670,0.0267214054746271,0.994655359511024,4,37,regulation of osteoclast differentiation,BP,MAFB;TJP2;KLF10;IL23A
4760,GO:0010963,0.0267965322254444,1,1,1,regulation of L-arginine import,BP,ARG1
14975,GO:0070947,0.0267965322254444,1,1,1,neutrophil mediated killing of fungus,BP,ARG1
14980,GO:0070953,0.0267965322254444,1,1,1,regulation of neutrophil mediated killing of fungus,BP,ARG1
14985,GO:0070965,0.0267965322254444,1,1,1,positive regulation of neutrophil mediated killing of fungus,BP,ARG1
19933,GO:2000552,0.0267965322254444,1,1,1,negative regulation of T-helper 2 cell cytokine production,BP,ARG1
11859,GO:0046916,0.0268470441070309,0.992160551271416,6,77,cellular transition metal ion homeostasis,BP,HMOX1;FTH1;EGLN1;ACO1;SLC39A14;TFRC
9124,GO:0035504,0.0269126345719075,1,1,1,regulation of myosin light chain kinase activity,BP,IL1B
9125,GO:0035505,0.0269126345719075,1,1,1,positive regulation of myosin light chain kinase activity,BP,IL1B
11546,GO:0046136,0.0269126345719075,1,1,1,positive regulation of vitamin metabolic process,BP,IL1B
13865,GO:0060557,0.0269126345719075,1,1,1,positive regulation of vitamin D biosynthetic process,BP,IL1B
13867,GO:0060559,0.0269126345719075,1,1,1,positive regulation of calcidiol 1-monooxygenase activity,BP,IL1B
11283,GO:0045639,0.0269600201243033,0.993247753875709,5,55,positive regulation of myeloid cell differentiation,BP,JUN;TRIB1;KLF10;IL23A;ETS1
19205,GO:1905404,0.0270074820482974,1,1,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
8719,GO:0034395,0.0270314729414579,1,1,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,HMOX1
2672,GO:0006050,0.0270968151065766,1,1,1,mannosamine metabolic process,BP,NAGK
2673,GO:0006051,0.0270968151065766,1,1,1,N-acetylmannosamine metabolic process,BP,NAGK
11075,GO:0045127,0.0270968151065766,1,1,1,N-acetylglucosamine kinase activity,MF,NAGK
2850,GO:0006357,0.0271197908023582,0.980831701872499,62,1593,regulation of transcription by RNA polymerase II,BP,NFKBIA;IL1A;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;ARNTL2;HMOX1;EGLN1;BRD2;SETX;SOD2;KLF10;NRG1;VGLL3;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ETS1;TGFA;NEDD4;PML;HES4;SOX11;HSPD1;MAGED1;SUPT3H
10062,GO:0042594,0.0271984312959317,0.989564635401362,9,139,response to starvation,BP,TP53;PMAIP1;JUN;HSPA5;ATF3;FADS1;XBP1;KLF10;OXCT1
779,GO:0002042,0.027217973624532,0.994525110765139,4,37,cell migration involved in sprouting angiogenesis,BP,SLIT2;ANXA1;HMOX1;NRP1
3631,GO:0008120,0.0272350285335607,1,1,1,ceramide glucosyltransferase activity,MF,UGCG
17127,GO:0102769,0.0272350285335607,1,1,1,dihydroceramide glucosyltransferase activity,MF,UGCG
9401,GO:0036003,0.0273275800761811,0.996142887362363,3,22,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,TP53;HSPA5;ATF3
707,GO:0001936,0.0273669027134687,0.991981468997668,6,75,regulation of endothelial cell proliferation,BP,JUN;VEGFC;ARG1;HMOX1;NRP1;NR2F2
14438,GO:0061880,0.0274104746039074,1,1,1,regulation of anterograde axonal transport of mitochondrion,BP,FEZ1
14439,GO:0061881,0.0274104746039074,1,1,1,positive regulation of anterograde axonal transport of mitochondrion,BP,FEZ1
10649,GO:0043946,0.0275267417766886,1,1,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,SUGT1
10650,GO:0043947,0.0275267417766886,1,1,1,positive regulation by host of symbiont catalytic activity,BP,SUGT1
13311,GO:0052422,0.0275267417766886,1,1,1,modulation by host of symbiont catalytic activity,BP,SUGT1
11390,GO:0045840,0.0276109165630956,0.99441208020864,4,38,positive regulation of mitotic nuclear division,BP,IL1A;EDN1;IL1B;TGFA
14602,GO:0070228,0.0276226741463061,0.994400052564174,4,39,regulation of lymphocyte apoptotic process,BP,TP53;CD274;LYN;ADAM8
15118,GO:0071276,0.027626880699386,0.996067987213344,3,23,cellular response to cadmium ion,BP,MMP9;JUN;HMOX1
3147,GO:0006772,0.0276562825996144,1,1,1,thiamine metabolic process,BP,THTPA
9939,GO:0042357,0.0276562825996144,1,1,1,thiamine diphosphate metabolic process,BP,THTPA
12431,GO:0050333,0.0276562825996144,1,1,1,thiamin-triphosphatase activity,MF,THTPA
2111,GO:0004917,0.0276833405745396,1,1,1,interleukin-7 receptor activity,MF,IL7R
9110,GO:0035470,0.0276874090873204,1,1,1,positive regulation of vascular wound healing,BP,XBP1
13939,GO:0060690,0.0276874090873204,1,1,1,epithelial cell differentiation involved in salivary gland development,BP,XBP1
13940,GO:0060691,0.0276874090873204,1,1,1,epithelial cell maturation involved in salivary gland development,BP,XBP1
17332,GO:1900098,0.0276874090873204,1,1,1,regulation of plasma cell differentiation,BP,XBP1
17333,GO:1900100,0.0276874090873204,1,1,1,positive regulation of plasma cell differentiation,BP,XBP1
18382,GO:1903489,0.0276874090873204,1,1,1,positive regulation of lactation,BP,XBP1
7189,GO:0031100,0.0277180684192997,0.992995767631947,5,57,animal organ regeneration,BP,NFKBIA;LCP1;CLDN1;AXL;HMOX1
5902,GO:0018196,0.0277906314095082,0.99435547246716,4,39,peptidyl-asparagine modification,BP,STT3A;DERL3;UGGT1;MAGT1
11628,GO:0046427,0.0278024895287306,0.994352321713916,4,39,positive regulation of JAK-STAT cascade,BP,IL6ST;LYN;IL24;IL23A
14846,GO:0070673,0.0279009890449771,0.998055855412017,2,9,response to interleukin-18,BP,CLDN1;RIPK2
6890,GO:0030500,0.0279011668155755,0.994344650335614,4,37,regulation of bone mineralization,BP,OSR2;FBN2;SLC8A1;ENPP1
6800,GO:0030278,0.0279367816868671,0.989961610032972,8,116,regulation of ossification,BP,OSR2;IL6ST;NOCT;FBN2;SLC8A1;CDK6;SOX11;ENPP1
957,GO:0002396,0.0279878526978266,1,1,1,MHC protein complex assembly,BP,CALR
958,GO:0002397,0.0279878526978266,1,1,1,MHC class I protein complex assembly,BP,CALR
1005,GO:0002501,0.0279878526978266,1,1,1,peptide antigen assembly with MHC protein complex,BP,CALR
1006,GO:0002502,0.0279878526978266,1,1,1,peptide antigen assembly with MHC class I protein complex,BP,CALR
7757,GO:0032303,0.0281426823954953,0.998029862767141,2,9,regulation of icosanoid secretion,BP,EDN1;IL1B
13437,GO:0055013,0.0281593573200553,0.994276075028009,4,37,cardiac muscle cell development,BP,EDN1;G6PD;SLC8A1;SORBS2
20036,GO:2000725,0.0282951420317474,0.99595243168411,3,22,regulation of cardiac muscle cell differentiation,BP,EDN1;G6PD;NRG1
3148,GO:0006775,0.0283762104611049,0.995919492984442,3,23,fat-soluble vitamin metabolic process,BP,NFKB1;IL1B;CYP1A1
6491,GO:0021885,0.0283917158871879,0.994214185697694,4,37,forebrain cell migration,BP,SLIT2;AXL;NRP1;NRG1
9758,GO:0040007,0.0284480733467124,0.982676463731583,29,648,growth,BP,CDKN2A;DSCAM;EDN1;TP53;CXCL16;SLIT2;PHLDA2;CRYAB;SEMA7A;ANXA1;G6PD;NBN;WWC1;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;DCUN1D3;NRG1;IFRD1;L1CAM;EIF4G2;CTR9;IGFBP3;SERP1;PML;ENPP1;SORBS2
10336,GO:0043185,0.0284654221910436,1,1,1,vascular endothelial growth factor receptor 3 binding,MF,VEGFC
6768,GO:0030224,0.0284819096248507,0.995915363223307,3,22,monocyte differentiation,BP,JUN;CDK6;MYH9
18227,GO:1903131,0.0284819096248507,0.995915363223307,3,22,mononuclear cell differentiation,BP,JUN;CDK6;MYH9
4881,GO:0014826,0.0285136852782789,1,1,1,vein smooth muscle contraction,BP,EDN1
6740,GO:0030185,0.0285136852782789,1,1,1,nitric oxide transport,BP,EDN1
7428,GO:0031583,0.0285136852782789,1,1,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,EDN1
7499,GO:0031705,0.0285136852782789,1,1,1,bombesin receptor binding,MF,EDN1
7500,GO:0031707,0.0285136852782789,1,1,1,endothelin A receptor binding,MF,EDN1
7501,GO:0031708,0.0285136852782789,1,1,1,endothelin B receptor binding,MF,EDN1
9305,GO:0035815,0.0285136852782789,1,1,1,positive regulation of renal sodium excretion,BP,EDN1
9920,GO:0042313,0.0285136852782789,1,1,1,protein kinase C deactivation,BP,EDN1
10332,GO:0043179,0.0285136852782789,1,1,1,rhythmic excitation,BP,EDN1
13466,GO:0055076,0.0285848459917108,0.990528819060055,7,99,transition metal ion homeostasis,BP,HMOX1;FTH1;EGLN1;ACO1;STEAP4;SLC39A14;TFRC
18676,GO:1904153,0.0285919927963296,0.997981212667698,2,9,negative regulation of retrograde protein transport, ER to cytosol,BP,DERL3;SVIP
14126,GO:0061050,0.0287997256105232,0.997958575662519,2,9,regulation of cell growth involved in cardiac muscle cell development,BP,EDN1;G6PD
4607,GO:0010745,0.0289214470608503,0.997945269227145,2,9,negative regulation of macrophage derived foam cell differentiation,BP,NFKBIA;ITGAV
15793,GO:0072538,0.0290306254227055,0.997933307486217,2,9,T-helper 17 type immune response,BP,IL23A;NLRP10
943,GO:0002368,0.029157205854845,1,1,1,B cell cytokine production,BP,HSPD1
1187,GO:0002842,0.029157205854845,1,1,1,positive regulation of T cell mediated immune response to tumor cell,BP,HSPD1
15863,GO:0072676,0.0292194076015421,0.993972733301446,4,39,lymphocyte migration,BP,SAA1;CXCL16;SPNS2;ADAM8
4596,GO:0010731,0.0292291881984147,1,1,1,protein glutathionylation,BP,G6PD
4597,GO:0010732,0.0292291881984147,1,1,1,regulation of protein glutathionylation,BP,G6PD
4598,GO:0010734,0.0292291881984147,1,1,1,negative regulation of protein glutathionylation,BP,G6PD
3516,GO:0007518,0.0293141594876985,1,1,1,myoblast fate determination,BP,IFRD1
6469,GO:0021840,0.0293477718713816,1,1,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,NRG1
6470,GO:0021842,0.0293477718713816,1,1,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,NRG1
1332,GO:0003206,0.0293726710445388,0.991252577878162,6,75,cardiac chamber morphogenesis,BP,NRP1;EGLN1;NRG1;CITED2;SOX11;PARVA
3725,GO:0008277,0.0294152470277965,0.991228372957946,6,77,regulation of G-protein coupled receptor protein signaling pathway,BP,EDN1;UBQLN2;MGLL;KLK6;GIT2;HTR1B
8197,GO:0032980,0.0294526301917546,1,1,1,keratinocyte activation,BP,KRT2
709,GO:0001938,0.0294639155510944,0.99243452163326,5,57,positive regulation of endothelial cell proliferation,BP,JUN;VEGFC;ARG1;HMOX1;NRP1
721,GO:0001954,0.0294667149092733,0.993915515481413,4,38,positive regulation of cell-matrix adhesion,BP,PLEKHA2;VEGFC;NRP1;CDK6
1912,GO:0004618,0.0294816481448308,1,1,1,phosphoglycerate kinase activity,MF,PGK1
9048,GO:0035326,0.0295287833588122,0.991190944223515,6,76,enhancer binding,MF,NFKB1;JUN;ARID3B;XBP1;ZFP42;SOX11
11366,GO:0045793,0.0296390842273321,0.99786618653479,2,9,positive regulation of cell size,BP,EDN1;HSP90AB1
8323,GO:0033204,0.0296445361342014,1,1,1,ribonuclease P RNA binding,MF,POP4
6392,GO:0021649,0.0296488333557867,1,1,1,vestibulocochlear nerve structural organization,BP,NRP1
9661,GO:0038085,0.0296488333557867,1,1,1,vascular endothelial growth factor binding,MF,NRP1
13691,GO:0060301,0.0296488333557867,1,1,1,positive regulation of cytokine activity,BP,NRP1
14307,GO:0061552,0.0296488333557867,1,1,1,ganglion morphogenesis,BP,NRP1
16537,GO:0097374,0.0296488333557867,1,1,1,sensory neuron axon guidance,BP,NRP1
17935,GO:1902378,0.0296488333557867,1,1,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,NRP1
18972,GO:1904835,0.0296488333557867,1,1,1,dorsal root ganglion morphogenesis,BP,NRP1
19068,GO:1905040,0.0296488333557867,1,1,1,otic placode development,BP,NRP1
454,GO:0001228,0.0297476813805436,0.985651857662676,14,258,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NFKB1;MAFB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;KLF10;MAFF;ETS1;SOX11
107,GO:0000224,0.0297996225565659,1,1,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,NGLY1
1390,GO:0003335,0.0298137353212292,1,1,1,corneocyte development,BP,CDSN
1391,GO:0003336,0.0298137353212292,1,1,1,corneocyte desquamation,BP,CDSN
19308,GO:1905715,0.0298137353212292,1,1,1,regulation of cornification,BP,CDSN
19309,GO:1905716,0.0298137353212292,1,1,1,negative regulation of cornification,BP,CDSN
830,GO:0002135,0.0298193746188626,1,1,1,CTP binding,MF,HSP90AB1
5805,GO:0017098,0.0298193746188626,1,1,1,sulfonylurea receptor binding,MF,HSP90AB1
17610,GO:1901388,0.0298193746188626,1,1,1,regulation of transforming growth factor beta activation,BP,HSP90AB1
17611,GO:1901389,0.0298193746188626,1,1,1,negative regulation of transforming growth factor beta activation,BP,HSP90AB1
18466,GO:1903659,0.0298193746188626,1,1,1,regulation of complement-dependent cytotoxicity,BP,HSP90AB1
18467,GO:1903660,0.0298193746188626,1,1,1,negative regulation of complement-dependent cytotoxicity,BP,HSP90AB1
19622,GO:1990913,0.0298193746188626,1,1,1,sperm head plasma membrane,CC,HSP90AB1
19623,GO:1990917,0.0298193746188626,1,1,1,ooplasm,CC,HSP90AB1
3163,GO:0006796,0.0298390390498176,0.977914639249867,84,2279,phosphate-containing compound metabolic process,BP,CDKN2A;MMP9;IL1A;NEFL;DSCAM;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;PSMB9;FGF5;DBNDD2;NAGK;SLIT2;CDKN2B;PGK1;JUN;RIPK2;PARP1;HSPA5;IL1B;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;SEMA7A;DUSP1;TRIB1;FADS1;PLBD1;ITGAV;LYN;GPR176;G6PD;NBN;PLEKHA2;WWC1;THTPA;VEGFC;PAPSS2;IL24;HSP90AA1;DAPP1;NRP1;EGLN1;SETX;GNPTAB;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;EYA3;MOCS2;PRR5L;HMGCS1;CORO1C;IL23A;DLG1;GDA;DHDDS;CHORDC1;TGFA;DNAJC3;HSP90B1;UBXN2B;CDK6;PML;EPHA2;BTBD10;CPPED1;ENPP1;MAGED1;MIDN;IRAK2
6929,GO:0030575,0.0298400546373311,0.997843847187641,2,9,nuclear body organization,BP,ETS1;PML
6891,GO:0030501,0.0298889392734959,0.995632981567067,3,22,positive regulation of bone mineralization,BP,OSR2;FBN2;SLC8A1
14568,GO:0070169,0.0298889392734959,0.995632981567067,3,22,positive regulation of biomineral tissue development,BP,OSR2;FBN2;SLC8A1
10205,GO:0042942,0.0299230749392436,1,1,1,D-serine transport,BP,NFKBIE
397,GO:0001074,0.0299425539039257,1,1,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,TP53
403,GO:0001084,0.0299425539039257,1,1,1,transcription factor activity, TFIID-class binding,MF,TP53
8409,GO:0033552,0.0299425539039257,1,1,1,response to vitamin B3,BP,TP53
8261,GO:0033091,0.029945332817568,1,1,1,positive regulation of immature T cell proliferation,BP,RIPK2
4253,GO:0009624,0.0299979473593677,1,1,1,response to nematode,BP,CYP1A1
4271,GO:0009692,0.0299979473593677,1,1,1,ethylene metabolic process,BP,CYP1A1
4272,GO:0009698,0.0299979473593677,1,1,1,phenylpropanoid metabolic process,BP,CYP1A1
4301,GO:0009804,0.0299979473593677,1,1,1,coumarin metabolic process,BP,CYP1A1
5612,GO:0016711,0.0299979473593677,1,1,1,flavonoid 3'-monooxygenase activity,MF,CYP1A1
6087,GO:0019341,0.0299979473593677,1,1,1,dibenzo-p-dioxin catabolic process,BP,CYP1A1
10489,GO:0043449,0.0299979473593677,1,1,1,cellular alkene metabolic process,BP,CYP1A1
3653,GO:0008160,0.0300172409786974,1,1,1,protein tyrosine phosphatase activator activity,MF,IGFBP3
2403,GO:0005591,0.0300460868918109,1,1,1,collagen type VIII trimer,CC,COL8A1
2409,GO:0005598,0.0300460868918109,1,1,1,short-chain collagen trimer,CC,COL8A1
7100,GO:0030935,0.0300460868918109,1,1,1,sheet-forming collagen trimer,CC,COL8A1
16761,GO:0098646,0.0300460868918109,1,1,1,collagen sheet,CC,COL8A1
265,GO:0000733,0.0302532840443997,0.997797650324806,2,9,DNA strand renaturation,BP,TP53;ANXA1
1650,GO:0004117,0.0302605052842218,1,1,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,PDE1C
9363,GO:0035931,0.0302816617331804,1,1,1,mineralocorticoid secretion,BP,C1QTNF1
9364,GO:0035932,0.0302816617331804,1,1,1,aldosterone secretion,BP,C1QTNF1
20112,GO:2000855,0.0302816617331804,1,1,1,regulation of mineralocorticoid secretion,BP,C1QTNF1
20113,GO:2000857,0.0302816617331804,1,1,1,positive regulation of mineralocorticoid secretion,BP,C1QTNF1
20114,GO:2000858,0.0302816617331804,1,1,1,regulation of aldosterone secretion,BP,C1QTNF1
20115,GO:2000860,0.0302816617331804,1,1,1,positive regulation of aldosterone secretion,BP,C1QTNF1
14566,GO:0070167,0.0303015771080921,0.993688742555334,4,38,regulation of biomineral tissue development,BP,OSR2;FBN2;SLC8A1;ENPP1
3497,GO:0007423,0.0303032227024963,0.984561692518638,16,306,sensory organ development,BP,TENM3;DSCAM;OSR2;MAFB;EDN1;JUN;SDK1;KRT13;CRYAB;FBN2;COL8A1;NRP1;DLG1;EPHA2;SOX11;CYP1A1
1434,GO:0003674,0.0303360073566554,0.983441926678592,351,11295,molecular_function,MF,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;ASPRV1;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;CCBE1;JUN;KRT4;CLDN11;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;CNTNAP1;ANPEP;JUNB;EFHD2;C1QTNF1;TJP2;IL6ST;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;CRCT1;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;CD83;STT3A;ITGAV;LYN;NCEH1;COBLL1;AP3M1;COL8A1;C1R;ANXA1;PDE1C;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SEMA3D;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;MMP19;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;UBTD2;KCTD12;HEPHL1;IL24;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SLC7A5P2;SNAI3;GGCX;ADAM8;C2ORF49;L1CAM;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;MOB3A;CALR;PDIA6;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;METTL2A;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;ADGRL3;TYW1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;CHORDC1;TGFA;MGST3;BAMBI;SUGT1;FOCAD;PRPF38A;DNAJC3;CBLL1;RSPRY1;BCAT1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA;TMPPE
17269,GO:0140115,0.0303869974645786,0.997782626226166,2,9,export across plasma membrane,BP,SLC8A1;DLG1
937,GO:0002357,0.0304145439834987,1,1,1,defense response to tumor cell,BP,RBMS3
17913,GO:1902306,0.0305760146459219,0.997761325271412,2,9,negative regulation of sodium ion transmembrane transport,BP,NEDD4L;NEDD4
3527,GO:0007565,0.0306450919530466,0.988783011072529,8,120,female pregnancy,BP,MMP9;IL1B;JUNB;ARG1;NR2F2;CALR;ARHGDIB;ETS1
12624,GO:0050868,0.0307691948319949,0.99200252830496,5,58,negative regulation of T cell activation,BP,CD274;CYLD;ANXA1;ARG1;DLG1
3647,GO:0008150,0.0308419141905191,0.982521351355228,349,11213,biological_process,BP,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;ASPRV1;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;HS3ST1;SPRR2E;MYO1B;DNAJB1;GREB1L;SPRR2D;PEG10;CCBE1;JUN;KRT4;CLDN11;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;TMEM265;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;CD83;STT3A;ITGAV;LYN;NCEH1;COBLL1;AP3M1;COL8A1;C1R;ANXA1;PDE1C;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SEMA3D;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;MMP19;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;KCTD12;HEPHL1;IL24;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;KRT34;SDR16C5;SLC7A5P2;SNAI3;GGCX;ADAM8;C2ORF49;L1CAM;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;METTL2A;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;ADGRL3;TYW1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;CHORDC1;TGFA;MGST3;BAMBI;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
611,GO:0001780,0.0308559831965253,0.997729639664245,2,9,neutrophil homeostasis,BP,AXL;ANXA1
993,GO:0002474,0.0308976760615196,0.990656429830914,6,83,antigen processing and presentation of peptide antigen via MHC class I,BP,PSMB9;ERAP1;ITGAV;CANX;CALR;SEC24D
1643,GO:0004108,0.030936789653228,1,1,1,citrate (Si)-synthase activity,MF,CS
9559,GO:0036440,0.030936789653228,1,1,1,citrate synthase activity,MF,CS
9105,GO:0035457,0.0309589942504804,0.997717940845602,2,9,cellular response to interferon-alpha,BP,AXL;IFNAR1
18063,GO:1902742,0.031116132834722,0.99538226332658,3,22,apoptotic process involved in development,BP,B4GALT1;SLIT2;CRYAB
1153,GO:0002774,0.0311168361513165,1,1,1,Fc receptor mediated inhibitory signaling pathway,BP,LYN
14840,GO:0070667,0.0311168361513165,1,1,1,negative regulation of mast cell proliferation,BP,LYN
8472,GO:0033674,0.0311668486017643,0.98278564054734,20,412,positive regulation of kinase activity,BP,SAA1;EDN1;RIPK2;HSPA5;IL1B;AXL;GADD45B;LYN;NBN;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IL23A;DLG1;TGFA;EPHA2;MAGED1;IRAK2
12310,GO:0048709,0.0311693259807127,0.991870895493384,5,58,oligodendrocyte differentiation,BP,CNTNAP1;LYN;NRG1;EIF2B1;SOX11
19714,GO:2000144,0.0311746633208575,0.99535109187485,3,23,positive regulation of DNA-templated transcription, initiation,BP,TP53;JUN;SETX
1487,GO:0003844,0.0312119116235281,1,1,1,1,4-alpha-glucan branching enzyme activity,MF,GBE1
17124,GO:0102752,0.0312119116235281,1,1,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,GBE1
3718,GO:0008270,0.0312925116506204,0.98132051662275,26,574,zinc ion binding,MF,MMP9;TRIM16;TP53;PEG10;PARP1;MSRB3;ANPEP;ERAP1;CYLD;TRAF3;CSRP1;MMP19;ZNF638;TRAF1;ADAM8;NR2F2;CALR;ZCCHC8;MME;GDA;ZMYM4;SEC24D;CHORDC1;PML;TRIM47;ENPP1
7661,GO:0032127,0.0312930558029431,1,1,1,dense core granule membrane,CC,ADAM8
15044,GO:0071065,0.0312930558029431,1,1,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,ADAM8
15058,GO:0071133,0.0312930558029431,1,1,1,alpha9-beta1 integrin-ADAM8 complex,CC,ADAM8
15790,GO:0072535,0.0312930558029431,1,1,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
15867,GO:0072680,0.0312930558029431,1,1,1,extracellular matrix-dependent thymocyte migration,BP,ADAM8
15868,GO:0072681,0.0312930558029431,1,1,1,fibronectin-dependent thymocyte migration,BP,ADAM8
19798,GO:2000307,0.0312930558029431,1,1,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19799,GO:2000309,0.0312930558029431,1,1,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19873,GO:2000410,0.0312930558029431,1,1,1,regulation of thymocyte migration,BP,ADAM8
19874,GO:2000412,0.0312930558029431,1,1,1,positive regulation of thymocyte migration,BP,ADAM8
19875,GO:2000413,0.0312930558029431,1,1,1,regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
19876,GO:2000415,0.0312930558029431,1,1,1,positive regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
5297,GO:0016032,0.0312950957837669,0.980775557148448,29,677,viral process,BP,NFKBIA;KRT8;LGALS1;TNIP1;KRT18;TP53;PSMB9;CLDN1;JUN;IL16;ANPEP;IL6ST;AXL;IFITM2;ITGAV;LYN;NEDD4L;HSP90AB1;PPID;UBP1;DLG1;ZC3H7B;TFRC;NEDD4;PML;EPHA2;PVR;HSPD1;SND1
1881,GO:0004576,0.0313098036084315,0.997629452977477,2,10,oligosaccharyl transferase activity,MF,STT3A;MAGT1
3849,GO:0008488,0.0313347528295636,1,1,1,gamma-glutamyl carboxylase activity,MF,GGCX
2114,GO:0004921,0.0313855232713867,1,1,1,interleukin-11 receptor activity,MF,IL6ST
6302,GO:0019970,0.0313855232713867,1,1,1,interleukin-11 binding,MF,IL6ST
9688,GO:0038154,0.0313855232713867,1,1,1,interleukin-11-mediated signaling pathway,BP,IL6ST
12803,GO:0051153,0.0314422433445021,0.991780840244642,5,58,regulation of striated muscle cell differentiation,BP,EDN1;G6PD;XBP1;NRG1;EHD1
768,GO:0002028,0.0315045090572275,0.991766689659664,5,57,regulation of sodium ion transport,BP,NETO1;SLC8A1;NEDD4L;DLG1;NEDD4
3383,GO:0007178,0.0315071053003488,0.985664918962116,12,211,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CDKN2B;PEG10;JUN;PARP1;HSPA5;FBN2;KLF10;HSP90AB1;CITED2;BAMBI;PML;SOX11
15948,GO:0085032,0.0315395347060814,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
10458,GO:0043392,0.0315781078305513,0.993317540063065,4,40,negative regulation of DNA binding,BP,NFKBIA;JUN;HMOX1;SOX11
17603,GO:1901379,0.0316018313660949,0.993320944172422,4,39,regulation of potassium ion transmembrane transport,BP,NETO1;NEDD4L;DLG1;NEDD4
12933,GO:0051365,0.0316095773788339,1,1,1,cellular response to potassium ion starvation,BP,JUN
6364,GO:0021571,0.0316724276547771,1,1,1,rhombomere 5 development,BP,MAFB
6365,GO:0021572,0.0316724276547771,1,1,1,rhombomere 6 development,BP,MAFB
9032,GO:0035283,0.0316724276547771,1,1,1,central nervous system segmentation,BP,MAFB
9033,GO:0035284,0.0316724276547771,1,1,1,brain segmentation,BP,MAFB
19792,GO:2000299,0.031686161210148,1,1,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,CHORDC1
18635,GO:1904021,0.0317717397405052,1,1,1,negative regulation of G-protein coupled receptor internalization,BP,UBQLN2
14411,GO:0061772,0.0317799474819979,1,1,1,drug transport across blood-nerve barrier,BP,CLDN1
18415,GO:1903544,0.0317799474819979,1,1,1,response to butyrate,BP,CLDN1
18416,GO:1903545,0.0317799474819979,1,1,1,cellular response to butyrate,BP,CLDN1
1780,GO:0004421,0.0318868324486732,1,1,1,hydroxymethylglutaryl-CoA synthase activity,MF,HMGCS1
4262,GO:0009645,0.0318868324486732,1,1,1,response to low light intensity stimulus,BP,HMGCS1
4387,GO:0010142,0.0318868324486732,1,1,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,HMGCS1
11772,GO:0046690,0.0318868324486732,1,1,1,response to tellurium ion,BP,HMGCS1
18072,GO:1902767,0.0318868324486732,1,1,1,isoprenoid biosynthetic process via mevalonate,BP,HMGCS1
14606,GO:0070232,0.0319169438828351,0.995178755943553,3,24,regulation of T cell apoptotic process,BP,TP53;CD274;ADAM8
17912,GO:1902305,0.0319936138721377,0.993212176324012,4,39,regulation of sodium ion transmembrane transport,BP,NETO1;NEDD4L;DLG1;NEDD4
3712,GO:0008260,0.032012830250844,1,1,1,3-oxoacid CoA-transferase activity,MF,OXCT1
11062,GO:0045105,0.0320372663586226,1,1,1,intermediate filament polymerization or depolymerization,BP,NEFL
18597,GO:1903937,0.0320372663586226,1,1,1,response to acrylamide,BP,NEFL
10459,GO:0043393,0.0320637641192635,0.986592778306885,10,169,regulation of protein binding,BP,MMP9;RIPK2;HERPUD1;HSPA5;PHLDA2;CYLD;NRP1;NRG1;HSP90AB1;BAMBI
4265,GO:0009649,0.0320833992254805,0.99516194184452,3,23,entrainment of circadian clock,BP,TP53;ARNTL2;PML
6766,GO:0030222,0.0320961282600739,1,1,1,eosinophil differentiation,BP,TRIB1
11284,GO:0045643,0.0320961282600739,1,1,1,regulation of eosinophil differentiation,BP,TRIB1
11285,GO:0045645,0.0320961282600739,1,1,1,positive regulation of eosinophil differentiation,BP,TRIB1
11093,GO:0045165,0.032168134814032,0.988118701881036,8,119,cell fate commitment,BP,CYLD;NRP1;NRG1;IFRD1;NR2F2;CTR9;IL23A;PML
10325,GO:0043171,0.0322024272349962,0.995137003999292,3,23,peptide catabolic process,BP,CHAC1;ANPEP;ERAP1
7526,GO:0031849,0.0322649968911231,1,1,1,olfactory receptor binding,MF,REEP1
13427,GO:0055002,0.0323011736282109,0.990156708422461,6,77,striated muscle cell development,BP,KRT8;EDN1;ACTG1;G6PD;SLC8A1;SORBS2
16747,GO:0098625,0.0323177076927728,1,1,1,methylselenol reductase activity,MF,TXNRD1
16748,GO:0098626,0.0323177076927728,1,1,1,methylseleninic acid reductase activity,MF,TXNRD1
10017,GO:0042509,0.032387300010527,0.993082373833257,4,41,regulation of tyrosine phosphorylation of STAT protein,BP,IL6ST;LYN;IL24;IL23A
4343,GO:0009956,0.0324394643455659,1,1,1,radial pattern formation,BP,NR2F2
14028,GO:0060849,0.0324394643455659,1,1,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,NR2F2
6367,GO:0021577,0.0324971704642797,1,1,1,hindbrain structural organization,BP,HSPA5
6371,GO:0021589,0.0324971704642797,1,1,1,cerebellum structural organization,BP,HSPA5
14043,GO:0060904,0.0324971704642797,1,1,1,regulation of protein folding in endoplasmic reticulum,BP,HSPA5
18748,GO:1904313,0.0324971704642797,1,1,1,response to methamphetamine hydrochloride,BP,HSPA5
18937,GO:1904762,0.0325302605662282,1,1,1,positive regulation of myofibroblast differentiation,BP,PARP1
11049,GO:0045083,0.0326202280065709,1,1,1,negative regulation of interleukin-12 biosynthetic process,BP,NFKB1
11739,GO:0046634,0.0326780835760493,0.993010692482182,4,40,regulation of alpha-beta T cell activation,BP,RIPK2;CD83;ANXA1;IL23A
6769,GO:0030225,0.0327664333313576,0.995018329996693,3,23,macrophage differentiation,BP,MMP9;PARP1;TRIB1
11219,GO:0045485,0.0328457551361668,1,1,1,omega-6 fatty acid desaturase activity,MF,FADS1
17471,GO:1900744,0.0328594559328925,0.99499867664256,3,23,regulation of p38MAPK cascade,BP,IL1B;GADD45B;DLG1
3838,GO:0008470,0.0329464077189887,1,1,1,isovaleryl-CoA dehydrogenase activity,MF,IVD
8021,GO:0032693,0.0329525902543116,0.997434911885557,2,10,negative regulation of interleukin-10 production,BP,CD274;IL23A
10743,GO:0044228,0.0329883495960897,1,1,1,host cell surface,CC,AXL
6529,GO:0021966,0.0330557814403401,1,1,1,corticospinal neuron axon guidance,BP,SLIT2
6530,GO:0021972,0.0330557814403401,1,1,1,corticospinal neuron axon guidance through spinal cord,BP,SLIT2
12666,GO:0050924,0.0330557814403401,1,1,1,positive regulation of negative chemotaxis,BP,SLIT2
12671,GO:0050929,0.0330557814403401,1,1,1,induction of negative chemotaxis,BP,SLIT2
15338,GO:0071623,0.0330557814403401,1,1,1,negative regulation of granulocyte chemotaxis,BP,SLIT2
16025,GO:0090024,0.0330557814403401,1,1,1,negative regulation of neutrophil chemotaxis,BP,SLIT2
16176,GO:0090260,0.0330557814403401,1,1,1,negative regulation of retinal ganglion cell axon guidance,BP,SLIT2
18024,GO:1902623,0.0330557814403401,1,1,1,negative regulation of neutrophil migration,BP,SLIT2
18512,GO:1903764,0.0330636957514538,1,1,1,regulation of potassium ion export across plasma membrane,BP,DLG1
18470,GO:1903672,0.0330864334956228,0.994950627047616,3,23,positive regulation of sprouting angiogenesis,BP,ANXA1;HMOX1;NRP1
2152,GO:0004998,0.0330875245990411,1,1,1,transferrin receptor activity,MF,TFRC
4957,GO:0015091,0.0330875245990411,1,1,1,ferric iron transmembrane transporter activity,MF,TFRC
8422,GO:0033570,0.0330875245990411,1,1,1,transferrin transmembrane transporter activity,MF,TFRC
15771,GO:0072510,0.0330875245990411,1,1,1,trivalent inorganic cation transmembrane transporter activity,MF,TFRC
17415,GO:1900243,0.0330974304031204,1,1,1,negative regulation of synaptic vesicle endocytosis,BP,SYT11
19108,GO:1905154,0.0330974304031204,1,1,1,negative regulation of membrane invagination,BP,SYT11
19110,GO:1905161,0.0330974304031204,1,1,1,protein localization to phagocytic vesicle,BP,SYT11
19111,GO:1905162,0.0330974304031204,1,1,1,regulation of phagosome maturation,BP,SYT11
19116,GO:1905169,0.0330974304031204,1,1,1,regulation of protein localization to phagocytic vesicle,BP,SYT11
19117,GO:1905171,0.0330974304031204,1,1,1,positive regulation of protein localization to phagocytic vesicle,BP,SYT11
19235,GO:1905468,0.0330974304031204,1,1,1,regulation of clathrin-coated pit assembly,BP,SYT11
19236,GO:1905469,0.0330974304031204,1,1,1,negative regulation of clathrin-coated pit assembly,BP,SYT11
19374,GO:1905953,0.0330979618432683,0.994948182989002,3,23,negative regulation of lipid localization,BP,NFKBIA;NFKB1;ITGAV
770,GO:0002031,0.0331028177727947,0.99741684573953,2,10,G-protein coupled receptor internalization,BP,UBQLN2;HTR1B
2732,GO:0006147,0.033113047021159,1,1,1,guanine catabolic process,BP,GDA
3977,GO:0008892,0.033113047021159,1,1,1,guanine deaminase activity,MF,GDA
9597,GO:0036494,0.0331200654041586,1,1,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,DNAJC3
13743,GO:0060370,0.0331251659123401,1,1,1,susceptibility to T cell mediated cytotoxicity,BP,PVR
17034,GO:0099580,0.0331325218681303,1,1,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,SLC8A1
6299,GO:0019962,0.0331340984682692,1,1,1,type I interferon binding,MF,IFNAR1
6012,GO:0019089,0.0331419053383994,1,1,1,transmission of virus,BP,NEDD4
10678,GO:0044007,0.0331419053383994,1,1,1,dissemination or transmission of symbiont from host,BP,NEDD4
13161,GO:0051821,0.0331419053383994,1,1,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,NEDD4
8849,GO:0034683,0.0331559352985702,1,1,1,integrin alphav-beta3 complex,CC,ITGAV
11321,GO:0045715,0.0331559352985702,1,1,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
12542,GO:0050748,0.0331559352985702,1,1,1,negative regulation of lipoprotein metabolic process,BP,ITGAV
13267,GO:0052066,0.0331559352985702,1,1,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,ITGAV
13277,GO:0052190,0.0331559352985702,1,1,1,modulation by symbiont of host phagocytosis,BP,ITGAV
13278,GO:0052191,0.0331559352985702,1,1,1,positive regulation by symbiont of host phagocytosis,BP,ITGAV
13288,GO:0052231,0.0331559352985702,1,1,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13304,GO:0052370,0.0331559352985702,1,1,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
13320,GO:0052522,0.0331559352985702,1,1,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,ITGAV
19925,GO:2000536,0.0331559352985702,1,1,1,negative regulation of entry of bacterium into host cell,BP,ITGAV
17594,GO:1901350,0.0331589480705888,1,1,1,cell-cell signaling involved in cell-cell junction organization,BP,TJP1
13552,GO:0060060,0.0331607866678066,1,1,1,post-embryonic retina morphogenesis in camera-type eye,BP,DSCAM
14806,GO:0070593,0.0331607866678066,1,1,1,dendrite self-avoidance,BP,DSCAM
18587,GO:1903918,0.0331709424165638,1,1,1,regulation of actin filament severing,BP,MYH9
18588,GO:1903919,0.0331709424165638,1,1,1,negative regulation of actin filament severing,BP,MYH9
20260,GO:2001288,0.0331925951895901,1,1,1,positive regulation of caveolin-mediated endocytosis,BP,NEDD4L
15369,GO:0071674,0.0331946293724994,0.994908712237102,3,24,mononuclear cell migration,BP,SLIT2;LYN;ANXA1
16440,GO:0097166,0.0331999108202097,1,1,1,lens epithelial cell proliferation,BP,SOX11
20168,GO:2001109,0.0331999108202097,1,1,1,regulation of lens epithelial cell proliferation,BP,SOX11
20169,GO:2001111,0.0331999108202097,1,1,1,positive regulation of lens epithelial cell proliferation,BP,SOX11
2407,GO:0005595,0.0332279133350216,1,1,1,collagen type XII trimer,CC,COL12A1
7041,GO:0030846,0.0332545487177139,1,1,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,SETX
7418,GO:0031554,0.0332545487177139,1,1,1,regulation of DNA-templated transcription, termination,BP,SETX
13872,GO:0060566,0.0332545487177139,1,1,1,positive regulation of DNA-templated transcription, termination,BP,SETX
18863,GO:1904594,0.0332545487177139,1,1,1,regulation of termination of RNA polymerase II transcription,BP,SETX
18864,GO:1904595,0.0332545487177139,1,1,1,positive regulation of termination of RNA polymerase II transcription,BP,SETX
20080,GO:2000804,0.0332545487177139,1,1,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,SETX
20081,GO:2000806,0.0332545487177139,1,1,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,SETX
14337,GO:0061618,0.0332644326954899,1,1,1,sublamina densa,CC,FRAS1
2500,GO:0005767,0.0333066026205781,0.997392265516552,2,10,secondary lysosome,CC,FTH1;ADAM8
481,GO:0001530,0.0333120503324271,0.997391607264385,2,10,lipopolysaccharide binding,MF,RNASE7;HSPD1
13628,GO:0060192,0.0334520514516624,0.997374670148805,2,10,negative regulation of lipase activity,BP,ANXA8;ANXA1
18189,GO:1903034,0.0334601160032261,0.98854010510142,7,100,regulation of response to wounding,BP,KRT1;SERPINB2;EDN1;C1QTNF1;LYN;ANXA1;XBP1
17299,GO:1900024,0.03347735261527,0.992785581641834,4,40,regulation of substrate adhesion-dependent cell spreading,BP,NRP1;CALR;CORO1C;HAS2
14844,GO:0070671,0.0336253934085434,0.992723727629889,4,42,response to interleukin-12,BP,SERPINB2;LCP1;RIPK2;SOD2
10081,GO:0042629,0.0337176838126719,0.997342425273366,2,10,mast cell granule,CC,LYN;ANXA1
12638,GO:0050886,0.0338861166530877,0.992669765548837,4,40,endocrine process,BP,EDN1;IL1B;C1QTNF1;MME
19988,GO:2000648,0.0339308432161298,0.994770696270614,3,23,positive regulation of stem cell proliferation,BP,EPCAM;VEGFC;SOX11
9818,GO:0042094,0.03394362189962,0.997314886669928,2,10,interleukin-2 biosynthetic process,BP,IL1A;IL1B
2626,GO:0005976,0.0339525506225272,0.989527680261113,6,78,polysaccharide metabolic process,BP,NFKB1;IL6ST;PHLDA2;HAS2;GBE1;ENPP1
6643,GO:0030016,0.0340044665630919,0.987297586569791,8,122,myofibril,CC,KRT8;CRYAB;ACTG1;SLC8A1;PDE4DIP;SORBS2;TPM4;PARVA
14741,GO:0070486,0.034325724809145,0.997268079909938,2,10,leukocyte aggregation,BP,IL1B;HAS2
12069,GO:0048145,0.0343268468630669,0.990802307987742,5,60,regulation of fibroblast proliferation,BP,TP53;JUN;FTH1;CDK6;PML
7784,GO:0032355,0.0344622780289846,0.989319304512333,6,81,response to estradiol,BP,CRYAB;DUSP1;ANXA1;NR2F2;CALR;ETS1
6998,GO:0030730,0.0346147874704091,0.997232475690634,2,10,sequestering of triglyceride,BP,IL1B;ENPP1
15119,GO:0071277,0.0347660014162601,0.992418901349116,4,40,cellular response to calcium ion,BP,EDN1;JUN;HSPA5;JUNB
12561,GO:0050777,0.0348011212344083,0.989189585131947,6,81,negative regulation of immune response,BP,LYN;ANXA1;ARG1;HMOX1;IL7R;NLRP10
5528,GO:0016540,0.0348621007285555,0.997201881127937,2,10,protein autoprocessing,BP,PARP1;KLK6
8590,GO:0034134,0.0348872490792387,0.997198763243423,2,10,toll-like receptor 2 signaling pathway,BP,RIPK2;LYN
14925,GO:0070862,0.0350356150254228,0.997180343224187,2,10,negative regulation of protein exit from endoplasmic reticulum,BP,DERL3;SVIP
7588,GO:0031996,0.035091465808235,0.997173397846074,2,10,thioesterase binding,MF,TRAF3;TRAF1
11768,GO:0046686,0.0351100221557972,0.992289415660952,4,43,response to cadmium ion,BP,MMP9;JUN;ARG1;HMOX1
636,GO:0001829,0.0352400889116677,0.997154885452285,2,10,trophectodermal cell differentiation,BP,JUNB;CTR9
7007,GO:0030800,0.0352958671717896,0.997147926421157,2,10,negative regulation of cyclic nucleotide metabolic process,BP,GPR176;EGLN1
7022,GO:0030815,0.0352958671717896,0.997147926421157,2,10,negative regulation of cAMP metabolic process,BP,GPR176;EGLN1
11475,GO:0046006,0.0353165532469863,0.99443199471976,3,25,regulation of activated T cell proliferation,BP,CD274;ARG1;IL23A
3170,GO:0006809,0.0354201306684389,0.992220115993982,4,41,nitric oxide biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
3182,GO:0006826,0.0355811913747951,0.99216318631276,4,42,iron ion transport,BP,FTH1;STEAP4;SLC39A14;TFRC
1268,GO:0003073,0.0356769325357124,0.992145947114089,4,41,regulation of systemic arterial blood pressure,BP,EDN1;SOD2;NR2F2;MME
12219,GO:0048536,0.0360922162848767,0.994280639027375,3,24,spleen development,BP,CDKN2B;NFKB2;CITED2
1140,GO:0002755,0.0363079420517462,0.994233028313152,3,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1;HSPD1;IRAK2
12513,GO:0050702,0.0363469703158298,0.994224402364321,3,24,interleukin-1 beta secretion,BP,TRIM16;RIPK2;PML
7812,GO:0032387,0.036351349871575,0.991939607305525,4,42,negative regulation of intracellular transport,BP,CRYAB;DERL3;HMOX1;SVIP
2958,GO:0006515,0.0363698012820821,0.994219354550144,3,24,protein quality control for misfolded or incompletely synthesized proteins,BP,UGGT1;NGLY1;SDF2L1
17881,GO:1902235,0.0364890180225865,0.994173267743424,3,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1;HERPUD1;XBP1
8938,GO:0035035,0.0364923932882349,0.994192227867442,3,24,histone acetyltransferase binding,MF,TP53;CITED2;ETS1
9614,GO:0036513,0.0366150976756333,0.99698154317022,2,10,Derlin-1 retrotranslocation complex,CC,SEL1L;SVIP
12068,GO:0048144,0.036667417387426,0.989994109197638,5,61,fibroblast proliferation,BP,TP53;JUN;FTH1;CDK6;PML
7586,GO:0031994,0.0366954327793292,0.996971300620877,2,10,insulin-like growth factor I binding,MF,ITGAV;IGFBP3
16820,GO:0098792,0.0369786041857396,0.996935096237552,2,10,xenophagy,BP,RIPK2;OPTN
18351,GO:1903409,0.0369812988671006,0.98988545148376,5,61,reactive oxygen species biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1;CYP1A1
10443,GO:0043369,0.0370292812108996,0.996928600495239,2,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,CYLD;IL23A
7564,GO:0031953,0.0370692267831511,0.99692347677202,2,10,negative regulation of protein autophosphorylation,BP,JUN;ENPP1
17684,GO:1901654,0.0372341030603908,0.985836457855994,8,125,response to ketone,BP,NEFL;EDN1;SLIT2;CLDN1;PARP1;DUSP1;ARG1;CALR
3276,GO:0006983,0.0373256275351574,0.996890514842487,2,10,ER overload response,BP,TP53;HSPA5
4622,GO:0010762,0.037493174199755,0.993969386654431,3,24,regulation of fibroblast migration,BP,SLC8A1;PRR5L;CORO1C
9231,GO:0035666,0.0376530053047834,0.993913020712106,3,25,TRIF-dependent toll-like receptor signaling pathway,BP,IKBKE;BIRC3;TRAF3
716,GO:0001946,0.0376609464509653,0.996847214608977,2,10,lymphangiogenesis,BP,CCBE1;VEGFC
9900,GO:0042277,0.0377723897100469,0.983760387688013,10,173,peptide binding,MF,NFKBIA;ANPEP;CRYAB;ERAP1;ITGAV;HSP90AB1;CALR;PPID;MME;TUBB3
12846,GO:0051224,0.0378532934788652,0.986678267875561,7,104,negative regulation of protein transport,BP,IL1B;ANXA1;DERL3;SYT11;SVIP;PML;MIDN
12216,GO:0048532,0.037885360086229,0.996818113960296,2,10,anatomical structure arrangement,BP,HSPA5;NRP1
9957,GO:0042391,0.038088717710887,0.982843046161045,11,195,regulation of membrane potential,BP,NETO1;EDN1;PMAIP1;JUN;PARP1;CNTNAP1;SLC8A1;NEDD4L;RIMS2;DLG1;NEDD4
3434,GO:0007260,0.0381509434954234,0.991400232398727,4,43,tyrosine phosphorylation of STAT protein,BP,IL6ST;LYN;IL24;IL23A
7971,GO:0032611,0.0381694210577758,0.991405584765464,4,42,interleukin-1 beta production,BP,TRIM16;RIPK2;IL1B;PML
3587,GO:0008037,0.038339320901911,0.989412320781905,5,61,cell recognition,BP,DSCAM;B4GALT1;NRP1;DLG1;PVR
17334,GO:1900101,0.0384092172346027,0.993742159817592,3,25,regulation of endoplasmic reticulum unfolded protein response,BP,HSPA5;DNAJB9;XBP1
11835,GO:0046879,0.038599790290693,0.98334795623513,10,171,hormone secretion,BP,EDN1;IL1B;C1QTNF1;LYN;ANXA1;RIMS2;SERP1;OXCT1;SOX11;MIDN
8708,GO:0034383,0.0386357569549795,0.993690703593652,3,25,low-density lipoprotein particle clearance,BP,NCEH1;HMOX1;EHD1
9827,GO:0042107,0.0386405221444081,0.989306725784522,5,61,cytokine metabolic process,BP,IL1A;NFKB1;IL1B;HMOX1;TNFSF15
4323,GO:0009892,0.0387346606989351,0.971133632118244,79,2166,negative regulation of metabolic process,BP,CDKN2A;MMP9;SERPINB2;OSR2;TNIP1;DUSP8;NFKB1;RELB;FEZ1;EDN1;TP53;PSMB9;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;DNAJB1;JUN;NFKB2;HERPUD1;PARP1;OPTN;IL1B;JUNB;CRYAB;ATF3;DNAJC10;GADD45B;NOCT;DUSP1;ANXA8;TRIB1;ITGAV;LYN;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;SUDS3;HMOX1;EGLN1;KLF10;NRG1;SERPINH1;HSP90AB1;SDR16C5;SNAI3;NR2F2;EIF4G2;CALR;PPID;CTR9;AJUBA;IGFBP3;ORMDL1;PRR5L;UBP1;CORO1C;DLG1;RBMS3;CITED2;ZNF814;CHORDC1;DNAJC3;ZC3H7B;SVIP;NEDD4;CDK6;PML;ZBTB21;SOX11;ENPP1;SND1;MAGED1;MIDN
2522,GO:0005793,0.0387903228157087,0.986277383989636,7,104,endoplasmic reticulum-Golgi intermediate compartment,CC,HSPA5;ANPEP;UGGT1;SERPINH1;CALR;PDIA6;TGFA
363,GO:0000982,0.0388693986073623,0.980552039428089,14,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;TP53;JUN;NFKB2;ARID3B;JUNB;ATF3;EHF;ARNTL2;KLF10;SNAI3;ETS1;ZFP42;SOX11
5597,GO:0016668,0.0389962972465854,0.996618045187352,2,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,PGK1;TXNRD1
12550,GO:0050766,0.0390037801461579,0.993606845895634,3,25,positive regulation of phagocytosis,BP,IL1B;ITGAV;CALR
17462,GO:1900543,0.0390370786944497,0.993599242358368,3,25,negative regulation of purine nucleotide metabolic process,BP,PARP1;GPR176;EGLN1
6619,GO:0023023,0.0390747732158904,0.996607512596369,2,11,MHC protein complex binding,MF,HSP90AA1;HSP90AB1
2591,GO:0005903,0.0390941866304643,0.989154694290111,5,60,brush border,CC,B4GALT1;MYO1B;HSP90AB1;MME;MYH9
9999,GO:0042474,0.0391508789256659,0.996597286717568,2,11,middle ear morphogenesis,BP,OSR2;EDN1
18193,GO:1903038,0.039151197818708,0.989119932277618,5,62,negative regulation of leukocyte cell-cell adhesion,BP,CD274;CYLD;ANXA1;ARG1;DLG1
2084,GO:0004861,0.0391797235066226,0.996593408105638,2,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,CDKN2A;CDKN2B
7312,GO:0031342,0.0392564640741602,0.996583081268032,2,11,negative regulation of cell killing,BP,IL7R;HSP90AB1
2637,GO:0005996,0.0393193428909412,0.982193987283043,11,198,monosaccharide metabolic process,BP,B4GALT1;PMAIP1;PGK1;C1QTNF1;PHLDA2;ATF3;G6PD;IGFBP3;SERP1;ENPP1;MIDN
4846,GO:0014706,0.0393204077286378,0.981500411451981,12,217,striated muscle tissue development,BP,EDN1;ATF3;G6PD;SLC8A1;EGLN1;NRG1;IFRD1;NR2F2;CALR;MAFF;SOX11;SORBS2
683,GO:0001906,0.039499832858805,0.988976381086437,5,65,cell killing,BP,ARG1;IL7R;HSP90AB1;IL23A;PVR
6757,GO:0030212,0.0395095728821874,0.993491063454106,3,25,hyaluronan metabolic process,BP,NFKB1;IL1B;HAS2
18555,GO:1903859,0.0395281396313971,0.996602135028893,2,10,regulation of dendrite extension,BP,NEDD4L;RIMS2
8570,GO:0034103,0.0395317575566941,0.990999800219325,4,42,regulation of tissue remodeling,BP,B4GALT1;ADAM8;IL23A;TFRC
8132,GO:0032885,0.0398380111334239,0.993437700929194,3,24,regulation of polysaccharide biosynthetic process,BP,NFKB1;HAS2;ENPP1
13044,GO:0051592,0.0398573954021646,0.98721196145326,6,82,response to calcium ion,BP,EDN1;JUN;HSPA5;JUNB;DUSP1;NEDD4
10510,GO:0043491,0.0400225409056417,0.98352961559416,9,148,protein kinase B signaling,BP,FGF5;IL1B;C1QTNF1;AXL;SETX;NRG1;ADAM8;DLG1;EPHA2
4295,GO:0009790,0.0400599191539098,0.974847293282255,29,665,embryo development,BP,MMP9;KRT8;OSR2;MAFB;EDN1;COL12A1;JUNB;PHLDA2;NOCT;FBN2;DUSP1;ITGAV;COL8A1;NBN;VEGFC;FRAS1;NRP1;EGLN1;NRG1;C2ORF49;NR2F2;CTR9;MAFF;DLG1;CITED2;TXNRD1;SEC24D;MYH9;SOX11
8320,GO:0033197,0.0401757107268321,0.996458495755753,2,11,response to vitamin E,BP,ARG1;HMGCS1
11371,GO:0045807,0.040193737067536,0.987078348938591,6,82,positive regulation of endocytosis,BP,IL1B;AXL;ITGAV;NEDD4L;CALR;CBLL1
15929,GO:0080090,0.0402426807350319,0.968283338692423,154,4503,regulation of primary metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;SERPINB2;SAA1;OSR2;TNIP1;DUSP8;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;PSMB9;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;PHLDA2;CRYAB;ATF3;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;ITGAV;LYN;C1R;ANXA1;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;IL24;HSP90AA1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;TNFSF15;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;ORMDL1;MAFF;MGA;PRR5L;HMGCS1;UBP1;CORO1C;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;TXNRD1;PTTG1IP;ETS1;HAS2;CHORDC1;TGFA;BAMBI;DNAJC3;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;PML;EPHA2;MYH9;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;CYP1A1
7873,GO:0032463,0.0404979147850031,0.996414442701229,2,11,negative regulation of protein homooligomerization,BP,CLDN7;CRYAB
1108,GO:0002704,0.0405653025042528,0.993226558393843,3,26,negative regulation of leukocyte mediated immunity,BP,ARG1;HMOX1;IL7R
10470,GO:0043406,0.0405753081675309,0.981538165293303,11,195,positive regulation of MAP kinase activity,BP,SAA1;EDN1;RIPK2;IL1B;GADD45B;NRG1;ADAM8;AJUBA;TGFA;MAGED1;IRAK2
9863,GO:0042176,0.040644130384595,0.978992728435886,15,300,regulation of protein catabolic process,BP,UBQLN2;HERPUD1;IL1B;TRIB1;DERL3;NEDD4L;XBP1;HSP90AA1;NRG1;HSP90AB1;ADAM8;PTTG1IP;SVIP;NEDD4;PML
12925,GO:0051347,0.0406601012752484,0.976209193251985,22,480,positive regulation of transferase activity,BP,SAA1;EDN1;RIPK2;HSPA5;IL1B;AXL;GADD45B;LYN;NBN;HSP90AA1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IL23A;DLG1;TGFA;EPHA2;MAGED1;IRAK2
20038,GO:2000727,0.0406814096747882,0.996389265663212,2,11,positive regulation of cardiac muscle cell differentiation,BP,EDN1;NRG1
16026,GO:0090025,0.0407608432840264,0.99637834673897,2,11,regulation of monocyte chemotaxis,BP,SLIT2;LYN
15159,GO:0071346,0.0408182640235781,0.985390667821082,7,107,cellular response to interferon-gamma,BP,EDN1;CLDN1;ACTG1;ARG1;HSP90AB1;IFNGR1;PML
16138,GO:0090200,0.0410143526029614,0.993102282951131,3,27,positive regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;PMAIP1
6475,GO:0021854,0.041188893860161,0.99631929976334,2,11,hypothalamus development,BP,NRP1;ETS1
14612,GO:0070243,0.0412217896829926,0.996314747540948,2,11,regulation of thymocyte apoptotic process,BP,TP53;ADAM8
12170,GO:0048385,0.0412689563416266,0.996308216885912,2,11,regulation of retinoic acid receptor signaling pathway,BP,TRIM16;CALR
8317,GO:0033189,0.0413076256431316,0.996302859611748,2,11,response to vitamin A,BP,ARG1;CYP1A1
4663,GO:0010829,0.0413846006807862,0.996292186972471,2,11,negative regulation of glucose transmembrane transport,BP,IL1B;ENPP1
11745,GO:0046640,0.0416578805103203,0.996254205684683,2,11,regulation of alpha-beta T cell proliferation,BP,RIPK2;IL23A
6909,GO:0030522,0.0417046906116007,0.980196895440095,12,221,intracellular receptor signaling pathway,BP,NFKBIA;TRIM16;RIPK2;PARP1;CYLD;BIRC3;NR2F2;CALR;CITED2;NEDD4;PML;IRAK2
4770,GO:0010977,0.0417851695662883,0.984985406127124,7,103,negative regulation of neuron projection development,BP,LGALS1;DPYSL3;SLIT2;SEMA7A;SEMA3D;NRP1;IFRD1
7129,GO:0031000,0.0419578617662235,0.996212350414409,2,11,response to caffeine,BP,TP53;SLC8A1
9505,GO:0036270,0.0419578617662235,0.996212350414409,2,11,response to diuretic,BP,TP53;SLC8A1
16499,GO:0097284,0.0419628822362665,0.996211648478473,2,11,hepatocyte apoptotic process,BP,KRT8;KRT18
671,GO:0001885,0.0420203463660578,0.990246443082689,4,42,endothelial cell development,BP,CLDN1;IL1B;TJP2;TJP1
4567,GO:0010675,0.0420346281395811,0.98634203052708,6,82,regulation of cellular carbohydrate metabolic process,BP,PMAIP1;C1QTNF1;PHLDA2;IGFBP3;ENPP1;MIDN
13321,GO:0052547,0.0422065923784884,0.978623009209218,14,283,regulation of peptidase activity,BP,MMP9;SERPINB2;PMAIP1;PSMB9;RIPK2;HERPUD1;CRYAB;ANXA8;LYN;BIRC3;TNFSF15;SERPINH1;PML;HSPD1
15254,GO:0071480,0.0422453787781724,0.992832252887918,3,26,cellular response to gamma radiation,BP,TP53;HSPA5;CRYAB
12729,GO:0051044,0.0423042468553101,0.996163809018936,2,11,positive regulation of membrane protein ectodomain proteolysis,BP,IL1B;ADAM8
7990,GO:0032642,0.0423735399043016,0.990114213562282,4,44,regulation of chemokine production,BP,IL1A;RIPK2;IL1B;HMOX1
19651,GO:2000010,0.0424402782302435,0.996144684104872,2,11,positive regulation of protein localization to cell surface,BP,NRG1;HSP90AB1
15604,GO:0072148,0.0425023444714958,0.996135946517278,2,11,epithelial cell fate commitment,BP,NRP1;NR2F2
11463,GO:0045980,0.0425425351256501,0.992761825466896,3,26,negative regulation of nucleotide metabolic process,BP,PARP1;GPR176;EGLN1
4944,GO:0015037,0.042555680760826,0.996077061373651,2,12,peptide disulfide oxidoreductase activity,MF,PDIA6;PDIA4
13430,GO:0055006,0.042630523899018,0.99005938684493,4,42,cardiac cell development,BP,EDN1;G6PD;SLC8A1;SORBS2
12184,GO:0048471,0.0427022923787332,0.974570355673762,23,510,perinuclear region of cytoplasm,CC,LCP1;KRT18;SPRR3;MYO1B;OPTN;HRNR;NOCT;CYLD;NFKBIE;LYN;WWC1;MOBP;HMOX1;SYT11;DCUN1D3;CALR;DLG1;TGFA;HSP90B1;TFRC;NEDD4;SORBS2;CLINT1
15396,GO:0071712,0.0427174668653497,0.99610560585564,2,11,ER-associated misfolded protein catabolic process,BP,UGGT1;SDF2L1
9796,GO:0042044,0.042731104911088,0.996103679427179,2,11,fluid transport,BP,EDN1;HAS2
4332,GO:0009914,0.0428140124958451,0.981196061110558,10,174,hormone transport,BP,EDN1;IL1B;C1QTNF1;LYN;ANXA1;RIMS2;SERP1;OXCT1;SOX11;MIDN
12751,GO:0051085,0.0428399861473872,0.992691123436043,3,26,chaperone cofactor-dependent protein refolding,BP,DNAJB1;HSPA5;HSPA6
16500,GO:0097286,0.0428948738132763,0.996080519148076,2,11,iron ion import,BP,STEAP4;TFRC
3611,GO:0008083,0.0429137144959772,0.987753036269714,5,65,growth factor activity,MF,CXCL1;FGF5;VEGFC;NRG1;TGFA
11333,GO:0045732,0.0429309255499701,0.98113380481191,10,175,positive regulation of protein catabolic process,BP,UBQLN2;HERPUD1;IL1B;TRIB1;NEDD4L;XBP1;HSP90AA1;ADAM8;PTTG1IP;NEDD4
17335,GO:1900102,0.0429584333658258,0.996071516973481,2,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,HSPA5;DNAJB9
7556,GO:0031941,0.0429591281622202,0.992662746903674,3,26,filamentous actin,CC,DPYSL3;ACTG1;TPM4
1242,GO:0003007,0.0430039079569035,0.982070164808351,9,148,heart morphogenesis,BP,JUN;NRP1;EGLN1;NRG1;CITED2;HAS2;NEDD4;SOX11;PARVA
8942,GO:0035051,0.0430259669045423,0.985942054221684,6,82,cardiocyte differentiation,BP,EDN1;G6PD;SLC8A1;NRG1;CALR;SORBS2
9822,GO:0042100,0.0430484264606368,0.989906210833967,4,44,B cell proliferation,BP,LYN;IL7R;TFRC;HSPD1
3162,GO:0006793,0.0431220588212225,0.967408420938681,85,2351,phosphorus metabolic process,BP,CDKN2A;MMP9;IL1A;NEFL;DSCAM;SAA1;TNIP1;DUSP8;NFKB1;EDN1;TP53;PSMB9;FGF5;DBNDD2;NAGK;SLIT2;CDKN2B;PGK1;JUN;RIPK2;PARP1;HSPA5;IL1B;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;AXL;DNAJC10;GADD45B;IKBKE;SEMA7A;DUSP1;TRIB1;FADS1;PLBD1;ITGAV;LYN;GPR176;G6PD;NBN;PLEKHA2;WWC1;THTPA;VEGFC;UGGT1;PAPSS2;IL24;HSP90AA1;DAPP1;NRP1;EGLN1;SETX;GNPTAB;TNFSF15;NRG1;HSP90AB1;ADAM8;NR2F2;AJUBA;IGFBP3;EYA3;MOCS2;PRR5L;HMGCS1;CORO1C;IL23A;DLG1;GDA;DHDDS;CHORDC1;TGFA;DNAJC3;HSP90B1;UBXN2B;CDK6;PML;EPHA2;BTBD10;CPPED1;ENPP1;MAGED1;MIDN;IRAK2
1208,GO:0002886,0.0432518763929197,0.992592883034272,3,26,regulation of myeloid leukocyte mediated immunity,BP,LYN;ARG1;HMOX1
1389,GO:0003334,0.0433836939618164,0.996011091133054,2,11,keratinocyte development,BP,KRT2;CDSN
10289,GO:0043112,0.0434139763325286,0.982972582926227,8,128,receptor metabolic process,BP,EDN1;UBQLN2;OPTN;ITGAV;NRG1;TFRC;HTR1B;NEDD4
3294,GO:0007010,0.0434269629674608,0.970600536944297,40,977,cytoskeleton organization,BP,NEFL;KRT8;CXCL1;KRT2;LCP1;KRT18;NEFM;EDN1;DPYSL3;SLIT2;MYO1B;KRT4;MAP7D2;KRT13;CNTNAP1;CRYAB;ACTG1;CYLD;FIGN;COBLL1;ANXA1;BIRC3;RHOB;NRP1;CALR;AJUBA;AMOTL2;ARHGDIB;CORO1C;DLG1;ZMYM4;CHORDC1;HSP90B1;TUBB3;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;PARVA
7885,GO:0032480,0.0434809846377947,0.989772313046083,4,44,negative regulation of type I interferon production,BP,RELB;IKBKE;CYLD;TRAF3
18311,GO:1903322,0.0436058473962463,0.984170294184784,7,107,positive regulation of protein modification by small protein conjugation or removal,BP,TNIP1;RIPK2;HSPA5;BIRC3;DCUN1D3;CTR9;PTTG1IP
3707,GO:0008250,0.0436743717669971,0.995916175597147,2,12,oligosaccharyltransferase complex,CC,STT3A;MAGT1
12637,GO:0050885,0.0437556259638112,0.992495277254101,3,25,neuromuscular process controlling balance,BP,NEFL;CNTNAP1;NBN
719,GO:0001952,0.0437921125360058,0.985631305807753,6,82,regulation of cell-matrix adhesion,BP,CDKN2A;PLEKHA2;VEGFC;NRP1;CORO1C;CDK6
10398,GO:0043277,0.0441541921694763,0.992376311343614,3,26,apoptotic cell clearance,BP,AXL;ITGAV;PDIA6
13140,GO:0051785,0.0443448797478919,0.989503546983422,4,44,positive regulation of nuclear division,BP,IL1A;EDN1;IL1B;TGFA
7362,GO:0031434,0.0444696047180212,0.989490141566445,4,42,mitogen-activated protein kinase kinase binding,MF,AXL;TRIB1;DLG1;EPHA2
16555,GO:0097421,0.0445019202239492,0.992270582180878,3,27,liver regeneration,BP,NFKBIA;CLDN1;HMOX1
4626,GO:0010766,0.0445683769860291,0.995840980583356,2,11,negative regulation of sodium ion transport,BP,NEDD4L;NEDD4
11567,GO:0046209,0.0445807801392818,0.989429845729683,4,44,nitric oxide metabolic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
11361,GO:0045780,0.0447165538030739,0.99581952046132,2,11,positive regulation of bone resorption,BP,ADAM8;TFRC
11826,GO:0046852,0.0447165538030739,0.99581952046132,2,11,positive regulation of bone remodeling,BP,ADAM8;TFRC
1253,GO:0003018,0.0447929423763373,0.985211690229036,6,84,vascular process in circulatory system,BP,EDN1;SLIT2;SLC8A1;HMOX1;SOD2;HTR1B
8137,GO:0032890,0.0449596170900345,0.992181430797974,3,26,regulation of organic acid transport,BP,EDN1;IL1B;ARG1
19029,GO:1904950,0.045095642482174,0.983506387981033,7,108,negative regulation of establishment of protein localization,BP,IL1B;ANXA1;DERL3;SYT11;SVIP;PML;MIDN
3531,GO:0007569,0.0451047481553462,0.98507837204537,6,85,cell aging,BP,CDKN2A;TP53;CALR;MME;CDK6;PML
5599,GO:0016671,0.045127595820465,0.995703659810689,2,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRB3;DNAJC10
6268,GO:0019896,0.0451712803483828,0.995753410356115,2,11,axonal transport of mitochondrion,BP,NEFL;FEZ1
3575,GO:0008015,0.045279608049649,0.977503764448218,13,249,blood circulation,BP,EDN1;SLIT2;ANPEP;ERAP1;SLC8A1;NEDD4L;VEGFC;HMOX1;SOD2;NR2F2;MME;DLG1;HTR1B
1765,GO:0004385,0.045568498877556,0.995695349463378,2,11,guanylate kinase activity,MF,TJP2;DLG1
10127,GO:0042742,0.0458809619890478,0.984732715044318,6,90,defense response to bacterium,BP,RNASE7;RIPK2;OPTN;SYT11;IL23A;NLRP10
15264,GO:0071495,0.0462181485458213,0.969023250201817,37,904,cellular response to endogenous stimulus,BP,NFKB1;EDN1;TP53;FGF5;SLIT2;CLDN1;CDKN2B;PEG10;JUN;RIPK2;PARP1;HSPA5;IL1B;JUNB;FBN2;DUSP1;LYN;ANXA1;SLC8A1;XBP1;ARG1;SETX;KLF10;HSP90AB1;NR2F2;CALR;HMGCS1;EHD1;CITED2;HAS2;BAMBI;HSP90B1;HTR1B;NEDD4;PML;SOX11;ENPP1
769,GO:0002029,0.0462257553812102,0.995540455788021,2,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,UBQLN2;HTR1B
6555,GO:0022401,0.0462257553812102,0.995540455788021,2,12,negative adaptation of signaling pathway,BP,UBQLN2;HTR1B
10389,GO:0043266,0.0464663350109822,0.988836023366989,4,44,regulation of potassium ion transport,BP,NETO1;NEDD4L;DLG1;NEDD4
13127,GO:0051764,0.0465056936126946,0.99555721495103,2,11,actin crosslink formation,BP,LCP1;DPYSL3
16812,GO:0098772,0.0465547824154405,0.96775681475061,44,1119,molecular function regulator,MF,IL32;CDKN2A;IL1A;NEFL;SERPINB2;CXCL1;SAA1;EDN1;CXCL16;FGF5;SLIT2;CDKN2B;DNAJB1;JUN;IL16;IL1B;DNAJC10;SEMA7A;TRIB1;ANXA1;NEDD4L;BIRC3;VEGFC;SEMA3D;IL24;HSP90AA1;NRP1;TNFSF15;NRG1;SERPINH1;HSP90AB1;STXBP5;IGFBP3;EIF2B1;ARHGDIB;GIT2;IL23A;DLG1;TGFA;DNAJC3;UBXN2B;NEDD4;MON1A;TOR1AIP1
4358,GO:0010001,0.0466575082821604,0.981431003691802,8,130,glial cell differentiation,BP,FGF5;CNTNAP1;IL6ST;LYN;NRG1;EIF2B1;CDK6;SOX11
19847,GO:2000377,0.0466777982877158,0.982795726690644,7,109,regulation of reactive oxygen species metabolic process,BP,EDN1;TP53;IL1B;CRYAB;G6PD;HSP90AA1;HSP90AB1
1141,GO:0002756,0.0467442936712398,0.991721176794807,3,27,MyD88-independent toll-like receptor signaling pathway,BP,IKBKE;BIRC3;TRAF3
6426,GO:0021761,0.0473361867947043,0.986134173189929,5,64,limbic system development,BP,NEFL;FEZ1;NRP1;ETS1;CDK6
8233,GO:0033036,0.0474930377477761,0.964052702247926,82,2268,macromolecule localization,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;NFKB1;EDN1;TP53;PMAIP1;CD274;RIPK2;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HSPA5;IL1B;CNTNAP1;C1QTNF1;IKBKE;CYLD;STOML1;FBN2;NFKBIE;STAC;ITGAV;LYN;AP3M1;ANXA1;DERL3;NEDD4L;VEGFC;RHOB;XBP1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;NRP1;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;AJUBA;ANO4;SEL1L;SERP1;PRR5L;RAB30;SEC22A;CORO1C;DLG1;PDIA4;EHD1;PTTG1IP;SEC24D;REEP1;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;ZDHHC6;PML;OXCT1;EPHA2;MON1A;EPB41L2;MYH9;TOR1AIP1;UGCG;ENPP1;TNFAIP2;CEP83;HSPD1;MIDN
12534,GO:0050728,0.0476077218140943,0.986016618098689,5,66,negative regulation of inflammatory response,BP,KRT1;SAA1;NFKB1;ETS1;NLRP10
7479,GO:0031670,0.0476217665672928,0.988455106083769,4,45,cellular response to nutrient,BP,CDKN2B;XBP1;HMOX1;HSP90B1
17301,GO:1900026,0.0476780704365617,0.991489089615894,3,27,positive regulation of substrate adhesion-dependent cell spreading,BP,NRP1;CALR;HAS2
10404,GO:0043292,0.047767439896493,0.98089681425555,8,131,contractile fiber,CC,KRT8;CRYAB;ACTG1;SLC8A1;PDE4DIP;SORBS2;TPM4;PARVA
20230,GO:2001238,0.0477737196160556,0.988394032402239,4,46,positive regulation of extrinsic apoptotic signaling pathway,BP,PMAIP1;ATF3;CYLD;PML
8894,GO:0034763,0.0478814279954733,0.985922213498081,5,65,negative regulation of transmembrane transport,BP,MMP9;IL1B;NEDD4L;NEDD4;ENPP1
1248,GO:0003013,0.0479174273317218,0.975992160950059,13,251,circulatory system process,BP,EDN1;SLIT2;ANPEP;ERAP1;SLC8A1;NEDD4L;VEGFC;HMOX1;SOD2;NR2F2;MME;DLG1;HTR1B
5769,GO:0017017,0.0479192006006999,0.995284423817528,2,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,DUSP8;DUSP1
11410,GO:0045893,0.0479579035561976,0.966985522127427,42,1051,positive regulation of transcription, DNA-templated,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;WWC1;XBP1;ARNTL2;EGLN1;SETX;KLF10;NRG1;NR2F2;EDRF1;CTR9;MAFF;IL23A;CITED2;ETS1;BAMBI;PML;SOX11;MAGED1;SUPT3H
18387,GO:1903508,0.0479579035561976,0.966985522127427,42,1051,positive regulation of nucleic acid-templated transcription,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;WWC1;XBP1;ARNTL2;EGLN1;SETX;KLF10;NRG1;NR2F2;EDRF1;CTR9;MAFF;IL23A;CITED2;ETS1;BAMBI;PML;SOX11;MAGED1;SUPT3H
9036,GO:0035296,0.0480342312981334,0.985864981812318,5,65,regulation of tube diameter,BP,EDN1;SLC8A1;HMOX1;SOD2;HTR1B
16691,GO:0097746,0.0480342312981334,0.985864981812318,5,65,regulation of blood vessel diameter,BP,EDN1;SLC8A1;HMOX1;SOD2;HTR1B
19649,GO:2000008,0.0480569791491996,0.991394366075008,3,27,regulation of protein localization to cell surface,BP,NEDD4L;NRG1;HSP90AB1
12552,GO:0050768,0.0481214160282502,0.978432192013012,10,176,negative regulation of neurogenesis,BP,LGALS1;DPYSL3;SLIT2;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;CALR;SOX11
12594,GO:0050821,0.0482430717545767,0.980661738885384,8,133,protein stabilization,BP,IFT46;CRYAB;HSP90AA1;HSP90AB1;CALR;SEL1L;SUGT1;HSPD1
18422,GO:1903556,0.0484549743601351,0.991271969947435,3,28,negative regulation of tumor necrosis factor superfamily cytokine production,BP,CD274;AXL;SYT11
3703,GO:0008238,0.0485102617359983,0.985686344402231,5,65,exopeptidase activity,MF,ANPEP;ERAP1;TPP2;PREP;MME
18040,GO:1902680,0.0485516205366234,0.966545144736762,42,1052,positive regulation of RNA biosynthetic process,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;WWC1;XBP1;ARNTL2;EGLN1;SETX;KLF10;NRG1;NR2F2;EDRF1;CTR9;MAFF;IL23A;CITED2;ETS1;BAMBI;PML;SOX11;MAGED1;SUPT3H
8104,GO:0032816,0.0485795361379213,0.995183166851243,2,12,positive regulation of natural killer cell activation,BP,AXL;IL23A
14166,GO:0061138,0.048620242131747,0.980497774414306,8,128,morphogenesis of a branching epithelium,BP,B4GALT1;EDN1;SLIT2;NRP1;DLG1;PML;EPHA2;MAGED1
18675,GO:1904152,0.0487256954235751,0.995160647438939,2,12,regulation of retrograde protein transport, ER to cytosol,BP,DERL3;SVIP
5638,GO:0016757,0.0488885863966091,0.977054184381143,11,206,transferase activity, transferring glycosyl groups,MF,B4GALT1;PARP1;STT3A;UGGT1;MGAT5;MAGT1;HAS2;GALNT14;GBE1;UGCG;SDF2L1
810,GO:0002088,0.0489215851442468,0.988050416002869,4,44,lens development in camera-type eye,BP,CRYAB;DLG1;EPHA2;SOX11
12613,GO:0050857,0.0489260716524978,0.995129711643043,2,12,positive regulation of antigen receptor-mediated signaling pathway,BP,CYLD;LYN
6542,GO:0022008,0.0489880873606729,0.966369626376884,41,1013,neurogenesis,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;FGF5;DBNDD2;SLIT2;CHAC1;JUN;SDK1;HSPA5;CNTNAP1;IL6ST;AXL;SEMA7A;LYN;ANXA1;NEDD4L;VEGFC;XBP1;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;NR2F2;CALR;EIF2B1;EHD1;ADGRL3;NEDD4;CDK6;TUBB3;NTNG1;SOX11
3206,GO:0006869,0.0489921790419424,0.977007486625203,11,201,lipid transport,BP,NFKBIA;NFKB1;EDN1;SPNS2;APOL6;IL1B;C1QTNF1;STOML1;ITGAV;ANXA1;ANO4
630,GO:0001823,0.049219038190144,0.985427973391313,5,64,mesonephros development,BP,OSR2;SLIT2;EPCAM;DLG1;MAGED1
7224,GO:0031175,0.0492548275499324,0.968732595371734,28,645,neuron projection development,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;SLIT2;JUN;SDK1;HSPA5;CNTNAP1;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;EHD1;NEDD4;TUBB3;NTNG1
7582,GO:0031984,0.049272232987021,0.965109384803762,49,1272,organelle subcompartment,CC,B4GALT1;CHAC1;MYO1B;HERPUD1;OPTN;HSPA5;DNAJB9;MGLL;ERAP1;FADS1;STT3A;NCEH1;FADS3;DERL3;XBP1;SEC11C;HMOX1;CANX;GNPTAB;SDR16C5;GGCX;STEAP4;CALR;PDIA6;SEL1L;MGAT5;SLC35B1;SERP1;ORMDL1;MAGT1;RAB30;SEC22A;DLG1;DHDDS;SEC24D;REEP1;CALU;MSMO1;TGFA;MGST3;DNAJC3;HSP90B1;SVIP;ZDHHC6;PML;GALNT14;UGCG;SDF2L1;CYP1A1
4708,GO:0010888,0.0493352898988776,0.995066307329592,2,12,negative regulation of lipid storage,BP,NFKBIA;ITGAV
12648,GO:0050905,0.0494475751712537,0.98788032850673,4,44,neuromuscular process,BP,NEFL;CNTNAP1;NBN;NRG1
10813,GO:0044342,0.0495122062517459,0.995038802245651,2,12,type B pancreatic cell proliferation,BP,IGFBP3;BTBD10
5307,GO:0016051,0.0497392968296759,0.978673023540145,9,157,carbohydrate biosynthetic process,BP,NFKB1;B4GALT1;PGK1;ATF3;G6PD;HAS2;GALNT14;GBE1;ENPP1
7465,GO:0031649,0.0498308402464776,0.99498912210583,2,12,heat generation,BP,IL1A;IL1B
9306,GO:0035821,0.0498913504992257,0.983065435914542,6,89,modification of morphology or physiology of other organism,BP,TNIP1;RNASE7;JUN;ITGAV;ARG1;SUGT1
2714,GO:0006109,0.0500029665438246,0.979823120433216,8,130,regulation of carbohydrate metabolic process,BP,NFKB1;PMAIP1;C1QTNF1;PHLDA2;IGFBP3;HAS2;ENPP1;MIDN
1802,GO:0004464,0.0501032896322789,0.999357955613318,1,2,leukotriene-C4 synthase activity,MF,MGST3
4372,GO:0010042,0.0502540644536874,0.994922852335549,2,12,response to manganese ion,BP,HSPA5;ARG1
4249,GO:0009612,0.0507788907966035,0.979439505450916,8,132,response to mechanical stimulus,BP,NFKBIA;NFKB1;EDN1;JUN;IL1B;JUNB;SLC8A1;ETS1
6778,GO:0030239,0.0509303687762323,0.990665909709684,3,27,myofibril assembly,BP,KRT8;EDN1;ACTG1
1095,GO:0002691,0.0509549617440902,0.994812397470117,2,12,regulation of cellular extravasation,BP,IL1A;ADAM8
6237,GO:0019838,0.0510350795948591,0.982599923495355,6,86,growth factor binding,MF,TRIM16;IL6ST;DUSP1;ITGAV;NRP1;IGFBP3
13426,GO:0055001,0.051060040237331,0.982589348674403,6,86,muscle cell development,BP,KRT8;EDN1;ACTG1;G6PD;SLC8A1;SORBS2
323,GO:0000904,0.0511305088486219,0.969336505181377,22,482,cell morphogenesis involved in differentiation,BP,NEFL;DSCAM;FEZ1;SLIT2;AXL;SEMA7A;ITGAV;NEDD4L;SEMA3D;NRP1;NRG1;IFRD1;L1CAM;CALR;CORO1C;HAS2;NEDD4;TUBB3;NTNG1;EPHA2;MYH9;PARVA
11295,GO:0045655,0.0511772300437104,0.99477718671609,2,12,regulation of monocyte differentiation,BP,JUN;CDK6
19666,GO:2000045,0.0512155420668533,0.979216509974296,8,135,regulation of G1/S transition of mitotic cell cycle,BP,CDKN2A;TP53;CDKN2B;ANXA1;DCUN1D3;CDK6;PML;CYP1A1
3589,GO:0008043,0.0512533292172085,0.999327740274262,1,2,intracellular ferritin complex,CC,FTH1
14635,GO:0070288,0.0512533292172085,0.999327740274262,1,2,ferritin complex,CC,FTH1
14122,GO:0061045,0.0514028942949308,0.987214829781159,4,46,negative regulation of wound healing,BP,KRT1;SERPINB2;EDN1;C1QTNF1
12793,GO:0051140,0.0514040977849537,0.999323726195725,1,2,regulation of NK T cell proliferation,BP,IL23A
12794,GO:0051142,0.0514040977849537,0.999323726195725,1,2,positive regulation of NK T cell proliferation,BP,IL23A
4485,GO:0010536,0.0515611589085584,0.999319531534879,1,2,positive regulation of activation of Janus kinase activity,BP,IL23A
18418,GO:1903547,0.0516325989277495,0.999317619166315,1,2,regulation of growth hormone activity,BP,PHLDA2
18770,GO:1904377,0.051720688766338,0.987123847303595,4,45,positive regulation of protein localization to cell periphery,BP,STAC;DLG1;EPHA2;EPB41L2
8888,GO:0034755,0.051725731290918,0.994689919077509,2,12,iron ion transmembrane transport,BP,STEAP4;SLC39A14
59,GO:0000122,0.0518119494443509,0.967518054055572,26,603,negative regulation of transcription by RNA polymerase II,BP,OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;WWC1;NEDD4L;SUDS3;KLF10;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;DLG1;CITED2;NEDD4;SOX11
6442,GO:0021782,0.0518718812916782,0.984401486614517,5,66,glial cell development,BP,CNTNAP1;LYN;EIF2B1;CDK6;SOX11
11736,GO:0046631,0.0520032868597193,0.984351070756741,5,66,alpha-beta T cell activation,BP,RELB;RIPK2;CD83;ANXA1;IL23A
12767,GO:0051101,0.0521325655583477,0.982109338314673,6,90,regulation of DNA binding,BP,NFKBIA;MMP9;JUN;PARP1;HMOX1;SOX11
16073,GO:0090100,0.0521925377944903,0.98427839515051,5,66,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CDKN2B;PARP1;HSP90AB1;CITED2;SOX11
4883,GO:0014829,0.0523599212953076,0.994588352274274,2,12,vascular smooth muscle contraction,BP,EDN1;SLC8A1
11780,GO:0046710,0.0523772633476343,0.99458556490475,2,12,GDP metabolic process,BP,TJP2;DLG1
6745,GO:0030199,0.0526428740107704,0.990223373709042,3,27,collagen fibril organization,BP,COL12A1;SERPINH1;LOX
8161,GO:0032922,0.0527749716814886,0.986775402735592,4,45,circadian regulation of gene expression,BP,RELB;NOCT;PML;MAGED1
18357,GO:1903426,0.0528106763513326,0.986736116443715,4,47,regulation of reactive oxygen species biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
19668,GO:2000048,0.0528709325336747,0.999284032204571,1,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,EPCAM
2346,GO:0005459,0.0529824077295511,0.99928096801477,1,2,UDP-galactose transmembrane transporter activity,MF,SLC35B1
15707,GO:0072334,0.0529824077295511,0.99928096801477,1,2,UDP-galactose transmembrane transport,BP,SLC35B1
12576,GO:0050798,0.0530138125828396,0.990077685904235,3,29,activated T cell proliferation,BP,CD274;ARG1;IL23A
6855,GO:0030366,0.0532887781858148,0.999272511974528,1,2,molybdopterin synthase activity,MF,MOCS2
19539,GO:1990622,0.0533226039729691,0.999271575244424,1,2,CHOP-ATF3 complex,CC,ATF3
19810,GO:2000321,0.0533983062086079,0.99926947659436,1,2,positive regulation of T-helper 17 cell differentiation,BP,IL23A
19818,GO:2000330,0.0533983062086079,0.99926947659436,1,2,positive regulation of T-helper 17 cell lineage commitment,BP,IL23A
2197,GO:0005094,0.0533986625861437,0.999269466707369,1,2,Rho GDP-dissociation inhibitor activity,MF,ARHGDIB
654,GO:0001849,0.0534376122230016,0.999268385712177,1,2,complement component C1q binding,MF,CALR
6575,GO:0022612,0.0535786383395122,0.981515399721329,6,86,gland morphogenesis,BP,B4GALT1;XBP1;ARG1;NRP1;PML;EPHA2
4888,GO:0014839,0.0537621662196433,0.999259346200852,1,2,myoblast migration involved in skeletal muscle regeneration,BP,ANXA1
6631,GO:0023058,0.053773215010429,0.994298143601099,2,13,adaptation of signaling pathway,BP,UBQLN2;HTR1B
7898,GO:0032495,0.0538039566191103,0.994354437922041,2,12,response to muramyl dipeptide,BP,NFKBIA;RIPK2
1767,GO:0004392,0.0538045655959532,0.999258161074856,1,2,heme oxygenase (decyclizing) activity,MF,HMOX1
3159,GO:0006788,0.0538045655959532,0.999258161074856,1,2,heme oxidation,BP,HMOX1
13736,GO:0060359,0.0538471085749739,0.983630762971752,5,67,response to ammonium ion,BP,SDK1;HSPA5;HSP90AB1;ADGRL3;HTR1B
9658,GO:0038066,0.053886433870312,0.989872185490846,3,28,p38MAPK cascade,BP,IL1B;GADD45B;DLG1
8725,GO:0034405,0.0538971803011416,0.989869354259105,3,28,response to fluid shear stress,BP,CITED2;ETS1;HAS2
16041,GO:0090049,0.0539744004873896,0.989849002946907,3,28,regulation of cell migration involved in sprouting angiogenesis,BP,ANXA1;HMOX1;NRP1
19126,GO:1905207,0.0540221045574098,0.989836424401499,3,28,regulation of cardiocyte differentiation,BP,EDN1;G6PD;NRG1
8617,GO:0034185,0.0540372404791986,0.994316305353509,2,12,apolipoprotein binding,MF,CANX;HSPD1
2441,GO:0005667,0.054041970461441,0.972423105894205,13,260,transcription factor complex,CC,MAFB;TP53;JUN;PARP1;JUNB;ARNTL2;SNAI3;AJUBA;EYA3;MED18;ETS1;ZFP42;SUPT3H
3433,GO:0007259,0.0540666972496936,0.981280350210792,6,90,JAK-STAT cascade,BP,IL6ST;LYN;IL24;IFNAR1;CTR9;IL23A
4326,GO:0009895,0.0541759597873669,0.974136496819349,11,208,negative regulation of catabolic process,BP,FEZ1;IL1B;NOCT;DERL3;HMOX1;EGLN1;NRG1;HSP90AB1;EIF4G2;SVIP;PML
1609,GO:0004053,0.0542191891745299,0.999246520378355,1,2,arginase activity,MF,ARG1
6160,GO:0019547,0.0542191891745299,0.999246520378355,1,2,arginine catabolic process to ornithine,BP,ARG1
19760,GO:2000242,0.0542383764396321,0.989755016776244,3,29,negative regulation of reproductive process,BP,DUSP1;CALR;ARHGDIB
19202,GO:1905397,0.0544242107392719,0.99924072989236,1,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
19203,GO:1905402,0.0544242107392719,0.99924072989236,1,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,CD274
12495,GO:0050680,0.0544912304774039,0.98111629757578,6,87,negative regulation of epithelial cell proliferation,BP,CDKN2B;KRT4;NR2F2;DLG1;CDK6;MAGED1
13087,GO:0051673,0.0544917341550805,0.999238817817811,1,2,membrane disruption in other organism,BP,RNASE7
20161,GO:2001057,0.0544988043822866,0.986171949535054,4,47,reactive nitrogen species metabolic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
11442,GO:0045935,0.0545769577951273,0.961069600709281,49,1270,positive regulation of nucleobase-containing compound metabolic process,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NBN;WWC1;XBP1;ARNTL2;HSP90AA1;EGLN1;SETX;KLF10;NRG1;HSP90AB1;NR2F2;CALR;EDRF1;CTR9;EYA3;MAFF;PRR5L;IL23A;CITED2;ETS1;BAMBI;TFRC;PML;SOX11;MAGED1;SUPT3H
9356,GO:0035924,0.0546071729989175,0.989681771220698,3,28,cellular response to vascular endothelial growth factor stimulus,BP,CCBE1;ANXA1;NRP1
19904,GO:2000482,0.0547026785763918,0.994144095658671,2,13,regulation of interleukin-8 secretion,BP,ANXA1;NLRP10
2249,GO:0005176,0.0547336422546137,0.999231947352652,1,2,ErbB-2 class receptor binding,MF,NRG1
1162,GO:0002792,0.0548015309401454,0.983250629377174,5,68,negative regulation of peptide secretion,BP,IL1B;ANXA1;SYT11;PML;MIDN
12520,GO:0050709,0.0548015309401454,0.983250629377174,5,68,negative regulation of protein secretion,BP,IL1B;ANXA1;SYT11;PML;MIDN
12101,GO:0048237,0.0548304781593282,0.999229188203529,1,2,rough endoplasmic reticulum lumen,CC,EDN1
18661,GO:1904062,0.0549545305290198,0.975991959910833,9,158,regulation of cation transmembrane transport,BP,MMP9;NETO1;STAC;LYN;G6PD;SLC8A1;NEDD4L;DLG1;NEDD4
20108,GO:2000848,0.0549692277279712,0.999225225936496,1,2,positive regulation of corticosteroid hormone secretion,BP,C1QTNF1
14252,GO:0061394,0.0550347637912296,0.999223350791548,1,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF3
3052,GO:0006633,0.0552623736087628,0.980757782361983,6,91,fatty acid biosynthetic process,BP,EDN1;MGLL;FADS1;ANXA1;FADS3;XBP1
12521,GO:0050710,0.0552933795620642,0.989474532990842,3,29,negative regulation of cytokine secretion,BP,ANXA1;SYT11;PML
11018,GO:0045041,0.0553250165357081,0.999215017924404,1,2,protein import into mitochondrial intermembrane space,BP,HSPD1
17882,GO:1902236,0.055426019929378,0.994023158462106,2,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,HERPUD1;XBP1
11123,GO:0045213,0.0557133274726442,0.999203798342225,1,2,neurotransmitter receptor metabolic process,BP,NRG1
17449,GO:1900424,0.0557925694585502,0.993961524192382,2,13,regulation of defense response to bacterium,BP,SYT11;NLRP10
4868,GO:0014806,0.0558251228713986,0.999200553014062,1,2,smooth muscle hyperplasia,BP,HMOX1
3243,GO:0006925,0.0558805339707831,0.993946698267382,2,13,inflammatory cell apoptotic process,BP,CDKN2A;ANXA1
16751,GO:0098632,0.055963945944002,0.989295066175204,3,29,cell-cell adhesion mediator activity,MF,KRT18;EPCAM;ANXA1
19703,GO:2000116,0.0559676755986044,0.974213014133915,10,189,regulation of cysteine-type endopeptidase activity,BP,MMP9;PMAIP1;PSMB9;RIPK2;HERPUD1;CRYAB;BIRC3;TNFSF15;PML;HSPD1
15239,GO:0071461,0.0560001358942542,0.999195458887363,1,2,cellular response to redox state,BP,ARHGDIB
14425,GO:0061827,0.0560166970521672,0.99919497597712,1,2,sperm head,CC,HSP90AB1
11312,GO:0045672,0.0561794937486926,0.99389620933618,2,13,positive regulation of osteoclast differentiation,BP,KLF10;IL23A
8408,GO:0033549,0.0562760409201738,0.99387987096671,2,13,MAP kinase phosphatase activity,MF,DUSP8;DUSP1
8139,GO:0032892,0.0564870916237424,0.993844099004951,2,13,positive regulation of organic acid transport,BP,EDN1;IL1B
12669,GO:0050927,0.0565728607414393,0.993829539450528,2,13,positive regulation of positive chemotaxis,BP,IL16;VEGFC
1229,GO:0002933,0.0566185338881646,0.999177325675613,1,2,lipid hydroxylation,BP,CYP1A1
17071,GO:0101020,0.0566185338881646,0.999177325675613,1,2,estrogen 16-alpha-hydroxylase activity,MF,CYP1A1
2105,GO:0004906,0.0566422575690599,0.999176625884645,1,2,interferon-gamma receptor activity,MF,IFNGR1
14977,GO:0070949,0.0566739637696243,0.999175690150445,1,2,regulation of neutrophil mediated killing of symbiont cell,BP,ARG1
14981,GO:0070960,0.0566739637696243,0.999175690150445,1,2,positive regulation of neutrophil mediated cytotoxicity,BP,ARG1
14982,GO:0070961,0.0566739637696243,0.999175690150445,1,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,ARG1
9302,GO:0035812,0.0567086551149093,0.999174665689796,1,2,renal sodium excretion,BP,EDN1
9303,GO:0035813,0.0567086551149093,0.999174665689796,1,2,regulation of renal sodium excretion,BP,EDN1
11738,GO:0046633,0.0567396083794349,0.993801196958946,2,13,alpha-beta T cell proliferation,BP,RIPK2;IL23A
17371,GO:1900150,0.0567865386260115,0.999172363346682,1,2,regulation of defense response to fungus,BP,ARG1
4400,GO:0010193,0.0568160012926799,0.999171491529066,1,2,response to ozone,BP,EDN1
3400,GO:0007198,0.0568525195320064,0.999170410276989,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR1B
15150,GO:0071332,0.0569806885287602,0.999166609632377,1,2,cellular response to fructose stimulus,BP,XBP1
18570,GO:1903894,0.0569835293527497,0.993759650145714,2,13,regulation of IRE1-mediated unfolded protein response,BP,HSPA5;DNAJB9
7870,GO:0032460,0.0570690796116272,0.99374505400365,2,13,negative regulation of protein oligomerization,BP,CLDN7;CRYAB
13282,GO:0052203,0.0570962926713109,0.999163173904753,1,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,SUGT1
16505,GO:0097305,0.0571819680584961,0.977950914335111,7,112,response to alcohol,BP,TP53;CLDN1;CLDN7;G6PD;HMGCS1;HTR1B;OXCT1
7964,GO:0032602,0.0572283233496843,0.985219169713152,4,49,chemokine production,BP,IL1A;RIPK2;IL1B;HMOX1
18740,GO:1904293,0.0572759808376253,0.993709701149243,2,13,negative regulation of ERAD pathway,BP,DERL3;SVIP
7229,GO:0031205,0.0573789724330664,0.99915474206455,1,2,endoplasmic reticulum Sec complex,CC,DNAJC3
1151,GO:0002767,0.0573821789509766,0.999154646170027,1,2,immune response-inhibiting cell surface receptor signaling pathway,BP,LYN
19486,GO:1990418,0.0575047766685049,0.999150975544868,1,2,response to insulin-like growth factor stimulus,BP,XBP1
6878,GO:0030432,0.0575142299595735,0.999150692169346,1,2,peristalsis,BP,DLG1
8276,GO:0033132,0.0575472367801456,0.999149702362141,1,2,negative regulation of glucokinase activity,BP,MIDN
18298,GO:1903300,0.0575472367801456,0.999149702362141,1,2,negative regulation of hexokinase activity,BP,MIDN
14141,GO:0061082,0.0575488790872745,0.993662958148164,2,13,myeloid leukocyte cytokine production,BP,SEMA7A;HMOX1
8856,GO:0034696,0.0576128370507405,0.999147733380883,1,2,response to prostaglandin F,BP,EDN1
16273,GO:0090500,0.057666625816602,0.999146117169625,1,2,endocardial cushion to mesenchymal transition,BP,HAS2
19699,GO:2000111,0.0576871878911419,0.999145498916514,1,2,positive regulation of macrophage apoptotic process,BP,CDKN2A
10415,GO:0043305,0.0576975562183347,0.999145187077936,1,2,negative regulation of mast cell degranulation,BP,HMOX1
9296,GO:0035801,0.057770635895353,0.999142987465651,1,2,adrenal cortex development,BP,CITED2
9297,GO:0035802,0.057770635895353,0.999142987465651,1,2,adrenal cortex formation,BP,CITED2
7712,GO:0032229,0.0577899181890547,0.999142406605763,1,2,negative regulation of synaptic transmission, GABAergic,BP,HTR1B
7336,GO:0031398,0.0577907038655602,0.9796556747438,6,91,positive regulation of protein ubiquitination,BP,RIPK2;HSPA5;BIRC3;DCUN1D3;CTR9;PTTG1IP
10318,GO:0043161,0.0578161402901392,0.967338658098028,17,371,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,TP53;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;TRIB1;DERL3;NEDD4L;HSP90AB1;SEL1L;HSP90B1;SVIP;UBXN2B;NEDD4;PML
14683,GO:0070374,0.0578455481420902,0.977637948461738,7,112,positive regulation of ERK1 and ERK2 cascade,BP,IL1A;JUN;RIPK2;AXL;SEMA7A;NRP1;EPHA2
7248,GO:0031247,0.057863482068037,0.999140188704948,1,2,actin rod assembly,BP,HSP90B1
17682,GO:1901652,0.0578671566803269,0.96793604878295,16,338,response to peptide,BP,NFKBIA;TRIM16;NEFL;NFKB1;EDN1;TP53;RIPK2;PARP1;IL1B;LYN;ANXA1;XBP1;ARG1;KLF10;EIF2B1;ENPP1
7334,GO:0031396,0.057892184942122,0.974447223093397,9,162,regulation of protein ubiquitination,BP,RIPK2;HERPUD1;HSPA5;BIRC3;HSP90AA1;DCUN1D3;HSP90AB1;CTR9;PTTG1IP
10436,GO:0043335,0.0579263996142554,0.999138289442332,1,2,protein unfolding,BP,HSP90AA1
6346,GO:0021546,0.0579607011460832,0.999137253088605,1,2,rhombomere development,BP,MAFB
816,GO:0002094,0.0579733505162883,0.999136870750647,1,2,polyprenyltransferase activity,MF,DHDDS
17466,GO:1900673,0.0579739223033276,0.999136853465836,1,2,olefin metabolic process,BP,CYP1A1
9684,GO:0038129,0.0580114650262729,0.999135718179526,1,2,ERBB3 signaling pathway,BP,NRG1
13963,GO:0060720,0.0580388116549023,0.999134890737602,1,2,spongiotrophoblast cell proliferation,BP,PHLDA2
13964,GO:0060721,0.0580388116549023,0.999134890737602,1,2,regulation of spongiotrophoblast cell proliferation,BP,PHLDA2
13965,GO:0060722,0.0580388116549023,0.999134890737602,1,2,cell proliferation involved in embryonic placenta development,BP,PHLDA2
13966,GO:0060723,0.0580388116549023,0.999134890737602,1,2,regulation of cell proliferation involved in embryonic placenta development,BP,PHLDA2
16149,GO:0090214,0.0580388116549023,0.999134890737602,1,2,spongiotrophoblast layer developmental growth,BP,PHLDA2
10697,GO:0044087,0.0580438947883994,0.962559360358554,28,663,regulation of cellular component biogenesis,BP,LCP1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;SLIT2;CLDN1;UBQLN2;CLDN7;DNAJB1;JUN;PARP1;CRYAB;CYLD;SYT11;HSP90AA1;NRP1;SETX;AJUBA;ORMDL1;CORO1C;DLG1;HAS2;ADGRL3;SVIP;EPHA2;TJP1
9509,GO:0036292,0.0580449697752469,0.999134704351706,1,2,DNA rewinding,BP,ANXA1
887,GO:0002266,0.0581090432643472,0.999132763832081,1,2,follicular dendritic cell activation,BP,NFKB2
888,GO:0002268,0.0581090432643472,0.999132763832081,1,2,follicular dendritic cell differentiation,BP,NFKB2
8341,GO:0033257,0.0581090432643472,0.999132763832081,1,2,Bcl3/NF-kappaB2 complex,CC,NFKB2
18443,GO:1903589,0.0581115108147668,0.999132689055449,1,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,HMOX1
8059,GO:0032764,0.0581312087984924,0.999132092008774,1,2,negative regulation of mast cell cytokine production,BP,HMOX1
20182,GO:2001160,0.0581740889439025,0.99913079157784,1,2,regulation of histone H3-K79 methylation,BP,CTR9
20183,GO:2001162,0.0581740889439025,0.99913079157784,1,2,positive regulation of histone H3-K79 methylation,BP,CTR9
11343,GO:0045745,0.0582197441056326,0.993547503074755,2,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,UBQLN2;KLK6
7849,GO:0032432,0.0582318417895476,0.984902878931239,4,47,actin filament bundle,CC,LCP1;CRYAB;MYH9;TPM4
4832,GO:0014062,0.0582393699624549,0.999128809866827,1,2,regulation of serotonin secretion,BP,HTR1B
5981,GO:0019008,0.0585376755120324,0.999119724723028,1,2,molybdopterin synthase complex,CC,MOCS2
18741,GO:1904294,0.0585635244487491,0.993488038332096,2,13,positive regulation of ERAD pathway,BP,UBQLN2;HERPUD1
7214,GO:0031133,0.0585995189730753,0.99911783514989,1,2,regulation of axon diameter,BP,NEFL
5393,GO:0016256,0.0586085371701576,0.999117559432274,1,2,N-glycan processing to lysosome,BP,GNPTAB
8714,GO:0034390,0.0586548399194244,0.993472209052326,2,13,smooth muscle cell apoptotic process,BP,CDKN2A;EDN1
8715,GO:0034391,0.0586548399194244,0.993472209052326,2,13,regulation of smooth muscle cell apoptotic process,BP,CDKN2A;EDN1
9414,GO:0036022,0.0586565795328488,0.999116089861934,1,2,limb joint morphogenesis,BP,OSR2
9415,GO:0036023,0.0586565795328488,0.999116089861934,1,2,embryonic skeletal limb joint morphogenesis,BP,OSR2
7333,GO:0031394,0.0587097513332183,0.99911446191762,1,2,positive regulation of prostaglandin biosynthetic process,BP,ANXA1
20257,GO:2001280,0.0587097513332183,0.99911446191762,1,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
6427,GO:0021762,0.0587524897831883,0.98851379545766,3,30,substantia nigra development,BP,HSPA5;G6PD;SUDS3
1900,GO:0004602,0.0587744004939152,0.993340436686277,2,15,glutathione peroxidase activity,MF,GPX8;MGST3
18381,GO:1903487,0.0587806734341818,0.999112288114836,1,2,regulation of lactation,BP,XBP1
15137,GO:0071313,0.0588097004583763,0.999111397627776,1,2,cellular response to caffeine,BP,SLC8A1
15208,GO:0071415,0.0588097004583763,0.999111397627776,1,2,cellular response to purine-containing compound,BP,SLC8A1
10230,GO:0043000,0.0588383125256945,0.999110519420335,1,2,Golgi to plasma membrane CFTR protein transport,BP,KRT18
13041,GO:0051589,0.0589397084123483,0.993422735883327,2,13,negative regulation of neurotransmitter transport,BP,SYT11;HTR1B
2104,GO:0004905,0.0589658713222529,0.999106598740526,1,2,type I interferon receptor activity,MF,IFNAR1
14483,GO:0070012,0.0591148632030296,0.999102008032727,1,2,oligopeptidase activity,MF,PREP
14724,GO:0070447,0.0591464087825122,0.999101034500746,1,2,positive regulation of oligodendrocyte progenitor proliferation,BP,LYN
17240,GO:0140031,0.059200731249852,0.999099356773906,1,2,phosphorylation-dependent protein binding,MF,LYN
14473,GO:0065007,0.0592548293436255,0.953079754629144,255,7891,biological regulation,BP,IL32;CDKN2A;NFKBIA;RPTN;MMP9;IL1A;FLG2;TRIM16;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;LCP1;TNIP1;DUSP8;KRT18;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;FGF5;DBNDD2;SLIT2;CLDN1;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;CLDN7;DNAJB1;PEG10;CCBE1;JUN;KRT4;MCAM;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;SDK1;HRNR;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;CD83;ITGAV;LYN;NCEH1;COL8A1;C1R;ANXA1;PDE1C;GPR176;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;ARG1;UGGT1;SEMA3D;SUDS3;TRAF3;CSRP1;ARNTL2;HMOX1;SYT11;KLK6;ZNF638;PAPSS2;IL24;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;TNFSF15;CXCR5;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;RRAS2;MGA;PRR5L;RAB30;HMGCS1;ARHGDIB;UBP1;GIT2;CORO1C;IL23A;MME;DLG1;PDIA4;MED18;RBMS3;EHD1;ZMYM4;CITED2;ZNF814;TXNRD1;PTTG1IP;ETS1;HAS2;ADGRL3;REEP1;PDE4DIP;CHORDC1;TGFA;BAMBI;SUGT1;DNAJC3;CBLL1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MYH9;EID3;BTBD10;TOR1AIP1;ZBTB21;HES4;SOX11;UGCG;ENPP1;AFAP1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
5828,GO:0017143,0.0592611111691975,0.999097490072652,1,2,insecticide metabolic process,BP,CYP1A1
5967,GO:0018894,0.0592611111691975,0.999097490072652,1,2,dibenzo-p-dioxin metabolic process,BP,CYP1A1
5502,GO:0016491,0.0592633810709826,0.963846871148796,22,526,oxidoreductase activity,MF,PGK1;MSRB3;GPX8;DNAJC10;FADS1;FADS3;G6PD;HMOX1;HEPHL1;FTH1;EGLN1;SOD2;SDR16C5;STEAP4;PDIA6;PDIA4;LOX;TXNRD1;IVD;MSMO1;MGST3;CYP1A1
3086,GO:0006679,0.0594159362588082,0.999092694405188,1,2,glucosylceramide biosynthetic process,BP,UGCG
8978,GO:0035150,0.0594166629726305,0.981417933458905,5,69,regulation of tube size,BP,EDN1;SLC8A1;HMOX1;SOD2;HTR1B
12633,GO:0050880,0.0594166629726305,0.981417933458905,5,69,regulation of blood vessel size,BP,EDN1;SLC8A1;HMOX1;SOD2;HTR1B
16497,GO:0097278,0.0594219214274669,0.999092508753048,1,2,complement-dependent cytotoxicity,BP,HSP90AB1
11774,GO:0046696,0.0594434533051697,0.999091840700268,1,2,lipopolysaccharide receptor complex,CC,HSPD1
8823,GO:0034644,0.0594692739182061,0.98139688584726,5,69,cellular response to UV,BP,TP53;PARP1;PPID;MME;NEDD4
8086,GO:0032796,0.0594856512464781,0.999090530722487,1,2,uropod organization,BP,MYH9
10710,GO:0044111,0.0594876069782726,0.999090469985843,1,2,development involved in symbiotic interaction,BP,NEDD4
1630,GO:0004084,0.0594924502944958,0.999090319564204,1,2,branched-chain-amino-acid transaminase activity,MF,BCAT1
4028,GO:0009082,0.0594924502944958,0.999090319564204,1,2,branched-chain amino acid biosynthetic process,BP,BCAT1
4036,GO:0009098,0.0594924502944958,0.999090319564204,1,2,leucine biosynthetic process,BP,BCAT1
4037,GO:0009099,0.0594924502944958,0.999090319564204,1,2,valine biosynthetic process,BP,BCAT1
13343,GO:0052654,0.0594924502944958,0.999090319564204,1,2,L-leucine transaminase activity,MF,BCAT1
13344,GO:0052655,0.0594924502944958,0.999090319564204,1,2,L-valine transaminase activity,MF,BCAT1
13345,GO:0052656,0.0594924502944958,0.999090319564204,1,2,L-isoleucine transaminase activity,MF,BCAT1
5933,GO:0018312,0.0595083647407622,0.99908982520984,1,2,peptidyl-serine ADP-ribosylation,BP,PARP1
19476,GO:1990404,0.0595083647407622,0.99908982520984,1,2,protein ADP-ribosylase activity,MF,PARP1
2228,GO:0005151,0.0598160127977419,0.999080241443695,1,2,interleukin-1, Type II receptor binding,MF,ERAP1
939,GO:0002360,0.0598284470951403,0.993267494944651,2,13,T cell lineage commitment,BP,CYLD;IL23A
967,GO:0002424,0.0600225215356833,0.999073779300205,1,2,T cell mediated immune response to tumor cell,BP,HSPD1
1186,GO:0002840,0.0600225215356833,0.999073779300205,1,2,regulation of T cell mediated immune response to tumor cell,BP,HSPD1
18309,GO:1903320,0.0600887744489822,0.971967542857917,10,188,regulation of protein modification by small protein conjugation or removal,BP,TNIP1;RIPK2;HERPUD1;HSPA5;BIRC3;HSP90AA1;DCUN1D3;HSP90AB1;CTR9;PTTG1IP
17115,GO:0102521,0.0600891366993819,0.999071689777355,1,2,tRNA-4-demethylwyosine synthase activity,MF,TYW1
6464,GO:0021826,0.0600914808607998,0.999071616203633,1,2,substrate-independent telencephalic tangential migration,BP,NRG1
6467,GO:0021830,0.0600914808607998,0.999071616203633,1,2,interneuron migration from the subpallium to the cortex,BP,NRG1
6471,GO:0021843,0.0600914808607998,0.999071616203633,1,2,substrate-independent telencephalic tangential interneuron migration,BP,NRG1
8577,GO:0034113,0.0601197885777141,0.988162526661313,3,29,heterotypic cell-cell adhesion,BP,IL1B;ITGAV;PARVA
14531,GO:0070101,0.0601216319733167,0.999070669614353,1,2,positive regulation of chemokine-mediated signaling pathway,BP,EDN1
19791,GO:2000298,0.0601460407556017,0.999069902940152,1,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,CHORDC1
18395,GO:1903518,0.0601656413689538,0.999069287053351,1,2,positive regulation of single strand break repair,BP,PARP1
1104,GO:0002700,0.0602099424949085,0.981090686910885,5,70,regulation of production of molecular mediator of immune response,BP,SEMA7A;XBP1;ARG1;HMOX1;TFRC
6356,GO:0021560,0.060262055828406,0.999066254474871,1,2,abducens nerve development,BP,MAFB
6375,GO:0021598,0.060262055828406,0.999066254474871,1,2,abducens nerve morphogenesis,BP,MAFB
6376,GO:0021599,0.060262055828406,0.999066254474871,1,2,abducens nerve formation,BP,MAFB
1799,GO:0004461,0.0602989922328877,0.999065091345083,1,2,lactose synthase activity,MF,B4GALT1
16399,GO:0097102,0.0603168318737818,0.999064529306135,1,2,endothelial tip cell fate specification,BP,NRP1
14796,GO:0070576,0.0603999930285578,0.999061907009624,1,2,vitamin D 24-hydroxylase activity,MF,CYP1A1
19879,GO:2000418,0.0604212975210795,0.999061234611946,1,2,positive regulation of eosinophil migration,BP,ADAM8
15371,GO:0071676,0.060457432878504,0.999060093564461,1,2,negative regulation of mononuclear cell migration,BP,SLIT2
16028,GO:0090027,0.060457432878504,0.999060093564461,1,2,negative regulation of monocyte chemotaxis,BP,SLIT2
13883,GO:0060584,0.0604626207725852,0.999059929687444,1,2,regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
13884,GO:0060585,0.0604626207725852,0.999059929687444,1,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,EDN1
19589,GO:1990791,0.0605017227005278,0.999058694047836,1,2,dorsal root ganglion development,BP,NRP1
123,GO:0000254,0.0605159941225502,0.999058242855504,1,2,C-4 methylsterol oxidase activity,MF,MSMO1
10194,GO:0042904,0.0605867908370141,0.999056002961571,1,2,9-cis-retinoic acid biosynthetic process,BP,CYP1A1
10195,GO:0042905,0.0605867908370141,0.999056002961571,1,2,9-cis-retinoic acid metabolic process,BP,CYP1A1
9705,GO:0038190,0.0606454850026093,0.99905414389131,1,2,VEGF-activated neuropilin signaling pathway,BP,NRP1
17921,GO:1902336,0.0606454850026093,0.99905414389131,1,2,positive regulation of retinal ganglion cell axon guidance,BP,NRP1
13520,GO:0060024,0.0606904861961949,0.999052717252122,1,2,rhythmic synaptic transmission,BP,EDN1
13689,GO:0060298,0.0607525423366266,0.999050748112943,1,2,positive regulation of sarcomere organization,BP,EDN1
11133,GO:0045226,0.0607890452773739,0.999049588831544,1,2,extracellular polysaccharide biosynthetic process,BP,HAS2
11612,GO:0046379,0.0607890452773739,0.999049588831544,1,2,extracellular polysaccharide metabolic process,BP,HAS2
18995,GO:1904879,0.0609726186528617,0.999043747733963,1,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
9801,GO:0042056,0.0610001700428209,0.99299768592633,2,14,chemoattractant activity,MF,SAA1;VEGFC
1590,GO:0004020,0.0612439930476424,0.999035079072757,1,2,adenylylsulfate kinase activity,MF,PAPSS2
2027,GO:0004779,0.0612439930476424,0.999035079072757,1,2,sulfate adenylyltransferase activity,MF,PAPSS2
2028,GO:0004781,0.0612439930476424,0.999035079072757,1,2,sulfate adenylyltransferase (ATP) activity,MF,PAPSS2
19707,GO:2000124,0.0612613118865695,0.999034524477041,1,2,regulation of endocannabinoid signaling pathway,BP,MGLL
9880,GO:0042246,0.0613104706250272,0.987805079196055,3,30,tissue regeneration,BP,ANXA1;KLK6;IFRD1
4753,GO:0010956,0.0613210899184633,0.999032608960425,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,NFKB1
7235,GO:0031214,0.0613518555111856,0.980649844920251,5,68,biomineral tissue development,BP,OSR2;FBN2;SLC8A1;KLF10;ENPP1
1572,GO:0003994,0.061416484783709,0.999029548085534,1,2,aconitate hydratase activity,MF,ACO1
1733,GO:0004345,0.0614706234970882,0.999027808750778,1,2,glucose-6-phosphate dehydrogenase activity,MF,G6PD
678,GO:0001892,0.061520204255571,0.98057203305305,5,69,embryonic placenta development,BP,KRT8;JUNB;PHLDA2;EGLN1;NR2F2
12641,GO:0050892,0.0615299477028312,0.992966528684492,2,13,intestinal absorption,BP,TJP2;ACO1
16638,GO:0097623,0.0615450957497929,0.999025413525955,1,2,potassium ion export across plasma membrane,BP,DLG1
8851,GO:0034685,0.0616065190731295,0.999023435699751,1,2,integrin alphav-beta6 complex,CC,ITGAV
83,GO:0000171,0.0616429826544866,0.999022260596188,1,2,ribonuclease MRP activity,MF,POP4
20007,GO:2000669,0.0617224883401144,0.999019695855059,1,2,negative regulation of dendritic cell apoptotic process,BP,AXL
14266,GO:0061441,0.0617427056476851,0.999019043120133,1,2,renal artery morphogenesis,BP,NRP1
14019,GO:0060838,0.061756711452041,0.99901859079796,1,2,lymphatic endothelial cell fate commitment,BP,NR2F2
9517,GO:0036303,0.0617605230367111,0.992925366167292,2,13,lymph vessel morphogenesis,BP,CCBE1;VEGFC
9538,GO:0036363,0.0617673294676516,0.999018247813827,1,2,transforming growth factor beta activation,BP,HSP90AB1
2165,GO:0005021,0.0617789443008031,0.999017872559547,1,2,vascular endothelial growth factor-activated receptor activity,MF,NRP1
6462,GO:0021824,0.0617920237980461,0.999017449895991,1,2,cerebral cortex tangential migration using cell-axon interactions,BP,NRP1
6466,GO:0021828,0.0617920237980461,0.999017449895991,1,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,NRP1
6477,GO:0021856,0.0617920237980461,0.999017449895991,1,2,hypothalamic tangential migration using cell-axon interactions,BP,NRP1
13757,GO:0060385,0.0617920237980461,0.999017449895991,1,2,axonogenesis involved in innervation,BP,NRP1
18332,GO:1903375,0.0617920237980461,0.999017449895991,1,2,facioacoustic ganglion development,BP,NRP1
6391,GO:0021648,0.0617965313759675,0.999017304211995,1,2,vestibulocochlear nerve morphogenesis,BP,NRP1
6645,GO:0030018,0.0618039588939178,0.980457247486709,5,69,Z disc,CC,KRT8;CRYAB;SLC8A1;SORBS2;PARVA
14079,GO:0060978,0.0618097468602999,0.999016877025975,1,2,angiogenesis involved in coronary vascular morphogenesis,BP,NRP1
13777,GO:0060412,0.0618419242147521,0.987683148891525,3,29,ventricular septum morphogenesis,BP,EGLN1;CITED2;SOX11
11226,GO:0045509,0.0619147386647281,0.999013479796011,1,2,interleukin-27 receptor activity,MF,IL6ST
670,GO:0001884,0.061955653612676,0.999012154268743,1,2,pyrimidine nucleoside binding,MF,HSP90AB1
829,GO:0002134,0.061955653612676,0.999012154268743,1,2,UTP binding,MF,HSP90AB1
7930,GO:0032551,0.061955653612676,0.999012154268743,1,2,pyrimidine ribonucleoside binding,MF,HSP90AB1
15866,GO:0072679,0.0619593965176482,0.999012032963453,1,2,thymocyte migration,BP,ADAM8
10041,GO:0042567,0.0621628858712672,0.999005426420903,1,2,insulin-like growth factor ternary complex,CC,IGFBP3
18634,GO:1904020,0.0622054643957797,0.999004041178199,1,2,regulation of G-protein coupled receptor internalization,BP,UBQLN2
1190,GO:0002857,0.0622063894786103,0.999004011070657,1,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,PVR
1193,GO:0002860,0.0622063894786103,0.999004011070657,1,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,PVR
2389,GO:0005547,0.0622386153600197,0.987571902445607,3,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,MYO1B;ANXA8;DAPP1
2411,GO:0005604,0.062286917852339,0.980281742069422,5,67,basement membrane,CC,COL8A1;COL4A4;FRAS1;NID2;DLG1
811,GO:0002089,0.0624205925428234,0.99280703381517,2,13,lens morphogenesis in camera-type eye,BP,EPHA2;SOX11
2588,GO:0005900,0.062500771659136,0.998994406299269,1,2,oncostatin-M receptor complex,CC,IL6ST
19712,GO:2000142,0.0625030783033897,0.987470252344329,3,30,regulation of DNA-templated transcription, initiation,BP,TP53;JUN;SETX
17478,GO:1900756,0.0625053733659817,0.998994255782049,1,2,protein processing in phagocytic vesicle,BP,MYH9
18589,GO:1903921,0.0625053733659817,0.998994255782049,1,2,regulation of protein processing in phagocytic vesicle,BP,MYH9
18590,GO:1903923,0.0625053733659817,0.998994255782049,1,2,positive regulation of protein processing in phagocytic vesicle,BP,MYH9
119,GO:0000248,0.0625679914123129,0.998992206452161,1,2,C-5 sterol desaturase activity,MF,FADS1
14859,GO:0070704,0.0625679914123129,0.998992206452161,1,2,sterol desaturase activity,MF,FADS1
4756,GO:0010959,0.06257108151238,0.970601489223572,10,187,regulation of metal ion transport,BP,NETO1;IL16;STAC;LYN;G6PD;SLC8A1;NEDD4L;DLG1;NEDD4;PML
12191,GO:0048485,0.0626104418034021,0.992772863130923,2,13,sympathetic nervous system development,BP,NRP1;SOX11
11843,GO:0046887,0.0626124355452927,0.980119597398251,5,70,positive regulation of hormone secretion,BP,EDN1;C1QTNF1;SERP1;OXCT1;SOX11
15837,GO:0072606,0.0626707315290294,0.992696304369525,2,14,interleukin-8 secretion,BP,ANXA1;NLRP10
10320,GO:0043163,0.0626778959322161,0.998988604346466,1,2,cell envelope organization,BP,HRNR
11134,GO:0045229,0.0626778959322161,0.998988604346466,1,2,external encapsulating structure organization,BP,HRNR
5366,GO:0016209,0.0627574525644492,0.98323994331142,4,53,antioxidant activity,MF,GPX8;SOD2;TXNRD1;MGST3
595,GO:0001763,0.0627623554295117,0.973458644477998,8,135,morphogenesis of a branching structure,BP,B4GALT1;EDN1;SLIT2;NRP1;DLG1;PML;EPHA2;MAGED1
11069,GO:0045117,0.0628258589862458,0.992668077744666,2,14,azole transport,BP,EDN1;LYN
7638,GO:0032089,0.0628382682573034,0.99898333625444,1,2,NACHT domain binding,MF,TRIM16
7013,GO:0030806,0.0628815697292165,0.99898191141467,1,2,negative regulation of cyclic nucleotide catabolic process,BP,EGLN1
7028,GO:0030821,0.0628815697292165,0.99898191141467,1,2,negative regulation of cAMP catabolic process,BP,EGLN1
8269,GO:0033122,0.0628815697292165,0.99898191141467,1,2,negative regulation of purine nucleotide catabolic process,BP,EGLN1
19407,GO:1990108,0.0629086987074723,0.99898101820741,1,2,protein linear deubiquitination,BP,CYLD
2110,GO:0004915,0.0630106424987684,0.998977658144841,1,2,interleukin-6 receptor activity,MF,IL6ST
2585,GO:0005896,0.0630106424987684,0.998977658144841,1,2,interleukin-6 receptor complex,CC,IL6ST
6303,GO:0019981,0.0630106424987684,0.998977658144841,1,2,interleukin-6 binding,MF,IL6ST
14536,GO:0070110,0.0630106424987684,0.998977658144841,1,2,ciliary neurotrophic factor receptor complex,CC,IL6ST
15446,GO:0071847,0.0631123726045675,0.998974299428804,1,2,TNFSF11-mediated signaling pathway,BP,TJP2
14835,GO:0070662,0.0631995295757178,0.99897141733178,1,2,mast cell proliferation,BP,LYN
14839,GO:0070666,0.0631995295757178,0.99897141733178,1,2,regulation of mast cell proliferation,BP,LYN
14841,GO:0070668,0.0631995295757178,0.99897141733178,1,2,positive regulation of mast cell proliferation,BP,LYN
14532,GO:0070102,0.0632075493419855,0.992664995800844,2,13,interleukin-6-mediated signaling pathway,BP,IL6ST;CTR9
20008,GO:2000670,0.0632411015411137,0.998970041162939,1,2,positive regulation of dendritic cell apoptotic process,BP,LYN
3602,GO:0008065,0.0633587694205135,0.998966140815328,1,2,establishment of blood-nerve barrier,BP,CLDN1
13588,GO:0060124,0.0634059964572934,0.998964573234409,1,2,positive regulation of growth hormone secretion,BP,SERP1
15481,GO:0071902,0.0635057778843338,0.966791532244319,13,263,positive regulation of protein serine/threonine kinase activity,BP,SAA1;EDN1;RIPK2;IL1B;GADD45B;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;TGFA;MAGED1;IRAK2
8934,GO:0035026,0.0635093397323596,0.998961138737313,1,2,leading edge cell differentiation,BP,JUN
1123,GO:0002719,0.0635200379032397,0.992541268137401,2,14,negative regulation of cytokine production involved in immune response,BP,ARG1;HMOX1
17464,GO:1900623,0.0635481097751031,0.998959848742739,1,2,regulation of monocyte aggregation,BP,HAS2
17465,GO:1900625,0.0635481097751031,0.998959848742739,1,2,positive regulation of monocyte aggregation,BP,HAS2
2115,GO:0004923,0.0635802075248957,0.998958780129261,1,2,leukemia inhibitory factor receptor activity,MF,IL6ST
10884,GO:0044501,0.0635918773329491,0.998958391471937,1,2,modulation of signal transduction in other organism,BP,TNIP1
13256,GO:0052027,0.0635918773329491,0.998958391471937,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13290,GO:0052250,0.0635918773329491,0.998958391471937,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
3262,GO:0006956,0.0636721049382396,0.992513380575628,2,14,complement activation,BP,KRT1;C1R
7454,GO:0031638,0.063726464772698,0.987097765174812,3,31,zymogen activation,BP,PGK1;RIPK2;C1R
14044,GO:0060907,0.0637315074576286,0.998953735343986,1,2,positive regulation of macrophage cytokine production,BP,SEMA7A
10865,GO:0044444,0.0637426670848776,0.948822868131646,231,7160,cytoplasmic part,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;KRT1;NEFL;KRT8;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;TNIP1;KRT18;SPRR3;NFKB1;NEFM;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;LCE3D;DBNDD2;NAGK;UBQLN2;CHAC1;COL12A1;KRT78;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;JUN;KRT4;RIPK2;IL16;NFKB2;SPNS2;HERPUD1;PARP1;OPTN;HRNR;HSPA5;IL1B;MSRB3;CDV3;KRT13;ANPEP;TJP2;HSPB8;CRYAB;GPX8;DNAJB9;ACTG1;DNAJC10;EHF;HSPA6;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;STAC;ANXA8;FADS1;PLBD1;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;WWC1;THTPA;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;HMOX1;FAM126B;SYT11;KLK6;PAPSS2;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;DCUN1D3;KCNQ5;GNPTAB;SOD2;ACO1;SERPINH1;PREP;HSP90AB1;KRT34;SDR16C5;GGCX;ADAM8;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;IFNAR1;PPID;AJUBA;IGFBP3;SEL1L;AMOTL2;MGAT5;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;IL23A;MME;DLG1;PDIA4;NGLY1;GDA;EHD1;TXNRD1;DHDDS;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;DNAJC3;CBLL1;BCAT1;ANKRD13A;HSP90B1;TFRC;SVIP;UBXN2B;NEDD4;CDK6;ZDHHC6;PML;OXCT1;MON1A;EPB41L2;MRPS24;MYH9;GALNT14;TRIM47;ZBTB21;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
2634,GO:0005988,0.0638102933952525,0.998951103399411,1,2,lactose metabolic process,BP,B4GALT1
2635,GO:0005989,0.0638102933952525,0.998951103399411,1,2,lactose biosynthetic process,BP,B4GALT1
11602,GO:0046351,0.0638102933952525,0.998951103399411,1,2,disaccharide biosynthetic process,BP,B4GALT1
8850,GO:0034684,0.0638255039705993,0.998950594877198,1,2,integrin alphav-beta5 complex,CC,ITGAV
9326,GO:0035868,0.0638944587819125,0.998948287971976,1,2,alphav-beta3 integrin-HMGB1 complex,CC,ITGAV
3705,GO:0008240,0.0639065749226144,0.99894788235219,1,2,tripeptidyl-peptidase activity,MF,TPP2
6298,GO:0019961,0.0639430068703583,0.998946662209609,1,2,interferon binding,MF,IFNAR1
428,GO:0001147,0.0640458928167438,0.998943212508876,1,2,transcription termination site sequence-specific DNA binding,MF,SETX
431,GO:0001160,0.0640458928167438,0.998943212508876,1,2,transcription termination site DNA binding,MF,SETX
11299,GO:0045659,0.0640629093442286,0.998942641393609,1,2,negative regulation of neutrophil differentiation,BP,TRIB1
6853,GO:0030350,0.0640863713726226,0.998941853690404,1,2,iron-responsive element binding,MF,ACO1
4277,GO:0009725,0.0641318555865281,0.958556301128457,27,647,response to hormone,BP,TRIM16;NEFL;NFKB1;EDN1;SLIT2;CLDN1;JUN;PARP1;IL1B;JUNB;CRYAB;DUSP1;LYN;ANXA1;XBP1;ARG1;MMP19;NR2F2;CALR;EIF2B1;HMGCS1;LOX;ETS1;HTR1B;NEDD4;OXCT1;ENPP1
16678,GO:0097718,0.0642640915696084,0.986970794576489,3,30,disordered domain specific binding,MF,TP53;HSP90AA1;HSP90AB1
16810,GO:0098770,0.0644417170253902,0.998929886402518,1,2,FBXO family protein binding,MF,CDK6
18509,GO:1903760,0.0644968656380221,0.998928022876926,1,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,DLG1
19059,GO:1905024,0.0644968656380221,0.998928022876926,1,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,DLG1
12058,GO:0048073,0.0645135176665313,0.998927459859091,1,2,regulation of eye pigmentation,BP,SPNS2
6271,GO:0019899,0.0645530816698113,0.951372241928389,67,1820,enzyme binding,MF,CDKN2A;NFKBIA;NEFL;LCP1;TNIP1;RELB;FEZ1;TP53;FGF5;CDKN2B;DNAJB1;CCBE1;JUN;RIPK2;PARP1;OPTN;HSPA5;AXL;ACTG1;DNAJC10;HSPA6;IKBKE;CYLD;TRIB1;ITGAV;LYN;AP3M1;WWC1;RHOB;MOBP;SUDS3;TRAF3;HMOX1;SYT11;RIMS2;HSP90AA1;NRP1;TRAF1;EGLN1;DCUN1D3;NRG1;HSP90AB1;STXBP5;CALR;CTR9;EIF2B1;PRR5L;ARHGDIB;GIT2;CORO1C;DLG1;EHD1;CITED2;ETS1;PDE4DIP;DNAJC3;HSP90B1;SVIP;NEDD4;PML;EPHA2;MON1A;TOR1AIP1;HSPD1;MIDN;SDF2L1;CYP1A1
9828,GO:0042108,0.0645652464658134,0.986884782870541,3,30,positive regulation of cytokine biosynthetic process,BP,IL1A;IL1B;HMOX1
4958,GO:0015093,0.064577085725199,0.998925309168928,1,2,ferrous iron transmembrane transporter activity,MF,SLC39A14
5132,GO:0015684,0.064577085725199,0.998925309168928,1,2,ferrous iron transport,BP,SLC39A14
18560,GO:1903874,0.064577085725199,0.998925309168928,1,2,ferrous iron transmembrane transport,BP,SLC39A14
9894,GO:0042271,0.0647926930512004,0.998917997961442,1,2,susceptibility to natural killer cell mediated cytotoxicity,BP,PVR
19627,GO:1990927,0.0649157307388824,0.9989138142869,1,2,calcium ion regulated lysosome exocytosis,BP,SYT11
19134,GO:1905224,0.0649249099787138,0.99891350182874,1,2,clathrin-coated pit assembly,BP,SYT11
14364,GO:0061669,0.0649372206682966,0.99891308270415,1,2,spontaneous neurotransmitter secretion,BP,RIMS2
14601,GO:0070227,0.0649718017083673,0.982477109022572,4,51,lymphocyte apoptotic process,BP,TP53;CD274;LYN;ADAM8
17910,GO:1902302,0.064979832155412,0.998911631325844,1,2,regulation of potassium ion export,BP,DLG1
16355,GO:0097016,0.0649971186945077,0.998911042248153,1,2,L27 domain binding,MF,DLG1
4403,GO:0010224,0.0650621324608761,0.992256661157894,2,14,response to UV-B,BP,TP53;MME
4510,GO:0010593,0.0651032119617422,0.998907423271027,1,2,negative regulation of lamellipodium assembly,BP,SLIT2
6461,GO:0021823,0.0651305931269191,0.998906488256307,1,2,cerebral cortex tangential migration using cell-cell interactions,BP,SLIT2
6465,GO:0021827,0.0651305931269191,0.998906488256307,1,2,postnatal olfactory bulb interneuron migration,BP,SLIT2
6468,GO:0021836,0.0651305931269191,0.998906488256307,1,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,SLIT2
1406,GO:0003357,0.0651357362158493,0.998906312583455,1,2,noradrenergic neuron differentiation,BP,SOX11
1562,GO:0003980,0.0652063416754778,0.998903899432289,1,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,UGGT1
16527,GO:0097359,0.0652063416754778,0.998903899432289,1,2,UDP-glucosylation,BP,UGGT1
544,GO:0001664,0.0652092910648661,0.974080596194745,7,117,G-protein coupled receptor binding,MF,CXCL1;SAA1;EDN1;CXCL16;REEP1;BAMBI;NEDD4
4628,GO:0010768,0.0652200926287197,0.998903429132611,1,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,NEDD4
14250,GO:0061386,0.0652396821239059,0.998902758967343,1,2,closure of optic fissure,BP,SOX11
6894,GO:0030505,0.0652587043705267,0.998902108005241,1,2,inorganic diphosphate transport,BP,ENPP1
8852,GO:0034686,0.0652595755798648,0.998902078186721,1,2,integrin alphav-beta8 complex,CC,ITGAV
9324,GO:0035866,0.0652595755798648,0.998902078186721,1,2,alphav-beta3 integrin-PKCalpha complex,CC,ITGAV
19493,GO:1990430,0.0652595755798648,0.998902078186721,1,2,extracellular matrix protein binding,MF,ITGAV
9053,GO:0035332,0.0652716174457729,0.998901665991883,1,2,positive regulation of hippo signaling,BP,SOX11
9325,GO:0035867,0.0653156645349242,0.998900157571834,1,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,ITGAV
7099,GO:0030934,0.0653408098643375,0.998899295974224,1,2,anchoring collagen complex,CC,COL12A1
4267,GO:0009651,0.0654311454714303,0.992187965346411,2,14,response to salt stress,BP,CLDN1;HSP90AB1
15276,GO:0071526,0.0655258087327341,0.986638358225418,3,29,semaphorin-plexin signaling pathway,BP,SEMA7A;SEMA3D;NRP1
12668,GO:0050926,0.0655409722345047,0.992167475948621,2,14,regulation of positive chemotaxis,BP,IL16;VEGFC
685,GO:0001909,0.0656355029470364,0.982224530587285,4,52,leukocyte mediated cytotoxicity,BP,ARG1;IL7R;IL23A;PVR
12224,GO:0048545,0.06572145364215,0.965447255180249,13,266,response to steroid hormone,BP,NEFL;EDN1;SLIT2;CLDN1;PARP1;DUSP1;ANXA1;ARG1;NR2F2;CALR;LOX;HTR1B;NEDD4
11687,GO:0046527,0.0660080767158586,0.992080107602443,2,14,glucosyltransferase activity,MF,UGGT1;UGCG
13211,GO:0051930,0.0663205245450164,0.992021463686452,2,14,regulation of sensory perception of pain,BP,EDN1;MGLL
13212,GO:0051931,0.0663205245450164,0.992021463686452,2,14,regulation of sensory perception,BP,EDN1;MGLL
10759,GO:0044264,0.0665114686543661,0.978519453464968,5,70,cellular polysaccharide metabolic process,BP,IL6ST;PHLDA2;HAS2;GBE1;ENPP1
13097,GO:0051702,0.0670533340218827,0.981726553981837,4,51,interaction with symbiont,BP,JUN;ARG1;SUGT1;HSPD1
7922,GO:0032535,0.0671810386527386,0.964562768492848,13,265,regulation of cellular component size,BP,NEFL;DSCAM;EDN1;SLIT2;SEMA7A;SEMA3D;NRP1;IL7R;NRG1;IFRD1;HSP90AB1;L1CAM;DLG1
12117,GO:0048261,0.0672123860659276,0.991853176087021,2,14,negative regulation of receptor-mediated endocytosis,BP,UBQLN2;SYT11
3265,GO:0006959,0.0672538062588221,0.97814541621181,5,77,humoral immune response,BP,KRT1;RNASE7;SPNS2;CD83;C1R
12813,GO:0051171,0.0674315456208234,0.94565368033759,148,4386,regulation of nitrogen compound metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;SERPINB2;SAA1;OSR2;TNIP1;DUSP8;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;PSMB9;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;CRYAB;ATF3;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;ITGAV;LYN;C1R;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;IL24;HSP90AA1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;TNFSF15;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;ORMDL1;MAFF;MGA;PRR5L;UBP1;CORO1C;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;PTTG1IP;ETS1;HAS2;CHORDC1;TGFA;BAMBI;DNAJC3;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;PML;EPHA2;MYH9;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
20231,GO:2001239,0.0677072243013899,0.985922299057309,3,32,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1A;IL1B;EYA3
12529,GO:0050718,0.0677596782693072,0.991749253504415,2,14,positive regulation of interleukin-1 beta secretion,BP,TRIM16;RIPK2
15252,GO:0071478,0.0680537811553735,0.970709515224064,8,141,cellular response to radiation,BP,TP53;PARP1;HSPA5;CRYAB;RHOB;PPID;MME;NEDD4
19734,GO:2000191,0.0680685872548114,0.99169037776342,2,14,regulation of fatty acid transport,BP,EDN1;IL1B
8101,GO:0032813,0.0682132580969313,0.985773830046324,3,32,tumor necrosis factor receptor superfamily binding,MF,TRAF3;TRAF1;TNFSF15
6566,GO:0022414,0.0682291424150873,0.953746904386896,33,824,reproductive process,BP,MMP9;IL1A;KRT8;B4GALT1;EDN1;SLIT2;CLDN11;IL1B;JUNB;PHLDA2;AXL;DUSP1;ANXA1;NBN;BIRC3;ARG1;MMP19;EGLN1;BRD2;SETX;HSP90AB1;NR2F2;CALR;MAFF;HMGCS1;ARHGDIB;DLG1;CITED2;ETS1;HAS2;ZFP42;MYH9;CYP1A1
15766,GO:0072503,0.0682530820547647,0.96611069636618,11,216,cellular divalent inorganic cation homeostasis,BP,SAA1;EDN1;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;CALR;SLC39A14;HSP90B1;PML
8424,GO:0033574,0.068765207203443,0.985611342299242,3,32,response to testosterone,BP,EDN1;DUSP1;CALR
2,GO:0000003,0.0691467297022394,0.953067322510312,33,825,reproduction,BP,MMP9;IL1A;KRT8;B4GALT1;EDN1;SLIT2;CLDN11;IL1B;JUNB;PHLDA2;AXL;DUSP1;ANXA1;NBN;BIRC3;ARG1;MMP19;EGLN1;BRD2;SETX;HSP90AB1;NR2F2;CALR;MAFF;HMGCS1;ARHGDIB;DLG1;CITED2;ETS1;HAS2;ZFP42;MYH9;CYP1A1
17646,GO:1901565,0.0691949298566076,0.951790075130354,38,982,organonitrogen compound catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;CHAC1;HERPUD1;HSPA5;IL1B;ANPEP;DNAJB9;DNAJC10;ERAP1;CYLD;TRIB1;DERL3;NEDD4L;XBP1;ARG1;UGGT1;HMOX1;HSP90AA1;EGLN1;NRG1;HSP90AB1;ADAM8;SEL1L;NGLY1;GDA;PTTG1IP;IVD;DNAJC3;BCAT1;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SDF2L1
638,GO:0001832,0.0692408773952521,0.991465517658576,2,14,blastocyst growth,BP,NBN;CTR9
5115,GO:0015629,0.069435424252585,0.960563840848999,16,343,actin cytoskeleton,CC,LCP1;DPYSL3;MYO1B;CRYAB;ACTG1;ANXA1;MOBP;ADAM8;CORO1C;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;TJP1;PARVA
10198,GO:0042921,0.0694366112425223,0.991427753410995,2,14,glucocorticoid receptor signaling pathway,BP,CALR;NEDD4
11211,GO:0045445,0.0694833616922537,0.980839801403822,4,51,myoblast differentiation,BP,LGALS1;NRG1;IFRD1;IGFBP3
13233,GO:0051961,0.0695720721475278,0.966681085389613,10,188,negative regulation of nervous system development,BP,LGALS1;DPYSL3;SLIT2;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;CALR;SOX11
7794,GO:0032369,0.0695811500385752,0.99139982624962,2,14,negative regulation of lipid transport,BP,NFKB1;ITGAV
4516,GO:0010605,0.069610495166616,0.946867213108252,72,2017,negative regulation of macromolecule metabolic process,BP,CDKN2A;MMP9;SERPINB2;OSR2;TNIP1;DUSP8;NFKB1;RELB;EDN1;TP53;PSMB9;DBNDD2;SLIT2;UBQLN2;CHAC1;CDKN2B;DNAJB1;JUN;NFKB2;HERPUD1;PARP1;OPTN;IL1B;JUNB;CRYAB;ATF3;DNAJC10;GADD45B;NOCT;DUSP1;ANXA8;TRIB1;ITGAV;LYN;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;SUDS3;KLF10;NRG1;SERPINH1;HSP90AB1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;IGFBP3;PRR5L;UBP1;CORO1C;DLG1;RBMS3;CITED2;ZNF814;CHORDC1;DNAJC3;ZC3H7B;SVIP;NEDD4;CDK6;PML;ZBTB21;SOX11;ENPP1;SND1;MAGED1
9643,GO:0038034,0.0697981261848372,0.980708832431534,4,52,signal transduction in absence of ligand,BP,IL1A;IL1B;ITGAV;EYA3
16453,GO:0097192,0.0697981261848372,0.980708832431534,4,52,extrinsic apoptotic signaling pathway in absence of ligand,BP,IL1A;IL1B;ITGAV;EYA3
15290,GO:0071548,0.069827422761367,0.985297038043845,3,32,response to dexamethasone,BP,EDN1;CLDN1;ARG1
472,GO:0001516,0.0698601402273407,0.99127920949226,2,15,prostaglandin biosynthetic process,BP,EDN1;ANXA1
11639,GO:0046457,0.0698601402273407,0.99127920949226,2,15,prostanoid biosynthetic process,BP,EDN1;ANXA1
3590,GO:0008045,0.0703308478299576,0.991254424183094,2,14,motor neuron axon guidance,BP,SLIT2;NRP1
12868,GO:0051254,0.0707143077573587,0.949609347532157,43,1113,positive regulation of RNA metabolic process,BP,NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;EPCAM;CDKN2B;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;WWC1;XBP1;ARNTL2;EGLN1;SETX;KLF10;NRG1;NR2F2;EDRF1;CTR9;MAFF;PRR5L;IL23A;CITED2;ETS1;BAMBI;PML;SOX11;MAGED1;SUPT3H
8253,GO:0033081,0.0707959441926938,0.99109579807301,2,15,regulation of T cell differentiation in thymus,BP,IL7R;ADAM8
12805,GO:0051155,0.0711133602629654,0.984913735605206,3,32,positive regulation of striated muscle cell differentiation,BP,EDN1;NRG1;EHD1
14615,GO:0070252,0.0711288128913443,0.980249297718521,4,50,actin-mediated cell contraction,BP,NEDD4L;DLG1;TPM4;PARVA
16512,GO:0097327,0.0715704920768677,0.976367936433369,5,73,response to antineoplastic agent,BP,NEFL;EDN1;CLDN1;ARG1;HMOX1
10120,GO:0042730,0.0717727773839785,0.990902813428467,2,15,fibrinolysis,BP,KRT1;SERPINB2
912,GO:0002313,0.0717744265169078,0.990902486303985,2,15,mature B cell differentiation involved in immune response,BP,LGALS1;XBP1
3395,GO:0007193,0.0718232672115462,0.984729465296104,3,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,EDN1;GPR176;HTR1B
10435,GO:0043331,0.071836841668922,0.976254899060791,5,73,response to dsRNA,BP,NFKBIA;NFKB1;PMAIP1;RIPK2;ZC3H7B
11823,GO:0046849,0.0720310385597021,0.979898137897864,4,51,bone remodeling,BP,ADAM8;TFRC;HTR1B;EPHA2
11809,GO:0046824,0.0720402572536269,0.979894708514834,4,51,positive regulation of nucleocytoplasmic transport,BP,TP53;IL1B;HSP90AB1;NEDD4
8346,GO:0033267,0.0725150345399612,0.962393774593038,12,241,axon part,CC,NEFL;DSCAM;FEZ1;DPYSL3;CNTNAP1;AP3M1;SYT11;NRP1;SETX;NRG1;L1CAM;DLG1
7273,GO:0031290,0.0726103370887223,0.990806697538158,2,14,retinal ganglion cell axon guidance,BP,SLIT2;NRP1
22,GO:0000041,0.0729773206418579,0.975748992883669,5,75,transition metal ion transport,BP,HEPHL1;FTH1;STEAP4;SLC39A14;TFRC
13565,GO:0060076,0.0729951998516535,0.990730273325739,2,14,excitatory synapse,CC,NETO1;SYT11
16769,GO:0098659,0.0733278337504863,0.984275975913094,3,31,inorganic cation import across plasma membrane,BP,SLC8A1;STEAP4;SLC39A14
17035,GO:0099587,0.0733278337504863,0.984275975913094,3,31,inorganic ion import across plasma membrane,BP,SLC8A1;STEAP4;SLC39A14
9844,GO:0042136,0.0734236491812104,0.979362035626562,4,52,neurotransmitter biosynthetic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
7277,GO:0031295,0.0734752441787878,0.984201811364666,3,32,T cell costimulation,BP,LGALS1;CD274;LYN
11839,GO:0046883,0.0735503810613921,0.967818344939193,8,143,regulation of hormone secretion,BP,EDN1;IL1B;C1QTNF1;ANXA1;SERP1;OXCT1;SOX11;MIDN
361,GO:0000980,0.0737177864509234,0.979251702342003,4,52,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,NFKB1;JUN;ARID3B;ZFP42
18081,GO:1902806,0.07375875750223,0.967694769531035,8,146,regulation of cell cycle G1/S phase transition,BP,CDKN2A;TP53;CDKN2B;ANXA1;DCUN1D3;CDK6;PML;CYP1A1
5800,GO:0017085,0.0738642698311727,0.990484383913215,2,15,response to insecticide,BP,NEFL;CYP1A1
17472,GO:1900745,0.0740265620385847,0.990451618504157,2,15,positive regulation of p38MAPK cascade,BP,IL1B;GADD45B
14274,GO:0061462,0.0747184902203127,0.983822993746425,3,32,protein localization to lysosome,BP,AP3M1;GNPTAB;NEDD4
19128,GO:1905209,0.0748186495753091,0.990291091976909,2,15,positive regulation of cardiocyte differentiation,BP,EDN1;NRG1
9954,GO:0042379,0.0748328664900486,0.990223924875562,2,16,chemokine receptor binding,MF,CXCL1;CXCL16
15102,GO:0071243,0.0752018874493052,0.990148307474034,2,16,cellular response to arsenic-containing substance,BP,ATF3;HMOX1
17795,GO:1901998,0.0752905465493562,0.983619188906001,3,33,toxin transport,BP,CD274;HSPA5;NRP1
10755,GO:0044257,0.075411101514886,0.950853719776137,26,635,cellular protein catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;CYLD;TRIB1;DERL3;NEDD4L;XBP1;UGGT1;HSP90AA1;HSP90AB1;SEL1L;NGLY1;PTTG1IP;DNAJC3;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SDF2L1
12250,GO:0048608,0.0757545422893878,0.958245951259055,14,297,reproductive structure development,BP,KRT8;SLIT2;JUNB;PHLDA2;AXL;ANXA1;MMP19;EGLN1;HSP90AB1;NR2F2;HMGCS1;DLG1;CITED2;ZFP42
7460,GO:0031644,0.075814896216884,0.983486607108983,3,32,regulation of neurological system process,BP,EDN1;MGLL;NRG1
2857,GO:0006366,0.0759594264571298,0.942479327595279,64,1759,transcription by RNA polymerase II,BP,NFKBIA;IL1A;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;ARNTL2;HMOX1;EGLN1;BRD2;SETX;SOD2;KLF10;NRG1;VGLL3;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ETS1;TGFA;NEDD4;PML;HES4;SOX11;HSPD1;MAGED1;SUPT3H
2960,GO:0006517,0.0759814835747193,0.983435308037146,3,32,protein deglycosylation,BP,UGGT1;SEL1L;NGLY1
70,GO:0000146,0.0764537023666501,0.990032816219945,2,14,microfilament motor activity,MF,MYO1B;MYH9
4484,GO:0010533,0.0764903451020346,0.997985831650446,1,3,regulation of activation of Janus kinase activity,BP,IL23A
3483,GO:0007399,0.0765882196337058,0.943072042042132,55,1466,nervous system development,BP,NEFL;CXCL1;TENM3;LGALS1;DSCAM;NEFM;MAFB;FEZ1;DPYSL3;FGF5;DBNDD2;SLIT2;CLDN1;CHAC1;JUN;CLDN11;SDK1;HSPA5;CNTNAP1;IL6ST;AXL;SEMA7A;LYN;ANXA1;G6PD;SLC8A1;NEDD4L;VEGFC;XBP1;MOBP;SEMA3D;SUDS3;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;NR2F2;CALR;EIF2B1;HMGCS1;DLG1;GDA;EHD1;ETS1;ADGRL3;NEDD4;CDK6;TUBB3;NTNG1;OXCT1;HES4;SOX11
7163,GO:0031065,0.0766443749693056,0.989917238312548,2,15,positive regulation of histone deacetylation,BP,TP53;SDR16C5
13492,GO:0055114,0.0767417060677883,0.949080854395748,28,714,oxidation-reduction process,BP,PGK1;MSRB3;IL6ST;PHLDA2;GPX8;DNAJC10;FADS1;FADS3;G6PD;HMOX1;HEPHL1;FTH1;EGLN1;SOD2;ACO1;SDR16C5;STEAP4;PDIA6;CS;PDIA4;LOX;TXNRD1;TYW1;IVD;MSMO1;GBE1;ENPP1;CYP1A1
5314,GO:0016064,0.076819500398813,0.978062100094418,4,53,immunoglobulin mediated immune response,BP,C1R;NBN;TFRC;HSPD1
6191,GO:0019724,0.076819500398813,0.978062100094418,4,53,B cell mediated immunity,BP,C1R;NBN;TFRC;HSPD1
19989,GO:2000649,0.0772590649487116,0.983040241873035,3,32,regulation of sodium ion transmembrane transporter activity,BP,NETO1;NEDD4L;NEDD4
16196,GO:0090288,0.0776924333375396,0.970509050378665,6,96,negative regulation of cellular response to growth factor stimulus,BP,SLIT2;PEG10;HSPA5;FBN2;BAMBI;NEDD4
1152,GO:0002768,0.0777368210871682,0.959202024650682,12,251,immune response-regulating cell surface receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;PSMB9;JUN;RIPK2;ACTG1;CYLD;LYN;HSP90AA1;HSP90AB1;EIF2B1
400,GO:0001077,0.0777787112132105,0.963641938005269,9,168,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;JUN;NFKB2;ARID3B;JUNB;EHF;KLF10;ETS1;SOX11
2386,GO:0005544,0.0778085979324395,0.982839587149804,3,33,calcium-dependent phospholipid binding,MF,ANXA8;ANXA1;SYT11
14480,GO:0070006,0.0778598236798859,0.989665390472992,2,15,metalloaminopeptidase activity,MF,ANPEP;ERAP1
3212,GO:0006880,0.0780514725400741,0.99790122976562,1,3,intracellular sequestering of iron ion,BP,FTH1
16631,GO:0097577,0.0780514725400741,0.99790122976562,1,3,sequestering of iron ion,BP,FTH1
17813,GO:1902043,0.0781839431668263,0.989597833170744,2,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;ATF3
7276,GO:0031294,0.0782691122040365,0.982695789305625,3,33,lymphocyte costimulation,BP,LGALS1;CD274;LYN
10517,GO:0043502,0.0783138000373011,0.977507270505023,4,52,regulation of muscle adaptation,BP,EDN1;PARP1;IL6ST;G6PD
11305,GO:0045665,0.0786065937740719,0.965121961406291,8,143,negative regulation of neuron differentiation,BP,LGALS1;DPYSL3;SLIT2;SEMA7A;SEMA3D;NRP1;IFRD1;CALR
13306,GO:0052405,0.0786314221875159,0.997869340773532,1,3,negative regulation by host of symbiont molecular function,BP,SUGT1
12279,GO:0048666,0.0787516833917196,0.947251237320067,29,705,neuron development,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;SLIT2;JUN;SDK1;HSPA5;CNTNAP1;SEMA7A;LYN;NEDD4L;XBP1;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;EHD1;NEDD4;TUBB3;NTNG1
1688,GO:0004177,0.078951707884913,0.982481955964004,3,33,aminopeptidase activity,MF,ANPEP;ERAP1;TPP2
6235,GO:0019834,0.0789853918453102,0.997849754887579,1,3,phospholipase A2 inhibitor activity,MF,ANXA1
728,GO:0001961,0.0790567890442891,0.982448964739035,3,33,positive regulation of cytokine-mediated signaling pathway,BP,EDN1;RIPK2;AXL
20196,GO:2001181,0.0790829828631734,0.997844338621967,1,3,positive regulation of interleukin-10 secretion,BP,CD274
6377,GO:0021602,0.0791293508778324,0.989399824647135,2,15,cranial nerve morphogenesis,BP,MAFB;NRP1
7951,GO:0032587,0.0791333021625676,0.97310861090946,5,73,ruffle membrane,CC,LCP1;ITGAV;WWC1;HSP90AA1;EPHA2
11844,GO:0046888,0.0792307662487321,0.982394300217854,3,33,negative regulation of hormone secretion,BP,EDN1;IL1B;MIDN
11307,GO:0045667,0.0792335380276942,0.973053337518269,5,74,regulation of osteoblast differentiation,BP,IL6ST;NOCT;FBN2;CDK6;SOX11
413,GO:0001101,0.079350849286028,0.959548519809205,11,223,response to acid chemical,BP,TRIM16;KRT8;EDN1;TP53;CLDN1;KRT13;DUSP1;LYN;XBP1;ARG1;SETX
8329,GO:0033218,0.0797044880195564,0.960834087170522,10,199,amide binding,MF,NFKBIA;ANPEP;CRYAB;ERAP1;ITGAV;HSP90AB1;CALR;PPID;MME;TUBB3
12919,GO:0051341,0.0797873118228109,0.976906033547603,4,54,regulation of oxidoreductase activity,BP,NFKB1;EDN1;IL1B;HSP90AA1
3208,GO:0006874,0.080047943891478,0.960643669884056,10,196,cellular calcium ion homeostasis,BP,SAA1;EDN1;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;CALR;HSP90B1;PML
860,GO:0002204,0.0803705319884737,0.982034865468268,3,33,somatic recombination of immunoglobulin genes involved in immune response,BP,NBN;TFRC;HSPD1
861,GO:0002208,0.0803705319884737,0.982034865468268,3,33,somatic diversification of immunoglobulins involved in immune response,BP,NBN;TFRC;HSPD1
11110,GO:0045190,0.0803705319884737,0.982034865468268,3,33,isotype switching,BP,NBN;TFRC;HSPD1
7871,GO:0032461,0.0803977559538799,0.989060355269874,2,16,positive regulation of protein oligomerization,BP,TP53;PMAIP1
14272,GO:0061458,0.0805303152909278,0.95519948834936,14,300,reproductive system development,BP,KRT8;SLIT2;JUNB;PHLDA2;AXL;ANXA1;MMP19;EGLN1;HSP90AB1;NR2F2;HMGCS1;DLG1;CITED2;ZFP42
8706,GO:0034381,0.0807150483733453,0.981896372214867,3,34,plasma lipoprotein particle clearance,BP,NCEH1;HMOX1;EHD1
1370,GO:0003279,0.0808232964495085,0.972366484468375,5,73,cardiac septum development,BP,NRP1;EGLN1;CITED2;SOX11;PARVA
4004,GO:0009051,0.080941444322003,0.997739844514012,1,3,pentose-phosphate shunt, oxidative branch,BP,G6PD
16103,GO:0090156,0.0813705259487314,0.997715353932119,1,3,cellular sphingolipid homeostasis,BP,ORMDL1
7482,GO:0031674,0.0815126237978622,0.97203913788181,5,75,I band,CC,KRT8;CRYAB;SLC8A1;SORBS2;PARVA
13159,GO:0051817,0.0815130831060984,0.972027794755443,5,76,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TNIP1;JUN;ITGAV;ARG1;SUGT1
3674,GO:0008194,0.0815301751145177,0.96864526301707,6,99,UDP-glycosyltransferase activity,MF,B4GALT1;UGGT1;MGAT5;HAS2;GALNT14;UGCG
4416,GO:0010269,0.0817776778627907,0.997691988258452,1,3,response to selenium ion,BP,ARG1
14611,GO:0070242,0.081855439096351,0.988747405402035,2,16,thymocyte apoptotic process,BP,TP53;ADAM8
4673,GO:0010842,0.0818592234518493,0.98882013767645,2,15,retina layer formation,BP,DSCAM;SDK1
15242,GO:0071466,0.0818608792707939,0.968462450516905,6,102,cellular response to xenobiotic stimulus,BP,NCEH1;SLC8A1;ARG1;HSP90AB1;MGST3;CYP1A1
2258,GO:0005212,0.0818833010487704,0.997685906569874,1,3,structural constituent of eye lens,MF,CRYAB
12788,GO:0051133,0.0819185479507958,0.997683875234743,1,3,regulation of NK T cell activation,BP,IL23A
12789,GO:0051135,0.0819185479507958,0.997683875234743,1,3,positive regulation of NK T cell activation,BP,IL23A
4216,GO:0009411,0.0819306172475318,0.965656830803279,7,123,response to UV,BP,TP53;PARP1;DCUN1D3;PPID;MME;NEDD4;PML
14703,GO:0070412,0.0819650032773355,0.988797439227147,2,15,R-SMAD binding,MF,JUN;PARP1
19392,GO:1990037,0.0819659163216749,0.997681143861806,1,3,Lewy body core,CC,HERPUD1
7065,GO:0030879,0.0819964121343464,0.968436171121926,6,97,mammary gland development,BP,B4GALT1;XBP1;ARG1;NRG1;PML;EPHA2
19842,GO:2000369,0.0821400880455926,0.988759830605639,2,15,regulation of clathrin-dependent endocytosis,BP,UBQLN2;SYT11
745,GO:0001990,0.0821471795486277,0.988684368442589,2,16,regulation of systemic arterial blood pressure by hormone,BP,EDN1;MME
3836,GO:0008467,0.0821588218313998,0.997670003197389,1,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,HS3ST1
15953,GO:0086005,0.0822151143869482,0.988743700055792,2,15,ventricular cardiac muscle cell action potential,BP,NEDD4L;DLG1
660,GO:0001867,0.0822466216339214,0.997664923403293,1,3,complement activation, lectin pathway,BP,KRT1
12502,GO:0050688,0.0822557808720467,0.975945824860934,4,54,regulation of defense response to virus,BP,IL1B;BIRC3;TRAF3;IL23A
13133,GO:0051771,0.0822670572140848,0.997663740246457,1,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
12528,GO:0050717,0.0823350047901389,0.997659804053138,1,3,positive regulation of interleukin-1 alpha secretion,BP,NLRP10
20235,GO:2001243,0.0823538389880565,0.971633703193975,5,78,negative regulation of intrinsic apoptotic signaling pathway,BP,MMP9;HERPUD1;XBP1;SOD2;PTTG1IP
13690,GO:0060300,0.082419986266379,0.997654876242699,1,3,regulation of cytokine activity,BP,NRP1
13734,GO:0060353,0.0824807502078306,0.997651349429071,1,3,regulation of cell adhesion molecule production,BP,IL1B
13735,GO:0060355,0.0824807502078306,0.997651349429071,1,3,positive regulation of cell adhesion molecule production,BP,IL1B
14972,GO:0070943,0.0824816935830269,0.997651294652709,1,3,neutrophil mediated killing of symbiont cell,BP,ARG1
399,GO:0001076,0.0824949831696685,0.963005399600052,8,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,TP53;DNAJB1;JUN;SDR16C5;MED18;CITED2;ZFP42;SOX11
9389,GO:0035986,0.0825346698838652,0.997648217558881,1,3,senescence-associated heterochromatin focus assembly,BP,CDKN2A
3620,GO:0008104,0.0828385721421263,0.935972154343846,73,2059,protein localization,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;TP53;PMAIP1;CD274;RIPK2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;CYLD;FBN2;NFKBIE;STAC;ITGAV;LYN;AP3M1;ANXA1;DERL3;NEDD4L;VEGFC;RHOB;XBP1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;NRP1;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;AJUBA;SEL1L;SERP1;PRR5L;RAB30;SEC22A;CORO1C;DLG1;PDIA4;EHD1;PTTG1IP;SEC24D;REEP1;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;ZDHHC6;PML;OXCT1;EPHA2;MON1A;EPB41L2;MYH9;TOR1AIP1;UGCG;TNFAIP2;CEP83;HSPD1;MIDN
14605,GO:0070231,0.082897596132786,0.981170751881623,3,35,T cell apoptotic process,BP,TP53;CD274;ADAM8
19816,GO:2000328,0.0829866130178133,0.997621881612055,1,3,regulation of T-helper 17 cell lineage commitment,BP,IL23A
969,GO:0002429,0.0830048549414124,0.957339277157762,11,228,immune response-activating cell surface receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;PSMB9;RIPK2;ACTG1;CYLD;LYN;HSP90AA1;HSP90AB1;EIF2B1
4044,GO:0009110,0.0830109417527724,0.988496947475595,2,16,vitamin biosynthetic process,BP,NFKB1;IL1B
10453,GO:0043382,0.0831951670170243,0.997609677203949,1,3,positive regulation of memory T cell differentiation,BP,IL23A
4327,GO:0009896,0.0833344149594371,0.952375859417548,15,328,positive regulation of catabolic process,BP,UBQLN2;RIPK2;HERPUD1;OPTN;IL1B;TRIB1;NEDD4L;XBP1;HMOX1;HSP90AA1;ADAM8;PRR5L;PTTG1IP;SVIP;NEDD4
10692,GO:0044062,0.0833531173269607,0.997600412471031,1,3,regulation of excretion,BP,EDN1
17291,GO:1900003,0.0833936894969257,0.997598029662494,1,3,regulation of serine-type endopeptidase activity,BP,ANXA8
17292,GO:1900004,0.0833936894969257,0.997598029662494,1,3,negative regulation of serine-type endopeptidase activity,BP,ANXA8
18005,GO:1902571,0.0833936894969257,0.997598029662494,1,3,regulation of serine-type peptidase activity,BP,ANXA8
18006,GO:1902572,0.0833936894969257,0.997598029662494,1,3,negative regulation of serine-type peptidase activity,BP,ANXA8
10587,GO:0043616,0.083516218268955,0.981031103269558,3,33,keratinocyte proliferation,BP,KRT2;SDR16C5;HAS2
14465,GO:0062012,0.0835284024046583,0.952239022151492,15,334,regulation of small molecule metabolic process,BP,NFKB1;PMAIP1;PSMB9;PARP1;IL1B;C1QTNF1;PHLDA2;ANXA1;GPR176;EGLN1;IGFBP3;HMGCS1;HAS2;ENPP1;MIDN
1126,GO:0002725,0.0835998950589926,0.997585900180106,1,3,negative regulation of T cell cytokine production,BP,ARG1
7294,GO:0031323,0.08362765512723,0.931781461327569,154,4612,regulation of cellular metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;SERPINB2;DSCAM;SAA1;OSR2;TNIP1;DUSP8;NFKB1;MAFB;RELB;FEZ1;EDN1;TP53;PMAIP1;PSMB9;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;PHLDA2;CRYAB;ATF3;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;ITGAV;LYN;ANXA1;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;IL24;HSP90AA1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;TNFSF15;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;ORMDL1;MAFF;MGA;PRR5L;UBP1;CORO1C;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;PTTG1IP;ETS1;HAS2;CHORDC1;TGFA;BAMBI;DNAJC3;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;PML;EPHA2;MYH9;EID3;BTBD10;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2
11215,GO:0045454,0.0838918389398607,0.975254337767501,4,57,cell redox homeostasis,BP,DNAJC10;PDIA6;PDIA4;TXNRD1
10617,GO:0043686,0.0839181999329921,0.997567114391805,1,3,co-translational protein modification,BP,STT3A
5995,GO:0019062,0.0839858525355847,0.997563111898394,1,3,virion attachment to host cell,BP,HSP90AB1
10919,GO:0044650,0.0839858525355847,0.997563111898394,1,3,adhesion of symbiont to host cell,BP,HSP90AB1
1916,GO:0004622,0.0840325737198134,0.98827375838232,2,16,lysophospholipase activity,MF,MGLL;PLBD1
9792,GO:0042035,0.0840848755382843,0.975227475603347,4,54,regulation of cytokine biosynthetic process,BP,IL1A;NFKB1;IL1B;HMOX1
1686,GO:0004175,0.0841032834708685,0.956675327399619,11,228,endopeptidase activity,MF,MMP9;ASPRV1;PSMB9;ERAP1;C1R;MMP19;KLK6;TPP2;PREP;ADAM8;MME
1150,GO:0002765,0.0841113585774787,0.997555677593001,1,3,immune response-inhibiting signal transduction,BP,LYN
2150,GO:0004993,0.0841145000191876,0.997555491359761,1,3,G-protein coupled serotonin receptor activity,MF,HTR1B
3407,GO:0007210,0.0841145000191876,0.997555491359761,1,3,serotonin receptor signaling pathway,BP,HTR1B
10329,GO:0043176,0.0841145000191876,0.997555491359761,1,3,amine binding,MF,HTR1B
12936,GO:0051378,0.0841145000191876,0.997555491359761,1,3,serotonin binding,MF,HTR1B
16773,GO:0098664,0.0841145000191876,0.997555491359761,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR1B
17036,GO:0099589,0.0841145000191876,0.997555491359761,1,3,serotonin receptor activity,MF,HTR1B
13887,GO:0060590,0.0841898134478639,0.980753623463916,3,35,ATPase regulator activity,MF,DNAJB1;DNAJC10;TOR1AIP1
7937,GO:0032558,0.0842045380514213,0.997550150522994,1,3,adenyl deoxyribonucleotide binding,MF,HSP90AB1
7941,GO:0032564,0.0842045380514213,0.997550150522994,1,3,dATP binding,MF,HSP90AB1
18650,GO:1904044,0.0842179921004658,0.997549351941016,1,3,response to aldosterone,BP,PARP1
15367,GO:0071672,0.0843524169652039,0.99754136555167,1,3,negative regulation of smooth muscle cell chemotaxis,BP,SLIT2
15294,GO:0071556,0.0844825712033664,0.98810722269949,2,17,integral component of lumenal side of endoplasmic reticulum membrane,CC,CANX;CALR
16720,GO:0098553,0.0844825712033664,0.98810722269949,2,17,lumenal side of endoplasmic reticulum membrane,CC,CANX;CALR
13192,GO:0051896,0.0844844728180019,0.964339871675752,7,122,regulation of protein kinase B signaling,BP,FGF5;C1QTNF1;AXL;NRG1;ADAM8;DLG1;EPHA2
10116,GO:0042723,0.0845381526333414,0.997530308470182,1,3,thiamine-containing compound metabolic process,BP,THTPA
18200,GO:1903051,0.0845654989168856,0.975020567509906,4,55,negative regulation of proteolysis involved in cellular protein catabolic process,BP,DERL3;HSP90AB1;SVIP;PML
10138,GO:0042756,0.0845725103689307,0.99752826028194,1,3,drinking behavior,BP,HTR1B
2371,GO:0005520,0.0845875336238278,0.988151834586664,2,16,insulin-like growth factor binding,MF,ITGAV;IGFBP3
14334,GO:0061614,0.0846603623918026,0.980661780127774,3,33,pri-miRNA transcription by RNA polymerase II,BP,TP53;JUN;ETS1
9345,GO:0035902,0.0846753796686997,0.988132490799992,2,16,response to immobilization stress,BP,SLC8A1;CYP1A1
2939,GO:0006486,0.0846766645886416,0.95792299045771,10,199,protein glycosylation,BP,B4GALT1;STT3A;DERL3;UGGT1;MGAT5;SERP1;MAGT1;DHDDS;GALNT14;SDF2L1
10476,GO:0043413,0.0846766645886416,0.95792299045771,10,199,macromolecule glycosylation,BP,B4GALT1;STT3A;DERL3;UGGT1;MGAT5;SERP1;MAGT1;DHDDS;GALNT14;SDF2L1
20101,GO:2000833,0.0847761589446124,0.997516101924808,1,3,positive regulation of steroid hormone secretion,BP,C1QTNF1
11181,GO:0045348,0.0847777499101236,0.9975160068178,1,3,positive regulation of MHC class II biosynthetic process,BP,XBP1
12707,GO:0051015,0.0847990560440881,0.964182573755288,7,121,actin filament binding,MF,LCP1;MYO1B;ANXA8;AJUBA;CORO1C;MYH9;TPM4
3613,GO:0008089,0.0848070144916668,0.980582899599992,3,34,anterograde axonal transport,BP,NEFL;FEZ1;AP3M1
6900,GO:0030512,0.0848228947074069,0.974935994667257,4,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,PEG10;HSPA5;FBN2;BAMBI
3927,GO:0008637,0.0849829459532651,0.966928993854898,6,104,apoptotic mitochondrial changes,BP,MMP9;TP53;PMAIP1;JUN;SOD2;HSPD1
16759,GO:0098644,0.0851645859739997,0.988102598880812,2,15,complex of collagen trimers,CC,COL8A1;COL4A4
15270,GO:0071502,0.085217377138388,0.997489653556421,1,3,cellular response to temperature stimulus,BP,HTR1B
7060,GO:0030868,0.0852631743198166,0.997486899942137,1,3,smooth endoplasmic reticulum membrane,CC,SVIP
16557,GO:0097425,0.0852631743198166,0.997486899942137,1,3,smooth endoplasmic reticulum part,CC,SVIP
7244,GO:0031232,0.0852806444649379,0.997485849113377,1,3,extrinsic component of external side of plasma membrane,CC,ANXA1
3702,GO:0008237,0.0854930399738465,0.966718828669713,6,99,metallopeptidase activity,MF,MMP9;ANPEP;ERAP1;MMP19;ADAM8;MME
14641,GO:0070295,0.0855461806059587,0.997469848977985,1,3,renal water absorption,BP,HAS2
1558,GO:0003976,0.0855867403437083,0.997467400361696,1,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,GNPTAB
15888,GO:0072717,0.0856782425579926,0.997461871789674,1,3,cellular response to actinomycin D,BP,TP53
5207,GO:0015833,0.0857579186738481,0.93571975378561,55,1520,peptide transport,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;EDN1;TP53;CD274;RIPK2;HERPUD1;OPTN;IL1B;ITGAV;LYN;AP3M1;ANXA1;DERL3;VEGFC;RHOB;XBP1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;SEL1L;SERP1;PRR5L;RAB30;SEC22A;PDIA4;EHD1;PTTG1IP;SEC24D;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;UGCG;HSPD1;MIDN
9672,GO:0038107,0.0858019695752563,0.997454386214396,1,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,CITED2
17330,GO:1900094,0.0858019695752563,0.997454386214396,1,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,CITED2
17379,GO:1900164,0.0858019695752563,0.997454386214396,1,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,CITED2
18208,GO:1903070,0.0858903011989602,0.997449035066923,1,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,SVIP
49,GO:0000103,0.0859465706557519,0.997445623202422,1,3,sulfate assimilation,BP,PAPSS2
13008,GO:0051538,0.0859592822502906,0.997444852113907,1,3,3 iron, 4 sulfur cluster binding,MF,ACO1
13239,GO:0051967,0.0859795885630804,0.99744362007656,1,3,negative regulation of synaptic transmission, glutamatergic,BP,HTR1B
12302,GO:0048699,0.08598930777106,0.939229674766764,37,943,generation of neurons,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;SLIT2;JUN;SDK1;HSPA5;CNTNAP1;IL6ST;AXL;SEMA7A;LYN;NEDD4L;VEGFC;XBP1;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;NR2F2;CALR;EHD1;ADGRL3;NEDD4;CDK6;TUBB3;NTNG1;SOX11
6492,GO:0021886,0.085999850582495,0.997442390418488,1,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,NRP1
6493,GO:0021888,0.085999850582495,0.997442390418488,1,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,NRP1
9805,GO:0042063,0.086102056629208,0.958915339887307,9,173,gliogenesis,BP,FGF5;CNTNAP1;IL6ST;LYN;ANXA1;NRG1;EIF2B1;CDK6;SOX11
14976,GO:0070948,0.0861040865315694,0.997436059699733,1,3,regulation of neutrophil mediated cytotoxicity,BP,ARG1
3280,GO:0006990,0.0861258468423298,0.997434737070168,1,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,XBP1
3465,GO:0007341,0.0861446592993662,0.997433593330114,1,3,penetration of zona pellucida,BP,B4GALT1
18289,GO:1903286,0.0861868916576339,0.99743102476482,1,3,regulation of potassium ion import,BP,DLG1
13726,GO:0060343,0.0862791450678004,0.987777224160364,2,16,trabecula formation,BP,FBN2;EGLN1
5749,GO:0016942,0.0863576647568302,0.997420624731955,1,3,insulin-like growth factor binding protein complex,CC,IGFBP3
9567,GO:0036454,0.0863576647568302,0.997420624731955,1,3,growth factor complex,CC,IGFBP3
16228,GO:0090330,0.0863869315929317,0.987753203659306,2,16,regulation of platelet aggregation,BP,C1QTNF1;LYN
18541,GO:1903827,0.0864147794453037,0.947683960673702,18,415,regulation of cellular protein localization,BP,LCP1;TP53;PMAIP1;PARP1;IL1B;CYLD;STAC;DERL3;NEDD4L;SYT11;NRG1;HSP90AB1;PRR5L;DLG1;SVIP;EPHA2;EPB41L2;UGCG
9956,GO:0042383,0.0864919112958971,0.96980481087959,5,76,sarcolemma,CC,KRT8;STAC;ANXA1;SLC8A1;DLG1
7058,GO:0030866,0.0865503560255138,0.980046801873365,3,33,cortical actin cytoskeleton organization,BP,CALR;DLG1;EPB41L2
6490,GO:0021884,0.0866544517643267,0.987693508130297,2,16,forebrain neuron development,BP,SLIT2;NRP1
8884,GO:0034751,0.0866671435738524,0.99740172181357,1,3,aryl hydrocarbon receptor complex,CC,HSP90AB1
11172,GO:0045337,0.0866817980910075,0.997400824935867,1,3,farnesyl diphosphate biosynthetic process,BP,HMGCS1
8211,GO:0033004,0.0868179052357468,0.997392487281127,1,3,negative regulation of mast cell activation,BP,HMOX1
8214,GO:0033007,0.0868179052357468,0.997392487281127,1,3,negative regulation of mast cell activation involved in immune response,BP,HMOX1
7411,GO:0031532,0.0870369232078121,0.969547247655561,5,77,actin cytoskeleton reorganization,BP,ANXA1;NRP1;ARHGDIB;MYH9;PARVA
8716,GO:0034392,0.0870656882054031,0.997377272884502,1,3,negative regulation of smooth muscle cell apoptotic process,BP,EDN1
7872,GO:0032462,0.0870735271767514,0.987528922749993,2,17,regulation of protein homooligomerization,BP,CLDN7;CRYAB
11105,GO:0045184,0.0871227178675112,0.934323588441265,57,1583,establishment of protein localization,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;TP53;PMAIP1;CD274;RIPK2;HERPUD1;OPTN;IL1B;ITGAV;LYN;AP3M1;ANXA1;DERL3;VEGFC;RHOB;XBP1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;SEL1L;SERP1;PRR5L;RAB30;SEC22A;CORO1C;PDIA4;EHD1;PTTG1IP;SEC24D;REEP1;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;UGCG;HSPD1;MIDN
5646,GO:0016774,0.0871395480476728,0.997372728816089,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,PGK1
2540,GO:0005829,0.0872550630861432,0.929000970740788,137,4102,cytosol,CC,IL32;CDKN2A;NFKBIA;RPTN;SPRR2G;SPRR2A;IL1A;TRIM16;TCHH;KRT1;NEFL;KRT8;LGALS1;KRT24;KRT2;LCP1;TNIP1;KRT18;SPRR3;NFKB1;RELB;TP53;DPYSL3;PMAIP1;PSMB9;FLG;LCE3D;NAGK;UBQLN2;CHAC1;KRT78;CDKN2B;NABP1;PGK1;SPRR2E;DNAJB1;SPRR2D;PEG10;JUN;KRT4;RIPK2;IL16;NFKB2;OPTN;IL1B;MSRB3;CDV3;KRT13;TJP2;HSPB8;CRYAB;ACTG1;HSPA6;IKBKE;MGLL;ERAP1;CYLD;NFKBIE;STAC;ANXA8;PLBD1;KRT23;ITGAV;LYN;ANXA1;PDE1C;G6PD;NBN;WWC1;THTPA;NEDD4L;BIRC3;RHOB;ARG1;SUDS3;TRAF3;HMOX1;FAM126B;PAPSS2;HSP90AA1;FTH1;DAPP1;NRP1;TPP2;TRAF1;EGLN1;ACO1;PREP;HSP90AB1;KRT34;STXBP5;NR2F2;EIF4G2;CALR;PDIA6;PPID;AJUBA;AMOTL2;SERP1;EIF2B1;MOCS2;HMGCS1;ARHGDIB;UBP1;GIT2;DLG1;NGLY1;GDA;TXNRD1;SEC24D;SUGT1;DNAJC3;CBLL1;BCAT1;HSP90B1;UBXN2B;NEDD4;CDK6;PML;MON1A;EPB41L2;MYH9;TRIM47;ZBTB21;GBE1;CPPED1;AFAP1;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;SND1;MIDN;IRAK2;TJP1;PARVA
5545,GO:0016576,0.0872578246948351,0.997365443565889,1,3,histone dephosphorylation,BP,EYA3
12454,GO:0050501,0.0872712427182852,0.997364616419132,1,3,hyaluronan synthase activity,MF,HAS2
9256,GO:0035725,0.0873394758440933,0.969434312036572,5,75,sodium ion transmembrane transport,BP,NETO1;SLC8A1;NEDD4L;DLG1;NEDD4
12763,GO:0051097,0.0874596467952613,0.99735298807095,1,3,negative regulation of helicase activity,BP,TP53
8057,GO:0032762,0.087515988653377,0.997349505457166,1,3,mast cell cytokine production,BP,HMOX1
8058,GO:0032763,0.087515988653377,0.997349505457166,1,3,regulation of mast cell cytokine production,BP,HMOX1
9596,GO:0036493,0.0875410103934283,0.997347958043713,1,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,DNAJC3
9840,GO:0042130,0.0875473225009338,0.979656451721759,3,35,negative regulation of T cell proliferation,BP,CD274;ARG1;DLG1
12922,GO:0051344,0.0875528680270403,0.997347224570634,1,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,EGLN1
6874,GO:0030426,0.0876242564054608,0.962699159854377,7,122,growth cone,CC,NEFL;DSCAM;FEZ1;DPYSL3;NRP1;SETX;L1CAM
7598,GO:0032010,0.0876386707253476,0.997341913957769,1,3,phagolysosome,CC,ADAM8
9557,GO:0036435,0.0877032183240801,0.997337915246749,1,3,K48-linked polyubiquitin modification-dependent protein binding,MF,IKBKE
10442,GO:0043368,0.0877291302368423,0.987452581523807,2,16,positive T cell selection,BP,CYLD;IL23A
19005,GO:1904892,0.0877294396973987,0.969211337650331,5,79,regulation of STAT cascade,BP,IL6ST;LYN;IL24;IL7R;IL23A
2627,GO:0005977,0.0877488607719065,0.973771226001671,4,54,glycogen metabolic process,BP,IL6ST;PHLDA2;GBE1;ENPP1
2691,GO:0006073,0.0877488607719065,0.973771226001671,4,54,cellular glucan metabolic process,BP,IL6ST;PHLDA2;GBE1;ENPP1
10687,GO:0044042,0.0877488607719065,0.973771226001671,4,54,glucan metabolic process,BP,IL6ST;PHLDA2;GBE1;ENPP1
8036,GO:0032727,0.0877515480780029,0.987447536740493,2,16,positive regulation of interferon-alpha production,BP,RIPK2;HSPD1
11136,GO:0045236,0.0877621589541108,0.997334261151149,1,3,CXCR chemokine receptor binding,MF,CXCL1
3800,GO:0008410,0.0877897728544919,0.99733254829577,1,3,CoA-transferase activity,MF,OXCT1
3512,GO:0007507,0.0878214257697886,0.948452616408634,16,353,heart development,BP,EDN1;JUN;G6PD;SLC8A1;NRP1;EGLN1;NRG1;CALR;CITED2;LOX;HAS2;NEDD4;OXCT1;SOX11;SORBS2;PARVA
9225,GO:0035658,0.0878238691005942,0.997330432557868,1,3,Mon1-Ccz1 complex,CC,MON1A
14026,GO:0060846,0.0878372223288588,0.997329603726129,1,3,blood vessel endothelial cell fate commitment,BP,NRP1
14027,GO:0060847,0.0878372223288588,0.997329603726129,1,3,endothelial cell fate specification,BP,NRP1
16398,GO:0097101,0.0878372223288588,0.997329603726129,1,3,blood vessel endothelial cell fate specification,BP,NRP1
7315,GO:0031345,0.0878632902711075,0.962567091320645,7,123,negative regulation of cell projection organization,BP,LGALS1;DPYSL3;SLIT2;SEMA7A;SEMA3D;NRP1;IFRD1
18064,GO:1902743,0.0879024259388116,0.979570240593561,3,34,regulation of lamellipodium organization,BP,SLIT2;CORO1C;EPHA2
1293,GO:0003148,0.0879046565923273,0.987413061291312,2,16,outflow tract septum morphogenesis,BP,NRP1;PARVA
12070,GO:0048146,0.0879766035443271,0.979514790165171,3,35,positive regulation of fibroblast proliferation,BP,JUN;CDK6;PML
4754,GO:0010957,0.0880867389830448,0.997314091630019,1,3,negative regulation of vitamin D biosynthetic process,BP,NFKB1
11547,GO:0046137,0.0880867389830448,0.997314091630019,1,3,negative regulation of vitamin metabolic process,BP,NFKB1
691,GO:0001915,0.0881428266694206,0.997310598293861,1,3,negative regulation of T cell mediated cytotoxicity,BP,IL7R
7568,GO:0031958,0.0882882792983602,0.987326521833269,2,16,corticosteroid receptor signaling pathway,BP,CALR;NEDD4
7443,GO:0031620,0.088330935060535,0.997298864974715,1,3,regulation of fever generation,BP,IL1B
7444,GO:0031622,0.088330935060535,0.997298864974715,1,3,positive regulation of fever generation,BP,IL1B
1090,GO:0002686,0.0883750317239215,0.987234477922084,2,17,negative regulation of leukocyte migration,BP,SLIT2;HMOX1
8494,GO:0033745,0.0884552013428649,0.997291099226533,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB3
18325,GO:1903362,0.088461895371205,0.95567252628515,10,202,regulation of cellular protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;DERL3;XBP1;HSP90AA1;HSP90AB1;PTTG1IP;SVIP;PML
13549,GO:0060057,0.0884741796024453,0.997289912199236,1,3,apoptotic process involved in mammary gland involution,BP,B4GALT1
13550,GO:0060058,0.0884741796024453,0.997289912199236,1,3,positive regulation of apoptotic process involved in mammary gland involution,BP,B4GALT1
17924,GO:1902339,0.0884741796024453,0.997289912199236,1,3,positive regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18396,GO:1903519,0.0884741796024453,0.997289912199236,1,3,regulation of mammary gland involution,BP,B4GALT1
18397,GO:1903521,0.0884741796024453,0.997289912199236,1,3,positive regulation of mammary gland involution,BP,B4GALT1
18927,GO:1904747,0.0884741796024453,0.997289912199236,1,3,positive regulation of apoptotic process involved in development,BP,B4GALT1
12589,GO:0050816,0.0885127361162431,0.997287499782379,1,3,phosphothreonine residue binding,MF,NEDD4
11713,GO:0046596,0.0886577935405752,0.987170159854053,2,17,regulation of viral entry into host cell,BP,LGALS1;IFITM2
3129,GO:0006740,0.0886580707087794,0.997278396383184,1,3,NADPH regeneration,BP,G6PD
320,GO:0000839,0.0886844738299062,0.997276740850735,1,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,SEL1L
11275,GO:0045629,0.0887823903634255,0.997270596692364,1,3,negative regulation of T-helper 2 cell differentiation,BP,ANXA1
18812,GO:1904468,0.0888046467471061,0.997269199121298,1,3,negative regulation of tumor necrosis factor secretion,BP,SYT11
7936,GO:0032557,0.0888354308616653,0.997267265443888,1,3,pyrimidine ribonucleotide binding,MF,HSP90AB1
8017,GO:0032689,0.0889174141429456,0.987110996500273,2,17,negative regulation of interferon-gamma production,BP,CD274;AXL
6476,GO:0021855,0.0889282206280957,0.997261432619056,1,3,hypothalamus cell migration,BP,NRP1
3045,GO:0006623,0.0889421523538735,0.979226459187607,3,34,protein targeting to vacuole,BP,AP3M1;GNPTAB;NEDD4
13361,GO:0052735,0.0889510591594796,0.997259995980042,1,3,tRNA (cytosine-3-)-methyltransferase activity,MF,METTL2A
4038,GO:0009100,0.0889882092441906,0.949726497537339,14,306,glycoprotein metabolic process,BP,TNIP1;B4GALT1;STT3A;DERL3;UGGT1;GNPTAB;SEL1L;MGAT5;SERP1;MAGT1;NGLY1;DHDDS;GALNT14;SDF2L1
16487,GO:0097252,0.0889895734742741,0.997257572379162,1,3,oligodendrocyte apoptotic process,BP,TP53
6711,GO:0030144,0.0890044826413252,0.997256633886026,1,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,MGAT5
18393,GO:1903516,0.0890661390043578,0.997252751001516,1,3,regulation of single strand break repair,BP,PARP1
14120,GO:0061043,0.0890865350185753,0.997251465907545,1,3,regulation of vascular wound healing,BP,XBP1
16750,GO:0098631,0.0891514123041994,0.979125518609303,3,35,cell adhesion mediator activity,MF,KRT18;EPCAM;ANXA1
2625,GO:0005975,0.0892556419360477,0.944951933570438,19,447,carbohydrate metabolic process,BP,NFKB1;B4GALT1;PMAIP1;NAGK;PGK1;C1QTNF1;IL6ST;PHLDA2;ATF3;G6PD;GNPTAB;IGFBP3;SERP1;CS;HAS2;GALNT14;GBE1;ENPP1;MIDN
6057,GO:0019227,0.0892874992008985,0.997238786981894,1,3,neuronal action potential propagation,BP,CNTNAP1
16866,GO:0098870,0.0892874992008985,0.997238786981894,1,3,action potential propagation,BP,CNTNAP1
627,GO:0001820,0.0893849168325208,0.99723262990902,1,3,serotonin secretion,BP,HTR1B
8880,GO:0034729,0.0894184440850169,0.997230509236961,1,3,histone H3-K79 methylation,BP,CTR9
13938,GO:0060689,0.0894487155249186,0.997228593774583,1,3,cell differentiation involved in salivary gland development,BP,XBP1
2213,GO:0005127,0.089489022682248,0.997226042218105,1,3,ciliary neurotrophic factor receptor binding,MF,IL6ST
12573,GO:0050794,0.0894965733379601,0.926920818358292,230,7107,regulation of cellular process,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;LCP1;TNIP1;DUSP8;KRT18;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;DBNDD2;SLIT2;CLDN1;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;CLDN7;DNAJB1;PEG10;CCBE1;JUN;KRT4;MCAM;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;SDK1;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;CD83;ITGAV;LYN;ANXA1;PDE1C;GPR176;DERL3;G6PD;NBN;SLC8A1;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;ARG1;UGGT1;SEMA3D;SUDS3;TRAF3;ARNTL2;HMOX1;SYT11;KLK6;ZNF638;IL24;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;TNFSF15;CXCR5;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;RRAS2;MGA;PRR5L;RAB30;ARHGDIB;UBP1;GIT2;CORO1C;IL23A;DLG1;PDIA4;MED18;RBMS3;EHD1;ZMYM4;CITED2;ZNF814;TXNRD1;PTTG1IP;ETS1;HAS2;ADGRL3;PDE4DIP;CHORDC1;TGFA;BAMBI;DNAJC3;CBLL1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;PML;OXCT1;EPHA2;MYH9;EID3;BTBD10;ZBTB21;HES4;SOX11;UGCG;ENPP1;AFAP1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
11841,GO:0046885,0.0895639598991789,0.987037114978566,2,16,regulation of hormone biosynthetic process,BP,NFKB1;IL1B
11880,GO:0046952,0.0895848362926728,0.997219972032802,1,3,ketone body catabolic process,BP,OXCT1
13546,GO:0060054,0.0897004382207852,0.997212638966536,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,B4GALT1
9696,GO:0038171,0.0897186802720799,0.997211480884248,1,3,cannabinoid signaling pathway,BP,MGLL
15491,GO:0071926,0.0897186802720799,0.997211480884248,1,3,endocannabinoid signaling pathway,BP,MGLL
11619,GO:0046394,0.0897508344262458,0.950417633035151,13,284,carboxylic acid biosynthetic process,BP,NFKB1;EDN1;PGK1;IL1B;MGLL;FADS1;ANXA1;FADS3;XBP1;HAS2;MGST3;BCAT1;CYP1A1
15092,GO:0071224,0.0899154045644883,0.997198976056804,1,3,cellular response to peptidoglycan,BP,RIPK2
13694,GO:0060306,0.0899685531420158,0.986944803837059,2,16,regulation of membrane repolarization,BP,NEDD4L;DLG1
2340,GO:0005432,0.0900319636653451,0.997191553182726,1,3,calcium:sodium antiporter activity,MF,SLC8A1
1009,GO:0002513,0.0900618921383729,0.997189645584189,1,3,tolerance induction to self antigen,BP,LYN
14651,GO:0070309,0.0901281642747869,0.997185419087772,1,3,lens fiber cell morphogenesis,BP,EPHA2
15769,GO:0072507,0.0901847891080542,0.952971662800012,11,227,divalent inorganic cation homeostasis,BP,SAA1;EDN1;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;CALR;SLC39A14;HSP90B1;PML
3475,GO:0007369,0.0901992237211175,0.961342144710788,7,122,gastrulation,BP,MMP9;COL12A1;DUSP1;ITGAV;COL8A1;CTR9;TXNRD1
17380,GO:1900165,0.090245099502296,0.99717795348002,1,3,negative regulation of interleukin-6 secretion,BP,SYT11
19877,GO:2000416,0.0902768131482095,0.997175926977238,1,3,regulation of eosinophil migration,BP,ADAM8
17651,GO:1901570,0.0902922985744348,0.972693145286991,4,57,fatty acid derivative biosynthetic process,BP,EDN1;FADS1;ANXA1;MGST3
11311,GO:0045671,0.0903727747733573,0.986852326394601,2,16,negative regulation of osteoclast differentiation,BP,MAFB;TJP2
20085,GO:2000810,0.0903773569671793,0.986851276647223,2,16,regulation of bicellular tight junction assembly,BP,CLDN1;TJP1
11298,GO:0045658,0.0904678410482862,0.997163704237891,1,3,regulation of neutrophil differentiation,BP,TRIB1
14074,GO:0060971,0.0905133927193331,0.997160785591405,1,3,embryonic heart tube left/right pattern formation,BP,CITED2
1174,GO:0002828,0.0906391807140708,0.986715997371456,2,17,regulation of type 2 immune response,BP,ANXA1;ARG1
16257,GO:0090403,0.0906580530915873,0.99715150633847,1,3,oxidative stress-induced premature senescence,BP,TP53
6646,GO:0030020,0.0907189867324695,0.997147593016409,1,3,extracellular matrix structural constituent conferring tensile strength,MF,COL12A1
6550,GO:0022029,0.0907264551762598,0.978632263338007,3,34,telencephalon cell migration,BP,SLIT2;NRP1;NRG1
19802,GO:2000312,0.0915767906599164,0.997092204953662,1,3,regulation of kainate selective glutamate receptor activity,BP,NETO1
13481,GO:0055093,0.0915971874750788,0.986494238378829,2,17,response to hyperoxia,BP,TP53;CYP1A1
5309,GO:0016053,0.0916174219751994,0.949217204596442,13,285,organic acid biosynthetic process,BP,NFKB1;EDN1;PGK1;IL1B;MGLL;FADS1;ANXA1;FADS3;XBP1;HAS2;MGST3;BCAT1;CYP1A1
18624,GO:1903984,0.0916583434258957,0.997086910182007,1,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,ATF3
5418,GO:0016300,0.0916965299832502,0.997084429211028,1,3,tRNA (uracil) methyltransferase activity,MF,TRMT44
10204,GO:0042940,0.0917518634909189,0.997080832250919,1,3,D-amino acid transport,BP,NFKBIE
953,GO:0002381,0.091772596800801,0.978248661721991,3,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,NBN;TFRC;HSPD1
5328,GO:0016094,0.0917745704508284,0.997079355512868,1,3,polyprenol biosynthetic process,BP,DHDDS
9034,GO:0035290,0.0917766028736363,0.997079223316056,1,3,trunk segmentation,BP,NRP1
9589,GO:0036484,0.0917766028736363,0.997079223316056,1,3,trunk neural crest cell migration,BP,NRP1
9590,GO:0036486,0.0917766028736363,0.997079223316056,1,3,ventral trunk neural crest cell migration,BP,NRP1
17530,GO:1901166,0.0917766028736363,0.997079223316056,1,3,neural crest cell migration involved in autonomic nervous system development,BP,NRP1
16582,GO:0097475,0.0918031597048257,0.997077495667761,1,3,motor neuron migration,BP,NRP1
696,GO:0001920,0.091824334371645,0.997076117772776,1,3,negative regulation of receptor recycling,BP,OPTN
4706,GO:0010886,0.0918711747688343,0.997073068532195,1,3,positive regulation of cholesterol storage,BP,EHD1
12255,GO:0048625,0.0919563350832731,0.997067520471292,1,3,myoblast fate commitment,BP,IFRD1
13688,GO:0060297,0.0920394354181534,0.99706210132738,1,3,regulation of sarcomere organization,BP,EDN1
18318,GO:1903348,0.0920606174040733,0.997060719171103,1,3,positive regulation of bicellular tight junction assembly,BP,CLDN1
6815,GO:0030297,0.0924205372100729,0.997037181979627,1,3,transmembrane receptor protein tyrosine kinase activator activity,MF,NRG1
15221,GO:0071435,0.0925236260781298,0.997030422356144,1,3,potassium ion export,BP,DLG1
17988,GO:1902532,0.0925720945694902,0.94430114893013,17,392,negative regulation of intracellular signal transduction,BP,MMP9;TNIP1;DUSP8;SLIT2;HERPUD1;OPTN;IL1B;ATF3;DUSP1;LYN;WWC1;XBP1;SOD2;AJUBA;DLG1;PTTG1IP;EPHA2
12284,GO:0048671,0.0926060319845741,0.997025013146709,1,3,negative regulation of collateral sprouting,BP,IFRD1
13053,GO:0051603,0.0926269330061917,0.939330026198551,24,592,proteolysis involved in cellular protein catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;CYLD;TRIB1;DERL3;NEDD4L;XBP1;UGGT1;HSP90AB1;SEL1L;NGLY1;DNAJC3;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SDF2L1
9666,GO:0038093,0.0927540335828939,0.957305135759321,8,154,Fc receptor signaling pathway,BP,NFKBIA;NFKB1;PSMB9;JUN;ACTG1;LYN;HSP90AA1;HSP90AB1
17284,GO:0150018,0.0927604909830766,0.997014860448748,1,3,basal dendrite development,BP,NRP1
17285,GO:0150019,0.0927604909830766,0.997014860448748,1,3,basal dendrite morphogenesis,BP,NRP1
17286,GO:0150020,0.0927604909830766,0.997014860448748,1,3,basal dendrite arborization,BP,NRP1
4838,GO:0014068,0.0927885772343181,0.977905717221092,3,35,positive regulation of phosphatidylinositol 3-kinase signaling,BP,NRG1;PRR5L;NEDD4
14306,GO:0061551,0.092886837522106,0.997006542170474,1,3,trigeminal ganglion development,BP,NRP1
19992,GO:2000653,0.0928984951077416,0.997005774060737,1,3,regulation of genetic imprinting,BP,CTR9
3786,GO:0008384,0.0929426277333473,0.997002865262152,1,3,IkappaB kinase activity,MF,IKBKE
16490,GO:0097267,0.0930429401354784,0.99699624814523,1,3,omega-hydroxylase P450 pathway,BP,CYP1A1
10518,GO:0043504,0.0930734886384017,0.996994231496345,1,3,mitochondrial DNA repair,BP,PARP1
16894,GO:0098915,0.0932556568906071,0.996982191043472,1,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,DLG1
7016,GO:0030809,0.093309465644177,0.986094374051809,2,17,negative regulation of nucleotide biosynthetic process,BP,PARP1;GPR176
17438,GO:1900372,0.093309465644177,0.986094374051809,2,17,negative regulation of purine nucleotide biosynthetic process,BP,PARP1;GPR176
18549,GO:1903845,0.0933336635649307,0.971470036177086,4,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,PEG10;HSPA5;FBN2;BAMBI
4627,GO:0010767,0.0934598669349393,0.99696866383904,1,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,NEDD4
8839,GO:0034666,0.0935038710200466,0.996965744797972,1,3,integrin alpha2-beta1 complex,CC,LYN
2257,GO:0005201,0.0936018941758036,0.977663570374434,3,34,extracellular matrix structural constituent,MF,COL12A1;FBN2;COL4A4
2116,GO:0004924,0.0936639861656377,0.996955111062582,1,3,oncostatin-M receptor activity,MF,IL6ST
9694,GO:0038165,0.0936639861656377,0.996955111062582,1,3,oncostatin-M-mediated signaling pathway,BP,IL6ST
15206,GO:0071407,0.093876205669208,0.942536760993596,18,417,cellular response to organic cyclic compound,BP,NFKBIA;LGALS1;NFKB1;EDN1;PARP1;HSPA5;IL1B;ANXA1;SLC8A1;ARG1;HSP90AB1;NR2F2;CALR;HMGCS1;ZC3H7B;HSP90B1;NEDD4;CYP1A1
6309,GO:0020016,0.093923831097172,0.996937812596659,1,3,ciliary pocket,CC,EHD1
6310,GO:0020018,0.093923831097172,0.996937812596659,1,3,ciliary pocket membrane,CC,EHD1
7012,GO:0030805,0.0939352446501774,0.996937051596563,1,3,regulation of cyclic nucleotide catabolic process,BP,EGLN1
7027,GO:0030820,0.0939352446501774,0.996937051596563,1,3,regulation of cAMP catabolic process,BP,EGLN1
8268,GO:0033121,0.0939352446501774,0.996937051596563,1,3,regulation of purine nucleotide catabolic process,BP,EGLN1
10346,GO:0043200,0.0939793659753896,0.966347164809049,5,79,response to amino acid,BP,EDN1;TP53;LYN;XBP1;ARG1
8592,GO:0034136,0.0939975738720174,0.996932894044567,1,3,negative regulation of toll-like receptor 2 signaling pathway,BP,LYN
20172,GO:2001137,0.0940280414819178,0.996930860688354,1,3,positive regulation of endocytic recycling,BP,EHD1
2101,GO:0004897,0.094156953383723,0.996922249534831,1,3,ciliary neurotrophic factor receptor activity,MF,IL6ST
14538,GO:0070120,0.094156953383723,0.996922249534831,1,3,ciliary neurotrophic factor-mediated signaling pathway,BP,IL6ST
1468,GO:0003756,0.0945794189195524,0.985794911276491,2,17,protein disulfide isomerase activity,MF,PDIA6;PDIA4
5706,GO:0016864,0.0945794189195524,0.985794911276491,2,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,PDIA6;PDIA4
9563,GO:0036446,0.0945951072545508,0.996892887130366,1,3,myofibroblast differentiation,BP,PARP1
18935,GO:1904760,0.0945951072545508,0.996892887130366,1,3,regulation of myofibroblast differentiation,BP,PARP1
4689,GO:0010869,0.0946141580864264,0.985786685041027,2,17,regulation of receptor biosynthetic process,BP,EDN1;ITGAV
12898,GO:0051295,0.0946328601738027,0.996890350340333,1,3,establishment of meiotic spindle localization,BP,MYH9
16519,GO:0097343,0.0946843677232025,0.996886887568808,1,3,ripoptosome assembly,BP,CYLD
17491,GO:1901026,0.0946843677232025,0.996886887568808,1,3,ripoptosome assembly involved in necroptotic process,BP,CYLD
9169,GO:0035580,0.0947385719902631,0.977180145790161,3,37,specific granule lumen,CC,CXCL1;NFKB1;ARG1
16825,GO:0098797,0.094746105081547,0.947210054043899,13,280,plasma membrane protein complex,CC,KRT8;CNTNAP1;IL6ST;ITGAV;LYN;TRAF3;KCNQ5;ADAM8;STXBP5;CORO1C;DLG1;TFRC;MYH9
15083,GO:0071214,0.0949624162842135,0.950018453783127,11,229,cellular response to abiotic stimulus,BP,NFKB1;RELB;TP53;PARP1;HSPA5;IL1B;CRYAB;RHOB;PPID;MME;NEDD4
17144,GO:0104004,0.0949624162842135,0.950018453783127,11,229,cellular response to environmental stimulus,BP,NFKB1;RELB;TP53;PARP1;HSPA5;IL1B;CRYAB;RHOB;PPID;MME;NEDD4
7529,GO:0031860,0.0950289024275453,0.996863673228826,1,3,telomeric 3' overhang formation,BP,NBN
14895,GO:0070820,0.0951738143234918,0.961853785521726,6,105,tertiary granule,CC,MMP9;FLG2;CXCL1;FTH1;ADAM8;SVIP
1448,GO:0003705,0.0951738717337864,0.970712138881349,4,56,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,NFKB1;JUN;ARID3B;VGLL3
8433,GO:0033596,0.0951749042322028,0.996853808597341,1,3,TSC1-TSC2 complex,CC,NEFL
18178,GO:1903011,0.0952164734224844,0.996850997007074,1,3,negative regulation of bone development,BP,TJP2
20213,GO:2001205,0.0952164734224844,0.996850997007074,1,3,negative regulation of osteoclast development,BP,TJP2
18355,GO:1903422,0.0952495914748124,0.996848756081481,1,3,negative regulation of synaptic vesicle recycling,BP,SYT11
6297,GO:0019960,0.0953692690418811,0.996840651176865,1,3,C-X3-C chemokine binding,MF,ITGAV
4780,GO:0010990,0.0954262066204281,0.996836791380657,1,3,regulation of SMAD protein complex assembly,BP,PARP1
96,GO:0000187,0.0955095651438248,0.961709800538988,6,102,activation of MAPK activity,BP,SAA1;RIPK2;IL1B;NRG1;TGFA;IRAK2
19061,GO:1905031,0.095557099401615,0.996827908819135,1,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,DLG1
12569,GO:0050789,0.095605982442186,0.921950466465822,241,7496,regulation of biological process,BP,IL32;CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;LCP1;TNIP1;DUSP8;KRT18;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FGF5;DBNDD2;SLIT2;CLDN1;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;CLDN7;DNAJB1;PEG10;CCBE1;JUN;KRT4;MCAM;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;SDK1;HSPA5;IL1B;IFT46;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;CD83;ITGAV;LYN;NCEH1;COL8A1;C1R;ANXA1;PDE1C;GPR176;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;ARG1;UGGT1;SEMA3D;SUDS3;TRAF3;ARNTL2;HMOX1;SYT11;KLK6;ZNF638;IL24;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;TNFSF15;CXCR5;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;RRAS2;MGA;PRR5L;RAB30;HMGCS1;ARHGDIB;UBP1;GIT2;CORO1C;IL23A;DLG1;PDIA4;MED18;RBMS3;EHD1;ZMYM4;CITED2;ZNF814;TXNRD1;PTTG1IP;ETS1;HAS2;ADGRL3;REEP1;PDE4DIP;CHORDC1;TGFA;BAMBI;DNAJC3;CBLL1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;PML;OXCT1;EPHA2;PVR;EPB41L2;MYH9;EID3;BTBD10;ZBTB21;HES4;SOX11;UGCG;ENPP1;AFAP1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
19052,GO:1904996,0.0956582241530586,0.996821037436968,1,3,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,ETS1
7996,GO:0032651,0.0956893593675601,0.976884586185941,3,36,regulation of interleukin-1 beta production,BP,TRIM16;RIPK2;PML
7302,GO:0031331,0.0957530635342598,0.946555569246243,13,281,positive regulation of cellular catabolic process,BP,UBQLN2;RIPK2;HERPUD1;OPTN;IL1B;TRIB1;XBP1;HMOX1;HSP90AA1;ADAM8;PRR5L;PTTG1IP;SVIP
11636,GO:0046449,0.095790137089046,0.996812062322925,1,3,creatinine metabolic process,BP,MME
13464,GO:0055074,0.0958124233168577,0.951260272969753,10,203,calcium ion homeostasis,BP,SAA1;EDN1;HERPUD1;C1QTNF1;ITGAV;LYN;SLC8A1;CALR;HSP90B1;PML
19894,GO:2000463,0.0958242743199693,0.985498984685435,2,17,positive regulation of excitatory postsynaptic potential,BP,NETO1;RIMS2
4941,GO:0015031,0.0958966113300268,0.927687270460372,54,1502,protein transport,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;TP53;CD274;RIPK2;HERPUD1;OPTN;IL1B;ITGAV;LYN;AP3M1;ANXA1;DERL3;VEGFC;RHOB;XBP1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;SEL1L;SERP1;PRR5L;RAB30;SEC22A;PDIA4;EHD1;PTTG1IP;SEC24D;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;UGCG;HSPD1;MIDN
12991,GO:0051481,0.0959141060421818,0.996803615639534,1,3,negative regulation of cytosolic calcium ion concentration,BP,SLC8A1
16360,GO:0097025,0.0959459513389248,0.996801443957892,1,3,MPP7-DLG1-LIN7 complex,CC,DLG1
16793,GO:0098735,0.0959821686984007,0.996798973186924,1,3,positive regulation of the force of heart contraction,BP,SLC8A1
14242,GO:0061364,0.0960542085871759,0.996794055613815,1,3,apoptotic process involved in luteolysis,BP,SLIT2
17475,GO:1900748,0.0960608312773309,0.996793603338819,1,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,CCBE1
12665,GO:0050923,0.0961075311976597,0.996790413172885,1,3,regulation of negative chemotaxis,BP,SLIT2
1409,GO:0003365,0.0961651551570104,0.996786474476535,1,3,establishment of cell polarity involved in ameboidal cell migration,BP,AMOTL2
7187,GO:0031098,0.0961891743653117,0.949259833663046,11,228,stress-activated protein kinase signaling cascade,BP,IL1A;NFKB1;EDN1;RIPK2;IL1B;CRYAB;GADD45B;TRIB1;LYN;DLG1;IRAK2
16606,GO:0097513,0.0962431487752463,0.99678113945436,1,3,myosin II filament,CC,MYH9
3515,GO:0007517,0.0962617009976234,0.949217852574161,11,227,muscle organ development,BP,EDN1;CRYAB;ATF3;G6PD;XBP1;EGLN1;NRG1;NR2F2;SERP1;MAFF;SOX11
12739,GO:0051054,0.0963137734573015,0.952973722035843,9,179,positive regulation of DNA metabolic process,BP,JUN;PARP1;NBN;HSP90AA1;HSP90AB1;CALR;EYA3;TFRC;PML
9172,GO:0035583,0.0963475719410048,0.996773989314513,1,3,sequestering of TGFbeta in extracellular matrix,BP,FBN2
6648,GO:0030023,0.0964000695087961,0.996770391527084,1,3,extracellular matrix constituent conferring elasticity,MF,FBN2
8542,GO:0034035,0.0964865294788568,0.985267464188898,2,18,purine ribonucleoside bisphosphate metabolic process,BP,PAPSS2;ENPP1
12441,GO:0050427,0.0964865294788568,0.985267464188898,2,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,PAPSS2;ENPP1
18190,GO:1903035,0.0964916571750646,0.970147278473973,4,57,negative regulation of response to wounding,BP,KRT1;SERPINB2;EDN1;C1QTNF1
14248,GO:0061383,0.096678386563529,0.976577020073497,3,35,trabecula morphogenesis,BP,FBN2;EGLN1;NRG1
9660,GO:0038084,0.0970503025980304,0.98520523675587,2,17,vascular endothelial growth factor signaling pathway,BP,CCBE1;NRP1
15066,GO:0071157,0.0970728421402692,0.985126016936826,2,18,negative regulation of cell cycle arrest,BP,HSP90AB1;CALR
9214,GO:0035635,0.0970825509063104,0.985197479588579,2,17,entry of bacterium into host cell,BP,ITGAV;CBLL1
7831,GO:0032413,0.0973150929560184,0.976323833676287,3,36,negative regulation of ion transmembrane transporter activity,BP,MMP9;NEDD4L;NEDD4
10189,GO:0042886,0.0973831976018761,0.926311091485233,55,1534,amide transport,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;EDN1;TP53;CD274;RIPK2;HERPUD1;OPTN;IL1B;ITGAV;LYN;AP3M1;ANXA1;DERL3;VEGFC;RHOB;XBP1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;ADAM8;STXBP5;CALR;PPID;SEL1L;SERP1;PRR5L;RAB30;SEC22A;PDIA4;EHD1;PTTG1IP;SEC24D;HSP90B1;TFRC;NLRP10;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;UGCG;HSPD1;MIDN
3616,GO:0008092,0.0973974075542059,0.934252454541722,27,668,cytoskeletal protein binding,MF,KRT2;LCP1;NFKB1;NEFM;B4GALT1;FEZ1;DPYSL3;MYO1B;CRYAB;AXL;ANXA8;LYN;COBLL1;SLC8A1;MOBP;SYT11;AJUBA;CORO1C;DLG1;REEP1;EPB41L2;MYH9;TOR1AIP1;SORBS2;AFAP1;TPM4;PARVA
8859,GO:0034702,0.0976952698863959,0.960601317521976,6,102,ion channel complex,CC,HERPUD1;CNTNAP1;KCNQ5;CLCC1;STXBP5;DLG1
1222,GO:0002920,0.0977103192608448,0.984971634640842,2,18,regulation of humoral immune response,BP,SPNS2;C1R
6725,GO:0030163,0.0979053347763813,0.932930716406589,29,742,protein catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;HERPUD1;HSPA5;IL1B;DNAJB9;DNAJC10;CYLD;TRIB1;DERL3;NEDD4L;XBP1;UGGT1;HSP90AA1;NRG1;HSP90AB1;ADAM8;SEL1L;NGLY1;PTTG1IP;DNAJC3;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SDF2L1
10224,GO:0042994,0.0979152625354272,0.984921871323658,2,18,cytoplasmic sequestering of transcription factor,BP,NFKBIA;NFKBIE
11726,GO:0046620,0.09803717326507,0.969521943497733,4,56,regulation of organ growth,BP,EDN1;G6PD;WWC1;SERP1
14519,GO:0070085,0.0981035757028912,0.949863686757686,10,205,glycosylation,BP,B4GALT1;STT3A;DERL3;UGGT1;MGAT5;SERP1;MAGT1;DHDDS;GALNT14;SDF2L1
8102,GO:0032814,0.0982689478408007,0.984835841708117,2,18,regulation of natural killer cell activation,BP,AXL;IL23A
1331,GO:0003205,0.0982828843422512,0.960311291623597,6,101,cardiac chamber development,BP,NRP1;EGLN1;NRG1;CITED2;SOX11;PARVA
12323,GO:0048738,0.0983843762305698,0.956940165029202,7,125,cardiac muscle tissue development,BP,EDN1;G6PD;SLC8A1;EGLN1;NRG1;CALR;SORBS2
13658,GO:0060251,0.0983887585219684,0.984881958551906,2,17,regulation of glial cell proliferation,BP,LYN;SOX11
12581,GO:0050805,0.0984061325993948,0.97594510409844,3,36,negative regulation of synaptic transmission,BP,IL1B;SYT11;HTR1B
18543,GO:1903829,0.0986973853367458,0.944631975670202,13,285,positive regulation of cellular protein localization,BP,TP53;PMAIP1;IL1B;CYLD;STAC;SYT11;NRG1;HSP90AB1;PRR5L;DLG1;EPHA2;EPB41L2;UGCG
7084,GO:0030900,0.098736124338295,0.947675421464036,11,227,forebrain development,BP,NEFL;FEZ1;SLIT2;AXL;SEMA7A;SLC8A1;NRP1;NRG1;NR2F2;ETS1;CDK6
19677,GO:2000059,0.09879446846267,0.975777726262574,3,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,HSP90AB1;SVIP;PML
3181,GO:0006825,0.0991173897108797,0.984628697903668,2,18,copper ion transport,BP,HEPHL1;STEAP4
12757,GO:0051091,0.0994338314413294,0.951131924048658,9,180,positive regulation of DNA binding transcription factor activity,BP,NFKBIA;NFKB1;EDN1;RIPK2;NFKB2;IL1B;TRAF1;ADAM8;IRAK2
11125,GO:0045216,0.0995565409437621,0.951090962028538,9,173,cell-cell junction organization,BP,CLDN1;SDK1;CNTNAP1;NRP1;AJUBA;CORO1C;DLG1;PVR;TJP1
6763,GO:0030218,0.100237867569772,0.963403902821611,5,80,erythrocyte differentiation,BP,MAFB;LYN;G6PD;ETS1;CDK6
18962,GO:1904813,0.100414931692143,0.95915084549281,6,109,ficolin-1-rich granule lumen,CC,MMP9;KRT1;HSPA6;HSP90AA1;FTH1;HSP90AB1
6875,GO:0030427,0.100460383373024,0.955805819418133,7,126,site of polarized growth,CC,NEFL;DSCAM;FEZ1;DPYSL3;NRP1;SETX;L1CAM
1169,GO:0002823,0.100819379063783,0.984209892084434,2,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ARG1;IL7R
14577,GO:0070182,0.100829710039171,0.984207336654651,2,18,DNA polymerase binding,MF,HSP90AA1;HSP90AB1
15389,GO:0071702,0.101029888166453,0.921459975043309,68,1932,organic substance transport,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;NFKB1;EDN1;TP53;CD274;SLC16A9;RIPK2;SPNS2;HERPUD1;APOL6;OPTN;IL1B;C1QTNF1;STOML1;NFKBIE;ITGAV;LYN;AP3M1;ANXA1;DERL3;VEGFC;RHOB;XBP1;ARG1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;SLC7A5P2;ADAM8;STXBP5;CALR;PPID;ANO4;SEL1L;SLC35B1;SERP1;PRR5L;RAB30;SEC22A;PDIA4;EHD1;PTTG1IP;SEC24D;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;UGCG;ENPP1;HSPD1;MIDN
16137,GO:0090199,0.101052096701773,0.974924671403414,3,39,regulation of release of cytochrome c from mitochondria,BP,MMP9;TP53;PMAIP1
462,GO:0001501,0.101326218042922,0.941589951087726,14,309,skeletal system development,BP,MMP9;OSR2;EDN1;COL12A1;SPNS2;TJP2;FBN2;PAPSS2;KLF10;SERPINH1;SERP1;DLG1;HAS2;SOX11
16585,GO:0097484,0.101337328323661,0.984160284990651,2,17,dendrite extension,BP,NEDD4L;RIMS2
8230,GO:0033032,0.101533744865884,0.984032811920632,2,18,regulation of myeloid cell apoptotic process,BP,CDKN2A;ANXA1
6536,GO:0021988,0.10158332029645,0.984099489068721,2,17,olfactory lobe development,BP,SLIT2;SEMA7A
7445,GO:0031623,0.101639086937379,0.967966859688365,4,58,receptor internalization,BP,UBQLN2;TFRC;HTR1B;NEDD4
10881,GO:0044464,0.101835857959452,0.931138408775961,343,11082,cell part,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;JUN;KRT4;CLDN11;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;CD83;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;UBTD2;KCTD12;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SLC7A5P2;SNAI3;GGCX;ADAM8;C2ORF49;L1CAM;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;MOB3A;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;ADGRL3;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;IQCJ-SCHIP1;BAMBI;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;IFNGR1;ANKRD13A;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
7438,GO:0031594,0.102016450271362,0.974678206680088,3,36,neuromuscular junction,CC,NRG1;DLG1;MYH9
16865,GO:0098869,0.102475177688975,0.96754036113496,4,62,cellular oxidant detoxification,BP,GPX8;SOD2;TXNRD1;MGST3
12952,GO:0051403,0.102481226793912,0.947189501382904,10,205,stress-activated MAPK cascade,BP,IL1A;NFKB1;EDN1;RIPK2;IL1B;CRYAB;GADD45B;TRIB1;DLG1;IRAK2
10473,GO:0043409,0.102613817397525,0.954601679837544,7,130,negative regulation of MAPK cascade,BP,TNIP1;DUSP8;IL1B;ATF3;DUSP1;LYN;DLG1
6644,GO:0030017,0.102804753040209,0.957954025718243,6,105,sarcomere,CC,KRT8;CRYAB;SLC8A1;SORBS2;TPM4;PARVA
7643,GO:0032094,0.102992840566177,0.983668749330045,2,18,response to food,BP,G6PD;CYP1A1
2030,GO:0004784,0.103052910105303,0.995847147729762,1,4,superoxide dismutase activity,MF,SOD2
5617,GO:0016721,0.103052910105303,0.995847147729762,1,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,SOD2
6760,GO:0030215,0.103139539357853,0.983712784131419,2,17,semaphorin receptor binding,MF,SEMA7A;SEMA3D
8090,GO:0032800,0.103247669973853,0.983604839724881,2,18,receptor biosynthetic process,BP,EDN1;ITGAV
8010,GO:0032677,0.103294525045074,0.974158490281732,3,38,regulation of interleukin-8 production,BP,IL1B;ANXA1;NLRP10
16215,GO:0090312,0.103398139064136,0.98356705751122,2,18,positive regulation of protein deacetylation,BP,TP53;SDR16C5
13990,GO:0060760,0.103480452450139,0.974124417269983,3,37,positive regulation of response to cytokine stimulus,BP,EDN1;RIPK2;AXL
2412,GO:0005605,0.103580596441621,0.983602530089906,2,17,basal lamina,CC,COL4A4;DLG1
130,GO:0000271,0.10364722946291,0.96711187297306,4,58,polysaccharide biosynthetic process,BP,NFKB1;HAS2;GBE1;ENPP1
12728,GO:0051043,0.103823621863506,0.983460037630616,2,18,regulation of membrane protein ectodomain proteolysis,BP,IL1B;ADAM8
9706,GO:0038191,0.104116003069689,0.983468302490711,2,17,neuropilin binding,MF,SEMA7A;SEMA3D
7055,GO:0030863,0.104187152085399,0.961536105360544,5,79,cortical cytoskeleton,CC,MOBP;RIMS2;EPB41L2;MYH9;TPM4
12915,GO:0051336,0.104193598545495,0.926090681925381,34,890,regulation of hydrolase activity,BP,MMP9;SERPINB2;TP53;PMAIP1;PSMB9;SLIT2;DNAJB1;JUN;RIPK2;HERPUD1;HSPA5;CRYAB;DNAJC10;ANXA8;LYN;ANXA1;BIRC3;NRP1;EGLN1;TNFSF15;SERPINH1;HSP90AB1;STXBP5;AJUBA;IGFBP3;ARHGDIB;GIT2;CORO1C;HSP90B1;UBXN2B;PML;EPHA2;TOR1AIP1;HSPD1
11429,GO:0045920,0.104346318063149,0.983328196761904,2,18,negative regulation of exocytosis,BP,ANXA1;HMOX1
7301,GO:0031330,0.104525212786297,0.948100455983059,9,181,negative regulation of cellular catabolic process,BP,FEZ1;NOCT;DERL3;HMOX1;EGLN1;HSP90AB1;EIF4G2;SVIP;PML
4557,GO:0010660,0.104530439666353,0.973749166683953,3,37,regulation of muscle cell apoptotic process,BP,CDKN2A;EDN1;HMOX1
15821,GO:0072583,0.104570148950229,0.973769538865757,3,36,clathrin-dependent endocytosis,BP,UBQLN2;SYT11;CANX
12873,GO:0051259,0.104649230606322,0.936969343920179,16,378,protein complex oligomerization,BP,B4GALT1;TP53;DPYSL3;PMAIP1;CLDN1;CLDN7;C1QTNF1;CRYAB;IKBKE;BIRC3;ARG1;HMOX1;SYT11;KCTD12;SOD2;EHD1
13517,GO:0060021,0.104872837765109,0.966606946043141,4,57,roof of mouth development,BP,OSR2;FRAS1;DLG1;SOX11
8455,GO:0033627,0.104900760265283,0.973616403834809,3,37,cell adhesion mediated by integrin,BP,ITGAV;LYN;EPHA2
7681,GO:0032182,0.105015309823784,0.96109951779288,5,82,ubiquitin-like protein binding,MF,UBTD2;DCUN1D3;UBXN2B;NEDD4;PML
3403,GO:0007204,0.105116651582768,0.953225892929562,7,130,positive regulation of cytosolic calcium ion concentration,BP,SAA1;EDN1;C1QTNF1;ITGAV;LYN;SLC8A1;PML
7816,GO:0032392,0.105160200560624,0.96104259457614,5,81,DNA geometric change,BP,TP53;PARP1;ANXA1;NBN;SETX
5485,GO:0016447,0.105246180128157,0.973492373207514,3,37,somatic recombination of immunoglobulin gene segments,BP,NBN;TFRC;HSPD1
973,GO:0002433,0.10556182533177,0.966290835203784,4,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,ACTG1;LYN;HSP90AA1;HSP90AB1
9669,GO:0038096,0.10556182533177,0.966290835203784,4,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,ACTG1;LYN;HSP90AA1;HSP90AB1
12716,GO:0051024,0.105729940702966,0.995623298349754,1,4,positive regulation of immunoglobulin secretion,BP,XBP1
1484,GO:0003839,0.105749881683038,0.995621607808555,1,4,gamma-glutamylcyclotransferase activity,MF,CHAC1
9918,GO:0042310,0.106003260946349,0.973219869825726,3,37,vasoconstriction,BP,EDN1;SLC8A1;HTR1B
15949,GO:0086001,0.106187991068621,0.973188543083184,3,36,cardiac muscle cell action potential,BP,SLC8A1;NEDD4L;DLG1
1695,GO:0004222,0.106342404546839,0.96595446279988,4,58,metalloendopeptidase activity,MF,MMP9;MMP19;ADAM8;MME
359,GO:0000978,0.106695106792172,0.939376243185199,13,286,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,MAFB;TP53;JUN;NFKB2;ARID3B;JUNB;ATF3;EHF;ARNTL2;KLF10;SNAI3;ETS1;ZFP42
13170,GO:0051852,0.106795968146874,0.995532443544882,1,4,disruption by host of symbiont cells,BP,ARG1
13175,GO:0051873,0.106795968146874,0.995532443544882,1,4,killing by host of symbiont cells,BP,ARG1
4942,GO:0015035,0.106816041933626,0.982555803094211,2,20,protein disulfide oxidoreductase activity,MF,DNAJC10;TXNRD1
11398,GO:0045860,0.106876032923145,0.935445939393243,16,369,positive regulation of protein kinase activity,BP,SAA1;EDN1;RIPK2;HSPA5;IL1B;GADD45B;TNFSF15;NRG1;HSP90AB1;ADAM8;AJUBA;IL23A;DLG1;TGFA;MAGED1;IRAK2
2420,GO:0005623,0.106878704315467,0.927393461202635,343,11087,cell,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;SERPINB2;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;JUN;KRT4;CLDN11;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;CNTNAP1;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;HSPB8;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;IFITM2;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;CD83;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;UBTD2;KCTD12;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SLC7A5P2;SNAI3;GGCX;ADAM8;C2ORF49;L1CAM;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;MOB3A;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;ADGRL3;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;IQCJ-SCHIP1;BAMBI;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;IFNGR1;ANKRD13A;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
12516,GO:0050705,0.106893208889879,0.995524107254373,1,4,regulation of interleukin-1 alpha secretion,BP,NLRP10
7437,GO:0031593,0.106913540791307,0.972891032600224,3,37,polyubiquitin modification-dependent protein binding,MF,TNIP1;OPTN;IKBKE
19408,GO:1990111,0.106921730697435,0.995521660580813,1,4,spermatoproteasome complex,CC,PSMB9
9059,GO:0035339,0.106995431115814,0.995515335124266,1,4,SPOTS complex,CC,ORMDL1
3535,GO:0007585,0.107011280296191,0.972855647171905,3,37,respiratory gaseous exchange,BP,MAFB;EDN1;CCBE1
2657,GO:0006024,0.107217733840292,0.960049861410505,5,81,glycosaminoglycan biosynthetic process,BP,NFKB1;B4GALT1;HS3ST1;IL1B;HAS2
3173,GO:0006812,0.107219718321116,0.92921762932523,23,572,cation transport,BP,MMP9;NETO1;EDN1;IL16;NFKBIE;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;ARG1;HEPHL1;FTH1;KCNQ5;STEAP4;SLC39A14;MAGT1;DLG1;TFRC;HTR1B;NEDD4;PML
8062,GO:0032768,0.107311912394377,0.97271286860559,3,38,regulation of monooxygenase activity,BP,NFKB1;IL1B;HSP90AA1
6682,GO:0030100,0.107369052254933,0.948962527880962,8,156,regulation of endocytosis,BP,UBQLN2;IL1B;AXL;ITGAV;NEDD4L;SYT11;CALR;CBLL1
4749,GO:0010951,0.107541201088829,0.951850208514598,7,135,negative regulation of endopeptidase activity,BP,MMP9;SERPINB2;HERPUD1;CRYAB;ANXA8;BIRC3;SERPINH1
659,GO:0001866,0.107557249333873,0.995466962278986,1,4,NK T cell proliferation,BP,IL23A
6084,GO:0019322,0.107577824320757,0.995465185595293,1,4,pentose biosynthetic process,BP,G6PD
8072,GO:0032781,0.10793401671404,0.972423819387615,3,40,positive regulation of ATPase activity,BP,DNAJB1;DNAJC10;TOR1AIP1
8105,GO:0032817,0.107950741541548,0.995432920288212,1,4,regulation of natural killer cell proliferation,BP,IL23A
8106,GO:0032819,0.107950741541548,0.995432920288212,1,4,positive regulation of natural killer cell proliferation,BP,IL23A
13907,GO:0060627,0.107977831652163,0.935844630369268,15,342,regulation of vesicle-mediated transport,BP,UBQLN2;IL1B;AXL;ITGAV;LYN;ANXA1;NEDD4L;HMOX1;SYT11;RIMS2;NRP1;STXBP5;CALR;EHD1;CBLL1
9388,GO:0035985,0.108001626444433,0.995428508352859,1,4,senescence-associated heterochromatin focus,CC,CDKN2A
7253,GO:0031253,0.108521924559395,0.94346271610799,10,204,cell projection membrane,CC,LCP1;B4GALT1;ITGAV;WWC1;HSP90AA1;NRG1;HSP90AB1;DLG1;EHD1;EPHA2
15370,GO:0071675,0.108685994450052,0.982140040025023,2,19,regulation of mononuclear cell migration,BP,SLIT2;LYN
13869,GO:0060561,0.108836818819716,0.982178845415237,2,18,apoptotic process involved in morphogenesis,BP,B4GALT1;CRYAB
16824,GO:0098796,0.109097384551729,0.924896497474714,28,730,membrane protein complex,CC,KRT8;HERPUD1;CNTNAP1;IL6ST;STT3A;ITGAV;LYN;AP3M1;DERL3;SEC11C;TRAF3;KCNQ5;ADAM8;CLCC1;STXBP5;CALR;SEL1L;ORMDL1;MAGT1;SEC22A;CORO1C;DLG1;SEC24D;DNAJC3;TFRC;SVIP;MYH9;HSPD1
13312,GO:0052428,0.109175406935197,0.995326115985649,1,4,modulation by host of symbiont molecular function,BP,SUGT1
944,GO:0002369,0.109187628880363,0.982009368736559,2,19,T cell cytokine production,BP,ARG1;DLG1
13661,GO:0060255,0.10950557459889,0.90947989543137,151,4568,regulation of macromolecule metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;SERPINB2;SAA1;OSR2;TNIP1;DUSP8;NFKB1;MAFB;RELB;EDN1;TP53;PMAIP1;PSMB9;FGF5;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;PHLDA2;CRYAB;ATF3;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;ITGAV;LYN;C1R;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;IL24;RIMS2;HSP90AA1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;TNFSF15;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;ORMDL1;MAFF;MGA;PRR5L;UBP1;CORO1C;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;PTTG1IP;ETS1;HAS2;CHORDC1;TGFA;BAMBI;DNAJC3;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;PML;EPHA2;MYH9;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
9667,GO:0038094,0.110055781213407,0.964320952765853,4,59,Fc-gamma receptor signaling pathway,BP,ACTG1;LYN;HSP90AA1;HSP90AB1
8039,GO:0032730,0.110125028490981,0.995242406160326,1,4,positive regulation of interleukin-1 alpha production,BP,NLRP10
929,GO:0002335,0.110200181475657,0.981744476366488,2,19,mature B cell differentiation,BP,LGALS1;XBP1
5855,GO:0017187,0.110402460428494,0.995217803036351,1,4,peptidyl-glutamic acid carboxylation,BP,GGCX
5916,GO:0018214,0.110402460428494,0.995217803036351,1,4,protein carboxylation,BP,GGCX
9254,GO:0035722,0.110542500795001,0.97146711585799,3,40,interleukin-12-mediated signaling pathway,BP,SERPINB2;LCP1;SOD2
15162,GO:0071349,0.110542500795001,0.97146711585799,3,40,cellular response to interleukin-12,BP,SERPINB2;LCP1;SOD2
3759,GO:0008330,0.110544286180553,0.995205199948587,1,4,protein tyrosine/threonine phosphatase activity,MF,DUSP1
8901,GO:0034774,0.110637623599355,0.94209151577772,10,218,secretory granule lumen,CC,CXCL1;NFKB1;HRNR;HSPA6;VEGFC;ARG1;HSP90AA1;HSP90AB1;DNAJC3;CPPED1
19915,GO:2000508,0.110644792036414,0.995196258130447,1,4,regulation of dendritic cell chemotaxis,BP,CALR
19916,GO:2000510,0.110644792036414,0.995196258130447,1,4,positive regulation of dendritic cell chemotaxis,BP,CALR
10782,GO:0044304,0.110778608637691,0.971480387245065,3,37,main axon,CC,CNTNAP1;NRG1;DLG1
1166,GO:0002820,0.110780892730247,0.981591875638372,2,19,negative regulation of adaptive immune response,BP,ARG1;IL7R
7137,GO:0031017,0.110909597443444,0.995172656984203,1,4,exocrine pancreas development,BP,XBP1
15391,GO:0071705,0.111053836754925,0.914257222152979,60,1702,nitrogen compound transport,BP,NFKBIA;IL1A;TRIM16;SAA1;LCP1;KRT18;EDN1;TP53;CD274;RIPK2;HERPUD1;OPTN;IL1B;NFKBIE;ITGAV;LYN;AP3M1;ANXA1;DERL3;VEGFC;RHOB;XBP1;ARG1;SYT11;FRAS1;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;SLC7A5P2;ADAM8;STXBP5;CALR;PPID;SEL1L;SLC35B1;SERP1;PRR5L;RAB30;SEC22A;PDIA4;EHD1;PTTG1IP;SEC24D;HSP90B1;TFRC;NLRP10;HTR1B;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MON1A;MYH9;UGCG;HSPD1;MIDN
14971,GO:0070942,0.11110880444949,0.995154862334429,1,4,neutrophil mediated cytotoxicity,BP,ARG1
13716,GO:0060333,0.111128128153686,0.963793012246322,4,62,interferon-gamma-mediated signaling pathway,BP,ARG1;HSP90AB1;IFNGR1;PML
1105,GO:0002701,0.11113785452192,0.981497826076133,2,19,negative regulation of production of molecular mediator of immune response,BP,ARG1;HMOX1
6338,GO:0021537,0.111192001045074,0.946734499653273,8,156,telencephalon development,BP,NEFL;FEZ1;SLIT2;SEMA7A;SLC8A1;NRP1;NRG1;CDK6
9352,GO:0035914,0.111209158324868,0.97128635031437,3,38,skeletal muscle cell differentiation,BP,ATF3;MAFF;SOX11
12347,GO:0048791,0.111382946111799,0.981513945384239,2,18,calcium ion-regulated exocytosis of neurotransmitter,BP,SYT11;RIMS2
15136,GO:0071312,0.111505572492,0.981400746684163,2,19,cellular response to alkaloid,BP,SLC8A1;HTR1B
4445,GO:0010455,0.111589941496384,0.995111741702082,1,4,positive regulation of cell fate commitment,BP,IL23A
11770,GO:0046688,0.111619905818319,0.981297831185278,2,20,response to copper ion,BP,IL1A;CYP1A1
10840,GO:0044406,0.111657786082377,0.995105645159865,1,4,adhesion of symbiont to host,BP,HSP90AB1
2363,GO:0005506,0.111715958361528,0.957817517513466,5,84,iron ion binding,MF,FTH1;EGLN1;CALR;MSMO1;CYP1A1
16102,GO:0090155,0.11176521682504,0.995095983221519,1,4,negative regulation of sphingolipid biosynthetic process,BP,ORMDL1
17318,GO:1900060,0.11176521682504,0.995095983221519,1,4,negative regulation of ceramide biosynthetic process,BP,ORMDL1
2717,GO:0006112,0.111807396979468,0.963552356463373,4,59,energy reserve metabolic process,BP,IL6ST;PHLDA2;GBE1;ENPP1
3444,GO:0007272,0.111842675193709,0.957781665154321,5,82,ensheathment of neurons,BP,CLDN11;CNTNAP1;KLK6;NRG1;DLG1
3777,GO:0008366,0.111842675193709,0.957781665154321,5,82,axon ensheathment,BP,CLDN11;CNTNAP1;KLK6;NRG1;DLG1
2561,GO:0005862,0.111865237317811,0.995086978732986,1,4,muscle thin filament tropomyosin,CC,TPM4
2355,GO:0005488,0.111884983904481,0.914432362852824,316,10118,binding,MF,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;NETO1;KRT8;CXCL1;TENM3;LGALS1;DSCAM;SAA1;OSR2;KRT2;LCP1;TNIP1;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;PSMB9;CD274;FLG;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;CLDN7;SPRR2E;MYO1B;DNAJB1;PEG10;CCBE1;JUN;KRT4;CLDN11;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;APOL6;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;KRT13;CNTNAP1;ANPEP;JUNB;EFHD2;C1QTNF1;TJP2;IL6ST;HSPB8;CRYAB;ATF3;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;CRCT1;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;SEMA7A;CDSN;FBN2;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FIGN;CD83;STT3A;ITGAV;LYN;COBLL1;AP3M1;COL8A1;C1R;ANXA1;PDE1C;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;PUS10;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEMA3D;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;MMP19;SYT11;KLK6;ZNF638;PAPSS2;FRAS1;UBTD2;KCTD12;HEPHL1;IL24;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;CXCR5;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;SDR16C5;SNAI3;ADAM8;L1CAM;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;MOB3A;CALR;PDIA6;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;AMOTL2;EYA3;ZCCHC8;SERP1;EIF2B1;MAFF;MAGT1;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;ADGRL3;TYW1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;CHORDC1;TGFA;MGST3;BAMBI;SUGT1;FOCAD;PRPF38A;DNAJC3;CBLL1;RSPRY1;BCAT1;ZC3H7B;IFNGR1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA;TMPPE
9965,GO:0042406,0.11189177811156,0.995084587902498,1,4,extrinsic component of endoplasmic reticulum membrane,CC,PML
8213,GO:0033006,0.111930650519249,0.981288276445193,2,19,regulation of mast cell activation involved in immune response,BP,LYN;HMOX1
10414,GO:0043304,0.111930650519249,0.981288276445193,2,19,regulation of mast cell degranulation,BP,LYN;HMOX1
9813,GO:0042089,0.111939388714197,0.963474090572222,4,60,cytokine biosynthetic process,BP,IL1A;NFKB1;IL1B;HMOX1
19357,GO:1905907,0.112153623990233,0.995060967703459,1,4,negative regulation of amyloid fibril formation,BP,CRYAB
10468,GO:0043403,0.112218777082174,0.981211891019266,2,19,skeletal muscle tissue regeneration,BP,ANXA1;IFRD1
14746,GO:0070492,0.112332334785908,0.995044812655099,1,4,oligosaccharide binding,MF,LGALS1
3925,GO:0008631,0.112343183712909,0.970832809295076,3,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PARP1;SOD2;PML
3364,GO:0007157,0.112446126248931,0.98115153238515,2,19,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,TENM3;PVR
10452,GO:0043380,0.11250439604257,0.995029232505518,1,4,regulation of memory T cell differentiation,BP,IL23A
8493,GO:0033743,0.112653113294843,0.995015745438543,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB3
14346,GO:0061629,0.112666973556664,0.995014487482035,1,4,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,IFRD1
4370,GO:0010040,0.112685369132567,0.995012817642952,1,4,response to iron(II) ion,BP,ACO1
11173,GO:0045338,0.112758354856243,0.995006189543263,1,4,farnesyl diphosphate metabolic process,BP,HMGCS1
10069,GO:0042609,0.112853372329249,0.994997553724963,1,4,CD4 receptor binding,MF,IL16
8255,GO:0033083,0.112899270360669,0.994993379397226,1,4,regulation of immature T cell proliferation,BP,RIPK2
7933,GO:0032554,0.112959388580537,0.994987909004311,1,4,purine deoxyribonucleotide binding,MF,HSP90AB1
15366,GO:0071671,0.112969230355861,0.994987013163323,1,4,regulation of smooth muscle cell chemotaxis,BP,SLIT2
1122,GO:0002718,0.112985487760258,0.970594070880184,3,39,regulation of cytokine production involved in immune response,BP,SEMA7A;ARG1;HMOX1
8669,GO:0034330,0.113157891942371,0.9405685108357,10,204,cell junction organization,BP,CLDN1;SDK1;CNTNAP1;ACTG1;NRP1;AJUBA;CORO1C;DLG1;PVR;TJP1
4921,GO:0014900,0.113221967381677,0.99496397910259,1,4,muscle hyperplasia,BP,HMOX1
2113,GO:0004920,0.113281848590964,0.99495851348474,1,4,interleukin-10 receptor activity,MF,IFNAR1
8896,GO:0034765,0.113288494962553,0.94046608480553,10,209,regulation of ion transmembrane transport,BP,MMP9;NETO1;STAC;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;DLG1;NEDD4
1538,GO:0003945,0.113292235901931,0.994957565072464,1,4,N-acetyllactosamine synthase activity,MF,B4GALT1
19932,GO:2000551,0.11329904025701,0.994956943750719,1,4,regulation of T-helper 2 cell cytokine production,BP,ARG1
15795,GO:0072540,0.113303317008851,0.994956553209796,1,4,T-helper 17 cell lineage commitment,BP,IL23A
4453,GO:0010466,0.113325797969608,0.948601711692884,7,137,negative regulation of peptidase activity,BP,MMP9;SERPINB2;HERPUD1;CRYAB;ANXA8;BIRC3;SERPINH1
8893,GO:0034762,0.113513448490457,0.936456194070131,12,262,regulation of transmembrane transport,BP,MMP9;NETO1;IL1B;STAC;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;DLG1;NEDD4;ENPP1
2521,GO:0005791,0.113521995783912,0.962736033140971,4,62,rough endoplasmic reticulum,CC,EDN1;DERL3;CANX;DNAJC3
12837,GO:0051205,0.113557672897901,0.970348126757643,3,40,protein insertion into membrane,BP,TP53;PMAIP1;REEP1
9104,GO:0035456,0.113757052922754,0.980727237952304,2,20,response to interferon-beta,BP,IFITM2;IKBKE
755,GO:0002002,0.113775846434134,0.994913305176411,1,4,regulation of angiotensin levels in blood,BP,MME
756,GO:0002003,0.113775846434134,0.994913305176411,1,4,angiotensin maturation,BP,MME
1852,GO:0004528,0.113775963551195,0.994913294433249,1,4,phosphodiesterase I activity,MF,ENPP1
15887,GO:0072716,0.113781113390788,0.994912822026069,1,4,response to actinomycin D,BP,TP53
11520,GO:0046098,0.113843873357993,0.994907063048912,1,4,guanine metabolic process,BP,GDA
9069,GO:0035360,0.113860127042654,0.994905571020286,1,4,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,CITED2
5505,GO:0016494,0.113872338108882,0.994904449937964,1,4,C-X-C chemokine receptor activity,MF,CXCR5
11486,GO:0046037,0.113966655982844,0.980745902715761,2,19,GMP metabolic process,BP,TJP2;DLG1
1279,GO:0003100,0.113985287737906,0.994894074025877,1,4,regulation of systemic arterial blood pressure by endothelin,BP,EDN1
8618,GO:0034186,0.113985761344717,0.994894030495473,1,4,apolipoprotein A-I binding,MF,HSPD1
18773,GO:1904380,0.114031617642587,0.980728497655007,2,19,endoplasmic reticulum mannose trimming,BP,UGGT1;SEL1L
16863,GO:0098862,0.114215969968088,0.956598538216688,5,83,cluster of actin-based cell projections,CC,B4GALT1;MYO1B;HSP90AB1;MME;MYH9
12804,GO:0051154,0.114263656534958,0.980666277554455,2,19,negative regulation of striated muscle cell differentiation,BP,G6PD;XBP1
1277,GO:0003097,0.114294078254955,0.994865650866945,1,4,renal water transport,BP,HAS2
14258,GO:0061428,0.114354052025937,0.994860120849251,1,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,CITED2
13649,GO:0060232,0.114546130192754,0.994842388764263,1,4,delamination,BP,CDSN
19496,GO:1990441,0.114577794554286,0.994839462519188,1,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,JUN
17519,GO:1901137,0.114628234608725,0.924433456460047,22,552,carbohydrate derivative biosynthetic process,BP,TNIP1;NFKB1;B4GALT1;NAGK;PGK1;HS3ST1;PARP1;IL1B;STT3A;GPR176;DERL3;G6PD;UGGT1;PAPSS2;MGAT5;SERP1;MAGT1;DHDDS;HAS2;GALNT14;UGCG;SDF2L1
10994,GO:0044877,0.114686825971288,0.921743484583358,26,662,protein-containing complex binding,MF,MMP9;LCP1;EPCAM;MYO1B;CCBE1;HSPA5;IL1B;C1QTNF1;CRYAB;SEMA7A;ANXA8;ITGAV;LYN;HSP90AA1;NRG1;SERPINH1;HSP90AB1;CALR;CTR9;AJUBA;CORO1C;NID2;MYH9;ENPP1;TPM4;HSPD1
11239,GO:0045581,0.114689957817027,0.98055176204999,2,19,negative regulation of T cell differentiation,BP,CYLD;ANXA1
4285,GO:0009750,0.114868511100024,0.994812555278623,1,4,response to fructose,BP,XBP1
18224,GO:1903121,0.115040247843816,0.994796625597221,1,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,ATF3
9362,GO:0035930,0.115093042182415,0.994791723418465,1,4,corticosteroid hormone secretion,BP,C1QTNF1
20106,GO:2000846,0.115093042182415,0.994791723418465,1,4,regulation of corticosteroid hormone secretion,BP,C1QTNF1
1291,GO:0003140,0.115287666101744,0.994773630769894,1,4,determination of left/right asymmetry in lateral mesoderm,BP,CITED2
14211,GO:0061303,0.115355243427104,0.994767340914817,1,4,cornea development in camera-type eye,BP,SOX11
1111,GO:0002707,0.115457618833791,0.98026842135853,2,20,negative regulation of lymphocyte mediated immunity,BP,ARG1;IL7R
3321,GO:0007050,0.115506572461059,0.93905133229399,10,214,cell cycle arrest,BP,CDKN2A;TP53;CDKN2B;DUSP1;NBN;HSP90AB1;EIF4G2;CALR;CDK6;PML
673,GO:0001887,0.115532175622526,0.994750853835972,1,4,selenium compound metabolic process,BP,TXNRD1
10315,GO:0043153,0.115556973565719,0.980318041530919,2,19,entrainment of circadian clock by photoperiod,BP,TP53;PML
10356,GO:0043219,0.115569945358165,0.994747330800811,1,4,lateral loop,CC,DLG1
6532,GO:0021979,0.115633838036238,0.994741368271402,1,4,hypothalamus cell differentiation,BP,NRP1
740,GO:0001976,0.115695329477104,0.994735626464683,1,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,SOD2
14140,GO:0061081,0.115702464698449,0.99473495999474,1,4,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,SEMA7A
4735,GO:0010927,0.115767146436068,0.961797768344031,4,59,cellular component assembly involved in morphogenesis,BP,KRT8;EDN1;CNTNAP1;ACTG1
14721,GO:0070444,0.115922972165711,0.99471434145209,1,4,oligodendrocyte progenitor proliferation,BP,LYN
14722,GO:0070445,0.115922972165711,0.99471434145209,1,4,regulation of oligodendrocyte progenitor proliferation,BP,LYN
14924,GO:0070861,0.11594045511899,0.980214317497223,2,19,regulation of protein exit from endoplasmic reticulum,BP,DERL3;SVIP
10352,GO:0043208,0.11597853747833,0.994709139125857,1,4,glycosphingolipid binding,MF,LYN
4800,GO:0014012,0.115978650521885,0.994709128539358,1,4,peripheral nervous system axon regeneration,BP,NEFL
4879,GO:0014824,0.115997777782246,0.994707337116022,1,4,artery smooth muscle contraction,BP,EDN1
10299,GO:0043125,0.116210494460448,0.994687392945182,1,4,ErbB-3 class receptor binding,MF,NRG1
13056,GO:0051607,0.116235682211475,0.943736021156992,8,161,defense response to virus,BP,PMAIP1;IL1B;IFITM2;BIRC3;TRAF3;IL23A;DNAJC3;PML
12507,GO:0050693,0.116350308346435,0.994674262573428,1,4,LBD domain binding,MF,CITED2
8822,GO:0034643,0.116381613298423,0.98009472840068,2,19,establishment of mitochondrion localization, microtubule-mediated,BP,NEFL;FEZ1
11972,GO:0047497,0.116381613298423,0.98009472840068,2,19,mitochondrion transport along microtubule,BP,NEFL;FEZ1
19828,GO:2000347,0.116412670570341,0.9946684004312,1,4,positive regulation of hepatocyte proliferation,BP,XBP1
6796,GO:0030274,0.116466130647954,0.994663372400098,1,4,LIM domain binding,MF,RIPK2
8229,GO:0033031,0.116541804094381,0.994656250887906,1,4,positive regulation of neutrophil apoptotic process,BP,ANXA1
14128,GO:0061052,0.116562925175695,0.994654262322363,1,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,G6PD
10121,GO:0042731,0.116567446081376,0.994653836625091,1,4,PH domain binding,MF,EPB41L2
7256,GO:0031258,0.116592806309039,0.980037378057001,2,19,lamellipodium membrane,CC,ITGAV;EPHA2
7986,GO:0032637,0.11661494398124,0.969199278442359,3,40,interleukin-8 production,BP,IL1B;ANXA1;NLRP10
3586,GO:0008035,0.116632493437865,0.994647709662862,1,4,high-density lipoprotein particle binding,MF,HSPD1
13742,GO:0060369,0.116702557018155,0.994641106075633,1,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,LYN
7894,GO:0032489,0.116761952564987,0.994635504605772,1,4,regulation of Cdc42 protein signal transduction,BP,NRP1
18205,GO:1903059,0.116814653313741,0.99463053192727,1,4,regulation of protein lipidation,BP,SVIP
18206,GO:1903061,0.116814653313741,0.99463053192727,1,4,positive regulation of protein lipidation,BP,SVIP
5951,GO:0018401,0.116820657876335,0.994629965201429,1,4,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,EGLN1
17804,GO:1902023,0.11696091434944,0.994616718475809,1,4,L-arginine transport,BP,ARG1
7797,GO:0032372,0.1169710400752,0.994615761471543,1,4,negative regulation of sterol transport,BP,NFKB1
7800,GO:0032375,0.1169710400752,0.994615761471543,1,4,negative regulation of cholesterol transport,BP,NFKB1
7493,GO:0031698,0.117007323946293,0.994612331468378,1,4,beta-2 adrenergic receptor binding,MF,NEDD4
18423,GO:1903557,0.117056135493317,0.969066374003436,3,39,positive regulation of tumor necrosis factor superfamily cytokine production,BP,RIPK2;ADAM8;IL23A
11553,GO:0046165,0.117071449345636,0.950385289323886,6,110,alcohol biosynthetic process,BP,NFKB1;IL1B;G6PD;HMGCS1;DHDDS;MSMO1
15209,GO:0071417,0.117125832693377,0.928288465692339,16,373,cellular response to organonitrogen compound,BP,NFKB1;EDN1;TP53;SLIT2;RIPK2;PARP1;HSPA5;IL1B;LYN;SLC8A1;XBP1;ARG1;KLF10;HSP90B1;HTR1B;ENPP1
13596,GO:0060136,0.117126429340338,0.994601064054581,1,4,embryonic process involved in female pregnancy,BP,JUNB
603,GO:0001772,0.11716563111409,0.979881498819809,2,19,immunological synapse,CC,DLG1;MYH9
7331,GO:0031392,0.117641669517698,0.994552179245597,1,4,regulation of prostaglandin biosynthetic process,BP,ANXA1
20256,GO:2001279,0.117641669517698,0.994552179245597,1,4,regulation of unsaturated fatty acid biosynthetic process,BP,ANXA1
18584,GO:1903912,0.117750609274057,0.9945418135505,1,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,DNAJC3
10177,GO:0042824,0.117770583877012,0.994539911826282,1,4,MHC class I peptide loading complex,CC,CALR
3167,GO:0006805,0.117786010146498,0.960793880140969,4,64,xenobiotic metabolic process,BP,NCEH1;HSP90AB1;MGST3;CYP1A1
9704,GO:0038189,0.117855900120571,0.994531785182805,1,4,neuropilin signaling pathway,BP,NRP1
4029,GO:0009083,0.117939690195111,0.9795911738003,2,20,branched-chain amino acid catabolic process,BP,IVD;BCAT1
8817,GO:0034637,0.117945772642512,0.960780184507119,4,61,cellular carbohydrate biosynthetic process,BP,B4GALT1;HAS2;GBE1;ENPP1
14263,GO:0061438,0.117948694846324,0.994522938957753,1,4,renal system vasculature morphogenesis,BP,NRP1
14264,GO:0061439,0.117948694846324,0.994522938957753,1,4,kidney vasculature morphogenesis,BP,NRP1
3600,GO:0008063,0.11809300709012,0.99450916653459,1,4,Toll signaling pathway,BP,TRAF3
12171,GO:0048386,0.118136585815916,0.994505004019648,1,4,positive regulation of retinoic acid receptor signaling pathway,BP,TRIM16
19636,GO:1990966,0.118233450291922,0.994495745847176,1,4,ATP generation from poly-ADP-D-ribose,BP,PARP1
18112,GO:1902895,0.118436110580763,0.979534072148005,2,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,TP53;JUN
19658,GO:2000020,0.118556918926687,0.994464769628303,1,4,positive regulation of male gonad development,BP,CITED2
15733,GO:0072376,0.118559701709173,0.979420600508965,2,20,protein activation cascade,BP,KRT1;C1R
965,GO:0002420,0.118592101392346,0.994461394935262,1,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,PVR
966,GO:0002423,0.118592101392346,0.994461394935262,1,4,natural killer cell mediated immune response to tumor cell,BP,PVR
1188,GO:0002855,0.118592101392346,0.994461394935262,1,4,regulation of natural killer cell mediated immune response to tumor cell,BP,PVR
1191,GO:0002858,0.118592101392346,0.994461394935262,1,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,PVR
18567,GO:1903891,0.118670523256583,0.994453868827592,1,4,regulation of ATF6-mediated unfolded protein response,BP,HSPA5
12476,GO:0050656,0.11869476980229,0.994451540808004,1,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,ENPP1
12378,GO:0048861,0.118710776097437,0.994450003689553,1,4,leukemia inhibitory factor signaling pathway,BP,IL6ST
9797,GO:0042045,0.118766685820846,0.994444632798677,1,4,epithelial fluid transport,BP,EDN1
12617,GO:0050861,0.118825585892085,0.994438971681203,1,4,positive regulation of B cell receptor signaling pathway,BP,LYN
10513,GO:0043496,0.118826641520101,0.979346989967499,2,20,regulation of protein homodimerization activity,BP,HSPA5;NRG1
14508,GO:0070064,0.118903334999611,0.979405716325668,2,19,proline-rich region binding,MF,CYLD;NEDD4
4691,GO:0010871,0.118957123149483,0.994426318141224,1,4,negative regulation of receptor biosynthetic process,BP,ITGAV
1209,GO:0002887,0.119106920385255,0.994411889568743,1,4,negative regulation of myeloid leukocyte mediated immunity,BP,HMOX1
8262,GO:0033093,0.119236318223391,0.994399410043413,1,4,Weibel-Palade body,CC,EDN1
8029,GO:0032713,0.119334051102489,0.994389974651516,1,4,negative regulation of interleukin-4 production,BP,CD83
14930,GO:0070876,0.119350102279135,0.994388424227416,1,4,SOSS complex,CC,NABP1
13519,GO:0060023,0.11935841446423,0.994387621243448,1,4,soft palate development,BP,SOX11
20258,GO:2001286,0.119366940141214,0.994386797572521,1,4,regulation of caveolin-mediated endocytosis,BP,NEDD4L
14563,GO:0070164,0.119382075094847,0.994385335218249,1,4,negative regulation of adiponectin secretion,BP,IL1B
16608,GO:0097524,0.119650180703707,0.994359397281812,1,4,sperm plasma membrane,CC,HSP90AB1
18504,GO:1903753,0.119679160832942,0.994356589816154,1,4,negative regulation of p38MAPK cascade,BP,DLG1
12375,GO:0048857,0.11977984588612,0.967995031349716,3,40,neural nucleus development,BP,HSPA5;G6PD;SUDS3
14530,GO:0070100,0.1198752179888,0.994337577315287,1,4,negative regulation of chemokine-mediated signaling pathway,BP,SLIT2
6378,GO:0021603,0.120098635999593,0.994315870386846,1,4,cranial nerve formation,BP,MAFB
6061,GO:0019233,0.120185770921775,0.96783948336945,3,40,sensory perception of pain,BP,EDN1;MGLL;MME
16913,GO:0098957,0.120196165261413,0.99430638086311,1,4,anterograde axonal transport of mitochondrion,BP,FEZ1
16697,GO:0097756,0.120204424006388,0.96786759186969,3,39,negative regulation of blood vessel diameter,BP,EDN1;SLC8A1;HTR1B
8718,GO:0034394,0.120258276616986,0.967846956405214,3,39,protein localization to cell surface,BP,NEDD4L;NRG1;HSP90AB1
14647,GO:0070304,0.120258791686371,0.948684778478447,6,108,positive regulation of stress-activated protein kinase signaling cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B;LYN
971,GO:0002431,0.120284279685189,0.959724415042401,4,61,Fc receptor mediated stimulatory signaling pathway,BP,ACTG1;LYN;HSP90AA1;HSP90AB1
14324,GO:0061588,0.120313210001109,0.994294981471414,1,4,calcium activated phospholipid scrambling,BP,ANO4
14325,GO:0061589,0.120313210001109,0.994294981471414,1,4,calcium activated phosphatidylserine scrambling,BP,ANO4
14326,GO:0061590,0.120313210001109,0.994294981471414,1,4,calcium activated phosphatidylcholine scrambling,BP,ANO4
14327,GO:0061591,0.120313210001109,0.994294981471414,1,4,calcium activated galactosylceramide scrambling,BP,ANO4
15253,GO:0071479,0.120535083867204,0.959590116529712,4,62,cellular response to ionizing radiation,BP,TP53;HSPA5;CRYAB;RHOB
15425,GO:0071804,0.120538478650456,0.953428360965554,5,84,cellular potassium ion transport,BP,NETO1;NEDD4L;KCNQ5;DLG1;NEDD4
15426,GO:0071805,0.120538478650456,0.953428360965554,5,84,potassium ion transmembrane transport,BP,NETO1;NEDD4L;KCNQ5;DLG1;NEDD4
10124,GO:0042734,0.12070168950951,0.967714265385736,3,38,presynaptic membrane,CC,SYT11;KCTD12;RIMS2
1981,GO:0004714,0.120719427127677,0.967707463037829,3,38,transmembrane receptor protein tyrosine kinase activity,MF,AXL;NRP1;EPHA2
1401,GO:0003348,0.120782652520621,0.994249139922398,1,4,cardiac endothelial cell differentiation,BP,NRG1
14066,GO:0060956,0.120782652520621,0.994249139922398,1,4,endocardial cell differentiation,BP,NRG1
2405,GO:0005593,0.120844059618934,0.994243129134335,1,4,FACIT collagen trimer,CC,COL12A1
1333,GO:0003207,0.12094508411802,0.994233233215155,1,4,cardiac chamber formation,BP,SOX11
1336,GO:0003211,0.12094508411802,0.994233233215155,1,4,cardiac ventricle formation,BP,SOX11
14598,GO:0070212,0.121000179535344,0.994227832528036,1,4,protein poly-ADP-ribosylation,BP,PARP1
12345,GO:0048787,0.121098208190773,0.994218216744305,1,4,presynaptic active zone membrane,CC,SYT11
12197,GO:0048495,0.121135711802627,0.994214535722055,1,4,Roundabout binding,MF,SLIT2
13050,GO:0051599,0.121168955407528,0.99421127179037,1,4,response to hydrostatic pressure,BP,KRT8
8600,GO:0034144,0.121344894279345,0.99419398153545,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,LYN
19569,GO:1990748,0.121487918368708,0.959080429109526,4,66,cellular detoxification,BP,GPX8;SOD2;TXNRD1;MGST3
9638,GO:0038027,0.121602312447312,0.994168634906884,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ITGAV
11175,GO:0045341,0.121640649426998,0.994164855076284,1,4,MHC class I biosynthetic process,BP,PML
11177,GO:0045343,0.121640649426998,0.994164855076284,1,4,regulation of MHC class I biosynthetic process,BP,PML
11178,GO:0045345,0.121640649426998,0.994164855076284,1,4,positive regulation of MHC class I biosynthetic process,BP,PML
20187,GO:2001168,0.121663404467465,0.994162610933796,1,4,positive regulation of histone H2B ubiquitination,BP,CTR9
14305,GO:0061550,0.12173426714328,0.994155619412101,1,4,cranial ganglion development,BP,NRP1
6957,GO:0030643,0.121754004065085,0.994153671322089,1,4,cellular phosphate ion homeostasis,BP,ENPP1
15764,GO:0072501,0.121754004065085,0.994153671322089,1,4,cellular divalent inorganic anion homeostasis,BP,ENPP1
15765,GO:0072502,0.121754004065085,0.994153671322089,1,4,cellular trivalent inorganic anion homeostasis,BP,ENPP1
12227,GO:0048549,0.121766014629903,0.994152485677584,1,4,positive regulation of pinocytosis,BP,AXL
16590,GO:0097490,0.121854897953585,0.994143707454204,1,4,sympathetic neuron projection extension,BP,NRP1
16591,GO:0097491,0.121854897953585,0.994143707454204,1,4,sympathetic neuron projection guidance,BP,NRP1
7625,GO:0032058,0.121872622500095,0.994141956125238,1,4,positive regulation of translational initiation in response to stress,BP,DNAJC3
6388,GO:0021636,0.121893383441774,0.994139904424163,1,4,trigeminal nerve morphogenesis,BP,NRP1
6389,GO:0021637,0.121893383441774,0.994139904424163,1,4,trigeminal nerve structural organization,BP,NRP1
18662,GO:1904063,0.121944948873006,0.967162519603124,3,40,negative regulation of cation transmembrane transport,BP,MMP9;NEDD4L;NEDD4
18214,GO:1903078,0.121986147123551,0.967182556740121,3,39,positive regulation of protein localization to plasma membrane,BP,STAC;DLG1;EPHA2
11812,GO:0046827,0.122274511223463,0.978386942052092,2,20,positive regulation of protein export from nucleus,BP,TP53;IL1B
3423,GO:0007229,0.122373920201561,0.958795894610031,4,60,integrin-mediated signaling pathway,BP,SEMA7A;ITGAV;NRP1;MYH9
15093,GO:0071225,0.122381725745088,0.994091534528998,1,4,cellular response to muramyl dipeptide,BP,RIPK2
540,GO:0001659,0.122476049526488,0.978330293179876,2,20,temperature homeostasis,BP,IL1A;IL1B
6358,GO:0021562,0.122533957236318,0.994076413186913,1,4,vestibulocochlear nerve development,BP,NRP1
10592,GO:0043622,0.122696524347355,0.994060242651163,1,4,cortical microtubule organization,BP,DLG1
9648,GO:0038044,0.122784574270593,0.994051474610666,1,4,transforming growth factor-beta secretion,BP,ITGAV
365,GO:0000987,0.12282344927885,0.928538524431523,13,293,proximal promoter sequence-specific DNA binding,MF,MAFB;TP53;JUN;NFKB2;ARID3B;JUNB;ATF3;EHF;ARNTL2;KLF10;SNAI3;ETS1;ZFP42
15124,GO:0071284,0.123119019427434,0.994018108176485,1,4,cellular response to lead ion,BP,CLDN1
7879,GO:0032469,0.123134774343834,0.978144729043547,2,20,endoplasmic reticulum calcium ion homeostasis,BP,HERPUD1;PML
538,GO:0001657,0.123279112487867,0.958360611165414,4,61,ureteric bud development,BP,SLIT2;EPCAM;DLG1;MAGED1
358,GO:0000977,0.123435791075154,0.921536026066298,18,433,RNA polymerase II regulatory region sequence-specific DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;KLF10;SNAI3;ETS1;ZFP42;SOX11
12344,GO:0048786,0.123473878270395,0.978133485231914,2,19,presynaptic active zone,CC,SYT11;RIMS2
14278,GO:0061476,0.123486548730721,0.993981327304047,1,4,response to anticoagulant,BP,SLIT2
15271,GO:0071503,0.123486548730721,0.993981327304047,1,4,response to heparin,BP,SLIT2
15272,GO:0071504,0.123486548730721,0.993981327304047,1,4,cellular response to heparin,BP,SLIT2
5611,GO:0016709,0.123515628061438,0.978037156797979,2,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,MSMO1;CYP1A1
13081,GO:0051660,0.123680115973918,0.993961907958078,1,4,establishment of centrosome localization,BP,DLG1
843,GO:0002175,0.123789140030583,0.99395095572598,1,4,protein localization to paranode region of axon,BP,CNTNAP1
3518,GO:0007520,0.123799646653592,0.977956799856211,2,20,myoblast fusion,BP,EHD1;MYH9
18065,GO:1902744,0.123826396908486,0.993947210605949,1,4,negative regulation of lamellipodium organization,BP,SLIT2
16782,GO:0098706,0.123942495542114,0.993935532330629,1,4,ferric iron import across plasma membrane,BP,STEAP4
2731,GO:0006145,0.124299092416503,0.993899588104,1,4,purine nucleobase catabolic process,BP,GDA
13587,GO:0060123,0.124559442385139,0.993873274434465,1,4,regulation of growth hormone secretion,BP,SERP1
9686,GO:0038132,0.124689648796026,0.993860091958413,1,4,neuregulin binding,MF,ITGAV
15856,GO:0072666,0.124795315204529,0.966055836714932,3,40,establishment of protein localization to vacuole,BP,AP3M1;GNPTAB;NEDD4
13193,GO:0051897,0.12482236209174,0.951242747134205,5,85,positive regulation of protein kinase B signaling,BP,FGF5;C1QTNF1;AXL;NRG1;ADAM8
7318,GO:0031348,0.124930120353586,0.946088822691051,6,113,negative regulation of defense response,BP,KRT1;SAA1;NFKB1;ARG1;ETS1;NLRP10
7886,GO:0032481,0.12497734382672,0.957539148585724,4,63,positive regulation of type I interferon production,BP,NFKB1;RIPK2;NFKB2;HSPD1
8350,GO:0033273,0.125060116668139,0.957501031720769,4,63,response to vitamin,BP,TP53;ARG1;HMGCS1;CYP1A1
10371,GO:0043237,0.125074770220787,0.993821013437752,1,4,laminin-1 binding,MF,SLIT2
4554,GO:0010657,0.125087193356623,0.965941830543264,3,40,muscle cell apoptotic process,BP,CDKN2A;EDN1;HMOX1
6526,GO:0021957,0.125129828979066,0.993815415876484,1,4,corticospinal tract morphogenesis,BP,SLIT2
3404,GO:0007205,0.125133419295194,0.977577887673038,2,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,EDN1;HTR1B
6036,GO:0019201,0.125140573429458,0.977575848366986,2,20,nucleotide kinase activity,MF,TJP2;DLG1
4569,GO:0010677,0.125386645948481,0.977505660030572,2,20,negative regulation of cellular carbohydrate metabolic process,BP,ENPP1;MIDN
6549,GO:0022028,0.125428779014666,0.993784976253819,1,4,tangential migration from the subventricular zone to the olfactory bulb,BP,SLIT2
15086,GO:0071218,0.125519897544242,0.977467615867442,2,20,cellular response to misfolded protein,BP,UGGT1;SDF2L1
15709,GO:0072338,0.125704116208407,0.993756870989131,1,4,cellular lactam metabolic process,BP,MME
11235,GO:0045577,0.125730244939026,0.977407508584474,2,20,regulation of B cell differentiation,BP,CYLD;XBP1
11309,GO:0045669,0.125754181583307,0.965680834609543,3,40,positive regulation of osteoblast differentiation,BP,IL6ST;FBN2;SOX11
7136,GO:0031016,0.125799274330512,0.965663165829035,3,40,pancreas development,BP,ANXA1;XBP1;CDK6
609,GO:0001778,0.125904760559849,0.993736347796046,1,4,plasma membrane repair,BP,SYT11
15078,GO:0071205,0.126026912839555,0.993723835823309,1,4,protein localization to juxtaparanode region of axon,BP,CNTNAP1
10471,GO:0043407,0.126261808219058,0.956926156720307,4,64,negative regulation of MAP kinase activity,BP,DUSP8;IL1B;DUSP1;LYN
445,GO:0001205,0.12626356286065,0.977254827644028,2,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,NFKB1;ARID3B
10324,GO:0043170,0.12628275967433,0.894746788354487,219,6848,macromolecule metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;SAA1;OSR2;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;RNASE7;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;APOL6;OPTN;HSPA5;IL1B;MSRB3;ANPEP;JUNB;C1QTNF1;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;ERAP1;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;STT3A;ITGAV;LYN;C1R;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;XBP1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;MMP19;KLK6;ZNF638;IL24;RIMS2;HSP90AA1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;PRR5L;UBP1;METTL2A;CORO1C;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;NGLY1;ZMYM4;CITED2;LOX;ZNF814;PTTG1IP;DHDDS;ETS1;HAS2;TYW1;CALU;CHORDC1;TGFA;BAMBI;PRPF38A;DNAJC3;CBLL1;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1
6632,GO:0023061,0.126369267994595,0.929884229519021,11,241,signal release,BP,EDN1;IL1B;C1QTNF1;LYN;ANXA1;SYT11;RIMS2;SERP1;OXCT1;SOX11;MIDN
10691,GO:0044060,0.12647808400286,0.977193298622372,2,20,regulation of endocrine process,BP,IL1B;C1QTNF1
12346,GO:0048788,0.12657021923991,0.993668025230833,1,4,cytoskeleton of presynaptic active zone,CC,RIMS2
17030,GO:0099569,0.12657021923991,0.993668025230833,1,4,presynaptic cytoskeleton,CC,RIMS2
12236,GO:0048568,0.126979766404408,0.92748648950421,12,267,embryonic organ development,BP,KRT8;OSR2;MAFB;EDN1;JUNB;PHLDA2;FBN2;EGLN1;NR2F2;DLG1;CITED2;SOX11
16415,GO:0097120,0.127120326582666,0.977008696865555,2,20,receptor localization to synapse,BP,NETO1;DLG1
13078,GO:0051654,0.1271962943863,0.97698682220601,2,20,establishment of mitochondrion localization,BP,NEFL;FEZ1
15564,GO:0072091,0.127207136862291,0.965110009795133,3,40,regulation of stem cell proliferation,BP,EPCAM;VEGFC;SOX11
11497,GO:0046058,0.127531283739885,0.964982237014748,3,40,cAMP metabolic process,BP,GPR176;EGLN1;EPHA2
9816,GO:0042092,0.127718123600231,0.976756173833975,2,21,type 2 immune response,BP,ANXA1;ARG1
2656,GO:0006023,0.128062517875641,0.949568616617423,5,86,aminoglycan biosynthetic process,BP,NFKB1;B4GALT1;HS3ST1;IL1B;HAS2
1066,GO:0002639,0.128146786653611,0.976631866018578,2,21,positive regulation of immunoglobulin production,BP,XBP1;TFRC
12765,GO:0051099,0.128422160942893,0.939932140108119,7,139,positive regulation of binding,BP,MMP9;RIPK2;HERPUD1;PARP1;NRP1;HSP90AB1;BAMBI
10638,GO:0043902,0.128529591047103,0.939861978805608,7,140,positive regulation of multi-organism process,BP,LGALS1;JUN;RIPK2;OPTN;ARG1;PPID;NLRP10
7993,GO:0032648,0.128670315408652,0.96449542823713,3,41,regulation of interferon-beta production,BP,RELB;RIPK2;TRAF3
15609,GO:0072163,0.129089097132713,0.95565539135598,4,62,mesonephric epithelium development,BP,SLIT2;EPCAM;DLG1;MAGED1
15610,GO:0072164,0.129089097132713,0.95565539135598,4,62,mesonephric tubule development,BP,SLIT2;EPCAM;DLG1;MAGED1
15256,GO:0071482,0.129137091448204,0.949000589617081,5,87,cellular response to light stimulus,BP,TP53;PARP1;PPID;MME;NEDD4
9579,GO:0036473,0.12935460255352,0.955488910476182,4,64,cell death in response to oxidative stress,BP,TP53;PARP1;SOD2;PML
12514,GO:0050703,0.129373833367948,0.992950488982289,1,5,interleukin-1 alpha secretion,BP,NLRP10
379,GO:0001012,0.129501170249442,0.917118212082746,18,436,RNA polymerase II regulatory region DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;KLF10;SNAI3;ETS1;ZFP42;SOX11
7565,GO:0031954,0.129650084081143,0.976275832947127,2,20,positive regulation of protein autophosphorylation,BP,NBN;VEGFC
18526,GO:1903793,0.129661334425487,0.976190559664669,2,21,positive regulation of anion transport,BP,EDN1;IL1B
6712,GO:0030145,0.129892757719558,0.964009676989466,3,41,manganese ion binding,MF,B4GALT1;ARG1;SOD2
13803,GO:0060444,0.13024507900204,0.976102140179232,2,20,branching involved in mammary gland duct morphogenesis,BP,PML;EPHA2
12709,GO:0051017,0.130247925702132,0.943184173569646,6,110,actin filament bundle assembly,BP,LCP1;DPYSL3;MYO1B;RHOB;NRP1;HSP90B1
14467,GO:0062014,0.130304035537691,0.955044958121931,4,64,negative regulation of small molecule metabolic process,BP,NFKB1;PARP1;GPR176;EGLN1
3562,GO:0007622,0.130770407701808,0.975865323807731,2,21,rhythmic behavior,BP,TP53;GPR176
12203,GO:0048512,0.130770407701808,0.975865323807731,2,21,circadian behavior,BP,TP53;GPR176
20248,GO:2001268,0.130800907781412,0.99278956456787,1,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9
4939,GO:0015026,0.13082132680441,0.975933440346205,2,20,coreceptor activity,MF,ITGAV;NRP1
20138,GO:2001023,0.130946946045457,0.96355342218413,3,42,regulation of response to drug,BP,TP53;ARG1;HTR1B
16905,GO:0098930,0.131204533858365,0.963485995817905,3,41,axonal transport,BP,NEFL;FEZ1;AP3M1
8226,GO:0033028,0.131388855702027,0.975683202987421,2,21,myeloid cell apoptotic process,BP,CDKN2A;ANXA1
6072,GO:0019262,0.131513610203939,0.992708476677156,1,5,N-acetylneuraminate catabolic process,BP,NAGK
8210,GO:0033003,0.131636846908998,0.975610021573417,2,21,regulation of mast cell activation,BP,LYN;HMOX1
10297,GO:0043123,0.131777127389932,0.937960748135291,7,140,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,IL1A;LGALS1;RIPK2;IKBKE;BIRC3;HMOX1;AJUBA
14927,GO:0070873,0.13180696940848,0.975643794767564,2,20,regulation of glycogen metabolic process,BP,PHLDA2;ENPP1
596,GO:0001764,0.1319999461511,0.947546849989133,5,85,neuron migration,BP,AXL;NRP1;NRG1;NR2F2;ADGRL3
13197,GO:0051901,0.132069043724723,0.992644949216565,1,5,positive regulation of mitochondrial depolarization,BP,PARP1
14902,GO:0070830,0.13209148101685,0.963168361391941,3,40,bicellular tight junction assembly,BP,CLDN1;DLG1;TJP1
12379,GO:0048863,0.132308470438734,0.93090587298255,9,199,stem cell differentiation,BP,EDN1;PSMB9;EPCAM;SEMA7A;SEMA3D;NRP1;NRG1;CORO1C;SOX11
3677,GO:0008199,0.132553761491511,0.992589271374452,1,5,ferric iron binding,MF,FTH1
15189,GO:0071385,0.13259199144548,0.962893182108714,3,42,cellular response to glucocorticoid stimulus,BP,EDN1;ANXA1;ARG1
12248,GO:0048598,0.13269150924017,0.917211569647331,16,379,embryonic morphogenesis,BP,MMP9;OSR2;MAFB;EDN1;COL12A1;FBN2;DUSP1;ITGAV;COL8A1;VEGFC;FRAS1;C2ORF49;CTR9;DLG1;TXNRD1;SOX11
11924,GO:0047134,0.132897386125326,0.992549665696153,1,5,protein-disulfide reductase activity,MF,PGK1
13243,GO:0051972,0.132936484942691,0.962754420604185,3,42,regulation of telomerase activity,BP,TP53;HSP90AA1;HSP90AB1
20194,GO:2001179,0.133537028120665,0.992475643620398,1,5,regulation of interleukin-10 secretion,BP,CD274
18326,GO:1903363,0.133562347548006,0.953490539018701,4,65,negative regulation of cellular protein catabolic process,BP,DERL3;HSP90AB1;SVIP;PML
2517,GO:0005787,0.133593528966173,0.992469086466844,1,5,signal peptidase complex,CC,SEC11C
2175,GO:0005044,0.133757325951729,0.974980707695683,2,21,scavenger receptor activity,MF,CXCL16;ENPP1
883,GO:0002260,0.133884648936851,0.962371611656185,3,42,lymphocyte homeostasis,BP,PMAIP1;SPNS2;LYN
7995,GO:0032650,0.133941510184461,0.992428635102904,1,5,regulation of interleukin-1 alpha production,BP,NLRP10
1683,GO:0004169,0.134014867368883,0.992420092981007,1,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,SDF2L1
149,GO:0000305,0.134074662215085,0.974807862628496,2,22,response to oxygen radical,BP,SOD2;TXNRD1
14316,GO:0061572,0.134244246069427,0.940943644859209,6,111,actin filament bundle organization,BP,LCP1;DPYSL3;MYO1B;RHOB;NRP1;HSP90B1
653,GO:0001848,0.13437522776262,0.992378056460495,1,5,complement binding,MF,CALR
13951,GO:0060706,0.134506276178923,0.974756910954351,2,21,cell differentiation involved in embryonic placenta development,BP,KRT8;NR2F2
3137,GO:0006751,0.134738953930109,0.992335502347323,1,5,glutathione catabolic process,BP,CHAC1
7161,GO:0031063,0.134762874894679,0.974680053014556,2,21,regulation of histone deacetylation,BP,TP53;SDR16C5
4486,GO:0010543,0.135012855619525,0.974605087735732,2,21,regulation of platelet activation,BP,C1QTNF1;LYN
4264,GO:0009648,0.135328021763748,0.974510448407814,2,21,photoperiodism,BP,TP53;PML
418,GO:0001106,0.136043552870003,0.974295064669535,2,21,RNA polymerase II transcription corepressor activity,MF,DNAJB1;CITED2
10825,GO:0044362,0.136224017961672,0.99216045327322,1,5,negative regulation of molecular function in other organism,BP,SUGT1
13283,GO:0052204,0.136224017961672,0.99216045327322,1,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,SUGT1
8040,GO:0032731,0.136246601011923,0.974233812916234,2,21,positive regulation of interleukin-1 beta production,BP,TRIM16;RIPK2
12787,GO:0051132,0.136270082665095,0.992154989953426,1,5,NK T cell activation,BP,IL23A
10770,GO:0044283,0.136424103846909,0.908941856696841,21,541,small molecule biosynthetic process,BP,NFKB1;EDN1;PGK1;IL1B;ATF3;MGLL;FADS1;ANXA1;FADS3;G6PD;XBP1;EGLN1;HMGCS1;GDA;DHDDS;HAS2;MSMO1;MGST3;BCAT1;ENPP1;CYP1A1
9985,GO:0042445,0.136457066162325,0.939647428180256,6,116,hormone metabolic process,BP,NFKB1;IL1B;KLK6;SDR16C5;MME;CYP1A1
10323,GO:0043169,0.136463499474587,0.888091900183434,101,2972,cation binding,MF,RPTN;MMP9;IL1A;FLG2;TRIM16;TCHH;OSR2;LCP1;B4GALT1;TP53;FLG;SLIT2;PEG10;CCBE1;ZNF165;PARP1;OPTN;HRNR;HSPA5;MSRB3;ANPEP;EFHD2;CRYAB;CREB5;NOCT;ERAP1;CYLD;FBN2;STAC;ANXA8;STT3A;ITGAV;C1R;ANXA1;PDE1C;SLC8A1;THTPA;BIRC3;ARG1;TRAF3;CSRP1;HMOX1;MMP19;SYT11;ZNF638;FRAS1;HEPHL1;RIMS2;CANX;FTH1;NRP1;TRAF1;EGLN1;GNPTAB;SOD2;ZNF132;KLF10;ACO1;ZNF697;SNAI3;ADAM8;NR2F2;STEAP4;MOB3A;CALR;AJUBA;IGFBP3;EYA3;ZCCHC8;GIT2;NID2;MME;TRMT44;NGLY1;GDA;EHD1;ZMYM4;LOX;ZNF814;ADGRL3;TYW1;SEC24D;CALU;MSMO1;CHORDC1;CBLL1;RSPRY1;ZC3H7B;HSP90B1;ZFP42;HTR1B;PML;GALNT14;TRIM47;ZBTB21;GBE1;CPPED1;ENPP1;TPM4;CYP1A1;TMPPE
676,GO:0001890,0.136480290592868,0.939654778293132,6,114,placenta development,BP,KRT8;JUNB;PHLDA2;EGLN1;HSP90AB1;NR2F2
7992,GO:0032647,0.136591114925703,0.974129753260877,2,21,regulation of interferon-alpha production,BP,RIPK2;HSPD1
5568,GO:0016605,0.136653381641271,0.945067469476162,5,88,PML body,CC,TRIM16;TP53;IKBKE;NBN;PML
613,GO:0001782,0.13666908521063,0.974106179265161,2,21,B cell homeostasis,BP,SPNS2;LYN
11715,GO:0046598,0.136670197996902,0.9921074509276,1,5,positive regulation of viral entry into host cell,BP,LGALS1
11106,GO:0045185,0.136875085333262,0.94493615943851,5,89,maintenance of protein location,BP,NFKBIA;HSPA5;FBN2;NFKBIE;PML
19731,GO:2000179,0.13688071876112,0.97404214949207,2,21,positive regulation of neural precursor cell proliferation,BP,LYN;VEGFC
1015,GO:0002523,0.136917809104687,0.992077955091508,1,5,leukocyte migration involved in inflammatory response,BP,ADAM8
7813,GO:0032388,0.136930321877424,0.927997706627051,9,193,positive regulation of intracellular transport,BP,FEZ1;TP53;IL1B;NRG1;HSP90AB1;PRR5L;EHD1;NEDD4;UGCG
933,GO:0002349,0.136993870130743,0.992068882856639,1,5,histamine production involved in inflammatory response,BP,LYN
978,GO:0002441,0.136993870130743,0.992068882856639,1,5,histamine secretion involved in inflammatory response,BP,LYN
1032,GO:0002553,0.136993870130743,0.992068882856639,1,5,histamine secretion by mast cell,BP,LYN
19667,GO:2000047,0.137052773590006,0.992061853317162,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,EPCAM
617,GO:0001787,0.137087239053891,0.992057738675674,1,5,natural killer cell proliferation,BP,IL23A
9145,GO:0035529,0.137294235340292,0.992033002723366,1,5,NADH pyrophosphatase activity,MF,ENPP1
1241,GO:0003006,0.137344896618749,0.912547091425275,17,413,developmental process involved in reproduction,BP,IL1A;KRT8;B4GALT1;SLIT2;IL1B;JUNB;PHLDA2;AXL;ANXA1;MMP19;EGLN1;HSP90AB1;NR2F2;HMGCS1;DLG1;CITED2;ZFP42
8576,GO:0034112,0.137440984681902,0.992015441518528,1,5,positive regulation of homotypic cell-cell adhesion,BP,LGALS1
11438,GO:0045931,0.137495987586703,0.939081518950771,6,114,positive regulation of mitotic cell cycle,BP,IL1A;EDN1;IL1B;ANXA1;TGFA;CYP1A1
5686,GO:0016833,0.137498335552136,0.992008572874996,1,5,oxo-acid-lyase activity,MF,TYW1
10899,GO:0044557,0.137518701034685,0.992006133042822,1,5,relaxation of smooth muscle,BP,SLC8A1
13208,GO:0051924,0.137536084200131,0.939058861284419,6,114,regulation of calcium ion transport,BP,IL16;STAC;LYN;G6PD;SLC8A1;PML
17067,GO:0101002,0.137712198141186,0.934413408790805,7,145,ficolin-1-rich granule,CC,MMP9;KRT1;HSPA6;HSP90AA1;FTH1;HSP90AB1;ADAM8
9065,GO:0035356,0.138000942809325,0.991948243817192,1,5,cellular triglyceride homeostasis,BP,XBP1
14726,GO:0070459,0.138270847990102,0.991915747075713,1,5,prolactin secretion,BP,ANXA1
6055,GO:0019222,0.138515177962256,0.883845635268597,160,4904,regulation of metabolic process,BP,CDKN2A;NFKBIA;MMP9;IL1A;TRIM16;SERPINB2;DSCAM;SAA1;OSR2;TNIP1;DUSP8;NFKB1;MAFB;RELB;FEZ1;EDN1;TP53;PMAIP1;PSMB9;FGF5;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;JUNB;C1QTNF1;IL6ST;PHLDA2;CRYAB;ATF3;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;ITGAV;LYN;C1R;ANXA1;GPR176;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;IL24;RIMS2;HSP90AA1;NRP1;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;TNFSF15;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;SERP1;ORMDL1;MAFF;MGA;PRR5L;HMGCS1;UBP1;CORO1C;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;TXNRD1;PTTG1IP;ETS1;HAS2;CHORDC1;TGFA;BAMBI;DNAJC3;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;PML;EPHA2;MYH9;EID3;BTBD10;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;CYP1A1
19905,GO:2000483,0.138519046569931,0.991885802472179,1,5,negative regulation of interleukin-8 secretion,BP,ANXA1
15957,GO:0086009,0.138618383632655,0.973514031455652,2,21,membrane repolarization,BP,NEDD4L;DLG1
8364,GO:0033299,0.138647727265475,0.991870254289914,1,5,secretion of lysosomal enzymes,BP,GNPTAB
13988,GO:0060754,0.138647732376969,0.99187025367199,1,5,positive regulation of mast cell chemotaxis,BP,VEGFC
7828,GO:0032410,0.138801590314692,0.960365630384927,3,42,negative regulation of transporter activity,BP,MMP9;NEDD4L;NEDD4
13538,GO:0060046,0.138895173533785,0.991840311516998,1,5,regulation of acrosome reaction,BP,B4GALT1
7057,GO:0030865,0.138937626963804,0.960348095465502,3,41,cortical cytoskeleton organization,BP,CALR;DLG1;EPB41L2
10179,GO:0042826,0.139030339187373,0.943797418213248,5,89,histone deacetylase binding,MF,TP53;PARP1;SUDS3;HSP90AA1;HSP90AB1
9868,GO:0042182,0.139065121872067,0.991819712678505,1,5,ketone catabolic process,BP,OXCT1
11072,GO:0045123,0.139103505815469,0.973365832123868,2,21,cellular extravasation,BP,IL1A;ADAM8
3924,GO:0008630,0.139186077925454,0.943672397358298,5,92,intrinsic apoptotic signaling pathway in response to DNA damage,BP,TP53;IKBKE;HMOX1;PML;EPHA2
11073,GO:0045124,0.139228135696257,0.973327705673205,2,21,regulation of bone resorption,BP,ADAM8;TFRC
15140,GO:0071316,0.139246653744116,0.9917976793662,1,5,cellular response to nicotine,BP,NFKB1
19440,GO:1990226,0.13932455336568,0.991788214696085,1,5,histone methyltransferase binding,MF,HSP90AB1
7609,GO:0032036,0.139387116053364,0.991780609238412,1,5,myosin heavy chain binding,MF,AXL
12541,GO:0050747,0.139649649932229,0.991748653418078,1,5,positive regulation of lipoprotein metabolic process,BP,SVIP
13733,GO:0060352,0.139656369596669,0.991747834630734,1,5,cell adhesion molecule production,BP,IL1B
10216,GO:0042982,0.139699086967085,0.959958851399827,3,43,amyloid precursor protein metabolic process,BP,LYN;KLK6;DLG1
19808,GO:2000319,0.140074578670412,0.991696791126032,1,5,regulation of T-helper 17 cell differentiation,BP,IL23A
7255,GO:0031256,0.140172897671228,0.937586174844808,6,112,leading edge membrane,CC,LCP1;ITGAV;WWC1;HSP90AA1;NRG1;EPHA2
4027,GO:0009081,0.140256743453822,0.972928657140435,2,22,branched-chain amino acid metabolic process,BP,IVD;BCAT1
2991,GO:0006552,0.140410050169942,0.991655725031147,1,5,leucine catabolic process,BP,IVD
10003,GO:0042482,0.141014780474221,0.991581426035981,1,5,positive regulation of odontogenesis,BP,EDN1
6107,GO:0019373,0.141113738895572,0.991569234362485,1,5,epoxygenase P450 pathway,BP,CYP1A1
17650,GO:1901569,0.141388263127119,0.991535363873448,1,5,fatty acid derivative catabolic process,BP,OXCT1
3585,GO:0008033,0.141401718614376,0.93680329514478,6,120,tRNA processing,BP,PUS10;POP4;C2ORF49;METTL2A;TRMT44;TYW1
864,GO:0002220,0.141485480906467,0.942422134233602,5,94,innate immune response activating cell surface receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;PSMB9;LYN
866,GO:0002223,0.141485480906467,0.942422134233602,5,94,stimulatory C-type lectin receptor signaling pathway,BP,NFKBIA;NFKB1;RELB;PSMB9;LYN
1919,GO:0004630,0.141507325385593,0.991520651653648,1,5,phospholipase D activity,MF,HMOX1
10025,GO:0042538,0.141510968379235,0.991520201283988,1,5,hyperosmotic salinity response,BP,CLDN1
12524,GO:0050713,0.141561108710755,0.991514001330139,1,5,negative regulation of interleukin-1 beta secretion,BP,PML
18441,GO:1903587,0.141567400318556,0.991513223189886,1,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,HMOX1
8251,GO:0033079,0.141677662222809,0.991499579939307,1,5,immature T cell proliferation,BP,RIPK2
17731,GO:1901799,0.14169604053478,0.959130992731164,3,43,negative regulation of proteasomal protein catabolic process,BP,DERL3;HSP90AB1;SVIP
10451,GO:0043379,0.141976846809344,0.991462501623327,1,5,memory T cell differentiation,BP,IL23A
16334,GO:0090713,0.141976846809344,0.991462501623327,1,5,immunological memory process,BP,IL23A
16335,GO:0090715,0.141976846809344,0.991462501623327,1,5,immunological memory formation process,BP,IL23A
17757,GO:1901888,0.142005839825563,0.949469069807625,4,64,regulation of cell junction assembly,BP,CLDN1;NRP1;CORO1C;TJP1
3493,GO:0007417,0.14203581824435,0.902934164709492,23,585,central nervous system development,BP,NEFL;MAFB;FEZ1;SLIT2;HSPA5;CNTNAP1;IL6ST;AXL;SEMA7A;LYN;G6PD;SLC8A1;SUDS3;KLK6;NRP1;NRG1;NR2F2;EIF2B1;HMGCS1;ETS1;CDK6;OXCT1;SOX11
1972,GO:0004704,0.142056656027432,0.99145259626404,1,5,NF-kappaB-inducing kinase activity,MF,IKBKE
11409,GO:0045892,0.142140972243331,0.896473035266787,33,892,negative regulation of transcription, DNA-templated,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;WWC1;NEDD4L;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;NEDD4;PML;ZBTB21;SOX11;MAGED1
4928,GO:0014911,0.142208384246282,0.972409500343586,2,21,positive regulation of smooth muscle cell migration,BP,NRP1;HAS2
876,GO:0002248,0.142221729282676,0.991432089142817,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,IL1A
831,GO:0002138,0.142244055167781,0.991429313581543,1,5,retinoic acid biosynthetic process,BP,CYP1A1
5331,GO:0016102,0.142244055167781,0.991429313581543,1,5,diterpenoid biosynthetic process,BP,CYP1A1
11655,GO:0046476,0.142305768901807,0.991421638821905,1,5,glycosylceramide biosynthetic process,BP,UGCG
7968,GO:0032608,0.142308912375353,0.958875780571092,3,43,interferon-beta production,BP,RELB;RIPK2;TRAF3
7416,GO:0031545,0.142392875011312,0.991410800030471,1,5,peptidyl-proline 4-dioxygenase activity,MF,EGLN1
11624,GO:0046415,0.142503052078613,0.991397080042395,1,5,urate metabolic process,BP,SLC16A9
5608,GO:0016705,0.142525480498566,0.94192274381458,5,90,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,FADS1;HMOX1;EGLN1;MSMO1;CYP1A1
7047,GO:0030854,0.14254992892972,0.99139123908901,1,5,positive regulation of granulocyte differentiation,BP,TRIB1
14127,GO:0061051,0.142665496581669,0.99137683010797,1,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,EDN1
632,GO:0001825,0.142744886637929,0.972157119968174,2,22,blastocyst formation,BP,JUNB;CTR9
9635,GO:0038024,0.142841030768255,0.958691719335403,3,42,cargo receptor activity,MF,CXCL16;TFRC;ENPP1
12172,GO:0048387,0.142886430779198,0.991349248330697,1,5,negative regulation of retinoic acid receptor signaling pathway,BP,CALR
19975,GO:2000630,0.142989759906391,0.991336332469792,1,5,positive regulation of miRNA metabolic process,BP,NFKB1
20099,GO:2000831,0.143008565981499,0.991333980658324,1,5,regulation of steroid hormone secretion,BP,C1QTNF1
14692,GO:0070391,0.143078543909485,0.991325226518597,1,5,response to lipoteichoic acid,BP,RIPK2
15091,GO:0071223,0.143078543909485,0.991325226518597,1,5,cellular response to lipoteichoic acid,BP,RIPK2
9167,GO:0035578,0.143241488377178,0.948781515503643,4,68,azurophil granule lumen,CC,HRNR;ARG1;DNAJC3;CPPED1
19554,GO:1990712,0.143256707198223,0.991302917307917,1,5,HFE-transferrin receptor complex,CC,TFRC
11176,GO:0045342,0.143441878373606,0.991279698262168,1,5,MHC class II biosynthetic process,BP,XBP1
11179,GO:0045346,0.143441878373606,0.991279698262168,1,5,regulation of MHC class II biosynthetic process,BP,XBP1
6672,GO:0030061,0.143461739358002,0.99127720589025,1,5,mitochondrial crista,CC,LYN
16632,GO:0097581,0.14351078641553,0.948715158088691,4,65,lamellipodium organization,BP,SLIT2;AJUBA;CORO1C;EPHA2
6767,GO:0030223,0.143535485861607,0.991267948060874,1,5,neutrophil differentiation,BP,TRIB1
12990,GO:0051480,0.144024333676043,0.93066458398351,7,141,regulation of cytosolic calcium ion concentration,BP,SAA1;EDN1;C1QTNF1;ITGAV;LYN;SLC8A1;PML
18327,GO:1903364,0.144027130338252,0.935342290534945,6,116,positive regulation of cellular protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;XBP1;HSP90AA1;PTTG1IP
6676,GO:0030072,0.144043591804208,0.930652978980756,7,141,peptide hormone secretion,BP,EDN1;IL1B;ANXA1;RIMS2;SERP1;OXCT1;MIDN
6441,GO:0021781,0.144192598548849,0.991185225982845,1,5,glial cell fate commitment,BP,NRG1
8814,GO:0034629,0.144296467844105,0.971671601554685,2,22,cellular protein-containing complex localization,BP,DLG1;TNFAIP2
9476,GO:0036155,0.144467108892486,0.991150545638308,1,5,acylglycerol acyl-chain remodeling,BP,MGLL
10620,GO:0043696,0.144549738348749,0.991140092421264,1,5,dedifferentiation,BP,CDK6
10621,GO:0043697,0.144549738348749,0.991140092421264,1,5,cell dedifferentiation,BP,CDK6
20219,GO:2001223,0.144567385978588,0.991137859018186,1,5,negative regulation of neuron migration,BP,NRG1
4553,GO:0010656,0.14471328733077,0.971540596815808,2,22,negative regulation of muscle cell apoptotic process,BP,EDN1;HMOX1
2583,GO:0005892,0.144806289289598,0.991107595007633,1,5,acetylcholine-gated channel complex,CC,STXBP5
6276,GO:0019904,0.145006597743795,0.901511712707848,22,561,protein domain specific binding,MF,TRIM16;NEFL;TP53;DPYSL3;JUN;RIPK2;HSPA5;IL1B;CNTNAP1;TJP2;LYN;PLEKHA2;HSP90AA1;DAPP1;HSP90AB1;L1CAM;CTR9;DLG1;CITED2;NEDD4;EPB41L2;MYH9
1433,GO:0003433,0.145107467277401,0.991069363789053,1,5,chondrocyte development involved in endochondral bone morphogenesis,BP,SERPINH1
11296,GO:0045656,0.145162192890653,0.991062407596298,1,5,negative regulation of monocyte differentiation,BP,CDK6
5796,GO:0017080,0.145333932613142,0.971345080289192,2,22,sodium channel regulator activity,MF,NEDD4L;NEDD4
10591,GO:0043621,0.14537818888546,0.957589654638423,3,43,protein self-association,MF,TP53;ADAM8;SVIP
20137,GO:2001022,0.145383175564137,0.94775652920187,4,67,positive regulation of response to DNA damage stimulus,BP,PMAIP1;PARP1;EYA3;EID3
560,GO:0001701,0.145511925210654,0.917054978086068,11,247,in utero embryonic development,BP,KRT8;EDN1;JUNB;PHLDA2;NBN;EGLN1;NR2F2;CTR9;MAFF;SEC24D;MYH9
319,GO:0000836,0.145674475948258,0.990997151154266,1,5,Hrd1p ubiquitin ligase complex,CC,SEL1L
6379,GO:0021604,0.145738635324008,0.990988960479131,1,5,cranial nerve structural organization,BP,NRP1
6381,GO:0021612,0.145738635324008,0.990988960479131,1,5,facial nerve structural organization,BP,NRP1
13143,GO:0051788,0.14577577820359,0.971205561509404,2,22,response to misfolded protein,BP,UGGT1;SDF2L1
612,GO:0001781,0.145825672417638,0.990977842858203,1,5,neutrophil apoptotic process,BP,ANXA1
8227,GO:0033029,0.145825672417638,0.990977842858203,1,5,regulation of neutrophil apoptotic process,BP,ANXA1
16053,GO:0090074,0.145853331700711,0.99097430828985,1,5,negative regulation of protein homodimerization activity,BP,HSPA5
16837,GO:0098814,0.14587675977837,0.990971313848367,1,5,spontaneous synaptic transmission,BP,RIMS2
7967,GO:0032607,0.145882802820801,0.971171726006089,2,22,interferon-alpha production,BP,RIPK2;HSPD1
19050,GO:1904994,0.145911470421725,0.990966876361434,1,5,regulation of leukocyte adhesion to vascular endothelial cell,BP,ETS1
15381,GO:0071692,0.146097968589776,0.99094301411921,1,5,protein localization to extracellular region,BP,FBN2
15382,GO:0071694,0.146097968589776,0.99094301411921,1,5,maintenance of protein location in extracellular region,BP,FBN2
6257,GO:0019870,0.146196235618725,0.990930427460171,1,5,potassium channel inhibitor activity,MF,NEDD4L
17250,GO:0140059,0.146217983250807,0.990927640627596,1,5,dendrite arborization,BP,NRP1
12903,GO:0051302,0.146219154812206,0.934082177940988,6,116,regulation of cell division,BP,IL1A;FGF5;IL1B;VEGFC;CXCR5;TGFA
3966,GO:0008823,0.146331947055562,0.990913029366998,1,5,cupric reductase activity,MF,STEAP4
13404,GO:0052851,0.146331947055562,0.990913029366998,1,5,ferric-chelate reductase (NADPH) activity,MF,STEAP4
14561,GO:0070162,0.146451748995521,0.990897656087927,1,5,adiponectin secretion,BP,IL1B
14562,GO:0070163,0.146451748995521,0.990897656087927,1,5,regulation of adiponectin secretion,BP,IL1B
8328,GO:0033216,0.14658047811842,0.99088112181097,1,5,ferric iron import,BP,STEAP4
1985,GO:0004720,0.146633342255081,0.990874327181116,1,5,protein-lysine 6-oxidase activity,MF,LOX
11297,GO:0045657,0.146645626878087,0.990872747851644,1,5,positive regulation of monocyte differentiation,BP,JUN
9024,GO:0035270,0.14675569475582,0.94710516267884,4,66,endocrine system development,BP,ANXA1;CITED2;ETS1;CDK6
20186,GO:2001166,0.146808302012019,0.990851820353397,1,5,regulation of histone H2B ubiquitination,BP,CTR9
7897,GO:0032494,0.147054952314724,0.990820041039765,1,5,response to peptidoglycan,BP,RIPK2
19656,GO:2000018,0.147152256340174,0.990807487874353,1,5,regulation of male gonad development,BP,CITED2
10411,GO:0043301,0.147188905838676,0.990802757361189,1,5,negative regulation of leukocyte degranulation,BP,HMOX1
2537,GO:0005826,0.147257708257188,0.990793873223075,1,5,actomyosin contractile ring,CC,MYH9
14017,GO:0060836,0.147380737927134,0.99077797556775,1,5,lymphatic endothelial cell differentiation,BP,NR2F2
402,GO:0001083,0.147530818590053,0.990758562628462,1,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,TP53
574,GO:0001726,0.147557923962724,0.928545012161962,7,139,ruffle,CC,LCP1;ITGAV;WWC1;HSP90AA1;CDK6;EPHA2;MYH9
17811,GO:1902041,0.147592312093557,0.956615853974887,3,44,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;ATF3;HMOX1
9608,GO:0036507,0.147632791380735,0.970616205497015,2,22,protein demannosylation,BP,UGGT1;SEL1L
9609,GO:0036508,0.147632791380735,0.970616205497015,2,22,protein alpha-1,2-demannosylation,BP,UGGT1;SEL1L
9814,GO:0042090,0.147855489813101,0.990716491887804,1,5,interleukin-12 biosynthetic process,BP,NFKB1
11041,GO:0045075,0.147855489813101,0.990716491887804,1,5,regulation of interleukin-12 biosynthetic process,BP,NFKB1
4219,GO:0009416,0.147870248680873,0.918000992434315,10,223,response to light stimulus,BP,NETO1;TP53;PARP1;DUSP1;DCUN1D3;PPID;HMGCS1;MME;NEDD4;PML
10402,GO:0043281,0.147892184661416,0.9242826018988,8,174,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,MMP9;PMAIP1;HERPUD1;CRYAB;BIRC3;TNFSF15;PML;HSPD1
7779,GO:0032350,0.148034222101217,0.970488172476652,2,22,regulation of hormone metabolic process,BP,NFKB1;IL1B
19924,GO:2000535,0.148108940201426,0.990683579058306,1,5,regulation of entry of bacterium into host cell,BP,ITGAV
5616,GO:0016717,0.148300604910073,0.99065864839233,1,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,FADS1
10565,GO:0043568,0.148452178174199,0.990638907423169,1,5,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP3
13595,GO:0060135,0.148604418946801,0.956223423442592,3,43,maternal process involved in female pregnancy,BP,JUNB;ARG1;NR2F2
7061,GO:0030870,0.148630020775002,0.990615716771163,1,5,Mre11 complex,CC,NBN
97,GO:0000188,0.148679068512234,0.97019906816667,2,23,inactivation of MAPK activity,BP,DUSP8;DUSP1
12957,GO:0051414,0.14879696290219,0.990593919676306,1,5,response to cortisol,BP,SLIT2
17972,GO:1902495,0.14888442914371,0.932553084443032,6,115,transmembrane transporter complex,CC,HERPUD1;CNTNAP1;KCNQ5;CLCC1;STXBP5;DLG1
8313,GO:0033184,0.149043811651133,0.99056163997218,1,5,positive regulation of histone ubiquitination,BP,CTR9
12056,GO:0048069,0.149110339097891,0.990552930271197,1,5,eye pigmentation,BP,SPNS2
16554,GO:0097418,0.149225483842806,0.990537845512979,1,5,neurofibrillary tangle,CC,NEFM
16566,GO:0097443,0.149355064288449,0.990520854214036,1,5,sorting endosome,CC,NRP1
19862,GO:2000394,0.149415604387838,0.990512910286787,1,5,positive regulation of lamellipodium morphogenesis,BP,CORO1C
11531,GO:0046113,0.149502854686625,0.990501455261829,1,5,nucleobase catabolic process,BP,GDA
11324,GO:0045719,0.14962040381053,0.990486010658958,1,5,negative regulation of glycogen biosynthetic process,BP,ENPP1
14928,GO:0070874,0.14962040381053,0.990486010658958,1,5,negative regulation of glycogen metabolic process,BP,ENPP1
19762,GO:2000249,0.149655626014675,0.969884978602892,2,23,regulation of actin cytoskeleton reorganization,BP,NRP1;ARHGDIB
600,GO:0001768,0.149809611416524,0.990461122818931,1,5,establishment of T cell polarity,BP,MYH9
17852,GO:1902175,0.149949691549147,0.96979013831915,2,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,PARP1;SOD2
18468,GO:1903670,0.150240644694681,0.955524936520147,3,43,regulation of sprouting angiogenesis,BP,ANXA1;HMOX1;NRP1
4281,GO:0009743,0.150250301101419,0.926864317769079,7,144,response to carbohydrate,BP,LGALS1;IL1B;LYN;SLC8A1;XBP1;EIF2B1;OXCT1
9516,GO:0036302,0.150458960274103,0.990375445196071,1,5,atrioventricular canal development,BP,HAS2
573,GO:0001725,0.150581958756254,0.955378761202272,3,43,stress fiber,CC,LCP1;MYH9;TPM4
16607,GO:0097517,0.150581958756254,0.955378761202272,3,43,contractile actin filament bundle,CC,LCP1;MYH9;TPM4
18944,GO:1904778,0.15084273114693,0.990324616566455,1,5,positive regulation of protein localization to cell cortex,BP,EPB41L2
4671,GO:0010838,0.15084933632366,0.990323740490265,1,5,positive regulation of keratinocyte proliferation,BP,HAS2
7046,GO:0030853,0.150880189562244,0.990319647716401,1,5,negative regulation of granulocyte differentiation,BP,TRIB1
8012,GO:0032680,0.150959181843063,0.944981977263211,4,68,regulation of tumor necrosis factor production,BP,RIPK2;AXL;SYT11;IL23A
6103,GO:0019369,0.150994825042511,0.96945209434507,2,23,arachidonic acid metabolic process,BP,MGLL;CYP1A1
1106,GO:0002702,0.151172291241702,0.955049457535115,3,45,positive regulation of production of molecular mediator of immune response,BP,SEMA7A;XBP1;TFRC
6495,GO:0021891,0.151400699731612,0.990250461092075,1,5,olfactory bulb interneuron development,BP,SLIT2
18130,GO:1902936,0.151419637898781,0.944775080847168,4,67,phosphatidylinositol bisphosphate binding,MF,MYO1B;ANXA8;PLEKHA2;DAPP1
3143,GO:0006766,0.151569670857237,0.936974657102246,5,94,vitamin metabolic process,BP,NFKB1;IL1B;THTPA;ENPP1;CYP1A1
15130,GO:0071300,0.15182419106605,0.954806217531525,3,44,cellular response to retinoic acid,BP,KRT13;LYN;SETX
7252,GO:0031252,0.15185540686477,0.90834016955061,13,301,cell leading edge,CC,LCP1;DPYSL3;ITGAV;WWC1;HSP90AA1;NRG1;AJUBA;SLC39A14;CORO1C;CDK6;EPHA2;MYH9;SORBS2
13919,GO:0060666,0.152066640932132,0.990161559653647,1,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,NRP1
633,GO:0001826,0.152069556547086,0.990161169478215,1,5,inner cell mass cell differentiation,BP,CTR9
11727,GO:0046621,0.152459240090871,0.969062005050465,2,22,negative regulation of organ growth,BP,G6PD;WWC1
16795,GO:0098739,0.152462231919623,0.954570578579802,3,43,import across plasma membrane,BP,SLC8A1;STEAP4;SLC39A14
15188,GO:0071384,0.152607618414328,0.954430849172109,3,45,cellular response to corticosteroid stimulus,BP,EDN1;ANXA1;ARG1
5653,GO:0016782,0.152950488834259,0.95424661565389,3,46,transferase activity, transferring sulfur-containing groups,MF,HS3ST1;MOCS2;OXCT1
17329,GO:1900087,0.153508674203356,0.968632786113411,2,23,positive regulation of G1/S transition of mitotic cell cycle,BP,ANXA1;CYP1A1
14388,GO:0061734,0.153610526756521,0.989953794564235,1,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,OPTN
2499,GO:0005766,0.153831648985239,0.929605073287728,6,121,primary lysosome,CC,B4GALT1;HRNR;ARG1;MAGT1;DNAJC3;CPPED1
10051,GO:0042582,0.153831648985239,0.929605073287728,6,121,azurophil granule,CC,B4GALT1;HRNR;ARG1;MAGT1;DNAJC3;CPPED1
3158,GO:0006787,0.153885290655811,0.989515790911813,1,6,porphyrin-containing compound catabolic process,BP,HMOX1
8219,GO:0033015,0.153885290655811,0.989515790911813,1,6,tetrapyrrole catabolic process,BP,HMOX1
9858,GO:0042167,0.153885290655811,0.989515790911813,1,6,heme catabolic process,BP,HMOX1
11550,GO:0046149,0.153885290655811,0.989515790911813,1,6,pigment catabolic process,BP,HMOX1
6633,GO:0030001,0.154194748853237,0.898780441124587,18,450,metal ion transport,BP,NETO1;IL16;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;HEPHL1;FTH1;KCNQ5;STEAP4;SLC39A14;MAGT1;DLG1;TFRC;NEDD4;PML
10870,GO:0044449,0.154340148354276,0.929339315126592,6,118,contractile fiber part,CC,KRT8;CRYAB;SLC8A1;SORBS2;TPM4;PARVA
11591,GO:0046330,0.15449156357323,0.935417411138033,5,91,positive regulation of JNK cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B
5140,GO:0015696,0.154840835650352,0.953462660616296,3,45,ammonium transport,BP,EDN1;LYN;HTR1B
12995,GO:0051491,0.154880057317404,0.968270298450178,2,22,positive regulation of filopodium assembly,BP,DPYSL3;NRP1
2399,GO:0005587,0.155204992888246,0.989736783173,1,5,collagen type IV trimer,CC,COL4A4
11831,GO:0046872,0.155250511397227,0.87180346266071,99,2929,metal ion binding,MF,RPTN;MMP9;IL1A;FLG2;TRIM16;TCHH;OSR2;LCP1;B4GALT1;TP53;FLG;SLIT2;PEG10;CCBE1;ZNF165;PARP1;OPTN;HRNR;HSPA5;MSRB3;ANPEP;EFHD2;CRYAB;CREB5;NOCT;ERAP1;CYLD;FBN2;STAC;ANXA8;STT3A;ITGAV;C1R;ANXA1;PDE1C;SLC8A1;THTPA;BIRC3;ARG1;TRAF3;CSRP1;HMOX1;MMP19;SYT11;ZNF638;FRAS1;HEPHL1;RIMS2;CANX;FTH1;NRP1;TRAF1;EGLN1;GNPTAB;SOD2;ZNF132;KLF10;ACO1;ZNF697;SNAI3;ADAM8;NR2F2;STEAP4;MOB3A;CALR;AJUBA;IGFBP3;EYA3;ZCCHC8;GIT2;NID2;MME;TRMT44;NGLY1;GDA;EHD1;ZMYM4;LOX;ZNF814;ADGRL3;TYW1;SEC24D;CALU;MSMO1;CHORDC1;CBLL1;RSPRY1;ZC3H7B;HSP90B1;ZFP42;PML;GALNT14;TRIM47;ZBTB21;CPPED1;ENPP1;TPM4;CYP1A1;TMPPE
16847,GO:0098831,0.15552796390805,0.989692523487587,1,5,presynaptic active zone cytoplasmic component,CC,RIMS2
12052,GO:0048048,0.155692978651704,0.968002623213457,2,22,embryonic eye morphogenesis,BP,FBN2;SOX11
7970,GO:0032610,0.155743114330908,0.989252377241835,1,6,interleukin-1 alpha production,BP,NLRP10
3588,GO:0008038,0.156270205513184,0.967812002705245,2,22,neuron recognition,BP,DSCAM;NRP1
12797,GO:0051147,0.156297193066958,0.934390800951119,5,93,regulation of muscle cell differentiation,BP,EDN1;G6PD;XBP1;NRG1;EHD1
13870,GO:0060562,0.156551961901157,0.91217738436565,10,221,epithelial tube morphogenesis,BP,B4GALT1;EDN1;SLIT2;RHOB;NRP1;DLG1;PML;EPHA2;SOX11;MAGED1
10639,GO:0043903,0.156656579205499,0.918701136301197,8,175,regulation of symbiosis, encompassing mutualism through parasitism,BP,LGALS1;TNIP1;JUN;IFITM2;ITGAV;ARG1;PPID;PML
20227,GO:2001235,0.156945821808481,0.922702681971203,7,150,positive regulation of apoptotic signaling pathway,BP,MMP9;TP53;PMAIP1;ATF3;CYLD;PML;MAGED1
11017,GO:0045040,0.157150130467538,0.989050555641634,1,6,protein import into mitochondrial outer membrane,BP,HSP90AA1
17498,GO:1901068,0.15752775142686,0.95225117923776,3,46,guanosine-containing compound metabolic process,BP,TJP2;MOCS2;DLG1
72,GO:0000149,0.157661028387591,0.933635904124572,5,93,SNARE binding,MF,SYT11;STXBP5;SEC22A;SEC24D;TNFAIP2
1102,GO:0002698,0.157743439927922,0.941530943586278,4,70,negative regulation of immune effector process,BP,ANXA1;ARG1;HMOX1;IL7R
13103,GO:0051709,0.157822809146104,0.988953357278757,1,6,regulation of killing of cells of other organism,BP,ARG1
13105,GO:0051712,0.157822809146104,0.988953357278757,1,6,positive regulation of killing of cells of other organism,BP,ARG1
11421,GO:0045912,0.157888290026707,0.967184484254183,2,23,negative regulation of carbohydrate metabolic process,BP,ENPP1;MIDN
14466,GO:0062013,0.158065067989896,0.933411812739914,5,93,positive regulation of small molecule metabolic process,BP,NFKB1;PMAIP1;IL1B;ANXA1;HAS2
17683,GO:1901653,0.158264047261289,0.90828435307995,11,253,cellular response to peptide,BP,NFKB1;EDN1;TP53;RIPK2;PARP1;IL1B;LYN;XBP1;ARG1;KLF10;ENPP1
14308,GO:0061564,0.158362825416968,0.901774261891885,14,330,axon development,BP,NEFL;DSCAM;NEFM;FEZ1;SLIT2;JUN;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;L1CAM;TUBB3;NTNG1
13160,GO:0051818,0.158818691496818,0.988808613569126,1,6,disruption of cells of other organism involved in symbiotic interaction,BP,ARG1
13182,GO:0051883,0.158818691496818,0.988808613569126,1,6,killing of cells in other organism involved in symbiotic interaction,BP,ARG1
467,GO:0001508,0.158983818967227,0.940970085247069,4,67,action potential,BP,CNTNAP1;SLC8A1;NEDD4L;DLG1
13714,GO:0060331,0.159057040347682,0.988773821843516,1,6,negative regulation of response to interferon-gamma,BP,ARG1
13719,GO:0060336,0.159057040347682,0.988773821843516,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,ARG1
19240,GO:1905477,0.159230975153388,0.932748605599864,5,94,positive regulation of protein localization to membrane,BP,TP53;PMAIP1;STAC;DLG1;EPHA2
16406,GO:0097110,0.159397642436349,0.951465692516634,3,45,scaffold protein binding,MF,KRT8;KRT18;HSP90AA1
362,GO:0000981,0.159413891512911,0.88619974670691,27,712,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;CREB5;EHF;NOC3L;XBP1;ARNTL2;KLF10;VGLL3;SNAI3;NR2F2;MAFF;MGA;UBP1;ZMYM4;ETS1;ZFP42;HES4;SOX11
6016,GO:0019103,0.159568466539992,0.988698973944391,1,6,pyrimidine nucleotide binding,MF,HSP90AB1
9513,GO:0036296,0.159661616498494,0.966506196969566,2,24,response to increased oxygen levels,BP,TP53;CYP1A1
4039,GO:0009101,0.159986481952224,0.90708615034777,11,254,glycoprotein biosynthetic process,BP,TNIP1;B4GALT1;STT3A;DERL3;UGGT1;MGAT5;SERP1;MAGT1;DHDDS;GALNT14;SDF2L1
15838,GO:0072608,0.160145860606433,0.988614151431092,1,6,interleukin-10 secretion,BP,CD274
7931,GO:0032552,0.160191329059501,0.988607457424814,1,6,deoxyribonucleotide binding,MF,HSP90AB1
12838,GO:0051208,0.160246168696513,0.940303803760232,4,68,sequestering of calcium ion,BP,LYN;SLC8A1;CALR;HSP90B1
12071,GO:0048147,0.160252809215434,0.96630675672422,2,24,negative regulation of fibroblast proliferation,BP,TP53;FTH1
14082,GO:0060986,0.160304850325527,0.966374013800414,2,23,endocrine hormone secretion,BP,IL1B;C1QTNF1
12269,GO:0048644,0.160329276443298,0.951093988550683,3,44,muscle organ morphogenesis,BP,EGLN1;NRG1;SERP1
5483,GO:0016445,0.160693887564693,0.950892404317115,3,45,somatic diversification of immunoglobulins,BP,NBN;TFRC;HSPD1
16173,GO:0090257,0.160702515219844,0.925572565441563,6,119,regulation of muscle system process,BP,EDN1;PARP1;IL6ST;G6PD;SLC8A1;DLG1
7059,GO:0030867,0.160957505153849,0.965990064088071,2,25,rough endoplasmic reticulum membrane,CC,DERL3;DNAJC3
67,GO:0000138,0.16124427671757,0.988451849507241,1,6,Golgi trans cisterna,CC,B4GALT1
159,GO:0000323,0.161276729834502,0.890997375556082,20,518,lytic vacuole,CC,B4GALT1;SPNS2;HRNR;IL1B;ANPEP;PLBD1;LYN;AP3M1;ANXA1;ARG1;SYT11;HSP90AA1;FTH1;HSP90AB1;ADAM8;IFNAR1;MAGT1;DNAJC3;CPPED1;ENPP1
2497,GO:0005764,0.161276729834502,0.890997375556082,20,518,lysosome,CC,B4GALT1;SPNS2;HRNR;IL1B;ANPEP;PLBD1;LYN;AP3M1;ANXA1;ARG1;SYT11;HSP90AA1;FTH1;HSP90AB1;ADAM8;IFNAR1;MAGT1;DNAJC3;CPPED1;ENPP1
16021,GO:0089720,0.161388257268972,0.988430483688888,1,6,caspase binding,MF,RIPK2
2553,GO:0005851,0.161500676377013,0.988413786678289,1,6,eukaryotic translation initiation factor 2B complex,CC,EIF2B1
506,GO:0001569,0.161623436019104,0.965928394732902,2,23,branching involved in blood vessel morphogenesis,BP,EDN1;NRP1
2032,GO:0004791,0.161735754038995,0.988378830136917,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD1
4797,GO:0014009,0.161747285398769,0.96588641677093,2,23,glial cell proliferation,BP,LYN;SOX11
13987,GO:0060753,0.161774072235584,0.988373126790744,1,6,regulation of mast cell chemotaxis,BP,VEGFC
18202,GO:1903053,0.161930432263101,0.965824301680667,2,23,regulation of extracellular matrix organization,BP,ETS1;HAS2
14249,GO:0061384,0.161981730987859,0.965806895225001,2,23,heart trabecula morphogenesis,BP,EGLN1;NRG1
15122,GO:0071281,0.162088664711481,0.98832624559295,1,6,cellular response to iron ion,BP,HMOX1
5674,GO:0016813,0.16210447637837,0.988323886637696,1,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,ARG1
631,GO:0001824,0.162125912658569,0.950217531124591,3,46,blastocyst development,BP,JUNB;NBN;CTR9
4353,GO:0009988,0.162127914672346,0.96559182068622,2,25,cell-cell recognition,BP,B4GALT1;DLG1
18199,GO:1903050,0.162299193879355,0.915066371173788,8,175,regulation of proteolysis involved in cellular protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;DERL3;XBP1;HSP90AB1;SVIP;PML
84,GO:0000172,0.162354249636276,0.988286588864022,1,6,ribonuclease MRP complex,CC,POP4
16803,GO:0098754,0.162586021944581,0.938975447756887,4,74,detoxification,BP,GPX8;SOD2;TXNRD1;MGST3
5378,GO:0016234,0.162674965429803,0.93906151659729,4,68,inclusion body,CC,NEFM;HERPUD1;NBN;HSP90AB1
12843,GO:0051220,0.16277092080437,0.96545187408217,2,24,cytoplasmic sequestering of protein,BP,NFKBIA;NFKBIE
1036,GO:0002562,0.162882409317242,0.949919265043244,3,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,NBN;TFRC;HSPD1
5482,GO:0016444,0.162882409317242,0.949919265043244,3,45,somatic cell DNA recombination,BP,NBN;TFRC;HSPD1
11357,GO:0045776,0.162914935117084,0.965402718422769,2,24,negative regulation of blood pressure,BP,VEGFC;SOD2
19697,GO:2000109,0.163062038188269,0.988180550732922,1,6,regulation of macrophage apoptotic process,BP,CDKN2A
15865,GO:0072678,0.163077976737627,0.965347033864851,2,24,T cell migration,BP,CXCL16;ADAM8
1271,GO:0003084,0.163320151466984,0.988141753662844,1,6,positive regulation of systemic arterial blood pressure,BP,NR2F2
9344,GO:0035900,0.1634552159367,0.988121424908647,1,6,response to isolation stress,BP,LGALS1
10316,GO:0043154,0.163775275916852,0.938426874546918,4,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,MMP9;HERPUD1;CRYAB;BIRC3
3363,GO:0007156,0.163836870864054,0.938514326723823,4,66,homophilic cell adhesion via plasma membrane adhesion molecules,BP,TENM3;DSCAM;SDK1;PVR
5327,GO:0016093,0.163939031992511,0.988048451715807,1,6,polyprenol metabolic process,BP,DHDDS
18595,GO:1903935,0.164204533161436,0.988008304693479,1,6,response to sodium arsenite,BP,NEFL
10526,GO:0043516,0.164326487654834,0.964919412061078,2,24,regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1;PTTG1IP
8275,GO:0033131,0.164646605744656,0.98794129759252,1,6,regulation of glucokinase activity,BP,MIDN
10824,GO:0044359,0.164863739465382,0.987908312179073,1,6,modulation of molecular function in other organism,BP,SUGT1
13284,GO:0052205,0.164863739465382,0.987908312179073,1,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,SUGT1
9020,GO:0035265,0.164922466772868,0.929593659171745,5,92,organ growth,BP,EDN1;G6PD;WWC1;SERP1;SORBS2
9270,GO:0035745,0.165021448900283,0.987884323757111,1,6,T-helper 2 cell cytokine production,BP,ARG1
19548,GO:1990668,0.165120225700183,0.987869286295591,1,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,CALR
13729,GO:0060348,0.165615763956411,0.922650889984072,6,118,bone development,BP,OSR2;SPNS2;TJP2;PAPSS2;SERPINH1;HAS2
5192,GO:0015809,0.165625474345125,0.987792212234622,1,6,arginine transport,BP,ARG1
11266,GO:0045620,0.165706386202357,0.964444300114228,2,24,negative regulation of lymphocyte differentiation,BP,CYLD;ANXA1
12920,GO:0051342,0.165713651481638,0.987778734229632,1,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,EGLN1
15262,GO:0071493,0.165850175847951,0.987757850523793,1,6,cellular response to UV-B,BP,MME
12620,GO:0050864,0.165931739101347,0.937336003814142,4,70,regulation of B cell activation,BP,CYLD;LYN;XBP1;TFRC
15864,GO:0072677,0.166168495737549,0.987709083744413,1,6,eosinophil migration,BP,ADAM8
15706,GO:0072332,0.166205646434475,0.937149178198381,4,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,TP53;PMAIP1;PTTG1IP;PML
12214,GO:0048525,0.166581471934,0.93697650694474,4,71,negative regulation of viral process,BP,TNIP1;JUN;IFITM2;PML
14029,GO:0060850,0.166586459867905,0.987644893254853,1,6,regulation of transcription involved in cell fate commitment,BP,NR2F2
12588,GO:0050815,0.166756313280545,0.987618756012706,1,6,phosphoserine residue binding,MF,NEDD4
11071,GO:0045121,0.166892713775044,0.908336916667517,9,200,membrane raft,CC,PGK1;EFHD2;STOML1;LYN;BIRC3;HMOX1;SERPINH1;CORO1C;DLG1
6733,GO:0030174,0.166955195909867,0.987588114001291,1,6,regulation of DNA-dependent DNA replication initiation,BP,NBN
5839,GO:0017157,0.167063864982493,0.921745688836034,6,121,regulation of exocytosis,BP,LYN;ANXA1;HMOX1;SYT11;RIMS2;STXBP5
4876,GO:0014820,0.167151682808688,0.98755780113484,1,6,tonic smooth muscle contraction,BP,EDN1
367,GO:0000989,0.167213808222561,0.8864129747142,20,517,transcription factor activity, transcription factor binding,MF,RELB;TP53;DNAJB1;JUN;NFKB2;JUNB;ATF3;WWC1;NRG1;SDR16C5;NR2F2;AJUBA;UBP1;MED18;CITED2;ZFP42;SOX11;SND1;MAGED1;SUPT3H
10694,GO:0044068,0.167225360977787,0.963918284866555,2,24,modulation by symbiont of host cellular process,BP,TNIP1;ITGAV
15941,GO:0080154,0.167381531554081,0.987522290965059,1,6,regulation of fertilization,BP,B4GALT1
15192,GO:0071389,0.167425981380013,0.987515417473557,1,6,cellular response to mineralocorticoid stimulus,BP,EDN1
11817,GO:0046835,0.167618806915726,0.963781520818652,2,24,carbohydrate phosphorylation,BP,NAGK;GNPTAB
3185,GO:0006833,0.167641170644712,0.987482112951052,1,6,water transport,BP,HAS2
13741,GO:0060368,0.167650562689594,0.987480658272111,1,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,LYN
8591,GO:0034135,0.167701393847058,0.98747278375471,1,6,regulation of toll-like receptor 2 signaling pathway,BP,LYN
6734,GO:0030175,0.167726413440867,0.936453104310997,4,68,filopodium,CC,LCP1;B4GALT1;MYO1B;ITGAV
9665,GO:0038092,0.16782682075127,0.987453341838332,1,6,nodal signaling pathway,BP,CITED2
13169,GO:0051851,0.16787363337652,0.947595949824122,3,47,modification by host of symbiont morphology or physiology,BP,JUN;ARG1;SUGT1
39,GO:0000079,0.167884447632698,0.936277158640848,4,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CDKN2A;CDKN2B;NR2F2;CDK6
13447,GO:0055025,0.168056990725651,0.963628956295756,2,24,positive regulation of cardiac muscle tissue development,BP,EDN1;NRG1
3150,GO:0006777,0.168272331496399,0.987384153980038,1,6,Mo-molybdopterin cofactor biosynthetic process,BP,MOCS2
6189,GO:0019720,0.168272331496399,0.987384153980038,1,6,Mo-molybdopterin cofactor metabolic process,BP,MOCS2
7988,GO:0032640,0.168276748064478,0.936095353497472,4,71,tumor necrosis factor production,BP,RIPK2;AXL;SYT11;IL23A
3099,GO:0006692,0.168435421008081,0.963413193197981,2,25,prostanoid metabolic process,BP,EDN1;ANXA1
3100,GO:0006693,0.168435421008081,0.963413193197981,2,25,prostaglandin metabolic process,BP,EDN1;ANXA1
2648,GO:0006011,0.168494977347101,0.987349500390786,1,6,UDP-glucose metabolic process,BP,UGGT1
4666,GO:0010832,0.16881610088224,0.987299429261622,1,6,negative regulation of myotube differentiation,BP,XBP1
5822,GO:0017128,0.169235717114065,0.987233840336564,1,6,phospholipid scramblase activity,MF,ANO4
3116,GO:0006720,0.169412985523496,0.93548001487817,4,72,isoprenoid metabolic process,BP,SDR16C5;HMGCS1;DHDDS;CYP1A1
9689,GO:0038155,0.169619251637919,0.987173732248128,1,6,interleukin-23-mediated signaling pathway,BP,IL23A
10182,GO:0042834,0.169629283752664,0.987172157961925,1,6,peptidoglycan binding,MF,RNASE7
4646,GO:0010812,0.169639437021307,0.946873542381125,3,45,negative regulation of cell-substrate adhesion,BP,CDKN2A;LGALS1;CORO1C
16838,GO:0098815,0.169642745145036,0.963074642284766,2,24,modulation of excitatory postsynaptic potential,BP,NETO1;RIMS2
4606,GO:0010744,0.169668945590886,0.987165933023568,1,6,positive regulation of macrophage derived foam cell differentiation,BP,NFKB1
11202,GO:0045410,0.169689631427702,0.987162685730083,1,6,positive regulation of interleukin-6 biosynthetic process,BP,IL1B
11422,GO:0045913,0.169882963925027,0.946762617701558,3,45,positive regulation of carbohydrate metabolic process,BP,NFKB1;PMAIP1;HAS2
19370,GO:1905941,0.170029705238857,0.987109237064963,1,6,positive regulation of gonad development,BP,CITED2
11263,GO:0045617,0.17022228167171,0.987078917245451,1,6,negative regulation of keratinocyte differentiation,BP,CDSN
602,GO:0001771,0.170269566546544,0.987071466709283,1,6,immunological synapse formation,BP,DLG1
8543,GO:0034036,0.170424402896351,0.987047053432122,1,6,purine ribonucleoside bisphosphate biosynthetic process,BP,PAPSS2
12442,GO:0050428,0.170424402896351,0.987047053432122,1,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,PAPSS2
7310,GO:0031340,0.170438265098539,0.987044866549188,1,6,positive regulation of vesicle fusion,BP,ANXA1
9067,GO:0035358,0.170497340942257,0.987035544593381,1,6,regulation of peroxisome proliferator activated receptor signaling pathway,BP,CITED2
16861,GO:0098857,0.170499848988214,0.905903577550624,9,201,membrane microdomain,CC,PGK1;EFHD2;STOML1;LYN;BIRC3;HMOX1;SERPINH1;CORO1C;DLG1
16675,GO:0097709,0.170503707242768,0.987034539798633,1,6,connective tissue replacement,BP,IL1A
18151,GO:1902961,0.170764005668091,0.986993420940947,1,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,LYN
19140,GO:1905247,0.170764005668091,0.986993420940947,1,6,positive regulation of aspartic-type peptidase activity,BP,LYN
8675,GO:0034340,0.170986032672194,0.934634231626147,4,73,response to type I interferon,BP,IFITM2;IKBKE;HSP90AB1;IFNAR1
2083,GO:0004860,0.17099223180186,0.934653257529492,4,72,protein kinase inhibitor activity,MF,CDKN2A;CDKN2B;TRIB1;DNAJC3
14018,GO:0060837,0.17103679841202,0.98695025315913,1,6,blood vessel endothelial cell differentiation,BP,NRP1
3188,GO:0006837,0.171036900705702,0.986950236957338,1,6,serotonin transport,BP,HTR1B
11257,GO:0045604,0.171064735725934,0.946141734816383,3,47,regulation of epidermal cell differentiation,BP,TRIM16;CDSN;MAFF
13446,GO:0055024,0.17123078910583,0.946105553454064,3,46,regulation of cardiac muscle tissue development,BP,EDN1;G6PD;NRG1
15308,GO:0071578,0.171243446275046,0.986917501135503,1,6,zinc ion import across plasma membrane,BP,SLC39A14
7623,GO:0032056,0.171310791560948,0.986906817899437,1,6,positive regulation of translation in response to stress,BP,DNAJC3
1519,GO:0003910,0.171547988878707,0.986869153000702,1,6,DNA ligase (ATP) activity,MF,PARP1
15890,GO:0072719,0.171578793723055,0.986864257181188,1,6,cellular response to cisplatin,BP,HMOX1
11730,GO:0046624,0.171828201252195,0.986824582603213,1,6,sphingolipid transporter activity,MF,SPNS2
3377,GO:0007171,0.171905775224911,0.986812229361395,1,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,NRG1
3678,GO:0008200,0.172035406594218,0.9621453065304,2,25,ion channel inhibitor activity,MF,NEDD4L;NEDD4
11842,GO:0046886,0.172092808473564,0.9867824196719,1,6,positive regulation of hormone biosynthetic process,BP,IL1B
18172,GO:1903003,0.172110465983313,0.986779603513958,1,6,positive regulation of protein deubiquitination,BP,TNIP1
15345,GO:0071635,0.172262289786109,0.986755376129328,1,6,negative regulation of transforming growth factor beta production,BP,HSP90AB1
13558,GO:0060068,0.172270304404393,0.986754096527296,1,6,vagina development,BP,AXL
15127,GO:0071287,0.172280961927369,0.986752394859884,1,6,cellular response to manganese ion,BP,HSPA5
11339,GO:0045741,0.1724267872101,0.986729099371675,1,6,positive regulation of epidermal growth factor-activated receptor activity,BP,TGFA
17979,GO:1902513,0.172537895768403,0.986711335055691,1,6,regulation of organelle transport along microtubule,BP,FEZ1
15407,GO:0071763,0.172544423828988,0.986710290934743,1,6,nuclear membrane organization,BP,TOR1AIP1
8216,GO:0033010,0.17264273038767,0.986694562093995,1,6,paranodal junction,CC,CNTNAP1
3386,GO:0007182,0.172800592686481,0.986669283488009,1,6,common-partner SMAD protein phosphorylation,BP,PML
12784,GO:0051129,0.172832134543661,0.883273333971805,19,488,negative regulation of cellular component organization,BP,LGALS1;FEZ1;DPYSL3;SLIT2;UBQLN2;CLDN7;DNAJB1;PARP1;CRYAB;SEMA7A;DUSP1;NBN;SEMA3D;SYT11;NRP1;IFRD1;SDR16C5;CORO1C;SVIP
9864,GO:0042177,0.172965707375538,0.924924376266973,5,98,negative regulation of protein catabolic process,BP,DERL3;NRG1;HSP90AB1;SVIP;PML
9170,GO:0035581,0.172984310232127,0.986639832109168,1,6,sequestering of extracellular ligand from receptor,BP,FBN2
8486,GO:0033690,0.173332667745282,0.986583891457422,1,6,positive regulation of osteoblast proliferation,BP,ITGAV
13048,GO:0051597,0.173429516777934,0.98656831666902,1,6,response to methylmercury,BP,ARG1
16489,GO:0097264,0.173497756867914,0.986557336782021,1,6,self proteolysis,BP,TENM3
6634,GO:0030002,0.173545596293214,0.986549636495427,1,6,cellular anion homeostasis,BP,ENPP1
6831,GO:0030320,0.173545596293214,0.986549636495427,1,6,cellular monovalent inorganic anion homeostasis,BP,ENPP1
6856,GO:0030368,0.173658001513474,0.986531534273601,1,6,interleukin-17 receptor activity,MF,IL6ST
6918,GO:0030546,0.17372537107001,0.986520678499376,1,6,receptor activator activity,MF,NRG1
2019,GO:0004771,0.173766447382165,0.986514057243893,1,6,sterol esterase activity,MF,NCEH1
318,GO:0000835,0.173835303127249,0.986502954178258,1,6,ER ubiquitin ligase complex,CC,SEL1L
3489,GO:0007411,0.173944761165462,0.907492586596367,8,170,axon guidance,BP,DSCAM;FEZ1;SLIT2;SEMA7A;SEMA3D;NRP1;L1CAM;TUBB3
6357,GO:0021561,0.173981900036772,0.986479298854539,1,6,facial nerve development,BP,NRP1
6380,GO:0021610,0.173981900036772,0.986479298854539,1,6,facial nerve morphogenesis,BP,NRP1
6494,GO:0021889,0.174092264845281,0.986461475317547,1,6,olfactory bulb interneuron differentiation,BP,SLIT2
10394,GO:0043271,0.174375720513253,0.932894620378614,4,71,negative regulation of ion transport,BP,MMP9;NEDD4L;HTR1B;NEDD4
13440,GO:0055017,0.174494184674565,0.944604447329393,3,46,cardiac muscle tissue growth,BP,EDN1;G6PD;SORBS2
663,GO:0001871,0.174575677832691,0.98638325658653,1,6,pattern binding,MF,ENPP1
6783,GO:0030247,0.174575677832691,0.98638325658653,1,6,polysaccharide binding,MF,ENPP1
12189,GO:0048483,0.174585840158132,0.961324719468911,2,24,autonomic nervous system development,BP,NRP1;SOX11
11320,GO:0045714,0.174684593206136,0.986365599969948,1,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
13224,GO:0051952,0.174722479056252,0.961187405714362,2,25,regulation of amine transport,BP,ARG1;HTR1B
12706,GO:0051014,0.174933658762985,0.986325176785357,1,6,actin filament severing,BP,MYH9
6579,GO:0022616,0.174940669166315,0.961109192184996,2,25,DNA strand elongation,BP,PARP1;NBN
7146,GO:0031045,0.175029158122843,0.986309660179075,1,6,dense core granule,CC,ADAM8
9595,GO:0036492,0.175106085879753,0.986297154159211,1,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,DNAJC3
9076,GO:0035374,0.175120304494131,0.986294841987837,1,6,chondroitin sulfate binding,MF,DPYSL3
17209,GO:0120032,0.175223867577761,0.916783855107129,6,122,regulation of plasma membrane bounded cell projection assembly,BP,DPYSL3;SLIT2;CYLD;NRP1;CORO1C;EPHA2
2632,GO:0005984,0.175225122246947,0.986277790471059,1,6,disaccharide metabolic process,BP,B4GALT1
6355,GO:0021559,0.175390366041551,0.986250885752099,1,6,trigeminal nerve development,BP,NRP1
14709,GO:0070424,0.175601680255733,0.986216438494938,1,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,BIRC3
8249,GO:0033077,0.175799052858528,0.94395898905302,3,47,T cell differentiation in thymus,BP,MAFB;IL7R;ADAM8
7909,GO:0032508,0.175900979100154,0.932086708911056,4,71,DNA duplex unwinding,BP,PARP1;ANXA1;NBN;SETX
17414,GO:1900242,0.17599174704642,0.98615272981786,1,6,regulation of synaptic vesicle endocytosis,BP,SYT11
16783,GO:0098711,0.176074089379387,0.98613926077445,1,6,iron ion import across plasma membrane,BP,STEAP4
10135,GO:0042753,0.176250619729749,0.986110361227849,1,6,positive regulation of circadian rhythm,BP,ARNTL2
9272,GO:0035748,0.176362671126279,0.986092000588722,1,6,myelin sheath abaxonal region,CC,DLG1
19107,GO:1905153,0.176441671628658,0.986079047769956,1,6,regulation of membrane invagination,BP,SYT11
5695,GO:0016846,0.176503886762505,0.985692681226482,1,7,carbon-sulfur lyase activity,MF,MGST3
18942,GO:1904776,0.176947878207851,0.985995896309181,1,6,regulation of protein localization to cell cortex,BP,EPB41L2
16883,GO:0098903,0.176956267902809,0.98599451593306,1,6,regulation of membrane repolarization during action potential,BP,DLG1
11340,GO:0045742,0.176996413302061,0.96036909788341,2,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,MMP9;TGFA
4373,GO:0010043,0.177017964036237,0.960278239754032,2,26,response to zinc ion,BP,PARP1;ARG1
13781,GO:0060416,0.177212520447815,0.960381305480426,2,24,response to growth hormone,BP,TRIM16;LYN
13457,GO:0055062,0.177238955452155,0.985947961748518,1,6,phosphate ion homeostasis,BP,ENPP1
15767,GO:0072505,0.177238955452155,0.985947961748518,1,6,divalent inorganic anion homeostasis,BP,ENPP1
15768,GO:0072506,0.177238955452155,0.985947961748518,1,6,trivalent inorganic anion homeostasis,BP,ENPP1
5076,GO:0015368,0.177284326769935,0.985940482038526,1,6,calcium:cation antiporter activity,MF,SLC8A1
14304,GO:0061549,0.177377493619963,0.985925116235279,1,6,sympathetic ganglion development,BP,NRP1
2082,GO:0004859,0.177490188536954,0.985526108143626,1,7,phospholipase inhibitor activity,MF,ANXA1
366,GO:0000988,0.177603878716119,0.878313686693935,20,522,transcription factor activity, protein binding,MF,RELB;TP53;DNAJB1;JUN;NFKB2;JUNB;ATF3;WWC1;NRG1;SDR16C5;NR2F2;AJUBA;UBP1;MED18;CITED2;ZFP42;SOX11;SND1;MAGED1;SUPT3H
18254,GO:1903201,0.177615075699285,0.943073744794984,3,48,regulation of oxidative stress-induced cell death,BP,TP53;PARP1;SOD2
16586,GO:0097485,0.177637747098501,0.905041663238181,8,171,neuron projection guidance,BP,DSCAM;FEZ1;SLIT2;SEMA7A;SEMA3D;NRP1;L1CAM;TUBB3
3341,GO:0007093,0.177770307635673,0.909553299759377,7,153,mitotic cell cycle checkpoint,BP,TP53;CDKN2B;NABP1;DUSP1;NBN;DLG1;PML
1983,GO:0004716,0.177949293016115,0.98583061205473,1,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,LYN
489,GO:0001542,0.177957313512842,0.98582928403726,1,6,ovulation from ovarian follicle,BP,MMP19
3302,GO:0007021,0.177983488158356,0.985442406362343,1,7,tubulin complex assembly,BP,CRYAB
599,GO:0001767,0.178013926878987,0.985819908199589,1,6,establishment of lymphocyte polarity,BP,MYH9
12028,GO:0048013,0.178025734950254,0.930932265700012,4,72,ephrin receptor signaling pathway,BP,MMP9;ACTG1;LYN;EPHA2
13534,GO:0060042,0.178319631368911,0.959980861821633,2,24,retina morphogenesis in camera-type eye,BP,DSCAM;SDK1
13644,GO:0060219,0.178554692038763,0.985730182288994,1,6,camera-type eye photoreceptor cell differentiation,BP,DSCAM
679,GO:0001893,0.178974476834992,0.959651544398954,2,25,maternal placenta development,BP,JUNB;NR2F2
16598,GO:0097501,0.1789885744693,0.985271060080117,1,7,stress response to metal ion,BP,HSPA5
4508,GO:0010591,0.179304903758727,0.959531162138192,2,25,regulation of lamellipodium assembly,BP,SLIT2;EPHA2
6445,GO:0021785,0.179316356407174,0.985603285035874,1,6,branchiomotor neuron axon guidance,BP,NRP1
7138,GO:0031018,0.17933433441665,0.959520432671888,2,25,endocrine pancreas development,BP,ANXA1;CDK6
17044,GO:0099612,0.179429270762091,0.985584421229447,1,6,protein localization to axon,BP,CNTNAP1
15857,GO:0072669,0.179777864269306,0.985135743931819,1,7,tRNA-splicing ligase complex,CC,C2ORF49
10050,GO:0042581,0.179783882490858,0.920967591657848,5,99,specific granule,CC,CXCL1;NFKB1;ITGAV;ARG1;ADAM8
10241,GO:0043015,0.179812794383348,0.959345836723476,2,25,gamma-tubulin binding,MF,FEZ1;LYN
6666,GO:0030050,0.1798476127403,0.985514415385904,1,6,vesicle transport along actin filament,BP,MOBP
14207,GO:0061299,0.179854880876119,0.985513197506951,1,6,retina vasculature morphogenesis in camera-type eye,BP,NRP1
3746,GO:0008307,0.180130039908677,0.959229898635839,2,25,structural constituent of muscle,MF,SORBS2;TPM4
19676,GO:2000058,0.180132603900972,0.913733021307265,6,125,regulation of ubiquitin-dependent protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;HSP90AB1;SVIP;PML
7186,GO:0031095,0.180283321159388,0.985441308448485,1,6,platelet dense tubular network membrane,CC,EHD1
3389,GO:0007186,0.180373654722384,0.883605989315326,15,378,G-protein coupled receptor signaling pathway,BP,CXCL1;SAA1;EDN1;CXCL16;UBQLN2;SPNS2;MGLL;ANXA1;GPR176;RHOB;KLK6;CXCR5;GIT2;ADGRL3;HTR1B
6678,GO:0030091,0.180589711495278,0.984995863363447,1,7,protein repair,BP,MSRB3
13902,GO:0060612,0.180599794473052,0.9590579750116,2,25,adipose tissue development,BP,XBP1;OXCT1
3240,GO:0006919,0.18079463148267,0.929380703866474,4,75,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;TNFSF15;PML;HSPD1
798,GO:0002072,0.180834085986835,0.985348611485528,1,6,optic cup morphogenesis involved in camera-type eye development,BP,SOX11
10434,GO:0043330,0.181034737979469,0.958812650954929,2,26,response to exogenous dsRNA,BP,NFKBIA;RIPK2
15950,GO:0086002,0.181150717131259,0.95894929485517,2,24,cardiac muscle cell action potential involved in contraction,BP,NEDD4L;DLG1
3775,GO:0008360,0.181367184385926,0.913006041045615,6,122,regulation of cell shape,BP,ANXA1;RHOB;DLG1;BAMBI;MYH9;PARVA
19461,GO:1990351,0.181530777413181,0.91289265411958,6,123,transporter complex,CC,HERPUD1;CNTNAP1;KCNQ5;CLCC1;STXBP5;DLG1
5692,GO:0016842,0.181607841122378,0.984819440028516,1,7,amidine-lyase activity,MF,CHAC1
6677,GO:0030073,0.181747636001924,0.912746444186825,6,124,insulin secretion,BP,IL1B;ANXA1;RIMS2;SERP1;OXCT1;MIDN
1453,GO:0003714,0.181865386959123,0.902173578863286,8,178,transcription corepressor activity,MF,RELB;DNAJB1;JUNB;ATF3;NR2F2;AJUBA;UBP1;CITED2
6670,GO:0030057,0.181901747834781,0.958673818770357,2,24,desmosome,CC,B4GALT1;CDSN
11728,GO:0046622,0.181957366247606,0.958559440831848,2,25,positive regulation of organ growth,BP,EDN1;SERP1
7205,GO:0031119,0.18204228577983,0.984743819445432,1,7,tRNA pseudouridine synthesis,BP,PUS10
18300,GO:1903305,0.182066294729736,0.9287661807943,4,72,regulation of regulated secretory pathway,BP,LYN;HMOX1;SYT11;RIMS2
8054,GO:0032757,0.182081005390293,0.958427304144731,2,26,positive regulation of interleukin-8 production,BP,IL1B;NLRP10
3615,GO:0008091,0.182329128575611,0.985095381492823,1,6,spectrin,CC,EPB41L2
13569,GO:0060080,0.182453515923586,0.985074206941804,1,6,inhibitory postsynaptic potential,BP,RIMS2
16427,GO:0097151,0.182453515923586,0.985074206941804,1,6,positive regulation of inhibitory postsynaptic potential,BP,RIMS2
16844,GO:0098828,0.182453515923586,0.985074206941804,1,6,modulation of inhibitory postsynaptic potential,BP,RIMS2
7457,GO:0031641,0.182578900996576,0.958330364319837,2,25,regulation of myelination,BP,NRG1;DLG1
1899,GO:0004601,0.182581238493789,0.958087725069346,2,28,peroxidase activity,MF,GPX8;MGST3
15449,GO:0071855,0.182630916157914,0.984641036858362,1,7,neuropeptide receptor binding,MF,EDN1
13040,GO:0051588,0.182929933004644,0.940573212660484,3,48,regulation of neurotransmitter transport,BP,SYT11;RIMS2;HTR1B
10703,GO:0044093,0.182945479537058,0.857879507585073,44,1248,positive regulation of molecular function,BP,NFKBIA;MMP9;CXCL1;SAA1;NFKB1;EDN1;PMAIP1;DNAJB1;JUN;RIPK2;NFKB2;HERPUD1;PARP1;HSPA5;IL1B;AXL;DNAJC10;GADD45B;STAC;LYN;NBN;HSP90AA1;NRP1;TRAF1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;ADAM8;STXBP5;AJUBA;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;TGFA;BAMBI;PML;EPHA2;TOR1AIP1;HSPD1;MAGED1;IRAK2
17759,GO:1901890,0.182967457855363,0.958186889727363,2,25,positive regulation of cell junction assembly,BP,CLDN1;NRP1
441,GO:0001190,0.183119128363205,0.940525106173666,3,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,JUN;CITED2;SOX11
1093,GO:0002689,0.183210124075163,0.984539535324373,1,7,negative regulation of leukocyte chemotaxis,BP,SLIT2
3428,GO:0007253,0.183273722990654,0.98452836809912,1,7,cytoplasmic sequestering of NF-kappaB,BP,NFKBIA
10695,GO:0044070,0.183347444079174,0.940375192723883,3,48,regulation of anion transport,BP,EDN1;IL1B;ARG1
6044,GO:0019210,0.183601906617216,0.927889768949326,4,74,kinase inhibitor activity,MF,CDKN2A;CDKN2B;TRIB1;DNAJC3
7796,GO:0032371,0.183605993219915,0.957862982336254,2,26,regulation of sterol transport,BP,NFKBIA;NFKB1
7799,GO:0032374,0.183605993219915,0.957862982336254,2,26,regulation of cholesterol transport,BP,NFKBIA;NFKB1
11026,GO:0045058,0.183677455125532,0.957924195298035,2,25,T cell selection,BP,CYLD;IL23A
5389,GO:0016248,0.18373275722034,0.957815931399052,2,26,channel inhibitor activity,MF,NEDD4L;NEDD4
16592,GO:0097493,0.183942089702433,0.984819542388081,1,6,structural molecule activity conferring elasticity,MF,FBN2
3612,GO:0008088,0.184120800486696,0.940007790282442,3,48,axo-dendritic transport,BP,NEFL;FEZ1;AP3M1
6278,GO:0019907,0.184213888614823,0.984362777192869,1,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,HSPD1
10494,GO:0043462,0.184600846036433,0.939663403027128,3,51,regulation of ATPase activity,BP,DNAJB1;DNAJC10;TOR1AIP1
4752,GO:0010955,0.184838106695623,0.957404736835897,2,26,negative regulation of protein processing,BP,CHAC1;BIRC3
18307,GO:1903318,0.184838106695623,0.957404736835897,2,26,negative regulation of protein maturation,BP,CHAC1;BIRC3
17451,GO:1900426,0.184852818067493,0.984249698452393,1,7,positive regulation of defense response to bacterium,BP,NLRP10
13833,GO:0060491,0.184925208991907,0.910773678882558,6,124,regulation of cell projection assembly,BP,DPYSL3;SLIT2;CYLD;NRP1;CORO1C;EPHA2
18642,GO:1904029,0.184950600121276,0.927136036120263,4,75,regulation of cyclin-dependent protein kinase activity,BP,CDKN2A;CDKN2B;NR2F2;CDK6
6104,GO:0019370,0.185036797892469,0.984217055652105,1,7,leukotriene biosynthetic process,BP,MGST3
3172,GO:0006811,0.18507856612024,0.862560093914244,31,856,ion transport,BP,MMP9;NETO1;EDN1;SLC16A9;IL16;IL1B;NFKBIE;STAC;ITGAV;LYN;ANXA1;G6PD;SLC8A1;NEDD4L;ARG1;HEPHL1;FTH1;KCNQ5;SLC7A5P2;CLCC1;STEAP4;ANO4;SLC39A14;SLC35B1;MAGT1;DLG1;TFRC;HTR1B;NEDD4;PML;ENPP1
8668,GO:0034329,0.185281230322136,0.899915450103106,8,174,cell junction assembly,BP,CLDN1;CNTNAP1;ACTG1;NRP1;AJUBA;CORO1C;DLG1;TJP1
6841,GO:0030330,0.185424125357711,0.917648640159984,5,100,DNA damage response, signal transduction by p53 class mediator,BP,TP53;PMAIP1;NBN;PTTG1IP;PML
10856,GO:0044430,0.185529914509811,0.856476083739178,42,1185,cytoskeletal part,CC,KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;RELB;FEZ1;DPYSL3;FLG;KRT78;MYO1B;KRT4;IFT46;KRT13;CRYAB;ACTG1;HSPA6;CYLD;FIGN;KRT23;ANXA1;SLC8A1;MOBP;NRP1;KRT34;ADAM8;AJUBA;EYA3;SERP1;DLG1;PDE4DIP;CDK6;TUBB3;EPB41L2;MYH9;TPM4;CEP83;TJP1
894,GO:0002279,0.18577981677217,0.957053111680106,2,26,mast cell activation involved in immune response,BP,LYN;HMOX1
10413,GO:0043303,0.18577981677217,0.957053111680106,2,26,mast cell degranulation,BP,LYN;HMOX1
14165,GO:0061136,0.185865152189884,0.904312263565213,7,154,regulation of proteasomal protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;DERL3;XBP1;HSP90AB1;SVIP
7095,GO:0030915,0.185953463175641,0.984053870115874,1,7,Smc5-Smc6 complex,CC,EID3
17168,GO:0106068,0.185953463175641,0.984053870115874,1,7,SUMO ligase complex,CC,EID3
2515,GO:0005785,0.186217420359481,0.984006711693196,1,7,signal recognition particle receptor complex,CC,DERL3
8046,GO:0032740,0.186238808322967,0.984002887230741,1,7,positive regulation of interleukin-17 production,BP,IL23A
11383,GO:0045833,0.186325365433387,0.938915366984636,3,49,negative regulation of lipid metabolic process,BP,NFKB1;IL1B;ORMDL1
19595,GO:1990823,0.186406128531409,0.926392062139389,4,73,response to leukemia inhibitory factor,BP,VEGFC;XBP1;TFRC;PML
19598,GO:1990830,0.186406128531409,0.926392062139389,4,73,cellular response to leukemia inhibitory factor,BP,VEGFC;XBP1;TFRC;PML
15947,GO:0085029,0.186426881555907,0.956900492091088,2,25,extracellular matrix assembly,BP,LOX;HAS2
1371,GO:0003281,0.186648010020361,0.938844290642031,3,47,ventricular septum development,BP,EGLN1;CITED2;SOX11
16552,GO:0097413,0.187258267058775,0.983820019421781,1,7,Lewy body,CC,HERPUD1
3790,GO:0008395,0.187802870689689,0.983721868306435,1,7,steroid hydroxylase activity,MF,CYP1A1
5188,GO:0015804,0.188086359144883,0.956186804111355,2,26,neutral amino acid transport,BP,NFKBIE;SLC7A5P2
18687,GO:1904181,0.188283983547127,0.983634892147143,1,7,positive regulation of membrane depolarization,BP,PARP1
2005,GO:0004745,0.188324242078857,0.983627602771287,1,7,retinol dehydrogenase activity,MF,SDR16C5
12744,GO:0051059,0.188449383856764,0.955965605691186,2,27,NF-kappaB binding,MF,CDKN2A;NFKBIA
6280,GO:0019911,0.188636678642371,0.983570971896366,1,7,structural constituent of myelin sheath,MF,MOBP
13898,GO:0060603,0.188719947407663,0.956038896345223,2,25,mammary gland duct morphogenesis,BP,PML;EPHA2
16074,GO:0090101,0.188725439772074,0.925126417300596,4,73,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,PEG10;HSPA5;FBN2;BAMBI
4187,GO:0009312,0.188812231967845,0.955912688064297,2,26,oligosaccharide biosynthetic process,BP,B4GALT1;GALNT14
9573,GO:0036462,0.188814682017371,0.983538660384366,1,7,TRAIL-activated apoptotic signaling pathway,BP,ATF3
18128,GO:1902931,0.188908568357623,0.98352160409187,1,7,negative regulation of alcohol biosynthetic process,BP,NFKB1
3174,GO:0006813,0.188950458396354,0.915597227127919,5,98,potassium ion transport,BP,NETO1;NEDD4L;KCNQ5;DLG1;NEDD4
13926,GO:0060674,0.189100299567189,0.955803705974373,2,26,placenta blood vessel development,BP,JUNB;NR2F2
18768,GO:1904375,0.189261025505574,0.924833194372923,4,73,regulation of protein localization to cell periphery,BP,STAC;DLG1;EPHA2;EPB41L2
3024,GO:0006591,0.189541773485423,0.983406319803976,1,7,ornithine metabolic process,BP,ARG1
11274,GO:0045628,0.189776857960999,0.983363408257073,1,7,regulation of T-helper 2 cell differentiation,BP,ANXA1
8033,GO:0032720,0.189793055552605,0.955456078660816,2,27,negative regulation of tumor necrosis factor production,BP,AXL;SYT11
15796,GO:0072542,0.189963655932198,0.983329267906428,1,7,protein phosphatase activator activity,MF,IGFBP3
18297,GO:1903299,0.19032853872536,0.983262470146028,1,7,regulation of hexokinase activity,BP,MIDN
6301,GO:0019966,0.190509861960317,0.98322922205668,1,7,interleukin-1 binding,MF,TRIM16
7142,GO:0031032,0.190537562542908,0.907274083713798,6,123,actomyosin structure organization,BP,KRT8;EDN1;ACTG1;NRP1;EPB41L2;MYH9
2942,GO:0006489,0.190750946220839,0.98318496051853,1,7,dolichyl diphosphate biosynthetic process,BP,DHDDS
11646,GO:0046465,0.190750946220839,0.98318496051853,1,7,dolichyl diphosphate metabolic process,BP,DHDDS
10212,GO:0042976,0.190824136189351,0.98317151077813,1,7,activation of Janus kinase activity,BP,IL23A
7765,GO:0032324,0.190972333306661,0.983144259491093,1,7,molybdopterin cofactor biosynthetic process,BP,MOCS2
10548,GO:0043545,0.190972333306661,0.983144259491093,1,7,molybdopterin cofactor metabolic process,BP,MOCS2
12828,GO:0051189,0.190972333306661,0.983144259491093,1,7,prosthetic group metabolic process,BP,MOCS2
5186,GO:0015802,0.19107249480446,0.983125827700355,1,7,basic amino acid transport,BP,ARG1
17213,GO:0120036,0.191224195041917,0.853960012426953,37,1025,plasma membrane bounded cell projection organization,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;SLIT2;JUN;SDK1;HSPA5;IFT46;CNTNAP1;CYLD;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;HSP90AA1;NRP1;SETX;NRG1;IFRD1;L1CAM;AJUBA;CORO1C;EHD1;NEDD4;TUBB3;NTNG1;EPHA2;MYH9;CEP83;PARVA
6430,GO:0021766,0.191450262536266,0.936444378206894,3,49,hippocampus development,BP,NEFL;FEZ1;CDK6
8063,GO:0032769,0.191888139166917,0.982975325064712,1,7,negative regulation of monooxygenase activity,BP,NFKB1
8580,GO:0034116,0.191921218558545,0.982969205947196,1,7,positive regulation of heterotypic cell-cell adhesion,BP,IL1B
527,GO:0001637,0.192071318447021,0.982941425052519,1,7,G-protein coupled chemoattractant receptor activity,MF,CXCR5
2127,GO:0004950,0.192071318447021,0.982941425052519,1,7,chemokine receptor activity,MF,CXCR5
14664,GO:0070330,0.192153477402256,0.982926208437573,1,7,aromatase activity,MF,CYP1A1
4534,GO:0010633,0.192181372692874,0.936089059009239,3,49,negative regulation of epithelial cell migration,BP,SLIT2;NR2F2;CORO1C
18312,GO:1903332,0.192259633697897,0.982906536378238,1,7,regulation of protein folding,BP,HSPA5
11342,GO:0045744,0.192414549860793,0.954454973252366,2,27,negative regulation of G-protein coupled receptor protein signaling pathway,BP,UBQLN2;HTR1B
7463,GO:0031647,0.1927470662547,0.890570605944762,9,212,regulation of protein stability,BP,IFT46;CRYAB;XBP1;HSP90AA1;HSP90AB1;CALR;SEL1L;SUGT1;HSPD1
10408,GO:0043297,0.192748750997096,0.935855387387017,3,48,apical junction assembly,BP,CLDN1;DLG1;TJP1
3146,GO:0006771,0.192800340753045,0.982806145798807,1,7,riboflavin metabolic process,BP,ENPP1
5243,GO:0015893,0.192819623847006,0.913243522992937,5,101,drug transport,BP,EDN1;CLDN1;NFKBIE;ARG1;HTR1B
7157,GO:0031058,0.192867921583493,0.922824234608034,4,74,positive regulation of histone modification,BP,TP53;IL1B;SDR16C5;CTR9
7587,GO:0031995,0.192939198137052,0.982780313254213,1,7,insulin-like growth factor II binding,MF,IGFBP3
11878,GO:0046950,0.192961317869676,0.982776196230747,1,7,cellular ketone body metabolic process,BP,OXCT1
17872,GO:1902224,0.192961317869676,0.982776196230747,1,7,ketone body metabolic process,BP,OXCT1
12737,GO:0051052,0.193009764040269,0.878283493724359,13,323,regulation of DNA metabolic process,BP,TP53;JUN;PARP1;DUSP1;FIGN;NBN;HSP90AA1;IL7R;HSP90AB1;CALR;EYA3;TFRC;PML
5817,GO:0017121,0.19307853945015,0.982754369501689,1,7,phospholipid scrambling,BP,ANO4
18039,GO:1902679,0.193443360075363,0.854324068038081,33,925,negative regulation of RNA biosynthetic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;WWC1;NEDD4L;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;NEDD4;PML;ZBTB21;SOX11;MAGED1
18386,GO:1903507,0.193443360075363,0.854324068038081,33,925,negative regulation of nucleic acid-templated transcription,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;WWC1;NEDD4L;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;NEDD4;PML;ZBTB21;SOX11;MAGED1
11308,GO:0045668,0.193635538751002,0.954073171628728,2,26,negative regulation of osteoblast differentiation,BP,NOCT;CDK6
3614,GO:0008090,0.193790288540168,0.982621518873727,1,7,retrograde axonal transport,BP,NEFL
12072,GO:0048148,0.193827949935334,0.982614473799433,1,7,behavioral response to cocaine,BP,SDK1
4640,GO:0010803,0.193895419187134,0.935172711701786,3,51,regulation of tumor necrosis factor-mediated signaling pathway,BP,CYLD;BIRC3;TRAF1
18239,GO:1903169,0.193992955774949,0.922201927055443,4,74,regulation of calcium ion transmembrane transport,BP,STAC;LYN;G6PD;SLC8A1
13051,GO:0051601,0.194202069221039,0.982544405428189,1,7,exocyst localization,BP,TNFAIP2
7468,GO:0031652,0.194606057000652,0.982468570964033,1,7,positive regulation of heat generation,BP,IL1B
8295,GO:0033157,0.194692445348188,0.889217975068468,9,211,regulation of intracellular protein transport,BP,LCP1;TP53;IL1B;DERL3;NRG1;HSP90AB1;PRR5L;SVIP;UGCG
3085,GO:0006678,0.194854995331471,0.982421752559444,1,7,glucosylceramide metabolic process,BP,UGCG
15125,GO:0071285,0.194864244734097,0.982420011694849,1,7,cellular response to lithium ion,BP,CALR
6345,GO:0021545,0.194872827912301,0.953596240192376,2,26,cranial nerve development,BP,MAFB;NRP1
9713,GO:0038203,0.194899279116803,0.982413416892918,1,7,TORC2 signaling,BP,PRR5L
7852,GO:0032435,0.194902113167167,0.953496439518397,2,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,HSP90AB1;SVIP
6653,GO:0030032,0.195002962526933,0.934711208041759,3,49,lamellipodium assembly,BP,SLIT2;AJUBA;EPHA2
1518,GO:0003909,0.19522230844801,0.982352547119696,1,7,DNA ligase activity,MF,PARP1
9361,GO:0035929,0.195260351665138,0.982345370948168,1,7,steroid hormone secretion,BP,C1QTNF1
13567,GO:0060078,0.195384053019153,0.934524314864395,3,49,regulation of postsynaptic membrane potential,BP,NETO1;SLC8A1;RIMS2
8187,GO:0032964,0.195459590219592,0.953280482609148,2,27,collagen biosynthetic process,BP,ARG1;SERPINH1
19974,GO:2000628,0.195523174260754,0.98229575082231,1,7,regulation of miRNA metabolic process,BP,NFKB1
5527,GO:0016538,0.195544074608113,0.953165315837728,2,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CDKN2A;CDKN2B
8456,GO:0033628,0.195816945405943,0.953141829234946,2,27,regulation of cell adhesion mediated by integrin,BP,LYN;EPHA2
7923,GO:0032536,0.195833482203353,0.982237068075429,1,7,regulation of cell projection size,BP,NEFL
7290,GO:0031313,0.195937135349787,0.982217442553501,1,7,extrinsic component of endosome membrane,CC,ANXA1
8109,GO:0032825,0.195993350641119,0.982206793908586,1,7,positive regulation of natural killer cell differentiation,BP,AXL
16736,GO:0098589,0.196026486444788,0.888302857943576,9,208,membrane region,CC,PGK1;EFHD2;STOML1;LYN;BIRC3;HMOX1;SERPINH1;CORO1C;DLG1
15794,GO:0072539,0.196170960097687,0.982173127246931,1,7,T-helper 17 cell differentiation,BP,IL23A
6273,GO:0019901,0.19627842104691,0.863561683015162,20,525,protein kinase binding,MF,CDKN2A;TNIP1;RELB;FEZ1;TP53;CDKN2B;PARP1;AXL;CYLD;TRIB1;ITGAV;RHOB;TRAF3;HSP90AA1;NRP1;NRG1;HSP90AB1;DLG1;DNAJC3;EPHA2
10831,GO:0044387,0.196307713380477,0.982147181458635,1,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,CORO1C
9471,GO:0036149,0.196373978037083,0.982134601879796,1,7,phosphatidylinositol acyl-chain remodeling,BP,PLBD1
17289,GO:0150034,0.196407594543814,0.892331115950515,8,180,distal axon,CC,NEFL;DSCAM;FEZ1;DPYSL3;SYT11;NRP1;SETX;L1CAM
6263,GO:0019885,0.196636277394453,0.982084760058187,1,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,ERAP1
904,GO:0002295,0.196721793384787,0.982068494073079,1,7,T-helper cell lineage commitment,BP,IL23A
10447,GO:0043373,0.196721793384787,0.982068494073079,1,7,CD4-positive, alpha-beta T cell lineage commitment,BP,IL23A
9841,GO:0042133,0.196938875501707,0.920540118833819,4,75,neurotransmitter metabolic process,BP,EDN1;IL1B;HSP90AA1;HSP90AB1
16255,GO:0090400,0.196954975060086,0.982024099793231,1,7,stress-induced premature senescence,BP,TP53
10512,GO:0043495,0.197205163092687,0.98197640130655,1,7,protein membrane anchor,MF,MYH9
11733,GO:0046627,0.197300799537895,0.952564256256483,2,27,negative regulation of insulin receptor signaling pathway,BP,IL1B;ENPP1
13544,GO:0060052,0.197425729065539,0.981934293207286,1,7,neurofilament cytoskeleton organization,BP,NEFL
6272,GO:0019900,0.197614900265536,0.860060757571655,22,585,kinase binding,MF,CDKN2A;TNIP1;RELB;FEZ1;TP53;CDKN2B;PARP1;AXL;CYLD;TRIB1;ITGAV;WWC1;RHOB;TRAF3;HSP90AA1;NRP1;NRG1;HSP90AB1;DLG1;DNAJC3;EPHA2;MIDN
11319,GO:0045713,0.197662724527256,0.981888988938063,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,ITGAV
9585,GO:0036480,0.197666416052405,0.981888282774074,1,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,PARP1
18333,GO:1903376,0.197666416052405,0.981888282774074,1,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,PARP1
984,GO:0002448,0.197713217812383,0.952403200914704,2,27,mast cell mediated immunity,BP,LYN;HMOX1
7830,GO:0032412,0.197731288265855,0.902682557125021,6,126,regulation of ion transmembrane transporter activity,BP,MMP9;NETO1;STAC;NEDD4L;DLG1;NEDD4
4260,GO:0009642,0.198022437927032,0.981820107724091,1,7,response to light intensity,BP,HMGCS1
4740,GO:0010935,0.198300370439611,0.981766789135689,1,7,regulation of macrophage cytokine production,BP,SEMA7A
17533,GO:1901186,0.198430827759996,0.952122418277192,2,27,positive regulation of ERBB signaling pathway,BP,MMP9;TGFA
7672,GO:0032147,0.198470804956813,0.88286296906241,10,236,activation of protein kinase activity,BP,SAA1;RIPK2;IL1B;GADD45B;TNFSF15;NRG1;IL23A;DLG1;TGFA;IRAK2
2705,GO:0006099,0.198618583660888,0.951964519684742,2,28,tricarboxylic acid cycle,BP,ACO1;CS
19704,GO:2000117,0.198654436977829,0.919533421709896,4,77,negative regulation of cysteine-type endopeptidase activity,BP,MMP9;HERPUD1;CRYAB;BIRC3
12972,GO:0051445,0.198708529716075,0.95201357462974,2,27,regulation of meiotic cell cycle,BP,DUSP1;CALR
6569,GO:0022602,0.198767210740775,0.952081649842882,2,26,ovulation cycle process,BP,SLIT2;MMP19
2206,GO:0005114,0.198951448451138,0.981641553230869,1,7,type II transforming growth factor beta receptor binding,MF,BAMBI
14482,GO:0070011,0.199056461103771,0.871436305036462,14,358,peptidase activity, acting on L-amino acid peptides,MF,MMP9;ASPRV1;PSMB9;ANPEP;ERAP1;CYLD;C1R;SEC11C;MMP19;KLK6;TPP2;PREP;ADAM8;MME
1358,GO:0003254,0.199204912556192,0.951818761941971,2,27,regulation of membrane depolarization,BP,PARP1;NEDD4L
19826,GO:2000345,0.199283373054215,0.981577527223841,1,7,regulation of hepatocyte proliferation,BP,XBP1
9594,GO:0036491,0.199325055557395,0.981569478366882,1,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,DNAJC3
12229,GO:0048557,0.199384670529099,0.981557963435465,1,7,embryonic digestive tract morphogenesis,BP,SOX11
5100,GO:0015459,0.199467398041137,0.951715611774872,2,27,potassium channel regulator activity,MF,NEDD4L;DLG1
16535,GO:0097371,0.199491110700199,0.981537394235193,1,7,MDM2/MDM4 family protein binding,MF,TP53
9544,GO:0036376,0.1995957807091,0.98151715492657,1,7,sodium ion export across plasma membrane,BP,SLC8A1
813,GO:0002091,0.199623068071035,0.98151187657396,1,7,negative regulation of receptor internalization,BP,UBQLN2
2280,GO:0005251,0.199638973123017,0.98150879958862,1,7,delayed rectifier potassium channel activity,MF,KCNQ5
6487,GO:0021879,0.199774693433484,0.951594734759208,2,27,forebrain neuron differentiation,BP,SLIT2;NRP1
10410,GO:0043300,0.20006735930549,0.951479494373958,2,27,regulation of leukocyte degranulation,BP,LYN;HMOX1
7093,GO:0030913,0.200123879629943,0.981414855773862,1,7,paranodal junction assembly,BP,CNTNAP1
13751,GO:0060379,0.200187294706708,0.981402550804995,1,7,cardiac muscle cell myoblast differentiation,BP,NRG1
1424,GO:0003413,0.20032514546653,0.981375787128269,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,SERPINH1
1471,GO:0003779,0.200459972461378,0.875282855872539,12,290,actin binding,MF,LCP1;MYO1B;ANXA8;COBLL1;MOBP;AJUBA;CORO1C;EPB41L2;MYH9;AFAP1;TPM4;PARVA
17469,GO:1900739,0.200576918170084,0.951193026878608,2,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;PMAIP1
17470,GO:1900740,0.200576918170084,0.951193026878608,2,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;PMAIP1
507,GO:0001570,0.20064778923006,0.931923540940778,3,49,vasculogenesis,BP,JUNB;ITGAV;HAS2
5603,GO:0016679,0.200656975815812,0.980947052718075,1,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,CYP1A1
12603,GO:0050847,0.201001960596712,0.981244079187715,1,7,progesterone receptor signaling pathway,BP,NEDD4
7780,GO:0032351,0.201003173982442,0.981243842608808,1,7,negative regulation of hormone metabolic process,BP,NFKB1
7782,GO:0032353,0.201003173982442,0.981243842608808,1,7,negative regulation of hormone biosynthetic process,BP,NFKB1
10292,GO:0043116,0.201027469933952,0.981239105182691,1,7,negative regulation of vascular permeability,BP,SLIT2
17922,GO:1902337,0.201251806555878,0.981195331336364,1,7,regulation of apoptotic process involved in morphogenesis,BP,B4GALT1
18928,GO:1904748,0.201251806555878,0.981195331336364,1,7,regulation of apoptotic process involved in development,BP,B4GALT1
14081,GO:0060982,0.201263237955257,0.981193099286307,1,7,coronary artery morphogenesis,BP,NRP1
17980,GO:1902514,0.201311913795144,0.981183593415704,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
7597,GO:0032009,0.201325919937783,0.981180857680513,1,7,early phagosome,CC,SYT11
11786,GO:0046717,0.20134577624051,0.931532821503393,3,50,acid secretion,BP,EDN1;IL1B;ANXA1
19781,GO:2000279,0.201397110860709,0.950954440717776,2,27,negative regulation of DNA biosynthetic process,BP,TP53;DUSP1
20212,GO:2001204,0.201565767535635,0.981133976028788,1,7,regulation of osteoclast development,BP,TJP2
7106,GO:0030949,0.201738517272649,0.981100170192272,1,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,IL1B
357,GO:0000976,0.201859316896712,0.860477302658474,19,497,transcription regulatory region sequence-specific DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;SETX;KLF10;SNAI3;ETS1;ZFP42;SOX11
10343,GO:0043197,0.202395249775488,0.907482371321796,5,100,dendritic spine,CC,CRYAB;SLC8A1;SYT11;CANX;NEDD4
2432,GO:0005655,0.202468567065974,0.980586066232683,1,8,nucleolar ribonuclease P complex,CC,POP4
8349,GO:0033270,0.202537096396941,0.98094346491862,1,7,paranode region of axon,CC,CNTNAP1
12798,GO:0051148,0.202835804230259,0.950383696625355,2,27,negative regulation of muscle cell differentiation,BP,G6PD;XBP1
4748,GO:0010950,0.203025254605992,0.899208751559069,6,133,positive regulation of endopeptidase activity,BP,PMAIP1;RIPK2;LYN;TNFSF15;PML;HSPD1
10250,GO:0043029,0.204029843321832,0.949820172547676,2,28,T cell homeostasis,BP,PMAIP1;SPNS2
6786,GO:0030252,0.204466910843665,0.980561859166717,1,7,growth hormone secretion,BP,SERP1
13486,GO:0055102,0.204563493351913,0.980164012059165,1,8,lipase inhibitor activity,MF,ANXA1
10486,GO:0043434,0.204662420677691,0.872122427149,12,297,response to peptide hormone,BP,TRIM16;NEFL;NFKB1;EDN1;PARP1;IL1B;LYN;ANXA1;XBP1;ARG1;EIF2B1;ENPP1
730,GO:0001964,0.204779268542168,0.980499704160985,1,7,startle response,BP,NRG1
1349,GO:0003231,0.204814628533942,0.916136376138739,4,74,cardiac ventricle development,BP,EGLN1;NRG1;CITED2;SOX11
7110,GO:0030953,0.205093109805743,0.980437144736998,1,7,astral microtubule organization,BP,DLG1
5548,GO:0016579,0.205453471484202,0.877785348343234,10,244,protein deubiquitination,BP,NFKBIA;TNIP1;TP53;PSMB9;RIPK2;CYLD;BIRC3;SUDS3;TRAF3;SUPT3H
13782,GO:0060419,0.205539802734457,0.929429910557946,3,50,heart growth,BP,EDN1;G6PD;SORBS2
11626,GO:0046425,0.205564663917175,0.915610199101867,4,78,regulation of JAK-STAT cascade,BP,IL6ST;LYN;IL24;IL23A
8897,GO:0034766,0.205656281893119,0.929328642671183,3,51,negative regulation of ion transmembrane transport,BP,MMP9;NEDD4L;NEDD4
9081,GO:0035385,0.205771330080091,0.980301577842645,1,7,Roundabout signaling pathway,BP,SLIT2
2368,GO:0005516,0.205830057805954,0.897487036002266,6,126,calmodulin binding,MF,MYO1B;PDE1C;SLC8A1;KCNQ5;MYH9;TJP1
12715,GO:0051023,0.205980277016305,0.979875770794405,1,8,regulation of immunoglobulin secretion,BP,XBP1
14914,GO:0070847,0.206114793255681,0.979848285765608,1,8,core mediator complex,CC,MED18
2573,GO:0005881,0.206674207448134,0.928814399583318,3,51,cytoplasmic microtubule,CC,SAA1;CYLD;SERP1
7185,GO:0031094,0.206792694952259,0.980096454903324,1,7,platelet dense tubular network,CC,EHD1
7405,GO:0031526,0.206928295921341,0.948744978641232,2,27,brush border membrane,CC,B4GALT1;HSP90AB1
6974,GO:0030674,0.206982125683515,0.896716141581804,6,128,protein binding, bridging,MF,NEFL;OPTN;CNTNAP1;TJP2;ANXA1;SORBS2
16349,GO:0097006,0.207099784319808,0.928557782633508,3,52,regulation of plasma lipoprotein particle levels,BP,NCEH1;HMOX1;EHD1
12607,GO:0050851,0.207109225676728,0.890171632735409,7,162,antigen receptor-mediated signaling pathway,BP,NFKBIA;NFKB1;PSMB9;RIPK2;CYLD;LYN;EIF2B1
11364,GO:0045787,0.207126855098858,0.870262564372272,12,301,positive regulation of cell cycle,BP,IL1A;EDN1;TP53;IL1B;ANXA1;CXCR5;HSP90AB1;CALR;CITED2;TGFA;PML;CYP1A1
3661,GO:0008175,0.207608362777372,0.948380488491287,2,28,tRNA methyltransferase activity,MF,METTL2A;TRMT44
10869,GO:0044448,0.20800616629267,0.89606564586358,6,127,cell cortex part,CC,MOBP;RIMS2;EPB41L2;MYH9;TNFAIP2;TPM4
14040,GO:0060900,0.208007158922453,0.979851038029448,1,7,embryonic camera-type eye formation,BP,SOX11
6738,GO:0030182,0.208100664036707,0.843355848486452,31,851,neuron differentiation,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;SLIT2;JUN;SDK1;HSPA5;CNTNAP1;SEMA7A;LYN;NEDD4L;XBP1;SEMA3D;KLK6;RIMS2;NRP1;SETX;NRG1;IFRD1;L1CAM;CALR;EHD1;NEDD4;TUBB3;NTNG1;SOX11
8488,GO:0033692,0.208679391152866,0.927797499109564,3,51,cellular polysaccharide biosynthetic process,BP,HAS2;GBE1;ENPP1
11824,GO:0046850,0.208777582315004,0.947997122612067,2,27,regulation of bone remodeling,BP,ADAM8;TFRC
11171,GO:0045335,0.208822644635843,0.903458691075243,5,105,phagocytic vesicle,CC,ACTG1;ITGAV;SYT11;ADAM8;CALR
15128,GO:0071294,0.209009361129152,0.979251883923539,1,8,cellular response to zinc ion,BP,PARP1
17322,GO:1900077,0.209477964954577,0.947621493175964,2,28,negative regulation of cellular response to insulin stimulus,BP,IL1B;ENPP1
8199,GO:0032982,0.209528689189245,0.979541245262811,1,7,myosin filament,CC,MYH9
7021,GO:0030814,0.209607023307027,0.947568926998143,2,28,regulation of cAMP metabolic process,BP,GPR176;EGLN1
11858,GO:0046915,0.2096494075604,0.947551658790311,2,28,transition metal ion transmembrane transporter activity,MF,SLC39A14;TFRC
4729,GO:0010917,0.210012075423951,0.979043063844489,1,8,negative regulation of mitochondrial membrane potential,BP,PMAIP1
11387,GO:0045837,0.210012075423951,0.979043063844489,1,8,negative regulation of membrane potential,BP,PMAIP1
3429,GO:0007254,0.210042042717586,0.888249009745851,7,156,JNK cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B;TRIB1;IRAK2
2505,GO:0005773,0.210230175820741,0.849810481341049,22,600,vacuole,CC,B4GALT1;UBQLN2;SPNS2;OPTN;HRNR;IL1B;ANPEP;PLBD1;LYN;AP3M1;ANXA1;ARG1;SYT11;HSP90AA1;FTH1;HSP90AB1;ADAM8;IFNAR1;MAGT1;DNAJC3;CPPED1;ENPP1
3496,GO:0007422,0.210291605472518,0.926976134328029,3,51,peripheral nervous system development,BP,CLDN1;CNTNAP1;NRG1
11600,GO:0046348,0.210457466748231,0.978949941954186,1,8,amino sugar catabolic process,BP,NAGK
18110,GO:1902893,0.210496785576365,0.947297765324936,2,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,TP53;JUN
7289,GO:0031312,0.210650933394937,0.947142916467664,2,28,extrinsic component of organelle membrane,CC,ANXA1;PML
19602,GO:1990837,0.210735460990013,0.851963194457844,20,530,sequence-specific double-stranded DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;SETX;KLF10;SNAI3;ETS1;ZFP42;SOX11;HSPD1
15470,GO:0071888,0.210863967660636,0.978864754002347,1,8,macrophage apoptotic process,BP,CDKN2A
720,GO:0001953,0.211074662619747,0.947061801628578,2,27,negative regulation of cell-matrix adhesion,BP,CDKN2A;CORO1C
12598,GO:0050830,0.211424680198419,0.946585509745708,2,31,defense response to Gram-positive bacterium,BP,RNASE7;RIPK2
10941,GO:0044754,0.211512019864635,0.978728556105846,1,8,autolysosome,CC,FTH1
6612,GO:0022898,0.211736202577573,0.893613471142254,6,129,regulation of transmembrane transporter activity,BP,MMP9;NETO1;STAC;NEDD4L;DLG1;NEDD4
9268,GO:0035743,0.211797295365194,0.97866844933423,1,8,CD4-positive, alpha-beta T cell cytokine production,BP,ARG1
6649,GO:0030027,0.212066102728672,0.886888139985882,7,155,lamellipodium,CC,DPYSL3;ITGAV;AJUBA;SLC39A14;CORO1C;EPHA2;SORBS2
5417,GO:0016298,0.21218519698967,0.911844140128563,4,77,lipase activity,MF,MGLL;PLBD1;NCEH1;HMOX1
2382,GO:0005539,0.21271696169909,0.901065127653075,5,104,glycosaminoglycan binding,MF,SAA1;DPYSL3;SLIT2;RNASE7;NRP1
13672,GO:0060272,0.213001421686089,0.978413719371306,1,8,embryonic skeletal joint morphogenesis,BP,OSR2
1031,GO:0002551,0.21331556602853,0.97834699039085,1,8,mast cell chemotaxis,BP,VEGFC
269,GO:0000768,0.213388844414988,0.946018666597118,2,28,syncytium formation by plasma membrane fusion,BP,EHD1;MYH9
19906,GO:2000484,0.213831060281152,0.978237247066479,1,8,positive regulation of interleukin-8 secretion,BP,NLRP10
12618,GO:0050862,0.213852315413212,0.978232715544066,1,8,positive regulation of T cell receptor signaling pathway,BP,CYLD
19356,GO:1905906,0.213980854527317,0.978205300418772,1,8,regulation of amyloid fibril formation,BP,CRYAB
5613,GO:0016712,0.214133686813739,0.978172679372837,1,8,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,CYP1A1
10787,GO:0044309,0.214203210661286,0.900175839132623,5,102,neuron spine,CC,CRYAB;SLC8A1;SYT11;CANX;NEDD4
7767,GO:0032329,0.214248242615721,0.978148210653613,1,8,serine transport,BP,NFKBIE
15855,GO:0072665,0.214447362414332,0.92480044639516,3,52,protein localization to vacuole,BP,AP3M1;GNPTAB;NEDD4
3696,GO:0008227,0.214464916684285,0.978101888729971,1,8,G-protein coupled amine receptor activity,MF,HTR1B
3267,GO:0006970,0.214541509573278,0.924751852832416,3,52,response to osmotic stress,BP,RELB;CLDN1;HSP90AB1
2826,GO:0006310,0.214823513213455,0.874912435361316,9,216,DNA recombination,BP,NABP1;PARP1;FIGN;NBN;IL7R;SETX;TFRC;EID3;HSPD1
12522,GO:0050711,0.214894750703915,0.978009836957012,1,8,negative regulation of interleukin-1 secretion,BP,PML
16220,GO:0090317,0.215129029913143,0.945210761199256,2,29,negative regulation of intracellular protein transport,BP,DERL3;SVIP
5786,GO:0017059,0.215162743524778,0.977952337356891,1,8,serine C-palmitoyltransferase complex,CC,ORMDL1
7233,GO:0031211,0.215162743524778,0.977952337356891,1,8,endoplasmic reticulum palmitoyltransferase complex,CC,ORMDL1
19378,GO:1905961,0.215162743524778,0.977952337356891,1,8,protein-cysteine S-palmitoyltransferase complex,CC,ORMDL1
2245,GO:0005172,0.215315068615751,0.977919618310407,1,8,vascular endothelial growth factor receptor binding,MF,VEGFC
6034,GO:0019199,0.215752334866602,0.924214519687,3,50,transmembrane receptor protein kinase activity,MF,AXL;NRP1;EPHA2
12505,GO:0050691,0.215792131082107,0.944935024516747,2,29,regulation of defense response to virus by host,BP,IL1B;IL23A
12976,GO:0051451,0.216057126666554,0.977759845368964,1,8,myoblast migration,BP,ANXA1
3011,GO:0006573,0.21639878542086,0.977686070092947,1,8,valine metabolic process,BP,BCAT1
7010,GO:0030803,0.216403737010555,0.977684999897444,1,8,negative regulation of cyclic nucleotide biosynthetic process,BP,GPR176
7025,GO:0030818,0.216403737010555,0.977684999897444,1,8,negative regulation of cAMP biosynthetic process,BP,GPR176
10239,GO:0043011,0.216405225243329,0.977684678237658,1,8,myeloid dendritic cell differentiation,BP,RELB
18127,GO:1902930,0.216500423138287,0.923738197269891,3,52,regulation of alcohol biosynthetic process,BP,NFKB1;IL1B;HMGCS1
13245,GO:0051974,0.21659349729419,0.977643965459071,1,8,negative regulation of telomerase activity,BP,TP53
5472,GO:0016427,0.216628666102533,0.977636355886153,1,8,tRNA (cytosine) methyltransferase activity,MF,METTL2A
5208,GO:0015837,0.216845634553616,0.944495737259185,2,29,amine transport,BP,ARG1;HTR1B
7474,GO:0031665,0.217372380127259,0.977475103455715,1,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,TRIB1
3390,GO:0007187,0.217437195043978,0.908774057414465,4,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,EDN1;ANXA1;GPR176;HTR1B
3117,GO:0006721,0.217459062997777,0.923198191457187,3,53,terpenoid metabolic process,BP,SDR16C5;HMGCS1;CYP1A1
8273,GO:0033129,0.217490064726661,0.977449528730923,1,8,positive regulation of histone phosphorylation,BP,IL1B
14936,GO:0070886,0.217510609822278,0.977445062322927,1,8,positive regulation of calcineurin-NFAT signaling cascade,BP,NRG1
17167,GO:0106058,0.217510609822278,0.977445062322927,1,8,positive regulation of calcineurin-mediated signaling,BP,NRG1
5245,GO:0015908,0.217695486803772,0.923117393266617,3,52,fatty acid transport,BP,EDN1;IL1B;ANXA1
12924,GO:0051346,0.217856726607433,0.865223815624969,11,277,negative regulation of hydrolase activity,BP,MMP9;SERPINB2;TP53;SLIT2;HERPUD1;CRYAB;ANXA8;ANXA1;BIRC3;EGLN1;SERPINH1
10236,GO:0043008,0.218136638388155,0.977308733686546,1,8,ATP-dependent protein binding,MF,HSP90AB1
11287,GO:0045647,0.218305404612353,0.97727190467446,1,8,negative regulation of erythrocyte differentiation,BP,MAFB
17063,GO:0099738,0.218610771437629,0.94384662100744,2,28,cell cortex region,CC,RIMS2;EPB41L2
1001,GO:0002483,0.218622381065215,0.977202643792339,1,8,antigen processing and presentation of endogenous peptide antigen,BP,ERAP1
7851,GO:0032434,0.218938723631794,0.897144366379829,5,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;HSP90AB1;SVIP
10117,GO:0042726,0.218965447018484,0.977127551741991,1,8,flavin-containing compound metabolic process,BP,ENPP1
10575,GO:0043587,0.218995567745474,0.977120952281804,1,8,tongue morphogenesis,BP,KRT13
11234,GO:0045576,0.219061472086293,0.943566937785,2,29,mast cell activation,BP,LYN;HMOX1
14650,GO:0070307,0.219123979380439,0.977092805516783,1,8,lens fiber cell development,BP,EPHA2
17207,GO:0120025,0.219209626139796,0.826660464847234,44,1262,plasma membrane bounded cell projection,CC,NEFL;TENM3;DSCAM;LCP1;NEFM;B4GALT1;FEZ1;DPYSL3;MYO1B;IFT46;CNTNAP1;IL6ST;CRYAB;CYLD;ITGAV;AP3M1;ANXA1;SLC8A1;WWC1;ARG1;SYT11;HSP90AA1;CANX;NRP1;SETX;NRG1;HSP90AB1;L1CAM;AJUBA;SLC39A14;CORO1C;MME;DLG1;EHD1;ADGRL3;IQCJ-SCHIP1;HTR1B;NEDD4;CDK6;TUBB3;EPHA2;MYH9;SORBS2;CEP83
13728,GO:0060347,0.219245125180366,0.977066233928274,1,8,heart trabecula formation,BP,EGLN1
15822,GO:0072584,0.21947951190865,0.977014776505116,1,8,caveolin-mediated endocytosis,BP,NEDD4L
1990,GO:0004726,0.219567622413486,0.976995416270913,1,8,non-membrane spanning protein tyrosine phosphatase activity,MF,DUSP1
2927,GO:0006470,0.219674431063561,0.86739140081689,10,244,protein dephosphorylation,BP,DUSP8;DUSP1;DAPP1;HSP90AB1;IGFBP3;EYA3;DLG1;HSP90B1;UBXN2B;CPPED1
3151,GO:0006778,0.219698436915937,0.943214046283248,2,30,porphyrin-containing compound metabolic process,BP,HMOX1;CYP1A1
11586,GO:0046325,0.219797367113477,0.976944893074995,1,8,negative regulation of glucose import,BP,ENPP1
1481,GO:0003831,0.220251347076162,0.976844879074615,1,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT1
20135,GO:2001020,0.220293321636171,0.881202628921361,7,162,regulation of response to DNA damage stimulus,BP,PMAIP1;PARP1;FIGN;EYA3;PTTG1IP;PML;EID3
746,GO:0001991,0.220347321870355,0.976823704877315,1,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,MME
11757,GO:0046660,0.220424021959888,0.907027553403795,4,78,female sex differentiation,BP,SLIT2;AXL;MMP19;ZFP42
6739,GO:0030183,0.220452066451632,0.907011104218224,4,78,B cell differentiation,BP,LGALS1;DNAJB9;CYLD;XBP1
6544,GO:0022010,0.22054667523517,0.976779689030251,1,8,central nervous system myelination,BP,CNTNAP1
7749,GO:0032291,0.22054667523517,0.976779689030251,1,8,axon ensheathment in central nervous system,BP,CNTNAP1
16206,GO:0090303,0.22065569876582,0.942894634758323,2,29,positive regulation of wound healing,BP,ANXA1;XBP1
10378,GO:0043249,0.220821381877158,0.976718960444278,1,8,erythrocyte maturation,BP,G6PD
17710,GO:1901699,0.220840222505586,0.848523266820017,17,447,cellular response to nitrogen compound,BP,NFKB1;EDN1;TP53;SLIT2;RIPK2;PARP1;HSPA5;IL1B;LYN;SLC8A1;XBP1;ARG1;KLF10;ZC3H7B;HSP90B1;HTR1B;ENPP1
650,GO:0001844,0.220881996148236,0.942713573173204,2,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,TP53;PMAIP1
7466,GO:0031650,0.220934971439573,0.976693824039938,1,8,regulation of heat generation,BP,IL1B
3279,GO:0006987,0.221001375497468,0.976679122476096,1,8,activation of signaling protein activity involved in unfolded protein response,BP,HSPA5
3495,GO:0007420,0.221249015636113,0.848201531907486,17,445,brain development,BP,NEFL;MAFB;FEZ1;SLIT2;HSPA5;AXL;SEMA7A;G6PD;SLC8A1;SUDS3;NRP1;NRG1;NR2F2;HMGCS1;ETS1;CDK6;OXCT1
12134,GO:0048291,0.221261518610601,0.976621478819761,1,8,isotype switching to IgG isotypes,BP,HSPD1
18389,GO:1903510,0.221576965921058,0.90635053237276,4,78,mucopolysaccharide metabolic process,BP,NFKB1;B4GALT1;IL1B;HAS2
13730,GO:0060349,0.221634771449497,0.921058140277543,3,52,bone morphogenesis,BP,OSR2;SERPINH1;HAS2
16048,GO:0090068,0.221711439574122,0.869927198268063,9,218,positive regulation of cell cycle process,BP,IL1A;EDN1;TP53;IL1B;ANXA1;CXCR5;TGFA;PML;CYP1A1
1298,GO:0003157,0.221724102821901,0.976518783964712,1,8,endocardium development,BP,NRG1
6394,GO:0021670,0.221728073730561,0.976517901340878,1,8,lateral ventricle development,BP,CDK6
18149,GO:1902959,0.221752015060593,0.976512579454546,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,LYN
19138,GO:1905245,0.221752015060593,0.976512579454546,1,8,regulation of aspartic-type peptidase activity,BP,LYN
16814,GO:0098779,0.221850097221235,0.976490769973527,1,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,OPTN
17628,GO:1901526,0.221850097221235,0.976490769973527,1,8,positive regulation of mitophagy,BP,OPTN
15961,GO:0086013,0.221881464880923,0.976483792731776,1,8,membrane repolarization during cardiac muscle cell action potential,BP,DLG1
6810,GO:0030291,0.221952358535191,0.942259352658842,2,30,protein serine/threonine kinase inhibitor activity,MF,CDKN2A;CDKN2B
5385,GO:0016242,0.222017085734973,0.942317834257522,2,29,negative regulation of macroautophagy,BP,FEZ1;HMOX1
8290,GO:0033148,0.222106868782611,0.976433621672114,1,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PARP1
12161,GO:0048368,0.222482582060081,0.976349863499862,1,8,lateral mesoderm development,BP,CITED2
6342,GO:0021542,0.222538232043626,0.97633744347967,1,8,dentate gyrus development,BP,CDK6
11865,GO:0046929,0.222670327751508,0.976307947851612,1,8,negative regulation of neurotransmitter secretion,BP,SYT11
3246,GO:0006930,0.222704594323988,0.976300293170337,1,8,substrate-dependent cell migration, cell extension,BP,NRP1
8768,GO:0034483,0.222991100545326,0.976236238338982,1,8,heparan sulfate sulfotransferase activity,MF,HS3ST1
15442,GO:0071837,0.223093631647641,0.976213292103526,1,8,HMG box domain binding,MF,JUN
11441,GO:0045934,0.223135280840844,0.826157395078067,38,1095,negative regulation of nucleobase-containing compound metabolic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;NOCT;DUSP1;GPR176;NBN;WWC1;NEDD4L;SUDS3;EGLN1;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;NEDD4;PML;ZBTB21;SOX11;MAGED1
5557,GO:0016593,0.2231798369971,0.976193990099238,1,8,Cdc73/Paf1 complex,CC,CTR9
480,GO:0001527,0.223309077655684,0.976165036024554,1,8,microfibril,CC,FBN2
702,GO:0001931,0.223465577492355,0.976129949070274,1,8,uropod,CC,MYH9
7254,GO:0031254,0.223465577492355,0.976129949070274,1,8,cell trailing edge,CC,MYH9
12799,GO:0051149,0.223467485728674,0.920007731895028,3,54,positive regulation of muscle cell differentiation,BP,EDN1;NRG1;EHD1
7019,GO:0030812,0.223497448805546,0.976122800101068,1,8,negative regulation of nucleotide catabolic process,BP,EGLN1
19380,GO:1990001,0.223516344450183,0.976118561112752,1,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,BIRC3
10045,GO:0042574,0.22360216677467,0.976099302791878,1,8,retinal metabolic process,BP,SDR16C5
9668,GO:0038095,0.223845014822823,0.893997647267755,5,109,Fc-epsilon receptor signaling pathway,BP,NFKBIA;NFKB1;PSMB9;JUN;LYN
7781,GO:0032352,0.223874155194415,0.976038212760089,1,8,positive regulation of hormone metabolic process,BP,IL1B
16965,GO:0099106,0.223989852845156,0.919731711458677,3,54,ion channel regulator activity,MF,NEDD4L;DLG1;NEDD4
5408,GO:0016281,0.224152636521604,0.975975575375645,1,8,eukaryotic translation initiation factor 4F complex,CC,EIF4G2
15178,GO:0071372,0.224517873485539,0.975893287910675,1,8,cellular response to follicle-stimulating hormone stimulus,BP,HMGCS1
2956,GO:0006511,0.224670724340224,0.842108258684758,19,515,ubiquitin-dependent protein catabolic process,BP,TP53;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;CYLD;TRIB1;DERL3;NEDD4L;XBP1;HSP90AB1;SEL1L;HSP90B1;SVIP;UBXN2B;NEDD4;PML
9593,GO:0036490,0.224876296979573,0.975812384764646,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,DNAJC3
11454,GO:0045954,0.224941235995764,0.975797710782361,1,8,positive regulation of natural killer cell mediated cytotoxicity,BP,PVR
20244,GO:2001257,0.225050634050069,0.904301175808264,4,78,regulation of cation channel activity,BP,MMP9;NETO1;STAC;DLG1
12110,GO:0048251,0.225075754508196,0.975767298625033,1,8,elastic fiber assembly,BP,LOX
9519,GO:0036310,0.22514968724698,0.975750574830902,1,8,annealing helicase activity,MF,ANXA1
5605,GO:0016684,0.225301440932579,0.940669358533986,2,32,oxidoreductase activity, acting on peroxide as acceptor,MF,GPX8;MGST3
13659,GO:0060252,0.225357794831587,0.975703466161386,1,8,positive regulation of glial cell proliferation,BP,LYN
12317,GO:0048729,0.225431417974467,0.844847198603526,17,448,tissue morphogenesis,BP,B4GALT1;EDN1;PSMB9;SLIT2;VEGFC;RHOB;FRAS1;NRP1;EGLN1;NRG1;AJUBA;DLG1;TXNRD1;PML;EPHA2;SOX11;MAGED1
14320,GO:0061577,0.225495272849966,0.975672318042444,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,G6PD
17446,GO:1900407,0.225511898438817,0.918925481990785,3,54,regulation of cellular response to oxidative stress,BP,TP53;PARP1;SOD2
17638,GO:1901550,0.225797781116905,0.975603701877967,1,8,regulation of endothelial cell development,BP,IL1B
18230,GO:1903140,0.225797781116905,0.975603701877967,1,8,regulation of establishment of endothelial barrier,BP,IL1B
13727,GO:0060346,0.225872275809545,0.975586788335268,1,8,bone trabecula formation,BP,FBN2
13721,GO:0060338,0.226090893922097,0.940577033130012,2,29,regulation of type I interferon-mediated signaling pathway,BP,HSP90AB1;IFNAR1
20170,GO:2001135,0.226105792065378,0.975533728076967,1,8,regulation of endocytic recycling,BP,EHD1
6651,GO:0030030,0.226116722463743,0.824155813287742,37,1046,cell projection organization,BP,NEFL;TENM3;LGALS1;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;SLIT2;JUN;SDK1;HSPA5;IFT46;CNTNAP1;CYLD;SEMA7A;LYN;NEDD4L;SEMA3D;KLK6;RIMS2;HSP90AA1;NRP1;SETX;NRG1;IFRD1;L1CAM;AJUBA;CORO1C;EHD1;NEDD4;TUBB3;NTNG1;EPHA2;MYH9;CEP83;PARVA
12367,GO:0048845,0.226160865414015,0.975521204889002,1,8,venous blood vessel morphogenesis,BP,CCBE1
6567,GO:0022417,0.226212345578511,0.975149857902069,1,9,protein maturation by protein folding,BP,CALR
7584,GO:0031987,0.22639338784782,0.975468292400421,1,8,locomotion involved in locomotory behavior,BP,ADGRL3
10382,GO:0043254,0.226404938113145,0.852830785853457,13,334,regulation of protein complex assembly,BP,LCP1;TP53;PMAIP1;SLIT2;CLDN7;JUN;PARP1;CRYAB;HSP90AA1;SETX;AJUBA;DLG1;SVIP
7105,GO:0030948,0.226454674792751,0.975454335533495,1,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,NEDD4
12307,GO:0048705,0.226586933601636,0.883764511540878,6,132,skeletal system morphogenesis,BP,OSR2;FBN2;SERPINH1;DLG1;HAS2;SOX11
4359,GO:0010002,0.226670245963058,0.975405208754928,1,8,cardioblast differentiation,BP,NRG1
17432,GO:1900364,0.226737081518688,0.975389966514543,1,8,negative regulation of mRNA polyadenylation,BP,CTR9
3580,GO:0008022,0.227079869809606,0.876517085220335,7,162,protein C-terminus binding,MF,NEFL;TP53;OPTN;IFT46;TJP2;FIGN;DLG1
2282,GO:0005254,0.227196956349215,0.940100571643017,2,29,chloride channel activity,MF,CLCC1;ANO4
5563,GO:0016600,0.227339774718216,0.975252283451642,1,8,flotillin complex,CC,CORO1C
40,GO:0000082,0.227371318939757,0.865788800706623,9,221,G1/S transition of mitotic cell cycle,BP,CDKN2A;TP53;CDKN2B;ANXA1;DCUN1D3;BCAT1;CDK6;PML;CYP1A1
10535,GO:0043531,0.227402287875813,0.940011940777077,2,29,ADP binding,MF,CHORDC1;MYH9
17215,GO:0120039,0.227476337435404,0.843223146739322,17,441,plasma membrane bounded cell projection morphogenesis,BP,NEFL;DSCAM;FEZ1;SLIT2;CNTNAP1;SEMA7A;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;CORO1C;NEDD4;TUBB3;NTNG1
15424,GO:0071803,0.228277911014622,0.975037125915798,1,8,positive regulation of podosome assembly,BP,LCP1
16381,GO:0097060,0.228393452685045,0.875656269296747,7,157,synaptic membrane,CC,NETO1;CRYAB;SLC8A1;SYT11;KCTD12;RIMS2;DLG1
5128,GO:0015677,0.228396707426307,0.975009807121719,1,8,copper ion import,BP,STEAP4
14303,GO:0061548,0.228416151240469,0.975005334190464,1,8,ganglion development,BP,NRP1
7459,GO:0031643,0.228504607118225,0.974984979874535,1,8,positive regulation of myelination,BP,NRG1
8113,GO:0032836,0.228532780427377,0.974978495078334,1,8,glomerular basement membrane development,BP,COL4A4
13620,GO:0060174,0.228698798892286,0.974940262901408,1,8,limb bud formation,BP,SOX11
19585,GO:1990782,0.228815482690783,0.917208719035343,3,53,protein tyrosine kinase binding,MF,TP53;HSP90AA1;NRG1
14624,GO:0070266,0.229029220343402,0.939217681630438,2,30,necroptotic process,BP,CYLD;BIRC3
18083,GO:1902808,0.229374928103626,0.93906738125182,2,30,positive regulation of cell cycle G1/S phase transition,BP,ANXA1;CYP1A1
18763,GO:1904354,0.22958403189496,0.97473585938132,1,8,negative regulation of telomere capping,BP,NBN
12636,GO:0050884,0.229670845492204,0.974715764416076,1,8,neuromuscular process controlling posture,BP,CNTNAP1
11099,GO:0045177,0.229755287100711,0.864078169803602,9,216,apical part of cell,CC,CLDN1;EPCAM;MYO1B;ANXA1;HSP90AB1;AMOTL2;DLG1;SORBS2;TJP1
404,GO:0001085,0.229884725337705,0.890182116734464,5,107,RNA polymerase II transcription factor binding,MF,TP53;JUN;XBP1;IFRD1;ZFP42
12376,GO:0048858,0.229962313853399,0.841221624518799,17,442,cell projection morphogenesis,BP,NEFL;DSCAM;FEZ1;SLIT2;CNTNAP1;SEMA7A;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;CORO1C;NEDD4;TUBB3;NTNG1
15374,GO:0071679,0.230277047135492,0.974575199302884,1,8,commissural neuron axon guidance,BP,NRP1
6206,GO:0019774,0.230509179440628,0.973849605466963,1,10,proteasome core complex, beta-subunit complex,CC,PSMB9
12200,GO:0048500,0.230772483995323,0.974085635367085,1,9,signal recognition particle,CC,DERL3
4479,GO:0010522,0.230786481367136,0.916108809022566,3,54,regulation of calcium ion transport into cytosol,BP,LYN;SLC8A1;PML
4303,GO:0009812,0.230846252429451,0.974068217156718,1,9,flavonoid metabolic process,BP,CYP1A1
20064,GO:2000774,0.230877828300439,0.974060759483861,1,9,positive regulation of cellular senescence,BP,CDKN2A
6260,GO:0019882,0.230932462875119,0.873769155308349,7,169,antigen processing and presentation,BP,RELB;PSMB9;ERAP1;ITGAV;CANX;CALR;SEC24D
13707,GO:0060322,0.231227884646153,0.838417528359496,18,478,head development,BP,NEFL;OSR2;MAFB;FEZ1;SLIT2;HSPA5;AXL;SEMA7A;G6PD;SLC8A1;SUDS3;NRP1;NRG1;NR2F2;HMGCS1;ETS1;CDK6;OXCT1
12696,GO:0050999,0.231464280985784,0.938155616246283,2,30,regulation of nitric-oxide synthase activity,BP,IL1B;HSP90AA1
18136,GO:1902946,0.231488492129355,0.97429300031756,1,8,protein localization to early endosome,BP,NRP1
3492,GO:0007416,0.232004559744015,0.900183261172082,4,77,synapse assembly,BP,DSCAM;SDK1;NRG1;ADGRL3
504,GO:0001562,0.232263977933872,0.973732207388875,1,9,response to protozoan,BP,ARG1
10181,GO:0042832,0.232263977933872,0.973732207388875,1,9,defense response to protozoan,BP,ARG1
4923,GO:0014902,0.232348206700185,0.915268081953877,3,54,myotube differentiation,BP,XBP1;EHD1;MYH9
4664,GO:0010830,0.232577846959956,0.93766729170608,2,30,regulation of myotube differentiation,BP,XBP1;EHD1
14645,GO:0070302,0.232760236551652,0.872570039235105,7,161,regulation of stress-activated protein kinase signaling cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B;LYN;DLG1
19146,GO:1905269,0.232910459549305,0.899557671657942,4,80,positive regulation of chromatin organization,BP,TP53;IL1B;SDR16C5;CTR9
11964,GO:0047429,0.233089952195791,0.973535344077134,1,9,nucleoside-triphosphate diphosphatase activity,MF,ENPP1
12892,GO:0051289,0.23328026616773,0.914681077748997,3,56,protein homotetramerization,BP,TP53;SYT11;SOD2
1451,GO:0003712,0.233451131622326,0.838372113216485,17,457,transcription cofactor activity,MF,RELB;DNAJB1;JUN;NFKB2;JUNB;ATF3;WWC1;NRG1;NR2F2;AJUBA;UBP1;MED18;CITED2;SOX11;SND1;MAGED1;SUPT3H
10231,GO:0043001,0.2337024728864,0.937172438151797,2,30,Golgi to plasma membrane protein transport,BP,KRT18;OPTN
18576,GO:1903900,0.233895758012146,0.887568618752491,5,109,regulation of viral life cycle,BP,LGALS1;TNIP1;IFITM2;PPID;PML
859,GO:0002200,0.234066089774612,0.914339734256122,3,54,somatic diversification of immune receptors,BP,NBN;TFRC;HSPD1
10383,GO:0043255,0.234540959458733,0.914127084903468,3,53,regulation of carbohydrate biosynthetic process,BP,NFKB1;HAS2;ENPP1
2706,GO:0006101,0.235158755856162,0.936441769657293,2,31,citrate metabolic process,BP,ACO1;CS
3370,GO:0007163,0.235281859482548,0.870824215347067,7,159,establishment or maintenance of cell polarity,BP,FEZ1;WWC1;RHOB;AMOTL2;DLG1;MYH9;PARVA
15096,GO:0071229,0.235370742247729,0.877824740161401,6,134,cellular response to acid chemical,BP,EDN1;CLDN1;KRT13;LYN;XBP1;SETX
4990,GO:0015165,0.235598070440693,0.972932572139907,1,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,SLC35B1
2968,GO:0006527,0.235919539953375,0.972854770663176,1,9,arginine catabolic process,BP,ARG1
3256,GO:0006949,0.236559581925967,0.935907677825327,2,30,syncytium formation,BP,EHD1;MYH9
12194,GO:0048488,0.236624137874256,0.935973386425946,2,29,synaptic vesicle endocytosis,BP,SYT11;CANX
11032,GO:0045064,0.236887028035488,0.972619874802844,1,9,T-helper 2 cell differentiation,BP,ANXA1
2670,GO:0006048,0.237295278371206,0.972520419628487,1,9,UDP-N-acetylglucosamine biosynthetic process,BP,NAGK
10514,GO:0043497,0.237798034002122,0.972397667204335,1,9,regulation of protein heterodimerization activity,BP,NRG1
10032,GO:0042552,0.237832960186738,0.896581993581982,4,80,myelination,BP,CNTNAP1;KLK6;NRG1;DLG1
15951,GO:0086003,0.237950725006315,0.935383104970048,2,29,cardiac muscle cell contraction,BP,NEDD4L;DLG1
12608,GO:0050852,0.238070533889599,0.875901502983786,6,141,T cell receptor signaling pathway,BP,NFKBIA;NFKB1;PSMB9;RIPK2;CYLD;EIF2B1
3264,GO:0006958,0.238159465535598,0.972309233041386,1,9,complement activation, classical pathway,BP,C1R
17724,GO:1901741,0.238223541069695,0.972293538841449,1,9,positive regulation of myoblast fusion,BP,EHD1
4656,GO:0010822,0.238244229666314,0.875807806478164,6,139,positive regulation of mitochondrion organization,BP,MMP9;TP53;PMAIP1;OPTN;NRG1;UGCG
10689,GO:0044057,0.238291196709343,0.853489187974267,10,248,regulation of system process,BP,EDN1;PARP1;IL1B;C1QTNF1;IL6ST;MGLL;G6PD;SLC8A1;NRG1;DLG1
1272,GO:0003085,0.238446291231702,0.972238941674587,1,9,negative regulation of systemic arterial blood pressure,BP,SOD2
5789,GO:0017062,0.238507015571991,0.972224047505101,1,9,respiratory chain complex III assembly,BP,UQCC1
8785,GO:0034551,0.238507015571991,0.972224047505101,1,9,mitochondrial respiratory chain complex III assembly,BP,UQCC1
5671,GO:0016810,0.238945748276971,0.884278720163092,5,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,DPYSL3;ARG1;SUDS3;NGLY1;GDA
780,GO:0002043,0.239085207608433,0.972082009538366,1,9,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,HMOX1
16614,GO:0097531,0.239354957488432,0.972015605680664,1,9,mast cell migration,BP,VEGFC
3498,GO:0007431,0.239377579107259,0.934649569807531,2,30,salivary gland development,BP,XBP1;NRP1
416,GO:0001104,0.239688516021705,0.895426277535033,4,81,RNA polymerase II transcription cofactor activity,MF,DNAJB1;MED18;CITED2;SOX11
408,GO:0001094,0.239720851136552,0.971925394462216,1,9,TFIID-class transcription factor binding,MF,TP53
12931,GO:0051353,0.239769225622577,0.934383990299365,2,31,positive regulation of oxidoreductase activity,BP,EDN1;IL1B
11080,GO:0045136,0.240057369899749,0.97184228346581,1,9,development of secondary sexual characteristics,BP,B4GALT1
12031,GO:0048016,0.240064502987181,0.934341284777199,2,30,inositol phosphate-mediated signaling,BP,EDN1;NRG1
8124,GO:0032874,0.240112400568985,0.883572111703925,5,107,positive regulation of stress-activated MAPK cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B
11957,GO:0047372,0.240184480806918,0.971810855064329,1,9,acylglycerol lipase activity,MF,MGLL
12485,GO:0050665,0.240238177901551,0.97179757251744,1,9,hydrogen peroxide biosynthetic process,BP,CYP1A1
11327,GO:0045723,0.240347205037773,0.971770592817858,1,9,positive regulation of fatty acid biosynthetic process,BP,ANXA1
10090,GO:0042641,0.240824444383091,0.910651430738061,3,54,actomyosin,CC,LCP1;MYH9;TPM4
4652,GO:0010818,0.240875135825204,0.971639749339711,1,9,T cell chemotaxis,BP,CXCL16
4822,GO:0014046,0.241290147953397,0.97153665610482,1,9,dopamine secretion,BP,HTR1B
4830,GO:0014059,0.241290147953397,0.97153665610482,1,9,regulation of dopamine secretion,BP,HTR1B
16575,GO:0097458,0.241663322018886,0.813277464391915,33,939,neuron part,CC,NEFL;NETO1;TENM3;DSCAM;NEFM;FEZ1;DPYSL3;DBNDD2;HERPUD1;CNTNAP1;IL6ST;CRYAB;LYN;AP3M1;SLC8A1;ARG1;SYT11;KCTD12;RIMS2;CANX;NRP1;SETX;NRG1;L1CAM;STXBP5;MME;DLG1;ADGRL3;IQCJ-SCHIP1;HTR1B;NEDD4;TUBB3;EPHA2
12549,GO:0050765,0.242032928560921,0.971351623326178,1,9,negative regulation of phagocytosis,BP,SYT11
10643,GO:0043922,0.242158951211366,0.971320163987442,1,9,negative regulation by host of viral transcription,BP,JUN
139,GO:0000290,0.242225393105059,0.97130357021839,1,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,NOCT
20062,GO:2000772,0.242587973262505,0.93311193953152,2,31,regulation of cellular senescence,BP,CDKN2A;CDK6
17008,GO:0099528,0.242952467391675,0.971121636044982,1,9,G-protein coupled neurotransmitter receptor activity,MF,HTR1B
8107,GO:0032823,0.242959068277733,0.971119981394405,1,9,regulation of natural killer cell differentiation,BP,AXL
12836,GO:0051204,0.24304553849867,0.93281862745817,2,32,protein insertion into mitochondrial membrane,BP,TP53;PMAIP1
18573,GO:1903897,0.243146729511335,0.971072918136223,1,9,regulation of PERK-mediated unfolded protein response,BP,HSPA5
7414,GO:0031543,0.243338091861215,0.971024882836838,1,9,peptidyl-proline dioxygenase activity,MF,EGLN1
3252,GO:0006939,0.243408037112484,0.909181283155954,3,55,smooth muscle contraction,BP,EDN1;SLC8A1;DLG1
6447,GO:0021795,0.243691015516914,0.932703316343309,2,30,cerebral cortex cell migration,BP,SLIT2;NRP1
12993,GO:0051489,0.243827549033891,0.932641306629405,2,30,regulation of filopodium assembly,BP,DPYSL3;NRP1
11200,GO:0045408,0.244001953968738,0.970857898451729,1,9,regulation of interleukin-6 biosynthetic process,BP,IL1B
4705,GO:0010885,0.244208411147321,0.970805858568844,1,9,regulation of cholesterol storage,BP,EHD1
13660,GO:0060253,0.244255074642647,0.970794089352929,1,9,negative regulation of glial cell proliferation,BP,SOX11
6289,GO:0019941,0.244257627282668,0.82606078333858,19,523,modification-dependent protein catabolic process,BP,TP53;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;CYLD;TRIB1;DERL3;NEDD4L;XBP1;HSP90AB1;SEL1L;HSP90B1;SVIP;UBXN2B;NEDD4;PML
12761,GO:0051095,0.244333706713798,0.970774251229272,1,9,regulation of helicase activity,BP,TP53
16229,GO:0090331,0.244383133841857,0.970761777402168,1,9,negative regulation of platelet aggregation,BP,C1QTNF1
6,GO:0000012,0.244486217287344,0.970735752914811,1,9,single strand break repair,BP,PARP1
940,GO:0002363,0.244515765683251,0.970728290741487,1,9,alpha-beta T cell lineage commitment,BP,IL23A
9260,GO:0035729,0.244670436894755,0.97068921270176,1,9,cellular response to hepatocyte growth factor stimulus,BP,NRP1
1413,GO:0003376,0.244878936431275,0.970636488934466,1,9,sphingosine-1-phosphate signaling pathway,BP,SPNS2
16279,GO:0090520,0.244878936431275,0.970636488934466,1,9,sphingolipid mediated signaling pathway,BP,SPNS2
5131,GO:0015682,0.244916109557035,0.931966516763224,2,32,ferric iron transport,BP,STEAP4;TFRC
15773,GO:0072512,0.244916109557035,0.931966516763224,2,32,trivalent inorganic cation transport,BP,STEAP4;TFRC
6827,GO:0030315,0.245228859397173,0.932003434918532,2,30,T-tubule,CC,STAC;SLC8A1
7305,GO:0031334,0.245241109095609,0.85766643265444,8,195,positive regulation of protein complex assembly,BP,LCP1;TP53;PMAIP1;JUN;PARP1;SETX;AJUBA;DLG1
8717,GO:0034393,0.245352264646143,0.970516601707506,1,9,positive regulation of smooth muscle cell apoptotic process,BP,CDKN2A
12251,GO:0048609,0.245486294780137,0.82859626313114,17,459,multicellular organismal reproductive process,BP,B4GALT1;EDN1;SLIT2;CLDN11;JUNB;AXL;ANXA1;BIRC3;ARG1;MMP19;BRD2;SETX;NR2F2;CALR;ETS1;HAS2;CYP1A1
15814,GO:0072574,0.245935727499767,0.970368444999677,1,9,hepatocyte proliferation,BP,XBP1
15815,GO:0072575,0.245935727499767,0.970368444999677,1,9,epithelial cell proliferation involved in liver morphogenesis,BP,XBP1
20189,GO:2001170,0.24618962417352,0.970303844869071,1,9,negative regulation of ATP biosynthetic process,BP,PARP1
12226,GO:0048548,0.246626752327938,0.970192440852949,1,9,regulation of pinocytosis,BP,AXL
368,GO:0000990,0.24665297987426,0.970185749265923,1,9,transcription factor activity, core RNA polymerase binding,MF,TP53
4550,GO:0010649,0.24673389912598,0.970165098596366,1,9,regulation of cell communication by electrical coupling,BP,SLC8A1
9683,GO:0038128,0.246804520314928,0.931189309076601,2,31,ERBB2 signaling pathway,BP,HSP90AA1;NRG1
2380,GO:0005536,0.246856701025062,0.970133744232327,1,9,glucose binding,MF,G6PD
13178,GO:0051879,0.246889656355907,0.931150245232566,2,31,Hsp90 protein binding,MF,PPID;CHORDC1
13861,GO:0060546,0.247006763764119,0.970095404613034,1,9,negative regulation of necroptotic process,BP,BIRC3
13130,GO:0051767,0.247316454881903,0.970016194876682,1,9,nitric-oxide synthase biosynthetic process,BP,EDN1
13131,GO:0051769,0.247316454881903,0.970016194876682,1,9,regulation of nitric-oxide synthase biosynthetic process,BP,EDN1
4739,GO:0010934,0.24732739815422,0.970013393780731,1,9,macrophage cytokine production,BP,SEMA7A
15889,GO:0072718,0.247342420749568,0.970009548283138,1,9,response to cisplatin,BP,HMOX1
3317,GO:0007043,0.247357687125189,0.890743583542048,4,80,cell-cell junction assembly,BP,CLDN1;CNTNAP1;DLG1;TJP1
14688,GO:0070382,0.247416225560279,0.878691010275507,5,112,exocytic vesicle,CC,DPYSL3;DBNDD2;SYT11;STXBP5;MME
7045,GO:0030852,0.247811456576214,0.969889345939121,1,9,regulation of granulocyte differentiation,BP,TRIB1
6749,GO:0030203,0.247932787790242,0.878403095161738,5,109,glycosaminoglycan metabolic process,BP,NFKB1;B4GALT1;HS3ST1;IL1B;HAS2
17473,GO:1900746,0.248004559752806,0.969839780531019,1,9,regulation of vascular endothelial growth factor signaling pathway,BP,CCBE1
17992,GO:1902547,0.248004559752806,0.969839780531019,1,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,CCBE1
736,GO:0001972,0.248099871361221,0.969815299367172,1,9,retinoic acid binding,MF,NR2F2
3281,GO:0006991,0.248217534728301,0.969785061806149,1,9,response to sterol depletion,BP,LYN
6886,GO:0030488,0.248361013812303,0.930385027827995,2,32,tRNA methylation,BP,METTL2A;TRMT44
3698,GO:0008233,0.248734961422837,0.832596898613346,14,375,peptidase activity,MF,MMP9;ASPRV1;PSMB9;ANPEP;ERAP1;CYLD;C1R;SEC11C;MMP19;KLK6;TPP2;PREP;ADAM8;MME
10225,GO:0042995,0.248840266912165,0.800199209443072,45,1311,cell projection,CC,NEFL;TENM3;DSCAM;LCP1;NEFM;B4GALT1;FEZ1;DPYSL3;MYO1B;IFT46;CNTNAP1;IL6ST;CRYAB;CYLD;ITGAV;AP3M1;ANXA1;SLC8A1;WWC1;ARG1;SYT11;HSP90AA1;CANX;NRP1;SETX;NRG1;HSP90AB1;L1CAM;AJUBA;SLC39A14;CORO1C;MME;DLG1;EHD1;ADGRL3;IQCJ-SCHIP1;HTR1B;NEDD4;CDK6;TUBB3;EPHA2;MYH9;SORBS2;CEP83;TJP1
13566,GO:0060077,0.248879914677723,0.969614526228618,1,9,inhibitory synapse,CC,SYT11
10757,GO:0044260,0.248998603589932,0.783518342589473,196,6226,cellular macromolecule metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;LGALS1;SAA1;OSR2;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;SLIT2;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;HERPUD1;PARP1;OPTN;HSPA5;IL1B;MSRB3;JUNB;C1QTNF1;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;STT3A;ITGAV;LYN;ANXA1;DERL3;G6PD;NBN;WWC1;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;XBP1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;IL24;HSP90AA1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;SERP1;EIF2B1;MAFF;MAGT1;MOCS2;MGA;PRR5L;UBP1;METTL2A;CORO1C;IL23A;DLG1;TRMT44;MED18;RBMS3;NGLY1;ZMYM4;CITED2;LOX;ZNF814;PTTG1IP;DHDDS;ETS1;HAS2;CALU;CHORDC1;TGFA;BAMBI;DNAJC3;CBLL1;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1
11269,GO:0045623,0.249022975510907,0.969577623723499,1,9,negative regulation of T-helper cell differentiation,BP,ANXA1
7085,GO:0030901,0.249315996964773,0.905801833736523,3,57,midbrain development,BP,HSPA5;G6PD;SUDS3
11344,GO:0045746,0.249690874899382,0.929770279205686,2,32,negative regulation of Notch signaling pathway,BP,NFKBIA;CHAC1
8298,GO:0033160,0.249869421593789,0.969358772281924,1,9,positive regulation of protein import into nucleus, translocation,BP,HSP90AB1
7369,GO:0031441,0.249930224753742,0.969343017757445,1,9,negative regulation of mRNA 3'-end processing,BP,CTR9
4623,GO:0010763,0.250226248337118,0.969266251471373,1,9,positive regulation of fibroblast migration,BP,SLC8A1
11291,GO:0045651,0.250334999141612,0.969238022792986,1,9,positive regulation of macrophage differentiation,BP,TRIB1
6978,GO:0030681,0.250342809989413,0.968884102639716,1,10,multimeric ribonuclease P complex,CC,POP4
8691,GO:0034364,0.250402991027018,0.968868304684155,1,10,high-density lipoprotein particle,CC,SAA1
8463,GO:0033643,0.250562490903939,0.969178925534958,1,9,host cell part,CC,AXL
13443,GO:0055021,0.250716856264091,0.929384191501792,2,31,regulation of cardiac muscle tissue growth,BP,EDN1;G6PD
11157,GO:0045294,0.250864457502945,0.969100383669909,1,9,alpha-catenin binding,MF,AJUBA
681,GO:0001895,0.251027768478422,0.929149901979195,2,32,retina homeostasis,BP,KRT1;ACTG1
17517,GO:1901135,0.251101743435331,0.806600539717961,31,909,carbohydrate derivative metabolic process,BP,TNIP1;NFKB1;B4GALT1;NAGK;PGK1;HS3ST1;PARP1;IL1B;TJP2;STT3A;GPR176;DERL3;G6PD;UGGT1;PAPSS2;EGLN1;GNPTAB;SEL1L;MGAT5;SERP1;MAGT1;MOCS2;DLG1;NGLY1;DHDDS;HAS2;EPHA2;GALNT14;UGCG;ENPP1;SDF2L1
11864,GO:0046928,0.251364535606955,0.929083389405421,2,31,regulation of neurotransmitter secretion,BP,SYT11;RIMS2
3168,GO:0006807,0.251593229705116,0.782064751840424,230,7379,nitrogen compound metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;SAA1;OSR2;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;RNASE7;UBQLN2;CHAC1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;HSPA5;IL1B;MSRB3;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;CRYAB;ATF3;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;ERAP1;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;STT3A;ITGAV;LYN;C1R;ANXA1;GPR176;DERL3;G6PD;NBN;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;MMP19;KLK6;ZNF638;PAPSS2;IL24;HSP90AA1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;PRR5L;UBP1;METTL2A;CORO1C;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;NGLY1;GDA;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;TYW1;CALU;IVD;CHORDC1;TGFA;MGST3;BAMBI;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;EID3;GALNT14;ZBTB21;HES4;SOX11;UGCG;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1;CYP1A1
9865,GO:0042178,0.251640248036913,0.968542525326027,1,10,xenobiotic catabolic process,BP,CYP1A1
19780,GO:2000278,0.251951928579908,0.887780971662741,4,84,regulation of DNA biosynthetic process,BP,TP53;DUSP1;HSP90AA1;HSP90AB1
19860,GO:2000392,0.252592719274005,0.96864871387566,1,9,regulation of lamellipodium morphogenesis,BP,CORO1C
1302,GO:0003161,0.2531138559199,0.968511800093435,1,9,cardiac conduction system development,BP,NRG1
8513,GO:0033865,0.253494763461241,0.927913256985211,2,33,nucleoside bisphosphate metabolic process,BP,PAPSS2;ENPP1
8519,GO:0033875,0.253494763461241,0.927913256985211,2,33,ribonucleoside bisphosphate metabolic process,BP,PAPSS2;ENPP1
8539,GO:0034032,0.253494763461241,0.927913256985211,2,33,purine nucleoside bisphosphate metabolic process,BP,PAPSS2;ENPP1
13767,GO:0060397,0.253830351391228,0.968323017290552,1,9,JAK-STAT cascade involved in growth hormone signaling pathway,BP,LYN
6973,GO:0030673,0.25427031069262,0.968206784032984,1,9,axolemma,CC,NRG1
10577,GO:0043589,0.254438513923919,0.968162283408507,1,9,skin morphogenesis,BP,CDSN
3296,GO:0007015,0.254714275182912,0.837066993864407,11,280,actin filament organization,BP,LCP1;DPYSL3;SLIT2;MYO1B;COBLL1;RHOB;NRP1;DLG1;HSP90B1;SORBS2;TPM4
2802,GO:0006282,0.254714846117421,0.886051480795015,4,84,regulation of DNA repair,BP,PARP1;FIGN;EYA3;PML
13134,GO:0051775,0.254894620787202,0.9676765842446,1,10,response to redox state,BP,ARHGDIB
16235,GO:0090343,0.254949161569261,0.967661959884466,1,10,positive regulation of cell aging,BP,CDKN2A
4146,GO:0009225,0.254964669603243,0.927222844475176,2,33,nucleotide-sugar metabolic process,BP,NAGK;UGGT1
17281,GO:0150005,0.25518756510197,0.9675979918967,1,10,enzyme activator complex,CC,HSPD1
2173,GO:0005041,0.255191346519433,0.967962684189668,1,9,low-density lipoprotein particle receptor activity,MF,CXCL16
3488,GO:0007409,0.255254941142686,0.833218108295849,12,305,axonogenesis,BP,NEFL;DSCAM;FEZ1;SLIT2;SEMA7A;SEMA3D;NRP1;NRG1;IFRD1;L1CAM;TUBB3;NTNG1
12143,GO:0048305,0.255281081424397,0.967572880497236,1,10,immunoglobulin secretion,BP,XBP1
1982,GO:0004715,0.255693006029468,0.927058759276349,2,31,non-membrane spanning protein tyrosine kinase activity,MF,RIPK2;LYN
3763,GO:0008340,0.255714752775566,0.96782350196507,1,9,determination of adult lifespan,BP,TP53
11412,GO:0045899,0.255831517511977,0.967424854854582,1,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53
16786,GO:0098719,0.255838703589619,0.967790492022406,1,9,sodium ion import across plasma membrane,BP,SLC8A1
687,GO:0001911,0.255957677325378,0.967390874363507,1,10,negative regulation of leukocyte mediated cytotoxicity,BP,IL7R
5291,GO:0016018,0.256032806643095,0.967370629269375,1,10,cyclosporin A binding,MF,PPID
4449,GO:0010460,0.256044405630575,0.967367503065196,1,10,positive regulation of heart rate,BP,EDN1
1421,GO:0003407,0.256540099785169,0.926659611300189,2,31,neural retina development,BP,DSCAM;SDK1
12867,GO:0051253,0.257093721967601,0.799135173279736,34,990,negative regulation of RNA metabolic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;NOCT;WWC1;NEDD4L;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;NEDD4;PML;ZBTB21;SOX11;MAGED1
16891,GO:0098911,0.257131413177207,0.967445095526664,1,9,regulation of ventricular cardiac muscle cell action potential,BP,DLG1
8347,GO:0033268,0.257237801408962,0.967416578055844,1,9,node of Ranvier,CC,DLG1
15143,GO:0071320,0.257241520818468,0.926328379861696,2,31,cellular response to cAMP,BP,HSPA5;SLC8A1
3606,GO:0008076,0.257377497847422,0.926170797803792,2,32,voltage-gated potassium channel complex,CC,CNTNAP1;KCNQ5
19465,GO:1990380,0.257384717582959,0.967377174057778,1,9,Lys48-specific deubiquitinase activity,MF,CYLD
2081,GO:0004857,0.257387575312491,0.843383218361052,9,232,enzyme inhibitor activity,MF,CDKN2A;SERPINB2;SLIT2;CDKN2B;TRIB1;ANXA1;BIRC3;SERPINH1;DNAJC3
15717,GO:0072350,0.257427154250136,0.926059757404224,2,33,tricarboxylic acid metabolic process,BP,ACO1;CS
17883,GO:1902237,0.257562919572,0.966956781394729,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,PMAIP1
16997,GO:0099515,0.257725360759902,0.967285708500531,1,9,actin filament-based transport,BP,MOBP
16268,GO:0090481,0.257798439625848,0.966892821558651,1,10,pyrimidine nucleotide-sugar transmembrane transport,BP,SLC35B1
16214,GO:0090311,0.258013514227256,0.925869434506243,2,32,regulation of protein deacetylation,BP,TP53;SDR16C5
15763,GO:0072498,0.258046642915423,0.966825342502031,1,10,embryonic skeletal joint development,BP,OSR2
19763,GO:2000251,0.258305191419475,0.966754969176055,1,10,positive regulation of actin cytoskeleton reorganization,BP,NRP1
7906,GO:0032504,0.258365294398295,0.818015955055255,17,464,multicellular organism reproduction,BP,B4GALT1;EDN1;SLIT2;CLDN11;JUNB;AXL;ANXA1;BIRC3;ARG1;MMP19;BRD2;SETX;NR2F2;CALR;ETS1;HAS2;CYP1A1
14206,GO:0061298,0.258503049808491,0.967076355084533,1,9,retina vasculature development in camera-type eye,BP,NRP1
26,GO:0000050,0.258666078943064,0.966656601102725,1,10,urea cycle,BP,ARG1
6170,GO:0019627,0.258666078943064,0.966656601102725,1,10,urea metabolic process,BP,ARG1
14828,GO:0070646,0.258762276914584,0.837814907337354,10,259,protein modification by small protein removal,BP,NFKBIA;TNIP1;TP53;PSMB9;RIPK2;CYLD;BIRC3;SUDS3;TRAF3;SUPT3H
10016,GO:0042501,0.258823681762024,0.966613591876616,1,10,serine phosphorylation of STAT protein,BP,IL24
11593,GO:0046332,0.259086545569442,0.900303305585829,3,56,SMAD binding,MF,JUN;PARP1;PML
12128,GO:0048280,0.25933157401233,0.966474778877193,1,10,vesicle fusion with Golgi apparatus,BP,SEC22A
17722,GO:1901739,0.259657073469678,0.966385646506962,1,10,regulation of myoblast fusion,BP,EHD1
12692,GO:0050995,0.259761908379749,0.966356911087458,1,10,negative regulation of lipid catabolic process,BP,IL1B
17307,GO:1900037,0.25993597544405,0.966309168665216,1,10,regulation of cellular response to hypoxia,BP,AJUBA
5648,GO:0016776,0.25997093452957,0.92484977362738,2,33,phosphotransferase activity, phosphate group as acceptor,MF,TJP2;DLG1
554,GO:0001676,0.260320978047588,0.899463038590437,3,59,long-chain fatty acid metabolic process,BP,MGLL;FADS1;CYP1A1
3700,GO:0008235,0.260738371300228,0.924572208267062,2,32,metalloexopeptidase activity,MF,ANPEP;ERAP1
6337,GO:0021536,0.260886958919704,0.924501185149283,2,32,diencephalon development,BP,NRP1;ETS1
10276,GO:0043085,0.260964217473333,0.795051582829652,35,1016,positive regulation of catalytic activity,BP,CXCL1;SAA1;EDN1;PMAIP1;DNAJB1;JUN;RIPK2;HSPA5;IL1B;AXL;DNAJC10;GADD45B;LYN;NBN;HSP90AA1;NRP1;DCUN1D3;TNFSF15;NRG1;HSP90AB1;ADAM8;STXBP5;AJUBA;ARHGDIB;GIT2;CORO1C;IL23A;DLG1;TGFA;PML;EPHA2;TOR1AIP1;HSPD1;MAGED1;IRAK2
4317,GO:0009886,0.261009580224745,0.966013866466131,1,10,post-embryonic animal morphogenesis,BP,DSCAM
2674,GO:0006054,0.261050075409642,0.966002699746166,1,10,N-acetylneuraminate metabolic process,BP,NAGK
1269,GO:0003081,0.261379571331055,0.965911763455484,1,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,MME
4690,GO:0010870,0.261802732582142,0.965794777199888,1,10,positive regulation of receptor biosynthetic process,BP,EDN1
11608,GO:0046364,0.261867374476665,0.898530521497464,3,60,monosaccharide biosynthetic process,BP,PGK1;ATF3;G6PD
13244,GO:0051973,0.262344750506777,0.923712844126358,2,33,positive regulation of telomerase activity,BP,HSP90AA1;HSP90AB1
10614,GO:0043666,0.262450550259966,0.8811355070727,4,85,regulation of phosphoprotein phosphatase activity,BP,HSP90AB1;IGFBP3;HSP90B1;UBXN2B
6230,GO:0019825,0.262660565821899,0.965556933110542,1,10,oxygen binding,MF,CYP1A1
1064,GO:0002637,0.262801291291926,0.92349332320293,2,33,regulation of immunoglobulin production,BP,XBP1;TFRC
12306,GO:0048704,0.26313388716778,0.897882407499034,3,58,embryonic skeletal system morphogenesis,BP,OSR2;DLG1;SOX11
4218,GO:0009415,0.263244679383874,0.965394452081928,1,10,response to water,BP,KRT8
7191,GO:0031103,0.263310647409114,0.923338531463826,2,32,axon regeneration,BP,NEFL;JUN
7827,GO:0032409,0.263350974613582,0.858383099751512,6,139,regulation of transporter activity,BP,MMP9;NETO1;STAC;NEDD4L;DLG1;NEDD4
569,GO:0001711,0.263384619746147,0.96535546164074,1,10,endodermal cell fate commitment,BP,CTR9
20014,GO:2000677,0.263969050838517,0.922930556888903,2,33,regulation of transcription regulatory region DNA binding,BP,PARP1;SOX11
6045,GO:0019211,0.264024449033851,0.965176877495839,1,10,phosphatase activator activity,MF,IGFBP3
7397,GO:0031507,0.264332384908089,0.965090745221802,1,10,heterochromatin assembly,BP,CDKN2A
12932,GO:0051354,0.264528354822246,0.965035868610131,1,10,negative regulation of oxidoreductase activity,BP,NFKB1
16061,GO:0090084,0.264980752883636,0.96490900078766,1,10,negative regulation of inclusion body assembly,BP,DNAJB1
3250,GO:0006936,0.265349548260244,0.849167089738713,7,169,muscle contraction,BP,EDN1;CRYAB;STAC;SLC8A1;NEDD4L;DLG1;TPM4
15704,GO:0072330,0.26548115536767,0.842632113861716,8,201,monocarboxylic acid biosynthetic process,BP,EDN1;PGK1;MGLL;FADS1;ANXA1;FADS3;XBP1;CYP1A1
5720,GO:0016886,0.265694195948623,0.964708402835993,1,10,ligase activity, forming phosphoric ester bonds,MF,PARP1
1121,GO:0002717,0.265820013086561,0.964672960384982,1,10,positive regulation of natural killer cell mediated immunity,BP,PVR
12019,GO:0048002,0.265903105008324,0.856458147776899,6,148,antigen processing and presentation of peptide antigen,BP,PSMB9;ERAP1;ITGAV;CANX;CALR;SEC24D
4835,GO:0014065,0.265936706513154,0.878936316825224,4,84,phosphatidylinositol 3-kinase signaling,BP,EDN1;NRG1;PRR5L;NEDD4
13460,GO:0055067,0.266168579205605,0.878734096678115,4,86,monovalent inorganic cation homeostasis,BP,EDN1;TP53;SLC8A1;NEDD4L
3102,GO:0006695,0.266675502031237,0.895781394649605,3,59,cholesterol biosynthetic process,BP,G6PD;HMGCS1;MSMO1
14821,GO:0070633,0.26671600448958,0.964419983400656,1,10,transepithelial transport,BP,EDN1
11258,GO:0045605,0.266744397027201,0.964411950388571,1,10,negative regulation of epidermal cell differentiation,BP,CDSN
10601,GO:0043632,0.266838852708773,0.807241933122648,19,532,modification-dependent macromolecule catabolic process,BP,TP53;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;CYLD;TRIB1;DERL3;NEDD4L;XBP1;HSP90AB1;SEL1L;HSP90B1;SVIP;UBXN2B;NEDD4;PML
14481,GO:0070008,0.266874569337018,0.964375108100705,1,10,serine-type exopeptidase activity,MF,PREP
4397,GO:0010181,0.266900393774849,0.964367796539884,1,10,FMN binding,MF,TYW1
14367,GO:0061684,0.267011951351295,0.964336202041902,1,10,chaperone-mediated autophagy,BP,HSP90AA1
13862,GO:0060547,0.267082400476658,0.964316241865613,1,10,negative regulation of necrotic cell death,BP,BIRC3
11237,GO:0045579,0.267445185230649,0.964213355587089,1,10,positive regulation of B cell differentiation,BP,XBP1
12955,GO:0051412,0.267450189632184,0.964211935167643,1,10,response to corticosterone,BP,NEFL
9875,GO:0042226,0.267601844327036,0.964168875376255,1,10,interleukin-6 biosynthetic process,BP,IL1B
5382,GO:0016239,0.267675399689979,0.895241346697634,3,58,positive regulation of macroautophagy,BP,RIPK2;OPTN;HMOX1
6261,GO:0019883,0.267692268569421,0.964143187090221,1,10,antigen processing and presentation of endogenous antigen,BP,ERAP1
10564,GO:0043567,0.267717209685534,0.964136099840927,1,10,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP3
6443,GO:0021783,0.26776924025763,0.96412131233746,1,10,preganglionic parasympathetic fiber development,BP,NRP1
10002,GO:0042481,0.268039017513818,0.964044584545067,1,10,regulation of odontogenesis,BP,EDN1
4474,GO:0010517,0.268040688986771,0.920954109864031,2,33,regulation of phospholipase activity,BP,ANXA8;ANXA1
13470,GO:0055081,0.268050803267419,0.921041998340833,2,32,anion homeostasis,BP,XBP1;ENPP1
6083,GO:0019321,0.268212157977121,0.963665344534816,1,11,pentose metabolic process,BP,G6PD
3610,GO:0008081,0.268216731740293,0.894924835033787,3,58,phosphoric diester hydrolase activity,MF,PDE1C;HMOX1;ENPP1
6144,GO:0019511,0.268439060929374,0.963930637891966,1,10,peptidyl-proline hydroxylation,BP,EGLN1
6002,GO:0019076,0.268500804657526,0.92072936881204,2,33,viral release from host cell,BP,PPID;PML
9340,GO:0035890,0.268500804657526,0.92072936881204,2,33,exit from host,BP,PPID;PML
9341,GO:0035891,0.268500804657526,0.92072936881204,2,33,exit from host cell,BP,PPID;PML
13270,GO:0052126,0.268500804657526,0.92072936881204,2,33,movement in host environment,BP,PPID;PML
13279,GO:0052192,0.268500804657526,0.92072936881204,2,33,movement in environment of other organism involved in symbiotic interaction,BP,PPID;PML
19650,GO:2000009,0.268618834689721,0.963879365882308,1,10,negative regulation of protein localization to cell surface,BP,NEDD4L
4712,GO:0010893,0.268790511964449,0.963830364783778,1,10,positive regulation of steroid biosynthetic process,BP,IL1B
20160,GO:2001056,0.268801184643762,0.864232950231174,5,117,positive regulation of cysteine-type endopeptidase activity,BP,PMAIP1;RIPK2;TNFSF15;PML;HSPD1
8862,GO:0034705,0.269030978702005,0.920470057412869,2,33,potassium channel complex,CC,CNTNAP1;KCNQ5
100,GO:0000212,0.269046689073029,0.963757175794022,1,10,meiotic spindle organization,BP,MYH9
6343,GO:0021543,0.269063574070674,0.864143621520438,5,112,pallium development,BP,NEFL;FEZ1;SLIT2;NRP1;CDK6
10589,GO:0043619,0.269075736830181,0.96374887168917,1,10,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,HMOX1
8599,GO:0034143,0.269355372943789,0.963668875232306,1,10,regulation of toll-like receptor 4 signaling pathway,BP,LYN
6842,GO:0030331,0.270198193473348,0.919897841925609,2,33,estrogen receptor binding,MF,PARP1;PPID
3894,GO:0008568,0.270528190084878,0.963332282382515,1,10,microtubule-severing ATPase activity,MF,FIGN
9996,GO:0042471,0.270704579959598,0.893465543811921,3,58,ear morphogenesis,BP,OSR2;MAFB;EDN1
13895,GO:0060600,0.27084636240512,0.963240667138102,1,10,dichotomous subdivision of an epithelial terminal unit,BP,NRP1
17232,GO:0120111,0.270939114050127,0.89328308328765,3,59,neuron projection cytoplasm,CC,NEFL;AP3M1;CANX
15816,GO:0072576,0.270953516399376,0.963209784006928,1,10,liver morphogenesis,BP,XBP1
13952,GO:0060707,0.270967339989224,0.96320579881083,1,10,trophoblast giant cell differentiation,BP,NR2F2
4786,GO:0010998,0.27131268525304,0.963106160503985,1,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,DNAJC3
5619,GO:0016723,0.271588051117485,0.963026603770403,1,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,STEAP4
7074,GO:0030889,0.271828942969216,0.962956927869122,1,10,negative regulation of B cell proliferation,BP,LYN
15121,GO:0071280,0.271865122207452,0.962607440211282,1,11,cellular response to copper ion,BP,CYP1A1
5583,GO:0016641,0.271892932450986,0.96293840703994,1,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOX
11303,GO:0045663,0.271897021542862,0.962937223334231,1,10,positive regulation of myoblast differentiation,BP,IGFBP3
5302,GO:0016043,0.271940228402053,0.762915818263631,146,4592,cellular component organization,BP,CDKN2A;MMP9;IL1A;TRIM16;NEFL;KRT8;CXCL1;TENM3;LGALS1;DSCAM;KRT2;LCP1;KRT18;NEFM;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;DBNDD2;SLIT2;CLDN1;UBQLN2;COL12A1;CLDN7;MYO1B;DNAJB1;JUN;KRT4;MAP7D2;NFKB2;PARP1;OPTN;SDK1;HRNR;HSPA5;IL1B;IFT46;KRT13;CNTNAP1;C1QTNF1;CRYAB;AXL;ACTG1;NOCT;IKBKE;CYLD;SEMA7A;FBN2;DUSP1;ANXA8;FIGN;ITGAV;LYN;COBLL1;COL8A1;ANXA1;COL4A4;G6PD;NBN;NEDD4L;BIRC3;RHOB;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;SYT11;KLK6;KCTD12;RIMS2;HSP90AA1;NRP1;IL7R;TRAF1;BRD2;SETX;DCUN1D3;GNPTAB;SOD2;NRG1;IFRD1;SERPINH1;HSP90AB1;SDR16C5;ADAM8;L1CAM;EIF4G2;UQCC1;CALR;PPID;CTR9;AJUBA;IGFBP3;ANO4;AMOTL2;EYA3;SERP1;RAB30;SEC22A;ARHGDIB;CORO1C;NID2;DLG1;EHD1;ZMYM4;LOX;ETS1;HAS2;ADGRL3;SEC24D;REEP1;PDE4DIP;CHORDC1;TGFA;BAMBI;CBLL1;HSP90B1;TFRC;SVIP;UBXN2B;NEDD4;TUBB3;NTNG1;PML;EPHA2;PVR;EPB41L2;MRPS24;MYH9;TOR1AIP1;UGCG;MRPL53;ENPP1;SORBS2;AFAP1;CLINT1;TPM4;CEP83;HSPD1;SUPT3H;TJP1;PARVA
2373,GO:0005522,0.272069421744949,0.962887297741281,1,10,profilin binding,MF,ACTG1
278,GO:0000781,0.272139044360505,0.852037560092278,6,146,chromosome, telomeric region,CC,NABP1;PARP1;NBN;SETX;PML;EID3
12974,GO:0051447,0.272153505513496,0.96286293408043,1,10,negative regulation of meiotic cell cycle,BP,DUSP1
17486,GO:1901017,0.272338236992925,0.962809375644468,1,10,negative regulation of potassium ion transmembrane transporter activity,BP,NEDD4L
17604,GO:1901380,0.272338236992925,0.962809375644468,1,10,negative regulation of potassium ion transmembrane transport,BP,NEDD4L
9,GO:0000018,0.272416060609596,0.892412397290875,3,59,regulation of DNA recombination,BP,FIGN;IL7R;TFRC
8311,GO:0033182,0.272499338986009,0.962762632507065,1,10,regulation of histone ubiquitination,BP,CTR9
991,GO:0002467,0.272563256977608,0.962744077775633,1,10,germinal center formation,BP,NFKB2
4845,GO:0014704,0.272800098684704,0.918710949975894,2,32,intercalated disc,CC,SLC8A1;DLG1
1850,GO:0004526,0.272852639933439,0.962318518505488,1,11,ribonuclease P activity,MF,POP4
10445,GO:0043371,0.272914767426447,0.962641944835997,1,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,ANXA1
14596,GO:0070208,0.273187686396101,0.962562538321829,1,10,protein heterotrimerization,BP,C1QTNF1
762,GO:0002020,0.273258932908123,0.874133666512313,4,87,protease binding,MF,TP53;CCBE1;RIPK2;ITGAV
2443,GO:0005669,0.27331244568261,0.918187982245348,2,35,transcription factor TFIID complex,CC,TP53;SUPT3H
6915,GO:0030540,0.273447677111652,0.962486804919619,1,10,female genitalia development,BP,AXL
12856,GO:0051238,0.274087966964321,0.961955330449909,1,11,sequestering of metal ion,BP,FTH1
5697,GO:0016853,0.274150144509784,0.860509037968293,5,120,isomerase activity,MF,PUS10;PDIA6;PPID;HMGCS1;PDIA4
4393,GO:0010165,0.27418177310721,0.917931220625232,2,33,response to X-ray,BP,TP53;ANXA1
7130,GO:0031005,0.274182621653392,0.962272254092827,1,10,filamin binding,MF,DPYSL3
10980,GO:0044843,0.274227022318184,0.830496021837219,9,233,cell cycle G1/S phase transition,BP,CDKN2A;TP53;CDKN2B;ANXA1;DCUN1D3;BCAT1;CDK6;PML;CYP1A1
5150,GO:0015718,0.274227083960214,0.873531339878904,4,86,monocarboxylic acid transport,BP,EDN1;SLC16A9;IL1B;ANXA1
18104,GO:1902882,0.274281362596217,0.891265277155631,3,60,regulation of response to oxidative stress,BP,TP53;PARP1;SOD2
5690,GO:0016840,0.274313336750488,0.961888859663625,1,11,carbon-nitrogen lyase activity,MF,CHAC1
18032,GO:1902653,0.274485157763604,0.891144413618102,3,60,secondary alcohol biosynthetic process,BP,G6PD;HMGCS1;MSMO1
14594,GO:0070206,0.274563825503859,0.917651166957353,2,34,protein trimerization,BP,C1QTNF1;ARG1
4072,GO:0009143,0.275651108571173,0.961492949140223,1,11,nucleoside triphosphate catabolic process,BP,ENPP1
12693,GO:0050996,0.275690696547217,0.961829842618646,1,10,positive regulation of lipid catabolic process,BP,IL1B
417,GO:0001105,0.275846425667376,0.917103126810467,2,33,RNA polymerase II transcription coactivator activity,MF,CITED2;SOX11
18191,GO:1903036,0.276205981821028,0.916832666975726,2,34,positive regulation of response to wounding,BP,ANXA1;XBP1
18811,GO:1904467,0.276268789889182,0.961659480124418,1,10,regulation of tumor necrosis factor secretion,BP,SYT11
18115,GO:1902902,0.27629264960422,0.961302267805565,1,11,negative regulation of autophagosome assembly,BP,FEZ1
3166,GO:0006801,0.276750889656154,0.916474241247076,2,35,superoxide metabolic process,BP,EDN1;SOD2
10880,GO:0044463,0.276976212492798,0.784043079357144,31,893,cell projection part,CC,NEFL;DSCAM;LCP1;B4GALT1;FEZ1;DPYSL3;IFT46;CNTNAP1;IL6ST;CRYAB;CYLD;ITGAV;AP3M1;SLC8A1;WWC1;SYT11;HSP90AA1;CANX;NRP1;SETX;NRG1;HSP90AB1;L1CAM;MME;DLG1;EHD1;HTR1B;NEDD4;TUBB3;EPHA2;CEP83
17214,GO:0120038,0.276976212492798,0.784043079357144,31,893,plasma membrane bounded cell projection part,CC,NEFL;DSCAM;LCP1;B4GALT1;FEZ1;DPYSL3;IFT46;CNTNAP1;IL6ST;CRYAB;CYLD;ITGAV;AP3M1;SLC8A1;WWC1;SYT11;HSP90AA1;CANX;NRP1;SETX;NRG1;HSP90AB1;L1CAM;MME;DLG1;EHD1;HTR1B;NEDD4;TUBB3;EPHA2;CEP83
2266,GO:0005229,0.277082903766472,0.961418836407849,1,10,intracellular calcium activated chloride channel activity,MF,ANO4
14412,GO:0061778,0.277082903766472,0.961418836407849,1,10,intracellular chloride channel activity,MF,ANO4
8002,GO:0032660,0.277105120716125,0.961060019206573,1,11,regulation of interleukin-17 production,BP,IL23A
7073,GO:0030888,0.277115483413152,0.91637779141332,2,34,regulation of B cell proliferation,BP,LYN;TFRC
2201,GO:0005104,0.277502718542557,0.961294411055475,1,10,fibroblast growth factor receptor binding,MF,FGF5
2236,GO:0005161,0.277558557821004,0.961277844269277,1,10,platelet-derived growth factor receptor binding,MF,LYN
13695,GO:0060307,0.277679262880063,0.96124201896396,1,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,DLG1
16620,GO:0097539,0.277689082518118,0.961239103668501,1,10,ciliary transition fiber,CC,CEP83
6771,GO:0030228,0.277703866523631,0.961234714297075,1,10,lipoprotein particle receptor activity,MF,CXCL16
12826,GO:0051187,0.277719910833086,0.915906860203426,2,36,cofactor catabolic process,BP,CHAC1;HMOX1
17494,GO:1901030,0.27777933209589,0.915958584453116,2,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;PMAIP1
12352,GO:0048812,0.277803370423674,0.804043247056424,16,429,neuron projection morphogenesis,BP,NEFL;DSCAM;FEZ1;SLIT2;CNTNAP1;SEMA7A;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;NEDD4;TUBB3;NTNG1
17350,GO:1900119,0.278012038467795,0.960788602119167,1,11,positive regulation of execution phase of apoptosis,BP,TP53
8204,GO:0032990,0.278063787117345,0.8016441739717,17,460,cell part morphogenesis,BP,NEFL;DSCAM;FEZ1;SLIT2;CNTNAP1;SEMA7A;NEDD4L;SEMA3D;RIMS2;NRP1;NRG1;IFRD1;L1CAM;CORO1C;NEDD4;TUBB3;NTNG1
14078,GO:0060977,0.278182323403209,0.961092508798763,1,10,coronary vasculature morphogenesis,BP,NRP1
18577,GO:1903901,0.278363448047941,0.888791604176004,3,61,negative regulation of viral life cycle,BP,TNIP1;IFITM2;PML
4111,GO:0009187,0.279148457559915,0.888409335790221,3,59,cyclic nucleotide metabolic process,BP,GPR176;EGLN1;EPHA2
12992,GO:0051482,0.279312568882999,0.960397528252159,1,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,EDN1
998,GO:0002479,0.279438500963126,0.887952129997246,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMB9;ITGAV;CALR
18905,GO:1904706,0.279554915586827,0.960324411404346,1,11,negative regulation of vascular smooth muscle cell proliferation,BP,HMOX1
16777,GO:0098693,0.280270349795721,0.914884397804462,2,33,regulation of synaptic vesicle cycle,BP,SYT11;RIMS2
15498,GO:0071941,0.28033804367015,0.960087617733632,1,11,nitrogen cycle metabolic process,BP,ARG1
16504,GO:0097300,0.280549137232479,0.914562770741425,2,35,programmed necrotic cell death,BP,CYLD;BIRC3
20071,GO:2000785,0.280625093846623,0.914612124476269,2,34,regulation of autophagosome assembly,BP,FEZ1;UBQLN2
2759,GO:0006198,0.280872548802081,0.960287441666117,1,10,cAMP catabolic process,BP,EGLN1
14548,GO:0070131,0.280903033063954,0.959916287728308,1,11,positive regulation of mitochondrial translation,BP,UQCC1
2649,GO:0006012,0.281491945465658,0.959737261390604,1,11,galactose metabolic process,BP,B4GALT1
3912,GO:0008610,0.28158210561148,0.796634018187813,18,507,lipid biosynthetic process,BP,NFKB1;EDN1;FGF5;IL1B;MGLL;FADS1;ANXA1;FADS3;G6PD;PLEKHA2;XBP1;AJUBA;ORMDL1;HMGCS1;DHDDS;MSMO1;UGCG;CYP1A1
11262,GO:0045616,0.281618130682348,0.914109539119493,2,34,regulation of keratinocyte differentiation,BP,TRIM16;CDSN
13194,GO:0051898,0.281906456894112,0.913963367054202,2,34,negative regulation of protein kinase B signaling,BP,DLG1;EPHA2
12769,GO:0051103,0.281943114263777,0.959599803065709,1,11,DNA ligation involved in DNA repair,BP,PARP1
2313,GO:0005338,0.282396506761575,0.959461400182182,1,11,nucleotide-sugar transmembrane transporter activity,MF,SLC35B1
10676,GO:0044003,0.282442970868799,0.913691075395149,2,34,modification by symbiont of host morphology or physiology,BP,TNIP1;ITGAV
17346,GO:1900115,0.282536070044927,0.959418743088704,1,11,extracellular regulation of signal transduction,BP,FBN2
17347,GO:1900116,0.282536070044927,0.959418743088704,1,11,extracellular negative regulation of signal transduction,BP,FBN2
8019,GO:0032691,0.282727532742744,0.959360181787716,1,11,negative regulation of interleukin-1 beta production,BP,PML
11538,GO:0046128,0.282760674930297,0.886107002514285,3,62,purine ribonucleoside metabolic process,BP,TJP2;MOCS2;DLG1
18501,GO:1903749,0.282958467027603,0.86770322348036,4,90,positive regulation of establishment of protein localization to mitochondrion,BP,TP53;PMAIP1;NRG1;UGCG
5521,GO:0016529,0.282991789182069,0.913412140014185,2,34,sarcoplasmic reticulum,CC,CALR;CALU
796,GO:0002070,0.283208500826281,0.959212860698759,1,11,epithelial cell maturation,BP,XBP1
1249,GO:0003014,0.283356822409869,0.885833177773667,3,60,renal system process,BP,EDN1;MCAM;HAS2
846,GO:0002178,0.283374749908435,0.959161868219718,1,11,palmitoyltransferase complex,CC,ORMDL1
11210,GO:0045444,0.283378186373832,0.843954342895366,6,144,fat cell differentiation,BP,NOCT;ERAP1;NOC3L;XBP1;STEAP4;ENPP1
4701,GO:0010881,0.283405800876202,0.959152340164427,1,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,SLC8A1
4467,GO:0010507,0.283538493425697,0.885723400113948,3,60,negative regulation of autophagy,BP,FEZ1;HMOX1;EIF4G2
824,GO:0002116,0.283742075939895,0.959418417388478,1,10,semaphorin receptor complex,CC,NRP1
5837,GO:0017154,0.283742075939895,0.959418417388478,1,10,semaphorin receptor activity,MF,NRP1
12312,GO:0048711,0.283821590099458,0.959024633083397,1,11,positive regulation of astrocyte differentiation,BP,IL6ST
3637,GO:0008134,0.283848876392026,0.794721070016498,18,505,transcription factor binding,MF,CDKN2A;NFKBIA;NFKB1;MAFB;TP53;JUN;PARP1;JUNB;TRIB1;NBN;XBP1;IFRD1;SDR16C5;CALR;PPID;ETS1;ZFP42;HES4
3376,GO:0007169,0.283937930335714,0.794659823872118,18,499,transmembrane receptor protein tyrosine kinase signaling pathway,BP,MMP9;FGF5;CCBE1;IL1B;AXL;ACTG1;ITGAV;LYN;VEGFC;HSP90AA1;NRP1;SETX;NRG1;IGFBP3;TGFA;NEDD4;EPHA2;ENPP1
1300,GO:0003159,0.283972728854042,0.958978155804141,1,11,morphogenesis of an endothelium,BP,RHOB
14176,GO:0061154,0.283972728854042,0.958978155804141,1,11,endothelial tube morphogenesis,BP,RHOB
6880,GO:0030449,0.283973541830043,0.958977905721973,1,11,regulation of complement activation,BP,C1R
19769,GO:2000257,0.283973541830043,0.958977905721973,1,11,regulation of protein activation cascade,BP,C1R
15142,GO:0071318,0.283979616999489,0.958976036892196,1,11,cellular response to ATP,BP,HSP90B1
10253,GO:0043032,0.284116385613332,0.958933951680807,1,11,positive regulation of macrophage activation,BP,HSPD1
17239,GO:0140030,0.284133778904167,0.853680502829334,5,114,modification-dependent protein binding,MF,TNIP1;OPTN;IKBKE;LYN;BRD2
10044,GO:0042573,0.284333996695411,0.958866939964672,1,11,retinoic acid metabolic process,BP,CYP1A1
16696,GO:0097755,0.284402688420667,0.912603714736402,2,35,positive regulation of blood vessel diameter,BP,HMOX1;SOD2
959,GO:0002407,0.284531183951699,0.958806164158464,1,11,dendritic cell chemotaxis,BP,CALR
11731,GO:0046625,0.284668722644565,0.958763742758073,1,11,sphingolipid binding,MF,LYN
2563,GO:0005865,0.284760194324039,0.958735516223655,1,11,striated muscle thin filament,CC,TPM4
6136,GO:0019471,0.284894139649247,0.958694163330701,1,11,4-hydroxyproline metabolic process,BP,EGLN1
19368,GO:1905939,0.284995288807587,0.958662920032476,1,11,regulation of gonad development,BP,CITED2
4513,GO:0010596,0.285037973778729,0.912368614526385,2,34,negative regulation of endothelial cell migration,BP,SLIT2;NR2F2
9446,GO:0036109,0.285159538491365,0.958612157508757,1,11,alpha-linolenic acid metabolic process,BP,FADS1
3640,GO:0008138,0.285288465947962,0.912150591956952,2,35,protein tyrosine/serine/threonine phosphatase activity,MF,DUSP8;DUSP1
16099,GO:0090151,0.285328492343798,0.958249243332443,1,12,establishment of protein localization to mitochondrial membrane,BP,HSP90AA1
5654,GO:0016783,0.285425836873204,0.958218908011169,1,12,sulfurtransferase activity,MF,MOCS2
11869,GO:0046934,0.285645972717535,0.912153104547697,2,33,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF5;NRG1
7056,GO:0030864,0.285723995741513,0.884445474186158,3,59,cortical actin cytoskeleton,CC,MOBP;EPB41L2;MYH9
8022,GO:0032695,0.285999052659183,0.958352148113288,1,11,negative regulation of interleukin-12 production,BP,NFKB1
32,GO:0000060,0.286002189568739,0.911784718427597,2,35,protein import into nucleus, translocation,BP,NFKBIA;HSP90AB1
2198,GO:0005095,0.286280165035217,0.958264877289735,1,11,GTPase inhibitor activity,MF,SLIT2
12192,GO:0048486,0.286298841942892,0.958259075408113,1,11,parasympathetic nervous system development,BP,NRP1
12027,GO:0048012,0.286310135613305,0.958255566867835,1,11,hepatocyte growth factor receptor signaling pathway,BP,NRP1
11601,GO:0046349,0.286406244077694,0.958225702631605,1,11,amino sugar biosynthetic process,BP,NAGK
4750,GO:0010952,0.286431058419532,0.841649462060297,6,150,positive regulation of peptidase activity,BP,PMAIP1;RIPK2;LYN;TNFSF15;PML;HSPD1
16062,GO:0090085,0.286595964780603,0.958166714268177,1,11,regulation of protein deubiquitination,BP,TNIP1
18633,GO:1904019,0.286855196091216,0.88371206854948,3,60,epithelial cell apoptotic process,BP,KRT8;KRT18;HMOX1
5215,GO:0015849,0.287176357345886,0.832931151960153,7,173,organic acid transport,BP,EDN1;SLC16A9;IL1B;NFKBIE;ANXA1;ARG1;SLC7A5P2
11873,GO:0046942,0.287176357345886,0.832931151960153,7,173,carboxylic acid transport,BP,EDN1;SLC16A9;IL1B;NFKBIE;ANXA1;ARG1;SLC7A5P2
11370,GO:0045806,0.287186623950889,0.911176038147033,2,35,negative regulation of endocytosis,BP,UBQLN2;SYT11
16829,GO:0098801,0.287282081448571,0.957952991218257,1,11,regulation of renal system process,BP,EDN1
2798,GO:0006273,0.287415789045391,0.957911269804246,1,11,lagging strand elongation,BP,PARP1
76,GO:0000153,0.287425693572564,0.957908178313815,1,11,cytoplasmic ubiquitin ligase complex,CC,SEL1L
12610,GO:0050854,0.287436412730337,0.911047431468287,2,35,regulation of antigen receptor-mediated signaling pathway,BP,CYLD;LYN
9097,GO:0035437,0.28766087684571,0.957834732933196,1,11,maintenance of protein localization in endoplasmic reticulum,BP,HSPA5
10528,GO:0043518,0.287742346161328,0.957809273937081,1,11,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,PTTG1IP
12511,GO:0050700,0.287782832903843,0.957796618668235,1,11,CARD domain binding,MF,RIPK2
6129,GO:0019433,0.287927972832029,0.957751233403818,1,11,triglyceride catabolic process,BP,MGLL
2655,GO:0006022,0.288285085483438,0.850727769183214,5,116,aminoglycan metabolic process,BP,NFKB1;B4GALT1;HS3ST1;IL1B;HAS2
15404,GO:0071731,0.288447177417501,0.957588651379253,1,11,response to nitric oxide,BP,EGLN1
9211,GO:0035631,0.28847489736738,0.957579961276349,1,11,CD40 receptor complex,CC,TRAF3
18164,GO:1902993,0.288488582225747,0.957575670750646,1,11,positive regulation of amyloid precursor protein catabolic process,BP,LYN
6836,GO:0030325,0.288549187459532,0.957556666619718,1,11,adrenal gland development,BP,CITED2
9119,GO:0035497,0.288596584030018,0.957541800994417,1,11,cAMP response element binding,MF,JUN
6265,GO:0019887,0.288726449570375,0.8399964658177,6,148,protein kinase regulator activity,MF,CDKN2A;CDKN2B;TRIB1;NRG1;HSP90AB1;DNAJC3
5433,GO:0016324,0.28881322839477,0.831709553107517,7,172,apical plasma membrane,CC,CLDN1;EPCAM;ANXA1;HSP90AB1;AMOTL2;DLG1;SORBS2
1914,GO:0004620,0.288954251454116,0.882387168449737,3,61,phospholipase activity,MF,MGLL;PLBD1;HMOX1
4698,GO:0010878,0.289471285276466,0.957266925840601,1,11,cholesterol storage,BP,EHD1
3293,GO:0007009,0.289633986539055,0.882016492519698,3,60,plasma membrane organization,BP,SYT11;ANO4;SERP1
16128,GO:0090190,0.289679625113527,0.957201306394359,1,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,MAGED1
12740,GO:0051055,0.289800950395735,0.909825873154412,2,35,negative regulation of lipid biosynthetic process,BP,NFKB1;ORMDL1
10527,GO:0043517,0.289878697413001,0.957138552441905,1,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,PMAIP1
15384,GO:0071696,0.28997974702269,0.957106678385958,1,11,ectodermal placode development,BP,NRP1
3477,GO:0007379,0.290256179533899,0.957019414543551,1,11,segment specification,BP,MAFB
8575,GO:0034111,0.290263541665781,0.957017089097917,1,11,negative regulation of homotypic cell-cell adhesion,BP,C1QTNF1
17732,GO:1901800,0.290482492788099,0.862700501504383,4,90,positive regulation of proteasomal protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;XBP1
9259,GO:0035728,0.291043479905598,0.956770328145025,1,11,response to hepatocyte growth factor,BP,NRP1
14086,GO:0060993,0.29130829572754,0.880990257540307,3,60,kidney morphogenesis,BP,FRAS1;DLG1;MAGED1
19020,GO:1904925,0.291421902439901,0.956650311445657,1,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,OPTN
13495,GO:0055119,0.291532848923487,0.956615088903194,1,11,relaxation of cardiac muscle,BP,SLC8A1
3617,GO:0008093,0.291539933163124,0.956612839293979,1,11,cytoskeletal adaptor activity,MF,SORBS2
13477,GO:0055089,0.291760711355946,0.956542697652987,1,11,fatty acid homeostasis,BP,XBP1
11214,GO:0045453,0.291774046249188,0.908800794232907,2,35,bone resorption,BP,ADAM8;TFRC
11289,GO:0045649,0.291868159142141,0.956508537980069,1,11,regulation of macrophage differentiation,BP,TRIB1
15959,GO:0086011,0.291939073484995,0.956485984613676,1,11,membrane repolarization during action potential,BP,DLG1
6484,GO:0021872,0.292262063863701,0.908546448645245,2,35,forebrain generation of neurons,BP,SLIT2;NRP1
16516,GO:0097340,0.292325508106477,0.956362967323807,1,11,inhibition of cysteine-type endopeptidase activity,BP,BIRC3
16517,GO:0097341,0.292325508106477,0.956362967323807,1,11,zymogen inhibition,BP,BIRC3
19848,GO:2000378,0.292643316621568,0.908259572703676,2,36,negative regulation of reactive oxygen species metabolic process,BP,CRYAB;G6PD
20241,GO:2001252,0.292673032819406,0.837124752772002,6,146,positive regulation of chromosome organization,BP,TP53;IL1B;NBN;SDR16C5;CTR9;PML
558,GO:0001682,0.292693698990736,0.95591866218604,1,12,tRNA 5'-leader removal,BP,POP4
5286,GO:0016010,0.292727199296047,0.956234883807458,1,11,dystrophin-associated glycoprotein complex,CC,KRT8
16320,GO:0090665,0.292727199296047,0.956234883807458,1,11,glycoprotein complex,CC,KRT8
8121,GO:0032870,0.292730330293553,0.78924136200179,17,474,cellular response to hormone stimulus,BP,NFKB1;EDN1;SLIT2;JUN;PARP1;IL1B;JUNB;DUSP1;LYN;ANXA1;XBP1;ARG1;NR2F2;CALR;HMGCS1;NEDD4;ENPP1
7893,GO:0032488,0.292913720471379,0.956175336915874,1,11,Cdc42 protein signal transduction,BP,NRP1
3522,GO:0007530,0.292975763857454,0.956155519350599,1,11,sex determination,BP,CITED2
14321,GO:0061578,0.29298726244952,0.956151845972016,1,11,Lys63-specific deubiquitinase activity,MF,CYLD
391,GO:0001047,0.293052742629516,0.847357605897718,5,116,core promoter binding,MF,RELB;TP53;XBP1;KLF10;SOX11
36,GO:0000075,0.293066481301801,0.821555271350421,8,207,cell cycle checkpoint,BP,TP53;CDKN2B;NABP1;DUSP1;NBN;DLG1;PML;SOX11
4539,GO:0010638,0.293293427187094,0.786686472218656,18,509,positive regulation of organelle organization,BP,MMP9;IL1A;LCP1;EDN1;TP53;PMAIP1;OPTN;IL1B;ANXA1;NBN;NRP1;NRG1;SDR16C5;CTR9;DLG1;TGFA;PML;UGCG
4836,GO:0014066,0.293374368196165,0.879673321727437,3,61,regulation of phosphatidylinositol 3-kinase signaling,BP,NRG1;PRR5L;NEDD4
4582,GO:0010715,0.293401374392659,0.956019435632742,1,11,regulation of extracellular matrix disassembly,BP,ETS1
6814,GO:0030296,0.29403960467907,0.955814919344026,1,11,protein tyrosine kinase activator activity,MF,NRG1
776,GO:0002039,0.294115164803094,0.879216134102489,3,61,p53 binding,MF,TP53;PTTG1IP;HSPD1
2188,GO:0005080,0.294346718369984,0.907456362397279,2,35,protein kinase C binding,MF,FEZ1;ITGAV
5549,GO:0016580,0.294930231103376,0.955528621121215,1,11,Sin3 complex,CC,SUDS3
9357,GO:0035925,0.294998436287428,0.955506652652601,1,11,mRNA 3'-UTR AU-rich region binding,MF,RBMS3
3387,GO:0007183,0.295047697749231,0.955490781995526,1,11,SMAD protein complex assembly,BP,PARP1
14968,GO:0070938,0.295128882162231,0.955464619625197,1,11,contractile ring,CC,MYH9
15875,GO:0072697,0.295179335088343,0.955448356325674,1,11,protein localization to cell cortex,BP,EPB41L2
1863,GO:0004551,0.295408004218119,0.955041599653716,1,12,nucleotide diphosphatase activity,MF,ENPP1
20037,GO:2000726,0.295450688812997,0.955360828496289,1,11,negative regulation of cardiac muscle cell differentiation,BP,G6PD
10059,GO:0042590,0.295531952834586,0.878055196717275,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,PSMB9;ITGAV;CALR
2757,GO:0006195,0.295941415699101,0.906529154615589,2,36,purine nucleotide catabolic process,BP,EGLN1;GDA
13783,GO:0060420,0.296263155555275,0.906449084239812,2,35,regulation of heart growth,BP,EDN1;G6PD
14401,GO:0061756,0.296412587875082,0.955049769474473,1,11,leukocyte adhesion to vascular endothelial cell,BP,ETS1
2156,GO:0005003,0.296450352868116,0.955037531902182,1,11,ephrin receptor activity,MF,EPHA2
2158,GO:0005005,0.296450352868116,0.955037531902182,1,11,transmembrane-ephrin receptor activity,MF,EPHA2
13761,GO:0060391,0.29666453021226,0.954968092784796,1,11,positive regulation of SMAD protein signal transduction,BP,PARP1
3319,GO:0007045,0.296918350115863,0.877526503464699,3,60,cell-substrate adherens junction assembly,BP,NRP1;AJUBA;CORO1C
12051,GO:0048041,0.296918350115863,0.877526503464699,3,60,focal adhesion assembly,BP,NRP1;AJUBA;CORO1C
11744,GO:0046639,0.297065875664912,0.954837806733563,1,11,negative regulation of alpha-beta T cell differentiation,BP,ANXA1
5481,GO:0016442,0.297528211678307,0.954687455576187,1,11,RISC complex,CC,SND1
7303,GO:0031332,0.297528211678307,0.954687455576187,1,11,RNAi effector complex,CC,SND1
10083,GO:0042632,0.297912741079229,0.905487868743338,2,36,cholesterol homeostasis,BP,XBP1;EHD1
13480,GO:0055092,0.297912741079229,0.905487868743338,2,36,sterol homeostasis,BP,XBP1;EHD1
18177,GO:1903010,0.298140903584777,0.95448776949357,1,11,regulation of bone development,BP,TJP2
9901,GO:0042278,0.298434666247773,0.876405487396129,3,64,purine nucleoside metabolic process,BP,TJP2;MOCS2;DLG1
151,GO:0000307,0.298861503566258,0.904899208742643,2,37,cyclin-dependent protein kinase holoenzyme complex,CC,CDK6;HSPD1
15200,GO:0071398,0.298876865043638,0.905067355650124,2,35,cellular response to fatty acid,BP,EDN1;CLDN1
539,GO:0001658,0.298908605113092,0.905050519863537,2,35,branching involved in ureteric bud morphogenesis,BP,DLG1;MAGED1
15422,GO:0071801,0.299159581547335,0.954154656340459,1,11,regulation of podosome assembly,BP,LCP1
10147,GO:0042770,0.299174792674859,0.842919285522119,5,120,signal transduction in response to DNA damage,BP,TP53;PMAIP1;NBN;PTTG1IP;PML
19581,GO:1990774,0.299296062502397,0.954109920961156,1,11,tumor necrosis factor secretion,BP,SYT11
5758,GO:0016999,0.299410694499915,0.856576694226143,4,94,antibiotic metabolic process,BP,NAGK;ACO1;CS;CYP1A1
17049,GO:0099625,0.299899983971279,0.953911669984611,1,11,ventricular cardiac muscle cell membrane repolarization,BP,DLG1
14259,GO:0061430,0.30011614567642,0.953840591329441,1,11,bone trabecula morphogenesis,BP,FBN2
15199,GO:0071397,0.300322187510652,0.953772782050082,1,11,cellular response to cholesterol,BP,HMGCS1
10396,GO:0043274,0.300362559839223,0.953759488674252,1,11,phospholipase binding,MF,NEFL
16106,GO:0090161,0.300375283647459,0.953755298659868,1,11,Golgi ribbon formation,BP,OPTN
14022,GO:0060841,0.300782860035958,0.953620966903359,1,11,venous blood vessel development,BP,CCBE1
7694,GO:0032205,0.301334989533746,0.903759484271717,2,35,negative regulation of telomere maintenance,BP,PARP1;NBN
13577,GO:0060090,0.301383473188058,0.830672652874286,6,146,molecular adaptor activity,MF,NEFL;OPTN;CNTNAP1;TJP2;ANXA1;SORBS2
15960,GO:0086012,0.301487836463414,0.953388090166323,1,11,membrane depolarization during cardiac muscle cell action potential,BP,SLC8A1
9023,GO:0035269,0.301490402017587,0.95304038538255,1,12,protein O-linked mannosylation,BP,SDF2L1
17047,GO:0099623,0.301678172558415,0.953325101601602,1,11,regulation of cardiac muscle cell membrane repolarization,BP,DLG1
3921,GO:0008625,0.301744380597904,0.874335225689891,3,64,extrinsic apoptotic signaling pathway via death domain receptors,BP,PMAIP1;ATF3;HMOX1
10298,GO:0043124,0.301795378789778,0.903513624231765,2,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;OPTN
4803,GO:0014015,0.301816750392287,0.903410263314717,2,36,positive regulation of gliogenesis,BP,IL6ST;LYN
3098,GO:0006691,0.301822469727579,0.952929696089254,1,12,leukotriene metabolic process,BP,MGST3
3517,GO:0007519,0.301846184203696,0.855023071078241,4,90,skeletal muscle tissue development,BP,ATF3;NR2F2;MAFF;SOX11
7406,GO:0031527,0.301935896868396,0.953239734502838,1,11,filopodium membrane,CC,ITGAV
16463,GO:0097202,0.302003001097073,0.952869456454047,1,12,activation of cysteine-type endopeptidase activity,BP,RIPK2
13432,GO:0055008,0.302066835644929,0.90336852523221,2,35,cardiac muscle tissue morphogenesis,BP,EGLN1;NRG1
13071,GO:0051646,0.302270269779001,0.903259720606363,2,35,mitochondrion localization,BP,NEFL;FEZ1
7094,GO:0030914,0.302331756025555,0.952759644545962,1,12,STAGA complex,CC,SUPT3H
17538,GO:1901201,0.302410901731263,0.953082162882798,1,11,regulation of extracellular matrix assembly,BP,HAS2
1343,GO:0003222,0.302461274279954,0.953065435199158,1,11,ventricular trabecula myocardium morphogenesis,BP,NRG1
8032,GO:0032717,0.302530207076364,0.952693286512344,1,12,negative regulation of interleukin-8 production,BP,ANXA1
3464,GO:0007340,0.302985022955429,0.952541004374132,1,12,acrosome reaction,BP,B4GALT1
12766,GO:0051100,0.303044485884814,0.840103974853484,5,122,negative regulation of binding,BP,NFKBIA;JUN;HSPA5;HMOX1;SOX11
10393,GO:0043270,0.303086510490023,0.840110111869947,5,120,positive regulation of ion transport,BP,EDN1;IL1B;STAC;G6PD;DLG1
5174,GO:0015780,0.303241274764789,0.95245508251101,1,12,nucleotide-sugar transmembrane transport,BP,SLC35B1
16100,GO:0090153,0.30331527441553,0.952430253709175,1,12,regulation of sphingolipid biosynthetic process,BP,ORMDL1
19066,GO:1905038,0.30331527441553,0.952430253709175,1,12,regulation of membrane lipid metabolic process,BP,ORMDL1
19796,GO:2000303,0.30331527441553,0.952430253709175,1,12,regulation of ceramide biosynthetic process,BP,ORMDL1
11714,GO:0046597,0.303403836849716,0.952400528971886,1,12,negative regulation of viral entry into host cell,BP,IFITM2
4801,GO:0014013,0.304065216562499,0.872918818667731,3,63,regulation of gliogenesis,BP,IL6ST;LYN;SOX11
5489,GO:0016459,0.304463730861461,0.902083026880889,2,35,myosin complex,CC,MYO1B;MYH9
8406,GO:0033539,0.304581830630568,0.952004141401589,1,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,IVD
1210,GO:0002888,0.304766427937191,0.951941855071888,1,12,positive regulation of myeloid leukocyte mediated immunity,BP,ARG1
13171,GO:0051861,0.305073678594593,0.951838080858924,1,12,glycolipid binding,MF,LYN
6708,GO:0030139,0.305359053334872,0.811948711783953,8,209,endocytic vesicle,CC,SAA1;ACTG1;ITGAV;SYT11;HSP90AA1;ADAM8;CALR;HSP90B1
3648,GO:0008152,0.305715234685233,0.733467920371565,255,8264,metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;DSCAM;SAA1;OSR2;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;RNASE7;UBQLN2;CHAC1;COL12A1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HSPA5;IL1B;MSRB3;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;STT3A;ITGAV;LYN;NCEH1;COL8A1;C1R;ANXA1;FADS3;GPR176;COL4A4;DERL3;G6PD;NBN;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;MMP19;KLK6;ZNF638;PAPSS2;HEPHL1;IL24;RIMS2;HSP90AA1;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;PRR5L;HMGCS1;UBP1;CS;METTL2A;CORO1C;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;TYW1;CALU;IVD;MSMO1;CHORDC1;TGFA;MGST3;BAMBI;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;MRPS24;MYH9;EID3;GALNT14;BTBD10;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1
14639,GO:0070293,0.306054666089321,0.951505893402628,1,12,renal absorption,BP,HAS2
5336,GO:0016126,0.306280173511859,0.871476131834308,3,64,sterol biosynthetic process,BP,G6PD;HMGCS1;MSMO1
8271,GO:0033127,0.306330511833502,0.95141224941591,1,12,regulation of histone phosphorylation,BP,IL1B
13600,GO:0060143,0.306624040014021,0.95131248895607,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,EHD1
17905,GO:1902287,0.306659562519123,0.951659254988081,1,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,NRP1
11807,GO:0046822,0.306662961823948,0.85169710274774,4,91,regulation of nucleocytoplasmic transport,BP,TP53;IL1B;HSP90AB1;NEDD4
12283,GO:0048670,0.306687050314098,0.951291058570277,1,12,regulation of collateral sprouting,BP,IFRD1
6735,GO:0030176,0.306768431500233,0.837414454881495,5,122,integral component of endoplasmic reticulum membrane,CC,HSPA5;DERL3;CANX;CALR;SLC35B1
3315,GO:0007041,0.307125421487906,0.85140668066827,4,90,lysosomal transport,BP,AP3M1;RHOB;GNPTAB;NEDD4
7455,GO:0031639,0.307737391624155,0.950933031729722,1,12,plasminogen activation,BP,PGK1
3846,GO:0008483,0.307769320665501,0.950922124631303,1,12,transaminase activity,MF,BCAT1
9546,GO:0036379,0.30781937333151,0.950905023627781,1,12,myofilament,CC,TPM4
2628,GO:0005978,0.308174408624609,0.89998290529999,2,36,glycogen biosynthetic process,BP,GBE1;ENPP1
4159,GO:0009250,0.308174408624609,0.89998290529999,2,36,glucan biosynthetic process,BP,GBE1;ENPP1
7107,GO:0030950,0.308811438474584,0.950565369451516,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOB
2359,GO:0005501,0.308815822576839,0.950563865482096,1,12,retinoid binding,MF,NR2F2
19708,GO:2000134,0.309221506200122,0.849880285395532,4,93,negative regulation of G1/S transition of mitotic cell cycle,BP,TP53;CDKN2B;DCUN1D3;PML
9832,GO:0042116,0.309418749354054,0.899305705294415,2,36,macrophage activation,BP,JUN;HSPD1
12445,GO:0050433,0.309419092313628,0.950356663040198,1,12,regulation of catecholamine secretion,BP,HTR1B
6293,GO:0019956,0.309829672486229,0.950215358439403,1,12,chemokine binding,MF,ITGAV
13378,GO:0052813,0.310007175538941,0.899080279058891,2,35,phosphatidylinositol bisphosphate kinase activity,MF,FGF5;NRG1
4695,GO:0010875,0.310265925494422,0.950064965715257,1,12,positive regulation of cholesterol efflux,BP,NFKBIA
17545,GO:1901216,0.3103513021713,0.868888369407874,3,64,positive regulation of neuron death,BP,TP53;JUN;PARP1
1458,GO:0003725,0.310481561871075,0.868849696979489,3,63,double-stranded RNA binding,MF,HSP90AB1;TFRC;HSPD1
7358,GO:0031430,0.310486999015489,0.949988653988881,1,12,M band,CC,CRYAB
16734,GO:0098586,0.31067179571703,0.898621652296523,2,36,cellular response to virus,BP,IKBKE;BIRC3
16932,GO:0099003,0.311265292053915,0.848548777527281,4,90,vesicle-mediated transport in synapse,BP,AP3M1;SYT11;RIMS2;CANX
10234,GO:0043005,0.311281645811802,0.758773710946079,26,755,neuron projection,CC,NEFL;TENM3;DSCAM;NEFM;FEZ1;DPYSL3;CNTNAP1;IL6ST;CRYAB;AP3M1;SLC8A1;ARG1;SYT11;CANX;NRP1;SETX;NRG1;L1CAM;MME;DLG1;ADGRL3;IQCJ-SCHIP1;HTR1B;NEDD4;TUBB3;EPHA2
13957,GO:0060712,0.311477633522701,0.949645877817947,1,12,spongiotrophoblast layer development,BP,PHLDA2
4488,GO:0010556,0.311686932694496,0.728862226657456,104,3254,regulation of macromolecule biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;ITGAV;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;SERP1;ORMDL1;MAFF;MGA;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;ETS1;HAS2;TGFA;BAMBI;DNAJC3;ZC3H7B;ZFP42;NLRP10;SVIP;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
13956,GO:0060711,0.311864585137249,0.897877487608154,2,37,labyrinthine layer development,BP,JUNB;EGLN1
7304,GO:0031333,0.311922323197096,0.848037753950423,4,92,negative regulation of protein complex assembly,BP,SLIT2;CLDN7;CRYAB;SVIP
16234,GO:0090342,0.311943398741148,0.897834231263367,2,37,regulation of cell aging,BP,CDKN2A;CDK6
17548,GO:1901224,0.312074498736523,0.897762259239825,2,37,positive regulation of NIK/NF-kappaB signaling,BP,TNFSF15;CALR
19018,GO:1904923,0.312289163161849,0.949364072446591,1,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,OPTN
8864,GO:0034707,0.312469083788923,0.949301472229544,1,12,chloride channel complex,CC,CLCC1
727,GO:0001960,0.312572073452617,0.897402467908933,2,38,negative regulation of cytokine-mediated signaling pathway,BP,SLIT2;ARG1
12585,GO:0050810,0.312638868609437,0.867425355218311,3,64,regulation of steroid biosynthetic process,BP,NFKB1;IL1B;HMGCS1
4966,GO:0015108,0.312727040299415,0.897495071174203,2,36,chloride transmembrane transporter activity,MF,CLCC1;ANO4
10303,GO:0043130,0.312755708993588,0.867307011758041,3,65,ubiquitin binding,MF,UBTD2;UBXN2B;NEDD4
11100,GO:0045178,0.313171957756094,0.897250437241968,2,36,basal part of cell,CC,EDN1;CLDN11
13765,GO:0060395,0.313232243925809,0.897217268808413,2,36,SMAD protein signal transduction,BP,JUN;PARP1
6976,GO:0030677,0.3133937017618,0.948662512882144,1,13,ribonuclease P complex,CC,POP4
18668,GO:1904115,0.313422923110311,0.897020642994749,2,37,axon cytoplasm,CC,NEFL;AP3M1
15551,GO:0072073,0.313471488188116,0.84701786770876,4,90,kidney epithelium development,BP,SLIT2;EPCAM;DLG1;MAGED1
12057,GO:0048070,0.313492418049922,0.948944575269751,1,12,regulation of developmental pigmentation,BP,SPNS2
10746,GO:0044233,0.313715602761245,0.948866546366149,1,12,ER-mitochondrion membrane contact site,CC,CANX
5384,GO:0016241,0.314036047894663,0.821096029130948,6,151,regulation of macroautophagy,BP,FEZ1;UBQLN2;RIPK2;OPTN;HMOX1;NEDD4
5702,GO:0016860,0.314068285486433,0.896495367152255,2,39,intramolecular oxidoreductase activity,MF,PDIA6;PDIA4
15000,GO:0070986,0.314322759408821,0.948653927903313,1,12,left/right axis specification,BP,CITED2
8404,GO:0033523,0.314468080622425,0.948602962997729,1,12,histone H2B ubiquitination,BP,CTR9
8805,GO:0034616,0.314766874644977,0.94849808297272,1,12,response to laminar fluid shear stress,BP,ETS1
1443,GO:0003690,0.314796892730124,0.762666850896038,21,602,double-stranded DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;ZNF638;SETX;KLF10;SNAI3;ETS1;ZFP42;SOX11;HSPD1
12452,GO:0050482,0.31499506102344,0.94841790415517,1,12,arachidonic acid secretion,BP,ANXA1
18609,GO:1903963,0.31499506102344,0.94841790415517,1,12,arachidonate transport,BP,ANXA1
1008,GO:0002507,0.315010772540494,0.94841238089136,1,12,tolerance induction,BP,LYN
12611,GO:0050855,0.315209905209367,0.948342347827016,1,12,regulation of B cell receptor signaling pathway,BP,LYN
14906,GO:0070838,0.315330498558591,0.797998941644839,9,238,divalent metal ion transport,BP,IL16;STAC;ITGAV;LYN;G6PD;SLC8A1;SLC39A14;MAGT1;PML
2274,GO:0005245,0.315435571769506,0.948262916939172,1,12,voltage-gated calcium channel activity,MF,ITGAV
7049,GO:0030856,0.31558292338573,0.845491188620728,4,92,regulation of epithelial cell differentiation,BP,TRIM16;IL1B;CDSN;MAFF
17300,GO:1900025,0.315951899703623,0.948080913743209,1,12,negative regulation of substrate adhesion-dependent cell spreading,BP,CORO1C
19918,GO:2000515,0.316235094442225,0.947980932614025,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ANXA1
18301,GO:1903306,0.31625047151114,0.947975500611139,1,12,negative regulation of regulated secretory pathway,BP,HMOX1
15847,GO:0072655,0.316339713426286,0.819267633592211,6,157,establishment of protein localization to mitochondrion,BP,TP53;PMAIP1;HSP90AA1;NRG1;UGCG;HSPD1
6996,GO:0030728,0.316511005635146,0.947883416370269,1,12,ovulation,BP,MMP19
7783,GO:0032354,0.316789357866719,0.947784930772417,1,12,response to follicle-stimulating hormone,BP,HMGCS1
17431,GO:1900363,0.316803360594915,0.947779973547178,1,12,regulation of mRNA polyadenylation,BP,CTR9
3469,GO:0007350,0.317034027459112,0.947698274181968,1,12,blastoderm segmentation,BP,NRP1
3175,GO:0006814,0.317124876756355,0.829916253631039,5,119,sodium ion transport,BP,NETO1;SLC8A1;NEDD4L;DLG1;NEDD4
15205,GO:0071404,0.317426106849579,0.947559235610092,1,12,cellular response to low-density lipoprotein particle stimulus,BP,HMGCS1
5581,GO:0016638,0.317950391404331,0.947372982160089,1,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOX
13540,GO:0060048,0.317984262354375,0.863981599910882,3,64,cardiac muscle contraction,BP,SLC8A1;NEDD4L;DLG1
7977,GO:0032620,0.318028712513868,0.94701916040271,1,13,interleukin-17 production,BP,IL23A
18129,GO:1902932,0.31864525032666,0.947125544950926,1,12,positive regulation of alcohol biosynthetic process,BP,IL1B
15429,GO:0071813,0.318677481759138,0.947114051189741,1,12,lipoprotein particle binding,MF,HSPD1
15430,GO:0071814,0.318677481759138,0.947114051189741,1,12,protein-lipid complex binding,MF,HSPD1
9025,GO:0035272,0.318824638723389,0.894025061619256,2,37,exocrine system development,BP,XBP1;NRP1
6568,GO:0022600,0.319019045902976,0.893916513071352,2,37,digestive system process,BP,TJP2;ACO1
10533,GO:0043525,0.319023270543455,0.8938251773915,2,38,positive regulation of neuron apoptotic process,BP,TP53;JUN
4350,GO:0009982,0.319201839670171,0.946598493373887,1,13,pseudouridine synthase activity,MF,PUS10
61,GO:0000124,0.319264168087006,0.946576089624838,1,13,SAGA complex,CC,SUPT3H
15390,GO:0071704,0.31997239556817,0.719137697241592,244,7906,organic substance metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;SAA1;OSR2;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;RNASE7;UBQLN2;CHAC1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HSPA5;IL1B;MSRB3;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;STT3A;ITGAV;LYN;NCEH1;C1R;ANXA1;FADS3;GPR176;DERL3;G6PD;NBN;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;MMP19;KLK6;ZNF638;PAPSS2;IL24;RIMS2;HSP90AA1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;PRR5L;HMGCS1;UBP1;CS;METTL2A;CORO1C;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;NGLY1;GDA;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;TYW1;CALU;IVD;MSMO1;CHORDC1;TGFA;MGST3;BAMBI;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;MRPS24;MYH9;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1
604,GO:0001773,0.320074653026173,0.946284270040435,1,13,myeloid dendritic cell activation,BP,RELB
783,GO:0002052,0.320129361380546,0.94659481423371,1,12,positive regulation of neuroblast proliferation,BP,VEGFC
8584,GO:0034121,0.320205107344915,0.893253156135902,2,37,regulation of toll-like receptor signaling pathway,BP,LYN;BIRC3
1858,GO:0004535,0.320285905953567,0.946538654188784,1,12,poly(A)-specific ribonuclease activity,MF,NOCT
4329,GO:0009898,0.320471606728324,0.827431470337505,5,120,cytoplasmic side of plasma membrane,CC,CYLD;LYN;G6PD;TRAF3;DLG1
13196,GO:0051900,0.320557447700913,0.94611000135485,1,13,regulation of mitochondrial depolarization,BP,PARP1
1275,GO:0003094,0.320941718710548,0.946303012247289,1,12,glomerular filtration,BP,MCAM
13138,GO:0051783,0.321125492086282,0.815672412834915,6,153,regulation of nuclear division,BP,IL1A;EDN1;IL1B;DUSP1;CALR;TGFA
1648,GO:0004114,0.321580534743681,0.946072901915094,1,12,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE1C
15832,GO:0072595,0.321691318375791,0.892329190785917,2,38,maintenance of protein localization in organelle,BP,HSPA5;PML
2507,GO:0005775,0.321752153590949,0.826390782247576,5,125,vacuolar lumen,CC,HRNR;ARG1;HSP90AA1;DNAJC3;CPPED1
1937,GO:0004653,0.321796459413371,0.945994994336675,1,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT14
5922,GO:0018243,0.321796459413371,0.945994994336675,1,12,protein O-linked glycosylation via threonine,BP,GALNT14
15065,GO:0071156,0.321959034397884,0.840911610800564,4,96,regulation of cell cycle arrest,BP,TP53;HSP90AB1;CALR;PML
3101,GO:0006694,0.322905902099851,0.825536339333275,5,125,steroid biosynthetic process,BP,NFKB1;IL1B;G6PD;HMGCS1;MSMO1
12280,GO:0048667,0.323286717109931,0.770914183392643,14,383,cell morphogenesis involved in neuron differentiation,BP,NEFL;DSCAM;FEZ1;SLIT2;SEMA7A;NEDD4L;SEMA3D;NRP1;NRG1;IFRD1;L1CAM;NEDD4;TUBB3;NTNG1
11411,GO:0045898,0.323825906923603,0.944921646087173,1,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53
15772,GO:0072511,0.323868513806871,0.791062624592498,9,240,divalent inorganic cation transport,BP,IL16;STAC;ITGAV;LYN;G6PD;SLC8A1;SLC39A14;MAGT1;PML
14256,GO:0061418,0.324169159911768,0.859700758115185,3,70,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB9;EGLN1;CITED2
13191,GO:0051895,0.324461241759066,0.945028160274568,1,12,negative regulation of focal adhesion assembly,BP,CORO1C
9964,GO:0042405,0.324479990495903,0.945021322712367,1,12,nuclear inclusion body,CC,NBN
16179,GO:0090266,0.324536489640216,0.944661307608196,1,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,DUSP1
18384,GO:1903504,0.324536489640216,0.944661307608196,1,13,regulation of mitotic spindle checkpoint,BP,DUSP1
18212,GO:1903076,0.324691234806426,0.859565446059819,3,65,regulation of protein localization to plasma membrane,BP,STAC;DLG1;EPHA2
8287,GO:0033145,0.324823405311449,0.944555988222444,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PARP1
10698,GO:0044088,0.324891576795181,0.890522023013499,2,38,regulation of vacuole organization,BP,FEZ1;UBQLN2
2195,GO:0005092,0.324909443615422,0.944524383199537,1,13,GDP-dissociation inhibitor activity,MF,ARHGDIB
11358,GO:0045777,0.325003240301708,0.94448991637224,1,13,positive regulation of blood pressure,BP,NR2F2
6683,GO:0030101,0.325098840500599,0.890317888919528,2,39,natural killer cell activation,BP,AXL;IL23A
8007,GO:0032673,0.325183594639716,0.944423608006643,1,13,regulation of interleukin-4 production,BP,CD83
11313,GO:0045682,0.325486616683088,0.858999136933181,3,66,regulation of epidermis development,BP,TRIM16;CDSN;MAFF
12328,GO:0048745,0.325552810817633,0.94462925093488,1,12,smooth muscle tissue development,BP,DLG1
2669,GO:0006047,0.325713539881784,0.944228505459396,1,13,UDP-N-acetylglucosamine metabolic process,BP,NAGK
7240,GO:0031227,0.325744894108665,0.823427944145466,5,125,intrinsic component of endoplasmic reticulum membrane,CC,HSPA5;DERL3;CANX;CALR;SLC35B1
2957,GO:0006513,0.32584138528767,0.8588101774893,3,65,protein monoubiquitination,BP,NEDD4L;CTR9;NEDD4
11969,GO:0047485,0.325934022863953,0.838099283728337,4,96,protein N-terminus binding,MF,FEZ1;TP53;PARP1;NBN
10768,GO:0044281,0.326001564123967,0.728991471242405,48,1501,small molecule metabolic process,BP,NFKB1;B4GALT1;EDN1;PMAIP1;PSMB9;NAGK;SLC16A9;PGK1;PARP1;IL1B;C1QTNF1;TJP2;PHLDA2;ATF3;MGLL;FADS1;ANXA1;FADS3;GPR176;G6PD;THTPA;XBP1;ARG1;UGGT1;PAPSS2;EGLN1;ACO1;SDR16C5;IGFBP3;SERP1;MOCS2;HMGCS1;CS;MME;DLG1;GDA;TXNRD1;DHDDS;HAS2;IVD;MSMO1;MGST3;BCAT1;OXCT1;EPHA2;ENPP1;MIDN;CYP1A1
8016,GO:0032688,0.326022366864348,0.94411462649972,1,13,negative regulation of interferon-beta production,BP,RELB
8578,GO:0034114,0.326084061990498,0.94409186051221,1,13,regulation of heterotypic cell-cell adhesion,BP,IL1B
5643,GO:0016769,0.326127469077282,0.944075839739918,1,13,transferase activity, transferring nitrogenous groups,MF,BCAT1
13599,GO:0060142,0.326138001920097,0.944071951857294,1,13,regulation of syncytium formation by plasma membrane fusion,BP,EHD1
8056,GO:0032760,0.326358072839814,0.889689242804447,2,38,positive regulation of tumor necrosis factor production,BP,RIPK2;IL23A
13720,GO:0060337,0.326466207741453,0.858270174445089,3,68,type I interferon signaling pathway,BP,IFITM2;HSP90AB1;IFNAR1
15170,GO:0071357,0.326466207741453,0.858270174445089,3,68,cellular response to type I interferon,BP,IFITM2;HSP90AB1;IFNAR1
11846,GO:0046890,0.326812203786965,0.822651666159598,5,124,regulation of lipid biosynthetic process,BP,NFKB1;IL1B;ANXA1;ORMDL1;HMGCS1
11446,GO:0045940,0.327163280605451,0.943692752057964,1,13,positive regulation of steroid metabolic process,BP,IL1B
4284,GO:0009749,0.327379633317373,0.822228659207626,5,124,response to glucose,BP,LGALS1;SLC8A1;XBP1;EIF2B1;OXCT1
4135,GO:0009214,0.327766839936303,0.943815009196509,1,12,cyclic nucleotide catabolic process,BP,EGLN1
18082,GO:1902807,0.327958380890789,0.836660212523017,4,96,negative regulation of cell cycle G1/S phase transition,BP,TP53;CDKN2B;DCUN1D3;PML
1125,GO:0002724,0.328400167040767,0.943233313342833,1,13,regulation of T cell cytokine production,BP,ARG1
7488,GO:0031690,0.328878983962673,0.943054876945691,1,13,adrenergic receptor binding,MF,NEDD4
16127,GO:0090189,0.328969574530336,0.943021080861918,1,13,regulation of branching involved in ureteric bud morphogenesis,BP,MAGED1
3095,GO:0006688,0.328991453906449,0.943012916710997,1,13,glycosphingolipid biosynthetic process,BP,UGCG
5448,GO:0016363,0.329479353458332,0.835630063196978,4,94,nuclear matrix,CC,KRT8;TP53;FIGN;PML
17904,GO:1902285,0.329638085211275,0.943121453635405,1,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,NRP1
13855,GO:0060538,0.32975754910284,0.835431514063548,4,94,skeletal muscle organ development,BP,ATF3;NR2F2;MAFF;SOX11
6238,GO:0019840,0.329795999465322,0.942712234612858,1,13,isoprenoid binding,MF,NR2F2
1573,GO:0003995,0.329846254802097,0.942693422284766,1,13,acyl-CoA dehydrogenase activity,MF,IVD
7549,GO:0031932,0.329895553538385,0.942674964565619,1,13,TORC2 complex,CC,PRR5L
2869,GO:0006388,0.330012829851342,0.942330730408472,1,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,C2ORF49
5682,GO:0016829,0.330015091997857,0.820168987715835,5,129,lyase activity,MF,CHAC1;ACO1;GGCX;TYW1;MGST3
17336,GO:1900103,0.330543701640881,0.942431973673255,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,XBP1
7190,GO:0031102,0.330836094240797,0.887128160335484,2,38,neuron projection regeneration,BP,NEFL;JUN
7238,GO:0031225,0.330863734972574,0.855320840913006,3,69,anchored component of membrane,CC,SEMA7A;SVIP;NTNG1
9575,GO:0036465,0.331157148346074,0.887037322739022,2,37,synaptic vesicle recycling,BP,SYT11;CANX
4443,GO:0010453,0.331555415971606,0.942051489388234,1,13,regulation of cell fate commitment,BP,IL23A
14623,GO:0070265,0.331654958763975,0.886483210237475,2,40,necrotic cell death,BP,CYLD;BIRC3
11068,GO:0045116,0.331877714346553,0.941626273615492,1,14,protein neddylation,BP,DCUN1D3
11899,GO:0046982,0.331934133692387,0.770269710494186,12,348,protein heterodimerization activity,MF,NEFL;TENM3;NFKB1;MAFB;TP53;JUN;ATF3;AXL;XBP1;TPM4;SUPT3H;IRAK2
10574,GO:0043586,0.332267407352996,0.94178285206429,1,13,tongue development,BP,KRT13
3135,GO:0006749,0.332356514424622,0.885920925100178,2,42,glutathione metabolic process,BP,CHAC1;G6PD
16219,GO:0090316,0.332511133908524,0.806875606028503,6,155,positive regulation of intracellular protein transport,BP,TP53;IL1B;NRG1;HSP90AB1;PRR5L;UGCG
4321,GO:0009890,0.332791857815709,0.727155431171523,40,1218,negative regulation of biosynthetic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;DUSP1;ITGAV;GPR176;WWC1;NEDD4L;SUDS3;EGLN1;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;ORMDL1;UBP1;DLG1;CITED2;ZNF814;ZC3H7B;NEDD4;PML;ZBTB21;SOX11;ENPP1;MAGED1
757,GO:0002009,0.332884377436491,0.762650152840583,14,394,morphogenesis of an epithelium,BP,B4GALT1;EDN1;PSMB9;SLIT2;VEGFC;RHOB;FRAS1;NRP1;AJUBA;DLG1;PML;EPHA2;SOX11;MAGED1
2666,GO:0006044,0.332940686487395,0.941528157125892,1,13,N-acetylglucosamine metabolic process,BP,NAGK
14801,GO:0070585,0.33323352624649,0.806247669983892,6,160,protein localization to mitochondrion,BP,TP53;PMAIP1;HSP90AA1;NRG1;UGCG;HSPD1
5759,GO:0017000,0.333787132723414,0.941207037980564,1,13,antibiotic biosynthetic process,BP,CYP1A1
4404,GO:0010225,0.333934772462765,0.941150922704697,1,13,response to UV-C,BP,DCUN1D3
3427,GO:0007252,0.334330237208495,0.941000460166485,1,13,I-kappaB phosphorylation,BP,IKBKE
14458,GO:0061951,0.334401835849233,0.884979094822137,2,39,establishment of protein localization to plasma membrane,BP,KRT18;OPTN
4585,GO:0010718,0.334845691035164,0.884811744687876,2,38,positive regulation of epithelial to mesenchymal transition,BP,IL1B;BAMBI
11810,GO:0046825,0.334916163060894,0.8846804834262,2,39,regulation of protein export from nucleus,BP,TP53;IL1B
10804,GO:0044331,0.335561859560689,0.940530432671625,1,13,cell-cell adhesion mediated by cadherin,BP,EPCAM
13227,GO:0051955,0.33566592491032,0.940490618505201,1,13,regulation of amino acid transport,BP,ARG1
17607,GO:1901385,0.335790786055718,0.940442827654284,1,13,regulation of voltage-gated calcium channel activity,BP,STAC
8671,GO:0034332,0.336391524278346,0.830728863832936,4,92,adherens junction organization,BP,NRP1;AJUBA;CORO1C;PVR
5911,GO:0018208,0.336405898147876,0.883645255829703,2,41,peptidyl-proline modification,BP,EGLN1;PPID
11314,GO:0045683,0.336408580926843,0.940206036882034,1,13,negative regulation of epidermis development,BP,CDSN
18499,GO:1903747,0.337046567610476,0.830089757440456,4,98,regulation of establishment of protein localization to mitochondrion,BP,TP53;PMAIP1;NRG1;UGCG
4496,GO:0010564,0.33718284152528,0.742859638720515,21,622,regulation of cell cycle process,BP,CDKN2A;IL1A;EDN1;TP53;PSMB9;CDKN2B;IL1B;DUSP1;ANXA1;NBN;HSP90AA1;DCUN1D3;CXCR5;HSP90AB1;CALR;MGA;CHORDC1;TGFA;CDK6;PML;CYP1A1
8681,GO:0034349,0.337289674715494,0.939867381317016,1,13,glial cell apoptotic process,BP,TP53
2557,GO:0005856,0.338058609336281,0.716488438599836,51,1555,cytoskeleton,CC,TCHH;KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;RELB;FEZ1;DPYSL3;FLG;KRT78;MYO1B;KRT4;MAP7D2;RIPK2;IFT46;KRT13;CRYAB;ACTG1;HSPA6;CYLD;FIGN;KRT23;ANXA1;SLC8A1;MOBP;RIMS2;NRP1;KRT34;ADAM8;AJUBA;EYA3;SERP1;ARHGDIB;CORO1C;DLG1;PDE4DIP;CDK6;TUBB3;EPB41L2;MYH9;SORBS2;AFAP1;TPM4;CEP83;TJP1;PARVA
12235,GO:0048566,0.338273543094188,0.939487906585375,1,13,embryonic digestive tract development,BP,SOX11
15177,GO:0071371,0.338711973510949,0.939318357333192,1,13,cellular response to gonadotropin stimulus,BP,HMGCS1
9066,GO:0035357,0.338714832800931,0.939317250684782,1,13,peroxisome proliferator activated receptor signaling pathway,BP,CITED2
19127,GO:1905208,0.338913990293484,0.939240140603391,1,13,negative regulation of cardiocyte differentiation,BP,G6PD
7456,GO:0031640,0.339212216981156,0.938532834134369,1,15,killing of cells of other organism,BP,ARG1
10826,GO:0044364,0.339212216981156,0.938532834134369,1,15,disruption of cells of other organism,BP,ARG1
6003,GO:0019079,0.339298391611371,0.828486680526065,4,97,viral genome replication,BP,TNIP1;IFITM2;PPID;UBP1
11253,GO:0045600,0.339337890401661,0.882098339961787,2,39,positive regulation of fat cell differentiation,BP,NOCT;XBP1
5490,GO:0016460,0.339394379192054,0.939053908006321,1,13,myosin II complex,CC,MYH9
13732,GO:0060351,0.33948529718582,0.939018624385849,1,13,cartilage development involved in endochondral bone morphogenesis,BP,SERPINH1
3136,GO:0006750,0.339662348298405,0.938631833018332,1,14,glutathione biosynthetic process,BP,CHAC1
4283,GO:0009746,0.339884031809517,0.812783813684112,5,126,response to hexose,BP,LGALS1;SLC8A1;XBP1;EIF2B1;OXCT1
986,GO:0002455,0.339913871817215,0.938533626233369,1,14,humoral immune response mediated by circulating immunoglobulin,BP,C1R
7462,GO:0031646,0.340303877504922,0.938700411809067,1,13,positive regulation of neurological system process,BP,NRG1
16636,GO:0097617,0.340623074351475,0.938576066282175,1,13,annealing activity,MF,ANXA1
9418,GO:0036035,0.34086082557955,0.938483352961752,1,13,osteoclast development,BP,TJP2
18354,GO:1903421,0.341539845909,0.938218113139106,1,13,regulation of synaptic vesicle recycling,BP,SYT11
15780,GO:0072523,0.341590864398728,0.880684196324404,2,40,purine-containing compound catabolic process,BP,EGLN1;GDA
7682,GO:0032183,0.341793981866742,0.938118670871904,1,13,SUMO binding,MF,PML
5683,GO:0016830,0.342274814924372,0.880196016728577,2,41,carbon-carbon lyase activity,MF,GGCX;TYW1
6895,GO:0030506,0.342521197244652,0.937833598647145,1,13,ankyrin binding,MF,SLC8A1
5921,GO:0018242,0.342658711796403,0.937779606178573,1,13,protein O-linked glycosylation via serine,BP,GALNT14
20015,GO:2000678,0.342793993587295,0.937402555298833,1,14,negative regulation of transcription regulatory region DNA binding,BP,SOX11
3187,GO:0006836,0.342844672185643,0.810551682400161,5,125,neurotransmitter transport,BP,EDN1;LYN;SYT11;RIMS2;HTR1B
9740,GO:0039535,0.342898322474833,0.937685462184078,1,13,regulation of RIG-I signaling pathway,BP,BIRC3
11679,GO:0046513,0.342905855782325,0.87990656267403,2,40,ceramide biosynthetic process,BP,ORMDL1;UGCG
605,GO:0001774,0.342992205281877,0.937648552578251,1,13,microglial cell activation,BP,JUN
13478,GO:0055090,0.343010004720812,0.937317238816706,1,14,acylglycerol homeostasis,BP,XBP1
14662,GO:0070328,0.343010004720812,0.937317238816706,1,14,triglyceride homeostasis,BP,XBP1
9045,GO:0035313,0.343072497230622,0.937616976027038,1,13,wound healing, spreading of epidermal cells,BP,AJUBA
11363,GO:0045786,0.343160545607269,0.743322797100562,18,532,negative regulation of cell cycle,BP,CDKN2A;TP53;PSMB9;CDKN2B;NABP1;DUSP1;NBN;RHOB;DCUN1D3;HSP90AB1;NR2F2;EIF4G2;CALR;MGA;DLG1;CDK6;PML;SOX11
16080,GO:0090110,0.343322155641155,0.937518732753459,1,13,cargo loading into COPII-coated vesicle,BP,SEC24D
1829,GO:0004497,0.34337311741621,0.879629670195366,2,40,monooxygenase activity,MF,MSMO1;CYP1A1
16464,GO:0097205,0.343410951152865,0.937483768982719,1,13,renal filtration,BP,MCAM
6665,GO:0030049,0.343673825850616,0.937054629056292,1,14,muscle filament sliding,BP,TPM4
8352,GO:0033275,0.343673825850616,0.937054629056292,1,14,actin-myosin filament sliding,BP,TPM4
16486,GO:0097242,0.343905135625318,0.937288971962315,1,13,amyloid-beta clearance,BP,MME
2089,GO:0004867,0.34397250895746,0.879189435298281,2,41,serine-type endopeptidase inhibitor activity,MF,SERPINB2;SERPINH1
1646,GO:0004112,0.344055849317597,0.937229493325908,1,13,cyclic-nucleotide phosphodiesterase activity,MF,PDE1C
9523,GO:0036315,0.344113728274484,0.937206642835469,1,13,cellular response to sterol,BP,HMGCS1
19405,GO:1990089,0.344303408334269,0.879166658063994,2,39,response to nerve growth factor,BP,HSPA5;EHD1
19406,GO:1990090,0.344303408334269,0.879166658063994,2,39,cellular response to nerve growth factor stimulus,BP,HSPA5;EHD1
17249,GO:0140058,0.344572274090409,0.937025438015691,1,13,neuron projection arborization,BP,NRP1
11337,GO:0045739,0.344790053735652,0.878788177712567,2,40,positive regulation of DNA repair,BP,PARP1;EYA3
13927,GO:0060675,0.344939671436123,0.878788553073305,2,39,ureteric bud morphogenesis,BP,DLG1;MAGED1
15613,GO:0072171,0.344939671436123,0.878788553073305,2,39,mesonephric tubule morphogenesis,BP,DLG1;MAGED1
10457,GO:0043388,0.34546463004722,0.878301465145022,2,41,positive regulation of DNA binding,BP,MMP9;PARP1
6601,GO:0022843,0.34557126940563,0.878412669247992,2,39,voltage-gated cation channel activity,MF,ITGAV;KCNQ5
13009,GO:0051539,0.345719036402442,0.878149760453079,2,41,4 iron, 4 sulfur cluster binding,MF,ACO1;TYW1
16157,GO:0090231,0.345876946398043,0.936178466447487,1,14,regulation of spindle checkpoint,BP,DUSP1
19238,GO:1905475,0.345938936334264,0.808151012094407,5,127,regulation of protein localization to membrane,BP,TP53;PMAIP1;STAC;DLG1;EPHA2
8353,GO:0033276,0.346298393538021,0.936010053240927,1,14,transcription factor TFTC complex,CC,SUPT3H
18343,GO:1903392,0.346700888824812,0.936180264045975,1,13,negative regulation of adherens junction organization,BP,CORO1C
16772,GO:0098662,0.346771348992388,0.75393582649767,13,371,inorganic cation transmembrane transport,BP,NETO1;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;STEAP4;SLC39A14;MAGT1;DLG1;NEDD4
10608,GO:0043651,0.346842168048829,0.935792373475544,1,14,linoleic acid metabolic process,BP,FADS1
16060,GO:0090083,0.347324253260971,0.935599026891452,1,14,regulation of inclusion body assembly,BP,DNAJB1
10748,GO:0044238,0.347664237486998,0.692419196428572,237,7694,primary metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;TENM3;LGALS1;SAA1;OSR2;ASPRV1;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;RNASE7;UBQLN2;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;HSPA5;IL1B;MSRB3;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;STT3A;ITGAV;LYN;NCEH1;C1R;ANXA1;FADS3;GPR176;DERL3;G6PD;NBN;PLEKHA2;WWC1;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;MMP19;KLK6;ZNF638;PAPSS2;IL24;HSP90AA1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;PRR5L;HMGCS1;UBP1;CS;METTL2A;CORO1C;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;NGLY1;GDA;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;TYW1;CALU;IVD;MSMO1;CHORDC1;TGFA;MGST3;BAMBI;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;EPHA2;MRPS24;MYH9;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1
19379,GO:1990000,0.347695247279208,0.935450003161588,1,14,amyloid fibril formation,BP,CRYAB
3900,GO:0008585,0.348397205819284,0.843529513108308,3,68,female gonad development,BP,SLIT2;MMP19;ZFP42
4878,GO:0014823,0.348852253836123,0.876360383227786,2,40,response to activity,BP,EDN1;OXCT1
15448,GO:0071850,0.348911353277362,0.934960093595474,1,14,mitotic cell cycle arrest,BP,DUSP1
12571,GO:0050792,0.349461754435643,0.793516690442053,6,160,regulation of viral process,BP,LGALS1;TNIP1;JUN;IFITM2;PPID;PML
3084,GO:0006677,0.349551853251675,0.934701194790635,1,14,glycosylceramide metabolic process,BP,UGCG
13910,GO:0060632,0.34955323200818,0.934700636828331,1,14,regulation of microtubule-based movement,BP,FEZ1
18777,GO:1904385,0.349645421595179,0.934663322730453,1,14,cellular response to angiotensin,BP,NFKB1
1692,GO:0004190,0.349713454948844,0.934635777950984,1,14,aspartic-type endopeptidase activity,MF,ASPRV1
14477,GO:0070001,0.349713454948844,0.934635777950984,1,14,aspartic-type peptidase activity,MF,ASPRV1
17707,GO:1901685,0.34988737792507,0.934018234201738,1,16,glutathione derivative metabolic process,BP,MGST3
17708,GO:1901687,0.34988737792507,0.934018234201738,1,16,glutathione derivative biosynthetic process,BP,MGST3
2281,GO:0005253,0.350595462783488,0.875311566078142,2,40,anion channel activity,MF,CLCC1;ANO4
4487,GO:0010544,0.35087993191026,0.934162445226742,1,14,negative regulation of platelet activation,BP,C1QTNF1
14934,GO:0070884,0.351269340229973,0.934003985166523,1,14,regulation of calcineurin-NFAT signaling cascade,BP,NRG1
17165,GO:0106056,0.351269340229973,0.934003985166523,1,14,regulation of calcineurin-mediated signaling,BP,NRG1
14262,GO:0061437,0.351309231524878,0.933987739774236,1,14,renal system vasculature development,BP,NRP1
14265,GO:0061440,0.351309231524878,0.933987739774236,1,14,kidney vasculature development,BP,NRP1
14198,GO:0061213,0.351598931657825,0.933869691461342,1,14,positive regulation of mesonephros development,BP,MAGED1
12309,GO:0048708,0.351778361476684,0.874597474068766,2,40,astrocyte differentiation,BP,IL6ST;CDK6
3415,GO:0007219,0.35180562352688,0.803644086976507,5,127,Notch signaling pathway,BP,NFKBIA;CHAC1;IL6ST;WWC1;SEL1L
19870,GO:2000406,0.351878431233125,0.933755682403883,1,14,positive regulation of T cell migration,BP,ADAM8
5520,GO:0016528,0.352211608895868,0.874335447456909,2,40,sarcoplasm,CC,CALR;CALU
4468,GO:0010508,0.352326371845162,0.818948216714814,4,97,positive regulation of autophagy,BP,RIPK2;OPTN;HMOX1;SVIP
10558,GO:0043558,0.352528119832968,0.933490226224148,1,14,regulation of translational initiation in response to stress,BP,DNAJC3
16832,GO:0098805,0.352554905692546,0.709589894813456,39,1195,whole membrane,CC,B4GALT1;PMAIP1;DBNDD2;PGK1;MYO1B;SPNS2;OPTN;ANPEP;EFHD2;IKBKE;STOML1;ANXA8;ITGAV;LYN;AP3M1;ANXA1;BIRC3;RHOB;ARG1;HMOX1;SYT11;IL7R;SERPINH1;HSP90AB1;ADAM8;STEAP4;CALR;MAGT1;CORO1C;MME;DLG1;EHD1;SEC24D;TGFA;TFRC;SVIP;PML;ENPP1;IRAK2
3463,GO:0007339,0.352626485358021,0.93315346366454,1,15,binding of sperm to zona pellucida,BP,B4GALT1
10148,GO:0042771,0.352826352749991,0.873792086634448,2,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,TP53;PML
16292,GO:0090559,0.352909897609694,0.840293340608077,3,71,regulation of membrane permeability,BP,TP53;PMAIP1;TJP2
4694,GO:0010874,0.353421649608784,0.933124120490685,1,14,regulation of cholesterol efflux,BP,NFKBIA
11264,GO:0045618,0.353468431287731,0.93310492012407,1,14,positive regulation of keratinocyte differentiation,BP,TRIM16
9852,GO:0042157,0.354055648268178,0.801831472193453,5,131,lipoprotein metabolic process,BP,APOL6;ITGAV;SVIP;NTNG1;ZDHHC6
12444,GO:0050432,0.354444190576487,0.932703705787688,1,14,catecholamine secretion,BP,HTR1B
15738,GO:0072384,0.354494910872968,0.839325520064454,3,68,organelle transport along microtubule,BP,NEFL;FEZ1;AP3M1
2372,GO:0005521,0.354724147044061,0.932588332460834,1,14,lamin binding,MF,TOR1AIP1
1441,GO:0003688,0.354763190674488,0.932572232894306,1,14,DNA replication origin binding,MF,HSPD1
17667,GO:1901617,0.354798164480118,0.789288631024893,6,159,organic hydroxy compound biosynthetic process,BP,NFKB1;IL1B;G6PD;HMGCS1;DHDDS;MSMO1
610,GO:0001779,0.355064777740406,0.932447797879374,1,14,natural killer cell differentiation,BP,AXL
4523,GO:0010614,0.355095455537442,0.932435132642098,1,14,negative regulation of cardiac muscle hypertrophy,BP,G6PD
6765,GO:0030220,0.355112573740819,0.932428064835903,1,14,platelet formation,BP,MYH9
18201,GO:1903052,0.355531255555359,0.816517470881057,4,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1;XBP1
11394,GO:0045844,0.355665857548386,0.872237038967534,2,40,positive regulation of striated muscle tissue development,BP,EDN1;NRG1
12262,GO:0048636,0.355665857548386,0.872237038967534,2,40,positive regulation of muscle organ development,BP,EDN1;NRG1
17751,GO:1901863,0.355665857548386,0.872237038967534,2,40,positive regulation of muscle tissue development,BP,EDN1;NRG1
4423,GO:0010324,0.355703237336072,0.872125542733003,2,41,membrane invagination,BP,SYT11;MYH9
8949,GO:0035067,0.355849391507597,0.932123433491422,1,14,negative regulation of histone acetylation,BP,SDR16C5
10794,GO:0044321,0.355887221089648,0.932107771402708,1,14,response to leptin,BP,EDN1
13991,GO:0060761,0.356069132803667,0.871817641510779,2,42,negative regulation of response to cytokine stimulus,BP,SLIT2;ARG1
6801,GO:0030279,0.356073384452442,0.871988382202148,2,40,negative regulation of ossification,BP,NOCT;CDK6
20063,GO:2000773,0.356082471522753,0.932026900609638,1,14,negative regulation of cellular senescence,BP,CDK6
14897,GO:0070822,0.356087071809892,0.932024994533382,1,14,Sin3-type complex,CC,SUDS3
6039,GO:0019205,0.356172701845824,0.871754340856716,2,42,nucleobase-containing compound kinase activity,MF,TJP2;DLG1
16770,GO:0098660,0.356367957986817,0.742226412024282,14,404,inorganic ion transmembrane transport,BP,NETO1;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;CLCC1;STEAP4;SLC39A14;MAGT1;DLG1;NEDD4
13444,GO:0055022,0.356391577943028,0.931898755967153,1,14,negative regulation of cardiac muscle tissue growth,BP,G6PD
14161,GO:0061117,0.356391577943028,0.931898755967153,1,14,negative regulation of heart growth,BP,G6PD
13760,GO:0060390,0.356711769582789,0.931765866009097,1,14,regulation of SMAD protein signal transduction,BP,PARP1
7613,GO:0032042,0.357126292376761,0.931593599039386,1,14,mitochondrial DNA metabolic process,BP,PARP1
4405,GO:0010226,0.357128122965496,0.931592837718051,1,14,response to lithium ion,BP,CALR
1387,GO:0003323,0.357254207591297,0.931540388531933,1,14,type B pancreatic cell development,BP,CDK6
2503,GO:0005770,0.357572881089639,0.777482021616574,7,190,late endosome,CC,STOML1;ANXA8;NEDD4L;RHOB;IFNAR1;ANKRD13A;MON1A
766,GO:0002026,0.357832601582732,0.931299482505257,1,14,regulation of the force of heart contraction,BP,SLC8A1
10390,GO:0043267,0.357888466460765,0.931276187914308,1,14,negative regulation of potassium ion transport,BP,NEDD4L
3644,GO:0008143,0.357946739601703,0.931251884167321,1,14,poly(A) binding,MF,RBMS3
7407,GO:0031528,0.358301607459144,0.931103771564419,1,14,microvillus membrane,CC,ITGAV
11338,GO:0045740,0.358518922478974,0.870401687694792,2,41,positive regulation of DNA replication,BP,JUN;CALR
6698,GO:0030127,0.358533091739,0.931007054848559,1,14,COPII vesicle coat,CC,SEC24D
8609,GO:0034162,0.358540076545624,0.931004135276009,1,14,toll-like receptor 9 signaling pathway,BP,IRAK2
3269,GO:0006972,0.358655652525135,0.930955815216931,1,14,hyperosmotic response,BP,CLDN1
17626,GO:1901524,0.358729023850739,0.930925129755612,1,14,regulation of mitophagy,BP,OPTN
7006,GO:0030799,0.358750710353205,0.870259289370064,2,41,regulation of cyclic nucleotide metabolic process,BP,GPR176;EGLN1
10033,GO:0042554,0.359624042011173,0.930241854915265,1,15,superoxide anion generation,BP,EDN1
13476,GO:0055088,0.35978905256407,0.835548688618063,3,70,lipid homeostasis,BP,XBP1;ORMDL1;EHD1
3051,GO:0006631,0.359871565266261,0.761099173547173,9,255,fatty acid metabolic process,BP,EDN1;MGLL;FADS1;ANXA1;FADS3;XBP1;IVD;MSMO1;CYP1A1
11732,GO:0046626,0.359979099682105,0.869503385507531,2,41,regulation of insulin receptor signaling pathway,BP,IL1B;ENPP1
13181,GO:0051882,0.36018188710158,0.93000659352187,1,15,mitochondrial depolarization,BP,PARP1
5794,GO:0017075,0.360641946735651,0.930122266138688,1,14,syntaxin-1 binding,MF,STXBP5
17857,GO:1902187,0.360674755377487,0.930108448443342,1,14,negative regulation of viral release from host cell,BP,PML
8484,GO:0033688,0.360976017004959,0.929981493667257,1,14,regulation of osteoblast proliferation,BP,ITGAV
1334,GO:0003208,0.361000270956095,0.868963957724425,2,40,cardiac ventricle morphogenesis,BP,NRG1;SOX11
16296,GO:0090575,0.361104417346975,0.796351486321625,5,131,RNA polymerase II transcription factor complex,CC,TP53;JUN;JUNB;MED18;SUPT3H
16622,GO:0097542,0.361155507998023,0.868777502687195,2,41,ciliary tip,CC,IFT46;CYLD
7914,GO:0032516,0.361162684346518,0.929902761894458,1,14,positive regulation of phosphoprotein phosphatase activity,BP,HSP90AB1
10776,GO:0044297,0.361809263857693,0.748948793187632,11,312,cell body,CC,FEZ1;DPYSL3;IL6ST;CRYAB;ARG1;SYT11;CANX;NRP1;NRG1;L1CAM;TUBB3
17492,GO:1901028,0.361831885071611,0.868190514906454,2,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,TP53;PMAIP1
13028,GO:0051571,0.362183178360869,0.929471418727653,1,14,positive regulation of histone H3-K4 methylation,BP,CTR9
13493,GO:0055117,0.362203186860928,0.868129429589205,2,41,regulation of cardiac muscle contraction,BP,SLC8A1;DLG1
20236,GO:2001244,0.362900648844765,0.867448835720591,2,44,positive regulation of intrinsic apoptotic signaling pathway,BP,TP53;PMAIP1
10682,GO:0044030,0.363187217741315,0.929045504964602,1,14,regulation of DNA methylation,BP,PARP1
2966,GO:0006525,0.363327915556729,0.928671055959454,1,15,arginine metabolic process,BP,ARG1
8658,GO:0034284,0.363659700630996,0.794370920502403,5,130,response to monosaccharide,BP,LGALS1;SLC8A1;XBP1;EIF2B1;OXCT1
3491,GO:0007413,0.364805482652683,0.928355845020978,1,14,axonal fasciculation,BP,NRP1
17159,GO:0106030,0.364805482652683,0.928355845020978,1,14,neuron projection fasciculation,BP,NRP1
14450,GO:0061912,0.365048054582715,0.866361941010168,2,41,selective autophagy,BP,RIPK2;OPTN
5229,GO:0015872,0.365061792745431,0.927928621672246,1,15,dopamine transport,BP,HTR1B
11697,GO:0046545,0.365075522232352,0.831830513659387,3,70,development of primary female sexual characteristics,BP,SLIT2;MMP19;ZFP42
7853,GO:0032436,0.365090679728839,0.831776229048799,3,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1
411,GO:0001098,0.365168778041046,0.866199133273269,2,42,basal transcription machinery binding,MF,TP53;CTR9
412,GO:0001099,0.365168778041046,0.866199133273269,2,42,basal RNA polymerase II transcription machinery binding,MF,TP53;CTR9
12322,GO:0048736,0.365482687105902,0.792998762912718,5,127,appendage development,BP,OSR2;FBN2;FRAS1;NR2F2;SOX11
13619,GO:0060173,0.365482687105902,0.792998762912718,5,127,limb development,BP,OSR2;FBN2;FRAS1;NR2F2;SOX11
9039,GO:0035304,0.365952218896388,0.80868378155406,4,100,regulation of protein dephosphorylation,BP,HSP90AB1;IGFBP3;HSP90B1;UBXN2B
19729,GO:2000177,0.366194343498386,0.865646573709488,2,41,regulation of neural precursor cell proliferation,BP,LYN;VEGFC
6521,GO:0021952,0.366524084834324,0.927619100496503,1,14,central nervous system projection neuron axonogenesis,BP,SLIT2
12196,GO:0048490,0.36680987988514,0.927175498451814,1,15,anterograde synaptic vesicle transport,BP,AP3M1
16996,GO:0099514,0.36680987988514,0.927175498451814,1,15,synaptic vesicle cytoskeletal transport,BP,AP3M1
16999,GO:0099517,0.36680987988514,0.927175498451814,1,15,synaptic vesicle transport along microtubule,BP,AP3M1
9379,GO:0035970,0.366834836573436,0.927164712897191,1,15,peptidyl-threonine dephosphorylation,BP,DUSP1
7298,GO:0031327,0.366882862016536,0.696275477303616,39,1202,negative regulation of cellular biosynthetic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;DUSP1;GPR176;WWC1;NEDD4L;SUDS3;EGLN1;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;ORMDL1;UBP1;DLG1;CITED2;ZNF814;ZC3H7B;NEDD4;PML;ZBTB21;SOX11;ENPP1;MAGED1
1943,GO:0004659,0.367090965698223,0.927053966711347,1,15,prenyltransferase activity,MF,DHDDS
6194,GO:0019731,0.367151083810532,0.92649987139674,1,17,antibacterial humoral response,BP,RNASE7
9986,GO:0042446,0.367739528807445,0.864506724758805,2,43,hormone biosynthetic process,BP,NFKB1;IL1B
8713,GO:0034389,0.367811943939123,0.926741692254039,1,15,lipid particle organization,BP,PPID
2959,GO:0006516,0.367999101449103,0.926660500333655,1,15,glycoprotein catabolic process,BP,NGLY1
6523,GO:0021954,0.368311855996363,0.864320268148401,2,41,central nervous system neuron development,BP,SLIT2;NRP1
5555,GO:0016591,0.368649579696474,0.806563250750874,4,103,DNA-directed RNA polymerase II, holoenzyme,CC,TP53;CTR9;MED18;SUPT3H
4713,GO:0010894,0.369164682657191,0.926153653276238,1,15,negative regulation of steroid biosynthetic process,BP,NFKB1
20016,GO:2000679,0.370111384102757,0.925740461977473,1,15,positive regulation of transcription regulatory region DNA binding,BP,PARP1
4702,GO:0010882,0.370397939536422,0.925615124297805,1,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,SLC8A1
4320,GO:0009889,0.370492093858654,0.672804375591422,107,3397,regulation of biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;ITGAV;ANXA1;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;SERP1;ORMDL1;MAFF;MGA;HMGCS1;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;ETS1;HAS2;TGFA;BAMBI;DNAJC3;ZC3H7B;ZFP42;NLRP10;SVIP;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
8924,GO:0035004,0.370496696411142,0.863039131947966,2,40,phosphatidylinositol 3-kinase activity,MF,FGF5;NRG1
9529,GO:0036336,0.370580094496719,0.925535385612757,1,15,dendritic cell migration,BP,CALR
18437,GO:1903579,0.370648560600478,0.925505401343134,1,15,negative regulation of ATP metabolic process,BP,PARP1
13489,GO:0055106,0.370724004415454,0.925186212666248,1,16,ubiquitin-protein transferase regulator activity,MF,TRIB1
4700,GO:0010880,0.37085290066351,0.925415869415257,1,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,SLC8A1
13780,GO:0060415,0.370939674760602,0.862665615146861,2,41,muscle tissue morphogenesis,BP,EGLN1;NRG1
5827,GO:0017137,0.371030725779829,0.776246625896125,6,157,Rab GTPase binding,MF,OPTN;AP3M1;MOBP;RIMS2;STXBP5;EHD1
16967,GO:0099116,0.371072437210665,0.925032934990856,1,16,tRNA 5'-end processing,BP,POP4
2332,GO:0005385,0.371075405863201,0.925318305852053,1,15,zinc ion transmembrane transporter activity,MF,SLC39A14
15307,GO:0071577,0.371075405863201,0.925318305852053,1,15,zinc ion transmembrane transport,BP,SLC39A14
5190,GO:0015807,0.371250368817031,0.862379743289415,2,42,L-amino acid transport,BP,ARG1;SLC7A5P2
7473,GO:0031664,0.37210943305749,0.924863914663051,1,15,regulation of lipopolysaccharide-mediated signaling pathway,BP,TRIB1
15413,GO:0071786,0.372114464898472,0.924861699479108,1,15,endoplasmic reticulum tubular network organization,BP,REEP1
3579,GO:0008021,0.372130010020315,0.80391730197002,4,103,synaptic vesicle,CC,DBNDD2;SYT11;STXBP5;MME
8191,GO:0032968,0.372269676176859,0.924793351264748,1,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,CTR9
9533,GO:0036344,0.372992540598976,0.924474547403924,1,15,platelet morphogenesis,BP,MYH9
1861,GO:0004549,0.373187032606617,0.924098717714458,1,16,tRNA-specific ribonuclease activity,MF,POP4
9474,GO:0036152,0.373376611996175,0.92430483506097,1,15,phosphatidylethanolamine acyl-chain remodeling,BP,PLBD1
2877,GO:0006400,0.373886051380688,0.82538480538869,3,74,tRNA modification,BP,PUS10;METTL2A;TRMT44
15187,GO:0071383,0.3739787361586,0.763938361303894,7,191,cellular response to steroid hormone stimulus,BP,EDN1;PARP1;ANXA1;ARG1;NR2F2;CALR;NEDD4
9825,GO:0042104,0.37405395331783,0.923713730750633,1,16,positive regulation of activated T cell proliferation,BP,IL23A
11589,GO:0046328,0.37417074857758,0.786096050129847,5,129,regulation of JNK cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B
6963,GO:0030659,0.374382025986772,0.717779862861445,17,505,cytoplasmic vesicle membrane,CC,B4GALT1;DBNDD2;ANPEP;ITGAV;AP3M1;ANXA1;SYT11;IL7R;ADAM8;STXBP5;CALR;MAGT1;MME;SEC24D;TGFA;TFRC;SVIP
7044,GO:0030851,0.374617503853631,0.923754965703826,1,15,granulocyte differentiation,BP,TRIB1
18323,GO:1903358,0.374904893298764,0.923627278965413,1,15,regulation of Golgi organization,BP,PDE4DIP
8217,GO:0033013,0.375015444203025,0.85982012820489,2,44,tetrapyrrole metabolic process,BP,HMOX1;CYP1A1
11775,GO:0046697,0.37544363405133,0.923387574792802,1,15,decidualization,BP,JUNB
11821,GO:0046847,0.375948439489429,0.859484957317657,2,41,filopodium assembly,BP,DPYSL3;NRP1
6127,GO:0019430,0.376305939014952,0.922708243966568,1,16,removal of superoxide radicals,BP,SOD2
8122,GO:0032872,0.376380901782021,0.77183854514503,6,160,regulation of stress-activated MAPK cascade,BP,IL1A;EDN1;RIPK2;IL1B;GADD45B;DLG1
8672,GO:0034333,0.376394570257841,0.82379913818658,3,69,adherens junction assembly,BP,NRP1;AJUBA;CORO1C
4861,GO:0014741,0.376491346439622,0.922920131691568,1,15,negative regulation of muscle hypertrophy,BP,G6PD
5840,GO:0017158,0.376763975668917,0.858872282514267,2,42,regulation of calcium ion-dependent exocytosis,BP,SYT11;RIMS2
1384,GO:0003309,0.376839546761392,0.922764405313415,1,15,type B pancreatic cell differentiation,BP,CDK6
15745,GO:0072395,0.376858705158322,0.823286139741265,3,73,signal transduction involved in cell cycle checkpoint,BP,TP53;PML;SOX11
3468,GO:0007346,0.376949772146509,0.710895283131217,19,574,regulation of mitotic cell cycle,BP,CDKN2A;IL1A;EDN1;TP53;PSMB9;CDKN2B;NABP1;IL1B;CYLD;DUSP1;ANXA1;NBN;HSP90AA1;DCUN1D3;DLG1;TGFA;CDK6;PML;CYP1A1
6041,GO:0019207,0.377239968336146,0.771078318375742,6,164,kinase regulator activity,MF,CDKN2A;CDKN2B;TRIB1;NRG1;HSP90AB1;DNAJC3
2818,GO:0006302,0.377374795092369,0.76106223819057,7,195,double-strand break repair,BP,NABP1;PARP1;FIGN;NBN;SETX;EYA3;PML
14900,GO:0070828,0.377488521968427,0.922473663226521,1,15,heterochromatin organization,BP,CDKN2A
11845,GO:0046889,0.377578465149729,0.858263146710234,2,43,positive regulation of lipid biosynthetic process,BP,IL1B;ANXA1
390,GO:0001046,0.377581562858089,0.822850976872033,3,71,core promoter sequence-specific DNA binding,MF,TP53;KLF10;SOX11
4558,GO:0010661,0.377650108021463,0.922401171213838,1,15,positive regulation of muscle cell apoptotic process,BP,CDKN2A
19700,GO:2000112,0.377917242239258,0.666453614814104,101,3206,regulation of cellular macromolecule biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;SERP1;MAFF;MGA;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;DNAJC3;ZC3H7B;ZFP42;NLRP10;SVIP;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
4210,GO:0009404,0.378434546062401,0.921750637431318,1,16,toxin metabolic process,BP,CYP1A1
11741,GO:0046636,0.378849166321208,0.921861978605387,1,15,negative regulation of alpha-beta T cell activation,BP,ANXA1
12123,GO:0048268,0.379158932346884,0.921722321238218,1,15,clathrin coat assembly,BP,CLINT1
1697,GO:0004298,0.379339927010907,0.920842999197197,1,18,threonine-type endopeptidase activity,MF,PSMB9
14478,GO:0070003,0.379339927010907,0.920842999197197,1,18,threonine-type peptidase activity,MF,PSMB9
2388,GO:0005546,0.379478749305305,0.857041596104525,2,43,phosphatidylinositol-4,5-bisphosphate binding,MF,MYO1B;ANXA8
94,GO:0000185,0.37956777033996,0.921537769830084,1,15,activation of MAPKKK activity,BP,GADD45B
17000,GO:0099518,0.379798278010192,0.856923790896011,2,42,vesicle cytoskeletal trafficking,BP,AP3M1;MOBP
2924,GO:0006465,0.379823562726311,0.921121965062273,1,16,signal peptide processing,BP,SEC11C
478,GO:0001523,0.379948805468201,0.856738647070035,2,43,retinoid metabolic process,BP,SDR16C5;CYP1A1
5772,GO:0017022,0.379951736776088,0.856736756878085,2,43,myosin binding,MF,AXL;MOBP
4014,GO:0009063,0.379975839720777,0.82098856601747,3,74,cellular amino acid catabolic process,BP,ARG1;IVD;BCAT1
3536,GO:0007586,0.380089424978322,0.856647957897395,2,43,digestion,BP,TJP2;ACO1
6030,GO:0019184,0.380538334927405,0.920797288513997,1,16,nonribosomal peptide biosynthetic process,BP,CHAC1
17853,GO:1902176,0.380594700360349,0.920771651375412,1,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,SOD2
466,GO:0001505,0.380608035672979,0.768341969456055,6,162,regulation of neurotransmitter levels,BP,EDN1;IL1B;SYT11;RIMS2;HSP90AA1;HSP90AB1
15860,GO:0072673,0.380626469904816,0.921058662697539,1,15,lamellipodium morphogenesis,BP,CORO1C
8514,GO:0033866,0.380790931476715,0.920682359415614,1,16,nucleoside bisphosphate biosynthetic process,BP,PAPSS2
8537,GO:0034030,0.380790931476715,0.920682359415614,1,16,ribonucleoside bisphosphate biosynthetic process,BP,PAPSS2
8540,GO:0034033,0.380790931476715,0.920682359415614,1,16,purine nucleoside bisphosphate biosynthetic process,BP,PAPSS2
8687,GO:0034358,0.380919876982591,0.920623652082019,1,16,plasma lipoprotein particle,CC,SAA1
19583,GO:1990777,0.380919876982591,0.920623652082019,1,16,lipoprotein particle,CC,SAA1
16766,GO:0098655,0.381094621328432,0.72032518196309,14,412,cation transmembrane transport,BP,MMP9;NETO1;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;STEAP4;SLC39A14;MAGT1;DLG1;NEDD4
10391,GO:0043268,0.381302338958,0.920751892391922,1,15,positive regulation of potassium ion transport,BP,DLG1
11331,GO:0045727,0.381464990947103,0.79672667009257,4,104,positive regulation of translation,BP,UQCC1;SERP1;RBMS3;DNAJC3
6636,GO:0030004,0.381947307444789,0.819597623067726,3,73,cellular monovalent inorganic cation homeostasis,BP,TP53;SLC8A1;NEDD4L
15181,GO:0071375,0.382002402815836,0.749057444980498,8,223,cellular response to peptide hormone stimulus,BP,NFKB1;EDN1;PARP1;IL1B;LYN;XBP1;ARG1;ENPP1
17730,GO:1901798,0.382220042919709,0.920030253622426,1,16,positive regulation of signal transduction by p53 class mediator,BP,PMAIP1
8020,GO:0032692,0.382269213858799,0.920007760132743,1,16,negative regulation of interleukin-1 production,BP,PML
17790,GO:1901990,0.382565039591611,0.726395684674882,12,357,regulation of mitotic cell cycle phase transition,BP,CDKN2A;TP53;PSMB9;CDKN2B;DUSP1;ANXA1;NBN;HSP90AA1;DCUN1D3;CDK6;PML;CYP1A1
459,GO:0001325,0.382869067907995,0.920038035679373,1,15,formation of extrachromosomal circular DNA,BP,NBN
16315,GO:0090656,0.382869067907995,0.920038035679373,1,15,t-circle formation,BP,NBN
16343,GO:0090737,0.382869067907995,0.920038035679373,1,15,telomere maintenance via telomere trimming,BP,NBN
2204,GO:0005112,0.382900239474064,0.920023794012431,1,15,Notch binding,MF,CHAC1
5216,GO:0015850,0.383050198548874,0.795554007108502,4,102,organic hydroxy compound transport,BP,NFKBIA;NFKB1;C1QTNF1;HTR1B
6398,GO:0021680,0.383265398667969,0.919856847173696,1,15,cerebellar Purkinje cell layer development,BP,HSPA5
6279,GO:0019908,0.383973359389795,0.919225854823616,1,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,HSPD1
15421,GO:0071800,0.384616791095605,0.919237193929656,1,15,podosome assembly,BP,LCP1
7711,GO:0032228,0.384687087141573,0.919204883009343,1,15,regulation of synaptic transmission, GABAergic,BP,HTR1B
257,GO:0000724,0.384716774269935,0.794261805444145,4,102,double-strand break repair via homologous recombination,BP,NABP1;PARP1;FIGN;NBN
7633,GO:0032075,0.38482320839719,0.918834223364064,1,16,positive regulation of nuclease activity,BP,HSPA5
14896,GO:0070821,0.384871532748598,0.853547231803266,2,43,tertiary granule membrane,CC,ADAM8;SVIP
9734,GO:0039529,0.385124534222919,0.919003640760094,1,15,RIG-I signaling pathway,BP,BIRC3
5776,GO:0017038,0.385410630798425,0.76433849811825,6,165,protein import,BP,NFKBIA;HSP90AA1;HSP90AB1;PTTG1IP;PML;HSPD1
13079,GO:0051656,0.385441802564644,0.723886940035375,12,349,establishment of organelle localization,BP,NEFL;FEZ1;LYN;AP3M1;MOBP;HMOX1;SYT11;RIMS2;DLG1;SEC24D;TGFA;MYH9
13568,GO:0060079,0.385461370235012,0.853162539970523,2,43,excitatory postsynaptic potential,BP,NETO1;RIMS2
8939,GO:0035036,0.386055151276024,0.917991302109986,1,17,sperm-egg recognition,BP,B4GALT1
13472,GO:0055083,0.386348253815828,0.918439091191252,1,15,monovalent inorganic anion homeostasis,BP,ENPP1
1215,GO:0002902,0.386426890336405,0.918092119478739,1,16,regulation of B cell apoptotic process,BP,LYN
4747,GO:0010948,0.38653901949494,0.732382755670866,10,295,negative regulation of cell cycle process,BP,TP53;PSMB9;CDKN2B;DUSP1;NBN;DCUN1D3;HSP90AB1;CALR;MGA;PML
10168,GO:0042805,0.38693927051793,0.918165591000305,1,15,actinin binding,MF,NFKB1
15563,GO:0072089,0.387010025878166,0.815985123204583,3,71,stem cell proliferation,BP,EPCAM;VEGFC;SOX11
13766,GO:0060396,0.387010749387898,0.918132476102575,1,15,growth hormone receptor signaling pathway,BP,LYN
11035,GO:0045069,0.387021793387071,0.815844293072869,3,74,regulation of viral genome replication,BP,TNIP1;IFITM2;PPID
7983,GO:0032633,0.387242133290321,0.917713315401149,1,16,interleukin-4 production,BP,CD83
12557,GO:0050773,0.387390852858766,0.792238499187089,4,100,regulation of dendrite development,BP,SDK1;NEDD4L;NRG1;NEDD4
14200,GO:0061217,0.387472663072859,0.917606009505041,1,16,regulation of mesonephros development,BP,MAGED1
4870,GO:0014808,0.387634832226429,0.917530473607143,1,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,SLC8A1
18391,GO:1903514,0.387634832226429,0.917530473607143,1,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,SLC8A1
19701,GO:2000113,0.387644682937947,0.679097340932874,36,1115,negative regulation of cellular macromolecule biosynthetic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;DUSP1;WWC1;NEDD4L;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;ZC3H7B;NEDD4;PML;ZBTB21;SOX11;ENPP1;MAGED1
11445,GO:0045939,0.387657004840519,0.917520142723105,1,16,negative regulation of steroid metabolic process,BP,NFKB1
9892,GO:0042269,0.387814620136605,0.917446682704754,1,16,regulation of natural killer cell mediated cytotoxicity,BP,PVR
7798,GO:0032373,0.387878345766128,0.917416970876118,1,16,positive regulation of sterol transport,BP,NFKBIA
7801,GO:0032376,0.387878345766128,0.917416970876118,1,16,positive regulation of cholesterol transport,BP,NFKBIA
1749,GO:0004364,0.388006089902039,0.916836466473431,1,18,glutathione transferase activity,MF,MGST3
5641,GO:0016765,0.388095663902814,0.851114690887028,2,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,DHDDS;MGST3
12443,GO:0050431,0.388126851222882,0.917614364129983,1,15,transforming growth factor beta binding,MF,ITGAV
13960,GO:0060716,0.388171715882616,0.917280105573988,1,16,labyrinthine layer blood vessel development,BP,JUNB
3179,GO:0006821,0.388360197619033,0.85126475985909,2,43,chloride transport,BP,CLCC1;ANO4
15445,GO:0071840,0.38852008082448,0.652259467960323,149,4800,cellular component organization or biogenesis,BP,CDKN2A;MMP9;IL1A;TRIM16;NEFL;KRT8;CXCL1;TENM3;LGALS1;DSCAM;KRT2;LCP1;KRT18;NEFM;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;CXCL16;PMAIP1;DBNDD2;SLIT2;CLDN1;UBQLN2;COL12A1;CLDN7;MYO1B;DNAJB1;JUN;KRT4;MAP7D2;NFKB2;PARP1;OPTN;SDK1;HRNR;HSPA5;IL1B;IFT46;KRT13;CNTNAP1;C1QTNF1;CRYAB;AXL;ACTG1;NOCT;IKBKE;CYLD;SEMA7A;FBN2;DUSP1;ANXA8;FIGN;ITGAV;LYN;COBLL1;COL8A1;ANXA1;COL4A4;G6PD;NBN;NEDD4L;BIRC3;RHOB;ARG1;SEMA3D;SUDS3;HMOX1;MMP19;SYT11;KLK6;KCTD12;RIMS2;HSP90AA1;NRP1;IL7R;TRAF1;BRD2;SETX;DCUN1D3;GNPTAB;SOD2;POP4;NRG1;IFRD1;SERPINH1;HSP90AB1;SDR16C5;ADAM8;L1CAM;EIF4G2;UQCC1;CALR;PPID;CTR9;AJUBA;IGFBP3;ANO4;AMOTL2;EYA3;SERP1;ORMDL1;RAB30;SEC22A;ARHGDIB;CORO1C;NID2;DLG1;EHD1;ZMYM4;LOX;ETS1;HAS2;ADGRL3;SEC24D;REEP1;PDE4DIP;CHORDC1;TGFA;BAMBI;CBLL1;HSP90B1;TFRC;SVIP;UBXN2B;NEDD4;TUBB3;NTNG1;PML;EPHA2;PVR;EPB41L2;MRPS24;MYH9;TOR1AIP1;UGCG;MRPL53;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;SUPT3H;TJP1;PARVA
11037,GO:0045071,0.388566127876945,0.850959995761416,2,45,negative regulation of viral genome replication,BP,TNIP1;IFITM2
5906,GO:0018200,0.388716322814985,0.917025671227436,1,16,peptidyl-glutamic acid modification,BP,GGCX
16054,GO:0090075,0.388872926283959,0.916952421118566,1,16,relaxation of muscle,BP,SLC8A1
17758,GO:1901889,0.389072700630647,0.917173751317776,1,15,negative regulation of cell junction assembly,BP,CORO1C
10699,GO:0044089,0.389198336675422,0.716606317965544,13,379,positive regulation of cellular component biogenesis,BP,LCP1;EDN1;TP53;DPYSL3;PMAIP1;CLDN1;JUN;PARP1;NRP1;SETX;AJUBA;DLG1;ADGRL3
11382,GO:0045830,0.389390132652028,0.916710226347323,1,16,positive regulation of isotype switching,BP,TFRC
11642,GO:0046461,0.389417831697221,0.916697243649548,1,16,neutral lipid catabolic process,BP,MGLL
11645,GO:0046464,0.389417831697221,0.916697243649548,1,16,acylglycerol catabolic process,BP,MGLL
2704,GO:0006098,0.389585085353311,0.916340672295793,1,17,pentose-phosphate shunt,BP,G6PD
15395,GO:0071711,0.38961725634087,0.916919436825315,1,15,basement membrane organization,BP,NID2
17791,GO:1901991,0.389765319838509,0.750565676671547,7,202,negative regulation of mitotic cell cycle phase transition,BP,TP53;PSMB9;CDKN2B;DUSP1;NBN;DCUN1D3;PML
3904,GO:0008593,0.389992301450632,0.813700108713964,3,73,regulation of Notch signaling pathway,BP,NFKBIA;CHAC1;IL6ST
997,GO:0002478,0.390166782356816,0.773047621115721,5,140,antigen processing and presentation of exogenous peptide antigen,BP,PSMB9;ITGAV;CANX;CALR;SEC24D
406,GO:0001091,0.390513677527239,0.916182640488109,1,16,RNA polymerase II basal transcription factor binding,MF,TP53
181,GO:0000394,0.390578153177628,0.915872750010084,1,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,C2ORF49
19867,GO:2000403,0.390827889256602,0.916034737578508,1,16,positive regulation of lymphocyte migration,BP,ADAM8
3233,GO:0006907,0.391329491663818,0.915798303442071,1,16,pinocytosis,BP,AXL
9711,GO:0038201,0.391366228330425,0.915780971648341,1,16,TOR complex,CC,PRR5L
6969,GO:0030667,0.39152248196225,0.749140782957244,7,196,secretory granule membrane,CC,B4GALT1;ANPEP;ITGAV;ADAM8;MAGT1;MME;SVIP
3756,GO:0008327,0.391555319976936,0.915691727240026,1,16,methyl-CpG binding,MF,ZBTB21
10563,GO:0043565,0.391630238313371,0.687111016473952,25,755,sequence-specific DNA binding,MF,OSR2;NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;SETX;KLF10;SNAI3;NR2F2;MAFF;UBP1;ETS1;ZFP42;ZBTB21;SOX11;HSPD1
2598,GO:0005921,0.391640678663305,0.915651422441218,1,16,gap junction,CC,TJP1
258,GO:0000725,0.391713170851587,0.788775057043759,4,103,recombinational repair,BP,NABP1;PARP1;FIGN;NBN
9770,GO:0040020,0.391743824662003,0.915602703368307,1,16,regulation of meiotic nuclear division,BP,CALR
7109,GO:0030952,0.391890447671246,0.915533419673265,1,16,establishment or maintenance of cytoskeleton polarity,BP,RHOB
12246,GO:0048596,0.39189951102009,0.915848499034909,1,15,embryonic camera-type eye morphogenesis,BP,SOX11
19582,GO:1990776,0.391942111103839,0.915508999043901,1,16,response to angiotensin,BP,NFKB1
17501,GO:1901071,0.392008889289414,0.915477427587141,1,16,glucosamine-containing compound metabolic process,BP,NAGK
3391,GO:0007188,0.392050539587051,0.812178258392781,3,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,EDN1;GPR176;HTR1B
15992,GO:0086064,0.392269117877042,0.915354328862995,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,SLC8A1
10401,GO:0043280,0.392319675933678,0.788193188101199,4,107,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,PMAIP1;TNFSF15;PML;HSPD1
7297,GO:0031326,0.392425577507175,0.65200151086564,105,3347,regulation of cellular biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;ANXA1;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;SERP1;ORMDL1;MAFF;MGA;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;ETS1;HAS2;TGFA;BAMBI;DNAJC3;ZC3H7B;ZFP42;NLRP10;SVIP;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
3426,GO:0007250,0.39256190713949,0.915215698950676,1,16,activation of NF-kappaB-inducing kinase activity,BP,TNFSF15
6269,GO:0019897,0.392702866617177,0.788026160619933,4,102,extrinsic component of plasma membrane,CC,CYLD;LYN;ANXA1;NLRP10
4667,GO:0010833,0.392726605569612,0.811633660539391,3,74,telomere maintenance via telomere lengthening,BP,PARP1;HSP90AA1;HSP90AB1
3715,GO:0008266,0.39291307561765,0.915049247849234,1,16,poly(U) RNA binding,MF,RBMS3
8296,GO:0033158,0.393141110126352,0.91494105622197,1,16,regulation of protein import into nucleus, translocation,BP,HSP90AB1
9337,GO:0035883,0.39356234788248,0.914740981080259,1,16,enteroendocrine cell differentiation,BP,CDK6
15944,GO:0080182,0.393581744408798,0.914731761514198,1,16,histone H3-K4 trimethylation,BP,CTR9
15266,GO:0071498,0.393617341798244,0.914714839787076,1,16,cellular response to fluid shear stress,BP,HAS2
3255,GO:0006942,0.394141890154915,0.847355563448384,2,44,regulation of striated muscle contraction,BP,SLC8A1;DLG1
12030,GO:0048015,0.394215406223614,0.786837030064727,4,102,phosphatidylinositol-mediated signaling,BP,EDN1;NRG1;PRR5L;NEDD4
767,GO:0002027,0.394403128368852,0.847181722429381,2,44,regulation of heart rate,BP,EDN1;SLC8A1
14075,GO:0060972,0.394720408872197,0.914189480082964,1,16,left/right pattern formation,BP,CITED2
10644,GO:0043923,0.394986038844281,0.914062678032049,1,16,positive regulation by host of viral transcription,BP,JUN
5388,GO:0016247,0.395599718070592,0.809454869297229,3,75,channel regulator activity,MF,NEDD4L;DLG1;NEDD4
13482,GO:0055094,0.395724559982205,0.913709542753552,1,16,response to lipoprotein particle,BP,HMGCS1
13076,GO:0051651,0.396128494868272,0.809103338797709,3,74,maintenance of location in cell,BP,HSPA5;FTH1;PML
12043,GO:0048029,0.396317437482664,0.845819802365982,2,45,monosaccharide binding,MF,G6PD;EGLN1
12232,GO:0048562,0.396755789832247,0.75492168408033,6,163,embryonic organ morphogenesis,BP,OSR2;MAFB;EDN1;FBN2;DLG1;SOX11
69,GO:0000145,0.397596017598579,0.912810768961449,1,16,exocyst,CC,TNFAIP2
9015,GO:0035258,0.397648679586944,0.807967923372246,3,74,steroid hormone receptor binding,MF,PARP1;CALR;PPID
12353,GO:0048813,0.397856852505903,0.783992370958295,4,101,dendrite morphogenesis,BP,DSCAM;NEDD4L;NRP1;NEDD4
8178,GO:0032947,0.398738423945505,0.807242119984843,3,72,protein-containing complex scaffold activity,MF,WWC1;DLG1;PDE4DIP
3126,GO:0006735,0.398796040972553,0.911940225643482,1,17,NADH regeneration,BP,PGK1
14339,GO:0061621,0.398796040972553,0.911940225643482,1,17,canonical glycolysis,BP,PGK1
14380,GO:0061718,0.398796040972553,0.911940225643482,1,17,glucose catabolic process to pyruvate,BP,PGK1
6049,GO:0019216,0.398966529681045,0.727454199111032,9,258,regulation of lipid metabolic process,BP,NFKB1;IL1B;FADS1;LYN;ANXA1;ORMDL1;HMGCS1;TXNRD1;CYP1A1
4960,GO:0015095,0.399196866860191,0.912037497639809,1,16,magnesium ion transmembrane transporter activity,MF,MAGT1
5137,GO:0015693,0.399196866860191,0.912037497639809,1,16,magnesium ion transport,BP,MAGT1
18544,GO:1903830,0.399196866860191,0.912037497639809,1,16,magnesium ion transmembrane transport,BP,MAGT1
17046,GO:0099622,0.399277478535999,0.911998450206073,1,16,cardiac muscle cell membrane repolarization,BP,DLG1
4791,GO:0012507,0.399430964218329,0.843730960683019,2,45,ER to Golgi transport vesicle membrane,CC,SEC24D;TGFA
2088,GO:0004866,0.39951836799395,0.806441277099364,3,77,endopeptidase inhibitor activity,MF,SERPINB2;BIRC3;SERPINH1
6868,GO:0030414,0.39951836799395,0.806441277099364,3,77,peptidase inhibitor activity,MF,SERPINB2;BIRC3;SERPINH1
17887,GO:1902254,0.400354803047822,0.91118208110521,1,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,PTTG1IP
2944,GO:0006491,0.40058694220289,0.911362694585453,1,16,N-glycan processing,BP,GNPTAB
10237,GO:0043009,0.400722069665553,0.702670910795635,14,412,chordate embryonic development,BP,KRT8;OSR2;EDN1;JUNB;PHLDA2;NBN;EGLN1;NR2F2;CTR9;MAFF;DLG1;SEC24D;MYH9;SOX11
5441,GO:0016339,0.401364724065282,0.910983766312011,1,16,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,AJUBA
9455,GO:0036120,0.401420210927789,0.910956696297797,1,16,cellular response to platelet-derived growth factor stimulus,BP,HAS2
9736,GO:0039531,0.401423430162418,0.910955125598173,1,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,BIRC3
11379,GO:0045823,0.401435316916322,0.910654242426019,1,17,positive regulation of heart contraction,BP,EDN1
18046,GO:1902692,0.401596781275737,0.910870520981013,1,16,regulation of neuroblast proliferation,BP,VEGFC
7603,GO:0032024,0.402101878081839,0.841927996834486,2,45,positive regulation of insulin secretion,BP,SERP1;OXCT1
13664,GO:0060261,0.402370122256559,0.910196059035103,1,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,TP53
6896,GO:0030507,0.402741905211278,0.910310418900604,1,16,spectrin binding,MF,EPB41L2
16634,GO:0097602,0.403838280191126,0.909473598928696,1,17,cullin family protein binding,MF,DCUN1D3
477,GO:0001522,0.403843673192897,0.909205852794889,1,18,pseudouridine synthesis,BP,PUS10
9634,GO:0038023,0.404549145386757,0.702781889213615,13,384,signaling receptor activity,MF,IL6ST;AXL;ITGAV;GPR176;NRP1;IL7R;CXCR5;NR2F2;IFNAR1;ADGRL3;IFNGR1;HTR1B;EPHA2
13576,GO:0060089,0.404549145386757,0.702781889213615,13,384,molecular transducer activity,MF,IL6ST;AXL;ITGAV;GPR176;NRP1;IL7R;CXCR5;NR2F2;IFNAR1;ADGRL3;IFNGR1;HTR1B;EPHA2
13756,GO:0060384,0.405115542490482,0.909142661665558,1,16,innervation,BP,NRP1
15184,GO:0071378,0.40552639485792,0.90893960594131,1,16,cellular response to growth hormone stimulus,BP,LYN
8064,GO:0032770,0.405660588886902,0.90857199215439,1,17,positive regulation of monooxygenase activity,BP,IL1B
11384,GO:0045834,0.405885752007361,0.801721072815567,3,75,positive regulation of lipid metabolic process,BP,IL1B;LYN;ANXA1
567,GO:0001709,0.40607478640088,0.908366308851421,1,17,cell fate determination,BP,IFRD1
6395,GO:0021675,0.406232815003686,0.83920728728079,2,44,nerve development,BP,MAFB;NRP1
758,GO:0002011,0.406283074977631,0.839172978019335,2,44,morphogenesis of an epithelial sheet,BP,AJUBA;SOX11
13180,GO:0051881,0.406365225563197,0.838787126310321,2,48,regulation of mitochondrial membrane potential,BP,PMAIP1;PARP1
12543,GO:0050750,0.406560386337466,0.90812481181916,1,17,low-density lipoprotein particle receptor binding,MF,HSP90B1
7351,GO:0031418,0.406666848283365,0.908071815037136,1,17,L-ascorbic acid binding,MF,EGLN1
6434,GO:0021772,0.406666936300065,0.908374475658501,1,16,olfactory bulb development,BP,SLIT2
13115,GO:0051726,0.406881423525846,0.664548626820312,32,999,regulation of cell cycle,BP,CDKN2A;IL1A;EDN1;TP53;PSMB9;CDKN2B;NABP1;JUN;IL1B;JUNB;GADD45B;CYLD;DUSP1;ANXA1;NBN;RHOB;HSP90AA1;DCUN1D3;CXCR5;HSP90AB1;NR2F2;EIF4G2;CALR;MGA;DLG1;CITED2;CHORDC1;TGFA;CDK6;PML;SOX11;CYP1A1
13189,GO:0051893,0.407315293877341,0.83846754283666,2,44,regulation of focal adhesion assembly,BP,NRP1;CORO1C
16079,GO:0090109,0.407315293877341,0.83846754283666,2,44,regulation of cell-substrate junction assembly,BP,NRP1;CORO1C
13804,GO:0060445,0.407373952019415,0.908023089803165,1,16,branching involved in salivary gland morphogenesis,BP,NRP1
12627,GO:0050871,0.407571731743062,0.838119156789986,2,46,positive regulation of B cell activation,BP,XBP1;TFRC
12311,GO:0048710,0.407761196457295,0.907525974283081,1,17,regulation of astrocyte differentiation,BP,IL6ST
1118,GO:0002714,0.407778576337969,0.907517289715605,1,17,positive regulation of B cell mediated immunity,BP,TFRC
1213,GO:0002891,0.407778576337969,0.907517289715605,1,17,positive regulation of immunoglobulin mediated immune response,BP,TFRC
14642,GO:0070296,0.407985117731594,0.907414045014568,1,17,sarcoplasmic reticulum calcium ion transport,BP,SLC8A1
10923,GO:0044703,0.408113650171808,0.684586428515005,18,547,multi-organism reproductive process,BP,MMP9;B4GALT1;EDN1;CLDN11;IL1B;JUNB;AXL;BIRC3;ARG1;MMP19;BRD2;SETX;NR2F2;CALR;MAFF;ARHGDIB;ETS1;CYP1A1
2502,GO:0005769,0.408240867074491,0.71928021363999,9,260,early endosome,CC,MYO1B;ANXA1;RHOB;NRP1;STEAP4;EHD1;TFRC;PML;HSPD1
14797,GO:0070577,0.408565975003506,0.907428807838056,1,16,lysine-acetylated histone binding,MF,BRD2
17241,GO:0140033,0.408565975003506,0.907428807838056,1,16,acetylation-dependent protein binding,MF,BRD2
13627,GO:0060191,0.408789309061282,0.837283910173835,2,46,regulation of lipase activity,BP,ANXA8;ANXA1
6373,GO:0021591,0.40890992173781,0.906950902442173,1,17,ventricular system development,BP,CDK6
15230,GO:0071450,0.409011838494929,0.906627976720652,1,18,cellular response to oxygen radical,BP,SOD2
15231,GO:0071451,0.409011838494929,0.906627976720652,1,18,cellular response to superoxide,BP,SOD2
3417,GO:0007221,0.409293091675995,0.907065163411147,1,16,positive regulation of transcription of Notch receptor target,BP,WWC1
8803,GO:0034613,0.409347672841916,0.651824632766501,46,1459,cellular protein localization,BP,NFKBIA;LCP1;KRT18;TP53;PMAIP1;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;CYLD;STAC;AP3M1;DERL3;NEDD4L;RHOB;SYT11;RIMS2;HSP90AA1;NRP1;GNPTAB;NRG1;HSP90AB1;CALR;AJUBA;SEL1L;PRR5L;RAB30;DLG1;EHD1;PTTG1IP;SEC24D;REEP1;HSP90B1;SVIP;NEDD4;ZDHHC6;PML;EPHA2;EPB41L2;TOR1AIP1;UGCG;TNFAIP2;CEP83;HSPD1
6262,GO:0019884,0.409634641045759,0.756998450390775,5,143,antigen processing and presentation of exogenous antigen,BP,PSMB9;ITGAV;CANX;CALR;SEC24D
6689,GO:0030118,0.409752191996417,0.836706970986999,2,45,clathrin coat,CC,AP3M1;KCNQ5
18448,GO:1903599,0.409793263636888,0.90650721432481,1,17,positive regulation of autophagy of mitochondrion,BP,OPTN
7119,GO:0030971,0.410174374475207,0.836416389965969,2,45,receptor tyrosine kinase binding,MF,TP53;NRG1
20054,GO:2000757,0.410301041809126,0.906251585619845,1,17,negative regulation of peptidyl-lysine acetylation,BP,SDR16C5
14005,GO:0060795,0.410527791404492,0.906137297085395,1,17,cell fate commitment involved in formation of primary germ layer,BP,CTR9
8947,GO:0035065,0.410807993614483,0.835894390675416,2,46,regulation of histone acetylation,BP,IL1B;SDR16C5
5501,GO:0016486,0.410910845912561,0.905944034093918,1,17,peptide hormone processing,BP,MME
12107,GO:0048246,0.410988489750728,0.905630442771734,1,18,macrophage chemotaxis,BP,SAA1
3184,GO:0006829,0.411122971555274,0.905836906166598,1,17,zinc ion transport,BP,SLC39A14
974,GO:0002437,0.411126226095268,0.905560693072665,1,18,inflammatory response to antigenic stimulus,BP,IL1B
10248,GO:0043027,0.411156733617334,0.905819848778127,1,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,BIRC3
12575,GO:0050796,0.411163908890742,0.773221743319033,4,106,regulation of insulin secretion,BP,IL1B;SERP1;OXCT1;MIDN
2606,GO:0005938,0.411753134996133,0.723302428789434,8,226,cell cortex,CC,RHOB;MOBP;RIMS2;NEDD4;EPB41L2;MYH9;TNFAIP2;TPM4
12281,GO:0048668,0.411807064657086,0.905490919774664,1,17,collateral sprouting,BP,IFRD1
16815,GO:0098780,0.411951753956329,0.905417643005566,1,17,response to mitochondrial depolarisation,BP,OPTN
2098,GO:0004888,0.412092217969966,0.704572845589414,11,324,transmembrane signaling receptor activity,MF,IL6ST;AXL;GPR176;NRP1;IL7R;CXCR5;IFNAR1;ADGRL3;IFNGR1;HTR1B;EPHA2
9055,GO:0035335,0.412176039672396,0.796925711230502,3,75,peptidyl-tyrosine dephosphorylation,BP,DUSP8;DUSP1;EYA3
12080,GO:0048169,0.412958013960704,0.904907074975395,1,17,regulation of long-term neuronal synaptic plasticity,BP,NETO1
8031,GO:0032715,0.413169716627686,0.904799445888142,1,17,negative regulation of interleukin-6 production,BP,SYT11
11117,GO:0045202,0.413664451567594,0.68194370665454,17,509,synapse,CC,NETO1;DSCAM;DBNDD2;SDK1;CRYAB;LYN;SLC8A1;SYT11;KCTD12;RIMS2;CANX;NRG1;STXBP5;MME;DLG1;NEDD4;MYH9
11432,GO:0045923,0.413967948857311,0.904392960245745,1,17,positive regulation of fatty acid metabolic process,BP,ANXA1
6533,GO:0021983,0.414106370707386,0.904322364109973,1,17,pituitary gland development,BP,ETS1
4296,GO:0009791,0.414195038146604,0.795420929017183,3,74,post-embryonic development,BP,DSCAM;ACO1;SERP1
18881,GO:1904646,0.414512031547581,0.904115291438041,1,17,cellular response to amyloid-beta,BP,PARP1
14335,GO:0061615,0.41481059744631,0.903683287671973,1,18,glycolytic process through fructose-6-phosphate,BP,PGK1
14338,GO:0061620,0.41481059744631,0.903683287671973,1,18,glycolytic process through glucose-6-phosphate,BP,PGK1
16822,GO:0098794,0.414885087424218,0.713415467164546,9,257,postsynapse,CC,NETO1;CRYAB;LYN;SLC8A1;SYT11;KCTD12;CANX;DLG1;NEDD4
794,GO:0002068,0.415224939263455,0.90375072152842,1,17,glandular epithelial cell development,BP,CDK6
9166,GO:0035577,0.415359972601532,0.832656527316722,2,47,azurophil granule membrane,CC,B4GALT1;MAGT1
13445,GO:0055023,0.415462842140284,0.903628874125194,1,17,positive regulation of cardiac muscle tissue growth,BP,EDN1
12032,GO:0048017,0.415525086374249,0.769721202933071,4,105,inositol lipid-mediated signaling,BP,EDN1;NRG1;PRR5L;NEDD4
7385,GO:0031468,0.415713363352031,0.903219842453781,1,18,nuclear envelope reassembly,BP,UBXN2B
7693,GO:0032204,0.415719665311137,0.794158160427532,3,76,regulation of telomere maintenance,BP,PARP1;NBN;PML
3223,GO:0006893,0.416016131170588,0.832282209634406,2,46,Golgi to plasma membrane transport,BP,KRT18;OPTN
4490,GO:0010558,0.416719825743491,0.650797611690396,37,1161,negative regulation of macromolecule biosynthetic process,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;DNAJB1;JUN;NFKB2;PARP1;JUNB;ATF3;DUSP1;ITGAV;WWC1;NEDD4L;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;UBP1;DLG1;CITED2;ZNF814;ZC3H7B;NEDD4;PML;ZBTB21;SOX11;ENPP1;MAGED1
1540,GO:0003950,0.416911816488773,0.902884718935217,1,17,NAD+ ADP-ribosyltransferase activity,MF,PARP1
14546,GO:0070129,0.417166310885511,0.902471107786032,1,18,regulation of mitochondrial translation,BP,UQCC1
14595,GO:0070207,0.41726318802982,0.902421059848988,1,18,protein homotrimerization,BP,ARG1
12625,GO:0050869,0.417287972324824,0.902690964328418,1,17,negative regulation of B cell activation,BP,LYN
9919,GO:0042311,0.417302872919923,0.902400553621901,1,18,vasodilation,BP,SOD2
8207,GO:0032994,0.417325730365337,0.902388741386041,1,18,protein-lipid complex,CC,SAA1
12884,GO:0051279,0.417669647540907,0.831127146515625,2,46,regulation of release of sequestered calcium ion into cytosol,BP,LYN;SLC8A1
8965,GO:0035107,0.417726870355001,0.767931794505895,4,105,appendage morphogenesis,BP,OSR2;FBN2;FRAS1;SOX11
8966,GO:0035108,0.417726870355001,0.767931794505895,4,105,limb morphogenesis,BP,OSR2;FBN2;FRAS1;SOX11
6639,GO:0030010,0.418645175737777,0.767212401510797,4,104,establishment of cell polarity,BP,FEZ1;WWC1;AMOTL2;MYH9
8860,GO:0034703,0.418826748324823,0.791756613886687,3,76,cation channel complex,CC,HERPUD1;CNTNAP1;KCNQ5
15344,GO:0071634,0.419095670275241,0.901756545052295,1,17,regulation of transforming growth factor beta production,BP,HSP90AB1
1251,GO:0003016,0.419184823634205,0.901710319565774,1,17,respiratory system process,BP,CCBE1
5899,GO:0018193,0.419727646894459,0.654482802765539,30,935,peptidyl-amino acid modification,BP,TRIM16;TP53;FGF5;RIPK2;PARP1;IL1B;IL6ST;AXL;IKBKE;STT3A;LYN;DERL3;VEGFC;UGGT1;IL24;HSP90AA1;NRP1;EGLN1;NRG1;SDR16C5;GGCX;PPID;CTR9;MAGT1;IL23A;TGFA;ZDHHC6;EPHA2;GALNT14;SUPT3H
18542,GO:1903828,0.419828871268224,0.790936121237698,3,77,negative regulation of cellular protein localization,BP,DERL3;NEDD4L;SVIP
9454,GO:0036119,0.419940991575676,0.901317716721047,1,17,response to platelet-derived growth factor,BP,HAS2
3338,GO:0007088,0.420189973952048,0.748213937635724,5,140,regulation of mitotic nuclear division,BP,IL1A;EDN1;IL1B;DUSP1;TGFA
1989,GO:0004725,0.420220931306729,0.790675017023877,3,76,protein tyrosine phosphatase activity,MF,DUSP8;DUSP1;EYA3
9870,GO:0042219,0.420338330564933,0.900824253331942,1,18,cellular modified amino acid catabolic process,BP,CHAC1
3203,GO:0006865,0.420501664158603,0.790456926843168,3,76,amino acid transport,BP,NFKBIE;ARG1;SLC7A5P2
5919,GO:0018230,0.420532824878741,0.900722727315566,1,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC6
5920,GO:0018231,0.420532824878741,0.900722727315566,1,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC6
2545,GO:0005839,0.420534632052496,0.900234594649777,1,20,proteasome core complex,CC,PSMB9
3273,GO:0006978,0.421329172863735,0.900306371504129,1,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,TP53
10772,GO:0044291,0.421415393003453,0.828584241940805,2,45,cell-cell contact zone,CC,SLC8A1;DLG1
10319,GO:0043162,0.421850911401491,0.900033012469977,1,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,NEDD4
17546,GO:1901222,0.421896823042672,0.828071413382728,2,47,regulation of NIK/NF-kappaB signaling,BP,TNFSF15;CALR
14862,GO:0070723,0.422009403881541,0.900238903909859,1,17,response to cholesterol,BP,HMGCS1
12195,GO:0048489,0.422062226814634,0.789242755005732,3,76,synaptic vesicle transport,BP,AP3M1;SYT11;RIMS2
16584,GO:0097480,0.422062226814634,0.789242755005732,3,76,establishment of synaptic vesicle localization,BP,AP3M1;SYT11;RIMS2
5651,GO:0016780,0.422653914135862,0.8996113934601,1,18,phosphotransferase activity, for other substituted phosphate groups,MF,GNPTAB
1472,GO:0003785,0.422930825443878,0.89946574856497,1,18,actin monomer binding,MF,COBLL1
10255,GO:0043034,0.422971825757637,0.899734489665614,1,17,costamere,CC,KRT8
9793,GO:0042036,0.423057195544657,0.899399239722529,1,18,negative regulation of cytokine biosynthetic process,BP,NFKB1
10555,GO:0043552,0.423141139051137,0.899645589864768,1,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,LYN
1119,GO:0002715,0.423418225011599,0.899209080843215,1,18,regulation of natural killer cell mediated immunity,BP,PVR
14449,GO:0061900,0.423586005312861,0.899411777978171,1,17,glial cell activation,BP,JUN
3525,GO:0007548,0.423663815443942,0.731933842635893,6,169,sex differentiation,BP,SLIT2;AXL;MMP19;HMGCS1;CITED2;ZFP42
16521,GO:0097345,0.424925985291032,0.825765093283498,2,49,mitochondrial outer membrane permeabilization,BP,TP53;PMAIP1
10979,GO:0044839,0.425071526385578,0.711421164468508,8,239,cell cycle G2/M phase transition,BP,TP53;PSMB9;CDKN2B;OPTN;NBN;HSP90AA1;AJUBA;CDK6
871,GO:0002230,0.425329810216708,0.898198556777916,1,18,positive regulation of defense response to virus by host,BP,IL23A
17785,GO:1901984,0.425498459519232,0.898109106836745,1,18,negative regulation of protein acetylation,BP,SDR16C5
6597,GO:0022839,0.425502075054442,0.761512123241725,4,107,ion gated channel activity,MF,ITGAV;KCNQ5;ANO4;DLG1
10043,GO:0042572,0.425511821388432,0.898102017773115,1,18,retinol metabolic process,BP,SDR16C5
8970,GO:0035116,0.425666332632494,0.898020020749805,1,18,embryonic hindlimb morphogenesis,BP,OSR2
3251,GO:0006937,0.426252112944288,0.785880551041608,3,78,regulation of muscle contraction,BP,EDN1;SLC8A1;DLG1
14659,GO:0070325,0.426373061119776,0.897644453870187,1,18,lipoprotein particle receptor binding,MF,HSP90B1
5445,GO:0016358,0.426587617984889,0.729447390226357,6,166,dendrite development,BP,DSCAM;SDK1;NEDD4L;NRP1;NRG1;NEDD4
11437,GO:0045930,0.4267061334806,0.702730706663241,9,273,negative regulation of mitotic cell cycle,BP,TP53;PSMB9;CDKN2B;NABP1;DUSP1;NBN;DCUN1D3;DLG1;PML
4665,GO:0010831,0.426914126483691,0.897356350578478,1,18,positive regulation of myotube differentiation,BP,EHD1
2233,GO:0005158,0.427312337708196,0.897440182004358,1,17,insulin receptor binding,MF,ENPP1
1437,GO:0003678,0.42743950949897,0.824220909666098,2,46,DNA helicase activity,MF,NBN;SETX
8760,GO:0034471,0.427839490277087,0.896597124039188,1,19,ncRNA 5'-end processing,BP,POP4
12308,GO:0048706,0.427937426623747,0.784599492733425,3,77,embryonic skeletal system development,BP,OSR2;DLG1;SOX11
1464,GO:0003743,0.428037310259546,0.82354537984569,2,49,translation initiation factor activity,MF,EIF4G2;EIF2B1
11466,GO:0045987,0.428117130784122,0.896714000234689,1,18,positive regulation of smooth muscle contraction,BP,EDN1
3439,GO:0007267,0.428198191711321,0.647574972119124,29,903,cell-cell signaling,BP,NETO1;NFKB1;EDN1;PSMB9;FGF5;IL1B;ANPEP;C1QTNF1;ERAP1;CYLD;FADS1;LYN;ANXA1;GPR176;SYT11;RIMS2;NRP1;KLF10;CTR9;AMOTL2;SERP1;DLG1;RBMS3;BAMBI;HTR1B;OXCT1;SOX11;MIDN;TJP1
14864,GO:0070727,0.428214375165223,0.633744737873546,46,1469,cellular macromolecule localization,BP,NFKBIA;LCP1;KRT18;TP53;PMAIP1;HERPUD1;PARP1;OPTN;HSPA5;IL1B;CNTNAP1;CYLD;STAC;AP3M1;DERL3;NEDD4L;RHOB;SYT11;RIMS2;HSP90AA1;NRP1;GNPTAB;NRG1;HSP90AB1;CALR;AJUBA;SEL1L;PRR5L;RAB30;DLG1;EHD1;PTTG1IP;SEC24D;REEP1;HSP90B1;SVIP;NEDD4;ZDHHC6;PML;EPHA2;EPB41L2;TOR1AIP1;UGCG;TNFAIP2;CEP83;HSPD1
17210,GO:0120033,0.428227179512258,0.896655116300719,1,18,negative regulation of plasma membrane bounded cell projection assembly,BP,SLIT2
3318,GO:0007044,0.428253943296381,0.784440199249684,3,75,cell-substrate junction assembly,BP,NRP1;AJUBA;CORO1C
9473,GO:0036151,0.428391389169954,0.896567214076149,1,18,phosphatidylcholine acyl-chain remodeling,BP,PLBD1
4790,GO:0012506,0.428536027729,0.668096626668177,17,522,vesicle membrane,CC,B4GALT1;DBNDD2;ANPEP;ITGAV;AP3M1;ANXA1;SYT11;IL7R;ADAM8;STXBP5;CALR;MAGT1;MME;SEC24D;TGFA;TFRC;SVIP
148,GO:0000303,0.428635503969679,0.896170143900331,1,19,response to superoxide,BP,SOD2
14908,GO:0070841,0.428676419730108,0.896414526839644,1,18,inclusion body assembly,BP,DNAJB1
9022,GO:0035268,0.428705668410276,0.896398850867572,1,18,protein mannosylation,BP,SDF2L1
7836,GO:0032418,0.428830510222609,0.823056693162882,2,48,lysosome localization,BP,LYN;HMOX1
10557,GO:0043555,0.429061419697054,0.896208067568002,1,18,regulation of translation in response to stress,BP,DNAJC3
15412,GO:0071782,0.430021285493742,0.895692231433993,1,18,endoplasmic reticulum tubular network,CC,REEP1
9280,GO:0035767,0.43034487974924,0.895517976008181,1,18,endothelial cell chemotaxis,BP,NRP1
16725,GO:0098562,0.430396486135584,0.739576720321292,5,139,cytoplasmic side of membrane,CC,CYLD;LYN;G6PD;TRAF3;DLG1
15770,GO:0072509,0.43061156960118,0.895374229114353,1,18,divalent inorganic cation transmembrane transporter activity,MF,SLC39A14
2251,GO:0005179,0.430874696877521,0.894963244250111,1,19,hormone activity,MF,EDN1
14291,GO:0061515,0.432275293952632,0.820663125959556,2,47,myeloid cell development,BP,TJP2;G6PD
6595,GO:0022836,0.432404717146058,0.755776174112195,4,108,gated channel activity,MF,ITGAV;KCNQ5;ANO4;DLG1
17705,GO:1901681,0.432434238547127,0.737778818043126,5,142,sulfur compound binding,MF,SAA1;DPYSL3;SLIT2;NRP1;ENPP1
5330,GO:0016101,0.43243446168975,0.820464399570183,2,48,diterpenoid metabolic process,BP,SDR16C5;CYP1A1
6051,GO:0019218,0.432497764460206,0.78091265439453,3,79,regulation of steroid metabolic process,BP,NFKB1;IL1B;HMGCS1
15556,GO:0072078,0.432550553618776,0.820464482320941,2,47,nephron tubule morphogenesis,BP,DLG1;MAGED1
15203,GO:0071402,0.4332178211853,0.893963040288533,1,18,cellular response to lipoprotein particle stimulus,BP,HMGCS1
7537,GO:0031901,0.433784303519892,0.754601293563413,4,109,early endosome membrane,CC,ANXA1;STEAP4;EHD1;PML
10745,GO:0044232,0.434113415189105,0.893475418594262,1,18,organelle membrane contact site,CC,CANX
7480,GO:0031672,0.434131108159276,0.893465771456212,1,18,A band,CC,CRYAB
18256,GO:1903203,0.434247498656082,0.893402295807848,1,18,regulation of oxidative stress-induced neuron death,BP,PARP1
19191,GO:1905368,0.434903665155918,0.778766855928742,3,85,peptidase complex,CC,PSMB9;SEC11C;SUPT3H
3679,GO:0008201,0.435494061731731,0.778531608768701,3,79,heparin binding,MF,SAA1;SLIT2;NRP1
6798,GO:0030276,0.435878476589288,0.818053983785202,2,47,clathrin binding,MF,SYT11;CLINT1
14649,GO:0070306,0.435952018829371,0.892470031668011,1,18,lens fiber cell differentiation,BP,EPHA2
8854,GO:0034694,0.436228464480377,0.892318361157619,1,18,response to prostaglandin,BP,EDN1
14164,GO:0061135,0.436282410482768,0.77778098835036,3,82,endopeptidase regulator activity,MF,SERPINB2;BIRC3;SERPINH1
10149,GO:0042772,0.436471844450161,0.891908806752626,1,19,DNA damage response, signal transduction resulting in transcription,BP,TP53
13497,GO:0055123,0.436756060008189,0.777612283472765,3,77,digestive system development,BP,XBP1;SOX11;CYP1A1
13859,GO:0060544,0.437086619311179,0.891570021627276,1,19,regulation of necroptotic process,BP,BIRC3
13772,GO:0060402,0.437099057378299,0.777294389523004,3,78,calcium ion transport into cytosol,BP,LYN;SLC8A1;PML
4297,GO:0009792,0.437202368929426,0.669133416455265,14,422,embryo development ending in birth or egg hatching,BP,KRT8;OSR2;EDN1;JUNB;PHLDA2;NBN;EGLN1;NR2F2;CTR9;MAFF;DLG1;SEC24D;MYH9;SOX11
589,GO:0001754,0.437305224213146,0.891726343263049,1,18,eye photoreceptor cell differentiation,BP,DSCAM
10863,GO:0044440,0.438085209521516,0.671999230037507,13,398,endosomal part,CC,MYO1B;OPTN;IKBKE;STOML1;ANXA8;ANXA1;RHOB;STEAP4;EHD1;TFRC;PML;MON1A;IRAK2
15275,GO:0071514,0.438170871727349,0.891248942879277,1,18,genetic imprinting,BP,CTR9
15325,GO:0071604,0.438251199428099,0.891204576705569,1,18,transforming growth factor beta production,BP,HSP90AB1
9285,GO:0035774,0.43850857203258,0.890783913281231,1,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,OXCT1
16150,GO:0090218,0.438689061045946,0.890962542516996,1,18,positive regulation of lipid kinase activity,BP,LYN
7425,GO:0031579,0.438691902786796,0.890682305785558,1,19,membrane raft organization,BP,DLG1
3638,GO:0008135,0.438770784403563,0.775831446028735,3,81,translation factor activity, RNA binding,MF,EIF4G2;EIF2B1;SOX11
7675,GO:0032154,0.438893197963972,0.815770598738697,2,48,cleavage furrow,CC,RHOB;MYH9
7024,GO:0030817,0.43903030017928,0.890494602204298,1,19,regulation of cAMP biosynthetic process,BP,GPR176
12738,GO:0051053,0.439776949056844,0.749590991753985,4,109,negative regulation of DNA metabolic process,BP,TP53;PARP1;DUSP1;NBN
6818,GO:0030301,0.439796879239813,0.815026686895552,2,49,cholesterol transport,BP,NFKBIA;NFKB1
4381,GO:0010107,0.440129028398012,0.890164232476284,1,18,potassium ion import,BP,DLG1
9856,GO:0042165,0.440266767742832,0.889807059504117,1,19,neurotransmitter binding,MF,HTR1B
17836,GO:1902115,0.440279827282449,0.731071325134658,5,140,regulation of organelle assembly,BP,LCP1;FEZ1;EDN1;UBQLN2;CYLD
17783,GO:1901981,0.440351037969123,0.749108836248167,4,109,phosphatidylinositol phosphate binding,MF,MYO1B;ANXA8;PLEKHA2;DAPP1
8529,GO:0033962,0.440458515998548,0.889981059442404,1,18,cytoplasmic mRNA processing body assembly,BP,NOCT
13533,GO:0060041,0.440581839972476,0.774549872950471,3,77,retina development in camera-type eye,BP,DSCAM;SDK1;NRP1
10291,GO:0043114,0.441201795234616,0.88956715160356,1,18,regulation of vascular permeability,BP,SLIT2
5105,GO:0015491,0.44135304163783,0.889482809530245,1,18,cation:cation antiporter activity,MF,SLC8A1
10596,GO:0043627,0.44142734500584,0.813829365830313,2,49,response to estrogen,BP,HMOX1;CITED2
18342,GO:1903391,0.441483590895832,0.813956890912729,2,47,regulation of adherens junction organization,BP,NRP1;CORO1C
19868,GO:2000404,0.441514178665884,0.889110731393822,1,19,regulation of T cell migration,BP,ADAM8
11259,GO:0045606,0.441668978734737,0.889024129612941,1,19,positive regulation of epidermal cell differentiation,BP,TRIM16
9406,GO:0036010,0.441857213575208,0.889201371421834,1,18,protein localization to endosome,BP,NRP1
5544,GO:0016575,0.441881941396426,0.773416753935936,3,79,histone deacetylation,BP,TP53;SUDS3;SDR16C5
2730,GO:0006144,0.442064041654578,0.888802924666427,1,19,purine nucleobase metabolic process,BP,GDA
19678,GO:2000060,0.442075730388592,0.773218365563909,3,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,UBQLN2;HERPUD1;TRIB1
7127,GO:0030992,0.442430747368783,0.888597353306646,1,19,intraciliary transport particle B,CC,IFT46
7695,GO:0032206,0.442439986959082,0.813083742908368,2,49,positive regulation of telomere maintenance,BP,NBN;PML
17028,GO:0099565,0.442564538999631,0.813074854738418,2,48,chemical synaptic transmission, postsynaptic,BP,NETO1;RIMS2
12923,GO:0051345,0.443319732352326,0.651690122357628,18,555,positive regulation of hydrolase activity,BP,PMAIP1;DNAJB1;JUN;RIPK2;HSPA5;DNAJC10;LYN;NRP1;TNFSF15;HSP90AB1;STXBP5;ARHGDIB;GIT2;CORO1C;PML;EPHA2;TOR1AIP1;HSPD1
8089,GO:0032799,0.443384768259814,0.888061436240239,1,19,low-density lipoprotein receptor particle metabolic process,BP,ITGAV
2848,GO:0006355,0.444287226382249,0.604344881186929,88,2828,regulation of transcription, DNA-templated,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
14430,GO:0061844,0.444475868470091,0.886746240773782,1,22,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,RNASE7
281,GO:0000784,0.444516228062388,0.745466588713158,4,114,nuclear chromosome, telomeric region,CC,NABP1;PARP1;NBN;PML
2629,GO:0005979,0.444541717549735,0.887695349089133,1,18,regulation of glycogen biosynthetic process,BP,ENPP1
4759,GO:0010962,0.444541717549735,0.887695349089133,1,18,regulation of glucan biosynthetic process,BP,ENPP1
14270,GO:0061448,0.444587773392288,0.727320799123495,5,141,connective tissue development,BP,OSR2;EDN1;XBP1;SERPINH1;OXCT1
789,GO:0002063,0.445074432679894,0.887394991139573,1,18,chondrocyte development,BP,SERPINH1
17531,GO:1901184,0.445074757619326,0.770797733663404,3,80,regulation of ERBB signaling pathway,BP,MMP9;NRG1;TGFA
17835,GO:1902110,0.445266083088619,0.810837545937194,2,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;PMAIP1
3254,GO:0006941,0.445283291189472,0.770671716963418,3,79,striated muscle contraction,BP,SLC8A1;NEDD4L;DLG1
17265,GO:0140103,0.445768190325726,0.886715579571121,1,19,catalytic activity, acting on a glycoprotein,MF,MGAT5
11420,GO:0045911,0.445882077419674,0.886651020377078,1,19,positive regulation of DNA recombination,BP,TFRC
6318,GO:0021510,0.446011780435105,0.810525328910897,2,48,spinal cord development,BP,NEFL;SOX11
4601,GO:0010737,0.446238832668609,0.886448638557707,1,19,protein kinase A signaling,BP,LCP1
5825,GO:0017134,0.44637364380184,0.886372103852133,1,19,fibroblast growth factor binding,MF,ITGAV
6035,GO:0019200,0.446503656245679,0.886298263093195,1,19,carbohydrate kinase activity,MF,NAGK
7300,GO:0031329,0.446509646776873,0.640274851948814,22,691,regulation of cellular catabolic process,BP,FEZ1;PSMB9;UBQLN2;RIPK2;HERPUD1;OPTN;IL1B;NOCT;TRIB1;DERL3;XBP1;HMOX1;HSP90AA1;EGLN1;HSP90AB1;ADAM8;EIF4G2;PRR5L;PTTG1IP;SVIP;NEDD4;PML
13451,GO:0055037,0.4465536389254,0.725573536517291,5,143,recycling endosome,CC,OPTN;SYT11;AMOTL2;EHD1;TFRC
20247,GO:2001267,0.446596815083828,0.885985926057749,1,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,MMP9
4661,GO:0010827,0.446884188305163,0.809877287472644,2,48,regulation of glucose transmembrane transport,BP,IL1B;ENPP1
3176,GO:0006816,0.4468917158695,0.700678858029508,7,205,calcium ion transport,BP,IL16;STAC;ITGAV;LYN;G6PD;SLC8A1;PML
4545,GO:0010644,0.447220975997367,0.885890324073315,1,19,cell communication by electrical coupling,BP,SLC8A1
6873,GO:0030425,0.447240569316974,0.667694779807596,12,362,dendrite,CC,FEZ1;IL6ST;CRYAB;SLC8A1;SYT11;CANX;NRG1;L1CAM;MME;HTR1B;NEDD4;TUBB3
16568,GO:0097447,0.447240569316974,0.667694779807596,12,362,dendritic tree,CC,FEZ1;IL6ST;CRYAB;SLC8A1;SYT11;CANX;NRG1;L1CAM;MME;HTR1B;NEDD4;TUBB3
6835,GO:0030324,0.447496655002667,0.743075606850773,4,109,lung development,BP,CCBE1;ARG1;LOX;SOX11
18880,GO:1904645,0.447543508223761,0.885706604222366,1,19,response to amyloid-beta,BP,PARP1
16583,GO:0097479,0.448418065196801,0.768128523437546,3,79,synaptic vesicle localization,BP,AP3M1;SYT11;RIMS2
19978,GO:2000637,0.448993706888005,0.884878273086111,1,19,positive regulation of gene silencing by miRNA,BP,AJUBA
9581,GO:0036475,0.449056986060348,0.884842044211332,1,19,neuron death in response to oxidative stress,BP,PARP1
13704,GO:0060317,0.44944474052877,0.88461989027082,1,19,cardiac epithelial to mesenchymal transition,BP,HAS2
3797,GO:0008406,0.449528404474741,0.722979109574968,5,143,gonad development,BP,SLIT2;MMP19;HMGCS1;CITED2;ZFP42
16236,GO:0090344,0.449699080967245,0.88447402764491,1,19,negative regulation of cell aging,BP,CDK6
18578,GO:1903902,0.450659173585625,0.806893520684667,2,50,positive regulation of viral life cycle,BP,LGALS1;PPID
18066,GO:1902745,0.451001547101819,0.883725271256333,1,19,positive regulation of lamellipodium organization,BP,CORO1C
4793,GO:0014002,0.451238925454819,0.883588483248379,1,19,astrocyte development,BP,CDK6
20240,GO:2001251,0.451262831087336,0.739816590137777,4,111,negative regulation of chromosome organization,BP,PARP1;DUSP1;NBN;SDR16C5
14938,GO:0070888,0.451522021972993,0.883425219264963,1,19,E-box binding,MF,ARNTL2
201,GO:0000423,0.451677998194816,0.883335205580456,1,19,mitophagy,BP,OPTN
5888,GO:0018126,0.451713536009673,0.883314690690138,1,19,protein hydroxylation,BP,EGLN1
20053,GO:2000756,0.452097384144405,0.80581381615928,2,50,regulation of peptidyl-lysine acetylation,BP,IL1B;SDR16C5
20245,GO:2001258,0.452764191244103,0.882440732178882,1,20,negative regulation of cation channel activity,BP,MMP9
2796,GO:0006271,0.453445414408858,0.882044990182046,1,20,DNA strand elongation involved in DNA replication,BP,PARP1
17788,GO:1901988,0.453655509545144,0.694471293339023,7,215,negative regulation of cell cycle phase transition,BP,TP53;PSMB9;CDKN2B;DUSP1;NBN;DCUN1D3;PML
17348,GO:1900117,0.453929817479934,0.881763081454489,1,20,regulation of execution phase of apoptosis,BP,TP53
3343,GO:0007095,0.454102502684855,0.881930446598606,1,19,mitotic G2 DNA damage checkpoint,BP,NBN
14763,GO:0070530,0.454492073855987,0.881703749179368,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,OPTN
15562,GO:0072088,0.454501644452363,0.804084316951553,2,49,nephron epithelium morphogenesis,BP,DLG1;MAGED1
2941,GO:0006488,0.454574751364568,0.881387096016128,1,20,dolichol-linked oligosaccharide biosynthetic process,BP,DHDDS
14226,GO:0061333,0.4550937108261,0.80363691940692,2,49,renal tubule morphogenesis,BP,DLG1;MAGED1
16993,GO:0099504,0.455372459693455,0.762440841148807,3,79,synaptic vesicle cycle,BP,SYT11;RIMS2;CANX
18258,GO:1903205,0.455460257130621,0.88086964586142,1,20,regulation of hydrogen peroxide-induced cell death,BP,TP53
3757,GO:0008328,0.455562819891224,0.881079264833679,1,19,ionotropic glutamate receptor complex,CC,DLG1
16871,GO:0098878,0.455562819891224,0.881079264833679,1,19,neurotransmitter receptor complex,CC,DLG1
4466,GO:0010506,0.455622246196049,0.676411525084377,9,272,regulation of autophagy,BP,FEZ1;UBQLN2;RIPK2;OPTN;XBP1;HMOX1;EIF4G2;SVIP;NEDD4
19793,GO:2000300,0.455925440233314,0.880867309886083,1,19,regulation of synaptic vesicle exocytosis,BP,RIMS2
4464,GO:0010499,0.4559531381963,0.880115176733357,1,22,proteasomal ubiquitin-independent protein catabolic process,BP,PSMB9
13213,GO:0051932,0.45610533725104,0.880762070781468,1,19,synaptic transmission, GABAergic,BP,HTR1B
4051,GO:0009119,0.456352849436474,0.761425156447159,3,84,ribonucleoside metabolic process,BP,TJP2;MOCS2;DLG1
9049,GO:0035327,0.456748068345733,0.880114591633106,1,20,transcriptionally active chromatin,CC,CTR9
11254,GO:0045601,0.457093949709066,0.88018269779194,1,19,regulation of endothelial cell differentiation,BP,IL1B
6705,GO:0030135,0.457262053862783,0.691265237980808,7,209,coated vesicle,CC,EDN1;IL7R;SEC24D;TGFA;TFRC;CLINT1;HSPD1
7746,GO:0032288,0.457282650489765,0.880071910487936,1,19,myelin assembly,BP,CNTNAP1
6972,GO:0030672,0.457649099622375,0.801536798347215,2,51,synaptic vesicle membrane,CC,DBNDD2;SYT11
16991,GO:0099501,0.457649099622375,0.801536798347215,2,51,exocytic vesicle membrane,CC,DBNDD2;SYT11
20068,GO:2000779,0.457859037127793,0.80145702190853,2,50,regulation of double-strand break repair,BP,FIGN;PML
4419,GO:0010288,0.45788065687485,0.879448077463249,1,20,response to lead ion,BP,CLDN1
1986,GO:0004721,0.457896987732687,0.715611223963714,5,144,phosphoprotein phosphatase activity,MF,DUSP8;DUSP1;EYA3;DLG1;CPPED1
5363,GO:0016202,0.458130650981758,0.760123461099892,3,80,regulation of striated muscle tissue development,BP,EDN1;G6PD;NRG1
9522,GO:0036314,0.458203083059404,0.879530599670767,1,19,response to sterol,BP,HMGCS1
6524,GO:0021955,0.458552504647827,0.87932470308008,1,19,central nervous system neuron axonogenesis,BP,SLIT2
4360,GO:0010008,0.458719279334418,0.656923422469272,12,371,endosome membrane,CC,MYO1B;OPTN;IKBKE;STOML1;ANXA8;ANXA1;RHOB;STEAP4;EHD1;TFRC;PML;IRAK2
1917,GO:0004623,0.458779204653596,0.878917646527559,1,20,phospholipase A2 activity,MF,PLBD1
2876,GO:0006399,0.458795806333062,0.7007620754655,6,184,tRNA metabolic process,BP,PUS10;POP4;C2ORF49;METTL2A;TRMT44;TYW1
4016,GO:0009065,0.459705528469869,0.878369290592084,1,20,glutamine family amino acid catabolic process,BP,ARG1
13217,GO:0051937,0.459799112856347,0.878313805042513,1,20,catecholamine transport,BP,HTR1B
6182,GO:0019682,0.459802236715449,0.878063814925003,1,21,glyceraldehyde-3-phosphate metabolic process,BP,G6PD
8140,GO:0032897,0.460120726894226,0.878123001277361,1,20,negative regulation of viral transcription,BP,JUN
2701,GO:0006094,0.461036982349902,0.798874271975014,2,52,gluconeogenesis,BP,PGK1;ATF3
15151,GO:0071333,0.461819596561379,0.756940229724805,3,83,cellular response to glucose stimulus,BP,LGALS1;XBP1;OXCT1
3033,GO:0006606,0.46231034005633,0.730267901314076,4,113,protein import into nucleus,BP,NFKBIA;HSP90AB1;PTTG1IP;PML
16881,GO:0098901,0.462536793138688,0.876961340097799,1,19,regulation of cardiac muscle cell action potential,BP,DLG1
4147,GO:0009226,0.462691197889838,0.876340099665103,1,21,nucleotide-sugar biosynthetic process,BP,NAGK
15958,GO:0086010,0.463755154967452,0.876232887930258,1,19,membrane depolarization during action potential,BP,SLC8A1
2467,GO:0005719,0.464382927323064,0.875323658454521,1,21,nuclear euchromatin,CC,JUN
12359,GO:0048821,0.464572443145698,0.875462621613097,1,20,erythrocyte development,BP,G6PD
352,GO:0000966,0.464642849315707,0.875167025923305,1,21,RNA 5'-end processing,BP,POP4
17787,GO:1901987,0.464974003329121,0.651000329753052,12,379,regulation of cell cycle phase transition,BP,CDKN2A;TP53;PSMB9;CDKN2B;DUSP1;ANXA1;NBN;HSP90AA1;DCUN1D3;CDK6;PML;CYP1A1
18043,GO:1902686,0.465113856441697,0.795664017606127,2,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,TP53;PMAIP1
15530,GO:0072028,0.465403879853542,0.795675505907654,2,50,nephron morphogenesis,BP,DLG1;MAGED1
19245,GO:1905517,0.465646162498369,0.874561254981484,1,21,macrophage migration,BP,SAA1
17263,GO:0140101,0.46566326882216,0.727228848785271,4,118,catalytic activity, acting on a tRNA,MF,POP4;METTL2A;TRMT44;TYW1
3668,GO:0008187,0.466319392930999,0.874408747314119,1,20,poly-pyrimidine tract binding,MF,RBMS3
6535,GO:0021987,0.466321489225102,0.75326902066634,3,81,cerebral cortex development,BP,NEFL;SLIT2;NRP1
12260,GO:0048634,0.466490779738988,0.753127306874272,3,81,regulation of muscle organ development,BP,EDN1;G6PD;NRG1
5323,GO:0016079,0.466540700100123,0.794796829989257,2,50,synaptic vesicle exocytosis,BP,SYT11;RIMS2
17749,GO:1901861,0.466761637348592,0.752900492105402,3,81,regulation of muscle tissue development,BP,EDN1;G6PD;NRG1
11081,GO:0045137,0.467257536178882,0.707264861698422,5,146,development of primary sexual characteristics,BP,SLIT2;MMP19;HMGCS1;CITED2;ZFP42
13602,GO:0060148,0.467266763678394,0.873834890657055,1,20,positive regulation of posttranscriptional gene silencing,BP,AJUBA
13784,GO:0060421,0.467596674634525,0.873634664493608,1,20,positive regulation of heart growth,BP,EDN1
17624,GO:1901522,0.468029697960448,0.873371554533753,1,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,XBP1
11251,GO:0045598,0.468063677853504,0.751765947186369,3,82,regulation of fat cell differentiation,BP,NOCT;XBP1;ENPP1
4455,GO:0010468,0.468522478806093,0.577513067168907,108,3507,regulation of gene expression,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;FGF5;CHAC1;EPCAM;CDKN2B;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;PHLDA2;CRYAB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;C1R;WWC1;NEDD4L;BIRC3;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;RIMS2;IL7R;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;SERP1;MAFF;MGA;PRR5L;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;DNAJC3;ZC3H7B;ZFP42;NLRP10;NEDD4;CDK6;PML;MYH9;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
3213,GO:0006882,0.468741080831239,0.872680984939579,1,21,cellular zinc ion homeostasis,BP,SLC39A14
13461,GO:0055069,0.468741080831239,0.872680984939579,1,21,zinc ion homeostasis,BP,SLC39A14
1393,GO:0003338,0.468843567441549,0.872876103595442,1,20,metanephros morphogenesis,BP,FRAS1
3178,GO:0006820,0.468955306112376,0.652116247283136,11,337,anion transport,BP,EDN1;SLC16A9;IL1B;NFKBIE;ANXA1;ARG1;SLC7A5P2;CLCC1;ANO4;SLC35B1;ENPP1
14800,GO:0070584,0.469193966144232,0.872404361270759,1,21,mitochondrion morphogenesis,BP,FEZ1
18385,GO:1903506,0.469407835773955,0.579717836439209,88,2845,regulation of nucleic acid-templated transcription,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
2647,GO:0006007,0.469490287304878,0.872223162409222,1,21,glucose catabolic process,BP,PGK1
3048,GO:0006626,0.469522295124939,0.723813300597796,4,120,protein targeting to mitochondrion,BP,HSP90AA1;NRG1;UGCG;HSPD1
15147,GO:0071326,0.469639190231185,0.750358921046754,3,84,cellular response to monosaccharide stimulus,BP,LGALS1;XBP1;OXCT1
15149,GO:0071331,0.469639190231185,0.750358921046754,3,84,cellular response to hexose stimulus,BP,LGALS1;XBP1;OXCT1
8857,GO:0034698,0.470010836055424,0.872163384665707,1,20,response to gonadotropin,BP,HMGCS1
4177,GO:0009299,0.470169003184341,0.872066616262603,1,20,mRNA transcription,BP,TP53
2943,GO:0006490,0.470850212408826,0.87138949214804,1,21,oligosaccharide-lipid intermediate biosynthetic process,BP,DHDDS
695,GO:0001919,0.471001557992715,0.87155648709134,1,20,regulation of receptor recycling,BP,OPTN
1273,GO:0003091,0.471315993239519,0.871363490121561,1,20,renal water homeostasis,BP,HAS2
14091,GO:0060998,0.47177550938609,0.790725079664684,2,50,regulation of dendritic spine development,BP,SDK1;NRG1
13190,GO:0051894,0.471924510415611,0.870989468303914,1,20,positive regulation of focal adhesion assembly,BP,NRP1
2508,GO:0005776,0.472126972643127,0.748302113261535,3,83,autophagosome,CC,UBQLN2;OPTN;FTH1
20175,GO:2001141,0.472224934886586,0.576943939156138,88,2847,regulation of RNA biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
18078,GO:1902803,0.472352279026845,0.870726131408105,1,20,regulation of synaptic vesicle transport,BP,RIMS2
708,GO:0001937,0.472490797400829,0.870640785853033,1,20,negative regulation of endothelial cell proliferation,BP,NR2F2
1860,GO:0004540,0.473416470478547,0.747090603138095,3,86,ribonuclease activity,MF,RNASE7;NOCT;POP4
5057,GO:0015298,0.4734440082824,0.870052515376835,1,20,solute:cation antiporter activity,MF,SLC8A1
9107,GO:0035459,0.474031608939782,0.869689037546286,1,20,cargo loading into vesicle,BP,SEC24D
1297,GO:0003156,0.474187103551643,0.869329346383193,1,21,regulation of animal organ formation,BP,CITED2
17452,GO:1900449,0.474194592945807,0.869588105009633,1,20,regulation of glutamate receptor signaling pathway,BP,NETO1
17833,GO:1902108,0.474433989377745,0.788325081204033,2,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,TP53;PMAIP1
5056,GO:0015297,0.474511991976724,0.788496003649999,2,51,antiporter activity,MF,SLC8A1;SLC7A5P2
2811,GO:0006293,0.474521796448157,0.869121568023594,1,21,nucleotide-excision repair, preincision complex stabilization,BP,PARP1
2813,GO:0006295,0.474521796448157,0.869121568023594,1,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,PARP1
6834,GO:0030323,0.475179427070013,0.719026549065987,4,113,respiratory tube development,BP,CCBE1;ARG1;LOX;SOX11
6545,GO:0022011,0.475350474557536,0.868870870369632,1,20,myelination in peripheral nervous system,BP,CNTNAP1
7750,GO:0032292,0.475350474557536,0.868870870369632,1,20,peripheral nervous system axon ensheathment,BP,CNTNAP1
15952,GO:0086004,0.475880842650507,0.868540937259332,1,20,regulation of cardiac muscle cell contraction,BP,DLG1
4802,GO:0014014,0.475886010092307,0.868272495083692,1,21,negative regulation of gliogenesis,BP,SOX11
614,GO:0001783,0.476015527598539,0.8681917037416,1,21,B cell apoptotic process,BP,LYN
19776,GO:2000273,0.476134053140975,0.868117741518208,1,21,positive regulation of signaling receptor activity,BP,TGFA
5803,GO:0017091,0.476256415951217,0.868041357161545,1,21,AU-rich element binding,MF,RBMS3
17886,GO:1902253,0.476552671256017,0.867614776468712,1,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,PTTG1IP
8969,GO:0035115,0.476693322339899,0.86776839165251,1,21,embryonic forelimb morphogenesis,BP,OSR2
5890,GO:0018146,0.476737330079447,0.867740877149865,1,21,keratan sulfate biosynthetic process,BP,B4GALT1
3058,GO:0006641,0.47729281402975,0.786222302050548,2,52,triglyceride metabolic process,BP,MGLL;SEL1L
10775,GO:0044295,0.477518536263666,0.867518832742485,1,20,axonal growth cone,CC,L1CAM
6573,GO:0022607,0.477581384131316,0.576487468032791,68,2212,cellular component assembly,BP,CDKN2A;NEFL;KRT8;DSCAM;LCP1;NEFM;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;SLIT2;CLDN1;UBQLN2;CLDN7;MYO1B;DNAJB1;JUN;PARP1;SDK1;IFT46;CNTNAP1;C1QTNF1;CRYAB;ACTG1;NOCT;IKBKE;CYLD;COBLL1;NBN;BIRC3;RHOB;ARG1;HMOX1;SYT11;KCTD12;HSP90AA1;NRP1;TRAF1;BRD2;SETX;SOD2;NRG1;HSP90AB1;UQCC1;CALR;PPID;AJUBA;CORO1C;DLG1;EHD1;LOX;HAS2;ADGRL3;SEC24D;PDE4DIP;TGFA;HSP90B1;SVIP;UBXN2B;PML;EPHA2;CLINT1;CEP83;HSPD1;TJP1;PARVA
12806,GO:0051156,0.477801075687788,0.866831945273352,1,22,glucose 6-phosphate metabolic process,BP,G6PD
4843,GO:0014075,0.478004896099269,0.866946809888336,1,21,response to amine,BP,ARG1
7207,GO:0031122,0.478131258919117,0.785639933708456,2,51,cytoplasmic microtubule organization,BP,FIGN;DLG1
23,GO:0000045,0.478531685550663,0.742821902957873,3,84,autophagosome assembly,BP,FEZ1;UBQLN2;UBXN2B
6774,GO:0030234,0.479085937411908,0.607151638595399,23,735,enzyme regulator activity,MF,CDKN2A;SERPINB2;CXCL1;SLIT2;CDKN2B;DNAJB1;JUN;DNAJC10;TRIB1;ANXA1;BIRC3;HSP90AA1;NRP1;NRG1;SERPINH1;HSP90AB1;STXBP5;IGFBP3;ARHGDIB;GIT2;DNAJC3;UBXN2B;TOR1AIP1
18162,GO:1902991,0.479209462505095,0.866189409617478,1,21,regulation of amyloid precursor protein catabolic process,BP,LYN
14772,GO:0070542,0.479796206972147,0.784237593155065,2,52,response to fatty acid,BP,EDN1;CLDN1
4325,GO:0009894,0.480178342314958,0.60442192338493,24,769,regulation of catabolic process,BP,FEZ1;PSMB9;UBQLN2;RIPK2;HERPUD1;OPTN;IL1B;NOCT;TRIB1;DERL3;NEDD4L;XBP1;HMOX1;HSP90AA1;EGLN1;NRG1;HSP90AB1;ADAM8;EIF4G2;PRR5L;PTTG1IP;SVIP;NEDD4;PML
4506,GO:0010586,0.481508357984408,0.864736328396253,1,21,miRNA metabolic process,BP,NFKB1
256,GO:0000723,0.482766131631421,0.693163952077762,5,153,telomere maintenance,BP,PARP1;NBN;HSP90AA1;HSP90AB1;PML
13086,GO:0051668,0.483641117534829,0.738443585237549,3,84,localization within membrane,BP,NETO1;DLG1;SEC24D
252,GO:0000717,0.48368942214148,0.863099922350617,1,22,nucleotide-excision repair, DNA duplex unwinding,BP,PARP1
3307,GO:0007030,0.48388394916173,0.711257239372503,4,115,Golgi organization,BP,OPTN;RAB30;PDE4DIP;UBXN2B
16186,GO:0090277,0.48447754140511,0.780420442572236,2,53,positive regulation of peptide hormone secretion,BP,SERP1;OXCT1
8992,GO:0035198,0.484568674351676,0.862786435002677,1,21,miRNA binding,MF,ZC3H7B
19175,GO:1905332,0.484629807025787,0.862747302653841,1,21,positive regulation of morphogenesis of an epithelium,BP,MAGED1
9292,GO:0035794,0.484639041767733,0.780140620823928,2,55,positive regulation of mitochondrial membrane permeability,BP,TP53;PMAIP1
19306,GO:1905710,0.484639041767733,0.780140620823928,2,55,positive regulation of membrane permeability,BP,TP53;PMAIP1
9580,GO:0036474,0.485100484373831,0.862195820849781,1,22,cell death in response to hydrogen peroxide,BP,TP53
19660,GO:2000027,0.485568796254542,0.676345206319646,6,184,regulation of organ morphogenesis,BP,B4GALT1;EDN1;PSMB9;XBP1;CITED2;MAGED1
4186,GO:0009311,0.485804832314824,0.779354181563894,2,53,oligosaccharide metabolic process,BP,B4GALT1;GALNT14
14185,GO:0061180,0.485805479163285,0.779433440298434,2,52,mammary gland epithelium development,BP,PML;EPHA2
4638,GO:0010800,0.486577500149225,0.861496809703428,1,21,positive regulation of peptidyl-threonine phosphorylation,BP,RIPK2
13026,GO:0051569,0.486729623534228,0.861398835543908,1,21,regulation of histone H3-K4 methylation,BP,CTR9
16,GO:0000030,0.486803269017767,0.86109974416939,1,22,mannosyltransferase activity,MF,SDF2L1
13448,GO:0055026,0.486817012967815,0.861342532873814,1,21,negative regulation of cardiac muscle tissue development,BP,G6PD
16185,GO:0090276,0.486846825985352,0.708557278727656,4,117,regulation of peptide hormone secretion,BP,IL1B;SERP1;OXCT1;MIDN
2474,GO:0005732,0.486855698908319,0.86062602337055,1,24,small nucleolar ribonucleoprotein complex,CC,POP4
14507,GO:0070063,0.486900687243339,0.77847175486962,2,53,RNA polymerase binding,MF,CTR9;NEDD4
14861,GO:0070717,0.487342770257862,0.861003492947941,1,21,poly-purine tract binding,MF,RBMS3
9733,GO:0039528,0.487390011013911,0.860973003342746,1,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,BIRC3
6703,GO:0030133,0.487873576894326,0.653785626302089,8,250,transport vesicle,CC,EDN1;DPYSL3;DBNDD2;SYT11;STXBP5;MME;SEC24D;TGFA
11122,GO:0045211,0.487968933910599,0.707632795349132,4,114,postsynaptic membrane,CC,NETO1;SLC8A1;KCTD12;DLG1
12606,GO:0050850,0.488042698237816,0.860298436289594,1,22,positive regulation of calcium-mediated signaling,BP,NRG1
13657,GO:0060249,0.48808712515846,0.645947490746237,9,284,anatomical structure homeostasis,BP,KRT1;PARP1;ACTG1;NBN;HSP90AA1;HSP90AB1;ADAM8;TFRC;PML
6937,GO:0030594,0.488290636430759,0.860137787016718,1,22,neurotransmitter receptor activity,MF,HTR1B
7075,GO:0030890,0.488738432765371,0.859847342162674,1,22,positive regulation of B cell proliferation,BP,TFRC
17029,GO:0099568,0.489462454472865,0.632611845591372,11,340,cytoplasmic region,CC,NEFL;AP3M1;RHOB;MOBP;RIMS2;CANX;NEDD4;EPB41L2;MYH9;TNFAIP2;TPM4
2693,GO:0006082,0.489610174056618,0.593627033880293,25,819,organic acid metabolic process,BP,NFKB1;B4GALT1;EDN1;PSMB9;NAGK;SLC16A9;PGK1;IL1B;MGLL;FADS1;ANXA1;FADS3;XBP1;ARG1;PAPSS2;EGLN1;ACO1;CS;HAS2;IVD;MSMO1;MGST3;BCAT1;ENPP1;CYP1A1
17302,GO:1900027,0.490058820569801,0.858988680122952,1,22,regulation of ruffle assembly,BP,CORO1C
10618,GO:0043687,0.490336161518471,0.637308636625972,10,319,post-translational protein modification,BP,LGALS1;PSMB9;STT3A;DCUN1D3;PDIA6;IGFBP3;CALU;DNAJC3;HSP90B1;NTNG1
6081,GO:0019319,0.490428177418878,0.775465876799314,2,55,hexose biosynthetic process,BP,PGK1;ATF3
2589,GO:0005901,0.490948735011282,0.775276566252846,2,52,caveola,CC,HMOX1;CORO1C
9007,GO:0035250,0.491267534447797,0.85819969362197,1,22,UDP-galactosyltransferase activity,MF,B4GALT1
10947,GO:0044772,0.49134668392509,0.614187581864223,15,484,mitotic cell cycle phase transition,BP,CDKN2A;TP53;PSMB9;CDKN2B;OPTN;DUSP1;ANXA1;NBN;HSP90AA1;DCUN1D3;AJUBA;BCAT1;CDK6;PML;CYP1A1
18221,GO:1903115,0.491788013332952,0.858115706209951,1,21,regulation of actin filament-based movement,BP,DLG1
8558,GO:0034067,0.492191143675597,0.857851934069658,1,21,protein localization to Golgi apparatus,BP,OPTN
1124,GO:0002720,0.49244639223672,0.857427475199042,1,22,positive regulation of cytokine production involved in immune response,BP,SEMA7A
251,GO:0000715,0.492529669459891,0.857138054707241,1,23,nucleotide-excision repair, DNA damage recognition,BP,PARP1
10551,GO:0043548,0.492570585885226,0.85760337398248,1,21,phosphatidylinositol 3-kinase binding,MF,AXL
8861,GO:0034704,0.492717481669054,0.857249515701695,1,22,calcium channel complex,CC,HERPUD1
7155,GO:0031056,0.492887978644572,0.703127660957173,4,117,regulation of histone modification,BP,TP53;IL1B;SDR16C5;CTR9
12584,GO:0050808,0.49302591511949,0.669502248230569,6,178,synapse organization,BP,DSCAM;SDK1;NRG1;L1CAM;ADGRL3;NEDD4
12982,GO:0051457,0.493162020664842,0.856957384975213,1,22,maintenance of protein location in nucleus,BP,PML
11451,GO:0045948,0.493555830582939,0.8566982707311,1,22,positive regulation of translational initiation,BP,DNAJC3
3659,GO:0008173,0.493670941774742,0.772824206942894,2,55,RNA methyltransferase activity,MF,METTL2A;TRMT44
16532,GO:0097366,0.49391909547969,0.856458987050414,1,22,response to bronchodilator,BP,EGLN1
1977,GO:0004709,0.494169494788567,0.772737008712266,2,51,MAP kinase kinase kinase activity,MF,AXL;EPHA2
10251,GO:0043030,0.494212480685092,0.856265546108828,1,22,regulation of macrophage activation,BP,HSPD1
8379,GO:0033344,0.494904771113662,0.855808426767085,1,22,cholesterol efflux,BP,NFKBIA
14021,GO:0060840,0.494940916995588,0.772021171165243,2,52,artery development,BP,NRP1;LOX
4655,GO:0010821,0.495526605023251,0.667028343263423,6,188,regulation of mitochondrion organization,BP,MMP9;TP53;PMAIP1;OPTN;NRG1;UGCG
3538,GO:0007589,0.495703644417617,0.771235660388824,2,54,body fluid secretion,BP,EDN1;XBP1
8162,GO:0032924,0.496154915627713,0.854980590627642,1,22,activin receptor signaling pathway,BP,CITED2
8447,GO:0033613,0.496834612640408,0.770306974277795,2,54,activating transcription factor binding,MF,JUN;SDR16C5
8975,GO:0035137,0.497751643015295,0.853918810507069,1,22,hindlimb morphogenesis,BP,OSR2
2791,GO:0006266,0.497853114915141,0.853611506578606,1,23,DNA ligation,BP,PARP1
10374,GO:0043243,0.497952975377041,0.853784575686263,1,22,positive regulation of protein complex disassembly,BP,SETX
17792,GO:1901992,0.498019500975514,0.769255496562807,2,55,positive regulation of mitotic cell cycle phase transition,BP,ANXA1;CYP1A1
11834,GO:0046875,0.498042818779551,0.853724648536883,1,22,ephrin receptor binding,MF,LYN
5142,GO:0015698,0.498370609443052,0.725582499558805,3,85,inorganic anion transport,BP,CLCC1;ANO4;ENPP1
4839,GO:0014069,0.498422475158503,0.678902757083029,5,147,postsynaptic density,CC,NETO1;CRYAB;LYN;SYT11;DLG1
12580,GO:0050804,0.498774432453337,0.664052971906962,6,183,modulation of chemical synaptic transmission,BP,NETO1;EDN1;IL1B;SYT11;RIMS2;HTR1B
16982,GO:0099177,0.498774432453337,0.664052971906962,6,183,regulation of trans-synaptic signaling,BP,NETO1;EDN1;IL1B;SYT11;RIMS2;HTR1B
8115,GO:0032839,0.499747127015861,0.852584843837977,1,22,dendrite cytoplasm,CC,CANX
2203,GO:0005109,0.499800457893659,0.852549085187037,1,22,frizzled binding,MF,BAMBI
5547,GO:0016578,0.500014810613615,0.852405304034359,1,22,histone deubiquitination,BP,SUPT3H
7368,GO:0031440,0.500044144383431,0.852385620816779,1,22,regulation of mRNA 3'-end processing,BP,CTR9
10655,GO:0043966,0.500375691558834,0.767309249552804,2,55,histone H3 acetylation,BP,TRIM16;SUPT3H
3311,GO:0007034,0.500381130840447,0.696279494251387,4,119,vacuolar transport,BP,AP3M1;RHOB;GNPTAB;NEDD4
18646,GO:1904036,0.500874527888817,0.851827723057503,1,22,negative regulation of epithelial cell apoptotic process,BP,HMOX1
261,GO:0000729,0.501615197334645,0.851328952830064,1,22,DNA double-strand break processing,BP,NBN
11288,GO:0045648,0.501624163943696,0.851322908039084,1,22,positive regulation of erythrocyte differentiation,BP,ETS1
17321,GO:1900076,0.502612513445336,0.765530600145434,2,54,regulation of cellular response to insulin stimulus,BP,IL1B;ENPP1
19065,GO:1905037,0.502688199099629,0.721686074627784,3,87,autophagosome organization,BP,FEZ1;UBQLN2;UBXN2B
8651,GO:0034250,0.503274576279794,0.693560971926926,4,122,positive regulation of cellular amide metabolic process,BP,UQCC1;SERP1;RBMS3;DNAJC3
10344,GO:0043198,0.503408109577047,0.850117107908683,1,22,dendritic shaft,CC,SLC8A1
13350,GO:0052689,0.503762525691287,0.720653850408409,3,89,carboxylic ester hydrolase activity,MF,MGLL;PLBD1;NCEH1
1462,GO:0003730,0.504201838012552,0.764207373908698,2,54,mRNA 3'-UTR binding,MF,TP53;RBMS3
2260,GO:0005216,0.504237148755911,0.673440245461811,5,150,ion channel activity,MF,ITGAV;KCNQ5;CLCC1;ANO4;DLG1
6187,GO:0019706,0.504243728426989,0.849304546499292,1,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC6
6188,GO:0019707,0.504243728426989,0.849304546499292,1,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC6
17032,GO:0099572,0.504641529298347,0.673101033022813,5,148,postsynaptic specialization,CC,NETO1;CRYAB;LYN;SYT11;DLG1
20151,GO:2001038,0.505378579243082,0.848531256740954,1,23,regulation of cellular response to drug,BP,TP53
19944,GO:2000573,0.505553981725978,0.762925639243297,2,56,positive regulation of DNA biosynthetic process,BP,HSP90AA1;HSP90AB1
8722,GO:0034399,0.505655198979414,0.691455351587202,4,119,nuclear periphery,CC,KRT8;TP53;FIGN;PML
7673,GO:0032148,0.505761805493083,0.848269546331745,1,23,activation of protein kinase B activity,BP,NRG1
12160,GO:0048365,0.505814203255206,0.762941654156327,2,53,Rac GTPase binding,MF,ARHGDIB;CORO1C
8585,GO:0034122,0.506039916221991,0.848326695861924,1,22,negative regulation of toll-like receptor signaling pathway,BP,LYN
18344,GO:1903393,0.506078636243703,0.848300251827244,1,22,positive regulation of adherens junction organization,BP,NRP1
13663,GO:0060260,0.506090406725856,0.848044906898575,1,23,regulation of transcription initiation from RNA polymerase II promoter,BP,TP53
14804,GO:0070588,0.506242867078227,0.6715483521565,5,151,calcium ion transmembrane transport,BP,STAC;ITGAV;LYN;G6PD;SLC8A1
8265,GO:0033116,0.506533349999462,0.762105707763498,2,56,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,CALR;TGFA
2692,GO:0006081,0.506632291406648,0.761950295525816,2,57,cellular aldehyde metabolic process,BP,G6PD;SDR16C5
680,GO:0001894,0.506673775996048,0.690468334042154,4,121,tissue homeostasis,BP,KRT1;ACTG1;ADAM8;TFRC
8746,GO:0034451,0.506908781084507,0.847732580709133,1,22,centriolar satellite,CC,KRT18
15778,GO:0072521,0.507571742955212,0.610086145261292,12,395,purine-containing compound metabolic process,BP,SLC16A9;PGK1;PARP1;TJP2;GPR176;PAPSS2;EGLN1;MOCS2;DLG1;GDA;EPHA2;ENPP1
13068,GO:0051642,0.508028515895396,0.846964700643275,1,22,centrosome localization,BP,DLG1
15145,GO:0071322,0.508713488528403,0.716240417941289,3,89,cellular response to carbohydrate stimulus,BP,LGALS1;XBP1;OXCT1
12350,GO:0048806,0.508830013005223,0.846413517085054,1,22,genitalia development,BP,AXL
4742,GO:0010939,0.508841587173178,0.845926818263743,1,24,regulation of necrotic cell death,BP,BIRC3
9168,GO:0035579,0.508969270665867,0.760135234537238,2,55,specific granule membrane,CC,ITGAV;ADAM8
4722,GO:0010907,0.508989612546967,0.846303607922276,1,22,positive regulation of glucose metabolic process,BP,PMAIP1
15518,GO:0072006,0.509021239970983,0.716086369628986,3,86,nephron development,BP,COL4A4;DLG1;MAGED1
12914,GO:0051321,0.509052992631455,0.668879569901577,5,153,meiotic cell cycle,BP,DUSP1;NBN;CALR;ZFP42;MYH9
6993,GO:0030705,0.509213090536358,0.668747639660349,5,152,cytoskeleton-dependent intracellular transport,BP,NEFL;FEZ1;IFT46;AP3M1;MOBP
9676,GO:0038111,0.509462160857622,0.845287183221524,1,25,interleukin-7-mediated signaling pathway,BP,IL7R
16808,GO:0098760,0.509462160857622,0.845287183221524,1,25,response to interleukin-7,BP,IL7R
16809,GO:0098761,0.509462160857622,0.845287183221524,1,25,cellular response to interleukin-7,BP,IL7R
6313,GO:0020037,0.509909321193723,0.759267438027271,2,56,heme binding,MF,HMOX1;CYP1A1
12024,GO:0048009,0.510105109021476,0.845533986877537,1,22,insulin-like growth factor receptor signaling pathway,BP,IGFBP3
3232,GO:0006906,0.510266011821718,0.687184127424311,4,120,vesicle fusion,BP,ANXA1;SYT11;CALR;SEC22A
11111,GO:0045191,0.510308966782693,0.845141810806998,1,23,regulation of isotype switching,BP,TFRC
7741,GO:0032279,0.510465274014836,0.667628261391679,5,149,asymmetric synapse,CC,NETO1;CRYAB;LYN;SYT11;DLG1
3382,GO:0007176,0.510582793376956,0.844952136072826,1,23,regulation of epidermal growth factor-activated receptor activity,BP,TGFA
10642,GO:0043921,0.510735556489167,0.844846254191368,1,23,modulation by host of viral transcription,BP,JUN
13296,GO:0052312,0.510735556489167,0.844846254191368,1,23,modulation of transcription in other organism involved in symbiotic interaction,BP,JUN
13314,GO:0052472,0.510735556489167,0.844846254191368,1,23,modulation by host of symbiont transcription,BP,JUN
15183,GO:0071377,0.511334423796858,0.84443071864602,1,23,cellular response to glucagon stimulus,BP,ARG1
42,GO:0000086,0.512380091522656,0.63962169231651,7,225,G2/M transition of mitotic cell cycle,BP,PSMB9;CDKN2B;OPTN;NBN;HSP90AA1;AJUBA;CDK6
12276,GO:0048663,0.512816213487202,0.843399438099883,1,23,neuron fate commitment,BP,NRG1
6901,GO:0030513,0.513058793323809,0.843230186938005,1,23,positive regulation of BMP signaling pathway,BP,SOX11
2501,GO:0005768,0.513204510525209,0.577413935118038,21,679,endosome,CC,MYO1B;OPTN;IKBKE;STOML1;ANXA8;ANXA1;NEDD4L;RHOB;TRAF3;SYT11;NRP1;STEAP4;IFNAR1;AMOTL2;EHD1;ANKRD13A;TFRC;PML;MON1A;HSPD1;IRAK2
8635,GO:0034220,0.513267059848959,0.584103682239681,18,579,ion transmembrane transport,BP,MMP9;NETO1;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;SLC7A5P2;CLCC1;STEAP4;ANO4;SLC39A14;SLC35B1;MAGT1;DLG1;NEDD4
5252,GO:0015918,0.513894806246881,0.755892912489134,2,56,sterol transport,BP,NFKBIA;NFKB1
12183,GO:0048469,0.513900395200026,0.711580433699038,3,89,cell maturation,BP,AXL;G6PD;XBP1
2504,GO:0005771,0.513970524094606,0.842359727476978,1,24,multivesicular body,CC,NEDD4L
8304,GO:0033173,0.514349107857343,0.842327913057111,1,23,calcineurin-NFAT signaling cascade,BP,NRG1
1475,GO:0003823,0.51507567693163,0.841584137747027,1,24,antigen binding,MF,IL7R
12574,GO:0050795,0.515132133500571,0.841778721445961,1,23,regulation of behavior,BP,HTR1B
17729,GO:1901797,0.515564700182947,0.841240151156481,1,24,negative regulation of signal transduction by p53 class mediator,BP,PTTG1IP
7907,GO:0032506,0.516183130646556,0.841039621382241,1,23,cytokinetic process,BP,MYH9
7275,GO:0031293,0.51620263399234,0.84102588463954,1,23,membrane protein intracellular domain proteolysis,BP,NFKB1
13771,GO:0060401,0.517196797253295,0.708639704716323,3,88,cytosolic calcium ion transport,BP,LYN;SLC8A1;PML
2091,GO:0004871,0.517198600714983,0.573466304331442,21,676,signal transducer activity,MF,LGALS1;RIPK2;IL6ST;AXL;IKBKE;ITGAV;LYN;GPR176;RHOB;TRAF3;HMOX1;NRP1;IL7R;CXCR5;NRG1;NR2F2;IFNAR1;ADGRL3;IFNGR1;HTR1B;EPHA2
6190,GO:0019722,0.518017445391938,0.707855090942286,3,89,calcium-mediated signaling,BP,EDN1;SLC8A1;NRG1
17784,GO:1901983,0.518929104980139,0.75151855157449,2,57,regulation of protein acetylation,BP,IL1B;SDR16C5
10964,GO:0044798,0.519073148172,0.659351318268268,5,157,nuclear transcription factor complex,CC,TP53;JUN;JUNB;MED18;SUPT3H
5675,GO:0016814,0.519190710862488,0.838674324387338,1,24,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,GDA
10733,GO:0044212,0.519502647325045,0.575515974973866,19,608,transcription regulatory region DNA binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;SETX;KLF10;SNAI3;ETS1;ZFP42;SOX11
12115,GO:0048259,0.519599587737534,0.751017488653311,2,56,regulation of receptor-mediated endocytosis,BP,UBQLN2;SYT11
1327,GO:0003197,0.520312722559807,0.8381136811647,1,23,endocardial cushion development,BP,NEDD4
6596,GO:0022838,0.520333028743981,0.65822623285813,5,153,substrate-specific channel activity,MF,ITGAV;KCNQ5;CLCC1;ANO4;DLG1
4733,GO:0010922,0.521203663115155,0.837477832661995,1,23,positive regulation of phosphatase activity,BP,HSP90AB1
12093,GO:0048207,0.521379044673169,0.749410631233468,2,57,vesicle targeting, rough ER to cis-Golgi,BP,SEC24D;TGFA
12094,GO:0048208,0.521379044673169,0.749410631233468,2,57,COPII vesicle coating,BP,SEC24D;TGFA
8077,GO:0032786,0.521656374575396,0.836914170597053,1,24,positive regulation of DNA-templated transcription, elongation,BP,CTR9
4820,GO:0014044,0.522459426796235,0.836578837269659,1,23,Schwann cell development,BP,CNTNAP1
395,GO:0001067,0.522669341383319,0.572372172215222,19,609,regulatory region nucleic acid binding,MF,NFKB1;MAFB;RELB;TP53;JUN;NFKB2;ARID3B;PARP1;JUNB;ATF3;EHF;XBP1;ARNTL2;SETX;KLF10;SNAI3;ETS1;ZFP42;SOX11
16927,GO:0098984,0.522770305027954,0.655943356547581,5,151,neuron to neuron synapse,CC,NETO1;CRYAB;LYN;SYT11;DLG1
9859,GO:0042168,0.522864682154963,0.835825494482572,1,25,heme metabolic process,BP,HMOX1
10460,GO:0043394,0.523635876707292,0.835733665250661,1,23,proteoglycan binding,MF,SLIT2
2183,GO:0005057,0.524224910860222,0.674199923921139,4,119,signal transducer activity, downstream of receptor,MF,AXL;IKBKE;LYN;EPHA2
4083,GO:0009154,0.524473270270829,0.834887920166641,1,24,purine ribonucleotide catabolic process,BP,EGLN1
5707,GO:0016866,0.524542627816179,0.83461494490285,1,25,intramolecular transferase activity,MF,PUS10
5212,GO:0015844,0.524597496203905,0.83479818319641,1,24,monoamine transport,BP,HTR1B
6843,GO:0030332,0.52468990346218,0.834731410255595,1,24,cyclin binding,MF,CDK6
3236,GO:0006911,0.524785454307398,0.834662347115327,1,24,phagocytosis, engulfment,BP,MYH9
2928,GO:0006471,0.524956379874785,0.83453875658148,1,24,protein ADP-ribosylation,BP,PARP1
537,GO:0001656,0.52497680174268,0.746372970841623,2,56,metanephros development,BP,OSR2;FRAS1
4997,GO:0015175,0.525162010330205,0.834389991600306,1,24,neutral amino acid transmembrane transporter activity,MF,SLC7A5P2
10760,GO:0044265,0.525319292667053,0.552854791028418,29,962,cellular macromolecule catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;HERPUD1;HSPA5;DNAJB9;DNAJC10;NOCT;CYLD;TRIB1;DERL3;NEDD4L;XBP1;UGGT1;HSP90AA1;HSP90AB1;SEL1L;PRR5L;NGLY1;PTTG1IP;DNAJC3;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SND1;SDF2L1
6962,GO:0030658,0.525780327641031,0.672605907712009,4,124,transport vesicle membrane,CC,DBNDD2;SYT11;SEC24D;TGFA
11762,GO:0046676,0.526658454062219,0.833304725595312,1,24,negative regulation of insulin secretion,BP,MIDN
16187,GO:0090278,0.526658454062219,0.833304725595312,1,24,negative regulation of peptide hormone secretion,BP,MIDN
13886,GO:0060589,0.526851370853186,0.60853322958819,9,283,nucleoside-triphosphatase regulator activity,MF,SLIT2;DNAJB1;JUN;DNAJC10;NRP1;STXBP5;ARHGDIB;GIT2;TOR1AIP1
1,GO:0000002,0.526975013270113,0.83307454889452,1,24,mitochondrial genome maintenance,BP,PARP1
3641,GO:0008139,0.5271104124737,0.833220755652343,1,23,nuclear localization sequence binding,MF,NFKBIA
6837,GO:0030326,0.527301705347852,0.699367350508686,3,89,embryonic limb morphogenesis,BP,OSR2;FBN2;FRAS1
8968,GO:0035113,0.527301705347852,0.699367350508686,3,89,embryonic appendage morphogenesis,BP,OSR2;FBN2;FRAS1
16679,GO:0097720,0.527452275961723,0.832727125677691,1,24,calcineurin-mediated signaling,BP,NRG1
6065,GO:0019239,0.527548358196374,0.832431823150775,1,25,deaminase activity,MF,GDA
13450,GO:0055029,0.527601841623755,0.670813715423408,4,127,nuclear DNA-directed RNA polymerase complex,CC,TP53;CTR9;MED18;SUPT3H
3272,GO:0006977,0.527913337170525,0.743595246718437,2,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,TP53;PML
555,GO:0001678,0.527996218886737,0.698648334342006,3,91,cellular glucose homeostasis,BP,LGALS1;XBP1;OXCT1
1970,GO:0004702,0.52818547322388,0.698636068817156,3,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,AXL;IKBKE;EPHA2
6706,GO:0030136,0.528935621471098,0.669650194336257,4,123,clathrin-coated vesicle,CC,EDN1;IL7R;TFRC;CLINT1
20218,GO:2001222,0.529160736692728,0.831726072142018,1,23,regulation of neuron migration,BP,NRG1
18497,GO:1903727,0.52925726731965,0.831408871894328,1,24,positive regulation of phospholipid metabolic process,BP,LYN
2932,GO:0006476,0.529341207033437,0.697446448336488,3,90,protein deacetylation,BP,TP53;SUDS3;SDR16C5
3284,GO:0006997,0.529675567357747,0.668924211810468,4,124,nucleus organization,BP,ETS1;UBXN2B;PML;TOR1AIP1
15291,GO:0071549,0.530314863738465,0.830405751486081,1,25,cellular response to dexamethasone stimulus,BP,ARG1
8237,GO:0033043,0.530357701234751,0.545512828368785,31,1011,regulation of organelle organization,BP,MMP9;IL1A;LCP1;FEZ1;EDN1;TP53;PMAIP1;SLIT2;UBQLN2;PARP1;OPTN;IL1B;CYLD;DUSP1;ANXA1;NBN;RHOB;SYT11;NRP1;NRG1;SDR16C5;CALR;CTR9;ARHGDIB;DLG1;PDE4DIP;CHORDC1;TGFA;PML;UGCG;AFAP1
2235,GO:0005160,0.530373159563789,0.830590473917753,1,24,transforming growth factor beta receptor binding,MF,BAMBI
18198,GO:1903047,0.530543140493489,0.556410250582593,23,758,mitotic cell cycle process,BP,CDKN2A;IL1A;EDN1;TP53;PSMB9;CDKN2B;NABP1;OPTN;IL1B;DUSP1;ANXA1;NBN;BIRC3;RHOB;HSP90AA1;DCUN1D3;AJUBA;DLG1;TGFA;BCAT1;CDK6;PML;CYP1A1
17653,GO:1901575,0.530985235400246,0.531091528482505,49,1630,organic substance catabolic process,BP,TP53;PMAIP1;PSMB9;NAGK;UBQLN2;CHAC1;PGK1;HERPUD1;HSPA5;IL1B;ANPEP;DNAJB9;DNAJC10;NOCT;MGLL;ERAP1;CYLD;TRIB1;PLBD1;NCEH1;DERL3;NEDD4L;XBP1;ARG1;UGGT1;HMOX1;HSP90AA1;EGLN1;NRG1;HSP90AB1;ADAM8;SEL1L;PRR5L;NGLY1;GDA;PTTG1IP;IVD;DNAJC3;BCAT1;HSP90B1;SVIP;UBXN2B;NEDD4;PML;OXCT1;ENPP1;SND1;SDF2L1;CYP1A1
3222,GO:0006892,0.531021559485263,0.695892362942433,3,90,post-Golgi vesicle-mediated transport,BP,KRT18;MYO1B;OPTN
155,GO:0000314,0.531075032840356,0.82926041020859,1,28,organellar small ribosomal subunit,CC,MRPS24
2496,GO:0005763,0.531075032840356,0.82926041020859,1,28,mitochondrial small ribosomal subunit,CC,MRPS24
8096,GO:0032806,0.531257773062159,0.829711527854114,1,25,carboxy-terminal domain protein kinase complex,CC,HSPD1
11756,GO:0046658,0.531970396076003,0.829185609902951,1,25,anchored component of plasma membrane,CC,NTNG1
15110,GO:0071260,0.532699717930468,0.739466678126697,2,58,cellular response to mechanical stimulus,BP,NFKB1;IL1B
17728,GO:1901796,0.533075178299459,0.645895822465438,5,160,regulation of signal transduction by p53 class mediator,BP,TP53;PMAIP1;NBN;PTTG1IP;PML
10877,GO:0044456,0.533557856988734,0.580154916100528,13,418,synapse part,CC,NETO1;DBNDD2;CRYAB;LYN;SLC8A1;SYT11;KCTD12;RIMS2;CANX;STXBP5;MME;DLG1;NEDD4
12612,GO:0050856,0.533710597816492,0.827896822711784,1,25,regulation of T cell receptor signaling pathway,BP,CYLD
10128,GO:0042743,0.534031500098925,0.827445810392772,1,26,hydrogen peroxide metabolic process,BP,CYP1A1
6270,GO:0019898,0.534056878889344,0.63022367533946,6,189,extrinsic component of membrane,CC,MGLL;CYLD;LYN;ANXA1;NLRP10;PML
17038,GO:0099601,0.534174391151192,0.827782934744634,1,24,regulation of neurotransmitter receptor activity,BP,NETO1
202,GO:0000428,0.534331655097084,0.664401211036518,4,128,DNA-directed RNA polymerase complex,CC,TP53;CTR9;MED18;SUPT3H
6965,GO:0030662,0.534503006586552,0.664285725790401,4,126,coated vesicle membrane,CC,IL7R;SEC24D;TGFA;TFRC
7953,GO:0032589,0.53467701431102,0.827409413942236,1,24,neuron projection membrane,CC,NRG1
15171,GO:0071359,0.53490996335053,0.737514397171365,2,58,cellular response to dsRNA,BP,NFKB1;ZC3H7B
17661,GO:1901606,0.534949709955198,0.737337104750199,2,60,alpha-amino acid catabolic process,BP,ARG1;IVD
6370,GO:0021587,0.5350241648905,0.827151118099011,1,24,cerebellum morphogenesis,BP,HSPA5
13238,GO:0051966,0.535441513737828,0.826840252287318,1,24,regulation of synaptic transmission, glutamatergic,BP,HTR1B
13075,GO:0051650,0.535919092695379,0.628393315272722,6,190,establishment of vesicle localization,BP,AP3M1;MOBP;SYT11;RIMS2;SEC24D;TGFA
11440,GO:0045933,0.536373041583124,0.825912585519987,1,25,positive regulation of muscle contraction,BP,EDN1
4670,GO:0010837,0.536576489735782,0.825992979788804,1,24,regulation of keratinocyte proliferation,BP,HAS2
3584,GO:0008028,0.536618585831432,0.825728828491281,1,25,monocarboxylic acid transmembrane transporter activity,MF,SLC16A9
14429,GO:0061842,0.536635568590802,0.825948801544664,1,24,microtubule organizing center localization,BP,DLG1
16862,GO:0098858,0.537271322120399,0.661715998001531,4,123,actin-based cell projection,CC,LCP1;B4GALT1;MYO1B;ITGAV
13539,GO:0060047,0.53756234321779,0.66138686944351,4,125,heart contraction,BP,EDN1;SLC8A1;NEDD4L;DLG1
15756,GO:0072431,0.53808153445843,0.73455547865639,2,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,TP53;PML
17942,GO:1902400,0.53808153445843,0.73455547865639,2,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,TP53;PML
2744,GO:0006171,0.538825546889331,0.824071426585068,1,25,cAMP biosynthetic process,BP,GPR176
1116,GO:0002712,0.538857676378362,0.82404722065752,1,25,regulation of B cell mediated immunity,BP,TFRC
1211,GO:0002889,0.538857676378362,0.82404722065752,1,25,regulation of immunoglobulin mediated immune response,BP,TFRC
4167,GO:0009261,0.539159734369368,0.823819545874221,1,25,ribonucleotide catabolic process,BP,EGLN1
2862,GO:0006376,0.539261123641229,0.823743080276783,1,25,mRNA splice site selection,BP,SETX
2523,GO:0005794,0.539620143831198,0.532199499970794,35,1143,Golgi apparatus,CC,SPRR3;B4GALT1;FEZ1;CHAC1;HS3ST1;MYO1B;OPTN;CRYAB;EHF;NFKBIE;LYN;AP3M1;NEDD4L;GNPTAB;ACO1;CLCC1;STEAP4;CALR;AJUBA;MGAT5;SLC35B1;RAB30;DLG1;SEC24D;CALU;PDE4DIP;TGFA;SVIP;UBXN2B;NEDD4;ZDHHC6;GALNT14;UGCG;CLINT1;CEP83
6688,GO:0030117,0.539696030970123,0.687726881287873,3,92,membrane coat,CC,AP3M1;KCNQ5;SEC24D
12185,GO:0048475,0.539696030970123,0.687726881287873,3,92,coated membrane,CC,AP3M1;KCNQ5;SEC24D
12213,GO:0048524,0.539884552122131,0.687474218662943,3,94,positive regulation of viral process,BP,LGALS1;JUN;PPID
3680,GO:0008202,0.540294352637591,0.62403157616516,6,196,steroid metabolic process,BP,NFKB1;IL1B;G6PD;HMGCS1;MSMO1;CYP1A1
7676,GO:0032155,0.540372679093188,0.732653893442964,2,58,cell division site part,CC,RHOB;MYH9
3929,GO:0008643,0.540603832627234,0.686913473172796,3,91,carbohydrate transport,BP,IL1B;SLC35B1;ENPP1
17838,GO:1902117,0.540679414076042,0.732455319369381,2,57,positive regulation of organelle assembly,BP,LCP1;EDN1
8267,GO:0033120,0.541079105176993,0.822368245659694,1,25,positive regulation of RNA splicing,BP,SETX
13006,GO:0051536,0.541515046544086,0.731418307242978,2,61,iron-sulfur cluster binding,MF,ACO1;TYW1
13010,GO:0051540,0.541515046544086,0.731418307242978,2,61,metal cluster binding,MF,ACO1;TYW1
9860,GO:0042169,0.541708591133537,0.822127386946404,1,24,SH2 domain binding,MF,CTR9
8435,GO:0033598,0.54181279180157,0.821811383571804,1,25,mammary gland epithelial cell proliferation,BP,EPHA2
16113,GO:0090174,0.542121863198952,0.657008131904332,4,125,organelle membrane fusion,BP,ANXA1;SYT11;CALR;SEC22A
3899,GO:0008584,0.542318138381789,0.685261046887757,3,92,male gonad development,BP,HMGCS1;CITED2;ZFP42
8645,GO:0034243,0.542356968642862,0.821397606816487,1,25,regulation of transcription elongation from RNA polymerase II promoter,BP,CTR9
12354,GO:0048814,0.542738022757902,0.730609802009734,2,57,regulation of dendrite morphogenesis,BP,NEDD4L;NEDD4
10792,GO:0044319,0.54308791073873,0.820840810862813,1,25,wound healing, spreading of cells,BP,AJUBA
16278,GO:0090505,0.54308791073873,0.820840810862813,1,25,epiboly involved in wound healing,BP,AJUBA
812,GO:0002090,0.54337890369108,0.820618824613232,1,25,regulation of receptor internalization,BP,UBQLN2
17812,GO:1902042,0.543473110960044,0.82032713704988,1,26,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,HMOX1
14787,GO:0070566,0.543545725802513,0.820491480276706,1,25,adenylyltransferase activity,MF,PAPSS2
12112,GO:0048255,0.544760694516534,0.819562206906626,1,25,mRNA stabilization,BP,NOCT
3125,GO:0006734,0.545242179086284,0.818971928018278,1,26,NADH metabolic process,BP,PGK1
18762,GO:1904353,0.545841854749731,0.81873257810398,1,25,regulation of telomere capping,BP,NBN
7066,GO:0030880,0.545906572093594,0.653232656794184,4,130,RNA polymerase complex,CC,TP53;CTR9;MED18;SUPT3H
7689,GO:0032200,0.546400760106412,0.632833309098343,5,166,telomere organization,BP,PARP1;NBN;HSP90AA1;HSP90AB1;PML
2592,GO:0005905,0.54666873013247,0.726989010852368,2,58,clathrin-coated pit,CC,TFRC;HSPD1
738,GO:0001974,0.546692012793896,0.818078419276904,1,25,blood vessel remodeling,BP,AXL
7877,GO:0032467,0.546992576555337,0.817846771192196,1,25,positive regulation of cytokinesis,BP,CXCR5
15749,GO:0072413,0.547386620335336,0.726123220009093,2,61,signal transduction involved in mitotic cell cycle checkpoint,BP,TP53;PML
17943,GO:1902402,0.547386620335336,0.726123220009093,2,61,signal transduction involved in mitotic DNA damage checkpoint,BP,TP53;PML
17944,GO:1902403,0.547386620335336,0.726123220009093,2,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,TP53;PML
8948,GO:0035066,0.547412329740514,0.817300153251516,1,26,positive regulation of histone acetylation,BP,IL1B
468,GO:0001510,0.547623845607534,0.725908045453432,2,61,RNA methylation,BP,METTL2A;TRMT44
2278,GO:0005249,0.547680293493303,0.817315996400693,1,25,voltage-gated potassium channel activity,MF,KCNQ5
7009,GO:0030802,0.547693186962408,0.81708304262558,1,26,regulation of cyclic nucleotide biosynthetic process,BP,GPR176
8286,GO:0033144,0.548021416749914,0.817052335894969,1,25,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,CALR
7050,GO:0030857,0.54903493459124,0.816267464060588,1,25,negative regulation of epithelial cell differentiation,BP,CDSN
3782,GO:0008378,0.54925609641939,0.815871709941797,1,26,galactosyltransferase activity,MF,B4GALT1
11698,GO:0046546,0.550212704073132,0.677738304080436,3,93,development of primary male sexual characteristics,BP,HMGCS1;CITED2;ZFP42
12480,GO:0050660,0.550245198456101,0.723593762353909,2,60,flavin adenine dinucleotide binding,MF,TXNRD1;IVD
14728,GO:0070461,0.550432903356905,0.814956083066779,1,26,SAGA-type complex,CC,SUPT3H
9682,GO:0038127,0.550510499036448,0.648858367917034,4,126,ERBB signaling pathway,BP,MMP9;HSP90AA1;NRG1;TGFA
264,GO:0000732,0.55057794663826,0.815068216043167,1,25,strand displacement,BP,NBN
9931,GO:0042339,0.550619670029559,0.814810486834833,1,26,keratan sulfate metabolic process,BP,B4GALT1
1452,GO:0003713,0.550888583128236,0.592464637478808,8,261,transcription coactivator activity,MF,JUN;NFKB2;JUNB;WWC1;CITED2;SOX11;MAGED1;SUPT3H
1250,GO:0003015,0.551083250965341,0.648275613818824,4,127,heart process,BP,EDN1;SLC8A1;NEDD4L;DLG1
14767,GO:0070536,0.551806017007687,0.814109994782166,1,25,protein K63-linked deubiquitination,BP,CYLD
2737,GO:0006163,0.552342788499651,0.570669448549409,11,374,purine nucleotide metabolic process,BP,PGK1;PARP1;TJP2;GPR176;PAPSS2;EGLN1;MOCS2;DLG1;GDA;EPHA2;ENPP1
5725,GO:0016891,0.552423684760001,0.813190523245411,1,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,POP4
11318,GO:0045687,0.552558551710771,0.813294457364222,1,26,positive regulation of glial cell differentiation,BP,IL6ST
16802,GO:0098751,0.552584996446201,0.813500456316313,1,25,bone cell development,BP,TJP2
6266,GO:0019888,0.553953535653243,0.720130890192899,2,61,protein phosphatase regulator activity,MF,IGFBP3;UBXN2B
19865,GO:2000401,0.553986301878914,0.812172764327704,1,26,regulation of lymphocyte migration,BP,ADAM8
11488,GO:0046039,0.554162371780457,0.811823233445698,1,27,GTP metabolic process,BP,MOCS2
4064,GO:0009135,0.554650786346935,0.673452822318548,3,94,purine nucleoside diphosphate metabolic process,BP,PGK1;TJP2;DLG1
4103,GO:0009179,0.554650786346935,0.673452822318548,3,94,purine ribonucleoside diphosphate metabolic process,BP,PGK1;TJP2;DLG1
12894,GO:0051291,0.554986284679201,0.672950335750606,3,99,protein heterooligomerization,BP,CLDN1;C1QTNF1;BIRC3
8037,GO:0032728,0.556058293292009,0.810536868855364,1,26,positive regulation of interferon-beta production,BP,RIPK2
5760,GO:0017001,0.5561256707141,0.810074250563361,1,28,antibiotic catabolic process,BP,NAGK
8974,GO:0035136,0.556277609734148,0.810363151986433,1,26,forelimb morphogenesis,BP,OSR2
10747,GO:0044237,0.556371205750733,0.487972189154091,238,7890,cellular metabolic process,BP,CDKN2A;NFKBIA;MMP9;SPRR2A;IL1A;TRIM16;LCE1B;KRT1;NEFL;SERPINB2;LGALS1;DSCAM;SAA1;OSR2;KRT2;TNIP1;DUSP8;SPRR3;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;RNASE7;UBQLN2;CHAC1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;SPRR2E;DNAJB1;SPRR2D;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;HSPA5;IL1B;MSRB3;ANPEP;JUNB;C1QTNF1;TJP2;IL6ST;PHLDA2;CRYAB;ATF3;DNAJB9;AXL;CREB5;DNAJC10;EHF;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;SEMA7A;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;STT3A;ITGAV;LYN;NCEH1;ANXA1;FADS3;GPR176;DERL3;G6PD;NBN;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;PUS10;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;IL24;HSP90AA1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;PDIA6;EDRF1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;PRR5L;HMGCS1;UBP1;CS;METTL2A;CORO1C;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;NGLY1;GDA;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;TYW1;CALU;IVD;MSMO1;CHORDC1;TGFA;MGST3;BAMBI;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;NTNG1;ZDHHC6;PML;OXCT1;EPHA2;MRPS24;MYH9;EID3;GALNT14;BTBD10;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1
5270,GO:0015949,0.556797692748058,0.809540590165694,1,28,nucleobase-containing small molecule interconversion,BP,TXNRD1
4499,GO:0010569,0.557069542590005,0.809734980088586,1,26,regulation of double-strand break repair via homologous recombination,BP,FIGN
2231,GO:0005154,0.557086830171656,0.809721251693861,1,26,epidermal growth factor receptor binding,MF,TGFA
14470,GO:0065003,0.557091893456644,0.508993889273843,42,1416,protein-containing complex assembly,BP,NEFL;LCP1;B4GALT1;TP53;DPYSL3;PMAIP1;SLIT2;CLDN1;CLDN7;JUN;PARP1;C1QTNF1;CRYAB;NOCT;IKBKE;CYLD;COBLL1;BIRC3;ARG1;HMOX1;SYT11;KCTD12;HSP90AA1;TRAF1;BRD2;SETX;SOD2;NRG1;HSP90AB1;UQCC1;CALR;PPID;AJUBA;DLG1;EHD1;SEC24D;PDE4DIP;TGFA;SVIP;PML;CLINT1;HSPD1
15245,GO:0071470,0.557113395922668,0.809700154025657,1,26,cellular response to osmotic stress,BP,RELB
14697,GO:0070405,0.55714886651054,0.809458967714601,1,27,ammonium ion binding,MF,HTR1B
15055,GO:0071108,0.557170964734542,0.809884687726133,1,25,protein K48-linked deubiquitination,BP,CYLD
10488,GO:0043436,0.557252965783584,0.527790053553765,24,812,oxoacid metabolic process,BP,NFKB1;B4GALT1;EDN1;PSMB9;NAGK;PGK1;IL1B;MGLL;FADS1;ANXA1;FADS3;XBP1;ARG1;PAPSS2;EGLN1;ACO1;CS;HAS2;IVD;MSMO1;MGST3;BCAT1;ENPP1;CYP1A1
12225,GO:0048546,0.557535279826251,0.809595434616161,1,25,digestive tract morphogenesis,BP,SOX11
18304,GO:1903312,0.557557248114556,0.71688169491283,2,60,negative regulation of mRNA metabolic process,BP,NOCT;CTR9
3229,GO:0006901,0.557826219673603,0.716562012477218,2,61,vesicle coating,BP,SEC24D;TGFA
10971,GO:0044818,0.55823209894948,0.808810280372589,1,26,mitotic G2/M transition checkpoint,BP,NBN
16277,GO:0090504,0.558313993570985,0.808745026925601,1,26,epiboly,BP,AJUBA
7168,GO:0031076,0.558408517017073,0.808900904532372,1,25,embryonic camera-type eye development,BP,SOX11
643,GO:0001837,0.559529104336405,0.66875096627016,3,94,epithelial to mesenchymal transition,BP,IL1B;HAS2;BAMBI
3290,GO:0007006,0.559669637359863,0.668433364179525,3,99,mitochondrial membrane organization,BP,TP53;PMAIP1;HSP90AA1
12711,GO:0051019,0.559795611899663,0.807561873261553,1,26,mitogen-activated protein kinase binding,MF,TNIP1
9916,GO:0042307,0.559957456316753,0.807432332249876,1,26,positive regulation of protein import into nucleus,BP,HSP90AB1
5425,GO:0016311,0.560154710263946,0.562845949470221,11,361,dephosphorylation,BP,DUSP8;DUSP1;THTPA;DAPP1;HSP90AB1;IGFBP3;EYA3;DLG1;HSP90B1;UBXN2B;CPPED1
18605,GO:1903955,0.560306733544836,0.714193293565463,2,62,positive regulation of protein targeting to mitochondrion,BP,NRG1;UGCG
6056,GO:0019226,0.560952292419158,0.806634763137865,1,26,transmission of nerve impulse,BP,CNTNAP1
2864,GO:0006379,0.5612544774492,0.806176111765199,1,27,mRNA cleavage,BP,POP4
3050,GO:0006629,0.561477769864199,0.516426830949763,29,969,lipid metabolic process,BP,NFKB1;EDN1;FGF5;SPNS2;IL1B;MGLL;FADS1;PLBD1;LYN;NCEH1;ANXA1;FADS3;G6PD;PLEKHA2;XBP1;NRG1;SDR16C5;NR2F2;AJUBA;SEL1L;ORMDL1;HMGCS1;TXNRD1;DHDDS;IVD;MSMO1;MGST3;UGCG;CYP1A1
8887,GO:0034754,0.56148883139723,0.713026426813771,2,63,cellular hormone metabolic process,BP,SDR16C5;CYP1A1
7908,GO:0032507,0.561836549244571,0.712838665631066,2,61,maintenance of protein location in cell,BP,HSPA5;PML
1446,GO:0003697,0.562130494168211,0.666154125900122,3,96,single-stranded DNA binding,MF,NABP1;ANXA1;HSPD1
3161,GO:0006790,0.562197559188758,0.58100479653926,8,272,sulfur compound metabolic process,BP,B4GALT1;CHAC1;G6PD;THTPA;PAPSS2;HMGCS1;MGST3;ENPP1
20055,GO:2000758,0.562393004196237,0.805259007031667,1,27,positive regulation of peptidyl-lysine acetylation,BP,IL1B
6366,GO:0021575,0.5625346346951,0.805361575973482,1,26,hindbrain morphogenesis,BP,HSPA5
18766,GO:1904357,0.562775071193627,0.805167619072844,1,26,negative regulation of telomere maintenance via telomere lengthening,BP,PARP1
5464,GO:0016417,0.563357610793984,0.804479698200509,1,27,S-acyltransferase activity,MF,ZDHHC6
5942,GO:0018345,0.563363339379713,0.804475063744627,1,27,protein palmitoylation,BP,ZDHHC6
15558,GO:0072080,0.563607608971471,0.711257229999275,2,60,nephron tubule development,BP,DLG1;MAGED1
7322,GO:0031369,0.563842779079606,0.804086930046375,1,27,translation initiation factor binding,MF,SYT11
9031,GO:0035282,0.563849329369893,0.711031187152942,2,60,segmentation,BP,MAFB;NRP1
3499,GO:0007435,0.563895921108655,0.804261712084285,1,26,salivary gland morphogenesis,BP,NRP1
13110,GO:0051721,0.564086396127512,0.80410748009818,1,26,protein phosphatase 2A binding,MF,TP53
2663,GO:0006040,0.564477986427933,0.80357188785723,1,27,amino sugar metabolic process,BP,NAGK
3128,GO:0006739,0.56453863985725,0.803320111401782,1,28,NADP metabolic process,BP,G6PD
16122,GO:0090184,0.564964097623069,0.803177115517693,1,27,positive regulation of kidney development,BP,MAGED1
3217,GO:0006886,0.565091268287629,0.515322869703657,27,917,intracellular protein transport,BP,NFKBIA;LCP1;TP53;HERPUD1;IL1B;AP3M1;DERL3;RHOB;RIMS2;HSP90AA1;GNPTAB;NRG1;HSP90AB1;CALR;SEL1L;PRR5L;RAB30;EHD1;PTTG1IP;SEC24D;HSP90B1;SVIP;NEDD4;ZDHHC6;PML;UGCG;HSPD1
12778,GO:0051123,0.566806533105921,0.80147190908575,1,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,TP53
371,GO:0000993,0.567106099279781,0.801431158627653,1,27,RNA polymerase II core binding,MF,CTR9
13073,GO:0051648,0.56731222554742,0.597136791488724,6,196,vesicle localization,BP,AP3M1;MOBP;SYT11;RIMS2;SEC24D;TGFA
15281,GO:0071539,0.567567477100615,0.801274184061888,1,26,protein localization to centrosome,BP,CEP83
10984,GO:0044853,0.567744096643181,0.707374776079942,2,60,plasma membrane raft,CC,HMOX1;CORO1C
4109,GO:0009185,0.568001917117987,0.660425399547628,3,96,ribonucleoside diphosphate metabolic process,BP,PGK1;TJP2;DLG1
6726,GO:0030165,0.568718029524616,0.706456240024219,2,60,PDZ domain binding,MF,PLEKHA2;DAPP1
10554,GO:0043551,0.569592278175403,0.799613392683885,1,26,regulation of phosphatidylinositol 3-kinase activity,BP,LYN
12500,GO:0050686,0.569684620787764,0.799315428891801,1,27,negative regulation of mRNA processing,BP,CTR9
286,GO:0000791,0.569927763658973,0.798908992304318,1,28,euchromatin,CC,JUN
2685,GO:0006066,0.570162350509566,0.582471069062146,7,233,alcohol metabolic process,BP,NFKB1;IL1B;G6PD;SDR16C5;HMGCS1;DHDDS;MSMO1
17566,GO:1901292,0.570459211326062,0.629028388842061,4,132,nucleoside phosphate catabolic process,BP,PGK1;EGLN1;GDA;ENPP1
4049,GO:0009116,0.570593861618614,0.657736910424219,3,100,nucleoside metabolic process,BP,TJP2;MOCS2;DLG1
5542,GO:0016573,0.570628881889037,0.628882204411347,4,131,histone acetylation,BP,TRIM16;IL1B;SDR16C5;SUPT3H
11706,GO:0046579,0.571042963131891,0.798194716596091,1,27,positive regulation of Ras protein signal transduction,BP,NRG1
10948,GO:0044773,0.571221089589332,0.657189542000436,3,98,mitotic DNA damage checkpoint,BP,TP53;NBN;PML
14151,GO:0061098,0.571431344140293,0.797873494668021,1,27,positive regulation of protein tyrosine kinase activity,BP,TGFA
5684,GO:0016831,0.571786936792056,0.797371698258704,1,28,carboxy-lyase activity,MF,GGCX
6059,GO:0019229,0.57252021984168,0.79697104298771,1,27,regulation of vasoconstriction,BP,EDN1
3876,GO:0008528,0.572967566792343,0.79639130989076,1,28,G-protein coupled peptide receptor activity,MF,CXCR5
14225,GO:0061326,0.573184309122442,0.702149011295007,2,61,renal tubule development,BP,DLG1;MAGED1
11853,GO:0046906,0.573374756064304,0.701828070851817,2,63,tetrapyrrole binding,MF,HMOX1;CYP1A1
12712,GO:0051020,0.574062976152693,0.528548116886574,16,519,GTPase binding,MF,NEFL;LCP1;FGF5;OPTN;AP3M1;MOBP;RIMS2;HSP90AA1;NRG1;STXBP5;EIF2B1;ARHGDIB;GIT2;CORO1C;EHD1;MON1A
616,GO:0001786,0.574703086093159,0.795153595354697,1,27,phosphatidylserine binding,MF,AXL
8285,GO:0033143,0.575212771959643,0.700142777637294,2,62,regulation of intracellular steroid hormone receptor signaling pathway,BP,PARP1;CALR
4584,GO:0010717,0.575279302933543,0.700079176092905,2,62,regulation of epithelial to mesenchymal transition,BP,IL1B;BAMBI
5148,GO:0015711,0.575282734999982,0.56775714550225,8,265,organic anion transport,BP,EDN1;SLC16A9;IL1B;NFKBIE;ANXA1;ARG1;SLC7A5P2;SLC35B1
5519,GO:0016525,0.575304895248808,0.700125920959092,2,61,negative regulation of angiogenesis,BP,PGK1;PML
17495,GO:1901031,0.575371780066652,0.794384827887003,1,28,regulation of response to reactive oxygen species,BP,TP53
788,GO:0002062,0.575746012969534,0.699704067356629,2,61,chondrocyte differentiation,BP,OSR2;SERPINH1
2799,GO:0006275,0.576223084327369,0.652280501710483,3,97,regulation of DNA replication,BP,JUN;NBN;CALR
16365,GO:0097035,0.576889437008515,0.793322088254718,1,27,regulation of membrane lipid distribution,BP,ANO4
3646,GO:0008146,0.577101454281604,0.792932932238175,1,28,sulfotransferase activity,MF,HS3ST1
4765,GO:0010970,0.578070652921707,0.621404064255422,4,131,transport along microtubule,BP,NEFL;FEZ1;IFT46;AP3M1
16966,GO:0099111,0.578070652921707,0.621404064255422,4,131,microtubule-based transport,BP,NEFL;FEZ1;IFT46;AP3M1
10945,GO:0044770,0.578138553471459,0.527490824340871,15,511,cell cycle phase transition,BP,CDKN2A;TP53;PSMB9;CDKN2B;OPTN;DUSP1;ANXA1;NBN;HSP90AA1;DCUN1D3;AJUBA;BCAT1;CDK6;PML;CYP1A1
16599,GO:0097502,0.5782052361054,0.792002739577953,1,28,mannosylation,BP,SDF2L1
5040,GO:0015267,0.578458038859724,0.600843847292944,5,164,channel activity,MF,ITGAV;KCNQ5;CLCC1;ANO4;DLG1
6587,GO:0022803,0.578458038859724,0.600843847292944,5,164,passive transmembrane transporter activity,MF,ITGAV;KCNQ5;CLCC1;ANO4;DLG1
2812,GO:0006294,0.578814946605183,0.791290354111839,1,29,nucleotide-excision repair, preincision complex assembly,BP,PARP1
17995,GO:1902555,0.578834485380183,0.791273821979154,1,29,endoribonuclease complex,CC,POP4
19183,GO:1905348,0.578834485380183,0.791273821979154,1,29,endonuclease complex,CC,POP4
13434,GO:0055010,0.579332073663044,0.791262609470975,1,27,ventricular cardiac muscle tissue morphogenesis,BP,NRG1
13857,GO:0060541,0.579385925416704,0.620123372067403,4,129,respiratory system development,BP,CCBE1;ARG1;LOX;SOX11
5420,GO:0016303,0.579451593251291,0.791390543215076,1,26,1-phosphatidylinositol-3-kinase activity,MF,FGF5
9914,GO:0042304,0.57977258086581,0.790676952008282,1,28,regulation of fatty acid biosynthetic process,BP,ANXA1
194,GO:0000413,0.580752909480847,0.789461029115959,1,30,protein peptidyl-prolyl isomerization,BP,PPID
1467,GO:0003755,0.580752909480847,0.789461029115959,1,30,peptidyl-prolyl cis-trans isomerase activity,MF,PPID
4007,GO:0009056,0.5808420596226,0.476043373192859,59,1989,catabolic process,BP,MMP9;FEZ1;TP53;PMAIP1;PSMB9;NAGK;UBQLN2;CHAC1;COL12A1;PGK1;RIPK2;HERPUD1;OPTN;HSPA5;IL1B;ANPEP;DNAJB9;DNAJC10;NOCT;MGLL;ERAP1;CYLD;TRIB1;PLBD1;NCEH1;COL8A1;COL4A4;DERL3;NEDD4L;XBP1;ARG1;UGGT1;HMOX1;MMP19;KLK6;HSP90AA1;EGLN1;NRG1;HSP90AB1;ADAM8;EIF4G2;SEL1L;PRR5L;NGLY1;GDA;PTTG1IP;IVD;DNAJC3;BCAT1;HSP90B1;SVIP;UBXN2B;NEDD4;PML;OXCT1;ENPP1;SND1;SDF2L1;CYP1A1
12812,GO:0051170,0.581041791757926,0.618350824766025,4,133,import into nucleus,BP,NFKBIA;HSP90AB1;PTTG1IP;PML
8423,GO:0033572,0.581240876669799,0.789230823140892,1,29,transferrin transport,BP,TFRC
19242,GO:1905508,0.581940372649642,0.789047887777605,1,27,protein localization to microtubule organizing center,BP,CEP83
3288,GO:0007004,0.58220018764101,0.693281791335791,2,64,telomere maintenance via telomerase,BP,HSP90AA1;HSP90AB1
13452,GO:0055038,0.582522292370945,0.692969628375599,2,64,recycling endosome membrane,CC,OPTN;EHD1
10942,GO:0044764,0.583138239914271,0.78781033397971,1,28,multi-organism cellular process,BP,BIRC3
2090,GO:0004869,0.583367256412236,0.787414107606356,1,29,cysteine-type endopeptidase inhibitor activity,MF,BIRC3
12691,GO:0050994,0.583892985987645,0.787163795663564,1,28,regulation of lipid catabolic process,BP,IL1B
11851,GO:0046902,0.583933096768153,0.691470660875252,2,66,regulation of mitochondrial membrane permeability,BP,TP53;PMAIP1
2530,GO:0005811,0.584205210710084,0.691335572876391,2,64,lipid droplet,CC,SDR16C5;EHD1
4011,GO:0009060,0.584397074893295,0.69089750993466,2,68,aerobic respiration,BP,ACO1;CS
2273,GO:0005244,0.58544592036243,0.690195643603848,2,63,voltage-gated ion channel activity,MF,ITGAV;KCNQ5
6592,GO:0022832,0.58544592036243,0.690195643603848,2,63,voltage-gated channel activity,MF,ITGAV;KCNQ5
793,GO:0002067,0.585528733671993,0.785757887957061,1,28,glandular epithelial cell differentiation,BP,CDK6
3342,GO:0007094,0.585712476518566,0.785397899596112,1,29,mitotic spindle assembly checkpoint,BP,DUSP1
15074,GO:0071173,0.585712476518566,0.785397899596112,1,29,spindle assembly checkpoint,BP,DUSP1
15075,GO:0071174,0.585712476518566,0.785397899596112,1,29,mitotic spindle checkpoint,BP,DUSP1
667,GO:0001881,0.585759381473399,0.785559132637459,1,28,receptor recycling,BP,OPTN
10247,GO:0043025,0.58634040239579,0.556363459005786,8,268,neuronal cell body,CC,FEZ1;IL6ST;CRYAB;ARG1;CANX;NRP1;L1CAM;TUBB3
12609,GO:0050853,0.586443708773364,0.784968677556596,1,28,B cell receptor signaling pathway,BP,LYN
534,GO:0001653,0.58658920367191,0.78464078100763,1,29,peptide receptor activity,MF,CXCR5
6277,GO:0019905,0.58696916814095,0.688708888479642,2,63,syntaxin binding,MF,SYT11;STXBP5
16082,GO:0090114,0.58759350069378,0.688029921728795,2,64,COPII-coated vesicle budding,BP,SEC24D;TGFA
7628,GO:0032069,0.587984525988067,0.78343200027491,1,29,regulation of nuclease activity,BP,HSPA5
14461,GO:0061980,0.588104345835306,0.783531149741603,1,28,regulatory RNA binding,MF,ZC3H7B
5818,GO:0017124,0.588121707607132,0.640364895375422,3,97,SH3 domain binding,MF,DPYSL3;CNTNAP1;LYN
5947,GO:0018393,0.588532947303237,0.610695896053862,4,134,internal peptidyl-lysine acetylation,BP,TRIM16;IL1B;SDR16C5;SUPT3H
6701,GO:0030131,0.589199511231461,0.78257947795536,1,28,clathrin adaptor complex,CC,AP3M1
18663,GO:1904064,0.589589758432036,0.686072462891824,2,64,positive regulation of cation transmembrane transport,BP,STAC;G6PD
15050,GO:0071103,0.590032064409674,0.561966866337897,7,245,DNA conformation change,BP,CDKN2A;TP53;PARP1;ANXA1;NBN;BRD2;SETX
4954,GO:0015085,0.590417180702874,0.685398682156805,2,62,calcium ion transmembrane transporter activity,MF,ITGAV;SLC8A1
10920,GO:0044665,0.590636173104011,0.781121879938507,1,29,MLL1/2 complex,CC,MGA
15155,GO:0071339,0.590636173104011,0.781121879938507,1,29,MLL1 complex,CC,MGA
11301,GO:0045661,0.590740491316649,0.781030648906607,1,29,regulation of myoblast differentiation,BP,IGFBP3
17187,GO:0110020,0.590886767189789,0.684865508641082,2,63,regulation of actomyosin structure organization,BP,EDN1;NRP1
18883,GO:1904659,0.591206385131319,0.684550693815151,2,63,glucose transmembrane transport,BP,IL1B;ENPP1
5541,GO:0016572,0.591266950717684,0.780569832166796,1,29,histone phosphorylation,BP,IL1B
3083,GO:0006672,0.59130187572766,0.684321062680431,2,65,ceramide metabolic process,BP,ORMDL1;UGCG
11688,GO:0046530,0.591411863649175,0.780648127030487,1,28,photoreceptor cell differentiation,BP,DSCAM
360,GO:0000979,0.591496805784646,0.780368425400673,1,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,SOX11
9186,GO:0035601,0.591824644120896,0.636538636048155,3,99,protein deacylation,BP,TP53;SUDS3;SDR16C5
5701,GO:0016859,0.591908479847301,0.779636411132677,1,31,cis-trans isomerase activity,MF,PPID
415,GO:0001103,0.592129470591409,0.779813398018265,1,29,RNA polymerase II repressing transcription factor binding,MF,ZFP42
4236,GO:0009566,0.592302207284677,0.683269343383931,2,66,fertilization,BP,B4GALT1;NR2F2
17837,GO:1902116,0.592361091195853,0.779609956491891,1,29,negative regulation of organelle assembly,BP,FEZ1
10048,GO:0042578,0.592605186790953,0.549862371647143,8,269,phosphoric ester hydrolase activity,MF,DUSP8;DUSP1;PDE1C;HMOX1;EYA3;DLG1;CPPED1;ENPP1
12089,GO:0048199,0.592767519705004,0.682874378353227,2,65,vesicle targeting, to, from or within Golgi,BP,SEC24D;TGFA
4732,GO:0010921,0.592995505928716,0.606137200610319,4,133,regulation of phosphatase activity,BP,HSP90AB1;IGFBP3;HSP90B1;UBXN2B
15831,GO:0072594,0.593370631967184,0.519175915321514,13,459,establishment of protein localization to organelle,BP,NFKBIA;TP53;PMAIP1;AP3M1;HSP90AA1;GNPTAB;NRG1;HSP90AB1;PTTG1IP;NEDD4;PML;UGCG;HSPD1
19732,GO:2000181,0.593724007764354,0.682064273042901,2,63,negative regulation of blood vessel morphogenesis,BP,PGK1;PML
7446,GO:0031624,0.593736566554676,0.778605847914886,1,28,ubiquitin conjugating enzyme binding,MF,DCUN1D3
6184,GO:0019693,0.595033576459707,0.526899689647969,11,386,ribose phosphate metabolic process,BP,PGK1;PARP1;TJP2;GPR176;G6PD;PAPSS2;EGLN1;MOCS2;DLG1;EPHA2;ENPP1
12839,GO:0051209,0.595592070421083,0.680142325238539,2,64,release of sequestered calcium ion into cytosol,BP,LYN;SLC8A1
12888,GO:0051283,0.595592070421083,0.680142325238539,2,64,negative regulation of sequestering of calcium ion,BP,LYN;SLC8A1
5278,GO:0015980,0.596181440444866,0.56731005111323,6,214,energy derivation by oxidation of organic compounds,BP,IL6ST;PHLDA2;ACO1;CS;GBE1;ENPP1
17789,GO:1901989,0.59638613866074,0.679220181224403,2,66,positive regulation of cell cycle phase transition,BP,ANXA1;CYP1A1
11315,GO:0045684,0.59651637327954,0.775743424728766,1,30,positive regulation of epidermis development,BP,TRIM16
11832,GO:0046873,0.596634766623919,0.567019656451829,6,199,metal ion transmembrane transporter activity,MF,ITGAV;SLC8A1;KCNQ5;SLC39A14;MAGT1;TFRC
8205,GO:0032991,0.597142604275629,0.447703736804443,114,3844,protein-containing complex,CC,NFKBIA;NEFL;KRT8;SAA1;LCP1;NFKB1;MAFB;RELB;TP53;DPYSL3;PSMB9;COL12A1;NABP1;MYO1B;CCBE1;JUN;RIPK2;NFKB2;HERPUD1;PARP1;HSPA5;IFT46;CNTNAP1;JUNB;C1QTNF1;IL6ST;ATF3;AXL;ACTG1;DNAJC10;HSPA6;NOCT;STT3A;ITGAV;LYN;AP3M1;COL8A1;COL4A4;DERL3;NBN;PLEKHA2;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HSP90AA1;CANX;FTH1;NRP1;DCUN1D3;KCNQ5;RBM28;POP4;HSP90AB1;GPATCH11;SDR16C5;SNAI3;ADAM8;C2ORF49;CLCC1;STXBP5;EIF4G2;CALR;PDIA6;CTR9;AJUBA;IGFBP3;SEL1L;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAGT1;MOCS2;MGA;PRR5L;SEC22A;CORO1C;IL23A;DLG1;MED18;CITED2;LOX;ETS1;SEC24D;SUGT1;PRPF38A;DNAJC3;CBLL1;HSP90B1;TFRC;ZFP42;SVIP;NEDD4;CDK6;EPHA2;MON1A;EPB41L2;MRPS24;MYH9;EID3;MRPL53;RPL26L1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;SDF2L1;TJP1
12630,GO:0050877,0.59728931505363,0.519595597882111,12,406,nervous system process,BP,NEFL;NETO1;EDN1;JUN;CNTNAP1;MGLL;NBN;SOD2;NRG1;EYA3;MAGT1;MME
10508,GO:0043489,0.597372839559754,0.775175719057817,1,29,RNA stabilization,BP,NOCT
17856,GO:1902186,0.597574280419428,0.774996196896642,1,29,regulation of viral release from host cell,BP,PML
1965,GO:0004693,0.597623306704614,0.77475738679503,1,30,cyclin-dependent protein serine/threonine kinase activity,MF,CDK6
2695,GO:0006084,0.597711964281791,0.774873436578537,1,29,acetyl-CoA metabolic process,BP,HMGCS1
12447,GO:0050435,0.597764473557319,0.77482660641682,1,29,amyloid-beta metabolic process,BP,MME
15017,GO:0071011,0.597823826770366,0.774395939663057,1,31,precatalytic spliceosome,CC,PRPF38A
16791,GO:0098732,0.59795453142757,0.630243578378494,3,100,macromolecule deacylation,BP,TP53;SUDS3;SDR16C5
3057,GO:0006639,0.598143797750936,0.677533363539569,2,65,acylglycerol metabolic process,BP,MGLL;SEL1L
18862,GO:1904591,0.598187159791231,0.774449386819867,1,29,positive regulation of protein import,BP,HSP90AB1
11391,GO:0045841,0.599111224809462,0.773427193028321,1,30,negative regulation of mitotic metaphase/anaphase transition,BP,DUSP1
17826,GO:1902100,0.599111224809462,0.773427193028321,1,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,DUSP1
3566,GO:0007626,0.599117002284559,0.629086174682734,3,99,locomotory behavior,BP,DSCAM;NRG1;ADGRL3
4531,GO:0010629,0.599246001315155,0.465881673330525,42,1429,negative regulation of gene expression,BP,CDKN2A;OSR2;NFKB1;RELB;EDN1;TP53;PSMB9;CHAC1;DNAJB1;JUN;NFKB2;PARP1;JUNB;CRYAB;ATF3;NOCT;WWC1;NEDD4L;BIRC3;SUDS3;KLF10;NRG1;SDR16C5;SNAI3;NR2F2;CALR;PPID;CTR9;AJUBA;PRR5L;UBP1;DLG1;RBMS3;CITED2;ZNF814;ZC3H7B;NEDD4;PML;ZBTB21;SOX11;SND1;MAGED1
2800,GO:0006278,0.599491846285262,0.676120025531656,2,66,RNA-dependent DNA biosynthetic process,BP,HSP90AA1;HSP90AB1
17778,GO:1901976,0.600292138313341,0.772367544935228,1,30,regulation of cell cycle checkpoint,BP,DUSP1
3681,GO:0008203,0.60032509987341,0.627771793873688,3,101,cholesterol metabolic process,BP,G6PD;HMGCS1;MSMO1
8775,GO:0034504,0.60045008481803,0.562972470962267,6,204,protein localization to nucleus,BP,NFKBIA;HSP90AB1;CALR;PTTG1IP;PML;TOR1AIP1
12079,GO:0048168,0.600646740594088,0.772245570483872,1,29,regulation of neuronal synaptic plasticity,BP,NETO1
4435,GO:0010390,0.601223333520739,0.771726755468752,1,29,histone monoubiquitination,BP,CTR9
6967,GO:0030665,0.601583817433365,0.674021560736896,2,66,clathrin-coated vesicle membrane,CC,IL7R;TFRC
18263,GO:1903214,0.601613273167886,0.673928059458177,2,67,regulation of protein targeting to mitochondrion,BP,NRG1;UGCG
11113,GO:0045197,0.601837838062236,0.771172913354865,1,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG1
12970,GO:0051443,0.601877611310541,0.770939411732698,1,30,positive regulation of ubiquitin-protein transferase activity,BP,DCUN1D3
86,GO:0000175,0.601884136995364,0.770933520661353,1,30,3'-5'-exoribonuclease activity,MF,NOCT
12842,GO:0051219,0.602252882719046,0.673482715590838,2,64,phosphoprotein binding,MF,LYN;NEDD4
287,GO:0000792,0.603612040968373,0.671979139473694,2,66,heterochromatin,CC,CDKN2A;PML
20246,GO:2001259,0.603921372894909,0.769288016934166,1,29,positive regulation of cation channel activity,BP,STAC
12887,GO:0051282,0.604292023302857,0.671358868280282,2,65,regulation of sequestering of calcium ion,BP,LYN;SLC8A1
2117,GO:0004930,0.604651962668406,0.593904726344829,4,139,G-protein coupled receptor activity,MF,GPR176;CXCR5;ADGRL3;HTR1B
3253,GO:0006940,0.60472222284661,0.768361304986085,1,30,regulation of smooth muscle contraction,BP,EDN1
11675,GO:0046503,0.604775590388023,0.768312742780514,1,30,glycerolipid catabolic process,BP,MGLL
10221,GO:0042987,0.604904621249542,0.768195300471457,1,30,amyloid precursor protein catabolic process,BP,LYN
14289,GO:0061512,0.60494085323958,0.768162315004832,1,30,protein localization to cilium,BP,EHD1
8383,GO:0033365,0.606110252850319,0.482957378263533,21,729,protein localization to organelle,BP,NFKBIA;TP53;PMAIP1;OPTN;HSPA5;AP3M1;SYT11;HSP90AA1;NRP1;GNPTAB;NRG1;HSP90AB1;CALR;EHD1;PTTG1IP;NEDD4;PML;TOR1AIP1;UGCG;CEP83;HSPD1
10754,GO:0044255,0.606163229504447,0.480990698956957,22,752,cellular lipid metabolic process,BP,EDN1;FGF5;SPNS2;MGLL;FADS1;PLBD1;LYN;ANXA1;FADS3;PLEKHA2;XBP1;NRG1;SDR16C5;AJUBA;SEL1L;ORMDL1;HMGCS1;DHDDS;IVD;MSMO1;UGCG;CYP1A1
3056,GO:0006638,0.606658699305434,0.668896464963033,2,66,neutral lipid metabolic process,BP,MGLL;SEL1L
16869,GO:0098876,0.607022392990382,0.668527289219304,2,66,vesicle-mediated transport to the plasma membrane,BP,KRT18;OPTN
2844,GO:0006351,0.607924322877897,0.440204091787325,89,2974,transcription, DNA-templated,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
4454,GO:0010467,0.608252517648199,0.435122987772906,127,4261,gene expression,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;ASPRV1;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;CCBE1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;C1QTNF1;PHLDA2;CRYAB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;C1R;WWC1;NEDD4L;BIRC3;PUS10;NOC3L;XBP1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;KLK6;ZNF638;RIMS2;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;SERP1;EIF2B1;MAFF;MGA;PRR5L;UBP1;METTL2A;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;ZMYM4;CITED2;ZNF814;ETS1;TYW1;TGFA;BAMBI;PRPF38A;DNAJC3;ZC3H7B;ZFP42;NLRP10;NEDD4;CDK6;PML;MRPS24;MYH9;EID3;ZBTB21;HES4;SOX11;MRPL53;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
10765,GO:0044273,0.608278509767295,0.764921179944771,1,31,sulfur compound catabolic process,BP,CHAC1
16821,GO:0098793,0.608607738635449,0.554363338175952,6,207,presynapse,CC,DBNDD2;SYT11;KCTD12;RIMS2;STXBP5;MME
12055,GO:0048066,0.608835048655517,0.764597677983381,1,30,developmental pigmentation,BP,SPNS2
7421,GO:0031571,0.608870107026116,0.666520271300397,2,68,mitotic G1 DNA damage checkpoint,BP,TP53;PML
10972,GO:0044819,0.608870107026116,0.666520271300397,2,68,mitotic G1/S transition checkpoint,BP,TP53;PML
16880,GO:0098900,0.608918728833871,0.764722460635669,1,29,regulation of action potential,BP,DLG1
17966,GO:1902475,0.608981529270874,0.764462841772748,1,30,L-alpha-amino acid transmembrane transport,BP,SLC7A5P2
7125,GO:0030990,0.609125924800232,0.764329871336568,1,30,intraciliary transport particle,CC,IFT46
19330,GO:1905819,0.609295863157272,0.763984448931489,1,31,negative regulation of chromosome separation,BP,DUSP1
20088,GO:2000816,0.609295863157272,0.763984448931489,1,31,negative regulation of mitotic sister chromatid separation,BP,DUSP1
16580,GO:0097472,0.609927439033441,0.763401594872225,1,31,cyclin-dependent protein kinase activity,MF,CDK6
3401,GO:0007200,0.610259366722223,0.76309486439067,1,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,EDN1
9042,GO:0035307,0.610560057945045,0.763006320798759,1,30,positive regulation of protein dephosphorylation,BP,HSP90AB1
3520,GO:0007528,0.61077938214175,0.763006355818966,1,29,neuromuscular junction development,BP,NEDD4
1440,GO:0003684,0.610947886317418,0.664461513783066,2,67,damaged DNA binding,MF,TP53;NBN
2931,GO:0006475,0.61098971423006,0.587271296591683,4,138,internal protein amino acid acetylation,BP,TRIM16;IL1B;SDR16C5;SUPT3H
2913,GO:0006446,0.611050699625959,0.664293270933181,2,68,regulation of translational initiation,BP,EIF4G2;DNAJC3
2093,GO:0004879,0.611121744004501,0.762486510626518,1,30,nuclear receptor activity,MF,NR2F2
16710,GO:0098531,0.611121744004501,0.762486510626518,1,30,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR2F2
5838,GO:0017156,0.611882679720408,0.663569398258977,2,66,calcium ion regulated exocytosis,BP,SYT11;RIMS2
10949,GO:0044774,0.612363435072314,0.615158684978498,3,104,mitotic DNA integrity checkpoint,BP,TP53;NBN;PML
10290,GO:0043113,0.612645185664213,0.761072570226718,1,30,receptor clustering,BP,DLG1
18400,GO:1903524,0.614129896579094,0.759497273530141,1,31,positive regulation of blood circulation,BP,EDN1
2860,GO:0006369,0.614481473090625,0.660709359098636,2,69,termination of RNA polymerase II transcription,BP,SETX;MED18
9583,GO:0036477,0.614484314676344,0.493202243079081,14,476,somatodendritic compartment,CC,FEZ1;IL6ST;CRYAB;SLC8A1;ARG1;SYT11;CANX;NRP1;NRG1;L1CAM;MME;HTR1B;NEDD4;TUBB3
13731,GO:0060350,0.614685263131479,0.759169763017832,1,30,endochondral bone morphogenesis,BP,SERPINH1
14460,GO:0061971,0.614685263131479,0.759169763017832,1,30,replacement bone morphogenesis,BP,SERPINH1
11827,GO:0046854,0.61477585755764,0.660663958965308,2,65,phosphatidylinositol phosphorylation,BP,FGF5;NRG1
19695,GO:2000107,0.614971128895819,0.758710251665665,1,31,negative regulation of leukocyte apoptotic process,BP,AXL
2434,GO:0005657,0.614980304979591,0.660256873558895,2,68,replication fork,CC,TP53;NBN
7160,GO:0031062,0.616435495259562,0.75752871141826,1,30,positive regulation of histone methylation,BP,CTR9
16446,GO:0097178,0.616469405563321,0.757303981610808,1,31,ruffle assembly,BP,CORO1C
1843,GO:0004518,0.616785197397627,0.560751111601457,5,176,nuclease activity,MF,RNASE7;NOCT;POP4;ENPP1;SND1
12896,GO:0051293,0.617037709163702,0.756962222987661,1,30,establishment of spindle localization,BP,MYH9
10953,GO:0044783,0.617332719769945,0.657764325722462,2,69,G1 DNA damage checkpoint,BP,TP53;PML
14953,GO:0070911,0.617347125561011,0.756296308841379,1,32,global genome nucleotide-excision repair,BP,PARP1
4814,GO:0014037,0.617348374521334,0.756669617978881,1,30,Schwann cell differentiation,BP,CNTNAP1
10125,GO:0042737,0.617810343472825,0.65715092619123,2,71,drug catabolic process,BP,NAGK;OXCT1
3551,GO:0007610,0.617990104355874,0.515227584709227,9,309,behavior,BP,NETO1;DSCAM;TP53;JUN;SDK1;GPR176;NRG1;ADGRL3;HTR1B
3216,GO:0006885,0.618864118986655,0.656176009992414,2,69,regulation of pH,BP,EDN1;TP53
11036,GO:0045070,0.619997817684502,0.753969124598525,1,31,positive regulation of viral genome replication,BP,PPID
14077,GO:0060976,0.620066340502794,0.754098901208337,1,30,coronary vasculature development,BP,NRP1
7538,GO:0031902,0.620191652069114,0.606832631553943,3,106,late endosome membrane,CC,STOML1;ANXA8;RHOB
6275,GO:0019903,0.620339796453389,0.60681138138798,3,102,protein phosphatase binding,MF,TP53;TRAF3;HSP90B1
8499,GO:0033762,0.620398918018964,0.753587962554652,1,31,response to glucagon,BP,ARG1
1851,GO:0004527,0.620520008333608,0.654515614114665,2,68,exonuclease activity,MF,NOCT;ENPP1
19584,GO:1990778,0.620622861669724,0.541599858363222,6,207,protein localization to cell periphery,BP,KRT18;OPTN;STAC;DLG1;EPHA2;EPB41L2
14092,GO:0060999,0.620637956305459,0.753555787886735,1,30,positive regulation of dendritic spine development,BP,NRG1
5262,GO:0015932,0.620760797557466,0.753060784527354,1,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC35B1
5672,GO:0016811,0.620767099827008,0.654195902180963,2,69,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,SUDS3;NGLY1
4079,GO:0009150,0.621045112668425,0.505225852661824,10,358,purine ribonucleotide metabolic process,BP,PGK1;PARP1;TJP2;GPR176;PAPSS2;EGLN1;MOCS2;DLG1;EPHA2;ENPP1
7424,GO:0031577,0.621442678227938,0.752410821628762,1,32,spindle checkpoint,BP,DUSP1
5948,GO:0018394,0.622190783757078,0.575327750930976,4,140,peptidyl-lysine acetylation,BP,TRIM16;IL1B;SDR16C5;SUPT3H
3144,GO:0006767,0.622214347633445,0.65268523367463,2,69,water-soluble vitamin metabolic process,BP,THTPA;ENPP1
17622,GO:1901505,0.622410344850375,0.751486344248989,1,32,carbohydrate derivative transmembrane transporter activity,MF,SLC35B1
6704,GO:0030134,0.623137197574313,0.651719787260618,2,69,COPII-coated ER to Golgi transport vesicle,CC,SEC24D;TGFA
6410,GO:0021695,0.623494097970436,0.750632375197613,1,31,cerebellar cortex development,BP,HSPA5
4220,GO:0009435,0.623548201785496,0.750396103985104,1,32,NAD biosynthetic process,BP,PGK1
11758,GO:0046661,0.623768340933014,0.603127095773245,3,103,male sex differentiation,BP,HMGCS1;CITED2;ZFP42
3930,GO:0008645,0.623818335250371,0.651133135390586,2,67,hexose transmembrane transport,BP,IL1B;ENPP1
7246,GO:0031234,0.624018020466903,0.650923785534595,2,67,extrinsic component of cytoplasmic side of plasma membrane,CC,CYLD;LYN
791,GO:0002065,0.624502664436727,0.650350830661135,2,68,columnar/cuboidal epithelial cell differentiation,BP,CDK6;SOX11
3539,GO:0007595,0.624859282657378,0.74932069745641,1,31,lactation,BP,XBP1
12742,GO:0051057,0.62507056267979,0.749117255404015,1,31,positive regulation of small GTPase mediated signal transduction,BP,NRG1
12193,GO:0048487,0.625284212896058,0.748726119345283,1,32,beta-tubulin binding,MF,SYT11
18031,GO:1902652,0.625921126853557,0.600757465689904,3,105,secondary alcohol metabolic process,BP,G6PD;HMGCS1;MSMO1
8953,GO:0035088,0.626703491506265,0.747540887746597,1,31,establishment or maintenance of apical/basal cell polarity,BP,DLG1
14203,GO:0061245,0.626703491506265,0.747540887746597,1,31,establishment or maintenance of bipolar cell polarity,BP,DLG1
15993,GO:0086065,0.626950152823784,0.747302150709786,1,31,cell communication involved in cardiac conduction,BP,SLC8A1
16246,GO:0090382,0.627166143088199,0.74673181538973,1,33,phagosome maturation,BP,SYT11
16660,GO:0097659,0.627185127763835,0.420344239466777,89,2988,nucleic acid-templated transcription,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
10330,GO:0043177,0.627702206690621,0.598781745601309,3,107,organic acid binding,MF,EGLN1;NR2F2;HMGCS1
14754,GO:0070509,0.627935796385712,0.746346544692591,1,31,calcium ion import,BP,SLC8A1
5730,GO:0016896,0.627959745032455,0.746136601384653,1,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,NOCT
10249,GO:0043028,0.628025403397978,0.746072812743871,1,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,BIRC3
9960,GO:0042398,0.628090715181957,0.745834021057171,1,33,cellular modified amino acid biosynthetic process,BP,CHAC1
3885,GO:0008542,0.628444822080271,0.745852010550304,1,31,visual learning,BP,NETO1
2946,GO:0006497,0.628511413865716,0.597880211150239,3,108,protein lipidation,BP,SVIP;NTNG1;ZDHHC6
19761,GO:2000243,0.629271672403855,0.74485983497384,1,32,positive regulation of reproductive process,BP,CITED2
11796,GO:0046777,0.629767782734466,0.54690299929154,5,171,protein autophosphorylation,BP,JUN;LYN;NBN;VEGFC;ENPP1
10764,GO:0044272,0.63025971278818,0.566581173080108,4,143,sulfur compound biosynthetic process,BP,B4GALT1;CHAC1;PAPSS2;MGST3
14106,GO:0061025,0.630446161471395,0.54608908413,5,176,membrane fusion,BP,ANXA1;SYT11;CALR;SEC22A;UBXN2B
2950,GO:0006501,0.630462483324866,0.74352042862771,1,33,C-terminal protein lipidation,BP,NTNG1
9006,GO:0035249,0.63060995799488,0.743740717716012,1,31,synaptic transmission, glutamatergic,BP,HTR1B
5117,GO:0015631,0.630904728040411,0.509285714434838,8,275,tubulin binding,MF,NEFM;FEZ1;MYO1B;CRYAB;LYN;SYT11;REEP1;MYH9
14163,GO:0061134,0.63093775253403,0.595235114414593,3,109,peptidase regulator activity,MF,SERPINB2;BIRC3;SERPINH1
1347,GO:0003229,0.631735919992967,0.742637748732804,1,31,ventricular cardiac muscle tissue development,BP,NRG1
11393,GO:0045843,0.632045528097551,0.742145026912304,1,32,negative regulation of striated muscle tissue development,BP,G6PD
5168,GO:0015749,0.632386122264329,0.642013905542988,2,68,monosaccharide transmembrane transport,BP,IL1B;ENPP1
2700,GO:0006091,0.632915710080666,0.492494724431269,10,364,generation of precursor metabolites and energy,BP,PGK1;IL6ST;PHLDA2;THTPA;ACO1;CS;TXNRD1;OXCT1;GBE1;ENPP1
324,GO:0000910,0.632967884376388,0.563711101918716,4,140,cytokinesis,BP,BIRC3;RHOB;CXCR5;MYH9
15476,GO:0071897,0.633206826672989,0.543066326789818,5,178,DNA biosynthetic process,BP,TP53;DUSP1;NBN;HSP90AA1;HSP90AB1
8238,GO:0033044,0.633357962032101,0.506608218021426,8,279,regulation of chromosome organization,BP,TP53;PARP1;IL1B;DUSP1;NBN;SDR16C5;CTR9;PML
15521,GO:0072009,0.63340963252412,0.640922378192135,2,68,nephron epithelium development,BP,DLG1;MAGED1
9659,GO:0038083,0.633817332557597,0.740589773291176,1,31,peptidyl-tyrosine autophosphorylation,BP,LYN
3310,GO:0007033,0.633858244594552,0.562700367462425,4,142,vacuole organization,BP,FEZ1;UBQLN2;GNPTAB;UBXN2B
17592,GO:1901343,0.634594948011529,0.639655647579119,2,68,negative regulation of vasculature development,BP,PGK1;PML
17447,GO:1900408,0.635387482631995,0.738667521478413,1,33,negative regulation of cellular response to oxidative stress,BP,SOD2
18255,GO:1903202,0.635387482631995,0.738667521478413,1,33,negative regulation of oxidative stress-induced cell death,BP,SOD2
9319,GO:0035861,0.635515917539875,0.738719061247126,1,32,site of double-strand break,CC,NBN
17786,GO:1901985,0.635718300802825,0.738339172182777,1,33,positive regulation of protein acetylation,BP,IL1B
9802,GO:0042058,0.636813978164512,0.637150603116234,2,70,regulation of epidermal growth factor receptor signaling pathway,BP,MMP9;TGFA
8091,GO:0032801,0.636868661820489,0.737374702395648,1,32,receptor catabolic process,BP,NEDD4
17934,GO:1902373,0.636929663978854,0.737313959784646,1,32,negative regulation of mRNA catabolic process,BP,NOCT
8288,GO:0033146,0.637156582134652,0.73708791711906,1,32,regulation of intracellular estrogen receptor signaling pathway,BP,PARP1
5763,GO:0017004,0.637608947417247,0.736287546874985,1,34,cytochrome complex assembly,BP,UQCC1
16178,GO:0090263,0.637707764855791,0.587859719643108,3,110,positive regulation of canonical Wnt signaling pathway,BP,NFKB1;PSMB9;BAMBI
5457,GO:0016409,0.638886432309853,0.735179430451915,1,33,palmitoyltransferase activity,MF,ZDHHC6
9853,GO:0042158,0.639474149336666,0.585930876516237,3,110,lipoprotein biosynthetic process,BP,SVIP;NTNG1;ZDHHC6
8898,GO:0034767,0.63991937021676,0.633803734226273,2,70,positive regulation of ion transmembrane transport,BP,STAC;G6PD
16938,GO:0099024,0.639996238809536,0.734066001158039,1,33,plasma membrane invagination,BP,MYH9
9890,GO:0042267,0.640110882676497,0.733780314391331,1,34,natural killer cell mediated cytotoxicity,BP,PVR
7156,GO:0031057,0.64064089640743,0.73359917202978,1,32,negative regulation of histone modification,BP,SDR16C5
17967,GO:1902476,0.640665093733401,0.733574826166627,1,32,chloride transmembrane transport,BP,CLCC1
8067,GO:0032774,0.640752356903454,0.406280317439935,89,2998,RNA biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
2354,GO:0005484,0.640803263594936,0.733083399294547,1,34,SNAP receptor activity,MF,SEC22A
15747,GO:0072401,0.641266041375972,0.63222654349752,2,72,signal transduction involved in DNA integrity checkpoint,BP,TP53;PML
15751,GO:0072422,0.641266041375972,0.63222654349752,2,72,signal transduction involved in DNA damage checkpoint,BP,TP53;PML
8363,GO:0033293,0.6419208633383,0.731955662918461,1,34,monocarboxylic acid binding,MF,NR2F2
1461,GO:0003729,0.642945932270723,0.532402143407676,5,180,mRNA binding,MF,TP53;NOCT;ACO1;CALR;RBMS3
10553,GO:0043550,0.643292419035564,0.730921652170023,1,32,regulation of lipid kinase activity,BP,LYN
13473,GO:0055085,0.643350651924599,0.436799685950917,25,866,transmembrane transport,BP,MMP9;NETO1;PSMB9;SLC16A9;SPNS2;IL1B;STAC;ITGAV;LYN;G6PD;SLC8A1;NEDD4L;KCNQ5;SLC7A5P2;CLCC1;STEAP4;ANO4;SEL1L;SLC39A14;SLC35B1;MAGT1;DLG1;NEDD4;ENPP1;HSPD1
12261,GO:0048635,0.643888292854561,0.730134125197825,1,33,negative regulation of muscle organ development,BP,G6PD
1460,GO:0003727,0.644147841810278,0.629153686530365,2,71,single-stranded RNA binding,MF,ANXA1;RBMS3
17750,GO:1901862,0.644271533767251,0.729744669004897,1,33,negative regulation of muscle tissue development,BP,G6PD
8242,GO:0033048,0.644291699695907,0.729551755764867,1,34,negative regulation of mitotic sister chromatid segregation,BP,DUSP1
17900,GO:1902275,0.644314388196724,0.551277587254221,4,141,regulation of chromatin organization,BP,TP53;IL1B;SDR16C5;CTR9
17660,GO:1901605,0.64464107995562,0.550791057329388,4,147,alpha-amino acid metabolic process,BP,ARG1;EGLN1;IVD;BCAT1
7674,GO:0032153,0.644664331320189,0.628651582132589,2,70,cell division site,CC,RHOB;MYH9
12841,GO:0051216,0.644674271698765,0.580351456577849,3,106,cartilage development,BP,OSR2;EDN1;SERPINH1
6201,GO:0019752,0.645121271439932,0.441755434494016,21,746,carboxylic acid metabolic process,BP,NFKB1;EDN1;PSMB9;NAGK;PGK1;IL1B;MGLL;FADS1;ANXA1;FADS3;XBP1;ARG1;EGLN1;ACO1;CS;HAS2;IVD;MSMO1;MGST3;BCAT1;CYP1A1
11380,GO:0045824,0.645280377035306,0.728544621792389,1,34,negative regulation of innate immune response,BP,ARG1
3576,GO:0008016,0.645284655593941,0.579645106794413,3,107,regulation of heart contraction,BP,EDN1;SLC8A1;DLG1
16626,GO:0097553,0.645380279309862,0.627870156972882,2,70,calcium ion transmembrane import into cytosol,BP,LYN;SLC8A1
13871,GO:0060563,0.645554059085428,0.728438336726389,1,33,neuroepithelial cell differentiation,BP,SOX11
16098,GO:0090150,0.645685718952439,0.502485461269565,7,266,establishment of protein localization to membrane,BP,KRT18;TP53;PMAIP1;OPTN;HSP90AA1;REEP1;ZDHHC6
14089,GO:0060996,0.646041838901129,0.627210089712484,2,69,dendritic spine development,BP,SDK1;NRG1
6193,GO:0019730,0.646278081930675,0.726924243709386,1,38,antimicrobial humoral response,BP,RNASE7
3734,GO:0008289,0.647059210025309,0.462279599607538,13,455,lipid binding,MF,RNASE7;MYO1B;APOL6;AXL;ANXA8;LYN;ANXA1;PLEKHA2;SYT11;DAPP1;NR2F2;CLINT1;HSPD1
11252,GO:0045599,0.648003151711149,0.725930866137059,1,33,negative regulation of fat cell differentiation,BP,ENPP1
8634,GO:0034219,0.648296170424691,0.624676585118995,2,70,carbohydrate transmembrane transport,BP,IL1B;ENPP1
3781,GO:0008376,0.648321811850269,0.725603358789636,1,33,acetylgalactosaminyltransferase activity,MF,GALNT14
12482,GO:0050662,0.648602086159305,0.511074785019677,6,220,coenzyme binding,MF,PARP1;G6PD;EGLN1;TXNRD1;TYW1;IVD
10834,GO:0044390,0.648887454876504,0.725021299321532,1,33,ubiquitin-like protein conjugating enzyme binding,MF,DCUN1D3
12876,GO:0051262,0.648922201010604,0.575374647994727,3,115,protein tetramerization,BP,TP53;SYT11;SOD2
1856,GO:0004532,0.648974455852583,0.724757116483202,1,34,exoribonuclease activity,MF,NOCT
4637,GO:0010799,0.649128164383231,0.724773327184683,1,33,regulation of peptidyl-threonine phosphorylation,BP,RIPK2
16310,GO:0090630,0.649497711453602,0.62341873111854,2,69,activation of GTPase activity,BP,CORO1C;EPHA2
6042,GO:0019208,0.649887444301247,0.622805034518003,2,72,phosphatase regulator activity,MF,IGFBP3;UBXN2B
14105,GO:0061024,0.650885628610283,0.439843238568082,19,665,membrane organization,BP,TP53;PMAIP1;ACTG1;ANXA1;SYT11;HSP90AA1;IL7R;CALR;ANO4;SERP1;SEC22A;DLG1;SEC24D;REEP1;TGFA;TFRC;UBXN2B;MYH9;TOR1AIP1
7422,GO:0031572,0.651305347895925,0.722522930103801,1,33,G2 DNA damage checkpoint,BP,NBN
5727,GO:0016893,0.651582138454847,0.721894439480715,1,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,POP4
12234,GO:0048565,0.652080755303581,0.620505083819551,2,70,digestive tract development,BP,SOX11;CYP1A1
7051,GO:0030858,0.652446032386926,0.721162276662238,1,34,positive regulation of epithelial cell differentiation,BP,TRIM16
4061,GO:0009132,0.652486441311002,0.571558857828218,3,110,nucleoside diphosphate metabolic process,BP,PGK1;TJP2;DLG1
12088,GO:0048194,0.652666676697484,0.619734810928384,2,72,Golgi vesicle budding,BP,SEC24D;TGFA
6052,GO:0019219,0.652940023895411,0.39228880288248,97,3267,regulation of nucleobase-containing compound metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;PRR5L;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;TFRC;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
5556,GO:0016592,0.653210052258971,0.720200134188079,1,35,mediator complex,CC,MED18
12129,GO:0048284,0.653442601145055,0.541069144559432,4,145,organelle fusion,BP,ANXA1;SYT11;CALR;SEC22A
1580,GO:0004003,0.653653492154186,0.720080563803513,1,33,ATP-dependent DNA helicase activity,MF,NBN
3508,GO:0007498,0.653677374174702,0.618674351789834,2,71,mesoderm development,BP,CITED2;TXNRD1
132,GO:0000278,0.655253313263244,0.422656194485982,26,907,mitotic cell cycle,BP,CDKN2A;IL1A;EDN1;TP53;PSMB9;CDKN2B;NABP1;OPTN;IL1B;CYLD;DUSP1;ANXA1;NBN;BIRC3;RHOB;HSP90AA1;DCUN1D3;AJUBA;DLG1;TGFA;SUGT1;BCAT1;CDK6;TUBB3;PML;CYP1A1
4046,GO:0009112,0.655476761948038,0.71782822640854,1,35,nucleobase metabolic process,BP,GDA
13937,GO:0060688,0.655673109125608,0.717789483105815,1,34,regulation of morphogenesis of a branching structure,BP,MAGED1
3238,GO:0006914,0.656107617948142,0.456766601284097,12,428,autophagy,BP,FEZ1;TP53;UBQLN2;RIPK2;OPTN;XBP1;HMOX1;HSP90AA1;EIF4G2;SVIP;UBXN2B;NEDD4
14451,GO:0061919,0.656107617948142,0.456766601284097,12,428,process utilizing autophagic mechanism,BP,FEZ1;TP53;UBQLN2;RIPK2;OPTN;XBP1;HMOX1;HSP90AA1;EIF4G2;SVIP;UBXN2B;NEDD4
5721,GO:0016887,0.656246587247942,0.467236611090345,10,349,ATPase activity,MF,MYO1B;HSPA5;HSPA6;FIGN;ANXA1;NBN;HSP90AA1;NLRP10;MYH9;HSPD1
6264,GO:0019886,0.656270131502424,0.615671136981816,2,73,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,CANX;SEC24D
13474,GO:0055086,0.656373228162599,0.44479802539281,15,547,nucleobase-containing small molecule metabolic process,BP,NAGK;PGK1;PARP1;TJP2;GPR176;G6PD;UGGT1;PAPSS2;EGLN1;MOCS2;DLG1;GDA;TXNRD1;EPHA2;ENPP1
3486,GO:0007405,0.656410668522265,0.717192392032419,1,33,neuroblast proliferation,BP,VEGFC
566,GO:0001708,0.657163738024044,0.716221334413181,1,34,cell fate specification,BP,NRP1
17647,GO:1901566,0.657251846120809,0.404603076253841,43,1520,organonitrogen compound biosynthetic process,BP,IL1A;TNIP1;NFKB1;B4GALT1;CHAC1;PGK1;HS3ST1;PARP1;IL1B;STT3A;ITGAV;GPR176;DERL3;ARG1;UGGT1;PAPSS2;ACO1;EIF4G2;UQCC1;CALR;AJUBA;MGAT5;SERP1;EIF2B1;ORMDL1;MAGT1;MOCS2;RBMS3;DHDDS;HAS2;MGST3;DNAJC3;BCAT1;SVIP;NTNG1;ZDHHC6;MRPS24;GALNT14;SOX11;UGCG;MRPL53;RPL26L1;SDF2L1
18105,GO:1902883,0.65784463184235,0.715334509322303,1,35,negative regulation of response to oxidative stress,BP,SOD2
9346,GO:0035904,0.657954998909486,0.715565016852618,1,33,aorta development,BP,LOX
13237,GO:0051965,0.657958190873982,0.715561646019971,1,33,positive regulation of synapse assembly,BP,ADGRL3
16276,GO:0090503,0.658379381609284,0.714769070494266,1,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,NOCT
5688,GO:0016836,0.659504372162268,0.713417180282297,1,36,hydro-lyase activity,MF,ACO1
17211,GO:0120034,0.659712259466323,0.611878250953052,2,72,positive regulation of plasma membrane bounded cell projection assembly,BP,DPYSL3;NRP1
7867,GO:0032456,0.661279836857645,0.711857370759263,1,34,endocytic recycling,BP,EHD1
3411,GO:0007215,0.661509227885449,0.711612697260198,1,34,glutamate receptor signaling pathway,BP,NETO1
4114,GO:0009190,0.661798987984329,0.711133327429047,1,35,cyclic nucleotide biosynthetic process,BP,GPR176
13342,GO:0052652,0.661798987984329,0.711133327429047,1,35,cyclic purine nucleotide metabolic process,BP,GPR176
5335,GO:0016125,0.661832941766806,0.561024185045704,3,111,sterol metabolic process,BP,G6PD;HMGCS1;MSMO1
1019,GO:0002532,0.662028770448637,0.710887783048863,1,35,production of molecular mediator involved in inflammatory response,BP,LYN
3568,GO:0007631,0.662492851223095,0.71039139111408,1,35,feeding behavior,BP,HTR1B
870,GO:0002228,0.662926574647551,0.709765891415248,1,36,natural killer cell mediated immunity,BP,PVR
154,GO:0000313,0.662952484310416,0.607613275150264,2,84,organellar ribosome,CC,MRPS24;MRPL53
2494,GO:0005761,0.662952484310416,0.607613275150264,2,84,mitochondrial ribosome,CC,MRPS24;MRPL53
6199,GO:0019748,0.663189736338698,0.709483676079251,1,36,secondary metabolic process,BP,CYP1A1
5657,GO:0016787,0.663504439145175,0.392719512075721,53,1822,hydrolase activity,MF,MMP9;ASPRV1;DUSP8;DPYSL3;PSMB9;RNASE7;MYO1B;HSPA5;ANPEP;HSPA6;NOCT;MGLL;ERAP1;CYLD;DUSP1;FIGN;PLBD1;NCEH1;C1R;ANXA1;PDE1C;NBN;THTPA;RHOB;ARG1;SEC11C;SUDS3;HMOX1;MMP19;KLK6;HSP90AA1;TPP2;SETX;POP4;PREP;ADAM8;EYA3;RRAS2;RAB30;ARHGDIB;MME;DLG1;NGLY1;GDA;NLRP10;TUBB3;MYH9;GBE1;CPPED1;ENPP1;HSPD1;SND1;TMPPE
12481,GO:0050661,0.663550165989706,0.709096815849195,1,36,NADP binding,MF,G6PD
414,GO:0001102,0.663686441180922,0.709111758609284,1,35,RNA polymerase II activating transcription factor binding,MF,JUN
13364,GO:0052742,0.663991053403198,0.7091370588653,1,33,phosphatidylinositol kinase activity,MF,FGF5
13077,GO:0051653,0.66417205386498,0.708761038776256,1,34,spindle localization,BP,MYH9
10328,GO:0043175,0.66423599225959,0.70852116528412,1,35,RNA polymerase core enzyme binding,MF,CTR9
4568,GO:0010676,0.664516500513092,0.708390623520588,1,34,positive regulation of cellular carbohydrate metabolic process,BP,PMAIP1
11617,GO:0046390,0.665264019806309,0.507458089173609,5,187,ribose phosphate biosynthetic process,BP,PGK1;PARP1;GPR176;G6PD;PAPSS2
8660,GO:0034308,0.666383518950588,0.706042177503534,1,36,primary alcohol metabolic process,BP,SDR16C5
8240,GO:0033046,0.666713332096398,0.705685042312187,1,36,negative regulation of sister chromatid segregation,BP,DUSP1
13250,GO:0051985,0.666713332096398,0.705685042312187,1,36,negative regulation of chromosome segregation,BP,DUSP1
9442,GO:0036092,0.667192824662562,0.705683408273687,1,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF5
14183,GO:0061178,0.667644936834126,0.70467449384291,1,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,OXCT1
2185,GO:0005070,0.668053590769743,0.704393484791672,1,35,SH3/SH2 adaptor activity,MF,CNTNAP1
7862,GO:0032451,0.668368625348919,0.704223837013593,1,34,demethylase activity,MF,CYP1A1
4165,GO:0009259,0.668530785102006,0.453571026421594,10,372,ribonucleotide metabolic process,BP,PGK1;PARP1;TJP2;GPR176;PAPSS2;EGLN1;MOCS2;DLG1;EPHA2;ENPP1
6274,GO:0019902,0.66855433989703,0.524035023817073,4,145,phosphatase binding,MF,TP53;TRAF3;DLG1;HSP90B1
447,GO:0001221,0.668753272773233,0.703632212752644,1,35,transcription cofactor binding,MF,TP53
10146,GO:0042769,0.668959335331292,0.703089713265936,1,37,DNA damage response, detection of DNA damage,BP,PARP1
16341,GO:0090734,0.669181948844528,0.703165070138056,1,35,site of DNA damage,CC,NBN
6732,GO:0030173,0.669626100171722,0.702516733234129,1,36,integral component of Golgi membrane,CC,SLC35B1
1178,GO:0002832,0.669713308547503,0.702421478019674,1,36,negative regulation of response to biotic stimulus,BP,TRIB1
12144,GO:0048306,0.669775070571458,0.702199142544621,1,37,calcium-dependent protein binding,MF,ANXA1
4008,GO:0009057,0.669781843000511,0.399995914891096,32,1127,macromolecule catabolic process,BP,TP53;PMAIP1;PSMB9;UBQLN2;HERPUD1;HSPA5;IL1B;DNAJB9;DNAJC10;NOCT;CYLD;TRIB1;DERL3;NEDD4L;XBP1;UGGT1;HSP90AA1;NRG1;HSP90AB1;ADAM8;SEL1L;PRR5L;NGLY1;PTTG1IP;DNAJC3;HSP90B1;SVIP;UBXN2B;NEDD4;PML;SND1;SDF2L1
17687,GO:1901657,0.670044672363764,0.55151894558962,3,116,glycosyl compound metabolic process,BP,TJP2;MOCS2;DLG1
17068,GO:0101003,0.670058756421223,0.702043928213372,1,36,ficolin-1-rich granule membrane,CC,ADAM8
2814,GO:0006296,0.670102125302848,0.701841516609833,1,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,PARP1
1004,GO:0002495,0.670296766950191,0.599699990759192,2,75,antigen processing and presentation of peptide antigen via MHC class II,BP,CANX;SEC24D
336,GO:0000932,0.670417397256362,0.59956174733419,2,75,P-body,CC,NOCT;AJUBA
12270,GO:0048645,0.670439405427692,0.701627486001397,1,36,animal organ formation,BP,CITED2
3569,GO:0007632,0.670525530008549,0.701697312102738,1,35,visual behavior,BP,NETO1
15851,GO:0072659,0.671262272643078,0.500723865332693,5,183,protein localization to plasma membrane,BP,KRT18;OPTN;STAC;DLG1;EPHA2
10938,GO:0044743,0.672044495380999,0.699563414155604,1,38,protein transmembrane import into intracellular organelle,BP,HSPD1
10321,GO:0043167,0.672554505203124,0.368279934339467,131,4374,ion binding,MF,RPTN;MMP9;IL1A;FLG2;TRIM16;TCHH;SAA1;OSR2;LCP1;B4GALT1;TP53;DPYSL3;FLG;NAGK;SLIT2;PGK1;MYO1B;PEG10;CCBE1;ZNF165;RIPK2;PARP1;OPTN;HRNR;HSPA5;MSRB3;ANPEP;EFHD2;CRYAB;AXL;ACTG1;CREB5;HSPA6;NOCT;IKBKE;ERAP1;CYLD;FBN2;STAC;ANXA8;FIGN;STT3A;ITGAV;LYN;C1R;ANXA1;PDE1C;SLC8A1;PLEKHA2;THTPA;BIRC3;RHOB;ARG1;TRAF3;CSRP1;HMOX1;MMP19;SYT11;ZNF638;PAPSS2;FRAS1;HEPHL1;RIMS2;HSP90AA1;CANX;FTH1;DAPP1;NRP1;TRAF1;EGLN1;SETX;GNPTAB;SOD2;ZNF132;KLF10;ACO1;ZNF697;HSP90AB1;SNAI3;ADAM8;NR2F2;STEAP4;MOB3A;CALR;AJUBA;IGFBP3;EYA3;ZCCHC8;RRAS2;RAB30;GIT2;NID2;MME;TRMT44;NGLY1;GDA;EHD1;ZMYM4;LOX;ZNF814;TXNRD1;ADGRL3;TYW1;SEC24D;CALU;IVD;MSMO1;CHORDC1;CBLL1;RSPRY1;ZC3H7B;HSP90B1;ZFP42;NLRP10;HTR1B;CDK6;TUBB3;PML;EPHA2;MYH9;GALNT14;TRIM47;ZBTB21;GBE1;CPPED1;ENPP1;TPM4;HSPD1;IRAK2;CYP1A1;TMPPE
8112,GO:0032835,0.672644033867302,0.699371837828439,1,35,glomerulus development,BP,COL4A4
17800,GO:1902017,0.672727150375451,0.699115311993722,1,36,regulation of cilium assembly,BP,CYLD
2285,GO:0005267,0.674066590827883,0.697637032912501,1,36,potassium channel activity,MF,KCNQ5
5063,GO:0015318,0.674666654671851,0.441221202145281,11,395,inorganic molecular entity transmembrane transporter activity,MF,SLC16A9;ITGAV;SLC8A1;KCNQ5;SLC7A5P2;CLCC1;ANO4;SLC39A14;MAGT1;DLG1;TFRC
5589,GO:0016651,0.675088527495882,0.593778333721279,2,83,oxidoreductase activity, acting on NAD(P)H,MF,PGK1;TXNRD1
16121,GO:0090183,0.675528691091301,0.696017074529994,1,36,regulation of kidney development,BP,MAGED1
3553,GO:0007612,0.676229432339987,0.59291997245394,2,74,learning,BP,NETO1;JUN
15067,GO:0071158,0.676336397935925,0.592629363393966,2,77,positive regulation of cell cycle arrest,BP,TP53;PML
8652,GO:0034260,0.676504549119829,0.69493217949597,1,36,negative regulation of GTPase activity,BP,SLIT2
10571,GO:0043583,0.676631384162458,0.544077533048369,3,111,ear development,BP,OSR2;MAFB;EDN1
17208,GO:0120031,0.676814372893343,0.433983776015569,12,428,plasma membrane bounded cell projection assembly,BP,DPYSL3;SLIT2;IFT46;CYLD;HSP90AA1;NRP1;AJUBA;CORO1C;EHD1;EPHA2;CEP83;PARVA
14543,GO:0070125,0.677158828017797,0.591245461046386,2,86,mitochondrial translational elongation,BP,MRPS24;MRPL53
10466,GO:0043401,0.677521240612746,0.513698976761533,4,148,steroid hormone mediated signaling pathway,BP,PARP1;NR2F2;CALR;NEDD4
4010,GO:0009059,0.677540263395366,0.363828646890875,121,4109,macromolecule biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PSMB9;EPCAM;CDKN2B;NABP1;HS3ST1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;STT3A;ITGAV;DERL3;NBN;WWC1;NEDD4L;NOC3L;XBP1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;MGAT5;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MGA;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;DHDDS;ETS1;HAS2;TGFA;BAMBI;DNAJC3;ZFP42;NLRP10;SVIP;NEDD4;NTNG1;ZDHHC6;PML;MRPS24;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1
1041,GO:0002576,0.677542221953313,0.591283815169582,2,76,platelet degranulation,BP,LYN;VEGFC
7401,GO:0031514,0.677625810192995,0.591186673137363,2,76,motile cilium,CC,IFT46;ANXA1
1007,GO:0002504,0.678002979060881,0.590748151475308,2,76,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,CANX;SEC24D
5782,GO:0017053,0.678219324445015,0.590609314793523,2,74,transcriptional repressor complex,CC,JUN;SDR16C5
3289,GO:0007005,0.678576708669716,0.427682454186554,13,485,mitochondrion organization,BP,MMP9;FEZ1;TP53;PMAIP1;JUN;PARP1;OPTN;HSP90AA1;SOD2;NRG1;UQCC1;UGCG;HSPD1
4410,GO:0010256,0.678611111504901,0.442406653249414,10,360,endomembrane system organization,BP,OPTN;ANXA8;SYT11;ANO4;SERP1;RAB30;REEP1;PDE4DIP;UBXN2B;TOR1AIP1
3592,GO:0008047,0.678679527718877,0.436765021431461,11,393,enzyme activator activity,MF,CXCL1;DNAJB1;JUN;DNAJC10;NRP1;NRG1;STXBP5;IGFBP3;ARHGDIB;GIT2;TOR1AIP1
6713,GO:0030148,0.678688239066593,0.589950604595706,2,76,sphingolipid biosynthetic process,BP,ORMDL1;UGCG
1528,GO:0003924,0.678843014504004,0.477103110649943,6,227,GTPase activity,MF,RHOB;RRAS2;RAB30;ARHGDIB;NLRP10;TUBB3
1449,GO:0003707,0.679339276965859,0.691763926824261,1,36,steroid hormone receptor activity,MF,NR2F2
11971,GO:0047496,0.679455755887264,0.691633206886996,1,36,vesicle transport along microtubule,BP,AP3M1
7184,GO:0031093,0.679976150043059,0.690889879787494,1,37,platelet alpha granule lumen,CC,VEGFC
3441,GO:0007269,0.68020749032604,0.588234437470439,2,75,neurotransmitter secretion,BP,SYT11;RIMS2
17061,GO:0099643,0.68020749032604,0.588234437470439,2,75,signal release from synapse,BP,SYT11;RIMS2
5904,GO:0018198,0.680690094437624,0.689935670849477,1,38,peptidyl-cysteine modification,BP,ZDHHC6
12866,GO:0051252,0.680791938074345,0.364404868722049,89,3022,regulation of RNA metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;EPCAM;CDKN2B;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;PRR5L;UBP1;IL23A;DLG1;MED18;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
7408,GO:0031529,0.681762074671142,0.688876667465936,1,37,ruffle organization,BP,CORO1C
14103,GO:0061014,0.682002749929334,0.688764160831813,1,36,positive regulation of mRNA catabolic process,BP,PRR5L
17461,GO:1900542,0.68387881335918,0.535540569036049,3,114,regulation of purine nucleotide metabolic process,BP,PARP1;GPR176;EGLN1
11162,GO:0045309,0.684472840109508,0.685962179549221,1,36,protein phosphorylated amino acid binding,MF,NEDD4
16998,GO:0099516,0.684490256722216,0.685942354006569,1,36,ion antiporter activity,MF,SLC8A1
7039,GO:0030837,0.684574760725246,0.685685596787893,1,37,negative regulation of actin filament polymerization,BP,SLIT2
5953,GO:0018410,0.684832717948575,0.685239570770606,1,38,C-terminal protein amino acid modification,BP,NTNG1
6082,GO:0019320,0.685188546673826,0.684833661932683,1,38,hexose catabolic process,BP,PGK1
12366,GO:0048844,0.68558332346532,0.684696168662792,1,36,artery morphogenesis,BP,NRP1
8123,GO:0032873,0.686018992868991,0.68403730307691,1,37,negative regulation of stress-activated MAPK cascade,BP,DLG1
14646,GO:0070303,0.686018992868991,0.68403730307691,1,37,negative regulation of stress-activated protein kinase signaling cascade,BP,DLG1
4998,GO:0015179,0.686347451872718,0.683661504618955,1,37,L-amino acid transmembrane transporter activity,MF,SLC7A5P2
5866,GO:0018023,0.6864698493074,0.683521378207235,1,37,peptidyl-lysine trimethylation,BP,CTR9
18794,GO:1904427,0.686581114295809,0.683393955107696,1,37,positive regulation of calcium ion transmembrane transport,BP,G6PD
14655,GO:0070317,0.686894569356479,0.683034766146054,1,37,negative regulation of G0 to G1 transition,BP,MGA
4658,GO:0010824,0.687564731045151,0.68226576840812,1,37,regulation of centrosome duplication,BP,CHORDC1
13000,GO:0051496,0.687834369983823,0.681955955696547,1,37,positive regulation of stress fiber assembly,BP,NRP1
2419,GO:0005622,0.688268454996231,0.369225547413934,316,10508,intracellular,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;LCE3D;FGF5;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;JUN;KRT4;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;ANPEP;JUNB;TJP2;HSPB8;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;SYT11;KLK6;ZNF638;PAPSS2;UBTD2;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;TNFSF15;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;MOB3A;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;ANO4;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;ZNF814;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;IQCJ-SCHIP1;BAMBI;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;ANKRD13A;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
5246,GO:0015909,0.688857640394024,0.680778096801965,1,37,long-chain fatty acid transport,BP,ANXA1
17994,GO:1902554,0.689007877266873,0.577702694141632,2,78,serine/threonine protein kinase complex,CC,CDK6;HSPD1
8480,GO:0033683,0.689245653433518,0.680031136613356,1,39,nucleotide-excision repair, DNA incision,BP,PARP1
2961,GO:0006518,0.689775067631653,0.393363600668462,21,783,peptide metabolic process,BP,TNIP1;CHAC1;ANPEP;ERAP1;G6PD;SEC11C;HSP90AA1;ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;EIF2B1;MME;RBMS3;DNAJC3;MRPS24;SOX11;MRPL53;RPL26L1
5609,GO:0016706,0.690146160698726,0.679290105531687,1,37,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,EGLN1
6906,GO:0030518,0.690158983396183,0.528144052320759,3,114,intracellular steroid hormone receptor signaling pathway,BP,PARP1;CALR;NEDD4
14544,GO:0070126,0.690396436148679,0.575582515948691,2,88,mitochondrial translational termination,BP,MRPS24;MRPL53
10648,GO:0043933,0.691717590234288,0.365597553595408,47,1665,protein-containing complex subunit organization,BP,NEFL;LCP1;B4GALT1;TP53;DPYSL3;PMAIP1;SLIT2;CLDN1;COL12A1;CLDN7;JUN;PARP1;C1QTNF1;CRYAB;NOCT;IKBKE;CYLD;COBLL1;BIRC3;ARG1;HMOX1;SYT11;KCTD12;HSP90AA1;TRAF1;BRD2;SETX;SOD2;NRG1;SERPINH1;HSP90AB1;UQCC1;CALR;PPID;AJUBA;DLG1;EHD1;LOX;SEC24D;PDE4DIP;TGFA;SVIP;PML;MRPS24;MRPL53;CLINT1;HSPD1
11816,GO:0046834,0.692045187024094,0.574248180050742,2,75,lipid phosphorylation,BP,FGF5;NRG1
12221,GO:0048538,0.692214736667791,0.676890032217598,1,37,thymus development,BP,MAFB
4963,GO:0015103,0.692851930260635,0.573226557612577,2,76,inorganic anion transmembrane transporter activity,MF,CLCC1;ANO4
7043,GO:0030850,0.693074861552844,0.675887962039452,1,37,prostate gland development,BP,ANXA1
3230,GO:0006903,0.693170953024751,0.572735573342592,2,78,vesicle targeting,BP,SEC24D;TGFA
14944,GO:0070897,0.693684099525798,0.674874160802652,1,39,DNA-templated transcriptional preinitiation complex assembly,BP,TP53
7464,GO:0031648,0.695129372390466,0.673328761414361,1,38,protein destabilization,BP,XBP1
18068,GO:1902749,0.695381167924428,0.47273823196847,5,195,regulation of cell cycle G2/M phase transition,BP,TP53;PSMB9;NBN;HSP90AA1;CDK6
792,GO:0002066,0.696723445080891,0.671453849147173,1,38,columnar/cuboidal epithelial cell development,BP,CDK6
4314,GO:0009880,0.697042390417167,0.671234207577959,1,37,embryonic pattern specification,BP,NRP1
5572,GO:0016616,0.697196510525522,0.567643738017328,2,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,G6PD;SDR16C5
3440,GO:0007268,0.697457278767942,0.435103835428494,8,295,chemical synaptic transmission,BP,NETO1;EDN1;IL1B;GPR176;SYT11;RIMS2;DLG1;HTR1B
16895,GO:0098916,0.697457278767942,0.435103835428494,8,295,anterograde trans-synaptic signaling,BP,NETO1;EDN1;IL1B;GPR176;SYT11;RIMS2;DLG1;HTR1B
13787,GO:0060425,0.698756354944595,0.669050560218624,1,38,lung morphogenesis,BP,SOX11
8625,GO:0034198,0.699109276129402,0.668482840910305,1,39,cellular response to amino acid starvation,BP,ATF3
17933,GO:1902369,0.699158979029859,0.668572947953482,1,38,negative regulation of RNA catabolic process,BP,NOCT
8990,GO:0035196,0.699235417601442,0.668482211630477,1,38,production of miRNAs involved in gene silencing by miRNA,BP,ZC3H7B
7926,GO:0032543,0.700544212996797,0.515347041473679,3,129,mitochondrial translation,BP,UQCC1;MRPS24;MRPL53
18520,GO:1903779,0.701518845623926,0.665762640615387,1,38,regulation of cardiac conduction,BP,SLC8A1
8831,GO:0034654,0.701549859425399,0.340952943786,99,3384,nucleobase-containing compound biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;GDA;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
531,GO:0001650,0.701964798120509,0.513920105714762,3,118,fibrillar center,CC,NFKBIE;TXNRD1;BTBD10
3237,GO:0006913,0.702673199183037,0.429054460063774,8,301,nucleocytoplasmic transport,BP,NFKBIA;TP53;IL1B;HSP90AB1;CALR;PTTG1IP;NEDD4;PML
10784,GO:0044306,0.702686613143044,0.561176135722285,2,79,neuron projection terminus,CC,SYT11;MME
5829,GO:0017144,0.703677962092462,0.395871476532405,14,529,drug metabolic process,BP,EDN1;NAGK;PGK1;PARP1;IL1B;FADS1;THTPA;HSP90AA1;ACO1;HSP90AB1;CS;OXCT1;ENPP1;CYP1A1
14236,GO:0061351,0.70369456178527,0.559997614648734,2,78,neural precursor cell proliferation,BP,LYN;VEGFC
13067,GO:0051641,0.703855785940044,0.346063268342666,63,2183,cellular localization,BP,NFKBIA;NEFL;NETO1;LCP1;KRT18;FEZ1;TP53;PMAIP1;HERPUD1;PARP1;OPTN;HSPA5;IL1B;IFT46;CNTNAP1;CRYAB;CYLD;STAC;ANXA8;LYN;AP3M1;DERL3;SLC8A1;WWC1;NEDD4L;RHOB;MOBP;HMOX1;SYT11;RIMS2;HSP90AA1;CANX;FTH1;NRP1;GNPTAB;NRG1;HSP90AB1;CALR;AJUBA;SEL1L;PRR5L;RAB30;SEC22A;DLG1;EHD1;PTTG1IP;SEC24D;REEP1;TGFA;HSP90B1;SVIP;NEDD4;ZDHHC6;PML;OXCT1;EPHA2;EPB41L2;MYH9;TOR1AIP1;UGCG;TNFAIP2;CEP83;HSPD1
12496,GO:0050681,0.703936078211368,0.662713837200343,1,39,androgen receptor binding,MF,CALR
9265,GO:0035735,0.703942279672181,0.662706374570936,1,39,intraciliary transport involved in cilium assembly,BP,IFT46
12446,GO:0050434,0.70407244933532,0.662406547726252,1,40,positive regulation of viral transcription,BP,JUN
8119,GO:0032868,0.704248527729714,0.462352405320664,5,191,response to insulin,BP,PARP1;IL1B;LYN;XBP1;ENPP1
17013,GO:0099537,0.704749953679777,0.426680640284711,8,297,trans-synaptic signaling,BP,NETO1;EDN1;IL1B;GPR176;SYT11;RIMS2;DLG1;HTR1B
5399,GO:0016266,0.705636953117031,0.660662155472667,1,39,O-glycan processing,BP,GALNT14
10001,GO:0042476,0.70604766322559,0.557060011452717,2,79,odontogenesis,BP,OSR2;EDN1
3285,GO:0006998,0.706617425093425,0.556307717378489,2,80,nuclear envelope organization,BP,UBXN2B;TOR1AIP1
2863,GO:0006378,0.707050104727866,0.65895002301751,1,39,mRNA polyadenylation,BP,CTR9
6652,GO:0030031,0.707248490062765,0.39975976844461,12,438,cell projection assembly,BP,DPYSL3;SLIT2;IFT46;CYLD;HSP90AA1;NRP1;AJUBA;CORO1C;EHD1;EPHA2;CEP83;PARVA
9284,GO:0035773,0.707311550664058,0.65848832605894,1,40,insulin secretion involved in cellular response to glucose stimulus,BP,OXCT1
8192,GO:0032970,0.707506152852622,0.432573908263723,7,263,regulation of actin filament-based process,BP,EDN1;SLIT2;RHOB;NRP1;ARHGDIB;DLG1;MYH9
5640,GO:0016763,0.707568231200577,0.65817629229944,1,40,transferase activity, transferring pentosyl groups,MF,PARP1
10696,GO:0044085,0.707746650825884,0.339619149975087,71,2474,cellular component biogenesis,BP,CDKN2A;NEFL;KRT8;DSCAM;LCP1;NEFM;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;SLIT2;CLDN1;UBQLN2;CLDN7;MYO1B;DNAJB1;JUN;PARP1;SDK1;IFT46;CNTNAP1;C1QTNF1;CRYAB;ACTG1;NOCT;IKBKE;CYLD;COBLL1;NBN;BIRC3;RHOB;ARG1;HMOX1;SYT11;KCTD12;HSP90AA1;NRP1;TRAF1;BRD2;SETX;SOD2;POP4;NRG1;HSP90AB1;UQCC1;CALR;PPID;AJUBA;ORMDL1;CORO1C;DLG1;EHD1;LOX;HAS2;ADGRL3;SEC24D;PDE4DIP;TGFA;HSP90B1;SVIP;UBXN2B;PML;EPHA2;RPL26L1;CLINT1;CEP83;HSPD1;TJP1;PARVA
17598,GO:1901362,0.707752442008536,0.333865284374745,103,3526,organic cyclic compound biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;GPR176;G6PD;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MOCS2;MGA;HMGCS1;UBP1;IL23A;DLG1;MED18;GDA;ZMYM4;CITED2;ZNF814;ETS1;MSMO1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
3437,GO:0007265,0.707984208178528,0.409091155623393,10,366,Ras protein signal transduction,BP,CDKN2A;TP53;JUN;RHOB;NRP1;NRG1;RRAS2;RAB30;ARHGDIB;GIT2
7241,GO:0031228,0.708028711845205,0.657615940684598,1,40,intrinsic component of Golgi membrane,CC,SLC35B1
9041,GO:0035306,0.708236391257239,0.657507459448063,1,39,positive regulation of dephosphorylation,BP,HSP90AB1
17012,GO:0099536,0.708514980268057,0.422308071488567,8,298,synaptic signaling,BP,NETO1;EDN1;IL1B;GPR176;SYT11;RIMS2;DLG1;HTR1B
8075,GO:0032784,0.709333876438363,0.656023732104546,1,40,regulation of DNA-templated transcription, elongation,BP,CTR9
14014,GO:0060828,0.709983351690457,0.455472581856514,5,196,regulation of canonical Wnt signaling pathway,BP,NFKB1;PSMB9;CYLD;RBMS3;BAMBI
2729,GO:0006140,0.710274557032045,0.503800396305869,3,119,regulation of nucleotide metabolic process,BP,PARP1;GPR176;EGLN1
14765,GO:0070534,0.710311565653562,0.65482715857595,1,40,protein K63-linked ubiquitination,BP,NEDD4
3618,GO:0008094,0.710498092789814,0.551567559803131,2,79,DNA-dependent ATPase activity,MF,ANXA1;NBN
17010,GO:0099531,0.71084471260878,0.551085693433387,2,80,presynaptic process involved in chemical synaptic transmission,BP,SYT11;RIMS2
8824,GO:0034645,0.712246324188431,0.327533152688786,118,4039,cellular macromolecule biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PSMB9;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;STT3A;DERL3;NBN;WWC1;NEDD4L;NOC3L;XBP1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;MGAT5;EYA3;SERP1;EIF2B1;MAFF;MAGT1;MGA;UBP1;IL23A;DLG1;MED18;RBMS3;ZMYM4;CITED2;ZNF814;DHDDS;ETS1;HAS2;TGFA;BAMBI;DNAJC3;ZFP42;NLRP10;SVIP;NEDD4;NTNG1;ZDHHC6;PML;MRPS24;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1
12811,GO:0051169,0.712410042016371,0.417733913484684,8,304,nuclear transport,BP,NFKBIA;TP53;IL1B;HSP90AB1;CALR;PTTG1IP;NEDD4;PML
565,GO:0001707,0.712528406909169,0.652247530825206,1,39,mesoderm formation,BP,TXNRD1
2304,GO:0005319,0.7126614871193,0.548827933121992,2,80,lipid transporter activity,MF,SPNS2;ANO4
16274,GO:0090501,0.71372472239185,0.499461782971569,3,123,RNA phosphodiester bond hydrolysis,BP,RNASE7;NOCT;POP4
5045,GO:0015276,0.713779887026287,0.650701719937457,1,39,ligand-gated ion channel activity,MF,DLG1
6593,GO:0022834,0.713779887026287,0.650701719937457,1,39,ligand-gated channel activity,MF,DLG1
2804,GO:0006284,0.715736368660803,0.647854705255249,1,42,base-excision repair,BP,TP53
2795,GO:0006270,0.715919862495452,0.647759107608741,1,41,DNA replication initiation,BP,NBN
1447,GO:0003700,0.71597677793535,0.350890193300046,31,1089,DNA binding transcription factor activity,MF,NFKB1;MAFB;RELB;TP53;JUN;ZNF165;NFKB2;ARID3B;PARP1;JUNB;ATF3;CREB5;EHF;NOCT;NOC3L;XBP1;ARNTL2;ZNF132;KLF10;VGLL3;SNAI3;NR2F2;MAFF;MGA;UBP1;ZMYM4;CITED2;ETS1;ZFP42;HES4;SOX11
2178,GO:0005048,0.716210492991606,0.647536712200335,1,40,signal sequence binding,MF,NFKBIA
488,GO:0001541,0.716287257599952,0.647301258678298,1,41,ovarian follicle development,BP,MMP19
487,GO:0001540,0.717062325313701,0.64633379500105,1,41,amyloid-beta binding,MF,CRYAB
5380,GO:0016236,0.717625940826215,0.420620055528633,7,271,macroautophagy,BP,FEZ1;UBQLN2;RIPK2;OPTN;HMOX1;UBXN2B;NEDD4
3745,GO:0008306,0.71763151088418,0.645762130923699,1,40,associative learning,BP,NETO1
282,GO:0000785,0.717805748541146,0.387630727098941,12,457,chromatin,CC,CDKN2A;TP53;JUN;JUNB;SUDS3;SDR16C5;CTR9;CITED2;ZFP42;NEDD4;PML;MAGED1
4767,GO:0010972,0.718623653614988,0.541028017086302,2,87,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB9;NBN
5889,GO:0018130,0.718667634476799,0.322647860350191,100,3433,heterocycle biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MOCS2;MGA;UBP1;IL23A;DLG1;MED18;GDA;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
8120,GO:0032869,0.718746655642124,0.464617011388654,4,157,cellular response to insulin stimulus,BP,PARP1;IL1B;XBP1;ENPP1
3934,GO:0008654,0.719110997834196,0.430093051789421,6,231,phospholipid biosynthetic process,BP,FGF5;FADS1;PLEKHA2;AJUBA;HMGCS1;DHDDS
11316,GO:0045685,0.719542521277717,0.643223542109279,1,41,regulation of glial cell differentiation,BP,IL6ST
11389,GO:0045839,0.720221642144281,0.642233897049391,1,42,negative regulation of mitotic nuclear division,BP,DUSP1
10860,GO:0044437,0.72036418086414,0.384712532939092,12,451,vacuolar part,CC,B4GALT1;SPNS2;HRNR;ANPEP;AP3M1;ARG1;HSP90AA1;HSP90AB1;MAGT1;DNAJC3;CPPED1;ENPP1
9915,GO:0042306,0.720767679340046,0.641679012669504,1,41,regulation of protein import into nucleus,BP,HSP90AB1
9038,GO:0035303,0.72163947633446,0.461077430125723,4,157,regulation of dephosphorylation,BP,HSP90AB1;IGFBP3;HSP90B1;UBXN2B
3299,GO:0007018,0.721857358690125,0.426829458829463,6,229,microtubule-based movement,BP,NEFL;FEZ1;MYO1B;IFT46;AP3M1;MYH9
10341,GO:0043195,0.722496725560407,0.639490024654418,1,41,terminal bouton,CC,SYT11
11228,GO:0045540,0.722611160145572,0.639344767303207,1,41,regulation of cholesterol biosynthetic process,BP,HMGCS1
19145,GO:1905268,0.722657034365842,0.639428181158584,1,40,negative regulation of chromatin organization,BP,SDR16C5
14654,GO:0070316,0.722870348110269,0.639015591616019,1,41,regulation of G0 to G1 transition,BP,MGA
10546,GO:0043543,0.72388560386459,0.438721999583083,5,198,protein acylation,BP,TRIM16;IL1B;SDR16C5;ZDHHC6;SUPT3H
7150,GO:0031050,0.7245878875666,0.636828088302496,1,41,dsRNA fragmentation,BP,ZC3H7B
14956,GO:0070918,0.7245878875666,0.636828088302496,1,41,production of small RNA involved in gene silencing by RNA,BP,ZC3H7B
12047,GO:0048037,0.725664636734769,0.394730532428765,9,352,cofactor binding,MF,PARP1;G6PD;HMOX1;EGLN1;ACO1;TXNRD1;TYW1;IVD;CYP1A1
10600,GO:0043631,0.725772890101321,0.635312550497536,1,41,RNA polyadenylation,BP,CTR9
10873,GO:0044452,0.726450160086748,0.45505272790301,4,163,nucleolar part,CC,NFKBIE;POP4;TXNRD1;BTBD10
7599,GO:0032011,0.728174681278565,0.632368242204842,1,40,ARF protein signal transduction,BP,GIT2
7600,GO:0032012,0.728174681278565,0.632368242204842,1,40,regulation of ARF protein signal transduction,BP,GIT2
4183,GO:0009308,0.728330655920494,0.528589623827311,2,89,amine metabolic process,BP,PSMB9;CYP1A1
7227,GO:0031201,0.729056398744706,0.630819311028425,1,43,SNARE complex,CC,SEC22A
2929,GO:0006473,0.729727686505383,0.451013764189858,4,162,protein acetylation,BP,TRIM16;IL1B;SDR16C5;SUPT3H
6285,GO:0019932,0.729844233741062,0.45090403312735,4,160,second-messenger-mediated signaling,BP,EDN1;SLC8A1;RIMS2;NRG1
1240,GO:0003002,0.729851532286091,0.431465266512533,5,197,regionalization,BP,MAFB;EDN1;NRP1;NR2F2;CITED2
4287,GO:0009755,0.730195643568067,0.45048569993564,4,159,hormone-mediated signaling pathway,BP,PARP1;NR2F2;CALR;NEDD4
12152,GO:0048332,0.7313033554396,0.628170848523167,1,41,mesoderm morphogenesis,BP,TXNRD1
3061,GO:0006644,0.731697973608799,0.3876726711928,9,343,phospholipid metabolic process,BP,FGF5;FADS1;PLBD1;LYN;PLEKHA2;NRG1;AJUBA;HMGCS1;DHDDS
10581,GO:0043603,0.731885443076214,0.341629993984299,24,907,cellular amide metabolic process,BP,TNIP1;CHAC1;ANPEP;ERAP1;G6PD;ARG1;SEC11C;HSP90AA1;ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;EIF2B1;ORMDL1;MME;RBMS3;DNAJC3;MRPS24;SOX11;UGCG;MRPL53;RPL26L1
11009,GO:0045023,0.732111657649767,0.626980037913693,1,42,G0 to G1 transition,BP,MGA
5301,GO:0016042,0.732191428406966,0.428536458884348,5,202,lipid catabolic process,BP,IL1B;MGLL;PLBD1;NCEH1;IVD
1773,GO:0004407,0.7322592111333,0.626787446399908,1,42,histone deacetylase activity,MF,SUDS3
11585,GO:0046324,0.73228323489049,0.62689359241212,1,41,regulation of glucose import,BP,ENPP1
16776,GO:0098687,0.732452032022158,0.394065555002767,8,312,chromosomal region,CC,NABP1;PARP1;NBN;SETX;GPATCH11;SUGT1;PML;EID3
11663,GO:0046488,0.7333632908948,0.446544646207305,4,159,phosphatidylinositol metabolic process,BP,FGF5;PLBD1;PLEKHA2;NRG1
5658,GO:0016788,0.733379242106231,0.358842838410372,15,559,hydrolase activity, acting on ester bonds,MF,DUSP8;RNASE7;NOCT;MGLL;DUSP1;PLBD1;NCEH1;PDE1C;HMOX1;POP4;EYA3;DLG1;CPPED1;ENPP1;SND1
18645,GO:1904035,0.734764062633901,0.623505487701288,1,42,regulation of epithelial cell apoptotic process,BP,HMOX1
8114,GO:0032838,0.734952512084666,0.472901128837477,3,123,plasma membrane bounded cell projection cytoplasm,CC,NEFL;AP3M1;CANX
5768,GO:0017016,0.7353409298569,0.372002851614722,11,403,Ras GTPase binding,MF,NEFL;FGF5;OPTN;AP3M1;MOBP;RIMS2;NRG1;STXBP5;ARHGDIB;CORO1C;EHD1
12023,GO:0048008,0.7354388192267,0.622755697417256,1,41,platelet-derived growth factor receptor signaling pathway,BP,NRP1
7392,GO:0031497,0.735487718198547,0.471952272975189,3,134,chromatin assembly,BP,CDKN2A;TP53;BRD2
17267,GO:0140110,0.73555088199668,0.322128383876328,40,1408,transcription regulator activity,MF,NFKB1;MAFB;RELB;TP53;DNAJB1;JUN;ZNF165;NFKB2;ARID3B;PARP1;JUNB;ATF3;CREB5;EHF;NOCT;WWC1;NOC3L;XBP1;ARNTL2;ZNF132;KLF10;NRG1;VGLL3;SDR16C5;SNAI3;NR2F2;AJUBA;MAFF;MGA;UBP1;MED18;ZMYM4;CITED2;ETS1;ZFP42;HES4;SOX11;SND1;MAGED1;SUPT3H
12604,GO:0050848,0.736221620643549,0.621452698884048,1,43,regulation of calcium-mediated signaling,BP,NRG1
16227,GO:0090329,0.737618723577159,0.619603663119633,1,43,regulation of DNA-dependent DNA replication,BP,NBN
2390,GO:0005548,0.738048535240871,0.619165853143099,1,42,phospholipid transporter activity,MF,ANO4
14371,GO:0061695,0.738173503981198,0.406990881915312,6,240,transferase complex, transferring phosphorus-containing groups,CC,TP53;CTR9;MED18;CDK6;HSPD1;SUPT3H
6659,GO:0030041,0.739026472673087,0.46764363283151,3,125,actin filament polymerization,BP,SLIT2;COBLL1;DLG1
7015,GO:0030808,0.739277483555369,0.514543207975932,2,85,regulation of nucleotide biosynthetic process,BP,PARP1;GPR176
17437,GO:1900371,0.739277483555369,0.514543207975932,2,85,regulation of purine nucleotide biosynthetic process,BP,PARP1;GPR176
12582,GO:0050806,0.739756574155295,0.513960671852168,2,84,positive regulation of synaptic transmission,BP,NETO1;RIMS2
3306,GO:0007029,0.739946577266514,0.616506113186123,1,43,endoplasmic reticulum organization,BP,REEP1
13066,GO:0051640,0.740326237467559,0.35401671696406,14,523,organelle localization,BP,NEFL;FEZ1;LYN;AP3M1;MOBP;HMOX1;SYT11;RIMS2;HSP90AA1;DLG1;SEC24D;TGFA;MYH9;CEP83
8414,GO:0033558,0.740667978813918,0.615541925329034,1,43,protein deacetylase activity,MF,SUDS3
2546,GO:0005840,0.740974157101576,0.417448624747789,5,225,ribosome,CC,CANX;SERP1;MRPS24;MRPL53;RPL26L1
7716,GO:0032233,0.741144283409929,0.614904212068503,1,43,positive regulation of actin filament bundle assembly,BP,NRP1
17488,GO:1901019,0.741297771366413,0.614698522278282,1,43,regulation of calcium ion transmembrane transporter activity,BP,STAC
15876,GO:0072698,0.741351929091785,0.614759313793017,1,42,protein localization to microtubule cytoskeleton,BP,CEP83
17237,GO:0140014,0.742094863711402,0.402200089241311,6,239,mitotic nuclear division,BP,IL1A;EDN1;IL1B;DUSP1;BIRC3;TGFA
1470,GO:0003777,0.742264906203761,0.510751673693647,2,82,microtubule motor activity,MF,MYO1B;MYH9
16067,GO:0090090,0.743088525356729,0.46231832780062,3,129,negative regulation of canonical Wnt signaling pathway,BP,PSMB9;CYLD;RBMS3
6690,GO:0030119,0.743758365536083,0.611388489840231,1,43,AP-type membrane coat adaptor complex,CC,AP3M1
10038,GO:0042562,0.743862109138169,0.611120536726041,1,44,hormone binding,MF,CALR
6964,GO:0030660,0.744585529657025,0.507439916750352,2,87,Golgi-associated vesicle membrane,CC,SEC24D;TGFA
4094,GO:0009166,0.745436919687901,0.459329655591671,3,127,nucleotide catabolic process,BP,PGK1;EGLN1;GDA
8724,GO:0034404,0.745466944157578,0.431164606878645,4,168,nucleobase-containing small molecule biosynthetic process,BP,PGK1;EGLN1;GDA;ENPP1
18234,GO:1903146,0.745871325794684,0.608398722338234,1,44,regulation of autophagy of mitochondrion,BP,OPTN
16506,GO:0097306,0.746278578226581,0.608108175528757,1,42,cellular response to alcohol,BP,HMGCS1
453,GO:0001227,0.74669911523833,0.429681505562507,4,163,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NFKB1;ATF3;SNAI3;ZFP42
3076,GO:0006665,0.746901635166848,0.457428923591082,3,127,sphingolipid metabolic process,BP,SPNS2;ORMDL1;UGCG
2945,GO:0006493,0.747188582435548,0.50401830077343,2,86,protein O-linked glycosylation,BP,GALNT14;SDF2L1
7086,GO:0030902,0.748609463864419,0.502164445629361,2,85,hindbrain development,BP,MAFB;HSPA5
3228,GO:0006900,0.748730617058845,0.501910463510873,2,87,vesicle budding from membrane,BP,SEC24D;TGFA
11609,GO:0046365,0.749088459915424,0.603765905110311,1,46,monosaccharide catabolic process,BP,PGK1
2423,GO:0005637,0.7494838221069,0.603464589550821,1,44,nuclear inner membrane,CC,TOR1AIP1
8180,GO:0032956,0.749696192380367,0.392829843238732,6,239,regulation of actin cytoskeleton organization,BP,EDN1;SLIT2;RHOB;NRP1;ARHGDIB;DLG1
3189,GO:0006839,0.75045796860399,0.39179698784244,6,249,mitochondrial transport,BP,TP53;PMAIP1;HSP90AA1;NRG1;UGCG;HSPD1
7262,GO:0031267,0.750525912827207,0.349598712510347,12,443,small GTPase binding,MF,NEFL;FGF5;OPTN;AP3M1;MOBP;RIMS2;NRG1;STXBP5;ARHGDIB;GIT2;CORO1C;EHD1
17518,GO:1901136,0.750866468188755,0.452187019087282,3,130,carbohydrate derivative catabolic process,BP,NAGK;EGLN1;NGLY1
156,GO:0000315,0.751145129961743,0.600414210933988,1,51,organellar large ribosomal subunit,CC,MRPL53
2495,GO:0005762,0.751145129961743,0.600414210933988,1,51,mitochondrial large ribosomal subunit,CC,MRPL53
3798,GO:0008408,0.751305711877392,0.600832428437428,1,45,3'-5' exonuclease activity,MF,NOCT
18860,GO:1904589,0.752304488050351,0.599451401044895,1,45,regulation of protein import,BP,HSP90AB1
3886,GO:0008543,0.75239720125487,0.496979570715532,2,87,fibroblast growth factor receptor signaling pathway,BP,FGF5;SETX
7583,GO:0031985,0.753165864192592,0.495941078588165,2,87,Golgi cisterna,CC,B4GALT1;RAB30
4234,GO:0009451,0.75321249759031,0.449065154597155,3,132,RNA modification,BP,PUS10;METTL2A;TRMT44
5050,GO:0015291,0.753543078391614,0.448801281382761,3,125,secondary active transmembrane transporter activity,MF,SLC16A9;SLC8A1;SLC7A5P2
1846,GO:0004521,0.753695226938863,0.597288927435009,1,47,endoribonuclease activity,MF,POP4
2821,GO:0006305,0.754066188470807,0.597129988910842,1,44,DNA alkylation,BP,PARP1
2822,GO:0006306,0.754066188470807,0.597129988910842,1,44,DNA methylation,BP,PARP1
6179,GO:0019674,0.754436332822779,0.596370973177484,1,46,NAD metabolic process,BP,PGK1
2529,GO:0005802,0.754482391413878,0.419676082082102,4,166,trans-Golgi network,CC,CHAC1;MYO1B;OPTN;RAB30
6130,GO:0019438,0.754755048155707,0.284100350339364,99,3430,aromatic compound biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;MAFF;MGA;UBP1;IL23A;DLG1;MED18;GDA;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
6675,GO:0030071,0.754963321199829,0.595635941404547,1,46,regulation of mitotic metaphase/anaphase transition,BP,DUSP1
17825,GO:1902099,0.754963321199829,0.595635941404547,1,46,regulation of metaphase/anaphase transition of cell cycle,BP,DUSP1
4050,GO:0009117,0.755265392275242,0.343882619585629,12,476,nucleotide metabolic process,BP,PGK1;PARP1;TJP2;GPR176;G6PD;PAPSS2;EGLN1;MOCS2;DLG1;GDA;EPHA2;ENPP1
11474,GO:0045995,0.755424511296113,0.49292540585793,2,86,regulation of embryonic development,BP,PHLDA2;NOCT
10851,GO:0044424,0.755437899127722,0.29445472358023,311,10390,intracellular part,CC,IL32;CDKN2A;NFKBIA;RPTN;MMP9;SPRR2G;SPRR2A;IL1A;FLG2;TRIM16;TCHH;LCE1B;KRT1;NEFL;KRT8;SERPINB2;CXCL1;LGALS1;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;LCE3D;LCE3E;DBNDD2;NAGK;SLIT2;CLDN1;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;CDKN2B;NABP1;PGK1;HS3ST1;SPRR2E;MYO1B;DNAJB1;SPRR2D;PEG10;JUN;KRT4;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;APOL6;OPTN;HRNR;HSPA5;IL1B;MSRB3;IFT46;CDV3;KRT13;ANPEP;JUNB;TJP2;HSPB8;PHLDA2;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;DUSP1;STAC;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;PDE1C;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;THTPA;NEDD4L;BIRC3;LCE1C;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;FAM126B;SYT11;KLK6;ZNF638;PAPSS2;UBTD2;RIMS2;HSP90AA1;FAM84B;CANX;FTH1;DAPP1;NRP1;TPP2;IL7R;TRAF1;EGLN1;BRD2;SETX;DCUN1D3;KCNQ5;GNPTAB;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;CLCC1;STXBP5;NR2F2;EIF4G2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;SLC39A14;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;HMGCS1;ARHGDIB;UBP1;GIT2;CS;CORO1C;IL23A;MME;DLG1;PDIA4;TRMT44;MED18;RBMS3;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;DHDDS;ETS1;HAS2;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;IQCJ-SCHIP1;BAMBI;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;ANKRD13A;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;EPHA2;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TNFAIP2;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
18398,GO:1903522,0.756520820355969,0.444827440829528,3,127,regulation of blood circulation,BP,EDN1;SLC8A1;DLG1
13025,GO:0051568,0.757203634205189,0.59261804443698,1,45,histone H3-K4 methylation,BP,CTR9
18121,GO:1902911,0.759294895925721,0.487512409835432,2,89,protein kinase complex,CC,CDK6;HSPD1
2314,GO:0005342,0.759411212877992,0.487396620092303,2,88,organic acid transmembrane transporter activity,MF,SLC16A9;SLC7A5P2
11874,GO:0046943,0.759411212877992,0.487396620092303,2,88,carboxylic acid transmembrane transporter activity,MF,SLC16A9;SLC7A5P2
5570,GO:0016614,0.759441359682401,0.487147097004376,2,93,oxidoreductase activity, acting on CH-OH group of donors,MF,G6PD;SDR16C5
5543,GO:0016574,0.760024019605441,0.588638993154397,1,45,histone ubiquitination,BP,CTR9
16208,GO:0090305,0.760053717271177,0.379839740778316,6,248,nucleic acid phosphodiester bond hydrolysis,BP,RNASE7;PARP1;NOCT;POP4;ENPP1;SND1
3013,GO:0006575,0.76022603729811,0.439774788534169,3,133,cellular modified amino acid metabolic process,BP,CHAC1;G6PD;EGLN1
16472,GO:0097223,0.760824553165191,0.485371331883758,2,90,sperm part,CC,HSP90AB1;CALR
10752,GO:0044248,0.761469299525796,0.28827336116027,50,1803,cellular catabolic process,BP,FEZ1;TP53;PMAIP1;PSMB9;NAGK;UBQLN2;CHAC1;PGK1;RIPK2;HERPUD1;OPTN;HSPA5;IL1B;ANPEP;DNAJB9;DNAJC10;NOCT;MGLL;ERAP1;CYLD;TRIB1;DERL3;NEDD4L;XBP1;ARG1;UGGT1;HMOX1;HSP90AA1;EGLN1;HSP90AB1;ADAM8;EIF4G2;SEL1L;PRR5L;NGLY1;GDA;PTTG1IP;IVD;DNAJC3;BCAT1;HSP90B1;SVIP;UBXN2B;NEDD4;PML;OXCT1;ENPP1;SND1;SDF2L1;CYP1A1
13235,GO:0051963,0.761683233081786,0.586408645239676,1,44,regulation of synapse assembly,BP,ADGRL3
13139,GO:0051784,0.761748593880824,0.58595344785828,1,47,negative regulation of nuclear division,BP,DUSP1
2963,GO:0006521,0.762095005048968,0.585043547989505,1,51,regulation of cellular amino acid metabolic process,BP,PSMB9
16771,GO:0098661,0.763078523232189,0.584291849933135,1,45,inorganic anion transmembrane transport,BP,CLCC1
13617,GO:0060170,0.763191651318553,0.58413008582131,1,45,ciliary membrane,CC,EHD1
4081,GO:0009152,0.764043676791833,0.407191477817638,4,172,purine ribonucleotide biosynthetic process,BP,PGK1;PARP1;GPR176;PAPSS2
3581,GO:0008023,0.764321508172456,0.582390353351097,1,46,transcription elongation factor complex,CC,CTR9
2890,GO:0006415,0.764453707433087,0.479986129135952,2,100,translational termination,BP,MRPS24;MRPL53
10244,GO:0043022,0.765688552296352,0.580308169947536,1,47,ribosome binding,MF,HSPA5
18117,GO:1902904,0.766784322453679,0.477172847674227,2,89,negative regulation of supramolecular fiber organization,BP,SLIT2;CRYAB
95,GO:0000186,0.766829583131735,0.578898861490636,1,45,activation of MAPKK activity,BP,GADD45B
9983,GO:0042440,0.76699696021575,0.57830715597413,1,48,pigment metabolic process,BP,HMOX1
3138,GO:0006753,0.767013297646828,0.32986526149533,12,481,nucleoside phosphate metabolic process,BP,PGK1;PARP1;TJP2;GPR176;G6PD;PAPSS2;EGLN1;MOCS2;DLG1;GDA;EPHA2;ENPP1
1388,GO:0003333,0.767019540071828,0.578502465698641,1,46,amino acid transmembrane transport,BP,SLC7A5P2
18495,GO:1903725,0.767215322358569,0.578219116924483,1,46,regulation of phospholipid metabolic process,BP,LYN
9014,GO:0035257,0.767217723508527,0.430492806268463,3,130,nuclear hormone receptor binding,MF,PARP1;CALR;PPID
6907,GO:0030520,0.767635896339701,0.577609871978626,1,46,intracellular estrogen receptor signaling pathway,BP,PARP1
2528,GO:0005801,0.767729898287903,0.577357014090524,1,47,cis-Golgi network,CC,RAB30
7734,GO:0032272,0.768450423893876,0.576311034587115,1,47,negative regulation of protein polymerization,BP,SLIT2
5577,GO:0016627,0.769424247999523,0.574674386066549,1,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,IVD
12969,GO:0051438,0.769465926381245,0.57472099659974,1,48,regulation of ubiquitin-protein transferase activity,BP,DCUN1D3
6522,GO:0021953,0.769714461330849,0.473082612876319,2,89,central nervous system neuron differentiation,BP,SLIT2;NRP1
11854,GO:0046907,0.770276647361521,0.283567742800537,40,1458,intracellular transport,BP,NFKBIA;NEFL;LCP1;FEZ1;TP53;HERPUD1;IL1B;IFT46;CRYAB;ANXA8;LYN;AP3M1;DERL3;WWC1;RHOB;MOBP;HMOX1;SYT11;RIMS2;HSP90AA1;GNPTAB;NRG1;HSP90AB1;CALR;SEL1L;PRR5L;RAB30;SEC22A;EHD1;PTTG1IP;SEC24D;REEP1;TGFA;HSP90B1;SVIP;NEDD4;ZDHHC6;PML;UGCG;HSPD1
3436,GO:0007264,0.770425074041302,0.325848130835514,12,456,small GTPase mediated signal transduction,BP,CDKN2A;TP53;SLIT2;JUN;RHOB;HMOX1;NRP1;NRG1;RRAS2;RAB30;ARHGDIB;GIT2
11096,GO:0045171,0.770833354661591,0.572723331958516,1,48,intercellular bridge,CC,SETX
2525,GO:0005796,0.771033638961979,0.572542326456452,1,47,Golgi lumen,CC,HS3ST1
4993,GO:0015171,0.771352486283621,0.572075116786319,1,47,amino acid transmembrane transporter activity,MF,SLC7A5P2
7403,GO:0031519,0.771678078633359,0.571597559564136,1,47,PcG protein complex,CC,ZFP42
3780,GO:0008375,0.771862133674034,0.571214962262986,1,48,acetylglucosaminyltransferase activity,MF,MGAT5
14469,GO:0065002,0.772063117341568,0.570708435115016,1,50,intracellular protein transmembrane transport,BP,HSPD1
4015,GO:0009064,0.772134485662995,0.570814862301219,1,48,glutamine family amino acid metabolic process,BP,ARG1
9997,GO:0042472,0.772403167651983,0.570649832003392,1,46,inner ear morphogenesis,BP,MAFB
5660,GO:0016791,0.772726302694989,0.377363857862035,5,208,phosphatase activity,MF,DUSP8;DUSP1;EYA3;DLG1;CPPED1
5663,GO:0016796,0.773461801608115,0.568860244265503,1,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,NOCT
9215,GO:0035637,0.773523630215372,0.467726778561546,2,89,multicellular organismal signaling,BP,CNTNAP1;SLC8A1
18069,GO:1902750,0.775781063455173,0.464213889438957,2,97,negative regulation of cell cycle G2/M phase transition,BP,PSMB9;NBN
9431,GO:0036064,0.776152041994509,0.463920567973862,2,91,ciliary basal body,CC,IFT46;CYLD
3340,GO:0007091,0.777998170342757,0.562011441034721,1,49,metaphase/anaphase transition of mitotic cell cycle,BP,DUSP1
10954,GO:0044784,0.777998170342757,0.562011441034721,1,49,metaphase/anaphase transition of cell cycle,BP,DUSP1
4340,GO:0009953,0.778224005958103,0.561782311106095,1,48,dorsal/ventral pattern formation,BP,EDN1
6736,GO:0030177,0.778311193698921,0.415280017916642,3,136,positive regulation of Wnt signaling pathway,BP,NFKB1;PSMB9;BAMBI
3761,GO:0008333,0.778716515581804,0.56104444256477,1,48,endosome to lysosome transport,BP,RHOB
2738,GO:0006164,0.77904254338288,0.387326733474005,4,176,purine nucleotide biosynthetic process,BP,PGK1;PARP1;GPR176;PAPSS2
1456,GO:0003723,0.779439748771477,0.27326789534588,40,1483,RNA binding,MF,CDKN2A;LGALS1;KRT18;TP53;NABP1;PEG10;JUN;PARP1;NOCT;ANXA1;PUS10;NOC3L;CSRP1;ZNF638;KCTD12;HSP90AA1;CANX;RBM28;POP4;ACO1;SERPINH1;HSP90AB1;EIF4G2;CALR;ZCCHC8;EIF2B1;CS;PDIA4;RBMS3;PRPF38A;ZC3H7B;HSP90B1;TFRC;MRPS24;MYH9;SOX11;SORBS2;RPL26L1;HSPD1;SND1
12743,GO:0051058,0.779596034906963,0.559837805639792,1,47,negative regulation of small GTPase mediated signal transduction,BP,SLIT2
8941,GO:0035050,0.779875494762174,0.559417552762221,1,47,embryonic heart tube development,BP,CITED2
17532,GO:1901185,0.780223139489631,0.558671136459888,1,49,negative regulation of ERBB signaling pathway,BP,NRG1
11629,GO:0046434,0.78051592645658,0.385385226017765,4,174,organophosphate catabolic process,BP,PGK1;EGLN1;GDA;ENPP1
10829,GO:0044380,0.7805317558564,0.558429251989163,1,47,protein localization to cytoskeleton,BP,CEP83
10123,GO:0042733,0.780952873667016,0.557679983268903,1,48,embryonic digit morphogenesis,BP,OSR2
13074,GO:0051649,0.781100577581758,0.268240257127793,46,1669,establishment of localization in cell,BP,NFKBIA;NEFL;LCP1;FEZ1;TP53;PMAIP1;HERPUD1;IL1B;IFT46;CRYAB;ANXA8;LYN;AP3M1;DERL3;SLC8A1;WWC1;RHOB;MOBP;HMOX1;SYT11;RIMS2;HSP90AA1;CANX;GNPTAB;NRG1;HSP90AB1;CALR;SEL1L;PRR5L;RAB30;SEC22A;DLG1;EHD1;PTTG1IP;SEC24D;REEP1;TGFA;HSP90B1;SVIP;NEDD4;ZDHHC6;PML;OXCT1;MYH9;UGCG;HSPD1
5377,GO:0016233,0.781347154471359,0.556769223164704,1,51,telomere capping,BP,NBN
10496,GO:0043467,0.781670672957343,0.455996477781229,2,92,regulation of generation of precursor metabolites and energy,BP,PHLDA2;ENPP1
17665,GO:1901615,0.782363071481104,0.332932701559273,8,326,organic hydroxy compound metabolic process,BP,NFKB1;IL1B;G6PD;SDR16C5;HMGCS1;DHDDS;MSMO1;CYP1A1
8927,GO:0035019,0.782761692306662,0.554832205691946,1,49,somatic stem cell population maintenance,BP,KLF10
16119,GO:0090181,0.783047332995708,0.554398372585063,1,49,regulation of cholesterol metabolic process,BP,HMGCS1
14966,GO:0070936,0.783452357315219,0.553782566167411,1,49,protein K48-linked ubiquitination,BP,NEDD4L
9807,GO:0042073,0.783573115342965,0.553598815130449,1,49,intraciliary transport,BP,IFT46
4761,GO:0010965,0.783647209304908,0.553380696434047,1,50,regulation of mitotic sister chromatid separation,BP,DUSP1
10763,GO:0044271,0.783667087001774,0.251329108468539,113,3949,cellular nitrogen compound biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;GPR176;NBN;WWC1;NEDD4L;NOC3L;XBP1;ARG1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;MGA;UBP1;IL23A;DLG1;MED18;RBMS3;GDA;ZMYM4;CITED2;ZNF814;ETS1;TGFA;BAMBI;DNAJC3;ZFP42;NLRP10;NEDD4;PML;MRPS24;EID3;ZBTB21;HES4;SOX11;UGCG;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
18407,GO:1903533,0.783875211189296,0.452702662203926,2,95,regulation of protein targeting,BP,NRG1;UGCG
3462,GO:0007338,0.784954913089295,0.55128443750717,1,51,single fertilization,BP,B4GALT1
2590,GO:0005902,0.785199562711614,0.551117276462012,1,49,microvillus,CC,ITGAV
5812,GO:0017111,0.785358013077301,0.292803221348359,17,647,nucleoside-triphosphatase activity,MF,MYO1B;HSPA5;HSPA6;FIGN;ANXA1;NBN;THTPA;RHOB;HSP90AA1;SETX;RRAS2;RAB30;ARHGDIB;NLRP10;TUBB3;MYH9;HSPD1
7308,GO:0031338,0.785569509973277,0.550661182279507,1,48,regulation of vesicle fusion,BP,ANXA1
7832,GO:0032414,0.7865838401481,0.548995409520577,1,49,positive regulation of ion transmembrane transporter activity,BP,STAC
5492,GO:0016462,0.786647065572582,0.289090979914934,18,685,pyrophosphatase activity,MF,MYO1B;HSPA5;HSPA6;FIGN;ANXA1;NBN;THTPA;RHOB;HSP90AA1;SETX;RRAS2;RAB30;ARHGDIB;NLRP10;TUBB3;MYH9;ENPP1;HSPD1
5127,GO:0015672,0.786860559838822,0.345588313833605,6,253,monovalent inorganic cation transport,BP,NETO1;SLC8A1;NEDD4L;KCNQ5;DLG1;NEDD4
15097,GO:0071230,0.787409174901739,0.547725986707466,1,49,cellular response to amino acid stimulus,BP,XBP1
4434,GO:0010389,0.788165195408577,0.37499504120738,4,180,regulation of G2/M transition of mitotic cell cycle,BP,PSMB9;NBN;HSP90AA1;CDK6
16676,GO:0097711,0.788301030987595,0.446318833535459,2,94,ciliary basal body-plasma membrane docking,BP,HSP90AA1;CEP83
12891,GO:0051287,0.789600238643423,0.544033835500097,1,52,NAD binding,MF,PARP1
12078,GO:0048167,0.789710401567705,0.444299863726699,2,93,regulation of synaptic plasticity,BP,NETO1;RIMS2
3314,GO:0007040,0.789930902447884,0.543618849543622,1,51,lysosome organization,BP,GNPTAB
15943,GO:0080171,0.789930902447884,0.543618849543622,1,51,lytic vacuole organization,BP,GNPTAB
5677,GO:0016817,0.789958153512022,0.285160763172949,18,687,hydrolase activity, acting on acid anhydrides,MF,MYO1B;HSPA5;HSPA6;FIGN;ANXA1;NBN;THTPA;RHOB;HSP90AA1;SETX;RRAS2;RAB30;ARHGDIB;NLRP10;TUBB3;MYH9;ENPP1;HSPD1
5678,GO:0016818,0.789958153512022,0.285160763172949,18,687,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,MYO1B;HSPA5;HSPA6;FIGN;ANXA1;NBN;THTPA;RHOB;HSP90AA1;SETX;RRAS2;RAB30;ARHGDIB;NLRP10;TUBB3;MYH9;ENPP1;HSPD1
15710,GO:0072341,0.790420325148242,0.54285848706321,1,51,modified amino acid binding,MF,AXL
5979,GO:0019003,0.791980476886364,0.540328510531269,1,52,GDP binding,MF,RHOB
11721,GO:0046605,0.792511131858402,0.539699619365183,1,50,regulation of centrosome cycle,BP,CHORDC1
5687,GO:0016835,0.793575042007065,0.537735982878592,1,53,carbon-oxygen lyase activity,MF,ACO1
3139,GO:0006754,0.793663606828539,0.438375830584043,2,96,ATP biosynthetic process,BP,PGK1;PARP1
4157,GO:0009247,0.794784007365836,0.535833840722885,1,53,glycolipid biosynthetic process,BP,UGCG
17654,GO:1901576,0.794850400092597,0.23743861664306,141,4892,organic substance biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PSMB9;FGF5;NAGK;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;HS3ST1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;MGLL;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;STT3A;ITGAV;ANXA1;FADS3;GPR176;DERL3;G6PD;NBN;PLEKHA2;WWC1;NEDD4L;NOC3L;XBP1;ARG1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;MGAT5;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;HMGCS1;UBP1;IL23A;DLG1;MED18;RBMS3;GDA;ZMYM4;CITED2;ZNF814;DHDDS;ETS1;HAS2;MSMO1;TGFA;MGST3;BAMBI;DNAJC3;BCAT1;ZFP42;NLRP10;SVIP;NEDD4;NTNG1;ZDHHC6;PML;MRPS24;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1;CYP1A1
17261,GO:0140097,0.795629789603329,0.364844022586282,4,178,catalytic activity, acting on DNA,MF,PARP1;ANXA1;NBN;SETX
6171,GO:0019637,0.795824688886539,0.271201614830155,22,848,organophosphate metabolic process,BP,FGF5;PGK1;PARP1;TJP2;FADS1;PLBD1;LYN;GPR176;G6PD;PLEKHA2;THTPA;PAPSS2;EGLN1;NRG1;AJUBA;MOCS2;HMGCS1;DLG1;GDA;DHDDS;EPHA2;ENPP1
6047,GO:0019213,0.79599646489474,0.534113068161462,1,51,deacetylase activity,MF,SUDS3
12907,GO:0051306,0.796753357006837,0.532815140061945,1,52,mitotic sister chromatid separation,BP,DUSP1
15427,GO:0071806,0.797535561592473,0.531385898029289,1,54,protein transmembrane transport,BP,HSPD1
1772,GO:0004402,0.797801754738044,0.531248834154869,1,51,histone acetyltransferase activity,MF,SUPT3H
6989,GO:0030695,0.797838631106073,0.331268464277677,6,248,GTPase regulator activity,MF,SLIT2;JUN;NRP1;STXBP5;ARHGDIB;GIT2
15383,GO:0071695,0.798118958072984,0.431805570533206,2,95,anatomical structure maturation,BP,G6PD;XBP1
548,GO:0001669,0.798524541334786,0.529998238461298,1,52,acrosomal vesicle,CC,CALR
11584,GO:0046323,0.798851213714667,0.529679612958911,1,50,glucose import,BP,ENPP1
10867,GO:0044446,0.799079317937164,0.232407244591806,206,7059,intracellular organelle part,CC,CDKN2A;MMP9;FLG2;TRIM16;KRT1;NEFL;KRT8;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;TNIP1;KRT18;NFKB1;NEFM;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;DBNDD2;CHAC1;COL12A1;KRT78;NABP1;HS3ST1;MYO1B;DNAJB1;JUN;KRT4;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;HRNR;HSPA5;IFT46;KRT13;ANPEP;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;ACTG1;DNAJC10;EHF;HSPA6;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;ANXA8;FADS1;FIGN;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;FADS3;COL4A4;DERL3;NBN;SLC8A1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;ARNTL2;GSTCD;HMOX1;SYT11;KLK6;ZNF638;HSP90AA1;CANX;FTH1;NRP1;TPP2;IL7R;BRD2;SETX;GNPTAB;RBM28;SOD2;POP4;NRG1;SERPINH1;HSP90AB1;GPATCH11;KRT34;SDR16C5;GGCX;ADAM8;C2ORF49;STXBP5;NR2F2;STEAP4;UQCC1;CALR;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;RAB30;SEC22A;UBP1;GIT2;CS;IL23A;MME;DLG1;PDIA4;MED18;EHD1;ZMYM4;CITED2;TXNRD1;PTTG1IP;DHDDS;ETS1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;PRPF38A;DNAJC3;CBLL1;HSP90B1;TFRC;ZFP42;SVIP;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TOR1AIP1;ZBTB21;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1
10278,GO:0043087,0.799086104956548,0.305177514766276,9,358,regulation of GTPase activity,BP,SLIT2;JUN;NRP1;STXBP5;AJUBA;ARHGDIB;GIT2;CORO1C;EPHA2
12583,GO:0050807,0.799716995034428,0.429457788447099,2,94,regulation of synapse organization,BP,ADGRL3;NEDD4
17662,GO:1901607,0.799726968865625,0.527981277509292,1,53,alpha-amino acid biosynthetic process,BP,BCAT1
2284,GO:0005262,0.800161739950199,0.527583378035958,1,50,calcium channel activity,MF,ITGAV
4009,GO:0009058,0.800293279247913,0.231471986507703,142,4932,biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PSMB9;FGF5;NAGK;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;HS3ST1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;MGLL;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;STT3A;ITGAV;ANXA1;FADS3;GPR176;DERL3;G6PD;NBN;PLEKHA2;WWC1;NEDD4L;NOC3L;XBP1;ARG1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;MGAT5;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;HMGCS1;UBP1;IL23A;DLG1;MED18;RBMS3;GDA;ZMYM4;CITED2;ZNF814;DHDDS;ETS1;HAS2;MSMO1;TGFA;MGST3;BAMBI;DNAJC3;BCAT1;ZFP42;NLRP10;SVIP;NEDD4;NTNG1;ZDHHC6;PML;MRPS24;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1;CYP1A1
116,GO:0000245,0.801155845140213,0.525688423095032,1,53,spliceosomal complex assembly,BP,SETX
4949,GO:0015075,0.801427587596033,0.292014702573141,11,441,ion transmembrane transporter activity,MF,SLC16A9;ITGAV;SLC8A1;KCNQ5;SLC7A5P2;CLCC1;ANO4;SLC39A14;MAGT1;DLG1;TFRC
3577,GO:0008017,0.801477505405626,0.339286238230818,5,212,microtubule binding,MF,NEFM;MYO1B;CRYAB;REEP1;MYH9
1469,GO:0003774,0.801992252675138,0.426045084037102,2,94,motor activity,MF,MYO1B;MYH9
6813,GO:0030295,0.802343887067496,0.523870056066699,1,52,protein kinase activator activity,MF,NRG1
19329,GO:1905818,0.802779971246204,0.523069622831303,1,53,regulation of chromosome separation,BP,DUSP1
6691,GO:0030120,0.802978396357518,0.522844772616634,1,52,vesicle coat,CC,SEC24D
8078,GO:0032787,0.804490493982813,0.292798878602543,10,413,monocarboxylic acid metabolic process,BP,EDN1;PGK1;MGLL;FADS1;ANXA1;FADS3;XBP1;IVD;MSMO1;CYP1A1
7158,GO:0031060,0.805068838217703,0.519552290168532,1,51,regulation of histone methylation,BP,CTR9
10075,GO:0042623,0.805137962940127,0.311751582113751,7,290,ATPase activity, coupled,MF,MYO1B;HSPA5;HSPA6;FIGN;ANXA1;NBN;MYH9
17260,GO:0140096,0.805771033142546,0.240006501511984,47,1695,catalytic activity, acting on a protein,MF,MMP9;ASPRV1;DUSP8;PSMB9;FGF5;RIPK2;PARP1;ANPEP;AXL;IKBKE;ERAP1;CYLD;DUSP1;FIGN;LYN;C1R;NEDD4L;BIRC3;SEC11C;SUDS3;TRAF3;MMP19;KLK6;HSP90AA1;NRP1;TPP2;EGLN1;NRG1;PREP;ADAM8;PDIA6;PPID;MGAT5;EYA3;MME;DLG1;PDIA4;MED18;LOX;CBLL1;NEDD4;CDK6;ZDHHC6;EPHA2;GALNT14;CPPED1;IRAK2
3094,GO:0006687,0.806761734758091,0.516591698506463,1,53,glycosphingolipid metabolic process,BP,UGCG
2498,GO:0005765,0.807076482845102,0.309166749150415,7,297,lysosomal membrane,CC,B4GALT1;SPNS2;ANPEP;AP3M1;HSP90AB1;MAGT1;ENPP1
16859,GO:0098852,0.807076482845102,0.309166749150415,7,297,lytic vacuole membrane,CC,B4GALT1;SPNS2;ANPEP;AP3M1;HSP90AB1;MAGT1;ENPP1
4166,GO:0009260,0.807398177990689,0.348461773592309,4,184,ribonucleotide biosynthetic process,BP,PGK1;PARP1;GPR176;PAPSS2
7182,GO:0031091,0.807662569513524,0.515114655811229,1,53,platelet alpha granule,CC,VEGFC
10769,GO:0044282,0.807780921842822,0.308194766877244,7,305,small molecule catabolic process,BP,NAGK;PGK1;ARG1;IVD;BCAT1;OXCT1;CYP1A1
10582,GO:0043604,0.807914672736004,0.263609600909716,18,733,amide biosynthetic process,BP,TNIP1;CHAC1;ARG1;ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;EIF2B1;ORMDL1;RBMS3;DNAJC3;MRPS24;SOX11;UGCG;MRPL53;RPL26L1
6898,GO:0030510,0.80803896510467,0.514592848871844,1,52,regulation of BMP signaling pathway,BP,SOX11
2568,GO:0005874,0.808900732540694,0.299012580882239,8,331,microtubule,CC,SAA1;FEZ1;CYLD;FIGN;SLC8A1;SERP1;DLG1;TUBB3
3320,GO:0007049,0.809591029458097,0.237982495828038,42,1543,cell cycle,BP,CDKN2A;IL1A;KRT18;EDN1;TP53;PSMB9;CDKN2B;NABP1;JUN;OPTN;IL1B;JUNB;GADD45B;CYLD;DUSP1;FIGN;ANXA1;NBN;BIRC3;RHOB;HSP90AA1;DCUN1D3;CXCR5;HSP90AB1;NR2F2;EIF4G2;CALR;AJUBA;MGA;DLG1;CITED2;CHORDC1;TGFA;SUGT1;BCAT1;ZFP42;CDK6;TUBB3;PML;EPB41L2;MYH9;CYP1A1
17247,GO:0140053,0.809598869167424,0.370756487057929,3,153,mitochondrial gene expression,BP,UQCC1;MRPS24;MRPL53
8931,GO:0035023,0.809809234980199,0.4141450181242,2,95,regulation of Rho protein signal transduction,BP,NRP1;ARHGDIB
17561,GO:1901264,0.810503761323176,0.51024491387451,1,55,carbohydrate derivative transport,BP,SLC35B1
14387,GO:0061733,0.810515536337898,0.510408497251351,1,53,peptide-lysine-N-acetyltransferase activity,MF,SUPT3H
1766,GO:0004386,0.812030572952529,0.367512478667425,3,137,helicase activity,MF,ANXA1;NBN;SETX
2385,GO:0005543,0.81228409972255,0.302319329386449,7,295,phospholipid binding,MF,MYO1B;AXL;ANXA8;ANXA1;PLEKHA2;SYT11;DAPP1
13210,GO:0051928,0.813261845056382,0.505743581670806,1,54,positive regulation of calcium ion transport,BP,G6PD
14129,GO:0061053,0.813894984688828,0.50487469890222,1,52,somite development,BP,SOX11
15779,GO:0072522,0.814320100670557,0.338697316590325,4,186,purine-containing compound biosynthetic process,BP,PGK1;PARP1;GPR176;PAPSS2
8335,GO:0033238,0.814703955388109,0.502906226420396,1,59,regulation of cellular amine metabolic process,BP,PSMB9
17293,GO:1900006,0.814949135472495,0.503105630103962,1,52,positive regulation of dendrite development,BP,NRG1
12962,GO:0051427,0.81529589274514,0.36262363466575,3,142,hormone receptor binding,MF,PARP1;CALR;PPID
11650,GO:0046470,0.815365300885222,0.502124065428257,1,55,phosphatidylcholine metabolic process,BP,PLBD1
18118,GO:1902905,0.816261854475863,0.361182187939048,3,143,positive regulation of supramolecular fiber organization,BP,EDN1;NRP1;DLG1
5263,GO:0015934,0.816296444974477,0.403507535676435,2,115,large ribosomal subunit,CC,MRPL53;RPL26L1
3732,GO:0008286,0.816971939032957,0.402904363622132,2,100,insulin receptor signaling pathway,BP,IL1B;ENPP1
11430,GO:0045921,0.817251107376898,0.498939198984621,1,55,positive regulation of exocytosis,BP,STXBP5
6584,GO:0022625,0.817316146777629,0.498209362868294,1,63,cytosolic large ribosomal subunit,CC,RPL26L1
4299,GO:0009798,0.818108012252447,0.497576068028305,1,54,axis specification,BP,CITED2
7018,GO:0030811,0.819992521902479,0.494364805979306,1,54,regulation of nucleotide catabolic process,BP,EGLN1
17238,GO:0140029,0.822523889836319,0.489841061387202,1,56,exocytic process,BP,LYN
7829,GO:0032411,0.822782121463423,0.489483420868502,1,55,positive regulation of transporter activity,BP,STAC
12127,GO:0048278,0.823318920798889,0.488468717772112,1,56,vesicle docking,BP,CEP83
6556,GO:0022402,0.824320556050365,0.228724099202693,30,1138,cell cycle process,BP,CDKN2A;IL1A;EDN1;TP53;PSMB9;CDKN2B;NABP1;OPTN;IL1B;DUSP1;ANXA1;NBN;BIRC3;RHOB;HSP90AA1;DCUN1D3;CXCR5;HSP90AB1;EIF4G2;CALR;AJUBA;MGA;DLG1;CHORDC1;TGFA;BCAT1;CDK6;PML;MYH9;CYP1A1
56,GO:0000118,0.825000458339643,0.485642036820983,1,55,histone deacetylase complex,CC,SUDS3
17387,GO:1900182,0.825253911470612,0.485113423371496,1,56,positive regulation of protein localization to nucleus,BP,HSP90AB1
401,GO:0001078,0.825464996661219,0.389511429337623,2,101,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,ATF3;ZFP42
2891,GO:0006417,0.825665666686276,0.270833236565213,9,386,regulation of translation,BP,ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;RBMS3;DNAJC3;ZC3H7B
10850,GO:0044422,0.825844004746709,0.203195050819707,208,7154,organelle part,CC,CDKN2A;MMP9;FLG2;TRIM16;KRT1;NEFL;NETO1;KRT8;CXCL1;LGALS1;SAA1;KRT24;KRT2;LCP1;TNIP1;KRT18;NFKB1;NEFM;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;DBNDD2;CHAC1;COL12A1;KRT78;NABP1;HS3ST1;MYO1B;DNAJB1;JUN;KRT4;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;HRNR;HSPA5;IFT46;KRT13;ANPEP;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;ACTG1;DNAJC10;EHF;HSPA6;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;ANXA8;FADS1;FIGN;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;FADS3;COL4A4;DERL3;NBN;SLC8A1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;ARNTL2;GSTCD;HMOX1;SYT11;KLK6;ZNF638;HSP90AA1;CANX;FTH1;NRP1;TPP2;IL7R;BRD2;SETX;GNPTAB;RBM28;SOD2;POP4;NRG1;SERPINH1;HSP90AB1;GPATCH11;KRT34;SDR16C5;GGCX;ADAM8;C2ORF49;STXBP5;NR2F2;STEAP4;UQCC1;CALR;PDIA6;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;RAB30;SEC22A;UBP1;GIT2;CS;IL23A;MME;DLG1;PDIA4;MED18;EHD1;ZMYM4;CITED2;TXNRD1;PTTG1IP;DHDDS;ETS1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;PRPF38A;DNAJC3;CBLL1;HSP90B1;TFRC;ZFP42;SVIP;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TOR1AIP1;ZBTB21;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
6415,GO:0021700,0.826274755919667,0.346261439300367,3,144,developmental maturation,BP,AXL;G6PD;XBP1
38,GO:0000077,0.826585019653269,0.345757819399767,3,146,DNA damage checkpoint,BP,TP53;NBN;PML
8895,GO:0034764,0.82663841894356,0.387644182278004,2,101,positive regulation of transmembrane transport,BP,STAC;G6PD
14745,GO:0070491,0.826716200588424,0.482563379938987,1,56,repressing transcription factor binding,MF,ZFP42
18305,GO:1903313,0.826814339356989,0.482391791091001,1,56,positive regulation of mRNA metabolic process,BP,PRR5L
15002,GO:0070988,0.826859264838915,0.48240125989101,1,55,demethylation,BP,CYP1A1
8398,GO:0033500,0.827176505859028,0.344867636569643,3,146,carbohydrate homeostasis,BP,LGALS1;XBP1;OXCT1
10061,GO:0042593,0.827176505859028,0.344867636569643,3,146,glucose homeostasis,BP,LGALS1;XBP1;OXCT1
8649,GO:0034248,0.827993345072129,0.26267835161846,10,425,regulation of cellular amide metabolic process,BP,ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;ORMDL1;RBMS3;DNAJC3;ZC3H7B
6581,GO:0022618,0.828211017769206,0.318716179578868,4,193,ribonucleoprotein complex assembly,BP,NOCT;HSP90AA1;SETX;HSP90AB1
5310,GO:0016054,0.828670751956659,0.318060828996648,4,192,organic acid catabolic process,BP,NAGK;ARG1;IVD;BCAT1
11620,GO:0046395,0.828670751956659,0.318060828996648,4,192,carboxylic acid catabolic process,BP,NAGK;ARG1;IVD;BCAT1
9180,GO:0035591,0.828914098182659,0.478795117528301,1,55,signaling adaptor activity,MF,CNTNAP1
4128,GO:0009206,0.829055685667281,0.383651684357642,2,105,purine ribonucleoside triphosphate biosynthetic process,BP,PGK1;PARP1
16275,GO:0090502,0.829437241438722,0.477538229425858,1,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,POP4
3933,GO:0008652,0.829767482504495,0.477034568274261,1,58,cellular amino acid biosynthetic process,BP,BCAT1
2832,GO:0006333,0.829839281815571,0.340676511777696,3,156,chromatin assembly or disassembly,BP,CDKN2A;TP53;BRD2
2472,GO:0005730,0.830027396114075,0.231791799863716,21,835,nucleolus,CC,KRT18;TP53;DNAJB1;PARP1;ATF3;DNAJB9;NFKBIE;NBN;NOC3L;ARNTL2;HMOX1;KLK6;SETX;RBM28;POP4;PPID;TXNRD1;PML;EID3;BTBD10;MIDN
4952,GO:0015079,0.830322475880783,0.476220715731039,1,56,potassium ion transmembrane transporter activity,MF,KCNQ5
7887,GO:0032482,0.830478212382521,0.475698284208874,1,59,Rab protein signal transduction,BP,RAB30
14150,GO:0061097,0.830730528515738,0.475412971273089,1,57,regulation of protein tyrosine kinase activity,BP,TGFA
2846,GO:0006353,0.830739059226389,0.380886978362087,2,107,DNA-templated transcription, termination,BP,SETX;MED18
6349,GO:0021549,0.831561646736424,0.47402338975214,1,56,cerebellum development,BP,HSPA5
7344,GO:0031406,0.8318996998963,0.379046352987619,2,106,carboxylic acid binding,MF,EGLN1;NR2F2
10350,GO:0043204,0.832008820542755,0.473142897845984,1,57,perikaryon,CC,CRYAB
3861,GO:0008509,0.832125162787552,0.313103829457552,4,186,anion transmembrane transporter activity,MF,SLC16A9;SLC7A5P2;CLCC1;ANO4
3649,GO:0008154,0.832128021435857,0.337355450243488,3,147,actin polymerization or depolymerization,BP,SLIT2;COBLL1;DLG1
5632,GO:0016746,0.832143510980786,0.313029032193817,4,190,transferase activity, transferring acyl groups,MF,HMGCS1;CS;ZDHHC6;SUPT3H
74,GO:0000151,0.832559066138242,0.284237267773423,6,267,ubiquitin ligase complex,CC,DCUN1D3;SEL1L;MED18;SUGT1;CBLL1;NEDD4
4074,GO:0009145,0.832798833439539,0.377593422220771,2,106,purine nucleoside triphosphate biosynthetic process,BP,PGK1;PARP1
16258,GO:0090407,0.833102404149383,0.248022685059825,12,498,organophosphate biosynthetic process,BP,FGF5;PGK1;PARP1;FADS1;GPR176;G6PD;PLEKHA2;PAPSS2;AJUBA;MOCS2;HMGCS1;DHDDS
8956,GO:0035091,0.833419575678035,0.3112237894963,4,185,phosphatidylinositol binding,MF,MYO1B;ANXA8;PLEKHA2;DAPP1
5419,GO:0016301,0.833725692011733,0.236212059107656,16,629,kinase activity,MF,FGF5;NAGK;PGK1;RIPK2;TJP2;AXL;IKBKE;LYN;PAPSS2;HSP90AA1;NRP1;NRG1;DLG1;CDK6;EPHA2;IRAK2
5912,GO:0018209,0.834058948207758,0.294018689344916,5,226,peptidyl-serine modification,BP,RIPK2;PARP1;IKBKE;IL24;GALNT14
11798,GO:0046782,0.834353642582304,0.468790972469317,1,59,regulation of viral transcription,BP,JUN
8280,GO:0033138,0.834550876186052,0.468516639904069,1,58,positive regulation of peptidyl-serine phosphorylation,BP,RIPK2
240,GO:0000502,0.834744160214546,0.467796761512692,1,63,proteasome complex,CC,PSMB9
6050,GO:0019217,0.83486955984672,0.468026695386097,1,57,regulation of fatty acid metabolic process,BP,ANXA1
10550,GO:0043547,0.835168639350478,0.271582725920184,7,298,positive regulation of GTPase activity,BP,JUN;NRP1;STXBP5;ARHGDIB;GIT2;CORO1C;EPHA2
12579,GO:0050803,0.8352807757517,0.373692168386461,2,102,regulation of synapse structure or activity,BP,ADGRL3;NEDD4
5913,GO:0018210,0.83583574522443,0.372755699136276,2,103,peptidyl-threonine modification,BP,RIPK2;GALNT14
6043,GO:0019209,0.837002635262672,0.464096513730815,1,58,kinase activator activity,MF,NRG1
18765,GO:1904356,0.837145731285244,0.463837382698842,1,58,regulation of telomere maintenance via telomere lengthening,BP,PARP1
10520,GO:0043507,0.837387131392683,0.463568208963748,1,56,positive regulation of JUN kinase activity,BP,EDN1
6610,GO:0022890,0.837538189534543,0.277309841317096,6,268,inorganic cation transmembrane transporter activity,MF,ITGAV;SLC8A1;KCNQ5;SLC39A14;MAGT1;TFRC
1844,GO:0004519,0.837599954389199,0.369720588834107,2,108,endonuclease activity,MF,RNASE7;POP4
10656,GO:0043967,0.839226412214717,0.459975095160179,1,59,histone H4 acetylation,BP,TRIM16
19192,GO:1905369,0.839630060040861,0.45887631512633,1,64,endopeptidase complex,CC,PSMB9
5264,GO:0015935,0.841096434329905,0.455939025629719,1,68,small ribosomal subunit,CC,MRPS24
3032,GO:0006605,0.841108488726423,0.256196240770026,8,367,protein targeting,BP,AP3M1;HSP90AA1;GNPTAB;NRG1;NEDD4;ZDHHC6;UGCG;HSPD1
6737,GO:0030178,0.841633645629212,0.322650150231488,3,153,negative regulation of Wnt signaling pathway,BP,PSMB9;CYLD;RBMS3
3053,GO:0006635,0.84244165818779,0.453923932575429,1,61,fatty acid beta-oxidation,BP,IVD
7147,GO:0031047,0.842761585851532,0.320865834008683,3,155,gene silencing by RNA,BP,AJUBA;ZC3H7B;SND1
10871,GO:0044450,0.843108695619731,0.320442423292981,3,148,microtubule organizing center part,CC,KRT18;HSPA6;CEP83
2199,GO:0005096,0.843414810419887,0.280626437347296,5,225,GTPase activator activity,MF,JUN;NRP1;STXBP5;ARHGDIB;GIT2
20188,GO:2001169,0.843828818372058,0.451510592123519,1,59,regulation of ATP biosynthetic process,BP,PARP1
6971,GO:0030670,0.844326842484742,0.450361653220397,1,62,phagocytic vesicle membrane,CC,CALR
2376,GO:0005525,0.844941150781856,0.266864698115225,6,277,GTP binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
20136,GO:2001021,0.845074588784416,0.449043476131569,1,61,negative regulation of response to DNA damage stimulus,BP,PTTG1IP
12978,GO:0051453,0.845572607162621,0.448115246777642,1,61,regulation of intracellular pH,BP,TP53
2283,GO:0005261,0.845684912891301,0.356437579289532,2,105,cation channel activity,MF,ITGAV;KCNQ5
8631,GO:0034212,0.846853781645261,0.445794811910823,1,60,peptide N-acetyltransferase activity,MF,SUPT3H
12996,GO:0051492,0.846853855673523,0.445872234834131,1,59,regulation of stress fiber assembly,BP,NRP1
8241,GO:0033047,0.847546974530778,0.444419211054685,1,61,regulation of mitotic sister chromatid segregation,BP,DUSP1
10853,GO:0044427,0.847889279647625,0.212893714080366,19,771,chromosomal part,CC,CDKN2A;TP53;NABP1;JUN;PARP1;JUNB;NBN;SUDS3;SETX;GPATCH11;SDR16C5;CTR9;CITED2;SUGT1;ZFP42;NEDD4;PML;EID3;MAGED1
9896,GO:0042273,0.848398341201432,0.442476636667852,1,66,ribosomal large subunit biogenesis,BP,RPL26L1
134,GO:0000281,0.849675273299035,0.440480975758219,1,60,mitotic cytokinesis,BP,RHOB
2809,GO:0006289,0.849748600531535,0.349383150158946,2,113,nucleotide-excision repair,BP,TP53;PARP1
12741,GO:0051056,0.849965080048535,0.259822639684385,6,265,regulation of small GTPase mediated signal transduction,BP,SLIT2;RHOB;NRP1;NRG1;ARHGDIB;GIT2
2189,GO:0005085,0.850147986902577,0.27083245689293,5,227,guanyl-nucleotide exchange factor activity,MF,NEFL;FGF5;NRG1;EIF2B1;MON1A
1864,GO:0004553,0.850698343206737,0.438465802424162,1,61,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,GBE1
13559,GO:0060070,0.850977967862217,0.269537785835032,5,237,canonical Wnt signaling pathway,BP,NFKB1;PSMB9;CYLD;RBMS3;BAMBI
3438,GO:0007266,0.851453850435636,0.307318902598641,3,149,Rho protein signal transduction,BP,RHOB;NRP1;ARHGDIB
4123,GO:0009201,0.851472129812193,0.346519639184834,2,111,ribonucleoside triphosphate biosynthetic process,BP,PGK1;PARP1
10753,GO:0044249,0.851909459743512,0.174793252194427,137,4826,cellular biosynthetic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;B4GALT1;EDN1;TP53;PSMB9;FGF5;NAGK;CHAC1;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;MGLL;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;STT3A;ANXA1;FADS3;GPR176;DERL3;NBN;PLEKHA2;WWC1;NEDD4L;NOC3L;XBP1;ARG1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;TRAF1;EGLN1;BRD2;SETX;SOD2;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;MGAT5;EYA3;SERP1;EIF2B1;ORMDL1;MAFF;MAGT1;MOCS2;MGA;HMGCS1;UBP1;IL23A;DLG1;MED18;RBMS3;GDA;ZMYM4;CITED2;ZNF814;DHDDS;ETS1;HAS2;TGFA;MGST3;BAMBI;DNAJC3;BCAT1;ZFP42;NLRP10;SVIP;NEDD4;NTNG1;ZDHHC6;PML;MRPS24;EID3;GALNT14;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;SDF2L1;CYP1A1
7929,GO:0032550,0.85201746332787,0.256804207096172,6,280,purine ribonucleoside binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
3449,GO:0007283,0.852455450659596,0.256202826530567,6,276,spermatogenesis,BP,CLDN11;AXL;BIRC3;BRD2;SETX;CALR
10815,GO:0044344,0.852466456889693,0.344886209935855,2,109,cellular response to fibroblast growth factor stimulus,BP,FGF5;SETX
6787,GO:0030258,0.85252192591536,0.282660647545488,4,194,lipid modification,BP,FGF5;NRG1;IVD;CYP1A1
3283,GO:0006996,0.852930635036716,0.177420379361492,86,3091,organelle organization,BP,CDKN2A;MMP9;IL1A;TRIM16;NEFL;KRT8;CXCL1;KRT2;LCP1;KRT18;NEFM;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;SLIT2;UBQLN2;MYO1B;JUN;KRT4;MAP7D2;PARP1;OPTN;IL1B;IFT46;KRT13;CNTNAP1;CRYAB;ACTG1;NOCT;CYLD;DUSP1;ANXA8;FIGN;COBLL1;ANXA1;NBN;BIRC3;RHOB;SUDS3;SYT11;HSP90AA1;NRP1;BRD2;SETX;GNPTAB;SOD2;NRG1;HSP90AB1;SDR16C5;UQCC1;CALR;PPID;CTR9;AJUBA;AMOTL2;EYA3;RAB30;SEC22A;ARHGDIB;CORO1C;DLG1;EHD1;ZMYM4;ETS1;SEC24D;REEP1;PDE4DIP;CHORDC1;TGFA;HSP90B1;UBXN2B;TUBB3;PML;EPB41L2;MYH9;TOR1AIP1;UGCG;SORBS2;AFAP1;TPM4;CEP83;HSPD1;SUPT3H;PARVA
5567,GO:0016604,0.853653257741261,0.2110920469917,16,652,nuclear body,CC,TRIM16;TP53;IL16;IKBKE;NBN;NOC3L;SUDS3;ZNF638;TPP2;BRD2;SETX;CTR9;ZCCHC8;MOCS2;CBLL1;PML
16210,GO:0090307,0.854224956952069,0.431723193278692,1,61,mitotic spindle assembly,BP,BIRC3
16767,GO:0098656,0.85423842477971,0.302858907613072,3,151,anion transmembrane transport,BP,SLC7A5P2;CLCC1;SLC35B1
5976,GO:0018995,0.855402402199659,0.429379977619468,1,62,host,CC,AXL
10613,GO:0043657,0.855402402199659,0.429379977619468,1,62,host cell,CC,AXL
10736,GO:0044215,0.855402402199659,0.429379977619468,1,62,other organism,CC,AXL
10737,GO:0044216,0.855402402199659,0.429379977619468,1,62,other organism cell,CC,AXL
10738,GO:0044217,0.855402402199659,0.429379977619468,1,62,other organism part,CC,AXL
11705,GO:0046578,0.855688843232195,0.277897622293912,4,189,regulation of Ras protein signal transduction,BP,NRP1;NRG1;ARHGDIB;GIT2
3379,GO:0007173,0.855908178443894,0.339005355027932,2,109,epidermal growth factor receptor signaling pathway,BP,MMP9;TGFA
133,GO:0000280,0.856100162227694,0.242502434584036,7,317,nuclear division,BP,IL1A;EDN1;IL1B;DUSP1;BIRC3;CALR;TGFA
669,GO:0001883,0.856406679866164,0.250505898808775,6,282,purine nucleoside binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
6552,GO:0022037,0.856715909072307,0.4269084858312,1,61,metencephalon development,BP,HSPA5
12899,GO:0051298,0.857204037049501,0.425959852050945,1,61,centrosome duplication,BP,CHORDC1
12902,GO:0051301,0.857323638640558,0.216555328584155,12,508,cell division,BP,IL1A;FGF5;IL1B;FIGN;BIRC3;VEGFC;RHOB;CXCR5;TGFA;CDK6;EPB41L2;MYH9
6888,GO:0030496,0.857327745274729,0.297867689240662,3,154,midbody,CC,HSPA5;CYLD;HSP90B1
9866,GO:0042180,0.857883606341139,0.296869347861286,3,161,cellular ketone metabolic process,BP,PSMB9;ANXA1;OXCT1
15784,GO:0072527,0.857915064289965,0.424233016597308,1,66,pyrimidine-containing compound metabolic process,BP,THTPA
4056,GO:0009126,0.858244761562319,0.258761780562688,5,248,purine nucleoside monophosphate metabolic process,BP,PGK1;PARP1;TJP2;DLG1;ENPP1
4095,GO:0009167,0.858244761562319,0.258761780562688,5,248,purine ribonucleoside monophosphate metabolic process,BP,PGK1;PARP1;TJP2;DLG1;ENPP1
10933,GO:0044728,0.858545718145898,0.42327077749032,1,62,DNA methylation or demethylation,BP,PARP1
15439,GO:0071826,0.858760867957949,0.273037100785523,4,204,ribonucleoprotein complex subunit organization,BP,NOCT;HSP90AA1;SETX;HSP90AB1
109,GO:0000226,0.858779793367438,0.22197525700613,10,427,microtubule cytoskeleton organization,BP,NEFL;MAP7D2;CRYAB;CYLD;FIGN;BIRC3;DLG1;CHORDC1;TUBB3;MYH9
7420,GO:0031570,0.859166037642453,0.294879228837298,3,156,DNA integrity checkpoint,BP,TP53;NBN;PML
12999,GO:0051495,0.859460036377509,0.29440512012251,3,156,positive regulation of cytoskeleton organization,BP,EDN1;NRP1;DLG1
6956,GO:0030641,0.859586744421913,0.421093028972496,1,64,regulation of cellular pH,BP,TP53
11661,GO:0046486,0.859698224234441,0.237433495339558,7,316,glycerolipid metabolic process,BP,FGF5;MGLL;PLBD1;PLEKHA2;NRG1;AJUBA;SEL1L
14102,GO:0061013,0.860938678820437,0.291956351883831,3,160,regulation of mRNA catabolic process,BP,PSMB9;NOCT;PRR5L
17685,GO:1901655,0.861266170895419,0.41785551699423,1,63,cellular response to ketone,BP,ARG1
4540,GO:0010639,0.861430139065748,0.243272117198694,6,279,negative regulation of organelle organization,BP,FEZ1;SLIT2;PARP1;DUSP1;NBN;SDR16C5
7940,GO:0032561,0.861432975801396,0.243239488052483,6,284,guanyl ribonucleotide binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
12997,GO:0051493,0.861469924817514,0.22288110945823,9,393,regulation of cytoskeleton organization,BP,EDN1;SLIT2;CYLD;RHOB;NRP1;ARHGDIB;DLG1;CHORDC1;AFAP1
6286,GO:0019933,0.861546562283871,0.4173015772415,1,63,cAMP-mediated signaling,BP,RIMS2
7928,GO:0032549,0.86184656293963,0.242639797478481,6,284,ribonucleoside binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
2830,GO:0006323,0.862414192211661,0.289480708333488,3,166,DNA packaging,BP,CDKN2A;TP53;BRD2
12639,GO:0050890,0.862567635977954,0.289389623664045,3,155,cognition,BP,NETO1;JUN;MAGT1
15411,GO:0071774,0.862871456574375,0.326858085137927,2,112,response to fibroblast growth factor,BP,FGF5;SETX
5977,GO:0019001,0.863707945755931,0.239930104881287,6,285,guanyl nucleotide binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
7952,GO:0032588,0.864185813528266,0.411990621527044,1,64,trans-Golgi network membrane,CC,MYO1B
3554,GO:0007613,0.864444133386753,0.411543071031931,1,63,memory,BP,NETO1
6912,GO:0030534,0.864622267296914,0.411187010831984,1,63,adult behavior,BP,SDK1
3322,GO:0007051,0.864821183575258,0.285703633758947,3,156,spindle organization,BP,BIRC3;DLG1;MYH9
19517,GO:1990542,0.865207999981728,0.409753431190569,1,67,mitochondrial transmembrane transport,BP,HSPD1
14347,GO:0061630,0.865800032108807,0.262211995144618,4,198,ubiquitin protein ligase activity,MF,NEDD4L;MED18;CBLL1;NEDD4
7035,GO:0030833,0.865935045356895,0.321425016511524,2,114,regulation of actin filament polymerization,BP,SLIT2;DLG1
15705,GO:0072331,0.86601025764584,0.247199229339165,5,245,signal transduction by p53 class mediator,BP,TP53;PMAIP1;NBN;PTTG1IP;PML
5306,GO:0016050,0.866293427642533,0.228040337280698,7,320,vesicle organization,BP,ANXA8;ANXA1;SYT11;CALR;SEC22A;SEC24D;TGFA
2532,GO:0005814,0.866530028905057,0.320426416506834,2,112,centriole,CC,HSPA6;CEP83
2889,GO:0006414,0.867140403381336,0.319040793456347,2,125,translational elongation,BP,MRPS24;MRPL53
7577,GO:0031974,0.867342143271484,0.158278225988919,120,4301,membrane-enclosed lumen,CC,MMP9;FLG2;TRIM16;KRT1;KRT8;CXCL1;LGALS1;SAA1;TNIP1;KRT18;NFKB1;RELB;EDN1;TP53;PSMB9;COL12A1;NABP1;HS3ST1;DNAJB1;JUN;IL16;NFKB2;ARID3B;PARP1;OPTN;HRNR;HSPA5;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;DNAJC10;EHF;HSPA6;NOCT;IKBKE;MGLL;ERAP1;NFKBIE;FIGN;LYN;COL8A1;ANXA1;COL4A4;NBN;SLC8A1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SUDS3;ARNTL2;GSTCD;HMOX1;KLK6;ZNF638;HSP90AA1;CANX;FTH1;TPP2;BRD2;SETX;RBM28;SOD2;POP4;NRG1;SERPINH1;HSP90AB1;C2ORF49;NR2F2;CALR;PDIA6;PPID;CTR9;IGFBP3;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;CS;IL23A;PDIA4;MED18;ZMYM4;CITED2;TXNRD1;PTTG1IP;ETS1;CALU;IVD;PRPF38A;DNAJC3;CBLL1;HSP90B1;ZFP42;CDK6;PML;OXCT1;EPB41L2;MRPS24;EID3;BTBD10;ZBTB21;MRPL53;CPPED1;SORBS2;CLINT1;HSPD1;SUPT3H;MIDN;SDF2L1
10368,GO:0043233,0.867342143271484,0.158278225988919,120,4301,organelle lumen,CC,MMP9;FLG2;TRIM16;KRT1;KRT8;CXCL1;LGALS1;SAA1;TNIP1;KRT18;NFKB1;RELB;EDN1;TP53;PSMB9;COL12A1;NABP1;HS3ST1;DNAJB1;JUN;IL16;NFKB2;ARID3B;PARP1;OPTN;HRNR;HSPA5;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;DNAJC10;EHF;HSPA6;NOCT;IKBKE;MGLL;ERAP1;NFKBIE;FIGN;LYN;COL8A1;ANXA1;COL4A4;NBN;SLC8A1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SUDS3;ARNTL2;GSTCD;HMOX1;KLK6;ZNF638;HSP90AA1;CANX;FTH1;TPP2;BRD2;SETX;RBM28;SOD2;POP4;NRG1;SERPINH1;HSP90AB1;C2ORF49;NR2F2;CALR;PDIA6;PPID;CTR9;IGFBP3;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;CS;IL23A;PDIA4;MED18;ZMYM4;CITED2;TXNRD1;PTTG1IP;ETS1;CALU;IVD;PRPF38A;DNAJC3;CBLL1;HSP90B1;ZFP42;CDK6;PML;OXCT1;EPB41L2;MRPS24;EID3;BTBD10;ZBTB21;MRPL53;CPPED1;SORBS2;CLINT1;HSPD1;SUPT3H;MIDN;SDF2L1
14484,GO:0070013,0.867342143271484,0.158278225988919,120,4301,intracellular organelle lumen,CC,MMP9;FLG2;TRIM16;KRT1;KRT8;CXCL1;LGALS1;SAA1;TNIP1;KRT18;NFKB1;RELB;EDN1;TP53;PSMB9;COL12A1;NABP1;HS3ST1;DNAJB1;JUN;IL16;NFKB2;ARID3B;PARP1;OPTN;HRNR;HSPA5;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;DNAJC10;EHF;HSPA6;NOCT;IKBKE;MGLL;ERAP1;NFKBIE;FIGN;LYN;COL8A1;ANXA1;COL4A4;NBN;SLC8A1;NEDD4L;BIRC3;VEGFC;NOC3L;XBP1;ARG1;UGGT1;SUDS3;ARNTL2;GSTCD;HMOX1;KLK6;ZNF638;HSP90AA1;CANX;FTH1;TPP2;BRD2;SETX;RBM28;SOD2;POP4;NRG1;SERPINH1;HSP90AB1;C2ORF49;NR2F2;CALR;PDIA6;PPID;CTR9;IGFBP3;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;CS;IL23A;PDIA4;MED18;ZMYM4;CITED2;TXNRD1;PTTG1IP;ETS1;CALU;IVD;PRPF38A;DNAJC3;CBLL1;HSP90B1;ZFP42;CDK6;PML;OXCT1;EPB41L2;MRPS24;EID3;BTBD10;ZBTB21;MRPL53;CPPED1;SORBS2;CLINT1;HSPD1;SUPT3H;MIDN;SDF2L1
11648,GO:0046467,0.867411294449063,0.318765788641691,2,116,membrane lipid biosynthetic process,BP,ORMDL1;UGCG
10835,GO:0044391,0.867593371028008,0.280826892285761,3,182,ribosomal subunit,CC,MRPS24;MRPL53;RPL26L1
15849,GO:0072657,0.867887321086055,0.209555973427233,10,452,protein localization to membrane,BP,KRT18;TP53;PMAIP1;OPTN;STAC;HSP90AA1;DLG1;REEP1;ZDHHC6;EPHA2
10363,GO:0043228,0.867971172235267,0.15988618205247,90,3265,non-membrane-bounded organelle,CC,CDKN2A;TCHH;KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;RELB;FEZ1;TP53;DPYSL3;FLG;KRT78;NABP1;MYO1B;DNAJB1;JUN;KRT4;MAP7D2;RIPK2;PARP1;IFT46;KRT13;JUNB;CRYAB;ATF3;DNAJB9;ACTG1;HSPA6;NOCT;CYLD;NFKBIE;FIGN;KRT23;ANXA1;NBN;SLC8A1;NOC3L;MOBP;SUDS3;ARNTL2;HMOX1;KLK6;RIMS2;CANX;NRP1;SETX;RBM28;POP4;GPATCH11;KRT34;SDR16C5;ADAM8;PPID;CTR9;AJUBA;EYA3;SERP1;ARHGDIB;CORO1C;DLG1;EHD1;CITED2;TXNRD1;PDE4DIP;SUGT1;ZFP42;NEDD4;CDK6;TUBB3;PML;EPB41L2;MRPS24;MYH9;EID3;BTBD10;MRPL53;SORBS2;AFAP1;RPL26L1;TPM4;CEP83;MAGED1;MIDN;TJP1;PARVA
10367,GO:0043232,0.867971172235267,0.15988618205247,90,3265,intracellular non-membrane-bounded organelle,CC,CDKN2A;TCHH;KRT1;NEFL;KRT8;SAA1;KRT24;KRT2;LCP1;KRT18;NEFM;RELB;FEZ1;TP53;DPYSL3;FLG;KRT78;NABP1;MYO1B;DNAJB1;JUN;KRT4;MAP7D2;RIPK2;PARP1;IFT46;KRT13;JUNB;CRYAB;ATF3;DNAJB9;ACTG1;HSPA6;NOCT;CYLD;NFKBIE;FIGN;KRT23;ANXA1;NBN;SLC8A1;NOC3L;MOBP;SUDS3;ARNTL2;HMOX1;KLK6;RIMS2;CANX;NRP1;SETX;RBM28;POP4;GPATCH11;KRT34;SDR16C5;ADAM8;PPID;CTR9;AJUBA;EYA3;SERP1;ARHGDIB;CORO1C;DLG1;EHD1;CITED2;TXNRD1;PDE4DIP;SUGT1;ZFP42;NEDD4;CDK6;TUBB3;PML;EPB41L2;MRPS24;MYH9;EID3;BTBD10;MRPL53;SORBS2;AFAP1;RPL26L1;TPM4;CEP83;MAGED1;MIDN;TJP1;PARVA
2547,GO:0005844,0.867972173415484,0.40406605185488,1,69,polysome,CC,CALR
7218,GO:0031146,0.868262482763221,0.40342086983371,1,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB9
4178,GO:0009301,0.868696239196251,0.402716871240372,1,67,snRNA transcription,BP,NABP1
10161,GO:0042795,0.868696239196251,0.402716871240372,1,67,snRNA transcription by RNA polymerase II,BP,NABP1
4057,GO:0009127,0.869724751993979,0.314655063310907,2,116,purine nucleoside monophosphate biosynthetic process,BP,PGK1;PARP1
4096,GO:0009168,0.869724751993979,0.314655063310907,2,116,purine ribonucleoside monophosphate biosynthetic process,BP,PGK1;PARP1
16937,GO:0099023,0.870241273508872,0.399696677697456,1,65,tethering complex,CC,TNFAIP2
2819,GO:0006303,0.871257939203193,0.397428971732004,1,68,double-strand break repair via nonhomologous end joining,BP,NBN
2491,GO:0005758,0.872745933647658,0.394197849048876,1,71,mitochondrial intermembrane space,CC,LYN
10615,GO:0043679,0.872822064172585,0.394334390133057,1,66,axon terminus,CC,SYT11
14227,GO:0061337,0.874204661311208,0.391538366609413,1,65,cardiac conduction,BP,SLC8A1
668,GO:0001882,0.874341885148521,0.224288083353211,6,290,nucleoside binding,MF,RHOB;HSP90AB1;RRAS2;RAB30;EHD1;TUBB3
12100,GO:0048232,0.874634488884749,0.223875243152002,6,286,male gamete generation,BP,CLDN11;AXL;BIRC3;BRD2;SETX;CALR
1951,GO:0004672,0.874803381637824,0.196461443117664,11,469,protein kinase activity,MF,FGF5;RIPK2;AXL;IKBKE;LYN;HSP90AA1;NRP1;NRG1;CDK6;EPHA2;IRAK2
18197,GO:1903046,0.875215111309955,0.304790690925415,2,116,meiotic cell cycle process,BP,CALR;MYH9
12872,GO:0051258,0.875416625625752,0.247026312741535,4,204,protein polymerization,BP,NEFL;SLIT2;COBLL1;DLG1
14360,GO:0061659,0.877679965271876,0.243430421651955,4,203,ubiquitin-like protein ligase activity,MF,NEDD4L;MED18;CBLL1;NEDD4
7714,GO:0032231,0.878222187080373,0.383074534874841,1,66,regulation of actin filament bundle assembly,BP,NRP1
13671,GO:0060271,0.878791869406324,0.21768675294666,6,286,cilium assembly,BP,IFT46;CYLD;HSP90AA1;EHD1;CEP83;PARVA
4071,GO:0009142,0.878900454453164,0.29798809004471,2,120,nucleoside triphosphate biosynthetic process,BP,PGK1;PARP1
263,GO:0000731,0.87990724073916,0.379389090893413,1,68,DNA synthesis involved in DNA repair,BP,NBN
2524,GO:0005795,0.879965126773196,0.296105391055609,2,117,Golgi stack,CC,B4GALT1;RAB30
4497,GO:0010565,0.881019332589214,0.294053759876568,2,122,regulation of cellular ketone metabolic process,BP,PSMB9;ANXA1
12905,GO:0051304,0.881822214565983,0.375252236158142,1,69,chromosome separation,BP,DUSP1
5436,GO:0016331,0.88185365961409,0.292651701476369,2,116,morphogenesis of embryonic epithelium,BP,VEGFC;SOX11
4089,GO:0009161,0.882013665247708,0.222696331773768,5,259,ribonucleoside monophosphate metabolic process,BP,PGK1;PARP1;TJP2;DLG1;ENPP1
7947,GO:0032580,0.882061829603666,0.374798184082684,1,68,Golgi cisterna membrane,CC,B4GALT1
6288,GO:0019935,0.882128584547784,0.37465530809975,1,68,cyclic-nucleotide-mediated signaling,BP,RIMS2
7040,GO:0030838,0.882459060385468,0.373832182445794,1,70,positive regulation of actin filament polymerization,BP,DLG1
4953,GO:0015081,0.882548450035418,0.373878075607649,1,66,sodium ion transmembrane transporter activity,MF,SLC8A1
110,GO:0000228,0.882675923349715,0.185635341353607,11,493,nuclear chromosome,CC,TP53;NABP1;JUN;PARP1;JUNB;NBN;SUDS3;SETX;CITED2;ZFP42;PML
16455,GO:0097194,0.882893931101958,0.372899258054652,1,70,execution phase of apoptosis,BP,TP53
7875,GO:0032465,0.883098139054455,0.372575806717368,1,68,regulation of cytokinesis,BP,CXCR5
14959,GO:0070925,0.883281570381282,0.174657386172753,15,636,organelle assembly,BP,KRT8;LCP1;FEZ1;EDN1;UBQLN2;IFT46;ACTG1;NOCT;CYLD;BIRC3;HSP90AA1;EHD1;UBXN2B;CEP83;PARVA
2492,GO:0005759,0.883847355146634,0.196484711759089,8,393,mitochondrial matrix,CC,TP53;SOD2;CS;IVD;OXCT1;MRPS24;MRPL53;HSPD1
8239,GO:0033045,0.884984482829968,0.368391321461605,1,70,regulation of sister chromatid segregation,BP,DUSP1
6658,GO:0030038,0.885040766768775,0.368384503780042,1,68,contractile actin filament bundle assembly,BP,NRP1
10314,GO:0043149,0.885040766768775,0.368384503780042,1,68,stress fiber assembly,BP,NRP1
3309,GO:0007032,0.885165969439803,0.367998156937876,1,70,endosome organization,BP,ANXA8
273,GO:0000776,0.885436184554207,0.285886765413546,2,121,kinetochore,CC,GPATCH11;SUGT1
14350,GO:0061640,0.885564271086957,0.367190948847282,1,69,cytoskeleton-dependent cytokinesis,BP,RHOB
18116,GO:1902903,0.88593919651457,0.216651994371132,5,249,regulation of supramolecular fiber organization,BP,EDN1;SLIT2;CRYAB;NRP1;DLG1
10260,GO:0043043,0.886744277367532,0.170014376938055,15,672,peptide biosynthetic process,BP,TNIP1;CHAC1;ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;EIF2B1;RBMS3;DNAJC3;MRPS24;SOX11;MRPL53;RPL26L1
3481,GO:0007389,0.88695841623719,0.215058396628877,5,249,pattern specification process,BP,MAFB;EDN1;NRP1;NR2F2;CITED2
10348,GO:0043202,0.887123729810908,0.363683240227492,1,71,lysosomal lumen,CC,HSP90AA1
10362,GO:0043227,0.887723889110128,0.137424833821387,270,9232,membrane-bounded organelle,CC,CDKN2A;NFKBIA;MMP9;FLG2;TRIM16;KRT1;KRT8;CXCL1;LGALS1;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;CD274;FLG;DBNDD2;NAGK;SLIT2;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;NABP1;PGK1;HS3ST1;MYO1B;DNAJB1;PEG10;JUN;KRT4;CLDN11;MCAM;ZNF165;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;KRT13;ANPEP;JUNB;TJP2;IL6ST;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;STOML1;CDSN;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;STT3A;ITGAV;LYN;NCEH1;COBLL1;AP3M1;COL8A1;C1R;ANXA1;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;SYT11;KLK6;ZNF638;KCTD12;RIMS2;HSP90AA1;CANX;FTH1;NRP1;TPP2;IL7R;EGLN1;BRD2;SETX;GNPTAB;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;KRT34;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;CLCC1;STXBP5;NR2F2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;ARHGDIB;UBP1;GIT2;CS;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;MED18;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;DHDDS;ETS1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;ANKRD13A;HSP90B1;TFRC;ZFP42;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1
7217,GO:0031145,0.888613907183068,0.360118134125641,1,77,anaphase-promoting complex-dependent catabolic process,BP,PSMB9
3474,GO:0007368,0.88867141653672,0.360402712033027,1,69,determination of left/right symmetry,BP,CITED2
3544,GO:0007600,0.888739327168083,0.225483835476631,4,211,sensory perception,BP,EDN1;MGLL;EYA3;MME
8961,GO:0035097,0.889613291900255,0.358271083438976,1,70,histone methyltransferase complex,CC,MGA
3072,GO:0006661,0.890363842610316,0.276663931742216,2,119,phosphatidylinositol biosynthetic process,BP,FGF5;PLEKHA2
10519,GO:0043506,0.890485783925334,0.356398053955598,1,69,regulation of JUN kinase activity,BP,EDN1
10952,GO:0044782,0.890625647948182,0.199778794918702,6,292,cilium organization,BP,IFT46;CYLD;HSP90AA1;EHD1;CEP83;PARVA
137,GO:0000288,0.890932665498173,0.355242355441696,1,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,NOCT
6232,GO:0019827,0.891159226236058,0.27513268904345,2,120,stem cell population maintenance,BP,KLF10;CTR9
12825,GO:0051186,0.891405790841608,0.180825201760623,9,428,cofactor metabolic process,BP,CHAC1;PGK1;G6PD;THTPA;HMOX1;HSP90AA1;MOCS2;HMGCS1;CYP1A1
2477,GO:0005739,0.892504840320115,0.143503248052185,35,1425,mitochondrion,CC,NFKB1;FEZ1;TP53;PMAIP1;PARP1;HSPA5;MSRB3;CRYAB;IKBKE;FADS1;LYN;ANXA1;SLC8A1;NOC3L;MOBP;ARG1;TRAF3;KLK6;SOD2;ACO1;HSP90AB1;UQCC1;MAFF;PRR5L;CS;TXNRD1;REEP1;IVD;BCAT1;OXCT1;MRPS24;MRPL53;HSPD1;SND1;CYP1A1
12840,GO:0051213,0.892515707903459,0.351770034786697,1,71,dioxygenase activity,MF,EGLN1
285,GO:0000790,0.892673007663886,0.19659398745582,6,303,nuclear chromatin,CC,TP53;JUN;JUNB;SUDS3;CITED2;ZFP42
3609,GO:0008080,0.892680970788499,0.35134736281881,1,72,N-acetyltransferase activity,MF,SUPT3H
8133,GO:0032886,0.892850464809879,0.238208231305334,3,166,regulation of microtubule-based process,BP,FEZ1;CYLD;CHORDC1
10875,GO:0044454,0.893163685171845,0.174407682571125,10,462,nuclear chromosome part,CC,TP53;NABP1;JUN;PARP1;JUNB;NBN;SUDS3;CITED2;ZFP42;PML
4518,GO:0010608,0.893612996048423,0.170442784186339,11,505,posttranscriptional regulation of gene expression,BP,PSMB9;NOCT;ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;RBMS3;DNAJC3;ZC3H7B
3036,GO:0006611,0.893683778138638,0.236699719557049,3,170,protein export from nucleus,BP,TP53;IL1B;CALR
16789,GO:0098727,0.893781385910472,0.270109151847534,2,121,maintenance of cell number,BP,KLF10;CTR9
16735,GO:0098588,0.894923231137688,0.138799565033571,39,1515,bounding membrane of organelle,CC,B4GALT1;PMAIP1;DBNDD2;MYO1B;SPNS2;OPTN;ANPEP;IKBKE;STOML1;ANXA8;ITGAV;AP3M1;ANXA1;DERL3;RHOB;ARG1;SYT11;IL7R;GNPTAB;HSP90AB1;ADAM8;STEAP4;CALR;MGAT5;SLC35B1;MAGT1;RAB30;MME;EHD1;SEC24D;TGFA;DNAJC3;TFRC;SVIP;PML;GALNT14;UGCG;ENPP1;IRAK2
2888,GO:0006413,0.89557212596198,0.233227461848891,3,184,translational initiation,BP,EIF4G2;EIF2B1;DNAJC3
1476,GO:0003824,0.895704634514129,0.126020605734811,121,4346,catalytic activity,MF,MMP9;ASPRV1;DUSP8;B4GALT1;DPYSL3;PSMB9;FGF5;NAGK;RNASE7;CHAC1;PGK1;HS3ST1;MYO1B;RIPK2;PARP1;HSPA5;MSRB3;ANPEP;TJP2;GPX8;AXL;DNAJC10;HSPA6;NOCT;IKBKE;MGLL;ERAP1;CYLD;DUSP1;FADS1;FIGN;PLBD1;STT3A;LYN;NCEH1;C1R;ANXA1;PDE1C;FADS3;G6PD;NBN;THTPA;NEDD4L;BIRC3;PUS10;RHOB;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;HMOX1;MMP19;KLK6;PAPSS2;HEPHL1;HSP90AA1;FTH1;NRP1;TPP2;EGLN1;SETX;GNPTAB;SOD2;POP4;NRG1;ACO1;PREP;SDR16C5;GGCX;ADAM8;STEAP4;PDIA6;PPID;MGAT5;EYA3;MAGT1;MOCS2;RRAS2;RAB30;HMGCS1;ARHGDIB;CS;METTL2A;MME;DLG1;PDIA4;TRMT44;MED18;NGLY1;GDA;LOX;TXNRD1;DHDDS;HAS2;TYW1;IVD;MSMO1;MGST3;CBLL1;BCAT1;NLRP10;NEDD4;CDK6;TUBB3;ZDHHC6;OXCT1;EPHA2;MYH9;GALNT14;GBE1;UGCG;CPPED1;ENPP1;HSPD1;SND1;SUPT3H;IRAK2;SDF2L1;CYP1A1;TMPPE
6606,GO:0022857,0.896046522721004,0.164223182713193,12,532,transmembrane transporter activity,MF,SLC16A9;ITGAV;SLC8A1;KCNQ5;SLC7A5P2;CLCC1;ANO4;SLC39A14;SLC35B1;MAGT1;DLG1;TFRC
259,GO:0000726,0.89646629314014,0.342663333793342,1,75,non-recombinational repair,BP,NBN
2072,GO:0004843,0.896738024054112,0.342248990927846,1,71,thiol-dependent ubiquitin-specific protease activity,MF,CYLD
18436,GO:1903578,0.897926127922801,0.339433944863699,1,73,regulation of ATP metabolic process,BP,PARP1
6764,GO:0030219,0.897947506073828,0.339147555252627,1,78,megakaryocyte differentiation,BP,CDKN2B
7576,GO:0031970,0.897953091366424,0.339134780490643,1,78,organelle envelope lumen,CC,LYN
5569,GO:0016607,0.898011194123839,0.181403194417902,7,340,nuclear speck,CC,IL16;NOC3L;ZNF638;BRD2;CTR9;MOCS2;CBLL1
10499,GO:0043473,0.898900919850971,0.337149555866797,1,74,pigmentation,BP,SPNS2
2506,GO:0005774,0.899091614975086,0.179766664163632,7,341,vacuolar membrane,CC,B4GALT1;SPNS2;ANPEP;AP3M1;HSP90AB1;MAGT1;ENPP1
4085,GO:0009156,0.899499454399779,0.258934658146208,2,127,ribonucleoside monophosphate biosynthetic process,BP,PGK1;PARP1
3219,GO:0006888,0.899623079943685,0.226175808391487,3,172,ER to Golgi vesicle-mediated transport,BP,SEC22A;SEC24D;TGFA
6687,GO:0030111,0.899800854002183,0.194622957498018,5,259,regulation of Wnt signaling pathway,BP,NFKB1;PSMB9;CYLD;RBMS3;BAMBI
6097,GO:0019362,0.90206984089938,0.25389876284408,2,127,pyridine nucleotide metabolic process,BP,PGK1;G6PD
11668,GO:0046496,0.90206984089938,0.25389876284408,2,127,nicotinamide nucleotide metabolic process,BP,PGK1;G6PD
3298,GO:0007017,0.902913329546202,0.150178868488956,14,606,microtubule-based process,BP,NEFL;FEZ1;MYO1B;MAP7D2;IFT46;CRYAB;CYLD;FIGN;AP3M1;BIRC3;DLG1;CHORDC1;TUBB3;MYH9
4053,GO:0009123,0.903581175495378,0.188452257255687,5,271,nucleoside monophosphate metabolic process,BP,PGK1;PARP1;TJP2;DLG1;ENPP1
2702,GO:0006096,0.904267413972623,0.324626344116275,1,75,glycolytic process,BP,PGK1
4313,GO:0009855,0.904326048029639,0.324536726758011,1,74,determination of bilateral symmetry,BP,CITED2
3455,GO:0007292,0.90459554336297,0.323853801822239,1,75,female gamete generation,BP,MMP19
3060,GO:0006643,0.904882580423787,0.216677836812062,3,177,membrane lipid metabolic process,BP,SPNS2;ORMDL1;UGCG
3270,GO:0006974,0.904927482519187,0.142380211007416,17,738,cellular response to DNA damage stimulus,BP,TP53;PMAIP1;NABP1;PARP1;IKBKE;FIGN;LYN;NBN;HMOX1;SETX;EYA3;PITHD1;PTTG1IP;NEDD4;PML;EPHA2;EID3
7640,GO:0032091,0.90624691192443,0.319811133315447,1,78,negative regulation of protein binding,BP,HSPA5
200,GO:0000422,0.906528326414344,0.319187177955221,1,77,autophagy of mitochondrion,BP,OPTN
14383,GO:0061726,0.906528326414344,0.319187177955221,1,77,mitochondrion disassembly,BP,OPTN
7395,GO:0031503,0.906694915762073,0.195402260052187,4,219,protein-containing complex localization,BP,NETO1;IFT46;DLG1;TNFAIP2
4300,GO:0009799,0.906985770977566,0.318191236442988,1,75,specification of symmetry,BP,CITED2
6115,GO:0019395,0.907150194722141,0.31766248973847,1,78,fatty acid oxidation,BP,IVD
3141,GO:0006757,0.907227837171593,0.317567444564931,1,76,ATP generation from ADP,BP,PGK1
3055,GO:0006637,0.907706686820113,0.316334295728853,1,78,acyl-CoA metabolic process,BP,HMGCS1
9079,GO:0035383,0.907706686820113,0.316334295728853,1,78,thioester metabolic process,BP,HMGCS1
2451,GO:0005681,0.907927664470236,0.211104979216257,3,181,spliceosomal complex,CC,RBM28;ZCCHC8;PRPF38A
5052,GO:0015293,0.908455300625672,0.314678782664087,1,75,symporter activity,MF,SLC16A9
6564,GO:0022411,0.908977267704803,0.151691942705573,10,475,cellular component disassembly,BP,MMP9;LCP1;OPTN;FBN2;MMP19;SETX;ADAM8;ETS1;MRPS24;MRPL53
8989,GO:0035195,0.908995469161576,0.239987587735302,2,134,gene silencing by miRNA,BP,AJUBA;ZC3H7B
8740,GO:0034440,0.90973578175411,0.311419086147282,1,79,lipid oxidation,BP,IVD
10188,GO:0042866,0.909994795466568,0.310881181837833,1,77,pyruvate biosynthetic process,BP,PGK1
2887,GO:0006412,0.910010665135482,0.140332916865873,14,653,translation,BP,TNIP1;ACO1;EIF4G2;UQCC1;CALR;AJUBA;SERP1;EIF2B1;RBMS3;DNAJC3;MRPS24;SOX11;MRPL53;RPL26L1
3601,GO:0008064,0.91012133362013,0.23778368707238,2,130,regulation of actin polymerization or depolymerization,BP,SLIT2;DLG1
2192,GO:0005088,0.910443907478178,0.206611289747642,3,170,Ras guanyl-nucleotide exchange factor activity,MF,NEFL;FGF5;NRG1
3755,GO:0008324,0.910763313799397,0.168318229788376,6,305,cation transmembrane transporter activity,MF,ITGAV;SLC8A1;KCNQ5;SLC39A14;MAGT1;TFRC
2962,GO:0006520,0.910995736018417,0.176305133101267,5,274,cellular amino acid metabolic process,BP,PSMB9;ARG1;EGLN1;IVD;BCAT1
847,GO:0002181,0.912545171165083,0.304360484539064,1,85,cytoplasmic translation,BP,RPL26L1
7034,GO:0030832,0.912567902421378,0.232796560655719,2,131,regulation of actin filament length,BP,SLIT2;DLG1
60,GO:0000123,0.912739561278192,0.304120997327181,1,79,histone acetyltransferase complex,CC,SUPT3H
4127,GO:0009205,0.912874663533793,0.184662043133957,4,233,purine ribonucleoside triphosphate metabolic process,BP,PGK1;PARP1;MOCS2;ENPP1
68,GO:0000139,0.913165618202687,0.137938008685371,13,582,Golgi membrane,CC,B4GALT1;MYO1B;OPTN;GNPTAB;STEAP4;MGAT5;SLC35B1;RAB30;SEC24D;TGFA;SVIP;GALNT14;UGCG
10706,GO:0044106,0.913196698125079,0.302802394426804,1,84,cellular amine metabolic process,BP,PSMB9
15781,GO:0072524,0.913753924222037,0.230354731041597,2,132,pyridine-containing compound metabolic process,BP,PGK1;G6PD
1463,GO:0003735,0.915740427572337,0.225954745264912,2,154,structural constituent of ribosome,MF,MRPS24;RPL26L1
2820,GO:0006304,0.91595439441029,0.296151377315812,1,80,DNA modification,BP,PARP1
3865,GO:0008514,0.916125560047789,0.225491510941702,2,131,organic anion transmembrane transporter activity,MF,SLC16A9;SLC7A5P2
18539,GO:1903825,0.916404896188852,0.295114524519939,1,78,organic acid transmembrane transport,BP,SLC7A5P2
19067,GO:1905039,0.916404896188852,0.295114524519939,1,78,carboxylic acid transmembrane transport,BP,SLC7A5P2
4006,GO:0009055,0.916550592989257,0.294404166285525,1,87,electron transfer activity,MF,TXNRD1
5458,GO:0016410,0.916799766481237,0.294045990124873,1,80,N-acyltransferase activity,MF,SUPT3H
10375,GO:0043244,0.916816402658176,0.294088420379941,1,78,regulation of protein complex disassembly,BP,SETX
19097,GO:1905114,0.917086446488763,0.143152971204999,9,431,cell surface receptor signaling pathway involved in cell-cell signaling,BP,NETO1;NFKB1;PSMB9;CYLD;RIMS2;CTR9;AMOTL2;RBMS3;BAMBI
11480,GO:0046031,0.917502241440459,0.292289806410404,1,80,ADP metabolic process,BP,PGK1
5539,GO:0016570,0.918466985507665,0.145024090370419,8,389,histone modification,BP,TRIM16;TP53;IL1B;SUDS3;SDR16C5;CTR9;EYA3;SUPT3H
4054,GO:0009124,0.918544727016264,0.220388352748289,2,136,nucleoside monophosphate biosynthetic process,BP,PGK1;PARP1
5318,GO:0016073,0.918951716435529,0.288491713962745,1,84,snRNA metabolic process,BP,NABP1
8264,GO:0033108,0.919155407887999,0.287803821117245,1,89,mitochondrial respiratory chain complex assembly,BP,UQCC1
12130,GO:0048285,0.919973590410553,0.147456426573112,7,354,organelle fission,BP,IL1A;EDN1;IL1B;DUSP1;BIRC3;CALR;TGFA
5537,GO:0016567,0.920078647578432,0.123155536153849,16,710,protein ubiquitination,BP,PSMB9;RIPK2;HERPUD1;HSPA5;NEDD4L;BIRC3;TRAF3;HSP90AA1;TPP2;DCUN1D3;HSP90AB1;CTR9;MED18;PTTG1IP;CBLL1;NEDD4
12087,GO:0048193,0.920427543332769,0.152729438496,6,311,Golgi vesicle transport,BP,KRT18;MYO1B;OPTN;SEC22A;SEC24D;TGFA
5664,GO:0016798,0.920577244156557,0.284412382019139,1,83,hydrolase activity, acting on glycosyl bonds,MF,GBE1
4093,GO:0009165,0.920958180327706,0.17047188746239,4,232,nucleotide biosynthetic process,BP,PGK1;PARP1;GPR176;PAPSS2
8988,GO:0035194,0.921394388635914,0.214354713786366,2,140,posttranscriptional gene silencing by RNA,BP,AJUBA;ZC3H7B
3552,GO:0007611,0.921778757975898,0.213650985868082,2,133,learning or memory,BP,NETO1;JUN
8650,GO:0034249,0.922391360790652,0.167920941746614,4,232,negative regulation of cellular amide metabolic process,BP,CALR;AJUBA;ORMDL1;ZC3H7B
4121,GO:0009199,0.922542864809653,0.167610382485931,4,239,ribonucleoside triphosphate metabolic process,BP,PGK1;PARP1;MOCS2;ENPP1
19441,GO:1990234,0.922990855162027,0.119114733070944,16,714,transferase complex,CC,TP53;STT3A;DCUN1D3;CTR9;SEL1L;ORMDL1;MAGT1;MGA;MED18;SUGT1;CBLL1;NEDD4;CDK6;EID3;HSPD1;SUPT3H
2527,GO:0005798,0.923301252943683,0.210365400638523,2,137,Golgi-associated vesicle,CC,SEC24D;TGFA
5480,GO:0016441,0.923528800213939,0.20982364324362,2,141,posttranscriptional gene silencing,BP,AJUBA;ZC3H7B
2788,GO:0006261,0.923559004796455,0.209817846300336,2,137,DNA-dependent DNA replication,BP,PARP1;NBN
4073,GO:0009144,0.923573320079753,0.165763579488867,4,240,purine nucleoside triphosphate metabolic process,BP,PGK1;PARP1;MOCS2;ENPP1
6240,GO:0019842,0.923939412993129,0.275751984328811,1,84,vitamin binding,MF,EGLN1
17385,GO:1900180,0.92441496272274,0.274556986758091,1,83,regulation of protein localization to nucleus,BP,HSP90AB1
3545,GO:0007601,0.9245319116571,0.274291274727069,1,82,visual perception,BP,EYA3
12677,GO:0050953,0.9245319116571,0.274291274727069,1,82,sensory perception of light stimulus,BP,EYA3
3063,GO:0006650,0.924662781579046,0.153367709399823,5,271,glycerophospholipid metabolic process,BP,FGF5;PLBD1;PLEKHA2;NRG1;AJUBA
8278,GO:0033135,0.924706844311792,0.273799389260004,1,83,regulation of peptidyl-serine phosphorylation,BP,RIPK2
10507,GO:0043488,0.924760026410118,0.207201086086742,2,141,regulation of mRNA stability,BP,PSMB9;NOCT
17567,GO:1901293,0.925182209609376,0.162905405528938,4,235,nucleoside phosphate biosynthetic process,BP,PGK1;PARP1;GPR176;PAPSS2
6291,GO:0019953,0.925236251052906,0.130796367108606,9,439,sexual reproduction,BP,B4GALT1;CLDN11;AXL;BIRC3;MMP19;BRD2;SETX;NR2F2;CALR
12810,GO:0051168,0.92744982028119,0.174337509261391,3,187,nuclear export,BP,TP53;IL1B;CALR
1439,GO:0003682,0.928382330310708,0.125978148105257,9,438,chromatin binding,MF,NFKB1;RELB;TP53;JUN;NFKB2;NOC3L;BRD2;AJUBA;CITED2
5538,GO:0016569,0.928383598700814,0.129599260595784,8,397,covalent chromatin modification,BP,TRIM16;TP53;IL1B;SUDS3;SDR16C5;CTR9;EYA3;SUPT3H
17195,GO:0110053,0.929492962004684,0.170366838405372,3,186,regulation of actin filament organization,BP,SLIT2;NRP1;DLG1
17808,GO:1902036,0.929774238603926,0.260074400445395,1,95,regulation of hematopoietic stem cell differentiation,BP,PSMB9
10477,GO:0043414,0.930976867184345,0.152398391092979,4,234,macromolecule methylation,BP,PARP1;CTR9;METTL2A;TRMT44
3124,GO:0006733,0.931072242416301,0.193536907485439,2,142,oxidoreduction coenzyme metabolic process,BP,PGK1;G6PD
2739,GO:0006165,0.932287065028183,0.253566316159123,1,87,nucleoside diphosphate phosphorylation,BP,PGK1
12827,GO:0051188,0.932325490281697,0.149897628296819,4,239,cofactor biosynthetic process,BP,CHAC1;PGK1;MOCS2;CYP1A1
4013,GO:0009062,0.933428490533906,0.250403751373787,1,89,fatty acid catabolic process,BP,IVD
11169,GO:0045333,0.934006647638783,0.186933615843493,2,153,cellular respiration,BP,ACO1;CS
7249,GO:0031248,0.934066807458789,0.248694202747702,1,88,protein acetyltransferase complex,CC,SUPT3H
17970,GO:1902493,0.934066807458789,0.248694202747702,1,88,acetyltransferase complex,CC,SUPT3H
5455,GO:0016407,0.93426005783526,0.24816577737653,1,88,acetyltransferase activity,MF,SUPT3H
7195,GO:0031109,0.934566224830712,0.247392860236586,1,86,microtubule polymerization or depolymerization,BP,CRYAB
14829,GO:0070647,0.934566311790566,0.0971941583367901,22,951,protein modification by small protein conjugation or removal,BP,NFKBIA;TNIP1;TP53;PSMB9;RIPK2;HERPUD1;HSPA5;CYLD;NEDD4L;BIRC3;SUDS3;TRAF3;HSP90AA1;TPP2;DCUN1D3;HSP90AB1;CTR9;MED18;PTTG1IP;CBLL1;NEDD4;SUPT3H
19173,GO:1905330,0.934665309658473,0.185579547064507,2,144,regulation of morphogenesis of an epithelium,BP,PSMB9;MAGED1
7209,GO:0031124,0.934898973472277,0.246414568843061,1,88,mRNA 3'-end processing,BP,CTR9
17262,GO:0140098,0.935380950885737,0.127842740172535,6,331,catalytic activity, acting on RNA,MF,RNASE7;NOCT;POP4;METTL2A;TRMT44;TYW1
8865,GO:0034708,0.9371048367216,0.240256837329243,1,90,methyltransferase complex,CC,MGA
13248,GO:0051983,0.937224032682365,0.239955808283739,1,89,regulation of chromosome segregation,BP,DUSP1
10506,GO:0043487,0.937359597341983,0.179502067711793,2,148,regulation of RNA stability,BP,PSMB9;NOCT
647,GO:0001841,0.937490473553456,0.239276902811904,1,87,neural tube formation,BP,SOX11
10750,GO:0044242,0.938072392033261,0.177907290178499,2,147,cellular lipid catabolic process,BP,MGLL;IVD
3583,GO:0008026,0.938210403953786,0.237265690530879,1,87,ATP-dependent helicase activity,MF,NBN
14492,GO:0070035,0.938210403953786,0.237265690530879,1,87,purine NTP-dependent helicase activity,MF,NBN
2479,GO:0005741,0.939871268862242,0.173829165906067,2,147,mitochondrial outer membrane,CC,PMAIP1;ARG1
9571,GO:0036459,0.939873426973014,0.232555153014612,1,88,thiol-dependent ubiquitinyl hydrolase activity,MF,CYLD
17069,GO:0101005,0.939873426973014,0.232555153014612,1,88,ubiquitinyl hydrolase activity,MF,CYLD
274,GO:0000777,0.940165914669533,0.231608068779838,1,92,condensed chromosome kinetochore,CC,GPATCH11
13643,GO:0060218,0.940344065490471,0.230893656890423,1,100,hematopoietic stem cell differentiation,BP,PSMB9
8908,GO:0034968,0.94078847827926,0.229929978223167,1,89,histone lysine methylation,BP,CTR9
5315,GO:0016070,0.941152121657391,0.0739089514239477,101,3759,RNA metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;RNASE7;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;TRIB1;FADS1;WWC1;NEDD4L;PUS10;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;IFRD1;ZNF697;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;MAFF;MGA;PRR5L;UBP1;METTL2A;IL23A;DLG1;TRMT44;MED18;ZMYM4;CITED2;ZNF814;ETS1;TYW1;TGFA;BAMBI;PRPF38A;ZC3H7B;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
5779,GO:0017048,0.941496832241824,0.170201392787109,2,140,Rho GTPase binding,MF,ARHGDIB;CORO1C
11653,GO:0046474,0.942428957749042,0.14441654796323,3,194,glycerophospholipid biosynthetic process,BP,FGF5;PLEKHA2;AJUBA
16816,GO:0098781,0.942735729671535,0.224218197091757,1,94,ncRNA transcription,BP,NABP1
11871,GO:0046939,0.94322847585543,0.222825794081905,1,93,nucleotide phosphorylation,BP,PGK1
7735,GO:0032273,0.943499542077759,0.222042946646444,1,93,positive regulation of protein polymerization,BP,DLG1
8820,GO:0034641,0.943792608514444,0.0695788600358184,141,5144,cellular nitrogen compound metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;RNASE7;CHAC1;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;ANPEP;JUNB;TJP2;ATF3;CREB5;EHF;NOCT;ERAP1;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;ANXA1;GPR176;G6PD;NBN;WWC1;THTPA;NEDD4L;PUS10;NOC3L;XBP1;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;EIF4G2;UQCC1;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;SERP1;EIF2B1;ORMDL1;MAFF;MOCS2;MGA;PRR5L;UBP1;METTL2A;IL23A;MME;DLG1;TRMT44;MED18;RBMS3;GDA;ZMYM4;CITED2;ZNF814;TXNRD1;ETS1;TYW1;TGFA;BAMBI;PRPF38A;DNAJC3;ZC3H7B;TFRC;ZFP42;NLRP10;NEDD4;PML;EPHA2;MRPS24;EID3;ZBTB21;HES4;SOX11;UGCG;MRPL53;ENPP1;RPL26L1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
3123,GO:0006732,0.943814088562413,0.119622292490119,5,295,coenzyme metabolic process,BP,PGK1;G6PD;THTPA;MOCS2;HMGCS1
5882,GO:0018107,0.944095543018939,0.220372931981792,1,91,peptidyl-threonine phosphorylation,BP,RIPK2
6897,GO:0030509,0.944862655995992,0.218141603515324,1,91,BMP signaling pathway,BP,SOX11
15019,GO:0071013,0.944976781076202,0.217673890991071,1,96,catalytic step 2 spliceosome,CC,ZCCHC8
4070,GO:0009141,0.945161287286597,0.125708382743933,4,257,nucleoside triphosphate metabolic process,BP,PGK1;PARP1;MOCS2;ENPP1
17630,GO:1901532,0.945234079203701,0.216756363218442,1,103,regulation of hematopoietic progenitor cell differentiation,BP,PSMB9
11483,GO:0046034,0.945320092849142,0.138361785891071,3,208,ATP metabolic process,BP,PGK1;PARP1;ENPP1
2845,GO:0006352,0.945838965274538,0.137302124290411,3,205,DNA-templated transcription, initiation,BP,TP53;JUN;SETX
3447,GO:0007276,0.946071503566083,0.104827327571757,7,376,gamete generation,BP,CLDN11;AXL;BIRC3;MMP19;BRD2;SETX;CALR
18303,GO:1903311,0.946460308266461,0.123236562765126,4,250,regulation of mRNA metabolic process,BP,PSMB9;NOCT;CTR9;PRR5L
6096,GO:0019359,0.947183655157282,0.211241476105105,1,94,nicotinamide nucleotide biosynthetic process,BP,PGK1
6098,GO:0019363,0.947183655157282,0.211241476105105,1,94,pyridine nucleotide biosynthetic process,BP,PGK1
7546,GO:0031929,0.947240955803948,0.211071862357633,1,94,TOR signaling,BP,PRR5L
14752,GO:0070507,0.947353839605998,0.156479940520304,2,148,regulation of microtubule cytoskeleton organization,BP,CYLD;CHORDC1
2859,GO:0006368,0.947510963329254,0.210195412616962,1,97,transcription elongation from RNA polymerase II promoter,BP,CTR9
14471,GO:0065004,0.947621938612271,0.133534133708176,3,213,protein-DNA complex assembly,BP,TP53;PARP1;BRD2
16819,GO:0098791,0.947864180539516,0.0860826588713081,14,659,Golgi subcompartment,CC,B4GALT1;CHAC1;MYO1B;OPTN;GNPTAB;STEAP4;MGAT5;SLC35B1;RAB30;SEC24D;TGFA;SVIP;GALNT14;UGCG
18176,GO:1903008,0.948104334778564,0.208457180985499,1,96,organelle disassembly,BP,OPTN
8809,GO:0034622,0.948379525869353,0.080295471528452,19,881,cellular protein-containing complex assembly,BP,NEFL;TP53;SLIT2;PARP1;CRYAB;NOCT;COBLL1;HSP90AA1;BRD2;SETX;NRG1;HSP90AB1;UQCC1;CALR;DLG1;SEC24D;PDE4DIP;CLINT1;HSPD1
7733,GO:0032271,0.949158700860112,0.152159086560567,2,152,regulation of protein polymerization,BP,SLIT2;DLG1
6585,GO:0022626,0.949550537099333,0.203827269222599,1,110,cytosolic ribosome,CC,RPL26L1
7573,GO:0031966,0.949587795276391,0.0880803969684068,11,577,mitochondrial membrane,CC,PMAIP1;IKBKE;LYN;ANXA1;ARG1;SOD2;UQCC1;REEP1;MRPS24;MRPL53;HSPD1
13560,GO:0060071,0.94984174021173,0.203182152624742,1,99,Wnt signaling pathway, planar cell polarity pathway,BP,PSMB9
5644,GO:0016772,0.949980954363477,0.0797099161145219,17,773,transferase activity, transferring phosphorus-containing groups,MF,FGF5;NAGK;PGK1;RIPK2;TJP2;AXL;IKBKE;LYN;PAPSS2;HSP90AA1;NRP1;GNPTAB;NRG1;DLG1;CDK6;EPHA2;IRAK2
6588,GO:0022804,0.950559551735227,0.127415525610632,3,200,active transmembrane transporter activity,MF,SLC16A9;SLC8A1;SLC7A5P2
5865,GO:0018022,0.950854145530274,0.20021910420985,1,95,peptidyl-lysine methylation,BP,CTR9
12361,GO:0048839,0.951387980411424,0.19859683777554,1,95,inner ear development,BP,MAFB
19617,GO:1990904,0.951634083022709,0.0804211659104442,14,701,ribonucleoprotein complex,CC,NOCT;DERL3;CANX;RBM28;POP4;CALR;AJUBA;ZCCHC8;SERP1;PRPF38A;MRPS24;MRPL53;RPL26L1;SND1
15782,GO:0072525,0.952012493795171,0.196642448039565,1,97,pyridine-containing compound biosynthetic process,BP,PGK1
5645,GO:0016773,0.952057979348378,0.0825797930993218,12,575,phosphotransferase activity, alcohol group as acceptor,MF,FGF5;RIPK2;AXL;IKBKE;LYN;PAPSS2;HSP90AA1;NRP1;NRG1;CDK6;EPHA2;IRAK2
14068,GO:0060964,0.952127606345048,0.196155233277262,1,103,regulation of gene silencing by miRNA,BP,AJUBA
3075,GO:0006664,0.952302350269482,0.195685801911699,1,100,glycolipid metabolic process,BP,UGCG
18388,GO:1903509,0.952302350269482,0.195685801911699,1,100,liposaccharide metabolic process,BP,UGCG
15703,GO:0072329,0.952536603737697,0.194967649042936,1,100,monocarboxylic acid catabolic process,BP,IVD
15409,GO:0071772,0.952889275503693,0.193977503192381,1,96,response to BMP,BP,SOX11
15410,GO:0071773,0.952889275503693,0.193977503192381,1,96,cellular response to BMP stimulus,BP,SOX11
16114,GO:0090175,0.953009651395239,0.193491663611387,1,101,regulation of establishment of planar polarity,BP,PSMB9
17248,GO:0140056,0.953370265754615,0.141989986891635,2,155,organelle localization by membrane tethering,BP,HSP90AA1;CEP83
12998,GO:0051494,0.953556775685516,0.191895082173576,1,97,negative regulation of cytoskeleton organization,BP,SLIT2
3419,GO:0007224,0.953775340684392,0.191218957985511,1,97,smoothened signaling pathway,BP,IFT46
12498,GO:0050684,0.955200200766531,0.186739114122241,1,99,regulation of mRNA processing,BP,CTR9
6214,GO:0019783,0.955901853398526,0.18456142459851,1,98,ubiquitin-like protein-specific protease activity,MF,CYLD
10503,GO:0043484,0.956079003907302,0.183959492827743,1,100,regulation of RNA splicing,BP,SETX
13601,GO:0060147,0.956382393608603,0.182880119952133,1,106,regulation of posttranscriptional gene silencing,BP,AJUBA
14070,GO:0060966,0.956382393608603,0.182880119952133,1,106,regulation of gene silencing by RNA,BP,AJUBA
5311,GO:0016055,0.956743395088274,0.0864702939464875,7,389,Wnt signaling pathway,BP,NFKB1;PSMB9;CYLD;CTR9;AMOTL2;RBMS3;BAMBI
644,GO:0001838,0.956994081996334,0.18109096565833,1,99,embryonic epithelial tube formation,BP,SOX11
12847,GO:0051225,0.957357109982048,0.179916860619921,1,100,spindle assembly,BP,BIRC3
2787,GO:0006260,0.957566036554105,0.101293934957788,4,257,DNA replication,BP,JUN;PARP1;NBN;CALR
2462,GO:0005694,0.957583127364625,0.0671037148503515,19,882,chromosome,CC,CDKN2A;TP53;NABP1;JUN;PARP1;JUNB;NBN;SUDS3;SETX;GPATCH11;SDR16C5;CTR9;CITED2;SUGT1;ZFP42;NEDD4;PML;EID3;MAGED1
17290,GO:0198738,0.958254916229114,0.0838171407034443,7,391,cell-cell signaling by wnt,BP,NFKB1;PSMB9;CYLD;CTR9;AMOTL2;RBMS3;BAMBI
2786,GO:0006259,0.958326693988359,0.0667246024677363,18,844,DNA metabolic process,BP,TP53;NABP1;JUN;PARP1;DUSP1;FIGN;ANXA1;NBN;HSP90AA1;IL7R;SETX;HSP90AB1;CALR;EYA3;TFRC;PML;EID3;HSPD1
2699,GO:0006090,0.9586750881507,0.175664970229281,1,102,pyruvate metabolic process,BP,PGK1
5880,GO:0018105,0.958710906233746,0.109733771535812,3,208,peptidyl-serine phosphorylation,BP,RIPK2;IKBKE;IL24
3645,GO:0008144,0.958815868334886,0.0603225592606719,30,1266,drug binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;PAPSS2;HSP90AA1;SETX;HSP90AB1;PPID;HMGCS1;EHD1;CHORDC1;HSP90B1;NLRP10;HTR1B;CDK6;EPHA2;MYH9;ENPP1;HSPD1;IRAK2;CYP1A1
276,GO:0000779,0.958888208993337,0.174940070590285,1,104,condensed chromosome, centromeric region,CC,GPATCH11
2259,GO:0005215,0.959015756821529,0.0692558667618987,14,678,transporter activity,MF,SLC16A9;SPNS2;ITGAV;SLC8A1;KCNQ5;SLC7A5P2;CLCC1;ANO4;SLC39A14;SLC35B1;MAGT1;SEC22A;DLG1;TFRC
9574,GO:0036464,0.959199827233296,0.127508490330569,2,161,cytoplasmic ribonucleoprotein granule,CC,NOCT;AJUBA
2801,GO:0006281,0.959275951142275,0.0765581458907328,9,485,DNA repair,BP,TP53;NABP1;PARP1;FIGN;NBN;SETX;EYA3;PML;EID3
7575,GO:0031968,0.959404789979696,0.126984015150151,2,162,organelle outer membrane,CC,PMAIP1;ARG1
10857,GO:0044431,0.959511516704915,0.067480143164348,15,716,Golgi apparatus part,CC,B4GALT1;CHAC1;HS3ST1;MYO1B;OPTN;GNPTAB;STEAP4;MGAT5;SLC35B1;RAB30;SEC24D;TGFA;SVIP;GALNT14;UGCG
17236,GO:0140013,0.959878597467882,0.171763239692058,1,103,meiotic nuclear division,BP,CALR
5833,GO:0017148,0.960315168209904,0.106139734639973,3,216,negative regulation of translation,BP,CALR;AJUBA;ZC3H7B
11006,GO:0045017,0.960974635415957,0.10469387446106,3,211,glycerolipid biosynthetic process,BP,FGF5;PLEKHA2;AJUBA
6559,GO:0022406,0.961067841575261,0.12277172449846,2,162,membrane docking,BP,HSP90AA1;CEP83
15617,GO:0072175,0.961144054164942,0.167661871265545,1,102,epithelial tube formation,BP,SOX11
6255,GO:0019867,0.96165158346719,0.121267069110897,2,164,outer membrane,CC,PMAIP1;ARG1
2833,GO:0006334,0.963157455486418,0.160774717012302,1,116,nucleosome assembly,BP,BRD2
3323,GO:0007052,0.963163910204062,0.160937673824931,1,105,mitotic spindle organization,BP,BIRC3
582,GO:0001736,0.96360166726973,0.159407137850186,1,109,establishment of planar polarity,BP,PSMB9
3371,GO:0007164,0.96360166726973,0.159407137850186,1,109,establishment of tissue polarity,BP,PSMB9
2531,GO:0005813,0.964041262178468,0.0707796575573823,8,440,centrosome,CC,KRT18;RELB;FEZ1;IFT46;CYLD;EYA3;PDE4DIP;CDK6
11776,GO:0046700,0.964834134187689,0.0653467923537651,10,548,heterocycle catabolic process,BP,PSMB9;PGK1;NOCT;HMOX1;EGLN1;PRR5L;GDA;ENPP1;SND1;CYP1A1
4950,GO:0015077,0.966452585613046,0.108778087340981,2,168,monovalent inorganic cation transmembrane transporter activity,MF,SLC8A1;KCNQ5
10243,GO:0043021,0.966452616585852,0.149752527385366,1,110,ribonucleoprotein complex binding,MF,HSPA5
6968,GO:0030666,0.966588692632244,0.149270364152121,1,111,endocytic vesicle membrane,CC,CALR
2533,GO:0005815,0.967237403976853,0.0586055362867226,12,610,microtubule organizing center,CC,KRT18;RELB;FEZ1;IFT46;HSPA6;CYLD;FIGN;AJUBA;EYA3;PDE4DIP;CDK6;CEP83
5627,GO:0016740,0.96726822763192,0.0457530413558156,46,1891,transferase activity,MF,B4GALT1;FGF5;NAGK;PGK1;HS3ST1;RIPK2;PARP1;TJP2;AXL;IKBKE;STT3A;LYN;NEDD4L;BIRC3;UGGT1;TRAF3;PAPSS2;HSP90AA1;NRP1;GNPTAB;NRG1;MGAT5;MAGT1;MOCS2;HMGCS1;CS;METTL2A;DLG1;TRMT44;MED18;DHDDS;HAS2;MGST3;CBLL1;BCAT1;NEDD4;CDK6;ZDHHC6;OXCT1;EPHA2;GALNT14;GBE1;UGCG;SUPT3H;IRAK2;SDF2L1
3346,GO:0007098,0.967406238367497,0.146506933925877,1,108,centrosome cycle,BP,CHORDC1
9282,GO:0035770,0.967827219008677,0.105122011695283,2,170,ribonucleoprotein granule,CC,NOCT;AJUBA
10864,GO:0044441,0.968472684402786,0.0786426694059806,4,269,ciliary part,CC,IFT46;CYLD;EHD1;CEP83
10593,GO:0043624,0.968557460939942,0.103116415447446,2,179,cellular protein complex disassembly,BP,MRPS24;MRPL53
5633,GO:0016747,0.968824208559514,0.102444883572897,2,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ZDHHC6;SUPT3H
14989,GO:0070972,0.969173449543998,0.140115278568551,1,125,protein localization to endoplasmic reticulum,BP,HSPA5
6131,GO:0019439,0.969205465445196,0.0580126765448258,10,557,aromatic compound catabolic process,BP,PSMB9;PGK1;NOCT;HMOX1;EGLN1;PRR5L;GDA;ENPP1;SND1;CYP1A1
20041,GO:2000736,0.969371675200841,0.139469405985493,1,121,regulation of stem cell differentiation,BP,PSMB9
15437,GO:0071824,0.969997173432577,0.0839250614270996,3,237,protein-DNA complex subunit organization,BP,TP53;PARP1;BRD2
98,GO:0000209,0.970289825147527,0.0747300959156888,4,276,protein polyubiquitination,BP,PSMB9;NEDD4L;TPP2;NEDD4
5540,GO:0016571,0.970354624518519,0.13613741006851,1,111,histone methylation,BP,CTR9
272,GO:0000775,0.970502917115774,0.0979085870264399,2,173,chromosome, centromeric region,CC,GPATCH11;SUGT1
288,GO:0000793,0.970915397813692,0.0967806250290713,2,174,condensed chromosome,CC,GPATCH11;EID3
10361,GO:0043226,0.971332770707047,0.0382754386875654,282,9764,organelle,CC,CDKN2A;NFKBIA;MMP9;FLG2;TRIM16;TCHH;KRT1;NEFL;NETO1;KRT8;CXCL1;LGALS1;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;CD274;FLG;DBNDD2;NAGK;SLIT2;RNASE7;KPRP;UBQLN2;CHAC1;COL12A1;KRT78;EPCAM;CDKN2B;NABP1;PGK1;HS3ST1;MYO1B;DNAJB1;PEG10;JUN;KRT4;CLDN11;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;SDK1;HRNR;HSPA5;IL1B;MSRB3;IFT46;KRT13;ANPEP;JUNB;TJP2;IL6ST;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;AXL;ACTG1;CREB5;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;CDSN;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;STT3A;ITGAV;LYN;NCEH1;COBLL1;AP3M1;COL8A1;C1R;ANXA1;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;SYT11;KLK6;ZNF638;KCTD12;RIMS2;HSP90AA1;CANX;FTH1;NRP1;TPP2;IL7R;EGLN1;BRD2;SETX;GNPTAB;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;CLCC1;STXBP5;NR2F2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;ARHGDIB;UBP1;GIT2;CS;CORO1C;NID2;IL23A;MME;DLG1;PDIA4;MED18;NGLY1;GDA;EHD1;PITHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;DHDDS;ETS1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;ANKRD13A;HSP90B1;TFRC;ZFP42;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;PVR;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;GBE1;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
3654,GO:0008168,0.971619314825634,0.0948460623015118,2,176,methyltransferase activity,MF,METTL2A;TRMT44
13055,GO:0051606,0.971642099527258,0.131466359236464,1,116,detection of stimulus,BP,PARP1
2478,GO:0005740,0.971752597955143,0.0523577581588013,11,617,mitochondrial envelope,CC,PMAIP1;IKBKE;LYN;ANXA1;ARG1;SOD2;UQCC1;REEP1;MRPS24;MRPL53;HSPD1
7858,GO:0032446,0.972242223513486,0.0471472366797546,16,790,protein modification by small protein conjugation,BP,PSMB9;RIPK2;HERPUD1;HSPA5;NEDD4L;BIRC3;TRAF3;HSP90AA1;TPP2;DCUN1D3;HSP90AB1;CTR9;MED18;PTTG1IP;CBLL1;NEDD4
2375,GO:0005524,0.972308631711595,0.0427097198056672,26,1149,ATP binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;PAPSS2;HSP90AA1;SETX;HSP90AB1;EHD1;CHORDC1;HSP90B1;NLRP10;CDK6;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
8977,GO:0035148,0.972599550778909,0.128049048501623,1,113,tube formation,BP,SOX11
16207,GO:0090304,0.973243843082023,0.0346436702500093,110,4174,nucleic acid metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;RNASE7;EPCAM;CDKN2B;NABP1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;ANXA1;NBN;WWC1;NEDD4L;PUS10;NOC3L;XBP1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;MAFF;MGA;PRR5L;UBP1;METTL2A;IL23A;DLG1;TRMT44;MED18;ZMYM4;CITED2;ZNF814;ETS1;TYW1;TGFA;BAMBI;PRPF38A;ZC3H7B;TFRC;ZFP42;NLRP10;NEDD4;PML;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
5488,GO:0016458,0.973809211604548,0.0748415224472743,3,237,gene silencing,BP,AJUBA;ZC3H7B;SND1
7141,GO:0031023,0.974098606899375,0.122536151835719,1,115,microtubule organizing center organization,BP,CHORDC1
5360,GO:0016197,0.97414809577169,0.0878434076592679,2,177,endosomal transport,BP,ANXA8;EHD1
7208,GO:0031123,0.974275948889473,0.121830145285855,1,119,RNA 3'-end processing,BP,CTR9
8759,GO:0034470,0.974594243173074,0.0567529733238982,6,396,ncRNA processing,BP,PUS10;POP4;C2ORF49;METTL2A;TRMT44;TYW1
2847,GO:0006354,0.974699994601061,0.120235712606612,1,121,DNA-templated transcription, elongation,BP,CTR9
7724,GO:0032259,0.97494239382193,0.0645482898490625,4,283,methylation,BP,PARP1;CTR9;METTL2A;TRMT44
6254,GO:0019866,0.975306629663974,0.0527112731906079,7,450,organelle inner membrane,CC,LYN;SOD2;UQCC1;MRPS24;TOR1AIP1;MRPL53;HSPD1
583,GO:0001738,0.975402718433391,0.117617627643409,1,121,morphogenesis of a polarized epithelium,BP,PSMB9
2481,GO:0005743,0.975857174590568,0.0542507914590074,6,407,mitochondrial inner membrane,CC,LYN;SOD2;UQCC1;MRPS24;MRPL53;HSPD1
17597,GO:1901361,0.976124620673627,0.0461357312582895,10,573,organic cyclic compound catabolic process,BP,PSMB9;PGK1;NOCT;HMOX1;EGLN1;PRR5L;GDA;ENPP1;SND1;CYP1A1
11659,GO:0046483,0.976277076113189,0.0306377436180325,125,4715,heterocycle metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;RNASE7;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;TJP2;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;ANXA1;GPR176;G6PD;NBN;WWC1;THTPA;NEDD4L;PUS10;NOC3L;XBP1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;MAFF;MOCS2;MGA;PRR5L;UBP1;METTL2A;IL23A;MME;DLG1;TRMT44;MED18;GDA;ZMYM4;CITED2;ZNF814;TXNRD1;ETS1;TYW1;TGFA;BAMBI;PRPF38A;ZC3H7B;TFRC;ZFP42;NLRP10;NEDD4;PML;EPHA2;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;CYP1A1
5628,GO:0016741,0.977773890499857,0.077504783623427,2,185,transferase activity, transferring one-carbon groups,MF,METTL2A;TRMT44
14072,GO:0060968,0.977921996668619,0.107993485329643,1,127,regulation of gene silencing,BP,AJUBA
3784,GO:0008380,0.978038053258775,0.0499233766677107,6,391,RNA splicing,BP,ZNF638;SETX;RBM28;C2ORF49;ZCCHC8;PRPF38A
7938,GO:0032559,0.978371675963175,0.0339250360300337,26,1169,adenyl ribonucleotide binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;PAPSS2;HSP90AA1;SETX;HSP90AB1;EHD1;CHORDC1;HSP90B1;NLRP10;CDK6;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
18094,GO:1902850,0.978473290835673,0.1059158216911,1,122,microtubule cytoskeleton organization involved in mitosis,BP,BIRC3
2071,GO:0004842,0.978876608138304,0.0482498552372472,6,379,ubiquitin-protein transferase activity,MF,NEDD4L;BIRC3;TRAF3;MED18;CBLL1;NEDD4
5909,GO:0018205,0.978943018173166,0.0512028596843821,5,337,peptidyl-lysine modification,BP,TRIM16;IL1B;SDR16C5;CTR9;SUPT3H
5650,GO:0016779,0.979140682546574,0.103265956442736,1,127,nucleotidyltransferase activity,MF,PAPSS2
4339,GO:0009952,0.979430983002929,0.102169600430598,1,123,anterior/posterior pattern specification,BP,NR2F2
4042,GO:0009108,0.980222776481923,0.0703286206785974,2,190,coenzyme biosynthetic process,BP,PGK1;MOCS2
10866,GO:0044445,0.980287286306174,0.0700882421418281,2,203,cytosolic part,CC,NEFL;RPL26L1
6508,GO:0021915,0.980345041320638,0.0985614372902602,1,123,neural tube development,BP,SOX11
2604,GO:0005929,0.980636614821841,0.0475739537270131,5,339,cilium,CC,IFT46;CYLD;ANXA1;EHD1;CEP83
16438,GO:0097164,0.980717629974666,0.0970203211619793,1,129,ammonium ion metabolic process,BP,PLBD1
5116,GO:0015630,0.980740966886648,0.0320755056840532,20,964,microtubule cytoskeleton,CC,SAA1;KRT18;RELB;FEZ1;MAP7D2;IFT46;CRYAB;HSPA6;CYLD;FIGN;SLC8A1;AJUBA;EYA3;SERP1;DLG1;PDE4DIP;CDK6;TUBB3;MYH9;CEP83
6926,GO:0030554,0.98126698106413,0.0296645679184229,26,1181,adenyl nucleotide binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;PAPSS2;HSP90AA1;SETX;HSP90AB1;EHD1;CHORDC1;HSP90B1;NLRP10;CDK6;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
6613,GO:0022900,0.981711600416686,0.0929298897825927,1,141,electron transport chain,BP,TXNRD1
2728,GO:0006139,0.981870170314278,0.0237124099782585,121,4611,nucleobase-containing compound metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;RNASE7;EPCAM;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;TJP2;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;ANXA1;GPR176;G6PD;NBN;WWC1;NEDD4L;PUS10;NOC3L;XBP1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;MAFF;MOCS2;MGA;PRR5L;UBP1;METTL2A;IL23A;DLG1;TRMT44;MED18;GDA;ZMYM4;CITED2;ZNF814;TXNRD1;ETS1;TYW1;TGFA;BAMBI;PRPF38A;ZC3H7B;TFRC;ZFP42;NLRP10;NEDD4;PML;EPHA2;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2
8879,GO:0034728,0.982105706435171,0.0913478136454652,1,139,nucleosome organization,BP,BRD2
3950,GO:0008757,0.982490687742845,0.0898429223846997,1,131,S-adenosylmethionine-dependent methyltransferase activity,MF,METTL2A
10762,GO:0044270,0.982793736210312,0.0353640473488254,9,548,cellular nitrogen compound catabolic process,BP,PSMB9;PGK1;NOCT;HMOX1;EGLN1;PRR5L;GDA;ENPP1;SND1
9159,GO:0035567,0.982882924171613,0.0882264043866458,1,132,non-canonical Wnt signaling pathway,BP,PSMB9
3119,GO:0006725,0.983618449363188,0.0214812602398947,124,4728,cellular aromatic compound metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;RNASE7;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;TJP2;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;ANXA1;GPR176;G6PD;NBN;WWC1;THTPA;NEDD4L;PUS10;NOC3L;XBP1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;MAFF;MOCS2;MGA;PRR5L;UBP1;METTL2A;IL23A;DLG1;TRMT44;MED18;GDA;ZMYM4;CITED2;ZNF814;TXNRD1;ETS1;TYW1;TGFA;BAMBI;PRPF38A;ZC3H7B;TFRC;ZFP42;NLRP10;NEDD4;PML;EPHA2;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;CYP1A1
16826,GO:0098798,0.984249039310903,0.058067472949203,2,218,mitochondrial protein complex,CC,MRPS24;MRPL53
5308,GO:0016052,0.98476052069714,0.0803808212779419,1,134,carbohydrate catabolic process,BP,PGK1
16533,GO:0097367,0.98494954347323,0.0227988357831527,36,1582,carbohydrate derivative binding,MF,SAA1;TP53;DPYSL3;NAGK;SLIT2;RNASE7;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;RHOB;PAPSS2;HSP90AA1;NRP1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;TYW1;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
5710,GO:0016874,0.985146133765207,0.0787368046286817,1,135,ligase activity,MF,PARP1
7181,GO:0031090,0.98525542060176,0.0211533072660186,52,2220,organelle membrane,CC,B4GALT1;PMAIP1;DBNDD2;MYO1B;SPNS2;OPTN;ANPEP;IKBKE;STOML1;ANXA8;ITGAV;LYN;AP3M1;ANXA1;DERL3;RHOB;ARG1;SEC11C;SYT11;IL7R;GNPTAB;SOD2;HSP90AB1;ADAM8;STXBP5;STEAP4;UQCC1;CALR;MGAT5;SLC35B1;MAGT1;RAB30;MME;EHD1;SEC24D;REEP1;TGFA;MGST3;PRPF38A;DNAJC3;TFRC;SVIP;PML;MRPS24;GALNT14;TOR1AIP1;UGCG;MRPL53;ENPP1;HSPD1;IRAK2;CYP1A1
7282,GO:0031301,0.986073169613784,0.0747254252308393,1,140,integral component of organelle membrane,CC,SLC35B1
1953,GO:0004674,0.986428391892132,0.0325761330128629,6,395,protein serine/threonine kinase activity,MF,RIPK2;AXL;IKBKE;CDK6;EPHA2;IRAK2
6217,GO:0019787,0.986829697982625,0.0317105149827374,6,403,ubiquitin-like protein transferase activity,MF,NEDD4L;BIRC3;TRAF3;MED18;CBLL1;NEDD4
17596,GO:1901360,0.987348207194327,0.0167334121177598,127,4863,organic cyclic compound metabolic process,BP,CDKN2A;NFKBIA;IL1A;TRIM16;OSR2;TNIP1;NFKB1;MAFB;RELB;EDN1;TP53;PSMB9;NAGK;RNASE7;EPCAM;SLC16A9;CDKN2B;NABP1;PGK1;DNAJB1;JUN;ZNF165;RIPK2;IL16;NFKB2;ARID3B;PARP1;HSPA5;IL1B;JUNB;TJP2;ATF3;CREB5;EHF;NOCT;CYLD;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;ANXA1;GPR176;G6PD;NBN;WWC1;THTPA;NEDD4L;PUS10;NOC3L;XBP1;UGGT1;SUDS3;TRAF3;ARNTL2;HMOX1;ZNF638;PAPSS2;HSP90AA1;IL7R;TRAF1;EGLN1;BRD2;SETX;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;IFRD1;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;ADAM8;C2ORF49;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;EYA3;ZCCHC8;MAFF;MOCS2;MGA;PRR5L;HMGCS1;UBP1;METTL2A;IL23A;MME;DLG1;TRMT44;MED18;GDA;ZMYM4;CITED2;ZNF814;TXNRD1;ETS1;TYW1;MSMO1;TGFA;BAMBI;PRPF38A;ZC3H7B;TFRC;ZFP42;NLRP10;NEDD4;PML;EPHA2;EID3;ZBTB21;HES4;SOX11;ENPP1;HSPD1;SND1;MAGED1;SUPT3H;IRAK2;CYP1A1
35,GO:0000070,0.987739721489264,0.0674021659792832,1,142,mitotic sister chromatid segregation,BP,DUSP1
8832,GO:0034655,0.987935318822939,0.0266040075069733,8,522,nucleobase-containing compound catabolic process,BP,PSMB9;PGK1;NOCT;EGLN1;PRR5L;GDA;ENPP1;SND1
8200,GO:0032984,0.988699412057119,0.036396941652906,3,274,protein-containing complex disassembly,BP,SETX;MRPS24;MRPL53
10855,GO:0044429,0.989236150800539,0.0200035117593395,15,851,mitochondrial part,CC,TP53;PMAIP1;IKBKE;LYN;ANXA1;ARG1;SOD2;UQCC1;CS;REEP1;IVD;OXCT1;MRPS24;MRPL53;HSPD1
10872,GO:0044451,0.989627602248031,0.018249745725214,19,975,nucleoplasm part,CC,TRIM16;TP53;IL16;IKBKE;NBN;NOC3L;SUDS3;ZNF638;TPP2;BRD2;SETX;CTR9;ZCCHC8;MOCS2;MGA;MED18;CBLL1;PML;SUPT3H
2858,GO:0006367,0.989853481171827,0.0577468690846542,1,150,transcription initiation from RNA polymerase II promoter,BP,TP53
2422,GO:0005635,0.990485654612688,0.0253684088625419,5,375,nuclear envelope,CC,PARP1;CALR;MGST3;PRPF38A;TOR1AIP1
874,GO:0002244,0.990490185975377,0.0547314345252583,1,158,hematopoietic progenitor cell differentiation,BP,PSMB9
8206,GO:0032993,0.990594578121378,0.0542187107477878,1,163,protein-DNA complex,CC,PARP1
2935,GO:0006479,0.990787512567428,0.0533648894425405,1,149,protein methylation,BP,CTR9
3689,GO:0008213,0.990787512567428,0.0533648894425405,1,149,protein alkylation,BP,CTR9
7932,GO:0032553,0.990811139885203,0.0146948621194837,31,1433,ribonucleotide binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;RHOB;PAPSS2;HSP90AA1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;TYW1;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
82,GO:0000166,0.990832830314059,0.0142676129690953,36,1628,nucleotide binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;PARP1;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;G6PD;RHOB;PAPSS2;HSP90AA1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;TXNRD1;TYW1;IVD;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ZBTB21;ENPP1;HSPD1;IRAK2
6576,GO:0022613,0.990909596476287,0.0227410540166003,6,446,ribonucleoprotein complex biogenesis,BP,NOCT;HSP90AA1;SETX;POP4;HSP90AB1;RPL26L1
17562,GO:1901265,0.99092646943962,0.0141295459080583,36,1629,nucleoside phosphate binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;PARP1;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;G6PD;RHOB;PAPSS2;HSP90AA1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;TXNRD1;TYW1;IVD;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ZBTB21;ENPP1;HSPD1;IRAK2
7281,GO:0031300,0.990946208691771,0.0525878349408828,1,154,intrinsic component of organelle membrane,CC,SLC35B1
3037,GO:0006612,0.991051241250849,0.0520430032201656,1,165,protein targeting to membrane,BP,ZDHHC6
2837,GO:0006338,0.991160155403816,0.0515617296944047,1,155,chromatin remodeling,BP,CDKN2A
3699,GO:0008234,0.991214502889405,0.05131844299592,1,151,cysteine-type peptidase activity,MF,CYLD
8835,GO:0034660,0.991430812906963,0.0195086457477013,8,546,ncRNA metabolic process,BP,NFKB1;NABP1;PUS10;POP4;C2ORF49;METTL2A;TRMT44;TYW1
2878,GO:0006401,0.99157328759737,0.0248894911160682,4,346,RNA catabolic process,BP,PSMB9;NOCT;PRR5L;SND1
9217,GO:0035639,0.991581534713434,0.0136141966809409,30,1402,purine ribonucleoside triphosphate binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;RHOB;PAPSS2;HSP90AA1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
10876,GO:0044455,0.991652165602464,0.0491497067388319,1,166,mitochondrial membrane part,CC,LYN
2874,GO:0006397,0.992021560014834,0.0202294501299405,6,439,mRNA processing,BP,NOCT;SETX;RBM28;CTR9;ZCCHC8;PRPF38A
136,GO:0000287,0.992030429758973,0.0473524815421931,1,154,magnesium ion binding,MF,THTPA
6007,GO:0019083,0.992519325615366,0.0448871783119706,1,170,viral transcription,BP,JUN
10364,GO:0043229,0.993183812898501,0.009488041546775,262,9288,intracellular organelle,CC,CDKN2A;NFKBIA;MMP9;FLG2;TRIM16;TCHH;KRT1;NEFL;KRT8;CXCL1;LGALS1;SAA1;OSR2;KRT24;KRT2;LCP1;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;NEFM;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;DPYSL3;PMAIP1;PSMB9;FLG;DBNDD2;UBQLN2;CHAC1;COL12A1;KRT78;CDKN2B;NABP1;HS3ST1;MYO1B;DNAJB1;PEG10;JUN;KRT4;MCAM;ZNF165;MAP7D2;RIPK2;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;HRNR;HSPA5;IL1B;MSRB3;IFT46;KRT13;ANPEP;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;ACTG1;CREB5;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;CYLD;STOML1;NFKBIE;DUSP1;ANXA8;TRIB1;FADS1;FIGN;PLBD1;KRT23;STT3A;ITGAV;LYN;NCEH1;AP3M1;COL8A1;ANXA1;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;VEGFC;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;SYT11;KLK6;ZNF638;RIMS2;HSP90AA1;CANX;FTH1;NRP1;TPP2;IL7R;EGLN1;BRD2;SETX;GNPTAB;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;GPATCH11;VGLL3;KRT34;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;CLCC1;STXBP5;NR2F2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;AMOTL2;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;ARHGDIB;UBP1;GIT2;CS;CORO1C;IL23A;MME;DLG1;PDIA4;MED18;NGLY1;EHD1;PITHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;DHDDS;ETS1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;ANKRD13A;HSP90B1;TFRC;ZFP42;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;MON1A;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;AFAP1;RPL26L1;CLINT1;TPM4;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1;TJP1;PARVA
7934,GO:0032555,0.993573441790633,0.0105489557748768,30,1422,purine ribonucleotide binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;RHOB;PAPSS2;HSP90AA1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
171,GO:0000377,0.994130615153379,0.0205372732235711,3,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,SETX;ZCCHC8;PRPF38A
183,GO:0000398,0.994130615153379,0.0205372732235711,3,298,mRNA splicing, via spliceosome,BP,SETX;ZCCHC8;PRPF38A
170,GO:0000375,0.994541167076833,0.0192673066133092,3,301,RNA splicing, via transesterification reactions,BP,SETX;ZCCHC8;PRPF38A
5795,GO:0017076,0.994641962058926,0.00888145887204174,30,1436,purine nucleotide binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;RHOB;PAPSS2;HSP90AA1;SETX;HSP90AB1;RRAS2;RAB30;EHD1;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
6004,GO:0019080,0.995165243874059,0.0311845823145018,1,184,viral gene expression,BP,JUN
2421,GO:0005634,0.99548943249606,0.00614189705598212,149,5706,nucleus,CC,CDKN2A;NFKBIA;FLG2;TRIM16;KRT1;KRT8;LGALS1;OSR2;KRT2;TNIP1;DUSP8;KRT18;NFKB1;MAFB;RELB;TP53;PMAIP1;PSMB9;FLG;UBQLN2;CDKN2B;NABP1;DNAJB1;PEG10;JUN;KRT4;MCAM;ZNF165;IL16;NFKB2;ARID3B;PARP1;OPTN;HRNR;HSPA5;KRT13;JUNB;TJP2;HSPB8;CRYAB;ATF3;DNAJB9;ACTG1;CREB5;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;NFKBIE;DUSP1;TRIB1;FIGN;LYN;ANXA1;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;NOC3L;RHOB;XBP1;ARG1;SUDS3;CSRP1;ARNTL2;GSTCD;HMOX1;KLK6;ZNF638;HSP90AA1;FTH1;TPP2;EGLN1;BRD2;SETX;RBM28;POP4;ZNF132;KLF10;NRG1;IFRD1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;C2ORF49;CLCC1;NR2F2;CALR;EDRF1;PPID;CTR9;AJUBA;IGFBP3;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;CS;DLG1;MED18;NGLY1;PITHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;ETS1;PDE4DIP;MGST3;SUGT1;PRPF38A;CBLL1;ZC3H7B;HSP90B1;ZFP42;UBXN2B;CDK6;TUBB3;PML;OXCT1;EPB41L2;MYH9;EID3;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;SORBS2;CLINT1;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2
9959,GO:0042393,0.995594389595396,0.0288672455854518,1,173,histone binding,MF,BRD2
9444,GO:0036094,0.995995884207724,0.00640206227607058,39,1811,small molecule binding,MF,TP53;NAGK;PGK1;MYO1B;RIPK2;PARP1;HSPA5;AXL;ACTG1;HSPA6;IKBKE;FIGN;LYN;G6PD;RHOB;PAPSS2;HSP90AA1;EGLN1;SETX;HSP90AB1;NR2F2;RRAS2;RAB30;HMGCS1;EHD1;TXNRD1;TYW1;IVD;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ZBTB21;ENPP1;HSPD1;IRAK2
2879,GO:0006402,0.996021782704957,0.0145651238393721,3,322,mRNA catabolic process,BP,PSMB9;NOCT;PRR5L
10322,GO:0043168,0.996297947809606,0.00581441814455993,44,2000,anion binding,MF,SAA1;TP53;DPYSL3;NAGK;SLIT2;PGK1;MYO1B;RIPK2;HSPA5;AXL;ACTG1;HSPA6;IKBKE;ANXA8;FIGN;LYN;ANXA1;PLEKHA2;RHOB;SYT11;PAPSS2;HSP90AA1;DAPP1;NRP1;EGLN1;SETX;HSP90AB1;NR2F2;RRAS2;RAB30;EHD1;TXNRD1;TYW1;IVD;CHORDC1;HSP90B1;NLRP10;CDK6;TUBB3;EPHA2;MYH9;ENPP1;HSPD1;IRAK2
2831,GO:0006325,0.996374790096825,0.00823630662927427,10,661,chromatin organization,BP,CDKN2A;TRIM16;TP53;IL1B;SUDS3;BRD2;SDR16C5;CTR9;EYA3;SUPT3H
7572,GO:0031965,0.996648500602053,0.0153905832648322,2,251,nuclear membrane,CC,PRPF38A;TOR1AIP1
1436,GO:0003677,0.997041377308488,0.00475283143572159,41,1918,DNA binding,MF,TRIM16;OSR2;NFKB1;MAFB;RELB;TP53;NABP1;PEG10;JUN;ZNF165;NFKB2;ARID3B;PARP1;JUNB;ATF3;CREB5;EHF;ANXA1;NBN;XBP1;ARNTL2;ZNF638;SETX;ZNF132;KLF10;ZNF697;SNAI3;NR2F2;CALR;MAFF;MGA;UBP1;ZMYM4;ETS1;ZFP42;PML;ZBTB21;HES4;SOX11;HSPD1;SUPT3H
342,GO:0000956,0.997137986011796,0.0200091876214735,1,200,nuclear-transcribed mRNA catabolic process,BP,NOCT
2873,GO:0006396,0.997221908682758,0.00578508040689828,14,876,RNA processing,BP,NOCT;PUS10;ZNF638;SETX;RBM28;POP4;C2ORF49;CTR9;ZCCHC8;METTL2A;TRMT44;TYW1;PRPF38A;ZC3H7B
6565,GO:0022412,0.997237622877578,0.0194319838082093,1,187,cellular process involved in reproduction in multicellular organism,BP,SLIT2
7574,GO:0031967,0.997415053928343,0.0052015733259952,16,972,organelle envelope,CC,PMAIP1;PARP1;IKBKE;LYN;ANXA1;ARG1;SOD2;UQCC1;CALR;REEP1;MGST3;PRPF38A;MRPS24;TOR1AIP1;MRPL53;HSPD1
7578,GO:0031975,0.997415053928343,0.0052015733259952,16,972,envelope,CC,PMAIP1;PARP1;IKBKE;LYN;ANXA1;ARG1;SOD2;UQCC1;CALR;REEP1;MGST3;PRPF38A;MRPS24;TOR1AIP1;MRPL53;HSPD1
12883,GO:0051276,0.998096533380572,0.0037748931124468,18,1048,chromosome organization,BP,CDKN2A;TRIM16;TP53;PARP1;IL1B;DUSP1;ANXA1;NBN;SUDS3;HSP90AA1;BRD2;SETX;HSP90AB1;SDR16C5;CTR9;EYA3;PML;SUPT3H
1435,GO:0003676,0.998199498834562,0.00268313378836078,75,3238,nucleic acid binding,MF,CDKN2A;TRIM16;LGALS1;OSR2;KRT18;NFKB1;MAFB;RELB;TP53;RNASE7;NABP1;PEG10;JUN;ZNF165;NFKB2;ARID3B;PARP1;JUNB;ATF3;CREB5;EHF;NOCT;ANXA1;NBN;PUS10;NOC3L;XBP1;CSRP1;ARNTL2;ZNF638;KCTD12;HSP90AA1;CANX;SETX;RBM28;POP4;ZNF132;KLF10;ACO1;SERPINH1;ZNF697;HSP90AB1;GPATCH11;SNAI3;NR2F2;EIF4G2;CALR;ZCCHC8;EIF2B1;MAFF;MGA;UBP1;CS;PDIA4;RBMS3;ZMYM4;ZNF814;ETS1;PRPF38A;ZC3H7B;HSP90B1;TFRC;ZFP42;PML;MRPS24;MYH9;ZBTB21;HES4;SOX11;ENPP1;SORBS2;RPL26L1;HSPD1;SND1;SUPT3H
5261,GO:0015931,0.998418920670189,0.012032060292265,1,207,nucleobase-containing compound transport,BP,SLC35B1
2431,GO:0005654,0.998536992850589,0.00222117147062328,69,3041,nucleoplasm,CC,TRIM16;KRT8;TNIP1;NFKB1;RELB;TP53;PSMB9;NABP1;DNAJB1;JUN;IL16;NFKB2;ARID3B;PARP1;OPTN;JUNB;TJP2;HSPB8;CRYAB;ATF3;EHF;NOCT;IKBKE;MGLL;ANXA1;NBN;SLC8A1;NEDD4L;BIRC3;NOC3L;XBP1;SUDS3;GSTCD;ZNF638;HSP90AA1;TPP2;BRD2;SETX;POP4;NRG1;HSP90AB1;C2ORF49;NR2F2;PPID;CTR9;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;MED18;ZMYM4;CITED2;TXNRD1;PTTG1IP;ETS1;PRPF38A;CBLL1;CDK6;PML;OXCT1;EPB41L2;EID3;ZBTB21;SORBS2;CLINT1;SUPT3H
9771,GO:0040029,0.998640842214542,0.00694438851206784,2,290,regulation of gene expression, epigenetic,BP,AJUBA;ZC3H7B
307,GO:0000819,0.998785871705204,0.00957092027047011,1,216,sister chromatid segregation,BP,DUSP1
5316,GO:0016071,0.998823864005943,0.00289549726245154,10,737,mRNA metabolic process,BP,TP53;PSMB9;NOCT;SETX;RBM28;POP4;CTR9;ZCCHC8;PRR5L;PRPF38A
9884,GO:0042254,0.999018616838447,0.00519406912769694,2,316,ribosome biogenesis,BP,POP4;RPL26L1
10366,GO:0043231,0.999019617724187,0.00141664174511177,224,8297,intracellular membrane-bounded organelle,CC,CDKN2A;NFKBIA;FLG2;TRIM16;KRT1;KRT8;LGALS1;OSR2;KRT2;TNIP1;DUSP8;KRT18;SPRR3;NFKB1;MAFB;RELB;B4GALT1;FEZ1;EDN1;TP53;PMAIP1;PSMB9;FLG;UBQLN2;CHAC1;COL12A1;CDKN2B;NABP1;HS3ST1;MYO1B;DNAJB1;PEG10;JUN;KRT4;MCAM;ZNF165;IL16;NFKB2;ARID3B;SPNS2;HERPUD1;PARP1;OPTN;HRNR;HSPA5;IL1B;MSRB3;KRT13;ANPEP;JUNB;TJP2;HSPB8;CRYAB;ATF3;GPX8;DNAJB9;ACTG1;CREB5;DNAJC10;EHF;HSPA6;GADD45B;NOCT;IKBKE;MGLL;ERAP1;NFKBIE;DUSP1;TRIB1;FADS1;FIGN;PLBD1;STT3A;LYN;NCEH1;AP3M1;COL8A1;ANXA1;FADS3;COL4A4;DERL3;G6PD;NBN;SLC8A1;PLEKHA2;WWC1;NEDD4L;BIRC3;NOC3L;RHOB;XBP1;MOBP;ARG1;UGGT1;SEC11C;SUDS3;TRAF3;CSRP1;ARNTL2;GSTCD;HMOX1;SYT11;KLK6;ZNF638;HSP90AA1;CANX;FTH1;TPP2;EGLN1;BRD2;SETX;GNPTAB;RBM28;SOD2;POP4;ZNF132;KLF10;NRG1;ACO1;IFRD1;SERPINH1;PREP;ZNF697;HSP90AB1;VGLL3;SDR16C5;SNAI3;GGCX;ADAM8;C2ORF49;CLCC1;NR2F2;STEAP4;UQCC1;CALR;PDIA6;EDRF1;IFNAR1;PPID;CTR9;AJUBA;IGFBP3;SEL1L;MGAT5;EYA3;ZCCHC8;SLC35B1;SERP1;ORMDL1;MAFF;MAGT1;MOCS2;RRAS2;MGA;PRR5L;RAB30;SEC22A;UBP1;GIT2;CS;IL23A;DLG1;PDIA4;MED18;NGLY1;EHD1;PITHD1;ZMYM4;CITED2;LOX;TXNRD1;PTTG1IP;DHDDS;ETS1;SEC24D;REEP1;CALU;IVD;MSMO1;PDE4DIP;TGFA;MGST3;SUGT1;PRPF38A;DNAJC3;CBLL1;BCAT1;ZC3H7B;HSP90B1;ZFP42;SVIP;UBXN2B;NEDD4;CDK6;TUBB3;ZDHHC6;PML;OXCT1;EPB41L2;MRPS24;MYH9;EID3;GALNT14;BTBD10;TRIM47;TOR1AIP1;ZBTB21;HES4;SOX11;UGCG;MRPL53;CPPED1;ENPP1;SORBS2;CLINT1;CEP83;HSPD1;SND1;MAGED1;SUPT3H;MIDN;IRAK2;SDF2L1;CYP1A1
17971,GO:1902494,0.999055055155165,0.0018655778734269,21,1230,catalytic complex,CC,TP53;PSMB9;STT3A;SEC11C;SUDS3;DCUN1D3;POP4;CTR9;SEL1L;ZCCHC8;ORMDL1;MAGT1;MGA;MED18;SUGT1;CBLL1;NEDD4;CDK6;EID3;HSPD1;SUPT3H
2536,GO:0005819,0.999130503016608,0.00466611688660288,2,298,spindle,CC,CYLD;MYH9
7579,GO:0031981,0.999348915860386,0.000995492765597062,80,3515,nuclear lumen,CC,TRIM16;KRT8;TNIP1;KRT18;NFKB1;RELB;TP53;PSMB9;NABP1;DNAJB1;JUN;IL16;NFKB2;ARID3B;PARP1;OPTN;JUNB;TJP2;HSPB8;CRYAB;ATF3;DNAJB9;EHF;NOCT;IKBKE;MGLL;NFKBIE;FIGN;ANXA1;NBN;SLC8A1;NEDD4L;BIRC3;NOC3L;XBP1;SUDS3;ARNTL2;GSTCD;HMOX1;KLK6;ZNF638;HSP90AA1;TPP2;BRD2;SETX;RBM28;POP4;NRG1;HSP90AB1;C2ORF49;NR2F2;PPID;CTR9;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;MED18;ZMYM4;CITED2;TXNRD1;PTTG1IP;ETS1;PRPF38A;CBLL1;ZFP42;CDK6;PML;OXCT1;EPB41L2;EID3;BTBD10;ZBTB21;SORBS2;CLINT1;SUPT3H;MIDN
2856,GO:0006364,0.99939812389209,0.00517750559507968,1,255,rRNA processing,BP,POP4
10854,GO:0044428,0.999535731639721,0.000709699803478008,87,3794,nuclear part,CC,TRIM16;KRT8;TNIP1;KRT18;NFKB1;RELB;TP53;PSMB9;NABP1;DNAJB1;JUN;IL16;NFKB2;ARID3B;PARP1;OPTN;HSPA5;JUNB;TJP2;HSPB8;CRYAB;ATF3;DNAJB9;EHF;HSPA6;NOCT;IKBKE;MGLL;NFKBIE;FIGN;ANXA1;NBN;SLC8A1;NEDD4L;BIRC3;NOC3L;XBP1;SUDS3;ARNTL2;GSTCD;HMOX1;KLK6;ZNF638;HSP90AA1;TPP2;BRD2;SETX;RBM28;POP4;NRG1;HSP90AB1;C2ORF49;NR2F2;CALR;PPID;CTR9;EYA3;ZCCHC8;MAFF;MOCS2;MGA;UBP1;GIT2;MED18;ZMYM4;CITED2;TXNRD1;PTTG1IP;ETS1;MGST3;PRPF38A;CBLL1;ZFP42;CDK6;PML;OXCT1;EPB41L2;MYH9;EID3;BTBD10;TOR1AIP1;ZBTB21;SORBS2;CLINT1;HSPD1;SUPT3H;MIDN
16836,GO:0098813,0.999612976609702,0.0035096555049054,1,252,nuclear chromosome segregation,BP,DUSP1
5317,GO:0016072,0.999760017039947,0.00229353100600597,1,284,rRNA metabolic process,BP,POP4
3326,GO:0007059,0.999916395585982,0.0008914882058694,1,300,chromosome segregation,BP,DUSP1
17599,GO:1901363,0.999968167722961,5.12667591974135e-05,104,4578,heterocyclic compound binding,MF,CDKN2A;TRIM16;LGALS1;OSR2;KRT18;NFKB1;MAFB;RELB;TP53;NAGK;RNASE7;NABP1;PGK1;MYO1B;PEG10;JUN;ZNF165;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;JUNB;ATF3;AXL;ACTG1;CREB5;EHF;HSPA6;NOCT;IKBKE;FIGN;LYN;ANXA1;G6PD;NBN;PUS10;NOC3L;RHOB;XBP1;CSRP1;ARNTL2;HMOX1;ZNF638;PAPSS2;KCTD12;HSP90AA1;CANX;SETX;RBM28;POP4;ZNF132;KLF10;ACO1;SERPINH1;ZNF697;HSP90AB1;GPATCH11;SNAI3;NR2F2;EIF4G2;CALR;ZCCHC8;EIF2B1;MAFF;RRAS2;MGA;RAB30;UBP1;CS;PDIA4;RBMS3;EHD1;ZMYM4;ZNF814;TXNRD1;ETS1;TYW1;IVD;CHORDC1;PRPF38A;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;CDK6;TUBB3;PML;EPHA2;MRPS24;MYH9;ZBTB21;HES4;SOX11;ENPP1;SORBS2;RPL26L1;HSPD1;SND1;SUPT3H;IRAK2;CYP1A1
16435,GO:0097159,0.999981154676427,3.07468233785827e-05,104,4616,organic cyclic compound binding,MF,CDKN2A;TRIM16;LGALS1;OSR2;KRT18;NFKB1;MAFB;RELB;TP53;NAGK;RNASE7;NABP1;PGK1;MYO1B;PEG10;JUN;ZNF165;RIPK2;NFKB2;ARID3B;PARP1;HSPA5;JUNB;ATF3;AXL;ACTG1;CREB5;EHF;HSPA6;NOCT;IKBKE;FIGN;LYN;ANXA1;G6PD;NBN;PUS10;NOC3L;RHOB;XBP1;CSRP1;ARNTL2;HMOX1;ZNF638;PAPSS2;KCTD12;HSP90AA1;CANX;SETX;RBM28;POP4;ZNF132;KLF10;ACO1;SERPINH1;ZNF697;HSP90AB1;GPATCH11;SNAI3;NR2F2;EIF4G2;CALR;ZCCHC8;EIF2B1;MAFF;RRAS2;MGA;RAB30;UBP1;CS;PDIA4;RBMS3;EHD1;ZMYM4;ZNF814;TXNRD1;ETS1;TYW1;IVD;CHORDC1;PRPF38A;ZC3H7B;HSP90B1;TFRC;ZFP42;NLRP10;HTR1B;CDK6;TUBB3;PML;EPHA2;MRPS24;MYH9;ZBTB21;HES4;SOX11;ENPP1;SORBS2;RPL26L1;HSPD1;SND1;SUPT3H;IRAK2;CYP1A1
10969,GO:0044806,0.999999999999954,0.794177939730165,0,7,G-quadruplex DNA unwinding,BP,
3,GO:0000009,1,0.970666835897531,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.941665682842566,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.969271124374127,0,1,vacuole inheritance,BP,
7,GO:0000014,1,0.800569248790695,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.972278588921025,0,1,phosphopyruvate hydratase complex,CC,
10,GO:0000019,1,0.909395691184784,0,3,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.728675551603918,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.936052262379461,0,2,maltose metabolic process,BP,
13,GO:0000026,1,0.909683299025497,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.48016961216837,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.617068314390334,0,18,ribosomal small subunit assembly,BP,
17,GO:0000032,1,0.972400159260788,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.917224217684745,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.950146313132071,0,2,acyl binding,MF,
20,GO:0000036,1,0.950146313132071,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.481776861071798,0,24,very long-chain fatty acid metabolic process,BP,
24,GO:0000048,1,0.970697543527611,0,1,peptidyltransferase activity,MF,
25,GO:0000049,1,0.19148782542616,0,54,tRNA binding,MF,
27,GO:0000052,1,0.801143089643601,0,7,citrulline metabolic process,BP,
28,GO:0000053,1,0.972258105402834,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.685712498185064,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.792622384886221,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.817222699796205,0,7,ribosomal small subunit export from nucleus,BP,
33,GO:0000062,1,0.603922577457855,0,17,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.879122633869925,0,4,L-ornithine transmembrane transporter activity,MF,
37,GO:0000076,1,0.632322447814526,0,15,DNA replication checkpoint,BP,
41,GO:0000083,1,0.475222772048228,0,24,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.971102205280444,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.397812447628815,0,30,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.655160414012093,0,14,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.804850137461969,0,7,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.876925696293072,0,4,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.9070686640828,0,3,sulfur amino acid transport,BP,
50,GO:0000104,1,0.864775387684425,0,5,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.939776356904482,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.735692363534865,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.9108977360921,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.967917692637554,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.966878164478491,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000120,1,0.861293309870136,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.968741153584299,0,1,glycerol-1-phosphatase activity,MF,
62,GO:0000125,1,0.862899153757373,0,5,PCAF complex,CC,
63,GO:0000126,1,0.935715564166231,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.829411425219054,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.569603738120894,0,18,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.705852942498975,0,11,Golgi cis cisterna,CC,
71,GO:0000147,1,0.904308353512,0,3,actin cortical patch assembly,BP,
73,GO:0000150,1,0.78726940130505,0,8,recombinase activity,MF,
75,GO:0000152,1,0.297987068281786,0,40,nuclear ubiquitin ligase complex,CC,
77,GO:0000154,1,0.369423234960444,0,34,rRNA modification,BP,
78,GO:0000159,1,0.553130180579193,0,19,protein phosphatase type 2A complex,CC,
79,GO:0000160,1,0.967795043925949,0,1,phosphorelay signal transduction system,BP,
80,GO:0000164,1,0.709822077225123,0,11,protein phosphatase type 1 complex,CC,
85,GO:0000173,1,0.972721020103614,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
87,GO:0000176,1,0.696848796234179,0,13,nuclear exosome (RNase complex),CC,
88,GO:0000177,1,0.641210683839173,0,15,cytoplasmic exosome (RNase complex),CC,
89,GO:0000178,1,0.521077735122229,0,22,exosome (RNase complex),CC,
90,GO:0000179,1,0.889370967372712,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
91,GO:0000182,1,0.726652219188186,0,10,rDNA binding,MF,
92,GO:0000183,1,0.348195100416464,0,39,chromatin silencing at rDNA,BP,
93,GO:0000184,1,0.0356744011715357,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
99,GO:0000210,1,0.968106967257537,0,1,NAD+ diphosphatase activity,MF,
101,GO:0000213,1,0.890948312842775,0,4,tRNA-intron endonuclease activity,MF,
102,GO:0000214,1,0.891473911958486,0,4,tRNA-intron endonuclease complex,CC,
103,GO:0000215,1,0.944191912354504,0,2,tRNA 2'-phosphotransferase activity,MF,
104,GO:0000217,1,0.484519785616783,0,23,DNA secondary structure binding,MF,
105,GO:0000220,1,0.860793659183209,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
106,GO:0000221,1,0.90984225982481,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
108,GO:0000225,1,0.973841657619043,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
111,GO:0000229,1,0.972859158557059,0,1,cytoplasmic chromosome,CC,
112,GO:0000235,1,0.773010290178896,0,8,astral microtubule,CC,
113,GO:0000242,1,0.543661546380921,0,19,pericentriolar material,CC,
114,GO:0000243,1,0.794611894386128,0,8,commitment complex,CC,
115,GO:0000244,1,0.705874977853166,0,11,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000246,1,0.967235729974955,0,1,delta24(24-1) sterol reductase activity,MF,
118,GO:0000247,1,0.973837630045166,0,1,C-8 sterol isomerase activity,MF,
120,GO:0000250,1,0.967257521265074,0,1,lanosterol synthase activity,MF,
121,GO:0000252,1,0.972846862323855,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
122,GO:0000253,1,0.89757468482135,0,4,3-keto sterol reductase activity,MF,
124,GO:0000255,1,0.935191645320397,0,2,allantoin metabolic process,BP,
125,GO:0000257,1,0.973397025980278,0,1,nitrilase activity,MF,
126,GO:0000262,1,0.972859158557059,0,1,mitochondrial chromosome,CC,
127,GO:0000266,1,0.35352015598786,0,33,mitochondrial fission,BP,
128,GO:0000268,1,0.883124348398394,0,4,peroxisome targeting sequence binding,MF,
129,GO:0000270,1,0.973797167582431,0,1,peptidoglycan metabolic process,BP,
131,GO:0000272,1,0.511477302189837,0,21,polysaccharide catabolic process,BP,
135,GO:0000285,1,0.910757927001303,0,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
138,GO:0000289,1,0.330209813211519,0,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,
140,GO:0000291,1,0.356849407545454,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
141,GO:0000293,1,0.908995656195043,0,3,ferric-chelate reductase activity,MF,
142,GO:0000294,1,0.937607728699283,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
143,GO:0000295,1,0.716435716291709,0,11,adenine nucleotide transmembrane transporter activity,MF,
144,GO:0000296,1,0.970919333972993,0,1,spermine transport,BP,
145,GO:0000298,1,0.887880067864205,0,4,endopolyphosphatase activity,MF,
146,GO:0000301,1,0.910616149820258,0,3,retrograde transport, vesicle recycling within Golgi,BP,
150,GO:0000306,1,0.87964928242431,0,4,extrinsic component of vacuolar membrane,CC,
152,GO:0000308,1,0.935541016701887,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
153,GO:0000309,1,0.93565619217012,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000320,1,0.935537565120312,0,2,re-entry into mitotic cell cycle,BP,
158,GO:0000322,1,0.914073900385318,0,3,storage vacuole,CC,
160,GO:0000332,1,0.975095393507231,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
161,GO:0000333,1,0.942782625126305,0,2,telomerase catalytic core complex,CC,
162,GO:0000338,1,0.750110864612162,0,10,protein deneddylation,BP,
163,GO:0000339,1,0.592299686078188,0,17,RNA cap binding,MF,
164,GO:0000340,1,0.751094739182867,0,9,RNA 7-methylguanosine cap binding,MF,
165,GO:0000346,1,0.675339482598124,0,13,transcription export complex,CC,
166,GO:0000347,1,0.839956945125172,0,6,THO complex,CC,
167,GO:0000349,1,0.94146402926519,0,2,generation of catalytic spliceosome for first transesterification step,BP,
168,GO:0000350,1,0.918685827518791,0,3,generation of catalytic spliceosome for second transesterification step,BP,
169,GO:0000354,1,0.936341829701942,0,2,cis assembly of pre-catalytic spliceosome,BP,
172,GO:0000379,1,0.916715251439127,0,3,tRNA-type intron splice site recognition and cleavage,BP,
173,GO:0000380,1,0.243761759842504,0,45,alternative mRNA splicing, via spliceosome,BP,
174,GO:0000381,1,0.35508758954826,0,33,regulation of alternative mRNA splicing, via spliceosome,BP,
175,GO:0000384,1,0.946189910737465,0,2,first spliceosomal transesterification activity,MF,
176,GO:0000386,1,0.910204527193718,0,3,second spliceosomal transesterification activity,MF,
177,GO:0000387,1,0.344385597180499,0,36,spliceosomal snRNP assembly,BP,
178,GO:0000389,1,0.831644300153197,0,6,mRNA 3'-splice site recognition,BP,
179,GO:0000390,1,0.943809953126358,0,2,spliceosomal complex disassembly,BP,
180,GO:0000393,1,0.864897514966993,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000395,1,0.858605053040817,0,5,mRNA 5'-splice site recognition,BP,
184,GO:0000400,1,0.609362068224186,0,16,four-way junction DNA binding,MF,
185,GO:0000403,1,0.821108974683907,0,6,Y-form DNA binding,MF,
186,GO:0000404,1,0.906713517930025,0,3,heteroduplex DNA loop binding,MF,
187,GO:0000405,1,0.796085803340381,0,7,bubble DNA binding,MF,
188,GO:0000406,1,0.936772627988305,0,2,double-strand/single-strand DNA junction binding,MF,
189,GO:0000407,1,0.363694947167933,0,32,phagophore assembly site,CC,
190,GO:0000408,1,0.866681614655392,0,5,EKC/KEOPS complex,CC,
191,GO:0000409,1,0.966845032825713,0,1,regulation of transcription by galactose,BP,
192,GO:0000411,1,0.966845032825713,0,1,positive regulation of transcription by galactose,BP,
193,GO:0000412,1,0.969280648273686,0,1,histone peptidyl-prolyl isomerization,BP,
195,GO:0000414,1,0.876497393273759,0,4,regulation of histone H3-K36 methylation,BP,
196,GO:0000415,1,0.966858779504773,0,1,negative regulation of histone H3-K36 methylation,BP,
197,GO:0000416,1,0.967773473778938,0,1,positive regulation of histone H3-K36 methylation,BP,
198,GO:0000417,1,0.967440622921063,0,1,HIR complex,CC,
199,GO:0000421,1,0.464959017866912,0,25,autophagosome membrane,CC,
203,GO:0000429,1,0.914563596495146,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
204,GO:0000430,1,0.94593059274664,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
205,GO:0000431,1,0.966845032825713,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
206,GO:0000432,1,0.94593059274664,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000435,1,0.966845032825713,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000436,1,0.914563596495146,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
209,GO:0000438,1,0.919716696146716,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
210,GO:0000439,1,0.763383449784488,0,9,core TFIIH complex,CC,
211,GO:0000444,1,0.887118357204817,0,4,MIS12/MIND type complex,CC,
212,GO:0000445,1,0.839956945125172,0,6,THO complex part of transcription export complex,CC,
213,GO:0000447,1,0.767631523209864,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
214,GO:0000448,1,0.938463972561331,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
215,GO:0000451,1,0.940073164695509,0,2,rRNA 2'-O-methylation,BP,
216,GO:0000453,1,0.940073164695509,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
217,GO:0000454,1,0.923279268466633,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
218,GO:0000455,1,0.944640171774524,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
219,GO:0000459,1,0.818279327553321,0,7,exonucleolytic trimming involved in rRNA processing,BP,
220,GO:0000460,1,0.376849823311413,0,33,maturation of 5.8S rRNA,BP,
221,GO:0000461,1,0.94973013775998,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
222,GO:0000462,1,0.337087954194112,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
223,GO:0000463,1,0.74875297257046,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000466,1,0.519886064175205,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000467,1,0.818279327553321,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000469,1,0.462545512427236,0,26,cleavage involved in rRNA processing,BP,
227,GO:0000470,1,0.496063337706423,0,24,maturation of LSU-rRNA,BP,
228,GO:0000472,1,0.909849284284414,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000478,1,0.632448817486929,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
230,GO:0000479,1,0.651718782133298,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000480,1,0.830082151793809,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000481,1,0.967921862451045,0,1,maturation of 5S rRNA,BP,
233,GO:0000491,1,0.767139638039597,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
234,GO:0000492,1,0.813868277068464,0,7,box C/D snoRNP assembly,BP,
235,GO:0000493,1,0.942616006545314,0,2,box H/ACA snoRNP assembly,BP,
236,GO:0000494,1,0.973811368227514,0,1,box C/D snoRNA 3'-end processing,BP,
237,GO:0000495,1,0.970086681792673,0,1,box H/ACA snoRNA 3'-end processing,BP,
238,GO:0000496,1,0.975095393507231,0,1,base pairing,MF,
239,GO:0000497,1,0.975095393507231,0,1,base pairing with DNA,MF,
241,GO:0000506,1,0.774269377584492,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
242,GO:0000578,1,0.495154106254568,0,22,embryonic axis specification,BP,
243,GO:0000700,1,0.889451801304242,0,4,mismatch base pair DNA N-glycosylase activity,MF,
244,GO:0000701,1,0.946402286351857,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000702,1,0.872606212803757,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
246,GO:0000703,1,0.94763428052612,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
247,GO:0000706,1,0.937354777354767,0,2,meiotic DNA double-strand break processing,BP,
248,GO:0000707,1,0.786095266017361,0,8,meiotic DNA recombinase assembly,BP,
249,GO:0000710,1,0.87741170766439,0,4,meiotic mismatch repair,BP,
250,GO:0000712,1,0.75384650282508,0,9,resolution of meiotic recombination intermediates,BP,
253,GO:0000718,1,0.972524513134103,0,1,nucleotide-excision repair, DNA damage removal,BP,
254,GO:0000720,1,0.912251955075032,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
255,GO:0000722,1,0.647217506790726,0,14,telomere maintenance via recombination,BP,
260,GO:0000727,1,0.860958090974016,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000730,1,0.738903474322953,0,10,DNA recombinase assembly,BP,
266,GO:0000737,1,0.512972794898075,0,22,DNA catabolic process, endonucleolytic,BP,
267,GO:0000738,1,0.885042256660427,0,4,DNA catabolic process, exonucleolytic,BP,
268,GO:0000741,1,0.972471937656193,0,1,karyogamy,BP,
270,GO:0000773,1,0.974153435035593,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
271,GO:0000774,1,0.718476485703621,0,11,adenyl-nucleotide exchange factor activity,MF,
275,GO:0000778,1,0.697963356244784,0,12,condensed nuclear chromosome kinetochore,CC,
277,GO:0000780,1,0.544155267994034,0,20,condensed nuclear chromosome, centromeric region,CC,
279,GO:0000782,1,0.736300711783908,0,10,telomere cap complex,CC,
280,GO:0000783,1,0.736300711783908,0,10,nuclear telomere cap complex,CC,
283,GO:0000786,1,0.107294577219013,0,84,nucleosome,CC,
284,GO:0000788,1,0.447768331460036,0,31,nuclear nucleosome,CC,
289,GO:0000794,1,0.130973402383023,0,65,condensed nuclear chromosome,CC,
290,GO:0000795,1,0.588998734048828,0,17,synaptonemal complex,CC,
291,GO:0000796,1,0.790838815591175,0,7,condensin complex,CC,
292,GO:0000797,1,0.966981321476975,0,1,condensin core heterodimer,CC,
293,GO:0000798,1,0.908898722431625,0,3,nuclear cohesin complex,CC,
294,GO:0000799,1,0.904192227683454,0,3,nuclear condensin complex,CC,
295,GO:0000800,1,0.797430053965755,0,7,lateral element,CC,
296,GO:0000801,1,0.967336691055266,0,1,central element,CC,
297,GO:0000803,1,0.457436964051334,0,25,sex chromosome,CC,
298,GO:0000805,1,0.801051001598111,0,7,X chromosome,CC,
299,GO:0000806,1,0.938929972654354,0,2,Y chromosome,CC,
300,GO:0000808,1,0.755356203246857,0,9,origin recognition complex,CC,
301,GO:0000811,1,0.91252725201061,0,3,GINS complex,CC,
302,GO:0000812,1,0.74236820935388,0,10,Swr1 complex,CC,
303,GO:0000813,1,0.76368061653954,0,9,ESCRT I complex,CC,
304,GO:0000814,1,0.917187038847361,0,3,ESCRT II complex,CC,
305,GO:0000815,1,0.701101819760594,0,12,ESCRT III complex,CC,
306,GO:0000818,1,0.942200092333485,0,2,nuclear MIS12/MIND complex,CC,
308,GO:0000820,1,0.934824579378187,0,2,regulation of glutamine family amino acid metabolic process,BP,
309,GO:0000821,1,0.966797215838241,0,1,regulation of arginine metabolic process,BP,
310,GO:0000822,1,0.906162615107931,0,3,inositol hexakisphosphate binding,MF,
311,GO:0000823,1,0.972346416876858,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
312,GO:0000824,1,0.972346416876858,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
313,GO:0000825,1,0.972346416876858,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
314,GO:0000827,1,0.880229652223824,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
315,GO:0000828,1,0.880229652223824,0,4,inositol hexakisphosphate kinase activity,MF,
316,GO:0000829,1,0.880229652223824,0,4,inositol heptakisphosphate kinase activity,MF,
317,GO:0000832,1,0.880229652223824,0,4,inositol hexakisphosphate 5-kinase activity,MF,
321,GO:0000900,1,0.725026586329387,0,10,translation repressor activity, mRNA regulatory element binding,MF,
325,GO:0000912,1,0.823027995295555,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
326,GO:0000915,1,0.823027995295555,0,6,actomyosin contractile ring assembly,BP,
327,GO:0000916,1,0.971240858915391,0,1,actomyosin contractile ring contraction,BP,
328,GO:0000917,1,0.972196297161597,0,1,division septum assembly,BP,
329,GO:0000920,1,0.604304843655005,0,17,cell separation after cytokinesis,BP,
330,GO:0000921,1,0.722599185868093,0,10,septin ring assembly,BP,
331,GO:0000922,1,0.011666167050832,0,142,spindle pole,CC,
332,GO:0000923,1,0.823533531756921,0,6,equatorial microtubule organizing center,CC,
333,GO:0000928,1,0.969271124374127,0,1,gamma-tubulin small complex, spindle pole body,CC,
334,GO:0000930,1,0.547055310017662,0,19,gamma-tubulin complex,CC,
335,GO:0000931,1,0.771714232539333,0,8,gamma-tubulin large complex,CC,
337,GO:0000938,1,0.878637832383209,0,4,GARP complex,CC,
338,GO:0000939,1,0.916094139472782,0,3,condensed chromosome inner kinetochore,CC,
339,GO:0000940,1,0.66588443794005,0,13,condensed chromosome outer kinetochore,CC,
340,GO:0000941,1,0.971025482406741,0,1,condensed nuclear chromosome inner kinetochore,CC,
341,GO:0000942,1,0.887158806896305,0,4,condensed nuclear chromosome outer kinetochore,CC,
343,GO:0000957,1,0.85078667086362,0,5,mitochondrial RNA catabolic process,BP,
344,GO:0000958,1,0.907871324178554,0,3,mitochondrial mRNA catabolic process,BP,
345,GO:0000959,1,0.283892418124077,0,41,mitochondrial RNA metabolic process,BP,
346,GO:0000960,1,0.879393306079554,0,4,regulation of mitochondrial RNA catabolic process,BP,
347,GO:0000961,1,0.937138620729106,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
348,GO:0000962,1,0.938391848283274,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
349,GO:0000963,1,0.618264992846755,0,16,mitochondrial RNA processing,BP,
350,GO:0000964,1,0.885782212596256,0,4,mitochondrial RNA 5'-end processing,BP,
351,GO:0000965,1,0.860368271365908,0,5,mitochondrial RNA 3'-end processing,BP,
353,GO:0000967,1,0.909849284284414,0,3,rRNA 5'-end processing,BP,
354,GO:0000972,1,0.804705544579959,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
355,GO:0000973,1,0.910945733700186,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
356,GO:0000974,1,0.678225859243801,0,13,Prp19 complex,CC,
364,GO:0000983,1,0.61932139237476,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
369,GO:0000991,1,0.940950827902102,0,2,transcription factor activity, core RNA polymerase II binding,MF,
370,GO:0000992,1,0.938310172706124,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
372,GO:0000994,1,0.972389448928635,0,1,RNA polymerase III core binding,MF,
373,GO:0000995,1,0.876759399548174,0,4,transcription factor activity, core RNA polymerase III binding,MF,
374,GO:0001002,1,0.938310172706124,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
375,GO:0001003,1,0.938310172706124,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
376,GO:0001007,1,0.879199632507471,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
377,GO:0001010,1,0.643375981987423,0,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
378,GO:0001011,1,0.966809193934678,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
380,GO:0001013,1,0.778258267897903,0,8,RNA polymerase I regulatory region DNA binding,MF,
381,GO:0001016,1,0.807752331203976,0,7,RNA polymerase III regulatory region DNA binding,MF,
382,GO:0001018,1,0.941585295603762,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
383,GO:0001025,1,0.903656146554954,0,3,RNA polymerase III transcription factor binding,MF,
384,GO:0001026,1,0.935715564166231,0,2,TFIIIB-type transcription factor activity,MF,
385,GO:0001030,1,0.852848145766519,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
386,GO:0001031,1,0.852848145766519,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
387,GO:0001032,1,0.883333559890791,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
388,GO:0001034,1,0.972318015031522,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
389,GO:0001042,1,0.823445190260625,0,6,RNA polymerase I core binding,MF,
392,GO:0001054,1,0.72673797900614,0,11,RNA polymerase I activity,MF,
393,GO:0001055,1,0.730145591389256,0,11,RNA polymerase II activity,MF,
394,GO:0001056,1,0.645315333055484,0,15,RNA polymerase III activity,MF,
396,GO:0001069,1,0.935042789696051,0,2,regulatory region RNA binding,MF,
398,GO:0001075,1,0.825507553656705,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
405,GO:0001087,1,0.966809193934678,0,1,transcription factor activity, TFIIB-class binding,MF,
407,GO:0001093,1,0.908884874732003,0,3,TFIIB-class transcription factor binding,MF,
409,GO:0001096,1,0.967839200098851,0,1,TFIIF-class transcription factor binding,MF,
410,GO:0001097,1,0.911525280636346,0,3,TFIIH-class transcription factor binding,MF,
419,GO:0001112,1,0.968952903910721,0,1,DNA-templated transcriptional open complex formation,BP,
420,GO:0001113,1,0.968952903910721,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
421,GO:0001120,1,0.968952903910721,0,1,protein-DNA complex remodeling,BP,
422,GO:0001128,1,0.973436590555629,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
423,GO:0001129,1,0.908968768912489,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
424,GO:0001132,1,0.908968768912489,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
425,GO:0001133,1,0.663859034529084,0,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
426,GO:0001134,1,0.481983887645723,0,23,transcription factor activity, transcription factor recruiting,MF,
427,GO:0001135,1,0.798107782481579,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
429,GO:0001156,1,0.903656146554954,0,3,TFIIIC-class transcription factor binding,MF,
432,GO:0001161,1,0.732072099882489,0,10,intronic transcription regulatory region sequence-specific DNA binding,MF,
433,GO:0001162,1,0.782165394037293,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
434,GO:0001163,1,0.778258267897903,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
435,GO:0001164,1,0.778258267897903,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
436,GO:0001165,1,0.96707099830397,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
437,GO:0001172,1,0.943054415074977,0,2,transcription, RNA-templated,BP,
438,GO:0001179,1,0.972163121122908,0,1,RNA polymerase I transcription factor binding,MF,
439,GO:0001181,1,0.941418548908023,0,2,transcription factor activity, core RNA polymerase I binding,MF,
440,GO:0001188,1,0.778258267897903,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
443,GO:0001192,1,0.974376703067167,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
444,GO:0001193,1,0.974376703067167,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
446,GO:0001206,1,0.82029799872619,0,6,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
448,GO:0001222,1,0.668736085678782,0,13,transcription corepressor binding,MF,
449,GO:0001223,1,0.599878496165301,0,16,transcription coactivator binding,MF,
450,GO:0001224,1,0.905572435602643,0,3,RNA polymerase II transcription cofactor binding,MF,
451,GO:0001225,1,0.935088695874,0,2,RNA polymerase II transcription coactivator binding,MF,
452,GO:0001226,1,0.968440502417451,0,1,RNA polymerase II transcription corepressor binding,MF,
455,GO:0001300,1,0.938393675905997,0,2,chronological cell aging,BP,
456,GO:0001302,1,0.830624386656596,0,6,replicative cell aging,BP,
460,GO:0001401,1,0.941708172255838,0,2,mitochondrial sorting and assembly machinery complex,CC,
461,GO:0001405,1,0.860976969549614,0,5,presequence translocase-associated import motor,CC,
463,GO:0001502,1,0.706126273361953,0,11,cartilage condensation,BP,
465,GO:0001504,1,0.607435568810755,0,16,neurotransmitter uptake,BP,
469,GO:0001512,1,0.973865752459095,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
470,GO:0001514,1,0.807908566832786,0,7,selenocysteine incorporation,BP,
471,GO:0001515,1,0.971835822898747,0,1,opioid peptide activity,MF,
473,GO:0001517,1,0.851663191795978,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
474,GO:0001518,1,0.817061645384721,0,6,voltage-gated sodium channel complex,CC,
475,GO:0001519,1,0.96777033007464,0,1,peptide amidation,BP,
476,GO:0001520,1,0.936887841844352,0,2,outer dense fiber,CC,
483,GO:0001534,1,0.967721618285783,0,1,radial spoke,CC,
484,GO:0001536,1,0.967721618285783,0,1,radial spoke stalk,CC,
485,GO:0001537,1,0.939034631642294,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
486,GO:0001539,1,0.60622020429229,0,16,cilium or flagellum-dependent cell motility,BP,
490,GO:0001543,1,0.966828681677727,0,1,ovarian follicle rupture,BP,
491,GO:0001544,1,0.966834436903263,0,1,initiation of primordial ovarian follicle growth,BP,
492,GO:0001545,1,0.967420111238722,0,1,primary ovarian follicle growth,BP,
493,GO:0001546,1,0.97271975895488,0,1,preantral ovarian follicle growth,BP,
494,GO:0001547,1,0.850725877960792,0,5,antral ovarian follicle growth,BP,
495,GO:0001550,1,0.935022264759081,0,2,ovarian cumulus expansion,BP,
496,GO:0001552,1,0.971938559881094,0,1,ovarian follicle atresia,BP,
497,GO:0001553,1,0.84959702603886,0,5,luteinization,BP,
499,GO:0001555,1,0.939438198796461,0,2,oocyte growth,BP,
500,GO:0001556,1,0.595044597672803,0,17,oocyte maturation,BP,
502,GO:0001560,1,0.935349034581201,0,2,regulation of cell growth by extracellular stimulus,BP,
503,GO:0001561,1,0.834889787479485,0,6,fatty acid alpha-oxidation,BP,
508,GO:0001572,1,0.96698600588414,0,1,lactosylceramide biosynthetic process,BP,
509,GO:0001573,1,0.737750416382401,0,10,ganglioside metabolic process,BP,
510,GO:0001574,1,0.886638795429779,0,4,ganglioside biosynthetic process,BP,
511,GO:0001575,1,0.944347270584458,0,2,globoside metabolic process,BP,
512,GO:0001576,1,0.97151119019705,0,1,globoside biosynthetic process,BP,
513,GO:0001578,1,0.240610149402028,0,45,microtubule bundle formation,BP,
514,GO:0001579,1,0.938118462139577,0,2,medium-chain fatty acid transport,BP,
515,GO:0001580,1,0.824519613625005,0,7,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
516,GO:0001582,1,0.970141245305701,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
517,GO:0001588,1,0.94791073774906,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
518,GO:0001595,1,0.973782924850729,0,1,angiotensin receptor activity,MF,
519,GO:0001605,1,0.966939668707445,0,1,adrenomedullin receptor activity,MF,
520,GO:0001608,1,0.859692322080414,0,5,G-protein coupled nucleotide receptor activity,MF,
521,GO:0001609,1,0.915264708128261,0,3,G-protein coupled adenosine receptor activity,MF,
522,GO:0001614,1,0.83533099857749,0,6,purinergic nucleotide receptor activity,MF,
524,GO:0001631,1,0.942022673272113,0,2,cysteinyl leukotriene receptor activity,MF,
525,GO:0001632,1,0.942022673272113,0,2,leukotriene B4 receptor activity,MF,
526,GO:0001635,1,0.913605184741018,0,3,calcitonin gene-related peptide receptor activity,MF,
528,GO:0001640,1,0.966864704463998,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
529,GO:0001642,1,0.966864704463998,0,1,group III metabotropic glutamate receptor activity,MF,
532,GO:0001651,1,0.943885092817484,0,2,dense fibrillar component,CC,
533,GO:0001652,1,0.887329009066064,0,4,granular component,CC,
542,GO:0001661,1,0.939140908473418,0,2,conditioned taste aversion,BP,
543,GO:0001662,1,0.571910267298413,0,18,behavioral fear response,BP,
545,GO:0001665,1,0.891194950567431,0,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
550,GO:0001672,1,0.796914524279264,0,7,regulation of chromatin assembly or disassembly,BP,
551,GO:0001673,1,0.73970647234504,0,10,male germ cell nucleus,CC,
552,GO:0001674,1,0.939262039800974,0,2,female germ cell nucleus,CC,
553,GO:0001675,1,0.772390418902906,0,8,acrosome assembly,BP,
556,GO:0001680,1,0.970960595886097,0,1,tRNA 3'-terminal CCA addition,BP,
557,GO:0001681,1,0.969389475418018,0,1,sialate O-acetylesterase activity,MF,
559,GO:0001696,1,0.827482624357021,0,6,gastric acid secretion,BP,
561,GO:0001702,1,0.554595346996925,0,18,gastrulation with mouth forming second,BP,
563,GO:0001705,1,0.936510670575175,0,2,ectoderm formation,BP,
568,GO:0001710,1,0.831013312283436,0,6,mesodermal cell fate commitment,BP,
570,GO:0001712,1,0.936510670575175,0,2,ectodermal cell fate commitment,BP,
571,GO:0001714,1,0.891834031726062,0,4,endodermal cell fate specification,BP,
572,GO:0001715,1,0.967630646658427,0,1,ectodermal cell fate specification,BP,
575,GO:0001727,1,0.853745268803513,0,5,lipid kinase activity,MF,
576,GO:0001729,1,0.937315530566489,0,2,ceramide kinase activity,MF,
577,GO:0001730,1,0.885634545903064,0,4,2'-5'-oligoadenylate synthetase activity,MF,
578,GO:0001731,1,0.778780959228013,0,8,formation of translation preinitiation complex,BP,
579,GO:0001732,1,0.93971371499215,0,2,formation of cytoplasmic translation initiation complex,BP,
580,GO:0001733,1,0.97020037744344,0,1,galactosylceramide sulfotransferase activity,MF,
581,GO:0001735,1,0.938037227479163,0,2,prenylcysteine oxidase activity,MF,
584,GO:0001739,1,0.83360534740077,0,6,sex chromatin,CC,
585,GO:0001740,1,0.912687011300685,0,3,Barr body,CC,
586,GO:0001741,1,0.712687037296146,0,11,XY body,CC,
587,GO:0001743,1,0.936146556202207,0,2,optic placode formation,BP,
588,GO:0001750,1,0.329380528792235,0,35,photoreceptor outer segment,CC,
591,GO:0001756,1,0.28506299985634,0,39,somitogenesis,BP,
592,GO:0001757,1,0.936336730897806,0,2,somite specification,BP,
593,GO:0001758,1,0.91080677944961,0,3,retinal dehydrogenase activity,MF,
594,GO:0001759,1,0.715926755983374,0,11,organ induction,BP,
597,GO:0001765,1,0.763875242084166,0,9,membrane raft assembly,BP,
598,GO:0001766,1,0.83592093216724,0,6,membrane raft polarization,BP,
601,GO:0001770,1,0.966840354114274,0,1,establishment of natural killer cell polarity,BP,
608,GO:0001777,1,0.974487401152989,0,1,T cell homeostatic proliferation,BP,
615,GO:0001784,1,0.417010859198338,0,27,phosphotyrosine residue binding,MF,
618,GO:0001792,1,0.967243239656887,0,1,polymeric immunoglobulin receptor activity,MF,
619,GO:0001806,1,0.916300338318668,0,3,type IV hypersensitivity,BP,
620,GO:0001807,1,0.945739199513949,0,2,regulation of type IV hypersensitivity,BP,
621,GO:0001808,1,0.971648205657051,0,1,negative regulation of type IV hypersensitivity,BP,
622,GO:0001809,1,0.973337072735663,0,1,positive regulation of type IV hypersensitivity,BP,
634,GO:0001827,1,0.93497608096625,0,2,inner cell mass cell fate commitment,BP,
635,GO:0001828,1,0.93497608096625,0,2,inner cell mass cellular morphogenesis,BP,
637,GO:0001831,1,0.96684791747628,0,1,trophectodermal cellular morphogenesis,BP,
639,GO:0001833,1,0.728574411418596,0,10,inner cell mass cell proliferation,BP,
640,GO:0001834,1,0.969271124374127,0,1,trophectodermal cell proliferation,BP,
641,GO:0001835,1,0.968512019901731,0,1,blastocyst hatching,BP,
645,GO:0001839,1,0.853382419576384,0,5,neural plate morphogenesis,BP,
646,GO:0001840,1,0.772323697546562,0,8,neural plate development,BP,
648,GO:0001842,1,0.857193519255807,0,5,neural fold formation,BP,
649,GO:0001843,1,0.0913137936056836,0,75,neural tube closure,BP,
651,GO:0001845,1,0.764983809796547,0,9,phagolysosome assembly,BP,
655,GO:0001850,1,0.972254001419291,0,1,complement component C3a binding,MF,
656,GO:0001851,1,0.972254001419291,0,1,complement component C3b binding,MF,
657,GO:0001855,1,0.972884886111529,0,1,complement component C4b binding,MF,
658,GO:0001865,1,0.849232342989483,0,5,NK T cell differentiation,BP,
661,GO:0001868,1,0.972075373765072,0,1,regulation of complement activation, lectin pathway,BP,
662,GO:0001869,1,0.972075373765072,0,1,negative regulation of complement activation, lectin pathway,BP,
664,GO:0001875,1,0.908340272953419,0,3,lipopolysaccharide receptor activity,MF,
665,GO:0001878,1,0.970866330437704,0,1,response to yeast,BP,
666,GO:0001880,1,0.935814291842891,0,2,Mullerian duct regression,BP,
672,GO:0001886,1,0.799561814726917,0,7,endothelial cell morphogenesis,BP,
674,GO:0001888,1,0.937203860847885,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
682,GO:0001905,1,0.966825842197298,0,1,activation of membrane attack complex,BP,
684,GO:0001907,1,0.916819395200171,0,3,killing by symbiont of host cells,BP,
693,GO:0001917,1,0.499357470055118,0,22,photoreceptor inner segment,CC,
694,GO:0001918,1,0.969521644602958,0,1,farnesylated protein binding,MF,
697,GO:0001921,1,0.65972569985775,0,13,positive regulation of receptor recycling,BP,
698,GO:0001922,1,0.904683913499112,0,3,B-1 B cell homeostasis,BP,
699,GO:0001923,1,0.910671306017416,0,3,B-1 B cell differentiation,BP,
700,GO:0001927,1,0.908027370342731,0,3,exocyst assembly,BP,
701,GO:0001928,1,0.97101368166219,0,1,regulation of exocyst assembly,BP,
710,GO:0001939,1,0.828913674242731,0,6,female pronucleus,CC,
711,GO:0001940,1,0.855325321155351,0,5,male pronucleus,CC,
712,GO:0001941,1,0.516986230082427,0,21,postsynaptic membrane organization,BP,
713,GO:0001942,1,0.125984393149542,0,66,hair follicle development,BP,
717,GO:0001947,1,0.322185795316256,0,35,heart looping,BP,
718,GO:0001951,1,0.906520311505581,0,3,intestinal D-glucose absorption,BP,
722,GO:0001955,1,0.854567693345384,0,5,blood vessel maturation,BP,
723,GO:0001956,1,0.750911410751583,0,9,positive regulation of neurotransmitter secretion,BP,
724,GO:0001957,1,0.88019916760338,0,4,intramembranous ossification,BP,
725,GO:0001958,1,0.603826625003119,0,16,endochondral ossification,BP,
729,GO:0001963,1,0.660939448614373,0,14,synaptic transmission, dopaminergic,BP,
731,GO:0001965,1,0.619062617612789,0,16,G-protein alpha-subunit binding,MF,
732,GO:0001967,1,0.798705665826438,0,7,suckling behavior,BP,
734,GO:0001969,1,0.966825842197298,0,1,regulation of activation of membrane attack complex,BP,
735,GO:0001971,1,0.966825842197298,0,1,negative regulation of activation of membrane attack complex,BP,
737,GO:0001973,1,0.864939286534859,0,5,adenosine receptor signaling pathway,BP,
739,GO:0001975,1,0.711460462151646,0,11,response to amphetamine,BP,
741,GO:0001977,1,0.758362340307135,0,9,renal system process involved in regulation of blood volume,BP,
742,GO:0001978,1,0.971236436711977,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
743,GO:0001983,1,0.971236436711977,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
744,GO:0001985,1,0.971236436711977,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
747,GO:0001992,1,0.967192255235484,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
748,GO:0001993,1,0.887162257552688,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
749,GO:0001994,1,0.971236436711977,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
750,GO:0001996,1,0.913041741650076,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
751,GO:0001997,1,0.971236436711977,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
752,GO:0001998,1,0.972000861812146,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
753,GO:0001999,1,0.879783883573038,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
754,GO:0002001,1,0.879783883573038,0,4,renin secretion into blood stream,BP,
759,GO:0002016,1,0.974698729998558,0,1,regulation of blood volume by renin-angiotensin,BP,
760,GO:0002017,1,0.97211030530945,0,1,regulation of blood volume by renal aldosterone,BP,
761,GO:0002019,1,0.974698729998558,0,1,regulation of renal output by angiotensin,BP,
763,GO:0002021,1,0.737364783550968,0,10,response to dietary excess,BP,
764,GO:0002024,1,0.855698228317569,0,5,diet induced thermogenesis,BP,
765,GO:0002025,1,0.97166272183182,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
771,GO:0002032,1,0.944493210839783,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
772,GO:0002034,1,0.972000861812146,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
773,GO:0002036,1,0.882926380357076,0,4,regulation of L-glutamate import across plasma membrane,BP,
774,GO:0002037,1,0.971408606612423,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
775,GO:0002038,1,0.970993033401337,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
778,GO:0002041,1,0.970916387817472,0,1,intussusceptive angiogenesis,BP,
781,GO:0002046,1,0.974187290790793,0,1,opsin binding,MF,
782,GO:0002051,1,0.875865015810347,0,4,osteoblast fate commitment,BP,
784,GO:0002053,1,0.559345438014733,0,18,positive regulation of mesenchymal cell proliferation,BP,
785,GO:0002054,1,0.917036313718116,0,3,nucleobase binding,MF,
786,GO:0002055,1,0.974613103042065,0,1,adenine binding,MF,
787,GO:0002060,1,0.917036313718116,0,3,purine nucleobase binding,MF,
795,GO:0002069,1,0.835530469106616,0,6,columnar/cuboidal epithelial cell maturation,BP,
797,GO:0002071,1,0.938982077028047,0,2,glandular epithelial cell maturation,BP,
799,GO:0002074,1,0.909977874871214,0,3,extraocular skeletal muscle development,BP,
800,GO:0002076,1,0.703331221947626,0,11,osteoblast development,BP,
801,GO:0002079,1,0.936383641307063,0,2,inner acrosomal membrane,CC,
802,GO:0002080,1,0.730329386744762,0,10,acrosomal membrane,CC,
803,GO:0002081,1,0.966815026778385,0,1,outer acrosomal membrane,CC,
804,GO:0002082,1,0.653298668030436,0,14,regulation of oxidative phosphorylation,BP,
805,GO:0002083,1,0.972744924885889,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
806,GO:0002084,1,0.762330406927758,0,9,protein depalmitoylation,BP,
807,GO:0002085,1,0.911133332468818,0,3,inhibition of neuroepithelial cell differentiation,BP,
808,GO:0002086,1,0.967935840521965,0,1,diaphragm contraction,BP,
809,GO:0002087,1,0.847957946374408,0,5,regulation of respiratory gaseous exchange by neurological system process,BP,
814,GO:0002092,1,0.621282820164235,0,15,positive regulation of receptor internalization,BP,
815,GO:0002093,1,0.802543313134222,0,7,auditory receptor cell morphogenesis,BP,
817,GO:0002097,1,0.617390149109683,0,16,tRNA wobble base modification,BP,
818,GO:0002098,1,0.69916250592094,0,12,tRNA wobble uridine modification,BP,
819,GO:0002100,1,0.966861873686312,0,1,tRNA wobble adenosine to inosine editing,BP,
820,GO:0002101,1,0.913426754754415,0,3,tRNA wobble cytosine modification,BP,
822,GO:0002114,1,0.967673526794939,0,1,interleukin-33 receptor activity,MF,
823,GO:0002115,1,0.687719482096186,0,12,store-operated calcium entry,BP,
825,GO:0002118,1,0.968198863601552,0,1,aggressive behavior,BP,
826,GO:0002121,1,0.968198863601552,0,1,inter-male aggressive behavior,BP,
827,GO:0002127,1,0.973235498447605,0,1,tRNA wobble base cytosine methylation,BP,
828,GO:0002133,1,0.934704307029464,0,2,polycystin complex,CC,
832,GO:0002143,1,0.891096889000232,0,4,tRNA wobble position uridine thiolation,BP,
833,GO:0002144,1,0.971467275123919,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
834,GO:0002151,1,0.826860259450741,0,6,G-quadruplex RNA binding,MF,
835,GO:0002153,1,0.970537207718945,0,1,steroid receptor RNA activator RNA binding,MF,
836,GO:0002154,1,0.851885142366424,0,5,thyroid hormone mediated signaling pathway,BP,
837,GO:0002155,1,0.911373822851602,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
838,GO:0002158,1,0.914280071895758,0,3,osteoclast proliferation,BP,
839,GO:0002159,1,0.877756411429387,0,4,desmosome assembly,BP,
840,GO:0002161,1,0.684776256577221,0,12,aminoacyl-tRNA editing activity,MF,
841,GO:0002162,1,0.789753802424072,0,7,dystroglycan binding,MF,
842,GO:0002169,1,0.938961912134006,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
844,GO:0002176,1,0.920692878946287,0,3,male germ cell proliferation,BP,
845,GO:0002177,1,0.917104113749605,0,3,manchette,CC,
848,GO:0002182,1,0.70898329540851,0,11,cytoplasmic translational elongation,BP,
849,GO:0002183,1,0.578025093600889,0,18,cytoplasmic translational initiation,BP,
850,GO:0002184,1,0.937247601966013,0,2,cytoplasmic translational termination,BP,
851,GO:0002188,1,0.905679667076472,0,3,translation reinitiation,BP,
852,GO:0002189,1,0.970201789851713,0,1,ribose phosphate diphosphokinase complex,CC,
853,GO:0002190,1,0.868028715287725,0,5,cap-independent translational initiation,BP,
854,GO:0002191,1,0.913424846037167,0,3,cap-dependent translational initiation,BP,
855,GO:0002192,1,0.947841238539283,0,2,IRES-dependent translational initiation of linear mRNA,BP,
856,GO:0002193,1,0.907381956613377,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
857,GO:0002196,1,0.972058556520553,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
858,GO:0002199,1,0.813926823321767,0,7,zona pellucida receptor complex,CC,
862,GO:0002209,1,0.571910267298413,0,18,behavioral defense response,BP,
868,GO:0002225,1,0.945979434538775,0,2,positive regulation of antimicrobial peptide production,BP,
869,GO:0002227,1,0.773478298247557,0,10,innate immune response in mucosa,BP,
873,GO:0002238,1,0.966933724327514,0,1,response to molecule of fungal origin,BP,
877,GO:0002249,1,0.934811348481785,0,2,lymphocyte anergy,BP,
879,GO:0002251,1,0.659138099235124,0,15,organ or tissue specific immune response,BP,
882,GO:0002254,1,0.943665657404999,0,2,kinin cascade,BP,
886,GO:0002265,1,0.904833866165118,0,3,astrocyte activation involved in immune response,BP,
891,GO:0002276,1,0.939687910380622,0,2,basophil activation involved in immune response,BP,
892,GO:0002277,1,0.97433684205675,0,1,myeloid dendritic cell activation involved in immune response,BP,
893,GO:0002278,1,0.888929767519875,0,4,eosinophil activation involved in immune response,BP,
895,GO:0002281,1,0.851112930100897,0,5,macrophage activation involved in immune response,BP,
900,GO:0002291,1,0.944905385773306,0,2,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
905,GO:0002296,1,0.935400366005196,0,2,T-helper 1 cell lineage commitment,BP,
906,GO:0002299,1,0.972940797722707,0,1,alpha-beta intraepithelial T cell differentiation,BP,
907,GO:0002300,1,0.972940797722707,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
908,GO:0002304,1,0.972940797722707,0,1,gamma-delta intraepithelial T cell differentiation,BP,
909,GO:0002305,1,0.972940797722707,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
910,GO:0002309,1,0.974451949676881,0,1,T cell proliferation involved in immune response,BP,
913,GO:0002314,1,0.944476861389888,0,2,germinal center B cell differentiation,BP,
914,GO:0002315,1,0.776404767541475,0,8,marginal zone B cell differentiation,BP,
915,GO:0002316,1,0.967250856401697,0,1,follicular B cell differentiation,BP,
917,GO:0002318,1,0.910785134474829,0,3,myeloid progenitor cell differentiation,BP,
918,GO:0002320,1,0.662075899546455,0,13,lymphoid progenitor cell differentiation,BP,
919,GO:0002322,1,0.935377190441042,0,2,B cell proliferation involved in immune response,BP,
920,GO:0002323,1,0.765912185568082,0,9,natural killer cell activation involved in immune response,BP,
921,GO:0002325,1,0.973797167582431,0,1,natural killer cell differentiation involved in immune response,BP,
922,GO:0002326,1,0.904754384320379,0,3,B cell lineage commitment,BP,
923,GO:0002327,1,0.817081042456766,0,6,immature B cell differentiation,BP,
924,GO:0002328,1,0.750750838117394,0,9,pro-B cell differentiation,BP,
925,GO:0002329,1,0.874067327407031,0,4,pre-B cell differentiation,BP,
926,GO:0002331,1,0.93469680508826,0,2,pre-B cell allelic exclusion,BP,
927,GO:0002332,1,0.966878212105565,0,1,transitional stage B cell differentiation,BP,
928,GO:0002333,1,0.966878212105565,0,1,transitional one stage B cell differentiation,BP,
930,GO:0002337,1,0.941816822758316,0,2,B-1a B cell differentiation,BP,
931,GO:0002339,1,0.946425532808485,0,2,B cell selection,BP,
934,GO:0002351,1,0.966933724327514,0,1,serotonin production involved in inflammatory response,BP,
935,GO:0002352,1,0.946425532808485,0,2,B cell negative selection,BP,
936,GO:0002353,1,0.943665657404999,0,2,plasma kallikrein-kinin cascade,BP,
938,GO:0002358,1,0.974487401152989,0,1,B cell homeostatic proliferation,BP,
945,GO:0002370,1,0.913585087689555,0,3,natural killer cell cytokine production,BP,
946,GO:0002371,1,0.882705847100833,0,4,dendritic cell cytokine production,BP,
947,GO:0002373,1,0.974256161845837,0,1,plasmacytoid dendritic cell cytokine production,BP,
948,GO:0002374,1,0.707595297003126,0,11,cytokine secretion involved in immune response,BP,
951,GO:0002378,1,0.967127367906034,0,1,immunoglobulin biosynthetic process,BP,
952,GO:0002380,1,0.967112338268432,0,1,immunoglobulin secretion involved in immune response,BP,
954,GO:0002384,1,0.967352949111577,0,1,hepatic immune response,BP,
955,GO:0002385,1,0.681407056038996,0,14,mucosal immune response,BP,
956,GO:0002386,1,0.940146528967516,0,2,immune response in mucosal-associated lymphoid tissue,BP,
960,GO:0002408,1,0.966883754519079,0,1,myeloid dendritic cell chemotaxis,BP,
961,GO:0002414,1,0.914223152308904,0,3,immunoglobulin transcytosis in epithelial cells,BP,
962,GO:0002415,1,0.940146528967516,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
963,GO:0002416,1,0.97243084272675,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
968,GO:0002428,1,0.916670976135863,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
970,GO:0002430,1,0.97092080711143,0,1,complement receptor mediated signaling pathway,BP,
972,GO:0002432,1,0.967157094321361,0,1,granuloma formation,BP,
975,GO:0002438,1,0.842313915305124,0,6,acute inflammatory response to antigenic stimulus,BP,
976,GO:0002439,1,0.944478176801545,0,2,chronic inflammatory response to antigenic stimulus,BP,
979,GO:0002442,1,0.966933724327514,0,1,serotonin secretion involved in inflammatory response,BP,
983,GO:0002447,1,0.888929767519875,0,4,eosinophil mediated immunity,BP,
988,GO:0002457,1,0.910607430429016,0,3,T cell antigen processing and presentation,BP,
990,GO:0002461,1,0.970825151529268,0,1,tolerance induction dependent upon immune response,BP,
992,GO:0002468,1,0.904315524374506,0,3,dendritic cell antigen processing and presentation,BP,
994,GO:0002475,1,0.829843637263562,0,6,antigen processing and presentation via MHC class Ib,BP,
995,GO:0002476,1,0.940981951719558,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
996,GO:0002477,1,0.974168510850873,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
999,GO:0002480,1,0.777299996522478,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1000,GO:0002481,1,0.974168510850873,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1002,GO:0002488,1,0.967445251707302,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1003,GO:0002489,1,0.967445251707302,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1010,GO:0002514,1,0.967037689005993,0,1,B cell tolerance induction,BP,
1011,GO:0002517,1,0.855652682581764,0,5,T cell tolerance induction,BP,
1012,GO:0002519,1,0.970825151529268,0,1,natural killer cell tolerance induction,BP,
1016,GO:0002524,1,0.916300338318668,0,3,hypersensitivity,BP,
1018,GO:0002528,1,0.936912150743359,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1020,GO:0002534,1,0.487347374555257,0,23,cytokine production involved in inflammatory response,BP,
1021,GO:0002536,1,0.946219012929571,0,2,respiratory burst involved in inflammatory response,BP,
1022,GO:0002537,1,0.966828305922411,0,1,nitric oxide production involved in inflammatory response,BP,
1023,GO:0002538,1,0.968683041538734,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1024,GO:0002540,1,0.968683041538734,0,1,leukotriene production involved in inflammatory response,BP,
1025,GO:0002541,1,0.94316755784644,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
1026,GO:0002542,1,0.971601671815208,0,1,Factor XII activation,BP,
1027,GO:0002543,1,0.938695825476341,0,2,activation of blood coagulation via clotting cascade,BP,
1028,GO:0002544,1,0.722487402407782,0,11,chronic inflammatory response,BP,
1029,GO:0002545,1,0.972104725895455,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1033,GO:0002554,1,0.966933724327514,0,1,serotonin secretion by platelet,BP,
1034,GO:0002560,1,0.967308775010198,0,1,basophil mediated immunity,BP,
1035,GO:0002561,1,0.967308775010198,0,1,basophil degranulation,BP,
1037,GO:0002566,1,0.626888465210035,0,15,somatic diversification of immune receptors via somatic mutation,BP,
1038,GO:0002568,1,0.848500113398229,0,5,somatic diversification of T cell receptor genes,BP,
1039,GO:0002572,1,0.937381671941022,0,2,pro-T cell differentiation,BP,
1042,GO:0002577,1,0.810433031129232,0,7,regulation of antigen processing and presentation,BP,
1043,GO:0002578,1,0.889344589323175,0,4,negative regulation of antigen processing and presentation,BP,
1044,GO:0002579,1,0.911297209624184,0,3,positive regulation of antigen processing and presentation,BP,
1045,GO:0002580,1,0.916975970544145,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1046,GO:0002581,1,0.941132374842231,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1047,GO:0002582,1,0.97433684205675,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1048,GO:0002583,1,0.896211007350393,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
1049,GO:0002584,1,0.919821901911461,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
1050,GO:0002585,1,0.97433684205675,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1051,GO:0002586,1,0.948397518723364,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1052,GO:0002587,1,0.973379338393176,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1053,GO:0002588,1,0.97433684205675,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1054,GO:0002589,1,0.944981804736433,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1055,GO:0002590,1,0.944981804736433,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1056,GO:0002604,1,0.904315524374506,0,3,regulation of dendritic cell antigen processing and presentation,BP,
1057,GO:0002605,1,0.966873533978975,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1058,GO:0002606,1,0.935304423972496,0,2,positive regulation of dendritic cell antigen processing and presentation,BP,
1059,GO:0002625,1,0.971924347519029,0,1,regulation of T cell antigen processing and presentation,BP,
1060,GO:0002626,1,0.971924347519029,0,1,negative regulation of T cell antigen processing and presentation,BP,
1061,GO:0002634,1,0.853302158570807,0,5,regulation of germinal center formation,BP,
1062,GO:0002635,1,0.966746089442833,0,1,negative regulation of germinal center formation,BP,
1063,GO:0002636,1,0.972997302627361,0,1,positive regulation of germinal center formation,BP,
1065,GO:0002638,1,0.85245244543042,0,5,negative regulation of immunoglobulin production,BP,
1067,GO:0002643,1,0.752755909930097,0,9,regulation of tolerance induction,BP,
1068,GO:0002645,1,0.8556116898131,0,5,positive regulation of tolerance induction,BP,
1069,GO:0002649,1,0.967037689005993,0,1,regulation of tolerance induction to self antigen,BP,
1070,GO:0002651,1,0.967037689005993,0,1,positive regulation of tolerance induction to self antigen,BP,
1071,GO:0002652,1,0.970825151529268,0,1,regulation of tolerance induction dependent upon immune response,BP,
1072,GO:0002661,1,0.967037689005993,0,1,regulation of B cell tolerance induction,BP,
1073,GO:0002663,1,0.967037689005993,0,1,positive regulation of B cell tolerance induction,BP,
1074,GO:0002664,1,0.855652682581764,0,5,regulation of T cell tolerance induction,BP,
1075,GO:0002666,1,0.88499297760215,0,4,positive regulation of T cell tolerance induction,BP,
1076,GO:0002667,1,0.934811348481785,0,2,regulation of T cell anergy,BP,
1077,GO:0002669,1,0.966858094661623,0,1,positive regulation of T cell anergy,BP,
1079,GO:0002674,1,0.889624346080065,0,4,negative regulation of acute inflammatory response,BP,
1081,GO:0002676,1,0.866375917272017,0,5,regulation of chronic inflammatory response,BP,
1082,GO:0002677,1,0.94081502981865,0,2,negative regulation of chronic inflammatory response,BP,
1083,GO:0002678,1,0.945773588158108,0,2,positive regulation of chronic inflammatory response,BP,
1084,GO:0002679,1,0.914882665881457,0,3,respiratory burst involved in defense response,BP,
1085,GO:0002681,1,0.848500113398229,0,5,somatic recombination of T cell receptor gene segments,BP,
1096,GO:0002692,1,0.882032007645956,0,4,negative regulation of cellular extravasation,BP,
1117,GO:0002713,1,0.883796644612018,0,4,negative regulation of B cell mediated immunity,BP,
1120,GO:0002716,1,0.764003300226172,0,9,negative regulation of natural killer cell mediated immunity,BP,
1127,GO:0002726,1,0.757635990264295,0,9,positive regulation of T cell cytokine production,BP,
1128,GO:0002727,1,0.913585087689555,0,3,regulation of natural killer cell cytokine production,BP,
1129,GO:0002728,1,0.967129757884894,0,1,negative regulation of natural killer cell cytokine production,BP,
1130,GO:0002729,1,0.944640412131455,0,2,positive regulation of natural killer cell cytokine production,BP,
1131,GO:0002730,1,0.882705847100833,0,4,regulation of dendritic cell cytokine production,BP,
1132,GO:0002731,1,0.941992561079262,0,2,negative regulation of dendritic cell cytokine production,BP,
1133,GO:0002732,1,0.967115907475312,0,1,positive regulation of dendritic cell cytokine production,BP,
1134,GO:0002736,1,0.974256161845837,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1135,GO:0002737,1,0.974256161845837,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1136,GO:0002739,1,0.755684809944912,0,9,regulation of cytokine secretion involved in immune response,BP,
1137,GO:0002740,1,0.972774966162281,0,1,negative regulation of cytokine secretion involved in immune response,BP,
1138,GO:0002741,1,0.802111921748609,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1144,GO:0002759,1,0.890120762948892,0,4,regulation of antimicrobial humoral response,BP,
1145,GO:0002760,1,0.945979434538775,0,2,positive regulation of antimicrobial humoral response,BP,
1154,GO:0002775,1,0.91556269585861,0,3,antimicrobial peptide production,BP,
1155,GO:0002778,1,0.91556269585861,0,3,antibacterial peptide production,BP,
1156,GO:0002784,1,0.91556269585861,0,3,regulation of antimicrobial peptide production,BP,
1157,GO:0002785,1,0.967851116867787,0,1,negative regulation of antimicrobial peptide production,BP,
1158,GO:0002786,1,0.91556269585861,0,3,regulation of antibacterial peptide production,BP,
1159,GO:0002787,1,0.967851116867787,0,1,negative regulation of antibacterial peptide production,BP,
1164,GO:0002803,1,0.945979434538775,0,2,positive regulation of antibacterial peptide production,BP,
1172,GO:0002826,1,0.911100226053976,0,3,negative regulation of T-helper 1 type immune response,BP,
1176,GO:0002830,1,0.784693573188808,0,8,positive regulation of type 2 immune response,BP,
1181,GO:0002835,1,0.939884319469728,0,2,negative regulation of response to tumor cell,BP,
1184,GO:0002838,1,0.939884319469728,0,2,negative regulation of immune response to tumor cell,BP,
1189,GO:0002856,1,0.939884319469728,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1192,GO:0002859,1,0.939884319469728,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1194,GO:0002861,1,0.85059009366751,0,6,regulation of inflammatory response to antigenic stimulus,BP,
1195,GO:0002862,1,0.896989834453278,0,4,negative regulation of inflammatory response to antigenic stimulus,BP,
1196,GO:0002863,1,0.948286788716088,0,2,positive regulation of inflammatory response to antigenic stimulus,BP,
1197,GO:0002864,1,0.921397287262301,0,3,regulation of acute inflammatory response to antigenic stimulus,BP,
1198,GO:0002865,1,0.971648205657051,0,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1199,GO:0002866,1,0.948286788716088,0,2,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1200,GO:0002870,1,0.934811348481785,0,2,T cell anergy,BP,
1201,GO:0002874,1,0.972774966162281,0,1,regulation of chronic inflammatory response to antigenic stimulus,BP,
1202,GO:0002875,1,0.972774966162281,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1203,GO:0002880,1,0.972104725895455,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1204,GO:0002882,1,0.972104725895455,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1205,GO:0002883,1,0.945739199513949,0,2,regulation of hypersensitivity,BP,
1206,GO:0002884,1,0.971648205657051,0,1,negative regulation of hypersensitivity,BP,
1207,GO:0002885,1,0.973337072735663,0,1,positive regulation of hypersensitivity,BP,
1212,GO:0002890,1,0.883796644612018,0,4,negative regulation of immunoglobulin mediated immune response,BP,
1214,GO:0002901,1,0.918993103461581,0,3,mature B cell apoptotic process,BP,
1217,GO:0002904,1,0.916528988143618,0,3,positive regulation of B cell apoptotic process,BP,
1218,GO:0002905,1,0.918993103461581,0,3,regulation of mature B cell apoptotic process,BP,
1219,GO:0002906,1,0.918993103461581,0,3,negative regulation of mature B cell apoptotic process,BP,
1220,GO:0002911,1,0.934811348481785,0,2,regulation of lymphocyte anergy,BP,
1221,GO:0002913,1,0.966858094661623,0,1,positive regulation of lymphocyte anergy,BP,
1223,GO:0002921,1,0.856156780692852,0,5,negative regulation of humoral immune response,BP,
1224,GO:0002922,1,0.895200122143528,0,4,positive regulation of humoral immune response,BP,
1225,GO:0002923,1,0.971016631740409,0,1,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1226,GO:0002924,1,0.971016631740409,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1227,GO:0002930,1,0.966914619760076,0,1,trabecular meshwork development,BP,
1228,GO:0002931,1,0.432207087778764,0,27,response to ischemia,BP,
1230,GO:0002934,1,0.746193103996106,0,9,desmosome organization,BP,
1231,GO:0002940,1,0.941373361832422,0,2,tRNA N2-guanine methylation,BP,
1232,GO:0002943,1,0.889751368691911,0,4,tRNA dihydrouridine synthesis,BP,
1233,GO:0002944,1,0.93873954800224,0,2,cyclin K-CDK12 complex,CC,
1234,GO:0002945,1,0.938773398216865,0,2,cyclin K-CDK13 complex,CC,
1235,GO:0002946,1,0.973235498447605,0,1,tRNA C5-cytosine methylation,BP,
1236,GO:0002947,1,0.967359145779692,0,1,tumor necrosis factor receptor superfamily complex,CC,
1237,GO:0002949,1,0.918348147565095,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1238,GO:0002950,1,0.910473575175235,0,3,ceramide phosphoethanolamine synthase activity,MF,
1239,GO:0002951,1,0.970697543527611,0,1,leukotriene-C(4) hydrolase,MF,
1244,GO:0003009,1,0.572618432806379,0,18,skeletal muscle contraction,BP,
1245,GO:0003010,1,0.941826257984801,0,2,voluntary skeletal muscle contraction,BP,
1246,GO:0003011,1,0.935926548843128,0,2,involuntary skeletal muscle contraction,BP,
1252,GO:0003017,1,0.966789154746894,0,1,lymph circulation,BP,
1254,GO:0003025,1,0.938939684484937,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1255,GO:0003032,1,0.940563848342968,0,2,detection of oxygen,BP,
1257,GO:0003050,1,0.968624167171928,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1258,GO:0003056,1,0.853888123181553,0,5,regulation of vascular smooth muscle contraction,BP,
1259,GO:0003057,1,0.914055867684192,0,3,regulation of the force of heart contraction by chemical signal,BP,
1260,GO:0003062,1,0.883743467088555,0,4,regulation of heart rate by chemical signal,BP,
1261,GO:0003064,1,0.972212830762555,0,1,regulation of heart rate by hormone,BP,
1262,GO:0003065,1,0.972357203156315,0,1,positive regulation of heart rate by epinephrine,BP,
1266,GO:0003071,1,0.713732429269483,0,11,renal system process involved in regulation of systemic arterial blood pressure,BP,
1267,GO:0003072,1,0.972000861812146,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1270,GO:0003083,1,0.974698729998558,0,1,negative regulation of renal output by angiotensin,BP,
1274,GO:0003093,1,0.780134674791575,0,8,regulation of glomerular filtration,BP,
1276,GO:0003096,1,0.856633896873052,0,5,renal sodium ion transport,BP,
1278,GO:0003099,1,0.971236436711977,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
1280,GO:0003104,1,0.88313467398102,0,4,positive regulation of glomerular filtration,BP,
1281,GO:0003105,1,0.91364658740727,0,3,negative regulation of glomerular filtration,BP,
1282,GO:0003106,1,0.974698729998558,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1283,GO:0003127,1,0.966928186928295,0,1,detection of nodal flow,BP,
1284,GO:0003128,1,0.865603366253695,0,5,heart field specification,BP,
1285,GO:0003129,1,0.915873598453327,0,3,heart induction,BP,
1286,GO:0003130,1,0.941949008554646,0,2,BMP signaling pathway involved in heart induction,BP,
1287,GO:0003131,1,0.969425204500395,0,1,mesodermal-endodermal cell signaling,BP,
1288,GO:0003133,1,0.941949008554646,0,2,endodermal-mesodermal cell signaling,BP,
1289,GO:0003134,1,0.941949008554646,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1290,GO:0003139,1,0.89025143280091,0,4,secondary heart field specification,BP,
1292,GO:0003143,1,0.275740665474014,0,40,embryonic heart tube morphogenesis,BP,
1294,GO:0003149,1,0.776996133337031,0,8,membranous septum morphogenesis,BP,
1295,GO:0003150,1,0.878698715673386,0,4,muscular septum morphogenesis,BP,
1301,GO:0003160,1,0.91309174911186,0,3,endocardium morphogenesis,BP,
1303,GO:0003162,1,0.934758501547006,0,2,atrioventricular node development,BP,
1304,GO:0003163,1,0.934980143604868,0,2,sinoatrial node development,BP,
1305,GO:0003164,1,0.934972815521467,0,2,His-Purkinje system development,BP,
1306,GO:0003165,1,0.96687745557907,0,1,Purkinje myocyte development,BP,
1307,GO:0003166,1,0.967005382163917,0,1,bundle of His development,BP,
1308,GO:0003167,1,0.967005382163917,0,1,atrioventricular bundle cell differentiation,BP,
1309,GO:0003169,1,0.935902370430625,0,2,coronary vein morphogenesis,BP,
1310,GO:0003170,1,0.420105584280649,0,27,heart valve development,BP,
1311,GO:0003171,1,0.617566232497146,0,15,atrioventricular valve development,BP,
1312,GO:0003174,1,0.773802265441808,0,8,mitral valve development,BP,
1313,GO:0003175,1,0.876360178081276,0,4,tricuspid valve development,BP,
1314,GO:0003176,1,0.886229142233988,0,4,aortic valve development,BP,
1315,GO:0003177,1,0.822974700967154,0,6,pulmonary valve development,BP,
1316,GO:0003179,1,0.461678560949152,0,24,heart valve morphogenesis,BP,
1317,GO:0003180,1,0.886229142233988,0,4,aortic valve morphogenesis,BP,
1318,GO:0003181,1,0.656567243484279,0,13,atrioventricular valve morphogenesis,BP,
1319,GO:0003183,1,0.798836924864279,0,7,mitral valve morphogenesis,BP,
1320,GO:0003184,1,0.822974700967154,0,6,pulmonary valve morphogenesis,BP,
1321,GO:0003186,1,0.876360178081276,0,4,tricuspid valve morphogenesis,BP,
1322,GO:0003188,1,0.800144404240615,0,7,heart valve formation,BP,
1323,GO:0003190,1,0.905257662806276,0,3,atrioventricular valve formation,BP,
1324,GO:0003192,1,0.936351348491402,0,2,mitral valve formation,BP,
1325,GO:0003193,1,0.968680067927164,0,1,pulmonary valve formation,BP,
1326,GO:0003195,1,0.968523206216462,0,1,tricuspid valve formation,BP,
1328,GO:0003198,1,0.70616314455908,0,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1329,GO:0003199,1,0.973015205241223,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1330,GO:0003203,1,0.580939975022101,0,17,endocardial cushion morphogenesis,BP,
1335,GO:0003209,1,0.578146053538399,0,17,cardiac atrium morphogenesis,BP,
1337,GO:0003213,1,0.934755542964287,0,2,cardiac right atrium morphogenesis,BP,
1338,GO:0003214,1,0.826998983856444,0,6,cardiac left ventricle morphogenesis,BP,
1339,GO:0003215,1,0.678248924364269,0,12,cardiac right ventricle morphogenesis,BP,
1340,GO:0003219,1,0.940312858747698,0,2,cardiac right ventricle formation,BP,
1341,GO:0003220,1,0.966798584676304,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1342,GO:0003221,1,0.96675833283641,0,1,right ventricular cardiac muscle tissue morphogenesis,BP,
1344,GO:0003223,1,0.822054499604106,0,6,ventricular compact myocardium morphogenesis,BP,
1345,GO:0003226,1,0.96675833283641,0,1,right ventricular compact myocardium morphogenesis,BP,
1346,GO:0003228,1,0.914455705648941,0,3,atrial cardiac muscle tissue development,BP,
1348,GO:0003230,1,0.508061329385022,0,21,cardiac atrium development,BP,
1350,GO:0003241,1,0.911207246604709,0,3,growth involved in heart morphogenesis,BP,
1351,GO:0003245,1,0.942517560717408,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1352,GO:0003247,1,0.972752451305582,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1353,GO:0003249,1,0.934622618464406,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1354,GO:0003250,1,0.934622618464406,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1355,GO:0003251,1,0.966798584676304,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1356,GO:0003252,1,0.966722078336713,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1357,GO:0003253,1,0.883269867471628,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1359,GO:0003256,1,0.907701708182088,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1360,GO:0003257,1,0.967216439068199,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1361,GO:0003263,1,0.863457940776035,0,5,cardioblast proliferation,BP,
1362,GO:0003264,1,0.834767209949469,0,6,regulation of cardioblast proliferation,BP,
1363,GO:0003266,1,0.860831507129483,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1364,GO:0003270,1,0.966785420358917,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1365,GO:0003272,1,0.661205139028378,0,13,endocardial cushion formation,BP,
1366,GO:0003273,1,0.909849978145084,0,3,cell migration involved in endocardial cushion formation,BP,
1367,GO:0003274,1,0.90614725940652,0,3,endocardial cushion fusion,BP,
1368,GO:0003275,1,0.936138145529685,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
1369,GO:0003278,1,0.908907017322846,0,3,apoptotic process involved in heart morphogenesis,BP,
1372,GO:0003283,1,0.636098997778412,0,14,atrial septum development,BP,
1373,GO:0003284,1,0.877698250104082,0,4,septum primum development,BP,
1374,GO:0003289,1,0.906084285679898,0,3,atrial septum primum morphogenesis,BP,
1375,GO:0003292,1,0.966875780878853,0,1,cardiac septum cell differentiation,BP,
1376,GO:0003294,1,0.938411411682389,0,2,atrial ventricular junction remodeling,BP,
1378,GO:0003299,1,0.67356198053042,0,12,muscle hypertrophy in response to stress,BP,
1381,GO:0003306,1,0.827552872393193,0,6,Wnt signaling pathway involved in heart development,BP,
1382,GO:0003307,1,0.91431169214325,0,3,regulation of Wnt signaling pathway involved in heart development,BP,
1383,GO:0003308,1,0.941896738543203,0,2,negative regulation of Wnt signaling pathway involved in heart development,BP,
1385,GO:0003310,1,0.973198875078459,0,1,pancreatic A cell differentiation,BP,
1386,GO:0003321,1,0.913041741650076,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1392,GO:0003337,1,0.804752943669253,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1394,GO:0003339,1,0.855215255590756,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1395,GO:0003340,1,0.937205045477404,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1396,GO:0003341,1,0.449858719172624,0,26,cilium movement,BP,
1397,GO:0003342,1,0.968981230560612,0,1,proepicardium development,BP,
1398,GO:0003343,1,0.968981230560612,0,1,septum transversum development,BP,
1399,GO:0003344,1,0.817830592207444,0,6,pericardium morphogenesis,BP,
1400,GO:0003345,1,0.967602382116593,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1402,GO:0003350,1,0.938945822758554,0,2,pulmonary myocardium development,BP,
1403,GO:0003351,1,0.742739035143777,0,10,epithelial cilium movement,BP,
1404,GO:0003352,1,0.857212606787762,0,5,regulation of cilium movement,BP,
1405,GO:0003356,1,0.857212606787762,0,5,regulation of cilium beat frequency,BP,
1407,GO:0003360,1,0.90933064930376,0,3,brainstem development,BP,
1408,GO:0003363,1,0.966868848279145,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1410,GO:0003366,1,0.966865927570967,0,1,cell-matrix adhesion involved in ameboidal cell migration,BP,
1411,GO:0003373,1,0.770969577268855,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1412,GO:0003374,1,0.770969577268855,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1414,GO:0003382,1,0.49523603096871,0,22,epithelial cell morphogenesis,BP,
1415,GO:0003383,1,0.903903709745926,0,3,apical constriction,BP,
1416,GO:0003400,1,0.971279171620866,0,1,regulation of COPII vesicle coating,BP,
1417,GO:0003401,1,0.476861462011874,0,23,axis elongation,BP,
1418,GO:0003402,1,0.874141296187725,0,4,planar cell polarity pathway involved in axis elongation,BP,
1419,GO:0003404,1,0.968420702674073,0,1,optic vesicle morphogenesis,BP,
1420,GO:0003406,1,0.908432442268283,0,3,retinal pigment epithelium development,BP,
1422,GO:0003408,1,0.934780109933537,0,2,optic cup formation involved in camera-type eye development,BP,
1423,GO:0003409,1,0.968420702674073,0,1,optic cup structural organization,BP,
1425,GO:0003415,1,0.877404698239414,0,4,chondrocyte hypertrophy,BP,
1426,GO:0003416,1,0.659315158380955,0,13,endochondral bone growth,BP,
1427,GO:0003417,1,0.776381422993791,0,8,growth plate cartilage development,BP,
1428,GO:0003418,1,0.880271647012879,0,4,growth plate cartilage chondrocyte differentiation,BP,
1429,GO:0003419,1,0.940271470207992,0,2,growth plate cartilage chondrocyte proliferation,BP,
1430,GO:0003420,1,0.940271470207992,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1431,GO:0003430,1,0.937454895704856,0,2,growth plate cartilage chondrocyte growth,BP,
1432,GO:0003431,1,0.880271647012879,0,4,growth plate cartilage chondrocyte development,BP,
1438,GO:0003680,1,0.832531978233741,0,6,AT DNA binding,MF,
1442,GO:0003689,1,0.787831936414594,0,8,DNA clamp loader activity,MF,
1444,GO:0003691,1,0.7580380565503,0,9,double-stranded telomeric DNA binding,MF,
1445,GO:0003696,1,0.883879400511879,0,4,satellite DNA binding,MF,
1450,GO:0003708,1,0.879798111476262,0,4,retinoic acid receptor activity,MF,
1454,GO:0003720,1,0.786696005000858,0,8,telomerase activity,MF,
1455,GO:0003721,1,0.975095393507231,0,1,telomerase RNA reverse transcriptase activity,MF,
1457,GO:0003724,1,0.147384847900497,0,60,RNA helicase activity,MF,
1459,GO:0003726,1,0.934899231187112,0,2,double-stranded RNA adenosine deaminase activity,MF,
1465,GO:0003746,1,0.616633195729475,0,16,translation elongation factor activity,MF,
1466,GO:0003747,1,0.829307576798795,0,6,translation release factor activity,MF,
1473,GO:0003796,1,0.973052005311541,0,1,lysozyme activity,MF,
1474,GO:0003810,1,0.910583749698824,0,3,protein-glutamine gamma-glutamyltransferase activity,MF,
1477,GO:0003826,1,0.94315062449036,0,2,alpha-ketoacid dehydrogenase activity,MF,
1478,GO:0003827,1,0.939509973069479,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1479,GO:0003828,1,0.935253958575388,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1480,GO:0003829,1,0.936129056394604,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1482,GO:0003835,1,0.93517313640759,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1483,GO:0003836,1,0.832852654549721,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1485,GO:0003841,1,0.547780180362851,0,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1486,GO:0003842,1,0.968512019901731,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1488,GO:0003845,1,0.946146468256271,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1489,GO:0003846,1,0.939173309592663,0,2,2-acylglycerol O-acyltransferase activity,MF,
1490,GO:0003847,1,0.892642017894174,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1491,GO:0003854,1,0.916090789447697,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1492,GO:0003857,1,0.768906807102482,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1493,GO:0003858,1,0.938429074145352,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1494,GO:0003860,1,0.97197117494094,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1495,GO:0003863,1,0.94315062449036,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1496,GO:0003865,1,0.941736154616668,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1497,GO:0003867,1,0.966958766715114,0,1,4-aminobutyrate transaminase activity,MF,
1498,GO:0003868,1,0.972341016766625,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1499,GO:0003870,1,0.970775214183799,0,1,5-aminolevulinate synthase activity,MF,
1500,GO:0003872,1,0.910015138976479,0,3,6-phosphofructokinase activity,MF,
1501,GO:0003873,1,0.905318624836953,0,3,6-phosphofructo-2-kinase activity,MF,
1502,GO:0003874,1,0.974265395836361,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1503,GO:0003875,1,0.968187544404538,0,1,ADP-ribosylarginine hydrolase activity,MF,
1504,GO:0003876,1,0.936006348136975,0,2,AMP deaminase activity,MF,
1505,GO:0003877,1,0.971448221446798,0,1,ATP adenylyltransferase activity,MF,
1506,GO:0003878,1,0.967190707001199,0,1,ATP citrate synthase activity,MF,
1507,GO:0003880,1,0.912432623307596,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1508,GO:0003881,1,0.972127021137971,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1509,GO:0003882,1,0.970448928008008,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1510,GO:0003883,1,0.937789331134001,0,2,CTP synthase activity,MF,
1511,GO:0003886,1,0.904823172255726,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1512,GO:0003887,1,0.446572091258736,0,26,DNA-directed DNA polymerase activity,MF,
1513,GO:0003896,1,0.915826700360196,0,3,DNA primase activity,MF,
1514,GO:0003899,1,0.29731530668078,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1515,GO:0003905,1,0.973974669279822,0,1,alkylbase DNA N-glycosylase activity,MF,
1516,GO:0003906,1,0.688307290393311,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1517,GO:0003908,1,0.973610751049146,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1520,GO:0003916,1,0.824094904799666,0,6,DNA topoisomerase activity,MF,
1521,GO:0003917,1,0.881523514036095,0,4,DNA topoisomerase type I activity,MF,
1522,GO:0003918,1,0.934874725346646,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1523,GO:0003919,1,0.971848715171512,0,1,FMN adenylyltransferase activity,MF,
1524,GO:0003920,1,0.972104725895455,0,1,GMP reductase activity,MF,
1525,GO:0003921,1,0.970408584984651,0,1,GMP synthase activity,MF,
1526,GO:0003922,1,0.970408584984651,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1527,GO:0003923,1,0.859783735554198,0,5,GPI-anchor transamidase activity,MF,
1529,GO:0003933,1,0.971902993724555,0,1,GTP cyclohydrolase activity,MF,
1530,GO:0003934,1,0.971902993724555,0,1,GTP cyclohydrolase I activity,MF,
1531,GO:0003937,1,0.971484850653794,0,1,IMP cyclohydrolase activity,MF,
1532,GO:0003938,1,0.943691001841849,0,2,IMP dehydrogenase activity,MF,
1533,GO:0003939,1,0.970225831804016,0,1,L-iditol 2-dehydrogenase activity,MF,
1534,GO:0003940,1,0.97120252451975,0,1,L-iduronidase activity,MF,
1535,GO:0003941,1,0.944471050035469,0,2,L-serine ammonia-lyase activity,MF,
1536,GO:0003943,1,0.938997463319236,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1537,GO:0003944,1,0.971164174276892,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1539,GO:0003948,1,0.97151119019705,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1541,GO:0003951,1,0.657677205512824,0,13,NAD+ kinase activity,MF,
1542,GO:0003952,1,0.970469143237632,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1543,GO:0003953,1,0.973101440390168,0,1,NAD+ nucleosidase activity,MF,
1544,GO:0003954,1,0.343897257277838,0,40,NADH dehydrogenase activity,MF,
1545,GO:0003955,1,0.914891842996643,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1546,GO:0003956,1,0.972752451305582,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1547,GO:0003957,1,0.967033443876448,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1548,GO:0003958,1,0.852474973101057,0,5,NADPH-hemoprotein reductase activity,MF,
1549,GO:0003960,1,0.919198937782137,0,3,NADPH:quinone reductase activity,MF,
1550,GO:0003962,1,0.972478537311936,0,1,cystathionine gamma-synthase activity,MF,
1551,GO:0003963,1,0.94141622578967,0,2,RNA-3'-phosphate cyclase activity,MF,
1552,GO:0003964,1,0.786696005000858,0,8,RNA-directed DNA polymerase activity,MF,
1553,GO:0003968,1,0.943054415074977,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1554,GO:0003972,1,0.969271124374127,0,1,RNA ligase (ATP) activity,MF,
1555,GO:0003973,1,0.966865901531705,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
1556,GO:0003974,1,0.972814755393376,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1557,GO:0003975,1,0.971346884516607,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1559,GO:0003977,1,0.940025415915286,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1560,GO:0003978,1,0.972814755393376,0,1,UDP-glucose 4-epimerase activity,MF,
1561,GO:0003979,1,0.968616412039525,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1563,GO:0003983,1,0.971349826100343,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1564,GO:0003985,1,0.915712298407657,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1565,GO:0003986,1,0.922568582993185,0,3,acetyl-CoA hydrolase activity,MF,
1566,GO:0003987,1,0.937177637766283,0,2,acetate-CoA ligase activity,MF,
1567,GO:0003988,1,0.840383771296016,0,6,acetyl-CoA C-acyltransferase activity,MF,
1568,GO:0003989,1,0.934661178698928,0,2,acetyl-CoA carboxylase activity,MF,
1569,GO:0003990,1,0.970469143237632,0,1,acetylcholinesterase activity,MF,
1570,GO:0003991,1,0.97155794017435,0,1,acetylglutamate kinase activity,MF,
1571,GO:0003993,1,0.841530807775386,0,6,acid phosphatase activity,MF,
1574,GO:0003996,1,0.971037284202953,0,1,acyl-CoA ligase activity,MF,
1575,GO:0003997,1,0.911210817174336,0,3,acyl-CoA oxidase activity,MF,
1576,GO:0003998,1,0.949143116051127,0,2,acylphosphatase activity,MF,
1577,GO:0003999,1,0.974613103042065,0,1,adenine phosphoribosyltransferase activity,MF,
1578,GO:0004000,1,0.827311115606076,0,6,adenosine deaminase activity,MF,
1579,GO:0004001,1,0.97161040612634,0,1,adenosine kinase activity,MF,
1581,GO:0004004,1,0.152138260258969,0,59,ATP-dependent RNA helicase activity,MF,
1582,GO:0004008,1,0.934761869510533,0,2,copper-exporting ATPase activity,MF,
1583,GO:0004012,1,0.645814189267148,0,13,phospholipid-translocating ATPase activity,MF,
1584,GO:0004013,1,0.908229462717815,0,3,adenosylhomocysteinase activity,MF,
1585,GO:0004014,1,0.968487030206462,0,1,adenosylmethionine decarboxylase activity,MF,
1586,GO:0004016,1,0.818101962797068,0,6,adenylate cyclase activity,MF,
1587,GO:0004017,1,0.856352947249141,0,5,adenylate kinase activity,MF,
1588,GO:0004018,1,0.973134129628015,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1589,GO:0004019,1,0.969588027203863,0,1,adenylosuccinate synthase activity,MF,
1591,GO:0004021,1,0.967549552025982,0,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1592,GO:0004022,1,0.969903373835275,0,1,alcohol dehydrogenase (NAD) activity,MF,
1593,GO:0004027,1,0.973690342801665,0,1,alcohol sulfotransferase activity,MF,
1594,GO:0004028,1,0.80426380221503,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1595,GO:0004029,1,0.643276655983682,0,14,aldehyde dehydrogenase (NAD) activity,MF,
1596,GO:0004030,1,0.855116652468332,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1597,GO:0004031,1,0.966948773059237,0,1,aldehyde oxidase activity,MF,
1598,GO:0004032,1,0.87325534116893,0,5,alditol:NADP+ 1-oxidoreductase activity,MF,
1599,GO:0004033,1,0.633883503129881,0,16,aldo-keto reductase (NADP) activity,MF,
1600,GO:0004034,1,0.970354031289477,0,1,aldose 1-epimerase activity,MF,
1601,GO:0004040,1,0.939755677603019,0,2,amidase activity,MF,
1602,GO:0004042,1,0.97155794017435,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1603,GO:0004043,1,0.96799442435341,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1604,GO:0004044,1,0.967746057707507,0,1,amidophosphoribosyltransferase activity,MF,
1605,GO:0004045,1,0.895416710021409,0,4,aminoacyl-tRNA hydrolase activity,MF,
1606,GO:0004046,1,0.917306513683113,0,3,aminoacylase activity,MF,
1607,GO:0004047,1,0.945398981448771,0,2,aminomethyltransferase activity,MF,
1608,GO:0004052,1,0.941838934349999,0,2,arachidonate 12-lipoxygenase activity,MF,
1610,GO:0004055,1,0.972258105402834,0,1,argininosuccinate synthase activity,MF,
1611,GO:0004056,1,0.971789875242554,0,1,argininosuccinate lyase activity,MF,
1612,GO:0004057,1,0.971140568782213,0,1,arginyltransferase activity,MF,
1613,GO:0004060,1,0.971720655281764,0,1,arylamine N-acetyltransferase activity,MF,
1614,GO:0004061,1,0.972602434471036,0,1,arylformamidase activity,MF,
1615,GO:0004062,1,0.896479976266149,0,4,aryl sulfotransferase activity,MF,
1616,GO:0004064,1,0.917090151443006,0,3,arylesterase activity,MF,
1617,GO:0004065,1,0.771962650628217,0,8,arylsulfatase activity,MF,
1618,GO:0004066,1,0.942060899665663,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1619,GO:0004069,1,0.942680283114389,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1620,GO:0004070,1,0.934809445040325,0,2,aspartate carbamoyltransferase activity,MF,
1621,GO:0004074,1,0.949057823212679,0,2,biliverdin reductase activity,MF,
1622,GO:0004075,1,0.906779820830466,0,3,biotin carboxylase activity,MF,
1623,GO:0004077,1,0.966868039012414,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1624,GO:0004078,1,0.966868039012414,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1625,GO:0004079,1,0.966868039012414,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1626,GO:0004080,1,0.966868039012414,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1627,GO:0004081,1,0.944547095755224,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1628,GO:0004082,1,0.919408981875856,0,3,bisphosphoglycerate mutase activity,MF,
1629,GO:0004083,1,0.969271124374127,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1631,GO:0004085,1,0.971995214098838,0,1,butyryl-CoA dehydrogenase activity,MF,
1632,GO:0004087,1,0.934809445040325,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1633,GO:0004088,1,0.934809445040325,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1634,GO:0004089,1,0.853351413130249,0,5,carbonate dehydratase activity,MF,
1635,GO:0004090,1,0.899624145899895,0,4,carbonyl reductase (NADPH) activity,MF,
1636,GO:0004092,1,0.969438841901601,0,1,carnitine O-acetyltransferase activity,MF,
1637,GO:0004095,1,0.881324291797651,0,4,carnitine O-palmitoyltransferase activity,MF,
1638,GO:0004096,1,0.918770555247667,0,3,catalase activity,MF,
1639,GO:0004098,1,0.972043112838423,0,1,cerebroside-sulfatase activity,MF,
1640,GO:0004103,1,0.943351284974692,0,2,choline kinase activity,MF,
1641,GO:0004104,1,0.941129534087427,0,2,cholinesterase activity,MF,
1642,GO:0004105,1,0.940667891660874,0,2,choline-phosphate cytidylyltransferase activity,MF,
1644,GO:0004109,1,0.9409278643845,0,2,coproporphyrinogen oxidase activity,MF,
1645,GO:0004111,1,0.889685213269458,0,4,creatine kinase activity,MF,
1647,GO:0004113,1,0.9669056065341,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1649,GO:0004115,1,0.793731661088803,0,7,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1651,GO:0004118,1,0.967296581267626,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1652,GO:0004122,1,0.970021395609411,0,1,cystathionine beta-synthase activity,MF,
1653,GO:0004123,1,0.972478537311936,0,1,cystathionine gamma-lyase activity,MF,
1654,GO:0004126,1,0.792881918712991,0,8,cytidine deaminase activity,MF,
1655,GO:0004127,1,0.93935553169551,0,2,cytidylate kinase activity,MF,
1656,GO:0004128,1,0.812014883516654,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1657,GO:0004129,1,0.620510465344636,0,18,cytochrome-c oxidase activity,MF,
1658,GO:0004132,1,0.97168157368543,0,1,dCMP deaminase activity,MF,
1659,GO:0004133,1,0.966837365625101,0,1,glycogen debranching enzyme activity,MF,
1660,GO:0004134,1,0.966837365625101,0,1,4-alpha-glucanotransferase activity,MF,
1661,GO:0004135,1,0.966837365625101,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1662,GO:0004137,1,0.937932534102628,0,2,deoxycytidine kinase activity,MF,
1663,GO:0004138,1,0.974119343852336,0,1,deoxyguanosine kinase activity,MF,
1664,GO:0004139,1,0.972524513134103,0,1,deoxyribose-phosphate aldolase activity,MF,
1665,GO:0004140,1,0.943364112159158,0,2,dephospho-CoA kinase activity,MF,
1666,GO:0004142,1,0.913682235340553,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1667,GO:0004143,1,0.768983436172762,0,8,diacylglycerol kinase activity,MF,
1668,GO:0004144,1,0.939173309592663,0,2,diacylglycerol O-acyltransferase activity,MF,
1669,GO:0004145,1,0.948789569640736,0,2,diamine N-acetyltransferase activity,MF,
1670,GO:0004146,1,0.942397018325225,0,2,dihydrofolate reductase activity,MF,
1671,GO:0004148,1,0.967961307241613,0,1,dihydrolipoyl dehydrogenase activity,MF,
1672,GO:0004149,1,0.969367461718085,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1673,GO:0004151,1,0.934809445040325,0,2,dihydroorotase activity,MF,
1674,GO:0004152,1,0.971569611463507,0,1,dihydroorotate dehydrogenase activity,MF,
1675,GO:0004155,1,0.97271975895488,0,1,6,7-dihydropteridine reductase activity,MF,
1676,GO:0004157,1,0.96708790686349,0,1,dihydropyrimidinase activity,MF,
1677,GO:0004161,1,0.943405128774232,0,2,dimethylallyltranstransferase activity,MF,
1678,GO:0004163,1,0.972330202712108,0,1,diphosphomevalonate decarboxylase activity,MF,
1679,GO:0004164,1,0.972351812347188,0,1,diphthine synthase activity,MF,
1680,GO:0004165,1,0.909002526441341,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1681,GO:0004167,1,0.95031985845199,0,2,dopachrome isomerase activity,MF,
1682,GO:0004168,1,0.971187775982608,0,1,dolichol kinase activity,MF,
1684,GO:0004170,1,0.972129803812724,0,1,dUTP diphosphatase activity,MF,
1685,GO:0004174,1,0.940175081930333,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1687,GO:0004176,1,0.879983942378361,0,4,ATP-dependent peptidase activity,MF,
1689,GO:0004180,1,0.576571217470318,0,18,carboxypeptidase activity,MF,
1690,GO:0004181,1,0.754143599194748,0,9,metallocarboxypeptidase activity,MF,
1691,GO:0004185,1,0.782257726666959,0,8,serine-type carboxypeptidase activity,MF,
1693,GO:0004197,1,0.098456672034574,0,75,cysteine-type endopeptidase activity,MF,
1694,GO:0004198,1,0.616738087443455,0,16,calcium-dependent cysteine-type endopeptidase activity,MF,
1698,GO:0004300,1,0.790564734694972,0,8,enoyl-CoA hydratase activity,MF,
1699,GO:0004301,1,0.817062394828118,0,7,epoxide hydrolase activity,MF,
1700,GO:0004303,1,0.822317161972534,0,7,estradiol 17-beta-dehydrogenase activity,MF,
1701,GO:0004304,1,0.972378719353157,0,1,estrone sulfotransferase activity,MF,
1702,GO:0004305,1,0.885264610906724,0,4,ethanolamine kinase activity,MF,
1703,GO:0004306,1,0.972171428556967,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1704,GO:0004307,1,0.945813440836012,0,2,ethanolaminephosphotransferase activity,MF,
1705,GO:0004308,1,0.887584324700119,0,4,exo-alpha-sialidase activity,MF,
1706,GO:0004309,1,0.880544804334902,0,4,exopolyphosphatase activity,MF,
1707,GO:0004310,1,0.971455551403725,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1708,GO:0004311,1,0.912614904132289,0,3,farnesyltranstransferase activity,MF,
1709,GO:0004312,1,0.76166019565816,0,9,fatty acid synthase activity,MF,
1710,GO:0004313,1,0.966805423739126,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1711,GO:0004314,1,0.939652377887213,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1712,GO:0004315,1,0.941267307850969,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1713,GO:0004316,1,0.966805423739126,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1714,GO:0004317,1,0.966805423739126,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1715,GO:0004319,1,0.966805423739126,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1716,GO:0004320,1,0.940160547185331,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1718,GO:0004324,1,0.972059959176842,0,1,ferredoxin-NADP+ reductase activity,MF,
1719,GO:0004325,1,0.966835748661928,0,1,ferrochelatase activity,MF,
1720,GO:0004326,1,0.970333993118907,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1721,GO:0004329,1,0.937069277753091,0,2,formate-tetrahydrofolate ligase activity,MF,
1722,GO:0004331,1,0.877491745734823,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1723,GO:0004332,1,0.94644668731669,0,2,fructose-bisphosphate aldolase activity,MF,
1724,GO:0004333,1,0.972351812347188,0,1,fumarate hydratase activity,MF,
1725,GO:0004334,1,0.973189676964147,0,1,fumarylacetoacetase activity,MF,
1726,GO:0004335,1,0.942898666119947,0,2,galactokinase activity,MF,
1727,GO:0004336,1,0.96922856721965,0,1,galactosylceramidase activity,MF,
1728,GO:0004337,1,0.943405128774232,0,2,geranyltranstransferase activity,MF,
1729,GO:0004340,1,0.905435702040609,0,3,glucokinase activity,MF,
1730,GO:0004342,1,0.943717940108006,0,2,glucosamine-6-phosphate deaminase activity,MF,
1731,GO:0004343,1,0.967543329131995,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1732,GO:0004344,1,0.966790451126607,0,1,glucose dehydrogenase activity,MF,
1734,GO:0004346,1,0.972754957723061,0,1,glucose-6-phosphatase activity,MF,
1735,GO:0004347,1,0.971514114982628,0,1,glucose-6-phosphate isomerase activity,MF,
1736,GO:0004348,1,0.939438670197354,0,2,glucosylceramidase activity,MF,
1737,GO:0004349,1,0.968133458427986,0,1,glutamate 5-kinase activity,MF,
1738,GO:0004350,1,0.968133458427986,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1739,GO:0004351,1,0.938831069420568,0,2,glutamate decarboxylase activity,MF,
1740,GO:0004352,1,0.968114720786149,0,1,glutamate dehydrogenase (NAD+) activity,MF,
1741,GO:0004353,1,0.968114720786149,0,1,glutamate dehydrogenase [NAD(P)+] activity,MF,
1742,GO:0004356,1,0.967187319288456,0,1,glutamate-ammonia ligase activity,MF,
1743,GO:0004357,1,0.937633238638339,0,2,glutamate-cysteine ligase activity,MF,
1744,GO:0004359,1,0.910402437945659,0,3,glutaminase activity,MF,
1745,GO:0004360,1,0.966801523233906,0,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1746,GO:0004361,1,0.972563614139016,0,1,glutaryl-CoA dehydrogenase activity,MF,
1747,GO:0004362,1,0.970978287439281,0,1,glutathione-disulfide reductase activity,MF,
1748,GO:0004363,1,0.972034677938239,0,1,glutathione synthase activity,MF,
1750,GO:0004365,1,0.973506143927433,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1751,GO:0004366,1,0.853920224443868,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1752,GO:0004367,1,0.967558959259688,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1753,GO:0004368,1,0.966870364153008,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
1754,GO:0004370,1,0.935696621994507,0,2,glycerol kinase activity,MF,
1755,GO:0004371,1,0.969271124374127,0,1,glycerone kinase activity,MF,
1756,GO:0004372,1,0.942343184763311,0,2,glycine hydroxymethyltransferase activity,MF,
1757,GO:0004373,1,0.968176288173277,0,1,glycogen (starch) synthase activity,MF,
1758,GO:0004375,1,0.96765332017958,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1759,GO:0004376,1,0.886490964260795,0,4,glycolipid mannosyltransferase activity,MF,
1760,GO:0004377,1,0.970208854953282,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1761,GO:0004378,1,0.969237981957712,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1762,GO:0004379,1,0.934993574071478,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1763,GO:0004382,1,0.940629858308638,0,2,guanosine-diphosphatase activity,MF,
1764,GO:0004383,1,0.818101962797068,0,6,guanylate cyclase activity,MF,
1768,GO:0004394,1,0.967325144180648,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1769,GO:0004395,1,0.973608638681413,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1770,GO:0004396,1,0.905435702040609,0,3,hexokinase activity,MF,
1771,GO:0004397,1,0.9686969601558,0,1,histidine ammonia-lyase activity,MF,
1774,GO:0004408,1,0.970925226765535,0,1,holocytochrome-c synthase activity,MF,
1775,GO:0004415,1,0.859674216619972,0,5,hyalurononglucosaminidase activity,MF,
1776,GO:0004416,1,0.942814454617799,0,2,hydroxyacylglutathione hydrolase activity,MF,
1777,GO:0004418,1,0.973159665436758,0,1,hydroxymethylbilane synthase activity,MF,
1778,GO:0004419,1,0.973079136849004,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
1779,GO:0004420,1,0.967104318565073,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1781,GO:0004422,1,0.945995402903846,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1782,GO:0004423,1,0.96687337656163,0,1,iduronate-2-sulfatase activity,MF,
1783,GO:0004427,1,0.921290934652698,0,3,inorganic diphosphatase activity,MF,
1784,GO:0004430,1,0.826046236312397,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1785,GO:0004435,1,0.635621012424406,0,14,phosphatidylinositol phospholipase C activity,MF,
1786,GO:0004438,1,0.630786451845277,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1787,GO:0004439,1,0.772204092286024,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1788,GO:0004441,1,0.971503876606367,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1789,GO:0004445,1,0.853439587782379,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1790,GO:0004446,1,0.96937967616693,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1791,GO:0004448,1,0.866709325569851,0,5,isocitrate dehydrogenase activity,MF,
1792,GO:0004449,1,0.918042042523693,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1793,GO:0004450,1,0.944097324810453,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1794,GO:0004452,1,0.945546325492082,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1795,GO:0004454,1,0.97054446572611,0,1,ketohexokinase activity,MF,
1796,GO:0004457,1,0.892144681532204,0,4,lactate dehydrogenase activity,MF,
1797,GO:0004458,1,0.970051889225651,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
1798,GO:0004459,1,0.919694013699641,0,3,L-lactate dehydrogenase activity,MF,
1800,GO:0004462,1,0.971639489950569,0,1,lactoylglutathione lyase activity,MF,
1801,GO:0004463,1,0.971555021305922,0,1,leukotriene-A4 hydrolase activity,MF,
1803,GO:0004465,1,0.911126187252281,0,3,lipoprotein lipase activity,MF,
1804,GO:0004466,1,0.887866696386397,0,4,long-chain-acyl-CoA dehydrogenase activity,MF,
1805,GO:0004467,1,0.751347677607886,0,9,long-chain fatty acid-CoA ligase activity,MF,
1806,GO:0004468,1,0.877419987004924,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1807,GO:0004470,1,0.885304457123216,0,4,malic enzyme activity,MF,
1808,GO:0004471,1,0.90932038513866,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1809,GO:0004473,1,0.90932038513866,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1810,GO:0004475,1,0.972834536924223,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1811,GO:0004476,1,0.972400159260788,0,1,mannose-6-phosphate isomerase activity,MF,
1812,GO:0004477,1,0.883302840409583,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1813,GO:0004478,1,0.969443812569944,0,1,methionine adenosyltransferase activity,MF,
1814,GO:0004479,1,0.969626763580086,0,1,methionyl-tRNA formyltransferase activity,MF,
1815,GO:0004482,1,0.96686298944931,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
1816,GO:0004483,1,0.939484005877423,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
1817,GO:0004484,1,0.967125256599071,0,1,mRNA guanylyltransferase activity,MF,
1818,GO:0004485,1,0.938961912134006,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
1819,GO:0004486,1,0.968131889980113,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
1820,GO:0004487,1,0.912587983424458,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
1821,GO:0004488,1,0.883302840409583,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
1822,GO:0004489,1,0.966838706754937,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
1823,GO:0004490,1,0.972868974604487,0,1,methylglutaconyl-CoA hydratase activity,MF,
1824,GO:0004491,1,0.971229065755609,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
1825,GO:0004492,1,0.971432088649501,0,1,methylmalonyl-CoA decarboxylase activity,MF,
1826,GO:0004493,1,0.974383917091779,0,1,methylmalonyl-CoA epimerase activity,MF,
1827,GO:0004494,1,0.969106094249871,0,1,methylmalonyl-CoA mutase activity,MF,
1828,GO:0004496,1,0.971556480791956,0,1,mevalonate kinase activity,MF,
1830,GO:0004498,1,0.970333993118907,0,1,calcidiol 1-monooxygenase activity,MF,
1831,GO:0004499,1,0.971352767457285,0,1,N,N-dimethylaniline monooxygenase activity,MF,
1832,GO:0004500,1,0.968924823804647,0,1,dopamine beta-monooxygenase activity,MF,
1833,GO:0004504,1,0.96777033007464,0,1,peptidylglycine monooxygenase activity,MF,
1834,GO:0004505,1,0.945554369127274,0,2,phenylalanine 4-monooxygenase activity,MF,
1835,GO:0004506,1,0.96903862727208,0,1,squalene monooxygenase activity,MF,
1836,GO:0004511,1,0.972037490433508,0,1,tyrosine 3-monooxygenase activity,MF,
1837,GO:0004512,1,0.970998932469491,0,1,inositol-3-phosphate synthase activity,MF,
1838,GO:0004513,1,0.970860445056348,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
1839,GO:0004514,1,0.912013816740886,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
1840,GO:0004515,1,0.904660046401403,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
1841,GO:0004516,1,0.969271124374127,0,1,nicotinate phosphoribosyltransferase activity,MF,
1842,GO:0004517,1,0.938226151552557,0,2,nitric-oxide synthase activity,MF,
1845,GO:0004520,1,0.253265302167339,0,45,endodeoxyribonuclease activity,MF,
1847,GO:0004522,1,0.972932328515233,0,1,ribonuclease A activity,MF,
1848,GO:0004523,1,0.843551098213398,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1849,GO:0004525,1,0.88130582073325,0,4,ribonuclease III activity,MF,
1853,GO:0004529,1,0.593989017210811,0,17,exodeoxyribonuclease activity,MF,
1854,GO:0004530,1,0.936603741698929,0,2,deoxyribonuclease I activity,MF,
1855,GO:0004531,1,0.971743766579281,0,1,deoxyribonuclease II activity,MF,
1857,GO:0004534,1,0.904889665184237,0,3,5'-3' exoribonuclease activity,MF,
1859,GO:0004536,1,0.155581521721907,0,61,deoxyribonuclease activity,MF,
1862,GO:0004550,1,0.708886751199534,0,12,nucleoside diphosphate kinase activity,MF,
1865,GO:0004556,1,0.971232014228794,0,1,alpha-amylase activity,MF,
1866,GO:0004557,1,0.94190194096825,0,2,alpha-galactosidase activity,MF,
1867,GO:0004558,1,0.936052262379461,0,2,alpha-1,4-glucosidase activity,MF,
1868,GO:0004559,1,0.655050945962118,0,13,alpha-mannosidase activity,MF,
1869,GO:0004560,1,0.943729372096556,0,2,alpha-L-fucosidase activity,MF,
1870,GO:0004561,1,0.969544511893736,0,1,alpha-N-acetylglucosaminidase activity,MF,
1871,GO:0004563,1,0.857366291683214,0,5,beta-N-acetylhexosaminidase activity,MF,
1872,GO:0004565,1,0.884043797022952,0,4,beta-galactosidase activity,MF,
1873,GO:0004566,1,0.944106070174806,0,2,beta-glucuronidase activity,MF,
1874,GO:0004567,1,0.968383354102579,0,1,beta-mannosidase activity,MF,
1875,GO:0004568,1,0.938028937656722,0,2,chitinase activity,MF,
1876,GO:0004569,1,0.967076375278614,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
1877,GO:0004571,1,0.798714211113919,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
1878,GO:0004572,1,0.934870007390984,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
1879,GO:0004573,1,0.969674964311459,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
1880,GO:0004574,1,0.967935840521965,0,1,oligo-1,6-glucosidase activity,MF,
1882,GO:0004577,1,0.943756378341431,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
1883,GO:0004578,1,0.967530999560944,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
1885,GO:0004581,1,0.97380630138426,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
1886,GO:0004582,1,0.924118894021634,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
1887,GO:0004583,1,0.881962447763425,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
1888,GO:0004584,1,0.970704860862804,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
1889,GO:0004586,1,0.910858004195815,0,3,ornithine decarboxylase activity,MF,
1890,GO:0004587,1,0.971820047232335,0,1,ornithine-oxo-acid transaminase activity,MF,
1891,GO:0004588,1,0.969870792292723,0,1,orotate phosphoribosyltransferase activity,MF,
1892,GO:0004590,1,0.969870792292723,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1893,GO:0004591,1,0.881205813616645,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
1894,GO:0004594,1,0.885604505353197,0,4,pantothenate kinase activity,MF,
1895,GO:0004595,1,0.970895769470444,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1896,GO:0004596,1,0.73497283876943,0,10,peptide alpha-N-acetyltransferase activity,MF,
1897,GO:0004597,1,0.967897691646369,0,1,peptide-aspartate beta-dioxygenase activity,MF,
1898,GO:0004598,1,0.96777033007464,0,1,peptidylamidoglycolate lyase activity,MF,
1901,GO:0004605,1,0.908989383255771,0,3,phosphatidate cytidylyltransferase activity,MF,
1902,GO:0004607,1,0.973416848341361,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
1903,GO:0004608,1,0.974153435035593,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
1904,GO:0004609,1,0.942053419092494,0,2,phosphatidylserine decarboxylase activity,MF,
1905,GO:0004610,1,0.971769721870013,0,1,phosphoacetylglucosamine mutase activity,MF,
1906,GO:0004611,1,0.971863023673316,0,1,phosphoenolpyruvate carboxykinase activity,MF,
1907,GO:0004613,1,0.971863023673316,0,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
1908,GO:0004614,1,0.882966473596464,0,4,phosphoglucomutase activity,MF,
1909,GO:0004615,1,0.945151904124368,0,2,phosphomannomutase activity,MF,
1910,GO:0004616,1,0.914086817718244,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
1911,GO:0004617,1,0.971709085988543,0,1,phosphoglycerate dehydrogenase activity,MF,
1913,GO:0004619,1,0.919408981875856,0,3,phosphoglycerate mutase activity,MF,
1915,GO:0004621,1,0.97092080711143,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
1918,GO:0004629,1,0.615823071170136,0,15,phospholipase C activity,MF,
1920,GO:0004631,1,0.973540550583237,0,1,phosphomevalonate kinase activity,MF,
1921,GO:0004632,1,0.973613917868065,0,1,phosphopantothenate--cysteine ligase activity,MF,
1922,GO:0004633,1,0.971128765039439,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1923,GO:0004634,1,0.972278588921025,0,1,phosphopyruvate hydratase activity,MF,
1924,GO:0004637,1,0.968173884301606,0,1,phosphoribosylamine-glycine ligase activity,MF,
1925,GO:0004638,1,0.968344858192287,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1926,GO:0004639,1,0.968344858192287,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
1927,GO:0004641,1,0.968173884301606,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1928,GO:0004642,1,0.966888903347889,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
1929,GO:0004643,1,0.971484850653794,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
1930,GO:0004644,1,0.968173884301606,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
1931,GO:0004645,1,0.882052269609797,0,4,phosphorylase activity,MF,
1932,GO:0004647,1,0.943991984099033,0,2,phosphoserine phosphatase activity,MF,
1933,GO:0004648,1,0.971418882288976,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
1934,GO:0004649,1,0.940765817500602,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
1935,GO:0004651,1,0.940761373788292,0,2,polynucleotide 5'-phosphatase activity,MF,
1936,GO:0004652,1,0.771220942672212,0,8,polynucleotide adenylyltransferase activity,MF,
1938,GO:0004654,1,0.967063986272255,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
1939,GO:0004655,1,0.968629998116401,0,1,porphobilinogen synthase activity,MF,
1940,GO:0004656,1,0.91312552136834,0,3,procollagen-proline 4-dioxygenase activity,MF,
1941,GO:0004657,1,0.971128765039439,0,1,proline dehydrogenase activity,MF,
1942,GO:0004658,1,0.943476678041007,0,2,propionyl-CoA carboxylase activity,MF,
1944,GO:0004660,1,0.943101327372675,0,2,protein farnesyltransferase activity,MF,
1945,GO:0004661,1,0.86267139482431,0,5,protein geranylgeranyltransferase activity,MF,
1946,GO:0004662,1,0.943337156762649,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
1947,GO:0004663,1,0.889657648563418,0,4,Rab geranylgeranyltransferase activity,MF,
1948,GO:0004666,1,0.935130022858712,0,2,prostaglandin-endoperoxide synthase activity,MF,
1949,GO:0004668,1,0.968614476728591,0,1,protein-arginine deiminase activity,MF,
1950,GO:0004671,1,0.966987199537202,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
1952,GO:0004673,1,0.974626891856109,0,1,protein histidine kinase activity,MF,
1954,GO:0004675,1,0.673397335742298,0,12,transmembrane receptor protein serine/threonine kinase activity,MF,
1955,GO:0004676,1,0.966841369286305,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
1956,GO:0004677,1,0.905960467051234,0,3,DNA-dependent protein kinase activity,MF,
1957,GO:0004679,1,0.802013543879409,0,7,AMP-activated protein kinase activity,MF,
1958,GO:0004683,1,0.498613423266512,0,22,calmodulin-dependent protein kinase activity,MF,
1959,GO:0004686,1,0.966831969670296,0,1,elongation factor-2 kinase activity,MF,
1960,GO:0004687,1,0.934743423033058,0,2,myosin light chain kinase activity,MF,
1961,GO:0004689,1,0.851118608393164,0,5,phosphorylase kinase activity,MF,
1962,GO:0004690,1,0.797888757597933,0,7,cyclic nucleotide-dependent protein kinase activity,MF,
1963,GO:0004691,1,0.824568991060138,0,6,cAMP-dependent protein kinase activity,MF,
1964,GO:0004692,1,0.967660209417963,0,1,cGMP-dependent protein kinase activity,MF,
1966,GO:0004694,1,0.876892635644988,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
1967,GO:0004697,1,0.677824481797847,0,12,protein kinase C activity,MF,
1968,GO:0004698,1,0.966798439213394,0,1,calcium-dependent protein kinase C activity,MF,
1969,GO:0004699,1,0.90747429677941,0,3,calcium-independent protein kinase C activity,MF,
1971,GO:0004703,1,0.940151719609044,0,2,G-protein coupled receptor kinase activity,MF,
1973,GO:0004705,1,0.910757220223632,0,3,JUN kinase activity,MF,
1974,GO:0004706,1,0.906130742668684,0,3,JUN kinase kinase kinase activity,MF,
1975,GO:0004707,1,0.689989720072592,0,12,MAP kinase activity,MF,
1976,GO:0004708,1,0.688883661720219,0,12,MAP kinase kinase activity,MF,
1978,GO:0004711,1,0.797309492229351,0,7,ribosomal protein S6 kinase activity,MF,
1979,GO:0004712,1,0.325711389755382,0,36,protein serine/threonine/tyrosine kinase activity,MF,
1984,GO:0004719,1,0.910227828086583,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
1987,GO:0004722,1,0.150483342739491,0,61,protein serine/threonine phosphatase activity,MF,
1988,GO:0004723,1,0.797538290185388,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
1991,GO:0004727,1,0.97161040612634,0,1,prenylated protein tyrosine phosphatase activity,MF,
1992,GO:0004728,1,0.970051889225651,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
1993,GO:0004729,1,0.972475898403431,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
1994,GO:0004730,1,0.972679242845724,0,1,pseudouridylate synthase activity,MF,
1995,GO:0004731,1,0.938484194864247,0,2,purine-nucleoside phosphorylase activity,MF,
1996,GO:0004733,1,0.968142895810993,0,1,pyridoxamine-phosphate oxidase activity,MF,
1997,GO:0004735,1,0.945455152484801,0,2,pyrroline-5-carboxylate reductase activity,MF,
1998,GO:0004736,1,0.967451775445963,0,1,pyruvate carboxylase activity,MF,
1999,GO:0004738,1,0.855425802327466,0,5,pyruvate dehydrogenase activity,MF,
2000,GO:0004739,1,0.942140240374814,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2001,GO:0004740,1,0.907788884152299,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2002,GO:0004741,1,0.904922852288986,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2003,GO:0004742,1,0.967194743315477,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2004,GO:0004743,1,0.969271124374127,0,1,pyruvate kinase activity,MF,
2006,GO:0004747,1,0.973748158611112,0,1,ribokinase activity,MF,
2007,GO:0004748,1,0.906920395232214,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2008,GO:0004749,1,0.889190209915898,0,4,ribose phosphate diphosphokinase activity,MF,
2009,GO:0004750,1,0.970892824701539,0,1,ribulose-phosphate 3-epimerase activity,MF,
2010,GO:0004751,1,0.972229327315741,0,1,ribose-5-phosphate isomerase activity,MF,
2011,GO:0004753,1,0.966871384739408,0,1,saccharopine dehydrogenase activity,MF,
2012,GO:0004756,1,0.941892974386419,0,2,selenide, water dikinase activity,MF,
2013,GO:0004757,1,0.973187374780922,0,1,sepiapterin reductase activity,MF,
2014,GO:0004758,1,0.854388019657728,0,5,serine C-palmitoyltransferase activity,MF,
2015,GO:0004766,1,0.97358746401213,0,1,spermidine synthase activity,MF,
2016,GO:0004767,1,0.858574196445053,0,5,sphingomyelin phosphodiesterase activity,MF,
2017,GO:0004768,1,0.908560653455886,0,3,stearoyl-CoA 9-desaturase activity,MF,
2018,GO:0004769,1,0.973837630045166,0,1,steroid delta-isomerase activity,MF,
2020,GO:0004772,1,0.968244772971475,0,1,sterol O-acyltransferase activity,MF,
2021,GO:0004773,1,0.966858585632847,0,1,steryl-sulfatase activity,MF,
2022,GO:0004774,1,0.917547475847786,0,3,succinate-CoA ligase activity,MF,
2023,GO:0004775,1,0.945222747214281,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2024,GO:0004776,1,0.944686619865718,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2025,GO:0004777,1,0.966914057987496,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2026,GO:0004778,1,0.972777461865426,0,1,succinyl-CoA hydrolase activity,MF,
2029,GO:0004782,1,0.969739494715775,0,1,sulfinoalanine decarboxylase activity,MF,
2031,GO:0004790,1,0.970146860703029,0,1,thioether S-methyltransferase activity,MF,
2033,GO:0004792,1,0.919724542459717,0,3,thiosulfate sulfurtransferase activity,MF,
2034,GO:0004793,1,0.942343184763311,0,2,threonine aldolase activity,MF,
2035,GO:0004794,1,0.973316924506978,0,1,L-threonine ammonia-lyase activity,MF,
2036,GO:0004795,1,0.971435022576243,0,1,threonine synthase activity,MF,
2037,GO:0004797,1,0.940679964045944,0,2,thymidine kinase activity,MF,
2038,GO:0004798,1,0.943732169123637,0,2,thymidylate kinase activity,MF,
2039,GO:0004799,1,0.972883663885171,0,1,thymidylate synthase activity,MF,
2040,GO:0004801,1,0.973652805281253,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2041,GO:0004802,1,0.97144968759749,0,1,transketolase activity,MF,
2042,GO:0004803,1,0.935612576706327,0,2,transposase activity,MF,
2043,GO:0004806,1,0.706840645312755,0,11,triglyceride lipase activity,MF,
2044,GO:0004807,1,0.973180461848399,0,1,triose-phosphate isomerase activity,MF,
2045,GO:0004809,1,0.914909869541635,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2046,GO:0004810,1,0.970960595886097,0,1,tRNA adenylyltransferase activity,MF,
2047,GO:0004812,1,0.260475282966639,0,44,aminoacyl-tRNA ligase activity,MF,
2048,GO:0004813,1,0.910184077900558,0,3,alanine-tRNA ligase activity,MF,
2049,GO:0004814,1,0.916998880707994,0,3,arginine-tRNA ligase activity,MF,
2050,GO:0004815,1,0.940032999450508,0,2,aspartate-tRNA ligase activity,MF,
2051,GO:0004816,1,0.941159211057113,0,2,asparagine-tRNA ligase activity,MF,
2052,GO:0004817,1,0.94285658228005,0,2,cysteine-tRNA ligase activity,MF,
2053,GO:0004818,1,0.935555124158177,0,2,glutamate-tRNA ligase activity,MF,
2054,GO:0004819,1,0.938400234661632,0,2,glutamine-tRNA ligase activity,MF,
2055,GO:0004820,1,0.943282920479748,0,2,glycine-tRNA ligase activity,MF,
2056,GO:0004821,1,0.943003119229604,0,2,histidine-tRNA ligase activity,MF,
2057,GO:0004822,1,0.93616814651111,0,2,isoleucine-tRNA ligase activity,MF,
2058,GO:0004823,1,0.935332523637509,0,2,leucine-tRNA ligase activity,MF,
2059,GO:0004824,1,0.971448221446798,0,1,lysine-tRNA ligase activity,MF,
2060,GO:0004825,1,0.939388466905041,0,2,methionine-tRNA ligase activity,MF,
2061,GO:0004826,1,0.862489343644639,0,5,phenylalanine-tRNA ligase activity,MF,
2062,GO:0004827,1,0.914148039597619,0,3,proline-tRNA ligase activity,MF,
2063,GO:0004828,1,0.944400851642094,0,2,serine-tRNA ligase activity,MF,
2064,GO:0004829,1,0.911156762023966,0,3,threonine-tRNA ligase activity,MF,
2065,GO:0004830,1,0.940146492655828,0,2,tryptophan-tRNA ligase activity,MF,
2066,GO:0004831,1,0.940957175217933,0,2,tyrosine-tRNA ligase activity,MF,
2067,GO:0004832,1,0.905241928122434,0,3,valine-tRNA ligase activity,MF,
2068,GO:0004833,1,0.972915348123467,0,1,tryptophan 2,3-dioxygenase activity,MF,
2069,GO:0004835,1,0.96691322630408,0,1,tubulin-tyrosine ligase activity,MF,
2070,GO:0004839,1,0.850370295814653,0,5,ubiquitin activating enzyme activity,MF,
2073,GO:0004844,1,0.867081976340822,0,5,uracil DNA N-glycosylase activity,MF,
2074,GO:0004849,1,0.864755124766407,0,5,uridine kinase activity,MF,
2075,GO:0004850,1,0.972300370201599,0,1,uridine phosphorylase activity,MF,
2076,GO:0004852,1,0.973410249818931,0,1,uroporphyrinogen-III synthase activity,MF,
2077,GO:0004853,1,0.973343770506078,0,1,uroporphyrinogen decarboxylase activity,MF,
2078,GO:0004854,1,0.934915758662178,0,2,xanthine dehydrogenase activity,MF,
2079,GO:0004855,1,0.966875058564527,0,1,xanthine oxidase activity,MF,
2080,GO:0004856,1,0.967811766649676,0,1,xylulokinase activity,MF,
2085,GO:0004862,1,0.811712652062759,0,7,cAMP-dependent protein kinase inhibitor activity,MF,
2086,GO:0004864,1,0.479002174187931,0,24,protein phosphatase inhibitor activity,MF,
2087,GO:0004865,1,0.820504337305693,0,7,protein serine/threonine phosphatase inhibitor activity,MF,
2092,GO:0004874,1,0.934945468069712,0,2,aryl hydrocarbon receptor activity,MF,
2094,GO:0004882,1,0.968464112479007,0,1,androgen receptor activity,MF,
2095,GO:0004883,1,0.966852478934071,0,1,glucocorticoid receptor activity,MF,
2096,GO:0004886,1,0.937198468295281,0,2,9-cis retinoic acid receptor activity,MF,
2097,GO:0004887,1,0.883654098972678,0,4,thyroid hormone receptor activity,MF,
2099,GO:0004890,1,0.9686969601558,0,1,GABA-A receptor activity,MF,
2102,GO:0004900,1,0.972190777828092,0,1,erythropoietin receptor activity,MF,
2106,GO:0004908,1,0.856740664006423,0,5,interleukin-1 receptor activity,MF,
2107,GO:0004909,1,0.939743511888425,0,2,interleukin-1, Type I, activating receptor activity,MF,
2108,GO:0004910,1,0.973244612249411,0,1,interleukin-1, Type II, blocking receptor activity,MF,
2109,GO:0004913,1,0.970628876790198,0,1,interleukin-4 receptor activity,MF,
2112,GO:0004918,1,0.970362629271163,0,1,interleukin-8 receptor activity,MF,
2118,GO:0004931,1,0.971674325577539,0,1,extracellularly ATP-gated cation channel activity,MF,
2119,GO:0004935,1,0.943712065958963,0,2,adrenergic receptor activity,MF,
2120,GO:0004936,1,0.971236436711977,0,1,alpha-adrenergic receptor activity,MF,
2121,GO:0004937,1,0.971236436711977,0,1,alpha1-adrenergic receptor activity,MF,
2122,GO:0004939,1,0.97166272183182,0,1,beta-adrenergic receptor activity,MF,
2123,GO:0004941,1,0.97166272183182,0,1,beta2-adrenergic receptor activity,MF,
2124,GO:0004945,1,0.973782924850729,0,1,angiotensin type II receptor activity,MF,
2125,GO:0004947,1,0.941734406342892,0,2,bradykinin receptor activity,MF,
2126,GO:0004948,1,0.966939668707445,0,1,calcitonin receptor activity,MF,
2128,GO:0004952,1,0.94791073774906,0,2,dopamine neurotransmitter receptor activity,MF,
2129,GO:0004953,1,0.860961813278315,0,5,icosanoid receptor activity,MF,
2130,GO:0004954,1,0.913963672822274,0,3,prostanoid receptor activity,MF,
2131,GO:0004955,1,0.941284438632703,0,2,prostaglandin receptor activity,MF,
2132,GO:0004957,1,0.968229905693104,0,1,prostaglandin E receptor activity,MF,
2133,GO:0004960,1,0.970979761919229,0,1,thromboxane receptor activity,MF,
2134,GO:0004961,1,0.970979761919229,0,1,thromboxane A2 receptor activity,MF,
2135,GO:0004962,1,0.967656759754395,0,1,endothelin receptor activity,MF,
2136,GO:0004965,1,0.935563272115653,0,2,G-protein coupled GABA receptor activity,MF,
2137,GO:0004966,1,0.918038310039434,0,3,galanin receptor activity,MF,
2138,GO:0004968,1,0.934831322511406,0,2,gonadotropin-releasing hormone receptor activity,MF,
2139,GO:0004969,1,0.937342590033324,0,2,histamine receptor activity,MF,
2140,GO:0004970,1,0.904168565851437,0,3,ionotropic glutamate receptor activity,MF,
2141,GO:0004972,1,0.904168565851437,0,3,NMDA glutamate receptor activity,MF,
2142,GO:0004974,1,0.942022673272113,0,2,leukotriene receptor activity,MF,
2143,GO:0004977,1,0.941839169649176,0,2,melanocortin receptor activity,MF,
2144,GO:0004979,1,0.972152030821871,0,1,beta-endorphin receptor activity,MF,
2145,GO:0004980,1,0.968821183055531,0,1,melanocyte-stimulating hormone receptor activity,MF,
2146,GO:0004984,1,0.919371724333116,0,3,olfactory receptor activity,MF,
2147,GO:0004985,1,0.917866639049934,0,3,opioid receptor activity,MF,
2148,GO:0004990,1,0.967192255235484,0,1,oxytocin receptor activity,MF,
2149,GO:0004992,1,0.96734639953885,0,1,platelet activating factor receptor activity,MF,
2151,GO:0004996,1,0.967604024860509,0,1,thyroid-stimulating hormone receptor activity,MF,
2153,GO:0004999,1,0.969501419093606,0,1,vasoactive intestinal polypeptide receptor activity,MF,
2154,GO:0005000,1,0.93679100831548,0,2,vasopressin receptor activity,MF,
2155,GO:0005001,1,0.717905129918409,0,10,transmembrane receptor protein tyrosine phosphatase activity,MF,
2157,GO:0005004,1,0.966859128570501,0,1,GPI-linked ephrin receptor activity,MF,
2159,GO:0005006,1,0.940714919933122,0,2,epidermal growth factor-activated receptor activity,MF,
2160,GO:0005007,1,0.849228251618105,0,5,fibroblast growth factor-activated receptor activity,MF,
2161,GO:0005008,1,0.966851272422428,0,1,hepatocyte growth factor-activated receptor activity,MF,
2162,GO:0005009,1,0.966791785505789,0,1,insulin-activated receptor activity,MF,
2163,GO:0005010,1,0.903671090161138,0,3,insulin-like growth factor-activated receptor activity,MF,
2164,GO:0005011,1,0.966996127916016,0,1,macrophage colony-stimulating factor receptor activity,MF,
2166,GO:0005024,1,0.791896874624306,0,7,transforming growth factor beta-activated receptor activity,MF,
2167,GO:0005025,1,0.905954176074313,0,3,transforming growth factor beta receptor activity, type I,MF,
2168,GO:0005026,1,0.967037689005993,0,1,transforming growth factor beta receptor activity, type II,MF,
2169,GO:0005030,1,0.966841851870227,0,1,neurotrophin receptor activity,MF,
2170,GO:0005031,1,0.582945346663858,0,18,tumor necrosis factor-activated receptor activity,MF,
2171,GO:0005034,1,0.968691981319906,0,1,osmosensor activity,MF,
2172,GO:0005035,1,0.582945346663858,0,18,death receptor activity,MF,
2174,GO:0005042,1,0.966938466368373,0,1,netrin receptor activity,MF,
2176,GO:0005046,1,0.943440865757765,0,2,KDEL sequence binding,MF,
2177,GO:0005047,1,0.858239449916893,0,5,signal recognition particle binding,MF,
2179,GO:0005049,1,0.769162225212724,0,8,nuclear export signal receptor activity,MF,
2180,GO:0005052,1,0.937608807946237,0,2,peroxisome matrix targeting signal-1 binding,MF,
2181,GO:0005053,1,0.973120145989118,0,1,peroxisome matrix targeting signal-2 binding,MF,
2182,GO:0005055,1,0.945153691492589,0,2,laminin receptor activity,MF,
2184,GO:0005068,1,0.795394729872414,0,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2186,GO:0005072,1,0.771247432874999,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2187,GO:0005078,1,0.792868684976463,0,7,MAP-kinase scaffold activity,MF,
2190,GO:0005086,1,0.616260422784652,0,15,ARF guanyl-nucleotide exchange factor activity,MF,
2191,GO:0005087,1,0.891230683926032,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2193,GO:0005089,1,0.141546917559478,0,59,Rho guanyl-nucleotide exchange factor activity,MF,
2194,GO:0005090,1,0.971279171620866,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2196,GO:0005093,1,0.941962086430607,0,2,Rab GDP-dissociation inhibitor activity,MF,
2202,GO:0005105,1,0.970959121783905,0,1,type 1 fibroblast growth factor receptor binding,MF,
2205,GO:0005113,1,0.853576068006801,0,5,patched binding,MF,
2207,GO:0005115,1,0.966872720920993,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2208,GO:0005119,1,0.936151225533156,0,2,smoothened binding,MF,
2209,GO:0005123,1,0.650379962039039,0,14,death receptor binding,MF,
2210,GO:0005124,1,0.942866727007643,0,2,scavenger receptor binding,MF,
2214,GO:0005128,1,0.968476920292855,0,1,erythropoietin receptor binding,MF,
2215,GO:0005131,1,0.878207345673169,0,4,growth hormone receptor binding,MF,
2216,GO:0005132,1,0.947738926065233,0,2,type I interferon receptor binding,MF,
2217,GO:0005134,1,0.913463316858723,0,3,interleukin-2 receptor binding,MF,
2218,GO:0005135,1,0.968476920292855,0,1,interleukin-3 receptor binding,MF,
2219,GO:0005136,1,0.968759429910579,0,1,interleukin-4 receptor binding,MF,
2220,GO:0005137,1,0.971282117686038,0,1,interleukin-5 receptor binding,MF,
2222,GO:0005141,1,0.972774966162281,0,1,interleukin-10 receptor binding,MF,
2223,GO:0005142,1,0.970731221353253,0,1,interleukin-11 receptor binding,MF,
2224,GO:0005143,1,0.939636285839999,0,2,interleukin-12 receptor binding,MF,
2225,GO:0005146,1,0.941136495459739,0,2,leukemia inhibitory factor receptor binding,MF,
2227,GO:0005150,1,0.941199223027957,0,2,interleukin-1, Type I receptor binding,MF,
2229,GO:0005152,1,0.911244619167301,0,3,interleukin-1 receptor antagonist activity,MF,
2230,GO:0005153,1,0.968757393536143,0,1,interleukin-8 receptor binding,MF,
2232,GO:0005157,1,0.970512554479437,0,1,macrophage colony-stimulating factor receptor binding,MF,
2234,GO:0005159,1,0.690030607479167,0,12,insulin-like growth factor receptor binding,MF,
2238,GO:0005165,1,0.798443749329239,0,7,neurotrophin receptor binding,MF,
2239,GO:0005166,1,0.974151547296457,0,1,neurotrophin p75 receptor binding,MF,
2240,GO:0005167,1,0.798443749329239,0,7,neurotrophin TRK receptor binding,MF,
2241,GO:0005168,1,0.81964163372392,0,6,neurotrophin TRKA receptor binding,MF,
2242,GO:0005169,1,0.941899350725908,0,2,neurotrophin TRKB receptor binding,MF,
2243,GO:0005170,1,0.966894352299046,0,1,neurotrophin TRKC receptor binding,MF,
2244,GO:0005171,1,0.971642395680002,0,1,hepatocyte growth factor receptor binding,MF,
2246,GO:0005173,1,0.904202606208331,0,3,stem cell factor receptor binding,MF,
2247,GO:0005174,1,0.970942908803566,0,1,CD40 receptor binding,MF,
2248,GO:0005175,1,0.974727551325241,0,1,CD27 receptor binding,MF,
2252,GO:0005183,1,0.972563614139016,0,1,gonadotropin hormone-releasing hormone activity,MF,
2253,GO:0005184,1,0.920802650973856,0,3,neuropeptide hormone activity,MF,
2255,GO:0005199,1,0.968301891102076,0,1,structural constituent of cell wall,MF,
2261,GO:0005217,1,0.635923741873519,0,14,intracellular ligand-gated ion channel activity,MF,
2262,GO:0005219,1,0.97419571844121,0,1,ryanodine-sensitive calcium-release channel activity,MF,
2263,GO:0005220,1,0.90353772540767,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2264,GO:0005225,1,0.767087378231272,0,8,volume-sensitive anion channel activity,MF,
2265,GO:0005227,1,0.668121786620706,0,13,calcium activated cation channel activity,MF,
2267,GO:0005230,1,0.728123688337665,0,10,extracellular ligand-gated ion channel activity,MF,
2268,GO:0005231,1,0.777182914951668,0,8,excitatory extracellular ligand-gated ion channel activity,MF,
2269,GO:0005234,1,0.934840034820457,0,2,extracellularly glutamate-gated ion channel activity,MF,
2270,GO:0005237,1,0.9686969601558,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
2271,GO:0005242,1,0.804447879109742,0,7,inward rectifier potassium channel activity,MF,
2272,GO:0005243,1,0.805883860927707,0,7,gap junction channel activity,MF,
2275,GO:0005246,1,0.581596104262626,0,18,calcium channel regulator activity,MF,
2276,GO:0005247,1,0.798241081442554,0,7,voltage-gated chloride channel activity,MF,
2277,GO:0005248,1,0.764556336557258,0,8,voltage-gated sodium channel activity,MF,
2279,GO:0005250,1,0.938533463103106,0,2,A-type (transient outward) potassium channel activity,MF,
2286,GO:0005272,1,0.63146720663842,0,14,sodium channel activity,MF,
2287,GO:0005275,1,0.968974671709387,0,1,amine transmembrane transporter activity,MF,
2288,GO:0005280,1,0.907672961753096,0,3,amino acid:proton symporter activity,MF,
2289,GO:0005283,1,0.799506458656088,0,7,amino acid:sodium symporter activity,MF,
2290,GO:0005287,1,0.938491039498632,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2291,GO:0005289,1,0.938491039498632,0,2,high-affinity arginine transmembrane transporter activity,MF,
2292,GO:0005290,1,0.939989483462396,0,2,L-histidine transmembrane transporter activity,MF,
2293,GO:0005292,1,0.938491039498632,0,2,high-affinity lysine transmembrane transporter activity,MF,
2294,GO:0005294,1,0.966777525645021,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2295,GO:0005295,1,0.968570346802033,0,1,neutral amino acid:sodium symporter activity,MF,
2296,GO:0005298,1,0.967192255235484,0,1,proline:sodium symporter activity,MF,
2297,GO:0005308,1,0.968025230469269,0,1,creatine transmembrane transporter activity,MF,
2298,GO:0005309,1,0.968025230469269,0,1,creatine:sodium symporter activity,MF,
2299,GO:0005310,1,0.527751529462828,0,20,dicarboxylic acid transmembrane transporter activity,MF,
2300,GO:0005313,1,0.824267780365486,0,6,L-glutamate transmembrane transporter activity,MF,
2301,GO:0005314,1,0.938444775986306,0,2,high-affinity glutamate transmembrane transporter activity,MF,
2302,GO:0005315,1,0.90620333529698,0,3,inorganic phosphate transmembrane transporter activity,MF,
2303,GO:0005316,1,0.968444119880823,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2305,GO:0005324,1,0.939667515556564,0,2,long-chain fatty acid transporter activity,MF,
2306,GO:0005326,1,0.479930414838929,0,23,neurotransmitter transporter activity,MF,
2307,GO:0005328,1,0.722975799732932,0,10,neurotransmitter:sodium symporter activity,MF,
2308,GO:0005329,1,0.935057270175788,0,2,dopamine transmembrane transporter activity,MF,
2309,GO:0005330,1,0.96709169219984,0,1,dopamine:sodium symporter activity,MF,
2310,GO:0005332,1,0.97177548306784,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
2311,GO:0005335,1,0.96709169219984,0,1,serotonin:sodium symporter activity,MF,
2312,GO:0005337,1,0.860314201004795,0,5,nucleoside transmembrane transporter activity,MF,
2315,GO:0005343,1,0.662321393282094,0,13,organic acid:sodium symporter activity,MF,
2316,GO:0005344,1,0.971912964036823,0,1,oxygen carrier activity,MF,
2317,GO:0005345,1,0.862075484522864,0,5,purine nucleobase transmembrane transporter activity,MF,
2318,GO:0005346,1,0.716435716291709,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2319,GO:0005347,1,0.782287696766531,0,8,ATP transmembrane transporter activity,MF,
2320,GO:0005350,1,0.940985355629703,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
2321,GO:0005351,1,0.777779019863794,0,8,carbohydrate:proton symporter activity,MF,
2322,GO:0005355,1,0.753475004231345,0,9,glucose transmembrane transporter activity,MF,
2323,GO:0005365,1,0.934675993595156,0,2,myo-inositol transmembrane transporter activity,MF,
2324,GO:0005366,1,0.96684253806538,0,1,myo-inositol:proton symporter activity,MF,
2325,GO:0005367,1,0.966733331174127,0,1,myo-inositol:sodium symporter activity,MF,
2326,GO:0005368,1,0.966855179735506,0,1,taurine transmembrane transporter activity,MF,
2327,GO:0005369,1,0.966855179735506,0,1,taurine:sodium symporter activity,MF,
2328,GO:0005372,1,0.889254648160024,0,4,water transmembrane transporter activity,MF,
2329,GO:0005375,1,0.828986188624911,0,6,copper ion transmembrane transporter activity,MF,
2331,GO:0005384,1,0.877310958811204,0,4,manganese ion transmembrane transporter activity,MF,
2333,GO:0005388,1,0.76661310136485,0,8,calcium-transporting ATPase activity,MF,
2334,GO:0005391,1,0.856044226725172,0,5,sodium:potassium-exchanging ATPase activity,MF,
2335,GO:0005402,1,0.706298164909602,0,11,carbohydrate:cation symporter activity,MF,
2336,GO:0005412,1,0.939305662853332,0,2,glucose:sodium symporter activity,MF,
2337,GO:0005415,1,0.942347258191155,0,2,nucleoside:sodium symporter activity,MF,
2338,GO:0005416,1,0.74841430179444,0,9,amino acid:cation symporter activity,MF,
2339,GO:0005427,1,0.968720981009603,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2341,GO:0005436,1,0.937316077260095,0,2,sodium:phosphate symporter activity,MF,
2342,GO:0005451,1,0.746810666414209,0,9,monovalent cation:proton antiporter activity,MF,
2343,GO:0005452,1,0.678645269344785,0,12,inorganic anion exchanger activity,MF,
2344,GO:0005456,1,0.972292210507128,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2345,GO:0005457,1,0.936473484045029,0,2,GDP-fucose transmembrane transporter activity,MF,
2347,GO:0005461,1,0.966856339508971,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2348,GO:0005462,1,0.939121679295889,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2349,GO:0005464,1,0.966847304086337,0,1,UDP-xylose transmembrane transporter activity,MF,
2350,GO:0005471,1,0.916154620924395,0,3,ATP:ADP antiporter activity,MF,
2351,GO:0005476,1,0.940490766409347,0,2,carnitine:acyl carnitine antiporter activity,MF,
2352,GO:0005477,1,0.968029675901383,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2353,GO:0005483,1,0.910386357894637,0,3,soluble NSF attachment protein activity,MF,
2356,GO:0005496,1,0.183479771261448,0,55,steroid binding,MF,
2357,GO:0005497,1,0.946772013505666,0,2,androgen binding,MF,
2358,GO:0005499,1,0.939554289552832,0,2,vitamin D binding,MF,
2360,GO:0005502,1,0.967029277276091,0,1,11-cis retinal binding,MF,
2361,GO:0005503,1,0.967029277276091,0,1,all-trans retinal binding,MF,
2362,GO:0005504,1,0.668220741795232,0,14,fatty acid binding,MF,
2366,GO:0005513,1,0.785486667121033,0,8,detection of calcium ion,BP,
2370,GO:0005519,1,0.967492970696135,0,1,cytoskeletal regulatory protein binding,MF,
2374,GO:0005523,1,0.81237372857918,0,7,tropomyosin binding,MF,
2377,GO:0005527,1,0.703800716366152,0,12,macrolide binding,MF,
2378,GO:0005528,1,0.703800716366152,0,12,FK506 binding,MF,
2379,GO:0005534,1,0.913413393168021,0,3,galactose binding,MF,
2381,GO:0005537,1,0.781892370944645,0,8,mannose binding,MF,
2383,GO:0005540,1,0.783998689771388,0,8,hyaluronic acid binding,MF,
2384,GO:0005542,1,0.837629954466167,0,6,folic acid binding,MF,
2387,GO:0005545,1,0.673641169069222,0,12,1-phosphatidylinositol binding,MF,
2393,GO:0005577,1,0.906797565864759,0,3,fibrinogen complex,CC,
2395,GO:0005579,1,0.966883705572623,0,1,membrane attack complex,CC,
2397,GO:0005583,1,0.765063421402451,0,8,fibrillar collagen trimer,CC,
2398,GO:0005584,1,0.934849212023159,0,2,collagen type I trimer,CC,
2400,GO:0005588,1,0.903765396102627,0,3,collagen type V trimer,CC,
2401,GO:0005589,1,0.909982616357103,0,3,collagen type VI trimer,CC,
2402,GO:0005590,1,0.966786400292585,0,1,collagen type VII trimer,CC,
2404,GO:0005592,1,0.966835269155217,0,1,collagen type XI trimer,CC,
2406,GO:0005594,1,0.94053829322611,0,2,collagen type IX trimer,CC,
2408,GO:0005597,1,0.966877820593443,0,1,collagen type XVI trimer,CC,
2410,GO:0005600,1,0.968892728804353,0,1,collagen type XIII trimer,CC,
2413,GO:0005606,1,0.903728119275785,0,3,laminin-1 complex,CC,
2414,GO:0005607,1,0.934889162915255,0,2,laminin-2 complex,CC,
2415,GO:0005608,1,0.934749933002293,0,2,laminin-3 complex,CC,
2416,GO:0005610,1,0.904178553736241,0,3,laminin-5 complex,CC,
2417,GO:0005614,1,0.76806323846299,0,8,interstitial matrix,CC,
2424,GO:0005638,1,0.883139415739126,0,4,lamin filament,CC,
2425,GO:0005639,1,0.773812306444201,0,8,integral component of nuclear inner membrane,CC,
2426,GO:0005640,1,0.587463059949865,0,17,nuclear outer membrane,CC,
2427,GO:0005641,1,0.802913446071365,0,7,nuclear envelope lumen,CC,
2428,GO:0005642,1,0.852068150944364,0,5,annulate lamellae,CC,
2429,GO:0005643,1,0.0916037888505759,0,76,nuclear pore,CC,
2430,GO:0005652,1,0.756379276283079,0,9,nuclear lamina,CC,
2433,GO:0005656,1,0.916634529085006,0,3,nuclear pre-replicative complex,CC,
2435,GO:0005658,1,0.83152780647144,0,6,alpha DNA polymerase:primase complex,CC,
2436,GO:0005662,1,0.653646508595794,0,14,DNA replication factor A complex,CC,
2437,GO:0005663,1,0.841172601064791,0,6,DNA replication factor C complex,CC,
2438,GO:0005664,1,0.755356203246857,0,9,nuclear origin of replication recognition complex,CC,
2439,GO:0005665,1,0.612164233666013,0,17,DNA-directed RNA polymerase II, core complex,CC,
2440,GO:0005666,1,0.60854316367137,0,17,DNA-directed RNA polymerase III complex,CC,
2442,GO:0005668,1,0.945234389204725,0,2,RNA polymerase transcription factor SL1 complex,CC,
2444,GO:0005671,1,0.645393714451037,0,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2445,GO:0005672,1,0.895985306999033,0,4,transcription factor TFIIA complex,CC,
2446,GO:0005673,1,0.942786328083191,0,2,transcription factor TFIIE complex,CC,
2447,GO:0005674,1,0.944133773214803,0,2,transcription factor TFIIF complex,CC,
2448,GO:0005675,1,0.681412110853353,0,13,holo TFIIH complex,CC,
2449,GO:0005677,1,0.749946662554115,0,9,chromatin silencing complex,CC,
2450,GO:0005680,1,0.535414941093293,0,21,anaphase-promoting complex,CC,
2452,GO:0005682,1,0.515422955623487,0,22,U5 snRNP,CC,
2453,GO:0005683,1,0.828390832020549,0,7,U7 snRNP,CC,
2454,GO:0005684,1,0.179825248230948,0,58,U2-type spliceosomal complex,CC,
2455,GO:0005685,1,0.562933895248903,0,20,U1 snRNP,CC,
2456,GO:0005686,1,0.564992669204192,0,20,U2 snRNP,CC,
2457,GO:0005687,1,0.735392256440281,0,11,U4 snRNP,CC,
2458,GO:0005688,1,0.80145248900992,0,8,U6 snRNP,CC,
2459,GO:0005689,1,0.479146330359987,0,26,U12-type spliceosomal complex,CC,
2460,GO:0005690,1,0.941361927042858,0,2,U4atac snRNP,CC,
2461,GO:0005691,1,0.967175809730914,0,1,U6atac snRNP,CC,
2463,GO:0005697,1,0.517223340979913,0,22,telomerase holoenzyme complex,CC,
2464,GO:0005712,1,0.93819755961677,0,2,chiasma,CC,
2465,GO:0005713,1,0.970397080614669,0,1,recombination nodule,CC,
2466,GO:0005715,1,0.970397080614669,0,1,late recombination nodule,CC,
2468,GO:0005720,1,0.361297345846636,0,33,nuclear heterochromatin,CC,
2469,GO:0005721,1,0.566142498468232,0,18,pericentric heterochromatin,CC,
2470,GO:0005724,1,0.972752451305582,0,1,nuclear telomeric heterochromatin,CC,
2471,GO:0005726,1,0.875745320900796,0,4,perichromatin fibrils,CC,
2473,GO:0005731,1,0.972548007553948,0,1,nucleolus organizer region,CC,
2475,GO:0005736,1,0.702852186451995,0,12,DNA-directed RNA polymerase I complex,CC,
2480,GO:0005742,1,0.797827021674914,0,8,mitochondrial outer membrane translocase complex,CC,
2482,GO:0005744,1,0.686644506335881,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2483,GO:0005745,1,0.939768361373051,0,2,m-AAA complex,CC,
2484,GO:0005746,1,0.141046210473033,0,72,mitochondrial respiratory chain,CC,
2485,GO:0005747,1,0.326506911951027,0,42,mitochondrial respiratory chain complex I,CC,
2486,GO:0005749,1,0.864775387684425,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2487,GO:0005750,1,0.731486532646153,0,11,mitochondrial respiratory chain complex III,CC,
2488,GO:0005751,1,0.77131907747073,0,10,mitochondrial respiratory chain complex IV,CC,
2489,GO:0005753,1,0.97119662536758,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2490,GO:0005757,1,0.892364064560515,0,4,mitochondrial permeability transition pore complex,CC,
2493,GO:0005760,1,0.935358708389735,0,2,gamma DNA polymerase complex,CC,
2509,GO:0005777,1,0.0411821991329095,0,105,peroxisome,CC,
2510,GO:0005778,1,0.207417614299046,0,51,peroxisomal membrane,CC,
2511,GO:0005779,1,0.639751437450667,0,15,integral component of peroxisomal membrane,CC,
2512,GO:0005782,1,0.395457761333693,0,31,peroxisomal matrix,CC,
2514,GO:0005784,1,0.897851151907228,0,4,Sec61 translocon complex,CC,
2516,GO:0005786,1,0.841626020743898,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2526,GO:0005797,1,0.812167786420595,0,7,Golgi medial cisterna,CC,
2534,GO:0005816,1,0.798214027985265,0,7,spindle pole body,CC,
2535,GO:0005818,1,0.773010290178896,0,8,aster,CC,
2538,GO:0005827,1,0.85299946814122,0,5,polar microtubule,CC,
2539,GO:0005828,1,0.795775556513735,0,7,kinetochore microtubule,CC,
2541,GO:0005832,1,0.739245664836783,0,10,chaperonin-containing T-complex,CC,
2542,GO:0005833,1,0.969052014050991,0,1,hemoglobin complex,CC,
2543,GO:0005834,1,0.54348314669911,0,20,heterotrimeric G-protein complex,CC,
2544,GO:0005838,1,0.552642058467251,0,21,proteasome regulatory particle,CC,
2548,GO:0005845,1,0.710797560583088,0,11,mRNA cap binding complex,CC,
2549,GO:0005846,1,0.939340191163791,0,2,nuclear cap binding complex,CC,
2550,GO:0005847,1,0.604608802181551,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2551,GO:0005849,1,0.568436346699845,0,18,mRNA cleavage factor complex,CC,
2552,GO:0005850,1,0.878988423496519,0,4,eukaryotic translation initiation factor 2 complex,CC,
2554,GO:0005852,1,0.608051204807651,0,17,eukaryotic translation initiation factor 3 complex,CC,
2555,GO:0005853,1,0.918016054238596,0,3,eukaryotic translation elongation factor 1 complex,CC,
2556,GO:0005854,1,0.941811263876019,0,2,nascent polypeptide-associated complex,CC,
2558,GO:0005858,1,0.771265247054639,0,8,axonemal dynein complex,CC,
2559,GO:0005859,1,0.802003317641105,0,7,muscle myosin complex,CC,
2560,GO:0005861,1,0.917938504171756,0,3,troponin complex,CC,
2562,GO:0005863,1,0.967789301379805,0,1,striated muscle myosin thick filament,CC,
2564,GO:0005868,1,0.545100892481392,0,20,cytoplasmic dynein complex,CC,
2565,GO:0005869,1,0.788944647330159,0,8,dynactin complex,CC,
2566,GO:0005871,1,0.239252112296321,0,44,kinesin complex,CC,
2567,GO:0005873,1,0.906195084185456,0,3,plus-end kinesin complex,CC,
2569,GO:0005875,1,0.0229261326838994,0,119,microtubule associated complex,CC,
2570,GO:0005876,1,0.170937999464602,0,56,spindle microtubule,CC,
2571,GO:0005879,1,0.854788469093373,0,5,axonemal microtubule,CC,
2572,GO:0005880,1,0.973183919512099,0,1,nuclear microtubule,CC,
2577,GO:0005885,1,0.753552660948359,0,10,Arp2/3 protein complex,CC,
2580,GO:0005889,1,0.936962981063104,0,2,potassium:proton exchanging ATPase complex,CC,
2581,GO:0005890,1,0.884381719289496,0,4,sodium:potassium-exchanging ATPase complex,CC,
2582,GO:0005891,1,0.757804420155379,0,9,voltage-gated calcium channel complex,CC,
2584,GO:0005895,1,0.971282117686038,0,1,interleukin-5 receptor complex,CC,
2586,GO:0005898,1,0.967461183300529,0,1,interleukin-13 receptor complex,CC,
2587,GO:0005899,1,0.934691049272749,0,2,insulin receptor complex,CC,
2596,GO:0005915,1,0.822200490527726,0,6,zonula adherens,CC,
2597,GO:0005916,1,0.821584888886366,0,6,fascia adherens,CC,
2599,GO:0005922,1,0.737331339790774,0,10,connexin complex,CC,
2603,GO:0005927,1,0.972973334258414,0,1,muscle tendon junction,CC,
2605,GO:0005930,1,0.137164771509146,0,63,axoneme,CC,
2607,GO:0005940,1,0.747282433868377,0,9,septin ring,CC,
2608,GO:0005942,1,0.594785697103013,0,16,phosphatidylinositol 3-kinase complex,CC,
2609,GO:0005943,1,0.935716512354516,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2610,GO:0005945,1,0.938224085988333,0,2,6-phosphofructokinase complex,CC,
2611,GO:0005947,1,0.862193062742742,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2612,GO:0005952,1,0.855173360550829,0,5,cAMP-dependent protein kinase complex,CC,
2613,GO:0005953,1,0.943337156762649,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2614,GO:0005954,1,0.970374102588315,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2615,GO:0005955,1,0.87754505768862,0,4,calcineurin complex,CC,
2616,GO:0005956,1,0.944361371753142,0,2,protein kinase CK2 complex,CC,
2617,GO:0005958,1,0.909659796093797,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2618,GO:0005960,1,0.941596383894804,0,2,glycine cleavage complex,CC,
2619,GO:0005964,1,0.851118608393164,0,5,phosphorylase kinase complex,CC,
2620,GO:0005965,1,0.943101327372675,0,2,protein farnesyltransferase complex,CC,
2621,GO:0005967,1,0.908126556760716,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2622,GO:0005968,1,0.884170904483035,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2623,GO:0005969,1,0.966816954594848,0,1,serine-pyruvate aminotransferase complex,CC,
2624,GO:0005971,1,0.906920395232214,0,3,ribonucleoside-diphosphate reductase complex,CC,
2630,GO:0005980,1,0.528206139265041,0,20,glycogen catabolic process,BP,
2631,GO:0005981,1,0.881377627432998,0,4,regulation of glycogen catabolic process,BP,
2633,GO:0005985,1,0.967935840521965,0,1,sucrose metabolic process,BP,
2636,GO:0005991,1,0.969119748035427,0,1,trehalose metabolic process,BP,
2638,GO:0005997,1,0.892008805453592,0,4,xylulose metabolic process,BP,
2639,GO:0005998,1,0.967811766649676,0,1,xylulose catabolic process,BP,
2640,GO:0005999,1,0.945852702443646,0,2,xylulose biosynthetic process,BP,
2641,GO:0006000,1,0.716097813539308,0,11,fructose metabolic process,BP,
2642,GO:0006001,1,0.885114518647252,0,4,fructose catabolic process,BP,
2643,GO:0006002,1,0.832956000823174,0,6,fructose 6-phosphate metabolic process,BP,
2644,GO:0006003,1,0.877491745734823,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2645,GO:0006004,1,0.662633625330067,0,13,fucose metabolic process,BP,
2650,GO:0006013,1,0.77949005591069,0,8,mannose metabolic process,BP,
2651,GO:0006014,1,0.92183060778134,0,3,D-ribose metabolic process,BP,
2652,GO:0006015,1,0.913595635025254,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2653,GO:0006020,1,0.723899800118003,0,10,inositol metabolic process,BP,
2654,GO:0006021,1,0.884507243394454,0,4,inositol biosynthetic process,BP,
2658,GO:0006026,1,0.268412402217487,0,42,aminoglycan catabolic process,BP,
2659,GO:0006027,1,0.286207937785099,0,40,glycosaminoglycan catabolic process,BP,
2660,GO:0006029,1,0.150265980688342,0,59,proteoglycan metabolic process,BP,
2661,GO:0006030,1,0.938028937656722,0,2,chitin metabolic process,BP,
2662,GO:0006032,1,0.938028937656722,0,2,chitin catabolic process,BP,
2664,GO:0006041,1,0.887300282194099,0,4,glucosamine metabolic process,BP,
2665,GO:0006043,1,0.943717940108006,0,2,glucosamine catabolic process,BP,
2667,GO:0006045,1,0.935655634345027,0,2,N-acetylglucosamine biosynthetic process,BP,
2668,GO:0006046,1,0.91751003360006,0,3,N-acetylglucosamine catabolic process,BP,
2671,GO:0006049,1,0.969202801296285,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2675,GO:0006055,1,0.973663261755306,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2676,GO:0006056,1,0.972400159260788,0,1,mannoprotein metabolic process,BP,
2677,GO:0006057,1,0.972400159260788,0,1,mannoprotein biosynthetic process,BP,
2678,GO:0006059,1,0.919204800234763,0,3,hexitol metabolic process,BP,
2679,GO:0006060,1,0.944328567830513,0,2,sorbitol metabolic process,BP,
2680,GO:0006061,1,0.973310190059817,0,1,sorbitol biosynthetic process,BP,
2681,GO:0006062,1,0.970225831804016,0,1,sorbitol catabolic process,BP,
2682,GO:0006063,1,0.700856724724699,0,12,uronic acid metabolic process,BP,
2683,GO:0006064,1,0.866448545848729,0,5,glucuronate catabolic process,BP,
2684,GO:0006065,1,0.909674233594306,0,3,UDP-glucuronate biosynthetic process,BP,
2686,GO:0006067,1,0.719420475561379,0,11,ethanol metabolic process,BP,
2687,GO:0006068,1,0.81477730608461,0,7,ethanol catabolic process,BP,
2688,GO:0006069,1,0.830444148330984,0,6,ethanol oxidation,BP,
2689,GO:0006071,1,0.717201722632608,0,11,glycerol metabolic process,BP,
2690,GO:0006072,1,0.795598688135424,0,7,glycerol-3-phosphate metabolic process,BP,
2694,GO:0006083,1,0.906164823273983,0,3,acetate metabolic process,BP,
2696,GO:0006085,1,0.564330554707103,0,18,acetyl-CoA biosynthetic process,BP,
2697,GO:0006086,1,0.660075997541165,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2698,GO:0006089,1,0.715091818712212,0,11,lactate metabolic process,BP,
2703,GO:0006097,1,0.944097324810453,0,2,glyoxylate cycle,BP,
2707,GO:0006102,1,0.866513305736215,0,5,isocitrate metabolic process,BP,
2708,GO:0006103,1,0.630149350681595,0,15,2-oxoglutarate metabolic process,BP,
2709,GO:0006104,1,0.836844771611191,0,6,succinyl-CoA metabolic process,BP,
2710,GO:0006105,1,0.737789600132335,0,10,succinate metabolic process,BP,
2711,GO:0006106,1,0.916612715832347,0,3,fumarate metabolic process,BP,
2712,GO:0006107,1,0.764621676267013,0,9,oxaloacetate metabolic process,BP,
2713,GO:0006108,1,0.838016621184435,0,6,malate metabolic process,BP,
2715,GO:0006110,1,0.198756409511205,0,51,regulation of glycolytic process,BP,
2716,GO:0006111,1,0.498854042355265,0,22,regulation of gluconeogenesis,BP,
2718,GO:0006113,1,0.969271124374127,0,1,fermentation,BP,
2719,GO:0006114,1,0.914542118614958,0,3,glycerol biosynthetic process,BP,
2720,GO:0006116,1,0.939663080069053,0,2,NADH oxidation,BP,
2721,GO:0006117,1,0.970086681792673,0,1,acetaldehyde metabolic process,BP,
2722,GO:0006119,1,0.0676649816310329,0,96,oxidative phosphorylation,BP,
2723,GO:0006120,1,0.297288987930105,0,45,mitochondrial electron transport, NADH to ubiquinone,BP,
2724,GO:0006121,1,0.892088381886471,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2725,GO:0006122,1,0.684156427460678,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2726,GO:0006123,1,0.683899376220689,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2727,GO:0006127,1,0.966870364153008,0,1,glycerophosphate shuttle,BP,
2733,GO:0006148,1,0.970556085034801,0,1,inosine catabolic process,BP,
2734,GO:0006152,1,0.842341803320613,0,6,purine nucleoside catabolic process,BP,
2735,GO:0006154,1,0.943912672484092,0,2,adenosine catabolic process,BP,
2736,GO:0006157,1,0.972997302627361,0,1,deoxyadenosine catabolic process,BP,
2740,GO:0006166,1,0.866187768063174,0,5,purine ribonucleoside salvage,BP,
2741,GO:0006167,1,0.866835504596457,0,5,AMP biosynthetic process,BP,
2742,GO:0006168,1,0.921975891451135,0,3,adenine salvage,BP,
2743,GO:0006169,1,0.97161040612634,0,1,adenosine salvage,BP,
2745,GO:0006172,1,0.970934067118117,0,1,ADP biosynthetic process,BP,
2746,GO:0006174,1,0.969271124374127,0,1,dADP phosphorylation,BP,
2747,GO:0006175,1,0.97161040612634,0,1,dATP biosynthetic process,BP,
2748,GO:0006177,1,0.866294519176327,0,5,GMP biosynthetic process,BP,
2749,GO:0006178,1,0.945995402903846,0,2,guanine salvage,BP,
2750,GO:0006182,1,0.64068860557995,0,14,cGMP biosynthetic process,BP,
2751,GO:0006183,1,0.780734414145448,0,9,GTP biosynthetic process,BP,
2752,GO:0006185,1,0.974159093896004,0,1,dGDP biosynthetic process,BP,
2753,GO:0006186,1,0.969271124374127,0,1,dGDP phosphorylation,BP,
2754,GO:0006188,1,0.734258759665667,0,10,IMP biosynthetic process,BP,
2755,GO:0006189,1,0.829302158968161,0,6,'de novo' IMP biosynthetic process,BP,
2756,GO:0006193,1,0.973946193002066,0,1,ITP catabolic process,BP,
2758,GO:0006196,1,0.935683242431113,0,2,AMP catabolic process,BP,
2760,GO:0006203,1,0.917348514698181,0,3,dGTP catabolic process,BP,
2761,GO:0006206,1,0.598638874592209,0,17,pyrimidine nucleobase metabolic process,BP,
2762,GO:0006207,1,0.825494362484141,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2763,GO:0006208,1,0.940880971855078,0,2,pyrimidine nucleobase catabolic process,BP,
2764,GO:0006210,1,0.940880971855078,0,2,thymine catabolic process,BP,
2765,GO:0006211,1,0.90357580708874,0,3,5-methylcytosine catabolic process,BP,
2766,GO:0006212,1,0.968755358580569,0,1,uracil catabolic process,BP,
2767,GO:0006213,1,0.338232121015018,0,37,pyrimidine nucleoside metabolic process,BP,
2768,GO:0006214,1,0.968755358580569,0,1,thymidine catabolic process,BP,
2769,GO:0006216,1,0.817167602497818,0,7,cytidine catabolic process,BP,
2770,GO:0006218,1,0.972300370201599,0,1,uridine catabolic process,BP,
2771,GO:0006220,1,0.307560877431942,0,41,pyrimidine nucleotide metabolic process,BP,
2772,GO:0006221,1,0.448034431747451,0,28,pyrimidine nucleotide biosynthetic process,BP,
2773,GO:0006222,1,0.765963367864795,0,9,UMP biosynthetic process,BP,
2774,GO:0006226,1,0.918908375206898,0,3,dUMP biosynthetic process,BP,
2775,GO:0006227,1,0.943732169123637,0,2,dUDP biosynthetic process,BP,
2776,GO:0006228,1,0.799895336023182,0,8,UTP biosynthetic process,BP,
2777,GO:0006231,1,0.917369473990968,0,3,dTMP biosynthetic process,BP,
2778,GO:0006233,1,0.943732169123637,0,2,dTDP biosynthetic process,BP,
2779,GO:0006235,1,0.89379703155424,0,4,dTTP biosynthetic process,BP,
2780,GO:0006238,1,0.973650711260201,0,1,CMP salvage,BP,
2781,GO:0006241,1,0.713364166442392,0,12,CTP biosynthetic process,BP,
2782,GO:0006244,1,0.709916987449125,0,12,pyrimidine nucleotide catabolic process,BP,
2783,GO:0006253,1,0.973915565672112,0,1,dCTP catabolic process,BP,
2784,GO:0006256,1,0.969177217676602,0,1,UDP catabolic process,BP,
2785,GO:0006258,1,0.945444848296351,0,2,UDP-glucose catabolic process,BP,
2789,GO:0006264,1,0.728370049669855,0,10,mitochondrial DNA replication,BP,
2790,GO:0006265,1,0.752836872672527,0,9,DNA topological change,BP,
2792,GO:0006267,1,0.916634529085006,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
2793,GO:0006268,1,0.804822296793155,0,7,DNA unwinding involved in DNA replication,BP,
2794,GO:0006269,1,0.857406945955699,0,5,DNA replication, synthesis of RNA primer,BP,
2797,GO:0006272,1,0.909982818414617,0,3,leading strand elongation,BP,
2803,GO:0006283,1,0.115011745160407,0,73,transcription-coupled nucleotide-excision repair,BP,
2805,GO:0006285,1,0.751997225229917,0,10,base-excision repair, AP site formation,BP,
2806,GO:0006286,1,0.947420791118721,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
2807,GO:0006287,1,0.854926100534669,0,5,base-excision repair, gap-filling,BP,
2808,GO:0006288,1,0.915769998289883,0,3,base-excision repair, DNA ligation,BP,
2810,GO:0006290,1,0.807089732853435,0,7,pyrimidine dimer repair,BP,
2815,GO:0006297,1,0.502964577728259,0,23,nucleotide-excision repair, DNA gap filling,BP,
2816,GO:0006298,1,0.383399123513921,0,31,mismatch repair,BP,
2817,GO:0006301,1,0.223734140294857,0,49,postreplication repair,BP,
2823,GO:0006307,1,0.743551105895028,0,10,DNA dealkylation involved in DNA repair,BP,
2824,GO:0006308,1,0.400810394083016,0,30,DNA catabolic process,BP,
2825,GO:0006309,1,0.598210850558038,0,17,apoptotic DNA fragmentation,BP,
2827,GO:0006311,1,0.968694967567319,0,1,meiotic gene conversion,BP,
2828,GO:0006312,1,0.504119762382769,0,22,mitotic recombination,BP,
2829,GO:0006313,1,0.967436019906839,0,1,transposition, DNA-mediated,BP,
2834,GO:0006335,1,0.426934805625278,0,32,DNA replication-dependent nucleosome assembly,BP,
2835,GO:0006336,1,0.238050814432001,0,50,DNA replication-independent nucleosome assembly,BP,
2836,GO:0006337,1,0.606710322843001,0,16,nucleosome disassembly,BP,
2838,GO:0006342,1,0.0448851822098585,0,107,chromatin silencing,BP,
2839,GO:0006343,1,0.967634582342254,0,1,establishment of chromatin silencing,BP,
2840,GO:0006344,1,0.877305068713288,0,4,maintenance of chromatin silencing,BP,
2841,GO:0006346,1,0.618935316915574,0,15,methylation-dependent chromatin silencing,BP,
2842,GO:0006348,1,0.79354027592652,0,8,chromatin silencing at telomere,BP,
2843,GO:0006349,1,0.655577569323394,0,13,regulation of gene expression by genetic imprinting,BP,
2849,GO:0006356,1,0.391575243387881,0,30,regulation of transcription by RNA polymerase I,BP,
2851,GO:0006359,1,0.459124694615772,0,25,regulation of transcription by RNA polymerase III,BP,
2852,GO:0006360,1,0.164655859285752,0,59,transcription by RNA polymerase I,BP,
2853,GO:0006361,1,0.354007469630776,0,35,transcription initiation from RNA polymerase I promoter,BP,
2854,GO:0006362,1,0.425009975279835,0,29,transcription elongation from RNA polymerase I promoter,BP,
2855,GO:0006363,1,0.411964052416798,0,30,termination of RNA polymerase I transcription,BP,
2861,GO:0006370,1,0.388263473286581,0,32,7-methylguanosine mRNA capping,BP,
2865,GO:0006382,1,0.849375318295127,0,5,adenosine to inosine editing,BP,
2866,GO:0006383,1,0.212520251121031,0,51,transcription by RNA polymerase III,BP,
2867,GO:0006384,1,0.800091081277438,0,7,transcription initiation from RNA polymerase III promoter,BP,
2868,GO:0006386,1,0.97451559116117,0,1,termination of RNA polymerase III transcription,BP,
2870,GO:0006390,1,0.670214464717301,0,13,mitochondrial transcription,BP,
2871,GO:0006391,1,0.914532714482154,0,3,transcription initiation from mitochondrial promoter,BP,
2872,GO:0006393,1,0.939484005877423,0,2,termination of mitochondrial transcription,BP,
2875,GO:0006398,1,0.85682168722326,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2880,GO:0006403,1,0.00150962903064708,0,209,RNA localization,BP,
2881,GO:0006404,1,0.915830490825345,0,3,RNA import into nucleus,BP,
2882,GO:0006405,1,0.0161747661235569,0,133,RNA export from nucleus,BP,
2883,GO:0006406,1,0.040405377211702,0,103,mRNA export from nucleus,BP,
2884,GO:0006407,1,0.916516738603292,0,3,rRNA export from nucleus,BP,
2885,GO:0006408,1,0.944753577792418,0,2,snRNA export from nucleus,BP,
2886,GO:0006409,1,0.365234236039285,0,32,tRNA export from nucleus,BP,
2892,GO:0006418,1,0.226943406241519,0,49,tRNA aminoacylation for protein translation,BP,
2893,GO:0006419,1,0.910184077900558,0,3,alanyl-tRNA aminoacylation,BP,
2894,GO:0006420,1,0.916998880707994,0,3,arginyl-tRNA aminoacylation,BP,
2895,GO:0006421,1,0.911335838782955,0,3,asparaginyl-tRNA aminoacylation,BP,
2896,GO:0006422,1,0.970792830181731,0,1,aspartyl-tRNA aminoacylation,BP,
2897,GO:0006423,1,0.94285658228005,0,2,cysteinyl-tRNA aminoacylation,BP,
2898,GO:0006424,1,0.935555124158177,0,2,glutamyl-tRNA aminoacylation,BP,
2899,GO:0006425,1,0.938400234661632,0,2,glutaminyl-tRNA aminoacylation,BP,
2900,GO:0006426,1,0.943282920479748,0,2,glycyl-tRNA aminoacylation,BP,
2901,GO:0006427,1,0.943003119229604,0,2,histidyl-tRNA aminoacylation,BP,
2902,GO:0006428,1,0.93616814651111,0,2,isoleucyl-tRNA aminoacylation,BP,
2903,GO:0006429,1,0.935332523637509,0,2,leucyl-tRNA aminoacylation,BP,
2904,GO:0006430,1,0.971448221446798,0,1,lysyl-tRNA aminoacylation,BP,
2905,GO:0006431,1,0.939388466905041,0,2,methionyl-tRNA aminoacylation,BP,
2906,GO:0006432,1,0.862489343644639,0,5,phenylalanyl-tRNA aminoacylation,BP,
2907,GO:0006433,1,0.914148039597619,0,3,prolyl-tRNA aminoacylation,BP,
2908,GO:0006434,1,0.944400851642094,0,2,seryl-tRNA aminoacylation,BP,
2909,GO:0006435,1,0.911156762023966,0,3,threonyl-tRNA aminoacylation,BP,
2910,GO:0006436,1,0.940146492655828,0,2,tryptophanyl-tRNA aminoacylation,BP,
2911,GO:0006437,1,0.940957175217933,0,2,tyrosyl-tRNA aminoacylation,BP,
2912,GO:0006438,1,0.905241928122434,0,3,valyl-tRNA aminoacylation,BP,
2914,GO:0006447,1,0.935094742761157,0,2,regulation of translational initiation by iron,BP,
2915,GO:0006448,1,0.593463802295487,0,17,regulation of translational elongation,BP,
2916,GO:0006449,1,0.803597710021343,0,7,regulation of translational termination,BP,
2917,GO:0006450,1,0.567172199766634,0,19,regulation of translational fidelity,BP,
2918,GO:0006451,1,0.807908566832786,0,7,translational readthrough,BP,
2919,GO:0006452,1,0.941269451399064,0,2,translational frameshifting,BP,
2922,GO:0006463,1,0.967752239478111,0,1,steroid hormone receptor complex assembly,BP,
2930,GO:0006474,1,0.642246884117079,0,14,N-terminal protein amino acid acetylation,BP,
2933,GO:0006477,1,0.855208457379297,0,5,protein sulfation,BP,
2934,GO:0006478,1,0.944335467051015,0,2,peptidyl-tyrosine sulfation,BP,
2936,GO:0006480,1,0.969271124374127,0,1,N-terminal protein amino acid methylation,BP,
2937,GO:0006481,1,0.912432623307596,0,3,C-terminal protein methylation,BP,
2938,GO:0006482,1,0.386188407909085,0,29,protein demethylation,BP,
2947,GO:0006498,1,0.851695461742801,0,5,N-terminal protein lipidation,BP,
2948,GO:0006499,1,0.876804344838363,0,4,N-terminal protein myristoylation,BP,
2949,GO:0006500,1,0.971373350382596,0,1,N-terminal protein palmitoylation,BP,
2951,GO:0006505,1,0.376112410853183,0,33,GPI anchor metabolic process,BP,
2952,GO:0006506,1,0.387406802782051,0,32,GPI anchor biosynthetic process,BP,
2953,GO:0006507,1,0.97092080711143,0,1,GPI anchor release,BP,
2964,GO:0006522,1,0.967549552025982,0,1,alanine metabolic process,BP,
2965,GO:0006524,1,0.967549552025982,0,1,alanine catabolic process,BP,
2967,GO:0006526,1,0.858096158426565,0,5,arginine biosynthetic process,BP,
2969,GO:0006528,1,0.917176654830599,0,3,asparagine metabolic process,BP,
2970,GO:0006529,1,0.942060899665663,0,2,asparagine biosynthetic process,BP,
2971,GO:0006531,1,0.831447837402071,0,6,aspartate metabolic process,BP,
2972,GO:0006532,1,0.942680283114389,0,2,aspartate biosynthetic process,BP,
2973,GO:0006533,1,0.942680283114389,0,2,aspartate catabolic process,BP,
2974,GO:0006534,1,0.71137651011603,0,11,cysteine metabolic process,BP,
2975,GO:0006535,1,0.970021395609411,0,1,cysteine biosynthetic process from serine,BP,
2976,GO:0006536,1,0.490553366978972,0,23,glutamate metabolic process,BP,
2977,GO:0006537,1,0.879002960476844,0,4,glutamate biosynthetic process,BP,
2978,GO:0006538,1,0.828421287184539,0,6,glutamate catabolic process,BP,
2979,GO:0006540,1,0.938565798360518,0,2,glutamate decarboxylation to succinate,BP,
2980,GO:0006541,1,0.579426919940413,0,17,glutamine metabolic process,BP,
2981,GO:0006542,1,0.967187319288456,0,1,glutamine biosynthetic process,BP,
2982,GO:0006543,1,0.907847456892714,0,3,glutamine catabolic process,BP,
2983,GO:0006544,1,0.786757543126083,0,8,glycine metabolic process,BP,
2984,GO:0006545,1,0.942343184763311,0,2,glycine biosynthetic process,BP,
2985,GO:0006546,1,0.914813832782786,0,3,glycine catabolic process,BP,
2986,GO:0006547,1,0.882372348503139,0,4,histidine metabolic process,BP,
2987,GO:0006548,1,0.93892743971815,0,2,histidine catabolic process,BP,
2988,GO:0006549,1,0.883688546285088,0,4,isoleucine metabolic process,BP,
2989,GO:0006550,1,0.944937587289344,0,2,isoleucine catabolic process,BP,
2992,GO:0006553,1,0.753673707766556,0,9,lysine metabolic process,BP,
2993,GO:0006554,1,0.777526397536121,0,8,lysine catabolic process,BP,
2994,GO:0006555,1,0.595543044180822,0,17,methionine metabolic process,BP,
2995,GO:0006556,1,0.941833118595661,0,2,S-adenosylmethionine biosynthetic process,BP,
2996,GO:0006557,1,0.968487030206462,0,1,S-adenosylmethioninamine biosynthetic process,BP,
2997,GO:0006558,1,0.897661751539668,0,4,L-phenylalanine metabolic process,BP,
2998,GO:0006559,1,0.897661751539668,0,4,L-phenylalanine catabolic process,BP,
2999,GO:0006560,1,0.836621472425469,0,6,proline metabolic process,BP,
3000,GO:0006561,1,0.889522294098567,0,4,proline biosynthetic process,BP,
3001,GO:0006562,1,0.940547465644902,0,2,proline catabolic process,BP,
3002,GO:0006563,1,0.747262359758864,0,10,L-serine metabolic process,BP,
3003,GO:0006564,1,0.840563140765667,0,6,L-serine biosynthetic process,BP,
3004,GO:0006565,1,0.91620975475856,0,3,L-serine catabolic process,BP,
3005,GO:0006566,1,0.919871703254353,0,3,threonine metabolic process,BP,
3006,GO:0006567,1,0.94692457799267,0,2,threonine catabolic process,BP,
3007,GO:0006568,1,0.864025949023762,0,5,tryptophan metabolic process,BP,
3008,GO:0006569,1,0.918918772447815,0,3,tryptophan catabolic process,BP,
3009,GO:0006570,1,0.895383557272284,0,4,tyrosine metabolic process,BP,
3010,GO:0006572,1,0.921146869412015,0,3,tyrosine catabolic process,BP,
3012,GO:0006574,1,0.890952865539165,0,4,valine catabolic process,BP,
3014,GO:0006576,1,0.420535724410554,0,29,cellular biogenic amine metabolic process,BP,
3015,GO:0006577,1,0.688730758460125,0,12,amino-acid betaine metabolic process,BP,
3016,GO:0006578,1,0.856987205374927,0,5,amino-acid betaine biosynthetic process,BP,
3017,GO:0006580,1,0.969770048460864,0,1,ethanolamine metabolic process,BP,
3018,GO:0006582,1,0.747705262440021,0,9,melanin metabolic process,BP,
3019,GO:0006584,1,0.464472569284661,0,25,catecholamine metabolic process,BP,
3020,GO:0006585,1,0.972037490433508,0,1,dopamine biosynthetic process from tyrosine,BP,
3021,GO:0006586,1,0.864025949023762,0,5,indolalkylamine metabolic process,BP,
3022,GO:0006589,1,0.968924823804647,0,1,octopamine biosynthetic process,BP,
3023,GO:0006590,1,0.748117562027126,0,9,thyroid hormone generation,BP,
3025,GO:0006592,1,0.968133458427986,0,1,ornithine biosynthetic process,BP,
3026,GO:0006595,1,0.670311293162842,0,14,polyamine metabolic process,BP,
3027,GO:0006596,1,0.706626626691473,0,12,polyamine biosynthetic process,BP,
3028,GO:0006597,1,0.941960526067818,0,2,spermine biosynthetic process,BP,
3029,GO:0006598,1,0.873017460553092,0,5,polyamine catabolic process,BP,
3030,GO:0006600,1,0.811467733324131,0,7,creatine metabolic process,BP,
3031,GO:0006601,1,0.974128837485256,0,1,creatine biosynthetic process,BP,
3034,GO:0006607,1,0.522921227767546,0,20,NLS-bearing protein import into nucleus,BP,
3035,GO:0006610,1,0.772289851845927,0,8,ribosomal protein import into nucleus,BP,
3038,GO:0006613,1,0.0757482889236496,0,96,cotranslational protein targeting to membrane,BP,
3039,GO:0006614,1,0.0885489155773383,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3040,GO:0006616,1,0.845390055767802,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3041,GO:0006617,1,0.94614997466784,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3042,GO:0006620,1,0.807405565810619,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3043,GO:0006621,1,0.785171452638243,0,8,protein retention in ER lumen,BP,
3046,GO:0006624,1,0.946759126024695,0,2,vacuolar protein processing,BP,
3047,GO:0006625,1,0.588971458418115,0,17,protein targeting to peroxisome,BP,
3049,GO:0006627,1,0.841392283593065,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3059,GO:0006642,1,0.90816242479956,0,3,triglyceride mobilization,BP,
3062,GO:0006646,1,0.70929155399309,0,11,phosphatidylethanolamine biosynthetic process,BP,
3064,GO:0006651,1,0.941873820285715,0,2,diacylglycerol biosynthetic process,BP,
3065,GO:0006654,1,0.384288023470533,0,30,phosphatidic acid biosynthetic process,BP,
3066,GO:0006655,1,0.734039760938896,0,10,phosphatidylglycerol biosynthetic process,BP,
3067,GO:0006656,1,0.425266017694054,0,28,phosphatidylcholine biosynthetic process,BP,
3068,GO:0006657,1,0.810751662141226,0,7,CDP-choline pathway,BP,
3069,GO:0006658,1,0.522485443518873,0,21,phosphatidylserine metabolic process,BP,
3070,GO:0006659,1,0.885165793296669,0,4,phosphatidylserine biosynthetic process,BP,
3071,GO:0006660,1,0.972378719353157,0,1,phosphatidylserine catabolic process,BP,
3073,GO:0006662,1,0.767133766150254,0,9,glycerol ether metabolic process,BP,
3074,GO:0006663,1,0.911702010154179,0,3,platelet activating factor biosynthetic process,BP,
3077,GO:0006666,1,0.966907885944598,0,1,3-keto-sphinganine metabolic process,BP,
3078,GO:0006667,1,0.939870745374807,0,2,sphinganine metabolic process,BP,
3079,GO:0006668,1,0.938492412464405,0,2,sphinganine-1-phosphate metabolic process,BP,
3080,GO:0006669,1,0.969103823831302,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3081,GO:0006670,1,0.740578353364407,0,10,sphingosine metabolic process,BP,
3082,GO:0006671,1,0.967170461726076,0,1,phytosphingosine metabolic process,BP,
3087,GO:0006680,1,0.910800109441608,0,3,glucosylceramide catabolic process,BP,
3088,GO:0006681,1,0.830666888981346,0,6,galactosylceramide metabolic process,BP,
3089,GO:0006682,1,0.911888204229103,0,3,galactosylceramide biosynthetic process,BP,
3090,GO:0006683,1,0.96922856721965,0,1,galactosylceramide catabolic process,BP,
3091,GO:0006684,1,0.674392892563231,0,13,sphingomyelin metabolic process,BP,
3092,GO:0006685,1,0.855823150441413,0,5,sphingomyelin catabolic process,BP,
3093,GO:0006686,1,0.833587234271732,0,6,sphingomyelin biosynthetic process,BP,
3096,GO:0006689,1,0.886376482777172,0,4,ganglioside catabolic process,BP,
3103,GO:0006696,1,0.943635286025369,0,2,ergosterol biosynthetic process,BP,
3104,GO:0006699,1,0.555919609178988,0,19,bile acid biosynthetic process,BP,
3105,GO:0006700,1,0.638124548126157,0,15,C21-steroid hormone biosynthetic process,BP,
3106,GO:0006701,1,0.883790949772358,0,4,progesterone biosynthetic process,BP,
3107,GO:0006702,1,0.854328369761581,0,5,androgen biosynthetic process,BP,
3108,GO:0006703,1,0.797498297873564,0,8,estrogen biosynthetic process,BP,
3109,GO:0006704,1,0.778798196340468,0,8,glucocorticoid biosynthetic process,BP,
3110,GO:0006705,1,0.879605861768887,0,4,mineralocorticoid biosynthetic process,BP,
3111,GO:0006706,1,0.681480798176318,0,13,steroid catabolic process,BP,
3112,GO:0006707,1,0.86105764354395,0,5,cholesterol catabolic process,BP,
3113,GO:0006710,1,0.972124237516894,0,1,androgen catabolic process,BP,
3114,GO:0006711,1,0.972378719353157,0,1,estrogen catabolic process,BP,
3115,GO:0006713,1,0.972359896806239,0,1,glucocorticoid catabolic process,BP,
3118,GO:0006722,1,0.970577892257981,0,1,triterpenoid metabolic process,BP,
3120,GO:0006726,1,0.966983061299026,0,1,eye pigment biosynthetic process,BP,
3121,GO:0006729,1,0.820024482042368,0,7,tetrahydrobiopterin biosynthetic process,BP,
3122,GO:0006730,1,0.504904399373684,0,22,one-carbon metabolic process,BP,
3127,GO:0006738,1,0.970556085034801,0,1,nicotinamide riboside catabolic process,BP,
3130,GO:0006741,1,0.884019759273364,0,4,NADP biosynthetic process,BP,
3131,GO:0006742,1,0.968106967257537,0,1,NADP catabolic process,BP,
3132,GO:0006743,1,0.649194238292444,0,15,ubiquinone metabolic process,BP,
3133,GO:0006744,1,0.671300864815298,0,14,ubiquinone biosynthetic process,BP,
3134,GO:0006747,1,0.971848715171512,0,1,FAD biosynthetic process,BP,
3140,GO:0006756,1,0.969271124374127,0,1,AMP phosphorylation,BP,
3142,GO:0006760,1,0.494009566540742,0,23,folic acid-containing compound metabolic process,BP,
3145,GO:0006768,1,0.709437389592409,0,11,biotin metabolic process,BP,
3149,GO:0006776,1,0.913468197387062,0,3,vitamin A metabolic process,BP,
3152,GO:0006779,1,0.531459429005468,0,21,porphyrin-containing compound biosynthetic process,BP,
3153,GO:0006780,1,0.945448192253126,0,2,uroporphyrinogen III biosynthetic process,BP,
3154,GO:0006781,1,0.971276225392721,0,1,succinyl-CoA pathway,BP,
3155,GO:0006782,1,0.817584261394876,0,7,protoporphyrinogen IX biosynthetic process,BP,
3156,GO:0006783,1,0.582016309786486,0,18,heme biosynthetic process,BP,
3157,GO:0006784,1,0.936888398874482,0,2,heme a biosynthetic process,BP,
3160,GO:0006789,1,0.942251459655213,0,2,bilirubin conjugation,BP,
3164,GO:0006797,1,0.853572988627828,0,5,polyphosphate metabolic process,BP,
3165,GO:0006798,1,0.880544804334902,0,4,polyphosphate catabolic process,BP,
3169,GO:0006808,1,0.942942219792453,0,2,regulation of nitrogen utilization,BP,
3177,GO:0006817,1,0.682402284226079,0,12,phosphate ion transport,BP,
3180,GO:0006824,1,0.913155655288332,0,3,cobalt ion transport,BP,
3183,GO:0006828,1,0.905454672527081,0,3,manganese ion transport,BP,
3186,GO:0006835,1,0.231697764728965,0,46,dicarboxylic acid transport,BP,
3190,GO:0006842,1,0.881777035785905,0,4,tricarboxylic acid transport,BP,
3191,GO:0006843,1,0.972839470589811,0,1,mitochondrial citrate transmembrane transport,BP,
3192,GO:0006844,1,0.943642967376316,0,2,acyl carnitine transport,BP,
3193,GO:0006848,1,0.909443347965455,0,3,pyruvate transport,BP,
3194,GO:0006850,1,0.939484005877423,0,2,mitochondrial pyruvate transmembrane transport,BP,
3195,GO:0006851,1,0.54184382191805,0,20,mitochondrial calcium ion transmembrane transport,BP,
3196,GO:0006853,1,0.726706802123007,0,10,carnitine shuttle,BP,
3197,GO:0006855,1,0.234264619188329,0,46,drug transmembrane transport,BP,
3198,GO:0006857,1,0.7790983448087,0,8,oligopeptide transport,BP,
3199,GO:0006858,1,0.916131779005702,0,3,extracellular transport,BP,
3200,GO:0006862,1,0.615546388939171,0,16,nucleotide transport,BP,
3201,GO:0006863,1,0.838996130828756,0,6,purine nucleobase transport,BP,
3202,GO:0006864,1,0.941097083339995,0,2,pyrimidine nucleotide transport,BP,
3204,GO:0006867,1,0.969547060048947,0,1,asparagine transport,BP,
3205,GO:0006868,1,0.881367317770242,0,4,glutamine transport,BP,
3210,GO:0006878,1,0.677106774945631,0,13,cellular copper ion homeostasis,BP,
3215,GO:0006884,1,0.563906942356686,0,18,cell volume homeostasis,BP,
3220,GO:0006890,1,0.0913284618468511,0,77,retrograde vesicle-mediated transport, Golgi to ER,BP,
3221,GO:0006891,1,0.39319590691924,0,30,intra-Golgi vesicle-mediated transport,BP,
3224,GO:0006895,1,0.538744163343937,0,19,Golgi to endosome transport,BP,
3225,GO:0006896,1,0.643384507108231,0,14,Golgi to vacuole transport,BP,
3231,GO:0006904,1,0.320613147168895,0,37,vesicle docking involved in exocytosis,BP,
3235,GO:0006910,1,0.827863039106108,0,6,phagocytosis, recognition,BP,
3241,GO:0006921,1,0.456283395253051,0,26,cellular component disassembly involved in execution phase of apoptosis,BP,
3242,GO:0006924,1,0.789580862953277,0,8,activation-induced cell death of T cells,BP,
3247,GO:0006931,1,0.910530378399358,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
3248,GO:0006933,1,0.944484249198969,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3263,GO:0006957,1,0.966883705572623,0,1,complement activation, alternative pathway,BP,
3266,GO:0006968,1,0.555373363260655,0,19,cellular defense response,BP,
3268,GO:0006971,1,0.7731712242618,0,8,hypotonic response,BP,
3271,GO:0006975,1,0.806753728800808,0,7,DNA damage induced protein phosphorylation,BP,
3275,GO:0006982,1,0.947442489309094,0,2,response to lipid hydroperoxide,BP,
3282,GO:0006995,1,0.749304288746613,0,10,cellular response to nitrogen starvation,BP,
3286,GO:0006999,1,0.622490452783582,0,15,nuclear pore organization,BP,
3287,GO:0007000,1,0.803455411813824,0,7,nucleolus organization,BP,
3291,GO:0007007,1,0.52791260501202,0,22,inner mitochondrial membrane organization,BP,
3292,GO:0007008,1,0.96827818880457,0,1,outer mitochondrial membrane organization,BP,
3295,GO:0007014,1,0.967789301379805,0,1,actin ubiquitination,BP,
3297,GO:0007016,1,0.76617537024979,0,8,cytoskeletal anchoring at plasma membrane,BP,
3300,GO:0007019,1,0.359304555603655,0,32,microtubule depolymerization,BP,
3301,GO:0007020,1,0.437684179039469,0,26,microtubule nucleation,BP,
3303,GO:0007023,1,0.891216010701728,0,4,post-chaperonin tubulin folding pathway,BP,
3304,GO:0007026,1,0.562394739952226,0,18,negative regulation of microtubule depolymerization,BP,
3305,GO:0007028,1,0.771377525170699,0,8,cytoplasm organization,BP,
3308,GO:0007031,1,0.4251333171797,0,28,peroxisome organization,BP,
3312,GO:0007035,1,0.568932553323186,0,19,vacuolar acidification,BP,
3313,GO:0007039,1,0.691716799308238,0,12,protein catabolic process in the vacuole,BP,
3316,GO:0007042,1,0.797795128112145,0,8,lysosomal lumen acidification,BP,
3324,GO:0007056,1,0.943177616542886,0,2,spindle assembly involved in female meiosis,BP,
3325,GO:0007057,1,0.943177616542886,0,2,spindle assembly involved in female meiosis I,BP,
3327,GO:0007060,1,0.940575451785144,0,2,male meiosis chromosome segregation,BP,
3328,GO:0007062,1,0.0244016394057992,0,120,sister chromatid cohesion,BP,
3329,GO:0007063,1,0.516498812426934,0,21,regulation of sister chromatid cohesion,BP,
3330,GO:0007064,1,0.501803818738344,0,22,mitotic sister chromatid cohesion,BP,
3331,GO:0007066,1,0.974259857496765,0,1,female meiosis sister chromatid cohesion,BP,
3332,GO:0007072,1,0.972548007553948,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3333,GO:0007076,1,0.59697392025654,0,16,mitotic chromosome condensation,BP,
3334,GO:0007077,1,0.27031979775134,0,42,mitotic nuclear envelope disassembly,BP,
3335,GO:0007079,1,0.906093596159258,0,3,mitotic chromosome movement towards spindle pole,BP,
3336,GO:0007080,1,0.27208664633328,0,43,mitotic metaphase plate congression,BP,
3337,GO:0007084,1,0.745393752226502,0,10,mitotic nuclear envelope reassembly,BP,
3339,GO:0007089,1,0.882604645672897,0,4,traversing start control point of mitotic cell cycle,BP,
3344,GO:0007096,1,0.63330122749721,0,15,regulation of exit from mitosis,BP,
3345,GO:0007097,1,0.590990686662108,0,16,nuclear migration,BP,
3347,GO:0007099,1,0.395975247151798,0,29,centriole replication,BP,
3348,GO:0007100,1,0.664921155217971,0,13,mitotic centrosome separation,BP,
3349,GO:0007113,1,0.918628733836658,0,3,endomitotic cell cycle,BP,
3350,GO:0007127,1,0.126495772554091,0,67,meiosis I,BP,
3351,GO:0007129,1,0.57402145007263,0,18,synapsis,BP,
3352,GO:0007130,1,0.805227554594826,0,7,synaptonemal complex assembly,BP,
3353,GO:0007131,1,0.328828761149682,0,36,reciprocal meiotic recombination,BP,
3354,GO:0007135,1,0.832625785045759,0,6,meiosis II,BP,
3355,GO:0007140,1,0.491488414515726,0,23,male meiotic nuclear division,BP,
3356,GO:0007141,1,0.698491492676809,0,12,male meiosis I,BP,
3357,GO:0007143,1,0.574725726526544,0,18,female meiotic nuclear division,BP,
3358,GO:0007144,1,0.835671292291196,0,6,female meiosis I,BP,
3359,GO:0007146,1,0.969271124374127,0,1,meiotic recombination nodule assembly,BP,
3360,GO:0007147,1,0.967901122023658,0,1,female meiosis II,BP,
3365,GO:0007158,1,0.795533273742533,0,7,neuron cell-cell adhesion,BP,
3368,GO:0007161,1,0.876491988477012,0,4,calcium-independent cell-matrix adhesion,BP,
3375,GO:0007168,1,0.940079855134589,0,2,receptor guanylyl cyclase signaling pathway,BP,
3378,GO:0007172,1,0.800323653767636,0,7,signal complex assembly,BP,
3380,GO:0007174,1,0.971087449616734,0,1,epidermal growth factor catabolic process,BP,
3381,GO:0007175,1,0.649981195317092,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3385,GO:0007181,1,0.94108653701354,0,2,transforming growth factor beta receptor complex assembly,BP,
3388,GO:0007185,1,0.873753468068921,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3392,GO:0007189,1,0.305322345087212,0,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3393,GO:0007190,1,0.641968712412799,0,14,activation of adenylate cyclase activity,BP,
3394,GO:0007191,1,0.832934036284729,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3396,GO:0007194,1,0.808294745004163,0,7,negative regulation of adenylate cyclase activity,BP,
3397,GO:0007195,1,0.938263733404428,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3398,GO:0007196,1,0.966864704463998,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3399,GO:0007197,1,0.937823736298729,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3402,GO:0007202,1,0.742721941304328,0,10,activation of phospholipase C activity,BP,
3405,GO:0007206,1,0.967287592119379,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3406,GO:0007207,1,0.941888121422677,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3408,GO:0007212,1,0.453420771104878,0,26,dopamine receptor signaling pathway,BP,
3409,GO:0007213,1,0.738215149544015,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3410,GO:0007214,1,0.827750825248406,0,6,gamma-aminobutyric acid signaling pathway,BP,
3412,GO:0007216,1,0.857663333790651,0,5,G-protein coupled glutamate receptor signaling pathway,BP,
3413,GO:0007217,1,0.970116019624571,0,1,tachykinin receptor signaling pathway,BP,
3414,GO:0007218,1,0.608250825888013,0,17,neuropeptide signaling pathway,BP,
3416,GO:0007220,1,0.62419112364251,0,15,Notch receptor processing,BP,
3418,GO:0007223,1,0.353837886581666,0,32,Wnt signaling pathway, calcium modulating pathway,BP,
3420,GO:0007225,1,0.967008574995129,0,1,patched ligand maturation,BP,
3421,GO:0007227,1,0.905371903229619,0,3,signal transduction downstream of smoothened,BP,
3422,GO:0007228,1,0.935770362399028,0,2,positive regulation of hh target transcription factor activity,BP,
3424,GO:0007231,1,0.942264777938266,0,2,osmosensory signaling pathway,BP,
3430,GO:0007256,1,0.818927708463939,0,6,activation of JNKK activity,BP,
3431,GO:0007257,1,0.400540139896265,0,28,activation of JUN kinase activity,BP,
3432,GO:0007258,1,0.882426676761865,0,4,JUN phosphorylation,BP,
3435,GO:0007263,1,0.780256256729738,0,8,nitric oxide mediated signal transduction,BP,
3442,GO:0007270,1,0.826768185333405,0,6,neuron-neuron synaptic transmission,BP,
3443,GO:0007271,1,0.732521981120657,0,10,synaptic transmission, cholinergic,BP,
3445,GO:0007274,1,0.745271844021596,0,9,neuromuscular synaptic transmission,BP,
3448,GO:0007281,1,0.014852153122245,0,134,germ cell development,BP,
3450,GO:0007284,1,0.935562380017936,0,2,spermatogonial cell division,BP,
3451,GO:0007286,1,0.116588840312514,0,69,spermatid development,BP,
3452,GO:0007288,1,0.73573929046772,0,10,sperm axoneme assembly,BP,
3453,GO:0007289,1,0.706039506562089,0,11,spermatid nucleus differentiation,BP,
3454,GO:0007290,1,0.966998837552156,0,1,spermatid nucleus elongation,BP,
3456,GO:0007296,1,0.879063095344689,0,4,vitellogenesis,BP,
3457,GO:0007308,1,0.970104831459515,0,1,oocyte construction,BP,
3458,GO:0007309,1,0.970104831459515,0,1,oocyte axis specification,BP,
3459,GO:0007314,1,0.970104831459515,0,1,oocyte anterior/posterior axis specification,BP,
3460,GO:0007315,1,0.970104831459515,0,1,pole plasm assembly,BP,
3461,GO:0007320,1,0.878165452367768,0,4,insemination,BP,
3466,GO:0007342,1,0.895069859046883,0,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3467,GO:0007344,1,0.972471937656193,0,1,pronuclear fusion,BP,
3470,GO:0007351,1,0.752036650934426,0,9,tripartite regional subdivision,BP,
3471,GO:0007352,1,0.966758957890763,0,1,zygotic specification of dorsal/ventral axis,BP,
3472,GO:0007354,1,0.912473850633113,0,3,zygotic determination of anterior/posterior axis, embryo,BP,
3473,GO:0007356,1,0.94223718848204,0,2,thorax and anterior abdomen determination,BP,
3476,GO:0007371,1,0.967754720267588,0,1,ventral midline determination,BP,
3478,GO:0007386,1,0.856339023598746,0,5,compartment pattern specification,BP,
3479,GO:0007387,1,0.969724940887173,0,1,anterior compartment pattern formation,BP,
3480,GO:0007388,1,0.969724940887173,0,1,posterior compartment specification,BP,
3482,GO:0007398,1,0.615604624134751,0,15,ectoderm development,BP,
3484,GO:0007402,1,0.974151547296457,0,1,ganglion mother cell fate determination,BP,
3485,GO:0007403,1,0.968206987373667,0,1,glial cell fate determination,BP,
3487,GO:0007406,1,0.880290772596464,0,4,negative regulation of neuroblast proliferation,BP,
3490,GO:0007412,1,0.942291720596607,0,2,axon target recognition,BP,
3494,GO:0007418,1,0.935669279365281,0,2,ventral midline development,BP,
3500,GO:0007439,1,0.969101554900902,0,1,ectodermal digestive tract development,BP,
3501,GO:0007440,1,0.817776288289736,0,6,foregut morphogenesis,BP,
3502,GO:0007442,1,0.876117774405824,0,4,hindgut morphogenesis,BP,
3503,GO:0007468,1,0.971622045369871,0,1,regulation of rhodopsin gene expression,BP,
3505,GO:0007494,1,0.796097222825889,0,7,midgut development,BP,
3506,GO:0007495,1,0.968637792191127,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3507,GO:0007497,1,0.966963099313768,0,1,posterior midgut development,BP,
3509,GO:0007499,1,0.967048650565242,0,1,ectoderm and mesoderm interaction,BP,
3510,GO:0007500,1,0.942404685952825,0,2,mesodermal cell fate determination,BP,
3511,GO:0007501,1,0.90994189066669,0,3,mesodermal cell fate specification,BP,
3513,GO:0007509,1,0.966853969882087,0,1,mesoderm migration involved in gastrulation,BP,
3514,GO:0007512,1,0.856042782581399,0,5,adult heart development,BP,
3519,GO:0007525,1,0.937519087168354,0,2,somatic muscle development,BP,
3521,GO:0007529,1,0.935984196489855,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3523,GO:0007538,1,0.935506685616655,0,2,primary sex determination,BP,
3524,GO:0007542,1,0.935506685616655,0,2,primary sex determination, germ-line,BP,
3526,GO:0007549,1,0.681210331574181,0,12,dosage compensation,BP,
3533,GO:0007576,1,0.970177806987535,0,1,nucleolar fragmentation,BP,
3541,GO:0007597,1,0.838040665905505,0,6,blood coagulation, intrinsic pathway,BP,
3542,GO:0007598,1,0.970737082952537,0,1,blood coagulation, extrinsic pathway,BP,
3546,GO:0007602,1,0.489129674639576,0,23,phototransduction,BP,
3547,GO:0007603,1,0.607092764600283,0,16,phototransduction, visible light,BP,
3548,GO:0007605,1,0.120686958303425,0,68,sensory perception of sound,BP,
3549,GO:0007606,1,0.378652392106881,0,32,sensory perception of chemical stimulus,BP,
3550,GO:0007608,1,0.626052485919362,0,15,sensory perception of smell,BP,
3555,GO:0007614,1,0.838027234929575,0,6,short-term memory,BP,
3556,GO:0007616,1,0.512548070223808,0,21,long-term memory,BP,
3557,GO:0007617,1,0.711243452382817,0,11,mating behavior,BP,
3558,GO:0007618,1,0.571473864020777,0,18,mating,BP,
3559,GO:0007619,1,0.912094499592289,0,3,courtship behavior,BP,
3560,GO:0007620,1,0.780332749356389,0,8,copulation,BP,
3561,GO:0007621,1,0.966830838912381,0,1,negative regulation of female receptivity,BP,
3564,GO:0007624,1,0.967342742604222,0,1,ultradian rhythm,BP,
3565,GO:0007625,1,0.836660695743583,0,6,grooming behavior,BP,
3567,GO:0007628,1,0.683696987813506,0,12,adult walking behavior,BP,
3570,GO:0007634,1,0.970477815511287,0,1,optokinetic behavior,BP,
3571,GO:0007635,1,0.798993888223594,0,7,chemosensory behavior,BP,
3572,GO:0007638,1,0.765352022902362,0,8,mechanosensory behavior,BP,
3574,GO:0008013,1,0.130637876262354,0,63,beta-catenin binding,MF,
3578,GO:0008020,1,0.939781934803575,0,2,G-protein coupled photoreceptor activity,MF,
3582,GO:0008024,1,0.776053664371371,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3591,GO:0008046,1,0.874329712690069,0,4,axon guidance receptor activity,MF,
3593,GO:0008048,1,0.970984185518004,0,1,calcium sensitive guanylate cyclase activator activity,MF,
3594,GO:0008049,1,0.97203186458473,0,1,male courtship behavior,BP,
3595,GO:0008050,1,0.938342711279315,0,2,female courtship behavior,BP,
3596,GO:0008052,1,0.974151547296457,0,1,sensory organ boundary specification,BP,
3597,GO:0008053,1,0.549792619335261,0,20,mitochondrial fusion,BP,
3598,GO:0008057,1,0.966831316178138,0,1,eye pigment granule organization,BP,
3599,GO:0008061,1,0.938028937656722,0,2,chitin binding,MF,
3603,GO:0008066,1,0.874200561876209,0,4,glutamate receptor activity,MF,
3604,GO:0008073,1,0.946596843036298,0,2,ornithine decarboxylase inhibitor activity,MF,
3605,GO:0008074,1,0.818101962797068,0,6,guanylate cyclase complex, soluble,CC,
3607,GO:0008078,1,0.966853969882087,0,1,mesodermal cell migration,BP,
3608,GO:0008079,1,0.829307576798795,0,6,translation termination factor activity,MF,
3619,GO:0008097,1,0.757509351870619,0,10,5S rRNA binding,MF,
3621,GO:0008106,1,0.713187564021603,0,12,alcohol dehydrogenase (NADP+) activity,MF,
3622,GO:0008107,1,0.93711563622514,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3623,GO:0008108,1,0.97345407233384,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3624,GO:0008109,1,0.936344145354268,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3625,GO:0008111,1,0.971842986967016,0,1,alpha-methylacyl-CoA racemase activity,MF,
3626,GO:0008112,1,0.972905619836635,0,1,nicotinamide N-methyltransferase activity,MF,
3627,GO:0008113,1,0.947299033833882,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3628,GO:0008117,1,0.966874295176783,0,1,sphinganine-1-phosphate aldolase activity,MF,
3629,GO:0008118,1,0.971112534214653,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3630,GO:0008119,1,0.968513880872825,0,1,thiopurine S-methyltransferase activity,MF,
3632,GO:0008121,1,0.824076565187867,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3633,GO:0008124,1,0.945554369127274,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3634,GO:0008126,1,0.969389475418018,0,1,acetylesterase activity,MF,
3635,GO:0008127,1,0.973538407309206,0,1,quercetin 2,3-dioxygenase activity,MF,
3636,GO:0008131,1,0.907793373160638,0,3,primary amine oxidase activity,MF,
3639,GO:0008137,1,0.364015616656701,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3642,GO:0008140,1,0.783529573789809,0,8,cAMP response element binding protein binding,MF,
3643,GO:0008142,1,0.879679997077381,0,4,oxysterol binding,MF,
3650,GO:0008156,1,0.354833443771956,0,33,negative regulation of DNA replication,BP,
3651,GO:0008157,1,0.649170762037268,0,14,protein phosphatase 1 binding,MF,
3652,GO:0008158,1,0.941945800127382,0,2,hedgehog receptor activity,MF,
3655,GO:0008169,1,0.913120189061397,0,3,C-methyltransferase activity,MF,
3656,GO:0008170,1,0.0975910455091458,0,75,N-methyltransferase activity,MF,
3657,GO:0008171,1,0.527512428466696,0,21,O-methyltransferase activity,MF,
3658,GO:0008172,1,0.859420380628287,0,5,S-methyltransferase activity,MF,
3660,GO:0008174,1,0.758606544519656,0,9,mRNA methyltransferase activity,MF,
3662,GO:0008176,1,0.946701227260789,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3663,GO:0008177,1,0.864775387684425,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
3664,GO:0008179,1,0.730397053357455,0,10,adenylate cyclase binding,MF,
3666,GO:0008184,1,0.937812768883068,0,2,glycogen phosphorylase activity,MF,
3667,GO:0008186,1,0.147172767984939,0,60,RNA-dependent ATPase activity,MF,
3669,GO:0008188,1,0.863324113601025,0,5,neuropeptide receptor activity,MF,
3670,GO:0008190,1,0.798402141864962,0,7,eukaryotic initiation factor 4E binding,MF,
3671,GO:0008191,1,0.809036210123075,0,7,metalloendopeptidase inhibitor activity,MF,
3672,GO:0008192,1,0.91079128797203,0,3,RNA guanylyltransferase activity,MF,
3673,GO:0008193,1,0.941756286630686,0,2,tRNA guanylyltransferase activity,MF,
3675,GO:0008195,1,0.749682653360932,0,9,phosphatidate phosphatase activity,MF,
3676,GO:0008198,1,0.601100407823962,0,17,ferrous iron binding,MF,
3682,GO:0008204,1,0.943635286025369,0,2,ergosterol metabolic process,BP,
3683,GO:0008206,1,0.450395719209769,0,26,bile acid metabolic process,BP,
3684,GO:0008207,1,0.567385127997141,0,19,C21-steroid hormone metabolic process,BP,
3685,GO:0008209,1,0.668342057254494,0,13,androgen metabolic process,BP,
3686,GO:0008210,1,0.604045727192546,0,17,estrogen metabolic process,BP,
3687,GO:0008211,1,0.673141405785162,0,13,glucocorticoid metabolic process,BP,
3688,GO:0008212,1,0.879605861768887,0,4,mineralocorticoid metabolic process,BP,
3690,GO:0008214,1,0.386188407909085,0,29,protein dealkylation,BP,
3691,GO:0008215,1,0.84448843396777,0,6,spermine metabolic process,BP,
3692,GO:0008216,1,0.822844104324401,0,7,spermidine metabolic process,BP,
3694,GO:0008218,1,0.968113167551316,0,1,bioluminescence,BP,
3697,GO:0008228,1,0.934818599810947,0,2,opsonization,BP,
3704,GO:0008239,1,0.832930968232302,0,6,dipeptidyl-peptidase activity,MF,
3706,GO:0008242,1,0.784441082253342,0,8,omega peptidase activity,MF,
3708,GO:0008251,1,0.937532766011768,0,2,tRNA-specific adenosine deaminase activity,MF,
3709,GO:0008252,1,0.708843135385064,0,11,nucleotidase activity,MF,
3710,GO:0008253,1,0.755548123548112,0,9,5'-nucleotidase activity,MF,
3711,GO:0008254,1,0.966837011679467,0,1,3'-nucleotidase activity,MF,
3713,GO:0008263,1,0.939833049971851,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3714,GO:0008265,1,0.969660586114332,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3716,GO:0008267,1,0.966816979336671,0,1,poly-glutamine tract binding,MF,
3717,GO:0008269,1,0.971161223769299,0,1,JAK pathway signal transduction adaptor activity,MF,
3719,GO:0008271,1,0.85090259064336,0,5,secondary active sulfate transmembrane transporter activity,MF,
3720,GO:0008272,1,0.800962174049094,0,7,sulfate transport,BP,
3721,GO:0008273,1,0.935110005333235,0,2,calcium, potassium:sodium antiporter activity,MF,
3722,GO:0008274,1,0.771714232539333,0,8,gamma-tubulin ring complex,CC,
3723,GO:0008275,1,0.878300447299748,0,4,gamma-tubulin small complex,CC,
3724,GO:0008276,1,0.106312500222863,0,72,protein methyltransferase activity,MF,
3726,GO:0008278,1,0.772358386317627,0,8,cohesin complex,CC,
3727,GO:0008281,1,0.967023720679825,0,1,sulfonylurea receptor activity,MF,
3728,GO:0008282,1,0.936902703701829,0,2,inward rectifying potassium channel,CC,
3733,GO:0008287,1,0.243642735386004,0,45,protein serine/threonine phosphatase complex,CC,
3735,GO:0008290,1,0.83393447255539,0,6,F-actin capping protein complex,CC,
3736,GO:0008294,1,0.966712535596693,0,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
3737,GO:0008295,1,0.890640979783045,0,4,spermidine biosynthetic process,BP,
3738,GO:0008296,1,0.788150983676043,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3739,GO:0008297,1,0.830874277264048,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3740,GO:0008298,1,0.698014582067066,0,12,intracellular mRNA localization,BP,
3742,GO:0008300,1,0.937949096498162,0,2,isoprenoid catabolic process,BP,
3743,GO:0008301,1,0.66349557002606,0,13,DNA binding, bending,MF,
3747,GO:0008308,1,0.693816948796762,0,12,voltage-gated anion channel activity,MF,
3748,GO:0008309,1,0.889489171012929,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
3749,GO:0008310,1,0.885019632655416,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3750,GO:0008311,1,0.945699639624452,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
3751,GO:0008312,1,0.817368073569513,0,7,7S RNA binding,MF,
3752,GO:0008318,1,0.808487445292889,0,7,protein prenyltransferase activity,MF,
3753,GO:0008320,1,0.693147536821726,0,13,protein transmembrane transporter activity,MF,
3754,GO:0008321,1,0.934871080269135,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
3758,GO:0008329,1,0.831184343755325,0,6,signaling pattern recognition receptor activity,MF,
3760,GO:0008331,1,0.911965161995959,0,3,high voltage-gated calcium channel activity,MF,
3762,GO:0008334,1,0.486339625469815,0,24,histone mRNA metabolic process,BP,
3764,GO:0008343,1,0.966817474312696,0,1,adult feeding behavior,BP,
3765,GO:0008344,1,0.312037778975699,0,37,adult locomotory behavior,BP,
3766,GO:0008347,1,0.354486466059611,0,33,glial cell migration,BP,
3767,GO:0008348,1,0.967851116867787,0,1,negative regulation of antimicrobial humoral response,BP,
3768,GO:0008349,1,0.721316121757806,0,10,MAP kinase kinase kinase kinase activity,MF,
3769,GO:0008352,1,0.969859967845246,0,1,katanin complex,CC,
3770,GO:0008353,1,0.62298405333511,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3771,GO:0008354,1,0.80201712213259,0,7,germ cell migration,BP,
3772,GO:0008355,1,0.967160540195298,0,1,olfactory learning,BP,
3773,GO:0008356,1,0.642946082849579,0,14,asymmetric cell division,BP,
3774,GO:0008358,1,0.970104831459515,0,1,maternal determination of anterior/posterior axis, embryo,BP,
3778,GO:0008373,1,0.649059496595221,0,14,sialyltransferase activity,MF,
3779,GO:0008374,1,0.302526150861396,0,38,O-acyltransferase activity,MF,
3783,GO:0008379,1,0.876515055053769,0,5,thioredoxin peroxidase activity,MF,
3785,GO:0008381,1,0.90836245500307,0,3,mechanosensitive ion channel activity,MF,
3787,GO:0008385,1,0.7569168783406,0,9,IkappaB kinase complex,CC,
3788,GO:0008391,1,0.942960549182287,0,2,arachidonic acid monooxygenase activity,MF,
3789,GO:0008392,1,0.942960549182287,0,2,arachidonic acid epoxygenase activity,MF,
3791,GO:0008396,1,0.970608466592276,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
3792,GO:0008398,1,0.968860959334366,0,1,sterol 14-demethylase activity,MF,
3793,GO:0008401,1,0.938043975612745,0,2,retinoic acid 4-hydroxylase activity,MF,
3794,GO:0008403,1,0.968660324416577,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
3795,GO:0008404,1,0.972165891252207,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3796,GO:0008405,1,0.972165891252207,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
3799,GO:0008409,1,0.601347551153578,0,16,5'-3' exonuclease activity,MF,
3801,GO:0008413,1,0.947083068729275,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
3802,GO:0008417,1,0.72842828665112,0,10,fucosyltransferase activity,MF,
3803,GO:0008418,1,0.973919528545206,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
3804,GO:0008419,1,0.96988434835041,0,1,RNA lariat debranching enzyme activity,MF,
3805,GO:0008420,1,0.782087476507318,0,8,CTD phosphatase activity,MF,
3806,GO:0008422,1,0.9358389708283,0,2,beta-glucosidase activity,MF,
3807,GO:0008424,1,0.968440502417451,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
3808,GO:0008425,1,0.973608638681413,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3809,GO:0008426,1,0.917935134789328,0,3,protein kinase C inhibitor activity,MF,
3810,GO:0008427,1,0.945686529619738,0,2,calcium-dependent protein kinase inhibitor activity,MF,
3811,GO:0008428,1,0.910988913386938,0,3,ribonuclease inhibitor activity,MF,
3812,GO:0008429,1,0.791734954933387,0,8,phosphatidylethanolamine binding,MF,
3813,GO:0008430,1,0.972437491413631,0,1,selenium binding,MF,
3814,GO:0008431,1,0.968910875910317,0,1,vitamin E binding,MF,
3815,GO:0008432,1,0.780217391044412,0,8,JUN kinase binding,MF,
3816,GO:0008434,1,0.967018484838147,0,1,calcitriol receptor activity,MF,
3817,GO:0008440,1,0.880491155222238,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
3818,GO:0008441,1,0.938229900024547,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
3819,GO:0008442,1,0.971830088619995,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
3820,GO:0008443,1,0.82383250681535,0,6,phosphofructokinase activity,MF,
3821,GO:0008444,1,0.97120252451975,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
3822,GO:0008446,1,0.972653762515299,0,1,GDP-mannose 4,6-dehydratase activity,MF,
3823,GO:0008448,1,0.972233445597759,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
3824,GO:0008449,1,0.904281228385001,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
3825,GO:0008452,1,0.969271124374127,0,1,RNA ligase activity,MF,
3826,GO:0008453,1,0.969271124374127,0,1,alanine-glyoxylate transaminase activity,MF,
3827,GO:0008454,1,0.93764636325157,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
3828,GO:0008455,1,0.969739494715775,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3829,GO:0008456,1,0.967770958234765,0,1,alpha-N-acetylgalactosaminidase activity,MF,
3830,GO:0008457,1,0.967364978844554,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
3831,GO:0008458,1,0.96851016029557,0,1,carnitine O-octanoyltransferase activity,MF,
3832,GO:0008459,1,0.938676039272289,0,2,chondroitin 6-sulfotransferase activity,MF,
3833,GO:0008460,1,0.97203186458473,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
3834,GO:0008465,1,0.973665350328931,0,1,glycerate dehydrogenase activity,MF,
3835,GO:0008466,1,0.972311234178041,0,1,glycogenin glucosyltransferase activity,MF,
3837,GO:0008469,1,0.786775547421554,0,8,histone-arginine N-methyltransferase activity,MF,
3839,GO:0008474,1,0.741307280975993,0,10,palmitoyl-(protein) hydrolase activity,MF,
3840,GO:0008475,1,0.908402596212651,0,3,procollagen-lysine 5-dioxygenase activity,MF,
3841,GO:0008476,1,0.944335467051015,0,2,protein-tyrosine sulfotransferase activity,MF,
3842,GO:0008478,1,0.966832925588559,0,1,pyridoxal kinase activity,MF,
3843,GO:0008479,1,0.894543187207188,0,4,queuine tRNA-ribosyltransferase activity,MF,
3844,GO:0008481,1,0.942113959752146,0,2,sphinganine kinase activity,MF,
3845,GO:0008482,1,0.970789893477674,0,1,sulfite oxidase activity,MF,
3847,GO:0008484,1,0.656619920942736,0,13,sulfuric ester hydrolase activity,MF,
3848,GO:0008486,1,0.887880067864205,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
3850,GO:0008489,1,0.969246239712162,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
3851,GO:0008493,1,0.972156191513383,0,1,tetracycline transmembrane transporter activity,MF,
3852,GO:0008494,1,0.813494894126862,0,7,translation activator activity,MF,
3853,GO:0008495,1,0.969023076497428,0,1,protoheme IX farnesyltransferase activity,MF,
3854,GO:0008496,1,0.96725928861041,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
3855,GO:0008499,1,0.737974149595518,0,10,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
3856,GO:0008503,1,0.944069085985097,0,2,benzodiazepine receptor activity,MF,
3857,GO:0008504,1,0.880968436065453,0,4,monoamine transmembrane transporter activity,MF,
3858,GO:0008506,1,0.93756814857238,0,2,sucrose:proton symporter activity,MF,
3859,GO:0008507,1,0.967964161263149,0,1,sodium:iodide symporter activity,MF,
3860,GO:0008508,1,0.945912209162533,0,2,bile acid:sodium symporter activity,MF,
3862,GO:0008510,1,0.845888420582079,0,5,sodium:bicarbonate symporter activity,MF,
3863,GO:0008511,1,0.966845721295149,0,1,sodium:potassium:chloride symporter activity,MF,
3864,GO:0008513,1,0.971199574989224,0,1,secondary active organic cation transmembrane transporter activity,MF,
3866,GO:0008515,1,0.93756814857238,0,2,sucrose transmembrane transporter activity,MF,
3867,GO:0008517,1,0.879011201156435,0,4,folic acid transmembrane transporter activity,MF,
3868,GO:0008518,1,0.969399299314024,0,1,reduced folate carrier activity,MF,
3869,GO:0008519,1,0.5897846888659,0,17,ammonium transmembrane transporter activity,MF,
3870,GO:0008520,1,0.966843581004278,0,1,L-ascorbate:sodium symporter activity,MF,
3871,GO:0008521,1,0.969862672246662,0,1,acetyl-CoA transmembrane transporter activity,MF,
3872,GO:0008523,1,0.968414436874247,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
3873,GO:0008525,1,0.828321732622164,0,6,phosphatidylcholine transporter activity,MF,
3874,GO:0008526,1,0.774825402080309,0,8,phosphatidylinositol transporter activity,MF,
3875,GO:0008527,1,0.826991066436186,0,7,taste receptor activity,MF,
3877,GO:0008531,1,0.969739494715775,0,1,riboflavin kinase activity,MF,
3878,GO:0008532,1,0.763234713949452,0,9,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
3879,GO:0008534,1,0.896899048577777,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
3880,GO:0008535,1,0.489561279496898,0,24,respiratory chain complex IV assembly,BP,
3881,GO:0008536,1,0.359239709518086,0,32,Ran GTPase binding,MF,
3882,GO:0008537,1,0.919290198581844,0,3,proteasome activator complex,CC,
3883,GO:0008540,1,0.709378065063224,0,12,proteasome regulatory particle, base subcomplex,CC,
3884,GO:0008541,1,0.822934285280092,0,7,proteasome regulatory particle, lid subcomplex,CC,
3888,GO:0008545,1,0.937055686571183,0,2,JUN kinase kinase activity,MF,
3889,GO:0008553,1,0.759716394861983,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3890,GO:0008555,1,0.966890989417339,0,1,chloride-transporting ATPase activity,MF,
3891,GO:0008556,1,0.856044226725172,0,5,potassium-transporting ATPase activity,MF,
3892,GO:0008559,1,0.876566417769471,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
3893,GO:0008565,1,0.113836996164977,0,71,protein transporter activity,MF,
3895,GO:0008569,1,0.698333810550581,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3896,GO:0008574,1,0.479706341940395,0,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,
3897,GO:0008579,1,0.966898774064661,0,1,JUN kinase phosphatase activity,MF,
3898,GO:0008582,1,0.934792870198119,0,2,regulation of synaptic growth at neuromuscular junction,BP,
3901,GO:0008589,1,0.175974148646913,0,54,regulation of smoothened signaling pathway,BP,
3902,GO:0008591,1,0.972322080150554,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
3903,GO:0008592,1,0.968534441759746,0,1,regulation of Toll signaling pathway,BP,
3905,GO:0008594,1,0.935920502102048,0,2,photoreceptor cell morphogenesis,BP,
3906,GO:0008595,1,0.752036650934426,0,9,anterior/posterior axis specification, embryo,BP,
3907,GO:0008597,1,0.943994177881053,0,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
3908,GO:0008603,1,0.858742047474619,0,5,cAMP-dependent protein kinase regulator activity,MF,
3909,GO:0008607,1,0.912839129433602,0,3,phosphorylase kinase regulator activity,MF,
3910,GO:0008608,1,0.423539450039401,0,28,attachment of spindle microtubules to kinetochore,BP,
3911,GO:0008609,1,0.966825554976583,0,1,alkylglycerone-phosphate synthase activity,MF,
3913,GO:0008611,1,0.858691367808245,0,5,ether lipid biosynthetic process,BP,
3914,GO:0008612,1,0.890992708048475,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
3915,GO:0008614,1,0.940469869935413,0,2,pyridoxine metabolic process,BP,
3916,GO:0008615,1,0.940469869935413,0,2,pyridoxine biosynthetic process,BP,
3917,GO:0008616,1,0.918942976228559,0,3,queuosine biosynthetic process,BP,
3918,GO:0008617,1,0.974119343852336,0,1,guanosine metabolic process,BP,
3919,GO:0008622,1,0.863497345044173,0,5,epsilon DNA polymerase complex,CC,
3920,GO:0008623,1,0.938361307540243,0,2,CHRAC,CC,
3922,GO:0008626,1,0.912716618619241,0,3,granzyme-mediated apoptotic signaling pathway,BP,
3923,GO:0008627,1,0.801116060393084,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3926,GO:0008635,1,0.762634091496136,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
3928,GO:0008641,1,0.732515914480749,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3931,GO:0008649,1,0.621007108102223,0,16,rRNA methyltransferase activity,MF,
3932,GO:0008650,1,0.96798138819432,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
3935,GO:0008655,1,0.707100936091078,0,12,pyrimidine-containing compound salvage,BP,
3936,GO:0008656,1,0.652221022056196,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3937,GO:0008670,1,0.947224154329512,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
3938,GO:0008689,1,0.973608638681413,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
3939,GO:0008700,1,0.969271124374127,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
3940,GO:0008705,1,0.966755791157029,0,1,methionine synthase activity,MF,
3941,GO:0008709,1,0.974233001572932,0,1,cholate 7-alpha-dehydrogenase activity,MF,
3942,GO:0008721,1,0.970365496604871,0,1,D-serine ammonia-lyase activity,MF,
3943,GO:0008725,1,0.973974669279822,0,1,DNA-3-methyladenine glycosylase activity,MF,
3944,GO:0008732,1,0.942343184763311,0,2,L-allo-threonine aldolase activity,MF,
3945,GO:0008745,1,0.973797167582431,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
3946,GO:0008746,1,0.967033443876448,0,1,NAD(P)+ transhydrogenase activity,MF,
3947,GO:0008747,1,0.9729468386134,0,1,N-acetylneuraminate lyase activity,MF,
3948,GO:0008750,1,0.967033443876448,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
3949,GO:0008753,1,0.968163500822096,0,1,NADPH dehydrogenase (quinone) activity,MF,
3951,GO:0008761,1,0.966897257206927,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
3952,GO:0008768,1,0.974391120946274,0,1,UDP-sugar diphosphatase activity,MF,
3953,GO:0008775,1,0.972262206971734,0,1,acetate CoA-transferase activity,MF,
3954,GO:0008781,1,0.946868536613354,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
3955,GO:0008783,1,0.971190725861634,0,1,agmatinase activity,MF,
3956,GO:0008785,1,0.972932328515233,0,1,alkyl hydroperoxide reductase activity,MF,
3957,GO:0008792,1,0.969271124374127,0,1,arginine decarboxylase activity,MF,
3958,GO:0008794,1,0.974307653684223,0,1,arsenate reductase (glutaredoxin) activity,MF,
3959,GO:0008796,1,0.944547095755224,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
3960,GO:0008798,1,0.966875471081089,0,1,beta-aspartyl-peptidase activity,MF,
3961,GO:0008802,1,0.96799442435341,0,1,betaine-aldehyde dehydrogenase activity,MF,
3962,GO:0008803,1,0.974162862846207,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
3963,GO:0008808,1,0.967682878933317,0,1,cardiolipin synthase activity,MF,
3964,GO:0008817,1,0.967347622863264,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
3965,GO:0008821,1,0.763088792996534,0,9,crossover junction endodeoxyribonuclease activity,MF,
3967,GO:0008829,1,0.972273132615553,0,1,dCTP deaminase activity,MF,
3968,GO:0008832,1,0.968608679122219,0,1,dGTPase activity,MF,
3969,GO:0008841,1,0.970333993118907,0,1,dihydrofolate synthase activity,MF,
3970,GO:0008852,1,0.969414081428014,0,1,exodeoxyribonuclease I activity,MF,
3971,GO:0008853,1,0.913770385629662,0,3,exodeoxyribonuclease III activity,MF,
3972,GO:0008859,1,0.974224637338252,0,1,exoribonuclease II activity,MF,
3973,GO:0008865,1,0.905435702040609,0,3,fructokinase activity,MF,
3974,GO:0008887,1,0.968536319142885,0,1,glycerate kinase activity,MF,
3975,GO:0008889,1,0.907677471816431,0,3,glycerophosphodiester phosphodiesterase activity,MF,
3976,GO:0008890,1,0.972886108049028,0,1,glycine C-acetyltransferase activity,MF,
3978,GO:0008893,1,0.97406006704497,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
3979,GO:0008894,1,0.969657976248665,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
3980,GO:0008897,1,0.969343147998182,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
3981,GO:0008900,1,0.967968451464564,0,1,potassium:proton exchanging ATPase activity,MF,
3982,GO:0008903,1,0.973929421485086,0,1,hydroxypyruvate isomerase activity,MF,
3983,GO:0008905,1,0.972834536924223,0,1,mannose-phosphate guanylyltransferase activity,MF,
3984,GO:0008934,1,0.882426189662117,0,4,inositol monophosphate 1-phosphatase activity,MF,
3985,GO:0008940,1,0.908711540383666,0,3,nitrate reductase activity,MF,
3986,GO:0008941,1,0.943028037613283,0,2,nitric oxide dioxygenase activity,MF,
3987,GO:0008948,1,0.884440523454949,0,4,oxaloacetate decarboxylase activity,MF,
3988,GO:0008962,1,0.942671367083784,0,2,phosphatidylglycerophosphatase activity,MF,
3989,GO:0008963,1,0.971346884516607,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
3990,GO:0008967,1,0.941332228510404,0,2,phosphoglycolate phosphatase activity,MF,
3991,GO:0008970,1,0.802957727695474,0,7,phosphatidylcholine 1-acylhydrolase activity,MF,
3992,GO:0008973,1,0.968519471979621,0,1,phosphopentomutase activity,MF,
3993,GO:0008988,1,0.939484005877423,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
3994,GO:0008995,1,0.970051889225651,0,1,ribonuclease E activity,MF,
3995,GO:0009000,1,0.970405707946907,0,1,selenocysteine lyase activity,MF,
3996,GO:0009007,1,0.967837881937826,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
3997,GO:0009008,1,0.852596566070318,0,5,DNA-methyltransferase activity,MF,
3998,GO:0009013,1,0.966914057987496,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
3999,GO:0009019,1,0.880460497819133,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4000,GO:0009020,1,0.971887307962299,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4001,GO:0009032,1,0.972694472677962,0,1,thymidine phosphorylase activity,MF,
4002,GO:0009041,1,0.914809539942954,0,3,uridylate kinase activity,MF,
4003,GO:0009048,1,0.721632523735799,0,10,dosage compensation by inactivation of X chromosome,BP,
4005,GO:0009052,1,0.863907821114731,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4012,GO:0009061,1,0.970605552599522,0,1,anaerobic respiration,BP,
4017,GO:0009066,1,0.285560490849928,0,41,aspartate family amino acid metabolic process,BP,
4018,GO:0009067,1,0.526204711961351,0,21,aspartate family amino acid biosynthetic process,BP,
4019,GO:0009068,1,0.693996142803257,0,12,aspartate family amino acid catabolic process,BP,
4020,GO:0009069,1,0.393129594507759,0,31,serine family amino acid metabolic process,BP,
4021,GO:0009070,1,0.660800775752127,0,14,serine family amino acid biosynthetic process,BP,
4022,GO:0009071,1,0.814190449190811,0,7,serine family amino acid catabolic process,BP,
4023,GO:0009072,1,0.733000423274507,0,11,aromatic amino acid family metabolic process,BP,
4024,GO:0009074,1,0.802030892364759,0,8,aromatic amino acid family catabolic process,BP,
4025,GO:0009078,1,0.967549552025982,0,1,pyruvate family amino acid metabolic process,BP,
4026,GO:0009080,1,0.967549552025982,0,1,pyruvate family amino acid catabolic process,BP,
4030,GO:0009084,1,0.648806318237238,0,14,glutamine family amino acid biosynthetic process,BP,
4031,GO:0009085,1,0.937227461839672,0,2,lysine biosynthetic process,BP,
4032,GO:0009086,1,0.716705414042119,0,11,methionine biosynthetic process,BP,
4033,GO:0009088,1,0.971435022576243,0,1,threonine biosynthetic process,BP,
4034,GO:0009092,1,0.888726369635939,0,4,homoserine metabolic process,BP,
4035,GO:0009093,1,0.970021395609411,0,1,cysteine catabolic process,BP,
4040,GO:0009106,1,0.941492583640779,0,2,lipoate metabolic process,BP,
4041,GO:0009107,1,0.972657592338812,0,1,lipoate biosynthetic process,BP,
4043,GO:0009109,1,0.697610037567616,0,12,coenzyme catabolic process,BP,
4045,GO:0009111,1,0.785113461236749,0,8,vitamin catabolic process,BP,
4047,GO:0009113,1,0.676650707958373,0,13,purine nucleobase biosynthetic process,BP,
4048,GO:0009115,1,0.934915758662178,0,2,xanthine catabolic process,BP,
4052,GO:0009120,1,0.839975068894311,0,6,deoxyribonucleoside metabolic process,BP,
4055,GO:0009125,1,0.762517383036775,0,9,nucleoside monophosphate catabolic process,BP,
4058,GO:0009128,1,0.78670767761857,0,8,purine nucleoside monophosphate catabolic process,BP,
4059,GO:0009129,1,0.664433472991259,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4060,GO:0009130,1,0.664433472991259,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4062,GO:0009133,1,0.892613843645539,0,4,nucleoside diphosphate biosynthetic process,BP,
4063,GO:0009134,1,0.813684215313501,0,7,nucleoside diphosphate catabolic process,BP,
4065,GO:0009136,1,0.945842242900382,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4066,GO:0009137,1,0.889367809870499,0,4,purine nucleoside diphosphate catabolic process,BP,
4067,GO:0009138,1,0.914639170350952,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4068,GO:0009139,1,0.943732169123637,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4069,GO:0009140,1,0.969177217676602,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4075,GO:0009146,1,0.840496697671944,0,6,purine nucleoside triphosphate catabolic process,BP,
4076,GO:0009147,1,0.565934987260719,0,20,pyrimidine nucleoside triphosphate metabolic process,BP,
4077,GO:0009148,1,0.616369285119593,0,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4078,GO:0009149,1,0.946770402126176,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4080,GO:0009151,1,0.750383230964572,0,10,purine deoxyribonucleotide metabolic process,BP,
4082,GO:0009153,1,0.946501149985887,0,2,purine deoxyribonucleotide biosynthetic process,BP,
4084,GO:0009155,1,0.839716547303723,0,6,purine deoxyribonucleotide catabolic process,BP,
4086,GO:0009157,1,0.771072657041959,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4087,GO:0009158,1,0.78670767761857,0,8,ribonucleoside monophosphate catabolic process,BP,
4088,GO:0009159,1,0.969271124374127,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4090,GO:0009162,1,0.728034050279973,0,11,deoxyribonucleoside monophosphate metabolic process,BP,
4091,GO:0009163,1,0.312277262367549,0,40,nucleoside biosynthetic process,BP,
4092,GO:0009164,1,0.542810739127352,0,21,nucleoside catabolic process,BP,
4097,GO:0009169,1,0.78670767761857,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4098,GO:0009170,1,0.974159093896004,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4099,GO:0009173,1,0.765963367864795,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4100,GO:0009174,1,0.765963367864795,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4101,GO:0009176,1,0.867538375106157,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4102,GO:0009177,1,0.867538375106157,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4104,GO:0009180,1,0.945842242900382,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4105,GO:0009181,1,0.889367809870499,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4106,GO:0009182,1,0.918764363378554,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4107,GO:0009183,1,0.974159093896004,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4108,GO:0009184,1,0.973042534048118,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4110,GO:0009186,1,0.867055799230398,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4112,GO:0009188,1,0.945842242900382,0,2,ribonucleoside diphosphate biosynthetic process,BP,
4113,GO:0009189,1,0.919341441182731,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
4115,GO:0009191,1,0.839293588905152,0,6,ribonucleoside diphosphate catabolic process,BP,
4116,GO:0009192,1,0.973042534048118,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4117,GO:0009193,1,0.969177217676602,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4118,GO:0009195,1,0.969177217676602,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4119,GO:0009196,1,0.943732169123637,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4120,GO:0009197,1,0.943732169123637,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4122,GO:0009200,1,0.630921325963295,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4124,GO:0009202,1,0.841719202149941,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4125,GO:0009203,1,0.973946193002066,0,1,ribonucleoside triphosphate catabolic process,BP,
4126,GO:0009204,1,0.817035159692269,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4129,GO:0009207,1,0.973946193002066,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4130,GO:0009208,1,0.668914298532328,0,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4131,GO:0009209,1,0.689686748755117,0,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4132,GO:0009211,1,0.846206284174542,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4133,GO:0009212,1,0.89379703155424,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4134,GO:0009213,1,0.946770402126176,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4136,GO:0009215,1,0.771187128977212,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4137,GO:0009216,1,0.941751589232374,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4138,GO:0009217,1,0.862989858148989,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4139,GO:0009218,1,0.558470785983113,0,20,pyrimidine ribonucleotide metabolic process,BP,
4140,GO:0009219,1,0.600453953788991,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4141,GO:0009220,1,0.594161709627458,0,18,pyrimidine ribonucleotide biosynthetic process,BP,
4142,GO:0009221,1,0.796994082832987,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4143,GO:0009222,1,0.969177217676602,0,1,pyrimidine ribonucleotide catabolic process,BP,
4144,GO:0009223,1,0.732514095559697,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4145,GO:0009224,1,0.973650711260201,0,1,CMP biosynthetic process,BP,
4148,GO:0009227,1,0.916323383516601,0,3,nucleotide-sugar catabolic process,BP,
4149,GO:0009231,1,0.969739494715775,0,1,riboflavin biosynthetic process,BP,
4150,GO:0009233,1,0.937504309156199,0,2,menaquinone metabolic process,BP,
4151,GO:0009234,1,0.967873889023191,0,1,menaquinone biosynthetic process,BP,
4152,GO:0009235,1,0.652981522395209,0,14,cobalamin metabolic process,BP,
4153,GO:0009236,1,0.906652217048717,0,3,cobalamin biosynthetic process,BP,
4154,GO:0009237,1,0.969195805889928,0,1,siderophore metabolic process,BP,
4155,GO:0009240,1,0.869581516372694,0,5,isopentenyl diphosphate biosynthetic process,BP,
4156,GO:0009245,1,0.950146313132071,0,2,lipid A biosynthetic process,BP,
4158,GO:0009249,1,0.829716614969316,0,7,protein lipoylation,BP,
4160,GO:0009251,1,0.528206139265041,0,20,glucan catabolic process,BP,
4161,GO:0009253,1,0.973797167582431,0,1,peptidoglycan catabolic process,BP,
4162,GO:0009256,1,0.851923085057515,0,5,10-formyltetrahydrofolate metabolic process,BP,
4163,GO:0009257,1,0.937069277753091,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4164,GO:0009258,1,0.936585065490026,0,2,10-formyltetrahydrofolate catabolic process,BP,
4168,GO:0009262,1,0.397132061544636,0,32,deoxyribonucleotide metabolic process,BP,
4169,GO:0009263,1,0.684065521826458,0,13,deoxyribonucleotide biosynthetic process,BP,
4170,GO:0009264,1,0.598092271705125,0,18,deoxyribonucleotide catabolic process,BP,
4171,GO:0009265,1,0.754329938851358,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4174,GO:0009268,1,0.509231901006728,0,22,response to pH,BP,
4175,GO:0009295,1,0.294947006158431,0,40,nucleoid,CC,
4176,GO:0009298,1,0.894089419137839,0,4,GDP-mannose biosynthetic process,BP,
4179,GO:0009303,1,0.438135916401314,0,27,rRNA transcription,BP,
4180,GO:0009304,1,0.802779976544496,0,7,tRNA transcription,BP,
4181,GO:0009305,1,0.966868039012414,0,1,protein biotinylation,BP,
4184,GO:0009309,1,0.684647492641895,0,13,amine biosynthetic process,BP,
4185,GO:0009310,1,0.725989610493311,0,11,amine catabolic process,BP,
4188,GO:0009313,1,0.754411007640557,0,9,oligosaccharide catabolic process,BP,
4190,GO:0009328,1,0.887148684924533,0,4,phenylalanine-tRNA ligase complex,CC,
4191,GO:0009330,1,0.935689682962206,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4192,GO:0009331,1,0.935501241718924,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
4193,GO:0009346,1,0.967190707001199,0,1,citrate lyase complex,CC,
4194,GO:0009353,1,0.973480177859163,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4195,GO:0009360,1,0.96975541520315,0,1,DNA polymerase III complex,CC,
4196,GO:0009368,1,0.945324143687567,0,2,endopeptidase Clp complex,CC,
4197,GO:0009372,1,0.968456823520522,0,1,quorum sensing,BP,
4198,GO:0009374,1,0.851358075429987,0,5,biotin binding,MF,
4199,GO:0009378,1,0.847473773255196,0,5,four-way junction helicase activity,MF,
4200,GO:0009383,1,0.937876321485263,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4201,GO:0009384,1,0.966897257206927,0,1,N-acylmannosamine kinase activity,MF,
4202,GO:0009386,1,0.970866330437704,0,1,translational attenuation,BP,
4203,GO:0009394,1,0.450389144268927,0,28,2'-deoxyribonucleotide metabolic process,BP,
4204,GO:0009395,1,0.4179164056066,0,28,phospholipid catabolic process,BP,
4205,GO:0009396,1,0.76317066507718,0,9,folic acid-containing compound biosynthetic process,BP,
4206,GO:0009397,1,0.882463053739624,0,4,folic acid-containing compound catabolic process,BP,
4207,GO:0009398,1,0.969739494715775,0,1,FMN biosynthetic process,BP,
4208,GO:0009400,1,0.969382123670748,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4209,GO:0009403,1,0.887528175767081,0,4,toxin biosynthetic process,BP,
4211,GO:0009405,1,0.934852290545463,0,2,pathogenesis,BP,
4212,GO:0009407,1,0.894024198398089,0,4,toxin catabolic process,BP,
4217,GO:0009414,1,0.838387887747401,0,6,response to water deprivation,BP,
4221,GO:0009436,1,0.969271124374127,0,1,glyoxylate catabolic process,BP,
4222,GO:0009437,1,0.711524390444411,0,11,carnitine metabolic process,BP,
4223,GO:0009438,1,0.867059920235161,0,5,methylglyoxal metabolic process,BP,
4224,GO:0009439,1,0.947743655513933,0,2,cyanate metabolic process,BP,
4225,GO:0009440,1,0.947743655513933,0,2,cyanate catabolic process,BP,
4226,GO:0009441,1,0.974265395836361,0,1,glycolate metabolic process,BP,
4227,GO:0009443,1,0.966832925588559,0,1,pyridoxal 5'-phosphate salvage,BP,
4228,GO:0009445,1,0.816288559981647,0,7,putrescine metabolic process,BP,
4229,GO:0009446,1,0.860366014174072,0,5,putrescine biosynthetic process,BP,
4230,GO:0009447,1,0.922791336777165,0,3,putrescine catabolic process,BP,
4231,GO:0009448,1,0.87837938855261,0,4,gamma-aminobutyric acid metabolic process,BP,
4232,GO:0009449,1,0.90844387197885,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4233,GO:0009450,1,0.934963136258068,0,2,gamma-aminobutyric acid catabolic process,BP,
4235,GO:0009452,1,0.375733552677802,0,33,7-methylguanosine RNA capping,BP,
4237,GO:0009581,1,0.227247070736094,0,47,detection of external stimulus,BP,
4238,GO:0009582,1,0.21969814144983,0,48,detection of abiotic stimulus,BP,
4239,GO:0009583,1,0.416847463214906,0,28,detection of light stimulus,BP,
4240,GO:0009584,1,0.501847948691878,0,22,detection of visible light,BP,
4241,GO:0009593,1,0.446874353347642,0,27,detection of chemical stimulus,BP,
4242,GO:0009595,1,0.774347832985893,0,8,detection of biotic stimulus,BP,
4243,GO:0009597,1,0.856371663102787,0,5,detection of virus,BP,
4246,GO:0009608,1,0.942258681479361,0,2,response to symbiont,BP,
4247,GO:0009609,1,0.942258681479361,0,2,response to symbiotic bacterium,BP,
4255,GO:0009629,1,0.833627257069568,0,6,response to gravity,BP,
4256,GO:0009631,1,0.966920568104527,0,1,cold acclimation,BP,
4259,GO:0009637,1,0.936859616243525,0,2,response to blue light,BP,
4261,GO:0009644,1,0.939360307433251,0,2,response to high light intensity,BP,
4263,GO:0009646,1,0.968435086332893,0,1,response to absence of light,BP,
4266,GO:0009650,1,0.695554127925601,0,12,UV protection,BP,
4269,GO:0009669,1,0.93756814857238,0,2,sucrose:cation symporter activity,MF,
4270,GO:0009674,1,0.966845721295149,0,1,potassium:sodium symporter activity,MF,
4273,GO:0009712,1,0.464472569284661,0,25,catechol-containing compound metabolic process,BP,
4274,GO:0009713,1,0.759475143269171,0,9,catechol-containing compound biosynthetic process,BP,
4276,GO:0009720,1,0.969055369057037,0,1,detection of hormone stimulus,BP,
4278,GO:0009726,1,0.937004241131495,0,2,detection of endogenous stimulus,BP,
4279,GO:0009737,1,0.967193497595987,0,1,response to abscisic acid,BP,
4280,GO:0009738,1,0.967193497595987,0,1,abscisic acid-activated signaling pathway,BP,
4282,GO:0009744,1,0.908792763517422,0,3,response to sucrose,BP,
4286,GO:0009753,1,0.947173314806185,0,2,response to jasmonic acid,BP,
4288,GO:0009756,1,0.837764360197416,0,6,carbohydrate mediated signaling,BP,
4289,GO:0009757,1,0.863215995267063,0,5,hexose mediated signaling,BP,
4290,GO:0009758,1,0.966798560430869,0,1,carbohydrate utilization,BP,
4291,GO:0009785,1,0.936859616243525,0,2,blue light signaling pathway,BP,
4292,GO:0009786,1,0.940950148444541,0,2,regulation of asymmetric cell division,BP,
4293,GO:0009787,1,0.967193497595987,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4294,GO:0009789,1,0.967193497595987,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4298,GO:0009794,1,0.884398400891698,0,4,regulation of mitotic cell cycle, embryonic,BP,
4302,GO:0009810,1,0.971161223769299,0,1,stilbene metabolic process,BP,
4304,GO:0009814,1,0.971181875985849,0,1,defense response, incompatible interaction,BP,
4305,GO:0009817,1,0.971181875985849,0,1,defense response to fungus, incompatible interaction,BP,
4306,GO:0009820,1,0.917439624486244,0,3,alkaloid metabolic process,BP,
4307,GO:0009822,1,0.972558416941406,0,1,alkaloid catabolic process,BP,
4308,GO:0009826,1,0.939969401117296,0,2,unidimensional cell growth,BP,
4309,GO:0009838,1,0.865228757822337,0,5,abscission,BP,
4310,GO:0009841,1,0.970716573199413,0,1,mitochondrial endopeptidase Clp complex,CC,
4311,GO:0009850,1,0.972262206971734,0,1,auxin metabolic process,BP,
4312,GO:0009852,1,0.972262206971734,0,1,auxin catabolic process,BP,
4315,GO:0009881,1,0.880433978946369,0,4,photoreceptor activity,MF,
4316,GO:0009882,1,0.936859616243525,0,2,blue light photoreceptor activity,MF,
4330,GO:0009912,1,0.859724862887456,0,5,auditory receptor cell fate commitment,BP,
4333,GO:0009918,1,0.969874856147979,0,1,sterol delta7 reductase activity,MF,
4334,GO:0009922,1,0.856212542519588,0,5,fatty acid elongase activity,MF,
4335,GO:0009925,1,0.507984076378225,0,21,basal plasma membrane,CC,
4336,GO:0009931,1,0.80617630394132,0,7,calcium-dependent protein serine/threonine kinase activity,MF,
4337,GO:0009948,1,0.416215344072431,0,28,anterior/posterior axis specification,BP,
4338,GO:0009950,1,0.701911878164422,0,11,dorsal/ventral axis specification,BP,
4341,GO:0009954,1,0.519766523038897,0,21,proximal/distal pattern formation,BP,
4342,GO:0009955,1,0.971173025433657,0,1,adaxial/abaxial pattern specification,BP,
4344,GO:0009957,1,0.938508703346222,0,2,epidermal cell fate specification,BP,
4348,GO:0009972,1,0.817167602497818,0,7,cytidine deamination,BP,
4349,GO:0009975,1,0.746466429798708,0,9,cyclase activity,MF,
4355,GO:0009992,1,0.971245280830003,0,1,cellular water homeostasis,BP,
4356,GO:0009994,1,0.407056140533899,0,29,oocyte differentiation,BP,
4357,GO:0009996,1,0.940846260957232,0,2,negative regulation of cell fate specification,BP,
4361,GO:0010009,1,0.857735555007881,0,5,cytoplasmic side of endosome membrane,CC,
4362,GO:0010015,1,0.974543632249742,0,1,root morphogenesis,BP,
4363,GO:0010025,1,0.939316984477824,0,2,wax biosynthetic process,BP,
4364,GO:0010032,1,0.84528470655378,0,5,meiotic chromosome condensation,BP,
4366,GO:0010034,1,0.968031160194604,0,1,response to acetate,BP,
4374,GO:0010044,1,0.886592026235155,0,4,response to aluminum ion,BP,
4375,GO:0010046,1,0.886696548476969,0,4,response to mycotoxin,BP,
4376,GO:0010053,1,0.974543632249742,0,1,root epidermal cell differentiation,BP,
4377,GO:0010054,1,0.974543632249742,0,1,trichoblast differentiation,BP,
4378,GO:0010070,1,0.970553179465225,0,1,zygote asymmetric cell division,BP,
4379,GO:0010092,1,0.612242048515685,0,16,specification of animal organ identity,BP,
4380,GO:0010106,1,0.971924347519029,0,1,cellular response to iron ion starvation,BP,
4382,GO:0010121,1,0.971820047232335,0,1,arginine catabolic process to proline via ornithine,BP,
4383,GO:0010124,1,0.972262206971734,0,1,phenylacetate catabolic process,BP,
4384,GO:0010133,1,0.940547465644902,0,2,proline catabolic process to glutamate,BP,
4385,GO:0010138,1,0.894040009500743,0,4,pyrimidine ribonucleotide salvage,BP,
4386,GO:0010139,1,0.972807317934447,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4388,GO:0010155,1,0.769745614616437,0,9,regulation of proton transport,BP,
4389,GO:0010157,1,0.966821717216446,0,1,response to chlorate,BP,
4390,GO:0010159,1,0.910672434115859,0,3,specification of animal organ position,BP,
4391,GO:0010160,1,0.974151547296457,0,1,formation of animal organ boundary,BP,
4392,GO:0010164,1,0.972807317934447,0,1,response to cesium ion,BP,
4394,GO:0010166,1,0.939316984477824,0,2,wax metabolic process,BP,
4395,GO:0010171,1,0.263886918295308,0,42,body morphogenesis,BP,
4396,GO:0010172,1,0.721486211188984,0,10,embryonic body morphogenesis,BP,
4398,GO:0010182,1,0.863215995267063,0,5,sugar mediated signaling pathway,BP,
4399,GO:0010189,1,0.972652485296482,0,1,vitamin E biosynthetic process,BP,
4402,GO:0010216,1,0.820667183280269,0,6,maintenance of DNA methylation,BP,
4406,GO:0010232,1,0.968755358580569,0,1,vascular transport,BP,
4408,GO:0010248,1,0.837823929990305,0,6,establishment or maintenance of transmembrane electrochemical gradient,BP,
4409,GO:0010255,1,0.863215995267063,0,5,glucose mediated signaling pathway,BP,
4411,GO:0010257,1,0.221965585440835,0,55,NADH dehydrogenase complex assembly,BP,
4413,GO:0010260,1,0.969271124374127,0,1,animal organ senescence,BP,
4414,GO:0010265,1,0.828952523850726,0,6,SCF complex assembly,BP,
4415,GO:0010266,1,0.912689521125665,0,3,response to vitamin B1,BP,
4417,GO:0010273,1,0.873301164775957,0,5,detoxification of copper ion,BP,
4418,GO:0010286,1,0.866858169429614,0,5,heat acclimation,BP,
4420,GO:0010309,1,0.972661419414799,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4421,GO:0010310,1,0.757498282369938,0,9,regulation of hydrogen peroxide metabolic process,BP,
4422,GO:0010314,1,0.732023896800674,0,10,phosphatidylinositol-5-phosphate binding,MF,
4425,GO:0010335,1,0.967113354260911,0,1,response to non-ionic osmotic stress,BP,
4426,GO:0010340,1,0.80496877232487,0,7,carboxyl-O-methyltransferase activity,MF,
4427,GO:0010348,1,0.969271124374127,0,1,lithium:proton antiporter activity,MF,
4428,GO:0010359,1,0.826002483840482,0,6,regulation of anion channel activity,BP,
4429,GO:0010360,1,0.908537613516256,0,3,negative regulation of anion channel activity,BP,
4430,GO:0010369,1,0.666429368964565,0,13,chromocenter,CC,
4431,GO:0010370,1,0.940286365315376,0,2,perinucleolar chromocenter,CC,
4432,GO:0010385,1,0.854660281820207,0,5,double-stranded methylated DNA binding,MF,
4433,GO:0010387,1,0.970913441825983,0,1,COP9 signalosome assembly,BP,
4436,GO:0010412,1,0.968383354102579,0,1,mannan metabolic process,BP,
4437,GO:0010420,1,0.973608638681413,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4438,GO:0010421,1,0.718533119807756,0,11,hydrogen peroxide-mediated programmed cell death,BP,
4439,GO:0010428,1,0.966871018255479,0,1,methyl-CpNpG binding,MF,
4440,GO:0010430,1,0.967021538070694,0,1,fatty acid omega-oxidation,BP,
4441,GO:0010447,1,0.711549266611108,0,11,response to acidic pH,BP,
4442,GO:0010452,1,0.751641967387668,0,9,histone H3-K36 methylation,BP,
4444,GO:0010454,1,0.911437377944431,0,3,negative regulation of cell fate commitment,BP,
4446,GO:0010457,1,0.696123858913991,0,11,centriole-centriole cohesion,BP,
4447,GO:0010458,1,0.452531050321862,0,26,exit from mitosis,BP,
4448,GO:0010459,1,0.892678188909295,0,4,negative regulation of heart rate,BP,
4450,GO:0010463,1,0.432508211472295,0,26,mesenchymal cell proliferation,BP,
4451,GO:0010464,1,0.477532429536343,0,23,regulation of mesenchymal cell proliferation,BP,
4452,GO:0010465,1,0.966841851870227,0,1,nerve growth factor receptor activity,MF,
4457,GO:0010470,1,0.482245039062376,0,23,regulation of gastrulation,BP,
4458,GO:0010481,1,0.912497887482764,0,3,epidermal cell division,BP,
4459,GO:0010482,1,0.912497887482764,0,3,regulation of epidermal cell division,BP,
4460,GO:0010484,1,0.877151006944042,0,4,H3 histone acetyltransferase activity,MF,
4461,GO:0010485,1,0.564255330453567,0,18,H4 histone acetyltransferase activity,MF,
4462,GO:0010494,1,0.277217858656081,0,40,cytoplasmic stress granule,CC,
4465,GO:0010501,1,0.27595313071581,0,41,RNA secondary structure unwinding,BP,
4469,GO:0010509,1,0.96688196133685,0,1,polyamine homeostasis,BP,
4470,GO:0010510,1,0.702636583562425,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4471,GO:0010511,1,0.888297404413127,0,4,regulation of phosphatidylinositol biosynthetic process,BP,
4472,GO:0010512,1,0.939802557413203,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4473,GO:0010513,1,0.945204846759328,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
4475,GO:0010518,1,0.458995632591667,0,25,positive regulation of phospholipase activity,BP,
4477,GO:0010520,1,0.939575034922951,0,2,regulation of reciprocal meiotic recombination,BP,
4478,GO:0010521,1,0.913863699996917,0,3,telomerase inhibitor activity,MF,
4480,GO:0010523,1,0.676017276928234,0,13,negative regulation of calcium ion transport into cytosol,BP,
4481,GO:0010524,1,0.43337043167459,0,27,positive regulation of calcium ion transport into cytosol,BP,
4482,GO:0010528,1,0.690601321201831,0,12,regulation of transposition,BP,
4483,GO:0010529,1,0.690601321201831,0,12,negative regulation of transposition,BP,
4491,GO:0010559,1,0.435110736062231,0,27,regulation of glycoprotein biosynthetic process,BP,
4492,GO:0010560,1,0.664523864942691,0,13,positive regulation of glycoprotein biosynthetic process,BP,
4493,GO:0010561,1,0.720616976657347,0,11,negative regulation of glycoprotein biosynthetic process,BP,
4498,GO:0010566,1,0.77712660673546,0,8,regulation of ketone biosynthetic process,BP,
4500,GO:0010571,1,0.820842274548359,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4501,GO:0010572,1,0.939902183974653,0,2,positive regulation of platelet activation,BP,
4505,GO:0010585,1,0.971978251341793,0,1,glutamine secretion,BP,
4507,GO:0010587,1,0.850757425005288,0,5,miRNA catabolic process,BP,
4509,GO:0010592,1,0.645562019717841,0,14,positive regulation of lamellipodium assembly,BP,
4514,GO:0010603,1,0.79184933880438,0,7,regulation of cytoplasmic mRNA processing body assembly,BP,
4517,GO:0010606,1,0.846235172654204,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4519,GO:0010609,1,0.941277209791786,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4521,GO:0010612,1,0.820189458728518,0,6,regulation of cardiac muscle adaptation,BP,
4524,GO:0010615,1,0.967042410544309,0,1,positive regulation of cardiac muscle adaptation,BP,
4525,GO:0010616,1,0.848154981362455,0,5,negative regulation of cardiac muscle adaptation,BP,
4526,GO:0010621,1,0.973949146632894,0,1,negative regulation of transcription by transcription factor localization,BP,
4528,GO:0010624,1,0.876662745083706,0,4,regulation of Schwann cell proliferation,BP,
4529,GO:0010626,1,0.876662745083706,0,4,negative regulation of Schwann cell proliferation,BP,
4536,GO:0010635,1,0.78273186898718,0,8,regulation of mitochondrial fusion,BP,
4537,GO:0010636,1,0.937951559098745,0,2,positive regulation of mitochondrial fusion,BP,
4538,GO:0010637,1,0.860609790756085,0,5,negative regulation of mitochondrial fusion,BP,
4541,GO:0010640,1,0.600759808680339,0,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4542,GO:0010641,1,0.87808934436125,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4543,GO:0010642,1,0.707307165594963,0,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4544,GO:0010643,1,0.909317633095034,0,3,cell communication by chemical coupling,BP,
4546,GO:0010645,1,0.938411411682389,0,2,regulation of cell communication by chemical coupling,BP,
4551,GO:0010650,1,0.966770617821941,0,1,positive regulation of cell communication by electrical coupling,BP,
4552,GO:0010652,1,0.938411411682389,0,2,positive regulation of cell communication by chemical coupling,BP,
4555,GO:0010658,1,0.498153244719721,0,22,striated muscle cell apoptotic process,BP,
4556,GO:0010659,1,0.530837340856121,0,20,cardiac muscle cell apoptotic process,BP,
4559,GO:0010662,1,0.53192648464498,0,20,regulation of striated muscle cell apoptotic process,BP,
4560,GO:0010663,1,0.824811764928394,0,6,positive regulation of striated muscle cell apoptotic process,BP,
4561,GO:0010664,1,0.623811146590921,0,15,negative regulation of striated muscle cell apoptotic process,BP,
4562,GO:0010665,1,0.566819996745253,0,18,regulation of cardiac muscle cell apoptotic process,BP,
4563,GO:0010666,1,0.824811764928394,0,6,positive regulation of cardiac muscle cell apoptotic process,BP,
4564,GO:0010667,1,0.687347305291751,0,12,negative regulation of cardiac muscle cell apoptotic process,BP,
4565,GO:0010668,1,0.849672614560728,0,5,ectodermal cell differentiation,BP,
4566,GO:0010669,1,0.667047716832039,0,13,epithelial structure maintenance,BP,
4570,GO:0010692,1,0.793416501660951,0,7,regulation of alkaline phosphatase activity,BP,
4571,GO:0010693,1,0.935092054748108,0,2,negative regulation of alkaline phosphatase activity,BP,
4572,GO:0010694,1,0.848515841171051,0,5,positive regulation of alkaline phosphatase activity,BP,
4573,GO:0010698,1,0.9436521001369,0,2,acetyltransferase activator activity,MF,
4574,GO:0010700,1,0.968804589995683,0,1,negative regulation of norepinephrine secretion,BP,
4575,GO:0010701,1,0.939584634486266,0,2,positive regulation of norepinephrine secretion,BP,
4576,GO:0010705,1,0.967074571644523,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4577,GO:0010710,1,0.914325476460298,0,3,regulation of collagen catabolic process,BP,
4578,GO:0010711,1,0.974552365021715,0,1,negative regulation of collagen catabolic process,BP,
4579,GO:0010712,1,0.497697113719431,0,23,regulation of collagen metabolic process,BP,
4580,GO:0010713,1,0.839493581103569,0,6,negative regulation of collagen metabolic process,BP,
4581,GO:0010714,1,0.63211188422448,0,15,positive regulation of collagen metabolic process,BP,
4583,GO:0010716,1,0.917590708660074,0,3,negative regulation of extracellular matrix disassembly,BP,
4586,GO:0010719,1,0.581878955820331,0,18,negative regulation of epithelial to mesenchymal transition,BP,
4589,GO:0010722,1,0.96683842825202,0,1,regulation of ferrochelatase activity,BP,
4590,GO:0010724,1,0.907785312947063,0,3,regulation of definitive erythrocyte differentiation,BP,
4591,GO:0010726,1,0.941249234598949,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4592,GO:0010727,1,0.878492828499352,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
4593,GO:0010728,1,0.882428767413145,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4594,GO:0010729,1,0.971694611920075,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4595,GO:0010730,1,0.908140737085045,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4599,GO:0010735,1,0.905040008559173,0,3,positive regulation of transcription via serum response element binding,BP,
4600,GO:0010736,1,0.967216439068199,0,1,serum response element binding,MF,
4602,GO:0010738,1,0.666285933507493,0,13,regulation of protein kinase A signaling,BP,
4603,GO:0010739,1,0.862291265399957,0,5,positive regulation of protein kinase A signaling,BP,
4608,GO:0010746,1,0.876140409806654,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4609,GO:0010748,1,0.876140409806654,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4610,GO:0010749,1,0.906843789421839,0,3,regulation of nitric oxide mediated signal transduction,BP,
4611,GO:0010750,1,0.970132828777112,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4612,GO:0010751,1,0.934767734822646,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
4613,GO:0010752,1,0.93515394026335,0,2,regulation of cGMP-mediated signaling,BP,
4614,GO:0010754,1,0.966873533978975,0,1,negative regulation of cGMP-mediated signaling,BP,
4615,GO:0010755,1,0.810260307862302,0,7,regulation of plasminogen activation,BP,
4616,GO:0010756,1,0.915632432742725,0,3,positive regulation of plasminogen activation,BP,
4617,GO:0010757,1,0.88494490128179,0,4,negative regulation of plasminogen activation,BP,
4618,GO:0010758,1,0.656039155339144,0,14,regulation of macrophage chemotaxis,BP,
4619,GO:0010759,1,0.808381398159327,0,7,positive regulation of macrophage chemotaxis,BP,
4620,GO:0010760,1,0.893555560007965,0,4,negative regulation of macrophage chemotaxis,BP,
4624,GO:0010764,1,0.833145102440982,0,6,negative regulation of fibroblast migration,BP,
4625,GO:0010765,1,0.512565768446876,0,21,positive regulation of sodium ion transport,BP,
4632,GO:0010792,1,0.828372606786721,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4633,GO:0010793,1,0.852122821518486,0,5,regulation of mRNA export from nucleus,BP,
4634,GO:0010795,1,0.973608638681413,0,1,regulation of ubiquinone biosynthetic process,BP,
4635,GO:0010796,1,0.918973012088457,0,3,regulation of multivesicular body size,BP,
4636,GO:0010797,1,0.973717272313053,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4639,GO:0010801,1,0.625247408031243,0,15,negative regulation of peptidyl-threonine phosphorylation,BP,
4641,GO:0010804,1,0.665167254437924,0,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4642,GO:0010807,1,0.826723404864891,0,6,regulation of synaptic vesicle priming,BP,
4643,GO:0010808,1,0.966857991330489,0,1,positive regulation of synaptic vesicle priming,BP,
4647,GO:0010813,1,0.940950580501804,0,2,neuropeptide catabolic process,BP,
4648,GO:0010814,1,0.966917666705161,0,1,substance P catabolic process,BP,
4649,GO:0010815,1,0.882833534508846,0,4,bradykinin catabolic process,BP,
4650,GO:0010816,1,0.966917666705161,0,1,calcitonin catabolic process,BP,
4653,GO:0010819,1,0.830646565548288,0,6,regulation of T cell chemotaxis,BP,
4654,GO:0010820,1,0.830646565548288,0,6,positive regulation of T cell chemotaxis,BP,
4657,GO:0010823,1,0.299432930026046,0,40,negative regulation of mitochondrion organization,BP,
4659,GO:0010825,1,0.823867473525791,0,6,positive regulation of centrosome duplication,BP,
4660,GO:0010826,1,0.686077137952904,0,12,negative regulation of centrosome duplication,BP,
4662,GO:0010828,1,0.415450957675431,0,27,positive regulation of glucose transmembrane transport,BP,
4668,GO:0010835,1,0.806907499295243,0,7,regulation of protein ADP-ribosylation,BP,
4669,GO:0010836,1,0.918032438384854,0,3,negative regulation of protein ADP-ribosylation,BP,
4672,GO:0010839,1,0.657285754584092,0,13,negative regulation of keratinocyte proliferation,BP,
4674,GO:0010845,1,0.969941585949058,0,1,positive regulation of reciprocal meiotic recombination,BP,
4675,GO:0010847,1,0.880219980015426,0,4,regulation of chromatin assembly,BP,
4676,GO:0010848,1,0.968462288209794,0,1,regulation of chromatin disassembly,BP,
4677,GO:0010849,1,0.97119662536758,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4678,GO:0010851,1,0.970984185518004,0,1,cyclase regulator activity,MF,
4679,GO:0010853,1,0.970984185518004,0,1,cyclase activator activity,MF,
4680,GO:0010856,1,0.968449556194877,0,1,adenylate cyclase activator activity,MF,
4681,GO:0010857,1,0.781861812255601,0,8,calcium-dependent protein kinase activity,MF,
4682,GO:0010858,1,0.945686529619738,0,2,calcium-dependent protein kinase regulator activity,MF,
4683,GO:0010859,1,0.967179412055763,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
4684,GO:0010862,1,0.456902234745961,0,25,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
4685,GO:0010863,1,0.627671376241001,0,15,positive regulation of phospholipase C activity,BP,
4686,GO:0010866,1,0.691598120864529,0,12,regulation of triglyceride biosynthetic process,BP,
4687,GO:0010867,1,0.758623673957036,0,9,positive regulation of triglyceride biosynthetic process,BP,
4688,GO:0010868,1,0.935838201295876,0,2,negative regulation of triglyceride biosynthetic process,BP,
4692,GO:0010872,1,0.865971783737867,0,5,regulation of cholesterol esterification,BP,
4693,GO:0010873,1,0.92197067971581,0,3,positive regulation of cholesterol esterification,BP,
4697,GO:0010877,1,0.945542311867348,0,2,lipid transport involved in lipid storage,BP,
4699,GO:0010879,1,0.970993033401337,0,1,cholesterol transport involved in cholesterol storage,BP,
4707,GO:0010887,1,0.832291847914572,0,6,negative regulation of cholesterol storage,BP,
4709,GO:0010889,1,0.783105288315631,0,8,regulation of sequestering of triglyceride,BP,
4710,GO:0010890,1,0.917457239299834,0,3,positive regulation of sequestering of triglyceride,BP,
4711,GO:0010891,1,0.853592457991392,0,5,negative regulation of sequestering of triglyceride,BP,
4714,GO:0010896,1,0.912060276310023,0,3,regulation of triglyceride catabolic process,BP,
4715,GO:0010897,1,0.97092080711143,0,1,negative regulation of triglyceride catabolic process,BP,
4716,GO:0010898,1,0.93938134168369,0,2,positive regulation of triglyceride catabolic process,BP,
4717,GO:0010899,1,0.91431836612076,0,3,regulation of phosphatidylcholine catabolic process,BP,
4718,GO:0010900,1,0.975074575144133,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
4719,GO:0010904,1,0.971229065755609,0,1,regulation of UDP-glucose catabolic process,BP,
4720,GO:0010905,1,0.971229065755609,0,1,negative regulation of UDP-glucose catabolic process,BP,
4723,GO:0010908,1,0.90793546250268,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4724,GO:0010909,1,0.90793546250268,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4725,GO:0010911,1,0.798038838717199,0,7,regulation of isomerase activity,BP,
4726,GO:0010912,1,0.798038838717199,0,7,positive regulation of isomerase activity,BP,
4727,GO:0010915,1,0.948660838787504,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4728,GO:0010916,1,0.948660838787504,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
4730,GO:0010918,1,0.807781626920047,0,7,positive regulation of mitochondrial membrane potential,BP,
4731,GO:0010919,1,0.796204944184825,0,7,regulation of inositol phosphate biosynthetic process,BP,
4734,GO:0010923,1,0.0964548469561031,0,74,negative regulation of phosphatase activity,BP,
4736,GO:0010931,1,0.966811453742384,0,1,macrophage tolerance induction,BP,
4737,GO:0010932,1,0.966811453742384,0,1,regulation of macrophage tolerance induction,BP,
4738,GO:0010933,1,0.966811453742384,0,1,positive regulation of macrophage tolerance induction,BP,
4741,GO:0010936,1,0.856295025978271,0,5,negative regulation of macrophage cytokine production,BP,
4743,GO:0010940,1,0.868262602124113,0,5,positive regulation of necrotic cell death,BP,
4746,GO:0010944,1,0.836637986035565,0,6,negative regulation of transcription by competitive promoter binding,BP,
4755,GO:0010958,1,0.882926380357076,0,4,regulation of amino acid import across plasma membrane,BP,
4757,GO:0010960,1,0.793104123821102,0,7,magnesium ion homeostasis,BP,
4758,GO:0010961,1,0.934901737751132,0,2,cellular magnesium ion homeostasis,BP,
4762,GO:0010966,1,0.904276606538859,0,3,regulation of phosphate transport,BP,
4763,GO:0010967,1,0.972602434471036,0,1,regulation of polyamine biosynthetic process,BP,
4764,GO:0010968,1,0.833218256132821,0,6,regulation of microtubule nucleation,BP,
4766,GO:0010971,1,0.554530507006313,0,19,positive regulation of G2/M transition of mitotic cell cycle,BP,
4771,GO:0010979,1,0.93832831333921,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
4772,GO:0010980,1,0.93832831333921,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
4773,GO:0010982,1,0.93921225172355,0,2,regulation of high-density lipoprotein particle clearance,BP,
4774,GO:0010983,1,0.93921225172355,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
4775,GO:0010984,1,0.7195013229805,0,11,regulation of lipoprotein particle clearance,BP,
4776,GO:0010985,1,0.863204274878811,0,5,negative regulation of lipoprotein particle clearance,BP,
4777,GO:0010986,1,0.88336952863438,0,4,positive regulation of lipoprotein particle clearance,BP,
4778,GO:0010988,1,0.835249011860667,0,6,regulation of low-density lipoprotein particle clearance,BP,
4779,GO:0010989,1,0.909931172172991,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
4781,GO:0010991,1,0.934994918857054,0,2,negative regulation of SMAD protein complex assembly,BP,
4782,GO:0010992,1,0.805691992316262,0,7,ubiquitin recycling,BP,
4783,GO:0010994,1,0.861774972199977,0,5,free ubiquitin chain polymerization,BP,
4784,GO:0010996,1,0.680895283823085,0,12,response to auditory stimulus,BP,
4785,GO:0010997,1,0.85527315697245,0,5,anaphase-promoting complex binding,MF,
4787,GO:0010999,1,0.967126574721264,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
4792,GO:0012510,1,0.671909625418197,0,13,trans-Golgi network transport vesicle membrane,CC,
4795,GO:0014004,1,0.937389453517596,0,2,microglia differentiation,BP,
4796,GO:0014005,1,0.937389453517596,0,2,microglia development,BP,
4798,GO:0014010,1,0.847608353359639,0,5,Schwann cell proliferation,BP,
4799,GO:0014011,1,0.969271124374127,0,1,Schwann cell proliferation involved in axon regeneration,BP,
4804,GO:0014016,1,0.970469143237632,0,1,neuroblast differentiation,BP,
4805,GO:0014020,1,0.0781942996642341,0,80,primary neural tube formation,BP,
4806,GO:0014022,1,0.907999259896507,0,3,neural plate elongation,BP,
4807,GO:0014028,1,0.973015205241223,0,1,notochord formation,BP,
4808,GO:0014029,1,0.730257375843952,0,10,neural crest formation,BP,
4812,GO:0014034,1,0.935741390624209,0,2,neural crest cell fate commitment,BP,
4813,GO:0014036,1,0.96754747341463,0,1,neural crest cell fate specification,BP,
4815,GO:0014038,1,0.91201989368218,0,3,regulation of Schwann cell differentiation,BP,
4816,GO:0014040,1,0.937841329491674,0,2,positive regulation of Schwann cell differentiation,BP,
4817,GO:0014041,1,0.801364536951268,0,7,regulation of neuron maturation,BP,
4818,GO:0014042,1,0.874602533150378,0,4,positive regulation of neuron maturation,BP,
4819,GO:0014043,1,0.94073001484724,0,2,negative regulation of neuron maturation,BP,
4821,GO:0014045,1,0.882594226567824,0,4,establishment of endothelial blood-brain barrier,BP,
4823,GO:0014047,1,0.543582088120562,0,19,glutamate secretion,BP,
4824,GO:0014048,1,0.853789262215901,0,5,regulation of glutamate secretion,BP,
4825,GO:0014049,1,0.881413172674976,0,4,positive regulation of glutamate secretion,BP,
4826,GO:0014051,1,0.845543925270294,0,5,gamma-aminobutyric acid secretion,BP,
4827,GO:0014052,1,0.90466283095687,0,3,regulation of gamma-aminobutyric acid secretion,BP,
4828,GO:0014053,1,0.966958766715114,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
4829,GO:0014054,1,0.967355834076593,0,1,positive regulation of gamma-aminobutyric acid secretion,BP,
4831,GO:0014061,1,0.910268983246926,0,3,regulation of norepinephrine secretion,BP,
4834,GO:0014064,1,0.96709169219984,0,1,positive regulation of serotonin secretion,BP,
4837,GO:0014067,1,0.753644175364048,0,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
4841,GO:0014072,1,0.593063750195446,0,17,response to isoquinoline alkaloid,BP,
4844,GO:0014701,1,0.905057956144159,0,3,junctional sarcoplasmic reticulum membrane,CC,
4847,GO:0014717,1,0.9426973062731,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4848,GO:0014718,1,0.9426973062731,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4849,GO:0014719,1,0.916826515918348,0,3,skeletal muscle satellite cell activation,BP,
4850,GO:0014721,1,0.941826257984801,0,2,twitch skeletal muscle contraction,BP,
4851,GO:0014722,1,0.889050798041685,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
4852,GO:0014731,1,0.823251234529127,0,6,spectrin-associated cytoskeleton,CC,
4853,GO:0014732,1,0.913928569754113,0,3,skeletal muscle atrophy,BP,
4854,GO:0014733,1,0.746066055737017,0,9,regulation of skeletal muscle adaptation,BP,
4855,GO:0014734,1,0.934758162119442,0,2,skeletal muscle hypertrophy,BP,
4856,GO:0014735,1,0.94104007830266,0,2,regulation of muscle atrophy,BP,
4857,GO:0014736,1,0.94104007830266,0,2,negative regulation of muscle atrophy,BP,
4858,GO:0014738,1,0.91142128009442,0,3,regulation of muscle hyperplasia,BP,
4859,GO:0014739,1,0.96908910236424,0,1,positive regulation of muscle hyperplasia,BP,
4860,GO:0014740,1,0.940497718370171,0,2,negative regulation of muscle hyperplasia,BP,
4864,GO:0014744,1,0.906027485122096,0,3,positive regulation of muscle adaptation,BP,
4865,GO:0014745,1,0.72571459564594,0,10,negative regulation of muscle adaptation,BP,
4866,GO:0014802,1,0.945932715368814,0,2,terminal cisterna,CC,
4869,GO:0014807,1,0.832211594470432,0,6,regulation of somitogenesis,BP,
4871,GO:0014809,1,0.91718765553976,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4872,GO:0014810,1,0.974536635775539,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
4874,GO:0014816,1,0.934775737509305,0,2,skeletal muscle satellite cell differentiation,BP,
4875,GO:0014819,1,0.866768642276186,0,5,regulation of skeletal muscle contraction,BP,
4880,GO:0014825,1,0.974480330032443,0,1,stomach fundus smooth muscle contraction,BP,
4882,GO:0014827,1,0.971099254143804,0,1,intestine smooth muscle contraction,BP,
4884,GO:0014831,1,0.856102207890692,0,5,gastro-intestinal system smooth muscle contraction,BP,
4885,GO:0014832,1,0.906010237669743,0,3,urinary bladder smooth muscle contraction,BP,
4886,GO:0014834,1,0.912779111337982,0,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
4887,GO:0014835,1,0.967216439068199,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
4889,GO:0014841,1,0.798220634802949,0,7,skeletal muscle satellite cell proliferation,BP,
4890,GO:0014842,1,0.798220634802949,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4891,GO:0014843,1,0.966848505673349,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
4892,GO:0014846,1,0.935226980226347,0,2,esophagus smooth muscle contraction,BP,
4893,GO:0014847,1,0.974480330032443,0,1,proximal stomach smooth muscle contraction,BP,
4894,GO:0014848,1,0.906010237669743,0,3,urinary tract smooth muscle contraction,BP,
4895,GO:0014850,1,0.64817459401721,0,14,response to muscle activity,BP,
4896,GO:0014852,1,0.969329840785849,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4897,GO:0014853,1,0.969329840785849,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
4898,GO:0014854,1,0.778490827616937,0,8,response to inactivity,BP,
4899,GO:0014855,1,0.304579085067216,0,37,striated muscle cell proliferation,BP,
4900,GO:0014856,1,0.798220634802949,0,7,skeletal muscle cell proliferation,BP,
4901,GO:0014857,1,0.798220634802949,0,7,regulation of skeletal muscle cell proliferation,BP,
4902,GO:0014858,1,0.934935679224251,0,2,positive regulation of skeletal muscle cell proliferation,BP,
4903,GO:0014859,1,0.968372791352032,0,1,negative regulation of skeletal muscle cell proliferation,BP,
4904,GO:0014866,1,0.907894551083057,0,3,skeletal myofibril assembly,BP,
4905,GO:0014870,1,0.824317433697836,0,6,response to muscle inactivity,BP,
4906,GO:0014874,1,0.800377712443298,0,7,response to stimulus involved in regulation of muscle adaptation,BP,
4907,GO:0014876,1,0.97335936320291,0,1,response to injury involved in regulation of muscle adaptation,BP,
4908,GO:0014877,1,0.850462603239668,0,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,
4909,GO:0014878,1,0.966895029669558,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
4910,GO:0014883,1,0.880563248066435,0,4,transition between fast and slow fiber,BP,
4911,GO:0014886,1,0.936636865003575,0,2,transition between slow and fast fiber,BP,
4912,GO:0014887,1,0.67356198053042,0,12,cardiac muscle adaptation,BP,
4913,GO:0014888,1,0.4761248107119,0,23,striated muscle adaptation,BP,
4914,GO:0014889,1,0.810503611015341,0,7,muscle atrophy,BP,
4915,GO:0014891,1,0.886194969301258,0,4,striated muscle atrophy,BP,
4916,GO:0014894,1,0.850462603239668,0,5,response to denervation involved in regulation of muscle adaptation,BP,
4917,GO:0014895,1,0.974698729998558,0,1,smooth muscle hypertrophy,BP,
4920,GO:0014898,1,0.67356198053042,0,12,cardiac muscle hypertrophy in response to stress,BP,
4922,GO:0014901,1,0.9426973062731,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
4924,GO:0014904,1,0.62270870560747,0,15,myotube cell development,BP,
4925,GO:0014908,1,0.966861199649043,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
4930,GO:0014916,1,0.9084256318999,0,3,regulation of lung blood pressure,BP,
4931,GO:0015002,1,0.620510465344636,0,18,heme-copper terminal oxidase activity,MF,
4932,GO:0015012,1,0.523645641154882,0,20,heparan sulfate proteoglycan biosynthetic process,BP,
4933,GO:0015014,1,0.876390345668698,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
4934,GO:0015015,1,0.879482893076936,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
4935,GO:0015016,1,0.935359295460452,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
4936,GO:0015018,1,0.973224082607255,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
4937,GO:0015019,1,0.966905026487985,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
4938,GO:0015020,1,0.648640481265597,0,14,glucuronosyltransferase activity,MF,
4940,GO:0015030,1,0.213158338107008,0,51,Cajal body,CC,
4945,GO:0015038,1,0.873264993159658,0,5,glutathione disulfide oxidoreductase activity,MF,
4946,GO:0015039,1,0.972059959176842,0,1,NADPH-adrenodoxin reductase activity,MF,
4947,GO:0015057,1,0.910122671079574,0,3,thrombin-activated receptor activity,MF,
4948,GO:0015074,1,0.730218381697623,0,10,DNA integration,BP,
4951,GO:0015078,1,0.105871885822175,0,75,proton transmembrane transporter activity,MF,
4955,GO:0015086,1,0.96732120893744,0,1,cadmium ion transmembrane transporter activity,MF,
4956,GO:0015087,1,0.96732120893744,0,1,cobalt ion transmembrane transporter activity,MF,
4959,GO:0015094,1,0.96732120893744,0,1,lead ion transmembrane transporter activity,MF,
4961,GO:0015098,1,0.972058556520553,0,1,molybdate ion transmembrane transporter activity,MF,
4962,GO:0015101,1,0.608444935699228,0,16,organic cation transmembrane transporter activity,MF,
4964,GO:0015105,1,0.973572586320672,0,1,arsenite transmembrane transporter activity,MF,
4965,GO:0015106,1,0.697222965802006,0,11,bicarbonate transmembrane transporter activity,MF,
4967,GO:0015111,1,0.905348350372831,0,3,iodide transmembrane transporter activity,MF,
4968,GO:0015112,1,0.969881634886428,0,1,nitrate transmembrane transporter activity,MF,
4969,GO:0015114,1,0.797564330959166,0,7,phosphate ion transmembrane transporter activity,MF,
4970,GO:0015116,1,0.827137038345003,0,6,sulfate transmembrane transporter activity,MF,
4971,GO:0015117,1,0.972082371452936,0,1,thiosulfate transmembrane transporter activity,MF,
4972,GO:0015119,1,0.9103716436562,0,3,hexose phosphate transmembrane transporter activity,MF,
4973,GO:0015125,1,0.886478378634662,0,4,bile acid transmembrane transporter activity,MF,
4974,GO:0015127,1,0.966925946302879,0,1,bilirubin transmembrane transporter activity,MF,
4975,GO:0015129,1,0.909885185094254,0,3,lactate transmembrane transporter activity,MF,
4976,GO:0015130,1,0.96734639953885,0,1,mevalonate transmembrane transporter activity,MF,
4977,GO:0015131,1,0.972082371452936,0,1,oxaloacetate transmembrane transporter activity,MF,
4978,GO:0015136,1,0.968388653488249,0,1,sialic acid transmembrane transporter activity,MF,
4979,GO:0015137,1,0.881777035785905,0,4,citrate transmembrane transporter activity,MF,
4980,GO:0015140,1,0.945235369189316,0,2,malate transmembrane transporter activity,MF,
4981,GO:0015141,1,0.910845283713539,0,3,succinate transmembrane transporter activity,MF,
4982,GO:0015142,1,0.881777035785905,0,4,tricarboxylic acid transmembrane transporter activity,MF,
4983,GO:0015143,1,0.972143702897848,0,1,urate transmembrane transporter activity,MF,
4984,GO:0015144,1,0.550803570041165,0,19,carbohydrate transmembrane transporter activity,MF,
4985,GO:0015145,1,0.706919445092897,0,11,monosaccharide transmembrane transporter activity,MF,
4986,GO:0015149,1,0.731183290171981,0,10,hexose transmembrane transporter activity,MF,
4987,GO:0015152,1,0.971458482824321,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
4988,GO:0015154,1,0.93756814857238,0,2,disaccharide transmembrane transporter activity,MF,
4989,GO:0015157,1,0.93756814857238,0,2,oligosaccharide transmembrane transporter activity,MF,
4991,GO:0015166,1,0.880553913634425,0,4,polyol transmembrane transporter activity,MF,
4992,GO:0015168,1,0.942105749239157,0,2,glycerol transmembrane transporter activity,MF,
4994,GO:0015172,1,0.824267780365486,0,6,acidic amino acid transmembrane transporter activity,MF,
4995,GO:0015173,1,0.970397080614669,0,1,aromatic amino acid transmembrane transporter activity,MF,
4996,GO:0015174,1,0.804764537487225,0,7,basic amino acid transmembrane transporter activity,MF,
4999,GO:0015180,1,0.851869496610947,0,5,L-alanine transmembrane transporter activity,MF,
5000,GO:0015181,1,0.856164611330497,0,5,arginine transmembrane transporter activity,MF,
5001,GO:0015182,1,0.969547060048947,0,1,L-asparagine transmembrane transporter activity,MF,
5002,GO:0015183,1,0.908545543075178,0,3,L-aspartate transmembrane transporter activity,MF,
5003,GO:0015184,1,0.935564466370217,0,2,L-cystine transmembrane transporter activity,MF,
5004,GO:0015185,1,0.97177548306784,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
5005,GO:0015186,1,0.881367317770242,0,4,L-glutamine transmembrane transporter activity,MF,
5006,GO:0015187,1,0.855896577980847,0,5,glycine transmembrane transporter activity,MF,
5007,GO:0015189,1,0.856164611330497,0,5,L-lysine transmembrane transporter activity,MF,
5008,GO:0015190,1,0.969547060048947,0,1,L-leucine transmembrane transporter activity,MF,
5009,GO:0015191,1,0.969547060048947,0,1,L-methionine transmembrane transporter activity,MF,
5010,GO:0015193,1,0.849534735170821,0,5,L-proline transmembrane transporter activity,MF,
5011,GO:0015194,1,0.810003342309486,0,7,L-serine transmembrane transporter activity,MF,
5012,GO:0015195,1,0.967225993095157,0,1,L-threonine transmembrane transporter activity,MF,
5013,GO:0015196,1,0.970397080614669,0,1,L-tryptophan transmembrane transporter activity,MF,
5014,GO:0015203,1,0.969271124374127,0,1,polyamine transmembrane transporter activity,MF,
5015,GO:0015204,1,0.911317635223612,0,3,urea transmembrane transporter activity,MF,
5016,GO:0015205,1,0.833480726228816,0,6,nucleobase transmembrane transporter activity,MF,
5017,GO:0015207,1,0.916154620924395,0,3,adenine transmembrane transporter activity,MF,
5018,GO:0015211,1,0.970376972568051,0,1,purine nucleoside transmembrane transporter activity,MF,
5019,GO:0015215,1,0.635424281959667,0,15,nucleotide transmembrane transporter activity,MF,
5020,GO:0015216,1,0.716435716291709,0,11,purine nucleotide transmembrane transporter activity,MF,
5021,GO:0015217,1,0.758942693310757,0,9,ADP transmembrane transporter activity,MF,
5022,GO:0015218,1,0.941097083339995,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5023,GO:0015220,1,0.880307489706829,0,4,choline transmembrane transporter activity,MF,
5024,GO:0015222,1,0.940049656111681,0,2,serotonin transmembrane transporter activity,MF,
5025,GO:0015226,1,0.884581176130178,0,4,carnitine transmembrane transporter activity,MF,
5026,GO:0015227,1,0.943642967376316,0,2,acyl carnitine transmembrane transporter activity,MF,
5027,GO:0015228,1,0.91257815150113,0,3,coenzyme A transmembrane transporter activity,MF,
5028,GO:0015229,1,0.966843581004278,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5029,GO:0015230,1,0.94085890685553,0,2,FAD transmembrane transporter activity,MF,
5030,GO:0015232,1,0.798540125023045,0,7,heme transporter activity,MF,
5031,GO:0015234,1,0.941504613526631,0,2,thiamine transmembrane transporter activity,MF,
5032,GO:0015238,1,0.143245516298208,0,62,drug transmembrane transporter activity,MF,
5033,GO:0015245,1,0.857563818232962,0,5,fatty acid transmembrane transporter activity,MF,
5034,GO:0015247,1,0.904348676639274,0,3,aminophospholipid transmembrane transporter activity,MF,
5035,GO:0015248,1,0.541788231588391,0,20,sterol transporter activity,MF,
5036,GO:0015250,1,0.889254648160024,0,4,water channel activity,MF,
5037,GO:0015252,1,0.968775772037672,0,1,proton channel activity,MF,
5038,GO:0015254,1,0.942105749239157,0,2,glycerol channel activity,MF,
5039,GO:0015265,1,0.968974671709387,0,1,urea channel activity,MF,
5041,GO:0015269,1,0.787657873023527,0,8,calcium-activated potassium channel activity,MF,
5042,GO:0015271,1,0.849197734617183,0,5,outward rectifier potassium channel activity,MF,
5043,GO:0015272,1,0.968854644376369,0,1,ATP-activated inward rectifier potassium channel activity,MF,
5044,GO:0015275,1,0.93716553485425,0,2,stretch-activated, cation-selective, calcium channel activity,MF,
5046,GO:0015278,1,0.635923741873519,0,14,calcium-release channel activity,MF,
5047,GO:0015279,1,0.854621330092129,0,5,store-operated calcium channel activity,MF,
5048,GO:0015280,1,0.907463843850752,0,3,ligand-gated sodium channel activity,MF,
5049,GO:0015288,1,0.8415433945096,0,6,porin activity,MF,
5051,GO:0015292,1,0.969271124374127,0,1,uniporter activity,MF,
5053,GO:0015294,1,0.182617388274619,0,53,solute:cation symporter activity,MF,
5054,GO:0015295,1,0.56913105533809,0,18,solute:proton symporter activity,MF,
5055,GO:0015296,1,0.793096110452938,0,7,anion:cation symporter activity,MF,
5058,GO:0015299,1,0.68061093464077,0,12,solute:proton antiporter activity,MF,
5059,GO:0015301,1,0.565289219301959,0,18,anion:anion antiporter activity,MF,
5060,GO:0015307,1,0.942268568895214,0,2,drug:proton antiporter activity,MF,
5061,GO:0015315,1,0.9103716436562,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5062,GO:0015317,1,0.972638415697209,0,1,phosphate:proton symporter activity,MF,
5064,GO:0015319,1,0.937316077260095,0,2,sodium:inorganic phosphate symporter activity,MF,
5065,GO:0015321,1,0.937316077260095,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
5066,GO:0015322,1,0.968720981009603,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5067,GO:0015327,1,0.966777525645021,0,1,cystine:glutamate antiporter activity,MF,
5068,GO:0015328,1,0.966777525645021,0,1,cystine secondary active transmembrane transporter activity,MF,
5069,GO:0015333,1,0.908081059925339,0,3,peptide:proton symporter activity,MF,
5070,GO:0015347,1,0.774487532511282,0,8,sodium-independent organic anion transmembrane transporter activity,MF,
5071,GO:0015349,1,0.937718849739727,0,2,thyroid hormone transmembrane transporter activity,MF,
5072,GO:0015350,1,0.937266646822699,0,2,methotrexate transmembrane transporter activity,MF,
5073,GO:0015355,1,0.889816143543419,0,4,secondary active monocarboxylate transmembrane transporter activity,MF,
5074,GO:0015362,1,0.967412496802885,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5075,GO:0015367,1,0.972384086535643,0,1,oxoglutarate:malate antiporter activity,MF,
5077,GO:0015369,1,0.966885193789385,0,1,calcium:proton antiporter activity,MF,
5078,GO:0015370,1,0.367889777837161,0,31,solute:sodium symporter activity,MF,
5079,GO:0015373,1,0.935869198489444,0,2,anion:sodium symporter activity,MF,
5080,GO:0015375,1,0.968570346802033,0,1,glycine:sodium symporter activity,MF,
5081,GO:0015377,1,0.819359038192958,0,6,cation:chloride symporter activity,MF,
5082,GO:0015378,1,0.966845721295149,0,1,sodium:chloride symporter activity,MF,
5083,GO:0015379,1,0.819359038192958,0,6,potassium:chloride symporter activity,MF,
5084,GO:0015385,1,0.771166729136572,0,8,sodium:proton antiporter activity,MF,
5085,GO:0015386,1,0.79563062973278,0,7,potassium:proton antiporter activity,MF,
5086,GO:0015389,1,0.97111696085987,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5087,GO:0015390,1,0.97111696085987,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5088,GO:0015391,1,0.97111696085987,0,1,nucleobase:cation symporter activity,MF,
5089,GO:0015399,1,0.101459109752049,0,73,primary active transmembrane transporter activity,MF,
5090,GO:0015405,1,0.101459109752049,0,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5091,GO:0015410,1,0.906957002995449,0,3,manganese-transporting ATPase activity,MF,
5092,GO:0015420,1,0.966857836354105,0,1,cobalamin-transporting ATPase activity,MF,
5093,GO:0015421,1,0.968035620527968,0,1,oligopeptide-transporting ATPase activity,MF,
5094,GO:0015431,1,0.966857836354105,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5095,GO:0015432,1,0.968028934220319,0,1,bile acid-exporting ATPase activity,MF,
5096,GO:0015433,1,0.936565418409099,0,2,peptide antigen-transporting ATPase activity,MF,
5097,GO:0015439,1,0.969054250352015,0,1,heme-transporting ATPase activity,MF,
5098,GO:0015440,1,0.878619251538425,0,4,peptide-transporting ATPase activity,MF,
5099,GO:0015450,1,0.823155247077654,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5101,GO:0015464,1,0.806465696806886,0,7,acetylcholine receptor activity,MF,
5102,GO:0015467,1,0.939546912945185,0,2,G-protein activated inward rectifier potassium channel activity,MF,
5103,GO:0015485,1,0.396315393583296,0,30,cholesterol binding,MF,
5104,GO:0015489,1,0.969271124374127,0,1,putrescine transmembrane transporter activity,MF,
5106,GO:0015499,1,0.969874856147979,0,1,formate transmembrane transporter activity,MF,
5107,GO:0015501,1,0.938444775986306,0,2,glutamate:sodium symporter activity,MF,
5108,GO:0015526,1,0.9103716436562,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5109,GO:0015538,1,0.968388653488249,0,1,sialic acid:proton symporter activity,MF,
5110,GO:0015556,1,0.80465958488097,0,7,C4-dicarboxylate transmembrane transporter activity,MF,
5111,GO:0015562,1,0.879928613750317,0,4,efflux transmembrane transporter activity,MF,
5112,GO:0015578,1,0.970437389339457,0,1,mannose transmembrane transporter activity,MF,
5113,GO:0015605,1,0.523000662749984,0,21,organophosphate ester transmembrane transporter activity,MF,
5114,GO:0015616,1,0.875987525666619,0,4,DNA translocase activity,MF,
5118,GO:0015643,1,0.809182354801595,0,7,toxic substance binding,MF,
5119,GO:0015645,1,0.729483328039729,0,10,fatty acid ligase activity,MF,
5120,GO:0015651,1,0.830196904994675,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5121,GO:0015658,1,0.969547060048947,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5122,GO:0015660,1,0.969874856147979,0,1,formate efflux transmembrane transporter activity,MF,
5123,GO:0015662,1,0.497141225750714,0,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5124,GO:0015669,1,0.917659294926989,0,3,gas transport,BP,
5125,GO:0015670,1,0.972676700292057,0,1,carbon dioxide transport,BP,
5126,GO:0015671,1,0.943441290414459,0,2,oxygen transport,BP,
5129,GO:0015679,1,0.934896124776584,0,2,plasma membrane copper ion transport,BP,
5130,GO:0015680,1,0.918272516990621,0,3,intracellular copper ion transport,BP,
5133,GO:0015688,1,0.946445992235584,0,2,iron chelate transport,BP,
5134,GO:0015689,1,0.972058556520553,0,1,molybdate ion transport,BP,
5135,GO:0015691,1,0.910395501308696,0,3,cadmium ion transport,BP,
5136,GO:0015692,1,0.96732120893744,0,1,lead ion transport,BP,
5138,GO:0015694,1,0.966925946302879,0,1,mercury ion transport,BP,
5139,GO:0015695,1,0.444448533774855,0,26,organic cation transport,BP,
5141,GO:0015697,1,0.753983531049339,0,9,quaternary ammonium group transport,BP,
5143,GO:0015700,1,0.973572586320672,0,1,arsenite transport,BP,
5144,GO:0015701,1,0.546193258867734,0,19,bicarbonate transport,BP,
5145,GO:0015705,1,0.875281448079633,0,4,iodide transport,BP,
5146,GO:0015706,1,0.969881634886428,0,1,nitrate transport,BP,
5147,GO:0015709,1,0.972082371452936,0,1,thiosulfate transport,BP,
5149,GO:0015712,1,0.885562225548606,0,4,hexose phosphate transport,BP,
5151,GO:0015721,1,0.667495880257352,0,13,bile acid and bile salt transport,BP,
5152,GO:0015722,1,0.906964321579941,0,3,canalicular bile acid transport,BP,
5153,GO:0015723,1,0.966925946302879,0,1,bilirubin transport,BP,
5154,GO:0015724,1,0.969874856147979,0,1,formate transport,BP,
5155,GO:0015727,1,0.880053105287271,0,4,lactate transport,BP,
5156,GO:0015728,1,0.96734639953885,0,1,mevalonate transport,BP,
5157,GO:0015729,1,0.972082371452936,0,1,oxaloacetate transport,BP,
5159,GO:0015734,1,0.966855179735506,0,1,taurine transport,BP,
5160,GO:0015739,1,0.968388653488249,0,1,sialic acid transport,BP,
5161,GO:0015740,1,0.749142318134916,0,9,C4-dicarboxylate transport,BP,
5162,GO:0015742,1,0.972384086535643,0,1,alpha-ketoglutarate transport,BP,
5163,GO:0015743,1,0.972082371452936,0,1,malate transport,BP,
5164,GO:0015744,1,0.910845283713539,0,3,succinate transport,BP,
5165,GO:0015746,1,0.881777035785905,0,4,citrate transport,BP,
5166,GO:0015747,1,0.972143702897848,0,1,urate transport,BP,
5167,GO:0015748,1,0.123897153423547,0,67,organophosphate ester transport,BP,
5169,GO:0015760,1,0.885562225548606,0,4,glucose-6-phosphate transport,BP,
5170,GO:0015761,1,0.970437389339457,0,1,mannose transmembrane transport,BP,
5171,GO:0015766,1,0.93756814857238,0,2,disaccharide transport,BP,
5172,GO:0015770,1,0.93756814857238,0,2,sucrose transport,BP,
5173,GO:0015772,1,0.93756814857238,0,2,oligosaccharide transport,BP,
5175,GO:0015782,1,0.972292210507128,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5176,GO:0015783,1,0.936473484045029,0,2,GDP-fucose transmembrane transport,BP,
5177,GO:0015786,1,0.970978287439281,0,1,UDP-glucose transmembrane transport,BP,
5178,GO:0015787,1,0.966856339508971,0,1,UDP-glucuronic acid transmembrane transport,BP,
5179,GO:0015790,1,0.966847304086337,0,1,UDP-xylose transmembrane transport,BP,
5180,GO:0015791,1,0.825604054428543,0,6,polyol transport,BP,
5181,GO:0015793,1,0.942105749239157,0,2,glycerol transport,BP,
5182,GO:0015797,1,0.969874856147979,0,1,mannitol transport,BP,
5183,GO:0015798,1,0.903586039052853,0,3,myo-inositol transport,BP,
5184,GO:0015800,1,0.371774303024509,0,31,acidic amino acid transport,BP,
5185,GO:0015801,1,0.94224938104642,0,2,aromatic amino acid transport,BP,
5187,GO:0015803,1,0.910532934578354,0,3,branched-chain amino acid transport,BP,
5189,GO:0015805,1,0.971102205280444,0,1,S-adenosyl-L-methionine transport,BP,
5191,GO:0015808,1,0.851869496610947,0,5,L-alanine transport,BP,
5193,GO:0015810,1,0.937087614690383,0,2,aspartate transmembrane transport,BP,
5194,GO:0015811,1,0.935564466370217,0,2,L-cystine transport,BP,
5195,GO:0015812,1,0.821668040529056,0,6,gamma-aminobutyric acid transport,BP,
5196,GO:0015813,1,0.662626699656587,0,13,L-glutamate transmembrane transport,BP,
5197,GO:0015816,1,0.82754657575209,0,6,glycine transport,BP,
5198,GO:0015817,1,0.969516579258239,0,1,histidine transport,BP,
5199,GO:0015819,1,0.972087965538841,0,1,lysine transport,BP,
5200,GO:0015820,1,0.939137269106888,0,2,leucine transport,BP,
5201,GO:0015821,1,0.969547060048947,0,1,methionine transport,BP,
5202,GO:0015822,1,0.877818057632956,0,4,ornithine transport,BP,
5203,GO:0015824,1,0.821651192036263,0,6,proline transport,BP,
5204,GO:0015825,1,0.810003342309486,0,7,L-serine transport,BP,
5205,GO:0015826,1,0.967225993095157,0,1,threonine transport,BP,
5206,GO:0015827,1,0.94224938104642,0,2,tryptophan transport,BP,
5209,GO:0015838,1,0.803388676460651,0,7,amino-acid betaine transport,BP,
5210,GO:0015840,1,0.911317635223612,0,3,urea transport,BP,
5211,GO:0015842,1,0.944857528127199,0,2,aminergic neurotransmitter loading into synaptic vesicle,BP,
5213,GO:0015846,1,0.833583290585921,0,6,polyamine transport,BP,
5214,GO:0015847,1,0.969271124374127,0,1,putrescine transport,BP,
5217,GO:0015851,1,0.811164870926563,0,7,nucleobase transport,BP,
5218,GO:0015853,1,0.891631511231981,0,4,adenine transport,BP,
5219,GO:0015855,1,0.940985355629703,0,2,pyrimidine nucleobase transport,BP,
5220,GO:0015858,1,0.860314201004795,0,5,nucleoside transport,BP,
5221,GO:0015860,1,0.942347258191155,0,2,purine nucleoside transmembrane transport,BP,
5222,GO:0015862,1,0.970798704413823,0,1,uridine transport,BP,
5223,GO:0015864,1,0.942756840571514,0,2,pyrimidine nucleoside transport,BP,
5224,GO:0015865,1,0.694030804381,0,12,purine nucleotide transport,BP,
5225,GO:0015866,1,0.758942693310757,0,9,ADP transport,BP,
5226,GO:0015867,1,0.757829215144442,0,9,ATP transport,BP,
5227,GO:0015868,1,0.694030804381,0,12,purine ribonucleotide transport,BP,
5228,GO:0015871,1,0.822930879426429,0,6,choline transport,BP,
5230,GO:0015874,1,0.852549310476057,0,5,norepinephrine transport,BP,
5231,GO:0015876,1,0.969862672246662,0,1,acetyl-CoA transport,BP,
5232,GO:0015878,1,0.968414436874247,0,1,biotin transport,BP,
5233,GO:0015879,1,0.859312543088577,0,5,carnitine transport,BP,
5234,GO:0015880,1,0.91257815150113,0,3,coenzyme A transport,BP,
5235,GO:0015881,1,0.968025230469269,0,1,creatine transmembrane transport,BP,
5236,GO:0015882,1,0.966843581004278,0,1,L-ascorbic acid transmembrane transport,BP,
5237,GO:0015884,1,0.856522807607738,0,5,folic acid transport,BP,
5238,GO:0015886,1,0.798540125023045,0,7,heme transport,BP,
5239,GO:0015887,1,0.968414436874247,0,1,pantothenate transmembrane transport,BP,
5240,GO:0015888,1,0.938144750146799,0,2,thiamine transport,BP,
5241,GO:0015889,1,0.89018686745658,0,4,cobalamin transport,BP,
5242,GO:0015891,1,0.946445992235584,0,2,siderophore transport,BP,
5244,GO:0015904,1,0.972156191513383,0,1,tetracycline transport,BP,
5247,GO:0015910,1,0.939667515556564,0,2,peroxisomal long-chain fatty acid import,BP,
5248,GO:0015911,1,0.850446643855322,0,5,plasma membrane long-chain fatty acid transport,BP,
5249,GO:0015914,1,0.227888700946174,0,47,phospholipid transport,BP,
5250,GO:0015916,1,0.969862672246662,0,1,fatty-acyl-CoA transport,BP,
5251,GO:0015917,1,0.874346951679101,0,4,aminophospholipid transport,BP,
5253,GO:0015919,1,0.605967759480522,0,16,peroxisomal membrane transport,BP,
5254,GO:0015920,1,0.969798087908722,0,1,lipopolysaccharide transport,BP,
5255,GO:0015923,1,0.634316830241972,0,14,mannosidase activity,MF,
5256,GO:0015924,1,0.746663041051583,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5257,GO:0015925,1,0.83266572670911,0,6,galactosidase activity,MF,
5258,GO:0015926,1,0.794579359405635,0,7,glucosidase activity,MF,
5259,GO:0015928,1,0.943729372096556,0,2,fucosidase activity,MF,
5260,GO:0015929,1,0.694534273794153,0,12,hexosaminidase activity,MF,
5265,GO:0015936,1,0.637500508115355,0,15,coenzyme A metabolic process,BP,
5266,GO:0015937,1,0.746528539942101,0,10,coenzyme A biosynthetic process,BP,
5267,GO:0015938,1,0.974119343852336,0,1,coenzyme A catabolic process,BP,
5268,GO:0015939,1,0.859261197924889,0,5,pantothenate metabolic process,BP,
5269,GO:0015942,1,0.913570295930369,0,3,formate metabolic process,BP,
5271,GO:0015950,1,0.972104725895455,0,1,purine nucleotide interconversion,BP,
5272,GO:0015951,1,0.972104725895455,0,1,purine ribonucleotide interconversion,BP,
5273,GO:0015959,1,0.809347468360268,0,7,diadenosine polyphosphate metabolic process,BP,
5274,GO:0015960,1,0.911577960910689,0,3,diadenosine polyphosphate biosynthetic process,BP,
5275,GO:0015961,1,0.887880067864205,0,4,diadenosine polyphosphate catabolic process,BP,
5276,GO:0015965,1,0.911577960910689,0,3,diadenosine tetraphosphate metabolic process,BP,
5277,GO:0015966,1,0.911577960910689,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5279,GO:0015985,1,0.791108245644968,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5280,GO:0015986,1,0.791108245644968,0,8,ATP synthesis coupled proton transport,BP,
5281,GO:0015988,1,0.537351423182916,0,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5282,GO:0015990,1,0.974526123860549,0,1,electron transport coupled proton transport,BP,
5283,GO:0015991,1,0.551420965792171,0,20,ATP hydrolysis coupled proton transport,BP,
5284,GO:0016004,1,0.782595148352653,0,8,phospholipase activator activity,MF,
5285,GO:0016005,1,0.937990331708285,0,2,phospholipase A2 activator activity,MF,
5287,GO:0016011,1,0.90953304242671,0,3,dystroglycan complex,CC,
5288,GO:0016012,1,0.940697495758499,0,2,sarcoglycan complex,CC,
5289,GO:0016013,1,0.938563470653249,0,2,syntrophin complex,CC,
5290,GO:0016015,1,0.94496006047619,0,2,morphogen activity,MF,
5292,GO:0016019,1,0.973797167582431,0,1,peptidoglycan receptor activity,MF,
5295,GO:0016024,1,0.661113837972237,0,13,CDP-diacylglycerol biosynthetic process,BP,
5296,GO:0016031,1,0.96827818880457,0,1,tRNA import into mitochondrion,BP,
5298,GO:0016034,1,0.97345407233384,0,1,maleylacetoacetate isomerase activity,MF,
5299,GO:0016035,1,0.94148969788727,0,2,zeta DNA polymerase complex,CC,
5300,GO:0016036,1,0.970979761919229,0,1,cellular response to phosphate starvation,BP,
5303,GO:0016045,1,0.825097298574631,0,6,detection of bacterium,BP,
5304,GO:0016048,1,0.805816862795559,0,7,detection of temperature stimulus,BP,
5312,GO:0016056,1,0.662744245848799,0,13,rhodopsin mediated signaling pathway,BP,
5313,GO:0016062,1,0.970121619109262,0,1,adaptation of rhodopsin mediated signaling,BP,
5319,GO:0016074,1,0.716745542507116,0,12,snoRNA metabolic process,BP,
5320,GO:0016075,1,0.644606269617181,0,15,rRNA catabolic process,BP,
5321,GO:0016077,1,0.966867738967312,0,1,snoRNA catabolic process,BP,
5322,GO:0016078,1,0.843292671884721,0,6,tRNA catabolic process,BP,
5324,GO:0016080,1,0.904984132794417,0,3,synaptic vesicle targeting,BP,
5325,GO:0016081,1,0.825030485774826,0,6,synaptic vesicle docking,BP,
5326,GO:0016082,1,0.704562274572845,0,11,synaptic vesicle priming,BP,
5329,GO:0016095,1,0.969862672246662,0,1,polyprenol catabolic process,BP,
5332,GO:0016103,1,0.96709745784248,0,1,diterpenoid catabolic process,BP,
5334,GO:0016115,1,0.96709745784248,0,1,terpenoid catabolic process,BP,
5337,GO:0016127,1,0.86105764354395,0,5,sterol catabolic process,BP,
5338,GO:0016128,1,0.915203682193559,0,3,phytosteroid metabolic process,BP,
5339,GO:0016129,1,0.915203682193559,0,3,phytosteroid biosynthetic process,BP,
5340,GO:0016131,1,0.969874856147979,0,1,brassinosteroid metabolic process,BP,
5341,GO:0016132,1,0.969874856147979,0,1,brassinosteroid biosynthetic process,BP,
5342,GO:0016137,1,0.683881596828004,0,13,glycoside metabolic process,BP,
5343,GO:0016139,1,0.809905360885652,0,7,glycoside catabolic process,BP,
5344,GO:0016149,1,0.967819551738724,0,1,translation release factor activity, codon specific,MF,
5345,GO:0016150,1,0.972799869871682,0,1,translation release factor activity, codon nonspecific,MF,
5346,GO:0016154,1,0.972694472677962,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5347,GO:0016155,1,0.936585065490026,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5348,GO:0016160,1,0.971232014228794,0,1,amylase activity,MF,
5349,GO:0016165,1,0.941526788461307,0,2,linoleate 13S-lipoxygenase activity,MF,
5350,GO:0016174,1,0.88154297273847,0,4,NAD(P)H oxidase activity,MF,
5351,GO:0016175,1,0.946222836964354,0,2,superoxide-generating NADPH oxidase activity,MF,
5352,GO:0016176,1,0.879494590049376,0,4,superoxide-generating NADPH oxidase activator activity,MF,
5353,GO:0016180,1,0.516259511260118,0,22,snRNA processing,BP,
5354,GO:0016182,1,0.966983061299026,0,1,synaptic vesicle budding from endosome,BP,
5355,GO:0016185,1,0.878446676002993,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5356,GO:0016188,1,0.853174120901998,0,5,synaptic vesicle maturation,BP,
5357,GO:0016189,1,0.966816954594848,0,1,synaptic vesicle to endosome fusion,BP,
5358,GO:0016191,1,0.87732449164173,0,4,synaptic vesicle uncoating,BP,
5361,GO:0016198,1,0.847681555969221,0,5,axon choice point recognition,BP,
5362,GO:0016199,1,0.87519345239816,0,4,axon midline choice point recognition,BP,
5364,GO:0016206,1,0.940783184811801,0,2,catechol O-methyltransferase activity,MF,
5365,GO:0016208,1,0.76429960517508,0,9,AMP binding,MF,
5367,GO:0016211,1,0.967187319288456,0,1,ammonia ligase activity,MF,
5368,GO:0016212,1,0.942410042115287,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5369,GO:0016213,1,0.968694967567319,0,1,linoleoyl-CoA desaturase activity,MF,
5370,GO:0016215,1,0.908560653455886,0,3,acyl-CoA desaturase activity,MF,
5371,GO:0016222,1,0.940348441535992,0,2,procollagen-proline 4-dioxygenase complex,CC,
5372,GO:0016226,1,0.563109913921916,0,20,iron-sulfur cluster assembly,BP,
5373,GO:0016229,1,0.582915736048537,0,19,steroid dehydrogenase activity,MF,
5374,GO:0016230,1,0.942184002828589,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5375,GO:0016231,1,0.966917221267379,0,1,beta-N-acetylglucosaminidase activity,MF,
5376,GO:0016232,1,0.969456266370381,0,1,HNK-1 sulfotransferase activity,MF,
5379,GO:0016235,1,0.338677122745028,0,34,aggresome,CC,
5381,GO:0016237,1,0.966945498521195,0,1,lysosomal microautophagy,BP,
5383,GO:0016240,1,0.883423047865682,0,4,autophagosome membrane docking,BP,
5386,GO:0016243,1,0.967466877993906,0,1,regulation of autophagosome size,BP,
5387,GO:0016246,1,0.630650808275718,0,15,RNA interference,BP,
5390,GO:0016250,1,0.9695751854904,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5391,GO:0016254,1,0.606062883653387,0,17,preassembly of GPI anchor in ER membrane,BP,
5392,GO:0016255,1,0.808915556099343,0,7,attachment of GPI anchor to protein,BP,
5394,GO:0016259,1,0.885231564158037,0,4,selenocysteine metabolic process,BP,
5395,GO:0016260,1,0.941892974386419,0,2,selenocysteine biosynthetic process,BP,
5396,GO:0016262,1,0.911051948405214,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5397,GO:0016263,1,0.945037306699468,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5398,GO:0016264,1,0.799687263714039,0,7,gap junction assembly,BP,
5400,GO:0016267,1,0.945037306699468,0,2,O-glycan processing, core 1,BP,
5401,GO:0016269,1,0.970328274139344,0,1,O-glycan processing, core 3,BP,
5402,GO:0016272,1,0.831168783925356,0,7,prefoldin complex,CC,
5403,GO:0016273,1,0.717961384800343,0,11,arginine N-methyltransferase activity,MF,
5404,GO:0016274,1,0.717961384800343,0,11,protein-arginine N-methyltransferase activity,MF,
5405,GO:0016277,1,0.970585167270237,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5406,GO:0016278,1,0.220332604953272,0,48,lysine N-methyltransferase activity,MF,
5407,GO:0016279,1,0.227346667116289,0,47,protein-lysine N-methyltransferase activity,MF,
5409,GO:0016282,1,0.967114883918046,0,1,eukaryotic 43S preinitiation complex,CC,
5410,GO:0016286,1,0.942202602523105,0,2,small conductance calcium-activated potassium channel activity,MF,
5411,GO:0016287,1,0.969782048895766,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5412,GO:0016289,1,0.667539883090949,0,14,CoA hydrolase activity,MF,
5413,GO:0016290,1,0.797186810095434,0,8,palmitoyl-CoA hydrolase activity,MF,
5414,GO:0016295,1,0.940160547185331,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5415,GO:0016296,1,0.940160547185331,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5416,GO:0016297,1,0.940160547185331,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5421,GO:0016307,1,0.636348603129975,0,14,phosphatidylinositol phosphate kinase activity,MF,
5422,GO:0016308,1,0.823992196642556,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5423,GO:0016309,1,0.906353783059965,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5426,GO:0016312,1,0.880091679071052,0,4,inositol bisphosphate phosphatase activity,MF,
5427,GO:0016314,1,0.934948271170153,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5428,GO:0016316,1,0.935315528921695,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5429,GO:0016320,1,0.941286296405893,0,2,endoplasmic reticulum membrane fusion,BP,
5430,GO:0016321,1,0.913241291638408,0,3,female meiosis chromosome segregation,BP,
5431,GO:0016322,1,0.823671451836662,0,6,neuron remodeling,BP,
5437,GO:0016332,1,0.967561061661216,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5438,GO:0016333,1,0.969157573015551,0,1,morphogenesis of follicular epithelium,BP,
5439,GO:0016334,1,0.969157573015551,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5442,GO:0016340,1,0.934807578652118,0,2,calcium-dependent cell-matrix adhesion,BP,
5443,GO:0016342,1,0.633955236534393,0,14,catenin complex,CC,
5444,GO:0016344,1,0.938228146969502,0,2,meiotic chromosome movement towards spindle pole,BP,
5446,GO:0016361,1,0.942333585015431,0,2,activin receptor activity, type I,MF,
5447,GO:0016362,1,0.934563773512821,0,2,activin receptor activity, type II,MF,
5449,GO:0016401,1,0.940009347636893,0,2,palmitoyl-CoA oxidase activity,MF,
5450,GO:0016402,1,0.969368681433598,0,1,pristanoyl-CoA oxidase activity,MF,
5451,GO:0016403,1,0.941797240188088,0,2,dimethylargininase activity,MF,
5452,GO:0016404,1,0.967125519838616,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5453,GO:0016405,1,0.642772001544398,0,14,CoA-ligase activity,MF,
5454,GO:0016406,1,0.827465100266656,0,6,carnitine O-acyltransferase activity,MF,
5456,GO:0016408,1,0.679787057973813,0,13,C-acyltransferase activity,MF,
5459,GO:0016411,1,0.484461740892875,0,23,acylglycerol O-acyltransferase activity,MF,
5460,GO:0016413,1,0.827125567473305,0,6,O-acetyltransferase activity,MF,
5461,GO:0016414,1,0.96851016029557,0,1,O-octanoyltransferase activity,MF,
5462,GO:0016415,1,0.96851016029557,0,1,octanoyltransferase activity,MF,
5463,GO:0016416,1,0.881324291797651,0,4,O-palmitoyltransferase activity,MF,
5465,GO:0016418,1,0.93508624573933,0,2,S-acetyltransferase activity,MF,
5466,GO:0016419,1,0.939652377887213,0,2,S-malonyltransferase activity,MF,
5467,GO:0016420,1,0.939652377887213,0,2,malonyltransferase activity,MF,
5468,GO:0016421,1,0.827978865739538,0,6,CoA carboxylase activity,MF,
5469,GO:0016422,1,0.915115243204801,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5470,GO:0016423,1,0.67314153723492,0,13,tRNA (guanine) methyltransferase activity,MF,
5471,GO:0016426,1,0.88462886816689,0,4,tRNA (adenine) methyltransferase activity,MF,
5473,GO:0016428,1,0.884771162702702,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5474,GO:0016429,1,0.912681455970233,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5475,GO:0016430,1,0.969271124374127,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5476,GO:0016433,1,0.838069864551707,0,6,rRNA (adenine) methyltransferase activity,MF,
5477,GO:0016434,1,0.909051454178093,0,3,rRNA (cytosine) methyltransferase activity,MF,
5478,GO:0016435,1,0.887108108544614,0,4,rRNA (guanine) methyltransferase activity,MF,
5479,GO:0016436,1,0.937917352852676,0,2,rRNA (uridine) methyltransferase activity,MF,
5484,GO:0016446,1,0.64840534258798,0,14,somatic hypermutation of immunoglobulin genes,BP,
5486,GO:0016453,1,0.890877849799757,0,4,C-acetyltransferase activity,MF,
5487,GO:0016454,1,0.854388019657728,0,5,C-palmitoyltransferase activity,MF,
5491,GO:0016461,1,0.807371108901614,0,7,unconventional myosin complex,CC,
5493,GO:0016469,1,0.498374639524882,0,24,proton-transporting two-sector ATPase complex,CC,
5494,GO:0016471,1,0.720649394970079,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5495,GO:0016476,1,0.909266467953696,0,3,regulation of embryonic cell shape,BP,
5497,GO:0016479,1,0.912690999153851,0,3,negative regulation of transcription by RNA polymerase I,BP,
5498,GO:0016480,1,0.918983275729952,0,3,negative regulation of transcription by RNA polymerase III,BP,
5499,GO:0016482,1,0.0156619105693825,0,131,cytosolic transport,BP,
5503,GO:0016492,1,0.967355834076593,0,1,G-protein coupled neurotensin receptor activity,MF,
5504,GO:0016493,1,0.940691070699654,0,2,C-C chemokine receptor activity,MF,
5506,GO:0016500,1,0.794628330394584,0,7,protein-hormone receptor activity,MF,
5507,GO:0016502,1,0.83533099857749,0,6,nucleotide receptor activity,MF,
5508,GO:0016503,1,0.973521226896569,0,1,pheromone receptor activity,MF,
5509,GO:0016504,1,0.368523551445524,0,33,peptidase activator activity,MF,
5510,GO:0016505,1,0.613502618890842,0,16,peptidase activator activity involved in apoptotic process,MF,
5511,GO:0016507,1,0.968911946648075,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5512,GO:0016508,1,0.909142182781922,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5513,GO:0016509,1,0.912939359957082,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5514,GO:0016514,1,0.661834128125201,0,13,SWI/SNF complex,CC,
5515,GO:0016517,1,0.97180856151349,0,1,interleukin-12 receptor activity,MF,
5516,GO:0016519,1,0.971674325577539,0,1,gastric inhibitory peptide receptor activity,MF,
5517,GO:0016520,1,0.967066158349568,0,1,growth hormone-releasing hormone receptor activity,MF,
5518,GO:0016524,1,0.939484005877423,0,2,latrotoxin receptor activity,MF,
5522,GO:0016530,1,0.843397752788759,0,6,metallochaperone activity,MF,
5523,GO:0016531,1,0.872336453508997,0,5,copper chaperone activity,MF,
5524,GO:0016532,1,0.917499658752713,0,3,superoxide dismutase copper chaperone activity,MF,
5525,GO:0016533,1,0.942320315440115,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5526,GO:0016534,1,0.967627284050277,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
5529,GO:0016553,1,0.690322349096285,0,12,base conversion or substitution editing,BP,
5530,GO:0016554,1,0.812816605825108,0,7,cytidine to uridine editing,BP,
5531,GO:0016556,1,0.638960546882194,0,15,mRNA modification,BP,
5532,GO:0016557,1,0.917937979520173,0,3,peroxisome membrane biogenesis,BP,
5533,GO:0016558,1,0.690053121268745,0,12,protein import into peroxisome matrix,BP,
5534,GO:0016559,1,0.817835589810316,0,7,peroxisome fission,BP,
5535,GO:0016560,1,0.881342792991229,0,4,protein import into peroxisome matrix, docking,BP,
5536,GO:0016561,1,0.940945440403307,0,2,protein import into peroxisome matrix, translocation,BP,
5546,GO:0016577,1,0.409649249228514,0,27,histone demethylation,BP,
5550,GO:0016581,1,0.618089513020772,0,15,NuRD complex,CC,
5551,GO:0016584,1,0.814013900640636,0,7,nucleosome positioning,BP,
5552,GO:0016586,1,0.935034503391646,0,2,RSC-type complex,CC,
5553,GO:0016589,1,0.801769218543218,0,7,NURF complex,CC,
5554,GO:0016590,1,0.966868782991402,0,1,ACF complex,CC,
5558,GO:0016594,1,0.855298336095428,0,5,glycine binding,MF,
5559,GO:0016595,1,0.824090934350641,0,6,glutamate binding,MF,
5560,GO:0016596,1,0.969271124374127,0,1,thienylcyclohexylpiperidine binding,MF,
5561,GO:0016597,1,0.349439646433488,0,34,amino acid binding,MF,
5562,GO:0016598,1,0.944177200658591,0,2,protein arginylation,BP,
5564,GO:0016601,1,0.338990153726266,0,34,Rac protein signal transduction,BP,
5565,GO:0016602,1,0.885630776333026,0,4,CCAAT-binding factor complex,CC,
5566,GO:0016603,1,0.944661716168537,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5571,GO:0016615,1,0.837462468334031,0,6,malate dehydrogenase activity,MF,
5573,GO:0016618,1,0.914981292865502,0,3,hydroxypyruvate reductase activity,MF,
5574,GO:0016620,1,0.428970041976082,0,27,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5575,GO:0016623,1,0.966948773059237,0,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5576,GO:0016624,1,0.782982433090915,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5578,GO:0016628,1,0.539228946664708,0,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5579,GO:0016634,1,0.833762166773104,0,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5580,GO:0016635,1,0.840179819990194,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5582,GO:0016639,1,0.968114720786149,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5584,GO:0016642,1,0.96765332017958,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5585,GO:0016645,1,0.545480900529443,0,20,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5586,GO:0016646,1,0.6323834264696,0,15,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5587,GO:0016647,1,0.944936117319735,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5588,GO:0016649,1,0.940175081930333,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5590,GO:0016652,1,0.967033443876448,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5591,GO:0016653,1,0.689701862572306,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5592,GO:0016655,1,0.267578369370771,0,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5593,GO:0016657,1,0.972104725895455,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5594,GO:0016661,1,0.858418362175639,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5595,GO:0016662,1,0.970021395609411,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5598,GO:0016670,1,0.800998254551353,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5600,GO:0016672,1,0.948318883858509,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5601,GO:0016675,1,0.602046691868373,0,19,oxidoreductase activity, acting on a heme group of donors,MF,
5602,GO:0016676,1,0.620510465344636,0,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5604,GO:0016681,1,0.824076565187867,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5606,GO:0016701,1,0.659181218679709,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5607,GO:0016702,1,0.659181218679709,0,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5610,GO:0016708,1,0.943028037613283,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
5614,GO:0016714,1,0.91911028582746,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5615,GO:0016715,1,0.937694042715049,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
5621,GO:0016725,1,0.847878923526376,0,5,oxidoreductase activity, acting on CH or CH2 groups,MF,
5622,GO:0016726,1,0.934915758662178,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
5623,GO:0016727,1,0.966875058564527,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
5624,GO:0016728,1,0.906920395232214,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
5625,GO:0016730,1,0.972059959176842,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5626,GO:0016731,1,0.972059959176842,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
5629,GO:0016742,1,0.804875348975377,0,7,hydroxymethyl-, formyl- and related transferase activity,MF,
5630,GO:0016743,1,0.934809445040325,0,2,carboxyl- or carbamoyltransferase activity,MF,
5631,GO:0016744,1,0.945852702443646,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
5634,GO:0016748,1,0.94103552481843,0,2,succinyltransferase activity,MF,
5635,GO:0016749,1,0.970775214183799,0,1,N-succinyltransferase activity,MF,
5636,GO:0016751,1,0.969367461718085,0,1,S-succinyltransferase activity,MF,
5637,GO:0016755,1,0.762890263884103,0,9,transferase activity, transferring amino-acyl groups,MF,
5642,GO:0016768,1,0.972612739467351,0,1,spermine synthase activity,MF,
5647,GO:0016775,1,0.867103968232584,0,5,phosphotransferase activity, nitrogenous group as acceptor,MF,
5649,GO:0016778,1,0.889190209915898,0,4,diphosphotransferase activity,MF,
5652,GO:0016781,1,0.941892974386419,0,2,phosphotransferase activity, paired acceptors,MF,
5655,GO:0016784,1,0.973146913806439,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
5656,GO:0016785,1,0.966877820593443,0,1,transferase activity, transferring selenium-containing groups,MF,
5659,GO:0016790,1,0.42682400377226,0,29,thiolester hydrolase activity,MF,
5661,GO:0016793,1,0.968608679122219,0,1,triphosphoric monoester hydrolase activity,MF,
5662,GO:0016794,1,0.97406006704497,0,1,diphosphoric monoester hydrolase activity,MF,
5665,GO:0016799,1,0.559590169139646,0,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
5666,GO:0016801,1,0.677975519661753,0,13,hydrolase activity, acting on ether bonds,MF,
5667,GO:0016802,1,0.908229462717815,0,3,trialkylsulfonium hydrolase activity,MF,
5668,GO:0016803,1,0.746538022940789,0,10,ether hydrolase activity,MF,
5669,GO:0016805,1,0.803923091077922,0,7,dipeptidase activity,MF,
5670,GO:0016807,1,0.969271124374127,0,1,cysteine-type carboxypeptidase activity,MF,
5673,GO:0016812,1,0.84660909480905,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5676,GO:0016815,1,0.973397025980278,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
5679,GO:0016822,1,0.946567176402695,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5680,GO:0016823,1,0.946567176402695,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
5681,GO:0016826,1,0.9695751854904,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
5685,GO:0016832,1,0.812832657347381,0,7,aldehyde-lyase activity,MF,
5689,GO:0016838,1,0.946433560054333,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
5691,GO:0016841,1,0.914901676751906,0,3,ammonia-lyase activity,MF,
5693,GO:0016843,1,0.969271124374127,0,1,amine-lyase activity,MF,
5694,GO:0016844,1,0.969271124374127,0,1,strictosidine synthase activity,MF,
5696,GO:0016849,1,0.746379160009079,0,9,phosphorus-oxygen lyase activity,MF,
5698,GO:0016854,1,0.676563224854884,0,13,racemase and epimerase activity,MF,
5699,GO:0016855,1,0.970365496604871,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5700,GO:0016857,1,0.736343647408437,0,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
5703,GO:0016861,1,0.795850984707182,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
5704,GO:0016862,1,0.95031985845199,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
5705,GO:0016863,1,0.754384934939092,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5708,GO:0016868,1,0.767234415778425,0,9,intramolecular transferase activity, phosphotransferases,MF,
5709,GO:0016872,1,0.970998932469491,0,1,intramolecular lyase activity,MF,
5711,GO:0016875,1,0.260475282966639,0,44,ligase activity, forming carbon-oxygen bonds,MF,
5712,GO:0016877,1,0.417925179523698,0,28,ligase activity, forming carbon-sulfur bonds,MF,
5713,GO:0016878,1,0.570807054942293,0,18,acid-thiol ligase activity,MF,
5714,GO:0016879,1,0.260686250873234,0,43,ligase activity, forming carbon-nitrogen bonds,MF,
5715,GO:0016880,1,0.937464069280388,0,2,acid-ammonia (or amide) ligase activity,MF,
5716,GO:0016881,1,0.608131970734193,0,16,acid-amino acid ligase activity,MF,
5717,GO:0016882,1,0.943346396679609,0,2,cyclo-ligase activity,MF,
5718,GO:0016884,1,0.733118958235331,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
5719,GO:0016885,1,0.778064708827156,0,8,ligase activity, forming carbon-carbon bonds,MF,
5722,GO:0016888,1,0.708682414734057,0,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5723,GO:0016889,1,0.556339283402296,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5724,GO:0016890,1,0.941138143507776,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
5726,GO:0016892,1,0.843968520038381,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5728,GO:0016894,1,0.469404481882604,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5729,GO:0016895,1,0.593989017210811,0,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5731,GO:0016898,1,0.970051889225651,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
5732,GO:0016899,1,0.935655963754885,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
5733,GO:0016900,1,0.948786299364761,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
5734,GO:0016901,1,0.966870364153008,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
5735,GO:0016903,1,0.335205990033478,0,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
5736,GO:0016907,1,0.937823736298729,0,2,G-protein coupled acetylcholine receptor activity,MF,
5737,GO:0016909,1,0.910757220223632,0,3,SAP kinase activity,MF,
5738,GO:0016917,1,0.906272045630969,0,3,GABA receptor activity,MF,
5739,GO:0016918,1,0.866061915206054,0,5,retinal binding,MF,
5740,GO:0016920,1,0.966840557062591,0,1,pyroglutamyl-peptidase activity,MF,
5741,GO:0016922,1,0.564302271327757,0,18,ligand-dependent nuclear receptor binding,MF,
5742,GO:0016925,1,0.0692170142800614,0,85,protein sumoylation,BP,
5743,GO:0016926,1,0.799535244370886,0,7,protein desumoylation,BP,
5744,GO:0016929,1,0.822024334531726,0,6,SUMO-specific protease activity,MF,
5745,GO:0016936,1,0.944341107531309,0,2,galactoside binding,MF,
5746,GO:0016938,1,0.969130023597335,0,1,kinesin I complex,CC,
5747,GO:0016939,1,0.905838591671691,0,3,kinesin II complex,CC,
5748,GO:0016941,1,0.968174685271712,0,1,natriuretic peptide receptor activity,MF,
5750,GO:0016964,1,0.966660666044657,0,1,alpha-2 macroglobulin receptor activity,MF,
5751,GO:0016971,1,0.90965653421085,0,3,flavin-linked sulfhydryl oxidase activity,MF,
5752,GO:0016972,1,0.879635574283738,0,4,thiol oxidase activity,MF,
5753,GO:0016973,1,0.733132779351171,0,10,poly(A)+ mRNA export from nucleus,BP,
5754,GO:0016979,1,0.9732876752177,0,1,lipoate-protein ligase activity,MF,
5755,GO:0016992,1,0.972657592338812,0,1,lipoate synthase activity,MF,
5756,GO:0016997,1,0.887584324700119,0,4,alpha-sialidase activity,MF,
5757,GO:0016998,1,0.942285095598058,0,2,cell wall macromolecule catabolic process,BP,
5761,GO:0017002,1,0.85150345857329,0,5,activin-activated receptor activity,MF,
5762,GO:0017003,1,0.970925226765535,0,1,protein-heme linkage,BP,
5764,GO:0017005,1,0.967880652335949,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
5765,GO:0017006,1,0.970925226765535,0,1,protein-tetrapyrrole linkage,BP,
5766,GO:0017014,1,0.736298314797121,0,10,protein nitrosylation,BP,
5770,GO:0017018,1,0.934925502324592,0,2,myosin phosphatase activity,MF,
5771,GO:0017020,1,0.969329840785849,0,1,myosin phosphatase regulator activity,MF,
5773,GO:0017024,1,0.97433684205675,0,1,myosin I binding,MF,
5774,GO:0017025,1,0.503833056566702,0,23,TBP-class protein binding,MF,
5775,GO:0017034,1,0.849525725693637,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
5777,GO:0017040,1,0.886606360094349,0,4,N-acylsphingosine amidohydrolase activity,MF,
5778,GO:0017046,1,0.618790003323984,0,15,peptide hormone binding,MF,
5780,GO:0017049,1,0.517644467334696,0,21,GTP-Rho binding,MF,
5781,GO:0017050,1,0.942113959752146,0,2,D-erythro-sphingosine kinase activity,MF,
5783,GO:0017055,1,0.939681581560548,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
5784,GO:0017056,1,0.451504628617483,0,25,structural constituent of nuclear pore,MF,
5785,GO:0017057,1,0.9417282427917,0,2,6-phosphogluconolactonase activity,MF,
5787,GO:0017060,1,0.940912735635132,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
5788,GO:0017061,1,0.966957798296392,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
5790,GO:0017064,1,0.971464344687056,0,1,fatty acid amide hydrolase activity,MF,
5791,GO:0017065,1,0.972922632298431,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
5792,GO:0017069,1,0.324430211140394,0,38,snRNA binding,MF,
5793,GO:0017070,1,0.721812140514895,0,11,U6 snRNA binding,MF,
5797,GO:0017081,1,0.672718076447096,0,13,chloride channel regulator activity,MF,
5798,GO:0017082,1,0.969271124374127,0,1,mineralocorticoid receptor activity,MF,
5799,GO:0017084,1,0.968133458427986,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
5801,GO:0017087,1,0.967545399117748,0,1,mitochondrial processing peptidase complex,CC,
5802,GO:0017089,1,0.943372407760107,0,2,glycolipid transporter activity,MF,
5804,GO:0017095,1,0.935696573253062,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
5806,GO:0017099,1,0.887866696386397,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
5807,GO:0017101,1,0.694774528449901,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5808,GO:0017102,1,0.939761314376377,0,2,methionyl glutamyl tRNA synthetase complex,CC,
5809,GO:0017108,1,0.828899749064729,0,6,5'-flap endonuclease activity,MF,
5810,GO:0017109,1,0.937633238638339,0,2,glutamate-cysteine ligase complex,CC,
5811,GO:0017110,1,0.675260596873193,0,13,nucleoside-diphosphatase activity,MF,
5813,GO:0017112,1,0.213267050574979,0,49,Rab guanyl-nucleotide exchange factor activity,MF,
5814,GO:0017113,1,0.968755358580569,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
5815,GO:0017116,1,0.908153655431522,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
5816,GO:0017119,1,0.686455421805674,0,12,Golgi transport complex,CC,
5819,GO:0017125,1,0.967007392330114,0,1,deoxycytidyl transferase activity,MF,
5820,GO:0017126,1,0.966894310519947,0,1,nucleologenesis,BP,
5821,GO:0017127,1,0.744482227393363,0,10,cholesterol transporter activity,MF,
5823,GO:0017130,1,0.966847112481757,0,1,poly(C) RNA binding,MF,
5824,GO:0017133,1,0.970731221353253,0,1,mitochondrial electron transfer flavoprotein complex,CC,
5826,GO:0017136,1,0.608547047213931,0,16,NAD-dependent histone deacetylase activity,MF,
5830,GO:0017145,1,0.420508975388976,0,27,stem cell division,BP,
5831,GO:0017146,1,0.874669876433838,0,4,NMDA selective glutamate receptor complex,CC,
5832,GO:0017147,1,0.509201399132062,0,21,Wnt-protein binding,MF,
5834,GO:0017150,1,0.889751368691911,0,4,tRNA dihydrouridine synthase activity,MF,
5835,GO:0017151,1,0.802495019717396,0,7,DEAD/H-box RNA helicase binding,MF,
5836,GO:0017153,1,0.879321208452825,0,4,sodium:dicarboxylate symporter activity,MF,
5841,GO:0017160,1,0.636976300351711,0,14,Ral GTPase binding,MF,
5842,GO:0017161,1,0.935315528921695,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
5843,GO:0017162,1,0.778284398008725,0,8,aryl hydrocarbon receptor binding,MF,
5844,GO:0017166,1,0.719709508756762,0,10,vinculin binding,MF,
5845,GO:0017168,1,0.967440622921063,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
5846,GO:0017169,1,0.815332320066334,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5848,GO:0017176,1,0.821027041709321,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
5849,GO:0017177,1,0.967566336644757,0,1,glucosidase II complex,CC,
5850,GO:0017178,1,0.969271124374127,0,1,diphthine-ammonia ligase activity,MF,
5851,GO:0017182,1,0.75843391613263,0,9,peptidyl-diphthamide metabolic process,BP,
5852,GO:0017183,1,0.75843391613263,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5853,GO:0017185,1,0.776486244868866,0,8,peptidyl-lysine hydroxylation,BP,
5854,GO:0017186,1,0.944661716168537,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
5856,GO:0017196,1,0.829840187931523,0,6,N-terminal peptidyl-methionine acetylation,BP,
5857,GO:0017198,1,0.974353186685951,0,1,N-terminal peptidyl-serine acetylation,BP,
5858,GO:0018002,1,0.974353186685951,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
5859,GO:0018008,1,0.934993574071478,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
5860,GO:0018009,1,0.971373350382596,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
5861,GO:0018011,1,0.969271124374127,0,1,N-terminal peptidyl-alanine methylation,BP,
5862,GO:0018012,1,0.969271124374127,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5863,GO:0018013,1,0.969271124374127,0,1,N-terminal peptidyl-glycine methylation,BP,
5864,GO:0018016,1,0.969271124374127,0,1,N-terminal peptidyl-proline dimethylation,BP,
5867,GO:0018024,1,0.282440680535089,0,40,histone-lysine N-methyltransferase activity,MF,
5868,GO:0018025,1,0.969271124374127,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5869,GO:0018026,1,0.755774165435006,0,9,peptidyl-lysine monomethylation,BP,
5870,GO:0018027,1,0.647160392541622,0,14,peptidyl-lysine dimethylation,BP,
5871,GO:0018032,1,0.96777033007464,0,1,protein amidation,BP,
5872,GO:0018057,1,0.90860689688993,0,3,peptidyl-lysine oxidation,BP,
5873,GO:0018063,1,0.970925226765535,0,1,cytochrome c-heme linkage,BP,
5874,GO:0018065,1,0.742133007592344,0,11,protein-cofactor linkage,BP,
5875,GO:0018076,1,0.873936852815961,0,4,N-terminal peptidyl-lysine acetylation,BP,
5876,GO:0018094,1,0.968234849772278,0,1,protein polyglycylation,BP,
5877,GO:0018095,1,0.777067935837732,0,8,protein polyglutamylation,BP,
5878,GO:0018101,1,0.968614476728591,0,1,protein citrullination,BP,
5879,GO:0018103,1,0.824899970702048,0,6,protein C-linked glycosylation,BP,
5881,GO:0018106,1,0.974626891856109,0,1,peptidyl-histidine phosphorylation,BP,
5884,GO:0018114,1,0.970365496604871,0,1,threonine racemase activity,MF,
5885,GO:0018117,1,0.972724801745671,0,1,protein adenylylation,BP,
5886,GO:0018119,1,0.736298314797121,0,10,peptidyl-cysteine S-nitrosylation,BP,
5887,GO:0018125,1,0.915801605707038,0,3,peptidyl-cysteine methylation,BP,
5892,GO:0018153,1,0.941507282722275,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
5893,GO:0018158,1,0.765067382052668,0,9,protein oxidation,BP,
5894,GO:0018160,1,0.973159665436758,0,1,peptidyl-pyrromethane cofactor linkage,BP,
5895,GO:0018166,1,0.96691322630408,0,1,C-terminal protein-tyrosinylation,BP,
5896,GO:0018171,1,0.891903076769218,0,4,peptidyl-cysteine oxidation,BP,
5897,GO:0018175,1,0.972724801745671,0,1,protein nucleotidylation,BP,
5898,GO:0018192,1,0.970440273114395,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
5900,GO:0018194,1,0.969271124374127,0,1,peptidyl-alanine modification,BP,
5901,GO:0018195,1,0.600168026051462,0,17,peptidyl-arginine modification,BP,
5903,GO:0018197,1,0.905354050624054,0,3,peptidyl-aspartic acid modification,BP,
5905,GO:0018199,1,0.889397509375609,0,4,peptidyl-glutamine modification,BP,
5907,GO:0018201,1,0.90625707073054,0,3,peptidyl-glycine modification,BP,
5908,GO:0018202,1,0.714648249197758,0,11,peptidyl-histidine modification,BP,
5910,GO:0018206,1,0.735152997782088,0,10,peptidyl-methionine modification,BP,
5914,GO:0018211,1,0.824899970702048,0,6,peptidyl-tryptophan modification,BP,
5917,GO:0018216,1,0.67310599639689,0,13,peptidyl-arginine methylation,BP,
5918,GO:0018217,1,0.967466877993906,0,1,peptidyl-aspartic acid phosphorylation,BP,
5923,GO:0018262,1,0.941507282722275,0,2,isopeptide cross-linking,BP,
5924,GO:0018271,1,0.966868039012414,0,1,biotin-protein ligase activity,MF,
5925,GO:0018272,1,0.972478537311936,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
5926,GO:0018277,1,0.970704860862804,0,1,protein deamination,BP,
5928,GO:0018282,1,0.938466942229925,0,2,metal incorporation into metallo-sulfur cluster,BP,
5929,GO:0018283,1,0.938466942229925,0,2,iron incorporation into metallo-sulfur cluster,BP,
5930,GO:0018293,1,0.973733769691756,0,1,protein-FAD linkage,BP,
5931,GO:0018298,1,0.908696714076932,0,3,protein-chromophore linkage,BP,
5932,GO:0018307,1,0.94546434375297,0,2,enzyme active site formation,BP,
5934,GO:0018315,1,0.967250856401697,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
5935,GO:0018317,1,0.824899970702048,0,6,protein C-linked glycosylation via tryptophan,BP,
5936,GO:0018322,1,0.96691322630408,0,1,protein tyrosinylation,BP,
5937,GO:0018323,1,0.974265395836361,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
5938,GO:0018335,1,0.879187071593844,0,4,protein succinylation,BP,
5939,GO:0018342,1,0.757823945529481,0,9,protein prenylation,BP,
5940,GO:0018343,1,0.914352603570736,0,3,protein farnesylation,BP,
5941,GO:0018344,1,0.834054838754175,0,6,protein geranylgeranylation,BP,
5943,GO:0018350,1,0.970625959753865,0,1,protein esterification,BP,
5944,GO:0018352,1,0.943967571853587,0,2,protein-pyridoxal-5-phosphate linkage,BP,
5945,GO:0018364,1,0.949351791459546,0,2,peptidyl-glutamine methylation,BP,
5946,GO:0018377,1,0.876804344838363,0,4,protein myristoylation,BP,
5949,GO:0018395,1,0.967910767110477,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
5950,GO:0018400,1,0.966851580325858,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
5952,GO:0018406,1,0.824899970702048,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
5954,GO:0018423,1,0.943587977007361,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
5955,GO:0018444,1,0.907081293536042,0,3,translation release factor complex,CC,
5956,GO:0018455,1,0.973581093466347,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
5957,GO:0018467,1,0.969903373835275,0,1,formaldehyde dehydrogenase activity,MF,
5958,GO:0018478,1,0.971229065755609,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
5959,GO:0018479,1,0.971470205227519,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
5960,GO:0018585,1,0.971295372891996,0,1,fluorene oxygenase activity,MF,
5961,GO:0018636,1,0.947173314806185,0,2,phenanthrene 9,10-monooxygenase activity,MF,
5962,GO:0018738,1,0.973754312131238,0,1,S-formylglutathione hydrolase activity,MF,
5963,GO:0018773,1,0.972646094615903,0,1,acetylpyruvate hydrolase activity,MF,
5964,GO:0018812,1,0.882620775853877,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
5965,GO:0018872,1,0.970394206106407,0,1,arsonoacetate metabolic process,BP,
5966,GO:0018879,1,0.914409568626431,0,3,biphenyl metabolic process,BP,
5968,GO:0018904,1,0.68375667719289,0,13,ether metabolic process,BP,
5969,GO:0018916,1,0.892675170458729,0,4,nitrobenzene metabolic process,BP,
5970,GO:0018917,1,0.971295372891996,0,1,fluorene metabolic process,BP,
5971,GO:0018931,1,0.973310190059817,0,1,naphthalene metabolic process,BP,
5972,GO:0018958,1,0.235952250945734,0,46,phenol-containing compound metabolic process,BP,
5973,GO:0018963,1,0.94271308458158,0,2,phthalate metabolic process,BP,
5974,GO:0018992,1,0.935506685616655,0,2,germ-line sex determination,BP,
5975,GO:0018993,1,0.969223868920637,0,1,somatic sex determination,BP,
5978,GO:0019002,1,0.940571056472134,0,2,GMP binding,MF,
5980,GO:0019005,1,0.203271942918312,0,52,SCF ubiquitin ligase complex,CC,
5982,GO:0019034,1,0.935222917506692,0,2,viral replication complex,CC,
5983,GO:0019035,1,0.966875672694054,0,1,viral integration complex,CC,
5984,GO:0019042,1,0.715282823301533,0,11,viral latency,BP,
5985,GO:0019043,1,0.765242185957714,0,9,establishment of viral latency,BP,
5986,GO:0019045,1,0.934760527572208,0,2,latent virus replication,BP,
5987,GO:0019046,1,0.934760527572208,0,2,release from viral latency,BP,
5988,GO:0019048,1,0.390374914947095,0,30,modulation by virus of host morphology or physiology,BP,
5989,GO:0019049,1,0.880438619766599,0,4,evasion or tolerance of host defenses by virus,BP,
5990,GO:0019050,1,0.916406871063324,0,3,suppression by virus of host apoptotic process,BP,
5991,GO:0019054,1,0.536103066377902,0,20,modulation by virus of host process,BP,
5993,GO:0019060,1,0.947568880251219,0,2,intracellular transport of viral protein in host cell,BP,
5994,GO:0019061,1,0.970963544183355,0,1,uncoating of virus,BP,
5996,GO:0019064,1,0.914937154059093,0,3,fusion of virus membrane with host plasma membrane,BP,
5997,GO:0019065,1,0.908365408703974,0,3,receptor-mediated endocytosis of virus by host cell,BP,
5998,GO:0019068,1,0.329923514533318,0,37,virion assembly,BP,
5999,GO:0019072,1,0.935389836699865,0,2,viral genome packaging,BP,
6000,GO:0019074,1,0.935389836699865,0,2,viral RNA genome packaging,BP,
6001,GO:0019075,1,0.939484005877423,0,2,virus maturation,BP,
6005,GO:0019081,1,0.649905359738001,0,14,viral translation,BP,
6006,GO:0019082,1,0.967307237707101,0,1,viral protein processing,BP,
6008,GO:0019085,1,0.936529754472411,0,2,early viral transcription,BP,
6009,GO:0019086,1,0.885883290626574,0,4,late viral transcription,BP,
6010,GO:0019087,1,0.91344267139993,0,3,transformation of host cell by virus,BP,
6011,GO:0019088,1,0.972883663885171,0,1,immortalization of host cell by virus,BP,
6013,GO:0019098,1,0.589768444658679,0,17,reproductive behavior,BP,
6014,GO:0019100,1,0.935506685616655,0,2,male germ-line sex determination,BP,
6015,GO:0019101,1,0.969223868920637,0,1,female somatic sex determination,BP,
6017,GO:0019104,1,0.655610824339539,0,15,DNA N-glycosylase activity,MF,
6018,GO:0019107,1,0.934993574071478,0,2,myristoyltransferase activity,MF,
6019,GO:0019118,1,0.973397025980278,0,1,phenanthrene-epoxide hydrolase activity,MF,
6020,GO:0019119,1,0.973397025980278,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6021,GO:0019135,1,0.972092158718329,0,1,deoxyhypusine monooxygenase activity,MF,
6022,GO:0019136,1,0.888846113643858,0,4,deoxynucleoside kinase activity,MF,
6023,GO:0019144,1,0.947442566859674,0,2,ADP-sugar diphosphatase activity,MF,
6024,GO:0019145,1,0.9702911699632,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6025,GO:0019150,1,0.971597303117115,0,1,D-ribulokinase activity,MF,
6026,GO:0019153,1,0.972851784312043,0,1,protein-disulfide reductase (glutathione) activity,MF,
6027,GO:0019158,1,0.905435702040609,0,3,mannokinase activity,MF,
6028,GO:0019166,1,0.918009212587583,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6029,GO:0019171,1,0.966805423739126,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6031,GO:0019185,1,0.937890746822545,0,2,snRNA-activating protein complex,CC,
6032,GO:0019187,1,0.967530999560944,0,1,beta-1,4-mannosyltransferase activity,MF,
6033,GO:0019198,1,0.717905129918409,0,10,transmembrane receptor protein phosphatase activity,MF,
6037,GO:0019202,1,0.968133458427986,0,1,amino acid kinase activity,MF,
6038,GO:0019203,1,0.853575994016667,0,5,carbohydrate phosphatase activity,MF,
6040,GO:0019206,1,0.723797109429349,0,11,nucleoside kinase activity,MF,
6046,GO:0019212,1,0.463820910358099,0,25,phosphatase inhibitor activity,MF,
6048,GO:0019215,1,0.70468153442978,0,11,intermediate filament binding,MF,
6058,GO:0019228,1,0.683088595676802,0,12,neuronal action potential,BP,
6060,GO:0019230,1,0.934803547338144,0,2,proprioception,BP,
6062,GO:0019236,1,0.941925715548933,0,2,response to pheromone,BP,
6063,GO:0019237,1,0.826715312633754,0,6,centromeric DNA binding,MF,
6064,GO:0019238,1,0.833986663267183,0,6,cyclohydrolase activity,MF,
6066,GO:0019240,1,0.874957823171193,0,4,citrulline biosynthetic process,BP,
6067,GO:0019242,1,0.971514114982628,0,1,methylglyoxal biosynthetic process,BP,
6068,GO:0019243,1,0.942814454617799,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6069,GO:0019249,1,0.91302461507728,0,3,lactate biosynthetic process,BP,
6070,GO:0019254,1,0.940341864617004,0,2,carnitine metabolic process, CoA-linked,BP,
6071,GO:0019255,1,0.94392619289359,0,2,glucose 1-phosphate metabolic process,BP,
6073,GO:0019264,1,0.942343184763311,0,2,glycine biosynthetic process from serine,BP,
6074,GO:0019276,1,0.969326219580173,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
6075,GO:0019285,1,0.96799442435341,0,1,glycine betaine biosynthetic process from choline,BP,
6076,GO:0019287,1,0.919672258153975,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6077,GO:0019290,1,0.969195805889928,0,1,siderophore biosynthetic process,BP,
6078,GO:0019303,1,0.948165605521868,0,2,D-ribose catabolic process,BP,
6079,GO:0019317,1,0.82293692396189,0,6,fucose catabolic process,BP,
6085,GO:0019323,1,0.890925284335129,0,4,pentose catabolic process,BP,
6086,GO:0019336,1,0.858062979774629,0,5,phenol-containing compound catabolic process,BP,
6088,GO:0019343,1,0.943322788515627,0,2,cysteine biosynthetic process via cystathionine,BP,
6089,GO:0019344,1,0.91567675347578,0,3,cysteine biosynthetic process,BP,
6090,GO:0019346,1,0.888726369635939,0,4,transsulfuration,BP,
6091,GO:0019348,1,0.863332896689992,0,5,dolichol metabolic process,BP,
6092,GO:0019353,1,0.969731551496732,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6093,GO:0019355,1,0.93565619217012,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6094,GO:0019357,1,0.969271124374127,0,1,nicotinate nucleotide biosynthetic process,BP,
6095,GO:0019358,1,0.969271124374127,0,1,nicotinate nucleotide salvage,BP,
6099,GO:0019364,1,0.968106967257537,0,1,pyridine nucleotide catabolic process,BP,
6100,GO:0019365,1,0.969271124374127,0,1,pyridine nucleotide salvage,BP,
6101,GO:0019367,1,0.856212542519588,0,5,fatty acid elongation, saturated fatty acid,BP,
6102,GO:0019368,1,0.856212542519588,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6105,GO:0019371,1,0.837189027747978,0,6,cyclooxygenase pathway,BP,
6106,GO:0019372,1,0.766105404464556,0,9,lipoxygenase pathway,BP,
6108,GO:0019374,1,0.830666888981346,0,6,galactolipid metabolic process,BP,
6109,GO:0019375,1,0.911888204229103,0,3,galactolipid biosynthetic process,BP,
6110,GO:0019376,1,0.96922856721965,0,1,galactolipid catabolic process,BP,
6111,GO:0019377,1,0.715869077568948,0,11,glycolipid catabolic process,BP,
6112,GO:0019388,1,0.788534863290944,0,8,galactose catabolic process,BP,
6113,GO:0019389,1,0.969911544203276,0,1,glucuronoside metabolic process,BP,
6114,GO:0019391,1,0.969911544203276,0,1,glucuronoside catabolic process,BP,
6116,GO:0019400,1,0.659204567270999,0,14,alditol metabolic process,BP,
6117,GO:0019401,1,0.890127252957228,0,4,alditol biosynthetic process,BP,
6118,GO:0019402,1,0.973399232439149,0,1,galactitol metabolic process,BP,
6119,GO:0019405,1,0.827939239987071,0,6,alditol catabolic process,BP,
6120,GO:0019406,1,0.973310190059817,0,1,hexitol biosynthetic process,BP,
6121,GO:0019407,1,0.970225831804016,0,1,hexitol catabolic process,BP,
6122,GO:0019408,1,0.937844494601746,0,2,dolichol biosynthetic process,BP,
6123,GO:0019413,1,0.937177637766283,0,2,acetate biosynthetic process,BP,
6124,GO:0019417,1,0.936620713975,0,2,sulfur oxidation,BP,
6125,GO:0019418,1,0.896237910150379,0,4,sulfide oxidation,BP,
6126,GO:0019427,1,0.937177637766283,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6128,GO:0019432,1,0.471001205434734,0,24,triglyceride biosynthetic process,BP,
6132,GO:0019441,1,0.918918772447815,0,3,tryptophan catabolic process to kynurenine,BP,
6133,GO:0019448,1,0.970021395609411,0,1,L-cysteine catabolic process,BP,
6134,GO:0019464,1,0.914813832782786,0,3,glycine decarboxylation via glycine cleavage system,BP,
6135,GO:0019470,1,0.884691399252906,0,4,4-hydroxyproline catabolic process,BP,
6137,GO:0019474,1,0.910171428890894,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6138,GO:0019477,1,0.910171428890894,0,3,L-lysine catabolic process,BP,
6139,GO:0019482,1,0.937740107265927,0,2,beta-alanine metabolic process,BP,
6140,GO:0019483,1,0.968755358580569,0,1,beta-alanine biosynthetic process,BP,
6141,GO:0019493,1,0.971820047232335,0,1,arginine catabolic process to proline,BP,
6142,GO:0019509,1,0.862037433998609,0,5,L-methionine salvage from methylthioadenosine,BP,
6143,GO:0019510,1,0.970913441825983,0,1,S-adenosylhomocysteine catabolic process,BP,
6145,GO:0019516,1,0.970051889225651,0,1,lactate oxidation,BP,
6146,GO:0019518,1,0.972886108049028,0,1,L-threonine catabolic process to glycine,BP,
6147,GO:0019519,1,0.970225831804016,0,1,pentitol metabolic process,BP,
6148,GO:0019520,1,0.942061421350217,0,2,aldonic acid metabolic process,BP,
6149,GO:0019521,1,0.942061421350217,0,2,D-gluconate metabolic process,BP,
6150,GO:0019527,1,0.970225831804016,0,1,pentitol catabolic process,BP,
6151,GO:0019530,1,0.90688716318204,0,3,taurine metabolic process,BP,
6152,GO:0019531,1,0.85090259064336,0,5,oxalate transmembrane transporter activity,MF,
6153,GO:0019532,1,0.85090259064336,0,5,oxalate transport,BP,
6154,GO:0019534,1,0.876676407075312,0,4,toxin transmembrane transporter activity,MF,
6156,GO:0019541,1,0.910803669056647,0,3,propionate metabolic process,BP,
6157,GO:0019542,1,0.937177637766283,0,2,propionate biosynthetic process,BP,
6158,GO:0019543,1,0.971863023673316,0,1,propionate catabolic process,BP,
6159,GO:0019544,1,0.971820047232335,0,1,arginine catabolic process to glutamate,BP,
6161,GO:0019550,1,0.942680283114389,0,2,glutamate catabolic process to aspartate,BP,
6162,GO:0019551,1,0.942680283114389,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6163,GO:0019556,1,0.9686969601558,0,1,histidine catabolic process to glutamate and formamide,BP,
6164,GO:0019557,1,0.9686969601558,0,1,histidine catabolic process to glutamate and formate,BP,
6165,GO:0019563,1,0.85335814326048,0,5,glycerol catabolic process,BP,
6166,GO:0019585,1,0.700856724724699,0,12,glucuronate metabolic process,BP,
6167,GO:0019605,1,0.971995214098838,0,1,butyrate metabolic process,BP,
6168,GO:0019614,1,0.858062979774629,0,5,catechol-containing compound catabolic process,BP,
6169,GO:0019626,1,0.813671595008174,0,7,short-chain fatty acid catabolic process,BP,
6172,GO:0019640,1,0.866448545848729,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6173,GO:0019646,1,0.683899376220689,0,14,aerobic electron transport chain,BP,
6174,GO:0019659,1,0.969271124374127,0,1,glucose catabolic process to lactate,BP,
6175,GO:0019660,1,0.969271124374127,0,1,glycolytic fermentation,BP,
6176,GO:0019661,1,0.969271124374127,0,1,glucose catabolic process to lactate via pyruvate,BP,
6177,GO:0019666,1,0.969271124374127,0,1,nitrogenous compound fermentation,BP,
6178,GO:0019673,1,0.824604516302838,0,7,GDP-mannose metabolic process,BP,
6180,GO:0019676,1,0.967187319288456,0,1,ammonia assimilation cycle,BP,
6181,GO:0019677,1,0.968106967257537,0,1,NAD catabolic process,BP,
6183,GO:0019692,1,0.424168875139037,0,30,deoxyribose phosphate metabolic process,BP,
6185,GO:0019694,1,0.90688716318204,0,3,alkanesulfonate metabolic process,BP,
6186,GO:0019695,1,0.881012673865018,0,4,choline metabolic process,BP,
6195,GO:0019732,1,0.939401974989527,0,2,antifungal humoral response,BP,
6196,GO:0019740,1,0.911996861488519,0,3,nitrogen utilization,BP,
6197,GO:0019742,1,0.970577892257981,0,1,pentacyclic triterpenoid metabolic process,BP,
6198,GO:0019747,1,0.974333202735356,0,1,regulation of isoprenoid metabolic process,BP,
6200,GO:0019751,1,0.0678698324809165,0,86,polyol metabolic process,BP,
6202,GO:0019755,1,0.88641117100033,0,4,one-carbon compound transport,BP,
6203,GO:0019763,1,0.940574758003071,0,2,immunoglobulin receptor activity,MF,
6204,GO:0019770,1,0.97243084272675,0,1,IgG receptor activity,MF,
6205,GO:0019773,1,0.831058949807718,0,7,proteasome core complex, alpha-subunit complex,CC,
6207,GO:0019776,1,0.912006572138103,0,3,Atg8 ligase activity,MF,
6208,GO:0019777,1,0.945138456570013,0,2,Atg12 transferase activity,MF,
6209,GO:0019778,1,0.966945498521195,0,1,Atg12 activating enzyme activity,MF,
6210,GO:0019779,1,0.966945498521195,0,1,Atg8 activating enzyme activity,MF,
6211,GO:0019780,1,0.966856159009552,0,1,FAT10 activating enzyme activity,MF,
6212,GO:0019781,1,0.944497815361295,0,2,NEDD8 activating enzyme activity,MF,
6213,GO:0019782,1,0.968367527964044,0,1,ISG15 activating enzyme activity,MF,
6215,GO:0019784,1,0.817787160681894,0,7,NEDD8-specific protease activity,MF,
6216,GO:0019785,1,0.939980265454257,0,2,ISG15-specific protease activity,MF,
6218,GO:0019788,1,0.8437926017832,0,6,NEDD8 transferase activity,MF,
6219,GO:0019789,1,0.611791593300178,0,16,SUMO transferase activity,MF,
6220,GO:0019797,1,0.91060985903053,0,3,procollagen-proline 3-dioxygenase activity,MF,
6221,GO:0019798,1,0.831481708381709,0,6,procollagen-proline dioxygenase activity,MF,
6222,GO:0019799,1,0.969271124374127,0,1,tubulin N-acetyltransferase activity,MF,
6223,GO:0019800,1,0.973100268977674,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6224,GO:0019808,1,0.918886145639378,0,3,polyamine binding,MF,
6225,GO:0019809,1,0.948789569640736,0,2,spermidine binding,MF,
6226,GO:0019810,1,0.968487030206462,0,1,putrescine binding,MF,
6227,GO:0019811,1,0.96709169219984,0,1,cocaine binding,MF,
6228,GO:0019814,1,0.966933724327514,0,1,immunoglobulin complex,CC,
6229,GO:0019815,1,0.966933724327514,0,1,B cell receptor complex,CC,
6231,GO:0019826,1,0.939218789755878,0,2,oxygen sensor activity,MF,
6233,GO:0019828,1,0.973506143927433,0,1,aspartic-type endopeptidase inhibitor activity,MF,
6234,GO:0019829,1,0.350987510866978,0,34,cation-transporting ATPase activity,MF,
6236,GO:0019835,1,0.652063838151275,0,15,cytolysis,BP,
6239,GO:0019841,1,0.894268712392924,0,4,retinol binding,MF,
6241,GO:0019843,1,0.20453301087601,0,56,rRNA binding,MF,
6242,GO:0019852,1,0.763499398418583,0,9,L-ascorbic acid metabolic process,BP,
6243,GO:0019853,1,0.973146913806439,0,1,L-ascorbic acid biosynthetic process,BP,
6244,GO:0019855,1,0.79249464877468,0,8,calcium channel inhibitor activity,MF,
6245,GO:0019856,1,0.825494362484141,0,6,pyrimidine nucleobase biosynthetic process,BP,
6246,GO:0019857,1,0.90357580708874,0,3,5-methylcytosine metabolic process,BP,
6247,GO:0019858,1,0.942848256357896,0,2,cytosine metabolic process,BP,
6248,GO:0019859,1,0.940880971855078,0,2,thymine metabolic process,BP,
6249,GO:0019860,1,0.942484005938633,0,2,uracil metabolic process,BP,
6250,GO:0019862,1,0.972925058067222,0,1,IgA binding,MF,
6251,GO:0019863,1,0.973303446394499,0,1,IgE binding,MF,
6252,GO:0019864,1,0.97243084272675,0,1,IgG binding,MF,
6253,GO:0019865,1,0.92083892214778,0,3,immunoglobulin binding,MF,
6256,GO:0019869,1,0.785174922062212,0,8,chloride channel inhibitor activity,MF,
6259,GO:0019878,1,0.937227461839672,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6267,GO:0019894,1,0.334444922988496,0,34,kinesin binding,MF,
6281,GO:0019912,1,0.942818421750709,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6283,GO:0019918,1,0.884922186077273,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6284,GO:0019919,1,0.810719819508367,0,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6287,GO:0019934,1,0.852355275165326,0,5,cGMP-mediated signaling,BP,
6290,GO:0019948,1,0.941121624268343,0,2,SUMO activating enzyme activity,MF,
6294,GO:0019957,1,0.941699500335699,0,2,C-C chemokine binding,MF,
6295,GO:0019958,1,0.885053933661072,0,4,C-X-C chemokine binding,MF,
6296,GO:0019959,1,0.970362629271163,0,1,interleukin-8 binding,MF,
6300,GO:0019964,1,0.968138171396349,0,1,interferon-gamma binding,MF,
6304,GO:0019985,1,0.303516967820357,0,39,translesion synthesis,BP,
6305,GO:0019988,1,0.969626763580086,0,1,charged-tRNA amino acid modification,BP,
6306,GO:0019992,1,0.778973549018848,0,8,diacylglycerol binding,MF,
6307,GO:0020003,1,0.969271124374127,0,1,symbiont-containing vacuole,CC,
6308,GO:0020012,1,0.937639811421786,0,2,evasion or tolerance of host immune response,BP,
6311,GO:0020021,1,0.972883663885171,0,1,immortalization of host cell,BP,
6312,GO:0020027,1,0.781898364963403,0,8,hemoglobin metabolic process,BP,
6314,GO:0021501,1,0.971519963423587,0,1,prechordal plate formation,BP,
6315,GO:0021502,1,0.935963957249836,0,2,neural fold elevation formation,BP,
6316,GO:0021503,1,0.966806438191093,0,1,neural fold bending,BP,
6317,GO:0021508,1,0.966848403352548,0,1,floor plate formation,BP,
6319,GO:0021511,1,0.769099763037823,0,8,spinal cord patterning,BP,
6320,GO:0021512,1,0.967258580998945,0,1,spinal cord anterior/posterior patterning,BP,
6321,GO:0021513,1,0.795150160466187,0,7,spinal cord dorsal/ventral patterning,BP,
6322,GO:0021514,1,0.873933744670176,0,4,ventral spinal cord interneuron differentiation,BP,
6323,GO:0021515,1,0.56439869414569,0,18,cell differentiation in spinal cord,BP,
6324,GO:0021516,1,0.906475204843836,0,3,dorsal spinal cord development,BP,
6325,GO:0021517,1,0.584505711798844,0,17,ventral spinal cord development,BP,
6326,GO:0021520,1,0.828280694639182,0,6,spinal cord motor neuron cell fate specification,BP,
6327,GO:0021521,1,0.903869688760566,0,3,ventral spinal cord interneuron specification,BP,
6328,GO:0021522,1,0.603897612814019,0,16,spinal cord motor neuron differentiation,BP,
6329,GO:0021523,1,0.944695215501319,0,2,somatic motor neuron differentiation,BP,
6330,GO:0021524,1,0.942891955077421,0,2,visceral motor neuron differentiation,BP,
6331,GO:0021526,1,0.972135366312545,0,1,medial motor column neuron differentiation,BP,
6332,GO:0021527,1,0.934780895294963,0,2,spinal cord association neuron differentiation,BP,
6333,GO:0021532,1,0.426515124758604,0,27,neural tube patterning,BP,
6334,GO:0021533,1,0.750468093642607,0,9,cell differentiation in hindbrain,BP,
6335,GO:0021534,1,0.85483341832506,0,5,cell proliferation in hindbrain,BP,
6336,GO:0021535,1,0.722229387428805,0,10,cell migration in hindbrain,BP,
6339,GO:0021539,1,0.944752026226395,0,2,subthalamus development,BP,
6340,GO:0021540,1,0.886025186364236,0,4,corpus callosum morphogenesis,BP,
6341,GO:0021541,1,0.967281305161034,0,1,ammon gyrus development,BP,
6344,GO:0021544,1,0.6026496513385,0,16,subpallium development,BP,
6347,GO:0021547,1,0.971519963423587,0,1,midbrain-hindbrain boundary initiation,BP,
6348,GO:0021548,1,0.851739660885294,0,5,pons development,BP,
6350,GO:0021553,1,0.96675833283641,0,1,olfactory nerve development,BP,
6351,GO:0021554,1,0.824907668905798,0,6,optic nerve development,BP,
6352,GO:0021555,1,0.940982819852689,0,2,midbrain-hindbrain boundary morphogenesis,BP,
6353,GO:0021557,1,0.94246368398676,0,2,oculomotor nerve development,BP,
6354,GO:0021558,1,0.973198875078459,0,1,trochlear nerve development,BP,
6359,GO:0021563,1,0.93630023383941,0,2,glossopharyngeal nerve development,BP,
6360,GO:0021564,1,0.94064446254361,0,2,vagus nerve development,BP,
6361,GO:0021566,1,0.966952385227903,0,1,hypoglossal nerve development,BP,
6362,GO:0021569,1,0.972854243557992,0,1,rhombomere 3 development,BP,
6363,GO:0021570,1,0.972854243557992,0,1,rhombomere 4 development,BP,
6368,GO:0021578,1,0.905188511042049,0,3,hindbrain maturation,BP,
6369,GO:0021586,1,0.967627284050277,0,1,pons maturation,BP,
6372,GO:0021590,1,0.935477904213125,0,2,cerebellum maturation,BP,
6374,GO:0021592,1,0.966899164759853,0,1,fourth ventricle development,BP,
6382,GO:0021615,1,0.968506445176159,0,1,glossopharyngeal nerve morphogenesis,BP,
6383,GO:0021618,1,0.966952385227903,0,1,hypoglossal nerve morphogenesis,BP,
6384,GO:0021622,1,0.968420702674073,0,1,oculomotor nerve morphogenesis,BP,
6385,GO:0021623,1,0.968420702674073,0,1,oculomotor nerve formation,BP,
6386,GO:0021626,1,0.905188511042049,0,3,central nervous system maturation,BP,
6387,GO:0021631,1,0.903901994221196,0,3,optic nerve morphogenesis,BP,
6390,GO:0021644,1,0.972999693281969,0,1,vagus nerve morphogenesis,BP,
6393,GO:0021650,1,0.966872720920993,0,1,vestibulocochlear nerve formation,BP,
6396,GO:0021678,1,0.918635870188311,0,3,third ventricle development,BP,
6397,GO:0021679,1,0.938276893472816,0,2,cerebellar molecular layer development,BP,
6399,GO:0021681,1,0.804614016193735,0,7,cerebellar granular layer development,BP,
6400,GO:0021682,1,0.966876358038284,0,1,nerve maturation,BP,
6401,GO:0021683,1,0.854123220636962,0,5,cerebellar granular layer morphogenesis,BP,
6402,GO:0021684,1,0.909820449423349,0,3,cerebellar granular layer formation,BP,
6403,GO:0021685,1,0.966835042104978,0,1,cerebellar granular layer structural organization,BP,
6404,GO:0021687,1,0.938276893472816,0,2,cerebellar molecular layer morphogenesis,BP,
6405,GO:0021688,1,0.968397512519548,0,1,cerebellar molecular layer formation,BP,
6406,GO:0021691,1,0.935477904213125,0,2,cerebellar Purkinje cell layer maturation,BP,
6407,GO:0021692,1,0.768115493637421,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6408,GO:0021693,1,0.936277876550706,0,2,cerebellar Purkinje cell layer structural organization,BP,
6409,GO:0021694,1,0.848590454543433,0,5,cerebellar Purkinje cell layer formation,BP,
6411,GO:0021696,1,0.545912298736702,0,19,cerebellar cortex morphogenesis,BP,
6412,GO:0021697,1,0.682802327659146,0,12,cerebellar cortex formation,BP,
6413,GO:0021698,1,0.936277876550706,0,2,cerebellar cortex structural organization,BP,
6414,GO:0021699,1,0.935477904213125,0,2,cerebellar cortex maturation,BP,
6416,GO:0021702,1,0.848590454543433,0,5,cerebellar Purkinje cell differentiation,BP,
6417,GO:0021707,1,0.909820449423349,0,3,cerebellar granule cell differentiation,BP,
6418,GO:0021718,1,0.967627284050277,0,1,superior olivary nucleus development,BP,
6419,GO:0021722,1,0.967627284050277,0,1,superior olivary nucleus maturation,BP,
6420,GO:0021730,1,0.966813595891231,0,1,trigeminal sensory nucleus development,BP,
6421,GO:0021740,1,0.966813595891231,0,1,principal sensory nucleus of trigeminal nerve development,BP,
6422,GO:0021747,1,0.904781966524722,0,3,cochlear nucleus development,BP,
6423,GO:0021756,1,0.661307742018048,0,13,striatum development,BP,
6424,GO:0021757,1,0.967880652335949,0,1,caudate nucleus development,BP,
6425,GO:0021758,1,0.967880652335949,0,1,putamen development,BP,
6428,GO:0021763,1,0.971081547402047,0,1,subthalamic nucleus development,BP,
6429,GO:0021764,1,0.934671128094105,0,2,amygdala development,BP,
6431,GO:0021768,1,0.968088487541745,0,1,nucleus accumbens development,BP,
6432,GO:0021769,1,0.908982487880466,0,3,orbitofrontal cortex development,BP,
6433,GO:0021771,1,0.966875889570171,0,1,lateral geniculate nucleus development,BP,
6435,GO:0021773,1,0.907900457488064,0,3,striatal medium spiny neuron differentiation,BP,
6436,GO:0021775,1,0.903869688760566,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6437,GO:0021776,1,0.903869688760566,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6438,GO:0021778,1,0.966794436185391,0,1,oligodendrocyte cell fate specification,BP,
6439,GO:0021779,1,0.966794436185391,0,1,oligodendrocyte cell fate commitment,BP,
6440,GO:0021780,1,0.966794436185391,0,1,glial cell fate specification,BP,
6444,GO:0021784,1,0.974715701145147,0,1,postganglionic parasympathetic fiber development,BP,
6446,GO:0021794,1,0.799036288581852,0,7,thalamus development,BP,
6448,GO:0021796,1,0.908908540121039,0,3,cerebral cortex regionalization,BP,
6449,GO:0021797,1,0.968250583109952,0,1,forebrain anterior/posterior pattern specification,BP,
6450,GO:0021798,1,0.93486432105978,0,2,forebrain dorsal/ventral pattern formation,BP,
6451,GO:0021799,1,0.511543557259047,0,21,cerebral cortex radially oriented cell migration,BP,
6453,GO:0021801,1,0.58249263909437,0,17,cerebral cortex radial glia guided migration,BP,
6454,GO:0021812,1,0.966871725165874,0,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6455,GO:0021814,1,0.796879296410833,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6456,GO:0021815,1,0.848292494274327,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6457,GO:0021816,1,0.937155359418775,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6458,GO:0021817,1,0.905194093148431,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6459,GO:0021819,1,0.731966646695328,0,10,layer formation in cerebral cortex,BP,
6460,GO:0021822,1,0.971360119840021,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6472,GO:0021846,1,0.631953167486187,0,14,cell proliferation in forebrain,BP,
6473,GO:0021847,1,0.935338326528137,0,2,ventricular zone neuroblast division,BP,
6474,GO:0021849,1,0.937015423465689,0,2,neuroblast division in subventricular zone,BP,
6478,GO:0021859,1,0.850890481691674,0,5,pyramidal neuron differentiation,BP,
6479,GO:0021860,1,0.850890481691674,0,5,pyramidal neuron development,BP,
6480,GO:0021861,1,0.813739213192758,0,7,forebrain radial glial cell differentiation,BP,
6481,GO:0021869,1,0.904351670175073,0,3,forebrain ventricular zone progenitor cell division,BP,
6482,GO:0021870,1,0.966866109864624,0,1,Cajal-Retzius cell differentiation,BP,
6483,GO:0021871,1,0.703815219130278,0,11,forebrain regionalization,BP,
6485,GO:0021873,1,0.820211269507755,0,6,forebrain neuroblast division,BP,
6486,GO:0021877,1,0.853239640303893,0,5,forebrain neuron fate commitment,BP,
6488,GO:0021881,1,0.968250583109952,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6489,GO:0021882,1,0.942686411809234,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6496,GO:0021892,1,0.918196506761829,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
6497,GO:0021893,1,0.942686411809234,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6498,GO:0021894,1,0.97402531348268,0,1,cerebral cortex GABAergic interneuron development,BP,
6499,GO:0021895,1,0.731528961215821,0,10,cerebral cortex neuron differentiation,BP,
6500,GO:0021896,1,0.934706072038978,0,2,forebrain astrocyte differentiation,BP,
6501,GO:0021897,1,0.934706072038978,0,2,forebrain astrocyte development,BP,
6502,GO:0021898,1,0.912751905120785,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6503,GO:0021902,1,0.934814825775619,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
6504,GO:0021903,1,0.858735840960667,0,5,rostrocaudal neural tube patterning,BP,
6505,GO:0021904,1,0.564506002430276,0,18,dorsal/ventral neural tube patterning,BP,
6506,GO:0021910,1,0.821012868929199,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6507,GO:0021914,1,0.938626587598,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6509,GO:0021924,1,0.85483341832506,0,5,cell proliferation in external granule layer,BP,
6510,GO:0021930,1,0.85483341832506,0,5,cerebellar granule cell precursor proliferation,BP,
6511,GO:0021932,1,0.798273170749431,0,7,hindbrain radial glia guided cell migration,BP,
6512,GO:0021934,1,0.934712821241778,0,2,hindbrain tangential cell migration,BP,
6513,GO:0021935,1,0.934712821241778,0,2,cerebellar granule cell precursor tangential migration,BP,
6514,GO:0021936,1,0.90487248254416,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
6515,GO:0021937,1,0.935669279365281,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6516,GO:0021938,1,0.935669279365281,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6517,GO:0021940,1,0.935669279365281,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
6518,GO:0021941,1,0.96709169219984,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
6519,GO:0021942,1,0.910219048385966,0,3,radial glia guided migration of Purkinje cell,BP,
6520,GO:0021943,1,0.877041787636284,0,4,formation of radial glial scaffolds,BP,
6525,GO:0021956,1,0.97177548306784,0,1,central nervous system interneuron axonogenesis,BP,
6527,GO:0021960,1,0.906493313880873,0,3,anterior commissure morphogenesis,BP,
6528,GO:0021965,1,0.934893474908931,0,2,spinal cord ventral commissure morphogenesis,BP,
6531,GO:0021978,1,0.856132097278675,0,5,telencephalon regionalization,BP,
6534,GO:0021984,1,0.85641703514889,0,5,adenohypophysis development,BP,
6537,GO:0021993,1,0.966899164759853,0,1,initiation of neural tube closure,BP,
6538,GO:0021997,1,0.934778774082012,0,2,neural plate axis specification,BP,
6539,GO:0021998,1,0.967910767110477,0,1,neural plate mediolateral regionalization,BP,
6540,GO:0021999,1,0.859855284562351,0,5,neural plate anterior/posterior regionalization,BP,
6541,GO:0022007,1,0.907999259896507,0,3,convergent extension involved in neural plate elongation,BP,
6543,GO:0022009,1,0.882594226567824,0,4,central nervous system vasculogenesis,BP,
6546,GO:0022012,1,0.96681211801048,0,1,subpallium cell proliferation in forebrain,BP,
6547,GO:0022018,1,0.96681211801048,0,1,lateral ganglionic eminence cell proliferation,BP,
6548,GO:0022027,1,0.873778038624563,0,4,interkinetic nuclear migration,BP,
6551,GO:0022030,1,0.58249263909437,0,17,telencephalon glial cell migration,BP,
6553,GO:0022038,1,0.666813516174843,0,13,corpus callosum development,BP,
6554,GO:0022400,1,0.705244794676575,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6557,GO:0022404,1,0.11781676139651,0,68,molting cycle process,BP,
6558,GO:0022405,1,0.11781676139651,0,68,hair cycle process,BP,
6563,GO:0022410,1,0.786411783406713,0,8,circadian sleep/wake cycle process,BP,
6572,GO:0022605,1,0.886267814624479,0,4,mammalian oogenesis stage,BP,
6577,GO:0022614,1,0.906161983398555,0,3,membrane to membrane docking,BP,
6578,GO:0022615,1,0.891560820299263,0,4,protein to membrane docking,BP,
6582,GO:0022622,1,0.974543632249742,0,1,root system development,BP,
6583,GO:0022624,1,0.507968697855327,0,24,proteasome accessory complex,CC,
6586,GO:0022627,1,0.313138504285312,0,43,cytosolic small ribosomal subunit,CC,
6589,GO:0022821,1,0.743970949630444,0,9,potassium ion antiporter activity,MF,
6590,GO:0022824,1,0.774677412085365,0,8,transmitter-gated ion channel activity,MF,
6591,GO:0022829,1,0.678116949263632,0,13,wide pore channel activity,MF,
6594,GO:0022835,1,0.774677412085365,0,8,transmitter-gated channel activity,MF,
6598,GO:0022840,1,0.888184635146199,0,4,leak channel activity,MF,
6599,GO:0022841,1,0.916054980726805,0,3,potassium ion leak channel activity,MF,
6600,GO:0022842,1,0.888184635146199,0,4,narrow pore channel activity,MF,
6602,GO:0022848,1,0.884518050729622,0,4,acetylcholine-gated cation-selective channel activity,MF,
6603,GO:0022849,1,0.966922312324612,0,1,glutamate-gated calcium ion channel activity,MF,
6604,GO:0022851,1,0.9686969601558,0,1,GABA-gated chloride ion channel activity,MF,
6605,GO:0022853,1,0.339416420581845,0,35,active ion transmembrane transporter activity,MF,
6607,GO:0022858,1,0.851869496610947,0,5,alanine transmembrane transporter activity,MF,
6608,GO:0022884,1,0.670619479067905,0,14,macromolecule transmembrane transporter activity,MF,
6609,GO:0022889,1,0.810003342309486,0,7,serine transmembrane transporter activity,MF,
6611,GO:0022894,1,0.971060890270179,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
6614,GO:0022904,1,0.0722152385398109,0,94,respiratory electron transport chain,BP,
6616,GO:0023016,1,0.936255226487344,0,2,signal transduction by trans-phosphorylation,BP,
6618,GO:0023021,1,0.913530613985782,0,3,termination of signal transduction,BP,
6620,GO:0023024,1,0.968616412039525,0,1,MHC class I protein complex binding,MF,
6621,GO:0023025,1,0.940691726534812,0,2,MHC class Ib protein complex binding,MF,
6623,GO:0023029,1,0.881952596751597,0,4,MHC class Ib protein binding,MF,
6624,GO:0023030,1,0.940691726534812,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
6625,GO:0023035,1,0.828243491735248,0,6,CD40 signaling pathway,BP,
6626,GO:0023041,1,0.915725833904313,0,3,neuronal signal transduction,BP,
6637,GO:0030007,1,0.800532587919193,0,7,cellular potassium ion homeostasis,BP,
6638,GO:0030008,1,0.683638872152334,0,13,TRAPP complex,CC,
6640,GO:0030011,1,0.750460187570373,0,9,maintenance of cell polarity,BP,
6641,GO:0030014,1,0.622144307327627,0,15,CCR4-NOT complex,CC,
6642,GO:0030015,1,0.85506109481713,0,5,CCR4-NOT core complex,CC,
6647,GO:0030021,1,0.96885044160037,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6654,GO:0030033,1,0.617409697966654,0,15,microvillus assembly,BP,
6655,GO:0030035,1,0.906441388418322,0,3,microspike assembly,BP,
6657,GO:0030037,1,0.966945713497047,0,1,actin filament reorganization involved in cell cycle,BP,
6660,GO:0030042,1,0.330212079817009,0,35,actin filament depolymerization,BP,
6661,GO:0030043,1,0.889113791858682,0,4,actin filament fragmentation,BP,
6662,GO:0030046,1,0.906494414815351,0,3,parallel actin filament bundle assembly,BP,
6663,GO:0030047,1,0.906766265153959,0,3,actin modification,BP,
6669,GO:0030056,1,0.816521230483905,0,6,hemidesmosome,CC,
6671,GO:0030060,1,0.920996013428948,0,3,L-malate dehydrogenase activity,MF,
6673,GO:0030062,1,0.836942555570449,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6674,GO:0030070,1,0.909461597345709,0,3,insulin processing,BP,
6684,GO:0030103,1,0.968691981319906,0,1,vasopressin secretion,BP,
6686,GO:0030108,1,0.973146913806439,0,1,HLA-A specific activating MHC class I receptor activity,MF,
6692,GO:0030121,1,0.827021576733749,0,6,AP-1 adaptor complex,CC,
6693,GO:0030122,1,0.681770649628455,0,12,AP-2 adaptor complex,CC,
6694,GO:0030123,1,0.749449645439895,0,9,AP-3 adaptor complex,CC,
6695,GO:0030124,1,0.887462965533233,0,4,AP-4 adaptor complex,CC,
6696,GO:0030125,1,0.46995058079967,0,24,clathrin vesicle coat,CC,
6697,GO:0030126,1,0.633706670101544,0,15,COPI vesicle coat,CC,
6699,GO:0030128,1,0.65927421785469,0,13,clathrin coat of endocytic vesicle,CC,
6700,GO:0030130,1,0.709709146285244,0,11,clathrin coat of trans-Golgi network vesicle,CC,
6702,GO:0030132,1,0.585833722845653,0,17,clathrin coat of coated pit,CC,
6707,GO:0030137,1,0.499504154751795,0,23,COPI-coated vesicle,CC,
6709,GO:0030140,1,0.418358980045016,0,28,trans-Golgi network transport vesicle,CC,
6714,GO:0030149,1,0.562607729848085,0,19,sphingolipid catabolic process,BP,
6715,GO:0030150,1,0.593934077071923,0,18,protein import into mitochondrial matrix,BP,
6716,GO:0030151,1,0.884359409572211,0,4,molybdenum ion binding,MF,
6719,GO:0030156,1,0.974614828529272,0,1,benzodiazepine receptor binding,MF,
6720,GO:0030157,1,0.776709800581376,0,8,pancreatic juice secretion,BP,
6721,GO:0030158,1,0.907066365267854,0,3,protein xylosyltransferase activity,MF,
6722,GO:0030159,1,0.544430577968453,0,19,receptor signaling complex scaffold activity,MF,
6723,GO:0030160,1,0.908628027484506,0,3,GKAP/Homer scaffold activity,MF,
6727,GO:0030166,1,0.248579364310251,0,43,proteoglycan biosynthetic process,BP,
6728,GO:0030167,1,0.912492878721341,0,3,proteoglycan catabolic process,BP,
6730,GO:0030169,1,0.820853696274181,0,6,low-density lipoprotein particle binding,MF,
6731,GO:0030170,1,0.36269287951332,0,33,pyridoxal phosphate binding,MF,
6742,GO:0030194,1,0.652189316108687,0,14,positive regulation of blood coagulation,BP,
6746,GO:0030200,1,0.912492878721341,0,3,heparan sulfate proteoglycan catabolic process,BP,
6747,GO:0030201,1,0.446739816369167,0,25,heparan sulfate proteoglycan metabolic process,BP,
6748,GO:0030202,1,0.875458507606664,0,4,heparin metabolic process,BP,
6750,GO:0030204,1,0.423199655286039,0,27,chondroitin sulfate metabolic process,BP,
6751,GO:0030205,1,0.753986309389803,0,9,dermatan sulfate metabolic process,BP,
6752,GO:0030206,1,0.558948504256821,0,18,chondroitin sulfate biosynthetic process,BP,
6753,GO:0030207,1,0.757371722286962,0,9,chondroitin sulfate catabolic process,BP,
6754,GO:0030208,1,0.776358775331845,0,8,dermatan sulfate biosynthetic process,BP,
6755,GO:0030209,1,0.97120252451975,0,1,dermatan sulfate catabolic process,BP,
6756,GO:0030210,1,0.875458507606664,0,4,heparin biosynthetic process,BP,
6759,GO:0030214,1,0.671234592518236,0,13,hyaluronan catabolic process,BP,
6770,GO:0030226,1,0.903536190175396,0,3,apolipoprotein receptor activity,MF,
6772,GO:0030229,1,0.905264155308037,0,3,very-low-density lipoprotein particle receptor activity,MF,
6773,GO:0030233,1,0.972737387699977,0,1,deoxynucleotide transmembrane transporter activity,MF,
6776,GO:0030237,1,0.937788823497037,0,2,female sex determination,BP,
6777,GO:0030238,1,0.824131814937801,0,6,male sex determination,BP,
6779,GO:0030240,1,0.966202232756588,0,1,skeletal muscle thin filament assembly,BP,
6780,GO:0030241,1,0.934163910572691,0,2,skeletal muscle myosin thick filament assembly,BP,
6781,GO:0030242,1,0.849452249680563,0,5,autophagy of peroxisome,BP,
6784,GO:0030249,1,0.970984185518004,0,1,guanylate cyclase regulator activity,MF,
6785,GO:0030250,1,0.970984185518004,0,1,guanylate cyclase activator activity,MF,
6788,GO:0030259,1,0.885372446546894,0,4,lipid glycosylation,BP,
6790,GO:0030261,1,0.411272202453935,0,28,chromosome condensation,BP,
6791,GO:0030262,1,0.48373706603663,0,24,apoptotic nuclear changes,BP,
6792,GO:0030263,1,0.878077207992564,0,4,apoptotic chromosome condensation,BP,
6793,GO:0030264,1,0.969271124374127,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6794,GO:0030267,1,0.914981292865502,0,3,glyoxylate reductase (NADP) activity,MF,
6795,GO:0030272,1,0.974358623205144,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
6797,GO:0030275,1,0.612722948863414,0,16,LRR domain binding,MF,
6799,GO:0030277,1,0.779934956732172,0,8,maintenance of gastrointestinal epithelium,BP,
6804,GO:0030283,1,0.974233001572932,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
6805,GO:0030284,1,0.852623767011447,0,5,estrogen receptor activity,MF,
6806,GO:0030285,1,0.800351692605192,0,7,integral component of synaptic vesicle membrane,CC,
6807,GO:0030286,1,0.347333300047929,0,34,dynein complex,CC,
6808,GO:0030289,1,0.888401436184869,0,4,protein phosphatase 4 complex,CC,
6809,GO:0030290,1,0.967971317716669,0,1,sphingolipid activator protein activity,MF,
6811,GO:0030292,1,0.91284210173846,0,3,protein tyrosine kinase inhibitor activity,MF,
6812,GO:0030294,1,0.971159748494165,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
6816,GO:0030298,1,0.973694495626685,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
6817,GO:0030299,1,0.913486926825375,0,3,intestinal cholesterol absorption,BP,
6819,GO:0030302,1,0.972737387699977,0,1,deoxynucleotide transport,BP,
6820,GO:0030305,1,0.972424186264088,0,1,heparanase activity,MF,
6821,GO:0030306,1,0.81967332704017,0,6,ADP-ribosylation factor binding,MF,
6824,GO:0030309,1,0.787447702942191,0,8,poly-N-acetyllactosamine metabolic process,BP,
6825,GO:0030311,1,0.787447702942191,0,8,poly-N-acetyllactosamine biosynthetic process,BP,
6826,GO:0030314,1,0.936181986808423,0,2,junctional membrane complex,CC,
6829,GO:0030317,1,0.422435350340425,0,28,flagellated sperm motility,BP,
6830,GO:0030318,1,0.657845791982721,0,13,melanocyte differentiation,BP,
6832,GO:0030321,1,0.937716708131965,0,2,transepithelial chloride transport,BP,
6833,GO:0030322,1,0.914798148251695,0,3,stabilization of membrane potential,BP,
6838,GO:0030327,1,0.908663146290974,0,3,prenylated protein catabolic process,BP,
6839,GO:0030328,1,0.938037227479163,0,2,prenylcysteine catabolic process,BP,
6840,GO:0030329,1,0.938037227479163,0,2,prenylcysteine metabolic process,BP,
6847,GO:0030337,1,0.943539804964205,0,2,DNA polymerase processivity factor activity,MF,
6848,GO:0030342,1,0.968660324416577,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
6849,GO:0030343,1,0.972807317934447,0,1,vitamin D3 25-hydroxylase activity,MF,
6850,GO:0030345,1,0.96885044160037,0,1,structural constituent of tooth enamel,MF,
6851,GO:0030346,1,0.830846440544886,0,6,protein phosphatase 2B binding,MF,
6852,GO:0030348,1,0.939965149590902,0,2,syntaxin-3 binding,MF,
6854,GO:0030351,1,0.96937967616693,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
6857,GO:0030371,1,0.544322512867894,0,19,translation repressor activity,MF,
6858,GO:0030372,1,0.966990835225408,0,1,high molecular weight B cell growth factor receptor binding,MF,
6859,GO:0030374,1,0.163980962470778,0,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,
6860,GO:0030375,1,0.905950278037873,0,3,thyroid hormone receptor coactivator activity,MF,
6861,GO:0030377,1,0.97322865209353,0,1,urokinase plasminogen activator receptor activity,MF,
6862,GO:0030378,1,0.970365496604871,0,1,serine racemase activity,MF,
6863,GO:0030379,1,0.966841851870227,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
6864,GO:0030388,1,0.888600885874315,0,4,fructose 1,6-bisphosphate metabolic process,BP,
6865,GO:0030389,1,0.974708918692917,0,1,fructosamine metabolic process,BP,
6867,GO:0030397,1,0.238249219041805,0,46,membrane disassembly,BP,
6869,GO:0030421,1,0.974333202735356,0,1,defecation,BP,
6870,GO:0030422,1,0.76545876655293,0,9,production of siRNA involved in RNA interference,BP,
6871,GO:0030423,1,0.884801331937792,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
6876,GO:0030430,1,0.882435899805913,0,4,host cell cytoplasm,CC,
6877,GO:0030431,1,0.67547189089283,0,13,sleep,BP,
6881,GO:0030473,1,0.846861587884526,0,5,nuclear migration along microtubule,BP,
6882,GO:0030474,1,0.969271124374127,0,1,spindle pole body duplication,BP,
6883,GO:0030478,1,0.877526326814229,0,4,actin cap,CC,
6884,GO:0030479,1,0.845544913180521,0,5,actin cortical patch,CC,
6885,GO:0030485,1,0.940874123208409,0,2,smooth muscle contractile fiber,CC,
6887,GO:0030490,1,0.20671617225833,0,53,maturation of SSU-rRNA,BP,
6889,GO:0030497,1,0.735862763186267,0,10,fatty acid elongation,BP,
6892,GO:0030502,1,0.822981688959535,0,6,negative regulation of bone mineralization,BP,
6893,GO:0030504,1,0.966812339540493,0,1,inorganic diphosphate transmembrane transporter activity,MF,
6902,GO:0030514,1,0.436683665161248,0,26,negative regulation of BMP signaling pathway,BP,
6903,GO:0030515,1,0.41238118939684,0,30,snoRNA binding,MF,
6908,GO:0030521,1,0.161191702020457,0,58,androgen receptor signaling pathway,BP,
6910,GO:0030523,1,0.967194743315477,0,1,dihydrolipoamide S-acyltransferase activity,MF,
6911,GO:0030532,1,0.127377969697429,0,69,small nuclear ribonucleoprotein complex,CC,
6913,GO:0030538,1,0.937775274348139,0,2,embryonic genitalia morphogenesis,BP,
6914,GO:0030539,1,0.77052073346339,0,8,male genitalia development,BP,
6919,GO:0030547,1,0.640159283246751,0,15,receptor inhibitor activity,MF,
6920,GO:0030548,1,0.84031985161577,0,6,acetylcholine receptor regulator activity,MF,
6921,GO:0030549,1,0.973848697763532,0,1,acetylcholine receptor activator activity,MF,
6922,GO:0030550,1,0.911699645640207,0,3,acetylcholine receptor inhibitor activity,MF,
6923,GO:0030551,1,0.579290782763598,0,17,cyclic nucleotide binding,MF,
6924,GO:0030552,1,0.675966913786388,0,12,cAMP binding,MF,
6925,GO:0030553,1,0.904974431877414,0,3,cGMP binding,MF,
6927,GO:0030572,1,0.967682878933317,0,1,phosphatidyltransferase activity,MF,
6930,GO:0030576,1,0.911093421508052,0,3,Cajal body organization,BP,
6932,GO:0030579,1,0.855598224108967,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
6933,GO:0030580,1,0.973608638681413,0,1,quinone cofactor methyltransferase activity,MF,
6934,GO:0030581,1,0.947568880251219,0,2,symbiont intracellular protein transport in host,BP,
6935,GO:0030586,1,0.968435086332893,0,1,[methionine synthase] reductase activity,MF,
6939,GO:0030611,1,0.974307653684223,0,1,arsenate reductase activity,MF,
6940,GO:0030613,1,0.923950831468729,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6941,GO:0030614,1,0.923950831468729,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
6942,GO:0030616,1,0.966798584676304,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
6943,GO:0030617,1,0.968839959821639,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
6944,GO:0030618,1,0.875797682317527,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
6945,GO:0030619,1,0.812483583325989,0,7,U1 snRNA binding,MF,
6946,GO:0030620,1,0.844235801398312,0,6,U2 snRNA binding,MF,
6947,GO:0030621,1,0.827331128510827,0,6,U4 snRNA binding,MF,
6948,GO:0030622,1,0.910186125419351,0,3,U4atac snRNA binding,MF,
6949,GO:0030623,1,0.966834285663228,0,1,U5 snRNA binding,MF,
6950,GO:0030624,1,0.967175809730914,0,1,U6atac snRNA binding,MF,
6951,GO:0030626,1,0.940624872723851,0,2,U12 snRNA binding,MF,
6952,GO:0030627,1,0.943871352934208,0,2,pre-mRNA 5'-splice site binding,MF,
6953,GO:0030628,1,0.839677979019714,0,6,pre-mRNA 3'-splice site binding,MF,
6954,GO:0030629,1,0.969271124374127,0,1,U6 snRNA 3'-end binding,MF,
6955,GO:0030638,1,0.868782159101456,0,5,polyketide metabolic process,BP,
6958,GO:0030644,1,0.941048709274744,0,2,cellular chloride ion homeostasis,BP,
6959,GO:0030647,1,0.868782159101456,0,5,aminoglycoside antibiotic metabolic process,BP,
6960,GO:0030653,1,0.966925946302879,0,1,beta-lactam antibiotic metabolic process,BP,
6966,GO:0030663,1,0.582835206168809,0,18,COPI-coated vesicle membrane,CC,
6970,GO:0030669,1,0.469054665149721,0,24,clathrin-coated endocytic vesicle membrane,CC,
6975,GO:0030676,1,0.674402040677124,0,12,Rac guanyl-nucleotide exchange factor activity,MF,
6977,GO:0030678,1,0.915957329131748,0,3,mitochondrial ribonuclease P complex,CC,
6979,GO:0030682,1,0.937639811421786,0,2,evasion or tolerance of host defense response,BP,
6980,GO:0030683,1,0.937639811421786,0,2,evasion or tolerance by virus of host immune response,BP,
6981,GO:0030684,1,0.110478921737149,0,73,preribosome,CC,
6982,GO:0030686,1,0.374926696093638,0,32,90S preribosome,CC,
6983,GO:0030687,1,0.506652148911519,0,23,preribosome, large subunit precursor,CC,
6984,GO:0030688,1,0.693079694533566,0,12,preribosome, small subunit precursor,CC,
6985,GO:0030689,1,0.913966879847465,0,3,Noc complex,CC,
6986,GO:0030690,1,0.969463757265561,0,1,Noc1p-Noc2p complex,CC,
6987,GO:0030691,1,0.969463757265561,0,1,Noc2p-Noc3p complex,CC,
6988,GO:0030692,1,0.942759802814697,0,2,Noc4p-Nop14p complex,CC,
6990,GO:0030696,1,0.968682049984167,0,1,tRNA (m5U54) methyltransferase activity,MF,
6991,GO:0030697,1,0.968682049984167,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
6992,GO:0030702,1,0.967440622921063,0,1,chromatin silencing at centromere,BP,
6994,GO:0030718,1,0.967644765305439,0,1,germ-line stem cell population maintenance,BP,
6995,GO:0030719,1,0.970104831459515,0,1,P granule organization,BP,
6997,GO:0030729,1,0.968360528740919,0,1,acetoacetate-CoA ligase activity,MF,
6999,GO:0030731,1,0.974128837485256,0,1,guanidinoacetate N-methyltransferase activity,MF,
7000,GO:0030735,1,0.969271124374127,0,1,carnosine N-methyltransferase activity,MF,
7001,GO:0030742,1,0.541713895434917,0,20,GTP-dependent protein binding,MF,
7002,GO:0030748,1,0.970146860703029,0,1,amine N-methyltransferase activity,MF,
7003,GO:0030760,1,0.972905619836635,0,1,pyridine N-methyltransferase activity,MF,
7004,GO:0030791,1,0.970394206106407,0,1,arsenite methyltransferase activity,MF,
7005,GO:0030792,1,0.970394206106407,0,1,methylarsonite methyltransferase activity,MF,
7008,GO:0030801,1,0.546010926482718,0,20,positive regulation of cyclic nucleotide metabolic process,BP,
7011,GO:0030804,1,0.635570110232851,0,15,positive regulation of cyclic nucleotide biosynthetic process,BP,
7014,GO:0030807,1,0.966868378302473,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7017,GO:0030810,1,0.37077837536272,0,32,positive regulation of nucleotide biosynthetic process,BP,
7020,GO:0030813,1,0.69631084364883,0,11,positive regulation of nucleotide catabolic process,BP,
7023,GO:0030816,1,0.696990676880812,0,12,positive regulation of cAMP metabolic process,BP,
7026,GO:0030819,1,0.762233404174252,0,9,positive regulation of cAMP biosynthetic process,BP,
7029,GO:0030822,1,0.966868378302473,0,1,positive regulation of cAMP catabolic process,BP,
7030,GO:0030823,1,0.664844758046247,0,13,regulation of cGMP metabolic process,BP,
7031,GO:0030825,1,0.783572649515898,0,8,positive regulation of cGMP metabolic process,BP,
7032,GO:0030826,1,0.806569494959395,0,7,regulation of cGMP biosynthetic process,BP,
7033,GO:0030828,1,0.833938887753411,0,6,positive regulation of cGMP biosynthetic process,BP,
7036,GO:0030834,1,0.364760148501026,0,32,regulation of actin filament depolymerization,BP,
7037,GO:0030835,1,0.464699351252447,0,24,negative regulation of actin filament depolymerization,BP,
7038,GO:0030836,1,0.809589520061776,0,7,positive regulation of actin filament depolymerization,BP,
7042,GO:0030849,1,0.966915617076266,0,1,autosome,CC,
7052,GO:0030859,1,0.619165477793495,0,15,polarized epithelial cell differentiation,BP,
7053,GO:0030860,1,0.938178575921468,0,2,regulation of polarized epithelial cell differentiation,BP,
7054,GO:0030862,1,0.966881269277234,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7062,GO:0030874,1,0.972548007553948,0,1,nucleolar chromatin,CC,
7063,GO:0030877,1,0.726902380291641,0,10,beta-catenin destruction complex,CC,
7064,GO:0030878,1,0.624361866530183,0,15,thyroid gland development,BP,
7067,GO:0030881,1,0.841511521295982,0,6,beta-2-microglobulin binding,MF,
7068,GO:0030882,1,0.967704783231378,0,1,lipid antigen binding,MF,
7069,GO:0030883,1,0.967704783231378,0,1,endogenous lipid antigen binding,MF,
7070,GO:0030884,1,0.967704783231378,0,1,exogenous lipid antigen binding,MF,
7071,GO:0030885,1,0.91989645491632,0,3,regulation of myeloid dendritic cell activation,BP,
7072,GO:0030886,1,0.944392283995138,0,2,negative regulation of myeloid dendritic cell activation,BP,
7076,GO:0030891,1,0.885930557442141,0,4,VCB complex,CC,
7077,GO:0030893,1,0.907997351136476,0,3,meiotic cohesin complex,CC,
7078,GO:0030894,1,0.45664249311414,0,26,replisome,CC,
7079,GO:0030895,1,0.942747376757642,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7080,GO:0030896,1,0.885314237688928,0,4,checkpoint clamp complex,CC,
7081,GO:0030897,1,0.637918091289569,0,14,HOPS complex,CC,
7083,GO:0030899,1,0.974125042245415,0,1,calcium-dependent ATPase activity,MF,
7087,GO:0030903,1,0.706969332208812,0,11,notochord development,BP,
7088,GO:0030904,1,0.537045686202087,0,20,retromer complex,CC,
7089,GO:0030905,1,0.884135396599595,0,4,retromer, tubulation complex,CC,
7090,GO:0030906,1,0.885435535627807,0,4,retromer, cargo-selective complex,CC,
7091,GO:0030910,1,0.936162794447199,0,2,olfactory placode formation,BP,
7096,GO:0030916,1,0.904922097840074,0,3,otic vesicle formation,BP,
7097,GO:0030917,1,0.88379100423237,0,4,midbrain-hindbrain boundary development,BP,
7098,GO:0030920,1,0.974353186685951,0,1,peptidyl-serine acetylation,BP,
7101,GO:0030936,1,0.968892728804353,0,1,transmembrane collagen trimer,CC,
7102,GO:0030942,1,0.917551885174056,0,3,endoplasmic reticulum signal peptide binding,MF,
7103,GO:0030943,1,0.913372769131287,0,3,mitochondrion targeting sequence binding,MF,
7108,GO:0030951,1,0.879916604230287,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7111,GO:0030955,1,0.74755122417947,0,9,potassium ion binding,MF,
7112,GO:0030956,1,0.914335147779862,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7113,GO:0030957,1,0.738279845333849,0,10,Tat protein binding,MF,
7114,GO:0030961,1,0.969271124374127,0,1,peptidyl-arginine hydroxylation,BP,
7115,GO:0030964,1,0.326506911951027,0,42,NADH dehydrogenase complex,CC,
7117,GO:0030969,1,0.909696875897417,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7120,GO:0030974,1,0.972737387699977,0,1,thiamine pyrophosphate transmembrane transport,BP,
7121,GO:0030976,1,0.853923980059074,0,5,thiamine pyrophosphate binding,MF,
7122,GO:0030981,1,0.906669495646831,0,3,cortical microtubule cytoskeleton,CC,
7123,GO:0030983,1,0.667049249492179,0,13,mismatched DNA binding,MF,
7124,GO:0030984,1,0.943892940538031,0,2,kininogen binding,MF,
7126,GO:0030991,1,0.769260037050563,0,8,intraciliary transport particle A,CC,
7128,GO:0030997,1,0.909275314801975,0,3,regulation of centriole-centriole cohesion,BP,
7131,GO:0031010,1,0.727411141418987,0,10,ISWI-type complex,CC,
7132,GO:0031011,1,0.646089695383988,0,15,Ino80 complex,CC,
7134,GO:0031013,1,0.972602434471036,0,1,troponin I binding,MF,
7135,GO:0031014,1,0.949401666048959,0,2,troponin T binding,MF,
7139,GO:0031021,1,0.914244697105105,0,3,interphase microtubule organizing center,CC,
7140,GO:0031022,1,0.935344779049474,0,2,nuclear migration along microfilament,BP,
7143,GO:0031033,1,0.849175314709218,0,5,myosin filament organization,BP,
7144,GO:0031034,1,0.874136110990019,0,4,myosin filament assembly,BP,
7145,GO:0031038,1,0.971455551403725,0,1,myosin II filament organization,BP,
7148,GO:0031048,1,0.937383612531307,0,2,chromatin silencing by small RNA,BP,
7149,GO:0031049,1,0.969425204500395,0,1,programmed DNA elimination,BP,
7151,GO:0031052,1,0.969425204500395,0,1,chromosome breakage,BP,
7152,GO:0031053,1,0.727639592670125,0,10,primary miRNA processing,BP,
7153,GO:0031054,1,0.667738255023371,0,13,pre-miRNA processing,BP,
7154,GO:0031055,1,0.306356659587884,0,42,chromatin remodeling at centromere,BP,
7159,GO:0031061,1,0.597808953150076,0,16,negative regulation of histone methylation,BP,
7162,GO:0031064,1,0.934723043513281,0,2,negative regulation of histone deacetylation,BP,
7164,GO:0031069,1,0.581976157623568,0,17,hair follicle morphogenesis,BP,
7165,GO:0031071,1,0.970658070045869,0,1,cysteine desulfurase activity,MF,
7167,GO:0031074,1,0.910850681495173,0,3,nucleocytoplasmic transport complex,CC,
7169,GO:0031077,1,0.808038437901348,0,7,post-embryonic camera-type eye development,BP,
7170,GO:0031078,1,0.70566307339394,0,11,histone deacetylase activity (H3-K14 specific),MF,
7171,GO:0031080,1,0.73104951879783,0,10,nuclear pore outer ring,CC,
7172,GO:0031081,1,0.937581056835452,0,2,nuclear pore distribution,BP,
7173,GO:0031082,1,0.579314144359112,0,18,BLOC complex,CC,
7174,GO:0031083,1,0.680979667049238,0,13,BLOC-1 complex,CC,
7175,GO:0031084,1,0.907078670073663,0,3,BLOC-2 complex,CC,
7176,GO:0031085,1,0.938029170046573,0,2,BLOC-3 complex,CC,
7177,GO:0031086,1,0.780779480135219,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7178,GO:0031087,1,0.805788606490178,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7179,GO:0031088,1,0.857686807014442,0,5,platelet dense granule membrane,CC,
7180,GO:0031089,1,0.861017897331617,0,5,platelet dense granule lumen,CC,
7183,GO:0031092,1,0.703371854366296,0,11,platelet alpha granule membrane,CC,
7192,GO:0031104,1,0.967388361166563,0,1,dendrite regeneration,BP,
7193,GO:0031105,1,0.747282433868377,0,9,septin complex,CC,
7194,GO:0031106,1,0.678474849001225,0,12,septin ring organization,BP,
7196,GO:0031110,1,0.164787502220468,0,57,regulation of microtubule polymerization or depolymerization,BP,
7197,GO:0031111,1,0.424506017648811,0,27,negative regulation of microtubule polymerization or depolymerization,BP,
7198,GO:0031112,1,0.469459916750212,0,24,positive regulation of microtubule polymerization or depolymerization,BP,
7199,GO:0031113,1,0.321627441280976,0,36,regulation of microtubule polymerization,BP,
7200,GO:0031114,1,0.492985969973385,0,22,regulation of microtubule depolymerization,BP,
7201,GO:0031115,1,0.755153109578002,0,9,negative regulation of microtubule polymerization,BP,
7202,GO:0031116,1,0.499754229120157,0,22,positive regulation of microtubule polymerization,BP,
7203,GO:0031117,1,0.939493068831548,0,2,positive regulation of microtubule depolymerization,BP,
7204,GO:0031118,1,0.802534574847226,0,8,rRNA pseudouridine synthesis,BP,
7206,GO:0031120,1,0.897153484781367,0,4,snRNA pseudouridine synthesis,BP,
7210,GO:0031125,1,0.71736180375321,0,12,rRNA 3'-end processing,BP,
7211,GO:0031126,1,0.82478973260678,0,7,snoRNA 3'-end processing,BP,
7212,GO:0031127,1,0.93711563622514,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7213,GO:0031128,1,0.589213568075357,0,17,developmental induction,BP,
7215,GO:0031134,1,0.911250670369527,0,3,sister chromatid biorientation,BP,
7216,GO:0031143,1,0.687182234389836,0,12,pseudopodium,CC,
7219,GO:0031151,1,0.966831115194704,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7220,GO:0031161,1,0.968714956774415,0,1,phosphatidylinositol catabolic process,BP,
7221,GO:0031163,1,0.563109913921916,0,20,metallo-sulfur cluster assembly,BP,
7222,GO:0031166,1,0.907072635094099,0,3,integral component of vacuolar membrane,CC,
7223,GO:0031167,1,0.537860520576995,0,21,rRNA methylation,BP,
7225,GO:0031177,1,0.918602255599685,0,3,phosphopantetheine binding,MF,
7226,GO:0031179,1,0.96777033007464,0,1,peptide modification,BP,
7228,GO:0031204,1,0.911563796869431,0,3,posttranslational protein targeting to membrane, translocation,BP,
7230,GO:0031208,1,0.93795473398648,0,2,POZ domain binding,MF,
7231,GO:0031209,1,0.768943325631992,0,8,SCAR complex,CC,
7232,GO:0031210,1,0.69395302912043,0,12,phosphatidylcholine binding,MF,
7234,GO:0031213,1,0.93559073057381,0,2,RSF complex,CC,
7236,GO:0031223,1,0.818751268930585,0,6,auditory behavior,BP,
7242,GO:0031229,1,0.773812306444201,0,8,intrinsic component of nuclear inner membrane,CC,
7243,GO:0031231,1,0.639751437450667,0,15,intrinsic component of peroxisomal membrane,CC,
7245,GO:0031233,1,0.697621973890062,0,12,intrinsic component of external side of plasma membrane,CC,
7247,GO:0031235,1,0.696538201979628,0,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7250,GO:0031249,1,0.970529952885172,0,1,denatured protein binding,MF,
7251,GO:0031251,1,0.934867168240458,0,2,PAN complex,CC,
7257,GO:0031260,1,0.973980540001144,0,1,pseudopodium membrane,CC,
7258,GO:0031261,1,0.859696509621031,0,5,DNA replication preinitiation complex,CC,
7259,GO:0031262,1,0.895737318061983,0,4,Ndc80 complex,CC,
7260,GO:0031264,1,0.76128780836558,0,9,death-inducing signaling complex,CC,
7261,GO:0031265,1,0.833499406109846,0,6,CD95 death-inducing signaling complex,CC,
7263,GO:0031268,1,0.694871624413365,0,12,pseudopodium organization,BP,
7264,GO:0031269,1,0.713452267674787,0,11,pseudopodium assembly,BP,
7265,GO:0031272,1,0.761332533413892,0,9,regulation of pseudopodium assembly,BP,
7266,GO:0031274,1,0.761332533413892,0,9,positive regulation of pseudopodium assembly,BP,
7267,GO:0031279,1,0.575604978073083,0,18,regulation of cyclase activity,BP,
7268,GO:0031280,1,0.808294745004163,0,7,negative regulation of cyclase activity,BP,
7269,GO:0031281,1,0.758202269189233,0,9,positive regulation of cyclase activity,BP,
7270,GO:0031282,1,0.885579119160691,0,4,regulation of guanylate cyclase activity,BP,
7271,GO:0031284,1,0.885579119160691,0,4,positive regulation of guanylate cyclase activity,BP,
7272,GO:0031289,1,0.968920525610699,0,1,actin phosphorylation,BP,
7274,GO:0031291,1,0.913286475610364,0,3,Ran protein signal transduction,BP,
7278,GO:0031296,1,0.973771704445665,0,1,B cell costimulation,BP,
7279,GO:0031297,1,0.441127555967062,0,26,replication fork processing,BP,
7280,GO:0031298,1,0.75839245022686,0,9,replication fork protection complex,CC,
7283,GO:0031302,1,0.966917666705161,0,1,intrinsic component of endosome membrane,CC,
7284,GO:0031304,1,0.345494949773623,0,36,intrinsic component of mitochondrial inner membrane,CC,
7285,GO:0031305,1,0.345494949773623,0,36,integral component of mitochondrial inner membrane,CC,
7286,GO:0031306,1,0.512112693341967,0,22,intrinsic component of mitochondrial outer membrane,CC,
7287,GO:0031307,1,0.529588499671715,0,21,integral component of mitochondrial outer membrane,CC,
7288,GO:0031310,1,0.907072635094099,0,3,intrinsic component of vacuolar membrane,CC,
7291,GO:0031314,1,0.853359648631377,0,5,extrinsic component of mitochondrial inner membrane,CC,
7292,GO:0031315,1,0.966842588914203,0,1,extrinsic component of mitochondrial outer membrane,CC,
7293,GO:0031320,1,0.970225831804016,0,1,hexitol dehydrogenase activity,MF,
7306,GO:0031335,1,0.970979761919229,0,1,regulation of sulfur amino acid metabolic process,BP,
7307,GO:0031337,1,0.970979761919229,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7309,GO:0031339,1,0.909616403768046,0,3,negative regulation of vesicle fusion,BP,
7320,GO:0031362,1,0.762638394216389,0,9,anchored component of external side of plasma membrane,CC,
7321,GO:0031365,1,0.469508276321598,0,24,N-terminal protein amino acid modification,BP,
7323,GO:0031370,1,0.967006887748022,0,1,eukaryotic initiation factor 4G binding,MF,
7324,GO:0031371,1,0.786873934828601,0,8,ubiquitin conjugating enzyme complex,CC,
7325,GO:0031372,1,0.944009302816489,0,2,UBC13-MMS2 complex,CC,
7326,GO:0031379,1,0.944597846197676,0,2,RNA-directed RNA polymerase complex,CC,
7327,GO:0031380,1,0.968435086332893,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7328,GO:0031386,1,0.712709103912742,0,12,protein tag,MF,
7329,GO:0031389,1,0.969256884090773,0,1,Rad17 RFC-like complex,CC,
7330,GO:0031390,1,0.788313357554426,0,8,Ctf18 RFC-like complex,CC,
7332,GO:0031393,1,0.937402447950454,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7335,GO:0031397,1,0.169680461238345,0,58,negative regulation of protein ubiquitination,BP,
7340,GO:0031402,1,0.771252202131204,0,8,sodium ion binding,MF,
7341,GO:0031403,1,0.9361329545644,0,2,lithium ion binding,MF,
7342,GO:0031404,1,0.91194702236869,0,3,chloride ion binding,MF,
7343,GO:0031405,1,0.966750387190908,0,1,lipoic acid binding,MF,
7345,GO:0031407,1,0.970696080330584,0,1,oxylipin metabolic process,BP,
7347,GO:0031414,1,0.757002971808128,0,9,N-terminal protein acetyltransferase complex,CC,
7348,GO:0031415,1,0.886592294175457,0,4,NatA complex,CC,
7349,GO:0031416,1,0.94174683650452,0,2,NatB complex,CC,
7350,GO:0031417,1,0.906711424932782,0,3,NatC complex,CC,
7352,GO:0031419,1,0.807099843371812,0,7,cobalamin binding,MF,
7353,GO:0031420,1,0.656324569980209,0,13,alkali metal ion binding,MF,
7355,GO:0031427,1,0.908234025825828,0,3,response to methotrexate,BP,
7356,GO:0031428,1,0.867210964143044,0,5,box C/D snoRNP complex,CC,
7357,GO:0031429,1,0.873706427278388,0,5,box H/ACA snoRNP complex,CC,
7359,GO:0031431,1,0.938013329906645,0,2,Dbf4-dependent protein kinase complex,CC,
7360,GO:0031432,1,0.781715958224731,0,8,titin binding,MF,
7361,GO:0031433,1,0.966202232756588,0,1,telethonin binding,MF,
7363,GO:0031435,1,0.599623695952667,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7364,GO:0031436,1,0.937857625056968,0,2,BRCA1-BARD1 complex,CC,
7365,GO:0031437,1,0.909424946753834,0,3,regulation of mRNA cleavage,BP,
7366,GO:0031438,1,0.968863067200497,0,1,negative regulation of mRNA cleavage,BP,
7367,GO:0031439,1,0.938656827518302,0,2,positive regulation of mRNA cleavage,BP,
7370,GO:0031442,1,0.756079664321831,0,9,positive regulation of mRNA 3'-end processing,BP,
7371,GO:0031443,1,0.966845632021391,0,1,fast-twitch skeletal muscle fiber contraction,BP,
7372,GO:0031444,1,0.974125042245415,0,1,slow-twitch skeletal muscle fiber contraction,BP,
7373,GO:0031445,1,0.940430616933096,0,2,regulation of heterochromatin assembly,BP,
7374,GO:0031453,1,0.940430616933096,0,2,positive regulation of heterochromatin assembly,BP,
7375,GO:0031455,1,0.96799442435341,0,1,glycine betaine metabolic process,BP,
7376,GO:0031456,1,0.96799442435341,0,1,glycine betaine biosynthetic process,BP,
7377,GO:0031460,1,0.966964748702037,0,1,glycine betaine transport,BP,
7378,GO:0031461,1,0.00726652611483926,0,157,cullin-RING ubiquitin ligase complex,CC,
7379,GO:0031462,1,0.690083823760367,0,12,Cul2-RING ubiquitin ligase complex,CC,
7380,GO:0031463,1,0.19776403111101,0,51,Cul3-RING ubiquitin ligase complex,CC,
7381,GO:0031464,1,0.692877896648641,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7382,GO:0031465,1,0.857279507559567,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7383,GO:0031466,1,0.887183432351476,0,4,Cul5-RING ubiquitin ligase complex,CC,
7384,GO:0031467,1,0.860869737178852,0,5,Cul7-RING ubiquitin ligase complex,CC,
7386,GO:0031475,1,0.97304016346374,0,1,myosin V complex,CC,
7387,GO:0031489,1,0.675377160501932,0,13,myosin V binding,MF,
7388,GO:0031490,1,0.061484075214628,0,92,chromatin DNA binding,MF,
7389,GO:0031491,1,0.140510963150186,0,66,nucleosome binding,MF,
7390,GO:0031492,1,0.300699187404953,0,42,nucleosomal DNA binding,MF,
7391,GO:0031493,1,0.912018693869804,0,3,nucleosomal histone binding,MF,
7393,GO:0031498,1,0.587550290104636,0,17,chromatin disassembly,BP,
7394,GO:0031501,1,0.897040916528317,0,4,mannosyltransferase complex,CC,
7396,GO:0031506,1,0.972400159260788,0,1,cell wall glycoprotein biosynthetic process,BP,
7398,GO:0031508,1,0.943414477804097,0,2,pericentric heterochromatin assembly,BP,
7399,GO:0031509,1,0.972752451305582,0,1,telomeric heterochromatin assembly,BP,
7400,GO:0031510,1,0.91589652115998,0,3,SUMO activating enzyme complex,CC,
7402,GO:0031515,1,0.914158836526339,0,3,tRNA (m1A) methyltransferase complex,CC,
7404,GO:0031523,1,0.937504831947416,0,2,Myb complex,CC,
7409,GO:0031530,1,0.972563614139016,0,1,gonadotropin-releasing hormone receptor binding,MF,
7410,GO:0031531,1,0.973480177859163,0,1,thyrotropin-releasing hormone receptor binding,MF,
7412,GO:0031533,1,0.96686298944931,0,1,mRNA cap methyltransferase complex,CC,
7413,GO:0031536,1,0.893566740872264,0,4,positive regulation of exit from mitosis,BP,
7415,GO:0031544,1,0.882340827059017,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7417,GO:0031547,1,0.934966316605291,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
7419,GO:0031559,1,0.967257521265074,0,1,oxidosqualene cyclase activity,MF,
7423,GO:0031573,1,0.678373501187548,0,13,intra-S DNA damage checkpoint,BP,
7426,GO:0031580,1,0.83592093216724,0,6,membrane raft distribution,BP,
7427,GO:0031581,1,0.701953821093784,0,11,hemidesmosome assembly,BP,
7429,GO:0031584,1,0.861436304973974,0,5,activation of phospholipase D activity,BP,
7430,GO:0031585,1,0.874305515821257,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7431,GO:0031587,1,0.904413499407302,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7432,GO:0031588,1,0.751603313790397,0,9,nucleotide-activated protein kinase complex,CC,
7434,GO:0031590,1,0.939438198796461,0,2,wybutosine metabolic process,BP,
7435,GO:0031591,1,0.939438198796461,0,2,wybutosine biosynthetic process,BP,
7436,GO:0031592,1,0.966818911246537,0,1,centrosomal corona,CC,
7439,GO:0031595,1,0.799084471576736,0,8,nuclear proteasome complex,CC,
7440,GO:0031597,1,0.705381170204985,0,12,cytosolic proteasome complex,CC,
7441,GO:0031616,1,0.766390207767717,0,9,spindle pole centrosome,CC,
7442,GO:0031618,1,0.77798475375305,0,8,nuclear pericentric heterochromatin,CC,
7448,GO:0031626,1,0.966907762965002,0,1,beta-endorphin binding,MF,
7449,GO:0031627,1,0.90919037823959,0,3,telomeric loop formation,BP,
7450,GO:0031628,1,0.8819973146882,0,4,opioid receptor binding,MF,
7451,GO:0031629,1,0.737290750760751,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7452,GO:0031630,1,0.967553199987795,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7453,GO:0031635,1,0.972152030821871,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7458,GO:0031642,1,0.826152026037546,0,6,negative regulation of myelination,BP,
7461,GO:0031645,1,0.803648383621443,0,7,negative regulation of neurological system process,BP,
7467,GO:0031651,1,0.96732830948403,0,1,negative regulation of heat generation,BP,
7471,GO:0031659,1,0.850826277274748,0,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7475,GO:0031666,1,0.884127137698586,0,4,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7481,GO:0031673,1,0.966606834006373,0,1,H zone,CC,
7483,GO:0031681,1,0.854277219172893,0,5,G-protein beta-subunit binding,MF,
7484,GO:0031682,1,0.968938833098782,0,1,G-protein gamma-subunit binding,MF,
7485,GO:0031683,1,0.691513009905067,0,12,G-protein beta/gamma-subunit complex binding,MF,
7486,GO:0031685,1,0.937229249323957,0,2,adenosine receptor binding,MF,
7487,GO:0031686,1,0.968804589995683,0,1,A1 adenosine receptor binding,MF,
7489,GO:0031691,1,0.94402147275147,0,2,alpha-1A adrenergic receptor binding,MF,
7490,GO:0031692,1,0.94402147275147,0,2,alpha-1B adrenergic receptor binding,MF,
7491,GO:0031694,1,0.973893711366085,0,1,alpha-2A adrenergic receptor binding,MF,
7492,GO:0031697,1,0.877747859674167,0,4,beta-1 adrenergic receptor binding,MF,
7494,GO:0031699,1,0.96732830948403,0,1,beta-3 adrenergic receptor binding,MF,
7495,GO:0031700,1,0.973208056237655,0,1,adrenomedullin receptor binding,MF,
7496,GO:0031701,1,0.773399679934271,0,8,angiotensin receptor binding,MF,
7497,GO:0031702,1,0.796367126741275,0,7,type 1 angiotensin receptor binding,MF,
7498,GO:0031704,1,0.968570346802033,0,1,apelin receptor binding,MF,
7502,GO:0031726,1,0.973694495626685,0,1,CCR1 chemokine receptor binding,MF,
7503,GO:0031729,1,0.973694495626685,0,1,CCR4 chemokine receptor binding,MF,
7504,GO:0031730,1,0.859009591148994,0,5,CCR5 chemokine receptor binding,MF,
7505,GO:0031731,1,0.975074575144133,0,1,CCR6 chemokine receptor binding,MF,
7506,GO:0031748,1,0.85603279457954,0,5,D1 dopamine receptor binding,MF,
7507,GO:0031749,1,0.937406454220892,0,2,D2 dopamine receptor binding,MF,
7508,GO:0031752,1,0.935122900202306,0,2,D5 dopamine receptor binding,MF,
7509,GO:0031753,1,0.969516579258239,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7510,GO:0031755,1,0.969516579258239,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
7511,GO:0031762,1,0.94402147275147,0,2,follicle-stimulating hormone receptor binding,MF,
7512,GO:0031763,1,0.974543632249742,0,1,galanin receptor binding,MF,
7513,GO:0031764,1,0.974543632249742,0,1,type 1 galanin receptor binding,MF,
7514,GO:0031765,1,0.974543632249742,0,1,type 2 galanin receptor binding,MF,
7515,GO:0031766,1,0.974543632249742,0,1,type 3 galanin receptor binding,MF,
7516,GO:0031775,1,0.966811552121987,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7517,GO:0031798,1,0.966826241955533,0,1,type 1 metabotropic glutamate receptor binding,MF,
7518,GO:0031802,1,0.910823147639836,0,3,type 5 metabotropic glutamate receptor binding,MF,
7519,GO:0031811,1,0.967575366468036,0,1,G-protein coupled nucleotide receptor binding,MF,
7520,GO:0031812,1,0.967575366468036,0,1,P2Y1 nucleotide receptor binding,MF,
7521,GO:0031821,1,0.831709122266925,0,6,G-protein coupled serotonin receptor binding,MF,
7522,GO:0031826,1,0.918499571324336,0,3,type 2A serotonin receptor binding,MF,
7523,GO:0031839,1,0.974480330032443,0,1,type 1 neuromedin U receptor binding,MF,
7524,GO:0031840,1,0.974480330032443,0,1,type 2 neuromedin U receptor binding,MF,
7525,GO:0031848,1,0.730486262391422,0,10,protection from non-homologous end joining at telomere,BP,
7527,GO:0031852,1,0.8819973146882,0,4,mu-type opioid receptor binding,MF,
7528,GO:0031859,1,0.972040302067759,0,1,platelet activating factor receptor binding,MF,
7530,GO:0031862,1,0.935576558281461,0,2,prostanoid receptor binding,MF,
7531,GO:0031867,1,0.967640794534725,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
7532,GO:0031870,1,0.966866422445734,0,1,thromboxane A2 receptor binding,MF,
7533,GO:0031871,1,0.910135262454824,0,3,proteinase activated receptor binding,MF,
7534,GO:0031883,1,0.971476064424368,0,1,taste receptor binding,MF,
7535,GO:0031893,1,0.971177450789815,0,1,vasopressin receptor binding,MF,
7536,GO:0031896,1,0.971177450789815,0,1,V2 vasopressin receptor binding,MF,
7539,GO:0031903,1,0.207417614299046,0,51,microbody membrane,CC,
7540,GO:0031904,1,0.601448702501743,0,17,endosome lumen,CC,
7541,GO:0031905,1,0.91494034530451,0,3,early endosome lumen,CC,
7542,GO:0031906,1,0.942486889795506,0,2,late endosome lumen,CC,
7543,GO:0031907,1,0.395457761333693,0,31,microbody lumen,CC,
7544,GO:0031914,1,0.913840304130419,0,3,negative regulation of synaptic plasticity,BP,
7545,GO:0031915,1,0.855987541284727,0,5,positive regulation of synaptic plasticity,BP,
7547,GO:0031930,1,0.973175847900552,0,1,mitochondria-nucleus signaling pathway,BP,
7548,GO:0031931,1,0.801764760189222,0,7,TORC1 complex,CC,
7550,GO:0031933,1,0.913280089008979,0,3,telomeric heterochromatin,CC,
7551,GO:0031935,1,0.5243293972651,0,20,regulation of chromatin silencing,BP,
7552,GO:0031936,1,0.772330653323832,0,8,negative regulation of chromatin silencing,BP,
7553,GO:0031937,1,0.771272663253079,0,8,positive regulation of chromatin silencing,BP,
7554,GO:0031938,1,0.94550319061087,0,2,regulation of chromatin silencing at telomere,BP,
7555,GO:0031940,1,0.972752451305582,0,1,positive regulation of chromatin silencing at telomere,BP,
7557,GO:0031943,1,0.780384527068721,0,8,regulation of glucocorticoid metabolic process,BP,
7558,GO:0031944,1,0.879757456734689,0,4,negative regulation of glucocorticoid metabolic process,BP,
7559,GO:0031945,1,0.96756951466631,0,1,positive regulation of glucocorticoid metabolic process,BP,
7560,GO:0031946,1,0.823150792544682,0,6,regulation of glucocorticoid biosynthetic process,BP,
7561,GO:0031947,1,0.879757456734689,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
7562,GO:0031948,1,0.96756951466631,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
7566,GO:0031956,1,0.876794331906253,0,4,medium-chain fatty acid-CoA ligase activity,MF,
7567,GO:0031957,1,0.804497658004029,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7569,GO:0031959,1,0.937182629722062,0,2,mineralocorticoid receptor signaling pathway,BP,
7571,GO:0031962,1,0.966870848147765,0,1,mineralocorticoid receptor binding,MF,
7585,GO:0031990,1,0.938564344261543,0,2,mRNA export from nucleus in response to heat stress,BP,
7589,GO:0031997,1,0.914359952735077,0,3,N-terminal myristoylation domain binding,MF,
7590,GO:0031998,1,0.696265144980009,0,11,regulation of fatty acid beta-oxidation,BP,
7591,GO:0031999,1,0.937137774348697,0,2,negative regulation of fatty acid beta-oxidation,BP,
7592,GO:0032000,1,0.845358250175632,0,5,positive regulation of fatty acid beta-oxidation,BP,
7593,GO:0032002,1,0.942080693223148,0,2,interleukin-28 receptor complex,CC,
7594,GO:0032006,1,0.089763876274196,0,77,regulation of TOR signaling,BP,
7595,GO:0032007,1,0.322942091413584,0,36,negative regulation of TOR signaling,BP,
7596,GO:0032008,1,0.396738411148166,0,30,positive regulation of TOR signaling,BP,
7601,GO:0032020,1,0.841945090674454,0,6,ISG15-protein conjugation,BP,
7602,GO:0032021,1,0.882620775853877,0,4,NELF complex,CC,
7604,GO:0032025,1,0.739842587316313,0,10,response to cobalt ion,BP,
7605,GO:0032026,1,0.793888953673886,0,7,response to magnesium ion,BP,
7606,GO:0032027,1,0.909838676273599,0,3,myosin light chain binding,MF,
7607,GO:0032028,1,0.971458482824321,0,1,myosin head/neck binding,MF,
7608,GO:0032029,1,0.96672856532305,0,1,myosin tail binding,MF,
7610,GO:0032039,1,0.657422370550477,0,13,integrator complex,CC,
7611,GO:0032040,1,0.369094196703161,0,33,small-subunit processome,CC,
7612,GO:0032041,1,0.70566307339394,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7614,GO:0032044,1,0.941748940616413,0,2,DSIF complex,CC,
7615,GO:0032045,1,0.780305962851065,0,8,guanyl-nucleotide exchange factor complex,CC,
7616,GO:0032048,1,0.649660683263057,0,14,cardiolipin metabolic process,BP,
7617,GO:0032049,1,0.782748741178967,0,8,cardiolipin biosynthetic process,BP,
7618,GO:0032050,1,0.803774569905616,0,7,clathrin heavy chain binding,MF,
7619,GO:0032051,1,0.847178454296651,0,5,clathrin light chain binding,MF,
7620,GO:0032052,1,0.864438658085018,0,5,bile acid binding,MF,
7621,GO:0032053,1,0.937137725613869,0,2,ciliary basal body organization,BP,
7622,GO:0032055,1,0.828333190282771,0,6,negative regulation of translation in response to stress,BP,
7624,GO:0032057,1,0.879620252674338,0,4,negative regulation of translational initiation in response to stress,BP,
7626,GO:0032059,1,0.801628534089756,0,7,bleb,CC,
7627,GO:0032060,1,0.731367047248396,0,10,bleb assembly,BP,
7629,GO:0032070,1,0.762673467287331,0,9,regulation of deoxyribonuclease activity,BP,
7630,GO:0032071,1,0.807965311486626,0,7,regulation of endodeoxyribonuclease activity,BP,
7631,GO:0032072,1,0.968210245910427,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7632,GO:0032074,1,0.829823713255836,0,6,negative regulation of nuclease activity,BP,
7634,GO:0032076,1,0.969718338266846,0,1,negative regulation of deoxyribonuclease activity,BP,
7635,GO:0032077,1,0.862486537045867,0,5,positive regulation of deoxyribonuclease activity,BP,
7636,GO:0032079,1,0.886013331534774,0,4,positive regulation of endodeoxyribonuclease activity,BP,
7639,GO:0032090,1,0.943196394141364,0,2,Pyrin domain binding,MF,
7642,GO:0032093,1,0.969271124374127,0,1,SAM domain binding,MF,
7644,GO:0032095,1,0.786655815434605,0,8,regulation of response to food,BP,
7645,GO:0032096,1,0.837006535327489,0,6,negative regulation of response to food,BP,
7646,GO:0032097,1,0.972152030821871,0,1,positive regulation of response to food,BP,
7647,GO:0032098,1,0.786720884346794,0,8,regulation of appetite,BP,
7648,GO:0032099,1,0.837006535327489,0,6,negative regulation of appetite,BP,
7649,GO:0032100,1,0.972152030821871,0,1,positive regulation of appetite,BP,
7653,GO:0032104,1,0.651408902422451,0,14,regulation of response to extracellular stimulus,BP,
7654,GO:0032105,1,0.786223051931748,0,8,negative regulation of response to extracellular stimulus,BP,
7655,GO:0032106,1,0.916312984000691,0,3,positive regulation of response to extracellular stimulus,BP,
7656,GO:0032107,1,0.651408902422451,0,14,regulation of response to nutrient levels,BP,
7657,GO:0032108,1,0.786223051931748,0,8,negative regulation of response to nutrient levels,BP,
7658,GO:0032109,1,0.916312984000691,0,3,positive regulation of response to nutrient levels,BP,
7659,GO:0032116,1,0.937055430197349,0,2,SMC loading complex,CC,
7660,GO:0032119,1,0.787409231270541,0,8,sequestering of zinc ion,BP,
7662,GO:0032129,1,0.941266565891632,0,2,histone deacetylase activity (H3-K9 specific),MF,
7663,GO:0032133,1,0.890362503161674,0,4,chromosome passenger complex,CC,
7664,GO:0032135,1,0.827547393265851,0,6,DNA insertion or deletion binding,MF,
7665,GO:0032137,1,0.909190427357559,0,3,guanine/thymine mispair binding,MF,
7666,GO:0032138,1,0.878311821534927,0,4,single base insertion or deletion binding,MF,
7667,GO:0032139,1,0.911901754331849,0,3,dinucleotide insertion or deletion binding,MF,
7668,GO:0032142,1,0.906052836624282,0,3,single guanine insertion binding,MF,
7669,GO:0032143,1,0.936931201196273,0,2,single thymine insertion binding,MF,
7670,GO:0032144,1,0.966958766715114,0,1,4-aminobutyrate transaminase complex,CC,
7671,GO:0032145,1,0.966958766715114,0,1,succinate-semialdehyde dehydrogenase binding,MF,
7677,GO:0032156,1,0.722813438416372,0,10,septin cytoskeleton,CC,
7678,GO:0032160,1,0.747282433868377,0,9,septin filament array,CC,
7679,GO:0032173,1,0.96902196849067,0,1,septin collar,CC,
7680,GO:0032181,1,0.936772627988305,0,2,dinucleotide repeat insertion binding,MF,
7683,GO:0032184,1,0.878127725847015,0,4,SUMO polymer binding,MF,
7684,GO:0032185,1,0.657604273054307,0,13,septin cytoskeleton organization,BP,
7685,GO:0032190,1,0.947282059724529,0,2,acrosin binding,MF,
7686,GO:0032194,1,0.967873889023191,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
7687,GO:0032196,1,0.625784066931724,0,15,transposition,BP,
7688,GO:0032197,1,0.967540232229231,0,1,transposition, RNA-mediated,BP,
7690,GO:0032201,1,0.444470561246334,0,27,telomere maintenance via semi-conservative replication,BP,
7691,GO:0032202,1,0.88789931622795,0,4,telomere assembly,BP,
7692,GO:0032203,1,0.972172812265828,0,1,telomere formation via telomerase,BP,
7696,GO:0032207,1,0.969254516020708,0,1,regulation of telomere maintenance via recombination,BP,
7697,GO:0032208,1,0.969254516020708,0,1,negative regulation of telomere maintenance via recombination,BP,
7698,GO:0032210,1,0.204487731999963,0,51,regulation of telomere maintenance via telomerase,BP,
7699,GO:0032211,1,0.549378004494706,0,19,negative regulation of telomere maintenance via telomerase,BP,
7700,GO:0032212,1,0.36431846841384,0,33,positive regulation of telomere maintenance via telomerase,BP,
7701,GO:0032213,1,0.939371268088885,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7702,GO:0032214,1,0.939371268088885,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
7703,GO:0032216,1,0.971031383184015,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
7704,GO:0032217,1,0.91060985903053,0,3,riboflavin transmembrane transporter activity,MF,
7705,GO:0032218,1,0.91060985903053,0,3,riboflavin transport,BP,
7706,GO:0032222,1,0.96677543328334,0,1,regulation of synaptic transmission, cholinergic,BP,
7707,GO:0032224,1,0.96677543328334,0,1,positive regulation of synaptic transmission, cholinergic,BP,
7708,GO:0032225,1,0.716711999754486,0,11,regulation of synaptic transmission, dopaminergic,BP,
7709,GO:0032226,1,0.862232373617417,0,5,positive regulation of synaptic transmission, dopaminergic,BP,
7710,GO:0032227,1,0.905976857448711,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
7713,GO:0032230,1,0.799207385001798,0,7,positive regulation of synaptic transmission, GABAergic,BP,
7715,GO:0032232,1,0.638461407645499,0,14,negative regulation of actin filament bundle assembly,BP,
7717,GO:0032237,1,0.904774906417865,0,3,activation of store-operated calcium channel activity,BP,
7718,GO:0032239,1,0.595042047107711,0,16,regulation of nucleobase-containing compound transport,BP,
7719,GO:0032240,1,0.934749146487717,0,2,negative regulation of nucleobase-containing compound transport,BP,
7720,GO:0032241,1,0.798620194779953,0,7,positive regulation of nucleobase-containing compound transport,BP,
7721,GO:0032252,1,0.906030811945534,0,3,secretory granule localization,BP,
7722,GO:0032253,1,0.969271124374127,0,1,dense core granule localization,BP,
7723,GO:0032258,1,0.941481884138061,0,2,protein localization by the Cvt pathway,BP,
7725,GO:0032261,1,0.815802318620313,0,7,purine nucleotide salvage,BP,
7726,GO:0032262,1,0.869721279698313,0,5,pyrimidine nucleotide salvage,BP,
7727,GO:0032263,1,0.945995402903846,0,2,GMP salvage,BP,
7728,GO:0032264,1,0.885448788057537,0,4,IMP salvage,BP,
7729,GO:0032266,1,0.372299453302803,0,31,phosphatidylinositol-3-phosphate binding,MF,
7736,GO:0032274,1,0.799434044519282,0,7,gonadotropin secretion,BP,
7737,GO:0032275,1,0.850655537264763,0,5,luteinizing hormone secretion,BP,
7738,GO:0032276,1,0.91011593865979,0,3,regulation of gonadotropin secretion,BP,
7739,GO:0032277,1,0.971270332458308,0,1,negative regulation of gonadotropin secretion,BP,
7740,GO:0032278,1,0.91011593865979,0,3,positive regulation of gonadotropin secretion,BP,
7742,GO:0032280,1,0.8744633271114,0,4,symmetric synapse,CC,
7743,GO:0032281,1,0.712489755477714,0,11,AMPA glutamate receptor complex,CC,
7744,GO:0032286,1,0.908468401566338,0,3,central nervous system myelin maintenance,BP,
7745,GO:0032287,1,0.772218709957013,0,8,peripheral nervous system myelin maintenance,BP,
7747,GO:0032289,1,0.911551949391596,0,3,central nervous system myelin formation,BP,
7748,GO:0032290,1,0.90353949925734,0,3,peripheral nervous system myelin formation,BP,
7751,GO:0032296,1,0.88130582073325,0,4,double-stranded RNA-specific ribonuclease activity,MF,
7752,GO:0032298,1,0.971059414813402,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
7753,GO:0032299,1,0.918609786429905,0,3,ribonuclease H2 complex,CC,
7754,GO:0032300,1,0.68126267013677,0,12,mismatch repair complex,CC,
7755,GO:0032301,1,0.936931201196273,0,2,MutSalpha complex,CC,
7756,GO:0032302,1,0.936772627988305,0,2,MutSbeta complex,CC,
7758,GO:0032304,1,0.966932510670261,0,1,negative regulation of icosanoid secretion,BP,
7764,GO:0032311,1,0.946965614101456,0,2,angiogenin-PRI complex,CC,
7766,GO:0032328,1,0.823715638158268,0,6,alanine transport,BP,
7768,GO:0032330,1,0.438575071027819,0,26,regulation of chondrocyte differentiation,BP,
7769,GO:0032331,1,0.690880636336313,0,12,negative regulation of chondrocyte differentiation,BP,
7770,GO:0032332,1,0.700406012076959,0,11,positive regulation of chondrocyte differentiation,BP,
7771,GO:0032341,1,0.879605861768887,0,4,aldosterone metabolic process,BP,
7772,GO:0032342,1,0.879605861768887,0,4,aldosterone biosynthetic process,BP,
7773,GO:0032344,1,0.879605861768887,0,4,regulation of aldosterone metabolic process,BP,
7774,GO:0032345,1,0.909095843726365,0,3,negative regulation of aldosterone metabolic process,BP,
7775,GO:0032346,1,0.96756951466631,0,1,positive regulation of aldosterone metabolic process,BP,
7776,GO:0032347,1,0.879605861768887,0,4,regulation of aldosterone biosynthetic process,BP,
7777,GO:0032348,1,0.909095843726365,0,3,negative regulation of aldosterone biosynthetic process,BP,
7778,GO:0032349,1,0.96756951466631,0,1,positive regulation of aldosterone biosynthetic process,BP,
7785,GO:0032356,1,0.733519553827254,0,10,oxidized DNA binding,MF,
7786,GO:0032357,1,0.755103224045309,0,9,oxidized purine DNA binding,MF,
7787,GO:0032358,1,0.974434133110297,0,1,oxidized pyrimidine DNA binding,MF,
7788,GO:0032361,1,0.971763958231126,0,1,pyridoxal phosphate catabolic process,BP,
7790,GO:0032365,1,0.402506523196432,0,29,intracellular lipid transport,BP,
7791,GO:0032366,1,0.589814256629111,0,17,intracellular sterol transport,BP,
7792,GO:0032367,1,0.589814256629111,0,17,intracellular cholesterol transport,BP,
7802,GO:0032377,1,0.808004912984764,0,7,regulation of intracellular lipid transport,BP,
7803,GO:0032378,1,0.967883366036458,0,1,negative regulation of intracellular lipid transport,BP,
7804,GO:0032379,1,0.917552921981302,0,3,positive regulation of intracellular lipid transport,BP,
7805,GO:0032380,1,0.808004912984764,0,7,regulation of intracellular sterol transport,BP,
7806,GO:0032381,1,0.967883366036458,0,1,negative regulation of intracellular sterol transport,BP,
7807,GO:0032382,1,0.917552921981302,0,3,positive regulation of intracellular sterol transport,BP,
7808,GO:0032383,1,0.808004912984764,0,7,regulation of intracellular cholesterol transport,BP,
7809,GO:0032384,1,0.967883366036458,0,1,negative regulation of intracellular cholesterol transport,BP,
7810,GO:0032385,1,0.917552921981302,0,3,positive regulation of intracellular cholesterol transport,BP,
7814,GO:0032389,1,0.801879902050062,0,7,MutLalpha complex,CC,
7815,GO:0032391,1,0.486988604559329,0,23,photoreceptor connecting cilium,CC,
7817,GO:0032393,1,0.947466454452379,0,2,MHC class I receptor activity,MF,
7818,GO:0032395,1,0.922088845595436,0,3,MHC class II receptor activity,MF,
7819,GO:0032397,1,0.973146913806439,0,1,activating MHC class I receptor activity,MF,
7820,GO:0032398,1,0.972648651805797,0,1,MHC class Ib protein complex,CC,
7821,GO:0032400,1,0.494249935155314,0,23,melanosome localization,BP,
7822,GO:0032401,1,0.525421698540566,0,21,establishment of melanosome localization,BP,
7823,GO:0032402,1,0.543477742324598,0,20,melanosome transport,BP,
7824,GO:0032404,1,0.784389518783661,0,8,mismatch repair complex binding,MF,
7825,GO:0032405,1,0.85771343308275,0,5,MutLalpha complex binding,MF,
7826,GO:0032407,1,0.860056022282358,0,5,MutSalpha complex binding,MF,
7833,GO:0032415,1,0.911337834556724,0,3,regulation of sodium:proton antiporter activity,BP,
7834,GO:0032416,1,0.971758192172493,0,1,negative regulation of sodium:proton antiporter activity,BP,
7835,GO:0032417,1,0.937828398613807,0,2,positive regulation of sodium:proton antiporter activity,BP,
7837,GO:0032419,1,0.971087449616734,0,1,extrinsic component of lysosome membrane,CC,
7838,GO:0032420,1,0.475725567790612,0,24,stereocilium,CC,
7839,GO:0032421,1,0.421100198805483,0,28,stereocilium bundle,CC,
7840,GO:0032422,1,0.91089550069828,0,3,purine-rich negative regulatory element binding,MF,
7841,GO:0032423,1,0.968210245910427,0,1,regulation of mismatch repair,BP,
7842,GO:0032425,1,0.968210245910427,0,1,positive regulation of mismatch repair,BP,
7843,GO:0032426,1,0.804181686813625,0,7,stereocilium tip,CC,
7844,GO:0032427,1,0.939313971533104,0,2,GBD domain binding,MF,
7845,GO:0032428,1,0.967971317716669,0,1,beta-N-acetylgalactosaminidase activity,MF,
7847,GO:0032430,1,0.913844179294331,0,3,positive regulation of phospholipase A2 activity,BP,
7848,GO:0032431,1,0.945085374047882,0,2,activation of phospholipase A2 activity,BP,
7850,GO:0032433,1,0.677650023168952,0,12,filopodium tip,CC,
7854,GO:0032437,1,0.909607215505715,0,3,cuticular plate,CC,
7855,GO:0032438,1,0.512012716892142,0,22,melanosome organization,BP,
7856,GO:0032440,1,0.973638127989234,0,1,2-alkenal reductase [NAD(P)] activity,MF,
7857,GO:0032444,1,0.934658276697999,0,2,activin responsive factor complex,CC,
7859,GO:0032447,1,0.970440273114395,0,1,protein urmylation,BP,
7860,GO:0032449,1,0.853618647834368,0,5,CBM complex,CC,
7861,GO:0032450,1,0.936052262379461,0,2,maltose alpha-glucosidase activity,MF,
7863,GO:0032452,1,0.435417115442769,0,25,histone demethylase activity,MF,
7864,GO:0032453,1,0.819091726950917,0,6,histone demethylase activity (H3-K4 specific),MF,
7865,GO:0032454,1,0.672375960928412,0,12,histone demethylase activity (H3-K9 specific),MF,
7866,GO:0032455,1,0.907060388074441,0,3,nerve growth factor processing,BP,
7868,GO:0032458,1,0.967599649711493,0,1,slow endocytic recycling,BP,
7874,GO:0032464,1,0.836806141694937,0,6,positive regulation of protein homooligomerization,BP,
7876,GO:0032466,1,0.835270366279289,0,6,negative regulation of cytokinesis,BP,
7878,GO:0032468,1,0.968090020587988,0,1,Golgi calcium ion homeostasis,BP,
7880,GO:0032470,1,0.966811552121987,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
7881,GO:0032471,1,0.813967850241621,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
7882,GO:0032472,1,0.940852660047652,0,2,Golgi calcium ion transport,BP,
7883,GO:0032474,1,0.935686390867588,0,2,otolith morphogenesis,BP,
7888,GO:0032483,1,0.8768157541845,0,4,regulation of Rab protein signal transduction,BP,
7889,GO:0032484,1,0.905358858111097,0,3,Ral protein signal transduction,BP,
7890,GO:0032485,1,0.905358858111097,0,3,regulation of Ral protein signal transduction,BP,
7891,GO:0032486,1,0.656497659942335,0,13,Rap protein signal transduction,BP,
7892,GO:0032487,1,0.904990432233828,0,3,regulation of Rap protein signal transduction,BP,
7895,GO:0032490,1,0.878031407813847,0,4,detection of molecule of bacterial origin,BP,
7896,GO:0032493,1,0.910305758602509,0,3,response to bacterial lipoprotein,BP,
7900,GO:0032497,1,0.969798087908722,0,1,detection of lipopolysaccharide,BP,
7901,GO:0032498,1,0.967115907475312,0,1,detection of muramyl dipeptide,BP,
7902,GO:0032499,1,0.967115907475312,0,1,detection of peptidoglycan,BP,
7903,GO:0032500,1,0.967115907475312,0,1,muramyl dipeptide binding,MF,
7910,GO:0032509,1,0.529176677234087,0,21,endosome transport via multivesicular body sorting pathway,BP,
7911,GO:0032510,1,0.827736646369711,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7912,GO:0032511,1,0.791906951120101,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
7913,GO:0032515,1,0.340345533748807,0,35,negative regulation of phosphoprotein phosphatase activity,BP,
7915,GO:0032525,1,0.828000579883588,0,6,somite rostral/caudal axis specification,BP,
7918,GO:0032528,1,0.543966527733765,0,19,microvillus organization,BP,
7919,GO:0032530,1,0.725429596651823,0,10,regulation of microvillus organization,BP,
7920,GO:0032532,1,0.882895684303465,0,4,regulation of microvillus length,BP,
7921,GO:0032534,1,0.821703168351665,0,6,regulation of microvillus assembly,BP,
7924,GO:0032541,1,0.858999819990932,0,5,cortical endoplasmic reticulum,CC,
7925,GO:0032542,1,0.939195254396703,0,2,sulfiredoxin activity,MF,
7927,GO:0032545,1,0.912952336003134,0,3,CURI complex,CC,
7935,GO:0032556,1,0.946770402126176,0,2,pyrimidine deoxyribonucleotide binding,MF,
7939,GO:0032560,1,0.968608679122219,0,1,guanyl deoxyribonucleotide binding,MF,
7942,GO:0032567,1,0.968608679122219,0,1,dGTP binding,MF,
7943,GO:0032570,1,0.422610124066148,0,28,response to progesterone,BP,
7944,GO:0032571,1,0.939777123444209,0,2,response to vitamin K,BP,
7945,GO:0032574,1,0.967506802728099,0,1,5'-3' RNA helicase activity,MF,
7946,GO:0032575,1,0.967506802728099,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
7948,GO:0032581,1,0.972205946231389,0,1,ER-dependent peroxisome organization,BP,
7949,GO:0032584,1,0.908492444058276,0,3,growth cone membrane,CC,
7950,GO:0032585,1,0.740233129581779,0,10,multivesicular body membrane,CC,
7954,GO:0032590,1,0.626551531764941,0,15,dendrite membrane,CC,
7955,GO:0032591,1,0.820086354563149,0,6,dendritic spine membrane,CC,
7956,GO:0032592,1,0.142999510292481,0,65,integral component of mitochondrial membrane,CC,
7957,GO:0032593,1,0.833917069460694,0,6,insulin-responsive compartment,CC,
7958,GO:0032594,1,0.524874951189081,0,21,protein transport within lipid bilayer,BP,
7959,GO:0032595,1,0.97125559745736,0,1,B cell receptor transport within lipid bilayer,BP,
7960,GO:0032596,1,0.859346358662414,0,5,protein transport into membrane raft,BP,
7961,GO:0032597,1,0.97125559745736,0,1,B cell receptor transport into membrane raft,BP,
7962,GO:0032599,1,0.97125559745736,0,1,protein transport out of membrane raft,BP,
7963,GO:0032600,1,0.97125559745736,0,1,chemokine receptor transport out of membrane raft,BP,
7975,GO:0032616,1,0.736470161447798,0,10,interleukin-13 production,BP,
7976,GO:0032618,1,0.945773118789527,0,2,interleukin-15 production,BP,
7978,GO:0032621,1,0.826569158240551,0,6,interleukin-18 production,BP,
7980,GO:0032625,1,0.96799369750859,0,1,interleukin-21 production,BP,
7981,GO:0032627,1,0.885104318648295,0,4,interleukin-23 production,BP,
7982,GO:0032632,1,0.938721020237118,0,2,interleukin-3 production,BP,
7984,GO:0032634,1,0.773527341137675,0,8,interleukin-5 production,BP,
7987,GO:0032639,1,0.972648651805797,0,1,TRAIL production,BP,
7989,GO:0032641,1,0.968806659122999,0,1,lymphotoxin A production,BP,
8000,GO:0032656,1,0.756256924747214,0,9,regulation of interleukin-13 production,BP,
8001,GO:0032658,1,0.972373347402656,0,1,regulation of interleukin-15 production,BP,
8003,GO:0032661,1,0.854373517605395,0,5,regulation of interleukin-18 production,BP,
8005,GO:0032667,1,0.885104318648295,0,4,regulation of interleukin-23 production,BP,
8006,GO:0032672,1,0.938721020237118,0,2,regulation of interleukin-3 production,BP,
8008,GO:0032674,1,0.773527341137675,0,8,regulation of interleukin-5 production,BP,
8011,GO:0032679,1,0.972648651805797,0,1,regulation of TRAIL production,BP,
8013,GO:0032682,1,0.742136226751925,0,10,negative regulation of chemokine production,BP,
8014,GO:0032685,1,0.968484268882947,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8015,GO:0032687,1,0.859083701097664,0,5,negative regulation of interferon-alpha production,BP,
8018,GO:0032690,1,0.973244612249411,0,1,negative regulation of interleukin-1 alpha production,BP,
8023,GO:0032696,1,0.910597638750135,0,3,negative regulation of interleukin-13 production,BP,
8024,GO:0032700,1,0.862787192709315,0,5,negative regulation of interleukin-17 production,BP,
8025,GO:0032701,1,0.94211496736251,0,2,negative regulation of interleukin-18 production,BP,
8026,GO:0032703,1,0.688382655723376,0,12,negative regulation of interleukin-2 production,BP,
8027,GO:0032707,1,0.97068437805089,0,1,negative regulation of interleukin-23 production,BP,
8028,GO:0032712,1,0.970825151529268,0,1,negative regulation of interleukin-3 production,BP,
8030,GO:0032714,1,0.937002946348582,0,2,negative regulation of interleukin-5 production,BP,
8044,GO:0032736,1,0.830545707907224,0,6,positive regulation of interleukin-13 production,BP,
8045,GO:0032738,1,0.972373347402656,0,1,positive regulation of interleukin-15 production,BP,
8047,GO:0032741,1,0.93635005105993,0,2,positive regulation of interleukin-18 production,BP,
8049,GO:0032747,1,0.938904271948309,0,2,positive regulation of interleukin-23 production,BP,
8050,GO:0032752,1,0.966933724327514,0,1,positive regulation of interleukin-3 production,BP,
8051,GO:0032753,1,0.766328010934981,0,9,positive regulation of interleukin-4 production,BP,
8052,GO:0032754,1,0.825561705180465,0,6,positive regulation of interleukin-5 production,BP,
8055,GO:0032759,1,0.972648651805797,0,1,positive regulation of TRAIL production,BP,
8060,GO:0032765,1,0.968806659122999,0,1,positive regulation of mast cell cytokine production,BP,
8061,GO:0032767,1,0.912259352833961,0,3,copper-dependent protein binding,MF,
8065,GO:0032771,1,0.967237767497311,0,1,regulation of monophenol monooxygenase activity,BP,
8066,GO:0032773,1,0.967237767497311,0,1,positive regulation of monophenol monooxygenase activity,BP,
8068,GO:0032775,1,0.967837881937826,0,1,DNA methylation on adenine,BP,
8069,GO:0032776,1,0.904823172255726,0,3,DNA methylation on cytosine,BP,
8070,GO:0032777,1,0.8859617445025,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8071,GO:0032780,1,0.809903049492624,0,7,negative regulation of ATPase activity,BP,
8073,GO:0032782,1,0.944353824579532,0,2,bile acid secretion,BP,
8074,GO:0032783,1,0.880509028985011,0,4,ELL-EAF complex,CC,
8076,GO:0032785,1,0.710344763432859,0,11,negative regulation of DNA-templated transcription, elongation,BP,
8079,GO:0032788,1,0.972777461865426,0,1,saturated monocarboxylic acid metabolic process,BP,
8080,GO:0032789,1,0.972777461865426,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8081,GO:0032790,1,0.782969573378392,0,8,ribosome disassembly,BP,
8082,GO:0032792,1,0.884701187620627,0,4,negative regulation of CREB transcription factor activity,BP,
8083,GO:0032793,1,0.726945327109304,0,10,positive regulation of CREB transcription factor activity,BP,
8084,GO:0032794,1,0.637725484209208,0,14,GTPase activating protein binding,MF,
8085,GO:0032795,1,0.973990308704834,0,1,heterotrimeric G-protein binding,MF,
8087,GO:0032797,1,0.71495144607107,0,11,SMN complex,CC,
8088,GO:0032798,1,0.939484005877423,0,2,Swi5-Sfr1 complex,CC,
8092,GO:0032802,1,0.671187612827047,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8093,GO:0032803,1,0.859232004011482,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8094,GO:0032804,1,0.940949330101454,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8095,GO:0032805,1,0.942513934865267,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8097,GO:0032807,1,0.885141093142124,0,4,DNA ligase IV complex,CC,
8098,GO:0032808,1,0.876136818398856,0,4,lacrimal gland development,BP,
8099,GO:0032809,1,0.796300119439863,0,7,neuronal cell body membrane,CC,
8100,GO:0032810,1,0.940783432208415,0,2,sterol response element binding,MF,
8103,GO:0032815,1,0.866932276710347,0,5,negative regulation of natural killer cell activation,BP,
8108,GO:0032824,1,0.973797167582431,0,1,negative regulation of natural killer cell differentiation,BP,
8110,GO:0032826,1,0.973797167582431,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8111,GO:0032827,1,0.973797167582431,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8116,GO:0032847,1,0.941189977954904,0,2,regulation of cellular pH reduction,BP,
8117,GO:0032848,1,0.967631208065156,0,1,negative regulation of cellular pH reduction,BP,
8118,GO:0032849,1,0.972676700292057,0,1,positive regulation of cellular pH reduction,BP,
8125,GO:0032875,1,0.793062577239885,0,7,regulation of DNA endoreduplication,BP,
8126,GO:0032876,1,0.875053300609062,0,4,negative regulation of DNA endoreduplication,BP,
8127,GO:0032877,1,0.935720535440859,0,2,positive regulation of DNA endoreduplication,BP,
8128,GO:0032878,1,0.521274335534843,0,20,regulation of establishment or maintenance of cell polarity,BP,
8134,GO:0032887,1,0.966837517356414,0,1,regulation of spindle elongation,BP,
8135,GO:0032888,1,0.966837517356414,0,1,regulation of mitotic spindle elongation,BP,
8136,GO:0032889,1,0.970234331001904,0,1,regulation of vacuole fusion, non-autophagic,BP,
8138,GO:0032891,1,0.770599061651491,0,8,negative regulation of organic acid transport,BP,
8141,GO:0032898,1,0.906384449964542,0,3,neurotrophin production,BP,
8142,GO:0032899,1,0.967585551816704,0,1,regulation of neurotrophin production,BP,
8143,GO:0032901,1,0.967585551816704,0,1,positive regulation of neurotrophin production,BP,
8144,GO:0032902,1,0.936754156149716,0,2,nerve growth factor production,BP,
8145,GO:0032905,1,0.828862390932571,0,6,transforming growth factor beta1 production,BP,
8146,GO:0032906,1,0.821580070532335,0,6,transforming growth factor beta2 production,BP,
8147,GO:0032907,1,0.907870166352988,0,3,transforming growth factor beta3 production,BP,
8148,GO:0032908,1,0.828862390932571,0,6,regulation of transforming growth factor beta1 production,BP,
8149,GO:0032909,1,0.821580070532335,0,6,regulation of transforming growth factor beta2 production,BP,
8150,GO:0032910,1,0.907870166352988,0,3,regulation of transforming growth factor beta3 production,BP,
8151,GO:0032911,1,0.908212326695507,0,3,negative regulation of transforming growth factor beta1 production,BP,
8152,GO:0032912,1,0.967237767497311,0,1,negative regulation of transforming growth factor beta2 production,BP,
8153,GO:0032913,1,0.97125559745736,0,1,negative regulation of transforming growth factor beta3 production,BP,
8154,GO:0032914,1,0.912652633161108,0,3,positive regulation of transforming growth factor beta1 production,BP,
8155,GO:0032915,1,0.971426219894716,0,1,positive regulation of transforming growth factor beta2 production,BP,
8156,GO:0032916,1,0.93474370992109,0,2,positive regulation of transforming growth factor beta3 production,BP,
8157,GO:0032917,1,0.948789569640736,0,2,polyamine acetylation,BP,
8158,GO:0032918,1,0.948789569640736,0,2,spermidine acetylation,BP,
8159,GO:0032919,1,0.974207866339602,0,1,spermine acetylation,BP,
8160,GO:0032920,1,0.974207866339602,0,1,putrescine acetylation,BP,
8163,GO:0032925,1,0.609874100996589,0,16,regulation of activin receptor signaling pathway,BP,
8164,GO:0032926,1,0.804837425181251,0,7,negative regulation of activin receptor signaling pathway,BP,
8165,GO:0032927,1,0.828725376071025,0,6,positive regulation of activin receptor signaling pathway,BP,
8166,GO:0032928,1,0.723556808886419,0,11,regulation of superoxide anion generation,BP,
8167,GO:0032929,1,0.945006835603252,0,2,negative regulation of superoxide anion generation,BP,
8168,GO:0032930,1,0.79189631834901,0,8,positive regulation of superoxide anion generation,BP,
8169,GO:0032933,1,0.775943894757514,0,8,SREBP signaling pathway,BP,
8170,GO:0032934,1,0.36014251834683,0,33,sterol binding,MF,
8171,GO:0032937,1,0.909852439274076,0,3,SREBP-SCAP-Insig complex,CC,
8173,GO:0032941,1,0.539710625524771,0,20,secretion by tissue,BP,
8179,GO:0032954,1,0.936294018861029,0,2,regulation of cytokinetic process,BP,
8181,GO:0032957,1,0.769589148373679,0,8,inositol trisphosphate metabolic process,BP,
8182,GO:0032958,1,0.576855340246953,0,17,inositol phosphate biosynthetic process,BP,
8183,GO:0032959,1,0.821881500420236,0,6,inositol trisphosphate biosynthetic process,BP,
8184,GO:0032960,1,0.878414743627624,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8185,GO:0032962,1,0.908214982347167,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8188,GO:0032965,1,0.544413910298703,0,20,regulation of collagen biosynthetic process,BP,
8189,GO:0032966,1,0.861423652888221,0,5,negative regulation of collagen biosynthetic process,BP,
8190,GO:0032967,1,0.63211188422448,0,15,positive regulation of collagen biosynthetic process,BP,
8193,GO:0032976,1,0.974487401152989,0,1,release of matrix enzymes from mitochondria,BP,
8194,GO:0032977,1,0.967099891441876,0,1,membrane insertase activity,MF,
8195,GO:0032978,1,0.967099891441876,0,1,protein insertion into membrane from inner side,BP,
8196,GO:0032979,1,0.967099891441876,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8198,GO:0032981,1,0.221965585440835,0,55,mitochondrial respiratory chain complex I assembly,BP,
8201,GO:0032986,1,0.574102260610935,0,18,protein-DNA complex disassembly,BP,
8202,GO:0032988,1,0.673149001361932,0,13,ribonucleoprotein complex disassembly,BP,
8208,GO:0032996,1,0.972146479838463,0,1,Bcl3-Bcl10 complex,CC,
8212,GO:0033005,1,0.759263998367963,0,9,positive regulation of mast cell activation,BP,
8215,GO:0033008,1,0.782822814556355,0,8,positive regulation of mast cell activation involved in immune response,BP,
8218,GO:0033014,1,0.481767053920841,0,24,tetrapyrrole biosynthetic process,BP,
8220,GO:0033017,1,0.549263587088032,0,19,sarcoplasmic reticulum membrane,CC,
8222,GO:0033023,1,0.935939676499738,0,2,mast cell homeostasis,BP,
8223,GO:0033024,1,0.935939676499738,0,2,mast cell apoptotic process,BP,
8224,GO:0033025,1,0.935939676499738,0,2,regulation of mast cell apoptotic process,BP,
8225,GO:0033026,1,0.966889747864385,0,1,negative regulation of mast cell apoptotic process,BP,
8228,GO:0033030,1,0.966864184449371,0,1,negative regulation of neutrophil apoptotic process,BP,
8231,GO:0033033,1,0.783927725600704,0,8,negative regulation of myeloid cell apoptotic process,BP,
8234,GO:0033037,1,0.966875018878917,0,1,polysaccharide localization,BP,
8235,GO:0033038,1,0.852455317395133,0,6,bitter taste receptor activity,MF,
8236,GO:0033041,1,0.970141245305701,0,1,sweet taste receptor activity,MF,
8243,GO:0033058,1,0.969271124374127,0,1,directional locomotion,BP,
8244,GO:0033059,1,0.252782613483137,0,45,cellular pigmentation,BP,
8245,GO:0033061,1,0.761923752349957,0,9,DNA recombinase mediator complex,CC,
8246,GO:0033063,1,0.811031438116274,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8247,GO:0033065,1,0.945040070061743,0,2,Rad51C-XRCC3 complex,CC,
8248,GO:0033076,1,0.972037490433508,0,1,isoquinoline alkaloid metabolic process,BP,
8250,GO:0033078,1,0.940433914985073,0,2,extrathymic T cell differentiation,BP,
8252,GO:0033080,1,0.909795430077857,0,3,immature T cell proliferation in thymus,BP,
8254,GO:0033082,1,0.966958645220431,0,1,regulation of extrathymic T cell differentiation,BP,
8256,GO:0033084,1,0.940294698324458,0,2,regulation of immature T cell proliferation in thymus,BP,
8257,GO:0033085,1,0.864931748622636,0,5,negative regulation of T cell differentiation in thymus,BP,
8258,GO:0033087,1,0.914492111374083,0,3,negative regulation of immature T cell proliferation,BP,
8259,GO:0033088,1,0.940294698324458,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8263,GO:0033106,1,0.944439466593535,0,2,cis-Golgi network membrane,CC,
8266,GO:0033119,1,0.511714344483516,0,22,negative regulation of RNA splicing,BP,
8270,GO:0033123,1,0.966868378302473,0,1,positive regulation of purine nucleotide catabolic process,BP,
8272,GO:0033128,1,0.942773596479607,0,2,negative regulation of histone phosphorylation,BP,
8274,GO:0033130,1,0.823783205583381,0,6,acetylcholine receptor binding,MF,
8277,GO:0033133,1,0.886378402924917,0,4,positive regulation of glucokinase activity,BP,
8279,GO:0033137,1,0.506905454693847,0,22,negative regulation of peptidyl-serine phosphorylation,BP,
8281,GO:0033139,1,0.83571643271413,0,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8282,GO:0033140,1,0.942537890480393,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8283,GO:0033141,1,0.886683451742197,0,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8284,GO:0033142,1,0.971211372538033,0,1,progesterone receptor binding,MF,
8289,GO:0033147,1,0.725389374527751,0,10,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8291,GO:0033149,1,0.935749787243716,0,2,FFAT motif binding,MF,
8292,GO:0033151,1,0.680915271822551,0,12,V(D)J recombination,BP,
8293,GO:0033152,1,0.880674581968318,0,4,immunoglobulin V(D)J recombination,BP,
8294,GO:0033153,1,0.848500113398229,0,5,T cell receptor V(D)J recombination,BP,
8297,GO:0033159,1,0.90856684464757,0,3,negative regulation of protein import into nucleus, translocation,BP,
8299,GO:0033162,1,0.844063957307946,0,6,melanosome membrane,CC,
8300,GO:0033167,1,0.966763055442951,0,1,ARC complex,CC,
8301,GO:0033168,1,0.966763055442951,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8302,GO:0033169,1,0.652259289826397,0,13,histone H3-K9 demethylation,BP,
8303,GO:0033170,1,0.787831936414594,0,8,protein-DNA loading ATPase activity,MF,
8305,GO:0033176,1,0.557395869411053,0,20,proton-transporting V-type ATPase complex,CC,
8306,GO:0033177,1,0.770098101796632,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8307,GO:0033178,1,0.744212117421991,0,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8308,GO:0033179,1,0.791212860615631,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8309,GO:0033180,1,0.78669287436348,0,8,proton-transporting V-type ATPase, V1 domain,CC,
8310,GO:0033181,1,0.972663969273576,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
8312,GO:0033183,1,0.907249011532629,0,3,negative regulation of histone ubiquitination,BP,
8314,GO:0033185,1,0.924118894021634,0,3,dolichol-phosphate-mannose synthase complex,CC,
8315,GO:0033186,1,0.908976179873318,0,3,CAF-1 complex,CC,
8316,GO:0033188,1,0.910473575175235,0,3,sphingomyelin synthase activity,MF,
8318,GO:0033192,1,0.850474336900901,0,5,calmodulin-dependent protein phosphatase activity,MF,
8319,GO:0033194,1,0.67441299909003,0,13,response to hydroperoxide,BP,
8322,GO:0033202,1,0.646089695383988,0,15,DNA helicase complex,CC,
8324,GO:0033206,1,0.878579660929265,0,4,meiotic cytokinesis,BP,
8326,GO:0033210,1,0.802103220043405,0,7,leptin-mediated signaling pathway,BP,
8327,GO:0033211,1,0.857320876348174,0,5,adiponectin-activated signaling pathway,BP,
8330,GO:0033220,1,0.878619251538425,0,4,amide-transporting ATPase activity,MF,
8331,GO:0033227,1,0.911506156269798,0,3,dsRNA transport,BP,
8332,GO:0033233,1,0.543009037255447,0,20,regulation of protein sumoylation,BP,
8333,GO:0033234,1,0.734015016113241,0,10,negative regulation of protein sumoylation,BP,
8334,GO:0033235,1,0.740338967141533,0,10,positive regulation of protein sumoylation,BP,
8336,GO:0033239,1,0.879245603503149,0,4,negative regulation of cellular amine metabolic process,BP,
8337,GO:0033240,1,0.812636721695412,0,7,positive regulation of cellular amine metabolic process,BP,
8338,GO:0033241,1,0.966797215838241,0,1,regulation of cellular amine catabolic process,BP,
8339,GO:0033242,1,0.966797215838241,0,1,negative regulation of cellular amine catabolic process,BP,
8342,GO:0033260,1,0.227552685830909,0,49,nuclear DNA replication,BP,
8343,GO:0033262,1,0.685043740959475,0,12,regulation of nuclear cell cycle DNA replication,BP,
8344,GO:0033263,1,0.876692884040169,0,4,CORVET complex,CC,
8345,GO:0033265,1,0.941129534087427,0,2,choline binding,MF,
8348,GO:0033269,1,0.939331814875649,0,2,internode region of axon,CC,
8351,GO:0033274,1,0.966838706754937,0,1,response to vitamin B2,BP,
8354,GO:0033277,1,0.938835404847971,0,2,abortive mitotic cell cycle,BP,
8355,GO:0033278,1,0.877363066005029,0,4,cell proliferation in midbrain,BP,
8356,GO:0033280,1,0.497374736698965,0,22,response to vitamin D,BP,
8357,GO:0033283,1,0.968028934220319,0,1,organic acid-transporting ATPase activity,MF,
8358,GO:0033284,1,0.968028934220319,0,1,carboxylic acid-transporting ATPase activity,MF,
8359,GO:0033285,1,0.968028934220319,0,1,monocarboxylic acid-transporting ATPase activity,MF,
8360,GO:0033290,1,0.967325934078978,0,1,eukaryotic 48S preinitiation complex,CC,
8361,GO:0033291,1,0.975213677039802,0,1,eukaryotic 80S initiation complex,CC,
8362,GO:0033292,1,0.934724597405876,0,2,T-tubule organization,BP,
8365,GO:0033300,1,0.936410967498919,0,2,dehydroascorbic acid transmembrane transporter activity,MF,
8366,GO:0033301,1,0.967781048315404,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8367,GO:0033306,1,0.940739623887527,0,2,phytol metabolic process,BP,
8368,GO:0033313,1,0.855591927451874,0,5,meiotic cell cycle checkpoint,BP,
8369,GO:0033314,1,0.782983212857513,0,8,mitotic DNA replication checkpoint,BP,
8370,GO:0033316,1,0.968953988832333,0,1,meiotic spindle assembly checkpoint,BP,
8371,GO:0033319,1,0.97149948734977,0,1,UDP-D-xylose metabolic process,BP,
8372,GO:0033320,1,0.97149948734977,0,1,UDP-D-xylose biosynthetic process,BP,
8373,GO:0033326,1,0.96695791890697,0,1,cerebrospinal fluid secretion,BP,
8374,GO:0033327,1,0.82614828574128,0,6,Leydig cell differentiation,BP,
8375,GO:0033328,1,0.967919776184163,0,1,peroxisome membrane targeting sequence binding,MF,
8376,GO:0033341,1,0.938042322280905,0,2,regulation of collagen binding,BP,
8377,GO:0033342,1,0.970237165646139,0,1,negative regulation of collagen binding,BP,
8378,GO:0033343,1,0.966820251092348,0,1,positive regulation of collagen binding,BP,
8380,GO:0033353,1,0.879553845688919,0,4,S-adenosylmethionine cycle,BP,
8381,GO:0033363,1,0.51938828639117,0,21,secretory granule organization,BP,
8382,GO:0033364,1,0.966690718061563,0,1,mast cell secretory granule organization,BP,
8384,GO:0033383,1,0.943405128774232,0,2,geranyl diphosphate metabolic process,BP,
8385,GO:0033384,1,0.943405128774232,0,2,geranyl diphosphate biosynthetic process,BP,
8386,GO:0033385,1,0.969468758932506,0,1,geranylgeranyl diphosphate metabolic process,BP,
8387,GO:0033386,1,0.969468758932506,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8388,GO:0033387,1,0.910858004195815,0,3,putrescine biosynthetic process from ornithine,BP,
8389,GO:0033388,1,0.971190725861634,0,1,putrescine biosynthetic process from arginine,BP,
8390,GO:0033391,1,0.822339477672686,0,6,chromatoid body,CC,
8391,GO:0033477,1,0.971786998054768,0,1,S-methylmethionine metabolic process,BP,
8393,GO:0033484,1,0.913691832947203,0,3,nitric oxide homeostasis,BP,
8394,GO:0033488,1,0.968860959334366,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8395,GO:0033489,1,0.885468810081632,0,4,cholesterol biosynthetic process via desmosterol,BP,
8396,GO:0033490,1,0.885468810081632,0,4,cholesterol biosynthetic process via lathosterol,BP,
8397,GO:0033499,1,0.944592982319529,0,2,galactose catabolic process via UDP-galactose,BP,
8399,GO:0033503,1,0.88259893012549,0,4,HULC complex,CC,
8400,GO:0033504,1,0.90392242287903,0,3,floor plate development,BP,
8401,GO:0033505,1,0.966848403352548,0,1,floor plate morphogenesis,BP,
8402,GO:0033512,1,0.910171428890894,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8403,GO:0033522,1,0.452930576533114,0,25,histone H2A ubiquitination,BP,
8405,GO:0033526,1,0.969731551496732,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
8407,GO:0033540,1,0.67474326908832,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
8410,GO:0033553,1,0.882326327652135,0,4,rDNA heterochromatin,CC,
8412,GO:0033555,1,0.378329123526147,0,31,multicellular organismal response to stress,BP,
8413,GO:0033557,1,0.91060985903053,0,3,Slx1-Slx4 complex,CC,
8416,GO:0033560,1,0.967553722205728,0,1,folate reductase activity,MF,
8418,GO:0033564,1,0.934900544955825,0,2,anterior/posterior axon guidance,BP,
8419,GO:0033565,1,0.908106515919224,0,3,ESCRT-0 complex,CC,
8420,GO:0033566,1,0.940715504993361,0,2,gamma-tubulin complex localization,BP,
8421,GO:0033567,1,0.861907030220558,0,5,DNA replication, Okazaki fragment processing,BP,
8425,GO:0033577,1,0.940360837587448,0,2,protein glycosylation in endoplasmic reticulum,BP,
8426,GO:0033578,1,0.856263429849588,0,5,protein glycosylation in Golgi,BP,
8427,GO:0033588,1,0.858969402499024,0,5,Elongator holoenzyme complex,CC,
8428,GO:0033590,1,0.915578835148507,0,3,response to cobalamin,BP,
8429,GO:0033591,1,0.885853040184994,0,4,response to L-ascorbic acid,BP,
8430,GO:0033592,1,0.851069152461922,0,5,RNA strand annealing activity,MF,
8431,GO:0033593,1,0.966737020206122,0,1,BRCA2-MAGE-D1 complex,CC,
8432,GO:0033594,1,0.970132828777112,0,1,response to hydroxyisoflavone,BP,
8434,GO:0033597,1,0.971321872275029,0,1,mitotic checkpoint complex,CC,
8436,GO:0033599,1,0.591381532107106,0,17,regulation of mammary gland epithelial cell proliferation,BP,
8437,GO:0033600,1,0.881337367874852,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
8438,GO:0033601,1,0.773295467691101,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
8439,GO:0033602,1,0.966958766715114,0,1,negative regulation of dopamine secretion,BP,
8440,GO:0033603,1,0.914015006249567,0,3,positive regulation of dopamine secretion,BP,
8441,GO:0033604,1,0.936791362799529,0,2,negative regulation of catecholamine secretion,BP,
8442,GO:0033605,1,0.858781266160103,0,5,positive regulation of catecholamine secretion,BP,
8443,GO:0033606,1,0.97125559745736,0,1,chemokine receptor transport within lipid bilayer,BP,
8444,GO:0033608,1,0.969271124374127,0,1,formyl-CoA transferase activity,MF,
8445,GO:0033609,1,0.969271124374127,0,1,oxalate metabolic process,BP,
8446,GO:0033612,1,0.71280235323944,0,11,receptor serine/threonine kinase binding,MF,
8448,GO:0033615,1,0.914058011561697,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
8449,GO:0033617,1,0.553659644585903,0,20,mitochondrial respiratory chain complex IV assembly,BP,
8451,GO:0033622,1,0.700424047881542,0,11,integrin activation,BP,
8452,GO:0033623,1,0.823327764785564,0,6,regulation of integrin activation,BP,
8453,GO:0033624,1,0.936115814150574,0,2,negative regulation of integrin activation,BP,
8454,GO:0033625,1,0.937689726154646,0,2,positive regulation of integrin activation,BP,
8457,GO:0033629,1,0.803307401744982,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8458,GO:0033630,1,0.690536111241119,0,12,positive regulation of cell adhesion mediated by integrin,BP,
8459,GO:0033631,1,0.751816155163374,0,9,cell-cell adhesion mediated by integrin,BP,
8460,GO:0033632,1,0.858523860228549,0,5,regulation of cell-cell adhesion mediated by integrin,BP,
8461,GO:0033633,1,0.966975943643651,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
8462,GO:0033634,1,0.912499853362785,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
8464,GO:0033644,1,0.967308775010198,0,1,host cell membrane,CC,
8465,GO:0033646,1,0.801230559019636,0,7,host intracellular part,CC,
8466,GO:0033647,1,0.854886324201271,0,5,host intracellular organelle,CC,
8467,GO:0033648,1,0.854886324201271,0,5,host intracellular membrane-bounded organelle,CC,
8468,GO:0033650,1,0.972456066014553,0,1,host cell mitochondrion,CC,
8469,GO:0033655,1,0.882435899805913,0,4,host cell cytoplasm part,CC,
8470,GO:0033668,1,0.886473239917902,0,4,negative regulation by symbiont of host apoptotic process,BP,
8474,GO:0033677,1,0.909460702969999,0,3,DNA/RNA helicase activity,MF,
8475,GO:0033678,1,0.969851861519865,0,1,5'-3' DNA/RNA helicase activity,MF,
8476,GO:0033679,1,0.967053800300271,0,1,3'-5' DNA/RNA helicase activity,MF,
8477,GO:0033680,1,0.937896295830744,0,2,ATP-dependent DNA/RNA helicase activity,MF,
8478,GO:0033681,1,0.967053800300271,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8479,GO:0033682,1,0.969851861519865,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
8481,GO:0033684,1,0.93704155886831,0,2,regulation of luteinizing hormone secretion,BP,
8482,GO:0033686,1,0.93704155886831,0,2,positive regulation of luteinizing hormone secretion,BP,
8485,GO:0033689,1,0.822233363299026,0,6,negative regulation of osteoblast proliferation,BP,
8487,GO:0033691,1,0.935309761215274,0,2,sialic acid binding,MF,
8490,GO:0033699,1,0.971709085988543,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
8491,GO:0033700,1,0.83147363620068,0,6,phospholipid efflux,BP,
8492,GO:0033737,1,0.9702911699632,0,1,1-pyrroline dehydrogenase activity,MF,
8495,GO:0033746,1,0.967910767110477,0,1,histone demethylase activity (H3-R2 specific),MF,
8496,GO:0033749,1,0.967910767110477,0,1,histone demethylase activity (H4-R3 specific),MF,
8497,GO:0033750,1,0.685712498185064,0,13,ribosome localization,BP,
8498,GO:0033754,1,0.972915348123467,0,1,indoleamine 2,3-dioxygenase activity,MF,
8500,GO:0033764,1,0.637694577510302,0,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
8501,GO:0033765,1,0.941736154616668,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
8502,GO:0033768,1,0.938984452513289,0,2,SUMO-targeted ubiquitin ligase complex,CC,
8503,GO:0033787,1,0.96937967616693,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8504,GO:0033814,1,0.973269589112886,0,1,propanoyl-CoA C-acyltransferase activity,MF,
8505,GO:0033823,1,0.969045314015446,0,1,procollagen glucosyltransferase activity,MF,
8506,GO:0033829,1,0.917440711982318,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
8507,GO:0033842,1,0.937314878108531,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
8508,GO:0033857,1,0.934868706651646,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
8509,GO:0033858,1,0.968668205019812,0,1,N-acetylgalactosamine kinase activity,MF,
8510,GO:0033860,1,0.920873690576666,0,3,regulation of NAD(P)H oxidase activity,BP,
8511,GO:0033862,1,0.969052014050991,0,1,UMP kinase activity,MF,
8512,GO:0033864,1,0.920873690576666,0,3,positive regulation of NAD(P)H oxidase activity,BP,
8515,GO:0033867,1,0.972734872908836,0,1,Fas-activated serine/threonine kinase activity,MF,
8516,GO:0033869,1,0.974119343852336,0,1,nucleoside bisphosphate catabolic process,BP,
8517,GO:0033871,1,0.971921502773169,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
8518,GO:0033872,1,0.971685920965881,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
8520,GO:0033878,1,0.967672944683654,0,1,hormone-sensitive lipase activity,MF,
8521,GO:0033882,1,0.97383158234957,0,1,choloyl-CoA hydrolase activity,MF,
8522,GO:0033883,1,0.946402501822094,0,2,pyridoxal phosphatase activity,MF,
8523,GO:0033885,1,0.971161223769299,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
8524,GO:0033897,1,0.973642326064336,0,1,ribonuclease T2 activity,MF,
8525,GO:0033906,1,0.943905448627755,0,2,hyaluronoglucuronidase activity,MF,
8526,GO:0033919,1,0.967566336644757,0,1,glucan 1,3-alpha-glucosidase activity,MF,
8527,GO:0033925,1,0.967113354260911,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
8528,GO:0033961,1,0.972467974045556,0,1,cis-stilbene-oxide hydrolase activity,MF,
8530,GO:0033967,1,0.973811368227514,0,1,box C/D snoRNA metabolic process,BP,
8531,GO:0033979,1,0.970086681792673,0,1,box H/ACA snoRNA metabolic process,BP,
8532,GO:0033981,1,0.974774713458026,0,1,D-dopachrome decarboxylase activity,MF,
8533,GO:0033989,1,0.969779379986498,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
8535,GO:0034012,1,0.969271124374127,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8536,GO:0034014,1,0.97092080711143,0,1,response to triglyceride,BP,
8538,GO:0034031,1,0.974119343852336,0,1,ribonucleoside bisphosphate catabolic process,BP,
8541,GO:0034034,1,0.974119343852336,0,1,purine nucleoside bisphosphate catabolic process,BP,
8544,GO:0034038,1,0.973772725565652,0,1,deoxyhypusine synthase activity,MF,
8545,GO:0034039,1,0.945000636933302,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
8546,GO:0034040,1,0.906923576148905,0,3,lipid-transporting ATPase activity,MF,
8547,GO:0034041,1,0.969055369057037,0,1,sterol-transporting ATPase activity,MF,
8548,GO:0034045,1,0.602522539848726,0,16,phagophore assembly site membrane,CC,
8549,GO:0034046,1,0.798362111969024,0,7,poly(G) binding,MF,
8550,GO:0034056,1,0.907772252489165,0,3,estrogen response element binding,MF,
8551,GO:0034057,1,0.938661295769158,0,2,RNA strand-exchange activity,MF,
8552,GO:0034058,1,0.722002953289168,0,10,endosomal vesicle fusion,BP,
8553,GO:0034059,1,0.907770705343834,0,3,response to anoxia,BP,
8554,GO:0034061,1,0.35113003341307,0,34,DNA polymerase activity,MF,
8555,GO:0034062,1,0.281524719056167,0,43,5'-3' RNA polymerase activity,MF,
8556,GO:0034063,1,0.655747809987068,0,13,stress granule assembly,BP,
8557,GO:0034066,1,0.943618419505185,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
8559,GO:0034080,1,0.324790297585015,0,40,CENP-A containing nucleosome assembly,BP,
8560,GO:0034085,1,0.801681193814881,0,7,establishment of sister chromatid cohesion,BP,
8561,GO:0034086,1,0.688697420975148,0,12,maintenance of sister chromatid cohesion,BP,
8562,GO:0034087,1,0.93580426756767,0,2,establishment of mitotic sister chromatid cohesion,BP,
8563,GO:0034088,1,0.688697420975148,0,12,maintenance of mitotic sister chromatid cohesion,BP,
8564,GO:0034091,1,0.782845460099343,0,8,regulation of maintenance of sister chromatid cohesion,BP,
8565,GO:0034092,1,0.910648580762839,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
8566,GO:0034093,1,0.859690380651508,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8568,GO:0034098,1,0.750726983719699,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
8571,GO:0034104,1,0.711581283380975,0,11,negative regulation of tissue remodeling,BP,
8579,GO:0034115,1,0.811342997038692,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8586,GO:0034123,1,0.671961207783669,0,13,positive regulation of toll-like receptor signaling pathway,BP,
8587,GO:0034124,1,0.940736342309879,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
8588,GO:0034127,1,0.855548190101394,0,5,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8589,GO:0034128,1,0.880351095931616,0,4,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
8593,GO:0034137,1,0.918670513234976,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
8594,GO:0034138,1,0.591939119641612,0,17,toll-like receptor 3 signaling pathway,BP,
8595,GO:0034139,1,0.778053446777635,0,8,regulation of toll-like receptor 3 signaling pathway,BP,
8596,GO:0034140,1,0.90684785048966,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
8597,GO:0034141,1,0.831660958494329,0,6,positive regulation of toll-like receptor 3 signaling pathway,BP,
8601,GO:0034145,1,0.83160316858362,0,6,positive regulation of toll-like receptor 4 signaling pathway,BP,
8602,GO:0034146,1,0.967148046407872,0,1,toll-like receptor 5 signaling pathway,BP,
8603,GO:0034147,1,0.967148046407872,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8604,GO:0034148,1,0.967148046407872,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
8605,GO:0034150,1,0.966871698975116,0,1,toll-like receptor 6 signaling pathway,BP,
8606,GO:0034154,1,0.882234355444336,0,4,toll-like receptor 7 signaling pathway,BP,
8607,GO:0034155,1,0.968070189002082,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8608,GO:0034157,1,0.968070189002082,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
8610,GO:0034163,1,0.906217626702654,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
8611,GO:0034164,1,0.966851605988894,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
8612,GO:0034165,1,0.937292787273269,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
8613,GO:0034166,1,0.96840462382504,0,1,toll-like receptor 10 signaling pathway,BP,
8614,GO:0034182,1,0.782845460099343,0,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,
8615,GO:0034183,1,0.910648580762839,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
8616,GO:0034184,1,0.859690380651508,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8619,GO:0034188,1,0.934704261123866,0,2,apolipoprotein A-I receptor activity,MF,
8620,GO:0034189,1,0.936842879537633,0,2,very-low-density lipoprotein particle binding,MF,
8621,GO:0034190,1,0.88301699400766,0,4,apolipoprotein receptor binding,MF,
8622,GO:0034191,1,0.91232504620271,0,3,apolipoprotein A-I receptor binding,MF,
8623,GO:0034196,1,0.970040787019777,0,1,acylglycerol transport,BP,
8624,GO:0034197,1,0.970040787019777,0,1,triglyceride transport,BP,
8626,GO:0034199,1,0.722575160012558,0,10,activation of protein kinase A activity,BP,
8627,GO:0034201,1,0.856301224696982,0,5,response to oleic acid,BP,
8628,GO:0034203,1,0.966921672521476,0,1,glycolipid translocation,BP,
8629,GO:0034204,1,0.586367894447686,0,16,lipid translocation,BP,
8630,GO:0034205,1,0.502292466638595,0,22,amyloid-beta formation,BP,
8632,GO:0034213,1,0.972973334258414,0,1,quinolinate catabolic process,BP,
8633,GO:0034214,1,0.799439583129213,0,7,protein hexamerization,BP,
8636,GO:0034224,1,0.971041710112933,0,1,cellular response to zinc ion starvation,BP,
8637,GO:0034227,1,0.867007053809212,0,5,tRNA thio-modification,BP,
8638,GO:0034235,1,0.859523855931281,0,5,GPI anchor binding,MF,
8639,GO:0034236,1,0.712024046990799,0,11,protein kinase A catalytic subunit binding,MF,
8640,GO:0034237,1,0.615182657996832,0,15,protein kinase A regulatory subunit binding,MF,
8641,GO:0034238,1,0.967483217434446,0,1,macrophage fusion,BP,
8642,GO:0034239,1,0.967483217434446,0,1,regulation of macrophage fusion,BP,
8643,GO:0034241,1,0.967483217434446,0,1,positive regulation of macrophage fusion,BP,
8644,GO:0034242,1,0.939681871747981,0,2,negative regulation of syncytium formation by plasma membrane fusion,BP,
8646,GO:0034244,1,0.734020794476957,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
8647,GO:0034245,1,0.96766598130761,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
8648,GO:0034247,1,0.973555526993504,0,1,snoRNA splicing,BP,
8653,GO:0034271,1,0.909937304472432,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8654,GO:0034272,1,0.909937304472432,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
8655,GO:0034274,1,0.905818356282021,0,3,Atg12-Atg5-Atg16 complex,CC,
8656,GO:0034275,1,0.972915348123467,0,1,kynurenic acid metabolic process,BP,
8657,GO:0034276,1,0.972915348123467,0,1,kynurenic acid biosynthetic process,BP,
8659,GO:0034285,1,0.908792763517422,0,3,response to disaccharide,BP,
8661,GO:0034309,1,0.974265395836361,0,1,primary alcohol biosynthetic process,BP,
8662,GO:0034310,1,0.81477730608461,0,7,primary alcohol catabolic process,BP,
8663,GO:0034311,1,0.607192996664578,0,17,diol metabolic process,BP,
8664,GO:0034312,1,0.643947225474196,0,15,diol biosynthetic process,BP,
8665,GO:0034314,1,0.412341348322569,0,29,Arp2/3 complex-mediated actin nucleation,BP,
8666,GO:0034315,1,0.64257965844454,0,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,
8667,GO:0034316,1,0.883372498881687,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
8670,GO:0034331,1,0.795888614781413,0,7,cell junction maintenance,BP,
8673,GO:0034334,1,0.877473510248443,0,4,adherens junction maintenance,BP,
8674,GO:0034338,1,0.91055095578213,0,3,short-chain carboxylesterase activity,MF,
8677,GO:0034342,1,0.941550281458841,0,2,response to type III interferon,BP,
8678,GO:0034343,1,0.907159660313465,0,3,type III interferon production,BP,
8679,GO:0034344,1,0.907159660313465,0,3,regulation of type III interferon production,BP,
8680,GO:0034346,1,0.968937753278181,0,1,positive regulation of type III interferon production,BP,
8682,GO:0034350,1,0.800448958654704,0,7,regulation of glial cell apoptotic process,BP,
8683,GO:0034351,1,0.800448958654704,0,7,negative regulation of glial cell apoptotic process,BP,
8684,GO:0034353,1,0.969271124374127,0,1,RNA pyrophosphohydrolase activity,MF,
8685,GO:0034355,1,0.969271124374127,0,1,NAD salvage,BP,
8686,GO:0034356,1,0.731803666747812,0,10,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
8688,GO:0034361,1,0.814719243568944,0,7,very-low-density lipoprotein particle,CC,
8689,GO:0034362,1,0.837156469340546,0,6,low-density lipoprotein particle,CC,
8690,GO:0034363,1,0.973791068722543,0,1,intermediate-density lipoprotein particle,CC,
8692,GO:0034365,1,0.973791068722543,0,1,discoidal high-density lipoprotein particle,CC,
8693,GO:0034366,1,0.969382123670748,0,1,spherical high-density lipoprotein particle,CC,
8694,GO:0034367,1,0.744351206012085,0,10,protein-containing complex remodeling,BP,
8695,GO:0034368,1,0.768219154788173,0,9,protein-lipid complex remodeling,BP,
8696,GO:0034369,1,0.768219154788173,0,9,plasma lipoprotein particle remodeling,BP,
8697,GO:0034370,1,0.947902765915722,0,2,triglyceride-rich lipoprotein particle remodeling,BP,
8698,GO:0034371,1,0.973791068722543,0,1,chylomicron remodeling,BP,
8699,GO:0034372,1,0.947902765915722,0,2,very-low-density lipoprotein particle remodeling,BP,
8700,GO:0034374,1,0.917541724681912,0,3,low-density lipoprotein particle remodeling,BP,
8701,GO:0034375,1,0.790093770493908,0,8,high-density lipoprotein particle remodeling,BP,
8702,GO:0034377,1,0.610043177631587,0,16,plasma lipoprotein particle assembly,BP,
8703,GO:0034378,1,0.91335111853114,0,3,chylomicron assembly,BP,
8704,GO:0034379,1,0.833115364138107,0,6,very-low-density lipoprotein particle assembly,BP,
8705,GO:0034380,1,0.757465281682597,0,9,high-density lipoprotein particle assembly,BP,
8707,GO:0034382,1,0.890531469380578,0,4,chylomicron remnant clearance,BP,
8709,GO:0034384,1,0.834338957493381,0,6,high-density lipoprotein particle clearance,BP,
8710,GO:0034385,1,0.814719243568944,0,7,triglyceride-rich plasma lipoprotein particle,CC,
8711,GO:0034386,1,0.966958766715114,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
8712,GO:0034388,1,0.82993964929,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8720,GO:0034397,1,0.749533891096381,0,9,telomere localization,BP,
8721,GO:0034398,1,0.849993371901249,0,5,telomere tethering at nuclear periphery,BP,
8723,GO:0034402,1,0.938656102868832,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
8726,GO:0034414,1,0.939688152745642,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
8727,GO:0034416,1,0.939589230574933,0,2,bisphosphoglycerate phosphatase activity,MF,
8728,GO:0034417,1,0.96937967616693,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
8729,GO:0034418,1,0.94271010339277,0,2,urate biosynthetic process,BP,
8730,GO:0034421,1,0.909274009036504,0,3,post-translational protein acetylation,BP,
8731,GO:0034423,1,0.969933379813278,0,1,autophagosome lumen,CC,
8732,GO:0034427,1,0.753797652812652,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8733,GO:0034431,1,0.887880067864205,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8734,GO:0034432,1,0.887880067864205,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
8735,GO:0034433,1,0.81616236712559,0,7,steroid esterification,BP,
8736,GO:0034434,1,0.81616236712559,0,7,sterol esterification,BP,
8737,GO:0034435,1,0.81616236712559,0,7,cholesterol esterification,BP,
8738,GO:0034436,1,0.913735003656745,0,3,glycoprotein transport,BP,
8739,GO:0034437,1,0.937977395603236,0,2,glycoprotein transporter activity,MF,
8741,GO:0034441,1,0.972331555473381,0,1,plasma lipoprotein particle oxidation,BP,
8743,GO:0034447,1,0.89416363659007,0,4,very-low-density lipoprotein particle clearance,BP,
8744,GO:0034448,1,0.894013357055513,0,4,EGO complex,CC,
8745,GO:0034450,1,0.688443169061283,0,12,ubiquitin-ubiquitin ligase activity,MF,
8747,GO:0034452,1,0.722084237952101,0,10,dynactin binding,MF,
8748,GO:0034453,1,0.476881234547315,0,23,microtubule anchoring,BP,
8749,GO:0034454,1,0.743898852399917,0,9,microtubule anchoring at centrosome,BP,
8750,GO:0034455,1,0.909392801072445,0,3,t-UTP complex,CC,
8751,GO:0034456,1,0.912952336003134,0,3,UTP-C complex,CC,
8752,GO:0034457,1,0.920260505965269,0,3,Mpp10 complex,CC,
8753,GO:0034458,1,0.938381963508662,0,2,3'-5' RNA helicase activity,MF,
8754,GO:0034459,1,0.967053800300271,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
8755,GO:0034462,1,0.971037284202953,0,1,small-subunit processome assembly,BP,
8756,GO:0034463,1,0.975213677039802,0,1,90S preribosome assembly,BP,
8757,GO:0034464,1,0.757608614655039,0,9,BBSome,CC,
8758,GO:0034465,1,0.886841404220056,0,4,response to carbon monoxide,BP,
8761,GO:0034472,1,0.662579973774134,0,14,snRNA 3'-end processing,BP,
8762,GO:0034473,1,0.922041108509009,0,3,U1 snRNA 3'-end processing,BP,
8763,GO:0034474,1,0.96684225844511,0,1,U2 snRNA 3'-end processing,BP,
8764,GO:0034475,1,0.805017214069602,0,8,U4 snRNA 3'-end processing,BP,
8765,GO:0034476,1,0.922041108509009,0,3,U5 snRNA 3'-end processing,BP,
8766,GO:0034477,1,0.969271124374127,0,1,U6 snRNA 3'-end processing,BP,
8767,GO:0034481,1,0.881780824886851,0,4,chondroitin sulfotransferase activity,MF,
8769,GO:0034485,1,0.879463622548659,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
8770,GO:0034497,1,0.683015462382249,0,12,protein localization to phagophore assembly site,BP,
8771,GO:0034498,1,0.78021226012055,0,8,early endosome to Golgi transport,BP,
8772,GO:0034499,1,0.934921952659669,0,2,late endosome to Golgi transport,BP,
8773,GO:0034501,1,0.615789685952922,0,16,protein localization to kinetochore,BP,
8774,GO:0034502,1,0.110167460606046,0,72,protein localization to chromosome,BP,
8776,GO:0034505,1,0.678339378102077,0,12,tooth mineralization,BP,
8777,GO:0034506,1,0.967445251707302,0,1,chromosome, centromeric core domain,CC,
8778,GO:0034508,1,0.235706700548482,0,50,centromere complex assembly,BP,
8779,GO:0034511,1,0.832500875568552,0,6,U3 snoRNA binding,MF,
8780,GO:0034512,1,0.969271124374127,0,1,box C/D snoRNA binding,MF,
8781,GO:0034513,1,0.873706427278388,0,5,box H/ACA snoRNA binding,MF,
8782,GO:0034515,1,0.938650991173491,0,2,proteasome storage granule,CC,
8783,GO:0034518,1,0.688935435181639,0,12,RNA cap binding complex,CC,
8784,GO:0034545,1,0.972646094615903,0,1,fumarylpyruvate hydrolase activity,MF,
8786,GO:0034552,1,0.890913422776242,0,4,respiratory chain complex II assembly,BP,
8787,GO:0034553,1,0.890913422776242,0,4,mitochondrial respiratory chain complex II assembly,BP,
8788,GO:0034584,1,0.967644765305439,0,1,piRNA binding,MF,
8789,GO:0034587,1,0.776449895222698,0,8,piRNA metabolic process,BP,
8790,GO:0034589,1,0.967225993095157,0,1,hydroxyproline transport,BP,
8791,GO:0034590,1,0.967225993095157,0,1,L-hydroxyproline transmembrane transporter activity,MF,
8792,GO:0034593,1,0.471040405365541,0,23,phosphatidylinositol bisphosphate phosphatase activity,MF,
8793,GO:0034594,1,0.850326932473734,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8794,GO:0034595,1,0.65508362690578,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
8795,GO:0034596,1,0.767738936226031,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
8796,GO:0034597,1,0.935315528921695,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
8798,GO:0034602,1,0.967224332854149,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
8799,GO:0034603,1,0.855425802327466,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8800,GO:0034604,1,0.855425802327466,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8806,GO:0034617,1,0.911986470900485,0,3,tetrahydrobiopterin binding,MF,
8807,GO:0034618,1,0.885408888107185,0,4,arginine binding,MF,
8810,GO:0034625,1,0.856212542519588,0,5,fatty acid elongation, monounsaturated fatty acid,BP,
8811,GO:0034626,1,0.856212542519588,0,5,fatty acid elongation, polyunsaturated fatty acid,BP,
8812,GO:0034627,1,0.93565619217012,0,2,'de novo' NAD biosynthetic process,BP,
8813,GO:0034628,1,0.93565619217012,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
8815,GO:0034634,1,0.966857836354105,0,1,glutathione transmembrane transporter activity,MF,
8816,GO:0034635,1,0.939549537761619,0,2,glutathione transport,BP,
8818,GO:0034638,1,0.835882400458846,0,6,phosphatidylcholine catabolic process,BP,
8819,GO:0034640,1,0.96855706090163,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
8821,GO:0034642,1,0.967663669181648,0,1,mitochondrion migration along actin filament,BP,
8825,GO:0034647,1,0.934705475497142,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8826,GO:0034648,1,0.876211291207507,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
8827,GO:0034649,1,0.967585551816704,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
8828,GO:0034650,1,0.850606519756684,0,5,cortisol metabolic process,BP,
8829,GO:0034651,1,0.850606519756684,0,5,cortisol biosynthetic process,BP,
8830,GO:0034653,1,0.96709745784248,0,1,retinoic acid catabolic process,BP,
8833,GO:0034656,1,0.346562848416918,0,36,nucleobase-containing small molecule catabolic process,BP,
8834,GO:0034657,1,0.88446029202453,0,4,GID complex,CC,
8836,GO:0034661,1,0.495551777470517,0,23,ncRNA catabolic process,BP,
8838,GO:0034665,1,0.935774561365985,0,2,integrin alpha1-beta1 complex,CC,
8840,GO:0034667,1,0.935736036264898,0,2,integrin alpha3-beta1 complex,CC,
8841,GO:0034669,1,0.966865927570967,0,1,integrin alpha4-beta7 complex,CC,
8842,GO:0034670,1,0.966775055545957,0,1,chemotaxis to arachidonic acid,BP,
8843,GO:0034673,1,0.934853849232303,0,2,inhibin-betaglycan-ActRII complex,CC,
8844,GO:0034676,1,0.966874597239023,0,1,integrin alpha6-beta4 complex,CC,
8845,GO:0034677,1,0.967726469444565,0,1,integrin alpha7-beta1 complex,CC,
8846,GO:0034678,1,0.935855679320102,0,2,integrin alpha8-beta1 complex,CC,
8847,GO:0034680,1,0.935700494505295,0,2,integrin alpha10-beta1 complex,CC,
8848,GO:0034681,1,0.967726469444565,0,1,integrin alpha11-beta1 complex,CC,
8853,GO:0034693,1,0.970414340934619,0,1,U11/U12 snRNP,CC,
8855,GO:0034695,1,0.635970743020796,0,14,response to prostaglandin E,BP,
8858,GO:0034699,1,0.909080933977107,0,3,response to luteinizing hormone,BP,
8863,GO:0034706,1,0.765390519022784,0,8,sodium channel complex,CC,
8866,GO:0034709,1,0.722340396273797,0,12,methylosome,CC,
8867,GO:0034711,1,0.913169444654427,0,3,inhibin binding,MF,
8868,GO:0034713,1,0.778337000101783,0,8,type I transforming growth factor beta receptor binding,MF,
8869,GO:0034714,1,0.909586021855393,0,3,type III transforming growth factor beta receptor binding,MF,
8870,GO:0034715,1,0.85164185021625,0,6,pICln-Sm protein complex,CC,
8871,GO:0034718,1,0.96688762225173,0,1,SMN-Gemin2 complex,CC,
8872,GO:0034719,1,0.633525460608429,0,16,SMN-Sm protein complex,CC,
8873,GO:0034720,1,0.819091726950917,0,6,histone H3-K4 demethylation,BP,
8874,GO:0034721,1,0.934705475497142,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
8875,GO:0034722,1,0.973106123315872,0,1,gamma-glutamyl-peptidase activity,MF,
8876,GO:0034723,1,0.426934805625278,0,32,DNA replication-dependent nucleosome organization,BP,
8877,GO:0034724,1,0.230170198225247,0,51,DNA replication-independent nucleosome organization,BP,
8878,GO:0034727,1,0.966945498521195,0,1,piecemeal microautophagy of the nucleus,BP,
8881,GO:0034736,1,0.968244772971475,0,1,cholesterol O-acyltransferase activity,MF,
8882,GO:0034739,1,0.945238261821573,0,2,histone deacetylase activity (H4-K16 specific),MF,
8883,GO:0034750,1,0.936163011673222,0,2,Scrib-APC-beta-catenin complex,CC,
8885,GO:0034752,1,0.966861873686312,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8886,GO:0034753,1,0.966861873686312,0,1,nuclear aryl hydrocarbon receptor complex,CC,
8889,GO:0034756,1,0.915382130403105,0,3,regulation of iron ion transport,BP,
8890,GO:0034757,1,0.966805179462858,0,1,negative regulation of iron ion transport,BP,
8891,GO:0034759,1,0.966805179462858,0,1,regulation of iron ion transmembrane transport,BP,
8892,GO:0034760,1,0.966805179462858,0,1,negative regulation of iron ion transmembrane transport,BP,
8899,GO:0034770,1,0.747787536980043,0,9,histone H4-K20 methylation,BP,
8900,GO:0034773,1,0.825483865577281,0,6,histone H4-K20 trimethylation,BP,
8902,GO:0034775,1,0.966857836354105,0,1,glutathione transmembrane transport,BP,
8903,GO:0034776,1,0.935145745436661,0,2,response to histamine,BP,
8904,GO:0034777,1,0.971080071857088,0,1,recycling endosome lumen,CC,
8905,GO:0034959,1,0.966917666705161,0,1,endothelin maturation,BP,
8906,GO:0034963,1,0.973811368227514,0,1,box C/D snoRNA processing,BP,
8907,GO:0034964,1,0.970086681792673,0,1,box H/ACA snoRNA processing,BP,
8909,GO:0034969,1,0.737632849051158,0,10,histone arginine methylation,BP,
8910,GO:0034970,1,0.939925055102856,0,2,histone H3-R2 methylation,BP,
8911,GO:0034971,1,0.969072194027201,0,1,histone H3-R17 methylation,BP,
8914,GO:0034979,1,0.589477023902779,0,17,NAD-dependent protein deacetylase activity,MF,
8915,GO:0034982,1,0.746506776205704,0,10,mitochondrial protein processing,BP,
8916,GO:0034983,1,0.824718502650896,0,6,peptidyl-lysine deacetylation,BP,
8917,GO:0034986,1,0.96683842825202,0,1,iron chaperone activity,MF,
8918,GO:0034987,1,0.966804312815079,0,1,immunoglobulin receptor binding,MF,
8919,GO:0034988,1,0.966804312815079,0,1,Fc-gamma receptor I complex binding,MF,
8920,GO:0034991,1,0.939207362057012,0,2,nuclear meiotic cohesin complex,CC,
8921,GO:0034992,1,0.848038361534356,0,5,microtubule organizing center attachment site,CC,
8922,GO:0034993,1,0.848038361534356,0,5,meiotic nuclear membrane microtubule tethering complex,CC,
8923,GO:0034998,1,0.969271124374127,0,1,oligosaccharyltransferase I complex,CC,
8925,GO:0035005,1,0.819143111129047,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8926,GO:0035014,1,0.820552467105308,0,6,phosphatidylinositol 3-kinase regulator activity,MF,
8928,GO:0035020,1,0.61864966548883,0,15,regulation of Rac protein signal transduction,BP,
8929,GO:0035021,1,0.879723961993364,0,4,negative regulation of Rac protein signal transduction,BP,
8930,GO:0035022,1,0.881073422208356,0,4,positive regulation of Rac protein signal transduction,BP,
8932,GO:0035024,1,0.579963534833037,0,17,negative regulation of Rho protein signal transduction,BP,
8933,GO:0035025,1,0.692325818342562,0,12,positive regulation of Rho protein signal transduction,BP,
8935,GO:0035032,1,0.830561691000031,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8936,GO:0035033,1,0.941032068600731,0,2,histone deacetylase regulator activity,MF,
8937,GO:0035034,1,0.94106095495564,0,2,histone acetyltransferase regulator activity,MF,
8940,GO:0035037,1,0.967101360471914,0,1,sperm entry,BP,
8943,GO:0035054,1,0.968710947667684,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
8944,GO:0035061,1,0.876089532398544,0,4,interchromatin granule,CC,
8945,GO:0035063,1,0.967817601496427,0,1,nuclear speck organization,BP,
8946,GO:0035064,1,0.169995059776994,0,56,methylated histone binding,MF,
8950,GO:0035068,1,0.750636700999916,0,9,micro-ribonucleoprotein complex,CC,
8951,GO:0035082,1,0.491092377687049,0,23,axoneme assembly,BP,
8952,GO:0035087,1,0.886830549655725,0,4,siRNA loading onto RISC involved in RNA interference,BP,
8954,GO:0035089,1,0.661274378811177,0,13,establishment of apical/basal cell polarity,BP,
8955,GO:0035090,1,0.854496774524928,0,5,maintenance of apical/basal cell polarity,BP,
8957,GO:0035092,1,0.904133821181646,0,3,sperm chromatin condensation,BP,
8958,GO:0035093,1,0.934816647676467,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
8960,GO:0035095,1,0.880388496869742,0,4,behavioral response to nicotine,BP,
8962,GO:0035098,1,0.602077810171511,0,16,ESC/E(Z) complex,CC,
8963,GO:0035101,1,0.908497429289101,0,3,FACT complex,CC,
8964,GO:0035102,1,0.688268119776095,0,12,PRC1 complex,CC,
8967,GO:0035112,1,0.820616638111992,0,6,genitalia morphogenesis,BP,
8971,GO:0035120,1,0.966742778732933,0,1,post-embryonic appendage morphogenesis,BP,
8972,GO:0035127,1,0.966742778732933,0,1,post-embryonic limb morphogenesis,BP,
8973,GO:0035128,1,0.966742778732933,0,1,post-embryonic forelimb morphogenesis,BP,
8976,GO:0035145,1,0.522472964493959,0,21,exon-exon junction complex,CC,
8979,GO:0035162,1,0.637435193143701,0,14,embryonic hemopoiesis,BP,
8980,GO:0035166,1,0.907582021669014,0,3,post-embryonic hemopoiesis,BP,
8981,GO:0035173,1,0.649845963678608,0,14,histone kinase activity,MF,
8982,GO:0035174,1,0.834183096897622,0,6,histone serine kinase activity,MF,
8983,GO:0035175,1,0.972568806346861,0,1,histone kinase activity (H3-S10 specific),MF,
8984,GO:0035176,1,0.370192256631149,0,31,social behavior,BP,
8985,GO:0035184,1,0.883557212557307,0,4,histone threonine kinase activity,MF,
8986,GO:0035188,1,0.968512019901731,0,1,hatching,BP,
8987,GO:0035189,1,0.910741086971407,0,3,Rb-E2F complex,CC,
8991,GO:0035197,1,0.749424136078854,0,9,siRNA binding,MF,
8993,GO:0035226,1,0.968858852908546,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
8994,GO:0035227,1,0.968858852908546,0,1,regulation of glutamate-cysteine ligase activity,BP,
8995,GO:0035229,1,0.968858852908546,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
8997,GO:0035235,1,0.748824538925535,0,9,ionotropic glutamate receptor signaling pathway,BP,
8999,GO:0035240,1,0.972037490433508,0,1,dopamine binding,MF,
9000,GO:0035241,1,0.912459992073188,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9001,GO:0035242,1,0.810719819508367,0,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9002,GO:0035243,1,0.884922186077273,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9003,GO:0035246,1,0.717961384800343,0,11,peptidyl-arginine N-methylation,BP,
9004,GO:0035247,1,0.762583171469124,0,9,peptidyl-arginine omega-N-methylation,BP,
9005,GO:0035248,1,0.969326219580173,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9009,GO:0035252,1,0.827039551259885,0,6,UDP-xylosyltransferase activity,MF,
9010,GO:0035253,1,0.75150179232319,0,9,ciliary rootlet,CC,
9013,GO:0035256,1,0.833201665714326,0,6,G-protein coupled glutamate receptor binding,MF,
9016,GO:0035259,1,0.706320882410226,0,11,glucocorticoid receptor binding,MF,
9017,GO:0035261,1,0.934634392161383,0,2,external genitalia morphogenesis,BP,
9018,GO:0035262,1,0.966798584676304,0,1,gonad morphogenesis,BP,
9019,GO:0035264,1,0.038670199487046,0,102,multicellular organism growth,BP,
9021,GO:0035267,1,0.568246411809841,0,19,NuA4 histone acetyltransferase complex,CC,
9026,GO:0035276,1,0.966882266381886,0,1,ethanol binding,MF,
9027,GO:0035278,1,0.686801324811705,0,12,miRNA mediated inhibition of translation,BP,
9028,GO:0035279,1,0.938205375931488,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9029,GO:0035280,1,0.802864625157978,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9030,GO:0035281,1,0.941752448276959,0,2,pre-miRNA export from nucleus,BP,
9037,GO:0035299,1,0.96716111732912,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9040,GO:0035305,1,0.0821877583792111,0,79,negative regulation of dephosphorylation,BP,
9043,GO:0035308,1,0.309921221038253,0,38,negative regulation of protein dephosphorylation,BP,
9044,GO:0035312,1,0.826370996461125,0,6,5'-3' exodeoxyribonuclease activity,MF,
9046,GO:0035315,1,0.455266450696154,0,25,hair cell differentiation,BP,
9047,GO:0035325,1,0.786283567667124,0,8,Toll-like receptor binding,MF,
9054,GO:0035333,1,0.686723324772359,0,12,Notch receptor processing, ligand-dependent,BP,
9056,GO:0035336,1,0.556417060270242,0,19,long-chain fatty-acyl-CoA metabolic process,BP,
9057,GO:0035337,1,0.374059080394907,0,32,fatty-acyl-CoA metabolic process,BP,
9058,GO:0035338,1,0.667623947928995,0,13,long-chain fatty-acyl-CoA biosynthetic process,BP,
9060,GO:0035349,1,0.91257815150113,0,3,coenzyme A transmembrane transport,BP,
9061,GO:0035350,1,0.94085890685553,0,2,FAD transmembrane transport,BP,
9062,GO:0035352,1,0.970993033401337,0,1,NAD transmembrane transport,BP,
9063,GO:0035354,1,0.968253078048579,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9064,GO:0035355,1,0.966871698975116,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9068,GO:0035359,1,0.967419661299281,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9070,GO:0035363,1,0.884187163423591,0,4,histone locus body,CC,
9071,GO:0035368,1,0.883988337407213,0,4,selenocysteine insertion sequence binding,MF,
9072,GO:0035370,1,0.941873907533776,0,2,UBC13-UEV1A complex,CC,
9073,GO:0035371,1,0.555623830257048,0,18,microtubule plus-end,CC,
9074,GO:0035372,1,0.658706387870316,0,13,protein localization to microtubule,BP,
9075,GO:0035373,1,0.934652465901426,0,2,chondroitin sulfate proteoglycan binding,MF,
9077,GO:0035376,1,0.859123790338223,0,5,sterol import,BP,
9078,GO:0035381,1,0.971674325577539,0,1,ATP-gated ion channel activity,MF,
9080,GO:0035384,1,0.260092964180769,0,43,thioester biosynthetic process,BP,
9082,GO:0035400,1,0.966896980846975,0,1,histone tyrosine kinase activity,MF,
9083,GO:0035401,1,0.966896980846975,0,1,histone kinase activity (H3-Y41 specific),MF,
9084,GO:0035402,1,0.939688855144682,0,2,histone kinase activity (H3-T11 specific),MF,
9085,GO:0035403,1,0.966798439213394,0,1,histone kinase activity (H3-T6 specific),MF,
9086,GO:0035404,1,0.75974803868356,0,9,histone-serine phosphorylation,BP,
9087,GO:0035405,1,0.883557212557307,0,4,histone-threonine phosphorylation,BP,
9088,GO:0035406,1,0.966896980846975,0,1,histone-tyrosine phosphorylation,BP,
9089,GO:0035407,1,0.939688855144682,0,2,histone H3-T11 phosphorylation,BP,
9090,GO:0035408,1,0.966798439213394,0,1,histone H3-T6 phosphorylation,BP,
9091,GO:0035409,1,0.966896980846975,0,1,histone H3-Y41 phosphorylation,BP,
9092,GO:0035418,1,0.500710649420092,0,22,protein localization to synapse,BP,
9093,GO:0035425,1,0.911587376690713,0,3,autocrine signaling,BP,
9094,GO:0035426,1,0.876878912145597,0,4,extracellular matrix-cell signaling,BP,
9095,GO:0035434,1,0.828986188624911,0,6,copper ion transmembrane transport,BP,
9096,GO:0035435,1,0.775284608267433,0,8,phosphate ion transmembrane transport,BP,
9098,GO:0035438,1,0.972620455257818,0,1,cyclic-di-GMP binding,MF,
9099,GO:0035441,1,0.966806597184198,0,1,cell migration involved in vasculogenesis,BP,
9100,GO:0035442,1,0.943372480327217,0,2,dipeptide transmembrane transport,BP,
9101,GO:0035443,1,0.966857836354105,0,1,tripeptide transmembrane transport,BP,
9102,GO:0035445,1,0.968775772037672,0,1,borate transmembrane transport,BP,
9106,GO:0035458,1,0.693118464444154,0,12,cellular response to interferon-beta,BP,
9108,GO:0035461,1,0.776359571390336,0,8,vitamin transmembrane transport,BP,
9109,GO:0035469,1,0.966889920942967,0,1,determination of pancreatic left/right asymmetry,BP,
9111,GO:0035473,1,0.940903514405665,0,2,lipase binding,MF,
9112,GO:0035482,1,0.947869763314347,0,2,gastric motility,BP,
9113,GO:0035483,1,0.974480330032443,0,1,gastric emptying,BP,
9114,GO:0035485,1,0.972211454369558,0,1,adenine/guanine mispair binding,MF,
9115,GO:0035490,1,0.968683041538734,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9116,GO:0035491,1,0.968683041538734,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9117,GO:0035493,1,0.648559524571562,0,14,SNARE complex assembly,BP,
9118,GO:0035494,1,0.912018029720848,0,3,SNARE complex disassembly,BP,
9120,GO:0035498,1,0.969271124374127,0,1,carnosine metabolic process,BP,
9121,GO:0035500,1,0.938133460842866,0,2,MH2 domain binding,MF,
9122,GO:0035501,1,0.969425204500395,0,1,MH1 domain binding,MF,
9123,GO:0035502,1,0.911070704470565,0,3,metanephric part of ureteric bud development,BP,
9126,GO:0035507,1,0.845486803311517,0,5,regulation of myosin-light-chain-phosphatase activity,BP,
9127,GO:0035508,1,0.966879396883875,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9128,GO:0035509,1,0.90445312977874,0,3,negative regulation of myosin-light-chain-phosphatase activity,BP,
9129,GO:0035510,1,0.45132356051076,0,26,DNA dealkylation,BP,
9130,GO:0035511,1,0.861332531984589,0,5,oxidative DNA demethylation,BP,
9131,GO:0035513,1,0.883819113776324,0,4,oxidative RNA demethylation,BP,
9132,GO:0035514,1,0.916789759266992,0,3,DNA demethylase activity,MF,
9133,GO:0035515,1,0.883819113776324,0,4,oxidative RNA demethylase activity,MF,
9134,GO:0035516,1,0.967232351662302,0,1,oxidative DNA demethylase activity,MF,
9135,GO:0035517,1,0.905353710653846,0,3,PR-DUB complex,CC,
9136,GO:0035518,1,0.585881876586058,0,17,histone H2A monoubiquitination,BP,
9137,GO:0035519,1,0.892818306882735,0,4,protein K29-linked ubiquitination,BP,
9138,GO:0035520,1,0.744717866843351,0,9,monoubiquitinated protein deubiquitination,BP,
9139,GO:0035521,1,0.880217752651552,0,4,monoubiquitinated histone deubiquitination,BP,
9140,GO:0035522,1,0.880217752651552,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9141,GO:0035523,1,0.879136491529733,0,4,protein K29-linked deubiquitination,BP,
9142,GO:0035524,1,0.849534735170821,0,5,proline transmembrane transport,BP,
9143,GO:0035525,1,0.970086681792673,0,1,NF-kappaB p50/p65 complex,CC,
9144,GO:0035526,1,0.935270771204366,0,2,retrograde transport, plasma membrane to Golgi,BP,
9146,GO:0035538,1,0.968498106095034,0,1,carbohydrate response element binding,MF,
9147,GO:0035539,1,0.947083068729275,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9148,GO:0035542,1,0.799555217230074,0,7,regulation of SNARE complex assembly,BP,
9149,GO:0035544,1,0.967123681197734,0,1,negative regulation of SNARE complex assembly,BP,
9150,GO:0035546,1,0.87526414351676,0,4,interferon-beta secretion,BP,
9151,GO:0035547,1,0.87526414351676,0,4,regulation of interferon-beta secretion,BP,
9152,GO:0035549,1,0.87526414351676,0,4,positive regulation of interferon-beta secretion,BP,
9153,GO:0035552,1,0.912854578746117,0,3,oxidative single-stranded DNA demethylation,BP,
9154,GO:0035553,1,0.911098997551435,0,3,oxidative single-stranded RNA demethylation,BP,
9156,GO:0035561,1,0.513523416959013,0,21,regulation of chromatin binding,BP,
9157,GO:0035562,1,0.77081571734443,0,8,negative regulation of chromatin binding,BP,
9158,GO:0035563,1,0.688305967589802,0,12,positive regulation of chromatin binding,BP,
9160,GO:0035568,1,0.969271124374127,0,1,N-terminal peptidyl-proline methylation,BP,
9161,GO:0035570,1,0.969271124374127,0,1,N-terminal peptidyl-serine methylation,BP,
9162,GO:0035572,1,0.969271124374127,0,1,N-terminal peptidyl-serine dimethylation,BP,
9163,GO:0035573,1,0.969271124374127,0,1,N-terminal peptidyl-serine trimethylation,BP,
9164,GO:0035574,1,0.937153108958589,0,2,histone H4-K20 demethylation,BP,
9165,GO:0035575,1,0.937153108958589,0,2,histone demethylase activity (H4-K20 specific),MF,
9171,GO:0035582,1,0.913515721148495,0,3,sequestering of BMP in extracellular matrix,BP,
9173,GO:0035584,1,0.773819794117731,0,9,calcium-mediated signaling using intracellular calcium source,BP,
9174,GO:0035585,1,0.969271124374127,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9175,GO:0035586,1,0.812017862638162,0,7,purinergic receptor activity,MF,
9176,GO:0035587,1,0.742010919722098,0,10,purinergic receptor signaling pathway,BP,
9177,GO:0035588,1,0.789739352796199,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9178,GO:0035589,1,0.859692322080414,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9179,GO:0035590,1,0.807747956669339,0,7,purinergic nucleotide receptor signaling pathway,BP,
9181,GO:0035594,1,0.912420106456451,0,3,ganglioside binding,MF,
9182,GO:0035596,1,0.941046476613088,0,2,methylthiotransferase activity,MF,
9183,GO:0035597,1,0.971697507826382,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9184,GO:0035598,1,0.968458643730939,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9185,GO:0035600,1,0.941046476613088,0,2,tRNA methylthiolation,BP,
9187,GO:0035602,1,0.967382766910371,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9188,GO:0035603,1,0.967382766910371,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9189,GO:0035604,1,0.967382766910371,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9190,GO:0035605,1,0.973506143927433,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9191,GO:0035606,1,0.94905902498314,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9192,GO:0035607,1,0.935338326528137,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9193,GO:0035608,1,0.937535511516887,0,2,protein deglutamylation,BP,
9194,GO:0035609,1,0.967144152014261,0,1,C-terminal protein deglutamylation,BP,
9195,GO:0035610,1,0.967144152014261,0,1,protein side chain deglutamylation,BP,
9196,GO:0035611,1,0.969388249164427,0,1,protein branching point deglutamylation,BP,
9197,GO:0035612,1,0.77183993703276,0,8,AP-2 adaptor complex binding,MF,
9198,GO:0035613,1,0.626636513607704,0,15,RNA stem-loop binding,MF,
9199,GO:0035614,1,0.917888569218558,0,3,snRNA stem-loop binding,MF,
9200,GO:0035615,1,0.705978945606772,0,11,clathrin adaptor activity,MF,
9201,GO:0035616,1,0.905711364295888,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9202,GO:0035617,1,0.911028988244293,0,3,stress granule disassembly,BP,
9203,GO:0035620,1,0.91154090002108,0,3,ceramide transporter activity,MF,
9204,GO:0035621,1,0.939640929451768,0,2,ER to Golgi ceramide transport,BP,
9205,GO:0035622,1,0.96754747341463,0,1,intrahepatic bile duct development,BP,
9206,GO:0035623,1,0.96853069110313,0,1,renal glucose absorption,BP,
9207,GO:0035624,1,0.93586969830087,0,2,receptor transactivation,BP,
9208,GO:0035625,1,0.967992970971516,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9209,GO:0035627,1,0.830218590435818,0,6,ceramide transport,BP,
9210,GO:0035630,1,0.936736390103247,0,2,bone mineralization involved in bone maturation,BP,
9212,GO:0035633,1,0.93906350352251,0,2,maintenance of permeability of blood-brain barrier,BP,
9213,GO:0035634,1,0.948997075057751,0,2,response to stilbenoid,BP,
9216,GO:0035638,1,0.967008574995129,0,1,signal maturation,BP,
9218,GO:0035640,1,0.711219589316504,0,11,exploration behavior,BP,
9219,GO:0035641,1,0.832652857712162,0,6,locomotory exploration behavior,BP,
9220,GO:0035642,1,0.969072194027201,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9221,GO:0035646,1,0.738335375726024,0,10,endosome to melanosome transport,BP,
9222,GO:0035650,1,0.888853962324234,0,4,AP-1 adaptor complex binding,MF,
9223,GO:0035651,1,0.91675908115178,0,3,AP-3 adaptor complex binding,MF,
9224,GO:0035655,1,0.835401520524459,0,6,interleukin-18-mediated signaling pathway,BP,
9226,GO:0035659,1,0.972561016164289,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9227,GO:0035662,1,0.924406145606357,0,3,Toll-like receptor 4 binding,MF,
9228,GO:0035663,1,0.940157838508883,0,2,Toll-like receptor 2 binding,MF,
9229,GO:0035664,1,0.972373347402656,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9230,GO:0035665,1,0.972373347402656,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9232,GO:0035668,1,0.936958656183887,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9233,GO:0035669,1,0.936958656183887,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9234,GO:0035671,1,0.941736154616668,0,2,enone reductase activity,MF,
9235,GO:0035672,1,0.826976880756296,0,6,oligopeptide transmembrane transport,BP,
9236,GO:0035673,1,0.876635996212735,0,4,oligopeptide transmembrane transporter activity,MF,
9237,GO:0035674,1,0.942265822494162,0,2,tricarboxylic acid transmembrane transport,BP,
9238,GO:0035686,1,0.917479583302819,0,3,sperm fibrous sheath,CC,
9240,GO:0035692,1,0.966942746580949,0,1,macrophage migration inhibitory factor receptor complex,CC,
9241,GO:0035694,1,0.881472040299321,0,4,mitochondrial protein catabolic process,BP,
9242,GO:0035695,1,0.967224332854149,0,1,mitophagy by induced vacuole formation,BP,
9243,GO:0035697,1,0.944954394752515,0,2,CD8-positive, alpha-beta T cell extravasation,BP,
9244,GO:0035698,1,0.944954394752515,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9245,GO:0035700,1,0.972381403541729,0,1,astrocyte chemotaxis,BP,
9246,GO:0035701,1,0.910812534455955,0,3,hematopoietic stem cell migration,BP,
9247,GO:0035709,1,0.971173025433657,0,1,memory T cell activation,BP,
9249,GO:0035711,1,0.968210245910427,0,1,T-helper 1 cell activation,BP,
9250,GO:0035712,1,0.968471423097752,0,1,T-helper 2 cell activation,BP,
9251,GO:0035718,1,0.973113139541563,0,1,macrophage migration inhibitory factor binding,MF,
9252,GO:0035720,1,0.90985747931129,0,3,intraciliary anterograde transport,BP,
9253,GO:0035721,1,0.68520233060157,0,12,intraciliary retrograde transport,BP,
9255,GO:0035723,1,0.775362358675333,0,8,interleukin-15-mediated signaling pathway,BP,
9257,GO:0035726,1,0.887110853314967,0,4,common myeloid progenitor cell proliferation,BP,
9258,GO:0035727,1,0.939179389433405,0,2,lysophosphatidic acid binding,MF,
9261,GO:0035730,1,0.974217190582425,0,1,S-nitrosoglutathione binding,MF,
9262,GO:0035731,1,0.974217190582425,0,1,dinitrosyl-iron complex binding,MF,
9263,GO:0035732,1,0.974217190582425,0,1,nitric oxide storage,BP,
9264,GO:0035733,1,0.882729220069413,0,4,hepatic stellate cell activation,BP,
9266,GO:0035739,1,0.881583699722745,0,4,CD4-positive, alpha-beta T cell proliferation,BP,
9267,GO:0035740,1,0.941523229097809,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
9269,GO:0035744,1,0.973855727613273,0,1,T-helper 1 cell cytokine production,BP,
9271,GO:0035747,1,0.914950082530714,0,3,natural killer cell chemotaxis,BP,
9273,GO:0035749,1,0.855834535323217,0,5,myelin sheath adaxonal region,CC,
9274,GO:0035750,1,0.966891806457121,0,1,protein localization to myelin sheath abaxonal region,BP,
9275,GO:0035751,1,0.731285874834449,0,11,regulation of lysosomal lumen pH,BP,
9276,GO:0035752,1,0.972041707561203,0,1,lysosomal lumen pH elevation,BP,
9277,GO:0035754,1,0.855348354292876,0,5,B cell chemotaxis,BP,
9278,GO:0035755,1,0.970104831459515,0,1,cardiolipin hydrolase activity,MF,
9279,GO:0035766,1,0.904588072325358,0,3,cell chemotaxis to fibroblast growth factor,BP,
9281,GO:0035768,1,0.904588072325358,0,3,endothelial cell chemotaxis to fibroblast growth factor,BP,
9283,GO:0035771,1,0.853755194266202,0,5,interleukin-4-mediated signaling pathway,BP,
9286,GO:0035787,1,0.908683511152775,0,3,cell migration involved in kidney development,BP,
9287,GO:0035788,1,0.939802557413203,0,2,cell migration involved in metanephros development,BP,
9288,GO:0035789,1,0.939802557413203,0,2,metanephric mesenchymal cell migration,BP,
9289,GO:0035790,1,0.967632893952598,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9290,GO:0035791,1,0.749317186426907,0,9,platelet-derived growth factor receptor-beta signaling pathway,BP,
9291,GO:0035793,1,0.939802557413203,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9293,GO:0035795,1,0.867442749970482,0,5,negative regulation of mitochondrial membrane permeability,BP,
9294,GO:0035799,1,0.907318747099373,0,3,ureter maturation,BP,
9295,GO:0035800,1,0.941824139959624,0,2,deubiquitinase activator activity,MF,
9298,GO:0035803,1,0.947282059724529,0,2,egg coat formation,BP,
9301,GO:0035811,1,0.966862288706958,0,1,negative regulation of urine volume,BP,
9304,GO:0035814,1,0.970979761919229,0,1,negative regulation of renal sodium excretion,BP,
9307,GO:0035822,1,0.936586424043033,0,2,gene conversion,BP,
9308,GO:0035825,1,0.328828761149682,0,36,homologous recombination,BP,
9309,GO:0035838,1,0.935253849617478,0,2,growing cell tip,CC,
9310,GO:0035841,1,0.966864704463998,0,1,new growing cell tip,CC,
9311,GO:0035844,1,0.909184737518515,0,3,cloaca development,BP,
9312,GO:0035845,1,0.799587854985249,0,7,photoreceptor cell outer segment organization,BP,
9313,GO:0035850,1,0.43507218577901,0,26,epithelial cell differentiation involved in kidney development,BP,
9314,GO:0035851,1,0.969087972544465,0,1,Krueppel-associated box domain binding,MF,
9315,GO:0035853,1,0.967119513851276,0,1,chromosome passenger complex localization to spindle midzone,BP,
9316,GO:0035855,1,0.679086870584367,0,12,megakaryocyte development,BP,
9317,GO:0035859,1,0.669277679585096,0,13,Seh1-associated complex,CC,
9318,GO:0035860,1,0.906114478345311,0,3,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
9320,GO:0035862,1,0.966867738967312,0,1,dITP metabolic process,BP,
9321,GO:0035863,1,0.966867738967312,0,1,dITP catabolic process,BP,
9322,GO:0035864,1,0.83604937833621,0,6,response to potassium ion,BP,
9323,GO:0035865,1,0.917171822008931,0,3,cellular response to potassium ion,BP,
9327,GO:0035869,1,0.220548158549706,0,49,ciliary transition zone,CC,
9328,GO:0035870,1,0.941674855545784,0,2,dITP diphosphatase activity,MF,
9329,GO:0035871,1,0.744094993637014,0,9,protein K11-linked deubiquitination,BP,
9331,GO:0035873,1,0.880053105287271,0,4,lactate transmembrane transport,BP,
9332,GO:0035877,1,0.887115629799474,0,4,death effector domain binding,MF,
9333,GO:0035878,1,0.802626875890061,0,7,nail development,BP,
9334,GO:0035879,1,0.909125601700776,0,3,plasma membrane lactate transport,BP,
9335,GO:0035880,1,0.939823836834976,0,2,embryonic nail plate morphogenesis,BP,
9336,GO:0035881,1,0.942686411809234,0,2,amacrine cell differentiation,BP,
9338,GO:0035886,1,0.668504884846182,0,13,vascular smooth muscle cell differentiation,BP,
9339,GO:0035887,1,0.972478537311936,0,1,aortic smooth muscle cell differentiation,BP,
9342,GO:0035897,1,0.858533819303631,0,5,proteolysis in other organism,BP,
9343,GO:0035898,1,0.910619071947509,0,3,parathyroid hormone secretion,BP,
9347,GO:0035905,1,0.909906267948715,0,3,ascending aorta development,BP,
9348,GO:0035907,1,0.852566193701854,0,5,dorsal aorta development,BP,
9349,GO:0035909,1,0.557650290712706,0,18,aorta morphogenesis,BP,
9350,GO:0035910,1,0.909906267948715,0,3,ascending aorta morphogenesis,BP,
9351,GO:0035912,1,0.880337964229001,0,4,dorsal aorta morphogenesis,BP,
9353,GO:0035915,1,0.971643848359948,0,1,pore formation in membrane of other organism,BP,
9354,GO:0035921,1,0.971490706398445,0,1,desmosome disassembly,BP,
9355,GO:0035922,1,0.968680067927164,0,1,foramen ovale closure,BP,
9358,GO:0035926,1,0.854963061193236,0,5,chemokine (C-C motif) ligand 2 secretion,BP,
9359,GO:0035927,1,0.888392583632513,0,4,RNA import into mitochondrion,BP,
9360,GO:0035928,1,0.917504239657358,0,3,rRNA import into mitochondrion,BP,
9365,GO:0035933,1,0.912547229501377,0,3,glucocorticoid secretion,BP,
9366,GO:0035935,1,0.968464112479007,0,1,androgen secretion,BP,
9367,GO:0035936,1,0.96684551725298,0,1,testosterone secretion,BP,
9368,GO:0035938,1,0.966857965499383,0,1,estradiol secretion,BP,
9369,GO:0035945,1,0.970354031289477,0,1,mitochondrial ncRNA surveillance,BP,
9370,GO:0035946,1,0.970354031289477,0,1,mitochondrial mRNA surveillance,BP,
9371,GO:0035947,1,0.850730607426449,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
9372,GO:0035948,1,0.907504376743104,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
9373,GO:0035962,1,0.96763853165673,0,1,response to interleukin-13,BP,
9374,GO:0035963,1,0.96763853165673,0,1,cellular response to interleukin-13,BP,
9375,GO:0035964,1,0.831286693371329,0,6,COPI-coated vesicle budding,BP,
9376,GO:0035965,1,0.857272639109714,0,5,cardiolipin acyl-chain remodeling,BP,
9380,GO:0035971,1,0.973704862035964,0,1,peptidyl-histidine dephosphorylation,BP,
9381,GO:0035973,1,0.80012131057668,0,7,aggrephagy,BP,
9383,GO:0035977,1,0.88105125286297,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
9384,GO:0035978,1,0.969425204500395,0,1,histone H2A-S139 phosphorylation,BP,
9385,GO:0035981,1,0.940983167055524,0,2,tongue muscle cell differentiation,BP,
9386,GO:0035983,1,0.912268788125393,0,3,response to trichostatin A,BP,
9387,GO:0035984,1,0.912268788125393,0,3,cellular response to trichostatin A,BP,
9391,GO:0035988,1,0.801122589784311,0,7,chondrocyte proliferation,BP,
9392,GO:0035989,1,0.880975671300483,0,4,tendon development,BP,
9393,GO:0035990,1,0.942493750877429,0,2,tendon cell differentiation,BP,
9394,GO:0035992,1,0.942493750877429,0,2,tendon formation,BP,
9395,GO:0035993,1,0.915233925307969,0,3,deltoid tuberosity development,BP,
9397,GO:0035995,1,0.966202232756588,0,1,detection of muscle stretch,BP,
9398,GO:0035998,1,0.971902993724555,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
9399,GO:0035999,1,0.785556980474627,0,8,tetrahydrofolate interconversion,BP,
9400,GO:0036002,1,0.374468867126551,0,32,pre-mRNA binding,MF,
9402,GO:0036004,1,0.973677862783445,0,1,GAF domain binding,MF,
9403,GO:0036005,1,0.855599568642203,0,5,response to macrophage colony-stimulating factor,BP,
9404,GO:0036006,1,0.855599568642203,0,5,cellular response to macrophage colony-stimulating factor stimulus,BP,
9405,GO:0036009,1,0.973811368227514,0,1,protein-glutamine N-methyltransferase activity,MF,
9407,GO:0036015,1,0.915677134529293,0,3,response to interleukin-3,BP,
9408,GO:0036016,1,0.915677134529293,0,3,cellular response to interleukin-3,BP,
9409,GO:0036017,1,0.899398966844633,0,4,response to erythropoietin,BP,
9410,GO:0036018,1,0.899398966844633,0,4,cellular response to erythropoietin,BP,
9411,GO:0036019,1,0.606182183357314,0,16,endolysosome,CC,
9412,GO:0036020,1,0.684138965825099,0,12,endolysosome membrane,CC,
9413,GO:0036021,1,0.886162690324552,0,4,endolysosome lumen,CC,
9416,GO:0036033,1,0.874110594010725,0,4,mediator complex binding,MF,
9417,GO:0036034,1,0.941446686665889,0,2,mediator complex assembly,BP,
9419,GO:0036037,1,0.806344493446002,0,7,CD8-positive, alpha-beta T cell activation,BP,
9420,GO:0036038,1,0.680133046671114,0,13,MKS complex,CC,
9421,GO:0036041,1,0.843896392389015,0,6,long-chain fatty acid binding,MF,
9422,GO:0036042,1,0.894780132835997,0,4,long-chain fatty acyl-CoA binding,MF,
9423,GO:0036046,1,0.968704944574209,0,1,protein demalonylation,BP,
9424,GO:0036047,1,0.968704944574209,0,1,peptidyl-lysine demalonylation,BP,
9425,GO:0036048,1,0.968704944574209,0,1,protein desuccinylation,BP,
9426,GO:0036049,1,0.968704944574209,0,1,peptidyl-lysine desuccinylation,BP,
9427,GO:0036054,1,0.968704944574209,0,1,protein-malonyllysine demalonylase activity,MF,
9428,GO:0036055,1,0.968704944574209,0,1,protein-succinyllysine desuccinylase activity,MF,
9429,GO:0036056,1,0.873952970173912,0,4,filtration diaphragm,CC,
9430,GO:0036057,1,0.873952970173912,0,4,slit diaphragm,CC,
9432,GO:0036065,1,0.482841247795182,0,23,fucosylation,BP,
9433,GO:0036066,1,0.641777273515232,0,14,protein O-linked fucosylation,BP,
9434,GO:0036071,1,0.968440502417451,0,1,N-glycan fucosylation,BP,
9435,GO:0036072,1,0.88019916760338,0,4,direct ossification,BP,
9436,GO:0036075,1,0.603826625003119,0,16,replacement ossification,BP,
9437,GO:0036080,1,0.936473484045029,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
9438,GO:0036085,1,0.968587527922183,0,1,GDP-fucose import into Golgi lumen,BP,
9439,GO:0036089,1,0.802779839943876,0,7,cleavage furrow formation,BP,
9440,GO:0036090,1,0.94423805016235,0,2,cleavage furrow ingression,BP,
9441,GO:0036091,1,0.882597625976018,0,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
9443,GO:0036093,1,0.920692878946287,0,3,germ cell proliferation,BP,
9445,GO:0036105,1,0.967919776184163,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
9447,GO:0036111,1,0.969779379986498,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
9448,GO:0036112,1,0.943607907694121,0,2,medium-chain fatty-acyl-CoA metabolic process,BP,
9449,GO:0036114,1,0.973015205241223,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
9450,GO:0036115,1,0.973015205241223,0,1,fatty-acyl-CoA catabolic process,BP,
9451,GO:0036116,1,0.973015205241223,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
9452,GO:0036117,1,0.942449317058416,0,2,hyaluranon cable,CC,
9453,GO:0036118,1,0.911758854669413,0,3,hyaluranon cable assembly,BP,
9456,GO:0036122,1,0.909952834733192,0,3,BMP binding,MF,
9457,GO:0036123,1,0.860291695577092,0,5,histone H3-K9 dimethylation,BP,
9458,GO:0036124,1,0.637879548628036,0,14,histone H3-K9 trimethylation,BP,
9459,GO:0036125,1,0.968911946648075,0,1,fatty acid beta-oxidation multienzyme complex,CC,
9460,GO:0036126,1,0.302198311212106,0,39,sperm flagellum,CC,
9461,GO:0036128,1,0.969590599808287,0,1,CatSper complex,CC,
9462,GO:0036132,1,0.913290029868771,0,3,13-prostaglandin reductase activity,MF,
9463,GO:0036135,1,0.937124547618538,0,2,Schwann cell migration,BP,
9464,GO:0036137,1,0.942410042115287,0,2,kynurenine aminotransferase activity,MF,
9465,GO:0036138,1,0.966844879899242,0,1,peptidyl-histidine hydroxylation,BP,
9466,GO:0036139,1,0.966844879899242,0,1,peptidyl-histidine dioxygenase activity,MF,
9467,GO:0036140,1,0.966844879899242,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9468,GO:0036145,1,0.972381403541729,0,1,dendritic cell homeostasis,BP,
9469,GO:0036146,1,0.912992195250756,0,3,cellular response to mycotoxin,BP,
9470,GO:0036148,1,0.703040576759296,0,11,phosphatidylglycerol acyl-chain remodeling,BP,
9472,GO:0036150,1,0.683299408171301,0,12,phosphatidylserine acyl-chain remodeling,BP,
9475,GO:0036153,1,0.969473766764352,0,1,triglyceride acyl-chain remodeling,BP,
9477,GO:0036156,1,0.93459273010636,0,2,inner dynein arm,CC,
9478,GO:0036157,1,0.910956094745376,0,3,outer dynein arm,CC,
9479,GO:0036158,1,0.832983250625224,0,6,outer dynein arm assembly,BP,
9480,GO:0036159,1,0.854868401996418,0,5,inner dynein arm assembly,BP,
9481,GO:0036164,1,0.973949146632894,0,1,cell-abiotic substrate adhesion,BP,
9482,GO:0036166,1,0.911054116128049,0,3,phenotypic switching,BP,
9483,GO:0036179,1,0.969608647494482,0,1,osteoclast maturation,BP,
9484,GO:0036194,1,0.921088265293666,0,3,muscle cell projection,CC,
9485,GO:0036195,1,0.921088265293666,0,3,muscle cell projection membrane,CC,
9487,GO:0036213,1,0.971240858915391,0,1,contractile ring contraction,BP,
9488,GO:0036215,1,0.969101554900902,0,1,response to stem cell factor,BP,
9489,GO:0036216,1,0.969101554900902,0,1,cellular response to stem cell factor stimulus,BP,
9490,GO:0036219,1,0.974656079851253,0,1,GTP diphosphatase activity,MF,
9491,GO:0036220,1,0.973946193002066,0,1,ITP diphosphatase activity,MF,
9492,GO:0036222,1,0.973946193002066,0,1,XTP diphosphatase activity,MF,
9493,GO:0036228,1,0.938894988759039,0,2,protein localization to nuclear inner membrane,BP,
9495,GO:0036245,1,0.940998405759092,0,2,cellular response to menadione,BP,
9496,GO:0036250,1,0.971975421382784,0,1,peroxisome transport along microtubule,BP,
9497,GO:0036255,1,0.96765332017958,0,1,response to methylamine,BP,
9498,GO:0036257,1,0.394620921365047,0,31,multivesicular body organization,BP,
9499,GO:0036258,1,0.407070776713025,0,30,multivesicular body assembly,BP,
9500,GO:0036260,1,0.375733552677802,0,33,RNA capping,BP,
9501,GO:0036261,1,0.967810473249221,0,1,7-methylguanosine cap hypermethylation,BP,
9502,GO:0036265,1,0.892331309887796,0,4,RNA (guanine-N7)-methylation,BP,
9503,GO:0036266,1,0.970165134653767,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
9504,GO:0036269,1,0.972915348123467,0,1,swimming behavior,BP,
9506,GO:0036284,1,0.940797207541514,0,2,tubulobulbar complex,CC,
9507,GO:0036289,1,0.825298160387458,0,6,peptidyl-serine autophosphorylation,BP,
9508,GO:0036290,1,0.967450840374247,0,1,protein trans-autophosphorylation,BP,
9512,GO:0036295,1,0.672851845769606,0,13,cellular response to increased oxygen levels,BP,
9514,GO:0036297,1,0.224501897030252,0,48,interstrand cross-link repair,BP,
9515,GO:0036301,1,0.911293145238609,0,3,macrophage colony-stimulating factor production,BP,
9518,GO:0036309,1,0.934449537626054,0,2,protein localization to M-band,BP,
9520,GO:0036312,1,0.745053533666885,0,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
9521,GO:0036313,1,0.940101526122395,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
9524,GO:0036316,1,0.969718338266846,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
9525,GO:0036317,1,0.969271124374127,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9526,GO:0036324,1,0.941851709024456,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
9527,GO:0036333,1,0.969934746833715,0,1,hepatocyte homeostasis,BP,
9528,GO:0036335,1,0.966901503007899,0,1,intestinal stem cell homeostasis,BP,
9530,GO:0036337,1,0.880467498496278,0,4,Fas signaling pathway,BP,
9531,GO:0036342,1,0.722985193529984,0,10,post-anal tail morphogenesis,BP,
9532,GO:0036343,1,0.974945144263898,0,1,psychomotor behavior,BP,
9534,GO:0036351,1,0.97084279414513,0,1,histone H2A-K13 ubiquitination,BP,
9535,GO:0036352,1,0.97084279414513,0,1,histone H2A-K15 ubiquitination,BP,
9536,GO:0036353,1,0.77790378015426,0,8,histone H2A-K119 monoubiquitination,BP,
9537,GO:0036361,1,0.970365496604871,0,1,racemase activity, acting on amino acids and derivatives,MF,
9539,GO:0036367,1,0.970121619109262,0,1,light adaption,BP,
9540,GO:0036369,1,0.934755984939109,0,2,transcription factor catabolic process,BP,
9541,GO:0036371,1,0.966814582471168,0,1,protein localization to T-tubule,BP,
9542,GO:0036372,1,0.974187290790793,0,1,opsin transport,BP,
9543,GO:0036374,1,0.913302840121274,0,3,glutathione hydrolase activity,MF,
9545,GO:0036378,1,0.943945857324745,0,2,calcitriol biosynthetic process from calciol,BP,
9547,GO:0036387,1,0.916634529085006,0,3,pre-replicative complex,CC,
9548,GO:0036388,1,0.916634529085006,0,3,pre-replicative complex assembly,BP,
9549,GO:0036392,1,0.967789301379805,0,1,chemokine (C-C motif) ligand 20 production,BP,
9550,GO:0036396,1,0.918189803666991,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
9551,GO:0036398,1,0.968456823520522,0,1,TCR signalosome,CC,
9552,GO:0036399,1,0.968456823520522,0,1,TCR signalosome assembly,BP,
9553,GO:0036402,1,0.848887325811921,0,6,proteasome-activating ATPase activity,MF,
9554,GO:0036403,1,0.969952542365966,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
9555,GO:0036404,1,0.966763055442951,0,1,conversion of ds siRNA to ss siRNA,BP,
9556,GO:0036414,1,0.968614476728591,0,1,histone citrullination,BP,
9558,GO:0036438,1,0.882042501668592,0,4,maintenance of lens transparency,BP,
9560,GO:0036442,1,0.518916082878726,0,22,proton-exporting ATPase activity,MF,
9561,GO:0036444,1,0.775988373550263,0,8,calcium import into the mitochondrion,BP,
9562,GO:0036445,1,0.719256044267885,0,10,neuronal stem cell division,BP,
9564,GO:0036449,1,0.79357524493889,0,7,microtubule minus-end,CC,
9565,GO:0036451,1,0.939484005877423,0,2,cap mRNA methylation,BP,
9566,GO:0036452,1,0.445684230845376,0,27,ESCRT complex,CC,
9568,GO:0036455,1,0.973900675778483,0,1,iron-sulfur transferase activity,MF,
9570,GO:0036458,1,0.97120252451975,0,1,hepatocyte growth factor binding,MF,
9572,GO:0036461,1,0.947746563488163,0,2,BLOC-2 complex binding,MF,
9576,GO:0036466,1,0.935155207826968,0,2,synaptic vesicle recycling via endosome,BP,
9577,GO:0036470,1,0.974265395836361,0,1,tyrosine 3-monooxygenase activator activity,MF,
9578,GO:0036471,1,0.974265395836361,0,1,cellular response to glyoxal,BP,
9582,GO:0036476,1,0.919167513411066,0,3,neuron death in response to hydrogen peroxide,BP,
9584,GO:0036478,1,0.974265395836361,0,1,L-dopa decarboxylase activator activity,MF,
9586,GO:0036481,1,0.839587094796942,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9587,GO:0036482,1,0.944896299882133,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9588,GO:0036483,1,0.967082315738923,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
9591,GO:0036487,1,0.966797215838241,0,1,nitric-oxide synthase inhibitor activity,MF,
9592,GO:0036488,1,0.947262816130034,0,2,CHOP-C/EBP complex,CC,
9598,GO:0036496,1,0.944593589287511,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
9599,GO:0036497,1,0.97065514888709,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
9603,GO:0036501,1,0.967171644435845,0,1,UFD1-NPL4 complex,CC,
9604,GO:0036502,1,0.968739129964349,0,1,Derlin-1-VIMP complex,CC,
9606,GO:0036505,1,0.969128880375881,0,1,prosaposin receptor activity,MF,
9607,GO:0036506,1,0.910396980501902,0,3,maintenance of unfolded protein,BP,
9610,GO:0036509,1,0.942501055860157,0,2,trimming of terminal mannose on B branch,BP,
9611,GO:0036510,1,0.91126565781022,0,3,trimming of terminal mannose on C branch,BP,
9612,GO:0036511,1,0.942501055860157,0,2,trimming of first mannose on A branch,BP,
9613,GO:0036512,1,0.942501055860157,0,2,trimming of second mannose on A branch,BP,
9615,GO:0036514,1,0.847430368259288,0,5,dopaminergic neuron axon guidance,BP,
9616,GO:0036515,1,0.874419397423853,0,4,serotonergic neuron axon guidance,BP,
9617,GO:0036517,1,0.966872720920993,0,1,chemoattraction of serotonergic neuron axon,BP,
9618,GO:0036518,1,0.937038189056382,0,2,chemorepulsion of dopaminergic neuron axon,BP,
9619,GO:0036524,1,0.974265395836361,0,1,protein deglycase activity,MF,
9620,GO:0036525,1,0.974265395836361,0,1,protein deglycation,BP,
9621,GO:0036526,1,0.974265395836361,0,1,peptidyl-cysteine deglycation,BP,
9622,GO:0036527,1,0.974265395836361,0,1,peptidyl-arginine deglycation,BP,
9623,GO:0036528,1,0.974265395836361,0,1,peptidyl-lysine deglycation,BP,
9624,GO:0036529,1,0.974265395836361,0,1,protein deglycation, glyoxal removal,BP,
9625,GO:0036530,1,0.974265395836361,0,1,protein deglycation, methylglyoxal removal,BP,
9626,GO:0036531,1,0.974265395836361,0,1,glutathione deglycation,BP,
9627,GO:0038001,1,0.942538107521299,0,2,paracrine signaling,BP,
9628,GO:0038002,1,0.966892302938226,0,1,endocrine signaling,BP,
9629,GO:0038003,1,0.887958635882542,0,4,opioid receptor signaling pathway,BP,
9630,GO:0038007,1,0.90640675758611,0,3,netrin-activated signaling pathway,BP,
9631,GO:0038016,1,0.939895706433727,0,2,insulin receptor internalization,BP,
9632,GO:0038018,1,0.935025287892791,0,2,Wnt receptor catabolic process,BP,
9633,GO:0038021,1,0.967254354164645,0,1,leptin receptor activity,MF,
9636,GO:0038025,1,0.93626007585128,0,2,reelin receptor activity,MF,
9637,GO:0038026,1,0.905469695380448,0,3,reelin-mediated signaling pathway,BP,
9639,GO:0038028,1,0.8789660381746,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
9640,GO:0038030,1,0.822313773244355,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9641,GO:0038031,1,0.849888120277165,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9642,GO:0038033,1,0.913480735038499,0,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
9644,GO:0038036,1,0.829551305253815,0,6,sphingosine-1-phosphate receptor activity,MF,
9645,GO:0038037,1,0.911184241347251,0,3,G-protein coupled receptor dimeric complex,CC,
9646,GO:0038039,1,0.96718609365172,0,1,G-protein coupled receptor heterodimeric complex,CC,
9647,GO:0038042,1,0.89104031607465,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
9649,GO:0038047,1,0.972152030821871,0,1,morphine receptor activity,MF,
9650,GO:0038049,1,0.934688213039333,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
9651,GO:0038051,1,0.966852478934071,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9652,GO:0038052,1,0.938265665465863,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9654,GO:0038062,1,0.967643061872856,0,1,protein tyrosine kinase collagen receptor activity,MF,
9655,GO:0038063,1,0.790486902902401,0,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,
9656,GO:0038064,1,0.935534069471229,0,2,collagen receptor activity,MF,
9657,GO:0038065,1,0.764242171375078,0,8,collagen-activated signaling pathway,BP,
9662,GO:0038086,1,0.968058844091218,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9663,GO:0038089,1,0.854013784842991,0,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9664,GO:0038091,1,0.968058844091218,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
9670,GO:0038098,1,0.971664172751245,0,1,sequestering of BMP from receptor via BMP binding,BP,
9671,GO:0038101,1,0.97251927832974,0,1,sequestering of nodal from receptor via nodal binding,BP,
9673,GO:0038108,1,0.912443466317868,0,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,
9674,GO:0038109,1,0.969101554900902,0,1,Kit signaling pathway,BP,
9675,GO:0038110,1,0.796183856862598,0,7,interleukin-2-mediated signaling pathway,BP,
9677,GO:0038112,1,0.970362629271163,0,1,interleukin-8-mediated signaling pathway,BP,
9678,GO:0038113,1,0.934905278498889,0,2,interleukin-9-mediated signaling pathway,BP,
9679,GO:0038114,1,0.875047348424297,0,4,interleukin-21-mediated signaling pathway,BP,
9680,GO:0038123,1,0.968253078048579,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
9681,GO:0038124,1,0.936173716074973,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
9685,GO:0038131,1,0.941336313160392,0,2,neuregulin receptor activity,MF,
9687,GO:0038145,1,0.912745864194606,0,3,macrophage colony-stimulating factor signaling pathway,BP,
9690,GO:0038158,1,0.941713817689692,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
9691,GO:0038161,1,0.969271124374127,0,1,prolactin signaling pathway,BP,
9692,GO:0038162,1,0.972190777828092,0,1,erythropoietin-mediated signaling pathway,BP,
9693,GO:0038163,1,0.974181664334021,0,1,thrombopoietin-mediated signaling pathway,BP,
9695,GO:0038166,1,0.859717147855029,0,5,angiotensin-activated signaling pathway,BP,
9697,GO:0038172,1,0.967673526794939,0,1,interleukin-33-mediated signaling pathway,BP,
9698,GO:0038179,1,0.427686744509699,0,27,neurotrophin signaling pathway,BP,
9699,GO:0038180,1,0.778281083972348,0,8,nerve growth factor signaling pathway,BP,
9700,GO:0038181,1,0.967018484838147,0,1,bile acid receptor activity,MF,
9701,GO:0038183,1,0.967018484838147,0,1,bile acid signaling pathway,BP,
9702,GO:0038186,1,0.967018484838147,0,1,lithocholic acid receptor activity,MF,
9703,GO:0038187,1,0.831184343755325,0,6,pattern recognition receptor activity,MF,
9707,GO:0038192,1,0.971674325577539,0,1,gastric inhibitory peptide signaling pathway,BP,
9708,GO:0038193,1,0.970979761919229,0,1,thromboxane A2 signaling pathway,BP,
9709,GO:0038194,1,0.967604024860509,0,1,thyroid-stimulating hormone signaling pathway,BP,
9710,GO:0038195,1,0.97322865209353,0,1,urokinase plasminogen activator signaling pathway,BP,
9712,GO:0038202,1,0.384149739661849,0,31,TORC1 signaling,BP,
9714,GO:0039003,1,0.967604024860509,0,1,pronephric field specification,BP,
9715,GO:0039007,1,0.966881269277234,0,1,pronephric nephron morphogenesis,BP,
9716,GO:0039008,1,0.966881269277234,0,1,pronephric nephron tubule morphogenesis,BP,
9717,GO:0039017,1,0.967604024860509,0,1,pattern specification involved in pronephros development,BP,
9718,GO:0039019,1,0.935826798097861,0,2,pronephric nephron development,BP,
9719,GO:0039020,1,0.966881269277234,0,1,pronephric nephron tubule development,BP,
9720,GO:0039022,1,0.966881269277234,0,1,pronephric duct development,BP,
9721,GO:0039023,1,0.966881269277234,0,1,pronephric duct morphogenesis,BP,
9722,GO:0039502,1,0.966906671281593,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9723,GO:0039503,1,0.966906671281593,0,1,suppression by virus of host innate immune response,BP,
9724,GO:0039506,1,0.937505932679055,0,2,modulation by virus of host molecular function,BP,
9725,GO:0039507,1,0.937505932679055,0,2,suppression by virus of host molecular function,BP,
9726,GO:0039513,1,0.969595749257649,0,1,suppression by virus of host catalytic activity,BP,
9727,GO:0039514,1,0.966906671281593,0,1,suppression by virus of host JAK-STAT cascade,BP,
9728,GO:0039516,1,0.969595749257649,0,1,modulation by virus of host catalytic activity,BP,
9729,GO:0039519,1,0.934918857634929,0,2,modulation by virus of host autophagy,BP,
9730,GO:0039520,1,0.966881537493648,0,1,induction by virus of host autophagy,BP,
9731,GO:0039521,1,0.966945498521195,0,1,suppression by virus of host autophagy,BP,
9732,GO:0039526,1,0.916406871063324,0,3,modulation by virus of host apoptotic process,BP,
9735,GO:0039530,1,0.75777520701478,0,9,MDA-5 signaling pathway,BP,
9737,GO:0039532,1,0.731722419120829,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9738,GO:0039533,1,0.827902294561446,0,6,regulation of MDA-5 signaling pathway,BP,
9739,GO:0039534,1,0.88570830685935,0,4,negative regulation of MDA-5 signaling pathway,BP,
9741,GO:0039536,1,0.803224540563055,0,7,negative regulation of RIG-I signaling pathway,BP,
9742,GO:0039552,1,0.966883559711651,0,1,RIG-I binding,MF,
9743,GO:0039562,1,0.966906671281593,0,1,suppression by virus of host STAT activity,BP,
9744,GO:0039563,1,0.966906671281593,0,1,suppression by virus of host STAT1 activity,BP,
9745,GO:0039564,1,0.966906671281593,0,1,suppression by virus of host STAT2 activity,BP,
9746,GO:0039650,1,0.969595749257649,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
9747,GO:0039656,1,0.942073850870519,0,2,modulation by virus of host gene expression,BP,
9748,GO:0039663,1,0.914937154059093,0,3,membrane fusion involved in viral entry into host cell,BP,
9749,GO:0039689,1,0.910883506008321,0,3,negative stranded viral RNA replication,BP,
9750,GO:0039692,1,0.739017921501912,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
9751,GO:0039694,1,0.474291938704964,0,24,viral RNA genome replication,BP,
9752,GO:0039695,1,0.967053800300271,0,1,DNA-templated viral transcription,BP,
9753,GO:0039702,1,0.537046086882524,0,21,viral budding via host ESCRT complex,BP,
9754,GO:0039706,1,0.83448144546411,0,6,co-receptor binding,MF,
9755,GO:0039713,1,0.968183517101338,0,1,viral factory,CC,
9756,GO:0039714,1,0.968183517101338,0,1,cytoplasmic viral factory,CC,
9757,GO:0040001,1,0.499744776242499,0,22,establishment of mitotic spindle localization,BP,
9760,GO:0040009,1,0.877368929858593,0,4,regulation of growth rate,BP,
9764,GO:0040014,1,0.256702484408427,0,43,regulation of multicellular organism growth,BP,
9765,GO:0040015,1,0.755832564388773,0,9,negative regulation of multicellular organism growth,BP,
9766,GO:0040016,1,0.803678692712532,0,7,embryonic cleavage,BP,
9768,GO:0040018,1,0.546972163108418,0,19,positive regulation of multicellular organism growth,BP,
9769,GO:0040019,1,0.544372707549414,0,19,positive regulation of embryonic development,BP,
9772,GO:0040030,1,0.967692894861768,0,1,regulation of molecular function, epigenetic,BP,
9773,GO:0040031,1,0.843164072079452,0,6,snRNA modification,BP,
9774,GO:0040032,1,0.972075373765072,0,1,post-embryonic body morphogenesis,BP,
9775,GO:0040033,1,0.686801324811705,0,12,negative regulation of translation, ncRNA-mediated,BP,
9776,GO:0040034,1,0.80982467688795,0,7,regulation of development, heterochronic,BP,
9777,GO:0040036,1,0.469307549129501,0,24,regulation of fibroblast growth factor receptor signaling pathway,BP,
9778,GO:0040037,1,0.66026581000598,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
9779,GO:0040038,1,0.936435057104345,0,2,polar body extrusion after meiotic divisions,BP,
9780,GO:0042000,1,0.970551726865232,0,1,translocation of peptides or proteins into host,BP,
9781,GO:0042007,1,0.973274116848162,0,1,interleukin-18 binding,MF,
9782,GO:0042008,1,0.968053573870318,0,1,interleukin-18 receptor activity,MF,
9783,GO:0042015,1,0.911697864419883,0,3,interleukin-20 binding,MF,
9784,GO:0042019,1,0.97180856151349,0,1,interleukin-23 binding,MF,
9785,GO:0042020,1,0.97180856151349,0,1,interleukin-23 receptor activity,MF,
9786,GO:0042022,1,0.97180856151349,0,1,interleukin-12 receptor complex,CC,
9787,GO:0042023,1,0.768677429275408,0,8,DNA endoreduplication,BP,
9788,GO:0042025,1,0.908005942245533,0,3,host cell nucleus,CC,
9790,GO:0042030,1,0.934822258620147,0,2,ATPase inhibitor activity,MF,
9794,GO:0042040,1,0.967250856401697,0,1,metal incorporation into metallo-molybdopterin complex,BP,
9795,GO:0042043,1,0.727298737864355,0,10,neurexin family protein binding,MF,
9798,GO:0042048,1,0.848160593367992,0,5,olfactory behavior,BP,
9799,GO:0042053,1,0.758286517875393,0,9,regulation of dopamine metabolic process,BP,
9800,GO:0042054,1,0.209523129831714,0,50,histone methyltransferase activity,MF,
9803,GO:0042059,1,0.291353265036287,0,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,
9806,GO:0042069,1,0.758286517875393,0,9,regulation of catecholamine metabolic process,BP,
9808,GO:0042074,1,0.819276377285908,0,6,cell migration involved in gastrulation,BP,
9809,GO:0042078,1,0.914637738359626,0,3,germ-line stem cell division,BP,
9810,GO:0042083,1,0.972883663885171,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
9811,GO:0042084,1,0.966755791157029,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
9815,GO:0042091,1,0.940954726771348,0,2,interleukin-10 biosynthetic process,BP,
9819,GO:0042095,1,0.804723891484092,0,7,interferon-gamma biosynthetic process,BP,
9820,GO:0042097,1,0.968523206216462,0,1,interleukin-4 biosynthetic process,BP,
9823,GO:0042101,1,0.801818587537955,0,7,T cell receptor complex,CC,
9826,GO:0042105,1,0.971016631740409,0,1,alpha-beta T cell receptor complex,CC,
9829,GO:0042109,1,0.968806659122999,0,1,lymphotoxin A biosynthetic process,BP,
9833,GO:0042117,1,0.854007669535325,0,5,monocyte activation,BP,
9834,GO:0042118,1,0.801659316843302,0,7,endothelial cell activation,BP,
9836,GO:0042126,1,0.884926868513766,0,4,nitrate metabolic process,BP,
9838,GO:0042128,1,0.970789893477674,0,1,nitrate assimilation,BP,
9842,GO:0042134,1,0.946601106350022,0,2,rRNA primary transcript binding,MF,
9843,GO:0042135,1,0.706966801328529,0,11,neurotransmitter catabolic process,BP,
9845,GO:0042137,1,0.972040302067759,0,1,sequestering of neurotransmitter,BP,
9846,GO:0042138,1,0.970786957051857,0,1,meiotic DNA double-strand break formation,BP,
9847,GO:0042140,1,0.969271124374127,0,1,late meiotic recombination nodule assembly,BP,
9848,GO:0042144,1,0.938183564025224,0,2,vacuole fusion, non-autophagic,BP,
9849,GO:0042147,1,0.11769604880187,0,68,retrograde transport, endosome to Golgi,BP,
9850,GO:0042148,1,0.784150341598807,0,8,strand invasion,BP,
9854,GO:0042159,1,0.693853878171611,0,12,lipoprotein catabolic process,BP,
9855,GO:0042162,1,0.332604338841793,0,35,telomeric DNA binding,MF,
9857,GO:0042166,1,0.857657265385058,0,5,acetylcholine binding,MF,
9861,GO:0042171,1,0.531031355708157,0,20,lysophosphatidic acid acyltransferase activity,MF,
9867,GO:0042181,1,0.476080505380187,0,25,ketone biosynthetic process,BP,
9869,GO:0042214,1,0.972037490433508,0,1,terpene metabolic process,BP,
9873,GO:0042222,1,0.968741153584299,0,1,interleukin-1 biosynthetic process,BP,
9874,GO:0042223,1,0.966933724327514,0,1,interleukin-3 biosynthetic process,BP,
9876,GO:0042228,1,0.828547351000539,0,6,interleukin-8 biosynthetic process,BP,
9877,GO:0042231,1,0.973855727613273,0,1,interleukin-13 biosynthetic process,BP,
9878,GO:0042241,1,0.968534441759746,0,1,interleukin-18 biosynthetic process,BP,
9879,GO:0042245,1,0.938276413173344,0,2,RNA repair,BP,
9881,GO:0042247,1,0.969157573015551,0,1,establishment of planar polarity of follicular epithelium,BP,
9882,GO:0042249,1,0.632527605705053,0,14,establishment of planar polarity of embryonic epithelium,BP,
9883,GO:0042253,1,0.941651644420885,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
9885,GO:0042255,1,0.218848430377634,0,54,ribosome assembly,BP,
9886,GO:0042256,1,0.862825683860118,0,5,mature ribosome assembly,BP,
9887,GO:0042262,1,0.87172338024558,0,5,DNA protection,BP,
9888,GO:0042264,1,0.935804112524524,0,2,peptidyl-aspartic acid hydroxylation,BP,
9889,GO:0042265,1,0.966844879899242,0,1,peptidyl-asparagine hydroxylation,BP,
9891,GO:0042268,1,0.895741563174803,0,4,regulation of cytolysis,BP,
9893,GO:0042270,1,0.915044748584328,0,3,protection from natural killer cell mediated cytotoxicity,BP,
9895,GO:0042272,1,0.934743010625543,0,2,nuclear RNA export factor complex,CC,
9897,GO:0042274,1,0.130020656632125,0,70,ribosomal small subunit biogenesis,BP,
9898,GO:0042275,1,0.97303779177044,0,1,error-free postreplication DNA repair,BP,
9899,GO:0042276,1,0.568939101471404,0,19,error-prone translesion synthesis,BP,
9902,GO:0042281,1,0.941709704758519,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
9903,GO:0042282,1,0.967104318565073,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
9904,GO:0042284,1,0.972185254463607,0,1,sphingolipid delta-4 desaturase activity,MF,
9905,GO:0042285,1,0.827039551259885,0,6,xylosyltransferase activity,MF,
9906,GO:0042287,1,0.63012559893115,0,15,MHC protein binding,MF,
9907,GO:0042288,1,0.758538348046806,0,9,MHC class I protein binding,MF,
9908,GO:0042289,1,0.972903184893448,0,1,MHC class II protein binding,MF,
9909,GO:0042292,1,0.970440273114395,0,1,URM1 activating enzyme activity,MF,
9910,GO:0042296,1,0.89199030400127,0,4,ISG15 transferase activity,MF,
9911,GO:0042297,1,0.874538753677803,0,4,vocal learning,BP,
9912,GO:0042301,1,0.832662751975443,0,6,phosphate ion binding,MF,
9913,GO:0042303,1,0.083800978076099,0,79,molting cycle,BP,
9917,GO:0042308,1,0.805191239945892,0,7,negative regulation of protein import into nucleus,BP,
9921,GO:0042316,1,0.966925946302879,0,1,penicillin metabolic process,BP,
9922,GO:0042320,1,0.966875889570171,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
9923,GO:0042321,1,0.972997302627361,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9924,GO:0042323,1,0.972997302627361,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
9928,GO:0042328,1,0.906001679301557,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
9930,GO:0042335,1,0.907853105651345,0,3,cuticle development,BP,
9932,GO:0042340,1,0.807735017359766,0,7,keratan sulfate catabolic process,BP,
9933,GO:0042350,1,0.916045532700833,0,3,GDP-L-fucose biosynthetic process,BP,
9934,GO:0042351,1,0.946776332755592,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
9935,GO:0042352,1,0.967546435727085,0,1,GDP-L-fucose salvage,BP,
9936,GO:0042354,1,0.82293692396189,0,6,L-fucose metabolic process,BP,
9937,GO:0042355,1,0.82293692396189,0,6,L-fucose catabolic process,BP,
9938,GO:0042356,1,0.973397025980278,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
9941,GO:0042360,1,0.972652485296482,0,1,vitamin E metabolic process,BP,
9942,GO:0042361,1,0.968625138126862,0,1,menaquinone catabolic process,BP,
9944,GO:0042363,1,0.880463819047,0,4,fat-soluble vitamin catabolic process,BP,
9945,GO:0042364,1,0.777933862551951,0,8,water-soluble vitamin biosynthetic process,BP,
9946,GO:0042365,1,0.915614575200805,0,3,water-soluble vitamin catabolic process,BP,
9948,GO:0042369,1,0.939921571306112,0,2,vitamin D catabolic process,BP,
9949,GO:0042371,1,0.967873889023191,0,1,vitamin K biosynthetic process,BP,
9950,GO:0042373,1,0.866043857103901,0,5,vitamin K metabolic process,BP,
9951,GO:0042374,1,0.943372253582683,0,2,phylloquinone metabolic process,BP,
9952,GO:0042376,1,0.943372253582683,0,2,phylloquinone catabolic process,BP,
9953,GO:0042377,1,0.968625138126862,0,1,vitamin K catabolic process,BP,
9955,GO:0042382,1,0.827977247197391,0,6,paraspeckles,CC,
9958,GO:0042392,1,0.858683445496413,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9961,GO:0042401,1,0.684647492641895,0,13,cellular biogenic amine biosynthetic process,BP,
9962,GO:0042402,1,0.750942226353468,0,10,cellular biogenic amine catabolic process,BP,
9963,GO:0042403,1,0.724307979216243,0,10,thyroid hormone metabolic process,BP,
9966,GO:0042407,1,0.644050720333765,0,15,cristae formation,BP,
9967,GO:0042412,1,0.969739494715775,0,1,taurine biosynthetic process,BP,
9968,GO:0042414,1,0.93976841502902,0,2,epinephrine metabolic process,BP,
9969,GO:0042415,1,0.804162638533342,0,7,norepinephrine metabolic process,BP,
9970,GO:0042416,1,0.809043824792642,0,7,dopamine biosynthetic process,BP,
9971,GO:0042417,1,0.591657080617492,0,17,dopamine metabolic process,BP,
9972,GO:0042418,1,0.972037490433508,0,1,epinephrine biosynthetic process,BP,
9973,GO:0042420,1,0.88561151733345,0,4,dopamine catabolic process,BP,
9974,GO:0042421,1,0.912511475865561,0,3,norepinephrine biosynthetic process,BP,
9975,GO:0042423,1,0.759475143269171,0,9,catecholamine biosynthetic process,BP,
9976,GO:0042424,1,0.858062979774629,0,5,catecholamine catabolic process,BP,
9977,GO:0042426,1,0.93613291493982,0,2,choline catabolic process,BP,
9978,GO:0042428,1,0.879099934398631,0,4,serotonin metabolic process,BP,
9979,GO:0042430,1,0.785621444776246,0,8,indole-containing compound metabolic process,BP,
9980,GO:0042436,1,0.918918772447815,0,3,indole-containing compound catabolic process,BP,
9981,GO:0042438,1,0.772735122459121,0,8,melanin biosynthetic process,BP,
9982,GO:0042439,1,0.829857441164283,0,6,ethanolamine-containing compound metabolic process,BP,
9984,GO:0042441,1,0.966983061299026,0,1,eye pigment metabolic process,BP,
9987,GO:0042447,1,0.835461018832374,0,6,hormone catabolic process,BP,
9988,GO:0042448,1,0.785900618456689,0,8,progesterone metabolic process,BP,
9989,GO:0042450,1,0.971789875242554,0,1,arginine biosynthetic process via ornithine,BP,
9990,GO:0042451,1,0.56519487540873,0,20,purine nucleoside biosynthetic process,BP,
9991,GO:0042454,1,0.648536309772357,0,15,ribonucleoside catabolic process,BP,
9992,GO:0042455,1,0.372789194345813,0,34,ribonucleoside biosynthetic process,BP,
9993,GO:0042461,1,0.565389498708919,0,18,photoreceptor cell development,BP,
9994,GO:0042462,1,0.686041605085499,0,12,eye photoreceptor cell development,BP,
9998,GO:0042473,1,0.835093315086941,0,6,outer ear morphogenesis,BP,
10000,GO:0042475,1,0.176050954887274,0,55,odontogenesis of dentin-containing tooth,BP,
10004,GO:0042483,1,0.966858779504773,0,1,negative regulation of odontogenesis,BP,
10005,GO:0042487,1,0.883885293998647,0,4,regulation of odontogenesis of dentin-containing tooth,BP,
10006,GO:0042488,1,0.970512554479437,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10007,GO:0042490,1,0.356077591585408,0,33,mechanoreceptor differentiation,BP,
10008,GO:0042491,1,0.531395894773559,0,20,inner ear auditory receptor cell differentiation,BP,
10009,GO:0042492,1,0.850870488361644,0,5,gamma-delta T cell differentiation,BP,
10011,GO:0042494,1,0.936173716074973,0,2,detection of bacterial lipoprotein,BP,
10012,GO:0042495,1,0.968253078048579,0,1,detection of triacyl bacterial lipopeptide,BP,
10013,GO:0042496,1,0.936173716074973,0,2,detection of diacyl bacterial lipopeptide,BP,
10014,GO:0042497,1,0.968253078048579,0,1,triacyl lipopeptide binding,MF,
10015,GO:0042500,1,0.831043659144272,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10019,GO:0042532,1,0.713038767791547,0,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10020,GO:0042533,1,0.781488630613328,0,8,tumor necrosis factor biosynthetic process,BP,
10021,GO:0042534,1,0.781488630613328,0,8,regulation of tumor necrosis factor biosynthetic process,BP,
10022,GO:0042535,1,0.882009976065019,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
10023,GO:0042536,1,0.916123991399468,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
10024,GO:0042537,1,0.687834412714042,0,13,benzene-containing compound metabolic process,BP,
10026,GO:0042539,1,0.936557827147341,0,2,hypotonic salinity response,BP,
10027,GO:0042541,1,0.832475923482164,0,6,hemoglobin biosynthetic process,BP,
10029,GO:0042543,1,0.974935339326814,0,1,protein N-linked glycosylation via arginine,BP,
10030,GO:0042546,1,0.972400159260788,0,1,cell wall biogenesis,BP,
10031,GO:0042551,1,0.451286592590555,0,25,neuron maturation,BP,
10034,GO:0042555,1,0.706596842537065,0,11,MCM complex,CC,
10035,GO:0042558,1,0.416335040798492,0,29,pteridine-containing compound metabolic process,BP,
10036,GO:0042559,1,0.665453141682354,0,14,pteridine-containing compound biosynthetic process,BP,
10037,GO:0042560,1,0.882463053739624,0,4,pteridine-containing compound catabolic process,BP,
10039,GO:0042564,1,0.967192255235484,0,1,NLS-dependent protein nuclear import complex,CC,
10040,GO:0042565,1,0.941752448276959,0,2,RNA nuclear export complex,CC,
10042,GO:0042568,1,0.974205999377343,0,1,insulin-like growth factor binary complex,CC,
10046,GO:0042575,1,0.61732430462815,0,16,DNA polymerase complex,CC,
10047,GO:0042577,1,0.804682962965275,0,7,lipid phosphatase activity,MF,
10049,GO:0042579,1,0.0411821991329095,0,105,microbody,CC,
10052,GO:0042583,1,0.855342202823014,0,5,chromaffin granule,CC,
10053,GO:0042584,1,0.882367541736154,0,4,chromaffin granule membrane,CC,
10054,GO:0042585,1,0.939262039800974,0,2,germinal vesicle,CC,
10055,GO:0042586,1,0.973837630045166,0,1,peptide deformylase activity,MF,
10056,GO:0042587,1,0.85682534045523,0,5,glycogen granule,CC,
10057,GO:0042588,1,0.760730421617331,0,9,zymogen granule,CC,
10058,GO:0042589,1,0.809277154786834,0,7,zymogen granule membrane,CC,
10063,GO:0042595,1,0.967634582342254,0,1,behavioral response to starvation,BP,
10064,GO:0042596,1,0.571910267298413,0,18,fear response,BP,
10065,GO:0042599,1,0.698053734500736,0,12,lamellar body,CC,
10066,GO:0042602,1,0.974405498331195,0,1,riboflavin reductase (NADPH) activity,MF,
10067,GO:0042605,1,0.659589785110142,0,14,peptide antigen binding,MF,
10068,GO:0042608,1,0.917167911846183,0,3,T cell receptor binding,MF,
10070,GO:0042610,1,0.971546262232685,0,1,CD8 receptor binding,MF,
10071,GO:0042611,1,0.741581816520021,0,11,MHC protein complex,CC,
10072,GO:0042612,1,0.78247396729051,0,9,MHC class I protein complex,CC,
10073,GO:0042613,1,0.947774247554769,0,2,MHC class II protein complex,CC,
10074,GO:0042622,1,0.823563767292235,0,6,photoreceptor outer segment membrane,CC,
10076,GO:0042624,1,0.974698729998558,0,1,ATPase activity, uncoupled,MF,
10077,GO:0042625,1,0.339416420581845,0,35,ATPase coupled ion transmembrane transporter activity,MF,
10078,GO:0042626,1,0.123394545196938,0,66,ATPase activity, coupled to transmembrane movement of substances,MF,
10079,GO:0042627,1,0.922088366968614,0,3,chylomicron,CC,
10080,GO:0042628,1,0.971003357007078,0,1,mating plug formation,BP,
10082,GO:0042631,1,0.967976345446045,0,1,cellular response to water deprivation,BP,
10084,GO:0042633,1,0.083800978076099,0,79,hair cycle,BP,
10085,GO:0042634,1,0.501548805770054,0,22,regulation of hair cycle,BP,
10086,GO:0042635,1,0.74359082607257,0,10,positive regulation of hair cycle,BP,
10087,GO:0042636,1,0.876277086392285,0,4,negative regulation of hair cycle,BP,
10088,GO:0042637,1,0.88513574074338,0,4,catagen,BP,
10089,GO:0042640,1,0.876043841799918,0,4,anagen,BP,
10091,GO:0042643,1,0.969157573015551,0,1,actomyosin, actin portion,CC,
10092,GO:0042645,1,0.294947006158431,0,40,mitochondrial nucleoid,CC,
10093,GO:0042659,1,0.798406911425427,0,7,regulation of cell fate specification,BP,
10094,GO:0042660,1,0.966848505673349,0,1,positive regulation of cell fate specification,BP,
10095,GO:0042661,1,0.90994189066669,0,3,regulation of mesodermal cell fate specification,BP,
10096,GO:0042662,1,0.972322080150554,0,1,negative regulation of mesodermal cell fate specification,BP,
10097,GO:0042663,1,0.943185821181583,0,2,regulation of endodermal cell fate specification,BP,
10098,GO:0042665,1,0.967630646658427,0,1,regulation of ectodermal cell fate specification,BP,
10099,GO:0042666,1,0.967630646658427,0,1,negative regulation of ectodermal cell fate specification,BP,
10100,GO:0042668,1,0.947436230128819,0,2,auditory receptor cell fate determination,BP,
10101,GO:0042670,1,0.908348768395088,0,3,retinal cone cell differentiation,BP,
10103,GO:0042693,1,0.833936569331421,0,6,muscle cell fate commitment,BP,
10104,GO:0042695,1,0.860272254841808,0,5,thelarche,BP,
10106,GO:0042699,1,0.94402147275147,0,2,follicle-stimulating hormone signaling pathway,BP,
10107,GO:0042700,1,0.967052969241231,0,1,luteinizing hormone signaling pathway,BP,
10108,GO:0042701,1,0.939053779410504,0,2,progesterone secretion,BP,
10109,GO:0042704,1,0.936581313100827,0,2,uterine wall breakdown,BP,
10110,GO:0042709,1,0.970725361079207,0,1,succinate-CoA ligase complex,CC,
10111,GO:0042711,1,0.829301415438194,0,6,maternal behavior,BP,
10112,GO:0042713,1,0.904397042575534,0,3,sperm ejaculation,BP,
10113,GO:0042719,1,0.871250596626742,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10114,GO:0042720,1,0.948235835686022,0,2,mitochondrial inner membrane peptidase complex,CC,
10115,GO:0042721,1,0.867437223050818,0,5,mitochondrial inner membrane protein insertion complex,CC,
10118,GO:0042727,1,0.942437813317731,0,2,flavin-containing compound biosynthetic process,BP,
10119,GO:0042728,1,0.967604024860509,0,1,flavin-containing compound catabolic process,BP,
10122,GO:0042732,1,0.94308214865628,0,2,D-xylose metabolic process,BP,
10126,GO:0042738,1,0.809415083974801,0,7,exogenous drug catabolic process,BP,
10129,GO:0042744,1,0.704467702608694,0,12,hydrogen peroxide catabolic process,BP,
10130,GO:0042745,1,0.742157302641531,0,10,circadian sleep/wake cycle,BP,
10131,GO:0042747,1,0.887334104677969,0,4,circadian sleep/wake cycle, REM sleep,BP,
10132,GO:0042748,1,0.909527348061384,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
10133,GO:0042749,1,0.886367493187597,0,4,regulation of circadian sleep/wake cycle,BP,
10136,GO:0042754,1,0.751732435373814,0,9,negative regulation of circadian rhythm,BP,
10137,GO:0042755,1,0.651267289986633,0,14,eating behavior,BP,
10139,GO:0042758,1,0.88357749741638,0,4,long-chain fatty acid catabolic process,BP,
10140,GO:0042759,1,0.759304035754928,0,9,long-chain fatty acid biosynthetic process,BP,
10141,GO:0042760,1,0.857738860124031,0,5,very long-chain fatty acid catabolic process,BP,
10142,GO:0042761,1,0.735862763186267,0,10,very long-chain fatty acid biosynthetic process,BP,
10143,GO:0042762,1,0.619472392572274,0,15,regulation of sulfur metabolic process,BP,
10144,GO:0042765,1,0.859783735554198,0,5,GPI-anchor transamidase complex,CC,
10145,GO:0042766,1,0.966810826821373,0,1,nucleosome mobilization,BP,
10150,GO:0042773,1,0.109991374074756,0,80,ATP synthesis coupled electron transport,BP,
10151,GO:0042774,1,0.969271124374127,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10152,GO:0042775,1,0.113499655852295,0,79,mitochondrial ATP synthesis coupled electron transport,BP,
10153,GO:0042776,1,0.899644541533709,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10154,GO:0042779,1,0.939688152745642,0,2,tRNA 3'-trailer cleavage,BP,
10155,GO:0042780,1,0.811948725327931,0,7,tRNA 3'-end processing,BP,
10156,GO:0042781,1,0.939688152745642,0,2,3'-tRNA processing endoribonuclease activity,MF,
10157,GO:0042788,1,0.449508028769173,0,29,polysomal ribosome,CC,
10158,GO:0042789,1,0.642041129195645,0,14,mRNA transcription by RNA polymerase II,BP,
10159,GO:0042790,1,0.692486980163177,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10160,GO:0042791,1,0.829411425219054,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10162,GO:0042796,1,0.829253032460958,0,6,snRNA transcription by RNA polymerase III,BP,
10163,GO:0042797,1,0.829411425219054,0,6,tRNA transcription by RNA polymerase III,BP,
10164,GO:0042799,1,0.880288402494801,0,4,histone methyltransferase activity (H4-K20 specific),MF,
10165,GO:0042800,1,0.609021894767551,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10169,GO:0042806,1,0.969271124374127,0,1,fucose binding,MF,
10170,GO:0042809,1,0.623072645138365,0,15,vitamin D receptor binding,MF,
10171,GO:0042813,1,0.59330504821752,0,16,Wnt-activated receptor activity,MF,
10172,GO:0042816,1,0.854377737972757,0,5,vitamin B6 metabolic process,BP,
10173,GO:0042819,1,0.90927208421826,0,3,vitamin B6 biosynthetic process,BP,
10174,GO:0042820,1,0.971763958231126,0,1,vitamin B6 catabolic process,BP,
10175,GO:0042822,1,0.90959514140003,0,3,pyridoxal phosphate metabolic process,BP,
10176,GO:0042823,1,0.93602963328934,0,2,pyridoxal phosphate biosynthetic process,BP,
10178,GO:0042825,1,0.907638935621761,0,3,TAP complex,CC,
10180,GO:0042827,1,0.714212678633515,0,11,platelet dense granule,CC,
10183,GO:0042835,1,0.967021538070694,0,1,BRE binding,MF,
10184,GO:0042839,1,0.973146913806439,0,1,D-glucuronate metabolic process,BP,
10185,GO:0042840,1,0.973146913806439,0,1,D-glucuronate catabolic process,BP,
10186,GO:0042851,1,0.967549552025982,0,1,L-alanine metabolic process,BP,
10187,GO:0042853,1,0.967549552025982,0,1,L-alanine catabolic process,BP,
10190,GO:0042887,1,0.414952503318623,0,29,amide transmembrane transporter activity,MF,
10191,GO:0042891,1,0.804092287720175,0,7,antibiotic transport,BP,
10192,GO:0042895,1,0.831382136128723,0,6,antibiotic transmembrane transporter activity,MF,
10193,GO:0042903,1,0.940197143621943,0,2,tubulin deacetylase activity,MF,
10196,GO:0042908,1,0.820235116735545,0,6,xenobiotic transport,BP,
10197,GO:0042910,1,0.820235116735545,0,6,xenobiotic transmembrane transporter activity,MF,
10199,GO:0042922,1,0.974480330032443,0,1,neuromedin U receptor binding,MF,
10200,GO:0042923,1,0.943821788937609,0,2,neuropeptide binding,MF,
10201,GO:0042937,1,0.966857836354105,0,1,tripeptide transmembrane transporter activity,MF,
10202,GO:0042938,1,0.943372480327217,0,2,dipeptide transport,BP,
10203,GO:0042939,1,0.939549537761619,0,2,tripeptide transport,BP,
10206,GO:0042946,1,0.969271124374127,0,1,glucoside transport,BP,
10207,GO:0042947,1,0.969271124374127,0,1,glucoside transmembrane transporter activity,MF,
10208,GO:0042953,1,0.826651540584952,0,6,lipoprotein transport,BP,
10209,GO:0042954,1,0.851636702643793,0,5,lipoprotein transporter activity,MF,
10210,GO:0042974,1,0.548835192825422,0,19,retinoic acid receptor binding,MF,
10211,GO:0042975,1,0.753492733093968,0,9,peroxisome proliferator activated receptor binding,MF,
10213,GO:0042978,1,0.937516612168837,0,2,ornithine decarboxylase activator activity,MF,
10214,GO:0042979,1,0.887441643817086,0,4,ornithine decarboxylase regulator activity,MF,
10217,GO:0042983,1,0.764769497698306,0,9,amyloid precursor protein biosynthetic process,BP,
10218,GO:0042984,1,0.764769497698306,0,9,regulation of amyloid precursor protein biosynthetic process,BP,
10219,GO:0042985,1,0.836317259772341,0,6,negative regulation of amyloid precursor protein biosynthetic process,BP,
10220,GO:0042986,1,0.941044517772655,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10222,GO:0042988,1,0.966909451937752,0,1,X11-like protein binding,MF,
10223,GO:0042989,1,0.846716350692751,0,6,sequestering of actin monomers,BP,
10226,GO:0042996,1,0.851906660327041,0,5,regulation of Golgi to plasma membrane protein transport,BP,
10227,GO:0042997,1,0.9103110124989,0,3,negative regulation of Golgi to plasma membrane protein transport,BP,
10228,GO:0042998,1,0.935857276001007,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10229,GO:0042999,1,0.967068128101878,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10232,GO:0043002,1,0.967068128101878,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10233,GO:0043004,1,0.967068128101878,0,1,cytoplasmic sequestering of CFTR protein,BP,
10235,GO:0043006,1,0.970132828777112,0,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
10240,GO:0043014,1,0.483466714049645,0,23,alpha-tubulin binding,MF,
10242,GO:0043020,1,0.946222836964354,0,2,NADPH oxidase complex,CC,
10245,GO:0043023,1,0.717361174141729,0,11,ribosomal large subunit binding,MF,
10246,GO:0043024,1,0.651084938159467,0,14,ribosomal small subunit binding,MF,
10252,GO:0043031,1,0.885408255475426,0,4,negative regulation of macrophage activation,BP,
10254,GO:0043033,1,0.966837365625101,0,1,isoamylase complex,CC,
10256,GO:0043035,1,0.967692894861768,0,1,chromatin insulator sequence binding,MF,
10257,GO:0043038,1,0.200758097978928,0,53,amino acid activation,BP,
10258,GO:0043039,1,0.207426611871262,0,52,tRNA aminoacylation,BP,
10259,GO:0043041,1,0.967987169749165,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
10261,GO:0043044,1,0.1305825752636,0,69,ATP-dependent chromatin remodeling,BP,
10262,GO:0043045,1,0.827627764385565,0,6,DNA methylation involved in embryo development,BP,
10263,GO:0043046,1,0.803318954179923,0,7,DNA methylation involved in gamete generation,BP,
10264,GO:0043047,1,0.709599608126164,0,11,single-stranded telomeric DNA binding,MF,
10265,GO:0043048,1,0.971187775982608,0,1,dolichyl monophosphate biosynthetic process,BP,
10266,GO:0043060,1,0.970397080614669,0,1,meiotic metaphase I plate congression,BP,
10273,GO:0043073,1,0.694742226651717,0,12,germ cell nucleus,CC,
10274,GO:0043083,1,0.875058841838797,0,4,synaptic cleft,CC,
10275,GO:0043084,1,0.881528230330827,0,4,penile erection,BP,
10279,GO:0043090,1,0.687354554407615,0,12,amino acid import,BP,
10280,GO:0043094,1,0.390288606074254,0,32,cellular metabolic compound salvage,BP,
10281,GO:0043095,1,0.97465950373319,0,1,regulation of GTP cyclohydrolase I activity,BP,
10282,GO:0043096,1,0.870253509904394,0,5,purine nucleobase salvage,BP,
10283,GO:0043097,1,0.72688395319684,0,11,pyrimidine nucleoside salvage,BP,
10284,GO:0043101,1,0.68214677135681,0,13,purine-containing compound salvage,BP,
10285,GO:0043102,1,0.837706999324698,0,6,amino acid salvage,BP,
10286,GO:0043103,1,0.918686094653788,0,3,hypoxanthine salvage,BP,
10287,GO:0043105,1,0.97465950373319,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10288,GO:0043111,1,0.94135774998948,0,2,replication fork arrest,BP,
10293,GO:0043117,1,0.882821123501738,0,4,positive regulation of vascular permeability,BP,
10294,GO:0043120,1,0.916749183589951,0,3,tumor necrosis factor binding,MF,
10295,GO:0043121,1,0.848483316915354,0,5,neurotrophin binding,MF,
10300,GO:0043126,1,0.973087365428067,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10301,GO:0043128,1,0.973087365428067,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10302,GO:0043129,1,0.852022446621615,0,5,surfactant homeostasis,BP,
10304,GO:0043131,1,0.966914057987496,0,1,erythrocyte enucleation,BP,
10305,GO:0043132,1,0.970993033401337,0,1,NAD transport,BP,
10306,GO:0043136,1,0.968741153584299,0,1,glycerol-3-phosphatase activity,MF,
10307,GO:0043137,1,0.889676975368286,0,4,DNA replication, removal of RNA primer,BP,
10308,GO:0043138,1,0.681374108798772,0,12,3'-5' DNA helicase activity,MF,
10309,GO:0043139,1,0.80758295649068,0,7,5'-3' DNA helicase activity,MF,
10310,GO:0043140,1,0.792383804098905,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10311,GO:0043141,1,0.85971733073358,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10312,GO:0043142,1,0.670096708549575,0,13,single-stranded DNA-dependent ATPase activity,MF,
10313,GO:0043144,1,0.802967195038383,0,8,snoRNA processing,BP,
10317,GO:0043159,1,0.967961307241613,0,1,acrosomal matrix,CC,
10326,GO:0043173,1,0.665304917593934,0,14,nucleotide salvage,BP,
10327,GO:0043174,1,0.629538731359568,0,16,nucleoside salvage,BP,
10331,GO:0043178,1,0.22430235087008,0,48,alcohol binding,MF,
10333,GO:0043181,1,0.967935840521965,0,1,vacuolar sequestering,BP,
10334,GO:0043183,1,0.94279959547716,0,2,vascular endothelial growth factor receptor 1 binding,MF,
10335,GO:0043184,1,0.858980704154733,0,5,vascular endothelial growth factor receptor 2 binding,MF,
10337,GO:0043186,1,0.805230192214371,0,7,P granule,CC,
10338,GO:0043189,1,0.568246411809841,0,19,H4/H2A histone acetyltransferase complex,CC,
10339,GO:0043190,1,0.822484546524129,0,6,ATP-binding cassette (ABC) transporter complex,CC,
10340,GO:0043194,1,0.749389836872655,0,9,axon initial segment,CC,
10342,GO:0043196,1,0.942240764587542,0,2,varicosity,CC,
10345,GO:0043199,1,0.912835614100631,0,3,sulfate binding,MF,
10347,GO:0043201,1,0.721932908606821,0,10,response to leucine,BP,
10349,GO:0043203,1,0.839709518286853,0,6,axon hillock,CC,
10354,GO:0043217,1,0.678409105101638,0,12,myelin maintenance,BP,
10355,GO:0043218,1,0.715048935771012,0,11,compact myelin,CC,
10357,GO:0043220,1,0.778344605504505,0,8,Schmidt-Lanterman incisure,CC,
10358,GO:0043221,1,0.967609518573669,0,1,SMC family protein binding,MF,
10359,GO:0043224,1,0.948521752938656,0,2,nuclear SCF ubiquitin ligase complex,CC,
10360,GO:0043225,1,0.765543919442579,0,8,ATPase-coupled anion transmembrane transporter activity,MF,
10372,GO:0043240,1,0.707702108232275,0,11,Fanconi anaemia nuclear complex,CC,
10373,GO:0043242,1,0.222325068205729,0,47,negative regulation of protein complex disassembly,BP,
10376,GO:0043247,1,0.664560169346888,0,13,telomere maintenance in response to DNA damage,BP,
10377,GO:0043248,1,0.717741203883935,0,12,proteasome assembly,BP,
10379,GO:0043250,1,0.973080313182277,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
10380,GO:0043251,1,0.973080313182277,0,1,sodium-dependent organic anion transport,BP,
10381,GO:0043252,1,0.728180466524316,0,10,sodium-independent organic anion transport,BP,
10384,GO:0043256,1,0.763878620820472,0,8,laminin complex,CC,
10385,GO:0043257,1,0.966871725165874,0,1,laminin-8 complex,CC,
10386,GO:0043259,1,0.903686449490435,0,3,laminin-10 complex,CC,
10387,GO:0043260,1,0.903687453869872,0,3,laminin-11 complex,CC,
10388,GO:0043262,1,0.912532426022542,0,3,adenosine-diphosphatase activity,MF,
10395,GO:0043273,1,0.966888969644663,0,1,CTPase activity,MF,
10397,GO:0043276,1,0.426406842873599,0,27,anoikis,BP,
10399,GO:0043278,1,0.593063750195446,0,17,response to morphine,BP,
10403,GO:0043291,1,0.934598905762087,0,2,RAVE complex,CC,
10405,GO:0043293,1,0.94017948497214,0,2,apoptosome,CC,
10406,GO:0043295,1,0.730352931076291,0,11,glutathione binding,MF,
10412,GO:0043302,1,0.670073500349995,0,13,positive regulation of leukocyte degranulation,BP,
10416,GO:0043306,1,0.782822814556355,0,8,positive regulation of mast cell degranulation,BP,
10417,GO:0043307,1,0.888929767519875,0,4,eosinophil activation,BP,
10418,GO:0043308,1,0.888929767519875,0,4,eosinophil degranulation,BP,
10419,GO:0043309,1,0.943455550401649,0,2,regulation of eosinophil degranulation,BP,
10420,GO:0043311,1,0.943455550401649,0,2,positive regulation of eosinophil degranulation,BP,
10422,GO:0043313,1,0.874399094446854,0,4,regulation of neutrophil degranulation,BP,
10423,GO:0043314,1,0.934840766227912,0,2,negative regulation of neutrophil degranulation,BP,
10424,GO:0043315,1,0.96734639953885,0,1,positive regulation of neutrophil degranulation,BP,
10425,GO:0043316,1,0.938591689143006,0,2,cytotoxic T cell degranulation,BP,
10426,GO:0043317,1,0.968131889980113,0,1,regulation of cytotoxic T cell degranulation,BP,
10427,GO:0043318,1,0.968131889980113,0,1,negative regulation of cytotoxic T cell degranulation,BP,
10428,GO:0043320,1,0.8299296873504,0,6,natural killer cell degranulation,BP,
10429,GO:0043321,1,0.938015611720022,0,2,regulation of natural killer cell degranulation,BP,
10430,GO:0043323,1,0.938015611720022,0,2,positive regulation of natural killer cell degranulation,BP,
10431,GO:0043324,1,0.966983061299026,0,1,pigment metabolic process involved in developmental pigmentation,BP,
10433,GO:0043328,1,0.893450164651315,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
10437,GO:0043337,1,0.967682878933317,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
10438,GO:0043353,1,0.821605688784541,0,6,enucleate erythrocyte differentiation,BP,
10439,GO:0043354,1,0.966914057987496,0,1,enucleate erythrocyte maturation,BP,
10440,GO:0043366,1,0.939857954138632,0,2,beta selection,BP,
10448,GO:0043374,1,0.852989657568349,0,5,CD8-positive, alpha-beta T cell differentiation,BP,
10449,GO:0043375,1,0.967631208065156,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
10450,GO:0043376,1,0.967923254807647,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
10454,GO:0043383,1,0.936377207940404,0,2,negative T cell selection,BP,
10455,GO:0043385,1,0.969652760557037,0,1,mycotoxin metabolic process,BP,
10456,GO:0043387,1,0.969652760557037,0,1,mycotoxin catabolic process,BP,
10461,GO:0043395,1,0.722414578838661,0,10,heparan sulfate proteoglycan binding,MF,
10462,GO:0043396,1,0.968570346802033,0,1,corticotropin-releasing hormone secretion,BP,
10463,GO:0043397,1,0.968570346802033,0,1,regulation of corticotropin-releasing hormone secretion,BP,
10464,GO:0043398,1,0.911060035610282,0,3,HLH domain binding,MF,
10465,GO:0043400,1,0.942245824512554,0,2,cortisol secretion,BP,
10467,GO:0043402,1,0.905922630514561,0,3,glucocorticoid mediated signaling pathway,BP,
10478,GO:0043415,1,0.882499666050418,0,4,positive regulation of skeletal muscle tissue regeneration,BP,
10479,GO:0043416,1,0.882499666050418,0,4,regulation of skeletal muscle tissue regeneration,BP,
10480,GO:0043418,1,0.911708674266419,0,3,homocysteine catabolic process,BP,
10481,GO:0043422,1,0.714270040212403,0,11,protein kinase B binding,MF,
10482,GO:0043423,1,0.967196618203223,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
10483,GO:0043425,1,0.513957141001715,0,21,bHLH transcription factor binding,MF,
10484,GO:0043426,1,0.882074953712737,0,4,MRF binding,MF,
10487,GO:0043435,1,0.970039400331912,0,1,response to corticotropin-releasing hormone,BP,
10490,GO:0043455,1,0.778992693585008,0,8,regulation of secondary metabolic process,BP,
10491,GO:0043456,1,0.891150164978193,0,4,regulation of pentose-phosphate shunt,BP,
10492,GO:0043457,1,0.615300204666766,0,16,regulation of cellular respiration,BP,
10493,GO:0043461,1,0.889332655982532,0,4,proton-transporting ATP synthase complex assembly,BP,
10495,GO:0043465,1,0.969271124374127,0,1,regulation of fermentation,BP,
10497,GO:0043470,1,0.160687339744164,0,58,regulation of carbohydrate catabolic process,BP,
10498,GO:0043471,1,0.762796776039222,0,9,regulation of cellular carbohydrate catabolic process,BP,
10500,GO:0043474,1,0.966983061299026,0,1,pigment metabolic process involved in pigmentation,BP,
10501,GO:0043476,1,0.690066480406785,0,12,pigment accumulation,BP,
10502,GO:0043482,1,0.690066480406785,0,12,cellular pigment accumulation,BP,
10504,GO:0043485,1,0.738335375726024,0,10,endosome to pigment granule transport,BP,
10505,GO:0043486,1,0.255060738134921,0,48,histone exchange,BP,
10509,GO:0043490,1,0.937087614690383,0,2,malate-aspartate shuttle,BP,
10511,GO:0043492,1,0.0880181129021935,0,76,ATPase activity, coupled to movement of substances,MF,
10516,GO:0043501,1,0.681801823460115,0,12,skeletal muscle adaptation,BP,
10521,GO:0043508,1,0.692433478195752,0,12,negative regulation of JUN kinase activity,BP,
10522,GO:0043509,1,0.971270332458308,0,1,activin A complex,CC,
10523,GO:0043511,1,0.971270332458308,0,1,inhibin complex,CC,
10524,GO:0043512,1,0.971270332458308,0,1,inhibin A complex,CC,
10525,GO:0043515,1,0.855111574525902,0,5,kinetochore binding,MF,
10529,GO:0043519,1,0.971455551403725,0,1,regulation of myosin II filament organization,BP,
10530,GO:0043522,1,0.741569184820143,0,10,leucine zipper domain binding,MF,
10534,GO:0043527,1,0.865423606436874,0,5,tRNA methyltransferase complex,CC,
10536,GO:0043532,1,0.966849452653211,0,1,angiostatin binding,MF,
10537,GO:0043533,1,0.850833939729536,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
10541,GO:0043537,1,0.487205911580846,0,23,negative regulation of blood vessel endothelial cell migration,BP,
10542,GO:0043538,1,0.968920525610699,0,1,regulation of actin phosphorylation,BP,
10543,GO:0043539,1,0.436315309331702,0,27,protein serine/threonine kinase activator activity,MF,
10544,GO:0043541,1,0.937700032021712,0,2,UDP-N-acetylglucosamine transferase complex,CC,
10547,GO:0043544,1,0.967961307241613,0,1,lipoamide binding,MF,
10549,GO:0043546,1,0.824727289064564,0,6,molybdopterin cofactor binding,MF,
10556,GO:0043553,1,0.909740928895779,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
10559,GO:0043559,1,0.846073488715736,0,5,insulin binding,MF,
10560,GO:0043560,1,0.722228915181672,0,10,insulin receptor substrate binding,MF,
10561,GO:0043562,1,0.749304288746613,0,10,cellular response to nitrogen levels,BP,
10562,GO:0043564,1,0.94044554780703,0,2,Ku70:Ku80 complex,CC,
10566,GO:0043569,1,0.876975559891305,0,4,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
10567,GO:0043570,1,0.876586619194668,0,4,maintenance of DNA repeat elements,BP,
10568,GO:0043574,1,0.570008107567632,0,18,peroxisomal transport,BP,
10569,GO:0043576,1,0.677322580619892,0,12,regulation of respiratory gaseous exchange,BP,
10570,GO:0043578,1,0.905065101800451,0,3,nuclear matrix organization,BP,
10572,GO:0043584,1,0.721230699511355,0,10,nose development,BP,
10573,GO:0043585,1,0.934784660656065,0,2,nose morphogenesis,BP,
10578,GO:0043596,1,0.282980996457079,0,41,nuclear replication fork,CC,
10579,GO:0043601,1,0.483029682479313,0,24,nuclear replisome,CC,
10580,GO:0043602,1,0.970282624874275,0,1,nitrate catabolic process,BP,
10583,GO:0043606,1,0.9686969601558,0,1,formamide metabolic process,BP,
10584,GO:0043610,1,0.966798560430869,0,1,regulation of carbohydrate utilization,BP,
10585,GO:0043614,1,0.935300196342935,0,2,multi-eIF complex,CC,
10586,GO:0043615,1,0.858243239081005,0,5,astrocyte cell migration,BP,
10594,GO:0043625,1,0.888166991804643,0,4,delta DNA polymerase complex,CC,
10595,GO:0043626,1,0.973455162864649,0,1,PCNA complex,CC,
10597,GO:0043628,1,0.452664863526777,0,27,ncRNA 3'-end processing,BP,
10598,GO:0043629,1,0.966816422806218,0,1,ncRNA polyadenylation,BP,
10599,GO:0043630,1,0.966816422806218,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
10602,GO:0043633,1,0.790470485735831,0,8,polyadenylation-dependent RNA catabolic process,BP,
10603,GO:0043634,1,0.817407248656133,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10604,GO:0043647,1,0.199919536065405,0,50,inositol phosphate metabolic process,BP,
10605,GO:0043648,1,0.0891117089407358,0,79,dicarboxylic acid metabolic process,BP,
10606,GO:0043649,1,0.654117153672015,0,14,dicarboxylic acid catabolic process,BP,
10607,GO:0043650,1,0.776431003963702,0,8,dicarboxylic acid biosynthetic process,BP,
10609,GO:0043652,1,0.789943463258388,0,8,engulfment of apoptotic cell,BP,
10610,GO:0043653,1,0.79363703532291,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
10611,GO:0043654,1,0.907663205280858,0,3,recognition of apoptotic cell,BP,
10612,GO:0043656,1,0.801230559019636,0,7,intracellular region of host,CC,
10616,GO:0043682,1,0.934761869510533,0,2,copper-transporting ATPase activity,MF,
10619,GO:0043691,1,0.780716352585516,0,8,reverse cholesterol transport,BP,
10622,GO:0043733,1,0.973974669279822,0,1,DNA-3-methylbase glycosylase activity,MF,
10623,GO:0043734,1,0.889339938513921,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
10624,GO:0043739,1,0.968517606911305,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
10625,GO:0043754,1,0.966750387190908,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
10626,GO:0043783,1,0.970731221353253,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
10627,GO:0043795,1,0.973310190059817,0,1,glyceraldehyde oxidoreductase activity,MF,
10628,GO:0043812,1,0.906450994400901,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10629,GO:0043813,1,0.846588150164099,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10630,GO:0043843,1,0.970141245305701,0,1,ADP-specific glucokinase activity,MF,
10631,GO:0043849,1,0.969208641159294,0,1,Ras palmitoyltransferase activity,MF,
10632,GO:0043865,1,0.969547060048947,0,1,methionine transmembrane transporter activity,MF,
10633,GO:0043874,1,0.971729326328899,0,1,acireductone synthase activity,MF,
10634,GO:0043890,1,0.970681453408741,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
10635,GO:0043891,1,0.973506143927433,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
10640,GO:0043914,1,0.967545399117748,0,1,NADPH:sulfur oxidoreductase activity,MF,
10641,GO:0043916,1,0.973974669279822,0,1,DNA-7-methylguanine glycosylase activity,MF,
10645,GO:0043928,1,0.378351503881023,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10646,GO:0043931,1,0.7971258172277,0,7,ossification involved in bone maturation,BP,
10647,GO:0043932,1,0.940721065642658,0,2,ossification involved in bone remodeling,BP,
10651,GO:0043949,1,0.58475867516394,0,17,regulation of cAMP-mediated signaling,BP,
10652,GO:0043950,1,0.852860701754861,0,5,positive regulation of cAMP-mediated signaling,BP,
10653,GO:0043951,1,0.756544807621592,0,9,negative regulation of cAMP-mediated signaling,BP,
10654,GO:0043954,1,0.461875824762608,0,24,cellular component maintenance,BP,
10657,GO:0043968,1,0.621279259349146,0,16,histone H2A acetylation,BP,
10658,GO:0043969,1,0.966798342251264,0,1,histone H2B acetylation,BP,
10659,GO:0043970,1,0.687662784906953,0,12,histone H3-K9 acetylation,BP,
10660,GO:0043972,1,0.967015476763912,0,1,histone H3-K23 acetylation,BP,
10661,GO:0043973,1,0.971171550280923,0,1,histone H3-K4 acetylation,BP,
10662,GO:0043974,1,0.906726594635007,0,3,histone H3-K27 acetylation,BP,
10663,GO:0043981,1,0.626720593596602,0,15,histone H4-K5 acetylation,BP,
10664,GO:0043982,1,0.626720593596602,0,15,histone H4-K8 acetylation,BP,
10665,GO:0043983,1,0.808267612941556,0,7,histone H4-K12 acetylation,BP,
10666,GO:0043984,1,0.546834493552377,0,19,histone H4-K16 acetylation,BP,
10667,GO:0043985,1,0.83364405130452,0,6,histone H4-R3 methylation,BP,
10668,GO:0043987,1,0.886755916248744,0,4,histone H3-S10 phosphorylation,BP,
10669,GO:0043988,1,0.913800748279839,0,3,histone H3-S28 phosphorylation,BP,
10670,GO:0043990,1,0.968819103914878,0,1,histone H2A-S1 phosphorylation,BP,
10671,GO:0043994,1,0.967015476763912,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
10672,GO:0043995,1,0.728154096952244,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10673,GO:0043996,1,0.728154096952244,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10674,GO:0043997,1,0.968757393536143,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
10675,GO:0043998,1,0.968357037104955,0,1,H2A histone acetyltransferase activity,MF,
10677,GO:0044004,1,0.916819395200171,0,3,disruption by symbiont of host cell,BP,
10679,GO:0044020,1,0.889164013309251,0,4,histone methyltransferase activity (H4-R3 specific),MF,
10680,GO:0044028,1,0.936432682662344,0,2,DNA hypomethylation,BP,
10681,GO:0044029,1,0.936432682662344,0,2,hypomethylation of CpG island,BP,
10683,GO:0044033,1,0.835132291283892,0,6,multi-organism metabolic process,BP,
10684,GO:0044035,1,0.972753704663536,0,1,multi-organism catabolic process,BP,
10685,GO:0044036,1,0.916273990848672,0,3,cell wall macromolecule metabolic process,BP,
10686,GO:0044038,1,0.972400159260788,0,1,cell wall macromolecule biosynthetic process,BP,
10688,GO:0044053,1,0.970551726865232,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
10690,GO:0044058,1,0.666854429707686,0,13,regulation of digestive system process,BP,
10693,GO:0044065,1,0.773307969357422,0,8,regulation of respiratory system process,BP,
10700,GO:0044090,1,0.680578503844242,0,12,positive regulation of vacuole organization,BP,
10701,GO:0044091,1,0.474868760432179,0,24,membrane biogenesis,BP,
10704,GO:0044094,1,0.908005942245533,0,3,host cell nuclear part,CC,
10705,GO:0044105,1,0.97445017076802,0,1,L-xylulose reductase (NAD+) activity,MF,
10707,GO:0044107,1,0.890732433915496,0,4,cellular alcohol metabolic process,BP,
10708,GO:0044108,1,0.890732433915496,0,4,cellular alcohol biosynthetic process,BP,
10709,GO:0044110,1,0.863235737232604,0,5,growth involved in symbiotic interaction,BP,
10711,GO:0044115,1,0.972753704663536,0,1,development of symbiont involved in interaction with host,BP,
10712,GO:0044116,1,0.863235737232604,0,5,growth of symbiont involved in interaction with host,BP,
10713,GO:0044117,1,0.863235737232604,0,5,growth of symbiont in host,BP,
10714,GO:0044126,1,0.886471388966478,0,4,regulation of growth of symbiont in host,BP,
10715,GO:0044128,1,0.966923611109347,0,1,positive regulation of growth of symbiont in host,BP,
10716,GO:0044130,1,0.916803017367834,0,3,negative regulation of growth of symbiont in host,BP,
10717,GO:0044144,1,0.886471388966478,0,4,modulation of growth of symbiont involved in interaction with host,BP,
10718,GO:0044145,1,0.972753704663536,0,1,modulation of development of symbiont involved in interaction with host,BP,
10719,GO:0044146,1,0.916803017367834,0,3,negative regulation of growth of symbiont involved in interaction with host,BP,
10720,GO:0044147,1,0.972753704663536,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10721,GO:0044148,1,0.966923611109347,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
10722,GO:0044154,1,0.804141030768126,0,7,histone H3-K14 acetylation,BP,
10724,GO:0044190,1,0.972456066014553,0,1,host cell mitochondrial envelope,CC,
10725,GO:0044194,1,0.914850103238628,0,3,cytolytic granule,CC,
10726,GO:0044205,1,0.911042259242226,0,3,'de novo' UMP biosynthetic process,BP,
10727,GO:0044206,1,0.894040009500743,0,4,UMP salvage,BP,
10728,GO:0044207,1,0.967325934078978,0,1,translation initiation ternary complex,CC,
10729,GO:0044208,1,0.943537022190642,0,2,'de novo' AMP biosynthetic process,BP,
10730,GO:0044209,1,0.946942303407906,0,2,AMP salvage,BP,
10731,GO:0044210,1,0.937789331134001,0,2,'de novo' CTP biosynthetic process,BP,
10732,GO:0044211,1,0.919516055820261,0,3,CTP salvage,BP,
10734,GO:0044213,1,0.732072099882489,0,10,intronic transcription regulatory region DNA binding,MF,
10735,GO:0044214,1,0.878506065550486,0,4,spanning component of plasma membrane,CC,
10739,GO:0044218,1,0.967308775010198,0,1,other organism cell membrane,CC,
10740,GO:0044220,1,0.966979317004639,0,1,host cell perinuclear region of cytoplasm,CC,
10741,GO:0044221,1,0.967308775010198,0,1,host cell synapse,CC,
10742,GO:0044224,1,0.824139261813328,0,6,juxtaparanode region of axon,CC,
10744,GO:0044231,1,0.967308775010198,0,1,host cell presynaptic membrane,CC,
10749,GO:0044241,1,0.913486926825375,0,3,lipid digestion,BP,
10751,GO:0044247,1,0.511477302189837,0,21,cellular polysaccharide catabolic process,BP,
10756,GO:0044258,1,0.970625959753865,0,1,intestinal lipid catabolic process,BP,
10766,GO:0044275,1,0.334656312609856,0,35,cellular carbohydrate catabolic process,BP,
10767,GO:0044279,1,0.967308775010198,0,1,other organism membrane,CC,
10771,GO:0044284,1,0.974327738831242,0,1,mitochondrial crista junction,CC,
10773,GO:0044292,1,0.730695270922133,0,10,dendrite terminus,CC,
10774,GO:0044294,1,0.796209164966981,0,7,dendritic growth cone,CC,
10777,GO:0044298,1,0.796300119439863,0,7,cell body membrane,CC,
10778,GO:0044299,1,0.966854947945547,0,1,C-fiber,CC,
10779,GO:0044300,1,0.904697964726807,0,3,cerebellar mossy fiber,CC,
10780,GO:0044301,1,0.967119255016035,0,1,climbing fiber,CC,
10781,GO:0044302,1,0.906717515339188,0,3,dentate gyrus mossy fiber,CC,
10783,GO:0044305,1,0.966857991330489,0,1,calyx of Held,CC,
10785,GO:0044307,1,0.966712885311102,0,1,dendritic branch,CC,
10786,GO:0044308,1,0.934937409863863,0,2,axonal spine,CC,
10788,GO:0044313,1,0.904613216063773,0,3,protein K6-linked deubiquitination,BP,
10789,GO:0044314,1,0.894097542136462,0,4,protein K27-linked ubiquitination,BP,
10790,GO:0044316,1,0.967782314811953,0,1,cone cell pedicle,CC,
10791,GO:0044317,1,0.973379338393176,0,1,rod spherule,CC,
10793,GO:0044320,1,0.729065622634756,0,10,cellular response to leptin stimulus,BP,
10796,GO:0044323,1,0.936314276657504,0,2,retinoic acid-responsive element binding,MF,
10797,GO:0044324,1,0.974311311496727,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
10799,GO:0044326,1,0.939863816202713,0,2,dendritic spine neck,CC,
10800,GO:0044327,1,0.775039219357785,0,8,dendritic spine head,CC,
10801,GO:0044328,1,0.969271124374127,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10802,GO:0044329,1,0.969271124374127,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10803,GO:0044330,1,0.969271124374127,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10805,GO:0044332,1,0.845059461913195,0,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
10806,GO:0044334,1,0.936725040021291,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
10807,GO:0044335,1,0.966767079523439,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
10808,GO:0044336,1,0.907657430823375,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
10809,GO:0044338,1,0.941176598461836,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
10810,GO:0044339,1,0.910123183360583,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
10811,GO:0044340,1,0.853547238311844,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
10812,GO:0044341,1,0.906704767063923,0,3,sodium-dependent phosphate transport,BP,
10814,GO:0044343,1,0.967130024404925,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10816,GO:0044345,1,0.967130024404925,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
10817,GO:0044346,1,0.58387157960526,0,17,fibroblast apoptotic process,BP,
10818,GO:0044349,1,0.972524513134103,0,1,DNA excision,BP,
10819,GO:0044351,1,0.829950522865239,0,6,macropinocytosis,BP,
10820,GO:0044352,1,0.880353893209319,0,4,pinosome,CC,
10821,GO:0044354,1,0.880353893209319,0,4,macropinosome,CC,
10822,GO:0044355,1,0.97321722048805,0,1,clearance of foreign intracellular DNA,BP,
10823,GO:0044356,1,0.97321722048805,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
10827,GO:0044375,1,0.947369392427681,0,2,regulation of peroxisome size,BP,
10828,GO:0044378,1,0.940915412713059,0,2,non-sequence-specific DNA binding, bending,MF,
10830,GO:0044381,1,0.629611722661428,0,14,glucose import in response to insulin stimulus,BP,
10832,GO:0044388,1,0.868884696817904,0,5,small protein activating enzyme binding,MF,
10836,GO:0044393,1,0.908834624454569,0,3,microspike,CC,
10837,GO:0044395,1,0.970040787019777,0,1,protein targeting to vacuolar membrane,BP,
10838,GO:0044396,1,0.904308353512,0,3,actin cortical patch organization,BP,
10842,GO:0044413,1,0.880438619766599,0,4,avoidance of host defenses,BP,
10843,GO:0044414,1,0.966906671281593,0,1,suppression of host defenses,BP,
10844,GO:0044415,1,0.880438619766599,0,4,evasion or tolerance of host defenses,BP,
10845,GO:0044416,1,0.945081375440417,0,2,induction by symbiont of host defense response,BP,
10846,GO:0044417,1,0.76584996725016,0,9,translocation of molecules into host,BP,
10861,GO:0044438,1,0.105128872463373,0,74,microbody part,CC,
10862,GO:0044439,1,0.105128872463373,0,74,peroxisomal part,CC,
10868,GO:0044447,1,0.60127637827159,0,16,axoneme part,CC,
10874,GO:0044453,1,0.773812306444201,0,8,nuclear membrane part,CC,
10878,GO:0044458,1,0.695425666042871,0,12,motile cilium assembly,BP,
10882,GO:0044495,1,0.974480330032443,0,1,modulation of blood pressure in other organism,BP,
10883,GO:0044497,1,0.974480330032443,0,1,positive regulation of blood pressure in other organism,BP,
10885,GO:0044524,1,0.972478537311936,0,1,protein sulfhydration,BP,
10886,GO:0044528,1,0.884419752217672,0,4,regulation of mitochondrial mRNA stability,BP,
10887,GO:0044530,1,0.908258150785033,0,3,supraspliceosomal complex,CC,
10888,GO:0044531,1,0.834454041093164,0,6,modulation of programmed cell death in other organism,BP,
10889,GO:0044532,1,0.834454041093164,0,6,modulation of apoptotic process in other organism,BP,
10890,GO:0044533,1,0.916819395200171,0,3,positive regulation of apoptotic process in other organism,BP,
10891,GO:0044539,1,0.907031907267595,0,3,long-chain fatty acid import,BP,
10892,GO:0044540,1,0.972478537311936,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
10893,GO:0044545,1,0.858061391591896,0,5,NSL complex,CC,
10894,GO:0044546,1,0.74993644073962,0,9,NLRP3 inflammasome complex assembly,BP,
10895,GO:0044547,1,0.854050531621564,0,5,DNA topoisomerase binding,MF,
10896,GO:0044548,1,0.716534493741627,0,11,S100 protein binding,MF,
10897,GO:0044549,1,0.97465950373319,0,1,GTP cyclohydrolase binding,MF,
10898,GO:0044550,1,0.664620399055979,0,13,secondary metabolite biosynthetic process,BP,
10900,GO:0044565,1,0.943065391673217,0,2,dendritic cell proliferation,BP,
10901,GO:0044571,1,0.896784568568748,0,4,[2Fe-2S] cluster assembly,BP,
10902,GO:0044594,1,0.969779379986498,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
10903,GO:0044595,1,0.973608638681413,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10904,GO:0044596,1,0.973608638681413,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
10905,GO:0044597,1,0.868782159101456,0,5,daunorubicin metabolic process,BP,
10906,GO:0044598,1,0.868782159101456,0,5,doxorubicin metabolic process,BP,
10907,GO:0044599,1,0.969271124374127,0,1,AP-5 adaptor complex,CC,
10908,GO:0044601,1,0.972724801745671,0,1,protein denucleotidylation,BP,
10909,GO:0044602,1,0.972724801745671,0,1,protein deadenylylation,BP,
10910,GO:0044603,1,0.972724801745671,0,1,protein adenylylhydrolase activity,MF,
10911,GO:0044609,1,0.941521799166667,0,2,DBIRD complex,CC,
10912,GO:0044610,1,0.970993033401337,0,1,FMN transmembrane transporter activity,MF,
10913,GO:0044611,1,0.904185665511318,0,3,nuclear pore inner ring,CC,
10914,GO:0044613,1,0.693029858218409,0,12,nuclear pore central transport channel,CC,
10915,GO:0044614,1,0.878054436217056,0,4,nuclear pore cytoplasmic filaments,CC,
10916,GO:0044615,1,0.744534424796287,0,9,nuclear pore nuclear basket,CC,
10917,GO:0044620,1,0.950146313132071,0,2,ACP phosphopantetheine attachment site binding,MF,
10918,GO:0044648,1,0.969271124374127,0,1,histone H3-K4 dimethylation,BP,
10921,GO:0044666,1,0.705875649386382,0,11,MLL3/4 complex,CC,
10922,GO:0044691,1,0.935421746229,0,2,tooth eruption,BP,
10925,GO:0044713,1,0.974656079851253,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10926,GO:0044714,1,0.974656079851253,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
10927,GO:0044715,1,0.947478469843577,0,2,8-oxo-dGDP phosphatase activity,MF,
10928,GO:0044716,1,0.973042534048118,0,1,8-oxo-GDP phosphatase activity,MF,
10929,GO:0044717,1,0.973042534048118,0,1,8-hydroxy-dADP phosphatase activity,MF,
10930,GO:0044721,1,0.971975421382784,0,1,protein import into peroxisome matrix, substrate release,BP,
10931,GO:0044725,1,0.966746636835489,0,1,chromatin reprogramming in the zygote,BP,
10932,GO:0044727,1,0.966746636835489,0,1,DNA demethylation of male pronucleus,BP,
10934,GO:0044729,1,0.908188940434844,0,3,hemi-methylated DNA-binding,MF,
10935,GO:0044730,1,0.972753704663536,0,1,bone sialoprotein binding,MF,
10936,GO:0044732,1,0.969271124374127,0,1,mitotic spindle pole body,CC,
10937,GO:0044736,1,0.969271124374127,0,1,acid-sensing ion channel activity,MF,
10939,GO:0044752,1,0.910259393940103,0,3,response to human chorionic gonadotropin,BP,
10940,GO:0044753,1,0.9692450588974,0,1,amphisome,CC,
10943,GO:0044766,1,0.119605030099398,0,69,multi-organism transport,BP,
10944,GO:0044769,1,0.588718345524587,0,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
10946,GO:0044771,1,0.938957772626028,0,2,meiotic cell cycle phase transition,BP,
10950,GO:0044778,1,0.942431722554825,0,2,meiotic DNA integrity checkpoint,BP,
10951,GO:0044779,1,0.968953988832333,0,1,meiotic spindle checkpoint,BP,
10955,GO:0044785,1,0.968953988832333,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
10956,GO:0044786,1,0.174727738076031,0,57,cell cycle DNA replication,BP,
10957,GO:0044788,1,0.569565714930873,0,18,modulation by host of viral process,BP,
10958,GO:0044789,1,0.848859434985182,0,5,modulation by host of viral release from host cell,BP,
10959,GO:0044791,1,0.848859434985182,0,5,positive regulation by host of viral release from host cell,BP,
10960,GO:0044793,1,0.880181015694038,0,4,negative regulation by host of viral process,BP,
10961,GO:0044794,1,0.667528951840658,0,13,positive regulation by host of viral process,BP,
10962,GO:0044795,1,0.973835614991994,0,1,trans-Golgi network to recycling endosome transport,BP,
10963,GO:0044796,1,0.973455162864649,0,1,DNA polymerase processivity factor complex,CC,
10965,GO:0044800,1,0.914937154059093,0,3,multi-organism membrane fusion,BP,
10966,GO:0044803,1,0.884700608637285,0,4,multi-organism membrane organization,BP,
10967,GO:0044804,1,0.573649832382909,0,18,autophagy of nucleus,BP,
10968,GO:0044805,1,0.935744776137518,0,2,late nucleophagy,BP,
10970,GO:0044815,1,0.0847304594781965,0,91,DNA packaging complex,CC,
10973,GO:0044821,1,0.879098639460228,0,4,meiotic telomere tethering at nuclear periphery,BP,
10974,GO:0044827,1,0.684368404196379,0,12,modulation by host of viral genome replication,BP,
10975,GO:0044828,1,0.880181015694038,0,4,negative regulation by host of viral genome replication,BP,
10976,GO:0044829,1,0.802013296855733,0,7,positive regulation by host of viral genome replication,BP,
10977,GO:0044830,1,0.937428383945411,0,2,modulation by host of viral RNA genome replication,BP,
10978,GO:0044837,1,0.799345965011819,0,7,actomyosin contractile ring organization,BP,
10981,GO:0044848,1,0.775383428916956,0,8,biological phase,BP,
10983,GO:0044851,1,0.775383428916956,0,8,hair cycle phase,BP,
10985,GO:0044854,1,0.887200158871916,0,4,plasma membrane raft assembly,BP,
10986,GO:0044855,1,0.969661891550934,0,1,plasma membrane raft distribution,BP,
10987,GO:0044856,1,0.969661891550934,0,1,plasma membrane raft localization,BP,
10988,GO:0044857,1,0.887200158871916,0,4,plasma membrane raft organization,BP,
10989,GO:0044858,1,0.969661891550934,0,1,plasma membrane raft polarization,BP,
10990,GO:0044860,1,0.884124010203997,0,4,protein localization to plasma membrane raft,BP,
10991,GO:0044861,1,0.939905575000641,0,2,protein transport into plasma membrane raft,BP,
10992,GO:0044868,1,0.966856649013832,0,1,modulation by host of viral molecular function,BP,
10993,GO:0044872,1,0.826651540584952,0,6,lipoprotein localization,BP,
10995,GO:0044878,1,0.892667848869636,0,4,mitotic cytokinesis checkpoint,BP,
10996,GO:0045002,1,0.805177597435841,0,7,double-strand break repair via single-strand annealing,BP,
10997,GO:0045003,1,0.738903474322953,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
10998,GO:0045004,1,0.936014531320663,0,2,DNA replication proofreading,BP,
10999,GO:0045005,1,0.367055964052177,0,32,DNA-dependent DNA replication maintenance of fidelity,BP,
11000,GO:0045006,1,0.731640460632553,0,11,DNA deamination,BP,
11001,GO:0045007,1,0.920402905773679,0,3,depurination,BP,
11002,GO:0045008,1,0.794188767143206,0,8,depyrimidination,BP,
11003,GO:0045009,1,0.844063957307946,0,6,chitosome,CC,
11004,GO:0045010,1,0.309993179335328,0,38,actin nucleation,BP,
11005,GO:0045016,1,0.968339658543737,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11007,GO:0045019,1,0.764217448262539,0,9,negative regulation of nitric oxide biosynthetic process,BP,
11008,GO:0045022,1,0.30401003376643,0,38,early endosome to late endosome transport,BP,
11010,GO:0045025,1,0.938391848283274,0,2,mitochondrial degradosome,CC,
11011,GO:0045026,1,0.62004774447002,0,16,plasma membrane fusion,BP,
11012,GO:0045027,1,0.971476064424368,0,1,DNA end binding,MF,
11013,GO:0045028,1,0.859692322080414,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11014,GO:0045031,1,0.941533320234112,0,2,ATP-activated adenosine receptor activity,MF,
11015,GO:0045032,1,0.968804589995683,0,1,ADP-activated adenosine receptor activity,MF,
11016,GO:0045039,1,0.847988392150709,0,6,protein import into mitochondrial inner membrane,BP,
11019,GO:0045046,1,0.828883650231442,0,6,protein import into peroxisome membrane,BP,
11020,GO:0045047,1,0.0658334178206488,0,101,protein targeting to ER,BP,
11021,GO:0045048,1,0.860071888240349,0,5,protein insertion into ER membrane,BP,
11022,GO:0045053,1,0.846970945615352,0,5,protein retention in Golgi apparatus,BP,
11023,GO:0045054,1,0.912555715514118,0,3,constitutive secretory pathway,BP,
11025,GO:0045056,1,0.626708030170581,0,15,transcytosis,BP,
11027,GO:0045059,1,0.854180154488469,0,5,positive thymic T cell selection,BP,
11028,GO:0045060,1,0.936377207940404,0,2,negative thymic T cell selection,BP,
11029,GO:0045061,1,0.724646320719239,0,10,thymic T cell selection,BP,
11030,GO:0045062,1,0.972571400581427,0,1,extrathymic T cell selection,BP,
11033,GO:0045065,1,0.941485005434612,0,2,cytotoxic T cell differentiation,BP,
11034,GO:0045066,1,0.64639084169478,0,14,regulatory T cell differentiation,BP,
11038,GO:0045072,1,0.826339093525097,0,6,regulation of interferon-gamma biosynthetic process,BP,
11040,GO:0045074,1,0.940954726771348,0,2,regulation of interleukin-10 biosynthetic process,BP,
11043,GO:0045077,1,0.971270332458308,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11044,GO:0045078,1,0.850792755488421,0,5,positive regulation of interferon-gamma biosynthetic process,BP,
11045,GO:0045079,1,0.972658868335958,0,1,negative regulation of chemokine biosynthetic process,BP,
11047,GO:0045081,1,0.967916998726286,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11048,GO:0045082,1,0.972146479838463,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
11050,GO:0045084,1,0.911076396353019,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
11051,GO:0045085,1,0.972485129024854,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
11056,GO:0045091,1,0.759842422679539,0,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11057,GO:0045092,1,0.967937244998564,0,1,interleukin-18 receptor complex,CC,
11059,GO:0045098,1,0.972684324308775,0,1,type III intermediate filament,CC,
11066,GO:0045112,1,0.911331454505952,0,3,integrin biosynthetic process,BP,
11067,GO:0045113,1,0.942626567662913,0,2,regulation of integrin biosynthetic process,BP,
11070,GO:0045120,1,0.688228158342861,0,12,pronucleus,CC,
11074,GO:0045125,1,0.737302554550521,0,10,bioactive lipid receptor activity,MF,
11076,GO:0045128,1,0.968694967567319,0,1,negative regulation of reciprocal meiotic recombination,BP,
11077,GO:0045131,1,0.969060968128612,0,1,pre-mRNA branch point binding,MF,
11078,GO:0045132,1,0.216830111591142,0,49,meiotic chromosome segregation,BP,
11079,GO:0045134,1,0.883964570397733,0,4,uridine-diphosphatase activity,MF,
11082,GO:0045141,1,0.775208230555281,0,8,meiotic telomere clustering,BP,
11083,GO:0045142,1,0.935647759762537,0,2,triplex DNA binding,MF,
11084,GO:0045143,1,0.433190044262784,0,27,homologous chromosome segregation,BP,
11085,GO:0045144,1,0.860250047445423,0,5,meiotic sister chromatid segregation,BP,
11086,GO:0045145,1,0.938839993874871,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11087,GO:0045153,1,0.973723465464243,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11088,GO:0045155,1,0.941474753930392,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11089,GO:0045159,1,0.883175695022817,0,4,myosin II binding,MF,
11090,GO:0045161,1,0.775764856092431,0,8,neuronal ion channel clustering,BP,
11091,GO:0045162,1,0.875582642844883,0,4,clustering of voltage-gated sodium channels,BP,
11092,GO:0045163,1,0.938294974534438,0,2,clustering of voltage-gated potassium channels,BP,
11094,GO:0045167,1,0.972561016164289,0,1,asymmetric protein localization involved in cell fate determination,BP,
11095,GO:0045168,1,0.942441113750598,0,2,cell-cell signaling involved in cell fate commitment,BP,
11097,GO:0045174,1,0.948318883858509,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11098,GO:0045176,1,0.746845924635536,0,9,apical protein localization,BP,
11101,GO:0045179,1,0.853562502735562,0,5,apical cortex,CC,
11102,GO:0045180,1,0.844929454816996,0,5,basal cortex,CC,
11103,GO:0045182,1,0.295570904214255,0,39,translation regulator activity,MF,
11104,GO:0045183,1,0.969271124374127,0,1,translation factor activity, non-nucleic acid binding,MF,
11107,GO:0045186,1,0.966829960371042,0,1,zonula adherens assembly,BP,
11108,GO:0045187,1,0.886367493187597,0,4,regulation of circadian sleep/wake cycle, sleep,BP,
11109,GO:0045188,1,0.940765254113389,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11112,GO:0045196,1,0.935610822160359,0,2,establishment or maintenance of neuroblast polarity,BP,
11114,GO:0045198,1,0.729548213418461,0,10,establishment of epithelial cell apical/basal polarity,BP,
11115,GO:0045199,1,0.854496774524928,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11116,GO:0045200,1,0.935610822160359,0,2,establishment of neuroblast polarity,BP,
11118,GO:0045204,1,0.905132841355249,0,3,MAPK export from nucleus,BP,
11119,GO:0045208,1,0.967988618209841,0,1,MAPK phosphatase export from nucleus,BP,
11120,GO:0045209,1,0.967988618209841,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11121,GO:0045210,1,0.934851162248968,0,2,FasL biosynthetic process,BP,
11126,GO:0045217,1,0.82316580273367,0,6,cell-cell junction maintenance,BP,
11127,GO:0045218,1,0.907538667882004,0,3,zonula adherens maintenance,BP,
11128,GO:0045219,1,0.966886192992835,0,1,regulation of FasL biosynthetic process,BP,
11129,GO:0045221,1,0.966886192992835,0,1,negative regulation of FasL biosynthetic process,BP,
11130,GO:0045222,1,0.97383158234957,0,1,CD4 biosynthetic process,BP,
11131,GO:0045223,1,0.97383158234957,0,1,regulation of CD4 biosynthetic process,BP,
11132,GO:0045225,1,0.97383158234957,0,1,negative regulation of CD4 biosynthetic process,BP,
11135,GO:0045234,1,0.972367970705438,0,1,protein palmitoleylation,BP,
11137,GO:0045239,1,0.669522662427392,0,13,tricarboxylic acid cycle enzyme complex,CC,
11138,GO:0045240,1,0.709365561947077,0,11,dihydrolipoyl dehydrogenase complex,CC,
11139,GO:0045244,1,0.970725361079207,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11140,GO:0045251,1,0.970731221353253,0,1,electron transfer flavoprotein complex,CC,
11141,GO:0045252,1,0.800978502477784,0,7,oxoglutarate dehydrogenase complex,CC,
11142,GO:0045254,1,0.803166501714872,0,7,pyruvate dehydrogenase complex,CC,
11143,GO:0045257,1,0.864775387684425,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11144,GO:0045259,1,0.945293114272846,0,2,proton-transporting ATP synthase complex,CC,
11145,GO:0045263,1,0.973330365825398,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11146,GO:0045271,1,0.326506911951027,0,42,respiratory chain complex I,CC,
11147,GO:0045272,1,0.919250928539794,0,3,plasma membrane respiratory chain complex I,CC,
11148,GO:0045273,1,0.864775387684425,0,5,respiratory chain complex II,CC,
11149,GO:0045274,1,0.970605552599522,0,1,plasma membrane respiratory chain complex II,CC,
11150,GO:0045275,1,0.731486532646153,0,11,respiratory chain complex III,CC,
11151,GO:0045277,1,0.7520874488785,0,11,respiratory chain complex IV,CC,
11152,GO:0045281,1,0.864775387684425,0,5,succinate dehydrogenase complex,CC,
11153,GO:0045282,1,0.970605552599522,0,1,plasma membrane succinate dehydrogenase complex,CC,
11154,GO:0045283,1,0.864775387684425,0,5,fumarate reductase complex,CC,
11155,GO:0045292,1,0.615591259412771,0,16,mRNA cis splicing, via spliceosome,BP,
11156,GO:0045293,1,0.918189803666991,0,3,mRNA editing complex,CC,
11158,GO:0045295,1,0.7403352348655,0,9,gamma-catenin binding,MF,
11160,GO:0045297,1,0.971003357007078,0,1,post-mating behavior,BP,
11161,GO:0045298,1,0.88265181493952,0,4,tubulin complex,CC,
11164,GO:0045322,1,0.939313044170512,0,2,unmethylated CpG binding,MF,
11165,GO:0045323,1,0.911255101347338,0,3,interleukin-1 receptor complex,CC,
11166,GO:0045324,1,0.7200831974941,0,11,late endosome to vacuole transport,BP,
11167,GO:0045329,1,0.885332066354469,0,4,carnitine biosynthetic process,BP,
11168,GO:0045332,1,0.606455406796895,0,15,phospholipid translocation,BP,
11170,GO:0045334,1,0.322399329809274,0,36,clathrin-coated endocytic vesicle,CC,
11174,GO:0045340,1,0.974265395836361,0,1,mercury ion binding,MF,
11180,GO:0045347,1,0.910431878827651,0,3,negative regulation of MHC class II biosynthetic process,BP,
11182,GO:0045349,1,0.886897096364363,0,4,interferon-alpha biosynthetic process,BP,
11183,GO:0045350,1,0.833445411158532,0,6,interferon-beta biosynthetic process,BP,
11184,GO:0045351,1,0.787896743823901,0,8,type I interferon biosynthetic process,BP,
11185,GO:0045352,1,0.972378719353157,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11186,GO:0045353,1,0.972378719353157,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11187,GO:0045354,1,0.886897096364363,0,4,regulation of interferon-alpha biosynthetic process,BP,
11188,GO:0045355,1,0.946634032409335,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11189,GO:0045356,1,0.936904613699025,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
11190,GO:0045357,1,0.833445411158532,0,6,regulation of interferon-beta biosynthetic process,BP,
11191,GO:0045358,1,0.946665517125938,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11192,GO:0045359,1,0.880418017336781,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11193,GO:0045360,1,0.968741153584299,0,1,regulation of interleukin-1 biosynthetic process,BP,
11194,GO:0045362,1,0.968741153584299,0,1,positive regulation of interleukin-1 biosynthetic process,BP,
11195,GO:0045381,1,0.968534441759746,0,1,regulation of interleukin-18 biosynthetic process,BP,
11196,GO:0045399,1,0.966933724327514,0,1,regulation of interleukin-3 biosynthetic process,BP,
11197,GO:0045401,1,0.966933724327514,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11198,GO:0045402,1,0.968523206216462,0,1,regulation of interleukin-4 biosynthetic process,BP,
11199,GO:0045403,1,0.968523206216462,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
11201,GO:0045409,1,0.936546890157423,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
11203,GO:0045414,1,0.85673733063525,0,5,regulation of interleukin-8 biosynthetic process,BP,
11204,GO:0045415,1,0.914572250172823,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
11205,GO:0045416,1,0.936777842041579,0,2,positive regulation of interleukin-8 biosynthetic process,BP,
11206,GO:0045423,1,0.966933724327514,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11207,GO:0045425,1,0.966933724327514,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11213,GO:0045448,1,0.884398400891698,0,4,mitotic cell cycle, embryonic,BP,
11217,GO:0045472,1,0.805309499060152,0,7,response to ether,BP,
11218,GO:0045475,1,0.797089134527523,0,7,locomotor rhythm,BP,
11220,GO:0045494,1,0.549542593768351,0,19,photoreceptor cell maintenance,BP,
11221,GO:0045495,1,0.805230192214371,0,7,pole plasm,CC,
11223,GO:0045503,1,0.614324906610814,0,15,dynein light chain binding,MF,
11224,GO:0045504,1,0.732032735438635,0,10,dynein heavy chain binding,MF,
11225,GO:0045505,1,0.518605792066033,0,21,dynein intermediate chain binding,MF,
11229,GO:0045541,1,0.864099511990963,0,5,negative regulation of cholesterol biosynthetic process,BP,
11230,GO:0045542,1,0.850653390062559,0,5,positive regulation of cholesterol biosynthetic process,BP,
11231,GO:0045545,1,0.855938431717615,0,5,syndecan binding,MF,
11232,GO:0045569,1,0.886405021371344,0,4,TRAIL binding,MF,
11233,GO:0045575,1,0.939687910380622,0,2,basophil activation,BP,
11236,GO:0045578,1,0.909286657564763,0,3,negative regulation of B cell differentiation,BP,
11241,GO:0045583,1,0.941485005434612,0,2,regulation of cytotoxic T cell differentiation,BP,
11242,GO:0045585,1,0.941485005434612,0,2,positive regulation of cytotoxic T cell differentiation,BP,
11243,GO:0045586,1,0.904459545529783,0,3,regulation of gamma-delta T cell differentiation,BP,
11244,GO:0045588,1,0.934945823695782,0,2,positive regulation of gamma-delta T cell differentiation,BP,
11245,GO:0045589,1,0.64639084169478,0,14,regulation of regulatory T cell differentiation,BP,
11246,GO:0045590,1,0.96800170974138,0,1,negative regulation of regulatory T cell differentiation,BP,
11247,GO:0045591,1,0.837596604743906,0,6,positive regulation of regulatory T cell differentiation,BP,
11255,GO:0045602,1,0.851523896385686,0,5,negative regulation of endothelial cell differentiation,BP,
11256,GO:0045603,1,0.797061004016914,0,7,positive regulation of endothelial cell differentiation,BP,
11260,GO:0045607,1,0.859743771575511,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11261,GO:0045608,1,0.911133332468818,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
11272,GO:0045626,1,0.93848508002167,0,2,negative regulation of T-helper 1 cell differentiation,BP,
11276,GO:0045630,1,0.889191995440226,0,4,positive regulation of T-helper 2 cell differentiation,BP,
11277,GO:0045631,1,0.859743771575511,0,5,regulation of mechanoreceptor differentiation,BP,
11278,GO:0045632,1,0.887009391728787,0,4,negative regulation of mechanoreceptor differentiation,BP,
11279,GO:0045634,1,0.854721395196209,0,5,regulation of melanocyte differentiation,BP,
11280,GO:0045636,1,0.904554495966054,0,3,positive regulation of melanocyte differentiation,BP,
11290,GO:0045650,1,0.944640225219563,0,2,negative regulation of macrophage differentiation,BP,
11292,GO:0045652,1,0.155291913765051,0,65,regulation of megakaryocyte differentiation,BP,
11293,GO:0045653,1,0.645005675522211,0,17,negative regulation of megakaryocyte differentiation,BP,
11294,GO:0045654,1,0.944076046989931,0,2,positive regulation of megakaryocyte differentiation,BP,
11300,GO:0045660,1,0.971792751801353,0,1,positive regulation of neutrophil differentiation,BP,
11302,GO:0045662,1,0.635935983727358,0,15,negative regulation of myoblast differentiation,BP,
11317,GO:0045686,1,0.691339524270083,0,12,negative regulation of glial cell differentiation,BP,
11322,GO:0045716,1,0.91274893907933,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11323,GO:0045717,1,0.690487259280069,0,12,negative regulation of fatty acid biosynthetic process,BP,
11325,GO:0045721,1,0.804430285316533,0,7,negative regulation of gluconeogenesis,BP,
11326,GO:0045722,1,0.750291156730672,0,9,positive regulation of gluconeogenesis,BP,
11328,GO:0045724,1,0.56783931362391,0,18,positive regulation of cilium assembly,BP,
11329,GO:0045725,1,0.765509320864677,0,8,positive regulation of glycogen biosynthetic process,BP,
11330,GO:0045726,1,0.966908443549658,0,1,positive regulation of integrin biosynthetic process,BP,
11332,GO:0045730,1,0.680054554491692,0,13,respiratory burst,BP,
11335,GO:0045737,1,0.427646841287076,0,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
11336,GO:0045738,1,0.517694269363558,0,21,negative regulation of DNA repair,BP,
11341,GO:0045743,1,0.83155620646588,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11345,GO:0045747,1,0.341392407229792,0,34,positive regulation of Notch signaling pathway,BP,
11346,GO:0045751,1,0.968534441759746,0,1,negative regulation of Toll signaling pathway,BP,
11347,GO:0045759,1,0.940962387848678,0,2,negative regulation of action potential,BP,
11348,GO:0045760,1,0.824860465894168,0,6,positive regulation of action potential,BP,
11349,GO:0045761,1,0.710433804222011,0,11,regulation of adenylate cyclase activity,BP,
11350,GO:0045762,1,0.935653765077748,0,2,positive regulation of adenylate cyclase activity,BP,
11351,GO:0045763,1,0.934824579378187,0,2,negative regulation of cellular amino acid metabolic process,BP,
11352,GO:0045764,1,0.94598998498773,0,2,positive regulation of cellular amino acid metabolic process,BP,
11355,GO:0045769,1,0.966748326942727,0,1,negative regulation of asymmetric cell division,BP,
11360,GO:0045779,1,0.829713636297954,0,6,negative regulation of bone resorption,BP,
11365,GO:0045792,1,0.800170486018048,0,7,negative regulation of cell size,BP,
11367,GO:0045794,1,0.874508714134975,0,4,negative regulation of cell volume,BP,
11368,GO:0045795,1,0.966845721295149,0,1,positive regulation of cell volume,BP,
11369,GO:0045799,1,0.940430616933096,0,2,positive regulation of chromatin assembly or disassembly,BP,
11372,GO:0045813,1,0.972322080150554,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
11373,GO:0045814,1,0.028527131411587,0,121,negative regulation of gene expression, epigenetic,BP,
11374,GO:0045815,1,0.108100865790076,0,77,positive regulation of gene expression, epigenetic,BP,
11375,GO:0045819,1,0.967537145007451,0,1,positive regulation of glycogen catabolic process,BP,
11376,GO:0045820,1,0.828634334587246,0,6,negative regulation of glycolytic process,BP,
11377,GO:0045821,1,0.720193070210879,0,10,positive regulation of glycolytic process,BP,
11378,GO:0045822,1,0.731935639237068,0,10,negative regulation of heart contraction,BP,
11381,GO:0045829,1,0.910183535824307,0,3,negative regulation of isotype switching,BP,
11385,GO:0045835,1,0.825584597068206,0,6,negative regulation of meiotic nuclear division,BP,
11386,GO:0045836,1,0.828749631504204,0,6,positive regulation of meiotic nuclear division,BP,
11388,GO:0045838,1,0.736732427162308,0,10,positive regulation of membrane potential,BP,
11392,GO:0045842,1,0.78189246980747,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11395,GO:0045851,1,0.325217116640073,0,38,pH reduction,BP,
11396,GO:0045852,1,0.912235829154499,0,3,pH elevation,BP,
11401,GO:0045869,1,0.785891434750638,0,8,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11402,GO:0045870,1,0.966875672694054,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11403,GO:0045872,1,0.971622045369871,0,1,positive regulation of rhodopsin gene expression,BP,
11404,GO:0045875,1,0.853389824949445,0,5,negative regulation of sister chromatid cohesion,BP,
11405,GO:0045876,1,0.732061102665121,0,10,positive regulation of sister chromatid cohesion,BP,
11406,GO:0045879,1,0.522902559344233,0,20,negative regulation of smoothened signaling pathway,BP,
11407,GO:0045880,1,0.493248467362317,0,22,positive regulation of smoothened signaling pathway,BP,
11408,GO:0045887,1,0.966833832087831,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
11413,GO:0045900,1,0.884535789157881,0,4,negative regulation of translational elongation,BP,
11414,GO:0045901,1,0.912140622036498,0,3,positive regulation of translational elongation,BP,
11415,GO:0045903,1,0.922135695015373,0,3,positive regulation of translational fidelity,BP,
11416,GO:0045905,1,0.941269451399064,0,2,positive regulation of translational termination,BP,
11417,GO:0045906,1,0.825571952204781,0,6,negative regulation of vasoconstriction,BP,
11418,GO:0045907,1,0.62525301584402,0,15,positive regulation of vasoconstriction,BP,
11419,GO:0045910,1,0.509131287702922,0,21,negative regulation of DNA recombination,BP,
11423,GO:0045914,1,0.940556723030937,0,2,negative regulation of catecholamine metabolic process,BP,
11424,GO:0045915,1,0.860522316463819,0,5,positive regulation of catecholamine metabolic process,BP,
11425,GO:0045916,1,0.911016211330778,0,3,negative regulation of complement activation,BP,
11426,GO:0045917,1,0.972254001419291,0,1,positive regulation of complement activation,BP,
11427,GO:0045918,1,0.973957996685046,0,1,negative regulation of cytolysis,BP,
11428,GO:0045919,1,0.919697780144267,0,3,positive regulation of cytolysis,BP,
11431,GO:0045922,1,0.62788841329189,0,15,negative regulation of fatty acid metabolic process,BP,
11433,GO:0045924,1,0.938342711279315,0,2,regulation of female receptivity,BP,
11434,GO:0045925,1,0.970537207718945,0,1,positive regulation of female receptivity,BP,
11439,GO:0045932,1,0.651619151477733,0,14,negative regulation of muscle contraction,BP,
11447,GO:0045943,1,0.513467380454917,0,21,positive regulation of transcription by RNA polymerase I,BP,
11449,GO:0045945,1,0.725445305879064,0,10,positive regulation of transcription by RNA polymerase III,BP,
11450,GO:0045947,1,0.591102792986503,0,17,negative regulation of translational initiation,BP,
11452,GO:0045950,1,0.940559333821542,0,2,negative regulation of mitotic recombination,BP,
11453,GO:0045953,1,0.789986850178439,0,8,negative regulation of natural killer cell mediated cytotoxicity,BP,
11455,GO:0045955,1,0.80183687625529,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11456,GO:0045956,1,0.712426793508821,0,11,positive regulation of calcium ion-dependent exocytosis,BP,
11457,GO:0045963,1,0.940556723030937,0,2,negative regulation of dopamine metabolic process,BP,
11458,GO:0045964,1,0.860522316463819,0,5,positive regulation of dopamine metabolic process,BP,
11459,GO:0045967,1,0.934623379391167,0,2,negative regulation of growth rate,BP,
11460,GO:0045974,1,0.686801324811705,0,12,regulation of translation, ncRNA-mediated,BP,
11461,GO:0045976,1,0.936794614613558,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11462,GO:0045977,1,0.973198875078459,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
11464,GO:0045981,1,0.283301457080884,0,41,positive regulation of nucleotide metabolic process,BP,
11465,GO:0045986,1,0.734292387838968,0,10,negative regulation of smooth muscle contraction,BP,
11467,GO:0045988,1,0.911080863080178,0,3,negative regulation of striated muscle contraction,BP,
11468,GO:0045989,1,0.810093472260171,0,7,positive regulation of striated muscle contraction,BP,
11469,GO:0045990,1,0.884573733491075,0,4,carbon catabolite regulation of transcription,BP,
11470,GO:0045991,1,0.884573733491075,0,4,carbon catabolite activation of transcription,BP,
11471,GO:0045992,1,0.529104482041363,0,20,negative regulation of embryonic development,BP,
11472,GO:0045993,1,0.967126574721264,0,1,negative regulation of translational initiation by iron,BP,
11473,GO:0045994,1,0.966882354835077,0,1,positive regulation of translational initiation by iron,BP,
11477,GO:0046015,1,0.889896470587941,0,4,regulation of transcription by glucose,BP,
11478,GO:0046016,1,0.91491497201432,0,3,positive regulation of transcription by glucose,BP,
11479,GO:0046030,1,0.701045155704342,0,11,inositol trisphosphate phosphatase activity,MF,
11481,GO:0046032,1,0.973005665015116,0,1,ADP catabolic process,BP,
11482,GO:0046033,1,0.739009970152557,0,10,AMP metabolic process,BP,
11484,GO:0046035,1,0.973650711260201,0,1,CMP metabolic process,BP,
11485,GO:0046036,1,0.713364166442392,0,12,CTP metabolic process,BP,
11487,GO:0046038,1,0.973278640440209,0,1,GMP catabolic process,BP,
11489,GO:0046040,1,0.688320605085429,0,12,IMP metabolic process,BP,
11490,GO:0046041,1,0.944639562889915,0,2,ITP metabolic process,BP,
11491,GO:0046048,1,0.969177217676602,0,1,UDP metabolic process,BP,
11492,GO:0046049,1,0.765963367864795,0,9,UMP metabolic process,BP,
11493,GO:0046051,1,0.775813191344035,0,9,UTP metabolic process,BP,
11494,GO:0046054,1,0.974159093896004,0,1,dGMP metabolic process,BP,
11495,GO:0046056,1,0.943139823020022,0,2,dADP metabolic process,BP,
11496,GO:0046057,1,0.973042534048118,0,1,dADP catabolic process,BP,
11498,GO:0046060,1,0.869408937966184,0,5,dATP metabolic process,BP,
11499,GO:0046061,1,0.918562118208313,0,3,dATP catabolic process,BP,
11500,GO:0046065,1,0.973915565672112,0,1,dCTP metabolic process,BP,
11501,GO:0046066,1,0.918764363378554,0,3,dGDP metabolic process,BP,
11502,GO:0046067,1,0.973042534048118,0,1,dGDP catabolic process,BP,
11503,GO:0046068,1,0.493734467965376,0,22,cGMP metabolic process,BP,
11504,GO:0046069,1,0.935224855428697,0,2,cGMP catabolic process,BP,
11505,GO:0046070,1,0.893601373215148,0,4,dGTP metabolic process,BP,
11506,GO:0046072,1,0.943732169123637,0,2,dTDP metabolic process,BP,
11507,GO:0046073,1,0.917369473990968,0,3,dTMP metabolic process,BP,
11508,GO:0046075,1,0.89379703155424,0,4,dTTP metabolic process,BP,
11509,GO:0046077,1,0.943732169123637,0,2,dUDP metabolic process,BP,
11510,GO:0046078,1,0.893985232884589,0,4,dUMP metabolic process,BP,
11511,GO:0046080,1,0.972129803812724,0,1,dUTP metabolic process,BP,
11512,GO:0046081,1,0.972129803812724,0,1,dUTP catabolic process,BP,
11513,GO:0046083,1,0.921975891451135,0,3,adenine metabolic process,BP,
11514,GO:0046084,1,0.921975891451135,0,3,adenine biosynthetic process,BP,
11515,GO:0046085,1,0.831469679578192,0,6,adenosine metabolic process,BP,
11516,GO:0046086,1,0.939949935052777,0,2,adenosine biosynthetic process,BP,
11517,GO:0046087,1,0.817167602497818,0,7,cytidine metabolic process,BP,
11518,GO:0046090,1,0.972997302627361,0,1,deoxyadenosine metabolic process,BP,
11519,GO:0046092,1,0.966930408211412,0,1,deoxycytidine metabolic process,BP,
11521,GO:0046099,1,0.945995402903846,0,2,guanine biosynthetic process,BP,
11522,GO:0046100,1,0.867304596570367,0,5,hypoxanthine metabolic process,BP,
11523,GO:0046101,1,0.892324381695033,0,4,hypoxanthine biosynthetic process,BP,
11524,GO:0046102,1,0.91611585101037,0,3,inosine metabolic process,BP,
11525,GO:0046103,1,0.943912672484092,0,2,inosine biosynthetic process,BP,
11526,GO:0046104,1,0.911283910179416,0,3,thymidine metabolic process,BP,
11527,GO:0046108,1,0.972300370201599,0,1,uridine metabolic process,BP,
11528,GO:0046110,1,0.909665916371659,0,3,xanthine metabolic process,BP,
11529,GO:0046111,1,0.972997302627361,0,1,xanthine biosynthetic process,BP,
11530,GO:0046112,1,0.558456645264184,0,19,nucleobase biosynthetic process,BP,
11532,GO:0046116,1,0.918942976228559,0,3,queuosine metabolic process,BP,
11533,GO:0046121,1,0.916691724699165,0,3,deoxyribonucleoside catabolic process,BP,
11534,GO:0046122,1,0.947813621326311,0,2,purine deoxyribonucleoside metabolic process,BP,
11535,GO:0046124,1,0.972997302627361,0,1,purine deoxyribonucleoside catabolic process,BP,
11536,GO:0046125,1,0.911283910179416,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
11537,GO:0046127,1,0.968755358580569,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
11539,GO:0046129,1,0.56519487540873,0,20,purine ribonucleoside biosynthetic process,BP,
11540,GO:0046130,1,0.842341803320613,0,6,purine ribonucleoside catabolic process,BP,
11541,GO:0046131,1,0.456216739361922,0,27,pyrimidine ribonucleoside metabolic process,BP,
11542,GO:0046132,1,0.594161709627458,0,18,pyrimidine ribonucleoside biosynthetic process,BP,
11543,GO:0046133,1,0.770015452720873,0,9,pyrimidine ribonucleoside catabolic process,BP,
11544,GO:0046134,1,0.497828862486447,0,24,pyrimidine nucleoside biosynthetic process,BP,
11545,GO:0046135,1,0.662770420370813,0,14,pyrimidine nucleoside catabolic process,BP,
11548,GO:0046146,1,0.820024482042368,0,7,tetrahydrobiopterin metabolic process,BP,
11549,GO:0046148,1,0.293875300661697,0,40,pigment biosynthetic process,BP,
11551,GO:0046160,1,0.936888398874482,0,2,heme a metabolic process,BP,
11552,GO:0046164,1,0.385337118609408,0,31,alcohol catabolic process,BP,
11554,GO:0046166,1,0.945393809647991,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
11555,GO:0046167,1,0.935696621994507,0,2,glycerol-3-phosphate biosynthetic process,BP,
11556,GO:0046168,1,0.967558959259688,0,1,glycerol-3-phosphate catabolic process,BP,
11557,GO:0046173,1,0.275641685029972,0,42,polyol biosynthetic process,BP,
11558,GO:0046174,1,0.566721344652496,0,18,polyol catabolic process,BP,
11559,GO:0046176,1,0.969271124374127,0,1,aldonic acid catabolic process,BP,
11560,GO:0046177,1,0.969271124374127,0,1,D-gluconate catabolic process,BP,
11561,GO:0046184,1,0.731177257358812,0,10,aldehyde biosynthetic process,BP,
11562,GO:0046185,1,0.768648969208322,0,9,aldehyde catabolic process,BP,
11563,GO:0046189,1,0.58675905086944,0,17,phenol-containing compound biosynthetic process,BP,
11564,GO:0046203,1,0.947091799670532,0,2,spermidine catabolic process,BP,
11565,GO:0046204,1,0.974207866339602,0,1,nor-spermidine metabolic process,BP,
11566,GO:0046208,1,0.92027951776441,0,3,spermine catabolic process,BP,
11568,GO:0046210,1,0.970282624874275,0,1,nitric oxide catabolic process,BP,
11569,GO:0046218,1,0.918918772447815,0,3,indolalkylamine catabolic process,BP,
11570,GO:0046222,1,0.969652760557037,0,1,aflatoxin metabolic process,BP,
11571,GO:0046223,1,0.969652760557037,0,1,aflatoxin catabolic process,BP,
11572,GO:0046272,1,0.971161223769299,0,1,stilbene catabolic process,BP,
11573,GO:0046292,1,0.913272885334872,0,3,formaldehyde metabolic process,BP,
11574,GO:0046293,1,0.966998837552156,0,1,formaldehyde biosynthetic process,BP,
11575,GO:0046294,1,0.944445484002437,0,2,formaldehyde catabolic process,BP,
11576,GO:0046295,1,0.974265395836361,0,1,glycolate biosynthetic process,BP,
11577,GO:0046305,1,0.969739494715775,0,1,alkanesulfonate biosynthetic process,BP,
11578,GO:0046316,1,0.969271124374127,0,1,gluconokinase activity,MF,
11579,GO:0046317,1,0.966920568104527,0,1,regulation of glucosylceramide biosynthetic process,BP,
11580,GO:0046318,1,0.966920568104527,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
11581,GO:0046320,1,0.597217104755172,0,16,regulation of fatty acid oxidation,BP,
11582,GO:0046321,1,0.771597927745024,0,8,positive regulation of fatty acid oxidation,BP,
11583,GO:0046322,1,0.883032759937562,0,4,negative regulation of fatty acid oxidation,BP,
11587,GO:0046326,1,0.442777882863795,0,25,positive regulation of glucose import,BP,
11588,GO:0046327,1,0.971863023673316,0,1,glycerol biosynthetic process from pyruvate,BP,
11590,GO:0046329,1,0.41569092467589,0,28,negative regulation of JNK cascade,BP,
11592,GO:0046331,1,0.942441113750598,0,2,lateral inhibition,BP,
11594,GO:0046333,1,0.968924823804647,0,1,octopamine metabolic process,BP,
11595,GO:0046337,1,0.623909683035513,0,15,phosphatidylethanolamine metabolic process,BP,
11596,GO:0046338,1,0.938697480435205,0,2,phosphatidylethanolamine catabolic process,BP,
11597,GO:0046339,1,0.685536711296601,0,12,diacylglycerol metabolic process,BP,
11598,GO:0046340,1,0.938340852656118,0,2,diacylglycerol catabolic process,BP,
11599,GO:0046341,1,0.642665996042501,0,14,CDP-diacylglycerol metabolic process,BP,
11603,GO:0046355,1,0.968383354102579,0,1,mannan catabolic process,BP,
11604,GO:0046356,1,0.946222996870898,0,2,acetyl-CoA catabolic process,BP,
11605,GO:0046359,1,0.971995214098838,0,1,butyrate catabolic process,BP,
11606,GO:0046360,1,0.971435022576243,0,1,2-oxobutyrate biosynthetic process,BP,
11607,GO:0046361,1,0.971435022576243,0,1,2-oxobutyrate metabolic process,BP,
11610,GO:0046368,1,0.887128758278175,0,4,GDP-L-fucose metabolic process,BP,
11611,GO:0046370,1,0.944328567830513,0,2,fructose biosynthetic process,BP,
11613,GO:0046380,1,0.967691712269395,0,1,N-acetylneuraminate biosynthetic process,BP,
11614,GO:0046381,1,0.973663261755306,0,1,CMP-N-acetylneuraminate metabolic process,BP,
11615,GO:0046385,1,0.754329938851358,0,10,deoxyribose phosphate biosynthetic process,BP,
11616,GO:0046386,1,0.579237880859824,0,19,deoxyribose phosphate catabolic process,BP,
11618,GO:0046391,1,0.913595635025254,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
11621,GO:0046398,1,0.909674233594306,0,3,UDP-glucuronate metabolic process,BP,
11622,GO:0046403,1,0.972524513134103,0,1,polynucleotide 3'-phosphatase activity,MF,
11623,GO:0046404,1,0.914391754148409,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
11625,GO:0046416,1,0.970365496604871,0,1,D-amino acid metabolic process,BP,
11627,GO:0046426,1,0.360392105736475,0,33,negative regulation of JAK-STAT cascade,BP,
11630,GO:0046437,1,0.970365496604871,0,1,D-amino acid biosynthetic process,BP,
11631,GO:0046439,1,0.853176919360576,0,5,L-cysteine metabolic process,BP,
11632,GO:0046440,1,0.910171428890894,0,3,L-lysine metabolic process,BP,
11633,GO:0046443,1,0.971848715171512,0,1,FAD metabolic process,BP,
11634,GO:0046444,1,0.969739494715775,0,1,FMN metabolic process,BP,
11635,GO:0046448,1,0.970469143237632,0,1,tropane alkaloid metabolic process,BP,
11637,GO:0046452,1,0.915520113979028,0,3,dihydrofolate metabolic process,BP,
11640,GO:0046459,1,0.678268016960084,0,13,short-chain fatty acid metabolic process,BP,
11641,GO:0046460,1,0.443568836127469,0,26,neutral lipid biosynthetic process,BP,
11643,GO:0046462,1,0.942496353952198,0,2,monoacylglycerol metabolic process,BP,
11644,GO:0046463,1,0.443568836127469,0,26,acylglycerol biosynthetic process,BP,
11647,GO:0046466,1,0.514903153034092,0,22,membrane lipid catabolic process,BP,
11649,GO:0046469,1,0.85709985120678,0,5,platelet activating factor metabolic process,BP,
11651,GO:0046471,1,0.456528557828579,0,25,phosphatidylglycerol metabolic process,BP,
11652,GO:0046473,1,0.371687534314267,0,31,phosphatidic acid metabolic process,BP,
11654,GO:0046475,1,0.62976115531575,0,15,glycerophospholipid catabolic process,BP,
11656,GO:0046477,1,0.831462396229329,0,6,glycosylceramide catabolic process,BP,
11657,GO:0046478,1,0.96698600588414,0,1,lactosylceramide metabolic process,BP,
11658,GO:0046479,1,0.736943729244281,0,10,glycosphingolipid catabolic process,BP,
11660,GO:0046485,1,0.808282974612894,0,7,ether lipid metabolic process,BP,
11662,GO:0046487,1,0.837401109465498,0,6,glyoxylate metabolic process,BP,
11664,GO:0046490,1,0.869581516372694,0,5,isopentenyl diphosphate metabolic process,BP,
11665,GO:0046491,1,0.974383917091779,0,1,L-methylmalonyl-CoA metabolic process,BP,
11666,GO:0046493,1,0.950146313132071,0,2,lipid A metabolic process,BP,
11667,GO:0046495,1,0.970556085034801,0,1,nicotinamide riboside metabolic process,BP,
11669,GO:0046497,1,0.969271124374127,0,1,nicotinate nucleotide metabolic process,BP,
11670,GO:0046498,1,0.834636467384295,0,6,S-adenosylhomocysteine metabolic process,BP,
11671,GO:0046499,1,0.968487030206462,0,1,S-adenosylmethioninamine metabolic process,BP,
11672,GO:0046500,1,0.738523818796033,0,10,S-adenosylmethionine metabolic process,BP,
11673,GO:0046501,1,0.764453554999149,0,9,protoporphyrinogen IX metabolic process,BP,
11674,GO:0046502,1,0.945448192253126,0,2,uroporphyrinogen III metabolic process,BP,
11676,GO:0046504,1,0.858691367808245,0,5,glycerol ether biosynthetic process,BP,
11677,GO:0046511,1,0.939870745374807,0,2,sphinganine biosynthetic process,BP,
11678,GO:0046512,1,0.785381423888545,0,8,sphingosine biosynthetic process,BP,
11680,GO:0046514,1,0.718353529143581,0,11,ceramide catabolic process,BP,
11681,GO:0046519,1,0.692848244351041,0,12,sphingoid metabolic process,BP,
11682,GO:0046520,1,0.759938188033675,0,9,sphingoid biosynthetic process,BP,
11683,GO:0046521,1,0.972152030821871,0,1,sphingoid catabolic process,BP,
11684,GO:0046523,1,0.968795296597484,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
11685,GO:0046525,1,0.972527128648594,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
11686,GO:0046526,1,0.970225831804016,0,1,D-xylulose reductase activity,MF,
11689,GO:0046532,1,0.852793655841235,0,5,regulation of photoreceptor cell differentiation,BP,
11690,GO:0046533,1,0.881786837413395,0,4,negative regulation of photoreceptor cell differentiation,BP,
11691,GO:0046534,1,0.967131092422207,0,1,positive regulation of photoreceptor cell differentiation,BP,
11692,GO:0046538,1,0.919408981875856,0,3,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
11693,GO:0046540,1,0.494468161478211,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11694,GO:0046541,1,0.941579421770098,0,2,saliva secretion,BP,
11695,GO:0046543,1,0.806230849014667,0,7,development of secondary female sexual characteristics,BP,
11696,GO:0046544,1,0.96692119683338,0,1,development of secondary male sexual characteristics,BP,
11699,GO:0046548,1,0.910022555343422,0,3,retinal rod cell development,BP,
11700,GO:0046549,1,0.908348768395088,0,3,retinal cone cell development,BP,
11701,GO:0046554,1,0.973521226896569,0,1,malate dehydrogenase (NADP+) activity,MF,
11702,GO:0046570,1,0.973621299038942,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
11703,GO:0046573,1,0.972749943694051,0,1,lactonohydrolase activity,MF,
11704,GO:0046577,1,0.967723435323319,0,1,long-chain-alcohol oxidase activity,MF,
11707,GO:0046580,1,0.268312006769976,0,41,negative regulation of Ras protein signal transduction,BP,
11708,GO:0046581,1,0.908479818926164,0,3,intercellular canaliculus,CC,
11709,GO:0046586,1,0.944110038657777,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
11710,GO:0046587,1,0.969000986240046,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
11711,GO:0046588,1,0.974314966650159,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
11712,GO:0046592,1,0.944936117319735,0,2,polyamine oxidase activity,MF,
11716,GO:0046599,1,0.582003216191089,0,17,regulation of centriole replication,BP,
11717,GO:0046600,1,0.774010535844708,0,8,negative regulation of centriole replication,BP,
11718,GO:0046601,1,0.907337999149584,0,3,positive regulation of centriole replication,BP,
11719,GO:0046602,1,0.778465906992274,0,8,regulation of mitotic centrosome separation,BP,
11720,GO:0046604,1,0.912030280569019,0,3,positive regulation of mitotic centrosome separation,BP,
11722,GO:0046606,1,0.666423098736577,0,13,negative regulation of centrosome cycle,BP,
11723,GO:0046607,1,0.751355364694545,0,9,positive regulation of centrosome cycle,BP,
11724,GO:0046618,1,0.942268568895214,0,2,drug export,BP,
11725,GO:0046619,1,0.966846142268539,0,1,optic placode formation involved in camera-type eye formation,BP,
11729,GO:0046623,1,0.966857836354105,0,1,sphingolipid-translocating ATPase activity,MF,
11734,GO:0046628,1,0.771840695113299,0,8,positive regulation of insulin receptor signaling pathway,BP,
11735,GO:0046629,1,0.754184160046033,0,9,gamma-delta T cell activation,BP,
11747,GO:0046642,1,0.909295494940707,0,3,negative regulation of alpha-beta T cell proliferation,BP,
11748,GO:0046643,1,0.874709185164951,0,4,regulation of gamma-delta T cell activation,BP,
11749,GO:0046645,1,0.904195419690202,0,3,positive regulation of gamma-delta T cell activation,BP,
11752,GO:0046653,1,0.61535354177244,0,16,tetrahydrofolate metabolic process,BP,
11753,GO:0046654,1,0.807229165999963,0,7,tetrahydrofolate biosynthetic process,BP,
11754,GO:0046655,1,0.570963636784864,0,18,folic acid metabolic process,BP,
11755,GO:0046657,1,0.942223521902691,0,2,folic acid catabolic process,BP,
11759,GO:0046666,1,0.942942219792453,0,2,retinal cell programmed cell death,BP,
11760,GO:0046668,1,0.967631208065156,0,1,regulation of retinal cell programmed cell death,BP,
11761,GO:0046671,1,0.967631208065156,0,1,negative regulation of retinal cell programmed cell death,BP,
11764,GO:0046680,1,0.971505339509089,0,1,response to DDT,BP,
11766,GO:0046684,1,0.939917011852934,0,2,response to pyrethroid,BP,
11769,GO:0046687,1,0.973957996685046,0,1,response to chromate,BP,
11771,GO:0046689,1,0.860020364232693,0,5,response to mercury ion,BP,
11773,GO:0046695,1,0.917746631288359,0,3,SLIK (SAGA-like) complex,CC,
11777,GO:0046703,1,0.780765517440227,0,9,natural killer cell lectin-like receptor binding,MF,
11778,GO:0046707,1,0.940765409068545,0,2,IDP metabolic process,BP,
11779,GO:0046709,1,0.940765409068545,0,2,IDP catabolic process,BP,
11781,GO:0046711,1,0.974159093896004,0,1,GDP biosynthetic process,BP,
11782,GO:0046712,1,0.973042534048118,0,1,GDP catabolic process,BP,
11783,GO:0046713,1,0.968775772037672,0,1,borate transport,BP,
11784,GO:0046715,1,0.968775772037672,0,1,active borate transmembrane transporter activity,MF,
11785,GO:0046716,1,0.683676629553008,0,12,muscle cell cellular homeostasis,BP,
11788,GO:0046719,1,0.805004658180534,0,7,regulation by virus of viral protein levels in host cell,BP,
11789,GO:0046724,1,0.969874856147979,0,1,oxalic acid secretion,BP,
11790,GO:0046725,1,0.967982831740707,0,1,negative regulation by virus of viral protein levels in host cell,BP,
11791,GO:0046726,1,0.877678498105578,0,4,positive regulation by virus of viral protein levels in host cell,BP,
11792,GO:0046730,1,0.945081375440417,0,2,induction of host immune response by virus,BP,
11793,GO:0046732,1,0.945081375440417,0,2,active induction of host immune response by virus,BP,
11794,GO:0046745,1,0.969271124374127,0,1,viral capsid secondary envelopment,BP,
11795,GO:0046755,1,0.49021295568339,0,24,viral budding,BP,
11797,GO:0046778,1,0.942073850870519,0,2,modification by virus of host mRNA processing,BP,
11799,GO:0046784,1,0.789102552348197,0,8,viral mRNA export from host cell nucleus,BP,
11800,GO:0046785,1,0.154074299587237,0,59,microtubule polymerization,BP,
11801,GO:0046786,1,0.966960234546914,0,1,viral replication complex formation and maintenance,BP,
11802,GO:0046790,1,0.913238859034402,0,3,virion binding,MF,
11803,GO:0046794,1,0.175845810682637,0,56,transport of virus,BP,
11804,GO:0046811,1,0.966876136173513,0,1,histone deacetylase inhibitor activity,MF,
11805,GO:0046813,1,0.944173172127171,0,2,receptor-mediated virion attachment to host cell,BP,
11806,GO:0046817,1,0.973694495626685,0,1,chemokine receptor antagonist activity,MF,
11808,GO:0046823,1,0.611810181881539,0,16,negative regulation of nucleocytoplasmic transport,BP,
11811,GO:0046826,1,0.813036457941459,0,7,negative regulation of protein export from nucleus,BP,
11813,GO:0046831,1,0.614988572231592,0,15,regulation of RNA export from nucleus,BP,
11814,GO:0046832,1,0.934749146487717,0,2,negative regulation of RNA export from nucleus,BP,
11815,GO:0046833,1,0.798620194779953,0,7,positive regulation of RNA export from nucleus,BP,
11818,GO:0046836,1,0.861545912688773,0,5,glycolipid transport,BP,
11819,GO:0046838,1,0.727091584099684,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11820,GO:0046839,1,0.391082623712215,0,29,phospholipid dephosphorylation,BP,
11822,GO:0046848,1,0.973361586692008,0,1,hydroxyapatite binding,MF,
11825,GO:0046851,1,0.802427266560714,0,7,negative regulation of bone remodeling,BP,
11828,GO:0046855,1,0.727091584099684,0,10,inositol phosphate dephosphorylation,BP,
11829,GO:0046856,1,0.501297914449096,0,21,phosphatidylinositol dephosphorylation,BP,
11830,GO:0046870,1,0.90756079506266,0,3,cadmium ion binding,MF,
11833,GO:0046874,1,0.972973334258414,0,1,quinolinate metabolic process,BP,
11836,GO:0046880,1,0.91011593865979,0,3,regulation of follicle-stimulating hormone secretion,BP,
11837,GO:0046881,1,0.91011593865979,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
11838,GO:0046882,1,0.971270332458308,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
11840,GO:0046884,1,0.880079401784611,0,4,follicle-stimulating hormone secretion,BP,
11847,GO:0046898,1,0.909249037274622,0,3,response to cycloheximide,BP,
11848,GO:0046899,1,0.940104796954272,0,2,nucleoside triphosphate adenylate kinase activity,MF,
11849,GO:0046900,1,0.944235821255632,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
11850,GO:0046901,1,0.970333993118907,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
11855,GO:0046911,1,0.973791068722543,0,1,metal chelating activity,MF,
11860,GO:0046920,1,0.855634927519253,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11861,GO:0046921,1,0.968440502417451,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11862,GO:0046922,1,0.938149050460301,0,2,peptide-O-fucosyltransferase activity,MF,
11863,GO:0046923,1,0.863984075262468,0,5,ER retention sequence binding,MF,
11866,GO:0046930,1,0.724209046144212,0,11,pore complex,CC,
11867,GO:0046931,1,0.628166802013519,0,15,pore complex assembly,BP,
11868,GO:0046933,1,0.922121379495475,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
11870,GO:0046935,1,0.904487020532142,0,3,1-phosphatidylinositol-3-kinase regulator activity,MF,
11872,GO:0046940,1,0.859630223411394,0,5,nucleoside monophosphate phosphorylation,BP,
11875,GO:0046946,1,0.908402596212651,0,3,hydroxylysine metabolic process,BP,
11876,GO:0046947,1,0.908402596212651,0,3,hydroxylysine biosynthetic process,BP,
11877,GO:0046949,1,0.462927560263748,0,25,fatty-acyl-CoA biosynthetic process,BP,
11879,GO:0046951,1,0.833742208198172,0,6,ketone body biosynthetic process,BP,
11881,GO:0046958,1,0.968478755404149,0,1,nonassociative learning,BP,
11882,GO:0046961,1,0.588718345524587,0,18,proton-transporting ATPase activity, rotational mechanism,MF,
11883,GO:0046963,1,0.94403300391882,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11884,GO:0046964,1,0.94403300391882,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
11885,GO:0046965,1,0.708729614812355,0,11,retinoid X receptor binding,MF,
11886,GO:0046966,1,0.433307618637151,0,27,thyroid hormone receptor binding,MF,
11887,GO:0046967,1,0.937567635097746,0,2,cytosol to ER transport,BP,
11888,GO:0046968,1,0.967445251707302,0,1,peptide antigen transport,BP,
11889,GO:0046969,1,0.941266565891632,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
11890,GO:0046970,1,0.971921502773169,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
11891,GO:0046972,1,0.728154096952244,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11892,GO:0046974,1,0.850373358474449,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11893,GO:0046975,1,0.829038484917464,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11894,GO:0046976,1,0.852844507573918,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11895,GO:0046977,1,0.883642224279666,0,4,TAP binding,MF,
11896,GO:0046978,1,0.883642224279666,0,4,TAP1 binding,MF,
11897,GO:0046979,1,0.913384481502161,0,3,TAP2 binding,MF,
11898,GO:0046980,1,0.967445251707302,0,1,tapasin binding,MF,
11901,GO:0046984,1,0.885942570368478,0,4,regulation of hemoglobin biosynthetic process,BP,
11902,GO:0046985,1,0.91606383829175,0,3,positive regulation of hemoglobin biosynthetic process,BP,
11903,GO:0046986,1,0.967126574721264,0,1,negative regulation of hemoglobin biosynthetic process,BP,
11904,GO:0046996,1,0.969271124374127,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11905,GO:0047006,1,0.97335713870546,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11906,GO:0047012,1,0.972846862323855,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
11907,GO:0047015,1,0.974233001572932,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
11908,GO:0047016,1,0.971223168458905,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
11909,GO:0047017,1,0.969271124374127,0,1,prostaglandin-F synthase activity,MF,
11910,GO:0047021,1,0.973656990594964,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
11911,GO:0047023,1,0.947173314806185,0,2,androsterone dehydrogenase activity,MF,
11912,GO:0047025,1,0.943137606192094,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
11913,GO:0047035,1,0.974153435035593,0,1,testosterone dehydrogenase (NAD+) activity,MF,
11914,GO:0047042,1,0.97335713870546,0,1,androsterone dehydrogenase (B-specific) activity,MF,
11915,GO:0047045,1,0.973661172275541,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
11916,GO:0047057,1,0.948786299364761,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
11917,GO:0047066,1,0.974252463448493,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
11918,GO:0047086,1,0.947173314806185,0,2,ketosteroid monooxygenase activity,MF,
11919,GO:0047105,1,0.9702911699632,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
11920,GO:0047115,1,0.947173314806185,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
11921,GO:0047117,1,0.966805423739126,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
11922,GO:0047130,1,0.966871384739408,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11923,GO:0047131,1,0.966871384739408,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
11925,GO:0047144,1,0.751121070668853,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
11926,GO:0047150,1,0.971786998054768,0,1,betaine-homocysteine S-methyltransferase activity,MF,
11927,GO:0047159,1,0.967517816678779,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
11928,GO:0047166,1,0.972009327178387,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
11929,GO:0047179,1,0.948437212253846,0,2,platelet-activating factor acetyltransferase activity,MF,
11930,GO:0047184,1,0.858213481163884,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
11931,GO:0047186,1,0.967583399341008,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
11932,GO:0047191,1,0.967517816678779,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
11933,GO:0047192,1,0.90929067819564,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
11934,GO:0047220,1,0.969531793100263,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
11935,GO:0047223,1,0.91210346468871,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11936,GO:0047224,1,0.970328274139344,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
11937,GO:0047237,1,0.938089248697746,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11938,GO:0047238,1,0.878016507246651,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
11939,GO:0047256,1,0.967364978844554,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
11940,GO:0047263,1,0.969246239712162,0,1,N-acylsphingosine galactosyltransferase activity,MF,
11941,GO:0047273,1,0.968393964896178,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
11942,GO:0047275,1,0.968023751139697,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
11943,GO:0047277,1,0.971915811029396,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
11944,GO:0047280,1,0.967071442505279,0,1,nicotinamide phosphoribosyltransferase activity,MF,
11945,GO:0047288,1,0.940511209148878,0,2,monosialoganglioside sialyltransferase activity,MF,
11946,GO:0047290,1,0.972729839728389,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
11947,GO:0047291,1,0.970860445056348,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
11948,GO:0047293,1,0.972744924885889,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
11949,GO:0047298,1,0.966958766715114,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
11950,GO:0047322,1,0.934801066136786,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
11951,GO:0047323,1,0.971385106655306,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
11952,GO:0047325,1,0.968502735511175,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
11953,GO:0047326,1,0.972346416876858,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
11954,GO:0047341,1,0.968208615996743,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
11955,GO:0047349,1,0.966886050587283,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
11956,GO:0047369,1,0.969271124374127,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
11958,GO:0047374,1,0.942156324468054,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
11959,GO:0047389,1,0.936558583351777,0,2,glycerophosphocholine phosphodiesterase activity,MF,
11960,GO:0047391,1,0.941973811550234,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
11961,GO:0047395,1,0.969167959629313,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
11962,GO:0047408,1,0.941320039692637,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
11963,GO:0047409,1,0.941320039692637,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
11965,GO:0047444,1,0.973663261755306,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
11966,GO:0047451,1,0.966805423739126,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
11967,GO:0047464,1,0.966932140930849,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
11968,GO:0047484,1,0.827478320389752,0,6,regulation of response to osmotic stress,BP,
11970,GO:0047493,1,0.910473575175235,0,3,ceramide cholinephosphotransferase activity,MF,
11973,GO:0047498,1,0.825987383669761,0,6,calcium-dependent phospholipase A2 activity,MF,
11974,GO:0047499,1,0.859975173133787,0,5,calcium-independent phospholipase A2 activity,MF,
11975,GO:0047522,1,0.913290029868771,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
11976,GO:0047536,1,0.971112534214653,0,1,2-aminoadipate transaminase activity,MF,
11977,GO:0047545,1,0.966865901531705,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
11978,GO:0047555,1,0.875500773052176,0,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,
11979,GO:0047560,1,0.966907885944598,0,1,3-dehydrosphinganine reductase activity,MF,
11980,GO:0047578,1,0.970446042451352,0,1,4-hydroxyglutamate transaminase activity,MF,
11981,GO:0047598,1,0.969874856147979,0,1,7-dehydrocholesterol reductase activity,MF,
11982,GO:0047617,1,0.705075068484665,0,12,acyl-CoA hydrolase activity,MF,
11983,GO:0047620,1,0.969167959629313,0,1,acylglycerol kinase activity,MF,
11984,GO:0047621,1,0.972646094615903,0,1,acylpyruvate hydrolase activity,MF,
11985,GO:0047623,1,0.936006348136975,0,2,adenosine-phosphate deaminase activity,MF,
11986,GO:0047631,1,0.871464959654416,0,5,ADP-ribose diphosphatase activity,MF,
11987,GO:0047635,1,0.967549552025982,0,1,alanine-oxo-acid transaminase activity,MF,
11988,GO:0047658,1,0.972602434471036,0,1,alpha-amino-acid esterase activity,MF,
11989,GO:0047661,1,0.970365496604871,0,1,amino-acid racemase activity,MF,
11990,GO:0047676,1,0.966909324684963,0,1,arachidonate-CoA ligase activity,MF,
11991,GO:0047685,1,0.973072073087175,0,1,amine sulfotransferase activity,MF,
11992,GO:0047693,1,0.974656079851253,0,1,ATP diphosphatase activity,MF,
11993,GO:0047696,1,0.940151719609044,0,2,beta-adrenergic receptor kinase activity,MF,
11994,GO:0047708,1,0.971587105550984,0,1,biotinidase activity,MF,
11995,GO:0047710,1,0.97397173123977,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
11996,GO:0047718,1,0.97335713870546,0,1,indanol dehydrogenase activity,MF,
11997,GO:0047726,1,0.970282624874275,0,1,iron-cytochrome-c reductase activity,MF,
11998,GO:0047734,1,0.969271124374127,0,1,CDP-glycerol diphosphatase activity,MF,
11999,GO:0047747,1,0.97068437805089,0,1,cholate-CoA ligase activity,MF,
12000,GO:0047750,1,0.948696605056361,0,2,cholestenol delta-isomerase activity,MF,
12001,GO:0047751,1,0.941736154616668,0,2,cholestenone 5-alpha-reductase activity,MF,
12002,GO:0047756,1,0.939397984017548,0,2,chondroitin 4-sulfotransferase activity,MF,
12003,GO:0047757,1,0.935316454345318,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12004,GO:0047760,1,0.968360528740919,0,1,butyrate-CoA ligase activity,MF,
12005,GO:0047800,1,0.967783582473553,0,1,cysteamine dioxygenase activity,MF,
12006,GO:0047801,1,0.971390983250086,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12007,GO:0047840,1,0.973915565672112,0,1,dCTP diphosphatase activity,MF,
12008,GO:0047844,1,0.840579731923595,0,6,deoxycytidine deaminase activity,MF,
12009,GO:0047860,1,0.973595945025665,0,1,diiodophenylpyruvate reductase activity,MF,
12010,GO:0047874,1,0.971440889515244,0,1,dolichyldiphosphatase activity,MF,
12011,GO:0047888,1,0.971912964036823,0,1,fatty acid peroxidase activity,MF,
12012,GO:0047894,1,0.946734871795923,0,2,flavonol 3-sulfotransferase activity,MF,
12013,GO:0047915,1,0.97264097656233,0,1,ganglioside galactosyltransferase activity,MF,
12014,GO:0047933,1,0.966805057349486,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12015,GO:0047936,1,0.966790451126607,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12016,GO:0047939,1,0.973146913806439,0,1,L-glucuronate reductase activity,MF,
12017,GO:0047977,1,0.970696080330584,0,1,hepoxilin-epoxide hydrolase activity,MF,
12018,GO:0047982,1,0.972478537311936,0,1,homocysteine desulfhydrase activity,MF,
12020,GO:0048003,1,0.905301184930984,0,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12021,GO:0048006,1,0.967704783231378,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12022,GO:0048007,1,0.905301184930984,0,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12026,GO:0048011,1,0.531495174988696,0,20,neurotrophin TRK receptor signaling pathway,BP,
12029,GO:0048014,1,0.966900671749979,0,1,Tie signaling pathway,BP,
12034,GO:0048019,1,0.746363250966375,0,10,receptor antagonist activity,MF,
12035,GO:0048020,1,0.837589575193322,0,6,CCR chemokine receptor binding,MF,
12036,GO:0048021,1,0.904182763311129,0,3,regulation of melanin biosynthetic process,BP,
12037,GO:0048022,1,0.934814937303634,0,2,negative regulation of melanin biosynthetic process,BP,
12038,GO:0048023,1,0.967237767497311,0,1,positive regulation of melanin biosynthetic process,BP,
12039,GO:0048024,1,0.1399817348368,0,63,regulation of mRNA splicing, via spliceosome,BP,
12040,GO:0048025,1,0.592423972188904,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12041,GO:0048026,1,0.69531231322176,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12042,GO:0048027,1,0.519801984656664,0,22,mRNA 5'-UTR binding,MF,
12045,GO:0048033,1,0.969023076497428,0,1,heme o metabolic process,BP,
12046,GO:0048034,1,0.969023076497428,0,1,heme O biosynthetic process,BP,
12048,GO:0048038,1,0.671405769250595,0,14,quinone binding,MF,
12049,GO:0048039,1,0.845398406713538,0,6,ubiquinone binding,MF,
12050,GO:0048040,1,0.97149948734977,0,1,UDP-glucuronate decarboxylase activity,MF,
12053,GO:0048050,1,0.841201325307904,0,6,post-embryonic eye morphogenesis,BP,
12054,GO:0048058,1,0.968391307688713,0,1,compound eye corneal lens development,BP,
12059,GO:0048075,1,0.967221687751424,0,1,positive regulation of eye pigmentation,BP,
12060,GO:0048087,1,0.800951929412876,0,7,positive regulation of developmental pigmentation,BP,
12061,GO:0048096,1,0.779366037751652,0,8,chromatin-mediated maintenance of transcription,BP,
12062,GO:0048102,1,0.808225106258437,0,7,autophagic cell death,BP,
12063,GO:0048103,1,0.591976633487333,0,16,somatic stem cell division,BP,
12064,GO:0048104,1,0.874723735544599,0,4,establishment of body hair or bristle planar orientation,BP,
12065,GO:0048105,1,0.874723735544599,0,4,establishment of body hair planar orientation,BP,
12066,GO:0048133,1,0.914637738359626,0,3,male germ-line stem cell asymmetric division,BP,
12067,GO:0048143,1,0.773034722389009,0,8,astrocyte activation,BP,
12073,GO:0048149,1,0.879082879302996,0,4,behavioral response to ethanol,BP,
12074,GO:0048156,1,0.713850590758364,0,11,tau protein binding,MF,
12075,GO:0048160,1,0.967052969241231,0,1,primary follicle stage,BP,
12076,GO:0048162,1,0.97271975895488,0,1,multi-layer follicle stage,BP,
12077,GO:0048165,1,0.935022264759081,0,2,fused antrum stage,BP,
12081,GO:0048170,1,0.879843545235123,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
12082,GO:0048172,1,0.797376743173231,0,7,regulation of short-term neuronal synaptic plasticity,BP,
12083,GO:0048179,1,0.942333585015431,0,2,activin receptor complex,CC,
12084,GO:0048180,1,0.971270332458308,0,1,activin complex,CC,
12085,GO:0048185,1,0.710757103307018,0,11,activin binding,MF,
12086,GO:0048188,1,0.687670810116995,0,12,Set1C/COMPASS complex,CC,
12090,GO:0048200,1,0.831286693371329,0,6,Golgi transport vesicle coating,BP,
12091,GO:0048203,1,0.942169549052023,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12092,GO:0048205,1,0.831286693371329,0,6,COPI coating of Golgi vesicle,BP,
12095,GO:0048209,1,0.939133095732982,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12096,GO:0048210,1,0.914589365337029,0,3,Golgi vesicle fusion to target membrane,BP,
12097,GO:0048211,1,0.938134877864366,0,2,Golgi vesicle docking,BP,
12098,GO:0048213,1,0.969409147882788,0,1,Golgi vesicle prefusion complex stabilization,BP,
12099,GO:0048227,1,0.782441445346217,0,8,plasma membrane to endosome transport,BP,
12102,GO:0048239,1,0.941568289628652,0,2,negative regulation of DNA recombination at telomere,BP,
12103,GO:0048240,1,0.809262904947105,0,7,sperm capacitation,BP,
12104,GO:0048243,1,0.880133212771,0,4,norepinephrine secretion,BP,
12105,GO:0048244,1,0.972684324308775,0,1,phytanoyl-CoA dioxygenase activity,MF,
12106,GO:0048245,1,0.889032395747771,0,4,eosinophil chemotaxis,BP,
12109,GO:0048250,1,0.945870051276587,0,2,iron import into the mitochondrion,BP,
12111,GO:0048254,1,0.890906406306882,0,4,snoRNA localization,BP,
12113,GO:0048256,1,0.779222908872752,0,8,flap endonuclease activity,MF,
12114,GO:0048257,1,0.940743672413886,0,2,3'-flap endonuclease activity,MF,
12116,GO:0048260,1,0.354717662599253,0,33,positive regulation of receptor-mediated endocytosis,BP,
12118,GO:0048262,1,0.860737109450578,0,5,determination of dorsal/ventral asymmetry,BP,
12119,GO:0048263,1,0.888279750752962,0,4,determination of dorsal identity,BP,
12120,GO:0048264,1,0.969003188651358,0,1,determination of ventral identity,BP,
12121,GO:0048265,1,0.77766369182299,0,8,response to pain,BP,
12122,GO:0048266,1,0.852254995106514,0,5,behavioral response to pain,BP,
12124,GO:0048269,1,0.941833118595661,0,2,methionine adenosyltransferase complex,CC,
12125,GO:0048270,1,0.971521425296424,0,1,methionine adenosyltransferase regulator activity,MF,
12126,GO:0048273,1,0.829121230410818,0,6,mitogen-activated protein kinase p38 binding,MF,
12131,GO:0048286,1,0.459336654796684,0,24,lung alveolus development,BP,
12132,GO:0048289,1,0.881444710468483,0,4,isotype switching to IgE isotypes,BP,
12133,GO:0048290,1,0.833882622664114,0,6,isotype switching to IgA isotypes,BP,
12135,GO:0048293,1,0.881444710468483,0,4,regulation of isotype switching to IgE isotypes,BP,
12136,GO:0048294,1,0.937006085305097,0,2,negative regulation of isotype switching to IgE isotypes,BP,
12137,GO:0048295,1,0.940713537535338,0,2,positive regulation of isotype switching to IgE isotypes,BP,
12138,GO:0048296,1,0.861152775075112,0,5,regulation of isotype switching to IgA isotypes,BP,
12139,GO:0048297,1,0.971379229025732,0,1,negative regulation of isotype switching to IgA isotypes,BP,
12140,GO:0048298,1,0.886534335110522,0,4,positive regulation of isotype switching to IgA isotypes,BP,
12141,GO:0048302,1,0.802140588316922,0,7,regulation of isotype switching to IgG isotypes,BP,
12142,GO:0048304,1,0.855697258256419,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12145,GO:0048308,1,0.636086356536237,0,15,organelle inheritance,BP,
12146,GO:0048311,1,0.630479978205289,0,14,mitochondrion distribution,BP,
12147,GO:0048312,1,0.820720746634759,0,6,intracellular distribution of mitochondria,BP,
12148,GO:0048313,1,0.656275905244109,0,14,Golgi inheritance,BP,
12149,GO:0048318,1,0.860178335540104,0,5,axial mesoderm development,BP,
12150,GO:0048319,1,0.93615413593038,0,2,axial mesoderm morphogenesis,BP,
12151,GO:0048320,1,0.968250583109952,0,1,axial mesoderm formation,BP,
12153,GO:0048333,1,0.61879916016728,0,15,mesodermal cell differentiation,BP,
12154,GO:0048338,1,0.967910767110477,0,1,mesoderm structural organization,BP,
12155,GO:0048339,1,0.635076745194065,0,14,paraxial mesoderm development,BP,
12156,GO:0048340,1,0.794629941356515,0,7,paraxial mesoderm morphogenesis,BP,
12157,GO:0048341,1,0.878339327018733,0,4,paraxial mesoderm formation,BP,
12158,GO:0048352,1,0.967910767110477,0,1,paraxial mesoderm structural organization,BP,
12159,GO:0048364,1,0.974543632249742,0,1,root development,BP,
12162,GO:0048369,1,0.935848883135704,0,2,lateral mesoderm morphogenesis,BP,
12163,GO:0048370,1,0.935848883135704,0,2,lateral mesoderm formation,BP,
12164,GO:0048371,1,0.935848883135704,0,2,lateral mesodermal cell differentiation,BP,
12165,GO:0048372,1,0.935848883135704,0,2,lateral mesodermal cell fate commitment,BP,
12166,GO:0048377,1,0.935848883135704,0,2,lateral mesodermal cell fate specification,BP,
12167,GO:0048378,1,0.935848883135704,0,2,regulation of lateral mesodermal cell fate specification,BP,
12168,GO:0048382,1,0.937884728201524,0,2,mesendoderm development,BP,
12173,GO:0048388,1,0.941545502731491,0,2,endosomal lumen acidification,BP,
12174,GO:0048389,1,0.972376033972612,0,1,intermediate mesoderm development,BP,
12175,GO:0048390,1,0.972376033972612,0,1,intermediate mesoderm morphogenesis,BP,
12176,GO:0048391,1,0.972376033972612,0,1,intermediate mesoderm formation,BP,
12177,GO:0048392,1,0.972376033972612,0,1,intermediate mesodermal cell differentiation,BP,
12178,GO:0048403,1,0.967585551816704,0,1,brain-derived neurotrophic factor binding,MF,
12179,GO:0048406,1,0.876918179842914,0,4,nerve growth factor binding,MF,
12180,GO:0048407,1,0.794322112684309,0,7,platelet-derived growth factor binding,MF,
12181,GO:0048408,1,0.887721537259636,0,4,epidermal growth factor binding,MF,
12186,GO:0048476,1,0.866110203760003,0,5,Holliday junction resolvase complex,CC,
12187,GO:0048477,1,0.238228844413612,0,46,oogenesis,BP,
12188,GO:0048478,1,0.804665131219815,0,7,replication fork protection,BP,
12190,GO:0048484,1,0.852551384295087,0,5,enteric nervous system development,BP,
12198,GO:0048496,1,0.907642679411154,0,3,maintenance of animal organ identity,BP,
12199,GO:0048499,1,0.915533259583809,0,3,synaptic vesicle membrane organization,BP,
12201,GO:0048505,1,0.83184767510268,0,6,regulation of timing of cell differentiation,BP,
12206,GO:0048515,1,0.102935982256754,0,73,spermatid differentiation,BP,
12209,GO:0048520,1,0.879137681746464,0,4,positive regulation of behavior,BP,
12210,GO:0048521,1,0.886822493099355,0,4,negative regulation of behavior,BP,
12215,GO:0048531,1,0.697380213532278,0,12,beta-1,3-galactosyltransferase activity,MF,
12220,GO:0048537,1,0.856810750673188,0,5,mucosal-associated lymphoid tissue development,BP,
12222,GO:0048539,1,0.882024917878301,0,4,bone marrow development,BP,
12223,GO:0048541,1,0.856810750673188,0,5,Peyer's patch development,BP,
12228,GO:0048550,1,0.857874250128044,0,5,negative regulation of pinocytosis,BP,
12230,GO:0048560,1,0.943191990108163,0,2,establishment of anatomical structure orientation,BP,
12231,GO:0048561,1,0.971122862993619,0,1,establishment of animal organ orientation,BP,
12233,GO:0048563,1,0.813393842249014,0,7,post-embryonic animal organ morphogenesis,BP,
12237,GO:0048569,1,0.64888432783297,0,14,post-embryonic animal organ development,BP,
12238,GO:0048570,1,0.854891610062754,0,5,notochord morphogenesis,BP,
12247,GO:0048597,1,0.921377862390986,0,3,post-embryonic camera-type eye morphogenesis,BP,
12249,GO:0048599,1,0.419992257948031,0,28,oocyte development,BP,
12252,GO:0048611,1,0.969101554900902,0,1,embryonic ectodermal digestive tract development,BP,
12253,GO:0048617,1,0.845884629334026,0,5,embryonic foregut morphogenesis,BP,
12254,GO:0048619,1,0.969394384283682,0,1,embryonic hindgut morphogenesis,BP,
12256,GO:0048627,1,0.942692763444433,0,2,myoblast development,BP,
12257,GO:0048630,1,0.90653451350216,0,3,skeletal muscle tissue growth,BP,
12258,GO:0048631,1,0.90653451350216,0,3,regulation of skeletal muscle tissue growth,BP,
12259,GO:0048633,1,0.90653451350216,0,3,positive regulation of skeletal muscle tissue growth,BP,
12266,GO:0048641,1,0.396231735800136,0,29,regulation of skeletal muscle tissue development,BP,
12267,GO:0048642,1,0.805638400727517,0,7,negative regulation of skeletal muscle tissue development,BP,
12268,GO:0048643,1,0.637602559264117,0,14,positive regulation of skeletal muscle tissue development,BP,
12277,GO:0048664,1,0.920221097053336,0,3,neuron fate determination,BP,
12278,GO:0048665,1,0.802091676417228,0,7,neuron fate specification,BP,
12282,GO:0048669,1,0.910887369529897,0,3,collateral sprouting in absence of injury,BP,
12285,GO:0048672,1,0.764125229621804,0,9,positive regulation of collateral sprouting,BP,
12286,GO:0048674,1,0.970472033429008,0,1,collateral sprouting of injured axon,BP,
12288,GO:0048677,1,0.966872799575289,0,1,axon extension involved in regeneration,BP,
12290,GO:0048679,1,0.570308969318962,0,18,regulation of axon regeneration,BP,
12291,GO:0048680,1,0.889316526069089,0,4,positive regulation of axon regeneration,BP,
12292,GO:0048681,1,0.708172043037742,0,11,negative regulation of axon regeneration,BP,
12293,GO:0048682,1,0.938320418044457,0,2,sprouting of injured axon,BP,
12294,GO:0048686,1,0.970472033429008,0,1,regulation of sprouting of injured axon,BP,
12295,GO:0048687,1,0.970472033429008,0,1,positive regulation of sprouting of injured axon,BP,
12296,GO:0048688,1,0.970472033429008,0,1,negative regulation of sprouting of injured axon,BP,
12297,GO:0048689,1,0.970472033429008,0,1,formation of growth cone in injured axon,BP,
12298,GO:0048693,1,0.970472033429008,0,1,regulation of collateral sprouting of injured axon,BP,
12299,GO:0048694,1,0.970472033429008,0,1,positive regulation of collateral sprouting of injured axon,BP,
12300,GO:0048696,1,0.973096753104129,0,1,regulation of collateral sprouting in absence of injury,BP,
12301,GO:0048697,1,0.973096753104129,0,1,positive regulation of collateral sprouting in absence of injury,BP,
12303,GO:0048701,1,0.361798561018642,0,32,embryonic cranial skeleton morphogenesis,BP,
12304,GO:0048702,1,0.798781192888473,0,7,embryonic neurocranium morphogenesis,BP,
12305,GO:0048703,1,0.79761021359755,0,7,embryonic viscerocranium morphogenesis,BP,
12313,GO:0048712,1,0.855449030795058,0,5,negative regulation of astrocyte differentiation,BP,
12314,GO:0048713,1,0.48931762008314,0,23,regulation of oligodendrocyte differentiation,BP,
12315,GO:0048714,1,0.686781053857887,0,12,positive regulation of oligodendrocyte differentiation,BP,
12316,GO:0048715,1,0.784750605730182,0,8,negative regulation of oligodendrocyte differentiation,BP,
12318,GO:0048730,1,0.546527375454592,0,19,epidermis morphogenesis,BP,
12321,GO:0048733,1,0.878766722900859,0,4,sebaceous gland development,BP,
12324,GO:0048739,1,0.826331212415577,0,6,cardiac muscle fiber development,BP,
12325,GO:0048741,1,0.660766884006193,0,13,skeletal muscle fiber development,BP,
12326,GO:0048742,1,0.850006443589728,0,5,regulation of skeletal muscle fiber development,BP,
12327,GO:0048743,1,0.936290130579662,0,2,positive regulation of skeletal muscle fiber development,BP,
12329,GO:0048747,1,0.424920394681527,0,27,muscle fiber development,BP,
12330,GO:0048749,1,0.968391307688713,0,1,compound eye development,BP,
12331,GO:0048752,1,0.912878449731133,0,3,semicircular canal morphogenesis,BP,
12332,GO:0048753,1,0.495409579674105,0,23,pigment granule organization,BP,
12334,GO:0048755,1,0.852588325039081,0,5,branching morphogenesis of a nerve,BP,
12335,GO:0048757,1,0.738335375726024,0,10,pigment granule maturation,BP,
12337,GO:0048763,1,0.966928186928295,0,1,calcium-induced calcium release activity,MF,
12338,GO:0048764,1,0.974543632249742,0,1,trichoblast maturation,BP,
12339,GO:0048765,1,0.974543632249742,0,1,root hair cell differentiation,BP,
12340,GO:0048767,1,0.974543632249742,0,1,root hair elongation,BP,
12341,GO:0048769,1,0.934138265108002,0,2,sarcomerogenesis,BP,
12348,GO:0048793,1,0.875449473799281,0,4,pronephros development,BP,
12349,GO:0048799,1,0.699482772751461,0,11,animal organ maturation,BP,
12351,GO:0048807,1,0.967048650565242,0,1,female genitalia morphogenesis,BP,
12355,GO:0048817,1,0.935232258365479,0,2,negative regulation of hair follicle maturation,BP,
12356,GO:0048818,1,0.884801600413099,0,4,positive regulation of hair follicle maturation,BP,
12357,GO:0048819,1,0.775383428916956,0,8,regulation of hair follicle maturation,BP,
12358,GO:0048820,1,0.619842010426257,0,15,hair follicle maturation,BP,
12360,GO:0048822,1,0.908073622844141,0,3,enucleate erythrocyte development,BP,
12362,GO:0048840,1,0.906228712547756,0,3,otolith development,BP,
12369,GO:0048850,1,0.934826440644086,0,2,hypophysis morphogenesis,BP,
12370,GO:0048852,1,0.907980829731255,0,3,diencephalon morphogenesis,BP,
12371,GO:0048853,1,0.798755992422367,0,7,forebrain morphogenesis,BP,
12372,GO:0048854,1,0.472475613869282,0,23,brain morphogenesis,BP,
12373,GO:0048855,1,0.966858740727338,0,1,adenohypophysis morphogenesis,BP,
12377,GO:0048859,1,0.941806052163384,0,2,formation of anatomical boundary,BP,
12381,GO:0048865,1,0.911549572070787,0,3,stem cell fate commitment,BP,
12382,GO:0048866,1,0.96754747341463,0,1,stem cell fate specification,BP,
12383,GO:0048867,1,0.974151547296457,0,1,stem cell fate determination,BP,
12388,GO:0048873,1,0.557474817626485,0,19,homeostasis of number of cells within a tissue,BP,
12389,GO:0048874,1,0.968456823520522,0,1,homeostasis of number of cells in a free-living population,BP,
12390,GO:0048875,1,0.801130225735041,0,7,chemical homeostasis within a tissue,BP,
12392,GO:0048880,1,0.937601161912488,0,2,sensory system development,BP,
12393,GO:0048934,1,0.829067201476651,0,6,peripheral nervous system neuron differentiation,BP,
12394,GO:0048935,1,0.829067201476651,0,6,peripheral nervous system neuron development,BP,
12395,GO:0048936,1,0.912130641898817,0,3,peripheral nervous system neuron axonogenesis,BP,
12396,GO:0050000,1,0.130154235080505,0,66,chromosome localization,BP,
12397,GO:0050011,1,0.972868974604487,0,1,itaconyl-CoA hydratase activity,MF,
12398,GO:0050023,1,0.972160350012557,0,1,L-fuconate dehydratase activity,MF,
12399,GO:0050038,1,0.97445017076802,0,1,L-xylulose reductase (NADP+) activity,MF,
12400,GO:0050046,1,0.969271124374127,0,1,lathosterol oxidase activity,MF,
12401,GO:0050072,1,0.807629673659262,0,7,m7G(5')pppN diphosphatase activity,MF,
12402,GO:0050080,1,0.971205473956507,0,1,malonyl-CoA decarboxylase activity,MF,
12403,GO:0050104,1,0.973085015774884,0,1,L-gulonate 3-dehydrogenase activity,MF,
12404,GO:0050115,1,0.96696680893007,0,1,myosin-light-chain-phosphatase activity,MF,
12405,GO:0050119,1,0.935359295460452,0,2,N-acetylglucosamine deacetylase activity,MF,
12406,GO:0050124,1,0.967691712269395,0,1,N-acylneuraminate-9-phosphatase activity,MF,
12407,GO:0050135,1,0.973101440390168,0,1,NAD(P)+ nucleosidase activity,MF,
12408,GO:0050136,1,0.364015616656701,0,38,NADH dehydrogenase (quinone) activity,MF,
12409,GO:0050144,1,0.969271124374127,0,1,nucleoside deoxyribosyltransferase activity,MF,
12410,GO:0050145,1,0.859630223411394,0,5,nucleoside phosphate kinase activity,MF,
12411,GO:0050146,1,0.966895072565491,0,1,nucleoside phosphotransferase activity,MF,
12412,GO:0050152,1,0.97358958566201,0,1,omega-amidase activity,MF,
12413,GO:0050178,1,0.95031985845199,0,2,phenylpyruvate tautomerase activity,MF,
12414,GO:0050185,1,0.96674322165405,0,1,phosphatidylinositol deacylase activity,MF,
12415,GO:0050201,1,0.967546435727085,0,1,fucokinase activity,MF,
12416,GO:0050211,1,0.939265116573749,0,2,procollagen galactosyltransferase activity,MF,
12417,GO:0050220,1,0.895873051938379,0,4,prostaglandin-E synthase activity,MF,
12418,GO:0050221,1,0.973656990594964,0,1,prostaglandin-E2 9-reductase activity,MF,
12419,GO:0050252,1,0.939173309592663,0,2,retinol O-fatty-acyltransferase activity,MF,
12420,GO:0050253,1,0.937527162470522,0,2,retinyl-palmitate esterase activity,MF,
12421,GO:0050262,1,0.969271124374127,0,1,ribosylnicotinamide kinase activity,MF,
12422,GO:0050265,1,0.906252665456142,0,3,RNA uridylyltransferase activity,MF,
12423,GO:0050277,1,0.96763853165673,0,1,sedoheptulokinase activity,MF,
12424,GO:0050290,1,0.967007898275979,0,1,sphingomyelin phosphodiesterase D activity,MF,
12425,GO:0050291,1,0.855489699189481,0,5,sphingosine N-acyltransferase activity,MF,
12426,GO:0050294,1,0.921822899737767,0,3,steroid sulfotransferase activity,MF,
12427,GO:0050308,1,0.853575994016667,0,5,sugar-phosphatase activity,MF,
12428,GO:0050309,1,0.972754957723061,0,1,sugar-terminal-phosphatase activity,MF,
12429,GO:0050313,1,0.974207866339602,0,1,sulfur dioxygenase activity,MF,
12430,GO:0050321,1,0.685145787895822,0,12,tau-protein kinase activity,MF,
12432,GO:0050337,1,0.974874550728037,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
12433,GO:0050346,1,0.969271124374127,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12434,GO:0050347,1,0.941665682842566,0,2,trans-octaprenyltranstransferase activity,MF,
12435,GO:0050353,1,0.969352855076672,0,1,trimethyllysine dioxygenase activity,MF,
12436,GO:0050354,1,0.969271124374127,0,1,triokinase activity,MF,
12437,GO:0050355,1,0.967125256599071,0,1,triphosphatase activity,MF,
12438,GO:0050379,1,0.966932140930849,0,1,UDP-glucuronate 5'-epimerase activity,MF,
12439,GO:0050405,1,0.934801066136786,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
12440,GO:0050421,1,0.970021395609411,0,1,nitrite reductase (NO-forming) activity,MF,
12448,GO:0050436,1,0.935542301121085,0,2,microfibril binding,MF,
12449,GO:0050444,1,0.968435086332893,0,1,aquacobalamin reductase (NADPH) activity,MF,
12450,GO:0050462,1,0.973663261755306,0,1,N-acetylneuraminate synthase activity,MF,
12451,GO:0050473,1,0.938051437253594,0,2,arachidonate 15-lipoxygenase activity,MF,
12453,GO:0050497,1,0.941046476613088,0,2,transferase activity, transferring alkylthio groups,MF,
12455,GO:0050508,1,0.937103354875564,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12456,GO:0050509,1,0.937103354875564,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
12457,GO:0050510,1,0.877766569505011,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
12458,GO:0050512,1,0.97151119019705,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
12459,GO:0050542,1,0.895694780520995,0,4,icosanoid binding,MF,
12460,GO:0050543,1,0.895694780520995,0,4,icosatetraenoic acid binding,MF,
12461,GO:0050544,1,0.895694780520995,0,4,arachidonic acid binding,MF,
12462,GO:0050560,1,0.968317264265488,0,1,aspartate-tRNA(Asn) ligase activity,MF,
12463,GO:0050561,1,0.967552678040097,0,1,glutamate-tRNA(Gln) ligase activity,MF,
12464,GO:0050567,1,0.914335147779862,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
12465,GO:0050577,1,0.973397025980278,0,1,GDP-L-fucose synthase activity,MF,
12466,GO:0050610,1,0.948318883858509,0,2,methylarsonate reductase activity,MF,
12467,GO:0050613,1,0.941440162187888,0,2,delta14-sterol reductase activity,MF,
12468,GO:0050614,1,0.967235729974955,0,1,delta24-sterol reductase activity,MF,
12469,GO:0050632,1,0.973269589112886,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
12470,GO:0050650,1,0.527215874038165,0,20,chondroitin sulfate proteoglycan biosynthetic process,BP,
12471,GO:0050651,1,0.73119231039249,0,10,dermatan sulfate proteoglycan biosynthetic process,BP,
12472,GO:0050652,1,0.967777255811998,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12473,GO:0050653,1,0.967777255811998,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12474,GO:0050654,1,0.410165027255581,0,28,chondroitin sulfate proteoglycan metabolic process,BP,
12475,GO:0050655,1,0.710117999631807,0,11,dermatan sulfate proteoglycan metabolic process,BP,
12477,GO:0050657,1,0.00450133999970109,0,173,nucleic acid transport,BP,
12478,GO:0050658,1,0.00450133999970109,0,173,RNA transport,BP,
12479,GO:0050659,1,0.934996487262452,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
12484,GO:0050664,1,0.834120138299084,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12486,GO:0050666,1,0.970979761919229,0,1,regulation of homocysteine metabolic process,BP,
12487,GO:0050667,1,0.713307958044994,0,11,homocysteine metabolic process,BP,
12488,GO:0050668,1,0.970979761919229,0,1,positive regulation of homocysteine metabolic process,BP,
12497,GO:0050682,1,0.93877420804346,0,2,AF-2 domain binding,MF,
12499,GO:0050685,1,0.527547015223262,0,21,positive regulation of mRNA processing,BP,
12501,GO:0050687,1,0.524704815040922,0,21,negative regulation of defense response to virus,BP,
12503,GO:0050689,1,0.866704735362628,0,5,negative regulation of defense response to virus by host,BP,
12504,GO:0050690,1,0.526052724653785,0,21,regulation of defense response to virus by virus,BP,
12506,GO:0050692,1,0.939974289761365,0,2,DBD domain binding,MF,
12508,GO:0050694,1,0.97020037744344,0,1,galactose 3-O-sulfotransferase activity,MF,
12509,GO:0050698,1,0.97020037744344,0,1,proteoglycan sulfotransferase activity,MF,
12510,GO:0050699,1,0.492915759402224,0,23,WW domain binding,MF,
12523,GO:0050712,1,0.973244612249411,0,1,negative regulation of interleukin-1 alpha secretion,BP,
12530,GO:0050720,1,0.968741153584299,0,1,interleukin-1 beta biosynthetic process,BP,
12531,GO:0050722,1,0.968741153584299,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12532,GO:0050725,1,0.968741153584299,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
12538,GO:0050732,1,0.29030283407345,0,40,negative regulation of peptidyl-tyrosine phosphorylation,BP,
12539,GO:0050733,1,0.883238306693181,0,4,RS domain binding,MF,
12545,GO:0050757,1,0.96991836037069,0,1,thymidylate synthase biosynthetic process,BP,
12546,GO:0050758,1,0.96991836037069,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12547,GO:0050760,1,0.96991836037069,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
12558,GO:0050774,1,0.754433254417902,0,9,negative regulation of dendrite morphogenesis,BP,
12559,GO:0050775,1,0.442218467663239,0,25,positive regulation of dendrite morphogenesis,BP,
12563,GO:0050779,1,0.49631454567764,0,22,RNA destabilization,BP,
12564,GO:0050780,1,0.729131642721827,0,10,dopamine receptor binding,MF,
12565,GO:0050783,1,0.970469143237632,0,1,cocaine metabolic process,BP,
12566,GO:0050785,1,0.97344752401555,0,1,advanced glycation end-product receptor activity,MF,
12567,GO:0050786,1,0.851314546837068,0,6,RAGE receptor binding,MF,
12568,GO:0050787,1,0.942040222999442,0,2,detoxification of mercury ion,BP,
12578,GO:0050802,1,0.786411783406713,0,8,circadian sleep/wake cycle, sleep,BP,
12586,GO:0050811,1,0.760892702054179,0,9,GABA receptor binding,MF,
12587,GO:0050812,1,0.680602168399359,0,12,regulation of acyl-CoA biosynthetic process,BP,
12593,GO:0050820,1,0.630554878250171,0,15,positive regulation of coagulation,BP,
12595,GO:0050822,1,0.968083895950353,0,1,peptide stabilization,BP,
12596,GO:0050823,1,0.968083895950353,0,1,peptide antigen stabilization,BP,
12600,GO:0050833,1,0.909443347965455,0,3,pyruvate transmembrane transporter activity,MF,
12605,GO:0050849,1,0.697405756763857,0,12,negative regulation of calcium-mediated signaling,BP,
12614,GO:0050858,1,0.616169268307282,0,16,negative regulation of antigen receptor-mediated signaling pathway,BP,
12615,GO:0050859,1,0.913161917098104,0,3,negative regulation of B cell receptor signaling pathway,BP,
12616,GO:0050860,1,0.655250995737342,0,14,negative regulation of T cell receptor signaling pathway,BP,
12628,GO:0050872,1,0.754085581395578,0,9,white fat cell differentiation,BP,
12629,GO:0050873,1,0.512175327094424,0,22,brown fat cell differentiation,BP,
12632,GO:0050879,1,0.440107292171052,0,26,multicellular organismal movement,BP,
12634,GO:0050881,1,0.440107292171052,0,26,musculoskeletal movement,BP,
12635,GO:0050882,1,0.822048780623383,0,6,voluntary musculoskeletal movement,BP,
12642,GO:0050893,1,0.915346725954193,0,3,sensory processing,BP,
12644,GO:0050897,1,0.966867738967312,0,1,cobalt ion binding,MF,
12646,GO:0050901,1,0.750842572606453,0,9,leukocyte tethering or rolling,BP,
12647,GO:0050904,1,0.936988562870134,0,2,diapedesis,BP,
12649,GO:0050906,1,0.431480685555905,0,28,detection of stimulus involved in sensory perception,BP,
12650,GO:0050907,1,0.711326593395278,0,12,detection of chemical stimulus involved in sensory perception,BP,
12651,GO:0050908,1,0.879857627587467,0,4,detection of light stimulus involved in visual perception,BP,
12652,GO:0050909,1,0.661192816008941,0,14,sensory perception of taste,BP,
12653,GO:0050910,1,0.937856292062444,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
12654,GO:0050911,1,0.919371724333116,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
12655,GO:0050912,1,0.79988763558382,0,8,detection of chemical stimulus involved in sensory perception of taste,BP,
12656,GO:0050913,1,0.774373082126207,0,9,sensory perception of bitter taste,BP,
12657,GO:0050915,1,0.969271124374127,0,1,sensory perception of sour taste,BP,
12658,GO:0050916,1,0.911163658424068,0,3,sensory perception of sweet taste,BP,
12659,GO:0050917,1,0.937921503462229,0,2,sensory perception of umami taste,BP,
12667,GO:0050925,1,0.934798565021638,0,2,negative regulation of negative chemotaxis,BP,
12670,GO:0050928,1,0.966900671749979,0,1,negative regulation of positive chemotaxis,BP,
12673,GO:0050931,1,0.485541688559698,0,23,pigment cell differentiation,BP,
12674,GO:0050932,1,0.802975524845792,0,7,regulation of pigment cell differentiation,BP,
12675,GO:0050942,1,0.849799918448405,0,5,positive regulation of pigment cell differentiation,BP,
12676,GO:0050951,1,0.779048741132199,0,8,sensory perception of temperature stimulus,BP,
12678,GO:0050954,1,0.106402248301263,0,72,sensory perception of mechanical stimulus,BP,
12679,GO:0050955,1,0.967349666574824,0,1,thermoception,BP,
12680,GO:0050957,1,0.967498873303469,0,1,equilibrioception,BP,
12681,GO:0050960,1,0.967349666574824,0,1,detection of temperature stimulus involved in thermoception,BP,
12682,GO:0050961,1,0.805816862795559,0,7,detection of temperature stimulus involved in sensory perception,BP,
12683,GO:0050962,1,0.879857627587467,0,4,detection of light stimulus involved in sensory perception,BP,
12684,GO:0050965,1,0.805816862795559,0,7,detection of temperature stimulus involved in sensory perception of pain,BP,
12685,GO:0050966,1,0.939308095001525,0,2,detection of mechanical stimulus involved in sensory perception of pain,BP,
12686,GO:0050968,1,0.967349666574824,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
12687,GO:0050974,1,0.855373664463732,0,5,detection of mechanical stimulus involved in sensory perception,BP,
12688,GO:0050982,1,0.677666097183429,0,12,detection of mechanical stimulus,BP,
12689,GO:0050992,1,0.945546325492082,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12690,GO:0050993,1,0.945546325492082,0,2,dimethylallyl diphosphate metabolic process,BP,
12694,GO:0050997,1,0.69395302912043,0,12,quaternary ammonium group binding,MF,
12695,GO:0050998,1,0.726834569220672,0,10,nitric-oxide synthase binding,MF,
12697,GO:0051000,1,0.685440475884172,0,12,positive regulation of nitric-oxide synthase activity,BP,
12698,GO:0051001,1,0.888779927969151,0,4,negative regulation of nitric-oxide synthase activity,BP,
12699,GO:0051004,1,0.736965300272316,0,10,regulation of lipoprotein lipase activity,BP,
12700,GO:0051005,1,0.916528738528223,0,3,negative regulation of lipoprotein lipase activity,BP,
12701,GO:0051006,1,0.886546180547824,0,4,positive regulation of lipoprotein lipase activity,BP,
12702,GO:0051010,1,0.649737104085513,0,13,microtubule plus-end binding,MF,
12703,GO:0051011,1,0.721161631379807,0,10,microtubule minus-end binding,MF,
12704,GO:0051012,1,0.940372286900652,0,2,microtubule sliding,BP,
12705,GO:0051013,1,0.829459878215168,0,6,microtubule severing,BP,
12708,GO:0051016,1,0.689447482020061,0,12,barbed-end actin filament capping,BP,
12710,GO:0051018,1,0.306365959514768,0,37,protein kinase A binding,MF,
12713,GO:0051021,1,0.886024700870762,0,4,GDP-dissociation inhibitor binding,MF,
12714,GO:0051022,1,0.886024700870762,0,4,Rho GDP-dissociation inhibitor binding,MF,
12717,GO:0051025,1,0.968863067200497,0,1,negative regulation of immunoglobulin secretion,BP,
12718,GO:0051026,1,0.885208982711207,0,4,chiasma assembly,BP,
12719,GO:0051028,1,0.014443840115012,0,135,mRNA transport,BP,
12720,GO:0051029,1,0.840890661464481,0,6,rRNA transport,BP,
12721,GO:0051030,1,0.894966154104731,0,4,snRNA transport,BP,
12722,GO:0051031,1,0.353616871869204,0,33,tRNA transport,BP,
12723,GO:0051032,1,0.967530999560944,0,1,nucleic acid transmembrane transporter activity,MF,
12724,GO:0051033,1,0.967530999560944,0,1,RNA transmembrane transporter activity,MF,
12725,GO:0051036,1,0.862141409488311,0,5,regulation of endosome size,BP,
12726,GO:0051040,1,0.968710947667684,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12727,GO:0051042,1,0.968710947667684,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
12730,GO:0051045,1,0.802080410807823,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
12745,GO:0051066,1,0.94538719775902,0,2,dihydrobiopterin metabolic process,BP,
12746,GO:0051068,1,0.967961307241613,0,1,dihydrolipoamide metabolic process,BP,
12747,GO:0051081,1,0.238249219041805,0,46,nuclear envelope disassembly,BP,
12749,GO:0051083,1,0.944440684121464,0,2,'de novo' cotranslational protein folding,BP,
12752,GO:0051086,1,0.971870171411436,0,1,chaperone mediated protein folding independent of cofactor,BP,
12754,GO:0051088,1,0.906103069219478,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
12755,GO:0051089,1,0.967533043751221,0,1,constitutive protein ectodomain proteolysis,BP,
12762,GO:0051096,1,0.828129994540268,0,6,positive regulation of helicase activity,BP,
12768,GO:0051102,1,0.967420561432537,0,1,DNA ligation involved in DNA recombination,BP,
12770,GO:0051105,1,0.83147840087534,0,6,regulation of DNA ligation,BP,
12771,GO:0051106,1,0.857862680061953,0,5,positive regulation of DNA ligation,BP,
12772,GO:0051107,1,0.969256884090773,0,1,negative regulation of DNA ligation,BP,
12774,GO:0051119,1,0.644008504204224,0,14,sugar transmembrane transporter activity,MF,
12775,GO:0051120,1,0.939998332307587,0,2,hepoxilin A3 synthase activity,MF,
12776,GO:0051121,1,0.884639720926334,0,4,hepoxilin metabolic process,BP,
12777,GO:0051122,1,0.884639720926334,0,4,hepoxilin biosynthetic process,BP,
12779,GO:0051124,1,0.817813005749787,0,6,synaptic growth at neuromuscular junction,BP,
12780,GO:0051125,1,0.497586985809802,0,22,regulation of actin nucleation,BP,
12781,GO:0051126,1,0.832906550240575,0,6,negative regulation of actin nucleation,BP,
12782,GO:0051127,1,0.674887684605147,0,12,positive regulation of actin nucleation,BP,
12790,GO:0051136,1,0.849232342989483,0,5,regulation of NK T cell differentiation,BP,
12791,GO:0051138,1,0.8782614202389,0,4,positive regulation of NK T cell differentiation,BP,
12792,GO:0051139,1,0.966885193789385,0,1,metal ion:proton antiporter activity,MF,
12795,GO:0051145,1,0.345535402715002,0,34,smooth muscle cell differentiation,BP,
12800,GO:0051150,1,0.57293789321407,0,18,regulation of smooth muscle cell differentiation,BP,
12801,GO:0051151,1,0.799628982438076,0,7,negative regulation of smooth muscle cell differentiation,BP,
12802,GO:0051152,1,0.787738056783434,0,8,positive regulation of smooth muscle cell differentiation,BP,
12807,GO:0051160,1,0.970225831804016,0,1,L-xylitol catabolic process,BP,
12808,GO:0051164,1,0.970225831804016,0,1,L-xylitol metabolic process,BP,
12809,GO:0051167,1,0.866448545848729,0,5,xylulose 5-phosphate metabolic process,BP,
12817,GO:0051176,1,0.910273002470195,0,3,positive regulation of sulfur metabolic process,BP,
12818,GO:0051177,1,0.885927781376948,0,4,meiotic sister chromatid cohesion,BP,
12820,GO:0051180,1,0.556397430195134,0,19,vitamin transport,BP,
12821,GO:0051181,1,0.403449737092825,0,30,cofactor transport,BP,
12822,GO:0051182,1,0.804714800026594,0,7,coenzyme transport,BP,
12823,GO:0051184,1,0.601647767107369,0,16,cofactor transmembrane transporter activity,MF,
12824,GO:0051185,1,0.830974701907052,0,6,coenzyme transmembrane transporter activity,MF,
12829,GO:0051192,1,0.950146313132071,0,2,prosthetic group binding,MF,
12830,GO:0051193,1,0.0910705836958395,0,76,regulation of cofactor metabolic process,BP,
12831,GO:0051194,1,0.657251992824346,0,13,positive regulation of cofactor metabolic process,BP,
12832,GO:0051195,1,0.752801810635748,0,9,negative regulation of cofactor metabolic process,BP,
12833,GO:0051196,1,0.116298289950355,0,68,regulation of coenzyme metabolic process,BP,
12834,GO:0051197,1,0.720193070210879,0,10,positive regulation of coenzyme metabolic process,BP,
12835,GO:0051198,1,0.828634334587246,0,6,negative regulation of coenzyme metabolic process,BP,
12848,GO:0051228,1,0.96691127005905,0,1,mitotic spindle disassembly,BP,
12849,GO:0051230,1,0.96691127005905,0,1,spindle disassembly,BP,
12850,GO:0051231,1,0.707285050672828,0,11,spindle elongation,BP,
12851,GO:0051232,1,0.970669758631045,0,1,meiotic spindle elongation,BP,
12852,GO:0051233,1,0.389730547649222,0,30,spindle midzone,CC,
12855,GO:0051236,1,0.00407147063785136,0,176,establishment of RNA localization,BP,
12869,GO:0051255,1,0.730894505686926,0,10,spindle midzone assembly,BP,
12870,GO:0051256,1,0.777927432148549,0,8,mitotic spindle midzone assembly,BP,
12871,GO:0051257,1,0.970397080614669,0,1,meiotic spindle midzone assembly,BP,
12875,GO:0051261,1,0.0916365239197671,0,75,protein depolymerization,BP,
12877,GO:0051264,1,0.969473766764352,0,1,mono-olein transacylation activity,MF,
12878,GO:0051265,1,0.969473766764352,0,1,diolein transacylation activity,MF,
12879,GO:0051267,1,0.968523206216462,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
12885,GO:0051280,1,0.745880988454894,0,10,negative regulation of release of sequestered calcium ion into cytosol,BP,
12886,GO:0051281,1,0.473601546397796,0,24,positive regulation of release of sequestered calcium ion into cytosol,BP,
12889,GO:0051284,1,0.745880988454894,0,10,positive regulation of sequestering of calcium ion,BP,
12890,GO:0051286,1,0.847246485418081,0,5,cell tip,CC,
12893,GO:0051290,1,0.314829061762654,0,42,protein heterotetramerization,BP,
12895,GO:0051292,1,0.72702602935479,0,10,nuclear pore complex assembly,BP,
12897,GO:0051294,1,0.482335841118146,0,23,establishment of spindle orientation,BP,
12900,GO:0051299,1,0.643449612356674,0,14,centrosome separation,BP,
12901,GO:0051300,1,0.969271124374127,0,1,spindle pole body organization,BP,
12904,GO:0051303,1,0.134634278629045,0,65,establishment of chromosome localization,BP,
12906,GO:0051305,1,0.850107888570469,0,5,chromosome movement towards spindle pole,BP,
12908,GO:0051307,1,0.684471065358734,0,12,meiotic chromosome separation,BP,
12909,GO:0051308,1,0.969271124374127,0,1,male meiosis chromosome separation,BP,
12910,GO:0051310,1,0.197678498277353,0,53,metaphase plate congression,BP,
12911,GO:0051311,1,0.970397080614669,0,1,meiotic metaphase plate congression,BP,
12912,GO:0051315,1,0.671394115833181,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12913,GO:0051316,1,0.941184593234634,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
12917,GO:0051339,1,0.558674487968429,0,19,regulation of lyase activity,BP,
12918,GO:0051340,1,0.792767252991858,0,8,regulation of ligase activity,BP,
12921,GO:0051343,1,0.914359952735077,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12927,GO:0051349,1,0.780458244793307,0,8,positive regulation of lyase activity,BP,
12928,GO:0051350,1,0.762169734925335,0,9,negative regulation of lyase activity,BP,
12929,GO:0051351,1,0.81792651094087,0,7,positive regulation of ligase activity,BP,
12930,GO:0051352,1,0.969256884090773,0,1,negative regulation of ligase activity,BP,
12934,GO:0051371,1,0.84440014473628,0,5,muscle alpha-actinin binding,MF,
12935,GO:0051377,1,0.907024226129769,0,3,mannose-ethanolamine phosphotransferase activity,MF,
12937,GO:0051379,1,0.943378165824141,0,2,epinephrine binding,MF,
12938,GO:0051380,1,0.97166272183182,0,1,norepinephrine binding,MF,
12939,GO:0051382,1,0.64960450090439,0,14,kinetochore assembly,BP,
12940,GO:0051383,1,0.555878559247471,0,19,kinetochore organization,BP,
12943,GO:0051386,1,0.8012812695147,0,7,regulation of neurotrophin TRK receptor signaling pathway,BP,
12944,GO:0051387,1,0.942862627777271,0,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
12945,GO:0051388,1,0.878847417480618,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
12946,GO:0051389,1,0.934805159717197,0,2,inactivation of MAPKK activity,BP,
12947,GO:0051391,1,0.967515302198389,0,1,tRNA acetylation,BP,
12948,GO:0051392,1,0.967515302198389,0,1,tRNA N-acetyltransferase activity,MF,
12949,GO:0051393,1,0.697523258917877,0,11,alpha-actinin binding,MF,
12950,GO:0051400,1,0.780817856668991,0,8,BH domain binding,MF,
12953,GO:0051409,1,0.762809174090197,0,9,response to nitrosative stress,BP,
12954,GO:0051410,1,0.861588796581818,0,5,detoxification of nitrogen compound,BP,
12956,GO:0051413,1,0.970276931855548,0,1,response to cortisone,BP,
12958,GO:0051415,1,0.823533531756921,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
12959,GO:0051417,1,0.969271124374127,0,1,microtubule nucleation by spindle pole body,BP,
12960,GO:0051418,1,0.769783051581137,0,8,microtubule nucleation by microtubule organizing center,BP,
12961,GO:0051425,1,0.87644253704225,0,4,PTB domain binding,MF,
12963,GO:0051428,1,0.765185181667368,0,9,peptide hormone receptor binding,MF,
12964,GO:0051429,1,0.914731415887467,0,3,corticotropin-releasing hormone receptor binding,MF,
12965,GO:0051430,1,0.939993777389746,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
12966,GO:0051431,1,0.973129472742572,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
12967,GO:0051433,1,0.967088377487509,0,1,BH2 domain binding,MF,
12968,GO:0051434,1,0.885396582613107,0,4,BH3 domain binding,MF,
12971,GO:0051444,1,0.683031253993079,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
12973,GO:0051446,1,0.754088792728603,0,9,positive regulation of meiotic cell cycle,BP,
12975,GO:0051450,1,0.76431049085353,0,9,myoblast proliferation,BP,
12977,GO:0051452,1,0.334798135292595,0,37,intracellular pH reduction,BP,
12979,GO:0051454,1,0.912235829154499,0,3,intracellular pH elevation,BP,
12980,GO:0051455,1,0.969271124374127,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
12981,GO:0051456,1,0.971025482406741,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
12983,GO:0051458,1,0.936575169925418,0,2,corticotropin secretion,BP,
12984,GO:0051459,1,0.936575169925418,0,2,regulation of corticotropin secretion,BP,
12985,GO:0051461,1,0.936575169925418,0,2,positive regulation of corticotropin secretion,BP,
12986,GO:0051462,1,0.942245824512554,0,2,regulation of cortisol secretion,BP,
12987,GO:0051463,1,0.966860836896287,0,1,negative regulation of cortisol secretion,BP,
12988,GO:0051464,1,0.974543632249742,0,1,positive regulation of cortisol secretion,BP,
12989,GO:0051466,1,0.968570346802033,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
12994,GO:0051490,1,0.913933722408504,0,3,negative regulation of filopodium assembly,BP,
13001,GO:0051497,1,0.66038518300703,0,13,negative regulation of stress fiber assembly,BP,
13002,GO:0051499,1,0.943479169385101,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13003,GO:0051500,1,0.943479169385101,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13004,GO:0051503,1,0.694030804381,0,12,adenine nucleotide transport,BP,
13005,GO:0051525,1,0.935072137010791,0,2,NFAT protein binding,MF,
13007,GO:0051537,1,0.574081528714202,0,19,2 iron, 2 sulfur cluster binding,MF,
13011,GO:0051541,1,0.884845306832972,0,4,elastin metabolic process,BP,
13012,GO:0051542,1,0.938494064635979,0,2,elastin biosynthetic process,BP,
13013,GO:0051543,1,0.970719502151624,0,1,regulation of elastin biosynthetic process,BP,
13014,GO:0051545,1,0.970719502151624,0,1,negative regulation of elastin biosynthetic process,BP,
13017,GO:0051548,1,0.934806612062042,0,2,negative regulation of keratinocyte migration,BP,
13019,GO:0051552,1,0.970722431445758,0,1,flavone metabolic process,BP,
13020,GO:0051560,1,0.572551130241999,0,18,mitochondrial calcium ion homeostasis,BP,
13021,GO:0051561,1,0.763896689537754,0,9,positive regulation of mitochondrial calcium ion concentration,BP,
13022,GO:0051562,1,0.939328439892474,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
13023,GO:0051563,1,0.936046578550127,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13024,GO:0051567,1,0.431175027134975,0,26,histone H3-K9 methylation,BP,
13027,GO:0051570,1,0.57842335303614,0,17,regulation of histone H3-K9 methylation,BP,
13029,GO:0051572,1,0.908608138901165,0,3,negative regulation of histone H3-K4 methylation,BP,
13030,GO:0051573,1,0.749411900883096,0,9,negative regulation of histone H3-K9 methylation,BP,
13031,GO:0051574,1,0.796913702046098,0,7,positive regulation of histone H3-K9 methylation,BP,
13032,GO:0051575,1,0.854989194829885,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13033,GO:0051580,1,0.761779256086414,0,9,regulation of neurotransmitter uptake,BP,
13034,GO:0051581,1,0.909763370287379,0,3,negative regulation of neurotransmitter uptake,BP,
13035,GO:0051582,1,0.944750568433127,0,2,positive regulation of neurotransmitter uptake,BP,
13036,GO:0051583,1,0.840838905259298,0,6,dopamine uptake involved in synaptic transmission,BP,
13037,GO:0051584,1,0.89243580532188,0,4,regulation of dopamine uptake involved in synaptic transmission,BP,
13038,GO:0051585,1,0.968670178669023,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13039,GO:0051586,1,0.972975736164372,0,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13042,GO:0051590,1,0.589480561656194,0,17,positive regulation of neurotransmitter transport,BP,
13045,GO:0051593,1,0.787178935799945,0,8,response to folic acid,BP,
13046,GO:0051595,1,0.916821705646306,0,3,response to methylglyoxal,BP,
13047,GO:0051596,1,0.942814454617799,0,2,methylglyoxal catabolic process,BP,
13049,GO:0051598,1,0.967063770019168,0,1,meiotic recombination checkpoint,BP,
13052,GO:0051602,1,0.566263420485209,0,18,response to electrical stimulus,BP,
13058,GO:0051610,1,0.905719692711381,0,3,serotonin uptake,BP,
13059,GO:0051611,1,0.9365452447849,0,2,regulation of serotonin uptake,BP,
13060,GO:0051612,1,0.9365452447849,0,2,negative regulation of serotonin uptake,BP,
13061,GO:0051615,1,0.966878485493823,0,1,histamine uptake,BP,
13062,GO:0051620,1,0.968670178669023,0,1,norepinephrine uptake,BP,
13063,GO:0051621,1,0.968670178669023,0,1,regulation of norepinephrine uptake,BP,
13064,GO:0051622,1,0.968670178669023,0,1,negative regulation of norepinephrine uptake,BP,
13069,GO:0051643,1,0.847515551538786,0,5,endoplasmic reticulum localization,BP,
13070,GO:0051645,1,0.687963432959136,0,12,Golgi localization,BP,
13072,GO:0051647,1,0.557272294221613,0,18,nucleus localization,BP,
13080,GO:0051657,1,0.76890667908061,0,8,maintenance of organelle location,BP,
13082,GO:0051661,1,0.848615780885451,0,5,maintenance of centrosome location,BP,
13083,GO:0051664,1,0.937581056835452,0,2,nuclear pore localization,BP,
13084,GO:0051665,1,0.810426874306935,0,7,membrane raft localization,BP,
13085,GO:0051666,1,0.904308353512,0,3,actin cortical patch localization,BP,
13089,GO:0051683,1,0.810466048898594,0,7,establishment of Golgi localization,BP,
13090,GO:0051684,1,0.906117303194175,0,3,maintenance of Golgi location,BP,
13091,GO:0051685,1,0.969271124374127,0,1,maintenance of ER location,BP,
13092,GO:0051686,1,0.966718921038226,0,1,establishment of ER localization,BP,
13093,GO:0051693,1,0.513710302932991,0,21,actin filament capping,BP,
13094,GO:0051694,1,0.939156944230204,0,2,pointed-end actin filament capping,BP,
13095,GO:0051697,1,0.889775847220134,0,4,protein delipidation,BP,
13098,GO:0051703,1,0.370192256631149,0,31,intraspecies interaction between organisms,BP,
13100,GO:0051705,1,0.295802202848219,0,38,multi-organism behavior,BP,
13102,GO:0051708,1,0.947568880251219,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
13104,GO:0051710,1,0.973797167582431,0,1,regulation of cytolysis in other organism,BP,
13106,GO:0051714,1,0.973797167582431,0,1,positive regulation of cytolysis in other organism,BP,
13107,GO:0051715,1,0.949526228302244,0,2,cytolysis in other organism,BP,
13109,GO:0051717,1,0.937272464997184,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
13111,GO:0051722,1,0.970420099366256,0,1,protein C-terminal methylesterase activity,MF,
13112,GO:0051723,1,0.970420099366256,0,1,protein methylesterase activity,MF,
13113,GO:0051724,1,0.970993033401337,0,1,NAD transmembrane transporter activity,MF,
13114,GO:0051725,1,0.942641696148983,0,2,protein de-ADP-ribosylation,BP,
13116,GO:0051728,1,0.969045314015446,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13117,GO:0051729,1,0.969045314015446,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13118,GO:0051731,1,0.884072285147229,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
13119,GO:0051732,1,0.972471937656193,0,1,polyribonucleotide kinase activity,MF,
13120,GO:0051733,1,0.914391754148409,0,3,polydeoxyribonucleotide kinase activity,MF,
13121,GO:0051734,1,0.914391754148409,0,3,ATP-dependent polynucleotide kinase activity,MF,
13122,GO:0051736,1,0.972471937656193,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
13123,GO:0051747,1,0.947853166089808,0,2,cytosine C-5 DNA demethylase activity,MF,
13124,GO:0051748,1,0.971349826100343,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
13125,GO:0051750,1,0.973608638681413,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
13126,GO:0051754,1,0.909340362595225,0,3,meiotic sister chromatid cohesion, centromeric,BP,
13128,GO:0051765,1,0.941717846568963,0,2,inositol tetrakisphosphate kinase activity,MF,
13129,GO:0051766,1,0.852748583381378,0,5,inositol trisphosphate kinase activity,MF,
13132,GO:0051770,1,0.820193568089944,0,6,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13135,GO:0051780,1,0.96734639953885,0,1,behavioral response to nutrient,BP,
13137,GO:0051782,1,0.649650395421205,0,14,negative regulation of cell division,BP,
13141,GO:0051786,1,0.968393964896178,0,1,all-trans-retinol 13,14-reductase activity,MF,
13144,GO:0051790,1,0.886350333873525,0,4,short-chain fatty acid biosynthetic process,BP,
13145,GO:0051791,1,0.810871852659908,0,7,medium-chain fatty acid metabolic process,BP,
13146,GO:0051792,1,0.889811377372901,0,4,medium-chain fatty acid biosynthetic process,BP,
13147,GO:0051793,1,0.911113497296196,0,3,medium-chain fatty acid catabolic process,BP,
13148,GO:0051794,1,0.88513574074338,0,4,regulation of timing of catagen,BP,
13149,GO:0051795,1,0.915124422608268,0,3,positive regulation of timing of catagen,BP,
13150,GO:0051796,1,0.967237767497311,0,1,negative regulation of timing of catagen,BP,
13151,GO:0051797,1,0.591295120753093,0,17,regulation of hair follicle development,BP,
13152,GO:0051798,1,0.74359082607257,0,10,positive regulation of hair follicle development,BP,
13153,GO:0051799,1,0.905070001012351,0,3,negative regulation of hair follicle development,BP,
13154,GO:0051800,1,0.966881371772236,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
13155,GO:0051805,1,0.937639811421786,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
13157,GO:0051807,1,0.937639811421786,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
13158,GO:0051808,1,0.970551726865232,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
13162,GO:0051823,1,0.885783212517696,0,4,regulation of synapse structural plasticity,BP,
13164,GO:0051832,1,0.880438619766599,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
13165,GO:0051833,1,0.966906671281593,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13166,GO:0051834,1,0.880438619766599,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
13167,GO:0051835,1,0.913816939619241,0,3,positive regulation of synapse structural plasticity,BP,
13168,GO:0051836,1,0.76584996725016,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13172,GO:0051864,1,0.767979377595938,0,8,histone demethylase activity (H3-K36 specific),MF,
13173,GO:0051865,1,0.188409433389944,0,53,protein autoubiquitination,BP,
13174,GO:0051870,1,0.967553722205728,0,1,methotrexate binding,MF,
13176,GO:0051875,1,0.494249935155314,0,23,pigment granule localization,BP,
13177,GO:0051877,1,0.939642102205622,0,2,pigment granule aggregation in cell center,BP,
13179,GO:0051880,1,0.792911578544482,0,7,G-quadruplex DNA binding,MF,
13183,GO:0051884,1,0.876043841799918,0,4,regulation of timing of anagen,BP,
13184,GO:0051885,1,0.966872720920993,0,1,positive regulation of timing of anagen,BP,
13185,GO:0051886,1,0.966913364007773,0,1,negative regulation of timing of anagen,BP,
13186,GO:0051890,1,0.935248651922646,0,2,regulation of cardioblast differentiation,BP,
13187,GO:0051891,1,0.966908443549658,0,1,positive regulation of cardioblast differentiation,BP,
13188,GO:0051892,1,0.967259642753024,0,1,negative regulation of cardioblast differentiation,BP,
13198,GO:0051902,1,0.858877096712487,0,5,negative regulation of mitochondrial depolarization,BP,
13199,GO:0051903,1,0.969903373835275,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
13200,GO:0051904,1,0.543477742324598,0,20,pigment granule transport,BP,
13201,GO:0051905,1,0.525421698540566,0,21,establishment of pigment granule localization,BP,
13202,GO:0051908,1,0.968606749360762,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
13203,GO:0051917,1,0.829899413648985,0,6,regulation of fibrinolysis,BP,
13204,GO:0051918,1,0.881051082657957,0,4,negative regulation of fibrinolysis,BP,
13205,GO:0051919,1,0.971601671815208,0,1,positive regulation of fibrinolysis,BP,
13206,GO:0051920,1,0.805334433017885,0,8,peroxiredoxin activity,MF,
13207,GO:0051923,1,0.761877534690261,0,9,sulfation,BP,
13209,GO:0051926,1,0.409404018087371,0,29,negative regulation of calcium ion transport,BP,
13214,GO:0051933,1,0.966859128570501,0,1,amino acid neurotransmitter reuptake,BP,
13215,GO:0051934,1,0.840838905259298,0,6,catecholamine uptake involved in synaptic transmission,BP,
13216,GO:0051935,1,0.966859128570501,0,1,glutamate reuptake,BP,
13218,GO:0051938,1,0.826638189380779,0,6,L-glutamate import,BP,
13219,GO:0051940,1,0.89243580532188,0,4,regulation of catecholamine uptake involved in synaptic transmission,BP,
13220,GO:0051941,1,0.966859128570501,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13221,GO:0051944,1,0.972975736164372,0,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
13222,GO:0051945,1,0.968670178669023,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
13223,GO:0051946,1,0.966859128570501,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
13225,GO:0051953,1,0.853662714210846,0,5,negative regulation of amine transport,BP,
13226,GO:0051954,1,0.691404299222096,0,12,positive regulation of amine transport,BP,
13228,GO:0051956,1,0.909667224110714,0,3,negative regulation of amino acid transport,BP,
13229,GO:0051957,1,0.827547565639731,0,6,positive regulation of amino acid transport,BP,
13230,GO:0051958,1,0.937266646822699,0,2,methotrexate transport,BP,
13231,GO:0051959,1,0.480977455571383,0,23,dynein light intermediate chain binding,MF,
13236,GO:0051964,1,0.875390170881648,0,4,negative regulation of synapse assembly,BP,
13240,GO:0051968,1,0.65343444177262,0,13,positive regulation of synaptic transmission, glutamatergic,BP,
13241,GO:0051969,1,0.882788721281839,0,4,regulation of transmission of nerve impulse,BP,
13242,GO:0051971,1,0.938378806958451,0,2,positive regulation of transmission of nerve impulse,BP,
13246,GO:0051977,1,0.97121579620829,0,1,lysophospholipid transport,BP,
13247,GO:0051978,1,0.97121579620829,0,1,lysophospholipid transporter activity,MF,
13249,GO:0051984,1,0.441341695208993,0,26,positive regulation of chromosome segregation,BP,
13251,GO:0051987,1,0.857861514833983,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13252,GO:0051988,1,0.687508353581089,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13253,GO:0051990,1,0.941717091418069,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
13254,GO:0051996,1,0.971455551403725,0,1,squalene synthase activity,MF,
13255,GO:0051998,1,0.80496877232487,0,7,protein carboxyl O-methyltransferase activity,MF,
13257,GO:0052029,1,0.966906671281593,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13258,GO:0052031,1,0.913800726549914,0,3,modulation by symbiont of host defense response,BP,
13259,GO:0052037,1,0.966906671281593,0,1,negative regulation by symbiont of host defense response,BP,
13260,GO:0052040,1,0.834454041093164,0,6,modulation by symbiont of host programmed cell death,BP,
13261,GO:0052041,1,0.886473239917902,0,4,negative regulation by symbiont of host programmed cell death,BP,
13262,GO:0052042,1,0.916819395200171,0,3,positive regulation by symbiont of host programmed cell death,BP,
13263,GO:0052047,1,0.966807821141104,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
13264,GO:0052053,1,0.969595749257649,0,1,negative regulation by symbiont of host catalytic activity,BP,
13265,GO:0052055,1,0.937505932679055,0,2,modulation by symbiont of host molecular function,BP,
13266,GO:0052056,1,0.937505932679055,0,2,negative regulation by symbiont of host molecular function,BP,
13268,GO:0052097,1,0.968456823520522,0,1,interspecies quorum sensing,BP,
13269,GO:0052106,1,0.968456823520522,0,1,quorum sensing involved in interaction with host,BP,
13271,GO:0052148,1,0.969595749257649,0,1,modulation by symbiont of host catalytic activity,BP,
13272,GO:0052150,1,0.857173353208446,0,5,modulation by symbiont of host apoptotic process,BP,
13273,GO:0052151,1,0.941774695915955,0,2,positive regulation by symbiont of host apoptotic process,BP,
13274,GO:0052167,1,0.966906671281593,0,1,modulation by symbiont of host innate immune response,BP,
13275,GO:0052170,1,0.966906671281593,0,1,negative regulation by symbiont of host innate immune response,BP,
13276,GO:0052173,1,0.833324733403499,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
13280,GO:0052199,1,0.969595749257649,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
13281,GO:0052200,1,0.833324733403499,0,6,response to host defenses,BP,
13285,GO:0052214,1,0.972753704663536,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13286,GO:0052227,1,0.972753704663536,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13287,GO:0052229,1,0.972753704663536,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13289,GO:0052248,1,0.834454041093164,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
13291,GO:0052251,1,0.945081375440417,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13292,GO:0052255,1,0.913800726549914,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13293,GO:0052261,1,0.966906671281593,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13294,GO:0052306,1,0.966906671281593,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13295,GO:0052309,1,0.966906671281593,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13297,GO:0052314,1,0.972037490433508,0,1,phytoalexin metabolic process,BP,
13298,GO:0052330,1,0.916819395200171,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13299,GO:0052360,1,0.972753704663536,0,1,catabolism by host of symbiont macromolecule,BP,
13300,GO:0052361,1,0.972753704663536,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13301,GO:0052362,1,0.972753704663536,0,1,catabolism by host of symbiont protein,BP,
13302,GO:0052363,1,0.972753704663536,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13303,GO:0052364,1,0.972753704663536,0,1,catabolism by host of substance in symbiont,BP,
13305,GO:0052381,1,0.971385106655306,0,1,tRNA dimethylallyltransferase activity,MF,
13307,GO:0052416,1,0.972753704663536,0,1,metabolism by host of symbiont macromolecule,BP,
13308,GO:0052417,1,0.972753704663536,0,1,metabolism by host of symbiont protein,BP,
13309,GO:0052418,1,0.972753704663536,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13310,GO:0052419,1,0.972753704663536,0,1,metabolism by host of substance in symbiont,BP,
13313,GO:0052433,1,0.834454041093164,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13315,GO:0052490,1,0.886473239917902,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13316,GO:0052493,1,0.966906671281593,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13317,GO:0052501,1,0.916819395200171,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
13318,GO:0052509,1,0.945081375440417,0,2,positive regulation by symbiont of host defense response,BP,
13319,GO:0052510,1,0.945081375440417,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13323,GO:0052550,1,0.972646094615903,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13324,GO:0052552,1,0.913800726549914,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13325,GO:0052553,1,0.913800726549914,0,3,modulation by symbiont of host immune response,BP,
13326,GO:0052561,1,0.966906671281593,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13327,GO:0052562,1,0.966906671281593,0,1,negative regulation by symbiont of host immune response,BP,
13328,GO:0052564,1,0.86188983985413,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
13329,GO:0052567,1,0.972646094615903,0,1,response to defense-related host reactive oxygen species production,BP,
13330,GO:0052572,1,0.86188983985413,0,5,response to host immune response,BP,
13331,GO:0052590,1,0.966870364153008,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13332,GO:0052591,1,0.966870364153008,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
13333,GO:0052593,1,0.938393411415409,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13334,GO:0052594,1,0.938393411415409,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13335,GO:0052595,1,0.938393411415409,0,2,aliphatic-amine oxidase activity,MF,
13336,GO:0052596,1,0.938393411415409,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13337,GO:0052629,1,0.695924094012197,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
13338,GO:0052642,1,0.97229493151541,0,1,lysophosphatidic acid phosphatase activity,MF,
13339,GO:0052646,1,0.77354294280231,0,8,alditol phosphate metabolic process,BP,
13340,GO:0052650,1,0.816761519546744,0,7,NADP-retinol dehydrogenase activity,MF,
13341,GO:0052651,1,0.942496353952198,0,2,monoacylglycerol catabolic process,BP,
13346,GO:0052657,1,0.973278640440209,0,1,guanine phosphoribosyltransferase activity,MF,
13347,GO:0052658,1,0.824083345461092,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13348,GO:0052659,1,0.746264699560529,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13349,GO:0052666,1,0.971887307962299,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
13351,GO:0052692,1,0.97327185349884,0,1,raffinose alpha-galactosidase activity,MF,
13352,GO:0052695,1,0.808951902843732,0,7,cellular glucuronidation,BP,
13353,GO:0052696,1,0.862639811344019,0,5,flavonoid glucuronidation,BP,
13354,GO:0052697,1,0.862639811344019,0,5,xenobiotic glucuronidation,BP,
13355,GO:0052717,1,0.966861873686312,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13356,GO:0052718,1,0.966861873686312,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
13357,GO:0052723,1,0.880229652223824,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13358,GO:0052724,1,0.880229652223824,0,4,inositol hexakisphosphate 3-kinase activity,MF,
13359,GO:0052725,1,0.968502735511175,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13360,GO:0052726,1,0.968502735511175,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13362,GO:0052739,1,0.971572528226367,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13363,GO:0052740,1,0.971572528226367,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
13365,GO:0052743,1,0.699417059072626,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13366,GO:0052744,1,0.630786451845277,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
13367,GO:0052745,1,0.542861846205887,0,19,inositol phosphate phosphatase activity,MF,
13368,GO:0052746,1,0.936695449847872,0,2,inositol phosphorylation,BP,
13369,GO:0052794,1,0.942064554436539,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13370,GO:0052795,1,0.942064554436539,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13371,GO:0052796,1,0.942064554436539,0,2,exo-alpha-(2->8)-sialidase activity,MF,
13372,GO:0052798,1,0.971484850653794,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
13373,GO:0052803,1,0.882372348503139,0,4,imidazole-containing compound metabolic process,BP,
13374,GO:0052805,1,0.93892743971815,0,2,imidazole-containing compound catabolic process,BP,
13375,GO:0052810,1,0.96776219038709,0,1,1-phosphatidylinositol-5-kinase activity,MF,
13376,GO:0052811,1,0.875468594049775,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
13377,GO:0052812,1,0.935754572857286,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
13379,GO:0052815,1,0.97383158234957,0,1,medium-chain acyl-CoA hydrolase activity,MF,
13380,GO:0052821,1,0.973974669279822,0,1,DNA-7-methyladenine glycosylase activity,MF,
13381,GO:0052822,1,0.973974669279822,0,1,DNA-3-methylguanine glycosylase activity,MF,
13382,GO:0052825,1,0.968502735511175,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13383,GO:0052826,1,0.96937967616693,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
13384,GO:0052827,1,0.938844309535261,0,2,inositol pentakisphosphate phosphatase activity,MF,
13385,GO:0052828,1,0.935315528921695,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
13386,GO:0052829,1,0.971503876606367,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
13387,GO:0052830,1,0.968502735511175,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13388,GO:0052831,1,0.968502735511175,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13389,GO:0052832,1,0.882426189662117,0,4,inositol monophosphate 3-phosphatase activity,MF,
13390,GO:0052833,1,0.882426189662117,0,4,inositol monophosphate 4-phosphatase activity,MF,
13391,GO:0052834,1,0.882426189662117,0,4,inositol monophosphate phosphatase activity,MF,
13392,GO:0052835,1,0.968502735511175,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
13393,GO:0052836,1,0.941564755079574,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13394,GO:0052839,1,0.941564755079574,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
13395,GO:0052840,1,0.887880067864205,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13396,GO:0052841,1,0.887880067864205,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13397,GO:0052842,1,0.887880067864205,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13398,GO:0052843,1,0.887880067864205,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13399,GO:0052844,1,0.887880067864205,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13400,GO:0052845,1,0.887880067864205,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13401,GO:0052846,1,0.887880067864205,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13402,GO:0052847,1,0.887880067864205,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13403,GO:0052848,1,0.887880067864205,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13405,GO:0052858,1,0.967977064918708,0,1,peptidyl-lysine acetyltransferase activity,MF,
13406,GO:0052866,1,0.42658869606135,0,26,phosphatidylinositol phosphate phosphatase activity,MF,
13407,GO:0052890,1,0.971995214098838,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
13408,GO:0052894,1,0.971556480791956,0,1,norspermine:oxygen oxidoreductase activity,MF,
13409,GO:0052895,1,0.971556480791956,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
13410,GO:0052899,1,0.972602434471036,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13411,GO:0052901,1,0.944936117319735,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
13412,GO:0052902,1,0.972602434471036,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13413,GO:0052903,1,0.972602434471036,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13414,GO:0052904,1,0.972602434471036,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13415,GO:0052905,1,0.91060985903053,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
13416,GO:0052906,1,0.966899361855569,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
13417,GO:0052907,1,0.969271124374127,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13418,GO:0052909,1,0.969271124374127,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13419,GO:0052917,1,0.970666835897531,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
13420,GO:0052918,1,0.966860772133016,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13421,GO:0052925,1,0.97304371892474,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
13422,GO:0052926,1,0.966860772133016,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13423,GO:0052927,1,0.970960595886097,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13424,GO:0052928,1,0.970960595886097,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13425,GO:0052929,1,0.970960595886097,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
13428,GO:0055003,1,0.763376649685046,0,8,cardiac myofibril assembly,BP,
13429,GO:0055005,1,0.966885193789385,0,1,ventricular cardiac myofibril assembly,BP,
13433,GO:0055009,1,0.914455705648941,0,3,atrial cardiac muscle tissue morphogenesis,BP,
13435,GO:0055011,1,0.972597274555966,0,1,atrial cardiac muscle cell differentiation,BP,
13436,GO:0055012,1,0.757842179729083,0,9,ventricular cardiac muscle cell differentiation,BP,
13438,GO:0055014,1,0.972597274555966,0,1,atrial cardiac muscle cell development,BP,
13439,GO:0055015,1,0.80941953003799,0,7,ventricular cardiac muscle cell development,BP,
13441,GO:0055018,1,0.972376033972612,0,1,regulation of cardiac muscle fiber development,BP,
13442,GO:0055020,1,0.972376033972612,0,1,positive regulation of cardiac muscle fiber development,BP,
13449,GO:0055028,1,0.966837517356414,0,1,cortical microtubule,CC,
13453,GO:0055048,1,0.966837517356414,0,1,anastral spindle assembly,BP,
13454,GO:0055056,1,0.853502746750722,0,5,D-glucose transmembrane transporter activity,MF,
13455,GO:0055057,1,0.719256044267885,0,10,neuroblast division,BP,
13456,GO:0055059,1,0.876978002076318,0,4,asymmetric neuroblast division,BP,
13458,GO:0055064,1,0.745961174241041,0,9,chloride ion homeostasis,BP,
13462,GO:0055070,1,0.620998856556889,0,16,copper ion homeostasis,BP,
13465,GO:0055075,1,0.634094191727536,0,14,potassium ion homeostasis,BP,
13467,GO:0055077,1,0.939213087849763,0,2,gap junction hemi-channel activity,MF,
13475,GO:0055087,1,0.91074593801269,0,3,Ski complex,CC,
13479,GO:0055091,1,0.876199337484901,0,4,phospholipid homeostasis,BP,
13483,GO:0055095,1,0.967646471250237,0,1,lipoprotein particle mediated signaling,BP,
13484,GO:0055096,1,0.967646471250237,0,1,low-density lipoprotein particle mediated signaling,BP,
13485,GO:0055100,1,0.909403500721563,0,3,adiponectin binding,MF,
13487,GO:0055103,1,0.968523206216462,0,1,ligase regulator activity,MF,
13488,GO:0055105,1,0.851431548306969,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13490,GO:0055108,1,0.971832956093877,0,1,Golgi to transport vesicle transport,BP,
13491,GO:0055113,1,0.966746249061119,0,1,epiboly involved in gastrulation with mouth forming second,BP,
13494,GO:0055118,1,0.911080863080178,0,3,negative regulation of cardiac muscle contraction,BP,
13496,GO:0055120,1,0.974052365523967,0,1,striated muscle dense body,CC,
13498,GO:0055129,1,0.889522294098567,0,4,L-proline biosynthetic process,BP,
13499,GO:0055131,1,0.863418510358631,0,5,C3HC4-type RING finger domain binding,MF,
13500,GO:0060001,1,0.966800623643846,0,1,minus-end directed microfilament motor activity,MF,
13501,GO:0060002,1,0.935472205710388,0,2,plus-end directed microfilament motor activity,MF,
13502,GO:0060003,1,0.934761869510533,0,2,copper ion export,BP,
13503,GO:0060004,1,0.722370588255236,0,10,reflex,BP,
13504,GO:0060005,1,0.967317297387139,0,1,vestibular reflex,BP,
13505,GO:0060007,1,0.967317297387139,0,1,linear vestibuloocular reflex,BP,
13506,GO:0060008,1,0.663815359293793,0,13,Sertoli cell differentiation,BP,
13507,GO:0060009,1,0.753561348128194,0,9,Sertoli cell development,BP,
13508,GO:0060010,1,0.968387769422698,0,1,Sertoli cell fate commitment,BP,
13509,GO:0060011,1,0.912074618974836,0,3,Sertoli cell proliferation,BP,
13510,GO:0060012,1,0.968570346802033,0,1,synaptic transmission, glycinergic,BP,
13511,GO:0060013,1,0.848781217633296,0,5,righting reflex,BP,
13512,GO:0060014,1,0.969223868920637,0,1,granulosa cell differentiation,BP,
13513,GO:0060017,1,0.853521563251767,0,5,parathyroid gland development,BP,
13514,GO:0060018,1,0.96754747341463,0,1,astrocyte fate commitment,BP,
13515,GO:0060019,1,0.766234206003247,0,9,radial glial cell differentiation,BP,
13516,GO:0060020,1,0.828693967477417,0,6,Bergmann glial cell differentiation,BP,
13521,GO:0060025,1,0.937367703848844,0,2,regulation of synaptic activity,BP,
13522,GO:0060026,1,0.700014663807877,0,11,convergent extension,BP,
13523,GO:0060027,1,0.79630421871019,0,7,convergent extension involved in gastrulation,BP,
13524,GO:0060028,1,0.849920476721496,0,5,convergent extension involved in axis elongation,BP,
13525,GO:0060029,1,0.877911908240586,0,4,convergent extension involved in organogenesis,BP,
13526,GO:0060031,1,0.966872720920993,0,1,mediolateral intercalation,BP,
13527,GO:0060032,1,0.966848403352548,0,1,notochord regression,BP,
13528,GO:0060033,1,0.824528118584891,0,6,anatomical structure regression,BP,
13529,GO:0060037,1,0.583423725851693,0,17,pharyngeal system development,BP,
13530,GO:0060038,1,0.369109530740766,0,31,cardiac muscle cell proliferation,BP,
13531,GO:0060039,1,0.630358731205839,0,14,pericardium development,BP,
13532,GO:0060040,1,0.939977127283198,0,2,retinal bipolar neuron differentiation,BP,
13535,GO:0060043,1,0.495539396242153,0,22,regulation of cardiac muscle cell proliferation,BP,
13536,GO:0060044,1,0.728606086691781,0,10,negative regulation of cardiac muscle cell proliferation,BP,
13537,GO:0060045,1,0.681917693651041,0,12,positive regulation of cardiac muscle cell proliferation,BP,
13541,GO:0060049,1,0.708993369303248,0,11,regulation of protein glycosylation,BP,
13542,GO:0060050,1,0.777856441671924,0,8,positive regulation of protein glycosylation,BP,
13543,GO:0060051,1,0.942804545396305,0,2,negative regulation of protein glycosylation,BP,
13545,GO:0060053,1,0.938451349683727,0,2,neurofilament cytoskeleton,CC,
13551,GO:0060059,1,0.873547459285404,0,4,embryonic retina morphogenesis in camera-type eye,BP,
13553,GO:0060061,1,0.940840087371164,0,2,Spemann organizer formation,BP,
13554,GO:0060064,1,0.973096753104129,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
13555,GO:0060065,1,0.65785769886955,0,13,uterus development,BP,
13556,GO:0060066,1,0.94163804996116,0,2,oviduct development,BP,
13557,GO:0060067,1,0.966872720920993,0,1,cervix development,BP,
13561,GO:0060072,1,0.966861342195489,0,1,large conductance calcium-activated potassium channel activity,MF,
13562,GO:0060073,1,0.878285847098862,0,4,micturition,BP,
13563,GO:0060074,1,0.750698189789898,0,9,synapse maturation,BP,
13564,GO:0060075,1,0.910845775782659,0,3,regulation of resting membrane potential,BP,
13570,GO:0060081,1,0.808160026526985,0,7,membrane hyperpolarization,BP,
13571,GO:0060083,1,0.935290136926937,0,2,smooth muscle contraction involved in micturition,BP,
13572,GO:0060084,1,0.966875889570171,0,1,synaptic transmission involved in micturition,BP,
13573,GO:0060086,1,0.939272722143286,0,2,circadian temperature homeostasis,BP,
13574,GO:0060087,1,0.892046133657259,0,4,relaxation of vascular smooth muscle,BP,
13575,GO:0060088,1,0.855987459401668,0,5,auditory receptor cell stereocilium organization,BP,
13578,GO:0060091,1,0.860178578234815,0,5,kinocilium,CC,
13579,GO:0060092,1,0.968570346802033,0,1,regulation of synaptic transmission, glycinergic,BP,
13580,GO:0060099,1,0.851761614742074,0,5,regulation of phagocytosis, engulfment,BP,
13581,GO:0060100,1,0.851761614742074,0,5,positive regulation of phagocytosis, engulfment,BP,
13582,GO:0060113,1,0.365552365482085,0,32,inner ear receptor cell differentiation,BP,
13583,GO:0060117,1,0.70274410565805,0,11,auditory receptor cell development,BP,
13584,GO:0060119,1,0.471136858399022,0,24,inner ear receptor cell development,BP,
13585,GO:0060120,1,0.859724862887456,0,5,inner ear receptor cell fate commitment,BP,
13586,GO:0060122,1,0.630141888152416,0,15,inner ear receptor cell stereocilium organization,BP,
13589,GO:0060125,1,0.966860836896287,0,1,negative regulation of growth hormone secretion,BP,
13590,GO:0060126,1,0.939586411385981,0,2,somatotropin secreting cell differentiation,BP,
13591,GO:0060127,1,0.971081547402047,0,1,prolactin secreting cell differentiation,BP,
13592,GO:0060128,1,0.968710947667684,0,1,corticotropin hormone secreting cell differentiation,BP,
13593,GO:0060129,1,0.93729249383517,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
13594,GO:0060134,1,0.905979899994538,0,3,prepulse inhibition,BP,
13598,GO:0060139,1,0.941774695915955,0,2,positive regulation of apoptotic process by virus,BP,
13603,GO:0060149,1,0.649828155094872,0,14,negative regulation of posttranscriptional gene silencing,BP,
13604,GO:0060151,1,0.93534885617511,0,2,peroxisome localization,BP,
13605,GO:0060152,1,0.93534885617511,0,2,microtubule-based peroxisome localization,BP,
13606,GO:0060154,1,0.913913935815524,0,3,cellular process regulating host cell cycle in response to virus,BP,
13607,GO:0060155,1,0.814346602790344,0,7,platelet dense granule organization,BP,
13608,GO:0060156,1,0.968755358580569,0,1,milk ejection reflex,BP,
13609,GO:0060157,1,0.935010075387587,0,2,urinary bladder development,BP,
13610,GO:0060158,1,0.891946356378183,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
13611,GO:0060159,1,0.88594563399001,0,4,regulation of dopamine receptor signaling pathway,BP,
13612,GO:0060161,1,0.910328806503733,0,3,positive regulation of dopamine receptor signaling pathway,BP,
13613,GO:0060164,1,0.973198875078459,0,1,regulation of timing of neuron differentiation,BP,
13614,GO:0060166,1,0.942211005197038,0,2,olfactory pit development,BP,
13615,GO:0060167,1,0.972997302627361,0,1,regulation of adenosine receptor signaling pathway,BP,
13616,GO:0060169,1,0.972997302627361,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13618,GO:0060171,1,0.967003558569999,0,1,stereocilium membrane,CC,
13621,GO:0060178,1,0.97101368166219,0,1,regulation of exocyst localization,BP,
13622,GO:0060179,1,0.912476455357872,0,3,male mating behavior,BP,
13623,GO:0060180,1,0.909503547937682,0,3,female mating behavior,BP,
13624,GO:0060183,1,0.968570346802033,0,1,apelin receptor signaling pathway,BP,
13625,GO:0060184,1,0.969045314015446,0,1,cell cycle switching,BP,
13626,GO:0060187,1,0.935014445273142,0,2,cell pole,CC,
13629,GO:0060193,1,0.384883902576162,0,31,positive regulation of lipase activity,BP,
13630,GO:0060197,1,0.940332512374301,0,2,cloacal septation,BP,
13631,GO:0060198,1,0.833990854849641,0,6,clathrin-sculpted vesicle,CC,
13632,GO:0060199,1,0.939248453141518,0,2,clathrin-sculpted glutamate transport vesicle,CC,
13633,GO:0060200,1,0.966986601575985,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13634,GO:0060201,1,0.966986601575985,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
13635,GO:0060203,1,0.939248453141518,0,2,clathrin-sculpted glutamate transport vesicle membrane,CC,
13637,GO:0060211,1,0.711884545836514,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13638,GO:0060212,1,0.972273132615553,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13639,GO:0060213,1,0.711884545836514,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
13640,GO:0060214,1,0.972958899086395,0,1,endocardium formation,BP,
13641,GO:0060215,1,0.852507859533459,0,5,primitive hemopoiesis,BP,
13642,GO:0060216,1,0.635685570247623,0,14,definitive hemopoiesis,BP,
13645,GO:0060221,1,0.96754747341463,0,1,retinal rod cell differentiation,BP,
13646,GO:0060228,1,0.949517158362187,0,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
13647,GO:0060229,1,0.782595148352653,0,8,lipase activator activity,MF,
13648,GO:0060231,1,0.666557898294318,0,13,mesenchymal to epithelial transition,BP,
13650,GO:0060235,1,0.908781628027142,0,3,lens induction in camera-type eye,BP,
13651,GO:0060236,1,0.333716146565961,0,35,regulation of mitotic spindle organization,BP,
13652,GO:0060242,1,0.804627723470876,0,7,contact inhibition,BP,
13653,GO:0060244,1,0.912597651196598,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
13654,GO:0060245,1,0.967754720267588,0,1,detection of cell density,BP,
13655,GO:0060246,1,0.967754720267588,0,1,detection of cell density by contact stimulus,BP,
13656,GO:0060248,1,0.967754720267588,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
13662,GO:0060259,1,0.798417237836884,0,7,regulation of feeding behavior,BP,
13665,GO:0060263,1,0.811908488539341,0,7,regulation of respiratory burst,BP,
13666,GO:0060264,1,0.946219012929571,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13667,GO:0060265,1,0.974419835594879,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
13668,GO:0060266,1,0.946219012929571,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
13669,GO:0060267,1,0.915501959770775,0,3,positive regulation of respiratory burst,BP,
13670,GO:0060268,1,0.914843214055902,0,3,negative regulation of respiratory burst,BP,
13673,GO:0060278,1,0.971270332458308,0,1,regulation of ovulation,BP,
13674,GO:0060279,1,0.971270332458308,0,1,positive regulation of ovulation,BP,
13675,GO:0060281,1,0.831320875984462,0,6,regulation of oocyte development,BP,
13676,GO:0060282,1,0.912514921291168,0,3,positive regulation of oocyte development,BP,
13677,GO:0060283,1,0.968174685271712,0,1,negative regulation of oocyte development,BP,
13679,GO:0060285,1,0.60622020429229,0,16,cilium-dependent cell motility,BP,
13680,GO:0060287,1,0.882648730649743,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
13681,GO:0060290,1,0.966870848147765,0,1,transdifferentiation,BP,
13682,GO:0060291,1,0.291965133599742,0,39,long-term synaptic potentiation,BP,
13683,GO:0060292,1,0.622250927942276,0,15,long term synaptic depression,BP,
13684,GO:0060293,1,0.805230192214371,0,7,germ plasm,CC,
13685,GO:0060294,1,0.73748611414524,0,10,cilium movement involved in cell motility,BP,
13686,GO:0060295,1,0.857212606787762,0,5,regulation of cilium movement involved in cell motility,BP,
13687,GO:0060296,1,0.857212606787762,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
13692,GO:0060302,1,0.945620806813157,0,2,negative regulation of cytokine activity,BP,
13693,GO:0060304,1,0.847395741261869,0,5,regulation of phosphatidylinositol dephosphorylation,BP,
13696,GO:0060309,1,0.974552365021715,0,1,elastin catabolic process,BP,
13697,GO:0060310,1,0.974552365021715,0,1,regulation of elastin catabolic process,BP,
13698,GO:0060311,1,0.974552365021715,0,1,negative regulation of elastin catabolic process,BP,
13699,GO:0060312,1,0.831493361744229,0,6,regulation of blood vessel remodeling,BP,
13700,GO:0060313,1,0.911046936453329,0,3,negative regulation of blood vessel remodeling,BP,
13701,GO:0060314,1,0.593181762302401,0,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,
13702,GO:0060315,1,0.793964398809364,0,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
13703,GO:0060316,1,0.811670155692106,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13705,GO:0060318,1,0.877691070964969,0,4,definitive erythrocyte differentiation,BP,
13706,GO:0060319,1,0.937584791733831,0,2,primitive erythrocyte differentiation,BP,
13708,GO:0060323,1,0.376628760377838,0,31,head morphogenesis,BP,
13709,GO:0060324,1,0.261773477309802,0,42,face development,BP,
13710,GO:0060325,1,0.437129564727776,0,26,face morphogenesis,BP,
13712,GO:0060327,1,0.969271124374127,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13715,GO:0060332,1,0.905334767861435,0,3,positive regulation of response to interferon-gamma,BP,
13718,GO:0060335,1,0.905334767861435,0,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,
13722,GO:0060339,1,0.802775979583297,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13723,GO:0060340,1,0.752604410776329,0,9,positive regulation of type I interferon-mediated signaling pathway,BP,
13725,GO:0060342,1,0.972107516066313,0,1,photoreceptor inner segment membrane,CC,
13737,GO:0060363,1,0.807908657402166,0,7,cranial suture morphogenesis,BP,
13738,GO:0060364,1,0.883270672141859,0,4,frontal suture morphogenesis,BP,
13739,GO:0060366,1,0.96681211801048,0,1,lambdoid suture morphogenesis,BP,
13740,GO:0060367,1,0.96681211801048,0,1,sagittal suture morphogenesis,BP,
13744,GO:0060371,1,0.907399157466279,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
13745,GO:0060372,1,0.966804312815079,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
13746,GO:0060373,1,0.879663632191451,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
13747,GO:0060374,1,0.907299743218521,0,3,mast cell differentiation,BP,
13748,GO:0060375,1,0.968523206216462,0,1,regulation of mast cell differentiation,BP,
13749,GO:0060377,1,0.968523206216462,0,1,negative regulation of mast cell differentiation,BP,
13750,GO:0060378,1,0.966822986412113,0,1,regulation of brood size,BP,
13752,GO:0060380,1,0.971587105550984,0,1,regulation of single-stranded telomeric DNA binding,BP,
13753,GO:0060381,1,0.971587105550984,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
13754,GO:0060382,1,0.935320094237243,0,2,regulation of DNA strand elongation,BP,
13755,GO:0060383,1,0.96738534365555,0,1,positive regulation of DNA strand elongation,BP,
13758,GO:0060386,1,0.966875564977941,0,1,synapse assembly involved in innervation,BP,
13759,GO:0060389,1,0.325882021415485,0,36,pathway-restricted SMAD protein phosphorylation,BP,
13762,GO:0060392,1,0.945988442088078,0,2,negative regulation of SMAD protein signal transduction,BP,
13763,GO:0060393,1,0.36052092717932,0,33,regulation of pathway-restricted SMAD protein phosphorylation,BP,
13764,GO:0060394,1,0.810419110575985,0,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
13768,GO:0060398,1,0.904047304400105,0,3,regulation of growth hormone receptor signaling pathway,BP,
13769,GO:0060399,1,0.934858688050213,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
13770,GO:0060400,1,0.967047633251379,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
13773,GO:0060405,1,0.911711130132946,0,3,regulation of penile erection,BP,
13774,GO:0060406,1,0.937017586229693,0,2,positive regulation of penile erection,BP,
13775,GO:0060407,1,0.972997302627361,0,1,negative regulation of penile erection,BP,
13779,GO:0060414,1,0.966828105581068,0,1,aorta smooth muscle tissue morphogenesis,BP,
13785,GO:0060423,1,0.94018406606226,0,2,foregut regionalization,BP,
13786,GO:0060424,1,0.94018406606226,0,2,lung field specification,BP,
13788,GO:0060426,1,0.912896965427538,0,3,lung vasculature development,BP,
13789,GO:0060428,1,0.499294967445412,0,22,lung epithelium development,BP,
13791,GO:0060430,1,0.935274335460292,0,2,lung saccule development,BP,
13792,GO:0060431,1,0.910135092570769,0,3,primary lung bud formation,BP,
13793,GO:0060433,1,0.77795770968256,0,8,bronchus development,BP,
13794,GO:0060434,1,0.938157824418695,0,2,bronchus morphogenesis,BP,
13795,GO:0060435,1,0.973473664600876,0,1,bronchiole development,BP,
13796,GO:0060437,1,0.941433163245348,0,2,lung growth,BP,
13797,GO:0060438,1,0.626430949730988,0,15,trachea development,BP,
13798,GO:0060439,1,0.756528826649828,0,9,trachea morphogenesis,BP,
13799,GO:0060440,1,0.830854843104118,0,6,trachea formation,BP,
13800,GO:0060441,1,0.549865087870715,0,19,epithelial tube branching involved in lung morphogenesis,BP,
13801,GO:0060442,1,0.747334312338729,0,9,branching involved in prostate gland morphogenesis,BP,
13805,GO:0060447,1,0.96682702947907,0,1,bud outgrowth involved in lung branching,BP,
13806,GO:0060448,1,0.909623385845561,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
13807,GO:0060449,1,0.830119802512576,0,6,bud elongation involved in lung branching,BP,
13808,GO:0060452,1,0.858996871658899,0,5,positive regulation of cardiac muscle contraction,BP,
13809,GO:0060453,1,0.8554289409215,0,5,regulation of gastric acid secretion,BP,
13810,GO:0060454,1,0.967349666574824,0,1,positive regulation of gastric acid secretion,BP,
13811,GO:0060455,1,0.942507597145177,0,2,negative regulation of gastric acid secretion,BP,
13812,GO:0060456,1,0.910188951931798,0,3,positive regulation of digestive system process,BP,
13813,GO:0060457,1,0.802895297733394,0,7,negative regulation of digestive system process,BP,
13814,GO:0060459,1,0.971081547402047,0,1,left lung development,BP,
13815,GO:0060460,1,0.971081547402047,0,1,left lung morphogenesis,BP,
13816,GO:0060462,1,0.846332013451133,0,5,lung lobe development,BP,
13817,GO:0060463,1,0.846332013451133,0,5,lung lobe morphogenesis,BP,
13818,GO:0060465,1,0.968174685271712,0,1,pharynx development,BP,
13819,GO:0060467,1,0.973337072735663,0,1,negative regulation of fertilization,BP,
13820,GO:0060474,1,0.94420719103213,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
13821,GO:0060478,1,0.946021832097299,0,2,acrosomal vesicle exocytosis,BP,
13822,GO:0060479,1,0.663462082415289,0,13,lung cell differentiation,BP,
13823,GO:0060480,1,0.973473664600876,0,1,lung goblet cell differentiation,BP,
13824,GO:0060481,1,0.94189394649034,0,2,lobar bronchus epithelium development,BP,
13825,GO:0060482,1,0.911334979818922,0,3,lobar bronchus development,BP,
13826,GO:0060484,1,0.852787445509617,0,5,lung-associated mesenchyme development,BP,
13828,GO:0060486,1,0.938500819218458,0,2,Clara cell differentiation,BP,
13829,GO:0060487,1,0.685271102179153,0,12,lung epithelial cell differentiation,BP,
13830,GO:0060488,1,0.93472830851768,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13831,GO:0060489,1,0.93472830851768,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13832,GO:0060490,1,0.93472830851768,0,2,lateral sprouting involved in lung morphogenesis,BP,
13834,GO:0060492,1,0.94018406606226,0,2,lung induction,BP,
13835,GO:0060501,1,0.881459601379787,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
13836,GO:0060502,1,0.777715746287649,0,8,epithelial cell proliferation involved in lung morphogenesis,BP,
13837,GO:0060503,1,0.972376033972612,0,1,bud dilation involved in lung branching,BP,
13838,GO:0060509,1,0.877047693195151,0,4,Type I pneumocyte differentiation,BP,
13839,GO:0060510,1,0.941394780372648,0,2,Type II pneumocyte differentiation,BP,
13840,GO:0060512,1,0.523868742872169,0,20,prostate gland morphogenesis,BP,
13841,GO:0060513,1,0.79925655118673,0,7,prostatic bud formation,BP,
13842,GO:0060516,1,0.96754747341463,0,1,primary prostatic bud elongation,BP,
13843,GO:0060517,1,0.96754747341463,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
13844,GO:0060523,1,0.935320376935814,0,2,prostate epithelial cord elongation,BP,
13845,GO:0060525,1,0.767260425422017,0,8,prostate glandular acinus development,BP,
13846,GO:0060526,1,0.874572793993427,0,4,prostate glandular acinus morphogenesis,BP,
13847,GO:0060527,1,0.874572793993427,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
13848,GO:0060528,1,0.907242147211254,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
13849,GO:0060529,1,0.935503357703711,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
13850,GO:0060532,1,0.935825008097229,0,2,bronchus cartilage development,BP,
13851,GO:0060534,1,0.799931035412578,0,7,trachea cartilage development,BP,
13852,GO:0060535,1,0.910586025087378,0,3,trachea cartilage morphogenesis,BP,
13853,GO:0060536,1,0.884619288086051,0,4,cartilage morphogenesis,BP,
13856,GO:0060539,1,0.854141664789378,0,5,diaphragm development,BP,
13858,GO:0060542,1,0.966874347694405,0,1,regulation of strand invasion,BP,
13860,GO:0060545,1,0.940497399978616,0,2,positive regulation of necroptotic process,BP,
13873,GO:0060571,1,0.604749634080321,0,16,morphogenesis of an epithelial fold,BP,
13874,GO:0060572,1,0.703643645298771,0,11,morphogenesis of an epithelial bud,BP,
13875,GO:0060573,1,0.903869688760566,0,3,cell fate specification involved in pattern specification,BP,
13876,GO:0060574,1,0.889843718890873,0,4,intestinal epithelial cell maturation,BP,
13877,GO:0060575,1,0.694665252473009,0,12,intestinal epithelial cell differentiation,BP,
13878,GO:0060576,1,0.764290484482642,0,9,intestinal epithelial cell development,BP,
13879,GO:0060577,1,0.971081547402047,0,1,pulmonary vein morphogenesis,BP,
13880,GO:0060578,1,0.971081547402047,0,1,superior vena cava morphogenesis,BP,
13881,GO:0060579,1,0.903869688760566,0,3,ventral spinal cord interneuron fate commitment,BP,
13882,GO:0060581,1,0.903869688760566,0,3,cell fate commitment involved in pattern specification,BP,
13885,GO:0060586,1,0.882721818251595,0,4,multicellular organismal iron ion homeostasis,BP,
13888,GO:0060591,1,0.909046207830828,0,3,chondroblast differentiation,BP,
13889,GO:0060592,1,0.879419770354348,0,4,mammary gland formation,BP,
13890,GO:0060594,1,0.935274520431273,0,2,mammary gland specification,BP,
13891,GO:0060595,1,0.967382766910371,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13892,GO:0060596,1,0.967005382163917,0,1,mammary placode formation,BP,
13893,GO:0060598,1,0.973671610620529,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
13894,GO:0060599,1,0.966872720920993,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
13896,GO:0060601,1,0.722670765003106,0,10,lateral sprouting from an epithelium,BP,
13897,GO:0060602,1,0.620770589962385,0,15,branch elongation of an epithelium,BP,
13899,GO:0060605,1,0.912498666833679,0,3,tube lumen cavitation,BP,
13900,GO:0060606,1,0.0913137936056836,0,75,tube closure,BP,
13901,GO:0060611,1,0.970512554479437,0,1,mammary gland fat development,BP,
13903,GO:0060613,1,0.829452112503155,0,6,fat pad development,BP,
13904,GO:0060615,1,0.967382766910371,0,1,mammary gland bud formation,BP,
13905,GO:0060620,1,0.969271124374127,0,1,regulation of cholesterol import,BP,
13906,GO:0060623,1,0.911418946175312,0,3,regulation of chromosome condensation,BP,
13908,GO:0060628,1,0.687810661977976,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
13909,GO:0060631,1,0.909169762828763,0,3,regulation of meiosis I,BP,
13911,GO:0060633,1,0.880474369817337,0,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
13912,GO:0060638,1,0.854374058067035,0,5,mesenchymal-epithelial cell signaling,BP,
13913,GO:0060644,1,0.713066319121069,0,11,mammary gland epithelial cell differentiation,BP,
13914,GO:0060648,1,0.967382766910371,0,1,mammary gland bud morphogenesis,BP,
13915,GO:0060661,1,0.971279171620866,0,1,submandibular salivary gland formation,BP,
13916,GO:0060662,1,0.912498666833679,0,3,salivary gland cavitation,BP,
13917,GO:0060664,1,0.936872769489343,0,2,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
13918,GO:0060665,1,0.966878069763278,0,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
13920,GO:0060667,1,0.967382766910371,0,1,branch elongation involved in salivary gland morphogenesis,BP,
13921,GO:0060668,1,0.96791630511705,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
13922,GO:0060669,1,0.502912890289514,0,22,embryonic placenta morphogenesis,BP,
13923,GO:0060670,1,0.734875133271155,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13924,GO:0060671,1,0.910639358375282,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13925,GO:0060672,1,0.910639358375282,0,3,epithelial cell morphogenesis involved in placental branching,BP,
13928,GO:0060676,1,0.887586439753218,0,4,ureteric bud formation,BP,
13929,GO:0060677,1,0.850281173303883,0,5,ureteric bud elongation,BP,
13930,GO:0060678,1,0.971001882139398,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
13931,GO:0060681,1,0.909746319489059,0,3,branch elongation involved in ureteric bud branching,BP,
13932,GO:0060683,1,0.969567497604305,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
13933,GO:0060684,1,0.886166147928178,0,4,epithelial-mesenchymal cell signaling,BP,
13934,GO:0060685,1,0.879411483715661,0,4,regulation of prostatic bud formation,BP,
13935,GO:0060686,1,0.879411483715661,0,4,negative regulation of prostatic bud formation,BP,
13936,GO:0060687,1,0.822734975239223,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
13941,GO:0060693,1,0.852291378275954,0,5,regulation of branching involved in salivary gland morphogenesis,BP,
13942,GO:0060694,1,0.972172812265828,0,1,regulation of cholesterol transporter activity,BP,
13943,GO:0060696,1,0.860544608194372,0,5,regulation of phospholipid catabolic process,BP,
13944,GO:0060697,1,0.969520377708811,0,1,positive regulation of phospholipid catabolic process,BP,
13945,GO:0060698,1,0.937175601543894,0,2,endoribonuclease inhibitor activity,MF,
13946,GO:0060699,1,0.885345133779403,0,4,regulation of endoribonuclease activity,BP,
13947,GO:0060700,1,0.760230348069039,0,9,regulation of ribonuclease activity,BP,
13948,GO:0060701,1,0.937175601543894,0,2,negative regulation of ribonuclease activity,BP,
13949,GO:0060702,1,0.937175601543894,0,2,negative regulation of endoribonuclease activity,BP,
13950,GO:0060703,1,0.969718338266846,0,1,deoxyribonuclease inhibitor activity,MF,
13953,GO:0060708,1,0.913419001775584,0,3,spongiotrophoblast differentiation,BP,
13954,GO:0060709,1,0.969335883777886,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
13955,GO:0060710,1,0.828386355491593,0,6,chorio-allantoic fusion,BP,
13958,GO:0060713,1,0.572887836449485,0,18,labyrinthine layer morphogenesis,BP,
13959,GO:0060715,1,0.910930103246966,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
13961,GO:0060717,1,0.799045010268805,0,7,chorion development,BP,
13962,GO:0060718,1,0.849715698509548,0,5,chorionic trophoblast cell differentiation,BP,
13967,GO:0060729,1,0.911458470057432,0,3,intestinal epithelial structure maintenance,BP,
13968,GO:0060730,1,0.968456823520522,0,1,regulation of intestinal epithelial structure maintenance,BP,
13969,GO:0060731,1,0.968456823520522,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
13970,GO:0060732,1,0.823223593217979,0,6,positive regulation of inositol phosphate biosynthetic process,BP,
13971,GO:0060733,1,0.935677560041918,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
13972,GO:0060734,1,0.967040826146869,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
13973,GO:0060735,1,0.973392610073937,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
13974,GO:0060736,1,0.793069128857051,0,7,prostate gland growth,BP,
13975,GO:0060737,1,0.904961409225752,0,3,prostate gland morphogenetic growth,BP,
13976,GO:0060739,1,0.96682702947907,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
13977,GO:0060740,1,0.540135797638046,0,19,prostate gland epithelium morphogenesis,BP,
13978,GO:0060742,1,0.77277546907472,0,8,epithelial cell differentiation involved in prostate gland development,BP,
13979,GO:0060743,1,0.97015247957824,0,1,epithelial cell maturation involved in prostate gland development,BP,
13980,GO:0060744,1,0.860272254841808,0,5,mammary gland branching involved in thelarche,BP,
13981,GO:0060745,1,0.874611398288625,0,4,mammary gland branching involved in pregnancy,BP,
13982,GO:0060746,1,0.801871638205741,0,7,parental behavior,BP,
13983,GO:0060748,1,0.96756951466631,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
13984,GO:0060749,1,0.735461256047945,0,10,mammary gland alveolus development,BP,
13985,GO:0060750,1,0.879996048361884,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
13986,GO:0060751,1,0.854627455671747,0,5,branch elongation involved in mammary gland duct branching,BP,
13992,GO:0060762,1,0.884054699215587,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
13993,GO:0060763,1,0.938345202414072,0,2,mammary duct terminal end bud growth,BP,
13994,GO:0060764,1,0.941264834738061,0,2,cell-cell signaling involved in mammary gland development,BP,
13995,GO:0060765,1,0.504440968618485,0,22,regulation of androgen receptor signaling pathway,BP,
13996,GO:0060766,1,0.777076584276149,0,8,negative regulation of androgen receptor signaling pathway,BP,
13997,GO:0060767,1,0.758318184947271,0,9,epithelial cell proliferation involved in prostate gland development,BP,
13998,GO:0060768,1,0.783770201032276,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
13999,GO:0060769,1,0.968206987373667,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14000,GO:0060770,1,0.837347442213681,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14001,GO:0060775,1,0.966872720920993,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14002,GO:0060784,1,0.96754747341463,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14003,GO:0060788,1,0.731733599615516,0,10,ectodermal placode formation,BP,
14004,GO:0060789,1,0.836084843766541,0,6,hair follicle placode formation,BP,
14006,GO:0060800,1,0.93728957256334,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
14007,GO:0060804,1,0.968710947667684,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14008,GO:0060809,1,0.966872720920993,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14009,GO:0060816,1,0.936115031683352,0,2,random inactivation of X chromosome,BP,
14010,GO:0060819,1,0.934812081999828,0,2,inactivation of X chromosome by genetic imprinting,BP,
14011,GO:0060821,1,0.9668000891798,0,1,inactivation of X chromosome by DNA methylation,BP,
14012,GO:0060823,1,0.968250583109952,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14013,GO:0060825,1,0.945537623685072,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
14015,GO:0060830,1,0.911580063158636,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
14016,GO:0060831,1,0.656709723051439,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
14023,GO:0060842,1,0.90881029782232,0,3,arterial endothelial cell differentiation,BP,
14024,GO:0060843,1,0.966785420358917,0,1,venous endothelial cell differentiation,BP,
14025,GO:0060844,1,0.940038474910201,0,2,arterial endothelial cell fate commitment,BP,
14030,GO:0060853,1,0.968397512519548,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
14031,GO:0060856,1,0.757780970871804,0,9,establishment of blood-brain barrier,BP,
14032,GO:0060857,1,0.970957647713041,0,1,establishment of glial blood-brain barrier,BP,
14033,GO:0060872,1,0.882574515104912,0,4,semicircular canal development,BP,
14034,GO:0060873,1,0.96681211801048,0,1,anterior semicircular canal development,BP,
14035,GO:0060875,1,0.96681211801048,0,1,lateral semicircular canal development,BP,
14036,GO:0060876,1,0.970477815511287,0,1,semicircular canal formation,BP,
14037,GO:0060887,1,0.969271124374127,0,1,limb epidermis development,BP,
14038,GO:0060896,1,0.777945094398006,0,8,neural plate pattern specification,BP,
14039,GO:0060897,1,0.832251961784301,0,6,neural plate regionalization,BP,
14041,GO:0060901,1,0.967237767497311,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
14042,GO:0060903,1,0.938556318928792,0,2,positive regulation of meiosis I,BP,
14045,GO:0060911,1,0.805575193605749,0,7,cardiac cell fate commitment,BP,
14046,GO:0060912,1,0.969271124374127,0,1,cardiac cell fate specification,BP,
14047,GO:0060913,1,0.969723619722645,0,1,cardiac cell fate determination,BP,
14048,GO:0060914,1,0.723487288432506,0,11,heart formation,BP,
14049,GO:0060915,1,0.967382766910371,0,1,mesenchymal cell differentiation involved in lung development,BP,
14050,GO:0060916,1,0.876217973241239,0,4,mesenchymal cell proliferation involved in lung development,BP,
14051,GO:0060920,1,0.904004060913384,0,3,cardiac pacemaker cell differentiation,BP,
14052,GO:0060921,1,0.934980143604868,0,2,sinoatrial node cell differentiation,BP,
14053,GO:0060922,1,0.966875780878853,0,1,atrioventricular node cell differentiation,BP,
14054,GO:0060923,1,0.857087870146208,0,5,cardiac muscle cell fate commitment,BP,
14055,GO:0060926,1,0.904004060913384,0,3,cardiac pacemaker cell development,BP,
14056,GO:0060928,1,0.966875780878853,0,1,atrioventricular node cell development,BP,
14057,GO:0060931,1,0.934980143604868,0,2,sinoatrial node cell development,BP,
14058,GO:0060932,1,0.967005382163917,0,1,His-Purkinje system cell differentiation,BP,
14059,GO:0060935,1,0.908278055164871,0,3,cardiac fibroblast cell differentiation,BP,
14060,GO:0060936,1,0.908278055164871,0,3,cardiac fibroblast cell development,BP,
14061,GO:0060938,1,0.908278055164871,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14062,GO:0060939,1,0.908278055164871,0,3,epicardium-derived cardiac fibroblast cell development,BP,
14063,GO:0060940,1,0.939418098851818,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
14064,GO:0060947,1,0.877390999950648,0,4,cardiac vascular smooth muscle cell differentiation,BP,
14065,GO:0060948,1,0.935902370430625,0,2,cardiac vascular smooth muscle cell development,BP,
14067,GO:0060957,1,0.969111776809505,0,1,endocardial cell fate commitment,BP,
14069,GO:0060965,1,0.689107677251082,0,12,negative regulation of gene silencing by miRNA,BP,
14071,GO:0060967,1,0.649828155094872,0,14,negative regulation of gene silencing by RNA,BP,
14073,GO:0060969,1,0.501729059913741,0,22,negative regulation of gene silencing,BP,
14076,GO:0060973,1,0.727908185198634,0,10,cell migration involved in heart development,BP,
14080,GO:0060979,1,0.903735505629401,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
14083,GO:0060987,1,0.970828091364878,0,1,lipid tube,CC,
14084,GO:0060988,1,0.939070329268706,0,2,lipid tube assembly,BP,
14085,GO:0060992,1,0.726021585348353,0,10,response to fungicide,BP,
14087,GO:0060994,1,0.941063323661941,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
14088,GO:0060995,1,0.936805710322018,0,2,cell-cell signaling involved in kidney development,BP,
14090,GO:0060997,1,0.322595506100466,0,35,dendritic spine morphogenesis,BP,
14093,GO:0061000,1,0.772490937239073,0,8,negative regulation of dendritic spine development,BP,
14094,GO:0061001,1,0.459940968121731,0,24,regulation of dendritic spine morphogenesis,BP,
14095,GO:0061002,1,0.909573303384925,0,3,negative regulation of dendritic spine morphogenesis,BP,
14096,GO:0061003,1,0.671701901574524,0,12,positive regulation of dendritic spine morphogenesis,BP,
14097,GO:0061004,1,0.814094582827641,0,7,pattern specification involved in kidney development,BP,
14098,GO:0061005,1,0.347134519938547,0,33,cell differentiation involved in kidney development,BP,
14100,GO:0061009,1,0.913907772449941,0,3,common bile duct development,BP,
14101,GO:0061010,1,0.966765759377405,0,1,gall bladder development,BP,
14104,GO:0061015,1,0.947309166299209,0,2,snRNA import into nucleus,BP,
14109,GO:0061030,1,0.967466877993906,0,1,epithelial cell differentiation involved in mammary gland alveolus development,BP,
14110,GO:0061031,1,0.971081547402047,0,1,endodermal digestive tract morphogenesis,BP,
14111,GO:0061032,1,0.969015328178466,0,1,visceral serous pericardium development,BP,
14112,GO:0061034,1,0.967224332854149,0,1,olfactory bulb mitral cell layer development,BP,
14113,GO:0061035,1,0.30030951850761,0,38,regulation of cartilage development,BP,
14114,GO:0061036,1,0.526723860951067,0,20,positive regulation of cartilage development,BP,
14115,GO:0061037,1,0.650324603050151,0,14,negative regulation of cartilage development,BP,
14116,GO:0061038,1,0.878815723550489,0,4,uterus morphogenesis,BP,
14117,GO:0061040,1,0.966798584676304,0,1,female gonad morphogenesis,BP,
14121,GO:0061044,1,0.968683041538734,0,1,negative regulation of vascular wound healing,BP,
14123,GO:0061046,1,0.884532586330623,0,4,regulation of branching involved in lung morphogenesis,BP,
14124,GO:0061047,1,0.914208118473108,0,3,positive regulation of branching involved in lung morphogenesis,BP,
14130,GO:0061054,1,0.96756951466631,0,1,dermatome development,BP,
14131,GO:0061055,1,0.935037639188014,0,2,myotome development,BP,
14132,GO:0061056,1,0.969271124374127,0,1,sclerotome development,BP,
14134,GO:0061072,1,0.830154797664981,0,6,iris morphogenesis,BP,
14135,GO:0061073,1,0.937607669573349,0,2,ciliary body morphogenesis,BP,
14136,GO:0061074,1,0.942686411809234,0,2,regulation of neural retina development,BP,
14137,GO:0061075,1,0.942686411809234,0,2,positive regulation of neural retina development,BP,
14139,GO:0061078,1,0.974914045590198,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
14142,GO:0061083,1,0.88273074387312,0,4,regulation of protein refolding,BP,
14143,GO:0061084,1,0.88273074387312,0,4,negative regulation of protein refolding,BP,
14144,GO:0061085,1,0.753306675651928,0,9,regulation of histone H3-K27 methylation,BP,
14145,GO:0061086,1,0.882749272432549,0,4,negative regulation of histone H3-K27 methylation,BP,
14146,GO:0061087,1,0.827363821377561,0,6,positive regulation of histone H3-K27 methylation,BP,
14147,GO:0061088,1,0.828286165580846,0,6,regulation of sequestering of zinc ion,BP,
14148,GO:0061091,1,0.966933255357631,0,1,regulation of phospholipid translocation,BP,
14149,GO:0061092,1,0.966933255357631,0,1,positive regulation of phospholipid translocation,BP,
14152,GO:0061099,1,0.465026521832393,0,25,negative regulation of protein tyrosine kinase activity,BP,
14153,GO:0061101,1,0.887726950697295,0,4,neuroendocrine cell differentiation,BP,
14154,GO:0061102,1,0.973198875078459,0,1,stomach neuroendocrine cell differentiation,BP,
14155,GO:0061105,1,0.973198875078459,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14156,GO:0061106,1,0.973198875078459,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
14157,GO:0061107,1,0.971003357007078,0,1,seminal vesicle development,BP,
14158,GO:0061108,1,0.971003357007078,0,1,seminal vesicle epithelium development,BP,
14159,GO:0061110,1,0.93572185955876,0,2,dense core granule biogenesis,BP,
14160,GO:0061113,1,0.967754720267588,0,1,pancreas morphogenesis,BP,
14162,GO:0061133,1,0.870163503819553,0,5,endopeptidase activator activity,MF,
14167,GO:0061140,1,0.916418939149578,0,3,lung secretory cell differentiation,BP,
14168,GO:0061141,1,0.966813595891231,0,1,lung ciliated cell differentiation,BP,
14169,GO:0061145,1,0.935825008097229,0,2,lung smooth muscle development,BP,
14170,GO:0061146,1,0.910730909438323,0,3,Peyer's patch morphogenesis,BP,
14171,GO:0061149,1,0.972376033972612,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14172,GO:0061150,1,0.972376033972612,0,1,renal system segmentation,BP,
14173,GO:0061151,1,0.972376033972612,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14174,GO:0061152,1,0.942699867145723,0,2,trachea submucosa development,BP,
14175,GO:0061153,1,0.942699867145723,0,2,trachea gland development,BP,
14177,GO:0061155,1,0.972376033972612,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14178,GO:0061156,1,0.909183275992289,0,3,pulmonary artery morphogenesis,BP,
14179,GO:0061157,1,0.51207855750002,0,21,mRNA destabilization,BP,
14180,GO:0061158,1,0.702696864450576,0,11,3'-UTR-mediated mRNA destabilization,BP,
14181,GO:0061162,1,0.618033959565073,0,15,establishment of monopolar cell polarity,BP,
14182,GO:0061163,1,0.969271124374127,0,1,endoplasmic reticulum polarization,BP,
14184,GO:0061179,1,0.817170322866966,0,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
14186,GO:0061183,1,0.96756951466631,0,1,regulation of dermatome development,BP,
14187,GO:0061184,1,0.96756951466631,0,1,positive regulation of dermatome development,BP,
14188,GO:0061187,1,0.934852570752362,0,2,regulation of chromatin silencing at rDNA,BP,
14189,GO:0061188,1,0.934852570752362,0,2,negative regulation of chromatin silencing at rDNA,BP,
14190,GO:0061193,1,0.974151547296457,0,1,taste bud development,BP,
14191,GO:0061196,1,0.879263325548442,0,4,fungiform papilla development,BP,
14192,GO:0061197,1,0.879263325548442,0,4,fungiform papilla morphogenesis,BP,
14193,GO:0061198,1,0.90940609314909,0,3,fungiform papilla formation,BP,
14194,GO:0061200,1,0.857989935515683,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
14195,GO:0061202,1,0.857989935515683,0,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
14196,GO:0061205,1,0.96756951466631,0,1,paramesonephric duct development,BP,
14197,GO:0061209,1,0.912627815413919,0,3,cell proliferation involved in mesonephros development,BP,
14199,GO:0061216,1,0.972376033972612,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14201,GO:0061218,1,0.915329656069454,0,3,negative regulation of mesonephros development,BP,
14202,GO:0061227,1,0.972376033972612,0,1,pattern specification involved in mesonephros development,BP,
14204,GO:0061289,1,0.936805710322018,0,2,Wnt signaling pathway involved in kidney development,BP,
14205,GO:0061290,1,0.936805710322018,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
14208,GO:0061300,1,0.94076506167437,0,2,cerebellum vasculature development,BP,
14209,GO:0061301,1,0.966833101784296,0,1,cerebellum vasculature morphogenesis,BP,
14210,GO:0061302,1,0.90943938868366,0,3,smooth muscle cell-matrix adhesion,BP,
14212,GO:0061304,1,0.873938611670634,0,4,retinal blood vessel morphogenesis,BP,
14213,GO:0061307,1,0.781878053445727,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
14214,GO:0061308,1,0.781878053445727,0,8,cardiac neural crest cell development involved in heart development,BP,
14215,GO:0061309,1,0.831097984307588,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14216,GO:0061311,1,0.606252257591716,0,16,cell surface receptor signaling pathway involved in heart development,BP,
14217,GO:0061312,1,0.861063076406622,0,5,BMP signaling pathway involved in heart development,BP,
14218,GO:0061314,1,0.85057751628249,0,5,Notch signaling involved in heart development,BP,
14219,GO:0061316,1,0.913835958177837,0,3,canonical Wnt signaling pathway involved in heart development,BP,
14220,GO:0061317,1,0.943848419840547,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
14221,GO:0061318,1,0.704870789402789,0,11,renal filtration cell differentiation,BP,
14222,GO:0061323,1,0.715622349555837,0,11,cell proliferation involved in heart morphogenesis,BP,
14223,GO:0061324,1,0.968206987373667,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
14224,GO:0061325,1,0.914228958688312,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
14228,GO:0061339,1,0.618033959565073,0,15,establishment or maintenance of monopolar cell polarity,BP,
14229,GO:0061341,1,0.93485976789363,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14230,GO:0061343,1,0.876089870204315,0,4,cell adhesion involved in heart morphogenesis,BP,
14231,GO:0061346,1,0.93485976789363,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
14232,GO:0061347,1,0.966872720920993,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14233,GO:0061348,1,0.966872720920993,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14234,GO:0061349,1,0.966872720920993,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14235,GO:0061350,1,0.966872720920993,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14237,GO:0061354,1,0.966872720920993,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14238,GO:0061355,1,0.883460093631418,0,4,Wnt protein secretion,BP,
14239,GO:0061356,1,0.883460093631418,0,4,regulation of Wnt protein secretion,BP,
14240,GO:0061357,1,0.908774154714327,0,3,positive regulation of Wnt protein secretion,BP,
14241,GO:0061358,1,0.972152030821871,0,1,negative regulation of Wnt protein secretion,BP,
14243,GO:0061365,1,0.886546180547824,0,4,positive regulation of triglyceride lipase activity,BP,
14244,GO:0061369,1,0.96756951466631,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
14245,GO:0061370,1,0.93837954125582,0,2,testosterone biosynthetic process,BP,
14246,GO:0061371,1,0.302853620576809,0,37,determination of heart left/right asymmetry,BP,
14247,GO:0061377,1,0.735461256047945,0,10,mammary gland lobule development,BP,
14253,GO:0061395,1,0.972549309821759,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
14254,GO:0061400,1,0.969271124374127,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14255,GO:0061408,1,0.913827568572224,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
14257,GO:0061419,1,0.852246345145607,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14260,GO:0061433,1,0.971921502773169,0,1,cellular response to caloric restriction,BP,
14267,GO:0061443,1,0.937000695692103,0,2,endocardial cushion cell differentiation,BP,
14268,GO:0061444,1,0.966868247792659,0,1,endocardial cushion cell development,BP,
14269,GO:0061445,1,0.969111776809505,0,1,endocardial cushion cell fate commitment,BP,
14273,GO:0061459,1,0.966828305922411,0,1,L-arginine transmembrane transporter activity,MF,
14275,GO:0061469,1,0.829896624391532,0,6,regulation of type B pancreatic cell proliferation,BP,
14276,GO:0061470,1,0.880546873861564,0,4,T follicular helper cell differentiation,BP,
14277,GO:0061474,1,0.970183444612442,0,1,phagolysosome membrane,CC,
14279,GO:0061478,1,0.749132019632651,0,9,response to platelet aggregation inhibitor,BP,
14280,GO:0061481,1,0.974434133110297,0,1,response to TNF agonist,BP,
14281,GO:0061484,1,0.90752622040623,0,3,hematopoietic stem cell homeostasis,BP,
14282,GO:0061485,1,0.966830186203397,0,1,memory T cell proliferation,BP,
14283,GO:0061495,1,0.969271124374127,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14284,GO:0061502,1,0.879137140809781,0,4,early endosome to recycling endosome transport,BP,
14285,GO:0061505,1,0.934874725346646,0,2,DNA topoisomerase II activity,MF,
14286,GO:0061507,1,0.972620455257818,0,1,cyclic-GMP-AMP binding,MF,
14287,GO:0061508,1,0.969271124374127,0,1,CDP phosphorylation,BP,
14288,GO:0061511,1,0.88195183623959,0,4,centriole elongation,BP,
14290,GO:0061513,1,0.9103716436562,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
14292,GO:0061517,1,0.969382123670748,0,1,macrophage proliferation,BP,
14293,GO:0061518,1,0.969382123670748,0,1,microglial cell proliferation,BP,
14294,GO:0061519,1,0.967951356623418,0,1,macrophage homeostasis,BP,
14295,GO:0061525,1,0.847098532630707,0,5,hindgut development,BP,
14296,GO:0061528,1,0.966958766715114,0,1,aspartate secretion,BP,
14297,GO:0061534,1,0.966714680106648,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
14298,GO:0061535,1,0.904428551867904,0,3,glutamate secretion, neurotransmission,BP,
14299,GO:0061536,1,0.968570346802033,0,1,glycine secretion,BP,
14300,GO:0061537,1,0.968570346802033,0,1,glycine secretion, neurotransmission,BP,
14301,GO:0061542,1,0.973608638681413,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
14302,GO:0061547,1,0.968176288173277,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
14309,GO:0061565,1,0.969271124374127,0,1,dAMP phosphorylation,BP,
14310,GO:0061566,1,0.969271124374127,0,1,CMP phosphorylation,BP,
14311,GO:0061567,1,0.969271124374127,0,1,dCMP phosphorylation,BP,
14312,GO:0061568,1,0.969271124374127,0,1,GDP phosphorylation,BP,
14313,GO:0061569,1,0.969271124374127,0,1,UDP phosphorylation,BP,
14314,GO:0061570,1,0.969271124374127,0,1,dCDP phosphorylation,BP,
14315,GO:0061571,1,0.969271124374127,0,1,TDP phosphorylation,BP,
14317,GO:0061573,1,0.969271124374127,0,1,actin filament bundle retrograde transport,BP,
14318,GO:0061574,1,0.912384043839368,0,3,ASAP complex,CC,
14319,GO:0061575,1,0.898216200362269,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
14322,GO:0061580,1,0.967361639798999,0,1,colon epithelial cell migration,BP,
14323,GO:0061582,1,0.935301225541148,0,2,intestinal epithelial cell migration,BP,
14328,GO:0061598,1,0.967250856401697,0,1,molybdopterin adenylyltransferase activity,MF,
14329,GO:0061599,1,0.967250856401697,0,1,molybdopterin molybdotransferase activity,MF,
14330,GO:0061604,1,0.970440273114395,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14331,GO:0061605,1,0.970440273114395,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
14332,GO:0061608,1,0.760588176405234,0,9,nuclear import signal receptor activity,MF,
14333,GO:0061611,1,0.972400159260788,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14336,GO:0061617,1,0.792557305110118,0,8,MICOS complex,CC,
14340,GO:0061622,1,0.942816403421206,0,2,glycolytic process through glucose-1-phosphate,BP,
14341,GO:0061623,1,0.973399232439149,0,1,glycolytic process from galactose,BP,
14342,GO:0061624,1,0.885114518647252,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
14343,GO:0061626,1,0.832237016229603,0,6,pharyngeal arch artery morphogenesis,BP,
14344,GO:0061627,1,0.971786998054768,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
14345,GO:0061628,1,0.938706761581376,0,2,H3K27me3 modified histone binding,MF,
14348,GO:0061631,1,0.458323758124637,0,26,ubiquitin conjugating enzyme activity,MF,
14349,GO:0061635,1,0.81061503171844,0,7,regulation of protein complex stability,BP,
14351,GO:0061641,1,0.324790297585015,0,40,CENP-A containing chromatin organization,BP,
14352,GO:0061642,1,0.966872720920993,0,1,chemoattraction of axon,BP,
14353,GO:0061643,1,0.937038189056382,0,2,chemorepulsion of axon,BP,
14354,GO:0061645,1,0.845544913180521,0,5,endocytic patch,CC,
14355,GO:0061646,1,0.966952385227903,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
14356,GO:0061647,1,0.314808555545555,0,36,histone H3-K9 modification,BP,
14357,GO:0061649,1,0.908215761635664,0,3,ubiquitin modification-dependent histone binding,MF,
14358,GO:0061650,1,0.446264551441901,0,27,ubiquitin-like protein conjugating enzyme activity,MF,
14359,GO:0061656,1,0.973744051883864,0,1,SUMO conjugating enzyme activity,MF,
14361,GO:0061663,1,0.966833353549414,0,1,NEDD8 ligase activity,MF,
14362,GO:0061665,1,0.859554165032901,0,5,SUMO ligase activity,MF,
14363,GO:0061668,1,0.829692546539067,0,6,mitochondrial ribosome assembly,BP,
14365,GO:0061673,1,0.854455697444935,0,5,mitotic spindle astral microtubule,CC,
14366,GO:0061676,1,0.825544325811627,0,6,importin-alpha family protein binding,MF,
14368,GO:0061685,1,0.969271124374127,0,1,diphthine methylesterase activity,MF,
14369,GO:0061687,1,0.820521672004078,0,7,detoxification of inorganic compound,BP,
14370,GO:0061689,1,0.91194229375506,0,3,tricellular tight junction,CC,
14372,GO:0061697,1,0.968704944574209,0,1,protein-glutaryllysine deglutarylase activity,MF,
14373,GO:0061698,1,0.968704944574209,0,1,protein deglutarylation,BP,
14374,GO:0061699,1,0.968704944574209,0,1,peptidyl-lysine deglutarylation,BP,
14375,GO:0061700,1,0.757473624113763,0,9,GATOR2 complex,CC,
14376,GO:0061702,1,0.811792362770771,0,7,inflammasome complex,CC,
14377,GO:0061709,1,0.966850849214278,0,1,reticulophagy,BP,
14378,GO:0061711,1,0.944581262035289,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
14379,GO:0061712,1,0.968458643730939,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
14381,GO:0061723,1,0.938282354706931,0,2,glycophagy,BP,
14382,GO:0061724,1,0.829920942392734,0,6,lipophagy,BP,
14384,GO:0061727,1,0.942814454617799,0,2,methylglyoxal catabolic process to lactate,BP,
14385,GO:0061731,1,0.906920395232214,0,3,ribonucleoside-diphosphate reductase activity,MF,
14386,GO:0061732,1,0.830909179014719,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14389,GO:0061736,1,0.966876039917269,0,1,engulfment of target by autophagosome,BP,
14390,GO:0061737,1,0.942022673272113,0,2,leukotriene signaling pathway,BP,
14391,GO:0061738,1,0.913785069998453,0,3,late endosomal microautophagy,BP,
14392,GO:0061739,1,0.906970894090192,0,3,protein lipidation involved in autophagosome assembly,BP,
14393,GO:0061740,1,0.911208041200889,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
14394,GO:0061741,1,0.941918601257097,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
14395,GO:0061743,1,0.972322080150554,0,1,motor learning,BP,
14396,GO:0061744,1,0.942723325614894,0,2,motor behavior,BP,
14397,GO:0061749,1,0.9350523489083,0,2,forked DNA-dependent helicase activity,MF,
14398,GO:0061750,1,0.970813394677128,0,1,acid sphingomyelin phosphodiesterase activity,MF,
14399,GO:0061752,1,0.941894270924987,0,2,telomeric repeat-containing RNA binding,MF,
14400,GO:0061753,1,0.966876039917269,0,1,substrate localization to autophagosome,BP,
14402,GO:0061757,1,0.96917953594209,0,1,leukocyte adhesion to arterial endothelial cell,BP,
14403,GO:0061760,1,0.969186499754276,0,1,antifungal innate immune response,BP,
14404,GO:0061762,1,0.93489987241677,0,2,CAMKK-AMPK signaling cascade,BP,
14405,GO:0061763,1,0.940141881840529,0,2,multivesicular body-lysosome fusion,BP,
14406,GO:0061767,1,0.966870848147765,0,1,negative regulation of lung blood pressure,BP,
14407,GO:0061768,1,0.966973738434739,0,1,magnesium:sodium antiporter activity,MF,
14408,GO:0061769,1,0.969271124374127,0,1,ribosylnicotinate kinase activity,MF,
14409,GO:0061770,1,0.971305680023273,0,1,translation elongation factor binding,MF,
14410,GO:0061771,1,0.915114254770645,0,3,response to caloric restriction,BP,
14413,GO:0061780,1,0.966765759377405,0,1,mitotic cohesin loading,BP,
14414,GO:0061783,1,0.94755339514668,0,2,peptidoglycan muralytic activity,MF,
14415,GO:0061789,1,0.966857991330489,0,1,dense core granule priming,BP,
14416,GO:0061792,1,0.96686629219166,0,1,secretory granule maturation,BP,
14417,GO:0061798,1,0.96732830948403,0,1,GTP 3',8'-cyclase activity,MF,
14418,GO:0061799,1,0.96732830948403,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
14419,GO:0061809,1,0.973101440390168,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
14420,GO:0061817,1,0.904505461912956,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
14421,GO:0061819,1,0.90954389962199,0,3,telomeric DNA-containing double minutes formation,BP,
14422,GO:0061820,1,0.748658054241419,0,9,telomeric D-loop disassembly,BP,
14423,GO:0061821,1,0.875277136698495,0,4,telomeric D-loop binding,MF,
14424,GO:0061825,1,0.967542295754707,0,1,podosome core,CC,
14426,GO:0061828,1,0.966826241955533,0,1,apical tubulobulbar complex,CC,
14427,GO:0061829,1,0.966826241955533,0,1,basal tubulobulbar complex,CC,
14428,GO:0061833,1,0.939264648412103,0,2,protein localization to tricellular tight junction,BP,
14431,GO:0061845,1,0.968502735511175,0,1,neuron projection branch point,CC,
14432,GO:0061846,1,0.968502735511175,0,1,dendritic spine cytoplasm,CC,
14433,GO:0061847,1,0.970866330437704,0,1,response to cholecystokinin,BP,
14434,GO:0061849,1,0.9350523489083,0,2,telomeric G-quadruplex DNA binding,MF,
14435,GO:0061850,1,0.974353186685951,0,1,growth cone leading edge,CC,
14436,GO:0061851,1,0.969702524821051,0,1,leading edge of lamellipodium,CC,
14437,GO:0061857,1,0.937868002824909,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
14440,GO:0061884,1,0.97166272183182,0,1,regulation of mini excitatory postsynaptic potential,BP,
14441,GO:0061885,1,0.97166272183182,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
14442,GO:0061888,1,0.911219495214373,0,3,regulation of astrocyte activation,BP,
14443,GO:0061889,1,0.96689975956694,0,1,negative regulation of astrocyte activation,BP,
14444,GO:0061890,1,0.942418763924218,0,2,positive regulation of astrocyte activation,BP,
14445,GO:0061896,1,0.967029277276091,0,1,all-trans retinol 3,4-desaturase activity,MF,
14446,GO:0061897,1,0.967029277276091,0,1,all-trans retinal 3,4-desaturase activity,MF,
14447,GO:0061898,1,0.967029277276091,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14448,GO:0061899,1,0.967029277276091,0,1,11-cis-retinal 3,4-desaturase activity,MF,
14452,GO:0061920,1,0.966798342251264,0,1,protein propionyltransferase activity,MF,
14453,GO:0061921,1,0.966798342251264,0,1,peptidyl-lysine propionylation,BP,
14454,GO:0061930,1,0.966914057987496,0,1,regulation of erythrocyte enucleation,BP,
14455,GO:0061931,1,0.966914057987496,0,1,positive regulation of erythrocyte enucleation,BP,
14456,GO:0061944,1,0.967204830564166,0,1,negative regulation of protein K48-linked ubiquitination,BP,
14457,GO:0061945,1,0.910860886575496,0,3,regulation of protein K48-linked ubiquitination,BP,
14459,GO:0061953,1,0.912681455970233,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
14462,GO:0061982,1,0.118437428288658,0,69,meiosis I cell cycle process,BP,
14463,GO:0061983,1,0.832625785045759,0,6,meiosis II cell cycle process,BP,
14468,GO:0065001,1,0.934834743918534,0,2,specification of axis polarity,BP,
14472,GO:0065005,1,0.572824662450011,0,18,protein-lipid complex assembly,BP,
14476,GO:0065010,1,0.969271124374127,0,1,extracellular membrane-bounded organelle,CC,
14479,GO:0070004,1,0.969271124374127,0,1,cysteine-type exopeptidase activity,MF,
14485,GO:0070016,1,0.72208697031663,0,10,armadillo repeat domain binding,MF,
14486,GO:0070022,1,0.875906190637827,0,4,transforming growth factor beta receptor complex,CC,
14487,GO:0070025,1,0.970021395609411,0,1,carbon monoxide binding,MF,
14488,GO:0070026,1,0.945009454120907,0,2,nitric oxide binding,MF,
14489,GO:0070032,1,0.943592400034249,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
14490,GO:0070033,1,0.943592400034249,0,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
14491,GO:0070034,1,0.526657914800065,0,21,telomerase RNA binding,MF,
14493,GO:0070037,1,0.974044651760147,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
14494,GO:0070039,1,0.940073164695509,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
14495,GO:0070042,1,0.968944237662839,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
14496,GO:0070044,1,0.887624962667137,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
14497,GO:0070050,1,0.911772848001795,0,3,neuron cellular homeostasis,BP,
14498,GO:0070051,1,0.937935037467596,0,2,fibrinogen binding,MF,
14499,GO:0070052,1,0.936579766669835,0,2,collagen V binding,MF,
14500,GO:0070053,1,0.937885536765463,0,2,thrombospondin receptor activity,MF,
14501,GO:0070054,1,0.909696875897417,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14502,GO:0070055,1,0.909696875897417,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
14504,GO:0070060,1,0.966789970763501,0,1,'de novo' actin filament nucleation,BP,
14505,GO:0070061,1,0.912887375698062,0,3,fructose binding,MF,
14509,GO:0070069,1,0.528133052313859,0,23,cytochrome complex,CC,
14510,GO:0070070,1,0.771994546636581,0,8,proton-transporting V-type ATPase complex assembly,BP,
14511,GO:0070071,1,0.686502838861948,0,12,proton-transporting two-sector ATPase complex assembly,BP,
14512,GO:0070072,1,0.771994546636581,0,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,
14513,GO:0070076,1,0.437817675954612,0,25,histone lysine demethylation,BP,
14514,GO:0070077,1,0.967910767110477,0,1,histone arginine demethylation,BP,
14515,GO:0070078,1,0.967910767110477,0,1,histone H3-R2 demethylation,BP,
14516,GO:0070079,1,0.967910767110477,0,1,histone H4-R3 demethylation,BP,
14517,GO:0070081,1,0.912982898897345,0,3,clathrin-sculpted monoamine transport vesicle,CC,
14518,GO:0070083,1,0.912982898897345,0,3,clathrin-sculpted monoamine transport vesicle membrane,CC,
14520,GO:0070086,1,0.887743316359425,0,4,ubiquitin-dependent endocytosis,BP,
14521,GO:0070087,1,0.820724396826747,0,6,chromo shadow domain binding,MF,
14522,GO:0070091,1,0.90726996263841,0,3,glucagon secretion,BP,
14523,GO:0070092,1,0.90726996263841,0,3,regulation of glucagon secretion,BP,
14524,GO:0070094,1,0.970071354924274,0,1,positive regulation of glucagon secretion,BP,
14525,GO:0070095,1,0.968658357762067,0,1,fructose-6-phosphate binding,MF,
14526,GO:0070096,1,0.96827818880457,0,1,mitochondrial outer membrane translocase complex assembly,BP,
14527,GO:0070097,1,0.934957888189919,0,2,delta-catenin binding,MF,
14533,GO:0070103,1,0.972584353089558,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14534,GO:0070104,1,0.972584353089558,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
14537,GO:0070119,1,0.967352949111577,0,1,ciliary neurotrophic factor binding,MF,
14539,GO:0070121,1,0.966881269277234,0,1,Kupffer's vesicle development,BP,
14540,GO:0070122,1,0.879696503180077,0,4,isopeptidase activity,MF,
14541,GO:0070123,1,0.966857345756882,0,1,transforming growth factor beta receptor activity, type III,MF,
14542,GO:0070124,1,0.944454567183387,0,2,mitochondrial translational initiation,BP,
14545,GO:0070127,1,0.781027127280413,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
14547,GO:0070130,1,0.969271124374127,0,1,negative regulation of mitochondrial translation,BP,
14549,GO:0070137,1,0.875572694055095,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14550,GO:0070138,1,0.906259177454305,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14551,GO:0070139,1,0.875572694055095,0,4,SUMO-specific endopeptidase activity,MF,
14552,GO:0070140,1,0.906259177454305,0,3,SUMO-specific isopeptidase activity,MF,
14554,GO:0070142,1,0.825496380379956,0,6,synaptic vesicle budding,BP,
14555,GO:0070143,1,0.966991449204409,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
14556,GO:0070145,1,0.968317264265488,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14557,GO:0070150,1,0.943282920479748,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
14558,GO:0070159,1,0.970643468281521,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
14564,GO:0070165,1,0.969271124374127,0,1,positive regulation of adiponectin secretion,BP,
14565,GO:0070166,1,0.749359509427993,0,9,enamel mineralization,BP,
14567,GO:0070168,1,0.798516666733549,0,7,negative regulation of biomineral tissue development,BP,
14569,GO:0070170,1,0.936323289286802,0,2,regulation of tooth mineralization,BP,
14570,GO:0070171,1,0.966858779504773,0,1,negative regulation of tooth mineralization,BP,
14571,GO:0070172,1,0.968420702674073,0,1,positive regulation of tooth mineralization,BP,
14572,GO:0070176,1,0.972332907948321,0,1,DRM complex,CC,
14573,GO:0070178,1,0.970365496604871,0,1,D-serine metabolic process,BP,
14574,GO:0070179,1,0.970365496604871,0,1,D-serine biosynthetic process,BP,
14575,GO:0070180,1,0.974884447150127,0,1,large ribosomal subunit rRNA binding,MF,
14576,GO:0070181,1,0.796574902939612,0,8,small ribosomal subunit rRNA binding,MF,
14578,GO:0070183,1,0.969447544639341,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
14579,GO:0070184,1,0.971305680023273,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
14580,GO:0070187,1,0.833419392107684,0,6,shelterin complex,CC,
14581,GO:0070189,1,0.891754875875488,0,4,kynurenine metabolic process,BP,
14582,GO:0070191,1,0.942073814608858,0,2,methionine-R-sulfoxide reductase activity,MF,
14583,GO:0070192,1,0.322051025984262,0,36,chromosome organization involved in meiotic cell cycle,BP,
14584,GO:0070193,1,0.735465252226532,0,10,synaptonemal complex organization,BP,
14585,GO:0070194,1,0.94172368696452,0,2,synaptonemal complex disassembly,BP,
14586,GO:0070195,1,0.967187933357248,0,1,growth hormone receptor complex,CC,
14587,GO:0070197,1,0.879098639460228,0,4,meiotic attachment of telomere to nuclear envelope,BP,
14588,GO:0070198,1,0.449960246833647,0,26,protein localization to chromosome, telomeric region,BP,
14589,GO:0070199,1,0.50271003302403,0,23,establishment of protein localization to chromosome,BP,
14590,GO:0070200,1,0.654099395238783,0,14,establishment of protein localization to telomere,BP,
14592,GO:0070202,1,0.719938279126231,0,11,regulation of establishment of protein localization to chromosome,BP,
14593,GO:0070203,1,0.742781439038161,0,10,regulation of establishment of protein localization to telomere,BP,
14597,GO:0070209,1,0.968346594058137,0,1,ASTRA complex,CC,
14599,GO:0070213,1,0.877909772553932,0,4,protein auto-ADP-ribosylation,BP,
14600,GO:0070221,1,0.896237910150379,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
14603,GO:0070229,1,0.46724039591174,0,25,negative regulation of lymphocyte apoptotic process,BP,
14607,GO:0070233,1,0.636302403323532,0,15,negative regulation of T cell apoptotic process,BP,
14609,GO:0070235,1,0.861916830056719,0,5,regulation of activation-induced cell death of T cells,BP,
14610,GO:0070236,1,0.886768702160528,0,4,negative regulation of activation-induced cell death of T cells,BP,
14613,GO:0070244,1,0.832570569012432,0,6,negative regulation of thymocyte apoptotic process,BP,
14616,GO:0070254,1,0.78808768982273,0,8,mucus secretion,BP,
14617,GO:0070255,1,0.808629517160177,0,7,regulation of mucus secretion,BP,
14618,GO:0070256,1,0.972997302627361,0,1,negative regulation of mucus secretion,BP,
14619,GO:0070257,1,0.831082225145076,0,6,positive regulation of mucus secretion,BP,
14620,GO:0070259,1,0.938136151675133,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
14621,GO:0070260,1,0.969271124374127,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14622,GO:0070262,1,0.677280607431223,0,13,peptidyl-serine dephosphorylation,BP,
14625,GO:0070267,1,0.967959882063429,0,1,oncosis,BP,
14627,GO:0070269,1,0.791339824080802,0,8,pyroptosis,BP,
14628,GO:0070273,1,0.489028216658175,0,23,phosphatidylinositol-4-phosphate binding,MF,
14629,GO:0070274,1,0.945528017232765,0,2,RES complex,CC,
14630,GO:0070278,1,0.940414916417988,0,2,extracellular matrix constituent secretion,BP,
14631,GO:0070279,1,0.36269287951332,0,33,vitamin B6 binding,MF,
14632,GO:0070280,1,0.96765332017958,0,1,pyridoxal binding,MF,
14633,GO:0070283,1,0.972657592338812,0,1,radical SAM enzyme activity,MF,
14634,GO:0070286,1,0.707667591283213,0,11,axonemal dynein complex assembly,BP,
14636,GO:0070290,1,0.851692056884481,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
14637,GO:0070291,1,0.883191740612548,0,4,N-acylethanolamine metabolic process,BP,
14638,GO:0070292,1,0.937191907183437,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
14640,GO:0070294,1,0.881538628016945,0,4,renal sodium ion absorption,BP,
14643,GO:0070300,1,0.570120447074956,0,18,phosphatidic acid binding,MF,
14648,GO:0070305,1,0.904442576022894,0,3,response to cGMP,BP,
14652,GO:0070314,1,0.853628177581729,0,5,G1 to G0 transition,BP,
14653,GO:0070315,1,0.938162628258838,0,2,G1 to G0 transition involved in cell differentiation,BP,
14656,GO:0070318,1,0.885443375644894,0,4,positive regulation of G0 to G1 transition,BP,
14657,GO:0070320,1,0.969831641248496,0,1,inward rectifier potassium channel inhibitor activity,MF,
14658,GO:0070324,1,0.856820947529162,0,5,thyroid hormone binding,MF,
14660,GO:0070326,1,0.916979887130097,0,3,very-low-density lipoprotein particle receptor binding,MF,
14661,GO:0070327,1,0.906699322846707,0,3,thyroid hormone transport,BP,
14663,GO:0070329,1,0.941892974386419,0,2,tRNA seleno-modification,BP,
14665,GO:0070335,1,0.966838985339169,0,1,aspartate binding,MF,
14666,GO:0070336,1,0.937160690276673,0,2,flap-structured DNA binding,MF,
14667,GO:0070337,1,0.966874347694405,0,1,3'-flap-structured DNA binding,MF,
14668,GO:0070339,1,0.910305758602509,0,3,response to bacterial lipopeptide,BP,
14669,GO:0070340,1,0.936173716074973,0,2,detection of bacterial lipopeptide,BP,
14670,GO:0070341,1,0.824983087720225,0,6,fat cell proliferation,BP,
14671,GO:0070343,1,0.967232351662302,0,1,white fat cell proliferation,BP,
14672,GO:0070344,1,0.824983087720225,0,6,regulation of fat cell proliferation,BP,
14673,GO:0070345,1,0.879588641725586,0,4,negative regulation of fat cell proliferation,BP,
14674,GO:0070346,1,0.969718338266846,0,1,positive regulation of fat cell proliferation,BP,
14675,GO:0070350,1,0.967232351662302,0,1,regulation of white fat cell proliferation,BP,
14676,GO:0070358,1,0.859996456800103,0,5,actin polymerization-dependent cell motility,BP,
14678,GO:0070369,1,0.905628917586793,0,3,beta-catenin-TCF7L2 complex,CC,
14679,GO:0070370,1,0.866858169429614,0,5,cellular heat acclimation,BP,
14684,GO:0070375,1,0.909698801827075,0,3,ERK5 cascade,BP,
14685,GO:0070376,1,0.969261624781041,0,1,regulation of ERK5 cascade,BP,
14686,GO:0070377,1,0.969261624781041,0,1,negative regulation of ERK5 cascade,BP,
14687,GO:0070381,1,0.936951274296865,0,2,endosome to plasma membrane transport vesicle,CC,
14689,GO:0070383,1,0.813873034056026,0,7,DNA cytosine deamination,BP,
14690,GO:0070384,1,0.908012589050696,0,3,Harderian gland development,BP,
14691,GO:0070390,1,0.972561016164289,0,1,transcription export complex 2,CC,
14693,GO:0070401,1,0.94455558678202,0,2,NADP+ binding,MF,
14694,GO:0070402,1,0.676351656587436,0,13,NADPH binding,MF,
14695,GO:0070403,1,0.698441207554422,0,12,NAD+ binding,MF,
14696,GO:0070404,1,0.919991111749684,0,3,NADH binding,MF,
14698,GO:0070407,1,0.968761467704374,0,1,oxidation-dependent protein catabolic process,BP,
14699,GO:0070408,1,0.966874900013976,0,1,carbamoyl phosphate metabolic process,BP,
14700,GO:0070409,1,0.966874900013976,0,1,carbamoyl phosphate biosynthetic process,BP,
14701,GO:0070410,1,0.796473581696388,0,7,co-SMAD binding,MF,
14702,GO:0070411,1,0.747693781537849,0,9,I-SMAD binding,MF,
14704,GO:0070413,1,0.969119748035427,0,1,trehalose metabolism in response to stress,BP,
14706,GO:0070418,1,0.966911336265999,0,1,DNA-dependent protein kinase complex,CC,
14707,GO:0070419,1,0.804240806196113,0,7,nonhomologous end joining complex,CC,
14710,GO:0070425,1,0.967148046407872,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14711,GO:0070426,1,0.941663934679467,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14713,GO:0070428,1,0.967148046407872,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14714,GO:0070429,1,0.967148046407872,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14716,GO:0070432,1,0.910723428216534,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14717,GO:0070433,1,0.967148046407872,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14718,GO:0070434,1,0.941663934679467,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14719,GO:0070435,1,0.93944432213088,0,2,Shc-EGFR complex,CC,
14720,GO:0070436,1,0.936750544027134,0,2,Grb2-EGFR complex,CC,
14723,GO:0070446,1,0.971921502773169,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
14725,GO:0070458,1,0.917100830830624,0,3,cellular detoxification of nitrogen compound,BP,
14727,GO:0070460,1,0.967604024860509,0,1,thyroid-stimulating hormone secretion,BP,
14729,GO:0070463,1,0.968128756894244,0,1,tubulin-dependent ATPase activity,MF,
14730,GO:0070469,1,0.117791707962798,0,78,respiratory chain,CC,
14731,GO:0070470,1,0.892223901512258,0,4,plasma membrane respiratory chain,CC,
14732,GO:0070471,1,0.90648834823221,0,3,uterine smooth muscle contraction,BP,
14733,GO:0070472,1,0.90648834823221,0,3,regulation of uterine smooth muscle contraction,BP,
14734,GO:0070474,1,0.90648834823221,0,3,positive regulation of uterine smooth muscle contraction,BP,
14735,GO:0070475,1,0.769735394430863,0,9,rRNA base methylation,BP,
14736,GO:0070476,1,0.974884447150127,0,1,rRNA (guanine-N7)-methylation,BP,
14737,GO:0070478,1,0.967305704152217,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
14738,GO:0070481,1,0.969214490445504,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14740,GO:0070483,1,0.968637792191127,0,1,detection of hypoxia,BP,
14743,GO:0070488,1,0.950673684276266,0,2,neutrophil aggregation,BP,
14744,GO:0070489,1,0.967493951822082,0,1,T cell aggregation,BP,
14747,GO:0070493,1,0.801834106113735,0,7,thrombin-activated receptor signaling pathway,BP,
14748,GO:0070494,1,0.91108057726758,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14749,GO:0070495,1,0.91108057726758,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
14751,GO:0070506,1,0.969798087908722,0,1,high-density lipoprotein particle receptor activity,MF,
14753,GO:0070508,1,0.859123790338223,0,5,cholesterol import,BP,
14755,GO:0070510,1,0.966839403368004,0,1,regulation of histone H4-K20 methylation,BP,
14756,GO:0070512,1,0.966839403368004,0,1,positive regulation of histone H4-K20 methylation,BP,
14757,GO:0070513,1,0.78806652492202,0,8,death domain binding,MF,
14758,GO:0070522,1,0.881587493489087,0,4,ERCC4-ERCC1 complex,CC,
14759,GO:0070524,1,0.973293313569966,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
14760,GO:0070525,1,0.682363752647692,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
14762,GO:0070528,1,0.549693965776271,0,19,protein kinase C signaling,BP,
14764,GO:0070531,1,0.854661469424094,0,5,BRCA1-A complex,CC,
14766,GO:0070535,1,0.851609473089318,0,5,histone H2A K63-linked ubiquitination,BP,
14768,GO:0070537,1,0.911106416051781,0,3,histone H2A K63-linked deubiquitination,BP,
14769,GO:0070538,1,0.973269589112886,0,1,oleic acid binding,MF,
14770,GO:0070539,1,0.968065642589633,0,1,linoleic acid binding,MF,
14771,GO:0070541,1,0.911597543852509,0,3,response to platinum ion,BP,
14773,GO:0070544,1,0.767979377595938,0,8,histone H3-K36 demethylation,BP,
14774,GO:0070545,1,0.88490404649896,0,4,PeBoW complex,CC,
14775,GO:0070548,1,0.966801523233906,0,1,L-glutamine aminotransferase activity,MF,
14776,GO:0070550,1,0.966765759377405,0,1,rDNA condensation,BP,
14777,GO:0070551,1,0.969271124374127,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14778,GO:0070552,1,0.912316819514928,0,3,BRISC complex,CC,
14779,GO:0070553,1,0.969271124374127,0,1,nicotinic acid receptor activity,MF,
14781,GO:0070557,1,0.945395659130652,0,2,PCNA-p21 complex,CC,
14782,GO:0070560,1,0.969271124374127,0,1,protein secretion by platelet,BP,
14783,GO:0070561,1,0.75224029017862,0,9,vitamin D receptor signaling pathway,BP,
14784,GO:0070562,1,0.828176307210916,0,6,regulation of vitamin D receptor signaling pathway,BP,
14785,GO:0070563,1,0.939355923320182,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
14786,GO:0070564,1,0.942565728421069,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
14788,GO:0070567,1,0.760972790918086,0,9,cytidylyltransferase activity,MF,
14789,GO:0070568,1,0.857865244293205,0,5,guanylyltransferase activity,MF,
14790,GO:0070569,1,0.805491873679159,0,7,uridylyltransferase activity,MF,
14791,GO:0070570,1,0.535138135976385,0,20,regulation of neuron projection regeneration,BP,
14792,GO:0070571,1,0.664524296700608,0,13,negative regulation of neuron projection regeneration,BP,
14793,GO:0070572,1,0.889316526069089,0,4,positive regulation of neuron projection regeneration,BP,
14794,GO:0070573,1,0.969271124374127,0,1,metallodipeptidase activity,MF,
14795,GO:0070574,1,0.910395501308696,0,3,cadmium ion transmembrane transport,BP,
14798,GO:0070578,1,0.759239972773733,0,9,RISC-loading complex,CC,
14799,GO:0070579,1,0.876520584435815,0,4,methylcytosine dioxygenase activity,MF,
14802,GO:0070586,1,0.786786099850739,0,8,cell-cell adhesion involved in gastrulation,BP,
14803,GO:0070587,1,0.811342997038692,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14805,GO:0070589,1,0.972400159260788,0,1,cellular component macromolecule biosynthetic process,BP,
14807,GO:0070601,1,0.781192334708579,0,8,centromeric sister chromatid cohesion,BP,
14808,GO:0070602,1,0.912890937275614,0,3,regulation of centromeric sister chromatid cohesion,BP,
14809,GO:0070603,1,0.123825409116611,0,67,SWI/SNF superfamily-type complex,CC,
14810,GO:0070611,1,0.969925183337138,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14811,GO:0070612,1,0.969925183337138,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
14813,GO:0070615,1,0.967393562446078,0,1,nucleosome-dependent ATPase activity,MF,
14814,GO:0070618,1,0.969787390375931,0,1,Grb2-Sos complex,CC,
14815,GO:0070625,1,0.971534577808934,0,1,zymogen granule exocytosis,BP,
14816,GO:0070626,1,0.973134129628015,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
14817,GO:0070627,1,0.96732120893744,0,1,ferrous iron import,BP,
14818,GO:0070628,1,0.586725934578245,0,18,proteasome binding,MF,
14819,GO:0070631,1,0.969271124374127,0,1,spindle pole body localization,BP,
14820,GO:0070632,1,0.969271124374127,0,1,establishment of spindle pole body localization,BP,
14822,GO:0070634,1,0.913559378391952,0,3,transepithelial ammonium transport,BP,
14823,GO:0070637,1,0.970556085034801,0,1,pyridine nucleoside metabolic process,BP,
14824,GO:0070638,1,0.970556085034801,0,1,pyridine nucleoside catabolic process,BP,
14825,GO:0070640,1,0.912675690359069,0,3,vitamin D3 metabolic process,BP,
14826,GO:0070643,1,0.972807317934447,0,1,vitamin D 25-hydroxylase activity,MF,
14827,GO:0070644,1,0.904360986989617,0,3,vitamin D response element binding,MF,
14830,GO:0070649,1,0.936435057104345,0,2,formin-nucleated actin cable assembly,BP,
14831,GO:0070650,1,0.969271124374127,0,1,actin filament bundle distribution,BP,
14832,GO:0070651,1,0.969214490445504,0,1,nonfunctional rRNA decay,BP,
14833,GO:0070652,1,0.784008378407356,0,8,HAUS complex,CC,
14842,GO:0070669,1,0.771487783316147,0,8,response to interleukin-2,BP,
14845,GO:0070672,1,0.749687532764224,0,9,response to interleukin-15,BP,
14847,GO:0070676,1,0.91900876562386,0,3,intralumenal vesicle formation,BP,
14848,GO:0070678,1,0.969806123725878,0,1,preprotein binding,MF,
14849,GO:0070679,1,0.817726648207141,0,6,inositol 1,4,5 trisphosphate binding,MF,
14850,GO:0070681,1,0.914335147779862,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
14851,GO:0070682,1,0.914641517566048,0,3,proteasome regulatory particle assembly,BP,
14852,GO:0070685,1,0.971445288908757,0,1,macropinocytic cup,CC,
14853,GO:0070694,1,0.969271124374127,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14854,GO:0070695,1,0.852329510161453,0,5,FHF complex,CC,
14855,GO:0070696,1,0.733207377964241,0,10,transmembrane receptor protein serine/threonine kinase binding,MF,
14856,GO:0070697,1,0.939065665717421,0,2,activin receptor binding,MF,
14857,GO:0070699,1,0.939065665717421,0,2,type II activin receptor binding,MF,
14858,GO:0070700,1,0.780817205316118,0,8,BMP receptor binding,MF,
14860,GO:0070715,1,0.968456823520522,0,1,sodium-dependent organic cation transport,BP,
14863,GO:0070724,1,0.968710947667684,0,1,BMP receptor complex,CC,
14865,GO:0070728,1,0.825509728954175,0,6,leucine binding,MF,
14866,GO:0070733,1,0.972724801745671,0,1,protein adenylyltransferase activity,MF,
14867,GO:0070734,1,0.572367695566,0,18,histone H3-K27 methylation,BP,
14868,GO:0070735,1,0.968234849772278,0,1,protein-glycine ligase activity,MF,
14869,GO:0070736,1,0.968234849772278,0,1,protein-glycine ligase activity, initiating,MF,
14870,GO:0070739,1,0.827148888871333,0,6,protein-glutamic acid ligase activity,MF,
14871,GO:0070740,1,0.827148888871333,0,6,tubulin-glutamic acid ligase activity,MF,
14873,GO:0070742,1,0.686825290689473,0,12,C2H2 zinc finger domain binding,MF,
14876,GO:0070761,1,0.837979891548426,0,6,pre-snoRNP complex,CC,
14877,GO:0070762,1,0.969271124374127,0,1,nuclear pore transmembrane ring,CC,
14878,GO:0070765,1,0.830479865339885,0,6,gamma-secretase complex,CC,
14879,GO:0070772,1,0.968792205220747,0,1,PAS complex,CC,
14880,GO:0070773,1,0.973430018690114,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
14881,GO:0070774,1,0.967170461726076,0,1,phytoceramidase activity,MF,
14882,GO:0070775,1,0.79775805674608,0,7,H3 histone acetyltransferase complex,CC,
14883,GO:0070776,1,0.79775805674608,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14884,GO:0070777,1,0.936269164126209,0,2,D-aspartate transport,BP,
14885,GO:0070778,1,0.879343852848948,0,4,L-aspartate transmembrane transport,BP,
14886,GO:0070779,1,0.936269164126209,0,2,D-aspartate import across plasma membrane,BP,
14887,GO:0070780,1,0.942990435262638,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
14888,GO:0070781,1,0.966868039012414,0,1,response to biotin,BP,
14889,GO:0070782,1,0.971314512889615,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
14890,GO:0070813,1,0.864629519151442,0,5,hydrogen sulfide metabolic process,BP,
14891,GO:0070814,1,0.887528175767081,0,4,hydrogen sulfide biosynthetic process,BP,
14892,GO:0070815,1,0.87924511503014,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
14893,GO:0070816,1,0.632481768965302,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14894,GO:0070818,1,0.972475898403431,0,1,protoporphyrinogen oxidase activity,MF,
14898,GO:0070826,1,0.96732120893744,0,1,paraferritin complex,CC,
14899,GO:0070827,1,0.877165173480465,0,4,chromatin maintenance,BP,
14901,GO:0070829,1,0.934951313664599,0,2,heterochromatin maintenance,BP,
14903,GO:0070831,1,0.79162512993908,0,7,basement membrane assembly,BP,
14904,GO:0070836,1,0.912545943539721,0,3,caveola assembly,BP,
14905,GO:0070837,1,0.936410967498919,0,2,dehydroascorbic acid transport,BP,
14907,GO:0070840,1,0.552396706031363,0,18,dynein complex binding,MF,
14909,GO:0070842,1,0.905494914704401,0,3,aggresome assembly,BP,
14910,GO:0070843,1,0.967361639798999,0,1,misfolded protein transport,BP,
14911,GO:0070844,1,0.967361639798999,0,1,polyubiquitinated protein transport,BP,
14912,GO:0070845,1,0.967361639798999,0,1,polyubiquitinated misfolded protein transport,BP,
14913,GO:0070846,1,0.967361639798999,0,1,Hsp90 deacetylation,BP,
14916,GO:0070849,1,0.290839545785893,0,39,response to epidermal growth factor,BP,
14918,GO:0070852,1,0.909375133916035,0,3,cell body fiber,CC,
14919,GO:0070853,1,0.934757914889569,0,2,myosin VI binding,MF,
14920,GO:0070856,1,0.966866266142908,0,1,myosin VI light chain binding,MF,
14921,GO:0070857,1,0.856039558205859,0,5,regulation of bile acid biosynthetic process,BP,
14922,GO:0070859,1,0.913044358502666,0,3,positive regulation of bile acid biosynthetic process,BP,
14923,GO:0070860,1,0.970869273443468,0,1,RNA polymerase I core factor complex,CC,
14926,GO:0070863,1,0.77334873698962,0,8,positive regulation of protein exit from endoplasmic reticulum,BP,
14929,GO:0070875,1,0.740640839682213,0,9,positive regulation of glycogen metabolic process,BP,
14931,GO:0070877,1,0.937417426579725,0,2,microprocessor complex,CC,
14932,GO:0070878,1,0.770855100277467,0,8,primary miRNA binding,MF,
14933,GO:0070883,1,0.861453234453993,0,5,pre-miRNA binding,MF,
14935,GO:0070885,1,0.908662553286529,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
14939,GO:0070889,1,0.941524183569312,0,2,platelet alpha granule organization,BP,
14940,GO:0070890,1,0.966843581004278,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
14941,GO:0070893,1,0.937410553681893,0,2,transposon integration,BP,
14942,GO:0070894,1,0.937410553681893,0,2,regulation of transposon integration,BP,
14943,GO:0070895,1,0.937410553681893,0,2,negative regulation of transposon integration,BP,
14945,GO:0070898,1,0.966743789855604,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
14946,GO:0070899,1,0.969012012988053,0,1,mitochondrial tRNA wobble uridine modification,BP,
14947,GO:0070900,1,0.767428872402256,0,9,mitochondrial tRNA modification,BP,
14948,GO:0070901,1,0.887655420686789,0,4,mitochondrial tRNA methylation,BP,
14949,GO:0070902,1,0.972679242845724,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
14950,GO:0070903,1,0.97185873293704,0,1,mitochondrial tRNA thio-modification,BP,
14951,GO:0070904,1,0.966843581004278,0,1,transepithelial L-ascorbic acid transport,BP,
14952,GO:0070905,1,0.942703417086346,0,2,serine binding,MF,
14954,GO:0070914,1,0.71088469603421,0,11,UV-damage excision repair,BP,
14955,GO:0070915,1,0.888850482135761,0,4,lysophosphatidic acid receptor activity,MF,
14957,GO:0070920,1,0.630330404809115,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
14958,GO:0070922,1,0.755010296675731,0,9,small RNA loading onto RISC,BP,
14960,GO:0070926,1,0.967608417626417,0,1,regulation of ATP:ADP antiporter activity,BP,
14961,GO:0070931,1,0.966875471081089,0,1,Golgi-associated vesicle lumen,CC,
14962,GO:0070932,1,0.532687724801554,0,20,histone H3 deacetylation,BP,
14963,GO:0070933,1,0.751188445460939,0,9,histone H4 deacetylation,BP,
14964,GO:0070934,1,0.879554012398623,0,4,CRD-mediated mRNA stabilization,BP,
14965,GO:0070935,1,0.706620559602806,0,11,3'-UTR-mediated mRNA stabilization,BP,
14967,GO:0070937,1,0.850831790412669,0,5,CRD-mediated mRNA stability complex,CC,
14969,GO:0070939,1,0.908114686774418,0,3,Dsl1/NZR complex,CC,
14970,GO:0070940,1,0.85427531441296,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
14973,GO:0070944,1,0.94278572904428,0,2,neutrophil mediated killing of bacterium,BP,
14974,GO:0070945,1,0.94278572904428,0,2,neutrophil mediated killing of gram-negative bacterium,BP,
14978,GO:0070950,1,0.969302166061177,0,1,regulation of neutrophil mediated killing of bacterium,BP,
14979,GO:0070951,1,0.969302166061177,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14983,GO:0070962,1,0.969302166061177,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
14984,GO:0070963,1,0.969302166061177,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
14986,GO:0070966,1,0.90649957181874,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
14987,GO:0070970,1,0.771604140006174,0,8,interleukin-2 secretion,BP,
14988,GO:0070971,1,0.621893244963223,0,15,endoplasmic reticulum exit site,CC,
14990,GO:0070973,1,0.879377958829723,0,4,protein localization to endoplasmic reticulum exit site,BP,
14991,GO:0070975,1,0.966833152131977,0,1,FHA domain binding,MF,
14992,GO:0070976,1,0.969726262371293,0,1,TIR domain binding,MF,
14993,GO:0070977,1,0.770987268357168,0,8,bone maturation,BP,
14994,GO:0070979,1,0.451744735988729,0,27,protein K11-linked ubiquitination,BP,
14995,GO:0070980,1,0.970722431445758,0,1,biphenyl catabolic process,BP,
14996,GO:0070981,1,0.970807517782275,0,1,L-asparagine biosynthetic process,BP,
14997,GO:0070982,1,0.970807517782275,0,1,L-asparagine metabolic process,BP,
14998,GO:0070984,1,0.967323567235443,0,1,SET domain binding,MF,
14999,GO:0070985,1,0.947108901656407,0,2,TFIIK complex,CC,
15001,GO:0070987,1,0.58288202485344,0,18,error-free translesion synthesis,BP,
15003,GO:0070989,1,0.732789797325832,0,10,oxidative demethylation,BP,
15004,GO:0070990,1,0.846691702817697,0,6,snRNP binding,MF,
15005,GO:0070991,1,0.910820018048946,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
15006,GO:0070992,1,0.944869158714786,0,2,translation initiation complex,CC,
15007,GO:0070993,1,0.935512467576817,0,2,translation preinitiation complex,CC,
15008,GO:0070995,1,0.968686018307077,0,1,NADPH oxidation,BP,
15010,GO:0071001,1,0.913894178644645,0,3,U4/U6 snRNP,CC,
15011,GO:0071004,1,0.601514887393622,0,17,U2-type prespliceosome,CC,
15012,GO:0071005,1,0.941361927042858,0,2,U2-type precatalytic spliceosome,CC,
15013,GO:0071006,1,0.912585501212048,0,3,U2-type catalytic step 1 spliceosome,CC,
15014,GO:0071007,1,0.427782470740727,0,29,U2-type catalytic step 2 spliceosome,CC,
15015,GO:0071008,1,0.88641232004204,0,4,U2-type post-mRNA release spliceosomal complex,CC,
15016,GO:0071010,1,0.52013049499604,0,22,prespliceosome,CC,
15018,GO:0071012,1,0.832367263221022,0,6,catalytic step 1 spliceosome,CC,
15020,GO:0071014,1,0.76377254146091,0,9,post-mRNA release spliceosomal complex,CC,
15021,GO:0071020,1,0.945752521639378,0,2,post-spliceosomal complex,CC,
15022,GO:0071021,1,0.972571400581427,0,1,U2-type post-spliceosomal complex,CC,
15023,GO:0071025,1,0.650494061369645,0,15,RNA surveillance,BP,
15024,GO:0071026,1,0.970354031289477,0,1,cytoplasmic RNA surveillance,BP,
15025,GO:0071027,1,0.691705631113315,0,13,nuclear RNA surveillance,BP,
15026,GO:0071028,1,0.691705631113315,0,13,nuclear mRNA surveillance,BP,
15027,GO:0071029,1,0.845475854578318,0,6,nuclear ncRNA surveillance,BP,
15028,GO:0071030,1,0.942934197113556,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15029,GO:0071031,1,0.945802508306395,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15030,GO:0071033,1,0.867343240017454,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15031,GO:0071034,1,0.886553030368633,0,4,CUT catabolic process,BP,
15032,GO:0071035,1,0.845475854578318,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15033,GO:0071038,1,0.872057944682349,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15034,GO:0071042,1,0.891666102017597,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15035,GO:0071043,1,0.886553030368633,0,4,CUT metabolic process,BP,
15036,GO:0071044,1,0.707987969428094,0,11,histone mRNA catabolic process,BP,
15037,GO:0071045,1,0.972737387699977,0,1,nuclear histone mRNA catabolic process,BP,
15038,GO:0071046,1,0.845475854578318,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15039,GO:0071047,1,0.891666102017597,0,4,polyadenylation-dependent mRNA catabolic process,BP,
15040,GO:0071048,1,0.942934197113556,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
15041,GO:0071049,1,0.945802508306395,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
15042,GO:0071051,1,0.873108160115521,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15043,GO:0071062,1,0.967247380922274,0,1,alphav-beta3 integrin-vitronectin complex,CC,
15045,GO:0071071,1,0.781127300132587,0,8,regulation of phospholipid biosynthetic process,BP,
15046,GO:0071072,1,0.880174713605873,0,4,negative regulation of phospholipid biosynthetic process,BP,
15047,GO:0071073,1,0.914213576458227,0,3,positive regulation of phospholipid biosynthetic process,BP,
15048,GO:0071074,1,0.972020602641156,0,1,eukaryotic initiation factor eIF2 binding,MF,
15049,GO:0071077,1,0.91257815150113,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15051,GO:0071104,1,0.934905278498889,0,2,response to interleukin-9,BP,
15052,GO:0071105,1,0.9669962861315,0,1,response to interleukin-11,BP,
15053,GO:0071106,1,0.91257815150113,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15054,GO:0071107,1,0.905502313244657,0,3,response to parathyroid hormone,BP,
15056,GO:0071109,1,0.934710551729516,0,2,superior temporal gyrus development,BP,
15057,GO:0071110,1,0.966868039012414,0,1,histone biotinylation,BP,
15059,GO:0071139,1,0.937862057622099,0,2,resolution of recombination intermediates,BP,
15060,GO:0071140,1,0.937862057622099,0,2,resolution of mitotic recombination intermediates,BP,
15061,GO:0071141,1,0.794303506319966,0,7,SMAD protein complex,CC,
15062,GO:0071144,1,0.934728144202923,0,2,heteromeric SMAD protein complex,CC,
15063,GO:0071148,1,0.934777064951079,0,2,TEAD-1-YAP complex,CC,
15064,GO:0071149,1,0.939130794001432,0,2,TEAD-2-YAP complex,CC,
15068,GO:0071159,1,0.945283531249984,0,2,NF-kappaB complex,CC,
15069,GO:0071163,1,0.917863208391798,0,3,DNA replication preinitiation complex assembly,BP,
15070,GO:0071164,1,0.967810473249221,0,1,RNA trimethylguanosine synthase activity,MF,
15071,GO:0071166,1,0.0229895636925725,0,122,ribonucleoprotein complex localization,BP,
15072,GO:0071168,1,0.51001979537884,0,22,protein localization to chromatin,BP,
15073,GO:0071169,1,0.793177213528751,0,8,establishment of protein localization to chromatin,BP,
15076,GO:0071203,1,0.827511554712959,0,6,WASH complex,CC,
15077,GO:0071204,1,0.835953417477265,0,6,histone pre-mRNA 3'end processing complex,CC,
15079,GO:0071207,1,0.940482259404427,0,2,histone pre-mRNA stem-loop binding,MF,
15080,GO:0071208,1,0.898385098764286,0,4,histone pre-mRNA DCP binding,MF,
15081,GO:0071209,1,0.920127702969655,0,3,U7 snRNA binding,MF,
15082,GO:0071211,1,0.881017670993485,0,4,protein targeting to vacuole involved in autophagy,BP,
15084,GO:0071215,1,0.967193497595987,0,1,cellular response to abscisic acid stimulus,BP,
15088,GO:0071220,1,0.910305758602509,0,3,cellular response to bacterial lipoprotein,BP,
15089,GO:0071221,1,0.910305758602509,0,3,cellular response to bacterial lipopeptide,BP,
15094,GO:0071226,1,0.966933724327514,0,1,cellular response to molecule of fungal origin,BP,
15095,GO:0071228,1,0.969186499754276,0,1,cellular response to tumor cell,BP,
15098,GO:0071233,1,0.770702830994109,0,8,cellular response to leucine,BP,
15101,GO:0071242,1,0.360418683318447,0,33,cellular response to ammonium ion,BP,
15103,GO:0071245,1,0.967884045210033,0,1,cellular response to carbon monoxide,BP,
15104,GO:0071247,1,0.973957996685046,0,1,cellular response to chromate,BP,
15106,GO:0071253,1,0.852373723000057,0,5,connexin binding,MF,
15107,GO:0071256,1,0.897851151907228,0,4,translocon complex,CC,
15108,GO:0071257,1,0.850482457693851,0,5,cellular response to electrical stimulus,BP,
15109,GO:0071258,1,0.96734639953885,0,1,cellular response to gravity,BP,
15111,GO:0071262,1,0.935677560041918,0,2,regulation of translational initiation in response to starvation,BP,
15112,GO:0071264,1,0.935677560041918,0,2,positive regulation of translational initiation in response to starvation,BP,
15113,GO:0071265,1,0.814641018729106,0,7,L-methionine biosynthetic process,BP,
15114,GO:0071266,1,0.972478537311936,0,1,'de novo' L-methionine biosynthetic process,BP,
15115,GO:0071267,1,0.837706999324698,0,6,L-methionine salvage,BP,
15116,GO:0071268,1,0.970913441825983,0,1,homocysteine biosynthetic process,BP,
15117,GO:0071275,1,0.971332173289546,0,1,cellular response to aluminum ion,BP,
15120,GO:0071279,1,0.887151756001164,0,4,cellular response to cobalt ion,BP,
15123,GO:0071283,1,0.946407940664742,0,2,cellular response to iron(III) ion,BP,
15126,GO:0071286,1,0.934838898894579,0,2,cellular response to magnesium ion,BP,
15129,GO:0071295,1,0.528399041919443,0,20,cellular response to vitamin,BP,
15131,GO:0071301,1,0.966833353549414,0,1,cellular response to vitamin B1,BP,
15132,GO:0071305,1,0.6399306357869,0,14,cellular response to vitamin D,BP,
15133,GO:0071306,1,0.939961513628034,0,2,cellular response to vitamin E,BP,
15134,GO:0071307,1,0.939777123444209,0,2,cellular response to vitamin K,BP,
15138,GO:0071314,1,0.969496377732309,0,1,cellular response to cocaine,BP,
15139,GO:0071315,1,0.909387849237781,0,3,cellular response to morphine,BP,
15141,GO:0071317,1,0.909387849237781,0,3,cellular response to isoquinoline alkaloid,BP,
15144,GO:0071321,1,0.904442576022894,0,3,cellular response to cGMP,BP,
15146,GO:0071324,1,0.966939668707445,0,1,cellular response to disaccharide stimulus,BP,
15148,GO:0071329,1,0.966939668707445,0,1,cellular response to sucrose stimulus,BP,
15152,GO:0071335,1,0.971279171620866,0,1,hair follicle cell proliferation,BP,
15153,GO:0071336,1,0.971279171620866,0,1,regulation of hair follicle cell proliferation,BP,
15154,GO:0071338,1,0.971279171620866,0,1,positive regulation of hair follicle cell proliferation,BP,
15156,GO:0071340,1,0.828544887174768,0,6,skeletal muscle acetylcholine-gated channel clustering,BP,
15157,GO:0071344,1,0.947104580756286,0,2,diphosphate metabolic process,BP,
15161,GO:0071348,1,0.9669962861315,0,1,cellular response to interleukin-11,BP,
15163,GO:0071350,1,0.775362358675333,0,8,cellular response to interleukin-15,BP,
15164,GO:0071351,1,0.835401520524459,0,6,cellular response to interleukin-18,BP,
15165,GO:0071352,1,0.771487783316147,0,8,cellular response to interleukin-2,BP,
15168,GO:0071355,1,0.934905278498889,0,2,cellular response to interleukin-9,BP,
15172,GO:0071360,1,0.6939996535947,0,12,cellular response to exogenous dsRNA,BP,
15173,GO:0071361,1,0.76716033843313,0,8,cellular response to ethanol,BP,
15174,GO:0071362,1,0.882242203849751,0,4,cellular response to ether,BP,
15176,GO:0071364,1,0.319859205890581,0,36,cellular response to epidermal growth factor stimulus,BP,
15179,GO:0071373,1,0.940248428669812,0,2,cellular response to luteinizing hormone stimulus,BP,
15180,GO:0071374,1,0.93658338805012,0,2,cellular response to parathyroid hormone stimulus,BP,
15182,GO:0071376,1,0.970039400331912,0,1,cellular response to corticotropin-releasing hormone stimulus,BP,
15185,GO:0071379,1,0.636302862236402,0,14,cellular response to prostaglandin stimulus,BP,
15186,GO:0071380,1,0.676373299978983,0,12,cellular response to prostaglandin E stimulus,BP,
15190,GO:0071386,1,0.934777117100517,0,2,cellular response to corticosterone stimulus,BP,
15191,GO:0071387,1,0.966907762965002,0,1,cellular response to cortisol stimulus,BP,
15193,GO:0071391,1,0.702151523002354,0,11,cellular response to estrogen stimulus,BP,
15194,GO:0071392,1,0.495709576988615,0,23,cellular response to estradiol stimulus,BP,
15195,GO:0071393,1,0.967420111238722,0,1,cellular response to progesterone stimulus,BP,
15196,GO:0071394,1,0.803329221022301,0,7,cellular response to testosterone stimulus,BP,
15197,GO:0071395,1,0.947173314806185,0,2,cellular response to jasmonic acid stimulus,BP,
15201,GO:0071400,1,0.938288957172031,0,2,cellular response to oleic acid,BP,
15202,GO:0071401,1,0.97092080711143,0,1,cellular response to triglyceride,BP,
15204,GO:0071403,1,0.938036160383379,0,2,cellular response to high density lipoprotein particle stimulus,BP,
15207,GO:0071409,1,0.936967976093126,0,2,cellular response to cycloheximide,BP,
15210,GO:0071418,1,0.973410249818931,0,1,cellular response to amine stimulus,BP,
15211,GO:0071420,1,0.935145745436661,0,2,cellular response to histamine,BP,
15212,GO:0071421,1,0.935968448179196,0,2,manganese ion transmembrane transport,BP,
15213,GO:0071422,1,0.910845283713539,0,3,succinate transmembrane transport,BP,
15214,GO:0071423,1,0.972082371452936,0,1,malate transmembrane transport,BP,
15215,GO:0071424,1,0.969271124374127,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15216,GO:0071425,1,0.640532685552619,0,14,hematopoietic stem cell proliferation,BP,
15217,GO:0071426,1,0.0236782279393224,0,121,ribonucleoprotein complex export from nucleus,BP,
15218,GO:0071427,1,0.040405377211702,0,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
15219,GO:0071428,1,0.645608558567671,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15220,GO:0071431,1,0.365234236039285,0,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
15222,GO:0071437,1,0.659108639503714,0,13,invadopodium,CC,
15223,GO:0071438,1,0.882894550743115,0,4,invadopodium membrane,CC,
15224,GO:0071439,1,0.779281909307541,0,8,clathrin complex,CC,
15225,GO:0071440,1,0.854598040351107,0,5,regulation of histone H3-K14 acetylation,BP,
15226,GO:0071441,1,0.967634582342254,0,1,negative regulation of histone H3-K14 acetylation,BP,
15227,GO:0071442,1,0.911199658320936,0,3,positive regulation of histone H3-K14 acetylation,BP,
15228,GO:0071447,1,0.853987810528997,0,5,cellular response to hydroperoxide,BP,
15229,GO:0071449,1,0.974298497481294,0,1,cellular response to lipid hydroperoxide,BP,
15233,GO:0071454,1,0.966831969670296,0,1,cellular response to anoxia,BP,
15234,GO:0071455,1,0.827057306934012,0,6,cellular response to hyperoxia,BP,
15236,GO:0071458,1,0.856038223339048,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
15237,GO:0071459,1,0.545200686730874,0,20,protein localization to chromosome, centromeric region,BP,
15238,GO:0071460,1,0.947944812636616,0,2,cellular response to cell-matrix adhesion,BP,
15240,GO:0071462,1,0.935960811297484,0,2,cellular response to water stimulus,BP,
15241,GO:0071464,1,0.966928186928295,0,1,cellular response to hydrostatic pressure,BP,
15243,GO:0071467,1,0.670066714513647,0,13,cellular response to pH,BP,
15244,GO:0071468,1,0.825577499269714,0,6,cellular response to acidic pH,BP,
15246,GO:0071471,1,0.967113354260911,0,1,cellular response to non-ionic osmotic stress,BP,
15247,GO:0071472,1,0.804494733742602,0,7,cellular response to salt stress,BP,
15248,GO:0071474,1,0.804612859670686,0,7,cellular hyperosmotic response,BP,
15249,GO:0071475,1,0.9153410595293,0,3,cellular hyperosmotic salinity response,BP,
15250,GO:0071476,1,0.799721742068982,0,7,cellular hypotonic response,BP,
15251,GO:0071477,1,0.936557827147341,0,2,cellular hypotonic salinity response,BP,
15255,GO:0071481,1,0.698356150475109,0,11,cellular response to X-ray,BP,
15257,GO:0071483,1,0.936859616243525,0,2,cellular response to blue light,BP,
15258,GO:0071484,1,0.936377277086893,0,2,cellular response to light intensity,BP,
15259,GO:0071485,1,0.968435086332893,0,1,cellular response to absence of light,BP,
15260,GO:0071486,1,0.966900162003065,0,1,cellular response to high light intensity,BP,
15263,GO:0071494,1,0.881619094980442,0,4,cellular response to UV-C,BP,
15267,GO:0071499,1,0.831448557435693,0,6,cellular response to laminar fluid shear stress,BP,
15268,GO:0071500,1,0.864756410938675,0,5,cellular response to nitrosative stress,BP,
15269,GO:0071501,1,0.775943894757514,0,8,cellular response to sterol depletion,BP,
15273,GO:0071505,1,0.93900151414314,0,2,response to mycophenolic acid,BP,
15274,GO:0071506,1,0.93900151414314,0,2,cellular response to mycophenolic acid,BP,
15277,GO:0071528,1,0.967588788735284,0,1,tRNA re-export from nucleus,BP,
15278,GO:0071532,1,0.87888076848343,0,4,ankyrin repeat binding,MF,
15279,GO:0071535,1,0.883515303600979,0,4,RING-like zinc finger domain binding,MF,
15280,GO:0071538,1,0.970866330437704,0,1,SH2 domain-mediated complex assembly,BP,
15282,GO:0071540,1,0.966895461624123,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
15283,GO:0071541,1,0.817751029776445,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15284,GO:0071542,1,0.603047456920049,0,16,dopaminergic neuron differentiation,BP,
15285,GO:0071543,1,0.887880067864205,0,4,diphosphoinositol polyphosphate metabolic process,BP,
15286,GO:0071544,1,0.973430018690114,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15287,GO:0071545,1,0.68463048735054,0,12,inositol phosphate catabolic process,BP,
15288,GO:0071546,1,0.938211682062162,0,2,pi-body,CC,
15289,GO:0071547,1,0.969585456016476,0,1,piP-body,CC,
15292,GO:0071550,1,0.789630570745857,0,8,death-inducing signaling complex assembly,BP,
15293,GO:0071554,1,0.916273990848672,0,3,cell wall organization or biogenesis,BP,
15295,GO:0071557,1,0.847096883641546,0,5,histone H3-K27 demethylation,BP,
15296,GO:0071558,1,0.847096883641546,0,5,histone demethylase activity (H3-K27 specific),MF,
15299,GO:0071561,1,0.966930318087253,0,1,nucleus-vacuole junction,CC,
15300,GO:0071564,1,0.687615379991143,0,12,npBAF complex,CC,
15301,GO:0071565,1,0.681736950815927,0,12,nBAF complex,CC,
15302,GO:0071566,1,0.969140329393705,0,1,UFM1 activating enzyme activity,MF,
15303,GO:0071567,1,0.945589018504509,0,2,UFM1 hydrolase activity,MF,
15304,GO:0071568,1,0.943974553419315,0,2,UFM1 transferase activity,MF,
15305,GO:0071569,1,0.839872807339342,0,6,protein ufmylation,BP,
15306,GO:0071573,1,0.969171428582719,0,1,shelterin complex assembly,BP,
15309,GO:0071579,1,0.971726436549267,0,1,regulation of zinc ion transport,BP,
15310,GO:0071580,1,0.971726436549267,0,1,regulation of zinc ion transmembrane transport,BP,
15311,GO:0071581,1,0.971726436549267,0,1,regulation of zinc ion transmembrane import,BP,
15312,GO:0071582,1,0.971726436549267,0,1,negative regulation of zinc ion transport,BP,
15313,GO:0071583,1,0.971726436549267,0,1,negative regulation of zinc ion transmembrane transport,BP,
15314,GO:0071584,1,0.971726436549267,0,1,negative regulation of zinc ion transmembrane import,BP,
15315,GO:0071585,1,0.971726436549267,0,1,detoxification of cadmium ion,BP,
15316,GO:0071586,1,0.942682023180035,0,2,CAAX-box protein processing,BP,
15317,GO:0071593,1,0.910325928683255,0,3,lymphocyte aggregation,BP,
15318,GO:0071595,1,0.939484005877423,0,2,Nem1-Spo7 phosphatase complex,CC,
15319,GO:0071596,1,0.903790318211602,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
15320,GO:0071598,1,0.858001427001306,0,5,neuronal ribonucleoprotein granule,CC,
15321,GO:0071599,1,0.820228938891612,0,6,otic vesicle development,BP,
15322,GO:0071600,1,0.904922097840074,0,3,otic vesicle morphogenesis,BP,
15323,GO:0071602,1,0.967170461726076,0,1,phytosphingosine biosynthetic process,BP,
15324,GO:0071603,1,0.936262479943515,0,2,endothelial cell-cell adhesion,BP,
15327,GO:0071606,1,0.971824351676263,0,1,chemokine (C-C motif) ligand 4 production,BP,
15328,GO:0071608,1,0.883004523046811,0,4,macrophage inflammatory protein-1 alpha production,BP,
15329,GO:0071609,1,0.758543892171851,0,9,chemokine (C-C motif) ligand 5 production,BP,
15330,GO:0071611,1,0.941429730320716,0,2,granulocyte colony-stimulating factor production,BP,
15331,GO:0071612,1,0.966729100888458,0,1,IP-10 production,BP,
15332,GO:0071614,1,0.972165891252207,0,1,linoleic acid epoxygenase activity,MF,
15333,GO:0071616,1,0.260092964180769,0,43,acyl-CoA biosynthetic process,BP,
15334,GO:0071617,1,0.531031355708157,0,20,lysophospholipid acyltransferase activity,MF,
15335,GO:0071619,1,0.970967966856243,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
15340,GO:0071625,1,0.696184297575114,0,11,vocalization behavior,BP,
15341,GO:0071629,1,0.972737387699977,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
15342,GO:0071630,1,0.906910159213409,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
15343,GO:0071633,1,0.969365023439283,0,1,dihydroceramidase activity,MF,
15346,GO:0071636,1,0.776190402069519,0,8,positive regulation of transforming growth factor beta production,BP,
15348,GO:0071638,1,0.942193999907254,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
15350,GO:0071640,1,0.883004523046811,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
15351,GO:0071641,1,0.940805113724649,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
15352,GO:0071642,1,0.93857257775085,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
15353,GO:0071643,1,0.971824351676263,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
15354,GO:0071644,1,0.971824351676263,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
15355,GO:0071649,1,0.779891323397811,0,8,regulation of chemokine (C-C motif) ligand 5 production,BP,
15356,GO:0071650,1,0.917412666589018,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
15357,GO:0071651,1,0.850131328732566,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
15358,GO:0071655,1,0.941429730320716,0,2,regulation of granulocyte colony-stimulating factor production,BP,
15359,GO:0071656,1,0.970825151529268,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
15360,GO:0071657,1,0.969723619722645,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
15361,GO:0071658,1,0.966729100888458,0,1,regulation of IP-10 production,BP,
15362,GO:0071660,1,0.966729100888458,0,1,positive regulation of IP-10 production,BP,
15363,GO:0071664,1,0.876914533626499,0,4,catenin-TCF7L2 complex,CC,
15364,GO:0071665,1,0.968301891102076,0,1,gamma-catenin-TCF7L2 complex,CC,
15368,GO:0071673,1,0.968754341634736,0,1,positive regulation of smooth muscle cell chemotaxis,BP,
15372,GO:0071677,1,0.744419707875902,0,10,positive regulation of mononuclear cell migration,BP,
15373,GO:0071678,1,0.966824930888283,0,1,olfactory bulb axon guidance,BP,
15375,GO:0071680,1,0.848179415842824,0,5,response to indole-3-methanol,BP,
15376,GO:0071681,1,0.848179415842824,0,5,cellular response to indole-3-methanol,BP,
15378,GO:0071684,1,0.968512019901731,0,1,organism emergence from protective structure,BP,
15379,GO:0071688,1,0.903212796953264,0,3,striated muscle myosin thick filament assembly,BP,
15380,GO:0071691,1,0.966844217498425,0,1,cardiac muscle thin filament assembly,BP,
15385,GO:0071697,1,0.731733599615516,0,10,ectodermal placode morphogenesis,BP,
15386,GO:0071698,1,0.936162794447199,0,2,olfactory placode development,BP,
15387,GO:0071699,1,0.936162794447199,0,2,olfactory placode morphogenesis,BP,
15388,GO:0071701,1,0.966975112615761,0,1,regulation of MAPK export from nucleus,BP,
15393,GO:0071707,1,0.97360441117037,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
15394,GO:0071709,1,0.55162895696734,0,19,membrane assembly,BP,
15397,GO:0071713,1,0.967021538070694,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
15399,GO:0071723,1,0.905934418465594,0,3,lipopeptide binding,MF,
15400,GO:0071724,1,0.936173716074973,0,2,response to diacyl bacterial lipopeptide,BP,
15401,GO:0071725,1,0.968253078048579,0,1,response to triacyl bacterial lipopeptide,BP,
15402,GO:0071726,1,0.936173716074973,0,2,cellular response to diacyl bacterial lipopeptide,BP,
15403,GO:0071727,1,0.968253078048579,0,1,cellular response to triacyl bacterial lipopeptide,BP,
15405,GO:0071732,1,0.735977818313302,0,10,cellular response to nitric oxide,BP,
15406,GO:0071733,1,0.911133048108722,0,3,transcriptional activation by promoter-enhancer looping,BP,
15408,GO:0071765,1,0.967287592119379,0,1,nuclear inner membrane organization,BP,
15414,GO:0071787,1,0.886023233316212,0,4,endoplasmic reticulum tubular network formation,BP,
15415,GO:0071789,1,0.969271124374127,0,1,spindle pole body localization to nuclear envelope,BP,
15416,GO:0071790,1,0.969271124374127,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15417,GO:0071796,1,0.973555526993504,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
15418,GO:0071797,1,0.884641958348305,0,4,LUBAC complex,CC,
15419,GO:0071798,1,0.940818402080827,0,2,response to prostaglandin D,BP,
15420,GO:0071799,1,0.940818402080827,0,2,cellular response to prostaglandin D stimulus,BP,
15423,GO:0071802,1,0.96730341083719,0,1,negative regulation of podosome assembly,BP,
15428,GO:0071812,1,0.968749262222874,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15431,GO:0071816,1,0.889578594650883,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
15432,GO:0071817,1,0.862706091907226,0,5,MMXD complex,CC,
15433,GO:0071818,1,0.91422545210686,0,3,BAT3 complex,CC,
15434,GO:0071819,1,0.943631643283208,0,2,DUBm complex,CC,
15435,GO:0071820,1,0.973198875078459,0,1,N-box binding,MF,
15436,GO:0071821,1,0.966839010669017,0,1,FANCM-MHF complex,CC,
15438,GO:0071825,1,0.475994036964156,0,24,protein-lipid complex subunit organization,BP,
15440,GO:0071827,1,0.506937299956917,0,22,plasma lipoprotein particle organization,BP,
15441,GO:0071830,1,0.890531469380578,0,4,triglyceride-rich lipoprotein particle clearance,BP,
15443,GO:0071838,1,0.883961636316434,0,4,cell proliferation in bone marrow,BP,
15444,GO:0071839,1,0.887179039473889,0,4,apoptotic process in bone marrow,BP,
15447,GO:0071848,1,0.968749262222874,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
15450,GO:0071863,1,0.855119679160408,0,5,regulation of cell proliferation in bone marrow,BP,
15451,GO:0071864,1,0.855119679160408,0,5,positive regulation of cell proliferation in bone marrow,BP,
15452,GO:0071865,1,0.884400260538384,0,4,regulation of apoptotic process in bone marrow,BP,
15453,GO:0071866,1,0.884400260538384,0,4,negative regulation of apoptotic process in bone marrow,BP,
15454,GO:0071867,1,0.469790113629117,0,24,response to monoamine,BP,
15455,GO:0071868,1,0.483902793718159,0,23,cellular response to monoamine stimulus,BP,
15456,GO:0071869,1,0.469790113629117,0,24,response to catecholamine,BP,
15457,GO:0071870,1,0.483902793718159,0,23,cellular response to catecholamine stimulus,BP,
15458,GO:0071871,1,0.754754510074899,0,9,response to epinephrine,BP,
15459,GO:0071872,1,0.777397755396782,0,8,cellular response to epinephrine stimulus,BP,
15460,GO:0071873,1,0.968127192255364,0,1,response to norepinephrine,BP,
15461,GO:0071874,1,0.968127192255364,0,1,cellular response to norepinephrine stimulus,BP,
15462,GO:0071875,1,0.704696330926235,0,11,adrenergic receptor signaling pathway,BP,
15463,GO:0071877,1,0.973430018690114,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15464,GO:0071878,1,0.966797215838241,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15465,GO:0071879,1,0.908334945175006,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15466,GO:0071880,1,0.770606330876476,0,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
15467,GO:0071881,1,0.973430018690114,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15468,GO:0071885,1,0.969271124374127,0,1,N-terminal protein N-methyltransferase activity,MF,
15471,GO:0071889,1,0.482735618832121,0,23,14-3-3 protein binding,MF,
15472,GO:0071893,1,0.972376033972612,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15473,GO:0071894,1,0.94049974986337,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
15474,GO:0071895,1,0.857524862888702,0,5,odontoblast differentiation,BP,
15475,GO:0071896,1,0.873868115156877,0,4,protein localization to adherens junction,BP,
15477,GO:0071898,1,0.912321295707214,0,3,regulation of estrogen receptor binding,BP,
15478,GO:0071899,1,0.912321295707214,0,3,negative regulation of estrogen receptor binding,BP,
15482,GO:0071907,1,0.910086484754849,0,3,determination of digestive tract left/right asymmetry,BP,
15483,GO:0071908,1,0.966889920942967,0,1,determination of intestine left/right asymmetry,BP,
15484,GO:0071909,1,0.966889920942967,0,1,determination of stomach left/right asymmetry,BP,
15485,GO:0071910,1,0.934910224810978,0,2,determination of liver left/right asymmetry,BP,
15486,GO:0071914,1,0.96763853165673,0,1,prominosome,CC,
15487,GO:0071918,1,0.937310878860775,0,2,urea transmembrane transport,BP,
15488,GO:0071920,1,0.942245537102124,0,2,cleavage body,CC,
15489,GO:0071921,1,0.82821658326039,0,6,cohesin loading,BP,
15490,GO:0071922,1,0.85448508389553,0,5,regulation of cohesin loading,BP,
15492,GO:0071929,1,0.938986020821876,0,2,alpha-tubulin acetylation,BP,
15493,GO:0071930,1,0.906674060482472,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15494,GO:0071931,1,0.969271124374127,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15495,GO:0071933,1,0.800799233978927,0,7,Arp2/3 complex binding,MF,
15496,GO:0071934,1,0.941504613526631,0,2,thiamine transmembrane transport,BP,
15497,GO:0071936,1,0.768944448096246,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
15499,GO:0071942,1,0.911957263817732,0,3,XPC complex,CC,
15501,GO:0071947,1,0.904183445571081,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
15502,GO:0071949,1,0.521266548534091,0,21,FAD binding,MF,
15503,GO:0071951,1,0.969626763580086,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
15504,GO:0071953,1,0.940892945689573,0,2,elastic fiber,CC,
15505,GO:0071955,1,0.934900864015832,0,2,recycling endosome to Golgi transport,BP,
15506,GO:0071960,1,0.974353186685951,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
15507,GO:0071962,1,0.916961072382531,0,3,mitotic sister chromatid cohesion, centromeric,BP,
15508,GO:0071963,1,0.972474578472334,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
15509,GO:0071971,1,0.831863072890708,0,6,extracellular exosome assembly,BP,
15510,GO:0071985,1,0.412416700252358,0,29,multivesicular body sorting pathway,BP,
15511,GO:0071986,1,0.82997119583643,0,6,Ragulator complex,CC,
15512,GO:0071987,1,0.878928336858079,0,4,WD40-repeat domain binding,MF,
15513,GO:0071988,1,0.966837517356414,0,1,protein localization to spindle pole body,BP,
15514,GO:0071997,1,0.966857836354105,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
15516,GO:0072003,1,0.967604024860509,0,1,kidney rudiment formation,BP,
15517,GO:0072004,1,0.967604024860509,0,1,kidney field specification,BP,
15519,GO:0072007,1,0.911698336286498,0,3,mesangial cell differentiation,BP,
15520,GO:0072008,1,0.911698336286498,0,3,glomerular mesangial cell differentiation,BP,
15522,GO:0072010,1,0.682420314294561,0,12,glomerular epithelium development,BP,
15523,GO:0072012,1,0.691422891926848,0,12,glomerulus vasculature development,BP,
15524,GO:0072014,1,0.884959670321705,0,4,proximal tubule development,BP,
15525,GO:0072015,1,0.770274199889191,0,8,glomerular visceral epithelial cell development,BP,
15526,GO:0072017,1,0.764411169509938,0,8,distal tubule development,BP,
15527,GO:0072019,1,0.971364530564028,0,1,proximal convoluted tubule development,BP,
15528,GO:0072021,1,0.934704307029464,0,2,ascending thin limb development,BP,
15529,GO:0072025,1,0.967604024860509,0,1,distal convoluted tubule development,BP,
15531,GO:0072033,1,0.819822159513581,0,6,renal vesicle formation,BP,
15532,GO:0072034,1,0.936166654859117,0,2,renal vesicle induction,BP,
15533,GO:0072036,1,0.967754720267588,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15534,GO:0072038,1,0.936096650142034,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15535,GO:0072039,1,0.936096650142034,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15536,GO:0072040,1,0.936096650142034,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15537,GO:0072044,1,0.774032401213357,0,8,collecting duct development,BP,
15538,GO:0072047,1,0.891124805061997,0,4,proximal/distal pattern formation involved in nephron development,BP,
15539,GO:0072048,1,0.814094582827641,0,7,renal system pattern specification,BP,
15540,GO:0072049,1,0.891408717073184,0,4,comma-shaped body morphogenesis,BP,
15541,GO:0072050,1,0.835202097016021,0,6,S-shaped body morphogenesis,BP,
15542,GO:0072053,1,0.936796650344884,0,2,renal inner medulla development,BP,
15543,GO:0072054,1,0.936796650344884,0,2,renal outer medulla development,BP,
15544,GO:0072055,1,0.966928186928295,0,1,renal cortex development,BP,
15545,GO:0072059,1,0.966928186928295,0,1,cortical collecting duct development,BP,
15546,GO:0072060,1,0.967561061661216,0,1,outer medullary collecting duct development,BP,
15547,GO:0072061,1,0.941734736244216,0,2,inner medullary collecting duct development,BP,
15548,GO:0072069,1,0.967604024860509,0,1,DCT cell differentiation,BP,
15549,GO:0072070,1,0.75453174563638,0,9,loop of Henle development,BP,
15550,GO:0072071,1,0.973198875078459,0,1,kidney interstitial fibroblast differentiation,BP,
15552,GO:0072074,1,0.685395033578946,0,12,kidney mesenchyme development,BP,
15553,GO:0072075,1,0.748988219528904,0,9,metanephric mesenchyme development,BP,
15554,GO:0072076,1,0.908190029467312,0,3,nephrogenic mesenchyme development,BP,
15555,GO:0072077,1,0.70408616042045,0,11,renal vesicle morphogenesis,BP,
15557,GO:0072079,1,0.716868861795033,0,11,nephron tubule formation,BP,
15559,GO:0072081,1,0.891124805061997,0,4,specification of nephron tubule identity,BP,
15560,GO:0072086,1,0.891124805061997,0,4,specification of loop of Henle identity,BP,
15561,GO:0072087,1,0.70408616042045,0,11,renal vesicle development,BP,
15565,GO:0072092,1,0.934651809527996,0,2,ureteric bud invasion,BP,
15566,GO:0072093,1,0.904508222655992,0,3,metanephric renal vesicle formation,BP,
15567,GO:0072095,1,0.940151891014175,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
15568,GO:0072096,1,0.972376033972612,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15569,GO:0072097,1,0.972376033972612,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15570,GO:0072098,1,0.972376033972612,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15571,GO:0072099,1,0.972376033972612,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15572,GO:0072100,1,0.972376033972612,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15573,GO:0072101,1,0.972376033972612,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15574,GO:0072102,1,0.909017860237583,0,3,glomerulus morphogenesis,BP,
15575,GO:0072103,1,0.940105469659427,0,2,glomerulus vasculature morphogenesis,BP,
15576,GO:0072104,1,0.940105469659427,0,2,glomerular capillary formation,BP,
15577,GO:0072106,1,0.913078592102041,0,3,regulation of ureteric bud formation,BP,
15578,GO:0072107,1,0.913078592102041,0,3,positive regulation of ureteric bud formation,BP,
15579,GO:0072108,1,0.912531535956918,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
15580,GO:0072109,1,0.76006590505712,0,9,glomerular mesangium development,BP,
15581,GO:0072110,1,0.808114832070136,0,7,glomerular mesangial cell proliferation,BP,
15582,GO:0072111,1,0.647505452033811,0,14,cell proliferation involved in kidney development,BP,
15583,GO:0072112,1,0.704870789402789,0,11,glomerular visceral epithelial cell differentiation,BP,
15584,GO:0072114,1,0.966881269277234,0,1,pronephros morphogenesis,BP,
15585,GO:0072124,1,0.808114832070136,0,7,regulation of glomerular mesangial cell proliferation,BP,
15586,GO:0072125,1,0.911561175946391,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
15587,GO:0072126,1,0.88654448923135,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
15588,GO:0072127,1,0.971001882139398,0,1,renal capsule development,BP,
15589,GO:0072128,1,0.971001882139398,0,1,renal capsule morphogenesis,BP,
15590,GO:0072129,1,0.971001882139398,0,1,renal capsule formation,BP,
15591,GO:0072130,1,0.971001882139398,0,1,renal capsule specification,BP,
15592,GO:0072131,1,0.907914910419151,0,3,kidney mesenchyme morphogenesis,BP,
15593,GO:0072132,1,0.435293931760535,0,26,mesenchyme morphogenesis,BP,
15594,GO:0072133,1,0.907914910419151,0,3,metanephric mesenchyme morphogenesis,BP,
15595,GO:0072134,1,0.935317367414622,0,2,nephrogenic mesenchyme morphogenesis,BP,
15596,GO:0072135,1,0.936463154918779,0,2,kidney mesenchymal cell proliferation,BP,
15597,GO:0072136,1,0.936463154918779,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
15598,GO:0072137,1,0.966637646288102,0,1,condensed mesenchymal cell proliferation,BP,
15599,GO:0072138,1,0.941949008554646,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
15600,GO:0072139,1,0.97125559745736,0,1,glomerular parietal epithelial cell differentiation,BP,
15601,GO:0072141,1,0.973198875078459,0,1,renal interstitial fibroblast development,BP,
15602,GO:0072143,1,0.911698336286498,0,3,mesangial cell development,BP,
15603,GO:0072144,1,0.911698336286498,0,3,glomerular mesangial cell development,BP,
15605,GO:0072156,1,0.904068022912491,0,3,distal tubule morphogenesis,BP,
15606,GO:0072160,1,0.721429004855735,0,10,nephron tubule epithelial cell differentiation,BP,
15607,GO:0072161,1,0.882718888824193,0,4,mesenchymal cell differentiation involved in kidney development,BP,
15608,GO:0072162,1,0.936587930494954,0,2,metanephric mesenchymal cell differentiation,BP,
15611,GO:0072166,1,0.969015328178466,0,1,posterior mesonephric tubule development,BP,
15612,GO:0072170,1,0.616845470037011,0,15,metanephric tubule development,BP,
15614,GO:0072172,1,0.887586439753218,0,4,mesonephric tubule formation,BP,
15615,GO:0072173,1,0.802124639716436,0,7,metanephric tubule morphogenesis,BP,
15616,GO:0072174,1,0.905833241888366,0,3,metanephric tubule formation,BP,
15618,GO:0072176,1,0.796182406879767,0,7,nephric duct development,BP,
15619,GO:0072177,1,0.934704307029464,0,2,mesonephric duct development,BP,
15620,GO:0072178,1,0.851826600000122,0,5,nephric duct morphogenesis,BP,
15621,GO:0072179,1,0.942110294577189,0,2,nephric duct formation,BP,
15622,GO:0072182,1,0.746117097084055,0,9,regulation of nephron tubule epithelial cell differentiation,BP,
15623,GO:0072183,1,0.967982831740707,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15624,GO:0072185,1,0.970707788420789,0,1,metanephric cap development,BP,
15625,GO:0072186,1,0.970707788420789,0,1,metanephric cap morphogenesis,BP,
15626,GO:0072189,1,0.797904513123434,0,7,ureter development,BP,
15627,GO:0072190,1,0.940817591240659,0,2,ureter urothelium development,BP,
15628,GO:0072191,1,0.940817591240659,0,2,ureter smooth muscle development,BP,
15629,GO:0072192,1,0.972376033972612,0,1,ureter epithelial cell differentiation,BP,
15630,GO:0072193,1,0.940817591240659,0,2,ureter smooth muscle cell differentiation,BP,
15631,GO:0072194,1,0.966928186928295,0,1,kidney smooth muscle tissue development,BP,
15632,GO:0072197,1,0.940817591240659,0,2,ureter morphogenesis,BP,
15633,GO:0072198,1,0.972376033972612,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15634,GO:0072199,1,0.972376033972612,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15635,GO:0072200,1,0.972376033972612,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
15636,GO:0072201,1,0.825647938330804,0,6,negative regulation of mesenchymal cell proliferation,BP,
15637,GO:0072202,1,0.637542930848242,0,14,cell differentiation involved in metanephros development,BP,
15638,GO:0072203,1,0.824986726165152,0,6,cell proliferation involved in metanephros development,BP,
15639,GO:0072204,1,0.936805710322018,0,2,cell-cell signaling involved in metanephros development,BP,
15640,GO:0072205,1,0.850803715604799,0,5,metanephric collecting duct development,BP,
15641,GO:0072207,1,0.577880013211373,0,17,metanephric epithelium development,BP,
15642,GO:0072208,1,0.966928186928295,0,1,metanephric smooth muscle tissue development,BP,
15643,GO:0072209,1,0.969303365112211,0,1,metanephric mesangial cell differentiation,BP,
15644,GO:0072210,1,0.453676960783709,0,25,metanephric nephron development,BP,
15645,GO:0072213,1,0.971001882139398,0,1,metanephric capsule development,BP,
15646,GO:0072214,1,0.966928186928295,0,1,metanephric cortex development,BP,
15647,GO:0072215,1,0.604960330470921,0,16,regulation of metanephros development,BP,
15648,GO:0072216,1,0.734692419124725,0,10,positive regulation of metanephros development,BP,
15649,GO:0072217,1,0.854450026833486,0,5,negative regulation of metanephros development,BP,
15650,GO:0072218,1,0.934704307029464,0,2,metanephric ascending thin limb development,BP,
15651,GO:0072219,1,0.966928186928295,0,1,metanephric cortical collecting duct development,BP,
15652,GO:0072221,1,0.967604024860509,0,1,metanephric distal convoluted tubule development,BP,
15653,GO:0072223,1,0.909901924350438,0,3,metanephric glomerular mesangium development,BP,
15654,GO:0072224,1,0.822509086522149,0,6,metanephric glomerulus development,BP,
15655,GO:0072229,1,0.971364530564028,0,1,metanephric proximal convoluted tubule development,BP,
15656,GO:0072234,1,0.637546467917546,0,14,metanephric nephron tubule development,BP,
15657,GO:0072235,1,0.904418151119467,0,3,metanephric distal tubule development,BP,
15658,GO:0072236,1,0.904377986168774,0,3,metanephric loop of Henle development,BP,
15659,GO:0072237,1,0.938993197469404,0,2,metanephric proximal tubule development,BP,
15660,GO:0072239,1,0.909901924350438,0,3,metanephric glomerulus vasculature development,BP,
15661,GO:0072240,1,0.967604024860509,0,1,metanephric DCT cell differentiation,BP,
15662,GO:0072243,1,0.616400760568323,0,15,metanephric nephron epithelium development,BP,
15663,GO:0072244,1,0.966872799575289,0,1,metanephric glomerular epithelium development,BP,
15664,GO:0072248,1,0.966872799575289,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
15665,GO:0072249,1,0.966872799575289,0,1,metanephric glomerular visceral epithelial cell development,BP,
15666,GO:0072254,1,0.969303365112211,0,1,metanephric glomerular mesangial cell differentiation,BP,
15667,GO:0072255,1,0.969303365112211,0,1,metanephric glomerular mesangial cell development,BP,
15668,GO:0072257,1,0.818959126196591,0,6,metanephric nephron tubule epithelial cell differentiation,BP,
15669,GO:0072262,1,0.938722457771011,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15670,GO:0072265,1,0.971001882139398,0,1,metanephric capsule morphogenesis,BP,
15671,GO:0072266,1,0.971001882139398,0,1,metanephric capsule formation,BP,
15672,GO:0072267,1,0.971001882139398,0,1,metanephric capsule specification,BP,
15673,GO:0072268,1,0.915485411739634,0,3,pattern specification involved in metanephros development,BP,
15674,GO:0072272,1,0.942830060934763,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
15675,GO:0072273,1,0.584076804583949,0,17,metanephric nephron morphogenesis,BP,
15676,GO:0072274,1,0.966872799575289,0,1,metanephric glomerular basement membrane development,BP,
15677,GO:0072278,1,0.940872584535151,0,2,metanephric comma-shaped body morphogenesis,BP,
15678,GO:0072282,1,0.829023859144402,0,6,metanephric nephron tubule morphogenesis,BP,
15679,GO:0072283,1,0.752133574956688,0,9,metanephric renal vesicle morphogenesis,BP,
15680,GO:0072284,1,0.881555591370516,0,4,metanephric S-shaped body morphogenesis,BP,
15681,GO:0072285,1,0.967754720267588,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15682,GO:0072287,1,0.966676978800731,0,1,metanephric distal tubule morphogenesis,BP,
15683,GO:0072289,1,0.936200047980482,0,2,metanephric nephron tubule formation,BP,
15684,GO:0072298,1,0.907704701875202,0,3,regulation of metanephric glomerulus development,BP,
15685,GO:0072299,1,0.969015328178466,0,1,negative regulation of metanephric glomerulus development,BP,
15686,GO:0072300,1,0.936734214543849,0,2,positive regulation of metanephric glomerulus development,BP,
15687,GO:0072301,1,0.938722457771011,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
15688,GO:0072302,1,0.969015328178466,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
15689,GO:0072303,1,0.968741153584299,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
15690,GO:0072304,1,0.967604024860509,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15691,GO:0072305,1,0.967604024860509,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15692,GO:0072307,1,0.818959126196591,0,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15693,GO:0072308,1,0.967982831740707,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
15694,GO:0072309,1,0.967604024860509,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15695,GO:0072310,1,0.770274199889191,0,8,glomerular epithelial cell development,BP,
15696,GO:0072311,1,0.704870789402789,0,11,glomerular epithelial cell differentiation,BP,
15697,GO:0072312,1,0.966872799575289,0,1,metanephric glomerular epithelial cell differentiation,BP,
15698,GO:0072313,1,0.966872799575289,0,1,metanephric glomerular epithelial cell development,BP,
15699,GO:0072318,1,0.852462350957917,0,5,clathrin coat disassembly,BP,
15700,GO:0072319,1,0.827935693388914,0,6,vesicle uncoating,BP,
15701,GO:0072320,1,0.90587336644392,0,3,volume-sensitive chloride channel activity,MF,
15702,GO:0072321,1,0.75091313718671,0,10,chaperone-mediated protein transport,BP,
15708,GO:0072337,1,0.682378364129931,0,12,modified amino acid transport,BP,
15711,GO:0072343,1,0.972172812265828,0,1,pancreatic stellate cell proliferation,BP,
15712,GO:0072344,1,0.885222257114927,0,4,rescue of stalled ribosome,BP,
15713,GO:0072345,1,0.85312934458948,0,5,NAADP-sensitive calcium-release channel activity,MF,
15715,GO:0072348,1,0.518334557818157,0,21,sulfur compound transport,BP,
15716,GO:0072349,1,0.744057632586777,0,9,modified amino acid transmembrane transporter activity,MF,
15718,GO:0072354,1,0.972568806346861,0,1,histone kinase activity (H3-T3 specific),MF,
15719,GO:0072355,1,0.972568806346861,0,1,histone H3-T3 phosphorylation,BP,
15720,GO:0072356,1,0.967445251707302,0,1,chromosome passenger complex localization to kinetochore,BP,
15721,GO:0072357,1,0.798617560634784,0,7,PTW/PP1 phosphatase complex,CC,
15724,GO:0072361,1,0.934687593809811,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
15725,GO:0072362,1,0.966818712915794,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15726,GO:0072363,1,0.966769151506575,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15727,GO:0072364,1,0.934670915098097,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
15728,GO:0072365,1,0.966801462422347,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
15729,GO:0072366,1,0.966769151506575,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
15730,GO:0072367,1,0.876121868516104,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
15731,GO:0072368,1,0.935120709231041,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
15732,GO:0072369,1,0.936918979547319,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
15734,GO:0072378,1,0.789145877452967,0,8,blood coagulation, fibrin clot formation,BP,
15735,GO:0072379,1,0.91422545210686,0,3,ER membrane insertion complex,CC,
15736,GO:0072382,1,0.966672091528993,0,1,minus-end-directed vesicle transport along microtubule,BP,
15737,GO:0072383,1,0.792568465161563,0,7,plus-end-directed vesicle transport along microtubule,BP,
15739,GO:0072385,1,0.876167657046494,0,4,minus-end-directed organelle transport along microtubule,BP,
15740,GO:0072386,1,0.766297865041452,0,8,plus-end-directed organelle transport along microtubule,BP,
15741,GO:0072387,1,0.94036230474728,0,2,flavin adenine dinucleotide metabolic process,BP,
15742,GO:0072388,1,0.971848715171512,0,1,flavin adenine dinucleotide biosynthetic process,BP,
15743,GO:0072389,1,0.967604024860509,0,1,flavin adenine dinucleotide catabolic process,BP,
15744,GO:0072393,1,0.696339112939063,0,11,microtubule anchoring at microtubule organizing center,BP,
15746,GO:0072396,1,0.827370074931897,0,6,response to cell cycle checkpoint signaling,BP,
15748,GO:0072402,1,0.827370074931897,0,6,response to DNA integrity checkpoint signaling,BP,
15750,GO:0072414,1,0.966840760053927,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15752,GO:0072423,1,0.827370074931897,0,6,response to DNA damage checkpoint signaling,BP,
15753,GO:0072425,1,0.703800637910704,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15754,GO:0072428,1,0.972143702897848,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
15755,GO:0072429,1,0.913247483691835,0,3,response to intra-S DNA damage checkpoint signaling,BP,
15757,GO:0072432,1,0.966840760053927,0,1,response to G1 DNA damage checkpoint signaling,BP,
15758,GO:0072434,1,0.936824497997617,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
15759,GO:0072487,1,0.853638471524611,0,5,MSL complex,CC,
15760,GO:0072488,1,0.810037678329875,0,7,ammonium transmembrane transport,BP,
15761,GO:0072492,1,0.972456066014553,0,1,host cell mitochondrial intermembrane space,CC,
15762,GO:0072497,1,0.824007946316304,0,6,mesenchymal stem cell differentiation,BP,
15774,GO:0072513,1,0.974497990047067,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
15775,GO:0072517,1,0.968183517101338,0,1,host cell viral assembly compartment,CC,
15776,GO:0072518,1,0.966857319942787,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
15777,GO:0072520,1,0.73123691185617,0,10,seminiferous tubule development,BP,
15783,GO:0072526,1,0.888381401393662,0,4,pyridine-containing compound catabolic process,BP,
15785,GO:0072528,1,0.350795008962196,0,36,pyrimidine-containing compound biosynthetic process,BP,
15786,GO:0072529,1,0.437069827434204,0,28,pyrimidine-containing compound catabolic process,BP,
15787,GO:0072530,1,0.786603710554652,0,8,purine-containing compound transmembrane transport,BP,
15788,GO:0072531,1,0.83373229269261,0,6,pyrimidine-containing compound transmembrane transport,BP,
15789,GO:0072534,1,0.966813102999172,0,1,perineuronal net,CC,
15791,GO:0072536,1,0.97180856151349,0,1,interleukin-23 receptor complex,CC,
15792,GO:0072537,1,0.854665258635138,0,5,fibroblast activation,BP,
15797,GO:0072545,1,0.971305680023273,0,1,tyrosine binding,MF,
15798,GO:0072546,1,0.730761107100935,0,10,ER membrane protein complex,CC,
15799,GO:0072553,1,0.881990409768024,0,4,terminal button organization,BP,
15800,GO:0072554,1,0.970718037632591,0,1,blood vessel lumenization,BP,
15801,GO:0072555,1,0.972851784312043,0,1,17-beta-ketosteroid reductase activity,MF,
15802,GO:0072556,1,0.967308775010198,0,1,other organism presynaptic membrane,CC,
15803,GO:0072557,1,0.948157935143627,0,2,IPAF inflammasome complex,CC,
15804,GO:0072558,1,0.917574467710177,0,3,NLRP1 inflammasome complex,CC,
15805,GO:0072559,1,0.839609934807487,0,6,NLRP3 inflammasome complex,CC,
15806,GO:0072560,1,0.968753325043455,0,1,type B pancreatic cell maturation,BP,
15808,GO:0072563,1,0.942413313520224,0,2,endothelial microparticle,CC,
15809,GO:0072566,1,0.941927962105828,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
15810,GO:0072567,1,0.740684127019802,0,10,chemokine (C-X-C motif) ligand 2 production,BP,
15811,GO:0072570,1,0.968529754294841,0,1,ADP-D-ribose binding,MF,
15812,GO:0072572,1,0.971361590140804,0,1,poly-ADP-D-ribose binding,MF,
15813,GO:0072573,1,0.967148046407872,0,1,tolerance induction to lipopolysaccharide,BP,
15817,GO:0072577,1,0.420939239823481,0,27,endothelial cell apoptotic process,BP,
15818,GO:0072578,1,0.82671663846337,0,6,neurotransmitter-gated ion channel clustering,BP,
15819,GO:0072579,1,0.967250856401697,0,1,glycine receptor clustering,BP,
15820,GO:0072582,1,0.972851784312043,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15823,GO:0072586,1,0.967107803577018,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15824,GO:0072587,1,0.967107803577018,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
15825,GO:0072588,1,0.810750015197295,0,8,box H/ACA RNP complex,CC,
15826,GO:0072589,1,0.897590015144484,0,4,box H/ACA scaRNP complex,CC,
15827,GO:0072590,1,0.966872852014943,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15828,GO:0072591,1,0.966872852014943,0,1,citrate-L-glutamate ligase activity,MF,
15829,GO:0072592,1,0.943508815630017,0,2,oxygen metabolic process,BP,
15833,GO:0072599,1,0.0595134551748589,0,104,establishment of protein localization to endoplasmic reticulum,BP,
15834,GO:0072602,1,0.879859473245896,0,4,interleukin-4 secretion,BP,
15835,GO:0072603,1,0.881998760869847,0,4,interleukin-5 secretion,BP,
15839,GO:0072610,1,0.883372949230901,0,4,interleukin-12 secretion,BP,
15840,GO:0072611,1,0.85713943672927,0,5,interleukin-13 secretion,BP,
15841,GO:0072615,1,0.971824351676263,0,1,interleukin-17 secretion,BP,
15842,GO:0072616,1,0.967470217255035,0,1,interleukin-18 secretion,BP,
15843,GO:0072619,1,0.96799369750859,0,1,interleukin-21 secretion,BP,
15844,GO:0072641,1,0.820088970263016,0,6,type I interferon secretion,BP,
15845,GO:0072642,1,0.820088970263016,0,6,interferon-alpha secretion,BP,
15846,GO:0072643,1,0.749022808147219,0,9,interferon-gamma secretion,BP,
15848,GO:0072656,1,0.857157415741154,0,5,maintenance of protein location in mitochondrion,BP,
15850,GO:0072658,1,0.966770617821941,0,1,maintenance of protein location in membrane,BP,
15852,GO:0072660,1,0.966770617821941,0,1,maintenance of protein location in plasma membrane,BP,
15853,GO:0072662,1,0.588971458418115,0,17,protein localization to peroxisome,BP,
15854,GO:0072663,1,0.588971458418115,0,17,establishment of protein localization to peroxisome,BP,
15858,GO:0072671,1,0.970165134653767,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
15861,GO:0072674,1,0.877873165592396,0,4,multinuclear osteoclast differentiation,BP,
15862,GO:0072675,1,0.877873165592396,0,4,osteoclast fusion,BP,
15869,GO:0072682,1,0.968229905693104,0,1,eosinophil extravasation,BP,
15870,GO:0072683,1,0.944954394752515,0,2,T cell extravasation,BP,
15871,GO:0072684,1,0.967662514804124,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
15872,GO:0072686,1,0.0639196618297912,0,87,mitotic spindle,CC,
15873,GO:0072687,1,0.88466878975052,0,4,meiotic spindle,CC,
15874,GO:0072695,1,0.941568289628652,0,2,regulation of DNA recombination at telomere,BP,
15877,GO:0072702,1,0.966878404456496,0,1,response to methyl methanesulfonate,BP,
15878,GO:0072703,1,0.966878404456496,0,1,cellular response to methyl methanesulfonate,BP,
15879,GO:0072706,1,0.970111822368665,0,1,response to sodium dodecyl sulfate,BP,
15880,GO:0072707,1,0.970111822368665,0,1,cellular response to sodium dodecyl sulfate,BP,
15881,GO:0072708,1,0.884272019983567,0,4,response to sorbitol,BP,
15882,GO:0072709,1,0.940716849791589,0,2,cellular response to sorbitol,BP,
15883,GO:0072710,1,0.747956368912329,0,9,response to hydroxyurea,BP,
15884,GO:0072711,1,0.771685979647534,0,8,cellular response to hydroxyurea,BP,
15885,GO:0072714,1,0.972490396683953,0,1,response to selenite ion,BP,
15886,GO:0072715,1,0.972490396683953,0,1,cellular response to selenite ion,BP,
15891,GO:0072720,1,0.969271124374127,0,1,response to dithiothreitol,BP,
15892,GO:0072733,1,0.915517188601324,0,3,response to staurosporine,BP,
15893,GO:0072734,1,0.915517188601324,0,3,cellular response to staurosporine,BP,
15894,GO:0072737,1,0.942240294532824,0,2,response to diamide,BP,
15895,GO:0072738,1,0.942240294532824,0,2,cellular response to diamide,BP,
15896,GO:0072739,1,0.942198233246685,0,2,response to anisomycin,BP,
15897,GO:0072740,1,0.972071172458697,0,1,cellular response to anisomycin,BP,
15898,GO:0072741,1,0.907992806407244,0,3,protein localization to cell division site,BP,
15899,GO:0072749,1,0.97230580442963,0,1,cellular response to cytochalasin B,BP,
15900,GO:0072750,1,0.973568327127081,0,1,cellular response to leptomycin B,BP,
15901,GO:0072752,1,0.966852838609525,0,1,cellular response to rapamycin,BP,
15902,GO:0072755,1,0.967730119844926,0,1,cellular response to benomyl,BP,
15903,GO:0072757,1,0.880935480366616,0,4,cellular response to camptothecin,BP,
15904,GO:0075044,1,0.875483912479025,0,4,autophagy of host cells involved in interaction with symbiont,BP,
15905,GO:0075071,1,0.875483912479025,0,4,autophagy involved in symbiotic interaction,BP,
15906,GO:0075109,1,0.966906671281593,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15907,GO:0075111,1,0.966906671281593,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15908,GO:0075112,1,0.966906671281593,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15909,GO:0075114,1,0.966906671281593,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15910,GO:0075136,1,0.833324733403499,0,6,response to host,BP,
15911,GO:0075341,1,0.970903132185849,0,1,host cell PML body,CC,
15912,GO:0075509,1,0.908365408703974,0,3,endocytosis involved in viral entry into host cell,BP,
15913,GO:0075519,1,0.974686820226212,0,1,microtubule-dependent intracellular transport of viral material,BP,
15914,GO:0075521,1,0.974686820226212,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15915,GO:0075522,1,0.734430833141757,0,10,IRES-dependent viral translational initiation,BP,
15916,GO:0075525,1,0.861773294801082,0,5,viral translational termination-reinitiation,BP,
15917,GO:0075528,1,0.913800726549914,0,3,modulation by virus of host immune response,BP,
15918,GO:0075606,1,0.974686820226212,0,1,transport of viral material towards nucleus,BP,
15919,GO:0075713,1,0.787433959058461,0,8,establishment of integrated proviral latency,BP,
15920,GO:0075732,1,0.935081507008148,0,2,viral penetration into host nucleus,BP,
15921,GO:0075733,1,0.193668728421814,0,53,intracellular transport of virus,BP,
15922,GO:0080008,1,0.367018749582597,0,32,Cul4-RING E3 ubiquitin ligase complex,CC,
15923,GO:0080009,1,0.740786560018535,0,10,mRNA methylation,BP,
15924,GO:0080019,1,0.939316984477824,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
15925,GO:0080023,1,0.939484005877423,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
15926,GO:0080025,1,0.533795351287533,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
15927,GO:0080058,1,0.973405845846992,0,1,protein deglutathionylation,BP,
15928,GO:0080084,1,0.852848145766519,0,5,5S rDNA binding,MF,
15930,GO:0080101,1,0.974153435035593,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
15931,GO:0080111,1,0.5399473601935,0,20,DNA demethylation,BP,
15932,GO:0080120,1,0.942682023180035,0,2,CAAX-box protein maturation,BP,
15933,GO:0080121,1,0.940634572470107,0,2,AMP transport,BP,
15934,GO:0080122,1,0.91257815150113,0,3,AMP transmembrane transporter activity,MF,
15935,GO:0080129,1,0.97396290637266,0,1,proteasome core complex assembly,BP,
15938,GO:0080144,1,0.94023578283128,0,2,amino acid homeostasis,BP,
15939,GO:0080146,1,0.972478537311936,0,1,L-cysteine desulfhydrase activity,MF,
15940,GO:0080147,1,0.974543632249742,0,1,root hair cell development,BP,
15942,GO:0080163,1,0.970615753505458,0,1,regulation of protein serine/threonine phosphatase activity,BP,
15945,GO:0080184,1,0.941869839053772,0,2,response to phenylpropanoid,BP,
15946,GO:0085020,1,0.812632860683139,0,7,protein K6-linked ubiquitination,BP,
15954,GO:0086006,1,0.935186553335691,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
15955,GO:0086007,1,0.935979895521743,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
15956,GO:0086008,1,0.9407142170486,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
15962,GO:0086014,1,0.719706974420563,0,10,atrial cardiac muscle cell action potential,BP,
15963,GO:0086015,1,0.936531264561691,0,2,SA node cell action potential,BP,
15964,GO:0086016,1,0.850699841517242,0,5,AV node cell action potential,BP,
15965,GO:0086017,1,0.937102767032392,0,2,Purkinje myocyte action potential,BP,
15966,GO:0086018,1,0.936531264561691,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
15967,GO:0086019,1,0.6158779407464,0,15,cell-cell signaling involved in cardiac conduction,BP,
15968,GO:0086020,1,0.936542886695722,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
15969,GO:0086021,1,0.936542886695722,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
15970,GO:0086023,1,0.873602680504206,0,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
15971,GO:0086024,1,0.966814385070265,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
15972,GO:0086026,1,0.719706974420563,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
15973,GO:0086027,1,0.850699841517242,0,5,AV node cell to bundle of His cell signaling,BP,
15974,GO:0086028,1,0.883585893653141,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
15975,GO:0086029,1,0.937102767032392,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
15976,GO:0086036,1,0.876839547656189,0,4,regulation of cardiac muscle cell membrane potential,BP,
15977,GO:0086038,1,0.969271124374127,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
15978,GO:0086039,1,0.966811552121987,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
15979,GO:0086040,1,0.967074571644523,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
15980,GO:0086042,1,0.821360944631983,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
15981,GO:0086043,1,0.883585893653141,0,4,bundle of His cell action potential,BP,
15982,GO:0086044,1,0.968680067927164,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
15983,GO:0086045,1,0.935770867715273,0,2,membrane depolarization during AV node cell action potential,BP,
15984,GO:0086046,1,0.966814582471168,0,1,membrane depolarization during SA node cell action potential,BP,
15985,GO:0086047,1,0.967404514182229,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
15986,GO:0086048,1,0.936077733588272,0,2,membrane depolarization during bundle of His cell action potential,BP,
15987,GO:0086053,1,0.936542886695722,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
15988,GO:0086054,1,0.968680067927164,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
15989,GO:0086055,1,0.968680067927164,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
15990,GO:0086056,1,0.96730341083719,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
15991,GO:0086057,1,0.967620588791187,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
15994,GO:0086066,1,0.719706974420563,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
15995,GO:0086067,1,0.822466947097042,0,6,AV node cell to bundle of His cell communication,BP,
15996,GO:0086068,1,0.937102767032392,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
15997,GO:0086069,1,0.747857109916001,0,9,bundle of His cell to Purkinje myocyte communication,BP,
15998,GO:0086070,1,0.905457842577803,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
15999,GO:0086072,1,0.970388459009409,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16000,GO:0086073,1,0.846436505998527,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16001,GO:0086075,1,0.907275773229803,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16002,GO:0086076,1,0.968680067927164,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16003,GO:0086077,1,0.936542886695722,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
16004,GO:0086078,1,0.968680067927164,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16005,GO:0086079,1,0.968680067927164,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16006,GO:0086080,1,0.767720163655699,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16007,GO:0086082,1,0.970388459009409,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
16008,GO:0086083,1,0.846436505998527,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16009,GO:0086089,1,0.969263997402086,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
16010,GO:0086091,1,0.573473822339683,0,17,regulation of heart rate by cardiac conduction,BP,
16011,GO:0086092,1,0.967074571644523,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
16012,GO:0086096,1,0.973430018690114,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
16013,GO:0086098,1,0.938232028344521,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
16014,GO:0086100,1,0.967656759754395,0,1,endothelin receptor signaling pathway,BP,
16015,GO:0086103,1,0.797833611923225,0,7,G-protein coupled receptor signaling pathway involved in heart process,BP,
16016,GO:0089700,1,0.906479736624402,0,3,protein kinase D signaling,BP,
16017,GO:0089701,1,0.867459726557745,0,5,U2AF,CC,
16018,GO:0089709,1,0.941130320503515,0,2,L-histidine transmembrane transport,BP,
16019,GO:0089717,1,0.821416215898247,0,6,spanning component of membrane,CC,
16020,GO:0089718,1,0.707609162817954,0,11,amino acid import across plasma membrane,BP,
16022,GO:0090009,1,0.875006515680413,0,4,primitive streak formation,BP,
16027,GO:0090026,1,0.787564284383152,0,8,positive regulation of monocyte chemotaxis,BP,
16029,GO:0090030,1,0.798676065649205,0,7,regulation of steroid hormone biosynthetic process,BP,
16030,GO:0090031,1,0.93881333168247,0,2,positive regulation of steroid hormone biosynthetic process,BP,
16031,GO:0090032,1,0.879757456734689,0,4,negative regulation of steroid hormone biosynthetic process,BP,
16032,GO:0090034,1,0.941085227635988,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16033,GO:0090035,1,0.941085227635988,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
16034,GO:0090036,1,0.703288623761234,0,11,regulation of protein kinase C signaling,BP,
16035,GO:0090037,1,0.829982293327451,0,6,positive regulation of protein kinase C signaling,BP,
16036,GO:0090038,1,0.937358903581566,0,2,negative regulation of protein kinase C signaling,BP,
16037,GO:0090042,1,0.758192810350477,0,9,tubulin deacetylation,BP,
16038,GO:0090043,1,0.806448289836111,0,7,regulation of tubulin deacetylation,BP,
16039,GO:0090044,1,0.972839470589811,0,1,positive regulation of tubulin deacetylation,BP,
16040,GO:0090045,1,0.832375268654672,0,6,positive regulation of deacetylase activity,BP,
16043,GO:0090051,1,0.664416569124042,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16044,GO:0090063,1,0.880609448357082,0,4,positive regulation of microtubule nucleation,BP,
16045,GO:0090065,1,0.975387957839165,0,1,regulation of production of siRNA involved in RNA interference,BP,
16047,GO:0090067,1,0.96709169219984,0,1,regulation of thalamus size,BP,
16049,GO:0090069,1,0.66333610160131,0,13,regulation of ribosome biogenesis,BP,
16050,GO:0090070,1,0.781155639500409,0,8,positive regulation of ribosome biogenesis,BP,
16051,GO:0090071,1,0.878347729822885,0,4,negative regulation of ribosome biogenesis,BP,
16052,GO:0090073,1,0.784531021357682,0,8,positive regulation of protein homodimerization activity,BP,
16056,GO:0090079,1,0.589698095935239,0,17,translation regulator activity, nucleic acid binding,MF,
16057,GO:0090080,1,0.934839065800973,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
16058,GO:0090081,1,0.972322080150554,0,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
16059,GO:0090082,1,0.972322080150554,0,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
16063,GO:0090086,1,0.921906463679087,0,3,negative regulation of protein deubiquitination,BP,
16065,GO:0090088,1,0.943372480327217,0,2,regulation of oligopeptide transport,BP,
16066,GO:0090089,1,0.943372480327217,0,2,regulation of dipeptide transport,BP,
16068,GO:0090091,1,0.878824626707187,0,4,positive regulation of extracellular matrix disassembly,BP,
16070,GO:0090094,1,0.970707788420789,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16071,GO:0090095,1,0.970707788420789,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16072,GO:0090096,1,0.970707788420789,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
16075,GO:0090102,1,0.499162713648636,0,22,cochlea development,BP,
16076,GO:0090103,1,0.683447509438827,0,12,cochlea morphogenesis,BP,
16077,GO:0090107,1,0.914292447552888,0,3,regulation of high-density lipoprotein particle assembly,BP,
16078,GO:0090108,1,0.971563776661133,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16081,GO:0090113,1,0.971279171620866,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
16083,GO:0090116,1,0.904823172255726,0,3,C-5 methylation of cytosine,BP,
16084,GO:0090118,1,0.852933596607375,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
16085,GO:0090119,1,0.967095524225961,0,1,vesicle-mediated cholesterol transport,BP,
16086,GO:0090128,1,0.828596592831486,0,6,regulation of synapse maturation,BP,
16087,GO:0090129,1,0.856976857928574,0,5,positive regulation of synapse maturation,BP,
16089,GO:0090131,1,0.972892213406625,0,1,mesenchyme migration,BP,
16091,GO:0090135,1,0.912823409587712,0,3,actin filament branching,BP,
16092,GO:0090136,1,0.676957251577483,0,12,epithelial cell-cell adhesion,BP,
16093,GO:0090138,1,0.967848460394819,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
16094,GO:0090140,1,0.55181113206583,0,19,regulation of mitochondrial fission,BP,
16095,GO:0090141,1,0.671575480292949,0,13,positive regulation of mitochondrial fission,BP,
16096,GO:0090148,1,0.680562599627659,0,12,membrane fission,BP,
16097,GO:0090149,1,0.938856959987397,0,2,mitochondrial membrane fission,BP,
16101,GO:0090154,1,0.80612266402373,0,7,positive regulation of sphingolipid biosynthetic process,BP,
16104,GO:0090158,1,0.860406536936632,0,5,endoplasmic reticulum membrane organization,BP,
16105,GO:0090160,1,0.776264096573766,0,8,Golgi to lysosome transport,BP,
16107,GO:0090162,1,0.448767238067597,0,25,establishment of epithelial cell polarity,BP,
16108,GO:0090164,1,0.937648273191771,0,2,asymmetric Golgi ribbon formation,BP,
16109,GO:0090166,1,0.834788010011039,0,6,Golgi disassembly,BP,
16110,GO:0090168,1,0.885915316295069,0,4,Golgi reassembly,BP,
16111,GO:0090169,1,0.455291769237644,0,25,regulation of spindle assembly,BP,
16112,GO:0090170,1,0.887538092969722,0,4,regulation of Golgi inheritance,BP,
16115,GO:0090176,1,0.966878815112889,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
16116,GO:0090177,1,0.654220907990502,0,13,establishment of planar polarity involved in neural tube closure,BP,
16117,GO:0090178,1,0.654220907990502,0,13,regulation of establishment of planar polarity involved in neural tube closure,BP,
16118,GO:0090179,1,0.676529123852159,0,12,planar cell polarity pathway involved in neural tube closure,BP,
16120,GO:0090182,1,0.94527550275601,0,2,regulation of secretion of lysosomal enzymes,BP,
16123,GO:0090185,1,0.754515394172377,0,9,negative regulation of kidney development,BP,
16124,GO:0090186,1,0.827658463346057,0,6,regulation of pancreatic juice secretion,BP,
16125,GO:0090187,1,0.971563776661133,0,1,positive regulation of pancreatic juice secretion,BP,
16126,GO:0090188,1,0.85189359343232,0,5,negative regulation of pancreatic juice secretion,BP,
16129,GO:0090191,1,0.944737416620082,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
16130,GO:0090192,1,0.759576835823432,0,9,regulation of glomerulus development,BP,
16131,GO:0090193,1,0.833308851345231,0,6,positive regulation of glomerulus development,BP,
16132,GO:0090194,1,0.911561175946391,0,3,negative regulation of glomerulus development,BP,
16133,GO:0090195,1,0.758238109020476,0,9,chemokine secretion,BP,
16134,GO:0090196,1,0.80847606830427,0,7,regulation of chemokine secretion,BP,
16135,GO:0090197,1,0.834093465127937,0,6,positive regulation of chemokine secretion,BP,
16136,GO:0090198,1,0.969302166061177,0,1,negative regulation of chemokine secretion,BP,
16139,GO:0090201,1,0.681845531453185,0,13,negative regulation of release of cytochrome c from mitochondria,BP,
16140,GO:0090202,1,0.911133048108722,0,3,gene looping,BP,
16141,GO:0090204,1,0.916788546874985,0,3,protein localization to nuclear pore,BP,
16142,GO:0090205,1,0.82441260988224,0,6,positive regulation of cholesterol metabolic process,BP,
16143,GO:0090206,1,0.864099511990963,0,5,negative regulation of cholesterol metabolic process,BP,
16144,GO:0090207,1,0.57683922377354,0,18,regulation of triglyceride metabolic process,BP,
16145,GO:0090208,1,0.712603185580396,0,11,positive regulation of triglyceride metabolic process,BP,
16146,GO:0090209,1,0.884799771961706,0,4,negative regulation of triglyceride metabolic process,BP,
16147,GO:0090210,1,0.937621440620057,0,2,regulation of establishment of blood-brain barrier,BP,
16148,GO:0090212,1,0.967349666574824,0,1,negative regulation of establishment of blood-brain barrier,BP,
16151,GO:0090219,1,0.881292546029918,0,4,negative regulation of lipid kinase activity,BP,
16152,GO:0090220,1,0.775208230555281,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16153,GO:0090222,1,0.934765372941533,0,2,centrosome-templated microtubule nucleation,BP,
16154,GO:0090224,1,0.302491946450954,0,38,regulation of spindle organization,BP,
16155,GO:0090226,1,0.974455505671406,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
16156,GO:0090230,1,0.878231307180064,0,4,regulation of centromere complex assembly,BP,
16158,GO:0090232,1,0.783229144972873,0,8,positive regulation of spindle checkpoint,BP,
16159,GO:0090233,1,0.96981148692978,0,1,negative regulation of spindle checkpoint,BP,
16160,GO:0090234,1,0.908215994826083,0,3,regulation of kinetochore assembly,BP,
16161,GO:0090235,1,0.79631446647733,0,7,regulation of metaphase plate congression,BP,
16162,GO:0090237,1,0.854127953364332,0,5,regulation of arachidonic acid secretion,BP,
16163,GO:0090238,1,0.88334668765116,0,4,positive regulation of arachidonic acid secretion,BP,
16164,GO:0090239,1,0.715442660281507,0,11,regulation of histone H4 acetylation,BP,
16165,GO:0090240,1,0.81173589624924,0,7,positive regulation of histone H4 acetylation,BP,
16166,GO:0090241,1,0.885658288929724,0,4,negative regulation of histone H4 acetylation,BP,
16167,GO:0090244,1,0.90910339749735,0,3,Wnt signaling pathway involved in somitogenesis,BP,
16168,GO:0090245,1,0.876899316867004,0,4,axis elongation involved in somitogenesis,BP,
16169,GO:0090246,1,0.967130024404925,0,1,convergent extension involved in somitogenesis,BP,
16170,GO:0090247,1,0.970051889225651,0,1,cell motility involved in somitogenic axis elongation,BP,
16171,GO:0090249,1,0.970051889225651,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
16172,GO:0090251,1,0.96673677223795,0,1,protein localization involved in establishment of planar polarity,BP,
16174,GO:0090258,1,0.937727655109927,0,2,negative regulation of mitochondrial fission,BP,
16177,GO:0090261,1,0.892035218887243,0,4,positive regulation of inclusion body assembly,BP,
16180,GO:0090267,1,0.808768819378538,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16181,GO:0090269,1,0.90401748819826,0,3,fibroblast growth factor production,BP,
16182,GO:0090270,1,0.90401748819826,0,3,regulation of fibroblast growth factor production,BP,
16183,GO:0090271,1,0.934991816115158,0,2,positive regulation of fibroblast growth factor production,BP,
16184,GO:0090272,1,0.966878069763278,0,1,negative regulation of fibroblast growth factor production,BP,
16188,GO:0090279,1,0.642655983792194,0,14,regulation of calcium ion import,BP,
16189,GO:0090280,1,0.85382086548553,0,5,positive regulation of calcium ion import,BP,
16190,GO:0090281,1,0.912744431091826,0,3,negative regulation of calcium ion import,BP,
16191,GO:0090283,1,0.911532846734319,0,3,regulation of protein glycosylation in Golgi,BP,
16192,GO:0090284,1,0.966836455744991,0,1,positive regulation of protein glycosylation in Golgi,BP,
16193,GO:0090285,1,0.942804545396305,0,2,negative regulation of protein glycosylation in Golgi,BP,
16194,GO:0090286,1,0.848038361534356,0,5,cytoskeletal anchoring at nuclear membrane,BP,
16197,GO:0090289,1,0.942063600580856,0,2,regulation of osteoclast proliferation,BP,
16198,GO:0090290,1,0.974065835179369,0,1,positive regulation of osteoclast proliferation,BP,
16199,GO:0090291,1,0.967148046407872,0,1,negative regulation of osteoclast proliferation,BP,
16200,GO:0090292,1,0.905065101800451,0,3,nuclear matrix anchoring at nuclear membrane,BP,
16201,GO:0090296,1,0.883905387572348,0,4,regulation of mitochondrial DNA replication,BP,
16202,GO:0090297,1,0.973583217915054,0,1,positive regulation of mitochondrial DNA replication,BP,
16203,GO:0090298,1,0.907895337015971,0,3,negative regulation of mitochondrial DNA replication,BP,
16204,GO:0090299,1,0.972689400917587,0,1,regulation of neural crest formation,BP,
16205,GO:0090301,1,0.972689400917587,0,1,negative regulation of neural crest formation,BP,
16209,GO:0090306,1,0.88193443680861,0,4,spindle assembly involved in meiosis,BP,
16211,GO:0090308,1,0.769202556072762,0,8,regulation of methylation-dependent chromatin silencing,BP,
16212,GO:0090309,1,0.876427609631081,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
16213,GO:0090310,1,0.937300758462112,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
16216,GO:0090313,1,0.436484386456058,0,27,regulation of protein targeting to membrane,BP,
16217,GO:0090314,1,0.49406495368776,0,23,positive regulation of protein targeting to membrane,BP,
16218,GO:0090315,1,0.885637176157968,0,4,negative regulation of protein targeting to membrane,BP,
16221,GO:0090322,1,0.584474185032077,0,18,regulation of superoxide metabolic process,BP,
16222,GO:0090323,1,0.974914045590198,0,1,prostaglandin secretion involved in immune response,BP,
16223,GO:0090324,1,0.856800542884786,0,5,negative regulation of oxidative phosphorylation,BP,
16224,GO:0090325,1,0.936788458235958,0,2,regulation of locomotion involved in locomotory behavior,BP,
16225,GO:0090326,1,0.9684314823452,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
16226,GO:0090327,1,0.96732830948403,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
16230,GO:0090335,1,0.775000275633857,0,8,regulation of brown fat cell differentiation,BP,
16231,GO:0090336,1,0.910587731295018,0,3,positive regulation of brown fat cell differentiation,BP,
16232,GO:0090340,1,0.971563776661133,0,1,positive regulation of secretion of lysosomal enzymes,BP,
16233,GO:0090341,1,0.972944423110542,0,1,negative regulation of secretion of lysosomal enzymes,BP,
16237,GO:0090345,1,0.970282624874275,0,1,cellular organohalogen metabolic process,BP,
16238,GO:0090346,1,0.970282624874275,0,1,cellular organofluorine metabolic process,BP,
16239,GO:0090360,1,0.912802495812256,0,3,platelet-derived growth factor production,BP,
16240,GO:0090361,1,0.912802495812256,0,3,regulation of platelet-derived growth factor production,BP,
16241,GO:0090362,1,0.939509397187399,0,2,positive regulation of platelet-derived growth factor production,BP,
16242,GO:0090365,1,0.971237910811323,0,1,regulation of mRNA modification,BP,
16243,GO:0090367,1,0.971237910811323,0,1,negative regulation of mRNA modification,BP,
16244,GO:0090370,1,0.967217092133575,0,1,negative regulation of cholesterol efflux,BP,
16245,GO:0090381,1,0.972322080150554,0,1,regulation of heart induction,BP,
16247,GO:0090383,1,0.541075345075801,0,21,phagosome acidification,BP,
16248,GO:0090385,1,0.836279274716545,0,6,phagosome-lysosome fusion,BP,
16249,GO:0090386,1,0.935099228555057,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16250,GO:0090387,1,0.935099228555057,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
16251,GO:0090389,1,0.966826266946068,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16252,GO:0090394,1,0.880125921340089,0,4,negative regulation of excitatory postsynaptic potential,BP,
16256,GO:0090402,1,0.942121238285537,0,2,oncogene-induced cell senescence,BP,
16259,GO:0090409,1,0.97092228028988,0,1,malonyl-CoA synthetase activity,MF,
16260,GO:0090410,1,0.97092228028988,0,1,malonate catabolic process,BP,
16261,GO:0090420,1,0.973310190059817,0,1,naphthalene-containing compound metabolic process,BP,
16262,GO:0090422,1,0.972737387699977,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
16263,GO:0090427,1,0.971173025433657,0,1,activation of meiosis,BP,
16264,GO:0090435,1,0.810487409500987,0,7,protein localization to nuclear envelope,BP,
16265,GO:0090461,1,0.967235729974955,0,1,glutamate homeostasis,BP,
16266,GO:0090472,1,0.967307237707101,0,1,dibasic protein processing,BP,
16267,GO:0090480,1,0.907691617390449,0,3,purine nucleotide-sugar transmembrane transport,BP,
16269,GO:0090482,1,0.659912556789431,0,13,vitamin transmembrane transporter activity,MF,
16270,GO:0090493,1,0.840838905259298,0,6,catecholamine uptake,BP,
16271,GO:0090494,1,0.840838905259298,0,6,dopamine uptake,BP,
16272,GO:0090498,1,0.938849355793106,0,2,extrinsic component of Golgi membrane,CC,
16280,GO:0090521,1,0.87868393717424,0,4,glomerular visceral epithelial cell migration,BP,
16281,GO:0090527,1,0.745588473611755,0,9,actin filament reorganization,BP,
16282,GO:0090529,1,0.972196297161597,0,1,cell septum assembly,BP,
16283,GO:0090533,1,0.801318479522501,0,7,cation-transporting ATPase complex,CC,
16284,GO:0090537,1,0.967393562446078,0,1,CERF complex,CC,
16285,GO:0090541,1,0.937453492479935,0,2,MIT domain binding,MF,
16286,GO:0090543,1,0.44463448984187,0,26,Flemming body,CC,
16287,GO:0090545,1,0.618089513020772,0,15,CHD-type complex,CC,
16288,GO:0090554,1,0.934704261123866,0,2,phosphatidylcholine-translocating ATPase activity,MF,
16289,GO:0090556,1,0.934704261123866,0,2,phosphatidylserine-translocating ATPase activity,MF,
16291,GO:0090558,1,0.974543632249742,0,1,plant epidermis development,BP,
16293,GO:0090560,1,0.971313040865049,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
16294,GO:0090568,1,0.424110483321427,0,27,nuclear transcriptional repressor complex,CC,
16295,GO:0090571,1,0.915467487247137,0,3,RNA polymerase II transcription repressor complex,CC,
16297,GO:0090576,1,0.776066779100986,0,8,RNA polymerase III transcription factor complex,CC,
16298,GO:0090579,1,0.911133048108722,0,3,dsDNA loop formation,BP,
16301,GO:0090599,1,0.875644288489746,0,4,alpha-glucosidase activity,MF,
16302,GO:0090600,1,0.967566336644757,0,1,alpha-1,3-glucosidase activity,MF,
16303,GO:0090601,1,0.966914057987496,0,1,enucleation,BP,
16304,GO:0090611,1,0.859889454678395,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16305,GO:0090615,1,0.939981847554697,0,2,mitochondrial mRNA processing,BP,
16306,GO:0090616,1,0.967063986272255,0,1,mitochondrial mRNA 3'-end processing,BP,
16307,GO:0090624,1,0.969271124374127,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16308,GO:0090625,1,0.969271124374127,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16309,GO:0090627,1,0.974543632249742,0,1,plant epidermal cell differentiation,BP,
16311,GO:0090646,1,0.699360597485885,0,12,mitochondrial tRNA processing,BP,
16312,GO:0090647,1,0.83131189413686,0,6,modulation of age-related behavioral decline,BP,
16313,GO:0090649,1,0.853449001049074,0,5,response to oxygen-glucose deprivation,BP,
16314,GO:0090650,1,0.853449001049074,0,5,cellular response to oxygen-glucose deprivation,BP,
16316,GO:0090657,1,0.702257699422009,0,11,telomeric loop disassembly,BP,
16317,GO:0090659,1,0.660993001566327,0,13,walking behavior,BP,
16318,GO:0090661,1,0.875229317560916,0,5,box H/ACA telomerase RNP complex,CC,
16319,GO:0090662,1,0.533264209377891,0,21,ATP hydrolysis coupled transmembrane transport,BP,
16321,GO:0090666,1,0.890182606013848,0,4,scaRNA localization to Cajal body,BP,
16322,GO:0090667,1,0.966820834779336,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16323,GO:0090668,1,0.966820834779336,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
16324,GO:0090669,1,0.884663652683763,0,4,telomerase RNA stabilization,BP,
16325,GO:0090670,1,0.572859176525036,0,19,RNA localization to Cajal body,BP,
16326,GO:0090671,1,0.572859176525036,0,19,telomerase RNA localization to Cajal body,BP,
16327,GO:0090672,1,0.572859176525036,0,19,telomerase RNA localization,BP,
16328,GO:0090673,1,0.966833958059187,0,1,endothelial cell-matrix adhesion,BP,
16329,GO:0090675,1,0.968119388084873,0,1,intermicrovillar adhesion,BP,
16330,GO:0090677,1,0.942318709292352,0,2,reversible differentiation,BP,
16331,GO:0090678,1,0.942318709292352,0,2,cell dedifferentiation involved in phenotypic switching,BP,
16332,GO:0090685,1,0.572859176525036,0,19,RNA localization to nucleus,BP,
16333,GO:0090694,1,0.937055430197349,0,2,Scc2-Scc4 cohesin loading complex,CC,
16336,GO:0090722,1,0.934821715755845,0,2,receptor-receptor interaction,MF,
16337,GO:0090723,1,0.709621166944409,0,11,growth cone part,CC,
16338,GO:0090724,1,0.88280824108438,0,4,central region of growth cone,CC,
16339,GO:0090725,1,0.942756367030629,0,2,peripheral region of growth cone,CC,
16340,GO:0090731,1,0.973791068722543,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
16342,GO:0090735,1,0.738903474322953,0,10,DNA repair complex assembly,BP,
16344,GO:0090741,1,0.844063957307946,0,6,pigment granule membrane,CC,
16345,GO:0093001,1,0.968583700232333,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
16346,GO:0095500,1,0.693241313392785,0,12,acetylcholine receptor signaling pathway,BP,
16347,GO:0097001,1,0.784845360784657,0,8,ceramide binding,MF,
16348,GO:0097003,1,0.939814911256743,0,2,adipokinetic hormone receptor activity,MF,
16350,GO:0097009,1,0.663731934664024,0,13,energy homeostasis,BP,
16351,GO:0097010,1,0.907590180271859,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
16352,GO:0097011,1,0.831380317739175,0,6,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
16353,GO:0097012,1,0.831380317739175,0,6,response to granulocyte macrophage colony-stimulating factor,BP,
16354,GO:0097014,1,0.132722644398299,0,64,ciliary plasm,CC,
16356,GO:0097017,1,0.940849212218031,0,2,renal protein absorption,BP,
16357,GO:0097018,1,0.97028832086229,0,1,renal albumin absorption,BP,
16358,GO:0097020,1,0.968307003644423,0,1,COPII adaptor activity,MF,
16359,GO:0097021,1,0.940223286548448,0,2,lymphocyte migration into lymphoid organs,BP,
16361,GO:0097026,1,0.9668146565074,0,1,dendritic cell dendrite assembly,BP,
16362,GO:0097027,1,0.813075533731355,0,7,ubiquitin-protein transferase activator activity,MF,
16364,GO:0097029,1,0.969302166061177,0,1,mature conventional dendritic cell differentiation,BP,
16366,GO:0097036,1,0.973230935260878,0,1,regulation of plasma membrane sterol distribution,BP,
16367,GO:0097037,1,0.968190772029406,0,1,heme export,BP,
16368,GO:0097038,1,0.728546481089382,0,10,perinuclear endoplasmic reticulum,CC,
16369,GO:0097039,1,0.85315485900988,0,5,protein linear polyubiquitination,BP,
16370,GO:0097045,1,0.96699549651765,0,1,phosphatidylserine exposure on blood platelet,BP,
16372,GO:0097049,1,0.853807881804397,0,5,motor neuron apoptotic process,BP,
16373,GO:0097050,1,0.777362376346983,0,8,type B pancreatic cell apoptotic process,BP,
16374,GO:0097051,1,0.904679339818442,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
16375,GO:0097052,1,0.942410042115287,0,2,L-kynurenine metabolic process,BP,
16376,GO:0097055,1,0.941344772028472,0,2,agmatine biosynthetic process,BP,
16377,GO:0097056,1,0.888073242364605,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
16378,GO:0097057,1,0.945907269638044,0,2,TRAF2-GSTP1 complex,CC,
16379,GO:0097058,1,0.972336963651941,0,1,CRLF-CLCF1 complex,CC,
16380,GO:0097059,1,0.972336963651941,0,1,CNTFR-CLCF1 complex,CC,
16382,GO:0097061,1,0.20125410195686,0,50,dendritic spine organization,BP,
16383,GO:0097062,1,0.661917016715236,0,13,dendritic spine maintenance,BP,
16384,GO:0097064,1,0.316119660266438,0,37,ncRNA export from nucleus,BP,
16385,GO:0097065,1,0.880318805998257,0,4,anterior head development,BP,
16386,GO:0097066,1,0.628449901514729,0,15,response to thyroid hormone,BP,
16387,GO:0097067,1,0.729989103891471,0,10,cellular response to thyroid hormone stimulus,BP,
16388,GO:0097068,1,0.907326380526009,0,3,response to thyroxine,BP,
16389,GO:0097069,1,0.937633238638339,0,2,cellular response to thyroxine stimulus,BP,
16390,GO:0097070,1,0.966874452739229,0,1,ductus arteriosus closure,BP,
16391,GO:0097084,1,0.830542865907751,0,6,vascular smooth muscle cell development,BP,
16392,GO:0097086,1,0.967859114801888,0,1,amniotic stem cell differentiation,BP,
16393,GO:0097089,1,0.972684324308775,0,1,methyl-branched fatty acid metabolic process,BP,
16394,GO:0097090,1,0.826128177339644,0,6,presynaptic membrane organization,BP,
16395,GO:0097091,1,0.875628237016932,0,4,synaptic vesicle clustering,BP,
16396,GO:0097094,1,0.708625352828487,0,11,craniofacial suture morphogenesis,BP,
16397,GO:0097100,1,0.860320439104899,0,5,supercoiled DNA binding,MF,
16400,GO:0097104,1,0.848341402282331,0,5,postsynaptic membrane assembly,BP,
16401,GO:0097105,1,0.848373029967535,0,5,presynaptic membrane assembly,BP,
16402,GO:0097106,1,0.795041735145767,0,7,postsynaptic density organization,BP,
16403,GO:0097107,1,0.873962663691477,0,4,postsynaptic density assembly,BP,
16404,GO:0097108,1,0.966821717216446,0,1,hedgehog family protein binding,MF,
16405,GO:0097109,1,0.935629873910602,0,2,neuroligin family protein binding,MF,
16407,GO:0097111,1,0.934798694115258,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
16408,GO:0097112,1,0.967250856401697,0,1,gamma-aminobutyric acid receptor clustering,BP,
16409,GO:0097113,1,0.85471980621723,0,5,AMPA glutamate receptor clustering,BP,
16410,GO:0097114,1,0.941496436413182,0,2,NMDA glutamate receptor clustering,BP,
16411,GO:0097116,1,0.967046418003942,0,1,gephyrin clustering involved in postsynaptic density assembly,BP,
16412,GO:0097117,1,0.96683855483417,0,1,guanylate kinase-associated protein clustering,BP,
16413,GO:0097118,1,0.966845338751458,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
16414,GO:0097119,1,0.879742851877048,0,4,postsynaptic density protein 95 clustering,BP,
16416,GO:0097123,1,0.971059414813402,0,1,cyclin A1-CDK2 complex,CC,
16417,GO:0097124,1,0.941436236816662,0,2,cyclin A2-CDK2 complex,CC,
16418,GO:0097125,1,0.944759585586846,0,2,cyclin B1-CDK1 complex,CC,
16419,GO:0097129,1,0.916115303947497,0,3,cyclin D2-CDK4 complex,CC,
16420,GO:0097134,1,0.944000398540777,0,2,cyclin E1-CDK2 complex,CC,
16421,GO:0097135,1,0.941610939636891,0,2,cyclin E2-CDK2 complex,CC,
16422,GO:0097136,1,0.831785906384325,0,6,Bcl-2 family protein complex,CC,
16423,GO:0097144,1,0.974487401152989,0,1,BAX complex,CC,
16424,GO:0097145,1,0.971205473956507,0,1,BAK complex,CC,
16425,GO:0097149,1,0.907071360479102,0,3,centralspindlin complex,CC,
16426,GO:0097150,1,0.57565806999016,0,17,neuronal stem cell population maintenance,BP,
16428,GO:0097152,1,0.800538338226034,0,7,mesenchymal cell apoptotic process,BP,
16429,GO:0097153,1,0.706409526850391,0,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,
16430,GO:0097154,1,0.891810933624976,0,4,GABAergic neuron differentiation,BP,
16431,GO:0097155,1,0.934704524474013,0,2,fasciculation of sensory neuron axon,BP,
16432,GO:0097156,1,0.966859128570501,0,1,fasciculation of motor neuron axon,BP,
16433,GO:0097157,1,0.778205014837735,0,8,pre-mRNA intronic binding,MF,
16434,GO:0097158,1,0.972739901292716,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
16436,GO:0097161,1,0.966859128570501,0,1,DH domain binding,MF,
16437,GO:0097162,1,0.968464112479007,0,1,MADS box domain binding,MF,
16439,GO:0097165,1,0.855073309253325,0,5,nuclear stress granule,CC,
16441,GO:0097167,1,0.883372263206552,0,4,circadian regulation of translation,BP,
16442,GO:0097168,1,0.967072779332276,0,1,mesenchymal stem cell proliferation,BP,
16443,GO:0097169,1,0.923821686522656,0,3,AIM2 inflammasome complex,CC,
16444,GO:0097176,1,0.891388102650585,0,4,epoxide metabolic process,BP,
16445,GO:0097177,1,0.918211682246263,0,3,mitochondrial ribosome binding,MF,
16447,GO:0097179,1,0.899856170678948,0,4,protease inhibitor complex,CC,
16448,GO:0097180,1,0.947925695763751,0,2,serine protease inhibitor complex,CC,
16449,GO:0097186,1,0.619450736010396,0,15,amelogenesis,BP,
16450,GO:0097187,1,0.91238217180593,0,3,dentinogenesis,BP,
16456,GO:0097195,1,0.939250357342138,0,2,pilomotor reflex,BP,
16457,GO:0097196,1,0.942071061851958,0,2,Shu complex,CC,
16458,GO:0097197,1,0.855684183369238,0,5,tetraspanin-enriched microdomain,CC,
16459,GO:0097198,1,0.93683595148445,0,2,histone H3-K36 trimethylation,BP,
16460,GO:0097199,1,0.863866556713742,0,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
16461,GO:0097200,1,0.725032394130351,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
16465,GO:0097208,1,0.859825048430294,0,5,alveolar lamellar body,CC,
16466,GO:0097209,1,0.885160623444089,0,4,epidermal lamellar body,CC,
16467,GO:0097210,1,0.908140852426292,0,3,response to gonadotropin-releasing hormone,BP,
16468,GO:0097211,1,0.908140852426292,0,3,cellular response to gonadotropin-releasing hormone,BP,
16469,GO:0097212,1,0.943715405925674,0,2,lysosomal membrane organization,BP,
16470,GO:0097213,1,0.971069743176799,0,1,regulation of lysosomal membrane permeability,BP,
16471,GO:0097222,1,0.967063986272255,0,1,mitochondrial mRNA polyadenylation,BP,
16473,GO:0097224,1,0.972471937656193,0,1,sperm connecting piece,CC,
16474,GO:0097225,1,0.742186293367321,0,10,sperm midpiece,CC,
16475,GO:0097226,1,0.970934067118117,0,1,sperm mitochondrial sheath,CC,
16476,GO:0097227,1,0.880074981786032,0,4,sperm annulus,CC,
16477,GO:0097228,1,0.690298105852434,0,12,sperm principal piece,CC,
16478,GO:0097229,1,0.973471491574502,0,1,sperm end piece,CC,
16479,GO:0097231,1,0.972553214748333,0,1,cell motility in response to calcium ion,BP,
16480,GO:0097232,1,0.96835006976693,0,1,lamellar body membrane,CC,
16481,GO:0097233,1,0.96835006976693,0,1,alveolar lamellar body membrane,CC,
16483,GO:0097238,1,0.948260596058352,0,2,cellular response to methylglyoxal,BP,
16484,GO:0097240,1,0.879098639460228,0,4,chromosome attachment to the nuclear envelope,BP,
16485,GO:0097241,1,0.942070819686976,0,2,hematopoietic stem cell migration to bone marrow,BP,
16488,GO:0097255,1,0.866105720565179,0,5,R2TP complex,CC,
16491,GO:0097272,1,0.966874452739229,0,1,ammonia homeostasis,BP,
16492,GO:0097273,1,0.966874452739229,0,1,creatinine homeostasis,BP,
16493,GO:0097274,1,0.936071366128723,0,2,urea homeostasis,BP,
16494,GO:0097275,1,0.966874452739229,0,1,cellular ammonia homeostasis,BP,
16495,GO:0097276,1,0.966874452739229,0,1,cellular creatinine homeostasis,BP,
16496,GO:0097277,1,0.966874452739229,0,1,cellular urea homeostasis,BP,
16498,GO:0097283,1,0.860708586474143,0,5,keratinocyte apoptotic process,BP,
16501,GO:0097291,1,0.971758192172493,0,1,renal phosphate ion absorption,BP,
16502,GO:0097296,1,0.69664157728402,0,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
16503,GO:0097298,1,0.967542295754707,0,1,regulation of nucleus size,BP,
16507,GO:0097309,1,0.939484005877423,0,2,cap1 mRNA methylation,BP,
16508,GO:0097310,1,0.969271124374127,0,1,cap2 mRNA methylation,BP,
16509,GO:0097320,1,0.63852959531502,0,14,plasma membrane tubulation,BP,
16510,GO:0097322,1,0.828962473331769,0,6,7SK snRNA binding,MF,
16511,GO:0097325,1,0.937376923839171,0,2,melanocyte proliferation,BP,
16513,GO:0097329,1,0.679267438654895,0,12,response to antimetabolite,BP,
16514,GO:0097332,1,0.942174480119961,0,2,response to antipsychotic drug,BP,
16515,GO:0097338,1,0.96711899637138,0,1,response to clozapine,BP,
16518,GO:0097342,1,0.831139924345341,0,6,ripoptosome,CC,
16520,GO:0097344,1,0.942660108154161,0,2,Rix1 complex,CC,
16522,GO:0097346,1,0.506760289438216,0,23,INO80-type complex,CC,
16524,GO:0097352,1,0.355229857375613,0,34,autophagosome maturation,BP,
16525,GO:0097354,1,0.757823945529481,0,9,prenylation,BP,
16526,GO:0097356,1,0.966829584104197,0,1,perinucleolar compartment,CC,
16528,GO:0097360,1,0.937874433761752,0,2,chorionic trophoblast cell proliferation,BP,
16529,GO:0097361,1,0.886442053315438,0,4,CIA complex,CC,
16530,GO:0097362,1,0.939152546980704,0,2,MCM8-MCM9 complex,CC,
16531,GO:0097363,1,0.937170440263719,0,2,protein O-GlcNAc transferase activity,MF,
16534,GO:0097368,1,0.910378584317895,0,3,establishment of Sertoli cell barrier,BP,
16536,GO:0097372,1,0.972548007553948,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
16538,GO:0097376,1,0.97327185349884,0,1,interneuron axon guidance,BP,
16539,GO:0097381,1,0.851252230010897,0,5,photoreceptor disc membrane,CC,
16540,GO:0097382,1,0.966867738967312,0,1,deoxynucleoside-diphosphatase activity,MF,
16541,GO:0097383,1,0.966867738967312,0,1,dIDP diphosphatase activity,MF,
16542,GO:0097384,1,0.810271825036574,0,7,cellular lipid biosynthetic process,BP,
16543,GO:0097386,1,0.70819620581807,0,11,glial cell projection,CC,
16544,GO:0097393,1,0.966742778732933,0,1,telomeric repeat-containing RNA transcription,BP,
16545,GO:0097394,1,0.966742778732933,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
16546,GO:0097396,1,0.881802911078687,0,4,response to interleukin-17,BP,
16547,GO:0097398,1,0.881802911078687,0,4,cellular response to interleukin-17,BP,
16548,GO:0097400,1,0.881802911078687,0,4,interleukin-17-mediated signaling pathway,BP,
16549,GO:0097403,1,0.968981230560612,0,1,cellular response to raffinose,BP,
16550,GO:0097409,1,0.971888734846851,0,1,glial cytoplasmic inclusion,CC,
16551,GO:0097411,1,0.880863375803019,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
16553,GO:0097414,1,0.971888734846851,0,1,classical Lewy body,CC,
16556,GO:0097422,1,0.85507059722784,0,5,tubular endosome,CC,
16558,GO:0097427,1,0.849313261729685,0,5,microtubule bundle,CC,
16559,GO:0097428,1,0.760489965499903,0,10,protein maturation by iron-sulfur cluster transfer,BP,
16560,GO:0097431,1,0.440114116554666,0,26,mitotic spindle pole,CC,
16563,GO:0097440,1,0.700887495499823,0,11,apical dendrite,CC,
16564,GO:0097441,1,0.912258104596684,0,3,basal dendrite,CC,
16565,GO:0097442,1,0.966877336087056,0,1,CA3 pyramidal cell dendrite,CC,
16567,GO:0097444,1,0.966916705902753,0,1,spine apparatus,CC,
16569,GO:0097449,1,0.827898299282965,0,6,astrocyte projection,CC,
16570,GO:0097450,1,0.937598435525397,0,2,astrocyte end-foot,CC,
16571,GO:0097451,1,0.937598435525397,0,2,glial limiting end-foot,CC,
16572,GO:0097452,1,0.886335575715598,0,4,GAIT complex,CC,
16573,GO:0097454,1,0.91153234145968,0,3,Schwann cell microvillus,CC,
16574,GO:0097457,1,0.935825718871225,0,2,hippocampal mossy fiber,CC,
16576,GO:0097462,1,0.971888734846851,0,1,Lewy neurite,CC,
16577,GO:0097466,1,0.88105125286297,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
16578,GO:0097468,1,0.718533119807756,0,11,programmed cell death in response to reactive oxygen species,BP,
16579,GO:0097470,1,0.848071462108331,0,5,ribbon synapse,CC,
16581,GO:0097473,1,0.966900162003065,0,1,retinal rod cell apoptotic process,BP,
16587,GO:0097486,1,0.942486889795506,0,2,multivesicular body lumen,CC,
16588,GO:0097487,1,0.917670183484772,0,3,multivesicular body, internal vesicle,CC,
16589,GO:0097489,1,0.970132828777112,0,1,multivesicular body, internal vesicle lumen,CC,
16593,GO:0097494,1,0.884715157621023,0,4,regulation of vesicle size,BP,
16594,GO:0097497,1,0.968691981319906,0,1,blood vessel endothelial cell delamination,BP,
16595,GO:0097498,1,0.939797788277746,0,2,endothelial tube lumen extension,BP,
16596,GO:0097499,1,0.834540022325094,0,6,protein localization to non-motile cilium,BP,
16597,GO:0097500,1,0.909158003242539,0,3,receptor localization to non-motile cilium,BP,
16600,GO:0097503,1,0.649059496595221,0,14,sialylation,BP,
16601,GO:0097504,1,0.713055130341502,0,11,Gemini of coiled bodies,CC,
16602,GO:0097505,1,0.966875138043782,0,1,Rad6-Rad18 complex,CC,
16603,GO:0097506,1,0.867081976340822,0,5,deaminated base DNA N-glycosylase activity,MF,
16604,GO:0097510,1,0.971620590876001,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
16609,GO:0097525,1,0.159191477898108,0,62,spliceosomal snRNP complex,CC,
16610,GO:0097526,1,0.433292139924017,0,29,spliceosomal tri-snRNP complex,CC,
16611,GO:0097527,1,0.88419421206318,0,4,necroptotic signaling pathway,BP,
16615,GO:0097532,1,0.968058844091218,0,1,stress response to acid chemical,BP,
16616,GO:0097533,1,0.968058844091218,0,1,cellular stress response to acid chemical,BP,
16617,GO:0097534,1,0.937586194682671,0,2,lymphoid lineage cell migration,BP,
16618,GO:0097535,1,0.937586194682671,0,2,lymphoid lineage cell migration into thymus,BP,
16619,GO:0097536,1,0.969760732043391,0,1,thymus epithelium morphogenesis,BP,
16621,GO:0097541,1,0.969271124374127,0,1,axonemal basal plate,CC,
16623,GO:0097543,1,0.937236068442464,0,2,ciliary inversin compartment,CC,
16624,GO:0097546,1,0.457441234703831,0,25,ciliary base,CC,
16625,GO:0097550,1,0.83905451802557,0,6,transcriptional preinitiation complex,CC,
16627,GO:0097573,1,0.973405845846992,0,1,glutathione oxidoreductase activity,MF,
16628,GO:0097574,1,0.936796387519517,0,2,lateral part of cell,CC,
16629,GO:0097575,1,0.936796387519517,0,2,lateral cell cortex,CC,
16630,GO:0097576,1,0.938183564025224,0,2,vacuole fusion,BP,
16633,GO:0097598,1,0.96688923701614,0,1,sperm cytoplasmic droplet,CC,
16635,GO:0097603,1,0.967349666574824,0,1,temperature-gated ion channel activity,MF,
16637,GO:0097621,1,0.970892824701539,0,1,monoamine oxidase activity,MF,
16639,GO:0097625,1,0.966828305922411,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16640,GO:0097626,1,0.966828305922411,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16641,GO:0097627,1,0.966828305922411,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16642,GO:0097629,1,0.855232778227878,0,5,extrinsic component of omegasome membrane,CC,
16643,GO:0097630,1,0.969271124374127,0,1,intrinsic component of omegasome membrane,CC,
16644,GO:0097631,1,0.969271124374127,0,1,integral component of omegasome membrane,CC,
16645,GO:0097632,1,0.937188469151739,0,2,extrinsic component of phagophore assembly site membrane,CC,
16646,GO:0097635,1,0.935032179984554,0,2,extrinsic component of autophagosome membrane,CC,
16647,GO:0097636,1,0.937580340174375,0,2,intrinsic component of autophagosome membrane,CC,
16648,GO:0097637,1,0.937580340174375,0,2,integral component of autophagosome membrane,CC,
16649,GO:0097638,1,0.934759409355443,0,2,L-arginine import across plasma membrane,BP,
16650,GO:0097639,1,0.966828305922411,0,1,L-lysine import across plasma membrane,BP,
16651,GO:0097640,1,0.966828305922411,0,1,L-ornithine import across plasma membrane,BP,
16652,GO:0097642,1,0.913605184741018,0,3,calcitonin family receptor activity,MF,
16653,GO:0097643,1,0.974316793231571,0,1,amylin receptor activity,MF,
16654,GO:0097644,1,0.942103295737847,0,2,calcitonin family binding,MF,
16655,GO:0097646,1,0.89104031607465,0,4,calcitonin family receptor signaling pathway,BP,
16656,GO:0097647,1,0.921512540619589,0,3,amylin receptor signaling pathway,BP,
16657,GO:0097648,1,0.911184241347251,0,3,G-protein coupled receptor complex,CC,
16658,GO:0097651,1,0.935716512354516,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
16659,GO:0097655,1,0.969271124374127,0,1,serpin family protein binding,MF,
16661,GO:0097676,1,0.907825135466658,0,3,histone H3-K36 dimethylation,BP,
16662,GO:0097677,1,0.833973394870883,0,6,STAT family protein binding,MF,
16663,GO:0097680,1,0.90861090651633,0,3,double-strand break repair via classical nonhomologous end joining,BP,
16664,GO:0097681,1,0.934591291872127,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
16665,GO:0097682,1,0.971461413919649,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
16666,GO:0097688,1,0.85471980621723,0,5,glutamate receptor clustering,BP,
16667,GO:0097692,1,0.966861899619982,0,1,histone H3-K4 monomethylation,BP,
16668,GO:0097694,1,0.905835750271854,0,3,establishment of RNA localization to telomere,BP,
16669,GO:0097695,1,0.905835750271854,0,3,establishment of protein-containing complex localization to telomere,BP,
16671,GO:0097698,1,0.973108463145435,0,1,telomere maintenance via base-excision repair,BP,
16672,GO:0097699,1,0.967131627594135,0,1,vascular endothelial cell response to fluid shear stress,BP,
16673,GO:0097707,1,0.974252463448493,0,1,ferroptosis,BP,
16677,GO:0097712,1,0.969271124374127,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16680,GO:0097722,1,0.408347595677794,0,29,sperm motility,BP,
16681,GO:0097724,1,0.972249895030127,0,1,sperm flagellum movement,BP,
16682,GO:0097726,1,0.973906637263941,0,1,LEM domain binding,MF,
16683,GO:0097729,1,0.302198311212106,0,39,9+2 motile cilium,CC,
16684,GO:0097730,1,0.136257481392607,0,63,non-motile cilium,CC,
16685,GO:0097731,1,0.19893622134285,0,51,9+0 non-motile cilium,CC,
16686,GO:0097732,1,0.860178578234815,0,5,9+2 non-motile cilium,CC,
16687,GO:0097733,1,0.19893622134285,0,51,photoreceptor cell cilium,CC,
16688,GO:0097734,1,0.598170620796598,0,17,extracellular exosome biogenesis,BP,
16689,GO:0097742,1,0.904665352809946,0,3,de novo centriole assembly,BP,
16690,GO:0097745,1,0.915957329131748,0,3,mitochondrial tRNA 5'-end processing,BP,
16692,GO:0097747,1,0.281524719056167,0,43,RNA polymerase activity,MF,
16693,GO:0097749,1,0.966858585632847,0,1,membrane tubulation,BP,
16694,GO:0097752,1,0.910835743597683,0,3,regulation of DNA stability,BP,
16695,GO:0097753,1,0.967684640507563,0,1,membrane bending,BP,
16698,GO:0098501,1,0.866792580135192,0,5,polynucleotide dephosphorylation,BP,
16699,GO:0098502,1,0.921386130135794,0,3,DNA dephosphorylation,BP,
16700,GO:0098503,1,0.972524513134103,0,1,DNA 3' dephosphorylation,BP,
16701,GO:0098504,1,0.972524513134103,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16702,GO:0098505,1,0.733933325031257,0,10,G-rich strand telomeric DNA binding,MF,
16703,GO:0098506,1,0.972524513134103,0,1,polynucleotide 3' dephosphorylation,BP,
16704,GO:0098507,1,0.940761373788292,0,2,polynucleotide 5' dephosphorylation,BP,
16705,GO:0098508,1,0.942173015898733,0,2,endothelial to hematopoietic transition,BP,
16706,GO:0098518,1,0.914909224349846,0,3,polynucleotide phosphatase activity,MF,
16707,GO:0098519,1,0.858158699294063,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16708,GO:0098528,1,0.881851998349408,0,4,skeletal muscle fiber differentiation,BP,
16709,GO:0098530,1,0.966874347694405,0,1,positive regulation of strand invasion,BP,
16711,GO:0098532,1,0.839520903956114,0,6,histone H3-K27 trimethylation,BP,
16712,GO:0098533,1,0.658993957282215,0,13,ATPase dependent transmembrane transport complex,CC,
16713,GO:0098534,1,0.384648681184575,0,30,centriole assembly,BP,
16714,GO:0098535,1,0.904665352809946,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
16715,GO:0098536,1,0.905291803677898,0,3,deuterosome,CC,
16717,GO:0098543,1,0.825097298574631,0,6,detection of other organism,BP,
16718,GO:0098547,1,0.971037284202953,0,1,lumenal side of Golgi membrane,CC,
16721,GO:0098554,1,0.685278587687389,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
16722,GO:0098556,1,0.878843455529691,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16723,GO:0098559,1,0.913000014711459,0,3,cytoplasmic side of early endosome membrane,CC,
16724,GO:0098560,1,0.940358802354773,0,2,cytoplasmic side of late endosome membrane,CC,
16726,GO:0098563,1,0.632560089644707,0,15,intrinsic component of synaptic vesicle membrane,CC,
16727,GO:0098573,1,0.138264028292474,0,66,intrinsic component of mitochondrial membrane,CC,
16728,GO:0098574,1,0.882347895913835,0,4,cytoplasmic side of lysosomal membrane,CC,
16729,GO:0098575,1,0.943532728965529,0,2,lumenal side of lysosomal membrane,CC,
16730,GO:0098576,1,0.887112311796463,0,4,lumenal side of membrane,CC,
16731,GO:0098577,1,0.966847112481757,0,1,inactive sex chromosome,CC,
16732,GO:0098581,1,0.800164859239403,0,7,detection of external biotic stimulus,BP,
16733,GO:0098582,1,0.935811798300053,0,2,innate vocalization behavior,BP,
16738,GO:0098592,1,0.908197037018323,0,3,cytoplasmic side of apical plasma membrane,CC,
16739,GO:0098594,1,0.974611377013966,0,1,mucin granule,CC,
16740,GO:0098596,1,0.874538753677803,0,4,imitative learning,BP,
16741,GO:0098597,1,0.845418964570846,0,5,observational learning,BP,
16742,GO:0098598,1,0.874538753677803,0,4,learned vocalization behavior or vocal learning,BP,
16743,GO:0098599,1,0.741307280975993,0,10,palmitoyl hydrolase activity,MF,
16745,GO:0098619,1,0.972051539942004,0,1,selenocysteine-tRNA ligase activity,MF,
16746,GO:0098621,1,0.966877820593443,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
16749,GO:0098629,1,0.969271124374127,0,1,trans-Golgi network membrane organization,BP,
16752,GO:0098633,1,0.970214510686921,0,1,collagen fibril binding,MF,
16753,GO:0098634,1,0.874773994707813,0,4,cell-matrix adhesion mediator activity,MF,
16755,GO:0098639,1,0.874773994707813,0,4,collagen binding involved in cell-matrix adhesion,MF,
16758,GO:0098643,1,0.765063421402451,0,8,banded collagen fibril,CC,
16762,GO:0098647,1,0.909982616357103,0,3,collagen beaded filament,CC,
16763,GO:0098648,1,0.966786400292585,0,1,collagen anchoring fibril,CC,
16765,GO:0098652,1,0.966786400292585,0,1,collagen type VII anchoring fibril,CC,
16774,GO:0098679,1,0.934687593809811,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16775,GO:0098680,1,0.975387957839165,0,1,template-free RNA nucleotidyltransferase,MF,
16778,GO:0098698,1,0.873962663691477,0,4,postsynaptic specialization assembly,BP,
16779,GO:0098700,1,0.944857528127199,0,2,neurotransmitter loading into synaptic vesicle,BP,
16780,GO:0098703,1,0.824758016468343,0,6,calcium ion import across plasma membrane,BP,
16781,GO:0098705,1,0.966998356290237,0,1,copper ion import across plasma membrane,BP,
16784,GO:0098712,1,0.826638189380779,0,6,L-glutamate import across plasma membrane,BP,
16785,GO:0098713,1,0.970995982889281,0,1,leucine import across plasma membrane,BP,
16787,GO:0098722,1,0.802091437110043,0,7,asymmetric stem cell division,BP,
16788,GO:0098725,1,0.969271124374127,0,1,symmetric cell division,BP,
16790,GO:0098728,1,0.914637738359626,0,3,germline stem cell asymmetric division,BP,
16792,GO:0098734,1,0.741307280975993,0,10,macromolecule depalmitoylation,BP,
16794,GO:0098736,1,0.966797215838241,0,1,negative regulation of the force of heart contraction,BP,
16797,GO:0098743,1,0.706126273361953,0,11,cell aggregation,BP,
16798,GO:0098745,1,0.972485129024854,0,1,Dcp1-Dcp2 complex,CC,
16799,GO:0098746,1,0.966986601575985,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
16800,GO:0098748,1,0.705978945606772,0,11,endocytic adaptor activity,MF,
16801,GO:0098749,1,0.967055051984345,0,1,cerebellar neuron development,BP,
16804,GO:0098756,1,0.875047348424297,0,4,response to interleukin-21,BP,
16805,GO:0098757,1,0.875047348424297,0,4,cellular response to interleukin-21,BP,
16806,GO:0098758,1,0.940027752087867,0,2,response to interleukin-8,BP,
16807,GO:0098759,1,0.940027752087867,0,2,cellular response to interleukin-8,BP,
16813,GO:0098773,1,0.118211041138565,0,68,skin epidermis development,BP,
16817,GO:0098787,1,0.643022824322144,0,14,mRNA cleavage involved in mRNA processing,BP,
16818,GO:0098789,1,0.706917514655821,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16823,GO:0098795,1,0.938205375931488,0,2,mRNA cleavage involved in gene silencing,BP,
16827,GO:0098799,1,0.705555863518489,0,12,outer mitochondrial membrane protein complex,CC,
16828,GO:0098800,1,0.0633421294169115,0,99,inner mitochondrial membrane protein complex,CC,
16831,GO:0098803,1,0.167915410618591,0,66,respiratory chain complex,CC,
16833,GO:0098808,1,0.942022770254554,0,2,mRNA cap binding,MF,
16834,GO:0098809,1,0.970021395609411,0,1,nitrite reductase activity,MF,
16835,GO:0098810,1,0.785986071750091,0,8,neurotransmitter reuptake,BP,
16839,GO:0098816,1,0.97166272183182,0,1,mini excitatory postsynaptic potential,BP,
16840,GO:0098821,1,0.90472305532769,0,3,BMP receptor activity,MF,
16841,GO:0098822,1,0.970440273114395,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
16842,GO:0098826,1,0.88584131522971,0,4,endoplasmic reticulum tubular network membrane,CC,
16845,GO:0098829,1,0.966855798110455,0,1,intestinal folate absorption,BP,
16846,GO:0098830,1,0.966983061299026,0,1,presynaptic endosome,CC,
16848,GO:0098833,1,0.966951016081948,0,1,presynaptic endocytic zone,CC,
16849,GO:0098835,1,0.966951016081948,0,1,presynaptic endocytic zone membrane,CC,
16850,GO:0098837,1,0.914099278549397,0,3,postsynaptic recycling endosome,CC,
16851,GO:0098838,1,0.969399299314024,0,1,reduced folate transmembrane transport,BP,
16853,GO:0098840,1,0.944394461165982,0,2,protein transport along microtubule,BP,
16854,GO:0098842,1,0.942511744809815,0,2,postsynaptic early endosome,CC,
16855,GO:0098843,1,0.833056635748525,0,6,postsynaptic endocytic zone,CC,
16856,GO:0098844,1,0.878446676002993,0,4,postsynaptic endocytic zone membrane,CC,
16857,GO:0098845,1,0.835052033635468,0,6,postsynaptic endosome,CC,
16858,GO:0098847,1,0.670232721221637,0,13,sequence-specific single stranded DNA binding,MF,
16860,GO:0098856,1,0.913486926825375,0,3,intestinal lipid absorption,BP,
16864,GO:0098868,1,0.637701252601823,0,14,bone growth,BP,
16867,GO:0098871,1,0.972610165070714,0,1,postsynaptic actin cytoskeleton,CC,
16868,GO:0098875,1,0.96701027744634,0,1,epididymosome,CC,
16870,GO:0098877,1,0.730798486479454,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16872,GO:0098881,1,0.909775280482782,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16873,GO:0098883,1,0.972322080150554,0,1,synapse disassembly,BP,
16874,GO:0098884,1,0.878446676002993,0,4,postsynaptic neurotransmitter receptor internalization,BP,
16875,GO:0098885,1,0.96683706223508,0,1,modification of postsynaptic actin cytoskeleton,BP,
16876,GO:0098886,1,0.937201750203985,0,2,modification of dendritic spine,BP,
16877,GO:0098887,1,0.854084727735353,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
16878,GO:0098888,1,0.966835975881254,0,1,extrinsic component of presynaptic membrane,CC,
16879,GO:0098890,1,0.966835975881254,0,1,extrinsic component of postsynaptic membrane,CC,
16882,GO:0098902,1,0.853308825662464,0,5,regulation of membrane depolarization during action potential,BP,
16884,GO:0098904,1,0.939993495024737,0,2,regulation of AV node cell action potential,BP,
16885,GO:0098905,1,0.943933490556692,0,2,regulation of bundle of His cell action potential,BP,
16886,GO:0098906,1,0.968680067927164,0,1,regulation of Purkinje myocyte action potential,BP,
16887,GO:0098907,1,0.966814582471168,0,1,regulation of SA node cell action potential,BP,
16888,GO:0098908,1,0.938729189539314,0,2,regulation of neuronal action potential,BP,
16889,GO:0098909,1,0.854413966630537,0,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
16890,GO:0098910,1,0.847434090878462,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16892,GO:0098912,1,0.96730341083719,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
16893,GO:0098914,1,0.937085910975704,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
16896,GO:0098917,1,0.913294019084921,0,3,retrograde trans-synaptic signaling,BP,
16897,GO:0098918,1,0.97230580442963,0,1,structural constituent of synapse,MF,
16898,GO:0098920,1,0.969690695435605,0,1,retrograde trans-synaptic signaling by lipid,BP,
16899,GO:0098921,1,0.969690695435605,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
16900,GO:0098923,1,0.966838884026404,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
16901,GO:0098924,1,0.966838884026404,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
16902,GO:0098926,1,0.966843708269384,0,1,postsynaptic signal transduction,BP,
16903,GO:0098927,1,0.276353173904686,0,41,vesicle-mediated transport between endosomal compartments,BP,
16904,GO:0098928,1,0.934341082338952,0,2,presynaptic signal transduction,BP,
16906,GO:0098935,1,0.904623196826585,0,3,dendritic transport,BP,
16907,GO:0098936,1,0.934987495695146,0,2,intrinsic component of postsynaptic membrane,CC,
16908,GO:0098937,1,0.904623196826585,0,3,anterograde dendritic transport,BP,
16909,GO:0098939,1,0.966854536010075,0,1,dendritic transport of mitochondrion,BP,
16910,GO:0098943,1,0.941143798013605,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
16911,GO:0098948,1,0.966851605988894,0,1,intrinsic component of postsynaptic specialization membrane,CC,
16912,GO:0098953,1,0.91087479738084,0,3,receptor diffusion trapping,BP,
16914,GO:0098960,1,0.856820786928405,0,5,postsynaptic neurotransmitter receptor activity,MF,
16915,GO:0098967,1,0.909775280482782,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
16916,GO:0098968,1,0.966906671281593,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
16917,GO:0098969,1,0.754639408213862,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16918,GO:0098970,1,0.91087479738084,0,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,
16919,GO:0098971,1,0.935640996699882,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
16920,GO:0098972,1,0.966854536010075,0,1,anterograde dendritic transport of mitochondrion,BP,
16921,GO:0098973,1,0.97230580442963,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16922,GO:0098974,1,0.97230580442963,0,1,postsynaptic actin cytoskeleton organization,BP,
16923,GO:0098976,1,0.880988809221028,0,4,excitatory chemical synaptic transmission,BP,
16924,GO:0098978,1,0.934831385371774,0,2,glutamatergic synapse,CC,
16925,GO:0098982,1,0.935037099471778,0,2,GABA-ergic synapse,CC,
16926,GO:0098983,1,0.935037099471778,0,2,symmetric, GABA-ergic, inhibitory synapse,CC,
16928,GO:0098985,1,0.934831385371774,0,2,asymmetric, glutamatergic, excitatory synapse,CC,
16929,GO:0098988,1,0.966864704463998,0,1,G-protein coupled glutamate receptor activity,MF,
16930,GO:0098989,1,0.940799769759582,0,2,NMDA selective glutamate receptor signaling pathway,BP,
16931,GO:0098993,1,0.790466163393419,0,8,anchored component of synaptic vesicle membrane,CC,
16933,GO:0099004,1,0.93489987241677,0,2,calmodulin dependent kinase signaling pathway,BP,
16934,GO:0099010,1,0.906115967161541,0,3,modification of postsynaptic structure,BP,
16935,GO:0099011,1,0.935483700368892,0,2,neuronal dense core vesicle exocytosis,BP,
16936,GO:0099022,1,0.943014941815211,0,2,vesicle tethering,BP,
16939,GO:0099039,1,0.966857836354105,0,1,sphingolipid translocation,BP,
16940,GO:0099044,1,0.943014941815211,0,2,vesicle tethering to endoplasmic reticulum,BP,
16941,GO:0099046,1,0.97321722048805,0,1,clearance of foreign intracellular nucleic acids,BP,
16942,GO:0099053,1,0.910842564523759,0,3,activating signal cointegrator 1 complex,CC,
16943,GO:0099054,1,0.678188397413875,0,12,presynapse assembly,BP,
16944,GO:0099055,1,0.934987495695146,0,2,integral component of postsynaptic membrane,CC,
16945,GO:0099060,1,0.966851605988894,0,1,integral component of postsynaptic specialization membrane,CC,
16946,GO:0099061,1,0.966851605988894,0,1,integral component of postsynaptic density membrane,CC,
16947,GO:0099068,1,0.720885171212758,0,10,postsynapse assembly,BP,
16948,GO:0099072,1,0.603704609503535,0,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
16949,GO:0099073,1,0.936556081116395,0,2,mitochondrion-derived vesicle,CC,
16950,GO:0099074,1,0.93923778297644,0,2,mitochondrion to lysosome transport,BP,
16951,GO:0099075,1,0.93923778297644,0,2,mitochondrion-derived vesicle mediated transport,BP,
16952,GO:0099077,1,0.966874544680097,0,1,histone-dependent DNA binding,MF,
16953,GO:0099078,1,0.789448565551284,0,8,BORC complex,CC,
16956,GO:0099082,1,0.974151547296457,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
16957,GO:0099083,1,0.974151547296457,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
16958,GO:0099084,1,0.795041735145767,0,7,postsynaptic specialization organization,BP,
16959,GO:0099086,1,0.588998734048828,0,17,synaptonemal structure,CC,
16960,GO:0099089,1,0.966718921038226,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
16961,GO:0099093,1,0.937171203938339,0,2,calcium export from the mitochondrion,BP,
16962,GO:0099094,1,0.360380698113822,0,32,ligand-gated cation channel activity,MF,
16963,GO:0099095,1,0.9686969601558,0,1,ligand-gated anion channel activity,MF,
16964,GO:0099098,1,0.96855706090163,0,1,microtubule polymerization based movement,BP,
16968,GO:0099118,1,0.944394461165982,0,2,microtubule-based protein transport,BP,
16969,GO:0099122,1,0.908063261415218,0,3,RNA polymerase II C-terminal domain binding,MF,
16970,GO:0099130,1,0.971114009766664,0,1,estrogen binding,MF,
16971,GO:0099131,1,0.533264209377891,0,21,ATP hydrolysis coupled ion transmembrane transport,BP,
16972,GO:0099132,1,0.394914411745362,0,30,ATP hydrolysis coupled cation transmembrane transport,BP,
16973,GO:0099133,1,0.765543919442579,0,8,ATP hydrolysis coupled anion transmembrane transport,BP,
16974,GO:0099146,1,0.966851605988894,0,1,intrinsic component of postsynaptic density membrane,CC,
16975,GO:0099159,1,0.96683706223508,0,1,regulation of modification of postsynaptic structure,BP,
16976,GO:0099163,1,0.966838884026404,0,1,synaptic signaling by nitric oxide,BP,
16977,GO:0099170,1,0.908703042006094,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
16978,GO:0099172,1,0.638669583258252,0,14,presynapse organization,BP,
16979,GO:0099173,1,0.114293592975092,0,68,postsynapse organization,BP,
16980,GO:0099174,1,0.90703588401745,0,3,regulation of presynapse organization,BP,
16981,GO:0099175,1,0.337471732722169,0,34,regulation of postsynapse organization,BP,
16983,GO:0099186,1,0.97230580442963,0,1,structural constituent of postsynapse,MF,
16984,GO:0099188,1,0.97230580442963,0,1,postsynaptic cytoskeleton organization,BP,
16985,GO:0099240,1,0.934987495695146,0,2,intrinsic component of synaptic membrane,CC,
16986,GO:0099243,1,0.966835975881254,0,1,extrinsic component of synaptic membrane,CC,
16987,GO:0099402,1,0.974543632249742,0,1,plant organ development,BP,
16988,GO:0099403,1,0.93462307427368,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
16989,GO:0099404,1,0.93462307427368,0,2,mitotic sister chromatid cohesion, telomeric,BP,
16990,GO:0099500,1,0.737290750760751,0,10,vesicle fusion to plasma membrane,BP,
17001,GO:0099519,1,0.969271124374127,0,1,dense core granule cytoskeletal transport,BP,
17002,GO:0099522,1,0.971671425417964,0,1,region of cytosol,CC,
17003,GO:0099523,1,0.971671425417964,0,1,presynaptic cytosol,CC,
17004,GO:0099524,1,0.971671425417964,0,1,postsynaptic cytosol,CC,
17005,GO:0099525,1,0.935483700368892,0,2,presynaptic dense core vesicle exocytosis,BP,
17006,GO:0099526,1,0.934341082338952,0,2,presynapse to nucleus signaling pathway,BP,
17007,GO:0099527,1,0.966843708269384,0,1,postsynapse to nucleus signaling pathway,BP,
17009,GO:0099529,1,0.856820786928405,0,5,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
17011,GO:0099532,1,0.934892723548599,0,2,synaptic vesicle endosomal processing,BP,
17014,GO:0099538,1,0.974151547296457,0,1,synaptic signaling via neuropeptide,BP,
17015,GO:0099540,1,0.974151547296457,0,1,trans-synaptic signaling by neuropeptide,BP,
17016,GO:0099541,1,0.938345376415947,0,2,trans-synaptic signaling by lipid,BP,
17017,GO:0099542,1,0.938345376415947,0,2,trans-synaptic signaling by endocannabinoid,BP,
17018,GO:0099543,1,0.966838884026404,0,1,trans-synaptic signaling by soluble gas,BP,
17019,GO:0099545,1,0.966969034767849,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17020,GO:0099547,1,0.908703042006094,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17021,GO:0099548,1,0.966838884026404,0,1,trans-synaptic signaling by nitric oxide,BP,
17022,GO:0099550,1,0.911520413831513,0,3,trans-synaptic signaling, modulating synaptic transmission,BP,
17023,GO:0099551,1,0.974151547296457,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17024,GO:0099552,1,0.967677609466671,0,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
17025,GO:0099553,1,0.967677609466671,0,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
17026,GO:0099557,1,0.966969034767849,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17027,GO:0099563,1,0.681006178002578,0,12,modification of synaptic structure,BP,
17031,GO:0099571,1,0.972610165070714,0,1,postsynaptic cytoskeleton,CC,
17033,GO:0099578,1,0.908703042006094,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
17037,GO:0099590,1,0.826634292162012,0,6,neurotransmitter receptor internalization,BP,
17039,GO:0099602,1,0.84031985161577,0,6,neurotransmitter receptor regulator activity,MF,
17040,GO:0099604,1,0.597423921177454,0,16,ligand-gated calcium channel activity,MF,
17041,GO:0099606,1,0.966801498908787,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17042,GO:0099607,1,0.966801498908787,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
17043,GO:0099609,1,0.934839924151085,0,2,microtubule lateral binding,MF,
17045,GO:0099617,1,0.968258076716336,0,1,matrix side of mitochondrial inner membrane,CC,
17048,GO:0099624,1,0.937085910975704,0,2,atrial cardiac muscle cell membrane repolarization,BP,
17050,GO:0099627,1,0.969271124374127,0,1,neurotransmitter receptor cycle,BP,
17051,GO:0099628,1,0.91087479738084,0,3,neurotransmitter receptor diffusion trapping,BP,
17052,GO:0099630,1,0.969271124374127,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17053,GO:0099631,1,0.948347096773058,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
17054,GO:0099632,1,0.664919041617675,0,13,protein transport within plasma membrane,BP,
17056,GO:0099637,1,0.664919041617675,0,13,neurotransmitter receptor transport,BP,
17057,GO:0099638,1,0.827111081351107,0,6,endosome to plasma membrane protein transport,BP,
17058,GO:0099639,1,0.827111081351107,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17059,GO:0099640,1,0.97433684205675,0,1,axo-dendritic protein transport,BP,
17060,GO:0099641,1,0.97433684205675,0,1,anterograde axonal protein transport,BP,
17062,GO:0099699,1,0.934987495695146,0,2,integral component of synaptic membrane,CC,
17064,GO:0100002,1,0.969335883777886,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
17065,GO:0100012,1,0.972322080150554,0,1,regulation of heart induction by canonical Wnt signaling pathway,BP,
17066,GO:0100057,1,0.966826941943737,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
17070,GO:0101006,1,0.918161357395093,0,3,protein histidine phosphatase activity,MF,
17072,GO:0101023,1,0.703406745615337,0,11,vascular endothelial cell proliferation,BP,
17073,GO:0101030,1,0.97345407233384,0,1,tRNA-guanine transglycosylation,BP,
17074,GO:0101031,1,0.719019198668521,0,11,chaperone complex,CC,
17075,GO:0102005,1,0.973063819527953,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
17076,GO:0102007,1,0.972749943694051,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
17077,GO:0102008,1,0.966937673856596,0,1,cytosolic dipeptidase activity,MF,
17078,GO:0102009,1,0.972068370471064,0,1,proline dipeptidase activity,MF,
17079,GO:0102077,1,0.971464344687056,0,1,oleamide hydrolase activity,MF,
17080,GO:0102084,1,0.940783184811801,0,2,L-dopa O-methyltransferase activity,MF,
17081,GO:0102092,1,0.934868706651646,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
17082,GO:0102113,1,0.966844879899242,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
17083,GO:0102121,1,0.940415839705692,0,2,ceramidase activity,MF,
17084,GO:0102131,1,0.966805423739126,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17085,GO:0102132,1,0.966805423739126,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17086,GO:0102148,1,0.916057695117387,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
17087,GO:0102158,1,0.882620775853877,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17088,GO:0102166,1,0.966917221267379,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17089,GO:0102167,1,0.966917221267379,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17090,GO:0102200,1,0.966906551654045,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
17091,GO:0102250,1,0.937812768883068,0,2,linear malto-oligosaccharide phosphorylase activity,MF,
17092,GO:0102336,1,0.856212542519588,0,5,3-oxo-arachidoyl-CoA synthase activity,MF,
17093,GO:0102337,1,0.856212542519588,0,5,3-oxo-cerotoyl-CoA synthase activity,MF,
17094,GO:0102338,1,0.856212542519588,0,5,3-oxo-lignoceronyl-CoA synthase activity,MF,
17095,GO:0102339,1,0.9701890855775,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
17096,GO:0102340,1,0.9701890855775,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
17097,GO:0102341,1,0.9701890855775,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
17098,GO:0102342,1,0.9701890855775,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
17099,GO:0102343,1,0.882620775853877,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17100,GO:0102344,1,0.882620775853877,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17101,GO:0102345,1,0.882620775853877,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
17102,GO:0102389,1,0.969862672246662,0,1,polyprenol reductase activity,MF,
17103,GO:0102390,1,0.969911544203276,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
17104,GO:0102391,1,0.876794331906253,0,4,decanoate-CoA ligase activity,MF,
17105,GO:0102420,1,0.880537391691943,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
17106,GO:0102485,1,0.937224771993531,0,2,dATP phosphohydrolase activity,MF,
17107,GO:0102486,1,0.937224771993531,0,2,dCTP phosphohydrolase activity,MF,
17108,GO:0102487,1,0.937224771993531,0,2,dUTP phosphohydrolase activity,MF,
17109,GO:0102488,1,0.937224771993531,0,2,dTTP phosphohydrolase activity,MF,
17110,GO:0102489,1,0.937224771993531,0,2,GTP phosphohydrolase activity,MF,
17111,GO:0102490,1,0.937224771993531,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17112,GO:0102491,1,0.937224771993531,0,2,dGTP phosphohydrolase activity,MF,
17113,GO:0102499,1,0.937812768883068,0,2,SHG alpha-glucan phosphorylase activity,MF,
17114,GO:0102500,1,0.966837365625101,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
17116,GO:0102522,1,0.971146470436641,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
17117,GO:0102524,1,0.969271124374127,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17118,GO:0102567,1,0.686449965814902,0,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
17119,GO:0102568,1,0.686449965814902,0,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
17120,GO:0102571,1,0.966917221267379,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17121,GO:0102704,1,0.969237981957712,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
17122,GO:0102707,1,0.970146860703029,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
17123,GO:0102751,1,0.972311234178041,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
17125,GO:0102756,1,0.856212542519588,0,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
17126,GO:0102758,1,0.973807315180373,0,1,very-long-chain enoyl-CoA reductase activity,MF,
17128,GO:0102773,1,0.967137022109188,0,1,dihydroceramide kinase activity,MF,
17129,GO:0102797,1,0.966948773059237,0,1,geranial:oxygen oxidoreductase activity,MF,
17130,GO:0102798,1,0.966948773059237,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
17131,GO:0102867,1,0.969660586114332,0,1,molybdenum cofactor sulfurtransferase activity,MF,
17132,GO:0102938,1,0.940783184811801,0,2,orcinol O-methyltransferase activity,MF,
17133,GO:0102953,1,0.913302840121274,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17134,GO:0102965,1,0.939316984477824,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
17135,GO:0102991,1,0.869596883344611,0,5,myristoyl-CoA hydrolase activity,MF,
17136,GO:0103025,1,0.971232014228794,0,1,alpha-amylase activity (releasing maltohexaose),MF,
17137,GO:0103045,1,0.97155794017435,0,1,methione N-acyltransferase activity,MF,
17138,GO:0103046,1,0.966937673856596,0,1,alanylglutamate dipeptidase activity,MF,
17139,GO:0103053,1,0.945081538212394,0,2,1-ethyladenine demethylase activity,MF,
17140,GO:0103066,1,0.972846862323855,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17141,GO:0103067,1,0.972846862323855,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
17142,GO:0103068,1,0.913302840121274,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17143,GO:0103073,1,0.971464344687056,0,1,anandamide amidohydrolase activity,MF,
17146,GO:0106001,1,0.906520311505581,0,3,intestinal hexose absorption,BP,
17147,GO:0106003,1,0.752682426830353,0,9,amyloid-beta complex,CC,
17148,GO:0106004,1,0.946701227260789,0,2,tRNA (guanine-N7)-methylation,BP,
17149,GO:0106005,1,0.96686298944931,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
17150,GO:0106014,1,0.943358500743453,0,2,regulation of inflammatory response to wounding,BP,
17151,GO:0106015,1,0.943358500743453,0,2,negative regulation of inflammatory response to wounding,BP,
17152,GO:0106017,1,0.904333594450636,0,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
17153,GO:0106018,1,0.630212982699576,0,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
17154,GO:0106019,1,0.722220321654282,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
17155,GO:0106020,1,0.939504897911249,0,2,regulation of vesicle docking,BP,
17156,GO:0106022,1,0.967553199987795,0,1,positive regulation of vesicle docking,BP,
17157,GO:0106027,1,0.188328496521687,0,52,neuron projection organization,BP,
17158,GO:0106028,1,0.966969034767849,0,1,neuron projection retraction,BP,
17160,GO:0106044,1,0.974265395836361,0,1,guanine deglycation,BP,
17161,GO:0106045,1,0.974265395836361,0,1,guanine deglycation, methylglyoxal removal,BP,
17162,GO:0106046,1,0.974265395836361,0,1,guanine deglycation, glyoxal removal,BP,
17163,GO:0106049,1,0.854234051580559,0,5,regulation of cellular response to osmotic stress,BP,
17164,GO:0106050,1,0.971887307962299,0,1,tRNA 2'-O-methyltransferase activity,MF,
17166,GO:0106057,1,0.908662553286529,0,3,negative regulation of calcineurin-mediated signaling,BP,
17169,GO:0106070,1,0.853236328196142,0,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17170,GO:0106071,1,0.907837305077528,0,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17171,GO:0106072,1,0.939871420629237,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
17172,GO:0106073,1,0.936564581736712,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
17173,GO:0106074,1,0.684776256577221,0,12,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
17174,GO:0106075,1,0.968757393536143,0,1,peptide N-succinyltransferase activity,MF,
17175,GO:0106077,1,0.879187071593844,0,4,histone succinylation,BP,
17176,GO:0106078,1,0.968757393536143,0,1,histone succinyltransferase activity,MF,
17177,GO:0106083,1,0.848038361534356,0,5,nuclear membrane protein complex,CC,
17178,GO:0106088,1,0.96684592538055,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17179,GO:0106089,1,0.96684592538055,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17180,GO:0106094,1,0.848038361534356,0,5,nuclear membrane microtubule tethering complex,CC,
17181,GO:0106101,1,0.972205946231389,0,1,ER-dependent peroxisome localization,BP,
17182,GO:0106104,1,0.938274069454644,0,2,regulation of glutamate receptor clustering,BP,
17183,GO:0110008,1,0.968908735522568,0,1,ncRNA deadenylation,BP,
17184,GO:0110009,1,0.936435057104345,0,2,formin-nucleated actin cable organization,BP,
17185,GO:0110011,1,0.844884148792217,0,5,regulation of basement membrane organization,BP,
17186,GO:0110017,1,0.947841238539283,0,2,cap-independent translational initiation of linear mRNA,BP,
17188,GO:0110021,1,0.940285396150496,0,2,cardiac muscle myoblast proliferation,BP,
17189,GO:0110022,1,0.940285396150496,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17190,GO:0110024,1,0.940285396150496,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
17191,GO:0110025,1,0.968899121715589,0,1,DNA strand resection involved in replication fork processing,BP,
17192,GO:0110026,1,0.968899121715589,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
17193,GO:0110028,1,0.966837517356414,0,1,positive regulation of mitotic spindle organization,BP,
17194,GO:0110029,1,0.968694967567319,0,1,negative regulation of meiosis I,BP,
17196,GO:0110057,1,0.96688425310474,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17197,GO:0110059,1,0.96688425310474,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17198,GO:0110075,1,0.974252463448493,0,1,regulation of ferroptosis,BP,
17199,GO:0110076,1,0.974252463448493,0,1,negative regulation of ferroptosis,BP,
17200,GO:0110095,1,0.920136781186306,0,3,cellular detoxification of aldehyde,BP,
17201,GO:0110096,1,0.86973008825055,0,5,cellular response to aldehyde,BP,
17202,GO:0120009,1,0.8569193890033,0,5,intermembrane lipid transfer,BP,
17203,GO:0120012,1,0.966888903347889,0,1,intermembrane sphingolipid transfer,BP,
17204,GO:0120013,1,0.8569193890033,0,5,intermembrane lipid transfer activity,MF,
17205,GO:0120016,1,0.966888903347889,0,1,intermembrane sphingolipid transfer activity,MF,
17206,GO:0120017,1,0.966888903347889,0,1,intermembrane ceramide transfer activity,MF,
17216,GO:0120043,1,0.967008236331754,0,1,stereocilium shaft,CC,
17217,GO:0120044,1,0.967008236331754,0,1,stereocilium base,CC,
17218,GO:0120048,1,0.969271124374127,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17219,GO:0120049,1,0.969271124374127,0,1,snRNA (adenine-N6)-methylation,BP,
17220,GO:0120060,1,0.974480330032443,0,1,regulation of gastric emptying,BP,
17221,GO:0120061,1,0.974480330032443,0,1,negative regulation of gastric emptying,BP,
17222,GO:0120063,1,0.974480330032443,0,1,stomach smooth muscle contraction,BP,
17223,GO:0120068,1,0.974480330032443,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17224,GO:0120069,1,0.974480330032443,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
17225,GO:0120077,1,0.96684592538055,0,1,angiogenic sprout fusion,BP,
17226,GO:0120078,1,0.96684592538055,0,1,cell adhesion involved in sprouting angiogenesis,BP,
17227,GO:0120092,1,0.968308710456113,0,1,crotonyl-CoA hydratase activity,MF,
17228,GO:0120093,1,0.968308710456113,0,1,regulation of peptidyl-lysine crotonylation,BP,
17229,GO:0120094,1,0.968308710456113,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
17230,GO:0120103,1,0.74611587986594,0,9,centriolar subdistal appendage,CC,
17231,GO:0120108,1,0.971709085988543,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
17233,GO:0120114,1,0.0950429092103589,0,79,Sm-like protein family complex,CC,
17234,GO:0140007,1,0.887658487896487,0,4,KICSTOR complex,CC,
17235,GO:0140009,1,0.967867155580196,0,1,L-aspartate import across plasma membrane,BP,
17242,GO:0140034,1,0.169995059776994,0,56,methylation-dependent protein binding,MF,
17243,GO:0140035,1,0.824992460571589,0,6,ubiquitination-like modification-dependent protein binding,MF,
17244,GO:0140036,1,0.824992460571589,0,6,ubiquitin-dependent protein binding,MF,
17245,GO:0140041,1,0.974265395836361,0,1,cellular detoxification of methylglyoxal,BP,
17246,GO:0140052,1,0.909238517662777,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
17251,GO:0140064,1,0.966798342251264,0,1,peptide crotonyltransferase activity,MF,
17252,GO:0140065,1,0.966798342251264,0,1,peptide butyryltransferase activity,MF,
17253,GO:0140066,1,0.936156472286728,0,2,peptidyl-lysine crotonylation,BP,
17254,GO:0140067,1,0.966798342251264,0,1,peptidyl-lysine butyrylation,BP,
17255,GO:0140068,1,0.966798342251264,0,1,histone crotonyltransferase activity,MF,
17256,GO:0140069,1,0.966798342251264,0,1,histone butyryltransferase activity,MF,
17257,GO:0140074,1,0.966909900049792,0,1,cardiac endothelial to mesenchymal transition,BP,
17258,GO:0140078,1,0.750454784934843,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17259,GO:0140080,1,0.750454784934843,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17264,GO:0140102,1,0.621007108102223,0,16,catalytic activity, acting on a rRNA,MF,
17266,GO:0140104,1,0.44349676602508,0,27,molecular carrier activity,MF,
17268,GO:0140112,1,0.56291267558226,0,19,extracellular vesicle biogenesis,BP,
17270,GO:0140131,1,0.780760983128138,0,8,positive regulation of lymphocyte chemotaxis,BP,
17271,GO:0140135,1,0.93716553485425,0,2,mechanosensitive cation channel activity,MF,
17272,GO:0140142,1,0.56967336083286,0,18,nucleocytoplasmic carrier activity,MF,
17273,GO:0140161,1,0.919210272764408,0,3,monocarboxylate:sodium symporter activity,MF,
17274,GO:0140192,1,0.934734232400969,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17275,GO:0140193,1,0.973430018690114,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17276,GO:0140194,1,0.973430018690114,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17277,GO:0140196,1,0.966838884026404,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17278,GO:0140199,1,0.966797215838241,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17279,GO:0140200,1,0.966814385070265,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17280,GO:0150003,1,0.911396836184269,0,3,regulation of spontaneous synaptic transmission,BP,
17282,GO:0150011,1,0.794103565544325,0,7,regulation of neuron projection arborization,BP,
17283,GO:0150012,1,0.794103565544325,0,7,positive regulation of neuron projection arborization,BP,
17287,GO:0150031,1,0.966857319942787,0,1,regulation of protein localization to lysosome,BP,
17288,GO:0150033,1,0.966857319942787,0,1,negative regulation of protein localization to lysosome,BP,
17294,GO:1900015,1,0.534175007185652,0,20,regulation of cytokine production involved in inflammatory response,BP,
17295,GO:1900016,1,0.781091461174524,0,8,negative regulation of cytokine production involved in inflammatory response,BP,
17296,GO:1900017,1,0.755648408122274,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17297,GO:1900019,1,0.879504253723388,0,4,regulation of protein kinase C activity,BP,
17298,GO:1900020,1,0.879504253723388,0,4,positive regulation of protein kinase C activity,BP,
17303,GO:1900028,1,0.88766308945654,0,4,negative regulation of ruffle assembly,BP,
17304,GO:1900029,1,0.713337224787813,0,11,positive regulation of ruffle assembly,BP,
17306,GO:1900036,1,0.970784020906889,0,1,positive regulation of cellular response to heat,BP,
17308,GO:1900038,1,0.8319898344474,0,6,negative regulation of cellular response to hypoxia,BP,
17309,GO:1900039,1,0.973795135489036,0,1,positive regulation of cellular response to hypoxia,BP,
17310,GO:1900040,1,0.850217774719573,0,5,regulation of interleukin-2 secretion,BP,
17311,GO:1900041,1,0.909580260149149,0,3,negative regulation of interleukin-2 secretion,BP,
17312,GO:1900042,1,0.934752749235296,0,2,positive regulation of interleukin-2 secretion,BP,
17313,GO:1900044,1,0.768405047271121,0,8,regulation of protein K63-linked ubiquitination,BP,
17314,GO:1900045,1,0.849221539406656,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17317,GO:1900048,1,0.652189316108687,0,14,positive regulation of hemostasis,BP,
17319,GO:1900062,1,0.967787392452991,0,1,regulation of replicative cell aging,BP,
17320,GO:1900063,1,0.908471554045002,0,3,regulation of peroxisome organization,BP,
17323,GO:1900078,1,0.537682570700588,0,19,positive regulation of cellular response to insulin stimulus,BP,
17324,GO:1900081,1,0.966797215838241,0,1,regulation of arginine catabolic process,BP,
17325,GO:1900082,1,0.966797215838241,0,1,negative regulation of arginine catabolic process,BP,
17326,GO:1900084,1,0.87768825611316,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
17327,GO:1900085,1,0.969831641248496,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
17328,GO:1900086,1,0.904997904572631,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
17331,GO:1900095,1,0.966755548948129,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
17337,GO:1900104,1,0.911758854669413,0,3,regulation of hyaluranon cable assembly,BP,
17338,GO:1900106,1,0.911758854669413,0,3,positive regulation of hyaluranon cable assembly,BP,
17339,GO:1900107,1,0.940189296584821,0,2,regulation of nodal signaling pathway,BP,
17340,GO:1900108,1,0.97251927832974,0,1,negative regulation of nodal signaling pathway,BP,
17341,GO:1900109,1,0.94697625052663,0,2,regulation of histone H3-K9 dimethylation,BP,
17342,GO:1900110,1,0.94697625052663,0,2,negative regulation of histone H3-K9 dimethylation,BP,
17343,GO:1900112,1,0.751305961206104,0,9,regulation of histone H3-K9 trimethylation,BP,
17344,GO:1900113,1,0.857159252092348,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17345,GO:1900114,1,0.935113901037329,0,2,positive regulation of histone H3-K9 trimethylation,BP,
17349,GO:1900118,1,0.805752829290951,0,7,negative regulation of execution phase of apoptosis,BP,
17352,GO:1900121,1,0.740770224259154,0,10,negative regulation of receptor binding,BP,
17355,GO:1900126,1,0.908997614898169,0,3,negative regulation of hyaluronan biosynthetic process,BP,
17357,GO:1900130,1,0.967919776184163,0,1,regulation of lipid binding,BP,
17358,GO:1900131,1,0.967919776184163,0,1,negative regulation of lipid binding,BP,
17359,GO:1900133,1,0.908587167883061,0,3,regulation of renin secretion into blood stream,BP,
17360,GO:1900134,1,0.967677609466671,0,1,negative regulation of renin secretion into blood stream,BP,
17361,GO:1900135,1,0.969302166061177,0,1,positive regulation of renin secretion into blood stream,BP,
17363,GO:1900139,1,0.966932510670261,0,1,negative regulation of arachidonic acid secretion,BP,
17364,GO:1900141,1,0.97028832086229,0,1,regulation of oligodendrocyte apoptotic process,BP,
17365,GO:1900142,1,0.97028832086229,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
17366,GO:1900145,1,0.940189296584821,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17367,GO:1900146,1,0.97251927832974,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17368,GO:1900147,1,0.937124547618538,0,2,regulation of Schwann cell migration,BP,
17369,GO:1900148,1,0.969271124374127,0,1,negative regulation of Schwann cell migration,BP,
17370,GO:1900149,1,0.96683706223508,0,1,positive regulation of Schwann cell migration,BP,
17372,GO:1900151,1,0.645547791961404,0,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17373,GO:1900152,1,0.972273132615553,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17374,GO:1900153,1,0.645547791961404,0,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
17375,GO:1900154,1,0.972612739467351,0,1,regulation of bone trabecula formation,BP,
17376,GO:1900155,1,0.972612739467351,0,1,negative regulation of bone trabecula formation,BP,
17377,GO:1900161,1,0.969520377708811,0,1,regulation of phospholipid scramblase activity,BP,
17378,GO:1900163,1,0.969520377708811,0,1,positive regulation of phospholipid scramblase activity,BP,
17381,GO:1900169,1,0.936986857014018,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
17382,GO:1900170,1,0.969271124374127,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17383,GO:1900175,1,0.940189296584821,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17384,GO:1900176,1,0.97251927832974,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17386,GO:1900181,1,0.623495589917643,0,15,negative regulation of protein localization to nucleus,BP,
17389,GO:1900193,1,0.859838766471603,0,5,regulation of oocyte maturation,BP,
17390,GO:1900194,1,0.968174685271712,0,1,negative regulation of oocyte maturation,BP,
17391,GO:1900195,1,0.943810002744717,0,2,positive regulation of oocyte maturation,BP,
17392,GO:1900200,1,0.967604024860509,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17393,GO:1900204,1,0.967604024860509,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17394,GO:1900205,1,0.967604024860509,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17395,GO:1900208,1,0.946471635269215,0,2,regulation of cardiolipin metabolic process,BP,
17396,GO:1900210,1,0.946471635269215,0,2,positive regulation of cardiolipin metabolic process,BP,
17397,GO:1900211,1,0.967604024860509,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17398,GO:1900212,1,0.967604024860509,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17399,GO:1900214,1,0.967604024860509,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17400,GO:1900215,1,0.967604024860509,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17401,GO:1900217,1,0.967604024860509,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17402,GO:1900218,1,0.967604024860509,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17403,GO:1900220,1,0.935022099654481,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17404,GO:1900221,1,0.75096810692706,0,9,regulation of amyloid-beta clearance,BP,
17405,GO:1900222,1,0.941015006000187,0,2,negative regulation of amyloid-beta clearance,BP,
17406,GO:1900223,1,0.822548376978389,0,6,positive regulation of amyloid-beta clearance,BP,
17407,GO:1900224,1,0.966758957890763,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
17408,GO:1900225,1,0.74993644073962,0,9,regulation of NLRP3 inflammasome complex assembly,BP,
17409,GO:1900226,1,0.88174903753476,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
17410,GO:1900227,1,0.877113440466661,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
17411,GO:1900238,1,0.939802557413203,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17412,GO:1900239,1,0.911054116128049,0,3,regulation of phenotypic switching,BP,
17413,GO:1900241,1,0.969303365112211,0,1,positive regulation of phenotypic switching,BP,
17416,GO:1900244,1,0.93948938337702,0,2,positive regulation of synaptic vesicle endocytosis,BP,
17417,GO:1900245,1,0.90666608543794,0,3,positive regulation of MDA-5 signaling pathway,BP,
17418,GO:1900246,1,0.847580426357361,0,5,positive regulation of RIG-I signaling pathway,BP,
17419,GO:1900247,1,0.70898329540851,0,11,regulation of cytoplasmic translational elongation,BP,
17420,GO:1900248,1,0.934846713718131,0,2,negative regulation of cytoplasmic translational elongation,BP,
17421,GO:1900259,1,0.972071172458697,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17422,GO:1900260,1,0.972071172458697,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17423,GO:1900262,1,0.840619992528202,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17424,GO:1900264,1,0.840619992528202,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17425,GO:1900271,1,0.551972623579356,0,19,regulation of long-term synaptic potentiation,BP,
17426,GO:1900272,1,0.831868256513422,0,6,negative regulation of long-term synaptic potentiation,BP,
17427,GO:1900273,1,0.704704373527882,0,11,positive regulation of long-term synaptic potentiation,BP,
17428,GO:1900274,1,0.587521706705275,0,17,regulation of phospholipase C activity,BP,
17429,GO:1900275,1,0.936112760094319,0,2,negative regulation of phospholipase C activity,BP,
17430,GO:1900276,1,0.968183517101338,0,1,regulation of proteinase activated receptor activity,BP,
17433,GO:1900365,1,0.908281713834455,0,3,positive regulation of mRNA polyadenylation,BP,
17434,GO:1900368,1,0.911826465698856,0,3,regulation of RNA interference,BP,
17435,GO:1900369,1,0.943055920127276,0,2,negative regulation of RNA interference,BP,
17436,GO:1900370,1,0.966890060423013,0,1,positive regulation of RNA interference,BP,
17439,GO:1900373,1,0.37077837536272,0,32,positive regulation of purine nucleotide biosynthetic process,BP,
17440,GO:1900376,1,0.874180136846116,0,4,regulation of secondary metabolite biosynthetic process,BP,
17441,GO:1900377,1,0.934814937303634,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
17442,GO:1900378,1,0.935148660432575,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
17443,GO:1900387,1,0.971490706398445,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
17444,GO:1900390,1,0.946816153135315,0,2,regulation of iron ion import,BP,
17445,GO:1900402,1,0.768800894076292,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17448,GO:1900409,1,0.713060783395018,0,11,positive regulation of cellular response to oxidative stress,BP,
17450,GO:1900425,1,0.858045257642355,0,5,negative regulation of defense response to bacterium,BP,
17453,GO:1900450,1,0.966969034767849,0,1,negative regulation of glutamate receptor signaling pathway,BP,
17454,GO:1900451,1,0.881013873312645,0,4,positive regulation of glutamate receptor signaling pathway,BP,
17455,GO:1900452,1,0.880110574543562,0,4,regulation of long term synaptic depression,BP,
17456,GO:1900453,1,0.941497849036913,0,2,negative regulation of long term synaptic depression,BP,
17457,GO:1900477,1,0.97154334172778,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
17458,GO:1900483,1,0.970040787019777,0,1,regulation of protein targeting to vacuolar membrane,BP,
17459,GO:1900533,1,0.973015205241223,0,1,palmitic acid metabolic process,BP,
17460,GO:1900535,1,0.973015205241223,0,1,palmitic acid biosynthetic process,BP,
17463,GO:1900544,1,0.283301457080884,0,41,positive regulation of purine nucleotide metabolic process,BP,
17467,GO:1900736,1,0.968183517101338,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17468,GO:1900737,1,0.968183517101338,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17474,GO:1900747,1,0.881954608076452,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
17476,GO:1900750,1,0.730352931076291,0,11,oligopeptide binding,MF,
17477,GO:1900753,1,0.967191635313368,0,1,doxorubicin transport,BP,
17479,GO:1900825,1,0.882573415372349,0,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17480,GO:1900827,1,0.966770617821941,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
17481,GO:1900864,1,0.767428872402256,0,9,mitochondrial RNA modification,BP,
17482,GO:1901003,1,0.969271124374127,0,1,negative regulation of fermentation,BP,
17483,GO:1901004,1,0.97359382616802,0,1,ubiquinone-6 metabolic process,BP,
17484,GO:1901006,1,0.97359382616802,0,1,ubiquinone-6 biosynthetic process,BP,
17487,GO:1901018,1,0.753312713146506,0,9,positive regulation of potassium ion transmembrane transporter activity,BP,
17489,GO:1901020,1,0.638057081699625,0,15,negative regulation of calcium ion transmembrane transporter activity,BP,
17490,GO:1901021,1,0.515617919765322,0,21,positive regulation of calcium ion transmembrane transporter activity,BP,
17493,GO:1901029,1,0.816553810776286,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
17496,GO:1901032,1,0.676311339263203,0,13,negative regulation of response to reactive oxygen species,BP,
17497,GO:1901033,1,0.834499322604269,0,6,positive regulation of response to reactive oxygen species,BP,
17499,GO:1901069,1,0.947039586187744,0,2,guanosine-containing compound catabolic process,BP,
17500,GO:1901070,1,0.698134599603778,0,13,guanosine-containing compound biosynthetic process,BP,
17502,GO:1901072,1,0.860637964799564,0,5,glucosamine-containing compound catabolic process,BP,
17503,GO:1901073,1,0.935655634345027,0,2,glucosamine-containing compound biosynthetic process,BP,
17504,GO:1901074,1,0.96684630815699,0,1,regulation of engulfment of apoptotic cell,BP,
17505,GO:1901076,1,0.96684630815699,0,1,positive regulation of engulfment of apoptotic cell,BP,
17506,GO:1901077,1,0.879544955559235,0,4,regulation of relaxation of muscle,BP,
17507,GO:1901078,1,0.966814385070265,0,1,negative regulation of relaxation of muscle,BP,
17508,GO:1901086,1,0.966925946302879,0,1,benzylpenicillin metabolic process,BP,
17509,GO:1901090,1,0.941497385704796,0,2,regulation of protein tetramerization,BP,
17510,GO:1901091,1,0.941497385704796,0,2,negative regulation of protein tetramerization,BP,
17511,GO:1901093,1,0.941497385704796,0,2,regulation of protein homotetramerization,BP,
17512,GO:1901094,1,0.941497385704796,0,2,negative regulation of protein homotetramerization,BP,
17513,GO:1901096,1,0.725361324841208,0,10,regulation of autophagosome maturation,BP,
17514,GO:1901097,1,0.881494153111406,0,4,negative regulation of autophagosome maturation,BP,
17515,GO:1901098,1,0.822231055232224,0,6,positive regulation of autophagosome maturation,BP,
17520,GO:1901142,1,0.823602720757851,0,6,insulin metabolic process,BP,
17521,GO:1901143,1,0.9360914501159,0,2,insulin catabolic process,BP,
17522,GO:1901145,1,0.936096650142034,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17523,GO:1901147,1,0.967604024860509,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
17524,GO:1901159,1,0.866448545848729,0,5,xylulose 5-phosphate biosynthetic process,BP,
17525,GO:1901160,1,0.802489848343935,0,7,primary amino compound metabolic process,BP,
17526,GO:1901162,1,0.941344772028472,0,2,primary amino compound biosynthetic process,BP,
17529,GO:1901165,1,0.86007841457444,0,5,positive regulation of trophoblast cell migration,BP,
17534,GO:1901187,1,0.93854479610963,0,2,regulation of ephrin receptor signaling pathway,BP,
17535,GO:1901189,1,0.970718037632591,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17536,GO:1901193,1,0.973893711366085,0,1,regulation of formation of translation preinitiation complex,BP,
17537,GO:1901194,1,0.973893711366085,0,1,negative regulation of formation of translation preinitiation complex,BP,
17539,GO:1901202,1,0.970737082952537,0,1,negative regulation of extracellular matrix assembly,BP,
17540,GO:1901203,1,0.767565824634056,0,8,positive regulation of extracellular matrix assembly,BP,
17541,GO:1901207,1,0.967494934004289,0,1,regulation of heart looping,BP,
17542,GO:1901213,1,0.781557401960252,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17547,GO:1901223,1,0.785304881769343,0,8,negative regulation of NIK/NF-kappaB signaling,BP,
17549,GO:1901228,1,0.967216439068199,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17550,GO:1901229,1,0.970051889225651,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17551,GO:1901231,1,0.970051889225651,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17552,GO:1901232,1,0.970051889225651,0,1,regulation of convergent extension involved in axis elongation,BP,
17553,GO:1901233,1,0.970051889225651,0,1,negative regulation of convergent extension involved in axis elongation,BP,
17554,GO:1901252,1,0.94228001680527,0,2,regulation of intracellular transport of viral material,BP,
17555,GO:1901253,1,0.974256161845837,0,1,negative regulation of intracellular transport of viral material,BP,
17556,GO:1901254,1,0.96718122436268,0,1,positive regulation of intracellular transport of viral material,BP,
17557,GO:1901255,1,0.940628851056333,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
17558,GO:1901256,1,0.911293145238609,0,3,regulation of macrophage colony-stimulating factor production,BP,
17559,GO:1901257,1,0.970825151529268,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
17560,GO:1901258,1,0.969723619722645,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
17563,GO:1901269,1,0.950146313132071,0,2,lipooligosaccharide metabolic process,BP,
17564,GO:1901271,1,0.950146313132071,0,2,lipooligosaccharide biosynthetic process,BP,
17565,GO:1901291,1,0.972013557050363,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
17568,GO:1901295,1,0.943848419840547,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17569,GO:1901296,1,0.972322080150554,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17570,GO:1901297,1,0.970718037632591,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
17571,GO:1901298,1,0.759856648062055,0,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,
17572,GO:1901299,1,0.858410781766367,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17573,GO:1901300,1,0.885235178878722,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
17574,GO:1901301,1,0.937773289348951,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
17575,GO:1901303,1,0.969718338266846,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
17576,GO:1901304,1,0.972602434471036,0,1,regulation of spermidine biosynthetic process,BP,
17577,GO:1901307,1,0.972602434471036,0,1,positive regulation of spermidine biosynthetic process,BP,
17578,GO:1901314,1,0.907249011532629,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17579,GO:1901315,1,0.907249011532629,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
17580,GO:1901317,1,0.890162313235512,0,4,regulation of flagellated sperm motility,BP,
17581,GO:1901318,1,0.969271124374127,0,1,negative regulation of flagellated sperm motility,BP,
17582,GO:1901321,1,0.972322080150554,0,1,positive regulation of heart induction,BP,
17583,GO:1901328,1,0.97230580442963,0,1,response to cytochalasin B,BP,
17584,GO:1901329,1,0.941790381178602,0,2,regulation of odontoblast differentiation,BP,
17585,GO:1901331,1,0.968683041538734,0,1,positive regulation of odontoblast differentiation,BP,
17586,GO:1901337,1,0.969862672246662,0,1,thioester transport,BP,
17587,GO:1901338,1,0.916994781933571,0,3,catecholamine binding,MF,
17588,GO:1901339,1,0.847826360712557,0,5,regulation of store-operated calcium channel activity,BP,
17589,GO:1901340,1,0.967355421209387,0,1,negative regulation of store-operated calcium channel activity,BP,
17590,GO:1901341,1,0.904774906417865,0,3,positive regulation of store-operated calcium channel activity,BP,
17593,GO:1901344,1,0.973568327127081,0,1,response to leptomycin B,BP,
17595,GO:1901355,1,0.939109976696036,0,2,response to rapamycin,BP,
17600,GO:1901373,1,0.973269589112886,0,1,lipid hydroperoxide transport,BP,
17601,GO:1901376,1,0.969652760557037,0,1,organic heteropentacyclic compound metabolic process,BP,
17602,GO:1901377,1,0.969652760557037,0,1,organic heteropentacyclic compound catabolic process,BP,
17605,GO:1901381,1,0.704229665143523,0,11,positive regulation of potassium ion transmembrane transport,BP,
17606,GO:1901382,1,0.937874433761752,0,2,regulation of chorionic trophoblast cell proliferation,BP,
17608,GO:1901386,1,0.883942938846852,0,4,negative regulation of voltage-gated calcium channel activity,BP,
17609,GO:1901387,1,0.905617236339693,0,3,positive regulation of voltage-gated calcium channel activity,BP,
17612,GO:1901407,1,0.761149990539281,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17613,GO:1901409,1,0.811219624839489,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17614,GO:1901419,1,0.967193497595987,0,1,regulation of response to alcohol,BP,
17615,GO:1901421,1,0.967193497595987,0,1,positive regulation of response to alcohol,BP,
17616,GO:1901474,1,0.884995386274651,0,4,azole transmembrane transporter activity,MF,
17617,GO:1901475,1,0.909443347965455,0,3,pyruvate transmembrane transport,BP,
17619,GO:1901491,1,0.936098619209884,0,2,negative regulation of lymphangiogenesis,BP,
17621,GO:1901503,1,0.858691367808245,0,5,ether biosynthetic process,BP,
17623,GO:1901509,1,0.936690152658608,0,2,regulation of endothelial tube morphogenesis,BP,
17625,GO:1901523,1,0.969271124374127,0,1,icosanoid catabolic process,BP,
17627,GO:1901525,1,0.824206438199874,0,6,negative regulation of mitophagy,BP,
17629,GO:1901529,1,0.937618273718749,0,2,positive regulation of anion channel activity,BP,
17631,GO:1901533,1,0.834961236510401,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17632,GO:1901534,1,0.936706973433497,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
17633,GO:1901535,1,0.848492177597034,0,5,regulation of DNA demethylation,BP,
17634,GO:1901536,1,0.938924304641783,0,2,negative regulation of DNA demethylation,BP,
17635,GO:1901537,1,0.90370116829136,0,3,positive regulation of DNA demethylation,BP,
17636,GO:1901538,1,0.827627764385565,0,6,changes to DNA methylation involved in embryo development,BP,
17637,GO:1901545,1,0.968981230560612,0,1,response to raffinose,BP,
17639,GO:1901551,1,0.967298849410928,0,1,negative regulation of endothelial cell development,BP,
17640,GO:1901552,1,0.93646870164952,0,2,positive regulation of endothelial cell development,BP,
17641,GO:1901555,1,0.9668440137745,0,1,response to paclitaxel,BP,
17642,GO:1901558,1,0.972172812265828,0,1,response to metformin,BP,
17643,GO:1901561,1,0.967730119844926,0,1,response to benomyl,BP,
17644,GO:1901563,1,0.851784697689633,0,5,response to camptothecin,BP,
17648,GO:1901567,1,0.540847705546406,0,21,fatty acid derivative binding,MF,
17655,GO:1901580,1,0.966742778732933,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17656,GO:1901581,1,0.966742778732933,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17657,GO:1901582,1,0.966742778732933,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
17658,GO:1901585,1,0.969436358891056,0,1,regulation of acid-sensing ion channel activity,BP,
17659,GO:1901594,1,0.967349666574824,0,1,response to capsazepine,BP,
17663,GO:1901611,1,0.763680953587331,0,9,phosphatidylglycerol binding,MF,
17664,GO:1901612,1,0.834945278096797,0,6,cardiolipin binding,MF,
17666,GO:1901616,1,0.310177193469052,0,38,organic hydroxy compound catabolic process,BP,
17668,GO:1901618,1,0.625429187432979,0,15,organic hydroxy compound transmembrane transporter activity,MF,
17669,GO:1901620,1,0.801359510484528,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17670,GO:1901621,1,0.851144712723448,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17671,GO:1901622,1,0.970074139523328,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
17672,GO:1901623,1,0.756753058326005,0,9,regulation of lymphocyte chemotaxis,BP,
17673,GO:1901626,1,0.830331934359593,0,6,regulation of postsynaptic membrane organization,BP,
17674,GO:1901628,1,0.913663182385444,0,3,positive regulation of postsynaptic membrane organization,BP,
17675,GO:1901629,1,0.941475738223037,0,2,regulation of presynaptic membrane organization,BP,
17676,GO:1901630,1,0.973791068722543,0,1,negative regulation of presynaptic membrane organization,BP,
17677,GO:1901631,1,0.966817301040855,0,1,positive regulation of presynaptic membrane organization,BP,
17678,GO:1901639,1,0.966867738967312,0,1,XDP catabolic process,BP,
17679,GO:1901640,1,0.966867738967312,0,1,XTP binding,MF,
17680,GO:1901641,1,0.966867738967312,0,1,ITP binding,MF,
17681,GO:1901642,1,0.860314201004795,0,5,nucleoside transmembrane transport,BP,
17686,GO:1901656,1,0.937468253019091,0,2,glycoside transport,BP,
17688,GO:1901658,1,0.439469817147024,0,28,glycosyl compound catabolic process,BP,
17689,GO:1901659,1,0.293306611284526,0,42,glycosyl compound biosynthetic process,BP,
17690,GO:1901660,1,0.825470024839775,0,6,calcium ion export,BP,
17691,GO:1901661,1,0.517307340158902,0,23,quinone metabolic process,BP,
17692,GO:1901662,1,0.943372253582683,0,2,quinone catabolic process,BP,
17693,GO:1901663,1,0.671300864815298,0,14,quinone biosynthetic process,BP,
17694,GO:1901664,1,0.914156666690371,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17695,GO:1901666,1,0.914156666690371,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
17696,GO:1901668,1,0.944325204731139,0,2,regulation of superoxide dismutase activity,BP,
17697,GO:1901671,1,0.974265395836361,0,1,positive regulation of superoxide dismutase activity,BP,
17698,GO:1901673,1,0.554693760212179,0,19,regulation of mitotic spindle assembly,BP,
17699,GO:1901674,1,0.906726594635007,0,3,regulation of histone H3-K27 acetylation,BP,
17700,GO:1901675,1,0.966850477456111,0,1,negative regulation of histone H3-K27 acetylation,BP,
17701,GO:1901676,1,0.967554767452462,0,1,positive regulation of histone H3-K27 acetylation,BP,
17702,GO:1901678,1,0.75574941991834,0,9,iron coordination entity transport,BP,
17703,GO:1901679,1,0.785554336235606,0,8,nucleotide transmembrane transport,BP,
17704,GO:1901680,1,0.966777525645021,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
17706,GO:1901682,1,0.567409374260535,0,18,sulfur compound transmembrane transporter activity,MF,
17713,GO:1901702,1,0.972143702897848,0,1,salt transmembrane transporter activity,MF,
17714,GO:1901707,1,0.973568327127081,0,1,leptomycin B binding,MF,
17715,GO:1901722,1,0.71429603170218,0,11,regulation of cell proliferation involved in kidney development,BP,
17716,GO:1901723,1,0.856420852125591,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17717,GO:1901724,1,0.834112211699647,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17718,GO:1901725,1,0.822123099437486,0,6,regulation of histone deacetylase activity,BP,
17719,GO:1901726,1,0.966748395534306,0,1,negative regulation of histone deacetylase activity,BP,
17720,GO:1901727,1,0.879128975556011,0,4,positive regulation of histone deacetylase activity,BP,
17721,GO:1901731,1,0.939902183974653,0,2,positive regulation of platelet aggregation,BP,
17723,GO:1901740,1,0.971884453653904,0,1,negative regulation of myoblast fusion,BP,
17725,GO:1901748,1,0.913302840121274,0,3,leukotriene D4 metabolic process,BP,
17726,GO:1901750,1,0.913302840121274,0,3,leukotriene D4 biosynthetic process,BP,
17727,GO:1901751,1,0.970696080330584,0,1,leukotriene A4 metabolic process,BP,
17733,GO:1901804,1,0.970585167270237,0,1,beta-glucoside metabolic process,BP,
17734,GO:1901805,1,0.970585167270237,0,1,beta-glucoside catabolic process,BP,
17735,GO:1901834,1,0.972485129024854,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17736,GO:1901835,1,0.972485129024854,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17737,GO:1901836,1,0.713284449207646,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17738,GO:1901837,1,0.944033708157882,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17739,GO:1901838,1,0.755604412321364,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17740,GO:1901841,1,0.885117474303571,0,4,regulation of high voltage-gated calcium channel activity,BP,
17741,GO:1901842,1,0.973153873268396,0,1,negative regulation of high voltage-gated calcium channel activity,BP,
17742,GO:1901843,1,0.935979895521743,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
17743,GO:1901844,1,0.805891720642813,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17744,GO:1901856,1,0.940446836187333,0,2,negative regulation of cellular respiration,BP,
17745,GO:1901857,1,0.869266373361689,0,5,positive regulation of cellular respiration,BP,
17746,GO:1901858,1,0.883905387572348,0,4,regulation of mitochondrial DNA metabolic process,BP,
17747,GO:1901859,1,0.907895337015971,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
17748,GO:1901860,1,0.973583217915054,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
17752,GO:1901873,1,0.937138620729106,0,2,regulation of post-translational protein modification,BP,
17753,GO:1901874,1,0.937138620729106,0,2,negative regulation of post-translational protein modification,BP,
17754,GO:1901879,1,0.173681949895406,0,55,regulation of protein depolymerization,BP,
17755,GO:1901880,1,0.261028584291034,0,42,negative regulation of protein depolymerization,BP,
17756,GO:1901881,1,0.760576255099063,0,9,positive regulation of protein depolymerization,BP,
17760,GO:1901894,1,0.912330384306475,0,3,regulation of calcium-transporting ATPase activity,BP,
17761,GO:1901895,1,0.966861899619982,0,1,negative regulation of calcium-transporting ATPase activity,BP,
17762,GO:1901896,1,0.943604534735945,0,2,positive regulation of calcium-transporting ATPase activity,BP,
17763,GO:1901897,1,0.905113892322329,0,3,regulation of relaxation of cardiac muscle,BP,
17764,GO:1901898,1,0.966814385070265,0,1,negative regulation of relaxation of cardiac muscle,BP,
17765,GO:1901906,1,0.887880067864205,0,4,diadenosine pentaphosphate metabolic process,BP,
17766,GO:1901907,1,0.887880067864205,0,4,diadenosine pentaphosphate catabolic process,BP,
17767,GO:1901908,1,0.887880067864205,0,4,diadenosine hexaphosphate metabolic process,BP,
17768,GO:1901909,1,0.887880067864205,0,4,diadenosine hexaphosphate catabolic process,BP,
17769,GO:1901910,1,0.887880067864205,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17770,GO:1901911,1,0.887880067864205,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
17771,GO:1901917,1,0.969626763580086,0,1,regulation of exoribonuclease activity,BP,
17772,GO:1901919,1,0.969626763580086,0,1,positive regulation of exoribonuclease activity,BP,
17773,GO:1901950,1,0.969271124374127,0,1,dense core granule transport,BP,
17774,GO:1901962,1,0.971102205280444,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
17775,GO:1901963,1,0.941458933750348,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17776,GO:1901964,1,0.972376033972612,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
17777,GO:1901970,1,0.78189246980747,0,8,positive regulation of mitotic sister chromatid separation,BP,
17779,GO:1901977,1,0.832776252898124,0,6,negative regulation of cell cycle checkpoint,BP,
17780,GO:1901978,1,0.759145527567705,0,9,positive regulation of cell cycle checkpoint,BP,
17781,GO:1901979,1,0.937599282231352,0,2,regulation of inward rectifier potassium channel activity,BP,
17782,GO:1901980,1,0.9667677345189,0,1,positive regulation of inward rectifier potassium channel activity,BP,
17793,GO:1901993,1,0.938957772626028,0,2,regulation of meiotic cell cycle phase transition,BP,
17794,GO:1901994,1,0.938957772626028,0,2,negative regulation of meiotic cell cycle phase transition,BP,
17796,GO:1902001,1,0.617937854465968,0,15,fatty acid transmembrane transport,BP,
17797,GO:1902003,1,0.585466211690489,0,17,regulation of amyloid-beta formation,BP,
17798,GO:1902004,1,0.755242500649668,0,9,positive regulation of amyloid-beta formation,BP,
17799,GO:1902010,1,0.968106967257537,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
17801,GO:1902018,1,0.77876411597764,0,8,negative regulation of cilium assembly,BP,
17802,GO:1902019,1,0.857212606787762,0,5,regulation of cilium-dependent cell motility,BP,
17803,GO:1902022,1,0.9122913486849,0,3,L-lysine transport,BP,
17805,GO:1902031,1,0.834490201645083,0,6,regulation of NADP metabolic process,BP,
17806,GO:1902033,1,0.855561770529146,0,5,regulation of hematopoietic stem cell proliferation,BP,
17807,GO:1902035,1,0.88227350955044,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
17809,GO:1902037,1,0.911586917801702,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
17810,GO:1902038,1,0.96817949782281,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17814,GO:1902044,1,0.938759298958877,0,2,regulation of Fas signaling pathway,BP,
17815,GO:1902045,1,0.970725361079207,0,1,negative regulation of Fas signaling pathway,BP,
17816,GO:1902047,1,0.858561109260835,0,5,polyamine transmembrane transport,BP,
17817,GO:1902065,1,0.75540410377754,0,9,response to L-glutamate,BP,
17818,GO:1902071,1,0.973795135489036,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17819,GO:1902073,1,0.973795135489036,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17821,GO:1902075,1,0.837651851907405,0,6,cellular response to salt,BP,
17822,GO:1902083,1,0.848472132493444,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17823,GO:1902093,1,0.918389890636094,0,3,positive regulation of flagellated sperm motility,BP,
17824,GO:1902098,1,0.967018484838147,0,1,calcitriol binding,MF,
17827,GO:1902101,1,0.78189246980747,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17828,GO:1902102,1,0.968953988832333,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17829,GO:1902103,1,0.968953988832333,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17834,GO:1902109,1,0.920508780234091,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
17839,GO:1902121,1,0.967018484838147,0,1,lithocholic acid binding,MF,
17840,GO:1902145,1,0.969271124374127,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17841,GO:1902151,1,0.969271124374127,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17842,GO:1902153,1,0.969271124374127,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17843,GO:1902162,1,0.946385290459086,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17844,GO:1902164,1,0.946385290459086,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17845,GO:1902165,1,0.667702406588769,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17846,GO:1902166,1,0.706767716654194,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17847,GO:1902167,1,0.974877851238786,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
17848,GO:1902170,1,0.688438210742952,0,12,cellular response to reactive nitrogen species,BP,
17849,GO:1902172,1,0.860708586474143,0,5,regulation of keratinocyte apoptotic process,BP,
17850,GO:1902173,1,0.968643652373865,0,1,negative regulation of keratinocyte apoptotic process,BP,
17851,GO:1902174,1,0.94298209997968,0,2,positive regulation of keratinocyte apoptotic process,BP,
17854,GO:1902177,1,0.861080890821969,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17855,GO:1902178,1,0.96722899523285,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
17858,GO:1902188,1,0.630874711595749,0,15,positive regulation of viral release from host cell,BP,
17859,GO:1902202,1,0.941837345310252,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
17860,GO:1902205,1,0.972584353089558,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17861,GO:1902206,1,0.972584353089558,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17862,GO:1902211,1,0.969271124374127,0,1,regulation of prolactin signaling pathway,BP,
17863,GO:1902213,1,0.969271124374127,0,1,positive regulation of prolactin signaling pathway,BP,
17864,GO:1902214,1,0.940316042966197,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
17865,GO:1902215,1,0.972584353089558,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17866,GO:1902216,1,0.96682458158099,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
17867,GO:1902218,1,0.854234051580559,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17868,GO:1902219,1,0.877083169265459,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17869,GO:1902220,1,0.973957996685046,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17870,GO:1902221,1,0.897661751539668,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17871,GO:1902222,1,0.897661751539668,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
17873,GO:1902226,1,0.943903168500547,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
17874,GO:1902227,1,0.972584353089558,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17875,GO:1902228,1,0.970512554479437,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
17876,GO:1902229,1,0.391824523530286,0,32,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17877,GO:1902230,1,0.479127331556854,0,25,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17878,GO:1902231,1,0.844195044240257,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
17879,GO:1902232,1,0.943171904514023,0,2,regulation of positive thymic T cell selection,BP,
17880,GO:1902233,1,0.972584353089558,0,1,negative regulation of positive thymic T cell selection,BP,
17884,GO:1902238,1,0.967304174340643,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17885,GO:1902239,1,0.967304174340643,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17888,GO:1902255,1,0.925627208310007,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
17889,GO:1902256,1,0.936138145529685,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17890,GO:1902257,1,0.96817949782281,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
17891,GO:1902259,1,0.732012765766572,0,10,regulation of delayed rectifier potassium channel activity,BP,
17892,GO:1902260,1,0.885737753036102,0,4,negative regulation of delayed rectifier potassium channel activity,BP,
17893,GO:1902261,1,0.935332726394625,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
17894,GO:1902262,1,0.88589694607621,0,4,apoptotic process involved in blood vessel morphogenesis,BP,
17895,GO:1902263,1,0.910983989485385,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
17896,GO:1902267,1,0.887441643817086,0,4,regulation of polyamine transmembrane transport,BP,
17897,GO:1902268,1,0.946596843036298,0,2,negative regulation of polyamine transmembrane transport,BP,
17898,GO:1902269,1,0.937516612168837,0,2,positive regulation of polyamine transmembrane transport,BP,
17899,GO:1902271,1,0.967018484838147,0,1,D3 vitamins binding,MF,
17901,GO:1902282,1,0.969263997402086,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
17902,GO:1902283,1,0.967450840374247,0,1,negative regulation of primary amine oxidase activity,BP,
17906,GO:1902292,1,0.973789034048043,0,1,cell cycle DNA replication initiation,BP,
17907,GO:1902296,1,0.96843869570832,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17908,GO:1902298,1,0.938762237265855,0,2,cell cycle DNA replication maintenance of fidelity,BP,
17909,GO:1902299,1,0.916634529085006,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
17911,GO:1902304,1,0.96699549651765,0,1,positive regulation of potassium ion export,BP,
17914,GO:1902307,1,0.662840549681751,0,13,positive regulation of sodium ion transmembrane transport,BP,
17915,GO:1902308,1,0.912512167794711,0,3,regulation of peptidyl-serine dephosphorylation,BP,
17916,GO:1902309,1,0.940103981283874,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
17917,GO:1902310,1,0.97065514888709,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
17918,GO:1902311,1,0.972405507157167,0,1,regulation of copper ion transmembrane transport,BP,
17919,GO:1902315,1,0.973789034048043,0,1,nuclear cell cycle DNA replication initiation,BP,
17920,GO:1902319,1,0.96843869570832,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
17923,GO:1902338,1,0.906304290465323,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
17925,GO:1902356,1,0.972082371452936,0,1,oxaloacetate(2-) transmembrane transport,BP,
17926,GO:1902358,1,0.827137038345003,0,6,sulfate transmembrane transport,BP,
17927,GO:1902359,1,0.942124797794782,0,2,Notch signaling pathway involved in somitogenesis,BP,
17928,GO:1902362,1,0.969496377732309,0,1,melanocyte apoptotic process,BP,
17929,GO:1902363,1,0.966837517356414,0,1,regulation of protein localization to spindle pole body,BP,
17930,GO:1902365,1,0.966837517356414,0,1,positive regulation of protein localization to spindle pole body,BP,
17931,GO:1902366,1,0.942124797794782,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17932,GO:1902367,1,0.942124797794782,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
17936,GO:1902379,1,0.966872720920993,0,1,chemoattractant activity involved in axon guidance,MF,
17937,GO:1902380,1,0.970529952885172,0,1,positive regulation of endoribonuclease activity,BP,
17938,GO:1902387,1,0.969271124374127,0,1,ceramide 1-phosphate binding,MF,
17939,GO:1902388,1,0.969271124374127,0,1,ceramide 1-phosphate transporter activity,MF,
17940,GO:1902389,1,0.969271124374127,0,1,ceramide 1-phosphate transport,BP,
17941,GO:1902396,1,0.967563168399323,0,1,protein localization to bicellular tight junction,BP,
17945,GO:1902410,1,0.832088154492474,0,6,mitotic cytokinetic process,BP,
17946,GO:1902412,1,0.905235522636262,0,3,regulation of mitotic cytokinesis,BP,
17947,GO:1902414,1,0.771679100155366,0,8,protein localization to cell junction,BP,
17948,GO:1902415,1,0.762767251634536,0,9,regulation of mRNA binding,BP,
17949,GO:1902416,1,0.809406284991206,0,7,positive regulation of mRNA binding,BP,
17950,GO:1902423,1,0.939127184520629,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17951,GO:1902425,1,0.939127184520629,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17952,GO:1902426,1,0.96981148692978,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
17953,GO:1902430,1,0.754676307927786,0,9,negative regulation of amyloid-beta formation,BP,
17954,GO:1902442,1,0.967757205679971,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17955,GO:1902443,1,0.967757205679971,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
17956,GO:1902445,1,0.921739582613162,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
17957,GO:1902455,1,0.878316707805458,0,4,negative regulation of stem cell population maintenance,BP,
17958,GO:1902459,1,0.847201570381113,0,5,positive regulation of stem cell population maintenance,BP,
17959,GO:1902460,1,0.967072779332276,0,1,regulation of mesenchymal stem cell proliferation,BP,
17960,GO:1902462,1,0.967072779332276,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
17961,GO:1902463,1,0.946583578438236,0,2,protein localization to cell leading edge,BP,
17962,GO:1902464,1,0.967159388348364,0,1,regulation of histone H3-K27 trimethylation,BP,
17963,GO:1902466,1,0.967159388348364,0,1,positive regulation of histone H3-K27 trimethylation,BP,
17964,GO:1902473,1,0.799020872061347,0,7,regulation of protein localization to synapse,BP,
17965,GO:1902474,1,0.824365898929728,0,6,positive regulation of protein localization to synapse,BP,
17968,GO:1902480,1,0.970521251331836,0,1,protein localization to mitotic spindle,BP,
17969,GO:1902488,1,0.966798560430869,0,1,cholangiocyte apoptotic process,BP,
17973,GO:1902498,1,0.906119912134916,0,3,regulation of protein autoubiquitination,BP,
17974,GO:1902499,1,0.96937967616693,0,1,positive regulation of protein autoubiquitination,BP,
17975,GO:1902504,1,0.969054250352015,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17976,GO:1902510,1,0.8172955334845,0,7,regulation of apoptotic DNA fragmentation,BP,
17977,GO:1902511,1,0.969718338266846,0,1,negative regulation of apoptotic DNA fragmentation,BP,
17978,GO:1902512,1,0.921780929062166,0,3,positive regulation of apoptotic DNA fragmentation,BP,
17981,GO:1902523,1,0.935930583730402,0,2,positive regulation of protein K63-linked ubiquitination,BP,
17982,GO:1902524,1,0.941750753205096,0,2,positive regulation of protein K48-linked ubiquitination,BP,
17983,GO:1902525,1,0.864430133781188,0,5,regulation of protein monoubiquitination,BP,
17984,GO:1902527,1,0.893196218520218,0,4,positive regulation of protein monoubiquitination,BP,
17985,GO:1902528,1,0.966807404810395,0,1,regulation of protein linear polyubiquitination,BP,
17986,GO:1902530,1,0.966807404810395,0,1,positive regulation of protein linear polyubiquitination,BP,
17990,GO:1902544,1,0.943754467357311,0,2,regulation of DNA N-glycosylase activity,BP,
17991,GO:1902546,1,0.974434133110297,0,1,positive regulation of DNA N-glycosylase activity,BP,
17993,GO:1902548,1,0.881954608076452,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
17996,GO:1902559,1,0.94403300391882,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
17997,GO:1902560,1,0.972104725895455,0,1,GMP reductase complex,CC,
17998,GO:1902562,1,0.285078068788408,0,41,H4 histone acetyltransferase complex,CC,
17999,GO:1902563,1,0.874399094446854,0,4,regulation of neutrophil activation,BP,
18000,GO:1902564,1,0.934840766227912,0,2,negative regulation of neutrophil activation,BP,
18001,GO:1902565,1,0.96734639953885,0,1,positive regulation of neutrophil activation,BP,
18002,GO:1902566,1,0.943455550401649,0,2,regulation of eosinophil activation,BP,
18003,GO:1902568,1,0.943455550401649,0,2,positive regulation of eosinophil activation,BP,
18004,GO:1902570,1,0.766118186162297,0,9,protein localization to nucleolus,BP,
18007,GO:1902576,1,0.884005162597781,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
18008,GO:1902579,1,0.119605030099398,0,69,multi-organism localization,BP,
18009,GO:1902581,1,0.860419141755221,0,5,multi-organism cellular localization,BP,
18010,GO:1902583,1,0.860419141755221,0,5,multi-organism intracellular transport,BP,
18011,GO:1902594,1,0.935081507008148,0,2,multi-organism nuclear import,BP,
18012,GO:1902595,1,0.943889168649033,0,2,regulation of DNA replication origin binding,BP,
18013,GO:1902600,1,0.0882555630847291,0,82,proton transmembrane transport,BP,
18014,GO:1902603,1,0.914349667869229,0,3,carnitine transmembrane transport,BP,
18015,GO:1902605,1,0.969644947158479,0,1,heterotrimeric G-protein complex assembly,BP,
18016,GO:1902606,1,0.974543632249742,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18017,GO:1902608,1,0.974543632249742,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18018,GO:1902612,1,0.969631952040813,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18019,GO:1902613,1,0.969631952040813,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
18020,GO:1902616,1,0.972135366312545,0,1,acyl carnitine transmembrane transport,BP,
18021,GO:1902617,1,0.880980175890264,0,4,response to fluoride,BP,
18022,GO:1902618,1,0.966869213969421,0,1,cellular response to fluoride,BP,
18026,GO:1902626,1,0.92405284424667,0,3,assembly of large subunit precursor of preribosome,BP,
18027,GO:1902629,1,0.973392610073937,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
18028,GO:1902630,1,0.96684328835837,0,1,regulation of membrane hyperpolarization,BP,
18029,GO:1902631,1,0.96684328835837,0,1,negative regulation of membrane hyperpolarization,BP,
18030,GO:1902636,1,0.944988539277299,0,2,kinociliary basal body,CC,
18033,GO:1902656,1,0.824758016468343,0,6,calcium ion import into cytosol,BP,
18034,GO:1902659,1,0.915620222686445,0,3,regulation of glucose mediated signaling pathway,BP,
18035,GO:1902661,1,0.915620222686445,0,3,positive regulation of glucose mediated signaling pathway,BP,
18041,GO:1902683,1,0.939153799245165,0,2,regulation of receptor localization to synapse,BP,
18042,GO:1902685,1,0.967245996953281,0,1,positive regulation of receptor localization to synapse,BP,
18044,GO:1902688,1,0.969271124374127,0,1,regulation of NAD metabolic process,BP,
18045,GO:1902689,1,0.969271124374127,0,1,negative regulation of NAD metabolic process,BP,
18047,GO:1902710,1,0.9686969601558,0,1,GABA receptor complex,CC,
18048,GO:1902711,1,0.9686969601558,0,1,GABA-A receptor complex,CC,
18049,GO:1902713,1,0.878729809081783,0,4,regulation of interferon-gamma secretion,BP,
18050,GO:1902714,1,0.939914954818193,0,2,negative regulation of interferon-gamma secretion,BP,
18051,GO:1902715,1,0.93491419951888,0,2,positive regulation of interferon-gamma secretion,BP,
18052,GO:1902722,1,0.914132292832844,0,3,positive regulation of prolactin secretion,BP,
18053,GO:1902723,1,0.968372791352032,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
18054,GO:1902724,1,0.934935679224251,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18055,GO:1902725,1,0.966862911564545,0,1,negative regulation of satellite cell differentiation,BP,
18056,GO:1902728,1,0.934935679224251,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18057,GO:1902730,1,0.90793546250268,0,3,positive regulation of proteoglycan biosynthetic process,BP,
18058,GO:1902731,1,0.93470230458211,0,2,negative regulation of chondrocyte proliferation,BP,
18059,GO:1902732,1,0.972752451305582,0,1,positive regulation of chondrocyte proliferation,BP,
18060,GO:1902737,1,0.96718122436268,0,1,dendritic filopodium,CC,
18061,GO:1902739,1,0.820088970263016,0,6,regulation of interferon-alpha secretion,BP,
18062,GO:1902741,1,0.820088970263016,0,6,positive regulation of interferon-alpha secretion,BP,
18067,GO:1902746,1,0.970564804675825,0,1,regulation of lens fiber cell differentiation,BP,
18070,GO:1902751,1,0.491256492696114,0,23,positive regulation of cell cycle G2/M phase transition,BP,
18071,GO:1902766,1,0.946217365896238,0,2,skeletal muscle satellite cell migration,BP,
18073,GO:1902769,1,0.966747024794232,0,1,regulation of choline O-acetyltransferase activity,BP,
18074,GO:1902771,1,0.966747024794232,0,1,positive regulation of choline O-acetyltransferase activity,BP,
18075,GO:1902773,1,0.968938833098782,0,1,GTPase activator complex,CC,
18076,GO:1902774,1,0.83160657805192,0,6,late endosome to lysosome transport,BP,
18077,GO:1902775,1,0.907281955105945,0,3,mitochondrial large ribosomal subunit assembly,BP,
18079,GO:1902804,1,0.911214041255256,0,3,negative regulation of synaptic vesicle transport,BP,
18080,GO:1902805,1,0.935034243576993,0,2,positive regulation of synaptic vesicle transport,BP,
18084,GO:1902809,1,0.912083266907901,0,3,regulation of skeletal muscle fiber differentiation,BP,
18085,GO:1902811,1,0.940983167055524,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
18086,GO:1902816,1,0.880441306618849,0,4,regulation of protein localization to microtubule,BP,
18087,GO:1902817,1,0.880441306618849,0,4,negative regulation of protein localization to microtubule,BP,
18088,GO:1902822,1,0.916750118187139,0,3,regulation of late endosome to lysosome transport,BP,
18089,GO:1902823,1,0.9684314823452,0,1,negative regulation of late endosome to lysosome transport,BP,
18090,GO:1902824,1,0.946638517508882,0,2,positive regulation of late endosome to lysosome transport,BP,
18091,GO:1902838,1,0.966914057987496,0,1,regulation of nuclear migration along microtubule,BP,
18092,GO:1902846,1,0.966837517356414,0,1,positive regulation of mitotic spindle elongation,BP,
18093,GO:1902847,1,0.969382123670748,0,1,regulation of neuronal signal transduction,BP,
18095,GO:1902855,1,0.728387218141256,0,10,regulation of non-motile cilium assembly,BP,
18096,GO:1902856,1,0.935857207688601,0,2,negative regulation of non-motile cilium assembly,BP,
18097,GO:1902857,1,0.802182534324257,0,7,positive regulation of non-motile cilium assembly,BP,
18098,GO:1902858,1,0.971364530564028,0,1,propionyl-CoA metabolic process,BP,
18099,GO:1902860,1,0.971364530564028,0,1,propionyl-CoA biosynthetic process,BP,
18100,GO:1902866,1,0.942686411809234,0,2,regulation of retina development in camera-type eye,BP,
18101,GO:1902868,1,0.942686411809234,0,2,positive regulation of retina development in camera-type eye,BP,
18102,GO:1902869,1,0.942686411809234,0,2,regulation of amacrine cell differentiation,BP,
18103,GO:1902871,1,0.942686411809234,0,2,positive regulation of amacrine cell differentiation,BP,
18106,GO:1902884,1,0.713060783395018,0,11,positive regulation of response to oxidative stress,BP,
18107,GO:1902889,1,0.966847112481757,0,1,protein localization to spindle microtubule,BP,
18108,GO:1902890,1,0.974543632249742,0,1,regulation of root hair elongation,BP,
18109,GO:1902891,1,0.974543632249742,0,1,negative regulation of root hair elongation,BP,
18111,GO:1902894,1,0.72000546299884,0,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
18113,GO:1902896,1,0.937502962431074,0,2,terminal web assembly,BP,
18114,GO:1902897,1,0.939997285272392,0,2,regulation of postsynaptic density protein 95 clustering,BP,
18119,GO:1902908,1,0.967237767497311,0,1,regulation of melanosome transport,BP,
18120,GO:1902910,1,0.967237767497311,0,1,positive regulation of melanosome transport,BP,
18122,GO:1902912,1,0.969271124374127,0,1,pyruvate kinase complex,CC,
18123,GO:1902913,1,0.968683041538734,0,1,positive regulation of neuroepithelial cell differentiation,BP,
18124,GO:1902914,1,0.620799108187478,0,15,regulation of protein polyubiquitination,BP,
18125,GO:1902915,1,0.821358932573681,0,6,negative regulation of protein polyubiquitination,BP,
18126,GO:1902916,1,0.7818903160817,0,8,positive regulation of protein polyubiquitination,BP,
18131,GO:1902937,1,0.971305680023273,0,1,inward rectifier potassium channel complex,CC,
18132,GO:1902938,1,0.939871894256828,0,2,regulation of intracellular calcium activated chloride channel activity,BP,
18133,GO:1902939,1,0.969268747198211,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18134,GO:1902941,1,0.96734639953885,0,1,regulation of voltage-gated chloride channel activity,BP,
18135,GO:1902943,1,0.96734639953885,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18137,GO:1902947,1,0.855977257521335,0,5,regulation of tau-protein kinase activity,BP,
18138,GO:1902948,1,0.966747024794232,0,1,negative regulation of tau-protein kinase activity,BP,
18139,GO:1902949,1,0.885430083974205,0,4,positive regulation of tau-protein kinase activity,BP,
18140,GO:1902950,1,0.832743031141664,0,6,regulation of dendritic spine maintenance,BP,
18141,GO:1902951,1,0.942080518505935,0,2,negative regulation of dendritic spine maintenance,BP,
18142,GO:1902952,1,0.941723236084936,0,2,positive regulation of dendritic spine maintenance,BP,
18143,GO:1902953,1,0.88254651693267,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
18144,GO:1902954,1,0.934674820678709,0,2,regulation of early endosome to recycling endosome transport,BP,
18145,GO:1902955,1,0.966747024794232,0,1,positive regulation of early endosome to recycling endosome transport,BP,
18146,GO:1902956,1,0.915288338799989,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18147,GO:1902957,1,0.968670178669023,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18148,GO:1902958,1,0.944896299882133,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18150,GO:1902960,1,0.938542595967806,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18152,GO:1902962,1,0.93550340604654,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18153,GO:1902963,1,0.93550340604654,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18154,GO:1902965,1,0.819130705696568,0,6,regulation of protein localization to early endosome,BP,
18155,GO:1902966,1,0.819130705696568,0,6,positive regulation of protein localization to early endosome,BP,
18156,GO:1902969,1,0.758476911001642,0,9,mitotic DNA replication,BP,
18157,GO:1902975,1,0.973789034048043,0,1,mitotic DNA replication initiation,BP,
18158,GO:1902977,1,0.971989563101758,0,1,mitotic DNA replication preinitiation complex assembly,BP,
18159,GO:1902983,1,0.96843869570832,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
18160,GO:1902988,1,0.90609582789551,0,3,neurofibrillary tangle assembly,BP,
18161,GO:1902990,1,0.91046982072597,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
18163,GO:1902992,1,0.708288810152843,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
18165,GO:1902994,1,0.941503987053583,0,2,regulation of phospholipid efflux,BP,
18166,GO:1902995,1,0.941503987053583,0,2,positive regulation of phospholipid efflux,BP,
18167,GO:1902996,1,0.937144587539649,0,2,regulation of neurofibrillary tangle assembly,BP,
18168,GO:1902997,1,0.966747024794232,0,1,negative regulation of neurofibrillary tangle assembly,BP,
18169,GO:1902998,1,0.969382123670748,0,1,positive regulation of neurofibrillary tangle assembly,BP,
18170,GO:1903000,1,0.973791068722543,0,1,regulation of lipid transport across blood brain barrier,BP,
18171,GO:1903002,1,0.973791068722543,0,1,positive regulation of lipid transport across blood brain barrier,BP,
18173,GO:1903004,1,0.967604024860509,0,1,regulation of protein K63-linked deubiquitination,BP,
18174,GO:1903006,1,0.967604024860509,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18175,GO:1903007,1,0.967604024860509,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
18179,GO:1903012,1,0.882790497588536,0,4,positive regulation of bone development,BP,
18180,GO:1903018,1,0.399774072059809,0,30,regulation of glycoprotein metabolic process,BP,
18181,GO:1903019,1,0.702262663213552,0,12,negative regulation of glycoprotein metabolic process,BP,
18182,GO:1903020,1,0.626581185547879,0,15,positive regulation of glycoprotein metabolic process,BP,
18183,GO:1903025,1,0.768231354462289,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18184,GO:1903026,1,0.87175154814213,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
18185,GO:1903027,1,0.966827629941778,0,1,regulation of opsonization,BP,
18186,GO:1903028,1,0.966827629941778,0,1,positive regulation of opsonization,BP,
18187,GO:1903031,1,0.942930938821145,0,2,regulation of microtubule plus-end binding,BP,
18188,GO:1903033,1,0.942930938821145,0,2,positive regulation of microtubule plus-end binding,BP,
18195,GO:1903044,1,0.785874996692729,0,8,protein localization to membrane raft,BP,
18196,GO:1903045,1,0.96687736586233,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
18203,GO:1903054,1,0.864193864996577,0,5,negative regulation of extracellular matrix organization,BP,
18204,GO:1903055,1,0.679739868035424,0,12,positive regulation of extracellular matrix organization,BP,
18210,GO:1903072,1,0.974265395836361,0,1,regulation of death-inducing signaling complex assembly,BP,
18211,GO:1903073,1,0.974265395836361,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18213,GO:1903077,1,0.586702926380368,0,17,negative regulation of protein localization to plasma membrane,BP,
18215,GO:1903093,1,0.917043526631778,0,3,regulation of protein K48-linked deubiquitination,BP,
18216,GO:1903094,1,0.948499635743767,0,2,negative regulation of protein K48-linked deubiquitination,BP,
18217,GO:1903095,1,0.937417426579725,0,2,ribonuclease III complex,CC,
18218,GO:1903096,1,0.968953988832333,0,1,protein localization to meiotic spindle midzone,BP,
18219,GO:1903108,1,0.966920568104527,0,1,regulation of mitochondrial transcription,BP,
18220,GO:1903109,1,0.966920568104527,0,1,positive regulation of mitochondrial transcription,BP,
18222,GO:1903116,1,0.935956164085337,0,2,positive regulation of actin filament-based movement,BP,
18223,GO:1903119,1,0.907992806407244,0,3,protein localization to actin cytoskeleton,BP,
18225,GO:1903122,1,0.974265395836361,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18226,GO:1903126,1,0.971382167968529,0,1,negative regulation of centriole-centriole cohesion,BP,
18228,GO:1903135,1,0.913978085376716,0,3,cupric ion binding,MF,
18229,GO:1903136,1,0.862726204678523,0,5,cuprous ion binding,MF,
18231,GO:1903141,1,0.967298849410928,0,1,negative regulation of establishment of endothelial barrier,BP,
18232,GO:1903142,1,0.93646870164952,0,2,positive regulation of establishment of endothelial barrier,BP,
18233,GO:1903143,1,0.966939668707445,0,1,adrenomedullin receptor complex,CC,
18235,GO:1903147,1,0.779016618221883,0,8,negative regulation of autophagy of mitochondrion,BP,
18236,GO:1903165,1,0.969770048460864,0,1,response to polycyclic arene,BP,
18237,GO:1903167,1,0.974265395836361,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18238,GO:1903168,1,0.974265395836361,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18240,GO:1903170,1,0.579441100650884,0,18,negative regulation of calcium ion transmembrane transport,BP,
18241,GO:1903173,1,0.940739623887527,0,2,fatty alcohol metabolic process,BP,
18242,GO:1903176,1,0.974265395836361,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18243,GO:1903178,1,0.974265395836361,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18244,GO:1903179,1,0.943507114699613,0,2,regulation of dopamine biosynthetic process,BP,
18245,GO:1903181,1,0.943507114699613,0,2,positive regulation of dopamine biosynthetic process,BP,
18246,GO:1903182,1,0.973744051883864,0,1,regulation of SUMO transferase activity,BP,
18247,GO:1903184,1,0.974265395836361,0,1,L-dopa metabolic process,BP,
18248,GO:1903185,1,0.974265395836361,0,1,L-dopa biosynthetic process,BP,
18249,GO:1903189,1,0.974265395836361,0,1,glyoxal metabolic process,BP,
18250,GO:1903195,1,0.974265395836361,0,1,regulation of L-dopa biosynthetic process,BP,
18251,GO:1903197,1,0.974265395836361,0,1,positive regulation of L-dopa biosynthetic process,BP,
18252,GO:1903198,1,0.974265395836361,0,1,regulation of L-dopa decarboxylase activity,BP,
18253,GO:1903200,1,0.974265395836361,0,1,positive regulation of L-dopa decarboxylase activity,BP,
18257,GO:1903204,1,0.646000097971169,0,14,negative regulation of oxidative stress-induced neuron death,BP,
18259,GO:1903206,1,0.676311339263203,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18260,GO:1903207,1,0.919167513411066,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18261,GO:1903208,1,0.919167513411066,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
18262,GO:1903209,1,0.713060783395018,0,11,positive regulation of oxidative stress-induced cell death,BP,
18264,GO:1903215,1,0.971237910811323,0,1,negative regulation of protein targeting to mitochondrion,BP,
18265,GO:1903223,1,0.905376595862083,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18266,GO:1903224,1,0.881629966208431,0,4,regulation of endodermal cell differentiation,BP,
18267,GO:1903225,1,0.934746343175689,0,2,negative regulation of endodermal cell differentiation,BP,
18268,GO:1903231,1,0.96908910236424,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
18269,GO:1903232,1,0.86634096316545,0,5,melanosome assembly,BP,
18270,GO:1903233,1,0.934857838406822,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
18271,GO:1903236,1,0.911420413752778,0,3,regulation of leukocyte tethering or rolling,BP,
18272,GO:1903237,1,0.974482098705163,0,1,negative regulation of leukocyte tethering or rolling,BP,
18273,GO:1903238,1,0.935291413908706,0,2,positive regulation of leukocyte tethering or rolling,BP,
18274,GO:1903242,1,0.820189458728518,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
18275,GO:1903243,1,0.848154981362455,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
18276,GO:1903244,1,0.967042410544309,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
18277,GO:1903248,1,0.966797215838241,0,1,regulation of citrulline biosynthetic process,BP,
18278,GO:1903249,1,0.966797215838241,0,1,negative regulation of citrulline biosynthetic process,BP,
18279,GO:1903251,1,0.855331718272058,0,5,multi-ciliated epithelial cell differentiation,BP,
18280,GO:1903259,1,0.969271124374127,0,1,exon-exon junction complex disassembly,BP,
18281,GO:1903265,1,0.788958683710561,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
18282,GO:1903276,1,0.945065214534284,0,2,regulation of sodium ion export across plasma membrane,BP,
18283,GO:1903278,1,0.945065214534284,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18284,GO:1903279,1,0.940102065781483,0,2,regulation of calcium:sodium antiporter activity,BP,
18285,GO:1903281,1,0.940102065781483,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18286,GO:1903282,1,0.968670178669023,0,1,regulation of glutathione peroxidase activity,BP,
18287,GO:1903284,1,0.968670178669023,0,1,positive regulation of glutathione peroxidase activity,BP,
18288,GO:1903285,1,0.968670178669023,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
18290,GO:1903288,1,0.945065214534284,0,2,positive regulation of potassium ion import,BP,
18291,GO:1903292,1,0.938159906145392,0,2,protein localization to Golgi membrane,BP,
18292,GO:1903293,1,0.243642735386004,0,45,phosphatase complex,CC,
18293,GO:1903294,1,0.935575039330035,0,2,regulation of glutamate secretion, neurotransmission,BP,
18294,GO:1903296,1,0.935575039330035,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
18295,GO:1903297,1,0.859976884272688,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18296,GO:1903298,1,0.859976884272688,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18299,GO:1903301,1,0.859132127129636,0,5,positive regulation of hexokinase activity,BP,
18302,GO:1903307,1,0.435203931975466,0,27,positive regulation of regulated secretory pathway,BP,
18310,GO:1903321,1,0.128343972940004,0,67,negative regulation of protein modification by small protein conjugation or removal,BP,
18313,GO:1903333,1,0.860579104109382,0,5,negative regulation of protein folding,BP,
18314,GO:1903335,1,0.889278555809886,0,4,regulation of vacuolar transport,BP,
18315,GO:1903336,1,0.9684314823452,0,1,negative regulation of vacuolar transport,BP,
18316,GO:1903337,1,0.946638517508882,0,2,positive regulation of vacuolar transport,BP,
18317,GO:1903347,1,0.90445312977874,0,3,negative regulation of bicellular tight junction assembly,BP,
18319,GO:1903349,1,0.828941353113404,0,6,omegasome membrane,CC,
18320,GO:1903350,1,0.709755552667045,0,11,response to dopamine,BP,
18321,GO:1903351,1,0.709755552667045,0,11,cellular response to dopamine,BP,
18322,GO:1903352,1,0.877818057632956,0,4,L-ornithine transmembrane transport,BP,
18324,GO:1903361,1,0.858942712908499,0,5,protein localization to basolateral plasma membrane,BP,
18328,GO:1903365,1,0.912089091632958,0,3,regulation of fear response,BP,
18329,GO:1903367,1,0.968755358580569,0,1,positive regulation of fear response,BP,
18330,GO:1903371,1,0.877635865256968,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
18331,GO:1903373,1,0.907758986259853,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
18334,GO:1903377,1,0.885668876451958,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18335,GO:1903378,1,0.936403533683414,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18336,GO:1903381,1,0.967082315738923,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18337,GO:1903382,1,0.967082315738923,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18338,GO:1903383,1,0.944896299882133,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18339,GO:1903384,1,0.944896299882133,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18340,GO:1903385,1,0.936082935516321,0,2,regulation of homophilic cell adhesion,BP,
18341,GO:1903387,1,0.9668989688311,0,1,positive regulation of homophilic cell adhesion,BP,
18345,GO:1903394,1,0.970737082952537,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
18346,GO:1903400,1,0.907359573789984,0,3,L-arginine transmembrane transport,BP,
18347,GO:1903401,1,0.9122913486849,0,3,L-lysine transmembrane transport,BP,
18348,GO:1903405,1,0.767522309522777,0,9,protein localization to nuclear body,BP,
18349,GO:1903406,1,0.967884045210033,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18350,GO:1903408,1,0.967884045210033,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
18352,GO:1903416,1,0.913550734177175,0,3,response to glycoside,BP,
18353,GO:1903420,1,0.966857784700779,0,1,protein localization to endoplasmic reticulum tubular network,BP,
18356,GO:1903423,1,0.850625203784265,0,5,positive regulation of synaptic vesicle recycling,BP,
18358,GO:1903427,1,0.60265762527324,0,17,negative regulation of reactive oxygen species biosynthetic process,BP,
18360,GO:1903429,1,0.627630651547894,0,15,regulation of cell maturation,BP,
18361,GO:1903430,1,0.887594874925391,0,4,negative regulation of cell maturation,BP,
18362,GO:1903431,1,0.798116505613868,0,7,positive regulation of cell maturation,BP,
18363,GO:1903432,1,0.479927505048582,0,24,regulation of TORC1 signaling,BP,
18364,GO:1903433,1,0.938092716385648,0,2,regulation of constitutive secretory pathway,BP,
18365,GO:1903434,1,0.967617256117397,0,1,negative regulation of constitutive secretory pathway,BP,
18366,GO:1903435,1,0.969490084539201,0,1,positive regulation of constitutive secretory pathway,BP,
18367,GO:1903436,1,0.936294018861029,0,2,regulation of mitotic cytokinetic process,BP,
18368,GO:1903438,1,0.936294018861029,0,2,positive regulation of mitotic cytokinetic process,BP,
18369,GO:1903439,1,0.942103295737847,0,2,calcitonin family receptor complex,CC,
18370,GO:1903440,1,0.974316793231571,0,1,amylin receptor complex,CC,
18371,GO:1903441,1,0.802870057629688,0,7,protein localization to ciliary membrane,BP,
18372,GO:1903442,1,0.96765332017958,0,1,response to lipoic acid,BP,
18373,GO:1903444,1,0.968691981319906,0,1,negative regulation of brown fat cell differentiation,BP,
18374,GO:1903445,1,0.918859249411646,0,3,protein transport from ciliary membrane to plasma membrane,BP,
18375,GO:1903450,1,0.966802009874153,0,1,regulation of G1 to G0 transition,BP,
18376,GO:1903452,1,0.966802009874153,0,1,positive regulation of G1 to G0 transition,BP,
18377,GO:1903461,1,0.968796327769778,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
18378,GO:1903463,1,0.909895102732001,0,3,regulation of mitotic cell cycle DNA replication,BP,
18379,GO:1903464,1,0.94107026162377,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
18380,GO:1903465,1,0.966878069763278,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
18383,GO:1903490,1,0.936294018861029,0,2,positive regulation of mitotic cytokinesis,BP,
18392,GO:1903515,1,0.966811552121987,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
18394,GO:1903517,1,0.969254516020708,0,1,negative regulation of single strand break repair,BP,
18399,GO:1903523,1,0.584611903832668,0,17,negative regulation of blood circulation,BP,
18401,GO:1903525,1,0.846484774709023,0,5,regulation of membrane tubulation,BP,
18402,GO:1903526,1,0.936088726643807,0,2,negative regulation of membrane tubulation,BP,
18403,GO:1903527,1,0.904294784002345,0,3,positive regulation of membrane tubulation,BP,
18408,GO:1903537,1,0.940995356690548,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18409,GO:1903538,1,0.940995356690548,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
18410,GO:1903539,1,0.754639408213862,0,9,protein localization to postsynaptic membrane,BP,
18411,GO:1903540,1,0.754639408213862,0,9,establishment of protein localization to postsynaptic membrane,BP,
18412,GO:1903541,1,0.653306290098278,0,14,regulation of exosomal secretion,BP,
18413,GO:1903542,1,0.940281995888033,0,2,negative regulation of exosomal secretion,BP,
18414,GO:1903543,1,0.653306290098278,0,14,positive regulation of exosomal secretion,BP,
18417,GO:1903546,1,0.884568066534908,0,4,protein localization to photoreceptor outer segment,BP,
18419,GO:1903551,1,0.831863072890708,0,6,regulation of extracellular exosome assembly,BP,
18420,GO:1903553,1,0.882246162814719,0,4,positive regulation of extracellular exosome assembly,BP,
18425,GO:1903564,1,0.87849934860149,0,4,regulation of protein localization to cilium,BP,
18426,GO:1903565,1,0.968244772971475,0,1,negative regulation of protein localization to cilium,BP,
18427,GO:1903566,1,0.907319014953605,0,3,positive regulation of protein localization to cilium,BP,
18428,GO:1903567,1,0.939860435273576,0,2,regulation of protein localization to ciliary membrane,BP,
18429,GO:1903568,1,0.968244772971475,0,1,negative regulation of protein localization to ciliary membrane,BP,
18430,GO:1903569,1,0.970687303066819,0,1,positive regulation of protein localization to ciliary membrane,BP,
18431,GO:1903570,1,0.968058844091218,0,1,regulation of protein kinase D signaling,BP,
18432,GO:1903572,1,0.968058844091218,0,1,positive regulation of protein kinase D signaling,BP,
18434,GO:1903575,1,0.942275586040614,0,2,cornified envelope assembly,BP,
18435,GO:1903576,1,0.971569611463507,0,1,response to L-arginine,BP,
18438,GO:1903580,1,0.519421585857497,0,21,positive regulation of ATP metabolic process,BP,
18439,GO:1903584,1,0.967175809730914,0,1,regulation of histone deubiquitination,BP,
18440,GO:1903586,1,0.967175809730914,0,1,positive regulation of histone deubiquitination,BP,
18442,GO:1903588,1,0.911409025018815,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
18444,GO:1903593,1,0.91724963347437,0,3,regulation of histamine secretion by mast cell,BP,
18445,GO:1903595,1,0.91724963347437,0,3,positive regulation of histamine secretion by mast cell,BP,
18446,GO:1903596,1,0.969831641248496,0,1,regulation of gap junction assembly,BP,
18447,GO:1903598,1,0.969831641248496,0,1,positive regulation of gap junction assembly,BP,
18449,GO:1903608,1,0.802319643580771,0,7,protein localization to cytoplasmic stress granule,BP,
18450,GO:1903609,1,0.969831641248496,0,1,negative regulation of inward rectifier potassium channel activity,BP,
18451,GO:1903613,1,0.966893007520594,0,1,regulation of protein tyrosine phosphatase activity,BP,
18452,GO:1903615,1,0.966893007520594,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
18453,GO:1903621,1,0.971925769609276,0,1,protein localization to photoreceptor connecting cilium,BP,
18454,GO:1903624,1,0.790100646559299,0,8,regulation of DNA catabolic process,BP,
18455,GO:1903625,1,0.969718338266846,0,1,negative regulation of DNA catabolic process,BP,
18456,GO:1903626,1,0.891119299196606,0,4,positive regulation of DNA catabolic process,BP,
18457,GO:1903630,1,0.97371107117682,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18458,GO:1903632,1,0.97371107117682,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
18459,GO:1903636,1,0.974914045590198,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18460,GO:1903638,1,0.974914045590198,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18461,GO:1903644,1,0.945816016987761,0,2,regulation of chaperone-mediated protein folding,BP,
18462,GO:1903645,1,0.974914045590198,0,1,negative regulation of chaperone-mediated protein folding,BP,
18463,GO:1903649,1,0.550519200673051,0,19,regulation of cytoplasmic transport,BP,
18464,GO:1903650,1,0.948736571985142,0,2,negative regulation of cytoplasmic transport,BP,
18465,GO:1903651,1,0.744273306083915,0,9,positive regulation of cytoplasmic transport,BP,
18469,GO:1903671,1,0.527354062807198,0,20,negative regulation of sprouting angiogenesis,BP,
18471,GO:1903673,1,0.972000861812146,0,1,mitotic cleavage furrow formation,BP,
18472,GO:1903674,1,0.972020602641156,0,1,regulation of cap-dependent translational initiation,BP,
18473,GO:1903676,1,0.972020602641156,0,1,positive regulation of cap-dependent translational initiation,BP,
18474,GO:1903677,1,0.915807332916588,0,3,regulation of cap-independent translational initiation,BP,
18475,GO:1903679,1,0.915807332916588,0,3,positive regulation of cap-independent translational initiation,BP,
18476,GO:1903689,1,0.816756553474714,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18477,GO:1903690,1,0.873836914279218,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
18478,GO:1903691,1,0.934701740572795,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
18479,GO:1903697,1,0.968329294978995,0,1,negative regulation of microvillus assembly,BP,
18480,GO:1903699,1,0.96672831997698,0,1,tarsal gland development,BP,
18481,GO:1903701,1,0.966908443549658,0,1,substantia propria of cornea development,BP,
18482,GO:1903704,1,0.975387957839165,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
18486,GO:1903709,1,0.96672831997698,0,1,uterine gland development,BP,
18487,GO:1903715,1,0.88232245965908,0,4,regulation of aerobic respiration,BP,
18488,GO:1903717,1,0.966874900013976,0,1,response to ammonia,BP,
18489,GO:1903718,1,0.966874900013976,0,1,cellular response to ammonia,BP,
18490,GO:1903719,1,0.916352419611839,0,3,regulation of I-kappaB phosphorylation,BP,
18491,GO:1903721,1,0.916352419611839,0,3,positive regulation of I-kappaB phosphorylation,BP,
18492,GO:1903722,1,0.94341093660364,0,2,regulation of centriole elongation,BP,
18493,GO:1903723,1,0.974318619150387,0,1,negative regulation of centriole elongation,BP,
18494,GO:1903724,1,0.968279873306857,0,1,positive regulation of centriole elongation,BP,
18496,GO:1903726,1,0.780734549207226,0,8,negative regulation of phospholipid metabolic process,BP,
18498,GO:1903729,1,0.750078399757415,0,9,regulation of plasma membrane organization,BP,
18500,GO:1903748,1,0.884297525698726,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18502,GO:1903750,1,0.887851350126848,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18503,GO:1903751,1,0.887851350126848,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18505,GO:1903755,1,0.973744051883864,0,1,positive regulation of SUMO transferase activity,BP,
18506,GO:1903756,1,0.938662081297364,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18507,GO:1903758,1,0.938662081297364,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
18508,GO:1903759,1,0.968691981319906,0,1,signal transduction involved in regulation of aerobic respiration,BP,
18510,GO:1903762,1,0.967494934004289,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18511,GO:1903763,1,0.881023833329604,0,4,gap junction channel activity involved in cell communication by electrical coupling,MF,
18513,GO:1903767,1,0.970141245305701,0,1,sweet taste receptor complex,CC,
18514,GO:1903768,1,0.970141245305701,0,1,taste receptor complex,CC,
18515,GO:1903770,1,0.969254516020708,0,1,negative regulation of beta-galactosidase activity,BP,
18516,GO:1903772,1,0.864804926478586,0,5,regulation of viral budding via host ESCRT complex,BP,
18517,GO:1903774,1,0.916319704055596,0,3,positive regulation of viral budding via host ESCRT complex,BP,
18518,GO:1903775,1,0.940580526972254,0,2,regulation of DNA double-strand break processing,BP,
18519,GO:1903778,1,0.937889732035859,0,2,protein localization to vacuolar membrane,BP,
18521,GO:1903781,1,0.935956164085337,0,2,positive regulation of cardiac conduction,BP,
18522,GO:1903786,1,0.969652760557037,0,1,regulation of glutathione biosynthetic process,BP,
18523,GO:1903788,1,0.969652760557037,0,1,positive regulation of glutathione biosynthetic process,BP,
18524,GO:1903789,1,0.855058712830251,0,5,regulation of amino acid transmembrane transport,BP,
18525,GO:1903792,1,0.65559636617706,0,13,negative regulation of anion transport,BP,
18527,GO:1903795,1,0.87898286898336,0,4,regulation of inorganic anion transmembrane transport,BP,
18528,GO:1903796,1,0.937084927443906,0,2,negative regulation of inorganic anion transmembrane transport,BP,
18529,GO:1903797,1,0.96734639953885,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18530,GO:1903798,1,0.64625492330911,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18531,GO:1903799,1,0.774320548855721,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18532,GO:1903800,1,0.810648082504902,0,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18533,GO:1903801,1,0.970995982889281,0,1,L-leucine import across plasma membrane,BP,
18534,GO:1903803,1,0.971978251341793,0,1,L-glutamine import across plasma membrane,BP,
18535,GO:1903817,1,0.859007746276065,0,5,negative regulation of voltage-gated potassium channel activity,BP,
18536,GO:1903818,1,0.904243916635302,0,3,positive regulation of voltage-gated potassium channel activity,BP,
18537,GO:1903823,1,0.969254516020708,0,1,telomere single strand break repair,BP,
18538,GO:1903824,1,0.969254516020708,0,1,negative regulation of telomere single strand break repair,BP,
18540,GO:1903826,1,0.882026666166818,0,4,arginine transmembrane transport,BP,
18545,GO:1903831,1,0.693241313392785,0,12,signal transduction involved in cellular response to ammonium ion,BP,
18546,GO:1903837,1,0.970382714489593,0,1,regulation of mRNA 3'-UTR binding,BP,
18547,GO:1903839,1,0.970382714489593,0,1,positive regulation of mRNA 3'-UTR binding,BP,
18551,GO:1903847,1,0.935089137569792,0,2,regulation of aorta morphogenesis,BP,
18552,GO:1903849,1,0.935089137569792,0,2,positive regulation of aorta morphogenesis,BP,
18553,GO:1903850,1,0.969857264588559,0,1,regulation of cristae formation,BP,
18554,GO:1903852,1,0.969857264588559,0,1,positive regulation of cristae formation,BP,
18556,GO:1903860,1,0.9389425364647,0,2,negative regulation of dendrite extension,BP,
18558,GO:1903862,1,0.863763459698281,0,5,positive regulation of oxidative phosphorylation,BP,
18559,GO:1903867,1,0.773012895070475,0,8,extraembryonic membrane development,BP,
18561,GO:1903881,1,0.967789301379805,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18562,GO:1903883,1,0.967789301379805,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18563,GO:1903884,1,0.967789301379805,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18564,GO:1903886,1,0.967789301379805,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
18565,GO:1903888,1,0.974543632249742,0,1,regulation of plant epidermal cell differentiation,BP,
18566,GO:1903889,1,0.974543632249742,0,1,negative regulation of plant epidermal cell differentiation,BP,
18568,GO:1903892,1,0.938814279522944,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
18569,GO:1903893,1,0.970313988985591,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
18572,GO:1903896,1,0.804187593194894,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18574,GO:1903898,1,0.857687842591709,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18575,GO:1903899,1,0.91212980808804,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
18579,GO:1903903,1,0.909295801034672,0,3,regulation of establishment of T cell polarity,BP,
18580,GO:1903905,1,0.937750301967209,0,2,positive regulation of establishment of T cell polarity,BP,
18581,GO:1903906,1,0.969661891550934,0,1,regulation of plasma membrane raft polarization,BP,
18582,GO:1903909,1,0.854248912023691,0,5,regulation of receptor clustering,BP,
18583,GO:1903911,1,0.911214677123147,0,3,positive regulation of receptor clustering,BP,
18585,GO:1903916,1,0.97065514888709,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18586,GO:1903917,1,0.97065514888709,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18591,GO:1903924,1,0.971114009766664,0,1,estradiol binding,MF,
18592,GO:1903925,1,0.972143702897848,0,1,response to bisphenol A,BP,
18593,GO:1903926,1,0.972143702897848,0,1,cellular response to bisphenol A,BP,
18594,GO:1903929,1,0.968676108019795,0,1,primary palate development,BP,
18596,GO:1903936,1,0.863469621001599,0,5,cellular response to sodium arsenite,BP,
18598,GO:1903939,1,0.968346594058137,0,1,regulation of TORC2 signaling,BP,
18599,GO:1903943,1,0.971884453653904,0,1,regulation of hepatocyte apoptotic process,BP,
18600,GO:1903944,1,0.971884453653904,0,1,negative regulation of hepatocyte apoptotic process,BP,
18601,GO:1903947,1,0.967494934004289,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18602,GO:1903949,1,0.935956164085337,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
18603,GO:1903952,1,0.967494934004289,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18604,GO:1903954,1,0.967494934004289,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18606,GO:1903959,1,0.578704623320909,0,17,regulation of anion transmembrane transport,BP,
18607,GO:1903960,1,0.723913031923569,0,10,negative regulation of anion transmembrane transport,BP,
18608,GO:1903961,1,0.910416081410773,0,3,positive regulation of anion transmembrane transport,BP,
18610,GO:1903964,1,0.937927575596019,0,2,monounsaturated fatty acid metabolic process,BP,
18611,GO:1903966,1,0.937927575596019,0,2,monounsaturated fatty acid biosynthetic process,BP,
18612,GO:1903969,1,0.943903168500547,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18613,GO:1903970,1,0.972584353089558,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18614,GO:1903971,1,0.970512554479437,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18615,GO:1903972,1,0.943903168500547,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18616,GO:1903973,1,0.972584353089558,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18617,GO:1903974,1,0.970512554479437,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18618,GO:1903975,1,0.835394850740396,0,6,regulation of glial cell migration,BP,
18619,GO:1903976,1,0.915616589324303,0,3,negative regulation of glial cell migration,BP,
18620,GO:1903977,1,0.938324913950444,0,2,positive regulation of glial cell migration,BP,
18621,GO:1903978,1,0.880908249929525,0,4,regulation of microglial cell activation,BP,
18622,GO:1903979,1,0.96689975956694,0,1,negative regulation of microglial cell activation,BP,
18623,GO:1903980,1,0.942418763924218,0,2,positive regulation of microglial cell activation,BP,
18625,GO:1903995,1,0.971236436711977,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18626,GO:1903997,1,0.971236436711977,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18627,GO:1903998,1,0.910940789640793,0,3,regulation of eating behavior,BP,
18628,GO:1903999,1,0.942229165808064,0,2,negative regulation of eating behavior,BP,
18629,GO:1904000,1,0.966798560430869,0,1,positive regulation of eating behavior,BP,
18630,GO:1904016,1,0.8778375700783,0,4,response to Thyroglobulin triiodothyronine,BP,
18631,GO:1904017,1,0.934804655078917,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
18636,GO:1904022,1,0.968570346802033,0,1,positive regulation of G-protein coupled receptor internalization,BP,
18637,GO:1904023,1,0.969271124374127,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18638,GO:1904024,1,0.969271124374127,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18639,GO:1904026,1,0.940398477581845,0,2,regulation of collagen fibril organization,BP,
18640,GO:1904027,1,0.970214510686921,0,1,negative regulation of collagen fibril organization,BP,
18641,GO:1904028,1,0.969271124374127,0,1,positive regulation of collagen fibril organization,BP,
18644,GO:1904031,1,0.403137947676554,0,30,positive regulation of cyclin-dependent protein kinase activity,BP,
18647,GO:1904037,1,0.582133665278951,0,17,positive regulation of epithelial cell apoptotic process,BP,
18648,GO:1904041,1,0.968435086332893,0,1,regulation of cystathionine beta-synthase activity,BP,
18649,GO:1904042,1,0.968435086332893,0,1,negative regulation of cystathionine beta-synthase activity,BP,
18651,GO:1904045,1,0.971152371918057,0,1,cellular response to aldosterone,BP,
18652,GO:1904046,1,0.947119596323413,0,2,negative regulation of vascular endothelial growth factor production,BP,
18653,GO:1904047,1,0.913385578646295,0,3,S-adenosyl-L-methionine binding,MF,
18654,GO:1904048,1,0.96708790686349,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18655,GO:1904050,1,0.96708790686349,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
18656,GO:1904054,1,0.966798560430869,0,1,regulation of cholangiocyte proliferation,BP,
18657,GO:1904056,1,0.966798560430869,0,1,positive regulation of cholangiocyte proliferation,BP,
18658,GO:1904057,1,0.972774966162281,0,1,negative regulation of sensory perception of pain,BP,
18659,GO:1904058,1,0.911355245296672,0,3,positive regulation of sensory perception of pain,BP,
18660,GO:1904059,1,0.966671915760962,0,1,regulation of locomotor rhythm,BP,
18664,GO:1904090,1,0.899856170678948,0,4,peptidase inhibitor complex,CC,
18665,GO:1904098,1,0.911114161890577,0,3,regulation of protein O-linked glycosylation,BP,
18666,GO:1904100,1,0.911114161890577,0,3,positive regulation of protein O-linked glycosylation,BP,
18667,GO:1904106,1,0.9692450588974,0,1,protein localization to microvillus,BP,
18669,GO:1904116,1,0.907695633726117,0,3,response to vasopressin,BP,
18670,GO:1904117,1,0.907695633726117,0,3,cellular response to vasopressin,BP,
18671,GO:1904121,1,0.972652485296482,0,1,phosphatidylethanolamine transporter activity,MF,
18672,GO:1904124,1,0.970512554479437,0,1,microglial cell migration,BP,
18673,GO:1904139,1,0.970512554479437,0,1,regulation of microglial cell migration,BP,
18674,GO:1904141,1,0.970512554479437,0,1,positive regulation of microglial cell migration,BP,
18677,GO:1904154,1,0.914425045142711,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
18678,GO:1904155,1,0.968345725959514,0,1,DN2 thymocyte differentiation,BP,
18679,GO:1904156,1,0.968345725959514,0,1,DN3 thymocyte differentiation,BP,
18680,GO:1904167,1,0.96675800891852,0,1,regulation of thyroid hormone receptor activity,BP,
18681,GO:1904168,1,0.96675800891852,0,1,negative regulation of thyroid hormone receptor activity,BP,
18682,GO:1904170,1,0.966995181695457,0,1,regulation of bleb assembly,BP,
18683,GO:1904172,1,0.966995181695457,0,1,positive regulation of bleb assembly,BP,
18684,GO:1904177,1,0.905029046226758,0,3,regulation of adipose tissue development,BP,
18685,GO:1904179,1,0.905029046226758,0,3,positive regulation of adipose tissue development,BP,
18686,GO:1904180,1,0.858877096712487,0,5,negative regulation of membrane depolarization,BP,
18688,GO:1904192,1,0.966798560430869,0,1,regulation of cholangiocyte apoptotic process,BP,
18689,GO:1904193,1,0.966798560430869,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18690,GO:1904195,1,0.966798560430869,0,1,regulation of granulosa cell proliferation,BP,
18691,GO:1904197,1,0.966798560430869,0,1,positive regulation of granulosa cell proliferation,BP,
18692,GO:1904199,1,0.967404514182229,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
18693,GO:1904200,1,0.966798560430869,0,1,iodide transmembrane transport,BP,
18694,GO:1904201,1,0.966798560430869,0,1,regulation of iodide transport,BP,
18695,GO:1904202,1,0.966798560430869,0,1,negative regulation of iodide transport,BP,
18696,GO:1904204,1,0.934758162119442,0,2,regulation of skeletal muscle hypertrophy,BP,
18697,GO:1904205,1,0.966862288706958,0,1,negative regulation of skeletal muscle hypertrophy,BP,
18698,GO:1904206,1,0.966798560430869,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18699,GO:1904207,1,0.940465448840111,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18700,GO:1904209,1,0.940465448840111,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
18702,GO:1904211,1,0.940241412931787,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
18703,GO:1904212,1,0.966798560430869,0,1,regulation of iodide transmembrane transport,BP,
18704,GO:1904213,1,0.966798560430869,0,1,negative regulation of iodide transmembrane transport,BP,
18705,GO:1904217,1,0.914964482279744,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18706,GO:1904219,1,0.914964482279744,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18707,GO:1904220,1,0.886841908943912,0,4,regulation of serine C-palmitoyltransferase activity,BP,
18708,GO:1904222,1,0.914964482279744,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
18709,GO:1904226,1,0.971229065755609,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18710,GO:1904227,1,0.971229065755609,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18711,GO:1904229,1,0.96683842825202,0,1,regulation of succinate dehydrogenase activity,BP,
18712,GO:1904231,1,0.96683842825202,0,1,positive regulation of succinate dehydrogenase activity,BP,
18713,GO:1904232,1,0.96683842825202,0,1,regulation of aconitate hydratase activity,BP,
18714,GO:1904234,1,0.96683842825202,0,1,positive regulation of aconitate hydratase activity,BP,
18715,GO:1904235,1,0.966807821141104,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18716,GO:1904237,1,0.966807821141104,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18717,GO:1904238,1,0.911698336286498,0,3,pericyte cell differentiation,BP,
18720,GO:1904245,1,0.942196497857037,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
18721,GO:1904246,1,0.972485129024854,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
18722,GO:1904247,1,0.968856747922694,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
18723,GO:1904251,1,0.832425921901853,0,6,regulation of bile acid metabolic process,BP,
18724,GO:1904253,1,0.913044358502666,0,3,positive regulation of bile acid metabolic process,BP,
18725,GO:1904259,1,0.844884148792217,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18726,GO:1904261,1,0.844884148792217,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18727,GO:1904262,1,0.712656403274978,0,11,negative regulation of TORC1 signaling,BP,
18728,GO:1904263,1,0.785894340373813,0,8,positive regulation of TORC1 signaling,BP,
18729,GO:1904265,1,0.966861640313706,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
18730,GO:1904266,1,0.96683706223508,0,1,regulation of Schwann cell chemotaxis,BP,
18731,GO:1904268,1,0.96683706223508,0,1,positive regulation of Schwann cell chemotaxis,BP,
18732,GO:1904271,1,0.970397080614669,0,1,L-proline import across plasma membrane,BP,
18733,GO:1904274,1,0.97111696085987,0,1,tricellular tight junction assembly,BP,
18734,GO:1904282,1,0.971924347519029,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18735,GO:1904283,1,0.971924347519029,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18736,GO:1904288,1,0.879072893951872,0,4,BAT3 complex binding,MF,
18737,GO:1904289,1,0.937165331531693,0,2,regulation of mitotic DNA damage checkpoint,BP,
18738,GO:1904290,1,0.967095524225961,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
18742,GO:1904298,1,0.96734639953885,0,1,regulation of transcytosis,BP,
18743,GO:1904300,1,0.96734639953885,0,1,positive regulation of transcytosis,BP,
18744,GO:1904301,1,0.96734639953885,0,1,regulation of maternal process involved in parturition,BP,
18745,GO:1904303,1,0.96734639953885,0,1,positive regulation of maternal process involved in parturition,BP,
18746,GO:1904304,1,0.942657817891265,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18747,GO:1904306,1,0.942657817891265,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
18749,GO:1904315,1,0.856820786928405,0,5,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
18750,GO:1904316,1,0.96734639953885,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18751,GO:1904317,1,0.96734639953885,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18752,GO:1904321,1,0.770485028542954,0,8,response to forskolin,BP,
18753,GO:1904322,1,0.770485028542954,0,8,cellular response to forskolin,BP,
18754,GO:1904327,1,0.93713703000047,0,2,protein localization to cytosolic proteasome complex,BP,
18755,GO:1904328,1,0.969702524821051,0,1,regulation of myofibroblast contraction,BP,
18756,GO:1904338,1,0.828256624185734,0,6,regulation of dopaminergic neuron differentiation,BP,
18757,GO:1904339,1,0.966840075130699,0,1,negative regulation of dopaminergic neuron differentiation,BP,
18758,GO:1904340,1,0.916192324664021,0,3,positive regulation of dopaminergic neuron differentiation,BP,
18759,GO:1904350,1,0.778677210432079,0,8,regulation of protein catabolic process in the vacuole,BP,
18760,GO:1904351,1,0.909812482006281,0,3,negative regulation of protein catabolic process in the vacuole,BP,
18761,GO:1904352,1,0.881848315338307,0,4,positive regulation of protein catabolic process in the vacuole,BP,
18764,GO:1904355,1,0.609943843056857,0,16,positive regulation of telomere capping,BP,
18767,GO:1904358,1,0.34092233029111,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18769,GO:1904376,1,0.550563236037465,0,19,negative regulation of protein localization to cell periphery,BP,
18771,GO:1904378,1,0.910396980501902,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
18772,GO:1904379,1,0.93713703000047,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
18774,GO:1904381,1,0.93532428068967,0,2,Golgi apparatus mannose trimming,BP,
18775,GO:1904382,1,0.88105125286297,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
18776,GO:1904383,1,0.97130862450244,0,1,response to sodium phosphate,BP,
18778,GO:1904386,1,0.907326380526009,0,3,response to L-phenylalanine derivative,BP,
18779,GO:1904387,1,0.937633238638339,0,2,cellular response to L-phenylalanine derivative,BP,
18780,GO:1904393,1,0.966817301040855,0,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18781,GO:1904395,1,0.966817301040855,0,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
18782,GO:1904396,1,0.903768299346086,0,3,regulation of neuromuscular junction development,BP,
18783,GO:1904398,1,0.934748768529664,0,2,positive regulation of neuromuscular junction development,BP,
18784,GO:1904404,1,0.966833353549414,0,1,response to formaldehyde,BP,
18785,GO:1904406,1,0.764217448262539,0,9,negative regulation of nitric oxide metabolic process,BP,
18787,GO:1904408,1,0.973865752459095,0,1,melatonin binding,MF,
18788,GO:1904412,1,0.967910767110477,0,1,regulation of cardiac ventricle development,BP,
18789,GO:1904414,1,0.967910767110477,0,1,positive regulation of cardiac ventricle development,BP,
18792,GO:1904424,1,0.749894679021423,0,9,regulation of GTP binding,BP,
18793,GO:1904426,1,0.937368619755664,0,2,positive regulation of GTP binding,BP,
18795,GO:1904428,1,0.910146132723589,0,3,negative regulation of tubulin deacetylation,BP,
18796,GO:1904429,1,0.800234098234333,0,7,regulation of t-circle formation,BP,
18797,GO:1904430,1,0.90750521358572,0,3,negative regulation of t-circle formation,BP,
18798,GO:1904431,1,0.881825061757921,0,4,positive regulation of t-circle formation,BP,
18799,GO:1904432,1,0.946816153135315,0,2,regulation of ferrous iron binding,BP,
18800,GO:1904434,1,0.946816153135315,0,2,positive regulation of ferrous iron binding,BP,
18801,GO:1904435,1,0.946816153135315,0,2,regulation of transferrin receptor binding,BP,
18802,GO:1904437,1,0.946816153135315,0,2,positive regulation of transferrin receptor binding,BP,
18803,GO:1904447,1,0.966855798110455,0,1,folic acid import across plasma membrane,BP,
18804,GO:1904448,1,0.966958766715114,0,1,regulation of aspartate secretion,BP,
18805,GO:1904450,1,0.966958766715114,0,1,positive regulation of aspartate secretion,BP,
18806,GO:1904454,1,0.966818911246537,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
18807,GO:1904455,1,0.934897359894498,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
18808,GO:1904457,1,0.970585167270237,0,1,positive regulation of neuronal action potential,BP,
18809,GO:1904464,1,0.972503543661223,0,1,regulation of matrix metallopeptidase secretion,BP,
18810,GO:1904465,1,0.972503543661223,0,1,negative regulation of matrix metallopeptidase secretion,BP,
18813,GO:1904469,1,0.794312270924522,0,7,positive regulation of tumor necrosis factor secretion,BP,
18814,GO:1904475,1,0.934805555383498,0,2,regulation of Ras GTPase binding,BP,
18815,GO:1904477,1,0.966859128570501,0,1,positive regulation of Ras GTPase binding,BP,
18816,GO:1904481,1,0.970425860258468,0,1,response to tetrahydrofolate,BP,
18817,GO:1904482,1,0.970425860258468,0,1,cellular response to tetrahydrofolate,BP,
18818,GO:1904491,1,0.89334882146329,0,4,protein localization to ciliary transition zone,BP,
18819,GO:1904498,1,0.907992806407244,0,3,protein localization to mitotic actomyosin contractile ring,BP,
18820,GO:1904499,1,0.968206987373667,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18821,GO:1904501,1,0.968206987373667,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18822,GO:1904502,1,0.854641288127701,0,5,regulation of lipophagy,BP,
18823,GO:1904504,1,0.854641288127701,0,5,positive regulation of lipophagy,BP,
18824,GO:1904505,1,0.879588933761212,0,4,regulation of telomere maintenance in response to DNA damage,BP,
18825,GO:1904506,1,0.879588933761212,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
18826,GO:1904515,1,0.968346594058137,0,1,positive regulation of TORC2 signaling,BP,
18827,GO:1904526,1,0.757401648225478,0,9,regulation of microtubule binding,BP,
18828,GO:1904527,1,0.908539411721985,0,3,negative regulation of microtubule binding,BP,
18829,GO:1904528,1,0.834902653530883,0,6,positive regulation of microtubule binding,BP,
18830,GO:1904529,1,0.936718319196495,0,2,regulation of actin filament binding,BP,
18831,GO:1904530,1,0.96880976549386,0,1,negative regulation of actin filament binding,BP,
18832,GO:1904531,1,0.966878212105565,0,1,positive regulation of actin filament binding,BP,
18833,GO:1904533,1,0.908436650591424,0,3,regulation of telomeric loop disassembly,BP,
18834,GO:1904534,1,0.939371268088885,0,2,negative regulation of telomeric loop disassembly,BP,
18835,GO:1904535,1,0.967074346987134,0,1,positive regulation of telomeric loop disassembly,BP,
18836,GO:1904542,1,0.969857264588559,0,1,regulation of free ubiquitin chain polymerization,BP,
18837,GO:1904544,1,0.969857264588559,0,1,positive regulation of free ubiquitin chain polymerization,BP,
18838,GO:1904550,1,0.971572528226367,0,1,response to arachidonic acid,BP,
18839,GO:1904555,1,0.970397080614669,0,1,L-proline transmembrane transport,BP,
18840,GO:1904556,1,0.970397080614669,0,1,L-tryptophan transmembrane transport,BP,
18841,GO:1904562,1,0.934761046750381,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
18842,GO:1904565,1,0.968754341634736,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18843,GO:1904566,1,0.968754341634736,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
18844,GO:1904567,1,0.969000986240046,0,1,response to wortmannin,BP,
18845,GO:1904568,1,0.969000986240046,0,1,cellular response to wortmannin,BP,
18846,GO:1904569,1,0.972490396683953,0,1,regulation of selenocysteine incorporation,BP,
18847,GO:1904570,1,0.972490396683953,0,1,negative regulation of selenocysteine incorporation,BP,
18848,GO:1904572,1,0.972490396683953,0,1,negative regulation of mRNA binding,BP,
18849,GO:1904573,1,0.972490396683953,0,1,regulation of selenocysteine insertion sequence binding,BP,
18850,GO:1904574,1,0.972490396683953,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
18851,GO:1904576,1,0.942930026405901,0,2,response to tunicamycin,BP,
18852,GO:1904577,1,0.942930026405901,0,2,cellular response to tunicamycin,BP,
18853,GO:1904578,1,0.913673372743755,0,3,response to thapsigargin,BP,
18854,GO:1904579,1,0.913673372743755,0,3,cellular response to thapsigargin,BP,
18855,GO:1904580,1,0.942317564207333,0,2,regulation of intracellular mRNA localization,BP,
18856,GO:1904582,1,0.942317564207333,0,2,positive regulation of intracellular mRNA localization,BP,
18857,GO:1904585,1,0.97130862450244,0,1,response to putrescine,BP,
18858,GO:1904586,1,0.97130862450244,0,1,cellular response to putrescine,BP,
18859,GO:1904587,1,0.88105125286297,0,4,response to glycoprotein,BP,
18861,GO:1904590,1,0.805191239945892,0,7,negative regulation of protein import,BP,
18865,GO:1904596,1,0.97344752401555,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18866,GO:1904597,1,0.97344752401555,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18867,GO:1904599,1,0.97344752401555,0,1,advanced glycation end-product binding,MF,
18868,GO:1904603,1,0.97344752401555,0,1,regulation of advanced glycation end-product receptor activity,BP,
18869,GO:1904604,1,0.97344752401555,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
18870,GO:1904612,1,0.93523932044511,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18871,GO:1904613,1,0.93523932044511,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18872,GO:1904616,1,0.936718319196495,0,2,regulation of actin binding,BP,
18873,GO:1904617,1,0.96880976549386,0,1,negative regulation of actin binding,BP,
18874,GO:1904618,1,0.966878212105565,0,1,positive regulation of actin binding,BP,
18875,GO:1904627,1,0.97321722048805,0,1,response to phorbol 13-acetate 12-myristate,BP,
18876,GO:1904628,1,0.97321722048805,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
18877,GO:1904631,1,0.971065316689889,0,1,response to glucoside,BP,
18878,GO:1904636,1,0.912496320643417,0,3,response to ionomycin,BP,
18879,GO:1904637,1,0.912496320643417,0,3,cellular response to ionomycin,BP,
18882,GO:1904647,1,0.966789574661012,0,1,response to rotenone,BP,
18884,GO:1904666,1,0.596874421997577,0,18,regulation of ubiquitin protein ligase activity,BP,
18885,GO:1904667,1,0.855112171402734,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18886,GO:1904668,1,0.698115169192188,0,12,positive regulation of ubiquitin protein ligase activity,BP,
18887,GO:1904672,1,0.905245525984098,0,3,regulation of somatic stem cell population maintenance,BP,
18888,GO:1904673,1,0.936096650142034,0,2,negative regulation of somatic stem cell population maintenance,BP,
18889,GO:1904674,1,0.967048650565242,0,1,positive regulation of somatic stem cell population maintenance,BP,
18890,GO:1904680,1,0.53453529142077,0,21,peptide transmembrane transporter activity,MF,
18891,GO:1904681,1,0.969770048460864,0,1,response to 3-methylcholanthrene,BP,
18892,GO:1904683,1,0.821330417002685,0,6,regulation of metalloendopeptidase activity,BP,
18893,GO:1904684,1,0.874797392177301,0,4,negative regulation of metalloendopeptidase activity,BP,
18894,GO:1904685,1,0.938902398654286,0,2,positive regulation of metalloendopeptidase activity,BP,
18895,GO:1904688,1,0.862272029189729,0,5,regulation of cytoplasmic translational initiation,BP,
18896,GO:1904689,1,0.973893711366085,0,1,negative regulation of cytoplasmic translational initiation,BP,
18897,GO:1904690,1,0.885394010032353,0,4,positive regulation of cytoplasmic translational initiation,BP,
18898,GO:1904691,1,0.971393921152701,0,1,negative regulation of type B pancreatic cell proliferation,BP,
18899,GO:1904693,1,0.905243368950918,0,3,midbrain morphogenesis,BP,
18900,GO:1904694,1,0.906005321494353,0,3,negative regulation of vascular smooth muscle contraction,BP,
18901,GO:1904695,1,0.972000861812146,0,1,positive regulation of vascular smooth muscle contraction,BP,
18902,GO:1904700,1,0.970029700335147,0,1,granulosa cell apoptotic process,BP,
18903,GO:1904701,1,0.972322080150554,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
18907,GO:1904708,1,0.970029700335147,0,1,regulation of granulosa cell apoptotic process,BP,
18908,GO:1904711,1,0.972322080150554,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18909,GO:1904713,1,0.969271124374127,0,1,beta-catenin destruction complex binding,MF,
18910,GO:1904714,1,0.831149206485935,0,6,regulation of chaperone-mediated autophagy,BP,
18911,GO:1904715,1,0.914256033863976,0,3,negative regulation of chaperone-mediated autophagy,BP,
18912,GO:1904716,1,0.970693154209324,0,1,positive regulation of chaperone-mediated autophagy,BP,
18913,GO:1904717,1,0.938274069454644,0,2,regulation of AMPA glutamate receptor clustering,BP,
18914,GO:1904719,1,0.970463364567673,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
18915,GO:1904720,1,0.940308188883483,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18916,GO:1904721,1,0.968863067200497,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18917,GO:1904722,1,0.970529952885172,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
18918,GO:1904723,1,0.972322080150554,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
18920,GO:1904732,1,0.942765171879605,0,2,regulation of electron transfer activity,BP,
18921,GO:1904734,1,0.975136865315259,0,1,positive regulation of electron transfer activity,BP,
18922,GO:1904738,1,0.678501050661089,0,12,vascular associated smooth muscle cell migration,BP,
18923,GO:1904742,1,0.884586256161402,0,4,regulation of telomeric DNA binding,BP,
18924,GO:1904743,1,0.934725421456018,0,2,negative regulation of telomeric DNA binding,BP,
18925,GO:1904744,1,0.946369125936034,0,2,positive regulation of telomeric DNA binding,BP,
18926,GO:1904746,1,0.906304290465323,0,3,negative regulation of apoptotic process involved in development,BP,
18929,GO:1904749,1,0.887764425015931,0,4,regulation of protein localization to nucleolus,BP,
18930,GO:1904750,1,0.966851272422428,0,1,negative regulation of protein localization to nucleolus,BP,
18931,GO:1904751,1,0.918208878595493,0,3,positive regulation of protein localization to nucleolus,BP,
18932,GO:1904752,1,0.678501050661089,0,12,regulation of vascular associated smooth muscle cell migration,BP,
18933,GO:1904753,1,0.912350313525416,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
18934,GO:1904754,1,0.74374011125807,0,9,positive regulation of vascular associated smooth muscle cell migration,BP,
18936,GO:1904761,1,0.935853891762705,0,2,negative regulation of myofibroblast differentiation,BP,
18938,GO:1904764,1,0.971671425417964,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
18939,GO:1904766,1,0.966845058315812,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
18940,GO:1904768,1,0.942204717904132,0,2,all-trans-retinol binding,MF,
18941,GO:1904772,1,0.969934746833715,0,1,response to tetrachloromethane,BP,
18943,GO:1904777,1,0.969271124374127,0,1,negative regulation of protein localization to cell cortex,BP,
18945,GO:1904779,1,0.822265947786576,0,6,regulation of protein localization to centrosome,BP,
18946,GO:1904781,1,0.84723534098156,0,5,positive regulation of protein localization to centrosome,BP,
18947,GO:1904782,1,0.966969034767849,0,1,negative regulation of NMDA glutamate receptor activity,BP,
18948,GO:1904783,1,0.937819304319089,0,2,positive regulation of NMDA glutamate receptor activity,BP,
18949,GO:1904784,1,0.966884051663891,0,1,NLRP1 inflammasome complex assembly,BP,
18950,GO:1904790,1,0.969171428582719,0,1,regulation of shelterin complex assembly,BP,
18951,GO:1904792,1,0.969171428582719,0,1,positive regulation of shelterin complex assembly,BP,
18952,GO:1904793,1,0.968206987373667,0,1,regulation of euchromatin binding,BP,
18953,GO:1904796,1,0.854429571384279,0,5,regulation of core promoter binding,BP,
18954,GO:1904797,1,0.966866109864624,0,1,negative regulation of core promoter binding,BP,
18955,GO:1904798,1,0.883720406043528,0,4,positive regulation of core promoter binding,BP,
18956,GO:1904799,1,0.967513796706459,0,1,regulation of neuron remodeling,BP,
18957,GO:1904800,1,0.967513796706459,0,1,negative regulation of neuron remodeling,BP,
18958,GO:1904803,1,0.974877851238786,0,1,regulation of translation involved in cellular response to UV,BP,
18959,GO:1904806,1,0.969271124374127,0,1,regulation of protein oxidation,BP,
18960,GO:1904808,1,0.969271124374127,0,1,positive regulation of protein oxidation,BP,
18961,GO:1904812,1,0.967515302198389,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
18963,GO:1904814,1,0.678179675710992,0,13,regulation of protein localization to chromosome, telomeric region,BP,
18964,GO:1904815,1,0.942024953727626,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
18965,GO:1904816,1,0.719955655983227,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
18966,GO:1904823,1,0.940985355629703,0,2,purine nucleobase transmembrane transport,BP,
18967,GO:1904826,1,0.966826941943737,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
18968,GO:1904828,1,0.966826941943737,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
18969,GO:1904829,1,0.972478537311936,0,1,regulation of aortic smooth muscle cell differentiation,BP,
18970,GO:1904831,1,0.972478537311936,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
18971,GO:1904833,1,0.974265395836361,0,1,positive regulation of removal of superoxide radicals,BP,
18973,GO:1904837,1,0.298893131515872,0,41,beta-catenin-TCF complex assembly,BP,
18974,GO:1904842,1,0.971305680023273,0,1,response to nitroglycerin,BP,
18975,GO:1904843,1,0.971305680023273,0,1,cellular response to nitroglycerin,BP,
18976,GO:1904844,1,0.946728469610716,0,2,response to L-glutamine,BP,
18977,GO:1904845,1,0.946728469610716,0,2,cellular response to L-glutamine,BP,
18978,GO:1904847,1,0.904588072325358,0,3,regulation of cell chemotaxis to fibroblast growth factor,BP,
18979,GO:1904849,1,0.934821715755845,0,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
18980,GO:1904850,1,0.969171428582719,0,1,negative regulation of establishment of protein localization to telomere,BP,
18981,GO:1904851,1,0.766426231305471,0,9,positive regulation of establishment of protein localization to telomere,BP,
18982,GO:1904854,1,0.968629998116401,0,1,proteasome core complex binding,MF,
18983,GO:1904861,1,0.797925126432885,0,7,excitatory synapse assembly,BP,
18984,GO:1904862,1,0.935007916595613,0,2,inhibitory synapse assembly,BP,
18985,GO:1904867,1,0.767522309522777,0,9,protein localization to Cajal body,BP,
18986,GO:1904868,1,0.934655075274389,0,2,telomerase catalytic core complex assembly,BP,
18987,GO:1904869,1,0.789506104838419,0,8,regulation of protein localization to Cajal body,BP,
18988,GO:1904871,1,0.789506104838419,0,8,positive regulation of protein localization to Cajal body,BP,
18989,GO:1904872,1,0.589280695712546,0,18,regulation of telomerase RNA localization to Cajal body,BP,
18990,GO:1904874,1,0.648929647772108,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
18991,GO:1904875,1,0.941570590236149,0,2,regulation of DNA ligase activity,BP,
18992,GO:1904876,1,0.969256884090773,0,1,negative regulation of DNA ligase activity,BP,
18993,GO:1904877,1,0.971437956199064,0,1,positive regulation of DNA ligase activity,BP,
18994,GO:1904878,1,0.966758703182479,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
18996,GO:1904880,1,0.941091420067498,0,2,response to hydrogen sulfide,BP,
18997,GO:1904881,1,0.969857264588559,0,1,cellular response to hydrogen sulfide,BP,
18998,GO:1904882,1,0.934655075274389,0,2,regulation of telomerase catalytic core complex assembly,BP,
18999,GO:1904884,1,0.934655075274389,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
19000,GO:1904885,1,0.849797884180808,0,5,beta-catenin destruction complex assembly,BP,
19001,GO:1904886,1,0.564025593774202,0,18,beta-catenin destruction complex disassembly,BP,
19002,GO:1904888,1,0.230846755038994,0,46,cranial skeletal system development,BP,
19003,GO:1904889,1,0.972561016164289,0,1,regulation of excitatory synapse assembly,BP,
19004,GO:1904891,1,0.972561016164289,0,1,positive regulation of excitatory synapse assembly,BP,
19006,GO:1904893,1,0.360392105736475,0,33,negative regulation of STAT cascade,BP,
19008,GO:1904895,1,0.972681784184379,0,1,ESCRT complex assembly,BP,
19009,GO:1904896,1,0.739237685848622,0,10,ESCRT complex disassembly,BP,
19010,GO:1904902,1,0.972681784184379,0,1,ESCRT III complex assembly,BP,
19011,GO:1904903,1,0.739237685848622,0,10,ESCRT III complex disassembly,BP,
19012,GO:1904907,1,0.93462307427368,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19013,GO:1904908,1,0.93462307427368,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
19014,GO:1904910,1,0.969171428582719,0,1,regulation of establishment of RNA localization to telomere,BP,
19015,GO:1904911,1,0.969171428582719,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19016,GO:1904913,1,0.969171428582719,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19017,GO:1904914,1,0.969171428582719,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
19019,GO:1904924,1,0.970577892257981,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19021,GO:1904928,1,0.93477956113179,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
19022,GO:1904929,1,0.822624045052417,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
19023,GO:1904933,1,0.966872720920993,0,1,regulation of cell proliferation in midbrain,BP,
19024,GO:1904934,1,0.966872720920993,0,1,negative regulation of cell proliferation in midbrain,BP,
19025,GO:1904938,1,0.847430368259288,0,5,planar cell polarity pathway involved in axon guidance,BP,
19026,GO:1904947,1,0.968968126026372,0,1,folic acid import into mitochondrion,BP,
19027,GO:1904948,1,0.731379933341713,0,10,midbrain dopaminergic neuron differentiation,BP,
19028,GO:1904949,1,0.0787500740132073,0,81,ATPase complex,CC,
19031,GO:1904953,1,0.777799273285621,0,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19032,GO:1904954,1,0.942156798132927,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19033,GO:1904955,1,0.966872720920993,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19034,GO:1904956,1,0.886070004448571,0,4,regulation of midbrain dopaminergic neuron differentiation,BP,
19035,GO:1904958,1,0.916192324664021,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
19036,GO:1904959,1,0.942765171879605,0,2,regulation of cytochrome-c oxidase activity,BP,
19037,GO:1904960,1,0.975136865315259,0,1,positive regulation of cytochrome-c oxidase activity,BP,
19038,GO:1904970,1,0.938342333556397,0,2,brush border assembly,BP,
19039,GO:1904971,1,0.967053800300271,0,1,regulation of viral translation,BP,
19040,GO:1904973,1,0.967053800300271,0,1,positive regulation of viral translation,BP,
19041,GO:1904975,1,0.935511606052758,0,2,response to bleomycin,BP,
19042,GO:1904976,1,0.935511606052758,0,2,cellular response to bleomycin,BP,
19043,GO:1904977,1,0.969302166061177,0,1,lymphatic endothelial cell migration,BP,
19044,GO:1904978,1,0.907900724730234,0,3,regulation of endosome organization,BP,
19045,GO:1904979,1,0.971087449616734,0,1,negative regulation of endosome organization,BP,
19046,GO:1904980,1,0.966840303383937,0,1,positive regulation of endosome organization,BP,
19047,GO:1904983,1,0.971402733249927,0,1,glycine import into mitochondrion,BP,
19048,GO:1904990,1,0.970482153549755,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19049,GO:1904992,1,0.970482153549755,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19051,GO:1904995,1,0.944446008449749,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
19053,GO:1904997,1,0.96917953594209,0,1,regulation of leukocyte adhesion to arterial endothelial cell,BP,
19054,GO:1904998,1,0.96917953594209,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
19055,GO:1905000,1,0.966804312815079,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
19056,GO:1905005,1,0.825007029343645,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19057,GO:1905006,1,0.939917608125833,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19058,GO:1905007,1,0.848706663177474,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
19060,GO:1905026,1,0.967494934004289,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19062,GO:1905033,1,0.967494934004289,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
19063,GO:1905034,1,0.969186499754276,0,1,regulation of antifungal innate immune response,BP,
19064,GO:1905035,1,0.969186499754276,0,1,negative regulation of antifungal innate immune response,BP,
19069,GO:1905041,1,0.938847849768765,0,2,regulation of epithelium regeneration,BP,
19070,GO:1905042,1,0.971060890270179,0,1,negative regulation of epithelium regeneration,BP,
19071,GO:1905044,1,0.969271124374127,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19072,GO:1905045,1,0.969271124374127,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19073,GO:1905048,1,0.668523702876033,0,13,regulation of metallopeptidase activity,BP,
19074,GO:1905049,1,0.824909887420069,0,6,negative regulation of metallopeptidase activity,BP,
19075,GO:1905050,1,0.810510109655698,0,7,positive regulation of metallopeptidase activity,BP,
19076,GO:1905051,1,0.947548434283015,0,2,regulation of base-excision repair,BP,
19077,GO:1905053,1,0.947548434283015,0,2,positive regulation of base-excision repair,BP,
19078,GO:1905062,1,0.969734197968282,0,1,positive regulation of cardioblast proliferation,BP,
19079,GO:1905063,1,0.856674247561718,0,5,regulation of vascular smooth muscle cell differentiation,BP,
19080,GO:1905064,1,0.938201248613005,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
19081,GO:1905065,1,0.913117369152999,0,3,positive regulation of vascular smooth muscle cell differentiation,BP,
19082,GO:1905066,1,0.943848419840547,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
19083,GO:1905067,1,0.972322080150554,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
19084,GO:1905068,1,0.970718037632591,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
19085,GO:1905069,1,0.967440622921063,0,1,allantois development,BP,
19086,GO:1905071,1,0.936533515731258,0,2,occluding junction disassembly,BP,
19087,GO:1905073,1,0.936533515731258,0,2,regulation of occluding junction disassembly,BP,
19088,GO:1905075,1,0.936533515731258,0,2,positive regulation of occluding junction disassembly,BP,
19089,GO:1905076,1,0.971824351676263,0,1,regulation of interleukin-17 secretion,BP,
19090,GO:1905077,1,0.971824351676263,0,1,negative regulation of interleukin-17 secretion,BP,
19091,GO:1905089,1,0.966717523131924,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19092,GO:1905090,1,0.966717523131924,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19093,GO:1905097,1,0.825797920690544,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
19094,GO:1905098,1,0.883410249008812,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
19095,GO:1905099,1,0.966859128570501,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
19096,GO:1905103,1,0.967466877993906,0,1,integral component of lysosomal membrane,CC,
19098,GO:1905123,1,0.935543001236353,0,2,regulation of glucosylceramidase activity,BP,
19099,GO:1905132,1,0.968953988832333,0,1,regulation of meiotic chromosome separation,BP,
19100,GO:1905133,1,0.968953988832333,0,1,negative regulation of meiotic chromosome separation,BP,
19101,GO:1905143,1,0.972958899086395,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
19102,GO:1905144,1,0.693241313392785,0,12,response to acetylcholine,BP,
19103,GO:1905145,1,0.693241313392785,0,12,cellular response to acetylcholine,BP,
19104,GO:1905146,1,0.755805390066453,0,9,lysosomal protein catabolic process,BP,
19105,GO:1905150,1,0.935102231767415,0,2,regulation of voltage-gated sodium channel activity,BP,
19106,GO:1905152,1,0.966870861231927,0,1,positive regulation of voltage-gated sodium channel activity,BP,
19109,GO:1905155,1,0.851761614742074,0,5,positive regulation of membrane invagination,BP,
19112,GO:1905165,1,0.825327542452538,0,6,regulation of lysosomal protein catabolic process,BP,
19113,GO:1905166,1,0.909812482006281,0,3,negative regulation of lysosomal protein catabolic process,BP,
19114,GO:1905167,1,0.934661050348219,0,2,positive regulation of lysosomal protein catabolic process,BP,
19115,GO:1905168,1,0.967795043925949,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19118,GO:1905172,1,0.967053800300271,0,1,RISC complex binding,MF,
19119,GO:1905174,1,0.942318709292352,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19120,GO:1905176,1,0.969303365112211,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
19121,GO:1905202,1,0.938961912134006,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
19122,GO:1905203,1,0.941362711567988,0,2,regulation of connective tissue replacement,BP,
19123,GO:1905204,1,0.97344752401555,0,1,negative regulation of connective tissue replacement,BP,
19124,GO:1905205,1,0.967042410544309,0,1,positive regulation of connective tissue replacement,BP,
19125,GO:1905206,1,0.856551596195155,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
19129,GO:1905214,1,0.713030303998376,0,11,regulation of RNA binding,BP,
19130,GO:1905215,1,0.972490396683953,0,1,negative regulation of RNA binding,BP,
19131,GO:1905216,1,0.782591298835741,0,8,positive regulation of RNA binding,BP,
19132,GO:1905222,1,0.968734077104336,0,1,atrioventricular canal morphogenesis,BP,
19133,GO:1905223,1,0.966859102709492,0,1,epicardium morphogenesis,BP,
19135,GO:1905232,1,0.880191582184023,0,4,cellular response to L-glutamate,BP,
19136,GO:1905242,1,0.96827818880457,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
19137,GO:1905244,1,0.773276049035499,0,8,regulation of modification of synaptic structure,BP,
19139,GO:1905246,1,0.938542595967806,0,2,negative regulation of aspartic-type peptidase activity,BP,
19141,GO:1905255,1,0.966856649013832,0,1,regulation of RNA binding transcription factor activity,BP,
19142,GO:1905258,1,0.94794641164482,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19143,GO:1905259,1,0.94794641164482,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19144,GO:1905267,1,0.939688152745642,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
19147,GO:1905271,1,0.974803166203612,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19148,GO:1905273,1,0.974803166203612,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
19149,GO:1905274,1,0.96683706223508,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19150,GO:1905276,1,0.597291953048934,0,16,regulation of epithelial tube formation,BP,
19151,GO:1905277,1,0.968876803468708,0,1,negative regulation of epithelial tube formation,BP,
19152,GO:1905278,1,0.913078592102041,0,3,positive regulation of epithelial tube formation,BP,
19153,GO:1905279,1,0.969271124374127,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19154,GO:1905285,1,0.967910767110477,0,1,fibrous ring of heart morphogenesis,BP,
19155,GO:1905286,1,0.94217365974953,0,2,serine-type peptidase complex,CC,
19156,GO:1905288,1,0.850713113099343,0,5,vascular associated smooth muscle cell apoptotic process,BP,
19157,GO:1905292,1,0.90958025499723,0,3,regulation of neural crest cell differentiation,BP,
19158,GO:1905294,1,0.90958025499723,0,3,positive regulation of neural crest cell differentiation,BP,
19159,GO:1905301,1,0.96708790686349,0,1,regulation of macropinocytosis,BP,
19160,GO:1905302,1,0.96708790686349,0,1,negative regulation of macropinocytosis,BP,
19161,GO:1905304,1,0.966798584676304,0,1,regulation of cardiac myofibril assembly,BP,
19162,GO:1905305,1,0.966798584676304,0,1,negative regulation of cardiac myofibril assembly,BP,
19163,GO:1905309,1,0.966765759377405,0,1,positive regulation of cohesin loading,BP,
19164,GO:1905310,1,0.90958025499723,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19165,GO:1905312,1,0.90958025499723,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19166,GO:1905313,1,0.971181875985849,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19167,GO:1905314,1,0.749982954406963,0,9,semi-lunar valve development,BP,
19168,GO:1905317,1,0.967037689005993,0,1,inferior endocardial cushion morphogenesis,BP,
19169,GO:1905319,1,0.969271124374127,0,1,mesenchymal stem cell migration,BP,
19170,GO:1905320,1,0.969271124374127,0,1,regulation of mesenchymal stem cell migration,BP,
19171,GO:1905322,1,0.969271124374127,0,1,positive regulation of mesenchymal stem cell migration,BP,
19174,GO:1905331,1,0.657534943932856,0,13,negative regulation of morphogenesis of an epithelium,BP,
19176,GO:1905333,1,0.947869763314347,0,2,regulation of gastric motility,BP,
19177,GO:1905335,1,0.96669046341227,0,1,regulation of aggrephagy,BP,
19178,GO:1905337,1,0.96669046341227,0,1,positive regulation of aggrephagy,BP,
19179,GO:1905340,1,0.88786165418459,0,4,regulation of protein localization to kinetochore,BP,
19180,GO:1905341,1,0.96981148692978,0,1,negative regulation of protein localization to kinetochore,BP,
19181,GO:1905342,1,0.88786165418459,0,4,positive regulation of protein localization to kinetochore,BP,
19182,GO:1905344,1,0.969271124374127,0,1,prostaglandin catabolic process,BP,
19184,GO:1905349,1,0.973747132258135,0,1,ciliary transition zone assembly,BP,
19185,GO:1905354,1,0.521077735122229,0,22,exoribonuclease complex,CC,
19186,GO:1905355,1,0.966916705902753,0,1,spine apparatus assembly,BP,
19187,GO:1905359,1,0.968953988832333,0,1,protein localization to meiotic spindle,BP,
19188,GO:1905360,1,0.54348314669911,0,20,GTPase complex,CC,
19189,GO:1905365,1,0.971087449616734,0,1,regulation of intralumenal vesicle formation,BP,
19190,GO:1905366,1,0.971087449616734,0,1,negative regulation of intralumenal vesicle formation,BP,
19193,GO:1905370,1,0.970577892257981,0,1,serine-type endopeptidase complex,CC,
19194,GO:1905371,1,0.940834586701284,0,2,ceramide phosphoethanolamine metabolic process,BP,
19195,GO:1905373,1,0.940834586701284,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
19196,GO:1905383,1,0.918386025191039,0,3,protein localization to presynapse,BP,
19197,GO:1905384,1,0.942579473441609,0,2,regulation of protein localization to presynapse,BP,
19198,GO:1905386,1,0.942579473441609,0,2,positive regulation of protein localization to presynapse,BP,
19199,GO:1905392,1,0.974543632249742,0,1,plant organ morphogenesis,BP,
19200,GO:1905394,1,0.911134467767708,0,3,retromer complex binding,MF,
19201,GO:1905395,1,0.942536446837297,0,2,response to flavonoid,BP,
19204,GO:1905403,1,0.971824351676263,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
19206,GO:1905405,1,0.966765759377405,0,1,regulation of mitotic cohesin loading,BP,
19207,GO:1905406,1,0.966765759377405,0,1,positive regulation of mitotic cohesin loading,BP,
19208,GO:1905407,1,0.96844774274042,0,1,regulation of creatine transmembrane transporter activity,BP,
19209,GO:1905408,1,0.96844774274042,0,1,negative regulation of creatine transmembrane transporter activity,BP,
19210,GO:1905419,1,0.972249895030127,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
19211,GO:1905421,1,0.974543632249742,0,1,regulation of plant organ morphogenesis,BP,
19212,GO:1905422,1,0.974543632249742,0,1,negative regulation of plant organ morphogenesis,BP,
19213,GO:1905424,1,0.942276784201444,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19214,GO:1905426,1,0.942276784201444,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19215,GO:1905429,1,0.971546262232685,0,1,response to glycine,BP,
19216,GO:1905430,1,0.971546262232685,0,1,cellular response to glycine,BP,
19217,GO:1905435,1,0.969271124374127,0,1,regulation of histone H3-K4 trimethylation,BP,
19218,GO:1905437,1,0.969271124374127,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19219,GO:1905438,1,0.966872720920993,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19220,GO:1905443,1,0.96711183140415,0,1,regulation of clathrin coat assembly,BP,
19221,GO:1905445,1,0.96711183140415,0,1,positive regulation of clathrin coat assembly,BP,
19222,GO:1905446,1,0.864715488957465,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19223,GO:1905447,1,0.968670178669023,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19224,GO:1905448,1,0.892691937146966,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19225,GO:1905449,1,0.939946330297141,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19226,GO:1905451,1,0.939946330297141,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19227,GO:1905456,1,0.803244916449258,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19228,GO:1905457,1,0.915962952445756,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
19229,GO:1905458,1,0.967495917243086,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19230,GO:1905459,1,0.850713113099343,0,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,
19231,GO:1905461,1,0.850713113099343,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
19232,GO:1905462,1,0.935338499055339,0,2,regulation of DNA duplex unwinding,BP,
19233,GO:1905463,1,0.966875672694054,0,1,negative regulation of DNA duplex unwinding,BP,
19234,GO:1905464,1,0.96738534365555,0,1,positive regulation of DNA duplex unwinding,BP,
19237,GO:1905474,1,0.973096753104129,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
19239,GO:1905476,1,0.5029872553314,0,22,negative regulation of protein localization to membrane,BP,
19241,GO:1905502,1,0.973764550524753,0,1,acetyl-CoA binding,MF,
19243,GO:1905515,1,0.230053031382445,0,47,non-motile cilium assembly,BP,
19244,GO:1905516,1,0.860776924080228,0,5,positive regulation of fertilization,BP,
19246,GO:1905521,1,0.635039587392228,0,15,regulation of macrophage migration,BP,
19247,GO:1905522,1,0.893555560007965,0,4,negative regulation of macrophage migration,BP,
19248,GO:1905523,1,0.782519969209083,0,8,positive regulation of macrophage migration,BP,
19249,GO:1905524,1,0.966825242880288,0,1,negative regulation of protein autoubiquitination,BP,
19250,GO:1905535,1,0.966904115245289,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19251,GO:1905537,1,0.966904115245289,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19252,GO:1905538,1,0.937334642652903,0,2,polysome binding,MF,
19253,GO:1905547,1,0.972752451305582,0,1,regulation of telomeric heterochromatin assembly,BP,
19254,GO:1905549,1,0.972752451305582,0,1,positive regulation of telomeric heterochromatin assembly,BP,
19255,GO:1905550,1,0.944886495010371,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19256,GO:1905552,1,0.944886495010371,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
19257,GO:1905553,1,0.915559342612374,0,3,regulation of blood vessel branching,BP,
19258,GO:1905555,1,0.940530751799888,0,2,positive regulation blood vessel branching,BP,
19259,GO:1905562,1,0.703406745615337,0,11,regulation of vascular endothelial cell proliferation,BP,
19260,GO:1905563,1,0.972172812265828,0,1,negative regulation of vascular endothelial cell proliferation,BP,
19261,GO:1905564,1,0.723558976751507,0,10,positive regulation of vascular endothelial cell proliferation,BP,
19262,GO:1905572,1,0.969406683426019,0,1,ganglioside GM1 transport to membrane,BP,
19263,GO:1905573,1,0.942275525278414,0,2,ganglioside GM1 binding,MF,
19264,GO:1905574,1,0.969406683426019,0,1,ganglioside GM2 binding,MF,
19265,GO:1905575,1,0.969406683426019,0,1,ganglioside GM3 binding,MF,
19266,GO:1905576,1,0.942275525278414,0,2,ganglioside GT1b binding,MF,
19267,GO:1905577,1,0.969406683426019,0,1,ganglioside GP1c binding,MF,
19268,GO:1905578,1,0.970472033429008,0,1,regulation of ERBB3 signaling pathway,BP,
19269,GO:1905580,1,0.970472033429008,0,1,positive regulation of ERBB3 signaling pathway,BP,
19270,GO:1905581,1,0.972753704663536,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19271,GO:1905590,1,0.968747232938517,0,1,fibronectin fibril organization,BP,
19272,GO:1905594,1,0.973865752459095,0,1,resveratrol binding,MF,
19273,GO:1905595,1,0.941509801519631,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19274,GO:1905596,1,0.967883366036458,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19275,GO:1905597,1,0.972753704663536,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19276,GO:1905598,1,0.967883366036458,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19277,GO:1905599,1,0.972753704663536,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
19278,GO:1905600,1,0.912474237432561,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19279,GO:1905601,1,0.967883366036458,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19280,GO:1905602,1,0.94275723701701,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
19281,GO:1905606,1,0.90703588401745,0,3,regulation of presynapse assembly,BP,
19282,GO:1905610,1,0.966904115245289,0,1,regulation of mRNA cap binding,BP,
19283,GO:1905612,1,0.966904115245289,0,1,positive regulation of mRNA cap binding,BP,
19284,GO:1905616,1,0.937189545450763,0,2,regulation of miRNA mediated inhibition of translation,BP,
19285,GO:1905618,1,0.937189545450763,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
19286,GO:1905634,1,0.826109817506487,0,6,regulation of protein localization to chromatin,BP,
19287,GO:1905636,1,0.973638127989234,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19288,GO:1905642,1,0.969271124374127,0,1,negative regulation of DNA methylation,BP,
19289,GO:1905643,1,0.966869357670083,0,1,positive regulation of DNA methylation,BP,
19290,GO:1905647,1,0.970397080614669,0,1,proline import across plasma membrane,BP,
19291,GO:1905651,1,0.906918149982651,0,3,regulation of artery morphogenesis,BP,
19292,GO:1905653,1,0.906918149982651,0,3,positive regulation of artery morphogenesis,BP,
19293,GO:1905661,1,0.940050921839898,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19294,GO:1905663,1,0.940050921839898,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
19295,GO:1905664,1,0.942080518505935,0,2,regulation of calcium ion import across plasma membrane,BP,
19296,GO:1905666,1,0.745870351422373,0,9,regulation of protein localization to endosome,BP,
19297,GO:1905668,1,0.745870351422373,0,9,positive regulation of protein localization to endosome,BP,
19298,GO:1905671,1,0.912102848886086,0,3,regulation of lysosome organization,BP,
19299,GO:1905672,1,0.971332173289546,0,1,negative regulation of lysosome organization,BP,
19300,GO:1905687,1,0.966874544680097,0,1,regulation of diacylglycerol kinase activity,BP,
19301,GO:1905689,1,0.966874544680097,0,1,positive regulation of diacylglycerol kinase activity,BP,
19302,GO:1905696,1,0.935045417610694,0,2,regulation of polysome binding,BP,
19303,GO:1905698,1,0.967053800300271,0,1,positive regulation of polysome binding,BP,
19304,GO:1905705,1,0.9668440137745,0,1,cellular response to paclitaxel,BP,
19305,GO:1905709,1,0.867442749970482,0,5,negative regulation of membrane permeability,BP,
19307,GO:1905711,1,0.967682878933317,0,1,response to phosphatidylethanolamine,BP,
19310,GO:1905719,1,0.939723740432566,0,2,protein localization to perinuclear region of cytoplasm,BP,
19311,GO:1905720,1,0.966837517356414,0,1,cytoplasmic microtubule bundle,CC,
19312,GO:1905764,1,0.90954389962199,0,3,regulation of protection from non-homologous end joining at telomere,BP,
19313,GO:1905765,1,0.90954389962199,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
19314,GO:1905767,1,0.966848633589569,0,1,regulation of double-stranded telomeric DNA binding,BP,
19315,GO:1905768,1,0.966848633589569,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
19316,GO:1905770,1,0.90994189066669,0,3,regulation of mesodermal cell differentiation,BP,
19317,GO:1905771,1,0.972322080150554,0,1,negative regulation of mesodermal cell differentiation,BP,
19318,GO:1905773,1,0.90455043155921,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
19319,GO:1905774,1,0.96738534365555,0,1,regulation of DNA helicase activity,BP,
19320,GO:1905776,1,0.96738534365555,0,1,positive regulation of DNA helicase activity,BP,
19321,GO:1905777,1,0.910834708776692,0,3,regulation of exonuclease activity,BP,
19322,GO:1905778,1,0.939371268088885,0,2,negative regulation of exonuclease activity,BP,
19323,GO:1905779,1,0.969626763580086,0,1,positive regulation of exonuclease activity,BP,
19324,GO:1905793,1,0.934796952435977,0,2,protein localization to pericentriolar material,BP,
19325,GO:1905794,1,0.966766892474835,0,1,response to puromycin,BP,
19326,GO:1905795,1,0.966766892474835,0,1,cellular response to puromycin,BP,
19327,GO:1905799,1,0.974724168030539,0,1,regulation of intraciliary retrograde transport,BP,
19328,GO:1905809,1,0.706188356165023,0,11,negative regulation of synapse organization,BP,
19331,GO:1905820,1,0.75594580389481,0,9,positive regulation of chromosome separation,BP,
19332,GO:1905832,1,0.876271538895811,0,4,positive regulation of spindle assembly,BP,
19333,GO:1905838,1,0.939371268088885,0,2,regulation of telomeric D-loop disassembly,BP,
19334,GO:1905839,1,0.939371268088885,0,2,negative regulation of telomeric D-loop disassembly,BP,
19335,GO:1905843,1,0.966743835328959,0,1,regulation of cellular response to gamma radiation,BP,
19336,GO:1905853,1,0.973791068722543,0,1,regulation of heparan sulfate binding,BP,
19337,GO:1905855,1,0.973791068722543,0,1,positive regulation of heparan sulfate binding,BP,
19338,GO:1905858,1,0.973791068722543,0,1,regulation of heparan sulfate proteoglycan binding,BP,
19339,GO:1905860,1,0.973791068722543,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
19340,GO:1905863,1,0.937480847553412,0,2,invadopodium organization,BP,
19341,GO:1905867,1,0.915624943614452,0,3,epididymis development,BP,
19342,GO:1905874,1,0.939997285272392,0,2,regulation of postsynaptic density organization,BP,
19343,GO:1905878,1,0.966774335944083,0,1,invadopodium disassembly,BP,
19344,GO:1905879,1,0.831320875984462,0,6,regulation of oogenesis,BP,
19345,GO:1905880,1,0.968174685271712,0,1,negative regulation of oogenesis,BP,
19346,GO:1905881,1,0.912514921291168,0,3,positive regulation of oogenesis,BP,
19347,GO:1905890,1,0.973791068722543,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
19348,GO:1905891,1,0.969382123670748,0,1,regulation of cellular response to thapsigargin,BP,
19349,GO:1905892,1,0.969382123670748,0,1,negative regulation of cellular response to thapsigargin,BP,
19350,GO:1905894,1,0.969382123670748,0,1,regulation of cellular response to tunicamycin,BP,
19351,GO:1905895,1,0.969382123670748,0,1,negative regulation of cellular response to tunicamycin,BP,
19354,GO:1905902,1,0.90994189066669,0,3,regulation of mesoderm formation,BP,
19355,GO:1905903,1,0.972322080150554,0,1,negative regulation of mesoderm formation,BP,
19358,GO:1905908,1,0.883593950364004,0,4,positive regulation of amyloid fibril formation,BP,
19359,GO:1905912,1,0.972212830762555,0,1,regulation of calcium ion export across plasma membrane,BP,
19360,GO:1905913,1,0.972212830762555,0,1,negative regulation of calcium ion export across plasma membrane,BP,
19361,GO:1905918,1,0.971302735357196,0,1,regulation of CoA-transferase activity,BP,
19362,GO:1905920,1,0.971302735357196,0,1,positive regulation of CoA-transferase activity,BP,
19363,GO:1905927,1,0.966774335944083,0,1,regulation of invadopodium disassembly,BP,
19364,GO:1905929,1,0.966774335944083,0,1,positive regulation of invadopodium disassembly,BP,
19365,GO:1905936,1,0.949129434784061,0,2,regulation of germ cell proliferation,BP,
19366,GO:1905937,1,0.97428565064263,0,1,negative regulation of germ cell proliferation,BP,
19367,GO:1905938,1,0.974181664334021,0,1,positive regulation of germ cell proliferation,BP,
19369,GO:1905940,1,0.911272403133572,0,3,negative regulation of gonad development,BP,
19371,GO:1905942,1,0.970472033429008,0,1,regulation of formation of growth cone in injured axon,BP,
19372,GO:1905943,1,0.970472033429008,0,1,negative regulation of formation of growth cone in injured axon,BP,
19376,GO:1905957,1,0.967193497595987,0,1,regulation of cellular response to alcohol,BP,
19377,GO:1905959,1,0.967193497595987,0,1,positive regulation of cellular response to alcohol,BP,
19381,GO:1990003,1,0.966867738967312,0,1,IDP phosphatase activity,MF,
19382,GO:1990005,1,0.942675581790794,0,2,granular vesicle,CC,
19383,GO:1990008,1,0.972563614139016,0,1,neurosecretory vesicle,CC,
19384,GO:1990009,1,0.966900162003065,0,1,retinal cell apoptotic process,BP,
19385,GO:1990023,1,0.660782565032851,0,13,mitotic spindle midzone,CC,
19386,GO:1990026,1,0.968040838393232,0,1,hippocampal mossy fiber expansion,CC,
19387,GO:1990029,1,0.968680067927164,0,1,vasomotion,BP,
19388,GO:1990031,1,0.968686018307077,0,1,pinceau fiber,CC,
19389,GO:1990032,1,0.967119255016035,0,1,parallel fiber,CC,
19390,GO:1990034,1,0.911088375058124,0,3,calcium ion export across plasma membrane,BP,
19391,GO:1990036,1,0.966811552121987,0,1,calcium ion import into sarcoplasmic reticulum,BP,
19393,GO:1990038,1,0.971888734846851,0,1,Lewy body corona,CC,
19394,GO:1990046,1,0.973583217915054,0,1,stress-induced mitochondrial fusion,BP,
19395,GO:1990047,1,0.970948803965608,0,1,spindle matrix,CC,
19396,GO:1990048,1,0.969271124374127,0,1,anterograde neuronal dense core vesicle transport,BP,
19397,GO:1990050,1,0.841649247102274,0,6,phosphatidic acid transporter activity,MF,
19398,GO:1990051,1,0.966878212105565,0,1,activation of protein kinase C activity,BP,
19399,GO:1990070,1,0.974562825664607,0,1,TRAPPI protein complex,CC,
19400,GO:1990071,1,0.942247069450418,0,2,TRAPPII protein complex,CC,
19401,GO:1990072,1,0.94461351850891,0,2,TRAPPIII protein complex,CC,
19402,GO:1990074,1,0.968064129622975,0,1,polyuridylation-dependent mRNA catabolic process,BP,
19403,GO:1990075,1,0.907365688546201,0,3,periciliary membrane compartment,CC,
19404,GO:1990086,1,0.906747115575404,0,3,lens fiber cell apoptotic process,BP,
19409,GO:1990112,1,0.939484005877423,0,2,RQC complex,CC,
19410,GO:1990116,1,0.939484005877423,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19411,GO:1990117,1,0.974487401152989,0,1,B cell receptor apoptotic signaling pathway,BP,
19412,GO:1990124,1,0.798300754995234,0,7,messenger ribonucleoprotein complex,CC,
19413,GO:1990126,1,0.606294052293609,0,16,retrograde transport, endosome to plasma membrane,BP,
19414,GO:1990127,1,0.967304174340643,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19415,GO:1990130,1,0.856486280074952,0,5,GATOR1 complex,CC,
19416,GO:1990131,1,0.919506668838006,0,3,Gtr1-Gtr2 GTPase complex,CC,
19417,GO:1990134,1,0.966932789112878,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
19418,GO:1990136,1,0.970274086466285,0,1,linoleate 9S-lipoxygenase activity,MF,
19420,GO:1990144,1,0.836751865599414,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
19421,GO:1990145,1,0.937855463682709,0,2,maintenance of translational fidelity,BP,
19422,GO:1990164,1,0.939195127905616,0,2,histone H2A phosphorylation,BP,
19423,GO:1990165,1,0.971709085988543,0,1,single-strand break-containing DNA binding,MF,
19424,GO:1990166,1,0.911961177753991,0,3,protein localization to site of double-strand break,BP,
19425,GO:1990167,1,0.909224957312091,0,3,protein K27-linked deubiquitination,BP,
19426,GO:1990168,1,0.909316311259778,0,3,protein K33-linked deubiquitination,BP,
19427,GO:1990169,1,0.873301164775957,0,5,stress response to copper ion,BP,
19428,GO:1990170,1,0.971726436549267,0,1,stress response to cadmium ion,BP,
19429,GO:1990172,1,0.966871698975116,0,1,G-protein coupled receptor catabolic process,BP,
19430,GO:1990173,1,0.742116848615157,0,10,protein localization to nucleoplasm,BP,
19431,GO:1990174,1,0.967620588791187,0,1,phosphodiesterase decapping endonuclease activity,MF,
19432,GO:1990175,1,0.967540232229231,0,1,EH domain binding,MF,
19433,GO:1990179,1,0.907992806407244,0,3,protein localization to actomyosin contractile ring,BP,
19434,GO:1990180,1,0.916867822433833,0,3,mitochondrial tRNA 3'-end processing,BP,
19435,GO:1990182,1,0.598170620796598,0,17,exosomal secretion,BP,
19436,GO:1990188,1,0.969956655382347,0,1,euchromatin binding,MF,
19437,GO:1990189,1,0.943519600390945,0,2,peptide-serine-N-acetyltransferase activity,MF,
19438,GO:1990190,1,0.974353186685951,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
19439,GO:1990204,1,0.0806845422653186,0,88,oxidoreductase complex,CC,
19442,GO:1990239,1,0.883032048793299,0,4,steroid hormone binding,MF,
19443,GO:1990246,1,0.882620775853877,0,4,uniplex complex,CC,
19444,GO:1990247,1,0.795497545327416,0,7,N6-methyladenosine-containing RNA binding,MF,
19445,GO:1990253,1,0.751115875635554,0,9,cellular response to leucine starvation,BP,
19446,GO:1990254,1,0.884015909349386,0,4,keratin filament binding,MF,
19447,GO:1990256,1,0.96672765123916,0,1,signal clustering,BP,
19448,GO:1990258,1,0.973811368227514,0,1,histone glutamine methylation,BP,
19449,GO:1990259,1,0.973811368227514,0,1,histone-glutamine methyltransferase activity,MF,
19450,GO:1990261,1,0.969271124374127,0,1,pre-mRNA catabolic process,BP,
19451,GO:1990262,1,0.969631952040813,0,1,anti-Mullerian hormone signaling pathway,BP,
19452,GO:1990264,1,0.940361917121702,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
19454,GO:1990269,1,0.939205902527285,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
19455,GO:1990275,1,0.969286613066286,0,1,preribosome binding,MF,
19456,GO:1990280,1,0.966847112481757,0,1,RNA localization to chromatin,BP,
19457,GO:1990298,1,0.971321872275029,0,1,bub1-bub3 complex,CC,
19458,GO:1990314,1,0.77817608497982,0,8,cellular response to insulin-like growth factor stimulus,BP,
19459,GO:1990316,1,0.771713507371269,0,8,Atg1/ULK1 kinase complex,CC,
19460,GO:1990332,1,0.967450840374247,0,1,Ire1 complex,CC,
19462,GO:1990356,1,0.973744051883864,0,1,sumoylated E2 ligase complex,CC,
19463,GO:1990357,1,0.915342058768495,0,3,terminal web,CC,
19464,GO:1990379,1,0.945759251419159,0,2,lipid transport across blood brain barrier,BP,
19466,GO:1990381,1,0.661241981221706,0,13,ubiquitin-specific protease binding,MF,
19467,GO:1990384,1,0.973581093466347,0,1,hyaloid vascular plexus regression,BP,
19468,GO:1990386,1,0.971832956093877,0,1,mitotic cleavage furrow ingression,BP,
19469,GO:1990390,1,0.968138171396349,0,1,protein K33-linked ubiquitination,BP,
19470,GO:1990391,1,0.321029331307682,0,36,DNA repair complex,CC,
19471,GO:1990393,1,0.850546491439995,0,5,3M complex,CC,
19472,GO:1990399,1,0.938847849768765,0,2,epithelium regeneration,BP,
19473,GO:1990401,1,0.969567497604305,0,1,embryonic lung development,BP,
19474,GO:1990402,1,0.971181875985849,0,1,embryonic liver development,BP,
19475,GO:1990403,1,0.776579643395398,0,8,embryonic brain development,BP,
19477,GO:1990405,1,0.878782611033581,0,4,protein antigen binding,MF,
19478,GO:1990406,1,0.942103295737847,0,2,CGRP receptor complex,CC,
19479,GO:1990407,1,0.974316793231571,0,1,calcitonin gene-related peptide binding,MF,
19480,GO:1990408,1,0.942103295737847,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
19481,GO:1990409,1,0.966939668707445,0,1,adrenomedullin binding,MF,
19482,GO:1990410,1,0.94103111945491,0,2,adrenomedullin receptor signaling pathway,BP,
19483,GO:1990414,1,0.882608578297821,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
19484,GO:1990415,1,0.911615676391595,0,3,Pex17p-Pex14p docking complex,CC,
19485,GO:1990416,1,0.824812776124731,0,6,cellular response to brain-derived neurotrophic factor stimulus,BP,
19487,GO:1990421,1,0.966742778732933,0,1,subtelomeric heterochromatin,CC,
19488,GO:1990423,1,0.90763739298048,0,3,RZZ complex,CC,
19489,GO:1990425,1,0.94132648576758,0,2,ryanodine receptor complex,CC,
19490,GO:1990426,1,0.938762237265855,0,2,mitotic recombination-dependent replication fork processing,BP,
19491,GO:1990428,1,0.935917065720325,0,2,miRNA transport,BP,
19492,GO:1990429,1,0.911615676391595,0,3,peroxisomal importomer complex,CC,
19494,GO:1990439,1,0.969141476350223,0,1,MAP kinase serine/threonine phosphatase activity,MF,
19497,GO:1990442,1,0.923591372662137,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
19498,GO:1990446,1,0.895376874355603,0,4,U1 snRNP binding,MF,
19499,GO:1990448,1,0.966852401878043,0,1,exon-exon junction complex binding,MF,
19500,GO:1990450,1,0.971508265038349,0,1,linear polyubiquitin binding,MF,
19501,GO:1990452,1,0.937329056716432,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
19502,GO:1990454,1,0.907651619642354,0,3,L-type voltage-gated calcium channel complex,CC,
19503,GO:1990456,1,0.967641927646083,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
19504,GO:1990459,1,0.834952075637742,0,6,transferrin receptor binding,MF,
19505,GO:1990460,1,0.911326553448114,0,3,leptin receptor binding,MF,
19506,GO:1990462,1,0.802606202563363,0,7,omegasome,CC,
19507,GO:1990481,1,0.888203099902243,0,4,mRNA pseudouridine synthesis,BP,
19508,GO:1990498,1,0.93474760081569,0,2,mitotic spindle microtubule,CC,
19509,GO:1990502,1,0.96686629219166,0,1,dense core granule maturation,BP,
19510,GO:1990504,1,0.904482222770437,0,3,dense core granule exocytosis,BP,
19511,GO:1990505,1,0.938762237265855,0,2,mitotic DNA replication maintenance of fidelity,BP,
19512,GO:1990511,1,0.878802422016914,0,4,piRNA biosynthetic process,BP,
19513,GO:1990518,1,0.967053800300271,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
19514,GO:1990519,1,0.941097083339995,0,2,pyrimidine nucleotide import into mitochondrion,BP,
19515,GO:1990523,1,0.96855706090163,0,1,bone regeneration,BP,
19516,GO:1990535,1,0.87750520771699,0,4,neuron projection maintenance,BP,
19518,GO:1990546,1,0.972839470589811,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
19519,GO:1990564,1,0.864008254233021,0,5,protein polyufmylation,BP,
19520,GO:1990565,1,0.972661419414799,0,1,HSP90-CDC37 chaperone complex,CC,
19521,GO:1990569,1,0.939121679295889,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
19522,GO:1990570,1,0.969271124374127,0,1,GDP-mannose transmembrane transport,BP,
19523,GO:1990572,1,0.975387957839165,0,1,TERT-RMRP complex,CC,
19524,GO:1990573,1,0.911825801272469,0,3,potassium ion import across plasma membrane,BP,
19525,GO:1990575,1,0.93909537631424,0,2,mitochondrial L-ornithine transmembrane transport,BP,
19526,GO:1990578,1,0.966873429031349,0,1,perinuclear endoplasmic reticulum membrane,CC,
19527,GO:1990579,1,0.967450840374247,0,1,peptidyl-serine trans-autophosphorylation,BP,
19528,GO:1990583,1,0.971832956093877,0,1,phospholipase D activator activity,MF,
19529,GO:1990589,1,0.9402339892695,0,2,ATF4-CREB1 transcription factor complex,CC,
19530,GO:1990590,1,0.943838180781505,0,2,ATF1-ATF4 transcription factor complex,CC,
19531,GO:1990592,1,0.864008254233021,0,5,protein K69-linked ufmylation,BP,
19532,GO:1990597,1,0.908445720426355,0,3,AIP1-IRE1 complex,CC,
19533,GO:1990599,1,0.90954389962199,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
19534,GO:1990603,1,0.968435086332893,0,1,dark adaptation,BP,
19535,GO:1990604,1,0.908245219893985,0,3,IRE1-TRAF2-ASK1 complex,CC,
19536,GO:1990613,1,0.968053573870318,0,1,mitochondrial membrane fusion,BP,
19537,GO:1990617,1,0.947563904448889,0,2,CHOP-ATF4 complex,CC,
19538,GO:1990619,1,0.941266565891632,0,2,histone H3-K9 deacetylation,BP,
19540,GO:1990630,1,0.967450840374247,0,1,IRE1-RACK1-PP2A complex,CC,
19541,GO:1990635,1,0.88276828768837,0,4,proximal dendrite,CC,
19542,GO:1990637,1,0.911149867206193,0,3,response to prolactin,BP,
19543,GO:1990641,1,0.939971413302112,0,2,response to iron ion starvation,BP,
19544,GO:1990646,1,0.969000986240046,0,1,cellular response to prolactin,BP,
19545,GO:1990654,1,0.966958645220431,0,1,sebum secreting cell proliferation,BP,
19546,GO:1990666,1,0.935843382297652,0,2,PCSK9-LDLR complex,CC,
19547,GO:1990667,1,0.941509801519631,0,2,PCSK9-AnxA2 complex,CC,
19549,GO:1990682,1,0.970512554479437,0,1,CSF1-CSF1R complex,CC,
19550,GO:1990698,1,0.940777528164613,0,2,palmitoleoyltransferase activity,MF,
19551,GO:1990700,1,0.967526924039313,0,1,nucleolar chromatin organization,BP,
19552,GO:1990705,1,0.966798560430869,0,1,cholangiocyte proliferation,BP,
19553,GO:1990707,1,0.966742778732933,0,1,nuclear subtelomeric heterochromatin,CC,
19555,GO:1990715,1,0.967416070932433,0,1,mRNA CDS binding,MF,
19556,GO:1990716,1,0.972553214748333,0,1,axonemal central apparatus,CC,
19557,GO:1990723,1,0.936714917617738,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
19558,GO:1990726,1,0.875802230327412,0,5,Lsm1-7-Pat1 complex,CC,
19559,GO:1990729,1,0.971884453653904,0,1,primary miRNA modification,BP,
19560,GO:1990730,1,0.936649526710676,0,2,VCP-NSFL1C complex,CC,
19561,GO:1990736,1,0.967404514182229,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
19562,GO:1990737,1,0.909757694143868,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
19563,GO:1990738,1,0.969271124374127,0,1,pseudouridine 5'-phosphatase activity,MF,
19564,GO:1990739,1,0.966798560430869,0,1,granulosa cell proliferation,BP,
19565,GO:1990742,1,0.942904943112281,0,2,microvesicle,CC,
19566,GO:1990743,1,0.913660383836791,0,3,protein sialylation,BP,
19567,GO:1990744,1,0.971884453653904,0,1,primary miRNA methylation,BP,
19568,GO:1990745,1,0.880266377640516,0,4,EARP complex,CC,
19570,GO:1990751,1,0.96683706223508,0,1,Schwann cell chemotaxis,BP,
19571,GO:1990752,1,0.44073646262151,0,25,microtubule end,CC,
19572,GO:1990755,1,0.969271124374127,0,1,mitotic spindle microtubule depolymerization,BP,
19573,GO:1990756,1,0.913811305806768,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
19574,GO:1990758,1,0.972237561519205,0,1,mitotic sister chromatid biorientation,BP,
19575,GO:1990761,1,0.939001794937529,0,2,growth cone lamellipodium,CC,
19576,GO:1990763,1,0.858429128635506,0,5,arrestin family protein binding,MF,
19577,GO:1990764,1,0.969702524821051,0,1,myofibroblast contraction,BP,
19578,GO:1990769,1,0.940688289988576,0,2,proximal neuron projection,CC,
19579,GO:1990771,1,0.966865927570967,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
19580,GO:1990773,1,0.972503543661223,0,1,matrix metallopeptidase secretion,BP,
19586,GO:1990784,1,0.967435102390078,0,1,response to dsDNA,BP,
19587,GO:1990785,1,0.905303170269504,0,3,response to water-immersion restraint stress,BP,
19588,GO:1990786,1,0.967435102390078,0,1,cellular response to dsDNA,BP,
19590,GO:1990796,1,0.969147216740997,0,1,photoreceptor cell terminal bouton,CC,
19591,GO:1990809,1,0.885838623740241,0,4,endoplasmic reticulum tubular network membrane organization,BP,
19592,GO:1990812,1,0.908179686904669,0,3,growth cone filopodium,CC,
19593,GO:1990817,1,0.970960595886097,0,1,RNA adenylyltransferase activity,MF,
19594,GO:1990822,1,0.882026666166818,0,4,basic amino acid transmembrane transport,BP,
19596,GO:1990825,1,0.734717146970029,0,10,sequence-specific mRNA binding,MF,
19597,GO:1990828,1,0.97130862450244,0,1,hepatocyte dedifferentiation,BP,
19599,GO:1990832,1,0.971671425417964,0,1,slow axonal transport,BP,
19600,GO:1990833,1,0.971671425417964,0,1,clathrin-uncoating ATPase activity,MF,
19601,GO:1990834,1,0.910714723053258,0,3,response to odorant,BP,
19603,GO:1990839,1,0.970866330437704,0,1,response to endothelin,BP,
19604,GO:1990841,1,0.345589549964542,0,33,promoter-specific chromatin binding,MF,
19605,GO:1990845,1,0.827330124719658,0,6,adaptive thermogenesis,BP,
19606,GO:1990851,1,0.90546296669463,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
19607,GO:1990859,1,0.970866330437704,0,1,cellular response to endothelin,BP,
19608,GO:1990868,1,0.853060095419881,0,5,response to chemokine,BP,
19609,GO:1990869,1,0.853060095419881,0,5,cellular response to chemokine,BP,
19611,GO:1990876,1,0.966852119391301,0,1,cytoplasmic side of nuclear pore,CC,
19612,GO:1990879,1,0.939484005877423,0,2,CST complex,CC,
19613,GO:1990882,1,0.967515302198389,0,1,rRNA acetylation,BP,
19614,GO:1990883,1,0.967515302198389,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19615,GO:1990884,1,0.967515302198389,0,1,RNA acetylation,BP,
19616,GO:1990889,1,0.972157577923836,0,1,H4K20me3 modified histone binding,MF,
19618,GO:1990907,1,0.698007658319368,0,11,beta-catenin-TCF complex,CC,
19619,GO:1990909,1,0.771590565241651,0,8,Wnt signalosome,CC,
19620,GO:1990910,1,0.915486675574744,0,3,response to hypobaric hypoxia,BP,
19621,GO:1990911,1,0.943779352173216,0,2,response to psychosocial stress,BP,
19624,GO:1990918,1,0.937354777354767,0,2,double-strand break repair involved in meiotic recombination,BP,
19625,GO:1990923,1,0.937805422993358,0,2,PET complex,CC,
19626,GO:1990926,1,0.967095524225961,0,1,short-term synaptic potentiation,BP,
19628,GO:1990928,1,0.935511038854426,0,2,response to amino acid starvation,BP,
19629,GO:1990930,1,0.972910486275814,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
19630,GO:1990931,1,0.967232351662302,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
19631,GO:1990936,1,0.942318709292352,0,2,vascular smooth muscle cell dedifferentiation,BP,
19632,GO:1990938,1,0.967466877993906,0,1,peptidyl-aspartic acid autophosphorylation,BP,
19633,GO:1990939,1,0.334753130156997,0,34,ATP-dependent microtubule motor activity,MF,
19634,GO:1990948,1,0.876289927755129,0,5,ubiquitin ligase inhibitor activity,MF,
19635,GO:1990955,1,0.96738534365555,0,1,G-rich single-stranded DNA binding,MF,
19637,GO:1990967,1,0.942555900516904,0,2,multi-organism toxin transport,BP,
19638,GO:1990968,1,0.966856649013832,0,1,modulation by host of RNA binding by virus,BP,
19639,GO:1990969,1,0.966856649013832,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
19640,GO:1990983,1,0.970065788551571,0,1,tRNA demethylation,BP,
19641,GO:1990984,1,0.970065788551571,0,1,tRNA demethylase activity,MF,
19642,GO:2000001,1,0.611409394929443,0,16,regulation of DNA damage checkpoint,BP,
19643,GO:2000002,1,0.858710093006349,0,5,negative regulation of DNA damage checkpoint,BP,
19644,GO:2000003,1,0.969271124374127,0,1,positive regulation of DNA damage checkpoint,BP,
19645,GO:2000004,1,0.972376033972612,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19646,GO:2000005,1,0.972376033972612,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19647,GO:2000006,1,0.972376033972612,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19648,GO:2000007,1,0.972376033972612,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
19652,GO:2000011,1,0.971173025433657,0,1,regulation of adaxial/abaxial pattern formation,BP,
19653,GO:2000015,1,0.914190378638464,0,3,regulation of determination of dorsal identity,BP,
19654,GO:2000016,1,0.974311311496727,0,1,negative regulation of determination of dorsal identity,BP,
19655,GO:2000017,1,0.938298190120698,0,2,positive regulation of determination of dorsal identity,BP,
19657,GO:2000019,1,0.96756951466631,0,1,negative regulation of male gonad development,BP,
19661,GO:2000035,1,0.914519883156557,0,3,regulation of stem cell division,BP,
19662,GO:2000036,1,0.555000054841182,0,18,regulation of stem cell population maintenance,BP,
19663,GO:2000040,1,0.967130024404925,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19664,GO:2000041,1,0.967130024404925,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19665,GO:2000042,1,0.746860057702511,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
19669,GO:2000049,1,0.911131581391245,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
19670,GO:2000050,1,0.59649681380474,0,16,regulation of non-canonical Wnt signaling pathway,BP,
19671,GO:2000051,1,0.874313214881559,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
19672,GO:2000052,1,0.727361536153885,0,10,positive regulation of non-canonical Wnt signaling pathway,BP,
19673,GO:2000053,1,0.934986582578025,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19674,GO:2000054,1,0.967130024404925,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19675,GO:2000055,1,0.966767079523439,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19679,GO:2000064,1,0.850606519756684,0,5,regulation of cortisol biosynthetic process,BP,
19680,GO:2000065,1,0.909095843726365,0,3,negative regulation of cortisol biosynthetic process,BP,
19681,GO:2000066,1,0.96756951466631,0,1,positive regulation of cortisol biosynthetic process,BP,
19682,GO:2000067,1,0.974543632249742,0,1,regulation of root morphogenesis,BP,
19683,GO:2000074,1,0.806817220049584,0,7,regulation of type B pancreatic cell development,BP,
19684,GO:2000077,1,0.939020651109834,0,2,negative regulation of type B pancreatic cell development,BP,
19685,GO:2000078,1,0.943522877541867,0,2,positive regulation of type B pancreatic cell development,BP,
19686,GO:2000079,1,0.967130024404925,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19687,GO:2000080,1,0.967130024404925,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19688,GO:2000095,1,0.749239018781433,0,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19689,GO:2000096,1,0.825567533779261,0,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
19690,GO:2000097,1,0.939855307781194,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
19691,GO:2000098,1,0.968683041538734,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
19692,GO:2000104,1,0.550064466799453,0,19,negative regulation of DNA-dependent DNA replication,BP,
19693,GO:2000105,1,0.684681792791802,0,12,positive regulation of DNA-dependent DNA replication,BP,
19698,GO:2000110,1,0.915147372025812,0,3,negative regulation of macrophage apoptotic process,BP,
19702,GO:2000114,1,0.556757354178754,0,18,regulation of establishment of cell polarity,BP,
19705,GO:2000118,1,0.967347214846736,0,1,regulation of sodium-dependent phosphate transport,BP,
19706,GO:2000121,1,0.807932263055108,0,7,regulation of removal of superoxide radicals,BP,
19709,GO:2000136,1,0.712453787206585,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19710,GO:2000137,1,0.940014938146272,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
19711,GO:2000138,1,0.856203288306393,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19713,GO:2000143,1,0.880474369817337,0,4,negative regulation of DNA-templated transcription, initiation,BP,
19718,GO:2000152,1,0.893312073063731,0,4,regulation of ubiquitin-specific protease activity,BP,
19719,GO:2000156,1,0.937899284654876,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
19720,GO:2000157,1,0.948499635743767,0,2,negative regulation of ubiquitin-specific protease activity,BP,
19721,GO:2000158,1,0.941824139959624,0,2,positive regulation of ubiquitin-specific protease activity,BP,
19722,GO:2000167,1,0.966889920942967,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
19723,GO:2000169,1,0.848472132493444,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19724,GO:2000171,1,0.581119307136421,0,17,negative regulation of dendrite development,BP,
19725,GO:2000172,1,0.9389425364647,0,2,regulation of branching morphogenesis of a nerve,BP,
19726,GO:2000173,1,0.967513796706459,0,1,negative regulation of branching morphogenesis of a nerve,BP,
19727,GO:2000174,1,0.967495917243086,0,1,regulation of pro-T cell differentiation,BP,
19728,GO:2000176,1,0.967495917243086,0,1,positive regulation of pro-T cell differentiation,BP,
19730,GO:2000178,1,0.665477575277863,0,13,negative regulation of neural precursor cell proliferation,BP,
19733,GO:2000182,1,0.936811438306951,0,2,regulation of progesterone biosynthetic process,BP,
19735,GO:2000192,1,0.847158347127401,0,5,negative regulation of fatty acid transport,BP,
19737,GO:2000194,1,0.812446628473187,0,7,regulation of female gonad development,BP,
19738,GO:2000195,1,0.941821048497055,0,2,negative regulation of female gonad development,BP,
19739,GO:2000196,1,0.941623547161403,0,2,positive regulation of female gonad development,BP,
19740,GO:2000197,1,0.825534333351204,0,6,regulation of ribonucleoprotein complex localization,BP,
19741,GO:2000199,1,0.968810801665616,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19742,GO:2000200,1,0.968810801665616,0,1,regulation of ribosomal subunit export from nucleus,BP,
19743,GO:2000202,1,0.968810801665616,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19744,GO:2000206,1,0.968810801665616,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19745,GO:2000208,1,0.968810801665616,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
19746,GO:2000209,1,0.548859719867496,0,19,regulation of anoikis,BP,
19747,GO:2000210,1,0.838808505718799,0,6,positive regulation of anoikis,BP,
19748,GO:2000211,1,0.966932325583997,0,1,regulation of glutamate metabolic process,BP,
19749,GO:2000212,1,0.966932325583997,0,1,negative regulation of glutamate metabolic process,BP,
19750,GO:2000224,1,0.96756951466631,0,1,regulation of testosterone biosynthetic process,BP,
19751,GO:2000225,1,0.96756951466631,0,1,negative regulation of testosterone biosynthetic process,BP,
19752,GO:2000226,1,0.973198875078459,0,1,regulation of pancreatic A cell differentiation,BP,
19753,GO:2000227,1,0.973198875078459,0,1,negative regulation of pancreatic A cell differentiation,BP,
19754,GO:2000229,1,0.972172812265828,0,1,regulation of pancreatic stellate cell proliferation,BP,
19755,GO:2000230,1,0.972172812265828,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
19756,GO:2000232,1,0.707853007938389,0,11,regulation of rRNA processing,BP,
19757,GO:2000233,1,0.937247437767205,0,2,negative regulation of rRNA processing,BP,
19758,GO:2000234,1,0.781155639500409,0,8,positive regulation of rRNA processing,BP,
19764,GO:2000252,1,0.942229165808064,0,2,negative regulation of feeding behavior,BP,
19765,GO:2000253,1,0.937087225896642,0,2,positive regulation of feeding behavior,BP,
19766,GO:2000254,1,0.949129434784061,0,2,regulation of male germ cell proliferation,BP,
19767,GO:2000255,1,0.97428565064263,0,1,negative regulation of male germ cell proliferation,BP,
19768,GO:2000256,1,0.974181664334021,0,1,positive regulation of male germ cell proliferation,BP,
19770,GO:2000258,1,0.911016211330778,0,3,negative regulation of protein activation cascade,BP,
19771,GO:2000259,1,0.972254001419291,0,1,positive regulation of protein activation cascade,BP,
19772,GO:2000269,1,0.64063704069411,0,14,regulation of fibroblast apoptotic process,BP,
19773,GO:2000270,1,0.827195809853519,0,6,negative regulation of fibroblast apoptotic process,BP,
19774,GO:2000271,1,0.794522989403257,0,7,positive regulation of fibroblast apoptotic process,BP,
19775,GO:2000272,1,0.505704384759347,0,22,negative regulation of signaling receptor activity,BP,
19777,GO:2000275,1,0.946201282002411,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
19778,GO:2000276,1,0.97119662536758,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
19779,GO:2000277,1,0.974265395836361,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19782,GO:2000280,1,0.974543632249742,0,1,regulation of root development,BP,
19783,GO:2000282,1,0.941914796816584,0,2,regulation of cellular amino acid biosynthetic process,BP,
19784,GO:2000283,1,0.966797215838241,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
19785,GO:2000284,1,0.974265395836361,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
19786,GO:2000286,1,0.910529940226318,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
19787,GO:2000288,1,0.833899113660003,0,6,positive regulation of myoblast proliferation,BP,
19788,GO:2000291,1,0.784672186834519,0,8,regulation of myoblast proliferation,BP,
19789,GO:2000295,1,0.968670178669023,0,1,regulation of hydrogen peroxide catabolic process,BP,
19790,GO:2000297,1,0.96689702673269,0,1,negative regulation of synapse maturation,BP,
19794,GO:2000301,1,0.911214041255256,0,3,negative regulation of synaptic vesicle exocytosis,BP,
19795,GO:2000302,1,0.935034243576993,0,2,positive regulation of synaptic vesicle exocytosis,BP,
19797,GO:2000304,1,0.80612266402373,0,7,positive regulation of ceramide biosynthetic process,BP,
19800,GO:2000310,1,0.749395501709266,0,9,regulation of NMDA receptor activity,BP,
19801,GO:2000311,1,0.748267653571832,0,9,regulation of AMPA receptor activity,BP,
19803,GO:2000313,1,0.945537623685072,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19804,GO:2000314,1,0.972689400917587,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19806,GO:2000317,1,0.908447407614447,0,3,negative regulation of T-helper 17 type immune response,BP,
19809,GO:2000320,1,0.908447407614447,0,3,negative regulation of T-helper 17 cell differentiation,BP,
19811,GO:2000322,1,0.802132519746792,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19812,GO:2000323,1,0.825614817074837,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19813,GO:2000324,1,0.971572528226367,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
19814,GO:2000325,1,0.96686371666909,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19815,GO:2000327,1,0.96686371666909,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19817,GO:2000329,1,0.968747232938517,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
19819,GO:2000331,1,0.9684314823452,0,1,regulation of terminal button organization,BP,
19820,GO:2000338,1,0.941927962105828,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19821,GO:2000340,1,0.941927962105828,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19822,GO:2000341,1,0.789442429645991,0,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19823,GO:2000342,1,0.940780630706092,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19824,GO:2000343,1,0.839160148187316,0,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
19825,GO:2000344,1,0.89022394447443,0,4,positive regulation of acrosome reaction,BP,
19827,GO:2000346,1,0.936913892093264,0,2,negative regulation of hepatocyte proliferation,BP,
19829,GO:2000348,1,0.880087488367554,0,4,regulation of CD40 signaling pathway,BP,
19830,GO:2000349,1,0.967148046407872,0,1,negative regulation of CD40 signaling pathway,BP,
19831,GO:2000351,1,0.49525908190295,0,22,regulation of endothelial cell apoptotic process,BP,
19832,GO:2000352,1,0.64230251021645,0,14,negative regulation of endothelial cell apoptotic process,BP,
19833,GO:2000353,1,0.771311104814933,0,8,positive regulation of endothelial cell apoptotic process,BP,
19834,GO:2000354,1,0.890080238241376,0,4,regulation of ovarian follicle development,BP,
19835,GO:2000355,1,0.971938559881094,0,1,negative regulation of ovarian follicle development,BP,
19836,GO:2000359,1,0.973337072735663,0,1,regulation of binding of sperm to zona pellucida,BP,
19837,GO:2000360,1,0.973337072735663,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19838,GO:2000361,1,0.967115907475312,0,1,regulation of prostaglandin-E synthase activity,BP,
19839,GO:2000363,1,0.967115907475312,0,1,positive regulation of prostaglandin-E synthase activity,BP,
19840,GO:2000367,1,0.946021832097299,0,2,regulation of acrosomal vesicle exocytosis,BP,
19841,GO:2000368,1,0.946021832097299,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
19843,GO:2000370,1,0.875792519388693,0,4,positive regulation of clathrin-dependent endocytosis,BP,
19844,GO:2000371,1,0.825188438857454,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19845,GO:2000373,1,0.825188438857454,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19846,GO:2000374,1,0.971643848359948,0,1,regulation of oxygen metabolic process,BP,
19850,GO:2000380,1,0.79983172636463,0,7,regulation of mesoderm development,BP,
19851,GO:2000381,1,0.884080926556399,0,4,negative regulation of mesoderm development,BP,
19852,GO:2000382,1,0.966758957890763,0,1,positive regulation of mesoderm development,BP,
19853,GO:2000383,1,0.967630646658427,0,1,regulation of ectoderm development,BP,
19854,GO:2000384,1,0.967630646658427,0,1,negative regulation of ectoderm development,BP,
19855,GO:2000386,1,0.941623547161403,0,2,positive regulation of ovarian follicle development,BP,
19856,GO:2000387,1,0.973337072735663,0,1,regulation of antral ovarian follicle growth,BP,
19857,GO:2000388,1,0.973337072735663,0,1,positive regulation of antral ovarian follicle growth,BP,
19861,GO:2000393,1,0.937198711623357,0,2,negative regulation of lamellipodium morphogenesis,BP,
19863,GO:2000395,1,0.947822418731131,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19864,GO:2000397,1,0.947822418731131,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
19866,GO:2000402,1,0.90638121310988,0,3,negative regulation of lymphocyte migration,BP,
19869,GO:2000405,1,0.96688420249101,0,1,negative regulation of T cell migration,BP,
19871,GO:2000407,1,0.944954394752515,0,2,regulation of T cell extravasation,BP,
19872,GO:2000409,1,0.972193538000053,0,1,positive regulation of T cell extravasation,BP,
19878,GO:2000417,1,0.968229905693104,0,1,negative regulation of eosinophil migration,BP,
19880,GO:2000419,1,0.968229905693104,0,1,regulation of eosinophil extravasation,BP,
19881,GO:2000420,1,0.968229905693104,0,1,negative regulation of eosinophil extravasation,BP,
19882,GO:2000422,1,0.969933379813278,0,1,regulation of eosinophil chemotaxis,BP,
19883,GO:2000424,1,0.969933379813278,0,1,positive regulation of eosinophil chemotaxis,BP,
19884,GO:2000425,1,0.936107713537485,0,2,regulation of apoptotic cell clearance,BP,
19885,GO:2000426,1,0.968210245910427,0,1,negative regulation of apoptotic cell clearance,BP,
19886,GO:2000427,1,0.96684630815699,0,1,positive regulation of apoptotic cell clearance,BP,
19887,GO:2000434,1,0.949561138523545,0,2,regulation of protein neddylation,BP,
19888,GO:2000435,1,0.949561138523545,0,2,negative regulation of protein neddylation,BP,
19889,GO:2000449,1,0.944954394752515,0,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19890,GO:2000451,1,0.972193538000053,0,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
19891,GO:2000452,1,0.944954394752515,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19892,GO:2000454,1,0.972193538000053,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
19893,GO:2000458,1,0.972381403541729,0,1,regulation of astrocyte chemotaxis,BP,
19895,GO:2000465,1,0.823993344847549,0,6,regulation of glycogen (starch) synthase activity,BP,
19896,GO:2000466,1,0.909502554497825,0,3,negative regulation of glycogen (starch) synthase activity,BP,
19897,GO:2000467,1,0.907941441480471,0,3,positive regulation of glycogen (starch) synthase activity,BP,
19898,GO:2000468,1,0.968670178669023,0,1,regulation of peroxidase activity,BP,
19899,GO:2000470,1,0.968670178669023,0,1,positive regulation of peroxidase activity,BP,
19900,GO:2000474,1,0.967423267941518,0,1,regulation of opioid receptor signaling pathway,BP,
19901,GO:2000479,1,0.692009895258805,0,12,regulation of cAMP-dependent protein kinase activity,BP,
19902,GO:2000480,1,0.810808624032736,0,7,negative regulation of cAMP-dependent protein kinase activity,BP,
19903,GO:2000481,1,0.878845586322615,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
19907,GO:2000489,1,0.911109330251554,0,3,regulation of hepatic stellate cell activation,BP,
19908,GO:2000490,1,0.940589179421466,0,2,negative regulation of hepatic stellate cell activation,BP,
19909,GO:2000491,1,0.968663277019924,0,1,positive regulation of hepatic stellate cell activation,BP,
19910,GO:2000492,1,0.969054250352015,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
19911,GO:2000494,1,0.969054250352015,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
19912,GO:2000501,1,0.946288732390855,0,2,regulation of natural killer cell chemotaxis,BP,
19913,GO:2000503,1,0.946288732390855,0,2,positive regulation of natural killer cell chemotaxis,BP,
19914,GO:2000504,1,0.970725361079207,0,1,positive regulation of blood vessel remodeling,BP,
19920,GO:2000520,1,0.944905385773306,0,2,regulation of immunological synapse formation,BP,
19921,GO:2000521,1,0.944905385773306,0,2,negative regulation of immunological synapse formation,BP,
19922,GO:2000532,1,0.97028832086229,0,1,regulation of renal albumin absorption,BP,
19923,GO:2000533,1,0.97028832086229,0,1,negative regulation of renal albumin absorption,BP,
19926,GO:2000537,1,0.967196618203223,0,1,regulation of B cell chemotaxis,BP,
19927,GO:2000538,1,0.967196618203223,0,1,positive regulation of B cell chemotaxis,BP,
19928,GO:2000542,1,0.87944269726097,0,4,negative regulation of gastrulation,BP,
19929,GO:2000543,1,0.939484005877423,0,2,positive regulation of gastrulation,BP,
19930,GO:2000544,1,0.904588072325358,0,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19931,GO:2000546,1,0.934821715755845,0,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
19934,GO:2000553,1,0.911122025537287,0,3,positive regulation of T-helper 2 cell cytokine production,BP,
19935,GO:2000561,1,0.881583699722745,0,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19936,GO:2000562,1,0.940469597096471,0,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19937,GO:2000563,1,0.937396893964663,0,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
19938,GO:2000564,1,0.941523229097809,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
19939,GO:2000566,1,0.972648651805797,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
19940,GO:2000567,1,0.971173025433657,0,1,regulation of memory T cell activation,BP,
19941,GO:2000568,1,0.971173025433657,0,1,positive regulation of memory T cell activation,BP,
19942,GO:2000569,1,0.968471423097752,0,1,regulation of T-helper 2 cell activation,BP,
19943,GO:2000570,1,0.968471423097752,0,1,positive regulation of T-helper 2 cell activation,BP,
19945,GO:2000574,1,0.788144871799519,0,8,regulation of microtubule motor activity,BP,
19946,GO:2000576,1,0.867631427723383,0,5,positive regulation of microtubule motor activity,BP,
19947,GO:2000580,1,0.895146505849985,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19948,GO:2000582,1,0.895146505849985,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19949,GO:2000583,1,0.967632893952598,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19950,GO:2000584,1,0.967632893952598,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19951,GO:2000586,1,0.800318647779802,0,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19952,GO:2000587,1,0.855947632731869,0,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19953,GO:2000588,1,0.935035628918684,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
19954,GO:2000589,1,0.939802557413203,0,2,regulation of metanephric mesenchymal cell migration,BP,
19955,GO:2000591,1,0.939802557413203,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
19956,GO:2000592,1,0.967604024860509,0,1,regulation of metanephric DCT cell differentiation,BP,
19957,GO:2000594,1,0.967604024860509,0,1,positive regulation of metanephric DCT cell differentiation,BP,
19958,GO:2000601,1,0.82157702613704,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
19959,GO:2000606,1,0.968876803468708,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19960,GO:2000607,1,0.968876803468708,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
19961,GO:2000609,1,0.911327801951481,0,3,regulation of thyroid hormone generation,BP,
19962,GO:2000611,1,0.937486423537796,0,2,positive regulation of thyroid hormone generation,BP,
19963,GO:2000612,1,0.967604024860509,0,1,regulation of thyroid-stimulating hormone secretion,BP,
19964,GO:2000615,1,0.733143210866658,0,10,regulation of histone H3-K9 acetylation,BP,
19965,GO:2000616,1,0.939937527919446,0,2,negative regulation of histone H3-K9 acetylation,BP,
19966,GO:2000617,1,0.829846215178213,0,6,positive regulation of histone H3-K9 acetylation,BP,
19967,GO:2000618,1,0.852964992305657,0,5,regulation of histone H4-K16 acetylation,BP,
19968,GO:2000619,1,0.91246778693556,0,3,negative regulation of histone H4-K16 acetylation,BP,
19969,GO:2000620,1,0.934804957746463,0,2,positive regulation of histone H4-K16 acetylation,BP,
19970,GO:2000622,1,0.87750397996537,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19971,GO:2000623,1,0.87750397996537,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
19972,GO:2000625,1,0.937774486568535,0,2,regulation of miRNA catabolic process,BP,
19973,GO:2000627,1,0.937774486568535,0,2,positive regulation of miRNA catabolic process,BP,
19976,GO:2000631,1,0.968523206216462,0,1,regulation of pre-miRNA processing,BP,
19977,GO:2000632,1,0.968523206216462,0,1,negative regulation of pre-miRNA processing,BP,
19979,GO:2000638,1,0.938449320159249,0,2,regulation of SREBP signaling pathway,BP,
19980,GO:2000639,1,0.938449320159249,0,2,negative regulation of SREBP signaling pathway,BP,
19981,GO:2000641,1,0.587566121067224,0,17,regulation of early endosome to late endosome transport,BP,
19982,GO:2000642,1,0.948736571985142,0,2,negative regulation of early endosome to late endosome transport,BP,
19983,GO:2000643,1,0.76989252437067,0,8,positive regulation of early endosome to late endosome transport,BP,
19984,GO:2000644,1,0.752129880884347,0,9,regulation of receptor catabolic process,BP,
19985,GO:2000645,1,0.9099038792955,0,3,negative regulation of receptor catabolic process,BP,
19986,GO:2000646,1,0.853216877340413,0,5,positive regulation of receptor catabolic process,BP,
19987,GO:2000647,1,0.732986780489338,0,10,negative regulation of stem cell proliferation,BP,
19991,GO:2000651,1,0.725695720028781,0,10,positive regulation of sodium ion transmembrane transporter activity,BP,
19993,GO:2000654,1,0.967634582342254,0,1,regulation of cellular response to testosterone stimulus,BP,
19994,GO:2000655,1,0.967634582342254,0,1,negative regulation of cellular response to testosterone stimulus,BP,
19995,GO:2000656,1,0.972113093622266,0,1,regulation of apolipoprotein binding,BP,
19996,GO:2000657,1,0.972113093622266,0,1,negative regulation of apolipoprotein binding,BP,
19997,GO:2000659,1,0.835029743039164,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
19998,GO:2000660,1,0.888584622383954,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
19999,GO:2000661,1,0.966960234546914,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
20000,GO:2000662,1,0.881998760869847,0,4,regulation of interleukin-5 secretion,BP,
20001,GO:2000663,1,0.967895637027138,0,1,negative regulation of interleukin-5 secretion,BP,
20002,GO:2000664,1,0.911261554611478,0,3,positive regulation of interleukin-5 secretion,BP,
20003,GO:2000665,1,0.85713943672927,0,5,regulation of interleukin-13 secretion,BP,
20004,GO:2000666,1,0.940622145458304,0,2,negative regulation of interleukin-13 secretion,BP,
20005,GO:2000667,1,0.911261554611478,0,3,positive regulation of interleukin-13 secretion,BP,
20009,GO:2000671,1,0.908260740687517,0,3,regulation of motor neuron apoptotic process,BP,
20010,GO:2000672,1,0.908260740687517,0,3,negative regulation of motor neuron apoptotic process,BP,
20011,GO:2000674,1,0.777362376346983,0,8,regulation of type B pancreatic cell apoptotic process,BP,
20012,GO:2000675,1,0.877838855889781,0,4,negative regulation of type B pancreatic cell apoptotic process,BP,
20013,GO:2000676,1,0.885579492670395,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
20017,GO:2000683,1,0.939251067843157,0,2,regulation of cellular response to X-ray,BP,
20018,GO:2000685,1,0.969425204500395,0,1,positive regulation of cellular response to X-ray,BP,
20019,GO:2000690,1,0.967259642753024,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20020,GO:2000691,1,0.967259642753024,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
20021,GO:2000696,1,0.703120261166132,0,11,regulation of epithelial cell differentiation involved in kidney development,BP,
20022,GO:2000697,1,0.937205045477404,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
20023,GO:2000698,1,0.886294871854252,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
20024,GO:2000699,1,0.968876803468708,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20025,GO:2000701,1,0.968876803468708,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20026,GO:2000702,1,0.968876803468708,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20027,GO:2000703,1,0.968876803468708,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20028,GO:2000705,1,0.93572185955876,0,2,regulation of dense core granule biogenesis,BP,
20029,GO:2000706,1,0.967859114801888,0,1,negative regulation of dense core granule biogenesis,BP,
20030,GO:2000707,1,0.966798439213394,0,1,positive regulation of dense core granule biogenesis,BP,
20031,GO:2000718,1,0.974353186685951,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20032,GO:2000719,1,0.974353186685951,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20033,GO:2000721,1,0.967069228521755,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20034,GO:2000722,1,0.969271124374127,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20035,GO:2000724,1,0.969271124374127,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20039,GO:2000733,1,0.968876803468708,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20040,GO:2000734,1,0.968876803468708,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20042,GO:2000737,1,0.598337453599177,0,16,negative regulation of stem cell differentiation,BP,
20043,GO:2000738,1,0.72746444822405,0,10,positive regulation of stem cell differentiation,BP,
20044,GO:2000739,1,0.875527643708433,0,4,regulation of mesenchymal stem cell differentiation,BP,
20045,GO:2000740,1,0.967859114801888,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20046,GO:2000741,1,0.90461046645007,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
20047,GO:2000742,1,0.971519963423587,0,1,regulation of anterior head development,BP,
20048,GO:2000744,1,0.971519963423587,0,1,positive regulation of anterior head development,BP,
20049,GO:2000752,1,0.969520377708811,0,1,regulation of glucosylceramide catabolic process,BP,
20050,GO:2000753,1,0.969520377708811,0,1,positive regulation of glucosylceramide catabolic process,BP,
20051,GO:2000754,1,0.969520377708811,0,1,regulation of sphingomyelin catabolic process,BP,
20052,GO:2000755,1,0.969520377708811,0,1,positive regulation of sphingomyelin catabolic process,BP,
20056,GO:2000759,1,0.966970495411747,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
20057,GO:2000761,1,0.966970495411747,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
20058,GO:2000765,1,0.487516563822861,0,23,regulation of cytoplasmic translation,BP,
20059,GO:2000766,1,0.823574558636798,0,6,negative regulation of cytoplasmic translation,BP,
20060,GO:2000767,1,0.779164655685282,0,8,positive regulation of cytoplasmic translation,BP,
20061,GO:2000768,1,0.97125559745736,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
20065,GO:2000775,1,0.971505339509089,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
20066,GO:2000777,1,0.943435355312185,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
20069,GO:2000780,1,0.548182207862229,0,19,negative regulation of double-strand break repair,BP,
20070,GO:2000781,1,0.640131319662296,0,14,positive regulation of double-strand break repair,BP,
20072,GO:2000786,1,0.6996600745774,0,11,positive regulation of autophagosome assembly,BP,
20073,GO:2000790,1,0.935517797712805,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20074,GO:2000791,1,0.935517797712805,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
20075,GO:2000793,1,0.934622618464406,0,2,cell proliferation involved in heart valve development,BP,
20076,GO:2000794,1,0.824529341681704,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20077,GO:2000795,1,0.966813595891231,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20078,GO:2000797,1,0.967859114801888,0,1,regulation of amniotic stem cell differentiation,BP,
20079,GO:2000798,1,0.967859114801888,0,1,negative regulation of amniotic stem cell differentiation,BP,
20082,GO:2000807,1,0.904010537408934,0,3,regulation of synaptic vesicle clustering,BP,
20083,GO:2000808,1,0.966881371772236,0,1,negative regulation of synaptic vesicle clustering,BP,
20084,GO:2000809,1,0.934981434457028,0,2,positive regulation of synaptic vesicle clustering,BP,
20086,GO:2000811,1,0.659642129197281,0,13,negative regulation of anoikis,BP,
20087,GO:2000812,1,0.967593119960487,0,1,regulation of barbed-end actin filament capping,BP,
20089,GO:2000819,1,0.93850118800438,0,2,regulation of nucleotide-excision repair,BP,
20090,GO:2000820,1,0.966869357670083,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
20091,GO:2000821,1,0.942880956746651,0,2,regulation of grooming behavior,BP,
20092,GO:2000822,1,0.912089091632958,0,3,regulation of behavioral fear response,BP,
20093,GO:2000823,1,0.893446300812224,0,4,regulation of androgen receptor activity,BP,
20094,GO:2000825,1,0.893446300812224,0,4,positive regulation of androgen receptor activity,BP,
20095,GO:2000826,1,0.469194948259625,0,24,regulation of heart morphogenesis,BP,
20096,GO:2000827,1,0.970354031289477,0,1,mitochondrial RNA surveillance,BP,
20097,GO:2000828,1,0.939875904169019,0,2,regulation of parathyroid hormone secretion,BP,
20098,GO:2000830,1,0.966878069763278,0,1,positive regulation of parathyroid hormone secretion,BP,
20100,GO:2000832,1,0.93638852665679,0,2,negative regulation of steroid hormone secretion,BP,
20102,GO:2000834,1,0.968464112479007,0,1,regulation of androgen secretion,BP,
20103,GO:2000836,1,0.968464112479007,0,1,positive regulation of androgen secretion,BP,
20104,GO:2000843,1,0.96684551725298,0,1,regulation of testosterone secretion,BP,
20105,GO:2000845,1,0.96684551725298,0,1,positive regulation of testosterone secretion,BP,
20107,GO:2000847,1,0.93638852665679,0,2,negative regulation of corticosteroid hormone secretion,BP,
20109,GO:2000849,1,0.912547229501377,0,3,regulation of glucocorticoid secretion,BP,
20110,GO:2000850,1,0.93638852665679,0,2,negative regulation of glucocorticoid secretion,BP,
20111,GO:2000851,1,0.974543632249742,0,1,positive regulation of glucocorticoid secretion,BP,
20116,GO:2000864,1,0.966857965499383,0,1,regulation of estradiol secretion,BP,
20117,GO:2000878,1,0.943372480327217,0,2,positive regulation of oligopeptide transport,BP,
20118,GO:2000880,1,0.943372480327217,0,2,positive regulation of dipeptide transport,BP,
20119,GO:2000909,1,0.969271124374127,0,1,regulation of sterol import,BP,
20120,GO:2000969,1,0.939438486836217,0,2,positive regulation of AMPA receptor activity,BP,
20121,GO:2000973,1,0.830244779321932,0,6,regulation of pro-B cell differentiation,BP,
20122,GO:2000974,1,0.915962952445756,0,3,negative regulation of pro-B cell differentiation,BP,
20123,GO:2000977,1,0.947436230128819,0,2,regulation of forebrain neuron differentiation,BP,
20124,GO:2000978,1,0.947436230128819,0,2,negative regulation of forebrain neuron differentiation,BP,
20125,GO:2000980,1,0.859743771575511,0,5,regulation of inner ear receptor cell differentiation,BP,
20126,GO:2000981,1,0.887009391728787,0,4,negative regulation of inner ear receptor cell differentiation,BP,
20127,GO:2000983,1,0.949080331618949,0,2,regulation of ATP citrate synthase activity,BP,
20128,GO:2000984,1,0.949080331618949,0,2,negative regulation of ATP citrate synthase activity,BP,
20129,GO:2000987,1,0.968755358580569,0,1,positive regulation of behavioral fear response,BP,
20130,GO:2001012,1,0.882718888824193,0,4,mesenchymal cell differentiation involved in renal system development,BP,
20131,GO:2001013,1,0.934930217982184,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
20132,GO:2001014,1,0.702935414702402,0,11,regulation of skeletal muscle cell differentiation,BP,
20133,GO:2001015,1,0.936426406774384,0,2,negative regulation of skeletal muscle cell differentiation,BP,
20134,GO:2001016,1,0.88289444254991,0,4,positive regulation of skeletal muscle cell differentiation,BP,
20139,GO:2001024,1,0.576084060906366,0,18,negative regulation of response to drug,BP,
20140,GO:2001025,1,0.698579692288341,0,12,positive regulation of response to drug,BP,
20141,GO:2001026,1,0.68372272391904,0,12,regulation of endothelial cell chemotaxis,BP,
20142,GO:2001027,1,0.934756329086002,0,2,negative regulation of endothelial cell chemotaxis,BP,
20143,GO:2001028,1,0.755949731235334,0,9,positive regulation of endothelial cell chemotaxis,BP,
20144,GO:2001029,1,0.966882266381886,0,1,regulation of cellular glucuronidation,BP,
20145,GO:2001031,1,0.966882266381886,0,1,positive regulation of cellular glucuronidation,BP,
20146,GO:2001032,1,0.688001472317995,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
20147,GO:2001033,1,0.86116107474056,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
20148,GO:2001034,1,0.852195126409204,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
20149,GO:2001035,1,0.940983167055524,0,2,regulation of tongue muscle cell differentiation,BP,
20150,GO:2001037,1,0.940983167055524,0,2,positive regulation of tongue muscle cell differentiation,BP,
20152,GO:2001039,1,0.676311339263203,0,13,negative regulation of cellular response to drug,BP,
20153,GO:2001040,1,0.83021973594957,0,6,positive regulation of cellular response to drug,BP,
20154,GO:2001044,1,0.757721182183241,0,9,regulation of integrin-mediated signaling pathway,BP,
20155,GO:2001045,1,0.935646715328892,0,2,negative regulation of integrin-mediated signaling pathway,BP,
20156,GO:2001046,1,0.855021359247215,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20157,GO:2001053,1,0.8279842100485,0,6,regulation of mesenchymal cell apoptotic process,BP,
20158,GO:2001054,1,0.852571867244805,0,5,negative regulation of mesenchymal cell apoptotic process,BP,
20159,GO:2001055,1,0.971173025433657,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
20162,GO:2001069,1,0.940522219524027,0,2,glycogen binding,MF,
20163,GO:2001070,1,0.938315479496472,0,2,starch binding,MF,
20164,GO:2001074,1,0.94223718848204,0,2,regulation of metanephric ureteric bud development,BP,
20165,GO:2001076,1,0.94223718848204,0,2,positive regulation of metanephric ureteric bud development,BP,
20166,GO:2001106,1,0.934805555383498,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20167,GO:2001108,1,0.966859128570501,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
20171,GO:2001136,1,0.968334470809809,0,1,negative regulation of endocytic recycling,BP,
20173,GO:2001138,1,0.836915542284012,0,6,regulation of phospholipid transport,BP,
20174,GO:2001140,1,0.836915542284012,0,6,positive regulation of phospholipid transport,BP,
20176,GO:2001144,1,0.971237910811323,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20177,GO:2001145,1,0.971237910811323,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20178,GO:2001148,1,0.943372480327217,0,2,regulation of dipeptide transmembrane transport,BP,
20179,GO:2001150,1,0.943372480327217,0,2,positive regulation of dipeptide transmembrane transport,BP,
20180,GO:2001151,1,0.968570346802033,0,1,regulation of renal water transport,BP,
20181,GO:2001153,1,0.968570346802033,0,1,positive regulation of renal water transport,BP,
20184,GO:2001163,1,0.970967966856243,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20185,GO:2001165,1,0.970967966856243,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20190,GO:2001171,1,0.583769740508729,0,17,positive regulation of ATP biosynthetic process,BP,
20191,GO:2001173,1,0.971382167968529,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
20192,GO:2001176,1,0.941446686665889,0,2,regulation of mediator complex assembly,BP,
20193,GO:2001178,1,0.941446686665889,0,2,positive regulation of mediator complex assembly,BP,
20195,GO:2001180,1,0.940882729397887,0,2,negative regulation of interleukin-10 secretion,BP,
20197,GO:2001182,1,0.883372949230901,0,4,regulation of interleukin-12 secretion,BP,
20198,GO:2001183,1,0.972093555988781,0,1,negative regulation of interleukin-12 secretion,BP,
20199,GO:2001184,1,0.93879154721918,0,2,positive regulation of interleukin-12 secretion,BP,
20200,GO:2001185,1,0.885725070261487,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
20201,GO:2001186,1,0.971924347519029,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
20202,GO:2001187,1,0.972648651805797,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
20203,GO:2001188,1,0.944905385773306,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20204,GO:2001189,1,0.944905385773306,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20205,GO:2001197,1,0.844884148792217,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20206,GO:2001198,1,0.91694759041724,0,3,regulation of dendritic cell differentiation,BP,
20207,GO:2001199,1,0.972893433612807,0,1,negative regulation of dendritic cell differentiation,BP,
20208,GO:2001200,1,0.942499617990061,0,2,positive regulation of dendritic cell differentiation,BP,
20209,GO:2001201,1,0.934816501074948,0,2,regulation of transforming growth factor-beta secretion,BP,
20210,GO:2001202,1,0.966807821141104,0,1,negative regulation of transforming growth factor-beta secretion,BP,
20211,GO:2001203,1,0.966913364007773,0,1,positive regulation of transforming growth factor-beta secretion,BP,
20214,GO:2001206,1,0.912861926278916,0,3,positive regulation of osteoclast development,BP,
20215,GO:2001212,1,0.800432529919806,0,7,regulation of vasculogenesis,BP,
20216,GO:2001213,1,0.966875058564527,0,1,negative regulation of vasculogenesis,BP,
20217,GO:2001214,1,0.856212938985492,0,5,positive regulation of vasculogenesis,BP,
20220,GO:2001224,1,0.629552871485743,0,14,positive regulation of neuron migration,BP,
20221,GO:2001225,1,0.85663712276969,0,5,regulation of chloride transport,BP,
20222,GO:2001226,1,0.93892513676381,0,2,negative regulation of chloride transport,BP,
20223,GO:2001228,1,0.934539017617746,0,2,regulation of response to gamma radiation,BP,
20224,GO:2001229,1,0.966690357334518,0,1,negative regulation of response to gamma radiation,BP,
20233,GO:2001241,1,0.699082993001779,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
20237,GO:2001245,1,0.935796953030736,0,2,regulation of phosphatidylcholine biosynthetic process,BP,
20238,GO:2001246,1,0.967517816678779,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
20239,GO:2001247,1,0.967217092133575,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
20242,GO:2001253,1,0.969003188651358,0,1,regulation of histone H3-K36 trimethylation,BP,
20243,GO:2001256,1,0.778534307341801,0,8,regulation of store-operated calcium entry,BP,
20249,GO:2001269,1,0.636792404123978,0,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
20250,GO:2001270,1,0.885536435416472,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20251,GO:2001271,1,0.908776110453037,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20252,GO:2001272,1,0.974434133110297,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
20253,GO:2001273,1,0.629611722661428,0,14,regulation of glucose import in response to insulin stimulus,BP,
20254,GO:2001274,1,0.937637952307428,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
20255,GO:2001275,1,0.693581846560021,0,11,positive regulation of glucose import in response to insulin stimulus,BP,
20259,GO:2001287,1,0.941555712226406,0,2,negative regulation of caveolin-mediated endocytosis,BP,
20261,GO:2001293,1,0.907743144791097,0,3,malonyl-CoA metabolic process,BP,
20262,GO:2001294,1,0.971205473956507,0,1,malonyl-CoA catabolic process,BP,
20263,GO:2001295,1,0.934661178698928,0,2,malonyl-CoA biosynthetic process,BP,
20264,GO:2001300,1,0.970696080330584,0,1,lipoxin metabolic process,BP,
20265,GO:2001301,1,0.970696080330584,0,1,lipoxin biosynthetic process,BP,
20266,GO:2001302,1,0.970696080330584,0,1,lipoxin A4 metabolic process,BP,
20267,GO:2001303,1,0.970696080330584,0,1,lipoxin A4 biosynthetic process,BP,
20268,GO:2001304,1,0.970696080330584,0,1,lipoxin B4 metabolic process,BP,
20269,GO:2001306,1,0.970696080330584,0,1,lipoxin B4 biosynthetic process,BP,
20270,GO:2001311,1,0.97229493151541,0,1,lysobisphosphatidic acid metabolic process,BP,
13778,GO:0060413,1.00000000000004,0.723788433542586,0,10,atrial septum morphogenesis,BP,
1216,GO:0002903,1.00000000000004,0.714734158996835,0,11,negative regulation of B cell apoptotic process,BP,
